PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Deng, ZS; Yang, F; Bai, Y; He, LJ; Li, Q; Wu, YR; Luo, L; Li, H; Ma, LM; Yang, ZQ; He, YS; Cui, LW				Deng, Zeshuai; Yang, Fang; Bai, Yao; He, Lijun; Li, Qing; Wu, Yanrui; Luo, Lan; Li, Hong; Ma, Limei; Yang, Zhaoqing; He, Yongshu; Cui, Liwang			Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ALPHA-THALASSEMIA; MOLECULAR CHARACTERIZATION; G6PD DEFICIENCY; PREVALENCE; THAILAND; VARIANT; CHINA; RESISTANCE; IDENTIFICATION	Glucose-6-phosphate dehydrogenase (G6PD) deficiency and hemoglobin E (HbE, beta(26) (Glu-Lys)) are two common red cell disorders in Southeast Asia. G6PD deficiency produces hemolytic anemia, which can be triggered by certain drugs or infections. HbE is asymptomatic or is manifested as microcytic, minimally hemolytic anemia. The association between G6PD deficiency and HbE is little understood. This study aimed to investigate G6PD deficiency and HbE in a Kachin ethnic group in the China-Myanmar border area. G6PD enzyme activity was measured using a quantitative G6PD assay, G6PD variants genotyped by the SNaP-shot assay, and an HbE gene mutation identified by an amplification refractory mutation system and subsequently confirmed by using a reverse dot blot hybridization assay from 100 unrelated individuals in the study area. G6PD enzyme activity ranged from 0.4 to 24.7 U/g Hb, and six males had severe G6PD deficiency (<0.12-1.2 U/g Hb), while six males and 12 females had mild G6PD deficiency (>1.2-4.5 U/g Hb). Among the 24 G6PD-deficient subjects, 22 (92%) had the Mahidol 487G> A mutation (12 male hemizygotes, one female homozygote, and nine female heterozygotes), while the G6PD genotypes in two female subjects were unknown. HbE was identified in 39 subjects (20 males and 19 females), including 15 HbEE (seven males and eight females) and 24 HbAE (13 males and 11 females). Twenty-three subjects co-inherited both G6PD deficiency and HbE (22 with HbAE and one with HbEE). Whereas mean Hb levels were not significantly different between the HbA and HbE groups, G6PD-deficient males had significantly lower Hb levels than G6PD-normal males (P < 0.05, t-test). However, it is noteworthy that two G6PD-deficient hemizygous males with HbAE were severely anemic with Hb levels below 50 g/L. This study revealed high prevalence of co-inheritance of G6PD deficiency with HbAE in the Kachin ethnicity, and a potential interaction of the G6PD Mahidol 487G> A and HbAE in males leading to severe anemia. The presence of 6% males with severe G6PD deficiency raised a major concern in the use of primaquine for radical cure of vivax malaria.	[Deng, Zeshuai; Yang, Fang; He, Lijun; Li, Qing; Wu, Yanrui; Luo, Lan; Li, Hong; He, Yongshu] Kunming Med Univ, Dept Cell Biol & Med Genet, Kunming, Yunnan Province, Peoples R China; [Bai, Yao; Yang, Zhaoqing] Kunming Med Univ, Dept Pathogen Biol & Immunol, Kunming, Yunnan Province, Peoples R China; [Ma, Limei] Kunming Med Univ, Dept Histol & Embryol, Kunming, Yunnan Province, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Kunming Medical University; Kunming Medical University; Kunming Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	He, YS (corresponding author), Kunming Med Univ, Dept Cell Biol & Med Genet, Kunming, Yunnan Province, Peoples R China.; Cui, LW (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	yongshuhe@hotmail.com; luc2@psu.edu	Deng, Zeshuai/ABE-6738-2020	Deng, Zeshuai/0000-0002-9570-2077	National Natural Science Foundation of China [31260264]; High Talent Introduction Project of Yunnan province [2013HA026]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [NIH U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Talent Introduction Project of Yunnan province; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural Science Foundation of China (#31260264); the High Talent Introduction Project of Yunnan province (#2013HA026); and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH U19AI089672).	Amoako N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112868; Bancone G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116063; Charoenkwan P, 2014, SE ASIAN J TROP MED, V45, P187; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Chu CS, 2016, EXPERT REV ANTI-INFE, V14, P885, DOI 10.1080/14787210.2016.1220304; FLINT J, 1993, BAILLIERE CLIN HAEM, V6, P215, DOI 10.1016/S0950-3536(05)80071-X; Glader BE, 1996, PEDIATR CLIN N AM, V43, P665, DOI 10.1016/S0031-3955(05)70427-2; He J, 2016, HEMATOLOGY, V21, P54, DOI 10.1179/1607845415Y.0000000044; Hu Y, 2016, ACTA TROP, V157, P12, DOI 10.1016/j.actatropica.2016.01.022; Khan TA, 2017, MICROB PATHOGENESIS, V102, P160, DOI 10.1016/j.micpath.2016.11.025; Li Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134593; Lithanatudom P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148079; Liu HX, 2016, AM J HUM BIOL, V28, P927, DOI 10.1002/ajhb.22868; Lopez C, 2010, GENE, V467, P1, DOI 10.1016/j.gene.2010.07.008; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Lyttleton C, 2016, SOC SCI MED, V150, P144, DOI 10.1016/j.socscimed.2015.12.033; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Naka I, 2008, BIOCHEM GENET, V46, P708, DOI 10.1007/s10528-008-9185-3; O'Riordan S, 2010, BRIT J HAEMATOL, V150, P359, DOI 10.1111/j.1365-2141.2010.08237.x; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Pornprasert S, 2013, HEMOGLOBIN, V37, P536, DOI 10.3109/03630269.2013.819558; Sanchaisuriya K, 2003, ANN HEMATOL, V82, P612, DOI 10.1007/s00277-003-0689-y; Sarkar S, 2010, INFECT GENET EVOL, V10, P1228, DOI 10.1016/j.meegid.2010.08.003; Shannon KL, 2015, AM J TROP MED HYG, V93, P281, DOI 10.4269/ajtmh.14-0623; Suresh S, 2013, BLOOD CELL MOL DIS, V50, P93, DOI 10.1016/j.bcmd.2012.10.001; Tagarelli A, 2000, FEBS LETT, V466, P139, DOI 10.1016/S0014-5793(99)01776-7; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Than AM, 2005, INT J HEMATOL, V82, P119, DOI 10.1532/IJH97.05028; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Tsegaye A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-438; Vizzi E, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1069-5; Wang S, 2015, COMPUT MATH METHOD M, V2015, P12, DOI DOI 10.3892/MMR.2015.4100; Yang YF, 2007, SCI CHINA SER C, V50, P479, DOI 10.1007/s11427-007-0072-7; Yanola J, 2014, SE ASIAN J TROP MED, V45, P920; Zhang L, 2015, INT J LAB HEMATOL, V37, P739, DOI 10.1111/ijlh.12405	36	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177917	10.1371/journal.pone.0177917	http://dx.doi.org/10.1371/journal.pone.0177917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531196	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400039
J	Rodrigues, MV; de Castro, SO; de Albuquerque, CZ; Mattaraia, VGD; Santoro, ML				Rodrigues, Mariana Valotta; de Castro, Simone Oliveira; de Albuquerque, Cynthia Zaccanini; de Moura Mattaraia, Vania Gomes; Santoro, Marcelo Larami			The gingival vein as a minimally traumatic site for multiple blood sampling in guinea pigs and hamsters	PLOS ONE			English	Article							SYRIAN-HAMSTER; SAPHENOUS-VEIN; COLLECTION; MODEL; PUNCTURE; SCIENCE; SAFETY; RAT	Laboratory animals are still necessary in scientific investigation and vaccine testing, but while novel methodological approaches are not available for their replacement, the search for new, humane, easy, and painless methods is necessary to diminish their stress and pain. When multiple blood samples are to be collected from hamsters and guinea pigs, the number of available venipuncture sites-which are greatly diminished in these species in comparison with other rodents due to the absence of a long tail-, harasses animal caregivers and researchers. Thus, this study aimed to evaluate if gingival vein puncture could be used as an additional route to obtain multiple blood samples from anesthetized hamsters and guinea pigs in such a way that animal behavior, well-being or hematological parameters would not be altered. Thus, twelve anesthetized Syrian golden hamsters and English guinea pigs were randomly allocated in two groups: a control group, whose blood samples were not collected, and an experimental group in which blood samples (200 microliters) were collected by gingival vein puncture at weekly intervals over six weeks. Clinical assessment, body weight gain and complete blood cell count were evaluated weekly, and control and experimental animals were euthanized at week seven, when the mentolabial region was processed to histological analyses. Multiple blood sampling from the gingival vein evoked no clinical manifestations or alteration in the behavioral repertoire, nor a statistically significant difference in weight gain in both species. Guinea pigs showed no alteration in red blood cell, leukocyte or platelet parameters over time. Hamsters developed a characteristic pattern of age-related physiological changes, which were considered normal. Histological analyses showed no difference in morphological structures in the interdental gingiva, confirming that multiple blood sampling is barely traumatic. Thus, these results evidence that blood collection from multiple gingival vein puncture is minimally invasive and traumatic to hamsters and guinea pigs, and that it can be accomplished during at least six weeks.	[Rodrigues, Mariana Valotta; de Castro, Simone Oliveira; de Albuquerque, Cynthia Zaccanini; de Moura Mattaraia, Vania Gomes] Inst Butantan, Anim Facil, Sao Paulo, SP, Brazil; [Santoro, Marcelo Larami] Inst Butantan, Lab Pathophysiol, Sao Paulo, SP, Brazil	Instituto Butantan; Instituto Butantan	Santoro, ML (corresponding author), Inst Butantan, Lab Pathophysiol, Sao Paulo, SP, Brazil.	marcelo.santoro@butantan.gov.br	Santoro, Marcelo L./K-7064-2019; Santoro, Marcelo/H-3892-2012	Santoro, Marcelo L./0000-0001-6364-3757; 	Sao Paulo Research Foundation (FAPESP) [2013/25177-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305245/2015-5]; Fundacao Butantan	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan	This work was supported by the Sao Paulo Research Foundation (FAPESP, grants # 2013/25177-0), URL: www.fapesp.br; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant # 305245/2015-5), URL: www.cnpq.br, and Fundacao Butantan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CR, 2014, J AM ASSOC LAB ANIM, V53, P81; [Anonymous], 2010, FARMACOPEIA BRASILEI; BAUMANS V, 1994, LAB ANIM-UK, V28, P97, DOI 10.1258/002367794780745308; Birck MM, 2014, JOVE-J VIS EXP, DOI 10.3791/51982; BULLOCK LP, 1983, LAB ANIM SCI, V33, P70; Burch R. L, 1958, PRINCIPLES HUMANE EX; CARSTAIRS KC, 1965, J PATHOL BACTERIOL, V90, P225, DOI 10.1002/path.1700900124; Casey W, 2011, PROCEDIA VACCINOL, V5, P33, DOI 10.1016/j.provac.2011.10.003; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Conselho Nacional de Controle de Experimentacao Animal, 2015, NORM CONC PROD MAN U; da Silva CB, 2016, ALTEX-ALTERN ANIM EX, V33, P322; Dang V, 2008, J AM ASSOC LAB ANIM, V47, P56; Desai R.G., 1968, GOLDEN HAMSTER ITS B, P185; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Donnelly Thomas M, 2004, Vet Clin North Am Exot Anim Pract, V7, P351, DOI 10.1016/j.cvex.2004.02.006; Donovan John, 2006, Curr Protoc Immunol, VChapter 1, DOI 10.1002/0471142735.im0108s73; DWYER SD, 1986, THROMB RES, V42, P139, DOI 10.1016/0049-3848(86)90290-2; Dyer Stephen M., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P423, DOI 10.1016/j.cvex.2008.03.008; Ellen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161941; Flecknell P., 2009, LAB ANIMAL ANAESTHES; GRACE ND, 1970, J NUTR, V100, P37, DOI 10.1093/jn/100.1.37; Haake David A, 2006, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12e02s02; Harkness JE, 2010, BIOL MED RABBITS ROD, V5th; Heimann M, 2009, LAB ANIM-UK, V43, P255, DOI 10.1258/la.2008.007073; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; HOCHMAN D, 1983, J PHARM SCI, V72, P975, DOI 10.1002/jps.2600720841; HOUSE EL, 1961, AM J PHYSIOL, V200, P1018, DOI 10.1152/ajplegacy.1961.200.5.1018; Joslin JO, 2009, J EXOT PET MED, V18, P117, DOI 10.1053/j.jepm.2009.04.002; Keino M, 2002, JPN J INFECT DIS, V55, P27; KREIENBUHL G, 1976, PFLUG ARCH EUR J PHY, V366, P167, DOI 10.1007/BF00585873; Munson E, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/504215; National Centre for the Replacement Refinement & Reduction of Animals in Research (NC, 2017, RETR; NAU R, 1993, LAB ANIM, V27, P23, DOI 10.1258/002367793781082449; Oliveira DT, 2009, SCAND J LAB ANIM SCI, V36, P109; Organization World Health., 2013, MAN QUAL CONTR DIPHT; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Picazo MG, 2009, LAB ANIMAL, V38, P211, DOI 10.1038/laban0609-211; Raabe BM, 2011, J AM ASSOC LAB ANIM, V50, P680; SACHSER N, 1984, AGGRESSIVE BEHAV, V10, P285, DOI 10.1002/1098-2337(1984)10:4<285::AID-AB2480100402>3.0.CO;2-8; Safronetz D, 2012, ANTIVIR RES, V95, P282, DOI 10.1016/j.antiviral.2012.06.002; Santoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120; Santoro ML, 2014, ESTUDO HISTOLOGICO C; Schneider JE, 2000, AM J PHYSIOL-REG I, V278, pR476, DOI 10.1152/ajpregu.2000.278.2.R476; Scipioni RL, 1997, LAB ANIM SCI, V47, P293; STEIN KF, 1945, P SOC EXP BIOL MED, V60, P313, DOI 10.3181/00379727-60-15173; Stewart MO, 1944, J EXP MED, V80, P189, DOI 10.1084/jem.80.3.189; Struillou X, 2010, OPEN DENT J, V4, P37, DOI 10.2174/1874210601004010037; Wahl-Jensen V, 2012, VIRUSES-BASEL, V4, P3754, DOI 10.3390/v4123754; Washington IM, 2012, AM COLL LAB, P57, DOI 10.1016/B978-0-12-380920-9.00003-1; Weiss DJ, 2010, SCHALMS VET HEMATOLO; Williams WR, 2016, LAB ANIMAL, V45, P35, DOI 10.1038/laban.911; Williams WR, 2015, LAB ANIMAL, V44, P207, DOI 10.1038/laban.787; Wolfensohn S, 2003, HDB LAB ANIMAL MANAG	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177967	10.1371/journal.pone.0177967	http://dx.doi.org/10.1371/journal.pone.0177967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531179	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400046
J	Lai, YC; Fujikawa, T; Maemura, T; Ando, T; Kitahara, G; Endo, Y; Yamato, O; Koiwa, M; Kubota, C; Miura, N				Lai, Yu-Chang; Fujikawa, Takuro; Maemura, Tadashi; Ando, Takaaki; Kitahara, Go; Endo, Yasuyuki; Yamato, Osamu; Koiwa, Masateru; Kubota, Chikara; Miura, Naoki			Inflammation-related microRNA expression level in the bovine milk is affected by mastitis	PLOS ONE			English	Article							KAPPA-B PATHWAY; DIGITAL PCR; ESCHERICHIA-COLI; MACROPHAGES; MIRNAS; QUANTIFICATION; IDENTIFICATION; BIOMARKERS; INHIBITOR; DIAGNOSIS	MicroRNA (miRNA) in tissue and liquid samples have been shown to be associated with many diseases including inflammation. We aimed to identify inflammation-related miRNA expression level in the bovine mastitis milk. Expression level of inflammation-related miRNA in milk from mastitis-affected and normal cows was analyzed using qPCR. We found that expression level of miR-21, miR-146a, miR-155, miR-222, and miR-383 was significantly upregulated in California mastitis test positive (CMT+) milk. We further analyzed these miRNA using a chip-based QuantStudio Digital PCR System. The digital PCR results correlated with those of qPCR, demonstrating upregulation of miR-21, miR-146a, miR-155, miR222, and miR-383 in CMT+milk. In conclusion, we identified miRNA that are upregulated in CMT+milk. These miRNA exhibited sensitivity and specificity greater than 80% for differentiating between CMT+milk and normal milk. Our findings suggest that inflammation-related miRNA expression level in the bovine milk was affected by mastitis, and miRNA in milk have potential for use as biomarkers of bovine mastitis.	[Lai, Yu-Chang; Maemura, Tadashi; Miura, Naoki] Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Kagoshima, Japan; [Lai, Yu-Chang; Fujikawa, Takuro] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Fujikawa, Takuro; Ando, Takaaki; Kubota, Chikara] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Theriogenol, Kagoshima, Japan; [Kitahara, Go] Univ Miyazaki, Fac Agr, Dept Vet Sci, Miyazaki, Japan; [Endo, Yasuyuki] Kagoshima Univ, Joint Fac Vet Med, Lab Small Anim Internal Med, Kagoshima, Japan; [Yamato, Osamu] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Clin Pathol, Kagoshima, Japan; [Koiwa, Masateru] Rakuno Gakuen Univ, Sch Vet Med, Ebetsu, Hokkaido, Japan	Kagoshima University; Yamaguchi University; Kagoshima University; University of Miyazaki; Kagoshima University; Kagoshima University; Rakuno Gakuen University	Miura, N (corresponding author), Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Kagoshima, Japan.	k9236024@kadai.jp	Miura, Naoki/A-5734-2010; Miura, Naoki/O-6997-2016	Miura, Naoki/0000-0002-4625-5231; Miura, Naoki/0000-0002-4625-5231; Yamato, Osamu/0000-0002-4430-5645	Project of the Bio-oriented Technology Research Advancement Institution, NARO; JSPS KAKENHI [25660243]; Morinaga Houshikai Research Grant; Grants-in-Aid for Scientific Research [17H03926, 16H05845] Funding Source: KAKEN	Project of the Bio-oriented Technology Research Advancement Institution, NARO; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Morinaga Houshikai Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology) to CK and NM, and by the the JSPS KAKENHI-25660243 to NM, and by the the Morinaga Houshikai Research Grant to NM.	Bai WL, 2013, J DAIRY SCI, V96, P4529, DOI 10.3168/jds.2013-6603; Chen CYA, 2016, NUCLEIC ACIDS RES, V44, P3772, DOI 10.1093/nar/gkw205; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Dilda F, 2012, VET J, V192, P514, DOI 10.1016/j.tvjl.2011.08.018; Fan GW, 2016, INFLAMMATION, V39, P375, DOI 10.1007/s10753-015-0259-1; FOX LK, 1993, VET CLIN N AM-FOOD A, V9, P475, DOI 10.1016/S0749-0720(15)30615-0; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Izumi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088843; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Kasimanickam V, 2016, SCI REP-UK, V6, DOI 10.1038/srep29509; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; KOBAYASHI Y, 1978, J DAIRY SCI, V61, P592, DOI 10.3168/jds.S0022-0302(78)94414-4; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kotsinas A, 2015, CURR MED CHEM, V22, P2666, DOI 10.2174/0929867322666150716113304; Lai YC, 2017, J ANIM SCI; Lam TJGM, 2009, IRISH VET J, V62, P34, DOI 10.1186/2046-0481-62-S4-S34; Larrea E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050627; Lawless N, 2014, MICRORNA REGULATION, VG3, P4; Lawless N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057543; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Li LH, 2015, J MOL NEUROSCI, V56, P858, DOI 10.1007/s12031-015-0526-5; Li N, 2014, J CANCER RES CLIN, V140, P145, DOI 10.1007/s00432-013-1555-5; Li R, 2015, INT J MOL SCI, V16, P4997, DOI 10.3390/ijms16034997; Ma J, 2013, BIOMARK INSIGHTS, V8, P127, DOI [10.4137/BMI.S13154, 10.4137/BMIMI.S13154]; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mangolini A, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0037-0; Mi Shuangli, 2013, Microrna, V2, P63, DOI 10.2174/2211536611302010007; Na RS, 2015, GENET MOL RES, V14, P11371, DOI 10.4238/2015.September.25.4; Naeem A, 2012, J DAIRY SCI, V95, P6397, DOI 10.3168/jds.2011-5173; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Ortega FJ, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0083-3; Rivkin M, 2016, GASTROENTEROLOGY, V151, P999, DOI 10.1053/j.gastro.2016.07.031; Saikumar J, 2014, CLIN CHEM, V60, P1158, DOI 10.1373/clinchem.2013.216044; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P429, DOI 10.5713/ajas.2011.10233; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; SMITH KL, 1993, VET CLIN N AM-FOOD A, V9, P489, DOI 10.1016/S0749-0720(15)30616-2; Song JL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00056; Sun JJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2044-9; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vikram A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12565; Wang HJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0704-9; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Wang XP, 2016, MOL CELL PROBES; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yagi Y, 2004, J VET MED SCI, V66, P381, DOI 10.1292/jvms.66.381; Yeh DW, 2016, CELL DEATH DIFFER, V23, P841, DOI 10.1038/cdd.2015.147; Zhang L, 2015, J IMMUNOL, V195, P5404, DOI 10.4049/jimmunol.1402933; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	57	35	36	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177182	10.1371/journal.pone.0177182	http://dx.doi.org/10.1371/journal.pone.0177182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520748	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700040
J	Gonzalez, D; Contreras, O; Rebolledo, DL; Espinoza, JP; van Zundert, B; Brandan, E				Gonzalez, David; Contreras, Osvaldo; Rebolledo, Daniela L.; Pablo Espinoza, Juan; van Zundert, Brigitte; Brandan, Enrique			ALS skeletal muscle shows enhanced TGF-beta signaling, fibrosis and induction of fibro/adipogenic progenitor markers	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TISSUE GROWTH-FACTOR; DUCHENNE MUSCULAR-DYSTROPHY; MOTOR-NEURON DEGENERATION; TRIGGER MOTONEURON DEATH; FACTOR GENE-EXPRESSION; MESENCHYMAL PROGENITORS; DISEASE PROGRESSION; FIBROTIC RESPONSE; SATELLITE CELLS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease in which upper and lower motoneurons degenerate leading to muscle wasting, paralysis and eventually death from respiratory failure. Several studies indicate that skeletal muscle contributes to disease progression; however the molecular mechanisms remain elusive. Fibrosis is a common feature in skeletal muscle under chronic damage conditions such as those caused by muscular dystrophies or denervation. However, the exact mechanisms of fibrosis induction and the cellular bases of this pathological response are unknown. We show that extracellular matrix (ECM) components are augmented in skeletal muscles of symptomatic hSOD1(G93A) mice, a widely used murine model of ALS. These mice also show increased TGF-beta 1 mRNA levels, total Smad3 protein levels and p-Smad3 positive nuclei. Furthermore, platelet-derived growth factor receptor-alpha (PDGFR alpha), Tcf4 and alpha-smooth muscle actin (alpha-SMA) levels are augmented in the skeletal muscle of symptomatic hSOD1(G93A) mice. Additionally, the fibro/adipogenic progenitors (FAPs), which are the main producers of ECM constituents, are also increased in these pathogenic conditions. Therefore, FAPs and ECM components are more abundant in symptomatic stages of the disease than in pre-symptomatic stages. We present evidence that fibrosis observed in skeletal muscle of symptomatic hSOD1(G93A) mice is accompanied with an induction of TGF-beta signaling, and also that FAPs might be involved in triggering a fibrotic response. Co-localization of p-Smad3 positive cells together with PDGFRa was observed in the interstitial cells of skeletal muscles from symptomatic hSOD1(G93A) mice. Finally, the targeting of pro-fibrotic factors such as TGF-beta, CTGF/CCN2 and platelet-derived growth factor (PDGF) signaling pathway might be a suitable therapeutic approach to improve muscle function in several degenerative diseases.	[Gonzalez, David; Contreras, Osvaldo; Rebolledo, Daniela L.; Pablo Espinoza, Juan; Brandan, Enrique] Pontificia Univ Catolica Chile, CARE Chile UC, Ctr Envejecimiento & Regenerac, Santiago, Chile; [Gonzalez, David; Contreras, Osvaldo; Rebolledo, Daniela L.; Pablo Espinoza, Juan; Brandan, Enrique] Pontificia Univ Catolica Chile, Dept Biol Celular & Mol, Fac Ciencias Biol, Santiago, Chile; [van Zundert, Brigitte] Univ Andres Bello, Ctr Invest Biomed, Fac Ciencias Biol, Santiago, Chile; [van Zundert, Brigitte] Univ Andres Bello, Fac Med, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad Andres Bello; Universidad Andres Bello	Brandan, E (corresponding author), Pontificia Univ Catolica Chile, CARE Chile UC, Ctr Envejecimiento & Regenerac, Santiago, Chile.; Brandan, E (corresponding author), Pontificia Univ Catolica Chile, Dept Biol Celular & Mol, Fac Ciencias Biol, Santiago, Chile.	ebrandan@bio.puc.cl	Rebolledo, Daniela/GXG-6724-2022; Contreras, Osvaldo/O-4518-2019; Brandan, Enrique/A-7063-2017	Rebolledo, Daniela/0000-0002-6240-6669; Contreras, Osvaldo/0000-0002-8722-9371; Brandan, Enrique/0000-0002-6820-5059	FONDECYT [1150106, 3140357, CARE-PFB-12/2007]; CONICYT [21130854]; ALS Therapy Alliance [2014-F-034]; DRI USA [2013-0030]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ALS Therapy Alliance; DRI USA	This study received financial support from FONDECYT, grant #1150106 to E.B., a CARE-PFB-12/2007 grant, FONDECYT grant #3140357 to D.L.R., CONICYT, 21130854, PhDc David Gonzalez and CONICYT Doctoral Fellowship grants to D.G. and O.C. This work was supported by the ALS Therapy Alliance-2014-F-034, and DRI USA 2013-0030 to B.v.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandan E, 2013, FEBS J, V280, P4109, DOI 10.1111/febs.12278; Bros-Facer V, 2014, HUM MOL GENET, V23, P4187, DOI 10.1093/hmg/ddu136; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Cabrera D, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-6; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; Chang Z, 2014, DIS MODEL MECH, V7, P83, DOI 10.1242/dmm.013326; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Contreras O, 2016, CELL TISSUE RES, V364, P647, DOI 10.1007/s00441-015-2343-0; Cozzoli A, 2011, PHARMACOL RES, V64, P482, DOI 10.1016/j.phrs.2011.06.002; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Day WA, 2005, NEUROBIOL DIS, V19, P323, DOI 10.1016/j.nbd.2005.01.010; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Fritz E, 2013, J NEUROPHYSIOL, V109, P2803, DOI 10.1152/jn.00500.2012; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Houi K, 2002, ACTA NEUROL SCAND, V106, P299, DOI 10.1034/j.1600-0404.2002.01301.x; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Ilzecka J, 2002, CYTOKINE, V20, P239, DOI 10.1006/cyto.2002.2005; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Acuna MJ, 2014, HUM MOL GENET, V23, P1237, DOI 10.1093/hmg/ddt514; Judson RN, 2013, FEBS J, V280, P4100, DOI 10.1111/febs.12370; Katsuno M, 2011, Curr Mol Med, V11, P48, DOI 10.2174/156652411794474356; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Le M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048040; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Lemos DR, 2012, STEM CELLS, V30, P1152, DOI 10.1002/stem.1082; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Mancuso R, 2015, PROG NEUROBIOL, V133, P1, DOI 10.1016/j.pneurobio.2015.07.004; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Mueller AA, 2016, NATURE, V540, P276, DOI 10.1038/nature20160; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Pansarasa O, 2014, MOL NEUROBIOL, V49, P984, DOI 10.1007/s12035-013-8578-4; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; Pessina P, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-7; Philips Thomas, 2015, Curr Protoc Pharmacol, V69, DOI 10.1002/0471141755.ph0567s69; Quattrocelli M, 2017, BBA-MOL CELL RES, V1864, P572, DOI 10.1016/j.bbamcr.2016.12.020; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rojas F, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00203, 10.3389/fncel.2015.00203]; Rojas F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00024; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Si Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138425; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Uezumi A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00068; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Van Dyke JM, 2016, EXP NEUROL IN PRESS; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	69	72	73	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177649	10.1371/journal.pone.0177649	http://dx.doi.org/10.1371/journal.pone.0177649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520806	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500052
J	Lee, SM; Lee, JM; Kang, HJ; Yang, HK; Yoon, JH; Chang, W; An, SJ; Lee, KB; Baek, SY				Lee, Sang Min; Lee, Jeong Min; Kang, Hyo-Jin; Yang, Hyung Kung; Yoon, Jeong Hee; Chang, Won; An, Su Joa; Lee, Kyoung Bun; Baek, Seung Yon			Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; CHRONIC HEPATITIS-B; TRANSIENT ELASTOGRAPHY; CLINICAL-USE; NONINVASIVE EVALUATION; STIFFNESS MEASUREMENT; WFUMB GUIDELINES; RECOMMENDATIONS; ACCURACY; BIOPSY	Objective To evaluate the applicability, reproducibility, and diagnostic performance of a new 2D-shear wave elastography (SWE) using the comb-push technique (2D CP-SWE) for detection of hepatic fibrosis, using histopathology as the reference standard. Materials and methods This prospective study was approved by the institutional review board, and informed consent was obtained from all patients. The liver stiffness (LS) measurements were obtained from 140 patients, using the new 2D-SWE, which uses comb-push excitation to produce shear waves and a time-aligned sequential tracking method to detect shear wave signals. The applicability rate of 2D CP-SWE was estimated, and factors associated with its applicability were identified. Intraobserver reproducibility was evaluated in the 105 patients with histopathologic diagnosis, and interobserver reproducibility was assessed in 20 patients. Diagnostic performance of the 2D CP-SWE for hepatic fibrosis was evaluated by receiver operating characteristic (ROC) curve analysis. Results The applicability rate of 2D CP-SWE was 90.8% (109 of 120). There was a significant difference in age, presence or absence of ascites, and the distance from the transducer to the Glisson capsule between the patients with applicable LS measurements and patients with unreliable measurement or technical failure. The intraclass correlation of interobserver agreement was 0.87, and the value for the intraobserver agreement was 0.95. The area under the ROC curve of LS values for stage F2 fibrosis or greater, stage F3 or greater, and stage F4 fibrosis was 0.874 (95% confidence interval [CI]: 0.794-0.930), 0.905 (95% CI: 0.832-0.954), and 0.894 (95% CI: 0.819-0.946), respectively. Conclusion 2D CP-SWE can be employed as a reliable method for assessing hepatic fibrosis with a reasonably good diagnostic performance, and its applicability might be influenced by age, ascites, and the distance between the transducer and Glisson capsule.	[Lee, Sang Min; Lee, Jeong Min; Kang, Hyo-Jin; Yang, Hyung Kung; Yoon, Jeong Hee; Chang, Won; An, Su Joa] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Lee, Jeong Min; Yoon, Jeong Hee; Chang, Won; An, Su Joa] Seoul Natl Univ, Inst Radiat Med, Coll Med, Seoul, South Korea; [Lee, Kyoung Bun] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Baek, Seung Yon] Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Lee, Sang Min] Hallym Univ, Sacred Heart Hosp, Dept Radiol, Anyang, South Korea; [Chang, Won] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University; Hallym University; Seoul National University (SNU)	Lee, JM (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Lee, JM (corresponding author), Seoul Natl Univ, Inst Radiat Med, Coll Med, Seoul, South Korea.	jmsh@snu.ac.kr	Lee, Jeong Min/V-3429-2019; Yoon, Jeong Hee/ABA-5127-2021; Lee, Kyoungbun/J-2571-2016	Lee, Jeong Min/0000-0003-0561-8777; Yoon, Jeong Hee/0000-0002-9925-9973; Lee, Sang Min/0000-0001-7719-3849; Lee, Kyoungbun/0000-0001-8427-3003	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2A10066037]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2A10066037) http://www.nrf.re.kr/nrf_eng_cms/. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Barr RG, 2015, RADIOLOGY, V276, P845, DOI 10.1148/radiol.2015150619; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bota S, 2013, LIVER INT, V33, P1138, DOI 10.1111/liv.12240; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Cassinotto C, 2014, J HEPATOL, V61, P550, DOI 10.1016/j.jhep.2014.04.044; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Friedrich-Rust M, 2016, NAT REV GASTRO HEPAT, V13, P402, DOI 10.1038/nrgastro.2016.86; Gareen IF, 2003, RADIOLOGY, V229, P305, DOI 10.1148/radiol.2292030324; Kudo M, 2013, J MED ULTRASON, V40, P325, DOI 10.1007/s10396-013-0460-5; Leung VYF, 2013, RADIOLOGY, V269, P910, DOI 10.1148/radiol.13130128; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martinez SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047715; Nierhoff J, 2013, EUR RADIOL, V23, P3040, DOI 10.1007/s00330-013-2927-6; Obuchowski NA, 2005, ACAD RADIOL, V12, P1198, DOI 10.1016/j.acra.2005.05.013; Palmeri ML, 2011, J HEPATOL, V55, P666, DOI 10.1016/j.jhep.2010.12.019; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Piscaglia F, 2016, ULTRASCHALL MED, V37, P1, DOI 10.1055/s-0035-1567037; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Poynard T, 2013, J HEPATOL, V58, P928, DOI 10.1016/j.jhep.2012.12.021; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Samir AE, 2015, RADIOLOGY, V274, P888, DOI 10.1148/radiol.14140839; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Shiina T, 2015, ULTRASOUND MED BIOL, V41, P1126, DOI 10.1016/j.ultrasmedbio.2015.03.009; Song PF, 2016, J ULTRAS MED, V35, P401, DOI 10.7863/ultra.15.03036; Song PF, 2015, IEEE T ULTRASON FERR, V62, P290, DOI 10.1109/TUFFC.2014.006628; Song PF, 2013, IEEE T MED IMAGING, V32, P1435, DOI 10.1109/TMI.2013.2257831; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Stotland BR, 1996, AM J GASTROENTEROL, V91, P1295; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x; Woo H, 2015, RADIOLOGY, V277, P881, DOI 10.1148/radiol.2015141975; Yoon JH, 2014, RADIOLOGY, V273, P772, DOI 10.1148/radiol.14132000	44	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177264	10.1371/journal.pone.0177264	http://dx.doi.org/10.1371/journal.pone.0177264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510583	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500019
J	Moutaoufik, MT; Morrow, G; Finet, S; Tanguay, RM				Moutaoufik, Mohamed Taha; Morrow, Genevieve; Finet, Stephanie; Tanguay, Robert M.			Effect of N-terminal region of nuclear Drosophila melanogaster small heat shock protein DmHsp27 on function and quaternary structure	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; CHAPERONE-LIKE ACTIVITY; PHOSPHOPROTEOME ANALYSIS; STRESS-PROTEIN; HSP27; SUBSTRATE; PHOSPHORYLATION; OLIGOMERIZATION; MECHANISM; DYNAMICS	The importance of the N-terminal region (NTR) in the oligomerization and chaperone-like activity of the Drosophila melanogaster small nuclear heat shock protein DmHsp27 was investigated by mutagenesis using size exclusion chromatography and native gel electrophoresis. Mutation of two sites of phosphorylation in the N-terminal region, S58 and S75, did not affect the oligomerization equilibrium or the intracellular localization of DmHsp27 when transfected into mammalian cells. Deletion or mutation of specific residues within the NTR region delineated a motif (FGFG) important for the oligomeric structure and chaperone-like activity of this sHsp. While deletion of the full N-terminal region, resulted in total loss of chaperone-like activity, removal of the (FGFG) at position 29 to 32 or single mutation of F29A/Y, G30R and G32R enhanced oligomerization and chaperoning capacity under non-heat shock conditions in the insulin assay suggesting the importance of this site for chaperone activity. Unlike mammalian sHsps DmHsp27 heat activation leads to enhanced association of oligomers to form large structures of approximately 1100 kDa. A new mechanism of thermal activation for DmHsp27 is presented.	[Moutaoufik, Mohamed Taha; Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Lab Genet Cellulaire & Dev, Dept Biol Mol Biochim Med & Pathol, IBIS, Quebec City, PQ, Canada; [Moutaoufik, Mohamed Taha; Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, PROTEO, Quebec City, PQ, Canada; [Finet, Stephanie] UPMC Paris 6, CNRS, IMPMC, UMR7590, 4 Pl Jussieu, Paris, France	Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Tanguay, RM (corresponding author), Univ Laval, Lab Genet Cellulaire & Dev, Dept Biol Mol Biochim Med & Pathol, IBIS, Quebec City, PQ, Canada.; Tanguay, RM (corresponding author), Univ Laval, PROTEO, Quebec City, PQ, Canada.	Robert.tanguay@fmed.ulaval.ca		Moutaoufik, Mohamed Taha/0000-0002-2013-1601	NSERC; FQRNT; PROTEO, Quebec	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT(FQRNT); PROTEO, Quebec	This work was funded by a grant from NSERC to RMT and a FQRNT exchange studentship to RMT and SF. MTM held a studentship from PROTEO, Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Baranova EV, 2011, J MOL BIOL, V411, P110, DOI 10.1016/j.jmb.2011.05.024; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; BEAULIEU JF, 1989, J CELL SCI, V92, P29; Benesch JLP, 2010, CHEM BIOL, V17, P1008, DOI 10.1016/j.chembiol.2010.06.016; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Bourrelle-Langlois M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162233; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Capponi S, 2011, J PERIPHER NERV SYST, V16, P287, DOI 10.1111/j.1529-8027.2011.00361.x; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; CRABBE MJC, 1994, BIOCHEM J, V297, P653, DOI 10.1042/bj2970653; Crack JA, 2002, EUR J BIOCHEM, V269, P933, DOI 10.1046/j.0014-2956.2001.02726.x; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Datta SA, 1999, J BIOL CHEM, V274, P34773, DOI 10.1074/jbc.274.49.34773; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; den Engelsman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073489; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Feil IK, 2001, J BIOL CHEM, V276, P12024, DOI 10.1074/jbc.M010856200; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Fu XM, 2006, J MOL EVOL, V62, P257, DOI 10.1007/s00239-005-0076-5; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Ghosh JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000498; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; Haslbeck M., 2015, BIG BOOK SMALL HEAT, P155, DOI [10.1007/978-3-319-16077-1_6, DOI 10.1007/978-3-319-16077-1_6]; Haslbeck M, 2016, BBA-GEN SUBJECTS, V1860, P149, DOI 10.1016/j.bbagen.2015.06.008; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Heirbaut M., 2015, BIG BOOK SMALL HEAT, P197; Heirbaut M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105892; Horwitz J, 1998, INT J BIOL MACROMOL, V22, P263, DOI 10.1016/S0141-8130(98)00024-5; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Kappe G, 2010, CELL STRESS CHAPERON, V15, P457, DOI 10.1007/s12192-009-0155-4; KATO K, 1994, J BIOL CHEM, V269, P11274; Kelley PB, 2003, MOL CELL BIOCHEM, V252, P273, DOI 10.1023/A:1025568417000; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kundu M, 2007, BIOPOLYMERS, V86, P177, DOI 10.1002/bip.20716; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Lund AA, 2001, J BIOL CHEM, V276, P29924, DOI 10.1074/jbc.M103373200; Maaroufi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081207; Marin R, 1996, EXP CELL RES, V223, P1, DOI 10.1006/excr.1996.0052; Mchaourab HS, 2012, BIOCHEMISTRY-US, V51, P5105, DOI 10.1021/bi300525x; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Michaud S, 2008, BBA-MOL CELL RES, V1783, P1200, DOI 10.1016/j.bbamcr.2008.01.031; Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Morrow G., 2015, BIG BOOK SMALL HEAT, P579, DOI DOI 10.1007/978-3-319-16077-1_25; Moutaoufik MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112742; Moutaoufik MT, 2016, CELL STRESS CHAPERON, P1; Muranova LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126248; Pasta SY, 2003, J BIOL CHEM, V278, P51159, DOI 10.1074/jbc.M307523200; Patel S, 2014, BIOPHYS J, V106, P2644, DOI 10.1016/j.bpj.2014.04.048; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Smith JB, 1996, EXP EYE RES, V63, P125, DOI 10.1006/exer.1996.0100; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Sun Y, 2004, J BIOL CHEM, V279, P39999, DOI 10.1074/jbc.M406999200; Theriault JR, 2004, J BIOL CHEM, V279, P23463, DOI 10.1074/jbc.M402325200; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Weeks SD, 2014, METHODS MOL BIOL, V1200, P511, DOI 10.1007/978-1-4939-1292-6_42; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; Zhang KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08811	78	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177821	10.1371/journal.pone.0177821	http://dx.doi.org/10.1371/journal.pone.0177821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520783	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500073
J	Soler, X; Liao, SY; Marin, JM; Lorenzi, G; Jen, R; DeYoung, P; Owens, RL; Ries, AL; Malhotra, A				Soler, Xavier; Liao, Shu-Yi; Maria Marin, Jose; Lorenzi-Filho, Geraldo; Jen, Rachel; DeYoung, Pamela; Owens, Robert L.; Ries, Andrew L.; Malhotra, Atul			Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease (COPD): The challenge to predict OSA in advanced COPD	PLOS ONE			English	Article							STOP-BANG SCORE; LUNG-DISEASE; GENERAL-POPULATION; OVERLAP SYNDROME; SEX-DIFFERENCES; RISK-FACTORS; PREVALENCE; ADULTS; DIAGNOSIS; SYMPTOMS	The combination of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) is associated with substantial morbidity and mortality. We hypothesized that predictors of OSA among patients with COPD may be distinct from OSA in the general population. Therefore, we investigated associations between traditional OSA risk factors (e.g. age), and sleep questionnaires [e.g. Epworth Sleepiness Scale] in 44 patients with advanced COPD. As a second aim we proposed a pilot, simplified screening test for OSA in patients with COPD. In a prospective, observational study of patients enrolled in the UCSD Pulmonary Rehabilitation Program we collected baseline characteristics, cardiovascular events (e.g. atrial fibrillation), and sleep questionnaires [e.g. Pittsburgh Sleep Quality Index (PSQI)]. For the pilot questionnaire, a BMI >= 25 kg/m(2) and the presence of cardiovascular disease were used to construct the pilot screening test. Male: 59%; OSA 66%. FEV1 (mean +/- SD) = 41.0 +/- 18.2% pred., FEV1/FVC = 41.5 +/- 12.7%]. Male gender, older age, and large neck circumference were not associated with OSA. Also, Epworth Sleepiness Scale and the STOP-Bang questionnaire were not associated with OSA in univariate logistic regression. In contrast, BMI >= 25 kg/m(2) (OR = 3.94, p = 0.04) and diagnosis of cardiovascular disease (OR = 5.06, p = 0.03) were significantly associated with OSA [area under curve (AUC) = 0.74]. The pilot COPD-OSA test (OR = 5.28, p = 0.05) and STOP-Bang questionnaire (OR = 5.13, p = 0.03) were both associated with OSA in Receiver Operating Characteristics (ROC) analysis. The COPD-OSA test had the best AUC (0.74), sensitivity (92%), and specificity (83%). A tenfold cross-validation validated our results. We found that traditional OSA predictors (e.g. gender, Epworth score) did not perform well in patients with more advanced COPD. Our pilot test may be an easy to implement instrument to screen for OSA. However, a larger validation study is necessary before further clinical implementation is warranted.	[Soler, Xavier; Jen, Rachel; DeYoung, Pamela; Owens, Robert L.; Ries, Andrew L.; Malhotra, Atul] Univ Calif San Diego, Dept Med, Pulm Crit Care & Sleep Div, San Diego, CA 92103 USA; [Liao, Shu-Yi] UC Riverside, Dept Med, Riverside, CA USA; [Maria Marin, Jose] Univ Hosp Miguel Servet, CIBERES, IISAragon, Pulm Div, Zaragoza, Spain; [Lorenzi-Filho, Geraldo] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Sleep Lab, Sao Paulo, Brazil	University of California System; University of California San Diego; University of California System; University of California Riverside; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Miguel Servet University Hospital; Universidade de Sao Paulo	Soler, X (corresponding author), Univ Calif San Diego, Dept Med, Pulm Crit Care & Sleep Div, San Diego, CA 92103 USA.	xsoler@ucsd.edu	Lorenzi-Filho, Geraldo GLF/E-1062-2012	Lorenzi-Filho, Geraldo GLF/0000-0002-7011-7373; Marin Trigo, Jose Maria/0000-0001-9096-2294; Family Name Deactivated, Given Names Deactivated/0000-0002-0099-0847	Tobacco Related Disease Research Program (TRDRP) [KT-0014]; National Institutes of Health [UL1TR000100]; ATS Foundation Recognition Awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085188, K24HL132105, T32HL134632] Funding Source: NIH RePORTER	Tobacco Related Disease Research Program (TRDRP)(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ATS Foundation Recognition Awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Xavier Soler was funded exclusively by the Tobacco Related Disease Research Program (TRDRP), New Investigator Award (KT-0014), http://trdrp.yes4yes.com/fundedresearch/person_ page.php?person_id=35105; a Center of Translational Research Institute (CTRI) seed grant, from the National Institutes of Health (grant UL1TR000100), http://www.ctri.ucsd.edu/funding/ Pilot-Projects/Pages/awardees-table.aspx; and the 2014 ATS Foundation Recognition Awards for Outstanding Early Career Investigators, http://foundation.thoracic.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2016, AM J RESP CRIT CARE, V193, P813, DOI 10.1164/rccm.201512-2379ED; Bednarek M, 2005, RESPIRATION, V72, P142, DOI 10.1159/000084044; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Biselli PJ, 1985, J APPL PHYSL; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Buysse D J, 1989, Psychiatry Res, V28, P193; Carmelli D, 2000, OBES RES, V8, P632, DOI 10.1038/oby.2000.81; CHAOUAT A, 1995, AM J RESP CRIT CARE, V151, P82, DOI 10.1164/ajrccm.151.1.7812577; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2013, OBES SURG, V23, P2050, DOI 10.1007/s11695-013-1006-z; CORMICK W, 1986, THORAX, V41, P846, DOI 10.1136/thx.41.11.846; DAVIES RJO, 1990, EUR RESPIR J, V3, P509; Dawson B, 2004, BASIC CLINICAL BIOST; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Fleetham JA, 2003, AM J RESP CRIT CARE, V167, P3, DOI 10.1164/rccm.2211003; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FLENLEY DC, 1985, CLIN CHEST MED, V6, P651; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; GUILLEMINAULT C, 1980, AM REV RESPIR DIS, V122, P397; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Hessel NS, 2002, EUR ARCH OTO-RHINO-L, V259, P154, DOI 10.1007/s00405-001-0427-9; Ibrahim AS, 2008, ANN SAUDI MED, V27, P421; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kapur VK, 2005, SLEEP, V28, P472, DOI 10.1093/sleep/28.4.472; KATZ I, 1990, AM REV RESPIR DIS, V141, P1228, DOI 10.1164/ajrccm/141.5_Pt_1.1228; KINSMAN RA, 1983, CHEST, V83, P755, DOI 10.1378/chest.83.5.755; KLINK ME, 1994, CHEST, V105, P151, DOI 10.1378/chest.105.1.151; Krachman SL, 2011, COPD, V8, P182, DOI 10.3109/15412555.2011.560583; Krachman SL, 2016, ANN AM THORAC SOC; Lavie P, 2007, J SLEEP RES, V16, P128, DOI 10.1111/j.1365-2869.2007.00578.x; Lindberg A, 2005, RESPIRATION, V72, P471, DOI 10.1159/000087670; Loredo JS, 1999, CHEST, V116, P655, DOI 10.1378/chest.116.3.655; Machado MCL, 2010, EUR RESPIR J, V35, P132, DOI 10.1183/09031936.00192008; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Martinez-Rivera C, 2008, OBESITY, V16, P113, DOI 10.1038/oby.2007.20; McNicholas WT, 2009, AM J RESP CRIT CARE, V180, P692, DOI 10.1164/rccm.200903-0347PP; Minino AM, 2011, NATL VITAL STAT REP, V59, P1; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Price D, 2013, INT J CHRONIC OBSTR, V8, P595, DOI 10.2147/COPD.S48570; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Sanders MH, 2003, AM J RESP CRIT CARE, V167, P7, DOI 10.1164/rccm.2203046; Sharma SK, 2004, SLEEP MED, V5, P351, DOI 10.1016/j.sleep.2004.03.004; Shepertycky MR, 2005, SLEEP, V28, P309; Soler X, 2015, ANN AM THORAC SOC, V12, P1219, DOI 10.1513/AnnalsATS.201407-336OC; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; Tam A, 2016, AM J RESP CRIT CARE, V193, P825, DOI 10.1164/rccm.201503-0487OC; Teodorescu M, 2014, J CLIN SLEEP MED, V10, P183, DOI 10.5664/jcsm.3450; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vogelmeier CF, 2017, RESPIROLOGY, V22, P575, DOI 10.1111/resp.13012; Weitzenblum Emmanuel, 2008, Proc Am Thorac Soc, V5, P237, DOI 10.1513/pats.200706-077MG; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	59	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177289	10.1371/journal.pone.0177289	http://dx.doi.org/10.1371/journal.pone.0177289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510598	Green Published, gold			2022-12-27	WOS:000401485500020
J	Poder, TG; Erraji, J; Coulibaly, LP; Koffi, K				Poder, Thomas G.; Erraji, Jihane; Coulibaly, Lucien P.; Koffi, Kouame			Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis	PLOS ONE			English	Review							ELEVATION MYOCARDIAL-INFARCTION; LONG-TERM OUTCOMES; CLINICAL-OUTCOMES; PATIENT-YEARS; FOLLOW-UP; PREDICTORS; EVENTS; SAFETY	Background Drug-eluting stents (DESs) were considered as ground-breaking technology promising to eradicate restenosis and the necessity to perform multiple revascularization procedures subsequent to percutaneous coronary intervention. Soon after DESs were released on the market, however, there were reports of a potential increase in mortality and of early or late thrombosis. In addition, DESs are far more expensive than bare-metal stents (BMSs), which has led to their limited use in many countries. The technology has improved over the last few years with the second generation of DESs (DES-2). Moreover, costs have come down and an improved safety profile with decreased thrombosis has been reported. Objective Perform a cost-benefit analysis of DES-2s versus BMSs in the context of a publicly funded university hospital in Quebec, Canada. Methods A systematic review of meta-analyses was conducted between 2012 and 2016 to extract data on clinical effectiveness. The clinical outcome of interest for the cost-benefit analysis was target-vessel revascularization (TVR). Cost units are those used in the Quebec healthcare system. The cost-benefit analysis was based on a 2-year perspective. Deterministic and stochastic models (discrete-event simulation) were used, and various risk factors of reintervention were considered. Results DES-2s are much more effective than BMSs with respect to TVR rate ratio (i.e., 0.29 to 0.62 in more recent meta-analyses). DES-2s seem to cause fewer deaths and in-stent thrombosis than BMSs, but results are rarely significant, with the exception of the cobalt-chromium everolimus DES. The rate ratio of myocardial infraction is systematically in favor of DES-2s and very often significant. Despite the higher cost of DES-2s, fewer reinterventions can lead to huge savings (i.e., -$ 479 to -$ 769 per patient). Moreover, the higher a patient's risk of reintervention, the higher the savings associated with the use of DES-2s. Conclusion Despite the higher purchase cost of DES-2s compared to BMSs, generalizing their use, in particular for patients at high risk of reintervention, should enable significant savings.	[Poder, Thomas G.] UETMIS, Sherbrooke, PQ, Canada; [Poder, Thomas G.] CHUS, CIUSSS Estrie, CRCHUS, Sherbrooke, PQ, Canada; [Poder, Thomas G.] Univ Sherbrooke, Dept Econ, Sherbrooke, PQ, Canada; [Poder, Thomas G.] Univ Sherbrooke, Ecole Gest, GREDI, Sherbrooke, PQ, Canada; [Erraji, Jihane; Koffi, Kouame] Univ Auvergne, CERDI, Clermont Ferrand, France; [Coulibaly, Lucien P.] Univ Sherbrooke, FMSS, Ecole Readaptat, Sherbrooke, PQ, Canada; [Koffi, Kouame] Univ Felix Houphouet Boigny, UFR Sci Pharmaceut, Dept Sante Publ, Abidjan, Cote Ivoire	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; Universite Clermont Auvergne (UCA); University of Sherbrooke	Poder, TG (corresponding author), UETMIS, Sherbrooke, PQ, Canada.; Poder, TG (corresponding author), CHUS, CIUSSS Estrie, CRCHUS, Sherbrooke, PQ, Canada.; Poder, TG (corresponding author), Univ Sherbrooke, Dept Econ, Sherbrooke, PQ, Canada.; Poder, TG (corresponding author), Univ Sherbrooke, Ecole Gest, GREDI, Sherbrooke, PQ, Canada.	tpoder.chus@ssss.gouv.qc.ca		Poder, Thomas/0000-0001-7017-096X	FRQS	FRQS	We are grateful to Martine Audibert, Suzanne K. Bedard, Christian Bellemare, Sylvain Bernier, Dr Simon Berube, Arianne Breton, Linda Cormier, Dr Pierre Dagenais, Helene Demers, Dr Veronique Dery, Dr Paul Farand, Linda Hubert, Andree Maltais, Serge Maltais, Monique Robillard, and Catherine Tremblay-Lavoie for their advice and support. TGP is member of the FRQS-funded Centre de recherche du CHUS (CRCHUS).	Bangalore S, 2013, CIRC-CARDIOVASC INTE, V6, P378, DOI 10.1161/CIRCINTERVENTIONS.113.000415; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bokov P, 2011, SANG THROMB VAISS, V23, P465, DOI 10.1684/stv.2011.0649; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Geng DF, 2013, CATHETER CARDIO INTE, V81, P1087, DOI 10.1002/ccd.24599; Kalesan B, 2012, EUR HEART J, V33, P977, DOI 10.1093/eurheartj/ehs036; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Palmerini T, 2013, J AM COLL CARDIOL, V62, P496, DOI 10.1016/j.jacc.2013.05.022; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Silvain J, 2014, M S-MED SCI, V30, P303, DOI 10.1051/medsci/20143003019; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Taniwaki M, 2015, EUROINTERVENTION, V11, P391, DOI 10.4244/EIJY14M07_12; Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; Valgimigli M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6427; Wang LP, 2014, ARQ BRAS CARDIOL, V102, P529, DOI 10.5935/abc.20140070; Willich SN, 2013, HERZ, V38, P57, DOI 10.1007/s00059-012-3581-5	20	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177476	10.1371/journal.pone.0177476	http://dx.doi.org/10.1371/journal.pone.0177476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498849	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314500019
J	Zhang, HW; Lu, JQ; Lu, YY; Zhou, JY; Wang, ZH; Liu, HO; Xu, CJ				Zhang, Hongwei; Lu, Jiaqi; Lu, Yingying; Zhou, Jiayi; Wang, Zehua; Liu, Haiou; Xu, Congjian			Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; RESPONSE MARKERS; IMMUNE-SYSTEM; SERUM-ALBUMIN; CANCER-CELLS; NEUTROPHIL; CHEMOTHERAPY; PLATELET; SURVIVAL	Chronic inflammation is a well-known epidemiologic factor of ovarian clear cell carcinomas (OCCC), but has an uncertain role in prognosis. We developed a systemic inflammation score (SIS) based on preoperative serum albumin and neutrophil-to-lymphocyte ratio (NLR) for predicting progression-free survival (PFS) and overall survival (OS) in OCCC patients. A retrospective review was performed in 155 patients with OCCC undergoing primary debulking and chemotherapy at a single institute between 1995 and 2010. Cox regression models were fitted to analyze the effect of prognostic factors on PFS and OS. Harrell's concordance index was calculated to assess predictive accuracy. The SIS consisting of serum albumin and NLR was retained as an independent indicator adjusting for traditional clinicopathological features. A high SIS was significantly associated with aggressive tumor behavior, platinum resistance, and served as an independent predictor of reduced PFS (P = 0.006) and OS (P = 0.019). The SIS had a good discrimination ability for the predictive PFS (c-index = 0.712) and OS (c-index = 0.722). We have developed a system inflammation score for predicting prognosis of OCCC patients, which may help stratify patients for postsurgical management.	[Zhang, Hongwei; Lu, Jiaqi; Xu, Congjian] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynaecol, Shanghai, Peoples R China; [Lu, Yingying; Zhou, Jiayi; Wang, Zehua; Liu, Haiou; Xu, Congjian] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China	Fudan University	Xu, CJ (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Gynaecol, Shanghai, Peoples R China.; Liu, HO; Xu, CJ (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China.	liuhaiou@fudan.edu.cn; xucongjian@gmail.com	Liu, Haiou/AFS-2886-2022	Liu, Haiou/0000-0003-0200-8981	National Natural Science Foundation of China [31570803, 81272879, 81402151]; National Key Research and Development Program [2016YFC1303101]; Research Program of Shanghai Municipal Commission of Health and Family Planning [20154Y0049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Research Program of Shanghai Municipal Commission of Health and Family Planning	This study was supported by grants from National Natural Science Foundation of China (31570803, 81272879, 81402151), National Key Research and Development Program (2016YFC1303101), Research Program of Shanghai Municipal Commission of Health and Family Planning (20154Y0049).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Asher V, 2011, CLIN TRANSL ONCOL, V13, P499, DOI 10.1007/s12094-011-0687-9; Ataseven B, 2015, GYNECOL ONCOL, V138, P560, DOI 10.1016/j.ygyno.2015.07.005; Campesi I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-4; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; ELHAG A, 1987, J IMMUNOL, V139, P2406; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; Granot Z, 2015, CANCER RES, V75, P4441, DOI 10.1158/0008-5472.CAN-15-1502; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kim HS, 2016, CANCER RES TREAT, V48, P250, DOI 10.4143/crt.2014.324; Klink M, 2008, SCAND J IMMUNOL, V68, P328, DOI 10.1111/j.1365-3083.2008.02139.x; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Nakamura K, 2016, ONCOL LETT, V11, P3975, DOI 10.3892/ol.2016.4513; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; PETRIE HT, 1985, J IMMUNOL, V134, P230; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Suryawanshi S, 2014, CLIN CANCER RES, V20, P6163, DOI 10.1158/1078-0432.CCR-14-1338; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Turner TB, 2016, GYNECOL ONCOL, V142, P349, DOI 10.1016/j.ygyno.2016.05.007; Wang Y, 2015, CANCER CHEMOTH PHARM, V75, P255, DOI 10.1007/s00280-014-2622-6; Wang YQ, 2016, CLIN CHIM ACTA, V456, P163, DOI 10.1016/j.cca.2016.03.013; Wei S, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19440; Williams KA, 2014, GYNECOL ONCOL, V132, P542, DOI 10.1016/j.ygyno.2014.01.026; Zhang WW, 2015, TUMOR BIOL, V36, P8831, DOI 10.1007/s13277-015-3533-9	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177520	10.1371/journal.pone.0177520	http://dx.doi.org/10.1371/journal.pone.0177520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498842	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314500025
J	Gitaka, J; Ogwang, C; Ngari, M; Akoo, P; Olotu, A; Kerubo, C; Fegan, G; Njuguna, P; Nyakaya, G; Otieno, T; Mwambingu, G; Awuondo, K; Lowe, B; Chilengi, R; Berkley, JA				Gitaka, Jesse; Ogwang, Caroline; Ngari, Moses; Akoo, Pauline; Olotu, Ally; Kerubo, Christine; Fegan, Greg; Njuguna, Patricia; Nyakaya, Godfrey; Otieno, Tuda; Mwambingu, Gabriel; Awuondo, Ken; Lowe, Brett; Chilengi, Roma; Berkley, James A.			Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study	PLOS ONE			English	Article							IMMUNOLOGICAL REFERENCE VALUES; PEDIATRIC REFERENCE INTERVALS; PLASMODIUM-FALCIPARUM; AFRICAN CHILDREN; REFERENCE RANGES; COAST; POPULATION; VARIABLES; INFANTS; ANEMIA	Reference intervals for clinical laboratory parameters are important for assessing eligibility, toxicity grading and management of adverse events in clinical trials. Nonetheless, haematological and biochemical parameters used for clinical trials in sub-Saharan Africa are typically derived from industrialized countries, or from WHO references that are not region-specific. We set out to establish community reference values for haematological and biochemical parameters amongst children aged 4 weeks to 17 months in Kilifi, Kenya. We conducted a cross sectional study nested within phase II and III trials of RTS, S malaria vaccine candidate. We analysed 10 haematological and 2 biochemical parameters from 1,070 and 423 community children without illness prior to experimental vaccine administration. Statistical analysis followed Clinical and Laboratory Standards Institute EP28-A3c guidelines. 95% reference ranges and their respective 90% confidence intervals were determined using non-parametric methods. Findings were compared with published ranges from Tanzania, Europe and The United States. We determined the reference ranges within the following age partitions: 4 weeks to < 6 months, 6 months to less than < 12 months, and 12 months to 17 months for the haematological parameters; and 4 weeks to 17 months for the biochemical parameters. There were no gender differences for all haematological and biochemical parameters in all age groups. Hb, MCV and platelets 95% reference ranges in infants largely overlapped with those from United States or Europe, except for the lower limit for Hb, Hct and platelets (lower); and upper limit for platelets (higher) and haematocrit(lower). Community norms for common haematological and biochemical parameters differ from developed countries. This reaffirms the need in clinical trials for locally derived reference values to detect deviation from what is usual in typical children in low and middle income countries.	[Gitaka, Jesse; Ogwang, Caroline; Ngari, Moses; Akoo, Pauline; Olotu, Ally; Kerubo, Christine; Fegan, Greg; Njuguna, Patricia; Nyakaya, Godfrey; Otieno, Tuda; Mwambingu, Gabriel; Awuondo, Ken; Lowe, Brett; Berkley, James A.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Clin Trials Facil, Kilifi, Kenya; [Gitaka, Jesse] Mt Kenya Univ, Sch Hlth Sci, Dept Clin Med, Thika, Kenya; [Ngari, Moses; Berkley, James A.] Childhood Acute Illness & Nutr Network CHAIN, Nairobi, Kenya; [Fegan, Greg; Lowe, Brett; Berkley, James A.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Fegan, Greg] Swansea Univ, Med Sch, Swansea Trials Unit, Swansea, W Glam, Wales; [Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia	Kenya Medical Research Institute; Mount Kenya University; University of Oxford; Swansea University	Gitaka, J (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Clin Trials Facil, Kilifi, Kenya.; Gitaka, J (corresponding author), Mt Kenya Univ, Sch Hlth Sci, Dept Clin Med, Thika, Kenya.	jgitaka@mku.ac.ke	Fegan, Greg W/O-8079-2018	Fegan, Greg W/0000-0002-2663-2765; Berkley, James/0000-0002-1236-849X; Ngari, Moses/0000-0001-7149-5491; Gitaka, Jesse/0000-0001-7516-522X; /0000-0001-9585-3820				Adeli K, 2014, CLIN BIOCHEM, V47, P737, DOI 10.1016/j.clinbiochem.2014.05.037; Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; [Anonymous], 2008, EP28A3C CLSI, VThird; [Anonymous], 2008, DEF EST VER REF INT, P28; [Anonymous], 2009, MANSONS TROPICAL DIS; ASHFORD RW, 1992, ANN TROP MED PARASIT, V86, P671, DOI 10.1080/00034983.1992.11812724; Atkinson SH, 2014, BLOOD, V123, P3221, DOI 10.1182/blood-2013-10-533000; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Buchanan AM, 2010, TROP MED INT HEALTH, V15, P1011, DOI 10.1111/j.1365-3156.2010.02585.x; BURRITT MF, 1990, MAYO CLIN PROC, V65, P329, DOI 10.1016/S0025-6196(12)62533-6; Campbell DI, 2003, PEDIATR RES, V54, P306, DOI 10.1203/01.PDR.0000076666.16021.5E; CASTRO OL, 1987, PUBLIC HEALTH REP, V102, P232; Ceriotti F, 2009, ANN CLIN BIOCHEM, V46, P8, DOI 10.1258/acb.2008.008170; Clement E., 2012, BLOOD CELL OVERVIEW, P18; Crane RJ, 2015, FOOD NUTR BULL, V36, pS76, DOI 10.1177/15648265150361S113; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; DoAI Syndrome, 2004, DIV AIDS TABL GRAD S; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; GOMEZ P, 1984, CLIN CHEM, V30, P407; Humberg A, 2011, TROP MED INT HEALTH, V16, P343, DOI 10.1111/j.1365-3156.2010.02705.x; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kumwenda NI, 2012, PAEDIATR INT CHILD H, V32, P213, DOI 10.1179/2046905512Y.0000000034; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Leon-Velarde F, 2000, High Alt Med Biol, V1, P97; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; LUNEL F, 1989, INFECT IMMUN, V57, P2043, DOI 10.1128/IAI.57.7.2043-2049.1989; Lusingu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014090; Maiga D, 2009, VACCINE, V27, P7249, DOI 10.1016/j.vaccine.2009.08.113; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Marsh VM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-13; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Obeid R, 2002, EUR J HAEMATOL, V69, P275, DOI 10.1034/j.1600-0609.2002.02798.x; Odutola AA, 2014, TROP MED INT HEALTH, V19, P275, DOI 10.1111/tmi.12245; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Omosa-Manyonyi GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014580; Pickett JA, 2007, PHYTOCHEMISTRY, V68, P2937, DOI 10.1016/j.phytochem.2007.09.025; PUKRITTAYAKAMEE S, 1989, T ROY SOC TROP MED H, V83, P762, DOI 10.1016/0035-9203(89)90321-0; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; Schafer AI, 2004, NEW ENGL J MED, V350, P1211, DOI 10.1056/NEJMra035363; Schnabl Kareena, 2008, Clin Biochem Rev, V29, P89; Smith OP., 2006, PEDIAT HEMATOLOGY, P792, DOI [10.1002/9780470987001, DOI 10.1002/9780470987001]; Spraggs C, 2007, PHARMACOGENET GENOM, V17, P1065, DOI 10.1097/FPC.0b013e3282f1b2d7; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; Tukey JW, 1977, EXPLORATORY DATA ANA; VINCENTVIRY M, 1990, ANN HUM BIOL, V17, P277, DOI 10.1080/03014469000001052; WHO, 2011, WHO TECH REP SER, V959, P1; Williams TN, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011692; Wolber EM, 2001, THROMB HAEMOSTASIS, V86, P1421; World Health Organization, 2014, HAEM CONC DIAGN AN A; YIP R, 1984, AM J CLIN NUTR, V39, P427, DOI 10.1093/ajcn/39.3.427; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	58	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177382	10.1371/journal.pone.0177382	http://dx.doi.org/10.1371/journal.pone.0177382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493930	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000401314300098
J	Inoue, M; Horimoto, K				Inoue, Masayo; Horimoto, Katsuhisa			Relationship between regulatory pattern of gene expression level and gene function	PLOS ONE			English	Article							GENOME-WIDE; UBIQUITIN; DNA; DEGRADATION; SEQUENCE; COMPLEX; DRAFT; MAP; P53	Regulation of gene expression levels is essential for all living systems and transcription factors (TFs) are the main regulators of gene expression through their ability to repress or induce transcription. A balance between synthesis and degradation rates controls gene expression levels. To determine which rate is dominant, we analyzed the correlation between expression levels of a TF and its regulated gene based on a mathematical model. We selected about 280,000 expression patterns of 355 TFs and 647 regulated genes using DNA microarray data from the Gene Expression Omnibus (GEO) data repository. Based on our model, correlation between the expressions of TF-regulated gene pairs corresponds to tuning of the synthesis rate, whereas no correlation indicates excessive synthesis and requires tuning of the degradation rate. The gene expression relationships between TF-regulated gene pairs were classified into four types that correspond to different gene regulatory mechanisms. It was surprising that fewer than 20% of these genes were governed by the familiar regulatory mechanism, i.e., through the synthesis rate. Moreover, we performed pathway analysis and found that each classification type corresponded to distinct gene functions: cellular regulation pathways were dominant in the type with synthesis rate regulation and terms associated with diseases such as cancer, Parkinson's disease, and Alzheimer's disease were dominant in the type with degradation rate regulation. Interestingly, these diseases are caused by the accumulation of proteins. These results indicated that gene expression is regulated structurally, not arbitrarily, according to the gene function. This funding is indicative of a systematic control of transcription processes at the whole-cell level.	[Inoue, Masayo; Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Inoue, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan.	inoue.m@aist.go.jp		Inoue, Masayo/0000-0002-2699-7879	National Cancer Center Research and Development Fund from National Cancer Center Japan [26-A-6]	National Cancer Center Research and Development Fund from National Cancer Center Japan	MI received The National Cancer Center Research and Development Fund (26-A-6) from National Cancer Center Japan (http://www.ncc.go.jp/en/index.html). This study is designed according to the plan document. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2008, MOL BIOL CELL, VFifth; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S24; Bilban Martin, 2002, Current Issues in Molecular Biology, V4, P57; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eser P, 2014, MOL SYST BIOL, V10; GOMPERTS BD, 2002, SIGNAL TRANSDUCTION; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Irizarry AR, 2006, BIOSTATISTICS, V22, P789; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Munoz J, 2014, ANGEW CHEM INT EDIT, V53, P10864, DOI 10.1002/anie.201406545; Orntoft TF, 2002, MOL CELL PROTEOMICS, V1, P37, DOI 10.1074/mcp.M100019-MCP200; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	38	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177430	10.1371/journal.pone.0177430	http://dx.doi.org/10.1371/journal.pone.0177430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494005	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300107
J	Lucyk, K; McLaren, L				Lucyk, Kelsey; McLaren, Lindsay			Taking stock of the social determinants of health: A scoping review	PLOS ONE			English	Review							PUBLIC-HEALTH; POPULATION HEALTH; WELFARE REGIMES; INEQUALITIES; POLICY; DISPARITIES; EQUITY; BARRIERS; CANADA; INTEGRATION	Background In recent decades, the social determinants of health ( SDOH) has gained increasing prominence as a foundational concept for population and public health in academic literature and policy documents, internationally. However, alongside its widespread dissemination, and in light of multiple conceptual models, lists, and frameworks, some dilution and confusion is apparent. This scoping review represents an attempt to take stock of SDOH literature in the context of contemporary population and public health. Methods We conducted a scoping review to synthesize and map SDOH literature, informed by the methods of Arksey and O'Malley (2005). We searched 5 academic and 3 grey literature databases for "social determinants of health" and "population health" or "public health" or "health promotion,"published 2004-2014. We also conducted a search on "inequity" or "inequality" or " disparity " or " social gradient" and "Canad*" to ensure that we captured articles where this language was used to discuss the SDOH. We included articles that discussed SDOH in depth, either explicitly or in implicit but nuanced ways. We hand-searched reference lists to further identify relevant articles. Findings Our synthesis of 108 articles showed wide variation by study setting, target audience, and geographic scope, with most articles published in an academic setting, by Canadian authors, for policy-maker audiences. SDOH were communicated by authors as a list, model, or story; each with strengths and weaknesses. Thematic analysis identified one theme: health equity as an overarching and binding concept to the SDOH. Health equity was understood in different ways with implications for action on the SDOH. Conclusions Among the vast SDOH literature, there is a need to identify and clearly articulate the essence and implications of the SDOH concept. We recommend that authors be intentional in their efforts to present and discuss SDOH to ensure that they speak to its foundational concept of health equity.	[Lucyk, Kelsey; McLaren, Lindsay] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada	University of Calgary	Lucyk, K (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.	klucyk@ucalgary.ca			Alberta Innovates-Health Solutions Graduate Studentship; Achievers in Medical Sciences recruitment scholarship from the University of Calgary; Applied Public Health Chair - Canadian Institutes of Health Research (Institute of Population and Public Health; Institute of Musculoskeletal Health and Arthritis); Public Health Agency of Canada; Alberta Innovates D Health Solutions; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions Graduate Studentship; Alberta Innovates [201400593, 201400083] Funding Source: researchfish	Alberta Innovates-Health Solutions Graduate Studentship; Achievers in Medical Sciences recruitment scholarship from the University of Calgary; Applied Public Health Chair - Canadian Institutes of Health Research (Institute of Population and Public Health; Institute of Musculoskeletal Health and Arthritis)(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Alberta Innovates D Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions Graduate Studentship; Alberta Innovates	LM is supported by an Applied Public Health Chair funded by the Canadian Institutes of Health Research (Institute of Population and Public Health; Institute of Musculoskeletal Health and Arthritis); the Public Health Agency of Canada; and Alberta Innovates - Health Solutions. URL: http:// www.cihr-irsa.gc.cat/e/48898.html. KL is supported by an Alberta Innovates - Health Solutions Graduate Studentship and an Achievers in Medical Sciences recruitment scholarship from the University of Calgary.; During the time of writing, Kelsey Lucyk was supported by an Alberta Innovates-Health Solutions Graduate Studentship and an Achievers in Medical Sciences recruitment scholarship from the University of Calgary. Lindsay McLaren is supported by an Applied Public Health Chair funded by the Canadian Institutes of Health Research (Institute of Population and Public Health; Institute of Musculoskeletal Health and Arthritis); the Public Health Agency of Canada; and Alberta Innovates D Health Solutions.	Adelson N, 2005, CAN J PUBLIC HEALTH, V96, pS45, DOI 10.1007/BF03403702; Amaro H, 2014, AM J PUBLIC HEALTH, V104, P964, DOI 10.2105/AJPH.2014.302032; [Anonymous], 2013, CANADIAN MEDICAL ASS; [Anonymous], 2006, WHITEHEAD M DGLU PAR; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Ashcroft R, 2010, HEALTH SOC WORK, V35, P249, DOI 10.1093/hsw/35.4.249; Association of Faculties of Medicine of Canada, 2010, THE FUTURE OF MEDICA; Bahadori M, 2015, IRAN J PUBLIC HEALTH, V44, P728; Bambra C., 2010, Journal of Epidemiology & Community Health, V64, P284, DOI 10.1136/jech.2008.082743; Bartley M., 2003, UNDERSTANDING HEALTH; Black D., 1980, INEQUALITIES IN HEAL; Blane D, 1999, SOCIAL DETERMINANTS; Borrell C, 2009, J PUBLIC HEALTH POL, V30, P189, DOI 10.1057/jphp.2009.17; Brassolotto J, 2014, CRIT PUBLIC HEALTH, V24, P321, DOI 10.1080/09581596.2013.820256; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062; Brennenstuhl S, 2012, J EPIDEMIOL COMMUN H, V66, P397, DOI 10.1136/jech-2011-200277; Bryant T, 2011, HEALTH POLICY, V101, P44, DOI 10.1016/j.healthpol.2010.08.022; Burris S, 2010, J LAW MED ETHICS, V38, P580, DOI 10.1111/j.1748-720X.2010.00513.x; Canadian Council on Social Determinants of Health, 2013, COMMUNICATING THE SO; Canadian Council on Social Determinants of Health, 2015, A REVIEW OF FRAMEWOR, P76; Canadian Nurses Association, 2005, SOCIAL DETERMINANTS; Canadian Public Health Association, WHAT ARE THE SOCIAL; Carey G, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0207-6; Carey G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1979-8; Cohen BE, POPULATION HEALTH AS; Commission on the Social Determinants of Health, CLOSING THE GAP IN A; Committee on Assuring the Health of the Public in the 21st Century, 2002, FUTURE OF THE PUBLIC; de Andrade LOM, 2014, LANCET; De Maio Fernando, 2013, R I Med J (2013), V96, P15; Dolatian Mahrokh, 2012, Glob J Health Sci, V5, P52, DOI 10.5539/gjhs.v5n1p52; Dunn JR, 1999, CAN J PUBLIC HEALTH, V90, pS7, DOI 10.1007/BF03403570; Dyck M., 2009, SOCIAL DETERMINANTS; Eastern Mediterranean Regional Office, 2008, SOCIAL DETERMINANTS; Eastern Mediterranean Regional Office, 2008, BUILDING THE KNOWLED; Embrett MG, 2014, SOC SCI MED, V108, P147, DOI 10.1016/j.socscimed.2014.03.004; EVANS RG, 1990, SOC SCI MED, V31, P1347, DOI 10.1016/0277-9536(90)90074-3; Fazalullasha F, 2014, FROM OFFICE TOOLS TO, V4, P195; Fox AM, 2009, BIOETHICS, V23, P112, DOI 10.1111/j.1467-8519.2008.00718.x; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Frohlich KL, 2006, HEALTH POLICY, V79, P132, DOI 10.1016/j.healthpol.2005.12.010; Gibson Linda, 2012, Br J Nurs, V21, P128; Graham AL, 2004, BRIEFING PAPER; Graham H, 2004, J SOC POLICY, V33, P115, DOI 10.1017/S0047279403007220; Graham H, 2004, MILBANK Q, V82, P101, DOI 10.1111/j.0887-378X.2004.00303.x; Graham H., 2007, UNEQUAL LIVES HEALTH; Guruge S, 2015, J AGING RESEARCH, V12, P12; Gustafsson PE, 2014, AM J PUBLIC HEALTH, V104, P904, DOI 10.2105/AJPH.2013.301707; Hamilton N, 1996, POPULATION HEALTH PR; Health Officers Council of BC, 2008, HEALTH INEQUITIES IN; Healthy Public Policy Health Promotion Disease and Injury Prevention, 2011, SOCIAL ENVIRONMENTS; Hertzman C, 2000, ISUMA, V1, P11; Hurrelmann K, 2011, J PUBLIC HEALTH-HEID, V19, P3, DOI 10.1007/s10389-010-0359-1; King A., 2010, PUBLIC HEALTH D EVER; Knight R, 2014, CRIT PUBLIC HEALTH, V24, P283, DOI 10.1080/09581596.2013.800188; Koh HK, 2011, HEALTH EDUC BEHAV, V38, P551, DOI 10.1177/1090198111428646; Koh HK, 2010, AM J PUBLIC HEALTH, V100, pS72, DOI 10.2105/AJPH.2009.167353; Krippendorff K., 2013, CONTENT ANALYSIS AN; Lalonde M., 1974, A NEW PERSPECTIVE ON; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Liu David M K I, 2011, Hawaii Med J, V70, P9; Loppie Reading C., 2009, HEALTH INEQUALITIES; Lucyk K., 2016, CANADIAN JOURNAL OF, V41, P632; Macdonald JJ, 2010, SOC ALTERN, V29, P34; Manzano AT, 2010, CAN J PUBLIC HEALTH, V101, P399, DOI 10.1007/BF03404861; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M., 2005, PUBLIC HEALTH; Marmot M., 2010, FAIR SOCIETY HEALTHY; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; McDowell I., SOCIETY THE INDIVIDU; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McIntyre Lynn, 2013, BMC Res Notes, V6, P247, DOI 10.1186/1756-0500-6-247; McKay L., 2000, MAKING THE LALONDE R; Mikkonen J., 2010, SOCIAL DETERMINANTS; Moore P., SOCIAL FACTORS ARE K, V82, P807; Morrison V., 2014, KEYWORDS IN HEALTHY; Muntaner C, 2008, J PUBLIC HEALTH POL, V29, P299, DOI 10.1057/jphp.2008.23; Muntaner C, 2011, SOCIOL HEALTH ILL, V33, P946, DOI 10.1111/j.1467-9566.2011.01339.x; Muntaner C, 2009, J PUBLIC HEALTH POL, V30, P163, DOI 10.1057/jphp.2009.15; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; NAT'L COLLABORATING CTR. FOR DETERMINANTS OF HEALTH, 2013, LETS TALK UNIVERSAL; National Collaborating Centre for Determinants of Health, 2014, LETS TALK MOVING UPS; Nesdole R, 2014, CAN J PUBLIC HEALTH, V105, pE209, DOI 10.17269/cjph.105.4308; Nexus H., 2008, PRIMER TO ACTION SOC; Niederdeppe J, 2008, MILBANK Q, V86, P481, DOI 10.1111/j.1468-0009.2008.00530.x; Nuffield Council on Bioethics, 2014, PUBLIC HEALTH ETHICA; O'Campo P, 2012, J URBAN HEALTH, V89, P881, DOI 10.1007/s11524-012-9695-5; Office of Disease Prevention and Health Promotion, SOCIAL DETERMINANTS; Popay J, 1998, SOCIOL HEALTH ILL, V20, P619, DOI 10.1111/1467-9566.00122; Potvin L, 2005, AM J PUBLIC HEALTH, V95, P591, DOI 10.2105/AJPH.2004.048017; Public Health Agency of Canada, 2011, WHAT DETERMINES HEAL; Public Health Agency of Canada, CANADAS RESPONSE TO; Public Health Agency of Canada, WHAT DETERMINES HEAL; Public Health Agency of Canada, 2004, WHAT IS THE POPULATI; QSR international Pty LTD, 2014, NVIVO QUALITATIVE DA; Raphael D., 2008, SOCIAL DETERMINANTS, P2; Raphael D., 2009, ESCAPING FROM THE PH; Raphael D., 2014, HLTH PROMOT INT; Raphael D., 2007, CANADIAN REVIEW OF S, V59, P76; Raphael D, 2015, COMMUNICATION; Raphael D., 2009, SOCIAL DETERMINANTS; Raphael D., 2008, SOCIAL DETERMINANTS, P20; Raphael Dennis, 2008, Promot Educ, V15, P15, DOI 10.1177/1025382308095650; Raphael D, 2008, HEALTH POLICY, V88, P222, DOI 10.1016/j.healthpol.2008.03.015; Raphael Dennis, 2006, Promot Educ, V13, P236; Raphael Dennis, 2004, Health Promot Int, V19, P269, DOI 10.1093/heapro/dah214; Raphael D, 2011, CRIT PUBLIC HEALTH, V21, P221, DOI 10.1080/09581596.2010.485606; Raphael D, 2009, HEALTH PROMOT INT, V24, P193, DOI 10.1093/heapro/dap005; Regidor E, 2006, J EPIDEMIOL COMMUN H, V60, P896, DOI 10.1136/jech.2005.044859; Richmond CAM, 2009, HEALTH PLACE, V15, P403, DOI 10.1016/j.healthplace.2008.07.004; Russell E, 2013, REV PANAM SALUD PUBL, V34, P461; Schofield T, 2007, HEALTH SOCIOL REV, V16, P105, DOI 10.5172/hesr.2007.16.2.105; Schrecker T., 2013, HOW TO THINK ABOUT S; Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020, 2010, DEVELOPING HEALTHY P; Solar O, 2007, A CONCEPTUAL FRAMEWO; Sparks M, 2009, HEALTH PROMOT INT, V24, P199, DOI 10.1093/heapro/dap027; Subcommittee on Population Health, 2009, SENATE COMMITTEE REP; Szaflarski M, 2014, EPILEPSY BEHAV, V41, P283, DOI 10.1016/j.yebeh.2014.06.013; Tarlov A., 1996, HEALTH AND SOCIAL OR, P69; van Kemenade S., 2003, SOCIAL CAPITAL AS A; Walker RJ, 2014, ENDOCRINE, V47, P29, DOI 10.1007/s12020-014-0195-0; Whitehead M., 1991, HEALTH PROMOT INT, V6, P217, DOI [10.1093/heapro/6.3.217, DOI 10.1093/HEAPRO/6.3.217, 10.2190/986llhq6-2vte-yrrn, DOI 10.2190/986LLHQ6-2VTE-YRRN]; Whitehead M, 2007, J EPIDEMIOL COMMUN H, V61, P473, DOI 10.1136/jech.2005.037242; Whiteside M, 2004, AUSTR SOCIAL WORK, V57, P381, DOI DOI 10.1111/J.0312-407X.2004.00168.X; Wiley Lindsay F., 2016, PUBL HLTH LAW POW, V3rd; Wilkinson RG, 2003, SOCIAL DETERMINANTS; Williams, 2005, CRITICAL PUBLIC HLTH, V15, P5, DOI DOI 10.1080/09581590500048192; Williams-Brennan L, 2012, ARCH GYNECOL OBSTET, V286, P1487, DOI 10.1007/s00404-012-2575-0; World Health Organization, HLTH PROMOTION; World Health Organization, 1986, OTTAWA CHARTER FOR H	133	55	56	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177306	10.1371/journal.pone.0177306	http://dx.doi.org/10.1371/journal.pone.0177306			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493934	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300083
J	Lloris-Carsi, JM; Barrios, C; Prieto-Moure, B; Lloris-Cejalvo, JM; Cejalvo-Lapena, D				Miguel Lloris-Carsi, Jose; Barrios, Carlos; Prieto-Moure, Beatriz; Miguel Lloris-Cejalvo, Jose; Cejalvo-Lapena, Dolores			The effect of biological sealants and adhesive treatments on matrix metalloproteinase expression during renal injury healing	PLOS ONE			English	Article							IN-VITRO; PARTIAL NEPHRECTOMY; TISSUE; CYANOACRYLATE; FIBROBLASTS; MMP-9; INFLAMMATION; MANAGEMENT; FIBROSIS; DISEASE	Background Renal injuries are relatively common in cases of abdominal trauma. Adhesives and sealants can be used to repair and preserve damaged organs. Using a rat model, this study explores the activity of different matrix metalloproteinases (MMP) during the healing of renal injuries treated by two biological adhesives (TachoSil and GelitaSpon) and a new synthetic elastic cyanoacrylate (Adhflex). Methods Renal traumatic injuries were experimentally induced in 90 male Wistar rats by a Stiefel Biopsy Punch in the anterior aspect of the left kidney. Animals were divided into five groups: 1, sham non-injured (n = 3); 2, non-treated standard punch injury (n = 6); 3, punch injury treated with TachoSil (n = 27); 4, punch injury treated with GelitaSpon (n = 27); and, 5, punch injury treated with Adhflex (n = 27). Wound healing was evaluated 2, 6, and 18 days after injury by determining the expression of MMPs, and the histopathological evolution of lesions. Findings Histologically, the wound size at 6 days post-injury was larger in Adhflex-treated samples than in the other treatments, but the scarring tissue was similar at 18 days post-injury. Only the MMPs subtypes 1, 2, 8, 9, and 13 were sufficiently expressed to be quantifiable. Both time since injury and treatment type had a significant influence on MMPs expression. Two days after injury, the expression of MMP8 and MMP9 was predominant. MMP2 expression was greater 6 days after injury. The Adhflex-treated group had a significantly higher MMPs expression than the other treatment groups at all healing stages. Conclusions All three sealant treatments induced almost similar expression of MMPs than untreated animals indicating a physiological healing process. Given that all renal trauma injuries must be considered emergencies, both biological and synthetic adhesives, such as Adhflex, should be considered as a treatment options.	[Miguel Lloris-Carsi, Jose] Univ Valencia, Dept Surg, Valencia, Spain; [Barrios, Carlos; Prieto-Moure, Beatriz; Miguel Lloris-Cejalvo, Jose; Cejalvo-Lapena, Dolores] Valencia Catholic Univ, Div Expt Surg, Valencia, Spain	University of Valencia; Universidad Catolica de Valencia San Vicente Martir	Lloris-Carsi, JM (corresponding author), Univ Valencia, Dept Surg, Valencia, Spain.	jm_lloris@mac.com	Moure, Beatriz Prieto/U-8171-2019; Lloris-Carsi, Jose/AAA-4891-2019; Cejalvo-Lapeña, D/AAA-4718-2019	Cejalvo-Lapeña, D/0000-0003-4825-1856; Lloris Carsi, Jose Miguel/0000-0002-8685-5936; Barrios, Carlos/0000-0002-6657-7246	Universidad Catolica de Valencia (Ayudas a la investigacion cientifica)	Universidad Catolica de Valencia (Ayudas a la investigacion cientifica)	The authors received funding by Universidad Catolica de Valencia (Ayudas a la investigacion cientifica 2015-2016).	Aslan G, 2005, INT J UROL, V12, P838, DOI 10.1111/j.1442-2042.2005.01169.x; Astrom P, 2014, EXP CELL RES, V328, P217, DOI 10.1016/j.yexcr.2014.07.010; Bathia SK, 2010, SPRINGER SCI BUSINES, P227; Beidler SK, 2008, WOUND REPAIR REGEN, V16, P642, DOI 10.1111/j.1524-475X.2008.00415.x; Brumann M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/435463; Butt MU, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-19; Caron A, 2005, EXP CELL RES, V310, P105, DOI 10.1016/j.yexcr.2005.07.004; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Consolo M, 2009, INT J MOL MED, V24, P143, DOI 10.3892/ijmm_00000217; Danielsen PL, 2011, SURGERY, V150, P897, DOI 10.1016/j.surg.2011.06.016; Davila F, 2009, REV SANID MILIT MEX, V63, P182; dos Santos OJ, 2012, ACTA CIR BRAS, V27, P624, DOI 10.1590/S0102-86502012000900006; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Gibson DJ, 2013, ADV WOUND CARE, V2, P18, DOI 10.1089/wound.2011.0359; Grinnell F, 1998, J INVEST DERMATOL, V110, P771, DOI 10.1046/j.1523-1747.1998.00192.x; Groen J, 2016, EUR UROL, V69, P324, DOI 10.1016/j.eururo.2015.07.071; Haas CS, 2004, CONNECT TISSUE RES, V45, P73, DOI 10.1080/03008200490442644; Hata S, 2014, J PHARMACOL SCI, V124, P230, DOI 10.1254/jphs.13209FP; Inkinen K, 2000, APMIS, V108, P318, DOI 10.1034/j.1600-0463.2000.d01-63.x; Johnston WK, 2006, J UROLOGY, V175, P2307, DOI 10.1016/S0022-5347(06)00282-5; Kang Young-Mi, 2016, J Bone Metab, V23, P165, DOI 10.11005/jbm.2016.23.3.165; Kim SH, 2009, KOREAN J RADIOL, V10, P377, DOI 10.3348/kjr.2009.10.4.377; Lanchon C, 2016, J UROLOGY, V195, P106, DOI 10.1016/j.juro.2015.07.100; Li HW, 2013, JAMA FACIAL PLAST SU, V15, P448, DOI 10.1001/jamafacial.2013.1211; Lloris-Carsi JM, 2016, WOUND REPAIR REGEN, V24, P568, DOI 10.1111/wrr.12424; Lloris-Carsi JM, 2016, EUR SURG RES, V56, P164, DOI 10.1159/000444320; Muto G, 2005, J UROLOGY, V174, P2239, DOI 10.1097/01.ju.0000181809.51544.20; Nessler MB, 2014, MED SCI MONITOR, V20, P91, DOI 10.12659/MSM.889135; Pursifull NF, 2007, CURR OPIN UROL, V17, P396, DOI 10.1097/MOU.0b013e3282f0d683; Ravanti L, 2000, INT J MOL MED, V6, P391; Salmela MT, 2004, SCAND J GASTROENTERO, V39, P1095, DOI 10.1080/00365520410003470; SALO T, 1994, LAB INVEST, V70, P176; Sheets AR, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0946-1; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; STERN R, 1990, Journal of Burn Care and Rehabilitation, V11, P7, DOI 10.1097/00004630-199001000-00003; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596; Toriseva MJ, 2007, J INVEST DERMATOL, V127, P49, DOI 10.1038/sj.jid.5700500; van der Wilden GM, 2013, JAMA SURG, V148, P924, DOI 10.1001/jamasurg.2013.2747; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Yamamoto K, 2015, MATRIX BIOL, V44-46, P255, DOI 10.1016/j.matbio.2015.02.007	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177665	10.1371/journal.pone.0177665	http://dx.doi.org/10.1371/journal.pone.0177665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494022	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300150
J	Sung, W; Park, JI; Kim, JI; Carlson, J; Ye, SJ; Park, JM				Sung, Wonmo; Park, Jong In; Kim, Jung-In; Carlson, Joel; Ye, Sung-Joon; Park, Jong Min			Monte Carlo simulation for scanning technique with scattering foil free electron beam: A proof of concept study	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; TOTAL SCALP IRRADIATION; CANCER-TREATMENT; PHOTON BEAMS; RADIOTHERAPY; IMRT; OPTIMIZATION; DOSIMETRY; CARCINOMA; MLC	This study investigated the potential of a newly proposed scattering foil free (SFF) electron beam scanning technique for the treatment of skin cancer on the irregular patient surfaces using Monte Carlo (MC) simulation. After benchmarking of the MC simulations, we removed the scattering foil to generate SFF electron beams. Cylindrical and spherical phantoms with 1 cm boluses were generated and the target volume was defined from the surface to 5 mm depth. The SFF scanning technique with 6 MeV electrons was simulated using those phantoms. For comparison, volumetric modulated arc therapy (VMAT) plans were also generated with two full arcs and 6 MV photon beams. When the scanning resolution resulted in a larger separation between beams than the field size, the plan qualities were worsened. In the cylindrical phantom with a radius of 10 cm, the conformity indices, homogeneity indices and body mean doses of the SFF plans (scanning resolution = 1 degrees) vs. VMAT plans were 1.04 vs. 1.54, 1.10 vs. 1.12 and 5 Gy vs. 14 Gy, respectively. Those of the spherical phantom were 1.04 vs. 1.83, 1.08 vs. 1.09 and 7 Gy vs. 26 Gy, respectively. The proposed SFF plans showed superior dose distributions compared to the VMAT plans.	[Sung, Wonmo; Park, Jong In; Carlson, Joel; Ye, Sung-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Program Biomed Radiat Sci, Seoul, South Korea; [Kim, Jung-In; Park, Jong Min] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Kim, Jung-In; Park, Jong Min] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Kim, Jung-In; Ye, Sung-Joon; Park, Jong Min] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Robot Res Lab Extreme Environm, Inst Smart Syst, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, JM (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Park, JM (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Park, JM (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.; Park, JM (corresponding author), Adv Inst Convergence Technol, Robot Res Lab Extreme Environm, Inst Smart Syst, Suwon, South Korea.	leodavinci@naver.com	Sung, Wonmo/AAR-3980-2021	Sung, Wonmo/0000-0002-0172-0646; Park, Jong Min/0000-0003-3617-3870	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1C1A1A01054192]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2015R1C1A1A01054192).	Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; Andreassen B, 2011, MED PHYS, V38, P4774, DOI 10.1118/1.3615059; Connell T, 2012, PHYS MED BIOL, V57, P3259, DOI 10.1088/0031-9155/57/11/3259; du Plessis FCP, 2006, PHYS MED BIOL, V51, P2113, DOI 10.1088/0031-9155/51/8/011; Eldib A, 2014, PHYS MED BIOL, V59, P819, DOI 10.1088/0031-9155/59/4/819; Hardcastle N, 2008, MED PHYS, V35, P5061, DOI 10.1118/1.2996288; Hyodynmaa S, 1996, MED PHYS, V23, P659, DOI 10.1118/1.597710; Inoue M, 2014, J APPL CLIN MED PHYS, V15, P152, DOI 10.1120/jacmp.v15i4.4786; Salguero FJ, 2010, PHYS MED BIOL, V55, P1413, DOI 10.1088/0031-9155/55/5/010; KARLSSON M, 1993, MED PHYS, V20, P143, DOI 10.1118/1.597162; KHAN FM, 1991, MED PHYS, V18, P73, DOI 10.1118/1.596695; Kim H, 2014, RADIAT ONCOL J, V32, P187, DOI 10.3857/roj.2014.32.3.187; Lee CY, 2015, PROG MED PHYS, V26, P9; Ma CM, 2003, PHYS MED BIOL, V48, P909, DOI 10.1088/0031-9155/48/7/308; McDowell MA, 2008, NATL HLTH STAT REP, V10, P1; Mihaljevic J, 2011, PHYS MED BIOL, V56, P829, DOI 10.1088/0031-9155/56/3/018; Nicolini G, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120543; Olofsson L, 2005, PHYS MED BIOL, V50, P1191, DOI 10.1088/0031-9155/50/6/010; Park JM, 2012, BRIT J RADIOL, V85, pE323, DOI 10.1259/bjr/19088580; Park Jong Min, 2014, J Appl Clin Med Phys, V15, P4970, DOI 10.1120/jacmp.v15i6.4970; ROGERS DWO, 1995, MED PHYS, V22, P503, DOI 10.1118/1.597552; Rong Y, 2010, MED PHYS, V37, P5509, DOI 10.1118/1.3489379; TUNG SS, 1993, INT J RADIAT ONCOL, V27, P153, DOI 10.1016/0360-3016(93)90433-V; Valdes G, 2015, J APPL CLIN MED PHYS, V16, P322, DOI 10.1120/jacmp.v16i4.5363; Wang XC, 2005, INT J RADIAT ONCOL, V63, P594, DOI 10.1016/j.ijrobp.2005.06.006; Wu Q, 2013, INT J RADIAT ONCOL, V87, pS121, DOI 10.1016/j.ijrobp.2013.06.311	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177380	10.1371/journal.pone.0177380	http://dx.doi.org/10.1371/journal.pone.0177380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493940	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300097
J	Braem, M; Asher, L; Furrer, S; Lechner, I; Wurbel, H; Melotti, L				Braem, Maya; Asher, Lucy; Furrer, Sibylle; Lechner, Isabel; Wurbel, Hanno; Melotti, Luca			Development of the "Highly Sensitive Dog" questionnaire to evaluate the personality dimension "Sensory Processing Sensitivity" in dogs	PLOS ONE			English	Article							QUALITY-OF-LIFE; TEST-RETEST RELIABILITY; DIFFERENTIAL SUSCEPTIBILITY; GREAT TITS; INDIVIDUAL-DIFFERENCES; TRAINING METHODS; PUMPKINSEED SUNFISH; ANIMAL PERSONALITY; ATOPIC-DERMATITIS; BREED DIFFERENCES	In humans, the personality dimension 'sensory processing sensitivity (SPS)', also referred to as "high sensitivity", involves deeper processing of sensory information, which can be associated with physiological and behavioral overarousal. However, it has not been studied up to now whether this dimension also exists in other species. SPS can influence how people perceive the environment and how this affects them, thus a similar dimension in animals would be highly relevant with respect to animal welfare. We therefore explored whether SPS translates to dogs, one of the primary model species in personality research. A 32-item questionnaire to assess the "highly sensitive dog score" (HSD-s) was developed based on the "highly sensitive person" (HSP) questionnaire. A large-scale, international online survey was conducted, including the HSD questionnaire, as well as questions on fearfulness, neuroticism, "demographic" (e.g. dog sex, age, weight; age at adoption, etc.) and "human" factors (e.g. owner age, sex, profession, communication style, etc.), and the HSP questionnaire. Data were analyzed using linear mixed effect models with forward stepwise selection to test prediction of HSD-s by the above-mentioned factors, with country of residence and dog breed treated as random effects. A total of 3647 questionnaires were fully completed. HSD-, fearfulness, neuroticism and HSP-scores showed good internal consistencies, and HSD-s only moderately correlated with fearfulness and neuroticism scores, paralleling previous findings in humans. Intra- (N = 447) and inter-rater (N = 120) reliabilities were good. Demographic and human factors, including HSP score, explained only a small amount of the variance of HSD-s. A PCA analysis identified three subtraits of SPS, comparable to human findings. Overall, the measured personality dimension in dogs showed good internal consistency, partial independence from fearfulness and neuroticism, and good intra-and inter-rater reliability, indicating good construct validity of the HSD questionnaire. Human and demographic factors only marginally affected the HSD-s suggesting that, as hypothesized for human SPS, a genetic basis may underlie this dimension within the dog species.	[Braem, Maya; Furrer, Sibylle; Wurbel, Hanno; Melotti, Luca] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Div Anim Welf, Bern, Switzerland; [Asher, Lucy] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England; [Lechner, Isabel] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Bern, Switzerland	University of Bern; Newcastle University - UK; University of Bern	Braem, M (corresponding author), Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Div Anim Welf, Bern, Switzerland.	maya.braem@vetsuisse.unibe.ch		Lechner, Isabel/0000-0001-5155-9734; Asher, Lucy/0000-0001-9729-7856	Margaret und Francis Fleitmann Stiftung Luzern, Switzerland	Margaret und Francis Fleitmann Stiftung Luzern, Switzerland	This study was funded by Margaret und Francis Fleitmann Stiftung Luzern, Switzerland (MB).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo BP, 2014, BRAIN BEHAV, V4, P580, DOI 10.1002/brb3.242; Akerberg H, 2012, J VET BEHAV, V7, P327, DOI 10.1016/j.jveb.2012.01.007; Appleby DL, 2002, VET REC, V150, P434, DOI 10.1136/vr.150.14.434; Aron A, 2010, SOC COGN AFFECT NEUR, V5, P219, DOI 10.1093/scan/nsq028; Aron EN, 2012, PERS SOC PSYCHOL REV, V16, P262, DOI 10.1177/1088868311434213; Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345; Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419; Aron EN, 2006, J JUNGIAN THEORY PRA, V8, P11; Aron EN, 2002, HARMONY; Arvelius P, 2014, J VET BEHAV, V9, P281, DOI 10.1016/j.jveb.2014.06.008; Asp HE, 2015, APPL ANIM BEHAV SCI, V169, P69, DOI 10.1016/j.applanim.2015.04.010; Battaglia CL, 2009, J VET BEHAV, V4, P203, DOI 10.1016/j.jveb.2009.03.003; Becuwe-Bonnet V, 2012, J VET BEHAV, V7, P194, DOI 10.1016/j.jveb.2011.07.003; Belshaw Z, 2015, VET J, V206, P203, DOI 10.1016/j.tvjl.2015.07.016; Belsky J, 1998, DEV PSYCHOPATHOL, V10, P301, DOI 10.1017/S095457949800162X; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Benham G, 2006, PERS INDIV DIFFER, V40, P1433, DOI 10.1016/j.paid.2005.11.021; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Berenbaum SA, 1997, PSYCHONEUROENDOCRINO, V22, P505, DOI 10.1016/S0306-4530(97)00049-8; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Booth C, 2015, PERS INDIV DIFFER, V87, P24, DOI 10.1016/j.paid.2015.07.020; Boterberg S, 2016, PERS INDIV DIFFER, V92, P80, DOI 10.1016/j.paid.2015.12.022; Bouissou MF, 1996, HORM BEHAV, V30, P93, DOI 10.1006/hbeh.1996.0013; Bradley RH, 2008, J CHILD PSYCHOL PSYC, V49, P124, DOI [10.1111/j-1469-7610.2007.01829.x, 10.1111/j.1469-7610.2007.01829.x]; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Carere C., 2013, ANIMAL PERSONALITIES; CAREY WB, 1978, PEDIATRICS, V61, P735; Chen C, 2011, PLOS ONE, V6; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Denissen JJA, 2008, J RES PERS, V42, P1285, DOI 10.1016/j.jrp.2008.04.002; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Diverio S, 2014, J VET BEHAV, P1; DRAPER TW, 1995, J GEN PSYCHOL, V122, P241, DOI 10.1080/00221309.1995.9921236; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; Evers A., 2008, INT J STRESS MANAG, V15, P189, DOI [10.1037/1072-5245.15.2.189, DOI 10.1037/1072-5245.15.2.189]; Fadel FR, 2016, NATURE, P1; Favrot C, 2010, VET DERMATOL, V21, P63, DOI 10.1111/j.1365-3164.2009.00781.x; Fielding WJ, 2008, ANTHROZOOS, V21, P351, DOI 10.2752/175303708X371573; Foyer P, 2015, NATURE; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Freeman LM, 2005, JAVMA-J AM VET MED A, V226, P1864, DOI 10.2460/javma.2005.226.1864; Gartner MC, 2015, PERS INDIV DIFFER, V75, P102, DOI 10.1016/j.paid.2014.10.042; Gazzano A, 2008, APPL ANIM BEHAV SCI, V110, P294, DOI 10.1016/j.applanim.2007.05.007; GODDARD ME, 1984, APPL ANIM BEHAV SCI, V12, P253, DOI 10.1016/0168-1591(84)90118-7; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Gosling SD, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P275; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Gosling SD, 2002, J RES PERS, V36, P607, DOI 10.1016/S0092-6566(02)00511-1; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Guardini G, 2016, APPL ANIM BEHAV SCI, V181, P137, DOI 10.1016/j.applanim.2016.05.006; Gupta RR, 2001, BRAIN RES, V888, P356, DOI 10.1016/S0006-8993(00)03116-4; Hansen SW, 1996, APPL ANIM BEHAV SCI, V49, P137, DOI 10.1016/0168-1591(96)01045-3; Harvey ND, 2016, J VET BEHAV, V16, P13, DOI 10.1016/j.jveb.2016.03.004; Harvey ND, 2016, J VET BEHAV, V11, P65, DOI 10.1016/j.jveb.2015.09.005; Haverbeke A, 2010, APPL ANIM BEHAV SCI, V123, P143, DOI 10.1016/j.applanim.2009.12.014; Herron ME, 2009, APPL ANIM BEHAV SCI, V117, P47, DOI 10.1016/j.applanim.2008.12.011; HESSING MJC, 1994, PHYSIOL BEHAV, V55, P39, DOI 10.1016/0031-9384(94)90007-8; Hodosy J, 2012, PHARMACOL BIOCHEM BE, V102, P191, DOI 10.1016/j.pbb.2012.04.005; Holton L, 2001, VET REC, V148, P525, DOI 10.1136/vr.148.17.525; Homberg JR, 2016, NEUROSCI BIOBEHAV R, V71, P472, DOI 10.1016/j.neubiorev.2016.09.029; Hournmady S, 2016, APPL ANIM BEHAV SCI, V177, P42, DOI 10.1016/j.applanim.2016.01.015; Houston AI, 2010, PHILOS T R SOC B, V365, P3969, DOI 10.1098/rstb.2010.0161; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jagiellowicz J, 2011, SOC COGN AFFECT NEUR, V6, P38, DOI 10.1093/scan/nsq001; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Jones A.C., 2008, THESIS; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kemler DS, 2006, PERCEPT MOTOR SKILL, V102, P747, DOI 10.2466/PMS.102.3.747-759; Kim HH, 2006, VET J, V172, P154, DOI 10.1016/j.tvjl.2005.02.028; Kis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083993; Kis A, 2012, INTERACT STUD, V13, P373, DOI 10.1075/is.13.3.03kis; Kochanska G, 2002, CHILD DEV, V73, P461, DOI 10.1111/1467-8624.00418; Kochanska G, 2007, DEV PSYCHOL, V43, P222, DOI 10.1037/0012-1649.43.1.222; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2009, APPL ANIM BEHAV SCI, V119, P85, DOI 10.1016/j.applanim.2009.02.027; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Lindley S., 2012, UK Vet: Companion Animal, V17, P50; Linek M, 2010, VET DERMATOL, V21, P456, DOI 10.1111/j.1365-3164.2010.00899.x; Lloyd AS, 2007, APPL ANIM BEHAV SCI, V105, P205, DOI 10.1016/j.applanim.2006.05.017; Locurto C, 2007, COMP COGN BEHAV REV, V2, P67; Marshall-Pescini S, 2016, ANIM COGN; Mathews GA, 2009, HORM BEHAV, V55, P285, DOI 10.1016/j.yhbeh.2008.11.007; McDermott CM, 2012, PHYSIOL BEHAV, V105, P1168, DOI 10.1016/j.physbeh.2011.12.016; McGarrity ME, 2016, APPL ANIM BEHAV SCI, V179, P82, DOI 10.1016/j.applanim.2016.03.013; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Mezulis AH, 2006, DEV PSYCHOL, V42, P1012, DOI 10.1037/0012-1649.42.6.1012; Miklosi A, 2014, THE SOCIAL DOG BEHAV; Miller LJ, 2008, ENCYCLOPEDIA OF INFA, P127; Mirko E, 2012, APPL ANIM BEHAV SCI, V138, P88, DOI 10.1016/j.applanim.2012.02.016; Momozawa Y, 2005, APPL ANIM BEHAV SCI, V92, P77, DOI 10.1016/j.applanim.2004.11.006; Morris AS, 2002, J MARRIAGE FAM, V64, P461, DOI 10.1111/j.1741-3737.2002.00461.x; Naguib M, 2011, DEV PSYCHOBIOL, V53, P592, DOI 10.1002/dev.20533; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Pageat P., 1998, PATHOLOGIE COMPORTEM; Petelle MB, 2013, ANIM BEHAV, V86, P1147, DOI 10.1016/j.anbehav.2013.09.016; Pluess M., 2015, CARDIAC CYTOARCHITEC, P1; Pluess M., 2010, FAM SCI, V1, P14, DOI [10.1080/19424620903388554, DOI 10.1080/19424620903388554]; Pluess M, 2015, PERS INDIV DIFFER, V82, P40, DOI 10.1016/j.paid.2015.03.011; Pluess M, 2010, DEV PSYCHOL, V46, P379, DOI 10.1037/a0015203; Pluess M, 2009, J CHILD PSYCHOL PSYC, V50, P396, DOI 10.1111/j.1469-7610.2008.01992.x; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Roshier AL, 2013, VET REC, V172, DOI 10.1136/vr.101125; Sangster MD, 2012, AN FMRI STUDY OF SEN, P136; Schroll S, 2007, VERHALTENSMEDIZIN BE; Segurson SA, 2005, JAVMA-J AM VET MED A, V227, P1755, DOI 10.2460/javma.2005.227.1755; Serpell JA, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00049; Sheppard G., 2002, INT J COMP PSYCHOL, V15, P201, DOI DOI 10.5811/WESTJEM.2011.5.6700; Shivley CB, 2016, JAVMA-J AM VET MED A, V248, P1165, DOI 10.2460/javma.248.10.1165; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Smolewska KA, 2006, PERS INDIV DIFFER, V40, P1269, DOI 10.1016/j.paid.2005.09.022; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Starling MJ, 2013, VET J, V197, P868, DOI 10.1016/j.tvjl.2013.05.019; Starling MJ, 2013, BEHAV PROCESS, V97, P53, DOI 10.1016/j.beproc.2013.04.008; Suomi SJ, 2003, NATURE NURTURE COMPL, P35; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Tiira K, 2014, APPL ANIM BEHAV SCI, V155, P82, DOI 10.1016/j.applanim.2014.03.007; Turcsan B, 2012, APPL ANIM BEHAV SCI, V140, P154, DOI 10.1016/j.applanim.2012.06.004; van Aken C, 2007, INFANT CHILD DEV, V16, P553, DOI 10.1002/icd.529; Vandenheede M, 1996, APPL ANIM BEHAV SCI, V47, P211, DOI 10.1016/0168-1591(95)00673-7; Vas J, 2007, APPL ANIM BEHAV SCI, V103, P105, DOI 10.1016/j.applanim.2006.03.017; Wan M, 2009, APPL ANIM BEHAV SCI, V121, P206, DOI 10.1016/j.applanim.2009.09.015; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; Wiseman-Orr ML, 2006, AM J VET RES, V67, P1826, DOI 10.2460/ajvr.67.11.1826; Wojciechowska JI, 2005, AM J VET RES, V66, P1461, DOI 10.2460/ajvr.2005.66.1461; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wright H.F., 2011, INT J COMP PSYCH, V24, P210, DOI DOI 10.5811/westjem.2011.5.6700; Zagron G, 2006, BEHAV BRAIN RES, V175, P323, DOI 10.1016/j.bbr.2006.09.003; Zeigler-Hill V, 2010, APPL ANIM BEHAV SCI, V124, P104, DOI 10.1016/j.applanim.2010.02.012; Ziv G., 2017, J VET BEHAV	146	6	6	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177616	10.1371/journal.pone.0177616	http://dx.doi.org/10.1371/journal.pone.0177616			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520773	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500044
J	Liao, XH; Xue, CJ; Su, FZ				Liao, Xiaohan; Xue, Cunjin; Su, Fenzhen			Tree-based approach for exploring marine spatial patterns with raster datasets	PLOS ONE			English	Article							SPATIOTEMPORAL ASSOCIATION PATTERNS; TIME-SERIES; MINING APPROACH; ENSO; FRAMEWORK; SYSTEM; SCIENCE; CLIMATE; IMAGES; RULES	From multiple raster datasets to spatial association patterns, the data-mining technique is divided into three subtasks, i.e., raster dataset pretreatment, mining algorithm design, and spatial pattern exploration from the mining results. Comparison with the former two subtasks reveals that the latter remains unresolved. Confronted with the interrelated marine environmental parameters, we propose a Tree-based Approach for eXploring Marine Spatial Patterns with multiple raster datasets called TAXMarSP, which includes two models. One is the Tree-based Cascading Organization Model (TCOM), and the other is the Spatial Neighborhood-based CAlculation Model (SNCAM). TCOM designs the "Spatial node -> Pattern node" from top to bottom layers to store the table-formatted frequent patterns. Together with TCOM, SNCAM considers the spatial neighborhood contributions to calculate the pattern-matching degree between the specified marine parameters and the table-formatted frequent patterns and then explores the marine spatial patterns. Using the prevalent quantification Apriori algorithm and a real remote sensing dataset from January 1998 to December 2014, a successful application of TAXMarSP to marine spatial patterns in the Pacific Ocean is described, and the obtained marine spatial patterns present not only the well-known but also new patterns to Earth scientists.	[Liao, Xiaohan; Su, Fenzhen] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Xue, Cunjin] Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Xue, Cunjin] Key Lab Earth Observat, Sanya, Hainan, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Xue, CJ (corresponding author), Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.; Xue, CJ (corresponding author), Key Lab Earth Observat, Sanya, Hainan, Peoples R China.	xuecj@radi.ac.cn		XUE, Cunjin/0000-0003-3605-6578	National Natural Science Foundation of China [41671401, 41371385]; Youth Innovation Promotion Association of Chinese Academy of Science [2013113]; National key research and development program of China [2016YFA0600304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of Chinese Academy of Science; National key research and development program of China	This study has been funded by National Natural Science Foundation of China with No.41671401 and No. 41371385, by Youth Innovation Promotion Association of Chinese Academy of Science with No.2013113, and by National key research and development program of China with No. 2016YFA0600304. CX received all funding. There was no additional external funding received for this study.	Agrawal R., 1995, P DATA ENG, V1995, P3, DOI DOI 10.1109/ICDE.1995.380415; [Anonymous], 2010, B CHIN ACAD SCI; Bayardo Jr Roberto J., 1999, P 5 ACM SIGKDD INT C, P145, DOI DOI 10.1145/312129.312219; Bertolotto M, 2007, INT J GEOGR INF SCI, V21, P895, DOI 10.1080/13658810701349052; Compieta P, 2007, J VISUAL LANG COMPUT, V18, P255, DOI 10.1016/j.jvlc.2007.02.006; Curtis S, 2007, J HYDROMETEOROL, V8, P678, DOI 10.1175/JHM601.1; Ertek G, 2006, LECT NOTES COMPUT SC, V4263, P593; Hoffman FM, 2011, PROCEDIA COMPUT SCI, V4, P1450, DOI 10.1016/j.procs.2011.04.157; Hofmann H., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P227, DOI 10.1145/347090.347133; Hofmann H, 2001, COMPUTATION STAT, V16, P399, DOI 10.1007/s001800100075; Hooker SB, 2000, PROG OCEANOGR, V45, P427, DOI 10.1016/S0079-6611(00)00012-4; INSELBERG A, 1990, PROCEEDINGS OF THE FIRST IEEE CONFERENCE ON VISUALIZATION - VISUALIZATION 90, P361, DOI 10.1109/VISUAL.1990.146402; Julea A, 2011, IEEE T GEOSCI REMOTE, V49, P1417, DOI 10.1109/TGRS.2010.2081372; Korting TS, 2013, COMPUT GEOSCI-UK, V57, P133, DOI 10.1016/j.cageo.2013.02.007; Kumar V, 2010, COMPUTER SCI, P6118; Li LW, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083615; Li X. Y., 2000, ACTA METEOROL SIN, V58, P102; Liao SH, 2012, EXPERT SYST APPL, V39, P11303, DOI 10.1016/j.eswa.2012.02.063; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Romani LAS, 2013, IEEE T GEOSCI REMOTE, V51, P140, DOI 10.1109/TGRS.2012.2199501; Saulquin B, 2014, IEEE J-STARS, V7, P3543, DOI 10.1109/JSTARS.2014.2329921; Sekhavat Y.A., 2013, INT J INTELL SCI, V3, P34; Srikant R., 1996, P 5 INT C EXT DAT TE, P3, DOI 10.1007/BFb0014140; Su FZ, 2004, ECOL MODEL, V174, P421, DOI 10.1016/j.ecolmodel.2003.10.006; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Wu E, 2008, THESIS; Xue CJ, 2014, INT J REMOTE SENS, V35, P4467, DOI 10.1080/01431161.2014.916436; Xue CJ, 2015, REMOTE SENS-BASEL, V7, P9149, DOI 10.3390/rs70709149; Xue CJ, 2015, INT J APPL EARTH OBS, V38, P105, DOI 10.1016/j.jag.2014.12.009; Xue CJ, 2015, COMPUT GEOSCI-UK, V76, P121, DOI 10.1016/j.cageo.2014.12.001; Yang J, 2013, NAT CLIM CHANGE, V3, P875, DOI [10.1038/nclimate1908, 10.1038/NCLIMATE1908]; Zhang JT, 2009, COMPUT GEOSCI-UK, V35, P1827, DOI 10.1016/j.cageo.2009.02.006	35	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177438	10.1371/journal.pone.0177438	http://dx.doi.org/10.1371/journal.pone.0177438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510602	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500030
J	Niego, B; Lee, N; Larsson, P; de Silva, TM; Au, AEL; McCutcheon, F; Medcalf, RL				Niego, Be'eri; Lee, Natasha; Larsson, Pia; de Silva, T. Michael; Au, Amanda E-Ling; McCutcheon, Fiona; Medcalf, Robert L.			Selective inhibition of brain endothelial Rhokinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; RHO-KINASE; CEREBRAL BARRIER; CELL; ROCK2; FASUDIL; LOCALIZATION; PERMEABILITY; MODULATION; EXPRESSION	Rho-kinase (ROCK) inhibition, broadly utilised in cardiovascular disease, may protect the blood-brain barrier (BBB) during thrombolysis from rt-PA-induced damage. While the use of nonselective ROCK inhibitors like fasudil together with rt-PA may be hindered by possible hypotensive side-effects and inadequate capacity to block detrimental rt-PA activity in brain endothelial cells (BECs), selective ROCK-2 inhibition may overcome these limitations. Here, we examined ROCK-2 expression in major brain cells and compared the ability of fasudil and KD025, a selective ROCK-2 inhibitor, to attenuate rt-PA-induced BBB impairment in an in vitro human model. ROCK-2 was highly expressed relative to ROCK-1 in all human and mouse brain cell types and particularly enriched in rodent brain endothelial cells and astrocytes compared to neurons. KD025 was more potent than fasudil in attenuation of rt-PA-and plasminogen-induced BBB permeation under normoxia, but especially under stroke-like conditions. Importantly, only KD025, but not fasudil, was able to block rt-PA-dependent permeability increases, morphology changes and tight junction degradation in isolated BECs. Selective ROCK-2 inhibition further diminished rt-PA-triggered myosin phosphorylation, shape alterations and matrix metalloprotease activation in astrocytes. These findings highlight ROCK-2 as the key isoform driving BBB impairment and brain endothelial damage by rt-PA and the potential of KD025 to optimally protect the BBB during thrombolysis.	[Niego, Be'eri; Lee, Natasha; Au, Amanda E-Ling; McCutcheon, Fiona; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic, Australia; [Larsson, Pia] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Wallenberg Lab, Gothenburg, Sweden; [de Silva, T. Michael] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Victoria, Melbourne, Vic, Australia; [Au, Amanda E-Ling] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Melbourne, Vic, Australia; [Au, Amanda E-Ling] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	Monash University; University of Gothenburg; La Trobe University; University of Melbourne	Niego, B (corresponding author), Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic, Australia.	beeri.niego@monash.edu	Niego, Beeri/AAG-5534-2019; Medcalf, Robert L/E-9632-2011	Niego, Beeri/0000-0001-6714-9131; De Silva, Travice/0000-0001-6351-7304; Au, Amanda/0000-0003-3656-2673	National Heart Foundation of Australia [100906]; National Health and Medical Research Council; High Blood Pressure Research Council of Australia; NHMRC	National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); High Blood Pressure Research Council of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	B.N. is supported by a postdoctoral fellowship from the National Heart Foundation of Australia (https://heartfoundation.org.au/), award number 100906. T.M.D. is the recipient of a National Health and Medical Research Council (https://www.nhmrc.gov.au/) Early Career Fellowship and a High Blood Pressure Research Council of Australia (http://www.hbprca.com.au/) Early Career Research Transition Grant. R.L.M is a Principal Research Fellow of the National Health and Medical Research Council (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; B.N. is supported by a postdoctoral fellowship from the National Heart Foundation of Australia (award number 100906). T.M.D. is the recipient of an NHMRC Early Career Fellowship and a High Blood Pressure Research Council of Australia Early Career Research Transition Grant. R.L.M is a Principal Research Fellow of the NHMRC of Australia. The authors wish to thank Monash Micro Imaging for their support with microscopy.	Allen C, 2010, STROKE, V41, P2056, DOI 10.1161/STROKEAHA.109.574939; Balami JS, 2013, CNS NEUROL DISORD-DR, V12, P155; Beckers CML, 2015, VASC PHARMACOL, V70, P45, DOI 10.1016/j.vph.2015.03.017; Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Silva TM, 2016, HYPERTENSION, V68, P809, DOI 10.1161/HYPERTENSIONAHA.116.07430; Dong MX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158848; Fu ZH, 2014, INT J CLIN EXP PATHO, V7, P7844; Fukuta T, 2017, FASEB J OFFICIAL PUB; Gibson CL, 2014, J NEUROCHEM, V129, P816, DOI 10.1111/jnc.12681; Greenidge AR, 2013, PATHOLOG RES INT, V2013; Hartmann S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00276; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Iizuka M, 2012, CELL STRUCT FUNCT, V37, P155, DOI 10.1247/csf.12018; Ishiguro M, 2012, NEUROSCIENCE, V220, P302, DOI 10.1016/j.neuroscience.2012.06.015; Jeon BT, 2013, NEUROTOX RES, V23, P238, DOI 10.1007/s12640-012-9339-2; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Lee JH, 2014, ANN CLIN TRANSL NEUR, V1, P2, DOI 10.1002/acn3.19; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Marcos-Contreras OA, 2016, BLOOD; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Mong PY, 2009, J IMMUNOL, V182, P2385, DOI 10.4049/jimmunol.0802811; Montalvo J, 2013, CURR MOL MED, V13, P205, DOI 10.2174/156652413804486296; Moretti A, 2015, PHARMACOL THERAPEUT, V153, P79, DOI 10.1016/j.pharmthera.2015.06.004; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Newell-Litwa KA, 2015, J CELL BIOL, V210, P225, DOI 10.1083/jcb.201504046; Niego B, 2013, JOVE-J VIS EXP, V12, P81; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Noma K, 2012, J CARDIOL, V60, P1, DOI 10.1016/j.jjcc.2012.03.005; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Saal KA, 2016, BRAIN PATHOLOGY ZURI; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; Satoh S, 2010, BRAIN RES BULL, V81, P191, DOI 10.1016/j.brainresbull.2009.08.021; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shi JJ, 2011, PEDIATR CARDIOL, V32, P297, DOI 10.1007/s00246-011-9920-0; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Shin HK, 2007, J CEREBR BLOOD F MET, V27, P998, DOI 10.1038/sj.jcbfm.9600406; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Suzuki Y, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00002; Wang S, 2006, STROKE, V37, P1910, DOI 10.1161/01.STR.0000226923.48905.39; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Yaghi S, 2014, JAMA NEUROL, V71, P1181, DOI 10.1001/jamaneurol.2014.1210; Yano K, 2008, EUR J PHARMACOL, V594, P77, DOI 10.1016/j.ejphar.2008.07.045; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Zanin-Zhorov A, 2014, P NATL ACAD SCI USA, V111, P16814, DOI 10.1073/pnas.1414189111	53	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177332	10.1371/journal.pone.0177332	http://dx.doi.org/10.1371/journal.pone.0177332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510599	Green Published, gold			2022-12-27	WOS:000401485500023
J	Prasetia, R; Sinniger, F; Hashizume, K; Harii, S				Prasetia, Rian; Sinniger, Frederic; Hashizume, Kaito; Harii, Saki			Reproductive biology of the deep brooding coral Seriatopora hystrix: Implications for shallow reef recovery	PLOS ONE			English	Article							GREAT-BARRIER-REEF; LONG-DISTANCE DISPERSAL; POCILLOPORA-DAMICORNIS; RED-SEA; STYLOPHORA-PISTILLATA; SCLERACTINIAN CORAL; SEXUAL REPRODUCTION; LUNAR PERIODICITY; CLIMATE-CHANGE; LARVAL RELEASE	Mesophotic coral ecosystems (MCEs, between 30 and 150 m depth) are hypothesized to contribute to the recovery of degraded shallow reefs through sexually produced larvae (referred to as Deep Reef Refuge Hypothesis). In Okinawa, Japan, the brooder coral Seriatopora hystrix was reported to be locally extinct in a shallow reef while it was found abundant at a MCE nearby. In this context, S. hystrix represents a key model to test the Deep Reef Refuge Hypothesis and to understand the potential contribution of mesophotic corals to shallow coral reef recovery. However, the reproductive biology of mesophotic S. hystrix and its potential to recolonize shallow reefs is currently unknown. This study reports for the first time, different temporal scales of reproductive periodicity and larval settlement of S. hystrix from an upper mesophotic reef (40 m depth) in Okinawa. We examined reproductive seasonality, lunar, and circadian periodicity (based on polyp dissection, histology, and ex situ planula release observations) and larval settlement rates in the laboratory. Mesophotic S. hystrix reproduced mainly in July and early August, with a small number of planulae being released at the end of May, June and August. Compared to shallow colonies in the same region, mesophotic S. hystrix has a 4-month shorter reproductive season, similar circadian periodicity, and smaller planula size. In addition, most of the planulae settled rapidly, limiting larval dispersal potential. The shorter reproductive season and smaller planula size may result from limited energy available for reproduction at deeper depths, while the similar circadian periodicity suggests that this reproductive aspect is not affected by environmental conditions differing with depth. Overall, contribution of mesophotic S. hystrix to shallow reef rapid recovery appears limited, although they may recruit to shallow reefs through a multi-step process over a few generations or through random extreme mixing such as typhoons.	[Prasetia, Rian; Sinniger, Frederic; Hashizume, Kaito; Harii, Saki] Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Motobu, Japan	University of the Ryukyus	Harii, S (corresponding author), Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Motobu, Japan.	sharii@lab.u-ryukyu.ac.jp	Harii, Saki/AHC-2263-2022	Harii, Saki/0000-0003-0440-7169; Prasetia, Rian/0000-0003-1492-0804	Japan Society for the Promotion of Science [16H02490]; Japan Science Society [27-749]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society	This work was funded by the Grant-in-Aid for Scientific Research(A) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) (No.16H02490) to SH and a Sasakawa Scientific Research Grant from the Japan Science Society (http://www.jss.or.jp/ikusei/sasakawa/) (No. 27-749) to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atoda K., 1951, Science Reports of the Tohoku University (4), V19, P33; ATODA K, 1947, SCI REP TOHOKU U, V18, P48; ATODA KENJI, 1947, SCI REPTS TOHOKU IMP UNIV SER 4, V18, P24; AYRE DJ, 1994, EVOLUTION, V48, P1183, DOI 10.1111/j.1558-5646.1994.tb05304.x; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602373; Bryan DR, 2013, J APPL ICHTHYOL, V29, P108, DOI 10.1111/j.1439-0426.2012.02055.x; Cacciapaglia C, 2016, GLOBAL CHANGE BIOL, V22, P1145, DOI 10.1111/gcb.13166; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Dai CF, 1992, P 7 INT COR REEF S G, V1, P448; de Putron SJ, 2011, B MAR SCI, V87, P75, DOI 10.5343/bms.2009.1027; Eyal-Shaham L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20964; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fan TY, 2002, ZOOL STUD, V41, P288; Garcia-Sais JR, 2010, CORAL REEFS, V29, P277, DOI 10.1007/s00338-009-0582-9; GLYNN PW, 1991, MAR BIOL, V109, P355, DOI 10.1007/BF01313501; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Harii S, 2003, CORAL REEFS, V22, P188, DOI 10.1007/s00338-003-0302-9; Harii S, 2001, CORAL REEFS, V20, P19; Harriott V.J., 1983, Coral Reefs, V2, P151, DOI 10.1007/BF00336721; Harrison P.L., 1990, P133; HAYASHIBARA T, 1993, MAR ECOL PROG SER, V101, P253, DOI 10.3354/meps101253; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holstein DM, 2016, CORAL REEFS, V35, P23, DOI 10.1007/s00338-015-1339-2; Holstein DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146068; Holstein DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12407; Hongo C, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001902; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Japan Oceanographic Data Center, 2005, STAT WAT TEMP SAL 1; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; JOKIEL PL, 1978, B MAR SCI, V28, P786; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; KOJIS BL, 1986, MAR BIOL, V91, P291, DOI 10.1007/BF00428623; Lin CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064584; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Loya Y, 2016, CORAL REEFS, V35, P1, DOI 10.1007/s00338-016-1410-7; Madsen A., 2014, SEX EARLY DEV AQUAT, V1, P25, DOI [10.3354/sedao00004, DOI 10.3354/SEDA000004, DOI 10.3354/SEDAO00004]; Maier E, 2005, MAR BIOL, V147, P1109, DOI 10.1007/s00227-005-0013-6; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; MNE, 2008, MAR ECOL PROG SER, V370, P111; Nir O, 2011, CORAL REEFS, V30, P1089, DOI 10.1007/s00338-011-0801-z; Nozawa Y, 2005, MAR ECOL PROG SER, V286, P115, DOI 10.3354/meps286115; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Prasetia R, 2016, CORAL REEFS, V35, P53, DOI 10.1007/s00338-015-1348-1; Pratchett MS, 2001, CORAL REEFS, V20, P13, DOI 10.1007/s003380000113; Puglise KA, 2016, MESOPHOTIC CORAL ECO, P83; Putnam HM, 2008, BIOL BULL-US, V215, P135, DOI 10.2307/25470694; R Core Team, 2013, R LANG ENV STAT COMP; RICHMOND RH, 1984, B MAR SCI, V34, P280; RICHMOND RH, 1987, B MAR SCI, V41, P594; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P145, DOI 10.3354/meps001145; RINKEVICH B, 1989, MAR BIOL, V101, P259, DOI 10.1007/BF00391465; RINKEVICH B, 1987, BIOL BULL, V173, P335, DOI 10.2307/1541546; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; Serrano XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21619; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; SHLESINGER Y, 1985, SCIENCE, V228, P1333, DOI 10.1126/science.228.4705.1333; Sinniger F, FRONT MAR S IN PRESS; Sinniger F., 2016, MESOPHOTIC CORAL ECO, P43; Sinniger F, 2013, CORAL REEFS, V32, P153, DOI 10.1007/s00338-012-0973-1; STIMSON JS, 1978, MAR BIOL, V48, P173, DOI 10.1007/BF00395017; STODDART JA, 1985, MAR ECOL PROG SER, V23, P153, DOI 10.3354/meps023153; SZMANTFROELICH A, 1985, B MAR SCI, V37, P880; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; VANMOORSEL GWNM, 1983, MAR ECOL PROG SER, V13, P273, DOI 10.3354/meps013273; Veron JEN, 2000, CORALS WORLD, V2, P48; Vize PD, 2006, CORAL REEFS, V25, P169, DOI 10.1007/s00338-005-0082-5; Warner PA, 2016, MOL ECOL, V25, P1398, DOI 10.1111/mec.13553; Yamazato K, 2008, J JAPANESE CORAL REE, V10, P1; Zakai D, 2006, MAR ECOL PROG SER, V311, P93, DOI 10.3354/meps311093	86	30	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177034	10.1371/journal.pone.0177034	http://dx.doi.org/10.1371/journal.pone.0177034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510601	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500010
J	Wang, H; Li, SY; Teng, SZ; Liang, HS; Xin, HJ; Gao, HH; Huang, DF; Lang, ZH				Wang, Hai; Li, Shengyan; Teng, Shouzhen; Liang, Haisheng; Xin, Hongjia; Gao, Hongjiang; Huang, Dafang; Lang, Zhihong			Transcriptome profiling revealed novel transcriptional regulators in maize responses to Ostrinia furnacalis and jasmonic acid	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; FEEDING SPODOPTERA-LITTORALIS; PATHOGENESIS-RELATED GENES; DROUGHT STRESS TOLERANCE; INDUCED PLANT DEFENSES; MADS DOMAIN PROTEIN; LIMA-BEAN LEAVES; ABSCISIC-ACID; MOLECULAR ANALYSIS; NICOTIANA-ATTENUATA	Chewing insects cause severe yield losses in crop production worldwide. Crop plants counteract chewing insects by transcriptionally promoting a repertoire of defense gene products that are either toxic to, or attractive to the natural enemies of, pest insects. However, the complexity of the transcriptional reprogramming in plant defense response against chewing insects is still not well understood. In this study, the genome-wide early responses in maize seedlings to Asian corn borer (ACB, Ostrinia furnacalis) and also to jasmonic acid(JA), the pivotal phytohormone controlling plant defense response against herbivory, were transcriptionally profiled by RNA-Seq. Clustering of differentially expressed genes (DEGs) along with functional enrichment analysis revealed important biological processes regulated in response to ACB infestation and/or jasmonic acid. Moreover, DEGs with distinct expression patterns were differentially enriched with diverse families of cis-elements on their promoters. Multiple inventories of differentially expressed transcription factors (DETFs) in each DEG group were also analyzed. A transient expression assay using transfected maize protoplastswas established to examine the potential roles of DETFs in maize defense response and JA signaling, and this was used to show that ZmNAC60, an ACB- and JA-inducible DETF, represented a novel positive regulator of JA and defense pathway genes. This study provided a comprehensive transcriptional picture for the early dynamics of maize defense responses and JA signaling, and the identification of DETFs offered potential targets for further functional genomics investigation of master regulators in maize defense responses against herbivory.	[Wang, Hai; Li, Shengyan; Teng, Shouzhen; Liang, Haisheng; Xin, Hongjia; Gao, Hongjiang; Huang, Dafang; Lang, Zhihong] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Lang, ZH (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	langzhihong@caas.cn		Wang, Hai/0000-0002-1722-1518	National Natural Science Foundation of China [31501325, 31570272]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant 31501325 to Hai Wang and Grant 31570272 to Zhihong Lang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ankala A, 2013, PLANT SCI, V199, P103, DOI 10.1016/j.plantsci.2012.09.017; Butron A, 2010, THEOR APPL GENET, V120, P721, DOI 10.1007/s00122-009-1192-1; Chuang WP, 2014, NEW PHYTOL, V201, P928, DOI 10.1111/nph.12581; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; CONE KC, 1986, P NATL ACAD SCI USA, V83, P9631, DOI 10.1073/pnas.83.24.9631; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Degenhardt J, 2009, P NATL ACAD SCI USA, V106, P13213, DOI 10.1073/pnas.0906365106; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Eveland AL, 2013, GENOME RES; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fescemyer HW, 2013, INSECT BIOCHEM MOLEC, V43, P280, DOI 10.1016/j.ibmb.2012.12.008; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Grunewald W, 2008, PLANT PHYSIOL, V148, P358, DOI 10.1104/pp.108.119131; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu P, 2013, MOL CELL, V50, P504, DOI 10.1016/j.molcel.2013.04.027; Hu W, 2006, PLANT J, V45, P399, DOI 10.1111/j.1365-313X.2005.02626.x; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Lawrence SD, 2012, PHYSIOL PLANTARUM, V144, P303, DOI 10.1111/j.1399-3054.2011.01557.x; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee SJ, 2009, MOL CELLS, V27, P409, DOI 10.1007/s10059-009-0058-3; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; Macel M, 2005, J CHEM ECOL, V31, P1493, DOI 10.1007/s10886-005-5793-0; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Manevski A, 2000, FEBS LETT, V483, P43, DOI 10.1016/S0014-5793(00)02056-1; Manzaneda AJ, 2010, NEW PHYTOL, V188, P464, DOI 10.1111/j.1469-8137.2010.03385.x; Mao JL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005760; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Mendes MA, 2013, PLANT CELL, V25, P2560, DOI 10.1105/tpc.112.108688; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Mukhtar MS, 2008, PLANT J, V56, P935, DOI 10.1111/j.1365-313X.2008.03651.x; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; PENACORTES H, 1995, P NATL ACAD SCI USA, V92, P4106, DOI 10.1073/pnas.92.10.4106; Pesch M, 2014, PLANT CELL, V26, P4067, DOI 10.1105/tpc.114.129379; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Santiago R, 2005, J ECON ENTOMOL, V98, P1349, DOI 10.1603/0022-0493-98.4.1349; Sasaki-Sekimoto Y, 2013, PLANT PHYSIOL, V163, P291, DOI 10.1104/pp.113.220129; Schafer M, 2011, PLANT PHYSIOL, V156, P1520, DOI 10.1104/pp.111.173567; Schluter U, 2010, J EXP BOT, V61, P4169, DOI 10.1093/jxb/erq166; Schmelz EA, 2012, PLANT PHYSIOL, V160, P1468, DOI 10.1104/pp.112.201061; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnee C, 2006, P NATL ACAD SCI USA, V103, P1129, DOI 10.1073/pnas.0508027103; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Schweizer F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00013; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; SHEEN J, 1991, PLANT CELL, V3, P225, DOI 10.1105/tpc.3.3.225; Shen BZ, 2000, P NATL ACAD SCI USA, V97, P14807, DOI 10.1073/pnas.240284097; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Tamayo MC, 2000, PLANTA, V211, P62, DOI 10.1007/s004250000258; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tilly JJ, 1998, DEVELOPMENT, V125, P1647; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tremousaygue D, 1999, PLANT J, V20, P553, DOI 10.1046/j.1365-313X.1999.00627.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151; Yang FS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16500; Ye M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036214; Yoshii M, 2010, PLANT J, V61, P804, DOI 10.1111/j.1365-313X.2009.04107.x; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	87	9	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177739	10.1371/journal.pone.0177739	http://dx.doi.org/10.1371/journal.pone.0177739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520800	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500065
J	Beckett, SJ; Weitz, JS				Beckett, Stephen J.; Weitz, Joshua S.			Disentangling niche competition from grazing mortality in phytoplankton dilution experiments	PLOS ONE			English	Article							MICROZOOPLANKTON; GROWTH; DYNAMICS; NITROGEN; PLANKTON; IMPACT; RATES; IRON	The dilution method is the principal tool used to infer in situ microzooplankton grazing rates. However, grazing is the only mortality process considered in the theoretical model underlying the interpretation of dilution method experiments. Here we evaluate the robustness of mortality estimates inferred from dilution experiments when there is concurrent niche competition amongst phytoplankton. Using a combination of mathematical analysis and numerical simulations, we find that grazing rates may be overestimated-the degree of overestimation is related to the importance of niche competition relative to microzooplankton grazing. In response, we propose a conceptual method to disentangle the effects of niche competition and grazing by diluting out microzooplankton, but not phytoplankton. Our theoretical results suggest this revised "Z-dilution" method can robustly infer grazing mortality, regardless of the dominant phytoplankton mortality driver in our system. Further, we show it is possible to independently estimate both grazing mortality and niche competition if the classical and Z-dilution methods can be used in tandem. We discuss the significance of these results for quantifying phytoplankton mortality rates; and the feasibility of implementing the Z-dilution method in practice, whether in model systems or in complex communities with overlap in the size distributions of phytoplankton and microzooplankton.	[Beckett, Stephen J.; Weitz, Joshua S.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Beckett, SJ; Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.; Weitz, JS (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	stephen.beckett@biology.gatech.edu; jsweitz@gatech.edu		Beckett, Stephen/0000-0002-4410-2960	Simons Foundation [329108]	Simons Foundation	JSW was awarded SCOPE Award ID 329108 from the Simons Foundation (https://www.simonsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis M, 2007, J EXP MAR BIOL ECOL, V341, P176, DOI 10.1016/j.jembe.2006.09.002; ANDERSEN T, 1991, MAR ECOL PROG SER, V69, P67, DOI 10.3354/meps069067; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Barbeau K, 1996, NATURE, V380, P61, DOI 10.1038/380061a0; Beckett SJ, 2017, CODE DISENTANGLING R; Brum J.R., 2014, ECO DAS 9 S PROC, P16; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Calbet A, 2013, J PLANKTON RES, V35, P1183, DOI 10.1093/plankt/fbt067; Caron DA, 2016, P NATL ACAD SCI USA, V113, P2806, DOI 10.1073/pnas.1600718113; Chen BZ, 2014, LIMNOL OCEANOGR, V59, P639, DOI 10.4319/lo.2014.59.3.0639; Dolan JR, 2005, OCEAN SCI, V1, P1, DOI 10.5194/os-1-1-2005; Evans C, 2003, AQUAT MICROB ECOL, V30, P207, DOI 10.3354/ame030207; EVANS GT, 1992, MAR ECOL PROG SER, V80, P285, DOI 10.3354/meps080285; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Kimmance SA, 2010, MANUAL AQUATIC VIRAL, P65, DOI [10.4319/mave.2010.978-0-9845591-0-7.65, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.65]; Kirchman DL, 2010, MICROBIAL ECOLOGY OC, V36; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; LANDRY MR, 1995, MAR ECOL PROG SER, V120, P53, DOI 10.3354/meps120053; Landry MR, 2014, LIMNOLOGY OCEANOGRAP, V59; Latasa M, 2014, LIMNOL OCEANOGR, V59, P1092, DOI 10.4319/lo.2014.59.3.1092; Lewis ND, 2012, BIOGEOCHEMISTRY, V110, P303, DOI 10.1007/s10533-011-9649-0; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; Verhulst P.F., 1845, NOUVEAUX M MOIRES LA, V18, P14; Ward BA, 2016, P NATL ACAD SCI USA, V113, P2958, DOI 10.1073/pnas.1517118113; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177517	10.1371/journal.pone.0177517	http://dx.doi.org/10.1371/journal.pone.0177517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505212	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500027
J	Li, YY; Zhao, Y; Wu, JP				Li, Yuanyuan; Zhao, Ying; Wu, Jianping			Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; INCREASED RISK; INFECTION; DISEASE; SEROPOSITIVITY; STEATOSIS; ATHEROSCLEROSIS; STEATOHEPATITIS	Background and aim As there is conflicting evidence for the relationship between hepatitis B virus surface antigen (HBsAg) positivity and the prevalence of metabolic syndrome (MetS), we performed a metaanalysis to investigate whether HBsAg positivity affects the incidence of MetS. Methods Observational studies on the relationship between HBsAg positivity and MetS were obtained from PubMed, Web of Science, and the Cochrane Library in April 2016. The pooled odds ratios (ORs) of MetS and its components (central obesity, increased fasting glucose, increased blood pressure, dyslipidemia) for subjects with or without HBsAg positivity were synthesized. The standardized mean difference of MetS components between HBsAg-positive participants and healthy controls was calculated. Heterogeneity was explored with subgroup analysis and sensitivity analysis. Publication bias was detected using Egger's test and Begg's test. Results Thirty studies were eligible for meta-analysis. The MetS OR for HBsAg-positive participants was significantly decreased compared with the controls [OR = 0.80, 95% confidence interval (CI), 0.70-0.90]. The negative effect of HBsAg positivity on elevated triglycerides (OR = 0.62, 95% CI, 0.59-0.64) was strong, while that for increased fasting blood glucose was weak (OR = 0.94, 95% CI, 0.90-0.98). The pooled ORs of central obesity (OR = 0.97, 95% CI, 0.91-1.04), reduced high-density lipoprotein cholesterol (OR = 0.98, 95% CI, 0.83-1.14), and elevated blood pressure (OR = 1.00, 95% CI, 0.80-1.25) for HBsAg-positive participants were all not significantly different compared with the controls. No publication bias was detected. Conclusions Serum HBsAg positivity is inversely associated with the prevalence of MetS. Among the five components of MetS, elevated triglycerides had the strongest inverse relationship with HBsAg positivity.	[Li, Yuanyuan; Zhao, Ying; Wu, Jianping] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Wu, JP (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Hangzhou, Zhejiang, Peoples R China.	jpwuzyyy@126.com			Medical Science and Technology Project of Zhejiang Province [2016KYB107]	Medical Science and Technology Project of Zhejiang Province	Support was provided by the Medical Science and Technology Project of Zhejiang Province (2016KYB107); [http://kj.zjwst.gov.cn/]. The funders played roles in decision to publish and preparation of the manuscript.	Ahmadieh H, 2014, DIABETES RES CLIN PR, V104, P53, DOI 10.1016/j.diabres.2014.01.003; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chen JY, 2010, J GASTROEN HEPATOL, V25, P1763, DOI 10.1111/j.1440-1746.2010.06300.x; Cheng YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080191; Chiang CH, 2014, WORLD J GASTROENTERO, V20, P7213, DOI 10.3748/wjg.v20.i23.7213; Chiang CH, 2013, OBESITY, V21, P291, DOI 10.1002/oby.20000; Choi JS, 2015, J EPIDEMIOL, V25, P74, DOI 10.2188/jea.JE20140053; Chu CM, 2007, INT J OBESITY, V31, P871, DOI 10.1038/sj.ijo.0803479; Chung TH, 2014, KOREAN J FAM MED, V35, P81, DOI 10.4082/kjfm.2014.35.2.81; Dai Fu-hong, 2012, Zhonghua Gan Zang Bing Za Zhi, V20, P517, DOI 10.3760/cma.j.issn.1007-3418.2012.07.008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan JY, 2015, CANCER NURS, V38, P169, DOI 10.1097/NCC.0000000000000153; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Ha M, 2015, OBES RES CLIN PRACT; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holstein A, 2002, J GASTROEN HEPATOL, V17, P677, DOI 10.1046/j.1440-1746.2002.02755.x; Hsieh PS, 2011, WORLD J GASTROENTERO, V17, P5240, DOI 10.3748/wjg.v17.i48.5240; Hsu CS, 2012, J VIRAL HEPATITIS, V19, pE48, DOI 10.1111/j.1365-2893.2011.01535.x; Hsu CS, 2015, HEPATOL INT, V9, P231, DOI 10.1007/s12072-015-9616-2; Huang CY, 2016, OBESITY, V24, P483, DOI 10.1002/oby.21333; Huang ZS, 2010, J GASTROEN HEPATOL, V25, P1420, DOI 10.1111/j.1440-1746.2010.06268.x; Ishizaka N, 2008, HEPATOL RES, V38, P775, DOI 10.1111/j.1872-034X.2008.00334.x; Jan CF, 2006, INT J OBESITY, V30, P794, DOI 10.1038/sj.ijo.0803204; Jarcuska P, 2014, EUR J INTERN MED, V25, P286, DOI 10.1016/j.ejim.2014.01.006; Jinjuvadia R, 2014, AM J MED SCI, V347, P23, DOI 10.1097/MAJ.0b013e31828b25a5; Karsen H, 2012, AFR HEALTH SCI, V12, P114, DOI 10.4314/ahs.v12i2.6; Katoonizadeh A, 2016, J MED VIROL, V88, P1230, DOI 10.1002/jmv.24466; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Lee JG, 2012, WORLD J GASTROENTERO, V18, P6120, DOI 10.3748/wjg.v18.i42.6120; Li WC, 2013, LIVER INT, V33, P1194, DOI 10.1111/liv.12224; Lin YC, 2007, WORLD J GASTROENTERO, V13, P1805, DOI 10.3748/wjg.v13.i12.1805; Liu PT, 2013, METABOLISM, V62, P220, DOI 10.1016/j.metabol.2012.07.022; Locarnini S, 2015, J HEPATOL, V62, pS76, DOI 10.1016/j.jhep.2015.01.018; Luo BY, 2007, CLIN CHIM ACTA, V380, P238, DOI 10.1016/j.cca.2007.01.012; Machado MV, 2011, J GASTROEN HEPATOL, V26, P1361, DOI 10.1111/j.1440-1746.2011.06801.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; McManus DD, 2012, OBESITY, V20, P1882, DOI 10.1038/oby.2011.32; Moritani M, 2005, J GASTROENTEROL, V40, P1049, DOI 10.1007/s00535-005-1655-3; Park B, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000091; Patton HM, 2010, AM J GASTROENTEROL, V105, P2093, DOI 10.1038/ajg.2010.152; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Shlomai A, 2008, MED HYPOTHESES, V71, P53, DOI 10.1016/j.mehy.2007.08.032; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su TC, 2004, J FORMOS MED ASSOC, V103, P286; Targher G, 2007, J HEPATOL, V46, P1126, DOI 10.1016/j.jhep.2007.01.021; Wang CC, 2008, J GASTROEN HEPATOL, V23, P779, DOI 10.1111/j.1440-1746.2007.05216.x; Wang CC, 2015, J GASTROEN HEPATOL, V30, P14, DOI 10.1111/jgh.12700; Wells G.A., NEWCASTLE OTTAWA SCA; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Wong VWS, 2010, AM J GASTROENTEROL, V105, P132, DOI 10.1038/ajg.2009.560; Yang KC, 2007, ATHEROSCLEROSIS, V195, P392, DOI 10.1016/j.atherosclerosis.2006.10.018; Yang KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27034	58	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177713	10.1371/journal.pone.0177713	http://dx.doi.org/10.1371/journal.pone.0177713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505202	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500035
J	Michl, SC; Ratten, JM; Beyer, M; Hasler, M; LaRoche, J; Schulz, C				Michl, Stephanie Celine; Ratten, Jenni-Marie; Beyer, Matt; Hasler, Mario; LaRoche, Julie; Schulz, Carsten			The malleable gut microbiome of juvenile rainbow trout (Oncorhynchus mykiss): Diet-dependent shifts of bacterial community structures	PLOS ONE			English	Article							MULTIPLE CONTRAST TESTS; PLANT-BASED DIET; GLUCOSE-METABOLISM; FISH-MEAL; INTESTINAL MICROBIOTA; SALMO-SALAR; ZEBRAFISH; PROTEIN; REPLACEMENT; CARP	Plant-derived protein sources are the most relevant substitutes for fishmeal in aquafeeds. Nevertheless, the effects of plant based diets on the intestinal microbiome especially of juvenile Rainbow trout (Oncorhynchus mykiss) are yet to be fully investigated. The present study demonstrates, based on 16S rDNA bacterial community profiling, that the intestinal microbiome of juvenile Rainbow trout is strongly affected by dietary plant protein inclusion levels. After first feeding of juveniles with either 0%, 50% or 97% of total dietary protein content derived from plants, statistically significant differences of the bacterial gut community for the three diet-types were detected, both at phylum and order level. The microbiome of juvenile fish consisted mainly of the phyla Proteobacteria, Firmicutes, Bacteroidetes, Fusobacteria and Actinobacteria, and thus fits the salmonid core microbiome suggested in previous studies. Dietary plant proteins significantly enhanced the relative abundance of the orders Lactobacillales, Bacillales and Pseudomonadales. Animal proteins in contrast significantly promoted Bacteroidales, Clostridiales, Vibrionales, Fusobacteriales and Alteromonadales. The overall alpha diversity significantly decreased with increasing plant protein inclusion levels and with age of experimental animals. In order to investigate permanent effects of the first feeding diet-type on the early development of the microbiome, a diet change was included in the study after 54 days, but no such effects could be detected. Instead, the microbiome of juvenile trout fry was highly dependent on the actual diet fed at the time of sampling.	[Michl, Stephanie Celine; Schulz, Carsten] Gesell Marine Aquakultur mbH GMA Busum, Busum, Germany; [Michl, Stephanie Celine; Schulz, Carsten] Christian Albrechts Univ Kiel, Inst Anim Breeding & Husb, Dept Marine Aquaculture, Kiel, Germany; [Michl, Stephanie Celine] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Ratten, Jenni-Marie; Beyer, Matt; LaRoche, Julie] Dalhousie Univ, Halifax, NS, Canada; [Hasler, Mario] Christian Albrechts Univ Kiel, Lehrfach Variat Stat, Kiel, Germany	University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Dalhousie University; University of Kiel	Michl, SC (corresponding author), Gesell Marine Aquakultur mbH GMA Busum, Busum, Germany.; Michl, SC (corresponding author), Christian Albrechts Univ Kiel, Inst Anim Breeding & Husb, Dept Marine Aquaculture, Kiel, Germany.; Michl, SC (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	michl@gma-buesum.de	Schulz, Carsten/C-2127-2017	LaRoche, Julie/0000-0003-4809-6411	Helmholtz Graduate School for Ocean System Science and Technology (HOSST); Geomar Helmholtz Centre for Ocean Research Kiel; NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); Dalhousie University; NSERC DISCOVERY; Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	Helmholtz Graduate School for Ocean System Science and Technology (HOSST); Geomar Helmholtz Centre for Ocean Research Kiel(Helmholtz Association); NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); Dalhousie University; NSERC DISCOVERY(Natural Sciences and Engineering Research Council of Canada (NSERC)); Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	SCM was supported by the Helmholtz Graduate School for Ocean System Science and Technology (HOSST); Geomar Helmholtz Centre for Ocean Research Kiel; http://www.geomar.de/ studieren/phd/hosst/. JMR was supported by the NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); Dalhousie University; http://www.tosst.org/; NSERC DISCOVERY grant to JLR. The authors also acknowledge financial support from Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful for the support of the Skretting Aquaculture Research Centre (Stavanger, Norway) by providing the chemical analysis of dietary fatty acids and amino acids. There are no conflicts of interest. We would like to thank Jennifer Tolman for her assistance during DNA sample preparation, Jackie Zorz and Dhwani Desai for their help during the QIIME data processing and our colleagues from GMA for substantial support during sampling. We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds.	Askarian F, 2012, AQUACULTURE, V326, P1, DOI 10.1016/j.aquaculture.2011.10.016; Atienza E, 2015, ANAEROBE, P7; Austin B, 2006, THESCIENTIFICWORLDJO, V6, P931, DOI 10.1100/tsw.2006.181; Bakke A, 2014, AQUACULT NUTR, V20, P381; Balasubramanian MN, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2804-1; Boutin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084772; Bretz F, 2011, MULTIPLE COMP USING, DOI DOI 10.1201/9781420010909; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carroll R.J., 1988, TRANSFORMATION WEIGH; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dawood MAO, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/514196; Dehler CE, 2017, AQUACULTURE, V467, P149, DOI 10.1016/j.aquaculture.2016.07.017; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fang L, 2014, BRIT J NUTR, V111, P808, DOI 10.1017/S0007114513003243; Gajardo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30893; Geurden I, 2007, AM J PHYSIOL-REG I, V292, pR2275, DOI 10.1152/ajpregu.00444.2006; Geurden I, 2014, J EXP BIOL, V217, P3396, DOI 10.1242/jeb.106062; Geurden I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083162; Ghanbari M, 2015, AQUACULTURE, V448, P464, DOI 10.1016/j.aquaculture.2015.06.033; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hanley B, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003338; Hardy RW, 2013, SPECIES PROFILE RAIN; Hartung J., 1999, MULTIVARIATE STAT LE, V6 th; Hasler M, 2008, BIOMETRICAL J, V50, P793, DOI 10.1002/bimj.200710466; Hasler M, 2014, INT J BIOSTAT, V10, P17, DOI 10.1515/ijb-2012-0015; Hothorn T., 2008, MULTCOMP SIMULTANEOU; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI [10.1016/j.actuaculture.2013.12.032, 10.1016/j.aquaculture.2013.12.032]; Ingerslev HC, 2014, FISH SHELLFISH IMMUN, V40, P624, DOI 10.1016/j.fsi.2014.08.021; Izquierdo MS, 2015, AQUACULTURE, V449, P18, DOI 10.1016/j.aquaculture.2015.03.032; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; KAUSHIK SJ, 1995, AQUACULTURE, V133, P257, DOI 10.1016/0044-8486(94)00403-B; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Li TT, 2015, MICROB ECOL, V69, P25, DOI 10.1007/s00248-014-0480-8; Lowrey LT, 2013, FISH SHELLFISH IMMUN, V34, P1721, DOI 10.1016/j.fsi.2013.03.261; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Oksanen J, 2022, R PACKAGE VERSION; R Core Team, 2006, R LANG ENV STAT COMP; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Ringo E, 2016, AQUACULT NUTR, V22, P219, DOI 10.1111/anu.12346; Ringo E, 2000, J APPL MICROBIOL, V89, P317, DOI 10.1046/j.1365-2672.2000.01116.x; Rocha F, 2015, BRIT J NUTR, V113, P403, DOI 10.1017/S0007114514003869; Schaperclaus W, 1998, LEHRBUCH TEICHWIRTSC; Schmidt V, APPL ENV MICROBIOL; Shafaeipour A, 2008, AQUACULT NUTR, V14, P110, DOI 10.1111/j.1365-2095.2007.00509.x; Slawski H, 2012, AQUACULT INT, V20, P443, DOI 10.1007/s10499-011-9476-2; Tacon AGJ, 2015, REV FISH SCI AQUAC, V23, P1, DOI 10.1080/23308249.2014.987209; Thu TTN, 2011, AQUACULT NUTR, V17, P80, DOI 10.1111/j.1365-2095.2009.00732.x; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Verbeke G, 2000, LINEAR MIXED MODELS; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Wilkins LGE, 2016, MOL ECOL; Wong S, 2013, APPL ENVIRON MICROB, V79, P4974, DOI 10.1128/AEM.00924-13; Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634; Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	63	67	71	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177735	10.1371/journal.pone.0177735	http://dx.doi.org/10.1371/journal.pone.0177735			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498878	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000401314500044
J	Ferrando, C; Suarez-Sipmann, F; Tusman, G; Leon, I; Romero, E; Gracia, E; Mugarra, A; Arocas, B; Pozo, N; Soro, M; Belda, FJ				Ferrando, Carlos; Suarez-Sipmann, Fernando; Tusman, Gerardo; Leon, Irene; Romero, Esther; Gracia, Estefania; Mugarra, Ana; Arocas, Blanca; Pozo, Natividad; Soro, Marina; Belda, Francisco J.			Open lung approach versus standard protective strategies: Effects on driving pressure and ventilatory efficiency during anesthesia - A pilot, randomized controlled trial	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR RECRUITMENT; MECHANICAL VENTILATION; GENERAL-ANESTHESIA; TIDAL-VOLUME; GAS-EXCHANGE; IMPROVES; OBESE; ATELECTASIS	Background Low tidal volume (VT) during anesthesia minimizes lung injury but may be associated to a decrease in functional lung volume impairing lung mechanics and efficiency. Lung recruitment (RM) can restore lung volume but this may critically depend on the post-RM selected PEEP. This study was a randomized, two parallel arm, open study whose primary outcome was to compare the effects on driving pressure of adding a RM to low-VT ventilation, with or without an individualized post-RM PEEP in patients without known previous lung disease during anesthesia. Methods Consecutive patients scheduled for major abdominal surgery were submitted to low-VT ventilation (6 ml.kg(-1)) and standard PEEP of 5 cmH(2)O (pre-RM, n = 36). After 30 min estabilization all patients received a RM and were randomly allocated to either continue with the same PEEP (RM-5 group, n = 18) or to an individualized open-lung PEEP (OL-PEEP) (Open Lung Approach, OLA group, n = 18) defined as the level resulting in maximal Cdyn during a decremental PEEP trial. We compared the effects on driving pressure and lung efficiency measured by volumetric capnography. Results OL-PEEP was found at 8 +/- 2 cmH(2)O. 36 patients were included in the final analysis. When compared with pre-RM, OLA resulted in a 22% increase in compliance and a 28% decrease in driving pressure when compared to pre-RM. These parameters did not improve in the RM-5. The trend of the DP was significantly different between the OLA and RM-5 groups (p = 0.002). VDalv/VTalv was significantly lower in the OLA group after the RM (p = 0.035). Conclusions Lung recruitment applied during low-VT ventilation improves driving pressure and lung efficiency only when applied as an open-lung strategy with an individualized PEEP in patients without lung diseases undergoing major abdominal surgery.	[Ferrando, Carlos; Leon, Irene; Romero, Esther; Gracia, Estefania; Mugarra, Ana; Arocas, Blanca; Soro, Marina; Belda, Francisco J.] Hosp Clin Univ, Dept Anesthesiol & Crit Care, Valencia, Spain; [Suarez-Sipmann, Fernando] Inst Salud Carlos III, GIBER Enfermedades Resp, Madrid, Spain; [Suarez-Sipmann, Fernando] Uppsala Univ Hosp, Dept Surg Sci, Hedenstierna Lab, Uppsala, Sweden; [Tusman, Gerardo] Hosp Privado Comunidad Mar Del Plata, Dept Anesthesiol, Mar Del Plata, Buenos Aires, Argentina; [Pozo, Natividad] Hosp Clin Univ, INCLIVA Clin Res Inst, Valencia, Spain	Hospital Clinic Universitari de Valencia; Instituto de Salud Carlos III; Uppsala University; Uppsala University Hospital	Ferrando, C (corresponding author), Hosp Clin Univ, Dept Anesthesiol & Crit Care, Valencia, Spain.	cafeoranestesia@gmail.com	Sipmann, Fernando Suarez/AAD-9104-2020; Leon, Irene/AAA-5711-2019; Belda, Javier/AAF-1597-2020	Sipmann, Fernando Suarez/0000-0002-7412-2970; Leon, Irene/0000-0003-2172-8933; Ferrando, Carlos/0000-0002-1907-5323	INCLIVA Biomedical Research Institute	INCLIVA Biomedical Research Institute	This work was funded by the INCLIVA Biomedical Research Institute.	Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Bohm SH, 2009, ANESTH ANALG, V109, P151, DOI 10.1213/ane.0b013e31819bcbb5; Bohr C., 1891, UBER LUNGGEATMUNG SK, V2, P236; Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-976OC; Borges JB, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1063-x; Cereda M, 2014, CRIT CARE MED, V41, P527; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Ferrando C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0694-1; Ferrando C, 2014, ANESTH ANALG, V118, P657, DOI 10.1213/ANE.0000000000000105; FLETCHER R, 1981, BRIT J ANAESTH, V53, P77, DOI 10.1093/bja/53.1.77; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; HEDENSTIERNA G, 1976, ACTA ANAESTH SCAND, V20, P334, DOI 10.1111/j.1399-6576.1976.tb05047.x; Jabaudon M, 2015, RESPIROLOGY, V20, P1131, DOI 10.1111/resp.12583; Kacmarek RM, 2016, CRIT CARE MED, V44, P32, DOI 10.1097/CCM.0000000000001383; Ladha K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3646; Maisch S, 2008, ANESTH ANALG, V106, P175, DOI 10.1213/01.ane.0000287684.74505.49; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Richard JC, 2001, AM J RESP CRIT CARE, V163, P1609, DOI 10.1164/ajrccm.163.7.2004215; Rusca M, 2003, ANESTH ANALG, V97, P1835, DOI 10.1213/01.ANE.0000087042.02266.F6; Serpa Neto A, LANCET RESP MED; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; SUTER PM, 1975, NEW ENGL J MED, V292, P284, DOI 10.1056/NEJM197502062920604; The PROVE Network Investigators, 2014, LANCET, V384, P495, DOI DOI 10.1016/S0140-6736(14)60416-5; TOKICS L, 1987, ANESTHESIOLOGY, V66, P157, DOI 10.1097/00000542-198702000-00009; Tusman G, 2004, CAN J ANAESTH, V51, P723, DOI 10.1007/BF03018433; Tusman G, 2004, ANESTH ANALG, V98, P1604, DOI 10.1213/01.ANE.0000068484.67655.1A; Tusman G, 2014, ANESTH ANALG, V118, P137, DOI 10.1213/01.ane.0000438350.29240.08; Tusman G, 2011, INTENS CARE MED, V37, P870, DOI 10.1007/s00134-011-2164-x; Tusman G, 2009, J CLIN MONIT COMPUT, V23, P197, DOI 10.1007/s10877-009-9182-z; Unzueta C, 2012, BRIT J ANAESTH, V108, P517, DOI 10.1093/bja/aer415	32	34	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177399	10.1371/journal.pone.0177399	http://dx.doi.org/10.1371/journal.pone.0177399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493943	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300102
J	Kurano, M; Nishikawa, M; Kuma, H; Jona, M; Yatomi, Y				Kurano, Makoto; Nishikawa, Masako; Kuma, Hiroyuki; Jona, Masahiro; Yatomi, Yutaka			Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes	PLOS ONE			English	Article							MAP KINASE PATHWAYS; K562 CELLS; HEREDITARY SPHEROCYTOSIS; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; SPHINGOSINE-1-PHOSPHATE; TRANSPORTER; METABOLISM; PLATELETS; BUTYRATE	Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator that is thought to be involved in various diseases. Although the main source of S1P in the plasma is erythrocytes, how S1P is exported from erythrocytes has not been elucidated. When we differentiated K562 cells into erythroblast-like cells with sodium butyrate, we observed that the efflux of S1P was increased without increased expression of previously proposed S1P transporters, while the expression levels of Band3 were increased. Therefore, in this study, we investigated the involvement of Band 3, the most characteristic membranous transporter for erythrocytes, in S1P efflux, using 4,4'-diisothiocyanatodihydrostilbene-2,2'-disulfonic acid, disodium salt (H2DIDS), which is an inhibitor of Band3. First, we treated human washed erythrocytes with H2DIDS and found that H2DIDS decreased the S1P levels in the supernatant, while it increased the cellular S1P contents. Next, when we injected H2DIDS into mice, the plasma S1P level was significantly decreased. Finally, when we overexpressed or suppressed Band3 in K562 cells, S1P efflux was enhanced or decreased, respectively, while the overexpression of Band3 in HEK293 cells did not modulate S1P efflux. These results suggested the possible involvement of Band3 in the transport of S1P, a multi-functional bioactive phospholipid, from erythrocytes.	[Kurano, Makoto; Nishikawa, Masako; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Kuma, Hiroyuki] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Clin Chem, Nagasaki, Japan; [Jona, Masahiro] Univ Tokyo Hosp, Dept Clin Lab, Tokyo, Japan	University of Tokyo; Nagasaki International University; University of Tokyo	Yatomi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan.	yatoyuta-tky@umin.ac.jp		Yatomi, Yutaka/0000-0003-1719-4297; Kuma, Hiroyuki/0000-0003-2027-8790	Grants-in-Aid for Scientific Research [16H06236, 15H05897] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Arakawa T, 2015, SCIENCE, V350, P680, DOI 10.1126/science.aaa4335; Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; Delaunay J, 1996, ANN GENET-PARIS, V39, P209; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Goetzl EJ, 2001, PROSTAG OTH LIPID M, V64, P11, DOI 10.1016/S0090-6980(01)00104-6; Grebenova D, 2006, BLOOD CELL MOL DIS, V37, P210, DOI 10.1016/j.bcmd.2006.08.001; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jonnalagadda D, 2014, BBA-MOL CELL BIOL L, V1841, P1581, DOI 10.1016/j.bbalip.2014.08.013; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kawasaki N, 1996, ARCH BIOCHEM BIOPHYS, V328, P289, DOI 10.1006/abbi.1996.0175; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kurano M, 2015, J BIOL CHEM, V290, P2477, DOI 10.1074/jbc.M114.596445; Kurano M, 2012, J LIPID RES, V53, P2275, DOI 10.1194/jlr.M026575; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Ohkawa R, 2008, ANN CLIN BIOCHEM, V45, P356, DOI 10.1258/acb.2007.007189; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Reithmeier RAF, 2016, BBA-BIOMEMBRANES, V1858, P1507, DOI 10.1016/j.bbamem.2016.03.030; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; SCHOFIELD AE, 1992, NATURE, V355, P836, DOI 10.1038/355836a0; Sutter I, 2014, J LIPID RES, V55, P1730, DOI 10.1194/jlr.M050021; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; VILLEVAL JL, 1983, EXP CELL RES, V146, P428, DOI 10.1016/0014-4827(83)90145-3; Williamson RC, 2008, BLOOD CELL MOL DIS, V41, P35, DOI 10.1016/j.bcmd.2008.01.001; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006; Zhang Y., 2014, EURASIP J ADV SIG PR, V2014, P1, DOI DOI 10.1016/J.ENGGE0.2014.08.024	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177543	10.1371/journal.pone.0177543	http://dx.doi.org/10.1371/journal.pone.0177543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494002	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300133
J	Baeza-Yates, R; Sangal, PM; Villoslada, P				Baeza-Yates, Ricardo; Sangal, Puneet Mohan; Villoslada, Pablo			Burden of neurological diseases in the US revealed by web searches	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; BEHAVIOR; PEOPLE; EPILEPSY; TRENDS	Background Analyzing the disease-related web searches of Internet users provides insight into the interests of the general population as well as the healthcare industry, which can be used to shape health care policies. Methods We analyzed the searches related to neurological diseases and drugs used in neurology using the most popular search engines in the US, Google and Bing/Yahoo. Results We found that the most frequently searched diseases were common diseases such as dementia or Attention Deficit/Hyperactivity Disorder (ADHD), as well as medium frequency diseases with high social impact such as Parkinson's disease, MS and ALS. The most frequently searched CNS drugs were generic drugs used for pain, followed by sleep disorders, dementia, ADHD, stroke and Parkinson's disease. Regarding the interests of the healthcare industry, ADHD, Alzheimer's disease, MS, ALS, meningitis, and hypersomnia received the higher advertising bids for neurological diseases, while painkillers and drugs for neuropathic pain, drugs for dementia or insomnia, and triptans had the highest advertising bidding prices. Conclusions Web searches reflect the interest of people and the healthcare industry, and are based either on the frequency or social impact of the disease.	[Baeza-Yates, Ricardo] Univ Pompeu Fabra, Barcelona, Spain; [Sangal, Puneet Mohan] Amazon, Seattle, WA USA; [Villoslada, Pablo] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Villoslada, Pablo] Univ Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain	Pompeu Fabra University; Amazon.com; University of California System; University of California San Francisco; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Villoslada, P (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.; Villoslada, P (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain.	Pablo.VillosladaDiaz@ucsf.edu	Villoslada, Pablo/AAF-9547-2019; Villoslada, Pablo/O-1757-2019; Baeza-Yates, Ricardo/H-5692-2015	Villoslada, Pablo/0000-0002-8735-6119; Baeza-Yates, Ricardo/0000-0003-3208-9778	CERCA Program / Generalitat de Catalunya; Amazon Inc.	CERCA Program / Generalitat de Catalunya; Amazon Inc.	This study was funded by CERCA Program / Generalitat de Catalunya to PV. Funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Amazon Inc., a commercial company provided support in the form of salaries for author PS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions.	Agarwal Vibhu, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P15; Brigo F, 2016, NEUROL SCI, V37, P781, DOI 10.1007/s10072-016-2501-5; Brigo F, 2015, J PUBLIC HEALTH-UK, V37, P555, DOI 10.1093/pubmed/fdu083; Brigo F, 2015, EPILEPSY BEHAV, V49, P146, DOI 10.1016/j.yebeh.2015.02.029; Brigo F, 2015, J CLIN NEUROSCI, V22, P1170, DOI 10.1016/j.jocn.2015.02.006; Brigo F, 2014, MULT SCLER RELAT DIS, V3, P440, DOI 10.1016/j.msard.2014.02.005; Brigo F, 2014, EPILEPSY BEHAV, V31, P67, DOI 10.1016/j.yebeh.2013.11.020; Cerminara C, 2014, EPILEPSY BEHAV, V41, P119, DOI 10.1016/j.yebeh.2014.09.053; Colombo C, 2014, INTERACT J MED RES, V3, P2, DOI 10.2196/ijmr.3034; De Lott LB, 2016, NEUROLOGY, V86, P1491, DOI 10.1212/WNL.0000000000002589; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Jansen Bernard J., 2008, International Journal of Electronic Business, V6, P114, DOI 10.1504/IJEB.2008.018068; Moccia M, 2016, J NEUROL NEUROSUR PS, V87, P1028, DOI 10.1136/jnnp-2016-313260; Otte WM, 2013, EPILEPSY BEHAV, V29, P571, DOI 10.1016/j.yebeh.2013.10.013; Vera C, 2012, TECH VASC INTERV RAD, V15, P153, DOI 10.1053/j.tvir.2012.02.009; White RW, 2013, J AM MED INFORM ASSN, V20, P404, DOI 10.1136/amiajnl-2012-001482; World Health Organization (OMS), 2006, NEUR DIS PUBL HLTH C	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178019	10.1371/journal.pone.0178019	http://dx.doi.org/10.1371/journal.pone.0178019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531237	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400050
J	Silva, RM; Lamas, J; Silva, CC; Coello, Y; Mouta, S; Santos, JA				Silva, Rosa Mariana; Lamas, Joao; Silva, Carlos Cesar; Coello, Yann; Mouta, Sandra; Santos, Jorge Almeida			Judging time-to-passage of looming sounds: Evidence for the use of distance-based information	PLOS ONE			English	Article							IMPENDING COLLISION; RHESUS-MONKEYS; PERCEPTION; LOCALIZATION; INTEGRATION; ACCURACY; ARRIVAL; MOTION; BIAS; CUES	Perceptual judgments are an essential mechanism for our everyday interaction with other moving agents or events. For instance, estimation of the time remaining before an object contacts or passes us is essential to act upon or to avoid that object. Previous studies have demonstrated that participants use different cues to estimate the time to contact or the time to passage of approaching visual stimuli. Despite the considerable number of studies on the judgment of approaching auditory stimuli, not much is known about the cues that guide listeners' performance in an auditory Time-to-Passage (TTP) task. The present study evaluates how accurately participants judge approaching white-noise stimuli in a TTP task that included variable occlusion periods (portion of the presentation time where the stimulus is not audible). Results showed that participants were able to accurately estimate TTP and their performance, in general, was weakly affected by occlusion periods. Moreover, we looked into the psychoacoustic variables provided by the stimuli and analysed how binaural cues related with the performance obtained in the psychophysical task. The binaural temporal difference seems to be the psychoacoustic cue guiding participants' performance for lower amounts of occlusion, while the binaural loudness difference seems to be the cue guiding performance for higher amounts of occlusion. These results allowed us to explain the perceptual strategies used by participants in a TTP task (maintaining accuracy by shifting the informative cue for TTP estimation), and to demonstrate that the psychoacoustic cue guiding listeners' performance changes according to the occlusion period.	[Silva, Rosa Mariana; Lamas, Joao; Silva, Carlos Cesar; Mouta, Sandra; Santos, Jorge Almeida] Ctr Comp Graph, Guimaraes, Portugal; [Silva, Rosa Mariana; Santos, Jorge Almeida] Univ Minho, Sch Psychol, Dept Basic Psychol, Braga, Portugal; [Silva, Carlos Cesar] Univ Minho, Dept Informat, Braga, Portugal; [Silva, Carlos Cesar; Mouta, Sandra] Inst Syst & Comp Engn Technol & Sci, INESC TEC, Porto, Portugal; [Mouta, Sandra] Univ Lille, UMR CNRS 9193, SCALab, Cognit & Affect Sci Lab, Villeneuve Dascq, France; [Santos, Jorge Almeida] Univ Minho, Ctr Algoritmi, Guimaraes, Portugal	Universidade do Minho; Universidade do Minho; INESC TEC; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille; Universidade do Minho	Silva, RM (corresponding author), Ctr Comp Graph, Guimaraes, Portugal.; Silva, RM (corresponding author), Univ Minho, Sch Psychol, Dept Basic Psychol, Braga, Portugal.	mariana.macedo.silva@gmail.com	Lamas, João PSA/J-3299-2017	Lamas, João PSA/0000-0002-0633-180X; Loureiro Silva, Carlos Cesar/0000-0002-4886-9405; Santos, Jorge/0000-0001-5881-8567; Silva, Rosa Mariana/0000-0002-9902-6205	Fundacao Bial [143/13]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/63393/2009, PTDC/EEA-ELC/112137/2009]; COMPETE [POCI-01-0145-FEDER-007043]; FCT-Fundacao para a Ciencia e Tecnologia [UID/CEC/00319/2013]; Bial Foundation [143/14]; FCT [PTDC/EEA-ELC/112137/2009]; Fundação para a Ciência e a Tecnologia [PTDC/EEA-ELC/112137/2009] Funding Source: FCT	Fundacao Bial(Bial Foundation); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE; FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Bial Foundation(Bial Foundation); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This study was supported by: Bial Foundation Grant 143/14 (https:/www.bial.com/en/bial_foundation.11/11th_symposium.219/ fellows_preliminary_results.2357fellows_ preliminary_results.a569.html); FCT PTDC/EEA-ELC/112137/2009 (https://www.fct.pt/apoios/ projectos/consultaA/vglobal_projecto?idProjecto=1121378& and COMPETE:POCI-01-0145-FEDER-007043 and FCT-Fundacao para a Ciencia e Tecnologia within the Project Scope: UID/CEC/00319/2013.; This work has been supported by Fundacao Bial (Grant 143/13), Fundacao para a Ciencia e Tecnologia (SFRH/BPD/63393/2009; PTDC/EEA-ELC/112137/2009). This work was funded by COMPETE: POCI-01-0145-FEDER-007043 and FCT-Fundacao para a Ciencia e Tecnologia within the Project Scope: UID/CEC/00319/2013.	Bach DR, 2009, INT J PSYCHOPHYSIOL, V74, P28, DOI 10.1016/j.ijpsycho.2009.06.004; Brungart DS, 1999, J ACOUST SOC AM, V106, P1956, DOI 10.1121/1.427943; Calabro FJ, 2011, VISION RES, V51, P2378, DOI 10.1016/j.visres.2011.09.016; Carlile S., 1996, VIRTUAL AUDITORY SPA, P27; Cheng CI, 2001, J AUDIO ENG SOC, V49, P231, DOI 10.1016/S0022-5096(00)00039-9; COLEMAN PD, 1963, PSYCHOL BULL, V60, P302, DOI 10.1037/h0045716; Cutting J.E., 1995, PERCEPTION SPACE MOT, P69, DOI 10.1016/B978-012240530-3/50005-5; Efron B., INTRO BOOTSTRAP; Gardner B., 1994, HRTF MEASUREMENTS OF; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; Gray R, 2001, PERCEPTION, V30, P1007, DOI 10.1068/p3220; Guski R., 1992, ECOL PSYCHOL, V4, P189, DOI DOI 10.1207/S15326969EC00403_4; Hancock PA, 1998, OCCUPATIONAL INJURY: RISK, PREVENTION AND INTERVENTION, P44; HEUER H, 1993, PERCEPTION, V22, P549, DOI 10.1068/p220549; Keil MS, 2012, PLOS COMPUTATIONAL B, V8, P1; KNOWLES WB, 1958, AM PSYCHOL, V13, P405; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Lina D.P., 2015, REHABILITATING COCO, P1; Lopez-Moliner J, 2007, PERCEPT PSYCHOPHYS, V69, P887, DOI 10.3758/BF03193925; Lugtigheid AJ, 2011, J VISION, V11, DOI 10.1167/11.13.1; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Mouta S, 2012, J VISION, V12, DOI 10.1167/12.2.21; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Neuhoff JG, 2012, EVOL HUM BEHAV, V33, P318, DOI 10.1016/j.evolhumbehav.2011.11.001; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; ROSENBLUM LD, 1993, PERCEPTION, V22, P1467, DOI 10.1068/p221467; ROSENBLUM LD, 1987, PERCEPTION, V16, P175, DOI 10.1068/p160175; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; SCHIFF W, 1979, PERCEPTION, V8, P647, DOI 10.1068/p080647; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Stevens S. S., 1983, HEARING ITS PSYCHOL; Tresilian JR, 1999, P ROY SOC B-BIOL SCI, V266, P39, DOI 10.1098/rspb.1999.0601; Wada Y, 2003, INT J PSYCHOPHYSIOL, V50, P117, DOI 10.1016/S0167-8760(03)00128-4; Yan JJ, 2011, J VISION, V11, DOI 10.1167/11.12.7	38	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177734	10.1371/journal.pone.0177734	http://dx.doi.org/10.1371/journal.pone.0177734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531210	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400027
J	Doxzen, KW; Doudna, JA				Doxzen, Kevin W.; Doudna, Jennifer A.			DNA recognition by an RNA-guided bacterial Argonaute	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TARGET RECOGNITION; PROTEINS; INSIGHTS; COMPLEX	Argonaute (Ago) proteins are widespread in prokaryotes and eukaryotes and share a four-domain architecture capable of RNA-or DNA-guided nucleic acid recognition. Previous studies identified a prokaryotic Argonaute protein from the eubacterium Marinitoga piezophila (MpAgo), which binds preferentially to 50-hydroxylated guide RNAs and cleaves single-stranded RNA (ssRNA) and DNA (ssDNA) targets. Here we present a 3.2 angstrom resolution crystal structure of MpAgo bound to a 21-nucleotide RNA guide and a complementary 21-nucleotide ssDNA substrate. Comparison of this ternary complex to other target-bound Argonaute structures reveals a unique orientation of the N-terminal domain, resulting in a straight helical axis of the entire RNA-DNA heteroduplex through the central cleft of the protein. Additionally, mismatches introduced into the heteroduplex reduce MpAgo cleavage efficiency with a symmetric profile centered around the middle of the helix. This pattern differs from the canonical mismatch tolerance of other Argonautes, which display decreased cleavage efficiency for substrates bearing sequence mismatches to the 50 region of the guide strand. This structural analysis of MpAgo bound to a hybrid helix advances our understanding of the diversity of target recognition mechanisms by Argonaute proteins.	[Doxzen, Kevin W.; Doudna, Jennifer A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Doxzen, Kevin/0000-0002-3616-6569	Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; NSF	Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; NSF(National Science Foundation (NSF))	This research was supported by the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group. This research was also supported through a NSF grant to JAD.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Carmell MA, 2002, ARGONAUTE FAMILY TEN; Cheatham TE, 1997, J AM CHEM SOC, V119, P4805, DOI 10.1021/ja963641w; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enghiad B, 2017, ACS SYNTH BIOL; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jiang F, 2016, ANN REV BIOPHYS, V46; Jo MH, 2015, MOL CELL, V59, P117, DOI 10.1016/j.molcel.2015.04.027; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaya E, 2016, P NATL ACAD SCI USA, V113, P4057, DOI 10.1073/pnas.1524385113; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Makarova KS, 2009, BIOLOGY; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Murakami R, 2016, NATURE COMMUNICATION, V7, P1; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; RATMEYER L, 1994, BIOCHEMISTRY-US, V33, P5298, DOI 10.1021/bi00183a037; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Sheng G, 2014, STRUCTURE BASED CLEA; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, P1; Turner DH, 1996, CURR OPIN STRUC BIOL, V6, P299, DOI 10.1016/S0959-440X(96)80047-9; Wang Y, 2008, NATURE; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Willkomm Sarah, 2015, Life-Basel, V5, P538, DOI 10.3390/life5010538; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	43	29	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177097	10.1371/journal.pone.0177097	http://dx.doi.org/10.1371/journal.pone.0177097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520746	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700036
J	Kim, GW; Kim, YH; Jeong, GW				Kim, Gwang-Won; Kim, Yun-Hyeon; Jeong, Gwang-Woo			Whole brain volume changes and its correlation with clinical symptom severity in patients with schizophrenia: A DARTEL-based VBM study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; ANTERIOR CINGULATE CORTEX; 1ST-EPISODE SCHIZOPHRENIA; SEX-DIFFERENCES; WHITE-MATTER; INSULAR CORTEX; LIKELIHOOD ESTIMATION; STRUCTURAL-CHANGES; PREFRONTAL CORTEX	The purpose of this study was to evaluate gray matter (GM) and white matter (WM) volume alterations in whole-brain structures in patients with schizophrenia and healthy controls using voxel-based morphometry (VBM), and further to assess the correlation between GM and WM volume variations and symptom severity in schizophrenia. A total of 22 patients with schizophrenia and 22 age-matched healthy controls participated. Magnetic resonance image data were processed using SPM8 software with diffeomorphic anatomical registration via an exponentiated Lie algebra (DARTEL) algorithm. Patients with schizophrenia exhibited significantly decreased GM volumes of the insula, superior temporal gyrus (STG), gyrus rectus, and anterior cingulate cortex (ACC) compared with healthy controls. The GM volumes of the STG and gyrus rectus were negatively correlated with the positive scales on the Positive and Negative Syndrome Scale (PANSS) and those of the STG and ACC were negatively correlated with the negative scales. The durations of illness in schizophrenia were negatively correlated with the GM volumes of the insula, STG, and ACC. Patients with schizophrenia exhibited significantly decreased WM volumes of the superior frontal gyrus, inferior temporal gyrus, and STG. The WM volumes of the STG were negatively correlated with the duration of illness. Our findings suggest that GM and WM volume abnormalities in the STG are associated with the psychopathology of schizophrenia.	[Kim, Gwang-Won; Jeong, Gwang-Woo] Chonnam Natl Univ, Med Sch, Res Inst Med Imaging, Gwangju, South Korea; [Kim, Yun-Hyeon; Jeong, Gwang-Woo] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Radiol, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital	Jeong, GW (corresponding author), Chonnam Natl Univ, Med Sch, Res Inst Med Imaging, Gwangju, South Korea.; Jeong, GW (corresponding author), Chonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Radiol, Gwangju, South Korea.	gwjeong@jnu.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2006730]; Chonnam National University	National Research Foundation of Korea (NRF) - Ministry of Education; Chonnam National University	This research was supported by the National Research Foundation of Korea (NRF) grants funded by the Ministry of Education (2014R1A1A2006730) and Chonnam National University Research Fund for JNU distinguished research emeritus professor (2017-2019).	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Asami T, 2012, NEUROIMAGE, V59, P986, DOI 10.1016/j.neuroimage.2011.08.066; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bagary MS, 2003, ARCH GEN PSYCHIAT, V60, P779, DOI 10.1001/archpsyc.60.8.779; BARTA PE, 1990, AM J PSYCHIAT, V147, P1457; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Benes FM, 2001, BIOL PSYCHIAT, V50, P395, DOI 10.1016/S0006-3223(01)01084-8; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Buchsbaum MS, 2006, BIOL PSYCHIAT, V60, P1181, DOI 10.1016/j.biopsych.2005.11.028; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Castellani U, 2012, J NEURAL TRANSM, V119, P395, DOI 10.1007/s00702-011-0693-7; Crespo-Facorro B, 2004, PSYCHIAT RES-NEUROIM, V132, P107, DOI 10.1016/j.pscychresns.2004.09.002; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; Dazzan P, 2005, NEUROPSYCHOPHARMACOL, V30, P765, DOI 10.1038/sj.npp.1300603; Egashira K, 2014, NEUROPSYCHOBIOLOGY, V70, P142, DOI 10.1159/000364827; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Fujiwara H, 2007, NEUROIMAGE, V36, P1236, DOI 10.1016/j.neuroimage.2007.03.068; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goldstein JM, 2002, ARCH GEN PSYCHIAT, V59, P154, DOI 10.1001/archpsyc.59.2.154; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P761, DOI 10.1001/archpsyc.57.8.761; Highley JR, 1999, BRIT J PSYCHIAT, V175, P127, DOI 10.1192/bjp.175.2.127; Hirayasu Y, 2001, CEREB CORTEX, V11, P374, DOI 10.1093/cercor/11.4.374; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Horn H, 2010, PSYCHIAT RES-NEUROIM, V182, P183, DOI 10.1016/j.pscychresns.2010.01.016; JAKOB H, 1986, J NEURAL TRANSM, V65, P303, DOI 10.1007/BF01249090; Kalayci D, 2013, KLIN PSIKOFARMAKOL B, V23, P215, DOI 10.5455/bcp.20130713094216; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim G, 2015, NEUROREPORT IN PRESS; Kim GW, 2017, NEUROSCIENCE, V343, P449, DOI 10.1016/j.neuroscience.2016.12.010; Kim GW, 2015, NEUROREPORT, V26, P647, DOI 10.1097/WNR.0000000000000405; Kim GW, 2015, J NEUROPSYCH CLIN N, V27, pE1, DOI 10.1176/appi.neuropsych.13080177; Kim JJ, 2003, SCHIZOPHR RES, V60, P173, DOI 10.1016/S0920-9964(02)00299-2; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; MENON RR, 1995, SCHIZOPHR RES, V16, P127, DOI 10.1016/0920-9964(94)00067-I; NASRALLAH HA, 1990, SCHIZOPHRENIA BULL, V16, P205, DOI 10.1093/schbul/16.2.205; Nishimura J, 2014, NEUROPSYCH DIS TREAT, V10, P2315, DOI 10.2147/NDT.S72715; Noga JT, 1995, PSYCHIAT RES-NEUROIM, V61, P201, DOI 10.1016/0925-4927(95)02612-2; Nopoulos P, 1997, AM J PSYCHIAT, V154, P1648, DOI 10.1176/ajp.154.12.1648; O'Daly OG, 2007, PSYCHIAT RES-NEUROIM, V156, P15, DOI 10.1016/j.pscychresns.2007.03.001; Pennington K, 2008, SCHIZOPHR RES, V106, P164, DOI 10.1016/j.schres.2008.08.022; Pennington K, 2008, PROTEOMICS, V8, P5097, DOI 10.1002/pmic.200800415; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Slewa-Younan S, 2004, AM J PSYCHIAT, V161, P1595, DOI 10.1176/appi.ajp.161.9.1595; Sun JH, 2009, BRAIN RES REV, V61, P14, DOI 10.1016/j.brainresrev.2009.03.004; Tomelleri L, 2009, EUR NEUROPSYCHOPHARM, V19, P835, DOI 10.1016/j.euroneuro.2009.07.007; Vita A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.116; Whitford TJ, 2007, AM J PSYCHIAT, V164, P1082, DOI 10.1176/appi.ajp.164.7.1082; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Wible CG, 2001, PSYCHIAT RES-NEUROIM, V108, P65, DOI 10.1016/S0925-4927(01)00109-3; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Yamasue H, 2004, PSYCHIAT RES-NEUROIM, V131, P195, DOI 10.1016/j.pscychresns.2004.05.004; Yao L, 2014, MAGN RESON MATER PHY, V27, P283, DOI 10.1007/s10334-013-0411-6	58	76	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177251	10.1371/journal.pone.0177251	http://dx.doi.org/10.1371/journal.pone.0177251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520743	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700041
J	Vanni, VS; Somigliana, E; Reschini, M; Pagliardini, L; Marotta, E; Faulisi, S; Paffoni, A; Vigano, P; Vegetti, W; Candiani, M; Papaleo, E				Vanni, V. S.; Somigliana, E.; Reschini, M.; Pagliardini, L.; Marotta, E.; Faulisi, S.; Paffoni, A.; Vigano, P.; Vegetti, W.; Candiani, M.; Papaleo, E.			Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; FRESH EMBRYO-TRANSFER; ELEVATED PROGESTERONE; PREGNANCY RATE; AGREEMENT; PREDICTORS; STRATEGY	Cycles with progesterone elevation during controlled ovarian stimulation (COS) for IVF/ICSI are commonly managed with a "freeze-all" strategy, due to a well-recognized detrimental effect of high progesterone levels on endometrial receptivity. However, also a detrimental effect of elevated progesterone on day-3 embryo quality has recently been found with regards to top quality embryo formation rate. Because blastocyst culture and cryopreservation are largely adopted, we deemed relevant to determine whether this detrimental effect is also seen on blastocyst quality on day 5-6. This issue was investigated through a large two-center retrospective study including 986 GnRH antagonist IVF/ICSI cycles and using top quality blastocyst formation rate as the main outcome. Results showed that on multivariate analysis sperm motility (p<0.01) and progesterone levels at ovulation triggering (p = 0.01) were the only two variables that significantly predicted top quality blastocyst formation rate after adjusting for relevant factors including female age, BMI, basal AMH and total dose of FSH used for COS. More specifically, progesterone levels at induction showed an inverse relation with top quality blastocyst formation (correlation coefficient B = -1.08, 95% CI -1.9 to -0.02) and ROC curve analysis identified P level > 1.49 ng/ml as the best cut-off for identification of patients at risk for the absence of top quality blastocysts (AUC 0.55, p< 0.01). Our study is the first to investigate the top quality blastocyst formation rate in relation to progesterone levels in IVF/ICSI cycles, showing that increasing progesterone is associated with lower rates of top quality blastocyst. Hence, the advantages of prolonging COS to maximize the number of collected oocytes might eventually be hindered by a decrease in top quality blastocysts available for transfer, if increasing progesterone levels are observed. This observation extends the results of two recent studies focused on day-3 embryos and deserves further research.	[Vanni, V. S.; Pagliardini, L.; Marotta, E.; Faulisi, S.; Vigano, P.; Papaleo, E.] IRCCS San Raffaele Sci Inst, Ctr Sci Natalita, Milan, Italy; [Somigliana, E.; Reschini, M.; Paffoni, A.; Vegetti, W.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy; [Somigliana, E.] Univ Milan, Milan, Italy; [Vigano, P.] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy; [Candiani, M.] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Vigano, P (corresponding author), IRCCS San Raffaele Sci Inst, Ctr Sci Natalita, Milan, Italy.; Vigano, P (corresponding author), IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy.	vigano.paola@hsr.it	Somigliana, Edgardo/Z-3749-2019; Vegetti, Walter/AAM-6980-2021; Candiani, Massimo/ABG-9811-2020; Papaleo, Enrico/AAN-9591-2021; Paffoni, Alessio/I-7404-2015; Reschini, Marco/ABI-2191-2020; Pagliardini, Luca/K-5886-2016; Vanni, Valeria/AAC-6059-2022	Somigliana, Edgardo/0000-0002-0223-0032; Papaleo, Enrico/0000-0003-0281-9143; Paffoni, Alessio/0000-0003-3112-3161; Reschini, Marco/0000-0002-9868-3043; Pagliardini, Luca/0000-0002-3960-7454; Vanni, Valeria/0000-0002-6539-7294; Vigano, Paola/0000-0003-3674-5912; Vegetti, Walter/0000-0003-0422-643X; CANDIANI, Massimo/0000-0002-2129-2626				Al-Azemi M, 2012, REPROD BIOMED ONLINE, V24, P381, DOI 10.1016/j.rbmo.2012.01.010; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Azem F, 2008, GYNECOL ENDOCRINOL, V24, P368, DOI 10.1080/09513590802196353; Bu ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100011; Cai QF, 2011, HUM REPROD, V26, P2532, DOI 10.1093/humrep/der228; Cai QF, 2014, J ASSIST REPROD GEN, V31, P185, DOI 10.1007/s10815-013-0129-4; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corti L, 2013, EUR J OBSTET GYN R B, V171, P73, DOI 10.1016/j.ejogrb.2013.08.017; Dominko T, 1997, THERIOGENOLOGY, V47, P1041, DOI 10.1016/S0093-691X(97)00061-7; Fair T, 2012, REPROD DOMEST ANIM, V47, P142, DOI 10.1111/j.1439-0531.2012.02068.x; Fanchin R, 1997, FERTIL STERIL, V68, P648, DOI 10.1016/S0015-0282(97)80464-5; Fanchin R, 1996, FERTIL STERIL, V65, P1178, DOI 10.1016/S0015-0282(16)58335-6; Faulisi S, GYNECOL OBSTET INVES; Ferraretti AP, 2014, HUM REPROD, V29, P1842, DOI 10.1093/humrep/deu139; Hamilton JAM, 2015, HUM REPROD, V30, P1110, DOI 10.1093/humrep/dev058; Hill MJ, 2015, FERTIL STERIL, V103, P1477, DOI 10.1016/j.fertnstert.2015.02.038; HOFMANN GE, 1993, FERTIL STERIL, V60, P675; Huang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145895; Intra G, 2016, REPROD BIOMED ONLINE, V33, P132, DOI 10.1016/j.rbmo.2016.05.008; Kofinas JD, 2016, J ASSIST REPROD GEN, V33, P1169, DOI 10.1007/s10815-016-0752-y; Lahoud R, 2012, ARCH GYNECOL OBSTET, V285, P535, DOI 10.1007/s00404-011-2045-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li PF, 2015, SYST BIOL REPROD MED, V61, P161, DOI 10.3109/19396368.2015.1033779; Navas P, 2017, REPROD BIOMED ONLINE; O'Shea LC, 2012, SYST BIOL REPROD MED, V58, P88, DOI 10.3109/19396368.2012.656217; Papaleo E, 2016, REPROD BIOMED ONLINE; Papanikolaou EG, 2009, FERTIL STERIL, V91, P949, DOI 10.1016/j.fertnstert.2006.12.064; Restelli L, 2014, J ASSIST REPROD GEN, V31, P1629, DOI 10.1007/s10815-014-0350-9; Roque M, 2013, FERTIL STERIL, V99, P156, DOI 10.1016/j.fertnstert.2012.09.003; Rubino P, 2016, HUM REPROD UPDATE, V22, P194, DOI 10.1093/humupd/dmv050; Shapiro BS, 2010, FERTIL STERIL, V93, P636, DOI 10.1016/j.fertnstert.2009.01.134; SILVERBERG KM, 1994, FERTIL STERIL, V61, P508; Storr A, 2017, HUM REPROD, V32, P307, DOI 10.1093/humrep/dew330; Ubaldi F, 1995, HUM REPROD, V10, P3091, DOI 10.1093/oxfordjournals.humrep.a135864; Urrego R, 2015, THERIOGENOLOGY, V83, P1179, DOI 10.1016/j.theriogenology.2014.12.024; Vanni VS, J ENDOCRINOL INVEST; Venetis CA, 2013, HUM REPROD UPDATE, V19, P433, DOI 10.1093/humupd/dmt014	37	60	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176482	10.1371/journal.pone.0176482	http://dx.doi.org/10.1371/journal.pone.0176482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520729	gold, Green Submitted, Green Published			2022-12-27	WOS:000401487700018
J	Hanafusa, N; Isoai, A; Ishihara, T; Inoue, T; Ishitani, K; Utsugisawa, T; Yamaka, T; Ito, T; Sugiyama, H; Arakawa, A; Yamada, Y; Itano, Y; Onodera, H; Kobayashi, R; Torii, N; Numata, T; Kashiwabara, T; Matsuno, Y; Kato, M				Hanafusa, Norio; Isoai, Ayako; Ishihara, Tomoaki; Inoue, Tetsuya; Ishitani, Ken; Utsugisawa, Taiju; Yamaka, Toshihiko; Ito, Tetsuya; Sugiyama, Hiroshi; Arakawa, Atsushi; Yamada, Yosuke; Itano, Yasuo; Onodera, Hirokazu; Kobayashi, Ryosuke; Torii, Naoko; Numata, Toyoko; Kashiwabara, Taihei; Matsuno, Yoshihiro; Kato, Michio			Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results	PLOS ONE			English	Article							MALIGNANCY-RELATED ASCITES; CANCER-PATIENTS; ALBUMIN; FLUID	We performed post-marketing surveillance to evaluate the safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART). In total, 356 CART sessions in 147 patients at 22 centers were performed. The most common primary disease was cancer (128 cases, 300 sessions). Mean amount of ascites collected was 3.7 L, and mean concentration ratio was 9.2. Mean amount of reinfused protein was 67.8 g (recovery rate, 72.0%). Performance status, dietary intake, urine volume, body weight and abdominal circumference were significantly improved after CART. Body temperature increased significantly, by 0.3 degrees C on average. Concomitant steroids and/or NSAIDs use before reinfusion was significantly and negatively associated with increases in body temperature. Most adverse events were fever and chills. This study examined a large number of patients compared with previous studies, and showed that CART is an effective and relatively safe treatment for refractory ascites, such as malignant ascites.	[Hanafusa, Norio] Tokyo Womens Med Univ, Dept Blood Purificat, Kidney Ctr, Tokyo, Japan; [Isoai, Ayako; Onodera, Hirokazu; Kobayashi, Ryosuke; Torii, Naoko; Numata, Toyoko; Matsuno, Yoshihiro] Asahi Kasei Med Co Ltd, Blood Purificat Div, Tokyo, Japan; [Ishihara, Tomoaki] Yokkaichi Digest Dis Ctr, Dept Gastroenterol & Hepatol, Yokaichi, Mie, Japan; [Inoue, Tetsuya] Hita Cent Hosp, Dept Surg, Oita, Japan; [Ishitani, Ken] Kitasato Univ, Dept Gynecol, Kitasato Inst Hosp, Tokyo, Japan; [Utsugisawa, Taiju] Tokyo Womens Med Univ, Dept Transfus Med & Cell Proc, Tokyo, Japan; [Yamaka, Toshihiko] Kanagawa Inst Technol, Dept Clin Engn, Fac Engn, Kanagawa, Japan; [Ito, Tetsuya] Japanese Red Cross Med Ctr, Dept Palliat Care, Tokyo, Japan; [Sugiyama, Hiroshi] Kizawa Mem Hosp, Dept Gastroenterol, Gifu, Japan; [Arakawa, Atsushi] Nagoya City Univ, Dept Obstet & Gynecol, Grad Sch Med Sci, Aichi, Japan; [Yamada, Yosuke] Shinshu Univ Hosp, Div Nephrol, Nagano, Japan; [Itano, Yasuo] Okayama Kyoritsu Gen Hosp, Dept Internal Med, Okayama, Japan; [Kashiwabara, Taihei] Asahi Kasei Med Co Ltd, Vigilance & Qual Assurance Div, Prod Vigilance & Qual Assurance Dept, Regulatory Affairs, Tokyo, Japan; [Kato, Michio] Kato Michio Clin Liver Dis, Med Corp, Kenseikai, Hyogo, Japan	Tokyo Women's Medical University; Kitasato University; Tokyo Women's Medical University; Kanagawa Institute Technology; Japanese Red Cross Medical Center; University of Tokyo; Nagoya City University; Shinshu University	Hanafusa, N (corresponding author), Tokyo Womens Med Univ, Dept Blood Purificat, Kidney Ctr, Tokyo, Japan.	hanafusa@twmu.ac.jp	Utsugisawa, Taiju/ABD-7059-2021	Ito, Tetsuya/0000-0002-3872-4632; Hanafusa, Norio/0000-0002-0563-3320				[Anonymous], 2014, PRACT GUID MAN TRANS, P41; BRADLEY SE, 1947, J CLIN INVEST, V26, P1010, DOI 10.1172/JCI101867; DASCOMBE MJ, 1985, PROG NEUROBIOL, V25, P327, DOI 10.1016/0301-0082(85)90019-X; Davis HA, 1939, J CLIN INVEST, V18, P219, DOI 10.1172/JCI101037; Ernest D, 1999, CRIT CARE MED, V27, P46, DOI 10.1097/00003246-199901000-00025; HALLOWELL P, 1978, ANN THORAC SURG, V25, P22, DOI 10.1016/S0003-4975(10)63481-9; Ito T, 2015, INT J CLIN ONCOL, V20, P623, DOI 10.1007/s10147-014-0750-y; Ito T, 2014, THER APHER DIAL, V18, P87, DOI 10.1111/1744-9987.12049; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; Maeda O, 2014, MOL CLIN ONCOL, V2, P1103, DOI 10.3892/mco.2014.335; Maeda S, 2015, THER APHER DIAL, V19, P342, DOI 10.1111/1744-9987.12343; Matsusaki K, 2011, INT J CLIN ONCOL, V16, P395, DOI 10.1007/s10147-011-0199-1; Mullens W, 2008, J AM COLL CARDIOL, V51, P300, DOI 10.1016/j.jacc.2007.09.043; Nakajima F, 2001, J JPN SOC DIAL THER, V34, P335, DOI DOI 10.4009/jsdt.34.335; Oda T, 1974, JPN J CLIN EXP MED, V51, P343; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Orimi S, 2011, THER APHER DIAL, V15, P411, DOI 10.1111/j.1744-9987.2011.00973.x; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; RUNYON BA, 1992, ANN INTERN MED, V117, P215, DOI 10.7326/0003-4819-117-3-215; SCHNEDITZ D, 1992, KIDNEY INT, V42, P1425, DOI 10.1038/ki.1992.437; Takamatsu S, 2003, KAN TAN SUI, V46, P663; Ueda T, 2012, ANTICANCER RES, V32, P2353; Wang LC, 2015, J OBSTET GYNAECOL RE, V41, P1614, DOI 10.1111/jog.12763; Yamaguchi H, 2015, EJSO-EUR J SURG ONC, V41, P875, DOI 10.1016/j.ejso.2015.04.013; Zaak D, 2001, Z GASTROENTEROL, V39, P5, DOI 10.1055/s-2001-10707	25	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177303	10.1371/journal.pone.0177303	http://dx.doi.org/10.1371/journal.pone.0177303			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510606	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500022
J	Lopez-Arias, B; Turiegano, E; Monedero, I; Canal, I; Torroja, L				Lopez-Arias, Begona; Turiegano, Enrique; Monedero, Ignacio; Canal, Inmaculada; Torroja, Laura			Presynaptic A beta 40 prevents synapse addition in the adult Drosophila neuromuscular junction	PLOS ONE			English	Article							A-BETA-OLIGOMER; AMYLOID-BETA; ALZHEIMERS-DISEASE; FUNCTIONAL SENESCENCE; PLASTICITY; PROTEIN; MEMORY; MODEL; AGE; MELANOGASTER	Complexity in the processing of the Amyloid Precursor Protein, which generates a mixture of beta amyloid peptides, lies beneath the difficulty in understanding the etiology of Alzheimer's disease. Moreover, whether A beta peptides have any physiological role in neurons is an unresolved question. By expressing single, defined A beta peptides in Drosophila, specific effects can be discriminated in vivo. Here, we show that in the adult neuromuscular junction (NMJ), presynaptic expression of A beta 40 hinders the synaptic addition that normally occurs in adults, yielding NMJs with an invariable number of active zones at all ages tested. A similar trend is observed for A beta 42 at young ages, but net synaptic loss occurs at older ages in NMJs expressing this amyloid species. In contrast, A beta 42arc produces net synaptic loss at all ages tested, although age-dependent synaptic variations are maintained. Inhibition of the PI3K synaptogenic pathway may mediate some of these effects, because western analyses show that A beta peptides block activation of this pathway, and A beta species-specific synaptotoxic effects persists in NMJs overgrown by over-expression of PI3K. Finally, individual A beta effects are also observed when toxicity is examined by quantifying neurodegeneration and survival. Our results suggest a physiological effect of A beta 40 in synaptic plasticity, and imply different toxic mechanisms for each peptide species.	[Lopez-Arias, Begona; Turiegano, Enrique; Monedero, Ignacio; Canal, Inmaculada; Torroja, Laura] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Torroja, L (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	laura.torroja@uam.es	Cobeta, Ignacio Monedero/AAD-5777-2022; Torroja, Laura/L-2449-2013; Torroja, Laura/AAU-7896-2021; Monedero, Ignacio/G-4858-2015; Turiegano, Enrique/M-8679-2013	Cobeta, Ignacio Monedero/0000-0001-6370-0467; Torroja, Laura/0000-0001-6939-6259; Torroja, Laura/0000-0001-6939-6259; Monedero, Ignacio/0000-0001-6370-0467; Turiegano, Enrique/0000-0003-4620-7894	Fundacion Centro de Investigacion de Enfermedades; Neurologicas - Fundacion Reina Sofia [PI0006-08]; Ministerio de Ciencia y Tecnologia (ES) [BFU2008-04683-C02-02]; Ministerio de Economia y Competitividad (ES) [BFU2016-8327-P]	Fundacion Centro de Investigacion de Enfermedades; Neurologicas - Fundacion Reina Sofia; Ministerio de Ciencia y Tecnologia (ES); Ministerio de Economia y Competitividad (ES)	Support was provided by Fundacion Centro de Investigacion de Enfermedades; Neurologicas - Fundacion Reina Sofia Grant PI0006-08 to LT and IC; Ministerio de Ciencia y Tecnologia (ES) grant BFU2008-04683-C02-02 to LT; Ministerio de Economia y Competitividad (ES) grant BFU2016-8327-P to LT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Beramendi A, 2007, J COMP NEUROL, V501, P498, DOI 10.1002/cne.21253; Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107; Costa R, 2011, J BIOL CHEM, V286, P41647, DOI 10.1074/jbc.M111.274548; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Donlea JM, 2014, SLEEP, V37, P1427, DOI 10.5665/sleep.3988; Fang LQ, 2012, NEUROSCI BULL, V28, P585, DOI 10.1007/s12264-012-1267-x; Feng JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023655; Garcia-Osta A, 2009, LEARN MEMORY, V16, P267, DOI 10.1101/lm.1310209; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Haddadi M, 2014, BEHAV BRAIN RES, V259, P60, DOI 10.1016/j.bbr.2013.10.036; Hebbar S, 2006, J NEUROBIOL, V66, P1140, DOI 10.1002/neu.20279; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iijima-Ando K, 2010, BRAIN STRUCT FUNCT, V214, P245, DOI 10.1007/s00429-009-0234-4; Iliadi KG, 2010, ANN NY ACAD SCI, V1197, P9, DOI 10.1111/j.1749-6632.2009.05372.x; Iwanami A, 2009, GENE DEV, V23, P1699, DOI 10.1101/gad.1832909; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kerr F, 2011, NEUROBIOL AGING, V32, P1977, DOI 10.1016/j.neurobiolaging.2009.10.015; Knafo S, 2012, CURR OPIN NEUROBIOL, V22, P405, DOI 10.1016/j.conb.2012.02.008; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Legan SK, 2008, J BIOL CHEM, V283, P32492, DOI 10.1074/jbc.M805832200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Ma T, 2012, J NEUROCHEM, V120, P140, DOI 10.1111/j.1471-4159.2011.07506.x; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; MCDONALD MP, 1994, BEHAV NEURAL BIOL, V62, P60, DOI 10.1016/S0163-1047(05)80059-7; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Norlin N, 2012, J STRUCT BIOL, V180, P174, DOI 10.1016/j.jsb.2012.06.010; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rivlin PK, 2004, J COMP NEUROL, V468, P596, DOI 10.1002/cne.10977; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sofola O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001087; Speretta E, 2012, J BIOL CHEM, V287, P20748, DOI 10.1074/jbc.M112.350124; Technau GM, 1984, J NEUROGENET, V1, P113, DOI 10.3109/01677068409107077; Thomas U, 2012, ADV EXP MED BIOL, V970, P3, DOI 10.1007/978-3-7091-0932-8_1; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wasling P, 2009, J ALZHEIMERS DIS, V16, P1, DOI 10.3233/JAD-2009-0918; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; William CM, 2012, J NEUROSCI, V32, P8004, DOI 10.1523/JNEUROSCI.5369-11.2012; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010; Zhou XY, 2014, CELL CYCLE, V13, P3164, DOI 10.4161/15384101.2014.962954	64	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177541	10.1371/journal.pone.0177541	http://dx.doi.org/10.1371/journal.pone.0177541			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520784	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500039
J	Rewald, S; Mesters, I; Lenssen, AF; Bansi, J; Lambeck, J; de Bie, RA; Waller, B				Rewald, Stefanie; Mesters, Ilse; Lenssen, Antoine F.; Bansi, Jens; Lambeck, Johan; de Bie, Rob A.; Waller, Benjamin			Aquatic cycling-What do we know? A scoping review on head-out aquatic cycling	PLOS ONE			English	Review							CENTRAL BLOOD-VOLUME; WATER IMMERSION; THERMAL RESPONSES; AEROBIC EXERCISE; PREGNANT-WOMEN; PHYSIOLOGICAL-RESPONSES; RATE-VARIABILITY; LEG EXERCISE; POWER; THERMOREGULATION	Over the past few years, aquatic cycling has become a trending fitness activity. However, the literature has not been reviewed exhaustively. Therefore, using scoping review methodology, the aim of this review was to explore the current state of the literature concerning aquatic cycling. This study specifically focused on study designs, populations and outcomes. A comprehensive search of seven databases (PubMed, MEDLINE, Cinahl, Embase, PEDro, Web of Science, WorldCat) was conducted up to 30th September 2016. GoogleScholar, World Cat, ResearchGate, specific aquatic therapy websites and aquatic therapy journals were searched to identify additional literature. Full-text publications in English, German or Dutch were included. Studies were included when the intervention involved head-out cycling carried out in 10 degrees to 35 degrees Celsius water. Exclusion criteria were the use of wet suits or confounding interventions that would affect participants' homeostasis. 63 articles were included and the study parameters of these studies were summarized. Using three grouping themes, included studies were categorised as 1) single session tests comparing aquatic versus land cycling, or 2) aquatic cycling only sessions investigating different exercise conditions and 3) aquatic cycling intervention programmes. Although the experimental conditions differed noticeably across the studies, shared characteristics were identified. Cardiovascular parameters were investigated by many of the studies with the results suggesting that the cardiac demand of aquatic cycling seems similar to land-based cycling. Only six studies evaluated the effect of aquatic cycling interventions. Therefore, future research should investigate the effects of aquatic cycling interventions, preferably in individuals that are expected to gain health benefits from aquatic cycling. Moreover, this comprehensive outline of available literature could serve as a starting point for systematic reviews or clinical studies on the effects of aquatic cycling on the cardiovascular responses.	[Rewald, Stefanie; Mesters, Ilse; Lenssen, Antoine F.; de Bie, Rob A.] Maastricht Univ, CAPHRI, Fac Hlth Med & Life Sci, Dept Epidemiol, Maastricht, Netherlands; [Lenssen, Antoine F.] Maastricht Univ, Med Ctr, Dept Phys Therapy, Maastricht, Netherlands; [Bansi, Jens] Kliniken Valens, Dept Sports Therapy, Rehabil Klin Valens, Valens, Switzerland; [Lambeck, Johan] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Leuven, Belgium; [Waller, Benjamin] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; KU Leuven; University of Jyvaskyla	Rewald, S (corresponding author), Maastricht Univ, CAPHRI, Fac Hlth Med & Life Sci, Dept Epidemiol, Maastricht, Netherlands.	stefanie.rewald@maastrichtuniversity.nl	mesters, Ilse/AAN-2824-2021; Bansi, Jens/L-3757-2019; aubertin, rebeckah/O-9624-2015	mesters, Ilse/0000-0003-0605-6286; Waller, Benjamin/0000-0002-0738-0670; aubertin, rebeckah/0000-0002-0558-7571	Netherlands Organisation for Scientific Research (NWO) [022.003.036]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organisation for Scientific Research (NWO), Grant number 022.003.036 (http://www.nwo.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Armstrong R, 2011, J PUBLIC HEALTH-UK, V33, P147, DOI 10.1093/pubmed/fdr015; AVELLINI BA, 1982, J APPL PHYSIOL, V53, P1291, DOI 10.1152/jappl.1982.53.5.1291; Bansi J, 2013, J NEUROL, V260, P2993, DOI 10.1007/s00415-013-7091-z; Bansi J, 2013, MULT SCLER J, V19, P613, DOI 10.1177/1352458512458605; Barbosa TM, 2009, J SPORT SCI MED, V8, P179; Barker AL, 2014, ARCH PHYS MED REHAB, V95, P1776, DOI 10.1016/j.apmr.2014.04.005; Bartels EM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub3; Becker BE., 2010, COMPREHENSIVE AQUATI; Becker BE, 2009, PM&R, V1, P859, DOI 10.1016/j.pmrj.2009.05.017; Boidin M, 2015, ANN PHYS REHABIL MED, V58, P269, DOI 10.1016/j.rehab.2015.07.002; Brasil RM, 2011, J HUM KINET, P59, DOI 10.2478/v10078-011-0060-7; Brechat PH, 1999, EUR RESPIR J, V13, P860, DOI 10.1034/j.1399-3003.1999.13d28.x; Chen A A, 1996, Can J Appl Physiol, V21, P134; CHRISTIE JL, 1990, J APPL PHYSIOL, V69, P657, DOI 10.1152/jappl.1990.69.2.657; CONNELLY TP, 1990, J APPL PHYSIOL, V69, P651, DOI 10.1152/jappl.1990.69.2.651; Costello JT, 2014, EUR J SPORT SCI, V14, P847, DOI 10.1080/17461391.2014.911354; CRAIG AB, 1968, J APPL PHYSIOL, V25, P28, DOI 10.1152/jappl.1968.25.1.28; Craig Albert BJ., 1969, MED SCI SPORT EXER, V1, P124; Di Masi F, 2007, J SPORT SCI MED, V6, P188; Dionne A, 2017, RESP PHYSIOL NEUROBI, V235, P1, DOI 10.1016/j.resp.2016.09.011; DRESSENDORFER R H, 1976, Undersea Biomedical Research, V3, P177; DUDDY JH, 1969, HUM FACTORS, V11, P507, DOI 10.1177/001872086901100509; Fenzl M, 2013, INT J SPORTS MED, V34, P795, DOI 10.1055/s-0033-1333696; Fenzl M, 2013, PHYS MED REHAB KUROR, V23, P225, DOI 10.1055/s-0033-1347205; Fenzl M, 2012, PHYS MED REHAB KUROR, V22, P183, DOI 10.1055/s-0032-1314863; Fenzl M, 2010, PHYS MED REHAB KUROR, V20, P27, DOI 10.1055/s-0029-1233455; Fenzl M, 2015, SPORT EXERC MED OPEN, V1, P64; Fenzl M, 2005, SCHWEIZ Z MED TRAUMA, V53, P172; Ferreira JD, 2011, PJST, V18, P105; Finkelstein I, 2011, REV BRAS GINECOL OBS, V33, P388, DOI 10.1590/S0100-72032011001200003; Fujimoto T, 2016, EUR J APPL PHYSIOL, V116, P1819, DOI 10.1007/s00421-016-3438-3; Garzon M, 2015, J SPORT HEAL SCI; Garzon M, 2017, EUR J SPORT SCI, V17, P310, DOI 10.1080/17461391.2016.1226391; Garzon M, 2015, J SCI MED SPORT, V18, P619, DOI 10.1016/j.jsams.2014.08.005; Garzon M, 2015, EUR J SPORT SCI, V15, P271, DOI 10.1080/17461391.2014.932015; Giacomini F, 2009, J SPORT MED PHYS FIT, V49, P432; GOLDEN FS, 1987, J PHYSIOL-LONDON, V391, P399, DOI 10.1113/jphysiol.1987.sp016744; HANNA RD, 1993, AM J CARDIOL, V71, P1041, DOI 10.1016/0002-9149(93)90570-3; Israel D J, 1989, J Burn Care Rehabil, V10, P336, DOI 10.1097/00004630-198907000-00009; KATZ VL, 1990, AM J PERINAT, V7, P118, DOI 10.1055/s-2007-999460; KATZ VL, 1988, OBSTET GYNECOL, V72, P225; KATZ VL, 1990, AM J PERINAT, V7, P281, DOI 10.1055/s-2007-999502; MCARDLE WD, 1984, J APPL PHYSIOL, V56, P1572, DOI 10.1152/jappl.1984.56.6.1572; MCARDLE WD, 1976, J APPL PHYSIOL, V40, P85, DOI 10.1152/jappl.1976.40.1.85; MCARDLE WD, 1992, EUR J APPL PHYSIOL O, V65, P265, DOI 10.1007/BF00705092; MCMURRAY RG, 1979, J APPL PHYSIOL, V46, P1086, DOI 10.1152/jappl.1979.46.6.1086; MCMURRAY RG, 1993, AM J PERINAT, V10, P178, DOI 10.1055/s-2007-994656; MCMURRAY RG, 1990, EUR J APPL PHYSIOL O, V61, P119, DOI 10.1007/BF00236704; MCMURRAY RG, 1988, INT J SPORTS MED, V9, P443, DOI 10.1055/s-2007-1025048; MCMURRAY RG, 1988, AM J OBSTET GYNECOL, V158, P481, DOI 10.1016/0002-9378(88)90009-9; MCMURRAY RG, 1994, AVIAT SPACE ENVIR MD, V65, P809; MCMURRAY RG, 1988, J CARDIOPULM REHABIL, V8, P69; Meyer Katharina, 2008, Clin Invest Med, V31, pE90; MORLOCK J F, 1974, Undersea Biomedical Research, V1, P335; Perini R, 1998, EUR J APPL PHYSIOL, V77, P326, DOI 10.1007/s004210050341; Pinto SS, 2015, J STRENGTH COND RES; Rewald S, 2015, J REHABIL MED; SHAPIRO Y, 1981, J APPL PHYSIOL, V50, P679, DOI 10.1152/jappl.1981.50.3.679; SHELDAHL LM, 1987, J AM COLL CARDIOL, V10, P1254, DOI 10.1016/S0735-1097(87)80127-4; SHELDAHL LM, 1982, INT J OBESITY, V6, P29; SHELDAHL LM, 1986, J APPL PHYSIOL, V60, P1878, DOI 10.1152/jappl.1986.60.6.1878; SHELDAHL LM, 1992, AM J PHYSIOL, V262, pR779, DOI 10.1152/ajpregu.1992.262.5.R779; SHELDAHL LM, 1984, J APPL PHYSIOL, V57, P1662, DOI 10.1152/jappl.1984.57.6.1662; SOGABE Y, 1987, Journal of UOEH, V9, P279; Sosner P, 2016, J AM SOC HYPERTENS, V10, P420, DOI 10.1016/j.jash.2016.02.011; Stachenfeld NS, 2014, AM J PHYSIOL-ENDOC M, V306, pE849, DOI 10.1152/ajpendo.00038.2014; TONER MM, 1986, PERCEPT MOTOR SKILL, V62, P211, DOI 10.2466/pms.1986.62.1.211; TONER MM, 1984, J APPL PHYSIOL, V56, P1355, DOI 10.1152/jappl.1984.56.5.1355; TONER MM, 1986, J APPL PHYSIOL, V60, P521, DOI 10.1152/jappl.1986.60.2.521; TONER MM, 1985, J APPL PHYSIOL, V59, P248, DOI 10.1152/jappl.1985.59.1.248; Wahl P, 2016, J STRENGTH COND RES; White LJ, 2005, INT J SPORT NUTR EXE, V15, P38, DOI 10.1123/ijsnem.15.1.38; Yazigi F, 2013, EUR J SPORT SCI, V13, P659, DOI 10.1080/17461391.2013.770924; YOUNG AJ, 1995, J APPL PHYSIOL, V78, P793, DOI 10.1152/jappl.1995.78.3.793; YOUNG AJ, 1993, J APPL PHYSIOL, V75, P49, DOI 10.1152/jappl.1993.75.1.49	76	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177704	10.1371/journal.pone.0177704	http://dx.doi.org/10.1371/journal.pone.0177704			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520802	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500060
J	Wang, S; Song, JY; Yang, YD; Chawla, NV; Ma, J; Wang, HJ				Wang, Shuo; Song, Jieyun; Yang, Yide; Chawla, Nitesh V.; Ma, Jun; Wang, Haijun			Rs12970134 near MC4R is associated with appetite and beverage intake in overweight and obese children: A family-based association study in Chinese population	PLOS ONE			English	Article							MELANOCORTIN-4 RECEPTOR MUTATIONS; BODY-MASS INDEX; EATING BEHAVIOR PATTERNS; COMMON GENETIC-VARIATION; GENOME-WIDE ASSOCIATION; CHILDHOOD OBESITY; FOOD-INTAKE; VARIANTS; WEIGHT; RISK	Background Recent studies indicated that eating behaviors are under genetic influence, and the melanocortin 4 receptor (MC4R) gene polymorphisms can affect the total energy intake and the consumption of fat, protein and carbohydrates. Our study aims at investigating the association of the MC4R polymorphism with appetite and food intake among Chinese children. Methods A family-based association study was conducted among 151 Chinese trios whose offsprings were overweight/obese children aged 9-15 years. The rs12970134 near MC4R was genotyped, and the Children Eating Behavior Questionnaire (CEBQ) and a self-designed questionnaire measuring food intake were performed. The FBAT and PBAT software packages were used. Results The family-based association analysis showed that there was a significant association between rs12970134 and obesity (Z = 2.449, P = 0.014). After adjusting for age, gender and standardized BMI, rs12970134 was significantly associated with food responsiveness (FR) among children (beta'(b) = 0.077, P-b = 0.028), and with satiety responsiveness (SR) in trios (P = -0.026). The polymorphism was associated with beverage intake (beta'(b) = 0.331, P-b = 0.00016 in children; P = 0.043 in trios), but not significantly associated with vegetable, fruit or meat intake (P>0.050). We further found a significant mediation effect among the rs12970134, FR and beverage intake (b = 0.177, P = 0.047). Conclusions Our study is the first to report that rs12970134 near MC4R was associated with appetite and beverage intake, and food responsiveness could mediate the effect of rs12970134 on beverage intake in overweight and obese Chinese children population. Further studies are needed to uncover the genetic basis for eating behaviors, which could lead to develop and implement effective interventional strategies early in life.	[Wang, Shuo; Song, Jieyun; Yang, Yide; Ma, Jun; Wang, Haijun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China; [Wang, Shuo; Chawla, Nitesh V.] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA; [Chawla, Nitesh V.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA	Peking University; University of Notre Dame; University of Notre Dame	Ma, J; Wang, HJ (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China.	majunt@bjmu.edu.cn; whjun1@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021; Chawla, Nitesh/F-2690-2016	Wang, Haijun/0000-0003-0849-2903; Chawla, Nitesh/0000-0003-3932-5956; Yang, Yide/0000-0003-3297-1306; Wang, Shuo/0000-0002-3146-5818	Research Special Fund for Public Welfare of Health [201202010]; National Natural Science Foundation of China [81573170]	Research Special Fund for Public Welfare of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for the study is provided by the Research Special Fund for Public Welfare of Health (201202010, JM, http://health1147.bjmu.edu.cn/) and the grant from National Natural Science Foundation of China (81573170, HW, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bellisle F, 2009, ENCEPHALE, V35, P182, DOI 10.1016/j.encep.2008.03.009; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Cao YT, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-5; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Dratva J, 2016, PUBLIC HEALTH NUTR, V19, P1944, DOI 10.1017/S136898001600015X; Dwivedi OP, 2013, J HUM GENET, V58, P27, DOI 10.1038/jhg.2012.129; Ewens KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016390; Faith MS, 2013, HUM HERED, V75, P80, DOI 10.1159/000353879; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fernandes AE, 2015, ENDOCRINE, V49, P653, DOI 10.1007/s12020-015-0616-8; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garcia-Dominic O, 2012, HEALTH PROMOT PRACT, V13, P763, DOI 10.1177/1524839911405847; Gardner KR, 2015, PEDIATR OBES, V10, P476, DOI 10.1111/ijpo.12010; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hebebrand J, 2004, MOL PSYCHIATR, V9, P796, DOI 10.1038/sj.mp.4001491; Ho-Urriola J, 2014, NUTRITION, V30, P145, DOI 10.1016/j.nut.2013.05.030; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hunsberger M, 2015, MATERN CHILD NUTR, V11, P260, DOI 10.1111/j.1740-8709.2012.00446.x; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Kochetova O V, 2015, Genetika, V51, P248; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Loh DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082885; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; McCaffery JM, 2017, PSYCHOSOM MED, V79, P224, DOI 10.1097/PSY.0000000000000380; Meng XR, 2014, PEDIATR RES, V76, P310, DOI 10.1038/pr.2014.88; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Obregon AM, 2017, J PHYSIOL BIOCHEM, V73, P29, DOI 10.1007/s13105-016-0521-5; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Rigoli L, 2010, ACTA PAEDIATR, V99, P722, DOI 10.1111/j.1651-2227.2010.01709.x; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Shugart YY, 2009, AM J MED GENET B, V150B, P886, DOI 10.1002/ajmg.b.30914; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Stutzmann F, 2009, INT J OBESITY, V33, P373, DOI 10.1038/ijo.2008.279; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Valette M, 2014, INT J OBESITY, V38, P883, DOI 10.1038/ijo.2013.190; Valette M, 2013, INT J OBESITY, V37, P1027, DOI 10.1038/ijo.2012.169; Valladares M, 2010, NUTR NEUROSCI, V13, P71, DOI 10.1179/147683010X12611460763643; Vega JA, 2016, ANN NUTR METAB, V68, P35, DOI 10.1159/000439092; Wang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145944; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Yoon YR, 2015, ENDOCRINOL METAB, V30, P576, DOI 10.3803/EnM.2015.30.4.576	57	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177983	10.1371/journal.pone.0177983	http://dx.doi.org/10.1371/journal.pone.0177983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520814	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500084
J	Balbaa, M; Abdulmalek, SA; Khalil, S				Balbaa, Mahmoud; Abdulmalek, Shaymaa A.; Khalil, Sofia			Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; ALZHEIMERS-DISEASE; MEMORY IMPAIRMENT; BLACK SEED; RESISTANCE; INFLAMMATION; GLUTATHIONE; GLIMEPIRIDE; METABOLISM; PHOSPHORYLATION	Background and objectives Insulin resistance of the brain is a specific form of type2-diabetes mellitus (T2DM) and the active insulin-signaling pathway plays a neuroprotective role against damaging conditions and Alzheimer's progression. The present study identifies the mediated emerging effects of the Nigella sativa oil (NSO) on the memory enhancing process, its anti-oxidative, acetylcho-linestrase (AChE) inhibition, anti-brain insulin resistance and anti-amyloidogenic activities. In addition, the possible role of some anti-diabetic drugs in the neuro-protection processes and their effect in combination with NSO and/or the insulin receptor inhibitor IOMe-AG538 were investigated. Methods T2DM-induced rats were orally and daily administrated 2.0 ml NSO, 100 mg metformin (MT), 0.8 mg glimepiride (GI) and different combinations (100 mg MT & 2.0 ml NSO, 0.8 mg GI & 2.0 ml NSO and 2.0 ml NSO & intraperitoneal injection of 1/100 LD50 of IOMe-AG538) per kg body weight for 21 days. Results A significant increase in the brain lipid peroxidation and decrease in the antioxidant status with peripheral and central production of pro-inflammatory mediators were observed in diabetes- induced rats. The brain AChE was activated and associated with diminished brain glucose level and cholinergic function. In addition, the brain insulin resistance and the attenuated insulin signaling pathway (p-IRS/p-AKT/p-GSK-3 beta) were accompanied by an augmentation in GSK-3 beta level, which in turn may contribute in the extensive alterations of Tau phosphorylation along with changes in PP2A level. Furthermore, neuronal loss and elevation in A beta-42 plaque formation were observed due to a low IDE formation and an increased expression of p53, BACE1 and APP with diminished ADAM10, SIRT1 and BDNF levels. The expression profile of AD-related miRNAs in sera and brain tissues displayed its neuro-protection role. The treatment of diabetes-induced rats with NSO and the anti-diabetic drugs alone and/or in combination have the potential to suppress the oxidative stress, the pro-inflammatory mediators and amyloidogenic pathway. Moreover, it lowers the insulin receptor inhibitory effect of IOMe-AG538 and modifies the insulin-signaling pathway. Therefore, it prevents the neurotoxicity, amyloid plaque formation and Tau hyper-phosphorylation and restores AD-related miRNA normal levels. Conclusion These data suggest that NSO or its combined treatments with anti-diabetic drugs have a possible benefit as disease modifying agents for the insulin resistance in the brain through enhancing brain insulin signaling pathway.	[Balbaa, Mahmoud; Abdulmalek, Shaymaa A.; Khalil, Sofia] Alexandria Univ, Biochem Dept, Fac Sci, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University	Balbaa, M (corresponding author), Alexandria Univ, Biochem Dept, Fac Sci, Alexandria, Egypt.	mahmoud.balbaa@alexu.edu.eg	Balbaa, Mahmoud/H-3572-2019; Abdulmalek, Shaymaa/AAY-7600-2021	Balbaa, Mahmoud/0000-0002-0876-6604; Abdel Monem, Nihad/0000-0002-9539-3614	Alexandria University, Egypt	Alexandria University, Egypt(Alexandria University)	This research work was supported in aid by Alexandria University, Egypt.	Aksoy N, 2003, CELL BIOCHEM FUNCT, V21, P121, DOI 10.1002/cbf.1006; Al-Majed AA, 2006, EUR J PHARMACOL, V543, P40, DOI 10.1016/j.ejphar.2006.05.046; Alhebshi AH, 2013, BIOCHEM BIOPH RES CO, V433, P362, DOI 10.1016/j.bbrc.2012.11.139; Aliev G, 2014, CNS NEUROL DISORD-DR, V13, P467, DOI 10.2174/18715273113126660153; Balbaa M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2492107; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beheshti F, 2016, AVICENNA J PHYTOMEDI, V6, P124; Beisswenger P, 2003, DIABETES METAB, V29, pS95; Bosco D, 2011, J CELL MOL MED, V15, P1807, DOI 10.1111/j.1582-4934.2011.01318.x; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carvalheira JBC, 2003, DIABETOLOGIA, V46, P1629, DOI 10.1007/s00125-003-1246-x; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Dinagaran S, 2016, INT J PHARM SCI RES, V7, P4473, DOI 10.13040/IJPSR.0975-8232.7(11).4473-79; DOUMAS BT, 1981, CLIN CHEM, V27, P1642; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hajhashemi V, 2004, PHYTOTHER RES, V18, P195, DOI 10.1002/ptr.1390; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hosseini M, 2015, CHIN J INTEGR MED, V21, P438, DOI 10.1007/s11655-014-1742-5; Ingham V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-115; Johnson R, 2012, PROG NEUROBIOL, V99, P293, DOI 10.1016/j.pneurobio.2012.09.006; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kalus U, 2003, PHYTOTHER RES, V17, P1209, DOI 10.1002/ptr.1356; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kroner Z, 2009, ALTERN MED REV, V14, P373; Kruszynska YT, 2002, J CLIN ENDOCR METAB, V87, P226, DOI 10.1210/jc.87.1.226; Le PM, 2004, J ETHNOPHARMACOL, V94, P251, DOI 10.1016/j.jep.2004.04.030; LITWACK G, 1953, J BIOL CHEM, V200, P303; Liu FY, 2013, NEUROSCI LETT, V557, P90, DOI 10.1016/j.neulet.2013.10.052; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MENDIVIL A, 2005, REV FAC MED, V53, P235; Mitchell K, 2010, METHODS MOL BIOL, V617, P279, DOI 10.1007/978-1-60327-323-7_21; MONTGOMERY H, 1961, ANALYST, V86, P414; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nakamura I, 2014, CARDIOVASC DIABETOL, V13, DOI [10.1186/1475-2840-13-15, 10.1186/s12933-014-0110-2]; Nelson PT, 2010, J ALZHEIMERS DIS, V21, P75, DOI 10.3233/JAD-2010-091603; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rahman AH, 2011, INT J PHARM SCI RES, V2, P1830, DOI 10.13040/IJPSR.0975-8232.2(7).1829-35; Rai S, 2014, PHARMACOL BIOCHEM BE, V117, P104, DOI 10.1016/j.pbb.2013.11.035; Rai S, 2013, J NEUROIMMUNOL, V254, P1, DOI 10.1016/j.jneuroim.2012.08.008; Rosenberg PB, 2006, INT REV PSYCHIATR, V17, P503, DOI 10.1080/02646830500382037; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Sheweita SA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5264064; SIMS NR, 1983, J NEUROCHEM, V41, P1329, DOI 10.1111/j.1471-4159.1983.tb00829.x; SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Steinberg GR, 2007, CELL CYCLE, V6, P888, DOI 10.4161/cc.6.8.4135; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; TAPPEL A. L., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P326, DOI 10.1016/0003-9861(59)90258-9; Wada A, 2005, J PHARMACOL SCI, V99, P128, DOI 10.1254/jphs.CRJ05006X; Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011; Zong YY, 2011, BRAIN RES, V1395, P108, DOI 10.1016/j.brainres.2011.04.035	67	40	43	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0172429	10.1371/journal.pone.0172429	http://dx.doi.org/10.1371/journal.pone.0172429			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505155	Green Submitted, gold, Green Published			2022-12-27	WOS:000401473500002
J	Biwer, C; Rothberg, A; IglayReger, H; Derksen, H; Burant, CF; Najarian, K				Biwer, Craig; Rothberg, Amy; IglayReger, Heidi; Derksen, Harm; Burant, Charles F.; Najarian, Kayvan			Windowed persistent homology: A topological signal processing algorithm applied to clinical obesity data	PLOS ONE			English	Article							WEIGHT-LOSS; TIME-SERIES	Overweight and obesity are highly prevalent in the population of the United States, affecting roughly 2/3 of Americans. These diseases, along with their associated conditions, are a major burden on the healthcare industry in terms of both dollars spent and effort expended. Volitional weight loss is attempted by many, but weight regain is common. The ability to predict which patients will lose weight and successfully maintain the loss versus those prone to regain weight would help ease this burden by allowing clinicians the ability to skip treatments likely to be ineffective. In this paper we introduce a new windowed approach to the persistent homology signal processing algorithm that, when paired with a modified, semimetric version of the Hausdorff distance, can differentiate the two groups where other commonly used methods fail. The novel approach is tested on accelerometer data gathered from an ongoing study at the University of Michigan. While most standard approaches to signal processing show no difference between the two groups, windowed persistent homology and the modified Hausdorff semimetric show a clear separation. This has significant implications for clinical decision making and patient care.	[Biwer, Craig; Najarian, Kayvan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Rothberg, Amy; IglayReger, Heidi; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Derksen, Harm] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Biwer, C (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	cbiwer@umich.edu	Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; ROTHBERG, AMY/0000-0002-0243-9135	National Institutes of Health; Nutrition Obesity Research Center [P30DK089503-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, P30DK092926, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CFB received funding from the National Institutes of Health, Nutrition Obesity Research Center, grant number P30DK089503-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendich P, 2016, ARXIV160206245; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Dubuisson MP, 1994, 1994 C A COMP VIS IM, V1, P1; Edelsbrunner H, 2008, CONTEMP MATH, V453, P257; Edelsbrunner Herbert, 2010, COMPUTATIONAL TOPOLO; Emrani S, 2015, IEEE SIGNAL PROC LET, V22, DOI 10.1109/LSP.2015.2441068; Emrani S, 2014, IEEE SIGNAL PROC LET, V21, P459, DOI 10.1109/LSP.2014.2305700; Fasy BT, 2014, ANN STAT, V42, P2301, DOI 10.1214/14-AOS1252; Ghrist R, 2008, B AM MATH SOC, V45, P61, DOI 10.1090/s0273-0979-07-01191-3; Goodman JE, 2006, SURV DISCR COMP GEOM, V453; Guillemard M, GROUPOID ALGEBRAS PE; Johansson K, 2014, AM J CLIN NUTR, V99, P14, DOI 10.3945/ajcn.113.070052; Kerber M, 2016, 2016 P 18 WORKSH ALG; Khasawneh FA, 2015, ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2014, VOL 4B; Khasawneh FA, 2016, MECH SYST SIGNAL PR, V70-71, P527, DOI 10.1016/j.ymssp.2015.09.046; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ochner CN, 2013, PHYSIOL BEHAV, V120, P106, DOI 10.1016/j.physbeh.2013.07.009; Perea JA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0645-6; Pereira CMM, 2015, EXPERT SYST APPL, V42, P6026, DOI 10.1016/j.eswa.2015.04.010; Roe J, 2006, NOTICES AM MATH SOC, V53, P668; Rothberg AE, 2013, OBESITY, V21, P2157, DOI 10.1002/oby.20597; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Turner K., 2014, INFORM INFERENCE	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177696	10.1371/journal.pone.0177696	http://dx.doi.org/10.1371/journal.pone.0177696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498844	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500042
J	Connor, N; Barberan, A; Clauset, A				Connor, Nora; Barberan, Albert; Clauset, Aaron			Using null models to infer microbial co-occurrence networks	PLOS ONE			English	Article							BACTERIAL; COMMUNITY; DIVERSITY; PATTERNS; COMPETITION; PREDICTION	Although microbial communities are ubiquitous in nature, relatively little is known about the structural and functional roles of their constituent organisms' underlying interactions. A common approach to study such questions begins with extracting a network of statistically significant pairwise co-occurrences from a matrix of observed operational taxonomic unit (OTU) abundances across sites. The structure of this network is assumed to encode information about ecological interactions and processes, resistance to perturbation, and the identity of keystone species. However, common methods for identifying these pairwise interactions can contaminate the network with spurious patterns that obscure true ecological signals. Here, we describe this problem in detail and develop a solution that incorporates null models to distinguish ecological signals from statistical noise. We apply these methods to the initial OTU abundance matrix and to the extracted network. We demonstrate this approach by applying it to a large soil microbiome data set and show that many previously reported patterns for these data are statistical artifacts. In contrast, we find the frequency of three-way interactions among microbial OTUs to be highly statistically significant. These results demonstrate the importance of using appropriate null models when studying observational microbiome data, and suggest that extracting and characterizing three-way interactions among OTUs is a promising direction for unraveling the structure and function of microbial ecosystems.	[Connor, Nora; Clauset, Aaron] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Barberan, Albert] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ USA; [Clauset, Aaron] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Clauset, Aaron] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Colorado System; University of Colorado Boulder; University of Arizona; University of Colorado System; University of Colorado Boulder; The Santa Fe Institute	Connor, N (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.	nora.connor@university.edu		CLAUSET, AARON/0000-0002-3529-8746; BARBERAN, ALBERT/0000-0002-3066-7530				Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Aicher C, 2015, J COMPLEX NETW, V3, P221, DOI 10.1093/comnet/cnu026; Amerise IL, 2015, J APPL STAT, V42, P2584, DOI 10.1080/02664763.2015.1043870; Ban YG, 2015, BIOINFORMATICS, V31, P3322, DOI 10.1093/bioinformatics/btv364; Barberan A, 2014, ECOL LETT, V17, P794, DOI 10.1111/ele.12282; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; DeChoudhury M, 2010, P 19 INT C WORLD WID, P301, DOI DOI 10.1145/1772690.1772722; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Goberna M, 2014, ECOL LETT, V17, P1191, DOI 10.1111/ele.12341; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Kara EL, 2013, ISME J, V7, P680, DOI 10.1038/ismej.2012.118; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Kendall MG, 1945, BIOMETRIKA, V33, P239, DOI 10.2307/2332303; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larremore DB, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012805; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Montoya D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8379; Navarrete AA, 2015, MOL ECOL, V24, P2433, DOI 10.1111/mec.13172; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; O'Dwyer JP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002832; Peura S, 2015, APPL ENVIRON MICROB, V81, P2090, DOI 10.1128/AEM.03660-14; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Pholchan MK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00068; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Thomas AC, 2011, ARXIV11010788; Tucker CM, 2016, OIKOS, V125, P778, DOI 10.1111/oik.02803; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235; Williams RJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00358; Yang Y., 2016, PREPRINT; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047	55	40	40	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176751	10.1371/journal.pone.0176751	http://dx.doi.org/10.1371/journal.pone.0176751			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493918	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300030
J	Iwamoto, T; Nakamura, T; Ishikawa, M; Yoshizaki, K; Sugimoto, A; Ida-Yonemochi, H; Ohshima, H; Saito, M; Yamada, Y; Fukumoto, S				Iwamoto, Tsutomu; Nakamura, Takashi; Ishikawa, Masaki; Yoshizaki, Keigo; Sugimoto, Asuna; Ida-Yonemochi, Hiroko; Ohshima, Hayato; Saito, Masahiro; Yamada, Yoshihiko; Fukumoto, Satoshi			Pannexin 3 regulates proliferation and differentiation of odontoblasts via its hemichannel activities	PLOS ONE			English	Article							GAP-JUNCTION PROTEINS; OSTEOBLAST DIFFERENTIATION; DENTINOGENESIS IMPERFECTA; METABOLIC CHECKPOINT; CELL-PROLIFERATION; MUTATIONS CAUSE; PULP CELLS; TEETH; AMPK; EXPRESSION	Highly coordinated regulation of cell proliferation and differentiation contributes to the formation of functionally shaped and sized teeth; however, the mechanism underlying the switch from cell cycle exit to cell differentiation during odontogenesis is poorly understood. Recently, we identified pannexin 3 (Panx3) as a member of the pannexin gap junction protein family from tooth germs. The expression of Panx3 was predominately localized in preodontoblasts that arise from dental papilla cells and can differentiate into dentin-secreting odontoblasts. Panx3 also co-localized with p21, a cyclin-dependent kinase inhibitor protein, in preodontoblasts. Panx3 was expressed in primary dental mesenchymal cells and in the mDP dental mesenchymal cell line. Both Panx3 and p21 were induced during the differentiation of mDP cells. Overexpression of Panx3 in mDP cells reduced cell proliferation via upregulation of p21, but not of p27, and promoted the Bone morphogenetic protein 2 (BMP2)induced phosphorylation of Smad1/5/8 and the expression of dentin sialophosphoprotein (Dspp), a marker of differentiated odontoblasts. Furthermore, Panx3 released intracellular ATP into the extracellular space through its hemichannel and induced the phosphorylation of AMP-activated protein kinase (AMPK). 5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR), an activator of AMPK, reduced mDP cell proliferation and induced p21 expression. Conversely, knockdown of endogenous Panx3 by siRNA inhibited AMPK phosphorylation, p21 expression, and the phosphorylation of Smad1/5/8 even in the presence of BMP2. Taken together, our results suggest that Panx3 modulates intracellular ATP levels, resulting in the inhibition of odontoblast proliferation through the AMPK/p21 signaling pathway and promotion of cell differentiation by the BMP/Smad signaling pathway.	[Iwamoto, Tsutomu; Sugimoto, Asuna] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Pediat Dent, Kuramoto, Tokushima, Japan; [Nakamura, Takashi; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Div Pediat Dent, Sendai, Miyagi, Japan; [Ishikawa, Masaki; Saito, Masahiro] Tohoku Univ, Grad Sch Dent, Div Operat Dent, Sendai, Miyagi, Japan; [Ishikawa, Masaki; Yoshizaki, Keigo; Yamada, Yoshihiko] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Yoshizaki, Keigo] Kyushu Univ, Fac Dent Sci, Sect Orthodont & Dentofacial Orthoped, Maidashi, Fukuoka, Japan; [Ida-Yonemochi, Hiroko; Ohshima, Hayato] Niigata Univ, Grad Sch Med & Dent Sci, Div Anat & Cell Biol Hard Tissue, Chuo Ku, Niigata, Japan	Tokushima University; Tohoku University; Tohoku University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University; Niigata University	Iwamoto, T (corresponding author), Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Pediat Dent, Kuramoto, Tokushima, Japan.	iwamoto@tokushima-u.ac.jp	Iwamoto, Tsutomu/AAA-6597-2019; Ohshima, Hayato/AAW-5545-2020; Iwamoto, Tsutomu/AAI-8952-2021; Nakamura, Takashi/A-8931-2012	Iwamoto, Tsutomu/0000-0001-8472-605X; Ohshima, Hayato/0000-0001-8571-9900; Nakamura, Takashi/0000-0001-9904-1037; Fukumoto, Satoshi/0000-0002-5046-6891; Yoshizaki, Keigo/0000-0002-0598-5879	Ministry of Education, Science, and Culture of Japan [22689053, 26293435, 20679006]; NEXT program [LS010]; Research Program of the NIH; NIDCR; Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [15H05688, 17H04414, 17H04415] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid (22689053 and 26293435 to T.I., 20679006 to S. F.) from the Ministry of Education, Science, and Culture of Japan and the NEXT program (LS010 to S.F.) and in part by the Research Program of the NIH, NIDCR (Y.Y). T.N., M.I., and K.Y. were supported in part by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Akazawa Y, 2015, INT J MOL MED, V36, P442, DOI 10.3892/ijmm.2015.2247; Arakaki M, 2012, J BIOL CHEM; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bennett M V, 1992, Semin Cell Biol, V3, P29; Bjorklund MA, 2010, EXP CELL RES, V316, P762, DOI 10.1016/j.yexcr.2009.12.014; Bond SR, 2011, J BONE MINER RES, V26, P2911, DOI 10.1002/jbmr.509; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Buhl DL, 2003, J NEUROSCI, V23, P1013; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; Fried KAJ, 1996, INT J DEV BIOL, V40, P985; Fukumoto E, 2003, J DENT RES, V82, P17, DOI 10.1177/154405910308200105; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ishikawa M, 2016, J CELL SCI; Ishikawa M, 2014, J BIOL CHEM, V289, P2839, DOI 10.1074/jbc.M113.523241; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Joao SMA, 2003, HISTOCHEM CELL BIOL, V119, P21, DOI 10.1007/s00418-002-0482-3; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lo CW, 1997, COMMUNICATION, V20, P119; McKnight DA, 2008, J DENT RES, V87, P1108, DOI 10.1177/154405910808701217; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nakamura T, 2004, J BIOL CHEM, V279, P626, DOI 10.1074/jbc.M307502200; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; Oh SK, 2015, FASEB J, V29, P4473, DOI 10.1096/fj.15-273722; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Qin W, 2012, J ENDODONT, V38, P66, DOI 10.1016/j.joen.2011.09.025; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Sasaki T, 1996, ANAT REC, V245, P235, DOI 10.1002/(SICI)1097-0185(199606)245:2<235::AID-AR10>3.0.CO;2-Q; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; USHIYAMA J, 1989, CELL TISSUE RES, V258, P611; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Wu BL, 2003, AM J MED GENET A, V121A, P102, DOI 10.1002/ajmg.a.20210; Yuasa K, 2004, J BIOL CHEM, V279, P10286, DOI 10.1074/jbc.M310013200	42	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177557	10.1371/journal.pone.0177557	http://dx.doi.org/10.1371/journal.pone.0177557			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494020	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300135
J	D'Auria, L; Reiter, C; Ward, E; Moyano, AL; Marshall, MS; Nguyen, D; Scesa, G; Hauck, Z; van Breemen, R; Givogri, MI; Bongarzone, ER				D'Auria, Ludovic; Reiter, Cory; Ward, Emma; Moyano, Ana Lis; Marshall, Michael S.; Duc Nguyen; Scesa, Giuseppe; Hauck, Zane; van Breemen, Richard; Givogri, Maria I.; Bongarzone, Ernesto R.			Psychosine enhances the shedding of membrane microvesicles: Implications in demyelination in Krabbe's disease	PLOS ONE			English	Article							GLOBOID-CELL LEUKODYSTROPHY; TWITCHER MOUSE; NERVOUS-SYSTEM; LIPID ORDER; RAT-BRAIN; TMA-DPH; FLUIDITY; CHOLESTEROL; PATHOGENESIS; MYELINATION	In prior studies, our laboratory showed that psychosine accumulates and disrupts lipid rafts in brain membranes of Krabbe's disease. A model of lipid raft disruption helped explaining psychosine's effects on several signaling pathways important for oligodendrocyte survival and differentiation but provided more limited insight in how this sphingolipid caused demyelination. Here, we have studied how this cationic inverted coned lipid affects the fluidity, stability and structure of myelin and plasma membranes. Using a combination of cutting-edge imaging techniques in non-myelinating (red blood cell), and myelinating (oligodendrocyte) cell models, we show that psychosine is sufficient to disrupt sphingomyelin-enriched domains, increases the rigidity of localized areas in the plasma membrane, and promotes the shedding of membranous microvesicles. The same physicochemical and structural changes were measured in myelin membranes purified from the mutant mouse Twitcher, a model for Krabbe's disease. Areas of higher rigidity were measured in Twitcher myelin and correlated with higher levels of psychosine and of myelin microvesiculation. These results expand our previous analyses and support, for the first time a pathogenic mechanism where psychosine's toxicity in Krabbe disease involves deregulation of cell signaling not only by disruption of membrane rafts, but also by direct local destabilization and fragmentation of the membrane through microvesiculation. This model of membrane disruption may be fundamental to introduce focal weak points in the myelin sheath, and consequent diffuse demyelination in this leukodystrophy, with possible commonality to other demyelinating disorders.	[D'Auria, Ludovic; Reiter, Cory; Ward, Emma; Moyano, Ana Lis; Marshall, Michael S.; Duc Nguyen; Scesa, Giuseppe; Givogri, Maria I.; Bongarzone, Ernesto R.] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60607 USA; [Hauck, Zane; van Breemen, Richard] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Bongarzone, Ernesto R.] Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquirn, Buenos Aires, DF, Argentina	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Buenos Aires	Bongarzone, ER (corresponding author), Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60607 USA.; Bongarzone, ER (corresponding author), Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquirn, Buenos Aires, DF, Argentina.	ebongarz@uic.edu	van Breemen, Richard/AAO-2875-2020; Marshall, Michael/B-9705-2015	Marshall, Michael/0000-0002-5742-2031; Moyano, Ana Lis/0000-0002-1089-8542; van Breemen, Richard/0000-0003-2016-0063; d'auria, ludovic/0000-0001-6270-7739	National Institutes of Health [R01 NS065808]; Legacy of Angels Foundation; European Leukodystrophy Association; National Multiple Sclerosis Society; Belgian American Educational Foundation; Chicago Biomedical Consortium pilot grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Legacy of Angels Foundation; European Leukodystrophy Association; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Belgian American Educational Foundation; Chicago Biomedical Consortium pilot grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was partially funded with grants from the National Institutes of Health (R01 NS065808), The Legacy of Angels Foundation, and the European Leukodystrophy Association to ERB. LDA was funded by a postdoctoral fellowship of the National Multiple Sclerosis Society, a fellowship from Belgian American Educational Foundation, and a Chicago Biomedical Consortium pilot grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLT G, 1988, ACTA NEUROPATHOL, V75, P456, DOI 10.1007/BF00687132; Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652; Boggs JM, 2000, BIOPHYS J, V78, P874, DOI 10.1016/S0006-3495(00)76645-8; Bongarzone ER, 2016, PEDIATR ENDOCR REV P, V13, P689; Carquin M, 2016, PROG LIPID RES, V62, P1, DOI 10.1016/j.plipres.2015.12.004; Castelvetri LC, 2011, ACTA NEUROPATHOL, V122, P35, DOI 10.1007/s00401-011-0814-2; Chauhan NB, 2003, J LIPID RES, V44, P2019, DOI 10.1194/jlr.R300010-JLR200; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; COOPER RA, 1977, NEW ENGL J MED, V297, P371; CRAVIOTO H, 1967, J NEUROPATH EXP NEUR, V26, P157; D'Auria L, 2013, BBA-BIOMEMBRANES, V1828, P2064, DOI 10.1016/j.bbamem.2013.05.006; D'Auria L, 2016, J NEUROSCI RES, V94, P1019, DOI 10.1002/jnr.23750; D'Auria L, 2013, J LIPID RES, V54, P1066, DOI 10.1194/jlr.M034314; D'auria L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017021; de Vito G, 2017, J BIOPHOTONICS, V10, P385, DOI 10.1002/jbio.201500305; DUCHEN LW, 1980, BRAIN, V103, P695, DOI 10.1093/brain/103.3.695; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; FLORINECASTEEL K, 1991, FASEB J, V5, P2078, DOI 10.1096/fasebj.5.7.2010060; FONTAINE G, 1973, ACTA NEUROPATHOL, V23, P118, DOI 10.1007/BF00685766; Galbiati F, 2007, J NEUROSCI, V27, P13730, DOI 10.1523/JNEUROSCI.3379-07.2007; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Givogri MI, 2002, J NEUROSCI RES, V67, P309, DOI 10.1002/jnr.10128; Golfetto O, 2013, BIOPHYS J, V104, P1238, DOI 10.1016/j.bpj.2012.12.057; GREGOIRE A, 1966, J NEUROPATH EXP NEUR, V25, P617, DOI 10.1097/00005072-196610000-00008; Grisendi G, 2015, BLOOD TRANSFUS-ITALY, V13, P274, DOI 10.2450/2014.0136-14; Hawkins-Salsbury JA, 2013, J LIPID RES, V54, P3303, DOI 10.1194/jlr.M039610; IGISU H, 1984, SCIENCE, V224, P753, DOI 10.1126/science.6719111; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; KOBAYASHI T, 1980, BRAIN RES, V202, P479, DOI 10.1016/0006-8993(80)90159-6; Koike T, 1998, BBA-MOL BASIS DIS, V1406, P327, DOI 10.1016/S0925-4439(98)00019-2; Kostova EB, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150019; KUHRY JG, 1983, CELL BIOPHYS, V5, P129, DOI 10.1007/BF02796139; KUHRY JG, 1985, BIOCHIM BIOPHYS ACTA, V845, P60, DOI 10.1016/0167-4889(85)90055-2; Leppimaki P, 2000, EUR J BIOCHEM, V267, P6385, DOI 10.1046/j.1432-1327.2000.01726.x; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; MARSH JB, 1966, J LIPID RES, V7, P574; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; MEIER C, 1976, ACTA NEUROPATHOL, V36, P369, DOI 10.1007/BF00699642; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; NAGARA H, 1982, BRAIN RES, V244, P289, DOI 10.1016/0006-8993(82)90087-7; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; PARNHAM MJ, 1993, CHEM PHYS LIPIDS, V64, P263, DOI 10.1016/0009-3084(93)90070-J; PELLISSIER JF, 1986, ACTA NEUROPATHOL, V72, P178, DOI 10.1007/BF00685981; Pituch KC, 2015, J BIOL CHEM, V290, P7040, DOI 10.1074/jbc.M115.636498; PRINEAS JW, 1984, ANN NY ACAD SCI, V436, P11, DOI 10.1111/j.1749-6632.1984.tb14773.x; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; PURPURA DP, 1978, NATURE, V276, P520, DOI 10.1038/276520a0; PURPURA DP, 1977, NATURE, V266, P552; Saldanha C, 2002, J MEMBRANE BIOL, V190, P75, DOI 10.1007/s00232-002-1025-5; Shaharabani R, 2016, J AM CHEM SOC, V138, P12159, DOI 10.1021/jacs.6b04826; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; TAKAHASHI H, 1984, ACTA NEUROPATHOL, V62, P298, DOI 10.1007/BF00687612; TANIIKE M, 1994, ACTA NEUROPATHOL, V88, P228; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Turgeon CT, 2015, J INHERIT METAB DIS, V38, P923, DOI 10.1007/s10545-015-9822-z; Tyteca D, 2010, BBA-BIOMEMBRANES, V1798, P909, DOI 10.1016/j.bbamem.2010.01.021; von Einem B, 2012, INT J MOL SCI, V13, P15801, DOI 10.3390/ijms131215801; Westerlund B, 2009, BBA-BIOMEMBRANES, V1788, P194, DOI 10.1016/j.bbamem.2008.11.010; White AB, 2011, J NEUROSCI RES, V89, P352, DOI 10.1002/jnr.22564; White AB, 2009, J NEUROSCI, V29, P6068, DOI 10.1523/JNEUROSCI.5597-08.2009; Yang XG, 2014, MOL NEUROBIOL, V50, P119, DOI 10.1007/s12035-014-8652-6; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; Zhu HL, 2012, ARCH PATHOL LAB MED, V136, P709, DOI 10.5858/arpa.2011-0667-LE	69	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178103	10.1371/journal.pone.0178103	http://dx.doi.org/10.1371/journal.pone.0178103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531236	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400057
J	De Groot, S; Blommestein, HM; Redekop, WK; Sleijfer, S; Kiemeney, LALM; Oosterwijk, E; Uyl-de Groot, CA				De Groot, S.; Blommestein, H. M.; Redekop, W. K.; Sleijfer, S.; Kiemeney, L. A. L. M.; Oosterwijk, E.; Uyl-de Groot, C. A.			Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTERFERON-ALPHA; PHASE-III; ECONOMIC-EVALUATION; PROGNOSTIC-FACTORS; SUNITINIB; TEMSIROLIMUS; SORAFENIB; SURVIVAL; THERAPIES	Introduction Randomised controlled trials have shown that targeted therapies like sunitinib are effective in metastatic renal cell carcinoma (mRCC). Little is known about the current use of these therapies, and their associated costs and effects in daily clinical practice. We estimated the real-world cost-effectiveness of different treatment strategies comprising one or more sequentially administered drugs. Methods Analyses were performed using patient-level data from a Dutch population-based registry including patients diagnosed with primary mRCC from January 2008 to December 2010 (i.e., treated between 2008 and 2013). The full disease course of these patients was estimated using a patient-level simulation model based on regression analyses of the registry data. A healthcare sector perspective was adopted; total costs included healthcare costs related to mRCC. Cost-effectiveness was expressed in cost per life-year and cost per quality-adjusted life-year (QALY) gained. Probabilistic sensitivity analysis was conducted to estimate the overall uncertainty surrounding cost-effectiveness. Results In current daily practice, 54% (336/621) of all patients was treated with targeted therapies. Most patients (84%; 282/336) received sunitinib as first-line therapy. Of the patients receiving first-line therapy, 30% (101/336) also received second-line therapy; the majority was treated with everolimus (40%, 40/101) or sorafenib (28%, 28/101). Current treatment practice (including patients not receiving targeted therapy) led to 0.807 QALYs; mean costs were (sic)58,912. This resulted in an additional (sic)105,011 per QALY gained compared to not using targeted therapy at all. Forty-six percent of all patients received no targeted therapy; of these patients, 24% (69/285) was eligible for sunitinib. If these patients were treated with first-line sunitinib, mean QALYs would improve by 0.062-0.076 (where the range reflects the choice of second-line therapy). This improvement is completely driven by the health gain seen amongst patients eligible to receive sunitinib but did not receive it, who gain 0.558-0.684 QALYs from sunitinib. Since additional costs would be (sic)7,072-9,913, incremental costs per QALY gained are (sic)93,107-111,972 compared to current practice. Discussion Health can be gained if more treatment-eligible patients receive targeted therapies. Moreover, it will be just as cost-effective to treat these patients with sunitinib as current treatment practice.	[De Groot, S.; Blommestein, H. M.; Redekop, W. K.; Uyl-de Groot, C. A.] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Sleijfer, S.] Erasmus MC Canc Inst, Dept Med Oncol & Canc Genom Netherlands, Rotterdam, Netherlands; [Kiemeney, L. A. L. M.; Oosterwijk, E.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Urol, Nijmegen, Netherlands; [Kiemeney, L. A. L. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Radboud University Nijmegen; Radboud University Nijmegen	De Groot, S (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands.	degroot@imta.eur.nl	Oosterwijk, Egbert/P-5466-2014; Kiemeney, Lambertus A./D-3357-2009; Redekop, Ken/AAA-2423-2020	Kiemeney, Lambertus A./0000-0002-2368-1326; Blommestein, Hedwig/0000-0002-5846-0531; Redekop, Ken/0000-0001-9538-4083; de Groot, Saskia/0000-0003-2782-3114	Netherlands Organisation for Health Research and Development [152001014]; Pfizer; Roche Nederland BV; Roche	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Pfizer(Pfizer); Roche Nederland BV; Roche(Roche Holding)	The PERCEPTION-registry was financially supported by the Netherlands Organisation for Health Research and Development (grant number: 152001014; http://www.zonmw.nl; LK CU). They were involved in the design of the PERCEPTION-registry. Additional financial support was provided by Pfizer (formerly Wyeth Pharmaceuticals BV) and Roche Nederland BV (CU). They were also involved in the design of the PERCEPTION-registry. Furthermore, they approved the final version of the manuscript.; The PERCEPTION registry was financially supported by the Netherlands Organisation for Health Research and Development (grant number: 152001014). Additional financial support was provided by Pfizer and Roche. The authors would like to thank the registration teams of the Comprehensive Cancer Center the Netherlands and the Comprehensive Cancer Center South for their extensive data collection.	[Anonymous], 2006, GUID PHARM RES; Benedict A, 2011, BJU INT, V108, P665, DOI 10.1111/j.1464-410X.2010.09957.x; Casciano R, 2011, VALUE HEALTH, V14, P846, DOI 10.1016/j.jval.2011.04.008; Cella D, 2013, BRIT J CANCER, V108, P1571, DOI 10.1038/bjc.2013.145; Cella D, 2012, EUR J CANCER, V48, P311, DOI 10.1016/j.ejca.2011.05.017; Centraal Bureau voor de Statistiek, CONS PRIC PRIC IND 2; Centraal Bureau voor de Statistiek, LIF EXP GEND AG 1950; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; De Groot S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2395-x; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Hoyle M, 2010, VALUE HEALTH, V13, P61, DOI 10.1111/j.1524-4733.2009.00617.x; Hoyle M, 2010, VALUE HEALTH, V13, P55, DOI 10.1111/j.1524-4733.2009.00616.x; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Lam JS, 2005, UROLOGY, V66, P1, DOI 10.1016/j.urology.2005.06.112; Motzer RJ, 2013, BRIT J CANCER, V108, P2470, DOI 10.1038/bjc.2013.236; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Prescribing and Primary Care team, 2014, US NICE APPR MED NHS; Remak E, 2008, J CLIN ONCOL, V26, P3995, DOI 10.1200/JCO.2007.13.2662; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Sleijfer S, 2009, CLIN PHARMACOL THER, V85, P136, DOI 10.1038/clpt.2008.245; Sternberg CN, 2013, EUR J CANCER, V49, P1287, DOI 10.1016/j.ejca.2012.12.010; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yang S, 2010, BRIT J CANCER, V102, P1456, DOI 10.1038/sj.bjc.6605647	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177364	10.1371/journal.pone.0177364	http://dx.doi.org/10.1371/journal.pone.0177364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531203	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400015
J	Katayama, I; Eida, S; Fujita, S; Hotokezaka, Y; Sumi, M; Nakamura, T				Katayama, Ikuo; Eida, Sato; Fujita, Shuichi; Hotokezaka, Yuka; Sumi, Misa; Nakamura, Takashi			Perfusion MR imaging detection of carcinoma arising from preexisting salivary gland pleomorphic adenoma by computer-assisted analysis of time-signal intensity maps	PLOS ONE			English	Article							INTRAVOXEL INCOHERENT MOTION; TUMORS; DIFFERENTIATION; BENIGN; PROGRESSION; DIFFUSION; HEAD	Tumor perfusion can be evaluated by analyzing the time-signal intensity curve (TIC) after dynamic contrast-enhanced (DCE) MR imaging. Accordingly, TIC profiles are characteristic of some benign and malignant salivary gland tumors. A carcinoma ex pleomorphic adenoma (CXPA) arises from a long-standing pleomorphic adenoma (PA) and has a distinctive prognostic risk depending on the tumor growth potential such as invasion beyond the preexisting capsule. Differentiating CXPA from PA can be very challenging. In this study, we have attempted to discriminate CXPA from PA based on a two-dimensional TIC mapping algorithm. TIC mapping analysis was performed on 8 patients with CXPA and 20 patients with PA after dynamic contrast-enhanced (DCE) MR imaging using a 1.5-T MR system. The TIC profiles obtained were automatically categorized into 5 types based on the enhancement ratio, maximum time, and washout ratio (Type 1 TIC with flat profile, Type 2 TIC with slow uptake, Type 3 TIC with rapid uptake and a low washout ratio, Type 4 TIC with rapid uptake and a high washout ratio, and Type 5 TIC not otherwise specific). The percentage tumor areas with each of the 5 TIC types were compared between CXPAs and PAs. Stepwise differentiation and cluster analysis using multiple TIC cut-off thresholds distinguished CXPAs from PAs with 75% sensitivity, 95% specificity, 86% accuracy, and 86% positive and 90% negative predictive values, when tumors with <= 1.1% Type 1 and >= 15% Type 4, or those with <= 1.1% Type 1, >= 78.1% Type 2, >= 16.1% Type 3, and <15% Type 4, or those with >1.1% Type 1, >= 78.1% Type 2, and >= 16.1% Type 3 areas were diagnosed as CXPAs. The overall TIC profiles predicted some aggressive CXPA growth patterns. These results suggest that stepwise differentiation based on TIC mapping is helpful in differentiating CXPAs from PAs.	[Katayama, Ikuo; Eida, Sato; Hotokezaka, Yuka; Sumi, Misa; Nakamura, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan; [Fujita, Shuichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Pathol & Bone Metab, Nagasaki, Japan	Nagasaki University; Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan.	taku@nagasaki-u.ac.jp			Grants-in-Aid for Scientific Research [15K11078] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Antony J, 2012, HEAD NECK PATHOL, V6, P1, DOI 10.1007/s12105-011-0281-z; Bryan RN, 2016, RADIOLOGY, V281, P665, DOI 10.1148/radiol.2016162151; DONAHUE KM, 1995, MAGN RESON MED, V34, P423, DOI 10.1002/mrm.1910340320; Eida S, 2008, J MAGN RESON IMAGING, V27, P1256, DOI 10.1002/jmri.21349; Eida S, 2010, J MAGN RESON IMAGING, V31, P673, DOI 10.1002/jmri.22091; Gnepp D.R., 2005, WHO CLASSIFICATION T, P242; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Katabi N, 2010, HUM PATHOL, V41, P927, DOI 10.1016/j.humpath.2009.12.011; Knopp MV, 1999, JMRI-J MAGN RESON IM, V10, P260, DOI 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7; Lewis JE, 2001, HUM PATHOL, V32, P596, DOI 10.1053/hupa.2001.25000; Nakamura T, METHODS CANC DIAGNOS, V7; Oshida K, 2005, EUR RADIOL, V15, P1353, DOI 10.1007/s00330-005-2661-9; Rito M, 2016, VIRCHOWS ARCH, V468, P297, DOI 10.1007/s00428-015-1887-4; Sasaki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112866; Stodulski D, 2016, EUR ARCH OTO-RHINO-L, V273, P3937, DOI 10.1007/s00405-016-4048-8; Sumi M, 2014, EUR RADIOL, V24, P223, DOI 10.1007/s00330-013-3002-z; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Sumi M, 2011, J MAGN RESON IMAGING, V33, P830, DOI 10.1002/jmri.22454; Suzuki M, 2016, ACTA OTO-LARYNGOL, V136, P1154, DOI 10.1080/00016489.2016.1191671; Wang K, 2016, CLIN CANCER RES, V22, P6061, DOI 10.1158/1078-0432.CCR-15-2568; Weiler C, 2011, HISTOPATHOLOGY, V59, P741, DOI 10.1111/j.1365-2559.2011.03937.x; Yabuuchi H, 2003, RADIOLOGY, V226, P345, DOI 10.1148/radiol.2262011486	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178002	10.1371/journal.pone.0178002	http://dx.doi.org/10.1371/journal.pone.0178002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531213	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058400047
J	Quader, ZS; Cogswell, ME; Fang, J; King, SMC; Merritt, RK				Quader, Zerleen S.; Cogswell, Mary E.; Fang, Jing; King, Sallyann M. Coleman; Merritt, Robert K.			Changes in primary healthcare providers' attitudes and counseling behaviors related to dietary sodium reduction, DocStyles 2010 and 2015	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; PHYSICIAN ADVICE; NATIONAL-HEALTH; BLOOD-PRESSURE; ADULTS; MANAGEMENT; EXERCISE	High blood pressure is a major risk factor for cardiovascular disease. The 2013 ACC/AHA Lifestyle Management Guideline recommends counseling pre-hypertensive and hypertensive patients to reduce sodium intake. Population sodium reduction efforts have been introduced in recent years, and dietary guidelines continued to emphasize sodium reduction in 2010 and 2015. The objective of this analysis was to determine changes in primary health care providers' sodium-reduction attitudes and counseling between 2010 and 2015. Primary care internists, family/general practitioners, and nurse practitioners answered questions about sodium-related attitudes and counseling behaviors in DocStyles, a repeated cross-sectional web-based survey in the United States. Differences in responses between years were examined. In 2015, the majority (78%) of participants (n = 1,251) agreed that most of their patients should reduce sodium intake, and reported advising hypertensive (85%), and chronic kidney disease patients (71%), but not diabetic patients (48%) and African-American patients (43%) to consume less salt. Since 2010, the proportion of participants agreeing their patients should reduce sodium intake decreased while the proportion advising patients with these characteristics to consume less salt increased and the prevalence of specific types of advice declined. Changes in behaviors between surveys remained significant after adjusting for provider and practice characteristics. More providers are advising patients to consume less salt in 2015 compared to 2010; however, fewer agree their patients should reduce intake and counseling is not universally applied across patient groups at risk for hypertension. Further efforts and educational resources may be required to enable patient counseling about sodium reduction strategies.	[Quader, Zerleen S.; Cogswell, Mary E.; Fang, Jing; King, Sallyann M. Coleman; Merritt, Robert K.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA; [Quader, Zerleen S.] IHRC Inc, Atlanta, GA 30346 USA	Centers for Disease Control & Prevention - USA	Quader, ZS (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA.; Quader, ZS (corresponding author), IHRC Inc, Atlanta, GA 30346 USA.	zquader@cdc.gov						Adler AJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009217.pub3; Agricultural Research Service U. S. Department of Agriculture, 2011, WWEIA DAT TABL; [Anonymous], NAT AMB MED CAR SURV; Ayala C, 2012, J CLIN HYPERTENS, V14, P447, DOI 10.1111/j.1751-7176.2012.00632.x; Corsino Leonor, 2009, N C Med J, V70, P391; Donahue KE, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130157; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Fang J, 2012, ARCH INTERN MED, V172, P76, DOI 10.1001/archinternmed.2011.620; Gillespie CD, 2013, MMWR-MORBID MORTAL W, V62, P144; Henderson JT, 2001, MED CARE, V39, P1281, DOI 10.1097/00005650-200112000-00004; Honda K, 2004, AM J HEALTH PROMOT, V18, P370, DOI 10.4278/0890-1171-18.5.370; Institute of Medicine [IOM], 2010, STRATEGIES REDUCE SO; Jackson SL, 2016, AM J PREV MED, V50, P30, DOI 10.1016/j.amepre.2015.04.034; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lopez L, 2009, AM J HYPERTENS, V22, P325, DOI 10.1038/ajh.2008.348; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; NYC Department of Health and Mental Hygiene, SOD IN; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub4; Ritseman TS, 2014, PREV CHRONIC DIS, V11, DOI [10.5888/pcd11.130175, 10.5888/pcd11.130175Eg]; Sinclair J, 2008, CAN FAM PHYSICIAN, V54, P404; Tabenkin H, 2010, ANN FAM MED, V8, P25, DOI 10.1370/afm.1071; US Department of Agriculture U. D. o. H. a. H. S, 2015, DIET GUID AM; Valderrama AL, 2010, J CLIN HYPERTENS, V12, P784, DOI 10.1111/j.1751-7176.2010.00323.x; Viera AJ, 2008, J CLIN HYPERTENS, V10, P105, DOI 10.1111/j.1751-7176.2008.07577.x; Wexler R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-23	29	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177693	10.1371/journal.pone.0177693	http://dx.doi.org/10.1371/journal.pone.0177693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531232	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400024
J	Schubert, C; Waletzko, O; Weiss, C; Voelzke, D; Toperim, S; Roeser, A; Puccini, S; Piroth, M; Mehrens, C; Kueter, JD; Hierholz, K; Gerull, K; Fogliata, A; Block, A; Cozzi, L				Schubert, Carolin; Waletzko, Oliver; Weiss, Christian; Voelzke, Dirk; Toperim, Sevda; Roeser, Arnd; Puccini, Silvia; Piroth, Marc; Mehrens, Christian; Kueter, Jan-Dirk; Hierholz, Kirsten; Gerull, Karsten; Fogliata, Antonella; Block, Andreas; Cozzi, Luca			Intercenter validation of a knowledge based model for automated planning of volumetric modulated arc therapy for prostate cancer. The experience of the German RapidPlan Consortium	PLOS ONE			English	Article							RADIATION-THERAPY; OPTIMIZATION ENGINE; AT-RISK; IMRT; QUALITY; RADIOTHERAPY	Purpose To evaluate the performance of a model-based optimisation process for volumetric modulated arc therapy applied to prostate cancer in a multicentric cooperative group. The RapidPlan (RP) knowledge-based engine was tested for the planning of Volumetric modulated arc therapy with RapidArc on prostate cancer patients. The study was conducted in the frame of the German RapidPlan Consortium (GRC). Methods and materials 43 patients from one institute of the GRC were used to build and train a RP model. This was further shared with all members of the GRC plus an external site from a different country to increase the heterogeneity of the patient's sampling. An in silico multicentric validation of the model was performed at planning level by comparing RP against reference plans optimized according to institutional procedures. A total of 60 patients from 7 institutes were used. Results On average, the automated RP based plans resulted fully consistent with the manually optimised set with a modest tendency to improvement in the medium-to-high dose region. A per-site stratification allowed to identify different patterns of performance of the model with some organs at risk resulting better spared with the manual or with the automated approach but in all cases the RP data fulfilled the clinical acceptability requirements. Discrepancies in the performance were due to different contouring protocols or to different emphasis put in the optimization of the manual cases. Conclusions The multicentric validation demonstrated that it was possible to satisfactorily optimize with the knowledge based model patients from all participating centres. In the presence of possibly significant differences in the contouring protocols, the automated plans, though acceptable and fulfilling the benchmark goals, might benefit from further fine tuning of the constraints. The study demonstrates that, at least for the case of prostate cancer patients, it is possibile to share models among different clinical institutes in a cooperative framework.	[Schubert, Carolin; Toperim, Sevda] Univ Med Ctr Hamburg Eppendorf, Dept Radiotherapy, Hamburg, Germany; [Schubert, Carolin; Toperim, Sevda] Univ Med Ctr Hamburg Eppendorf, Radiat Oncol Dept, Hamburg, Germany; [Waletzko, Oliver] Dr Rohn & Kollegen Klinikum Dortmund, Radiat Oncol Dept, Dortmund, Germany; [Weiss, Christian; Hierholz, Kirsten] Klinikum Darmstadt GmbH, Radiat Oncol Dept, Darmstadt, Germany; [Voelzke, Dirk; Puccini, Silvia] Strahlentherapie Bonn Rhein Sieg, Radiat Oncol Grp Practice, Bonn, Germany; [Roeser, Arnd; Piroth, Marc] Witten Herdecke Univ, Helios Univ Klinikum, Radiat Oncol Dept, Wuppertal, Germany; [Mehrens, Christian; Block, Andreas] Klinikum Dortmund, Med Phys Dept, Dortmund, Germany; [Kueter, Jan-Dirk; Gerull, Karsten] Univ Med Ctr Schleswig Holstein, Radiat Oncol Dept, Campus Luebeck, Lubeck, Germany; [Fogliata, Antonella; Cozzi, Luca] Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg Dept, Rozzano, Italy	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Klinikum Darmstadt; Klinikum Dortmund; University of Kiel; Schleswig Holstein University Hospital; IRCCS Humanitas Research Hospital	Cozzi, L (corresponding author), Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg Dept, Rozzano, Italy.	luca.cozzi@humanitas.it	Block, Andreas/GLU-6047-2022; Puccini, Silvia/AAY-8691-2020; cozzi, luca/GZL-4895-2022	cozzi, luca/0000-0001-7862-898X; Fogliata, Antonella/0000-0002-2282-9894				Appenzoller LM, 2012, MED PHYS, V39, P7446, DOI 10.1118/1.4761864; Aznar MC, 2010, RADIOTHER ONCOL, V97, P480, DOI 10.1016/j.radonc.2010.09.014; Berry SL, 2016, RADIOTHER ONCOL, V120, P349, DOI 10.1016/j.radonc.2016.06.010; Boero IJ, 2016, J CLIN ONCOL, V34, P684, DOI 10.1200/JCO.2015.63.9898; Chang ATY, 2016, INT J RADIAT ONCOL, V95, P981, DOI 10.1016/j.ijrobp.2016.02.017; Chanyavanich V, 2011, MED PHYS, V38, P2515, DOI 10.1118/1.3574874; Delaney A, 2017, ACTA ONCOL; Delaney AR, 2016, INT J RADIAT ONCOL, V94, P469, DOI 10.1016/j.ijrobp.2015.11.011; Fogliata A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145137; Fogliata A, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0530-5; Fogliata A, 2014, RADIOTHER ONCOL, V113, P385, DOI 10.1016/j.radonc.2014.11.009; Fogliata A, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0236-0; Good D, 2013, INT J RADIAT ONCOL, V87, P176, DOI 10.1016/j.ijrobp.2013.03.015; Hussein M, 2016, RADIOTHER ONCOL, V120, P473, DOI 10.1016/j.radonc.2016.06.022; Li N, 2017, INT J RADIAT ONCOL, V97, P164, DOI 10.1016/j.ijrobp.2016.10.005; Moore KL, 2011, INT J RADIAT ONCOL, V81, P545, DOI 10.1016/j.ijrobp.2010.11.030; Pesce GA, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-54; Snyder K, 2016, J APPL CLIN MED PHYS, V17, P6429; Tol JP, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0542-1; Wu H, 2016, J APPL CLIN MED PHYS, V17, P6410; Wu H, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0684-9; Yuan LL, 2012, MED PHYS, V39, P6868, DOI 10.1118/1.4757927; Zhu XF, 2011, MED PHYS, V38, P719, DOI 10.1118/1.3539749	23	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178034	10.1371/journal.pone.0178034	http://dx.doi.org/10.1371/journal.pone.0178034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531226	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400052
J	Xiao, YJ; Yu, SQ; Xue, QL; Lang, S; Sun, JP; Feng, D; Wang, JX				Xiao, Yongjiu; Yu, Shuqing; Xue, Qingliang; Lang, Shan; Sun, Junping; Feng, Dan; Wang, Jianxin			A scoring system to effectively evaluate central nervous system tuberculosis in patients with military tuberculosis	PLOS ONE			English	Article							ERYTHROCYTE SEDIMENTATION-RATE; RESPIRATORY-DISTRESS-SYNDROME; HUMAN-IMMUNODEFICIENCY-VIRUS; MILIARY TUBERCULOSIS; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; CLINICAL-ASPECTS; RISK-FACTORS; MENINGITIS; ADULTS	There is currently no convenient way to effectively evaluate whether a miliary tuberculosis patient is complicated with central nervous system (CNS) tuberculosis. We aimed to find such a way by analyzing the clinical data of these patients. Fifty patients with confirmed miliary tuberculosis and 31 patients with confirmed miliary tuberculosis complicated with CNS tuberculosis from 2010 to 2014 were selected. Their general conditions, clinical features and laboratory tests were analyzed. Factors that were significantly different between them were chosen to performed multivariate and univariate logistic regression analyses, and factors with significant P values were used to establish a scoring system. Eight factors, i.e., age, cough, nausea, headache, hemoglobin (HGB), serum albumin (ALB), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), were significantly different (P < 0.05). Multivariate logistic regression analysis showed that ALB was the independent risk predictor (HR = 1.29, 95% CI 1.09-1.52, P < 0.01), whereas the others were non-independent predictors except age (P < 0.05). The scoring system was based on a summation of the scores of the assigned values of the seven predictors and had an area under the curve (AUC) of 0.86 to confirm CNS tuberculosis, with a sensitivity of 81.5% and a specificity of 81.4% at a score of 0.75 and with a specificity of 95.3% at a score of 2.75. In contrast, a score below -0.75 excluded CNS tuberculosis, with a sensitivity of 88.9% and a specificity of 62.7%. The scoring system should be useful to evaluate whether a miliary tuberculosis patient is complicated with CNS tuberculosis and could help doctors avoid excessive investigation.	[Xiao, Yongjiu; Lang, Shan; Sun, Junping; Feng, Dan; Wang, Jianxin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing, Peoples R China; [Xiao, Yongjiu; Xue, Qingliang] Lanzhou Gen Hosp Chinese PLA, Dept Resp Dis, Lanzhou, Gansu, Peoples R China; [Yu, Shuqing] Lanzhou Pulm Hosp, Ward 2, Lanzhou, Gansu, Peoples R China	Chinese People's Liberation Army General Hospital	Wang, JX (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing, Peoples R China.	wangjianxin301@yeah.net			National Science and Technology Major Project of China [2015ZX09J15105-004]	National Science and Technology Major Project of China	This work was supported by National Science and Technology Major Project of China (No. 2015ZX09J15105-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abakay O, 2015, INFLAMMATION, V38, P691, DOI 10.1007/s10753-014-9978-y; Abaxis Global Diagnostics, 2006, RABB REF RANG COMM A; ADERELE WI, 1978, E AFR MED J, V55, P166; Al-Jahdali H, 2000, INT J TUBERC LUNG D, V4, P252; American Thoracic Society CDC America aIDSo, 2003, TREATM TUB 2003; Andronikou S, 2006, PEDIATR RADIOL, V36, P1289, DOI 10.1007/s00247-006-0319-7; Baker SK, 2004, TUBERCULOSIS, P427; Bento J, 2011, ACTA MEDICA PORT, V24, P145; BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; BIEHL JP, 1958, AM REV TUBERC PULM, V77, P605; Brigden ML, 1999, AM FAM PHYSICIAN, V60, P1443; CHAPMAN CB, 1946, NEW ENGL J MED, V235, P239, DOI 10.1056/NEJM194608222350801; Cherian A, 2011, AFR HEALTH SCI, V11, P116; Deng W, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-121; Escalante Patricio, 2009, Ann Intern Med, V150, pITC61; GELB AF, 1973, AM REV RESPIR DIS, V108, P1327; Group. TA, 2014, 2014 REP TUB RES FUN; Hiratsuka Takeaki, 2004, Kansenshogaku Zasshi, V78, P929; Hussain SF, 2004, INT J TUBERC LUNG D, V8, P493; Ida T, 1990, Kekkaku, V65, P477; Jayakumar A, 2015, TUBERCULOSIS, V95, P415, DOI 10.1016/j.tube.2015.04.011; Kalita J, 2004, NEUROL INDIA, V52, P194; Kim SW, 2015, LUNG, V193, P575, DOI 10.1007/s00408-015-9728-4; Kimura Hiroshi, 2014, Kekkaku, V89, P571; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lee YM, 2013, INFECTION, V41, P1089, DOI 10.1007/s15010-013-0478-z; Light RW, 2010, RESPIROLOGY, V15, P451, DOI 10.1111/j.1440-1843.2010.01723.x; LINCOLN EM, 1959, NEW ENGL J MED, V261, P113, DOI 10.1056/NEJM195907162610302; MAARTENS G, 1990, AM J MED, V89, P291, DOI 10.1016/0002-9343(90)90340-J; Mert A, 2001, Respirology, V6, P217, DOI 10.1046/j.1440-1843.2001.00328.x; National Institute for Health and Clinical Excellence, CLIN GUID 117 TUB; Nelson CA, 2011, CLIN INFECT DIS, V53, P915, DOI 10.1093/cid/cir508; Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351; Rich AR, 1933, B JOHNS HOPKINS HOSP, V52, P5; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Savic I, 2016, ANN SAUDI MED, V36, P42, DOI 10.5144/0256-4947.2016.42; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sharma SK, 2006, INT J TUBERC LUNG D, V10, P429; Sharma SK, 2005, LANCET INFECT DIS, V5, P415, DOI 10.1016/S1473-3099(05)70163-8; Sharma SK, 2012, INDIAN J MED RES, V135, P703; SIME PJ, 1994, RESP MED, V88, P609, DOI 10.1016/S0954-6111(05)80009-5; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6; TUDDENHAM WJ, 1984, AM J ROENTGENOL, V143, P509, DOI 10.2214/ajr.143.3.509; Ukpe IS, 2006, SAMJ S AFR MED J, V96, P427; van Lettow M, 2005, EUR J CLIN NUTR, V59, P526, DOI 10.1038/sj.ejcn.1602116; Venkatraman N, 2016, EUR RESPIR J, V47, P1578, DOI 10.1183/13993003.01958-2015; Vinay K., 2007, ROBBINS BASIC PATHOL; World Health Organization, 2015, CHECKL PER EV TB INF	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176651	10.1371/journal.pone.0176651	http://dx.doi.org/10.1371/journal.pone.0176651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531173	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400006
J	Janulewicz, PA; Krengel, MH; Maule, A; White, RF; Cirillo, J; Sisson, E; Heeren, T; Sullivan, K				Janulewicz, Patricia A.; Krengel, Maxine H.; Maule, Alexis; White, Roberta F.; Cirillo, Joanna; Sisson, Emily; Heeren, Timothy; Sullivan, Kimberly			Neuropsychological characteristics of Gulf War illness: A meta-analysis	PLOS ONE			English	Article							US ARMY VETERANS; LOW-LEVEL SARIN; CYCLOSARIN EXPOSURE; TOXICANT EXPOSURES; BRAIN; SYMPTOMS; SAMPLE	Objective Gulf War illness (GWI) is a disorder related to military service in the 1991 GW. Prominent symptoms include fatigue, pain and cognitive problems. These symptoms were reported by GW Veterans (GWV) immediately after the war and were eventually incorporated into case definitions of GWI. Neuropsychological function in GW veterans has been studied both among deployed GWV and in GWV diagnosed with GWI. Results have been inconsistent between and across GW populations. The purpose of the present investigation was to better characterize neuropsychological function in this veteran population. Methods Meta-analysis techniques were applied to published studies on neuropsychological performance in GWV to identify domains of dysfunction in deployed vs. non-deployed GW-era veterans and symptomatic vs. non-symptomatic GWVs. Results Significantly decreased performance was found in three functional domains: attention and executive function, visuospatial skills and learning/memory. Conclusions These findings document the cognitive decrements associated with GW service, validate current GWI case definitions using cognitive criteria, and identify test measures for use in GWI research assessing GWI treatment trial efficacy.	[Janulewicz, Patricia A.; Maule, Alexis; White, Roberta F.; Cirillo, Joanna; Sullivan, Kimberly] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Krengel, Maxine H.] VA Boston Healthcare Syst, Jamaica Plain, MA USA; [Krengel, Maxine H.; White, Roberta F.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [White, Roberta F.] Harvard Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Sisson, Emily] Boston Univ, Data Coordinating Ctr, Boston, MA 02215 USA; [Heeren, Timothy] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Boston University	Janulewicz, PA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.	paj@bu.edu		Sullivan, Kimberly/0000-0001-7940-6123; Krengel, Maxine/0000-0001-7632-590X	Congressionally Directed Medical Research Program [W81XWH-13-2-0072]	Congressionally Directed Medical Research Program(United States Department of Defense)	This work was supported by the Congressionally Directed Medical Research Program (Award number: W81XWH-13-2-0072; http://cdmrp.army.mil/).	Anger K, 1999, JOURNAL OF THE INTER, V5, P203; [Anonymous], 2014, CHRONIC MULTISYMPTOM; Axelrod BN, 1997, J NEUROPSYCH CLIN N, V9, P23; Benton A, 1989, MULTILINGUAL ASPHASI; Binns J, 2011, FEDERAL PRACTITIONER, V28, P37; Bunegin L, 2001, TOXICOL IND HEALTH, V17, P128, DOI 10.1191/0748233701th100oa; Chao LL, 2016, NEUROTOXICOLOGY, V53, P246, DOI 10.1016/j.neuro.2016.02.009; Chao LL, 2014, NEUROTOXICOLOGY, V44, P263, DOI 10.1016/j.neuro.2014.07.003; Chao LDL, 2011, NEUROTOXICOLOGY, V32, P814, DOI 10.1016/j.neuro.2011.06.006; Chao LL, 2010, NEUROTOXICOLOGY, V31, P493, DOI 10.1016/j.neuro.2010.05.006; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; David AS, 2002, PSYCHOL MED, V32, P1357, DOI 10.1017/S0033291702006359; Delis DC., 2000, CALIFORNIA VERBAL LE; Foundation PR, 1948, EXAMINERS MANUAL FOR; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Golden CJ, 1978, STROOP COLOR AND WOR; Goldstein G, 1996, J Int Neuropsychol Soc, V2, P368; Goldstein G, 1996, JOURNAL OF THE INTER, V2; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton, 1981, WISCONSIN CARD SORTI; Heaton KJ, 2007, NEUROTOXICOLOGY, V28, P761, DOI 10.1016/j.neuro.2007.03.006; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hom J, 1997, ARCH CLIN NEUROPSYCH, V12, P531, DOI 10.1016/S0887-6177(97)00035-8; Ismail A.A. B TE, 2012, OCCUPATIONAL AND ENV; Jastak S., 1997, WIDE RANGE ACHIEVEME; Kang HK, 2009, OCCUP ENVIRON MED, V51, P401, DOI DOI 10.1097/JOM.0B013E3181A2FEEB; Lange G, 2001, J CLIN EXP NEUROPSYC, V23, P240, DOI 10.1076/jcen.23.2.240.1208; Letz R., 1991, VERSION 4 4; Levy JI, 2001, ENVIRON HEALTH PERSP, V109, P1215, DOI 10.2307/3454743; Matthews C, 1964, INSTRUCTION MANUAL F; Proctor S, 2003, JOURNAL OF PSYCHOPAT, V25; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Proctor SP, 2006, NEUROTOXICOLOGY, V27, P931, DOI 10.1016/j.neuro.2006.08.001; RAC-GWVI, 2014, GULF WAR ILLNESS AND; RAC-GWVI, 2008, GULF WAR ILLNESS AND; Reitan R., 1974, CLINICAL NEUROPSYCHO; Reitan RM, 1985, THE HALSTEAD REITAN; Reitan RM, 1992, TRAIL MAKING TEST MA; Rohlman DS, 2011, NEUROTOXICOLOGY, V32, P268, DOI 10.1016/j.neuro.2010.12.008; Ross SM, 2013, CRIT REV TOXICOL, V43, P21, DOI 10.3109/10408444.2012.738645; Sillanpaa MC, 1997, J CLIN EXP NEUROPSYC, V19, P211, DOI 10.1080/01688639708403852; Smith A, 1968, HEAR DISORD, V3, P83; Smith BN, 2012, J J OCCUP ENVIRON ME; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Taylor E., 1959, PSYCHOLOGICAL APPRAI; Toomey R, 2009, J INT NEUROPSYCH SOC, V15, P717, DOI 10.1017/S1355617709990294; Vasterling JJ, 2006, PHILOS T R SOC B, V361, P593, DOI 10.1098/rstb.2006.1819; Wallin MT, 2009, COGN BEHAV NEUROL, V22, P155, DOI 10.1097/WNN.0b013e3181b278e8; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1955, MANUAL FOR THE WECHS; Wechsler D., 1997, MANUAL FOR THE WECHS; Wetzel L, 1987, SHORT CATEGORY TEST; White R, 2011, FEDERAL PRACTITIONER; White RF, 2001, AM J IND MED, V40, P42, DOI 10.1002/ajim.1070; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wilkinson G., 1993, THE WIDE RANGE ACHIE; Yee M, 2015, J HEAD TRAUMA REHABI	59	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177121	10.1371/journal.pone.0177121	http://dx.doi.org/10.1371/journal.pone.0177121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520755	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700037
J	Castro, ACMCE; Barbosa, NCCP				Morales-Correa e Castro, Adriana C.; Chiarini Pena Barbosa, Nara Cristina			Recent evolutionary history of Chrysoperla externa (Hagen 1861) (Neuroptera: Chrysopidae) in Brazil	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; GENETIC-STRUCTURE; OUTGROUP SELECTION; MITOCHONDRIAL GENE; PHYLOGEOGRAPHY; INFERENCE; SOFTWARE; NEUTRALITY; SEQUENCES	This work aimed to elucidate the distribution of Chrysoperla externa haplotypes and investigate whether it exhibits structure based on genetic composition as opposed to geographic location. The genetic diversity of C. externa, analyzed by AMOVA using the COI and 16S rRNA genes as mitochondrial markers, showed significant haplotype structure arising from genetic differences that was not associated with sampling location. This was reflected in the network grouping. Bayesian inference showed that haplotype distribution may have its origins in C. externa divergence into two distinct clades, which dispersed to various locations, and their subsequent diversification. The evolutionary history of C. externa may include multiple ancestral haplotypes differentiating within the same geographic area to generate the current broad genetic diversity, so that the earlier geographical history has been erased, and now we have highlighted its more recent genetic history.	[Morales-Correa e Castro, Adriana C.; Chiarini Pena Barbosa, Nara Cristina] Univ Estadual Paulista, Inst Biociencias Letras & Ciencias Exatas, Dept Biol, Programa Posgrad Biociencias, Sao Jose Do Rio Preto, SP, Brazil; [Morales-Correa e Castro, Adriana C.] Univ Estadual Paulista, Fac Ciencias Agrarias & Veterinarias, Dept Biol Aplicada Agropecuaria, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Castro, ACMCE (corresponding author), Univ Estadual Paulista, Inst Biociencias Letras & Ciencias Exatas, Dept Biol, Programa Posgrad Biociencias, Sao Jose Do Rio Preto, SP, Brazil.; Castro, ACMCE (corresponding author), Univ Estadual Paulista, Fac Ciencias Agrarias & Veterinarias, Dept Biol Aplicada Agropecuaria, Jaboticabal, SP, Brazil.	dri_morales@fcav.unesp.br		Coletto Morales, Adriana/0000-0002-2108-427X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Programa Taxonomia [150150/2007-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Programa Taxonomia	ACMCC received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Programa Taxonomia (150150/2007-5). NCCPB received support from Conselho Nacional de Desenvolvimento Cientffico e Tecnologico-(grant to master degree).	ALBUQUERQUE GS, 1994, BIOL CONTROL, V4, P8, DOI 10.1006/bcon.1994.1002; Barbosa NCCP, 2014, REV BRAS ENTOMOL, V58, P203, DOI 10.1590/S0085-56262014000200012; Brooks S.J., 1990, Bulletin of the British Museum (Natural History) Entomology, V59, P117; Brooks S.J., 1994, Bulletin of the Natural History Museum Entomology Series, V63, P137; Canestrelli D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05042; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Vinas MD, 2015, J EXP MAR BIOL ECOL, V468, P97, DOI 10.1016/j.jembe.2015.03.012; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferreri M, 2011, AFR J BIOTECHNOL, V10, P12799; Finn DS, 2007, FRESHWATER BIOL, V52, P1881, DOI 10.1111/j.1365-2427.2007.01813.x; Fu YX, 1997, GENETICS, V147, P915; Godoy JA, 2004, MOL ECOL, V13, P371, DOI 10.1046/j.1365-294X.2003.02075.x; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Hartl D.L., 2010, PRINCIPIOS GENETICA, V4; Horn A, 2006, MOL ECOL, V15, P1603, DOI 10.1111/j.1365-294X.2006.02872.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lavagnini TC, 2015, BRAZ J BIOL, V75, P878, DOI 10.1590/1519-6984.02014; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luo A-Rong, 2010, Acta Entomologica Sinica, V53, P192; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Milot E, 2000, MOL ECOL, V9, P667, DOI 10.1046/j.1365-294x.2000.00897.x; Morales AC, 2013, NEOTROP ENTOMOL, V42, P32, DOI 10.1007/s13744-012-0085-1; Morales AC, 2010, BRAZ J BIOL, V70, P1115, DOI 10.1590/S1519-69842010000500030; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Oswald J.D., 2015, NEUROPTERIDA SPECIES; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2002, TREE ANNOTATOR V1 8; Rambaut A, 2014, TRACER V1 6 SOFTWARE; Rambaut A., 2006, FIGTREE V 1 4 2 SOFT; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Technelysium Ltd, 1998, CHROM LIT VERS 2 1 1; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Turchetto-Zolet AC, 2012, MOL PHYLOGENET EVOL, V65, P174, DOI 10.1016/j.ympev.2012.06.012; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615	48	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177414	10.1371/journal.pone.0177414	http://dx.doi.org/10.1371/journal.pone.0177414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510607	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500028
J	Wobst, HJ; Delsing, L; Brandon, NJ; Moss, SJ				Wobst, Heike J.; Delsing, Louise; Brandon, Nicholas J.; Moss, Stephen J.			Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; IN-VITRO; SIGNATURE PROTEIN; RNA TARGETS; CELL-DEATH; MUTATIONS; APOPTOSIS; CLEAVAGE	The RNA-binding and -processing protein TAR DNA-binding protein 43 (TDP-43) is heavily linked to the underlying causes and pathology of neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. In these diseases, TDP-43 is mislocalized, hyperphosphorylated, ubiquitinated, aggregated and cleaved. The importance of TDP-43 cleavage in the disease pathogenesis is still poorly understood. Here we detail the use of D-sorbitol as an exogenous stressor that causes TDP-43 cleavage in HeLa cells, resulting in a 35 kDa truncated product that accumulates in the cytoplasm within one hour of treatment. We confirm that the formation of this 35 kDa cleavage product is mediated by the activation of caspases. Inhibition of caspases blocks the cleavage of TDP-43, but does not prevent the accumulation of full-length protein in the cytoplasm. Using D-sorbitol as a stressor and caspase activator, we also demonstrate that the A90V variant of TDP-43, which lies adjacent to the caspase cleavage site within the nuclear localization sequence of TDP-43, confers partial resistance against caspase-mediated generation of the 35 kDa cleavage product.	[Wobst, Heike J.; Delsing, Louise; Brandon, Nicholas J.; Moss, Stephen J.] Tufts Univ, AstraZenecaTufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA; [Delsing, Louise] AstraZeneca, Discovery Sci, Innovat Med & Early Dev Biotech Unit, Molndal, Sweden; [Brandon, Nicholas J.] AstraZeneca, Neurosci, Innovat Med & Early Dev, Waltham, MA USA; [Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University; AstraZeneca; AstraZeneca; Tufts University	Moss, SJ (corresponding author), Tufts Univ, AstraZenecaTufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA.; Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu	Wobst, Heike/AAA-8276-2020	Delsing, Louise/0000-0003-2899-3801; Brandon, Nicholas/0000-0002-3917-0096	AstraZeneca; National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke [NS051195, NS056359, NS081735, R21NS080064, NS087662]; NIH-National Institute of Mental Health [MH097446, MH106954]; DOD [AR140209]	AstraZeneca(AstraZeneca); National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DOD(United States Department of Defense)	This work was supported by funding from AstraZeneca, National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke Grants NS051195, NS056359, NS081735, R21NS080064 and NS087662 (SJM) and NIH-National Institute of Mental Health Grants MH097446, MH106954 and DOD, AR140209 (SJM). AstraZeneca provided support in the form of salaries [NJB, LD]. The specific roles of authors NJB and LD are articulated in the 'author contributions' section.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Buendia B, 1999, J CELL SCI, V112, P1743; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chang HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3757; Chiang CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21581; Chiang HH, 2012, J HUM GENET, V57, P316, DOI 10.1038/jhg.2012.24; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; D'Alton S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086513; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; Ferrando-May E, 2001, CELL DEATH DIFFER, V8, P495, DOI 10.1038/sj.cdd.4400837; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ilzecka J, 2012, NEUROL SCI, V33, P825, DOI 10.1007/s10072-011-0837-4; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Ishiguro A, 2016, GENES CELLS, V21, P466, DOI 10.1111/gtc.12352; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kelley JB, 2007, MOL BIOL CELL, V18, P4365, DOI 10.1091/mbc.E07-01-0089; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kramer A, 2010, NANOMED-NANOTECHNOL, V6, P605, DOI 10.1016/j.nano.2010.04.006; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lowe AR, 2015, ELIFE, V4, DOI 10.7554/eLife.04052; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Narayanan RK, 2013, AMYOTROPH LAT SCL FR, V14, P252, DOI 10.3109/21678421.2012.734520; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strasser C, 2012, NUCLEUS-PHILA, V3, P540, DOI 10.4161/nucl.21982; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Su JH, 2000, EXP NEUROL, V163, P9, DOI 10.1006/exnr.2000.7340; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Wobst HJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00046; Wobst HJ, 2017, FRONTIERS IN MOLECUL, V10; Xiao SX, 2015, ACTA NEUROPATHOL, V130, P49, DOI 10.1007/s00401-015-1412-5; Yang Y, 2004, INT J BIOCHEM CELL B, V36, P223, DOI 10.1016/S1357-2725(03)00215-2; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	66	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177181	10.1371/journal.pone.0177181	http://dx.doi.org/10.1371/journal.pone.0177181			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510586	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500016
J	Mondejar, R; Perez, C; Onaindia, A; Martinez, N; Gonzalez-Rincon, J; Pisonero, H; Vague, JP; Cereceda, L; Santibanez, M; Sanchez-Beato, M; Piris, MA				Mondejar, Rufino; Perez, Cristina; Onaindia, Arantza; Martinez, Nerea; Gonzalez-Rincon, Julia; Pisonero, Helena; Vague, Jose Pedro; Cereceda, Laura; Santibanez, Miguel; Sanchez-Beato, Margarita; Piris, Miguel Angel			Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines	PLOS ONE			English	Article							PERIPHERAL T-CELL; ACTIVATING MUTATIONS; RECURRENT MUTATIONS; UP-REGULATION; LYMPHOMA; BORTEZOMIB; LANDSCAPE; EXPRESSION; PROGNOSIS; SURVIVAL	T and NK-cell lymphoma is a collection of aggressive disorders with unfavorable outcome, in which targeted treatments are still at a preliminary phase. To gain deeper insights into the deregulated mechanisms promoting this disease, we searched a panel of 31 representative T-cell and 2 NK-cell lymphoma/leukemia cell lines for predictive markers of response to targeted therapy. To this end, targeted sequencing was performed alongside the expression of specific biomarkers corresponding to potentially activated survival pathways. The study identified TP53, NOTCH1 and DNMT3A as the most frequently mutated genes. We also found common alterations in JAK/STAT and epigenetic pathways. Immunohistochemical analysis showed nuclear accumulation of MYC (in 85% of the cases), NFKB (62%), p-STAT (44%) and p-MAPK (30%). This panel of cell lines captures the complexity of T/NK-cell lymphoproliferative processes samples, with the partial exception of AITL cases. Integrated mutational and immunohistochemical analysis shows that mutational changes cannot fully explain the activation of key survival pathways and the resulting phenotypes. The combined integration of mutational/expression changes forms a useful tool with which new compounds may be assayed.	[Mondejar, Rufino; Perez, Cristina; Martinez, Nerea; Pisonero, Helena; Vague, Jose Pedro; Cereceda, Laura; Piris, Miguel Angel] IDIVAL, Inst Invest Marques de Valdecilla, Canc Genom Lab, Santander, Spain; [Onaindia, Arantza; Piris, Miguel Angel] Hosp Univ Marques de Valdecilla, Pathol Dept, Santander, Spain; [Gonzalez-Rincon, Julia; Sanchez-Beato, Margarita] Inst Invest Sanitaria Puerta Hierro Majadahonda I, Oncohematol Area, Med Oncol Serv, Lymphoma Res Grp, Madrid, Spain; [Vague, Jose Pedro] Univ Cantabria, Dept Biol Mol, CSIC, IBBTEC,Inst Biomed & Biotecnol Cantabria, Santander, Spain; [Santibanez, Miguel] Univ Cantabria, IDIVAL, Santander, Spain; [Piris, Miguel Angel] Fdn Jimenez Diaz, Pathol Serv, Madrid, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Universidad de Cantabria	Piris, MA (corresponding author), IDIVAL, Inst Invest Marques de Valdecilla, Canc Genom Lab, Santander, Spain.; Piris, MA (corresponding author), Hosp Univ Marques de Valdecilla, Pathol Dept, Santander, Spain.; Piris, MA (corresponding author), Fdn Jimenez Diaz, Pathol Serv, Madrid, Spain.	miguel.piris@quironsalud.es	Sanchez-Beato, Margarita/G-8753-2012; Piris, Miguel A/AAP-1445-2020; Vaqué, José P/H-8413-2015; Magunacelaya, Nerea Martinez/M-5040-2016; Gonzalez-Rincon, Julia/ABE-6664-2021; Santibanez, Miguel/L-3323-2017; CERECEDA, LAURA/K-2608-2017	Sanchez-Beato, Margarita/0000-0002-0058-7599; Piris, Miguel A/0000-0001-5839-3634; Vaqué, José P/0000-0002-3913-2495; Magunacelaya, Nerea Martinez/0000-0002-3983-0867; Santibanez, Miguel/0000-0003-2634-615X; CERECEDA, LAURA/0000-0002-0106-1898; Mondejar, Rufino/0000-0001-6641-2073	Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII and CIBER CANCER) [SAF2013-47416-R, RD06/0020/0107- RD012/0036/0060, PI16/ 01294, PIE15/0081]; SCIII-MINECO-AES-FEDER [PI14/00221]; Asociacion Espanola Contra el Cancer (AECC); ISCIII [CD13/00088]; Rio Hortega specialised healthcare post-training contract (ISCIII) [CM15/00186]; ISCIII-MINECO-AES-FEDER [IFI14/00003]; Miguel Servet contract from the ISCIII-MINECO-AES-FEDER [CP11/00018]; Miguel Servet II contract [CPII16/00024]; ISCIII-MINECO-AES-FEDER; Fundacion de Investigacion Biomedica Puerta de Hierro; Ramon y Cajal research program [RYC-2013-14097]	Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII and CIBER CANCER); SCIII-MINECO-AES-FEDER; Asociacion Espanola Contra el Cancer (AECC); ISCIII(Instituto de Salud Carlos III); Rio Hortega specialised healthcare post-training contract (ISCIII); ISCIII-MINECO-AES-FEDER; Miguel Servet contract from the ISCIII-MINECO-AES-FEDER; Miguel Servet II contract; ISCIII-MINECO-AES-FEDER; Fundacion de Investigacion Biomedica Puerta de Hierro; Ramon y Cajal research program(Spanish Government)	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII and CIBER CANCER) to MAP (SAF2013-47416-R, RD06/0020/0107- RD012/0036/0060 and Plan Nacional I+D+I: PI16/ 01294 and PIE15/0081) and from ISCIII-MINECO-AES-FEDER to MSB (Plan Estatal I+D+I 2013-2016: PI14/00221), and the Asociacion Espanola Contra el Cancer (AECC to MAP). CP is a recipient of a Sara Borrel postdoctoral contract from ISCIII (CD13/00088). RM is a recipient of a Rio Hortega specialised healthcare post-training contract (ISCIII, CM15/00186). JG-R is a recipient of an iPFIS predoctoral fellowship (IFI14/00003) from ISCIII-MINECO-AES-FEDER (Plan Estatal I+D+I 2013-2016). MSB was supported by a Miguel Servet contract (CP11/00018) from the ISCIII-MINECO-AES-FEDER (Plan Nacional I+D+I 2008-2011), and currently holds a Miguel Servet II contract (CPII16/00024), supported by ISCIII-MINECO-AES-FEDER (Plan Estatal I+D+I 2013-2016) and Fundacion de Investigacion Biomedica Puerta de Hierro. JPV was supported by a Ramon y Cajal research program (RYC-2013-14097). http://www.rticc.org/, http://www.isciii.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Abouyabis AN, 2011, ISRN HEMATOL, V2011, P623924; Aref S, 2016, CL LYMPH MYELOM LEUK, V16, P43, DOI 10.1016/j.clml.2015.11.003; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Bacher U, 2010, ANN HEMATOL, V89, P643, DOI 10.1007/s00277-010-0920-6; BENE MC, 1995, LEUKEMIA, V9, P1783; Bouchekioua A, 2014, LEUKEMIA, V28, P338, DOI 10.1038/leu.2013.157; Chang TP, 2015, J IMMUNOL, V194, P2942, DOI 10.4049/jimmunol.1402610; Choi J, 2015, NAT GENET, V47, P1011, DOI 10.1038/ng.3356; Cillessen SAGM, 2015, HAEMATOLOGICA, V100, pE365, DOI 10.3324/haematol.2014.118828; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; d'Amore F, 2015, ANN ONCOL, V26, pV108, DOI 10.1093/annonc/mdv201; Almeida ACD, 2015, NAT GENET, V47, P1465, DOI 10.1038/ng.3442; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Herranz D, 2015, NAT MED, V21, P1182, DOI 10.1038/nm.3955; Hsu FD, 2002, MODERN PATHOL, V15, P1374, DOI 10.1097/01.MP.0000039571.02827.CE; Ishitsuka K, 2015, CANCER SCI, V106, P1219, DOI 10.1111/cas.12735; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Kiel MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9470; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; Lesokhin AM, 2016, J CLIN ONCOL, V34, P2698, DOI 10.1200/JCO.2015.65.9789; Lindahl LM, 2016, ONCOTARGET, V7, P45730, DOI 10.18632/oncotarget.10160; Losdyck E, 2015, J BIOL CHEM, V290, P29022, DOI 10.1074/jbc.M115.670224; Munoz J, 2014, ONCOLOGIST, V19, P536, DOI 10.1634/theoncologist.2013-0407; Nakagawa M, 2014, J EXP MED, V211, P2497, DOI 10.1084/jem.20140987; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Odqvist L, 2013, CLIN CANCER RES, V19, P2319, DOI 10.1158/1078-0432.CCR-12-3151; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Perez C, 2015, HAEMATOLOGICA, V100, pE450, DOI 10.3324/haematol.2015.132837; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rohr J, 2016, LEUKEMIA, V30, P1062, DOI 10.1038/leu.2015.357; Rubio-Camarillo M, 2013, BIOINFORMATICS, V29, P1687, DOI 10.1093/bioinformatics/btt203; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Schmitz N, 2010, BLOOD, V116, P3418, DOI 10.1182/blood-2010-02-270785; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talamillo A, 2017, ONCOGENE, V36, P1733, DOI 10.1038/onc.2016.341; Ungewickell A, 2015, NAT GENET, V47, P1056, DOI 10.1038/ng.3370; Vallois D, 2016, BLOOD, V128, P1490, DOI 10.1182/blood-2016-02-698977; van der Wijst MGP, 2015, EPIGENETICS-US, V10, P671, DOI 10.1080/15592294.2015.1062204; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Vicente C, 2015, HAEMATOLOGICA, V100, P1301, DOI 10.3324/haematol.2015.130179; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Wang C, 2015, BLOOD, V126, P1741, DOI 10.1182/blood-2015-05-644591; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Willemze R, 2013, ANN ONCOL, V24, P149, DOI 10.1093/annonc/mdt242; Yoshida N, 2016, J PATHOL, V238, P621, DOI 10.1002/path.4699; Yuan XQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003519	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177524	10.1371/journal.pone.0177524	http://dx.doi.org/10.1371/journal.pone.0177524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505169	Green Published, gold			2022-12-27	WOS:000401473500028
J	Sradhanjali, S; Tripathy, D; Rath, S; Mittal, R; Reddy, MM				Sradhanjali, Swatishree; Tripathy, Devjyoti; Rath, Suryasnata; Mittal, Ruchi; Reddy, Mamatha M.			Overexpression of pyruvate dehydrogenase kinase 1 in retinoblastoma: A potential therapeutic opportunity for targeting vitreous seeds and hypoxic regions	PLOS ONE			English	Article							DICHLOROACETATE INDUCES APOPTOSIS; CANCER-CELLS; DRUG-RESISTANCE; COLORECTAL-CANCER; METABOLIC SWITCH; GENE-EXPRESSION; MYCN PROTEIN; IN-VITRO; GROWTH; NEUROBLASTOMA	Pyruvate dehydrogenase kinase 1 (PDK1), a key enzyme implicated in metabolic reprogramming of tumors, is induced in several tumors including glioblastoma, breast cancer and melanoma. However, the role played by PDK1 is not studied in retinoblastoma (RB). In this study, we have evaluated the expression of PDK1 in RB clinical samples, and studied its inhibition as a strategy to decrease cell growth and migration. We show that PDK1 is specifically overexpressed in RB patient samples especially in vitreous seeds and hypoxic regions and cell lines compared to control retina using immunohistochemistry and real-time PCR. Our results further demonstrate that inhibition of PDK1 using small molecule inhibitors dichloroacetic acid (DCA) and dichloroacetophenone (DAP) resulted in reduced cell growth and increased apoptosis. We also confirm that combination treatment of DCA with chemotherapeutic agent carboplatin further enhanced the therapeutic efficacy compared to single drug treatment. In addition, we observed changes in glucose uptake, lactate and reactive oxygen species (ROS) levels as well as decreased cell migration in response to PDK1 inhibition. Additionally, we show that DCA treatment led to inhibition of PI3K/Akt pathway and reduction in PDK1 protein levels. Overall, our data suggest that targeting PDK1 could be a novel therapeutic strategy for RB.	[Sradhanjali, Swatishree; Tripathy, Devjyoti; Rath, Suryasnata; Mittal, Ruchi; Reddy, Mamatha M.] LV Prasad Eye Inst, Operat Eyesight Universal Inst Eye Canc, Bhubaneswar, Orissa, India; [Sradhanjali, Swatishree; Reddy, Mamatha M.] KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India; [Tripathy, Devjyoti; Rath, Suryasnata] LV Prasad Eye Inst, Ophthalm Plast Orbit & Ocular Oncol Serv, Bhubaneswar, Orissa, India; [Mittal, Ruchi] LV Prasad Eye Inst, Dalmia Ophthalm Pathol Serv, Bhubaneswar, Orissa, India	L. V. Prasad Eye Institute; Kalinga Institute of Industrial Technology (KIIT); L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Reddy, MM (corresponding author), LV Prasad Eye Inst, Operat Eyesight Universal Inst Eye Canc, Bhubaneswar, Orissa, India.; Reddy, MM (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India.	mamathamuppidi@gmail.com			Department of Biotechnology, Government of India [BT/Bio-CARe/07/9859/2013-14]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Support was provided by Department of Biotechnology, Government of India, BT/Bio-CARe/07/9859/2013-14 for MR.	Bhanot H, 2015, LEUKEMIA, V29, P1555, DOI 10.1038/leu.2015.46; Boutrid H, 2008, INVEST OPHTH VIS SCI, V49, P2799, DOI 10.1167/iovs.08-1751; Camassei FD, 2003, INVEST OPHTH VIS SCI, V44, P2399, DOI 10.1167/iovs.02-0934; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; Chakraborty S, 2007, GENOMICS, V90, P344, DOI 10.1016/j.ygeno.2007.05.002; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chu QSC, 2015, INVEST NEW DRUG, V33, P603, DOI 10.1007/s10637-015-0221-y; Clem BF, 2012, CLIN CANCER RES, V18, P6096, DOI 10.1158/1078-0432.CCR-11-3164; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; DOU QP, 1992, P NATL ACAD SCI USA, V89, P3256, DOI 10.1073/pnas.89.8.3256; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Ganguly A, 2010, MOL VIS, V16, P1292; Gong F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.438; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Houston SK, 2011, CLIN OPHTHALMOL, V5, P129, DOI 10.2147/OPTH.S15179; Jha Mithilesh Kumar, 2013, Brain Tumor Res Treat, V1, P57, DOI 10.14791/btrt.2013.1.2.57; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Lu CW, 2011, AM J PATHOL, V179, P1405, DOI 10.1016/j.ajpath.2011.05.050; MacPherson D, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-9; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Manjandavida FP, 2015, INDIAN J OPHTHALMOL, V63, P141, DOI 10.4103/0301-4738.154390; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Olszewski U, 2010, CLIN PHARMACOL-ADV A, V2, P177, DOI 10.2147/CPAA.S11795; Pina Y, 2010, INVEST OPHTH VIS SCI, V51, P6149, DOI 10.1167/iovs.09-5033; Populo H, 2015, EXPERT OPIN THER TAR, V19, P733, DOI 10.1517/14728222.2015.1045416; Qin LJ, 2016, ONCOTARGET, V7, P1395, DOI 10.18632/oncotarget.6366; Reddy MM, 2012, LEUKEMIA, V26, P481, DOI 10.1038/leu.2011.225; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Subramanian N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070422; Sudhakar J, 2013, PEDIATR BLOOD CANCER, V60, P1598, DOI 10.1002/pbc.24599; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Xie Q, 2015, MOL MED REP, V11, P2935, DOI 10.3892/mmr.2014.3080; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang Y, 2016, J BIOL CHEM, V291, P17405, DOI 10.1074/jbc.M116.713735	43	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177744	10.1371/journal.pone.0177744	http://dx.doi.org/10.1371/journal.pone.0177744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505181	gold, Green Published, Green Submitted			2022-12-27	WOS:000401473500039
J	Thirunavukkarasu, S; Plain, KM; Purdie, AC; Whittington, RJ; de Silva, K				Thirunavukkarasu, Shyamala; Plain, Karren M.; Purdie, Auriol C.; Whittington, Richard J.; de Silva, Kumudika			IFN-gamma fails to overcome inhibition of selected macrophage activation events in response to pathogenic mycobacteria	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; NECROSIS-FACTOR-ALPHA; INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; MHC CLASS-II; NITRIC-OXIDE; CROHNS-DISEASE; TNF-ALPHA; INTERFERON-GAMMA; BOVINE MONOCYTES	According to most models of mycobacterial infection, inhibition of the pro-inflammatory macrophage immune responses contributes to the persistence of bacteria. Mycobacterium avium subsp. paratuberculosis (MAP) is a highly successful pathogen in cattle and sheep and is also implicated as the causative agent of Crohn's disease in humans. Pathogenic mycobacteria such as MAP have developed multiple strategies to evade host defence mechanisms including interfering with the macrophages' capacity to respond to IFN-gamma, a feature which might be lacking in non-pathogenic mycobacteria such as M. smegmatis. We hypothesized that pre-sensitisation of macrophages with the pro-inflammatory cytokine IFN-gamma would help in overcoming the inhibitory effect of MAP or its antigens on macrophage inflammatory responses. Herein we have compared a series of macrophage activation parameters in response to MAP and M. smegmatis as well as mycobacterial antigens. While IFN-gamma did overcome the inhibition in immune suppressive mechanisms in response to MAP antigen as well as M. smegmatis, we could not find a clear role for IFN-gamma in overcoming the inhibition of macrophage inflammatory responses to the pathogenic mycobacterium, MAP. We demonstrate that suppression of macrophage defence mechanisms by pathogenic mycobacteria is unlikely to be overcome by prior sensitization with IFN-gamma alone. This indicates that IFN-gamma signaling pathway-independent mechanisms may exist for overcoming inhibition of macrophage effector functions in response to pathogenic mycobacteria. These findings have important implications in understanding the survival mechanisms of pathogenic mycobacteria directed towards finding better therapeutics and vaccination strategies.	[Thirunavukkarasu, Shyamala; Plain, Karren M.; Purdie, Auriol C.; Whittington, Richard J.; de Silva, Kumudika] Univ Sydney, Sch Vet Sci, Fac Sci, Sydney, NSW, Australia	University of Sydney	de Silva, K (corresponding author), Univ Sydney, Sch Vet Sci, Fac Sci, Sydney, NSW, Australia.	kumi.desilva@sydney.edu.au	Thirunavukkarasu, Shyamala/AAL-5979-2020	Thirunavukkarasu, Shyamala/0000-0001-9888-3304; Purdie, Auriol/0000-0003-1941-6658; de Silva, Kumudika/0000-0001-5973-5077; Plain, Karren/0000-0001-7126-9865				ADAMS JL, 1994, MICROB PATHOGENESIS, V16, P401, DOI 10.1006/mpat.1994.1040; Alzuherri HM, 1996, VET IMMUNOL IMMUNOP, V49, P331, DOI 10.1016/0165-2427(95)05477-4; Bannantine JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128966; Begg DJ, 2010, VET MICROBIOL, V141, P301, DOI 10.1016/j.vetmic.2009.09.007; Berghaus LJ, 2010, COMP IMMUNOL MICROB, V33, P443, DOI 10.1016/j.cimid.2009.07.001; Bhat KH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39706; Bohsali A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-237; Bosshard C, 2006, J FOOD PROTECT, V69, P1662, DOI 10.4315/0362-028X-69.7.1662; Caulfield AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004252; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; CHIODINI RJ, 1984, DIGEST DIS SCI, V29, P1073, DOI 10.1007/BF01317078; CHIODINI RJ, 1984, J CLIN MICROBIOL, V20, P966, DOI 10.1128/JCM.20.5.966-971.1984; Clancy R, 2007, DIGEST LIVER DIS, V39, P445, DOI 10.1016/j.dld.2006.12.006; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; de Silva K, 2011, VET IMMUNOL IMMUNOP, V139, P10, DOI 10.1016/j.vetimm.2010.07.022; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Dhiman R, 2007, BBA-GEN SUBJECTS, V1770, P649, DOI 10.1016/j.bbagen.2006.11.016; Dow CT, 2011, MED HYPOTHESES, V77, P977, DOI 10.1016/j.mehy.2011.08.024; ENDO Y, 1991, IMMUNOL LETT, V27, P75, DOI 10.1016/0165-2478(91)90248-9; Fu YR, 2015, INT J BIOL SCI, V11, P22, DOI 10.7150/ijbs.10217; Gill CO, 2011, J FOOD PROTECT, V74, P480, DOI 10.4315/0362-028X.JFP-10-301; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Haque MF, 2015, INNATE IMMUN-LONDON, V21, P746, DOI 10.1177/1753425915594245; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Hasan Z, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-78; Held TK, 1999, INFECT IMMUN, V67, P206, DOI 10.1128/IAI.67.1.206-212.1999; Helguera-Repetto AC, 2014, BIOMED RES INT, V2014, P10; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; JURKOVICH GJ, 1991, J SURG RES, V51, P197, DOI 10.1016/0022-4804(91)90094-3; Kabara E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00215; Katti MK, 2011, ARCH MED RES, V42, P199, DOI 10.1016/j.arcmed.2011.04.012; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Lafuse WP, 2006, J INTERF CYTOK RES, V26, P548, DOI 10.1089/jir.2006.26.548; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Madan-Lala R, 2011, INFECT IMMUN, V79, P4828, DOI 10.1128/IAI.05574-11; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Mustafa T, 2001, SCAND J IMMUNOL, V54, P630, DOI 10.1046/j.1365-3083.2001.01020.x; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Naser SA, 2014, WORLD J GASTROENTERO, V20, P7403, DOI 10.3748/wjg.v20.i23.7403; Newell KN, 2006, J IMMUNE BASED THER, V4, P476; Oddo M, 1998, J IMMUNOL, V160, P5448; Okura Hisako, 2011, Vet Med Int, V2011, P152687, DOI 10.4061/2011/152687; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Park E, 2000, INT J LEPROSY, V68, P444; Periasamy S, 2013, VET MICROBIOL, V165, P392, DOI 10.1016/j.vetmic.2013.03.030; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Plain KM, 2010, VET IMMUNOL IMMUNOP, V137, P142, DOI 10.1016/j.vetimm.2010.04.002; Purdie AC, 2012, COMP IMMUNOL MICROB, V35, P151, DOI 10.1016/j.cimid.2011.12.007; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Savi R, 2015, VET MICROBIOL, V177, P403, DOI 10.1016/j.vetmic.2015.03.013; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SCHULLERLEVIS GB, 1994, INFECT IMMUN, V62, P4671, DOI 10.1128/IAI.62.10.4671-4674.1994; Sechi LA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00096; Sendide K, 2005, J IMMUNOL, V175, P5324, DOI 10.4049/jimmunol.175.8.5324; Shu DR, 2011, CLIN VACCINE IMMUNOL, V18, P1467, DOI 10.1128/CVI.05201-11; Sibartie S, 2010, INFLAMM BOWEL DIS, V16, P296, DOI 10.1002/ibd.21052; Singh S. V., 2014, Journal of Biological Sciences, V14, P237; Singh SV, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00049; Smeed Jennifer A, 2007, BMC Vet Res, V3, P18, DOI 10.1186/1746-6148-3-18; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Sweet MJ, 1998, J INTERF CYTOK RES, V18, P263, DOI 10.1089/jir.1998.18.263; Thirunavukkarasu S., 2014, CRIT REV MICROBIOL, P1; Thirunavukkarasu S, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv085; Thirunavukkarasu S, 2013, VET IMMUNOL IMMUNOP, V156, P20, DOI 10.1016/j.vetimm.2013.08.008; Trajkovic V, 2002, INFECT IMMUN, V70, P6558, DOI 10.1128/IAI.70.12.6558-6566.2002; Vadiveloo PK, 2000, CYTOKINE, V12, P1639, DOI 10.1006/cyto.2000.0766; VANKRUININGEN HJ, 1986, DIGEST DIS SCI, V31, P1351, DOI 10.1007/BF01299814; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; WADEE AA, 1995, CLIN EXP IMMUNOL, V100, P434; Wang J, 2015, NAT IMMUNOL, V16, P237, DOI 10.1038/ni.3096; Weiss DJ, 2008, AM J VET RES, V69, P804, DOI 10.2460/ajvr.69.6.804; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490; Whittington RJ, 2012, VET IMMUNOL IMMUNOP, V148, P29, DOI 10.1016/j.vetimm.2011.03.003; WILLIAMS JG, 1992, J LEUKOCYTE BIOL, V52, P579, DOI 10.1002/jlb.52.6.579; Woo SR, 2006, VET IMMUNOL IMMUNOP, V110, P109, DOI 10.1016/j.vetimm.2005.09.010	81	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176400	10.1371/journal.pone.0176400	http://dx.doi.org/10.1371/journal.pone.0176400			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505170	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500007
J	Huipao, N; Borwornpinyo, S; Wiboon-ut, S; Campbell, CR; Lee, IH; Hiranyachattada, S; Sukasem, C; Thitithanyanont, A; Pholpramool, C; Cook, DI; Dinudom, A				Huipao, Nawiya; Borwornpinyo, Suparerk; Wiboon-ut, Suwimon; Campbell, Craig R.; Lee, Il-Ha; Hiranyachattada, Siriphun; Sukasem, Chonlaphat; Thitithanyanont, Arunee; Pholpramool, Chumpol; Cook, David I.; Dinudom, Anuwat			P2Y(6) receptors are involved in mediating the effect of inactivated avian influenza virus H5N1 on IL-6 & CXCL8 mRNA expression in respiratory epithelium	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROINFLAMMATORY CYTOKINES; INTERLEUKIN-8 PRODUCTION; CFTR EXPRESSION; CELLS; INFECTION; RESPONSES; RELEASE; HYPERINDUCTION; INFLAMMATION	One of the key pathophysiologies of H5N1 infection is excessive proinflammatory cytokine response (cytokine storm) characterized by increases in IFN-beta, TNF-alpha, IL-6, CXCL10, CCL4, CCL2 and CCL5 in the respiratory tract. H5N1-induced cytokine release can occur via an infection-independent mechanism, however, detail of the cellular signaling involved is poorly understood. To elucidate this mechanism, the effect of inactivated (beta-propiolactonetreated) H5N1 on the cytokine and chemokine mRNA expression in 16HBE14o-human respiratory epithelial cells was investigated. We found that the inactivated-H5N1 increased mRNA for IL-6 and CXCL8 but not TNF-alpha, CCL5 or CXCL10. This effect of the inactivatedH5N1 was inhibited by sialic acid receptor inhibitor (alpha-2,3sialidase), adenosine diphosphatase (apyrase), P2Y receptor (P2YR) inhibitor (suramin), P2Y(6)R antagonist (MRS2578), phospholipase C inhibitor (U73122), protein kinase C inhibitors (BIM and Go E 6976) and cellpermeant Ca2+ chelator (BAPTA-AM). Inhibitors of MAPK signaling, including of ERK1/2 (PD98059), p38 MAPK (SB203580) and JNK (SP600125) significantly suppressed the inactivated-H5N1-induced mRNA expression of CXCL8. On the other hand, the inactivatedH5N1-induced mRNA expression of IL-6 was inhibited by SB203580, but not PD98059 or SP600125, whereas SN-50, an inhibitor of NF-kappa B, inhibited the effect of virus on mRNA expression of both of IL-6 and CXCL8. Taken together, our data suggest that, without infection, inactivated-H5N1 induces mRNA expression of IL-6 and CXCL8 by a mechanism, or mechanisms, requiring interaction between viral hemagglutinin and alpha-2,3 sialic acid receptors at the cell membrane of host cells, and involves activation of P2Y(6) purinergic receptors.	[Huipao, Nawiya; Hiranyachattada, Siriphun] Prince Songkla Univ, Dept Physiol, Fac Sci, Hat Yai, Thailand; [Borwornpinyo, Suparerk] Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand; [Wiboon-ut, Suwimon; Thitithanyanont, Arunee] Mahidol Univ, Dept Microbiol, Fac Sci, Bangkok, Thailand; [Campbell, Craig R.; Lee, Il-Ha; Cook, David I.; Dinudom, Anuwat] Univ Sydney, Bosch Inst, Sch Med Sci, Discipline Physiol, Sydney, NSW, Australia; [Sukasem, Chonlaphat] Mahidol Univ, Ramathibodi Hosp, Div Pharmacogen & Personalized Med, Dept Pathol,Fac Med, Bangkok, Thailand; [Pholpramool, Chumpol] Mahidol Univ, Dept Physiol, Fac Sci, Bangkok, Thailand	Prince of Songkla University; Mahidol University; Mahidol University; University of Sydney; Mahidol University; Mahidol University	Dinudom, A (corresponding author), Univ Sydney, Bosch Inst, Sch Med Sci, Discipline Physiol, Sydney, NSW, Australia.	anuwat@physiol.usyd.edu.au	Thitithanyanont, Arunee/AAN-4383-2021; Campbell, Craig R/B-5983-2012	Thitithanyanont, Arunee/0000-0002-9756-4763; Campbell, Craig R/0000-0002-0843-7579; Manopwisedjaroen, Suwimon/0000-0002-7571-8733; Borwornpinyo, Suparerk/0000-0001-6211-3615	National Health and Medical Research Council of Australia [10027447]; Mahidol University; Science Achievement Scholarship of Thailand (SAST)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Mahidol University; Science Achievement Scholarship of Thailand (SAST)	This project was supported by the National Health and Medical Research Council of Australia (Project grant number: 10027447) and, in part, by Mahidol University. NH is a recipient of the Science Achievement Scholarship of Thailand (SAST). We thank Olympus Bioimaging Center, Mahidol University, for providing equipment for confocal image studies in this project.; National Health and Medical Research Council of Australia (Project grant number: 10027447), AD & DC, no role in design, data collection, decision to publish or preparation of manuscript. Mahidol University (Seeding Grant), CP, SB & AD, no role in design, data collection, decision to publish or preparation of manuscript. Science Achievement Scholarship of Thailand (SAST), NH, no role in design, data collection, decision to publish or preparation of manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Boeynaems JM, 2005, SEMIN THROMB HEMOST, V31, P139, DOI 10.1055/s-2005-869519; Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200; Buchholz KR, 2007, INFECT IMMUN, V75, P5924, DOI 10.1128/IAI.01029-07; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cheng X, 2010, VIROLOGY, V406, P28, DOI 10.1016/j.virol.2010.06.048; Chokephaibulkit K, 2004, PEDIATR INFECT DIS J, V23, P793; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Hao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106235; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Humphries-Waa K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-549; Khine AA, 2006, BLOOD, V107, P2936, DOI 10.1182/blood-2005-06-2314; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Koch A, 2004, EUR RESPIR J, V23, P805, DOI 10.1183/09031936.04.00104304; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Lam WY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-344; Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; Londino JD, 2013, AM J PHYSIOL-LUNG C, V304, pL582, DOI 10.1152/ajplung.00314.2012; Londino JD, 2015, FASEB J, V29, P2712, DOI 10.1096/fj.14-268755; Marcet B, 2007, J CELL PHYSIOL, V211, P716, DOI 10.1002/jcp.20979; Meusel TR, 2003, J IMMUNOL, V171, P3768, DOI 10.4049/jimmunol.171.7.3768; Ohman T, 2009, J IMMUNOL, V182, P5682, DOI 10.4049/jimmunol.0803093; Paulson JC, 2013, VIRUS RES, V178, P99, DOI 10.1016/j.virusres.2013.02.015; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; PERRIN P, 1995, BIOLOGICALS, V23, P207, DOI 10.1006/biol.1995.0034; Ramos I, 2011, J VIROL, V85, P4421, DOI 10.1128/JVI.02356-10; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Satrawaha S, 2011, ARCH ORAL BIOL, V56, P1230, DOI 10.1016/j.archoralbio.2011.05.003; Sauer AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089529; Shi L, 2012, AM J RESP CELL MOL, V47, P363, DOI 10.1165/rcmb.2011-0267OC; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x; Thitithanyanont A, 2007, J IMMUNOL, V179, P5220, DOI 10.4049/jimmunol.179.8.5220; Thitithanyanont A, 2010, BIOCHEM BIOPH RES CO, V398, P752, DOI 10.1016/j.bbrc.2010.07.017; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; Uratsuji H, 2012, J IMMUNOL, V188, P436, DOI 10.4049/jimmunol.1003746; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Vogel AJ, 2014, VIRAL IMMUNOL, V27, P214, DOI 10.1089/vim.2013.0095; Wang C, 2014, CLIN INFECT DIS, V58, P1095, DOI 10.1093/cid/ciu053; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC; Wong AM, 2009, AM J RESP CELL MOL, V40, P733, DOI 10.1165/rcmb.2008-0020OC; Xing Z, 2010, J GEN VIROL, V91, P343, DOI 10.1099/vir.0.015578-0; Xu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0022900; Zeng H, 2015, J VIROL, V89, P4655, DOI 10.1128/JVI.03095-14	62	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176974	10.1371/journal.pone.0176974	http://dx.doi.org/10.1371/journal.pone.0176974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494003	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300046
J	Li, P; Bian, XY; Chen, Q; Yao, XF; Wang, XD; Zhang, WC; Tao, YJ; Jin, R; Zhang, L				Li, Ping; Bian, Xue-yan; Chen, Qing; Yao, Xiao-feng; Wang, Xu-dong; Zhang, Wen-chao; Tao, Ying-jie; Jin, Rui; Zhang, Lun			Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; ER STRESS INDUCER; CANCER; CALCIUM; STIM1; THAPSIGARGIN; METASTASIS; ACTIVATION; MIGRATION; PLAYS	Calcium signal plays an important role in a variety of cancer cell metabolism, but knowledge on its role in head and neck squamous cell carcinoma (HNSCC) is limited. Store-operated calcium entry (SOCE) is the principal Ca2+ entry mechanism that maintains calcium concentration and produces calcium signal in non-excitable cells. SOCE is triggered by stromal interaction molecule 1 (STIM1), which is located in endoplasmic reticulum (ER) as Ca2+ sensor. Although, many studies demonstrated that STIM1 and SOCE play important functions in the regulation of many cancer progressions, their clinical relevance in HNSCC remains unclear. In this study, STIM1 expression levels notably increased in 89% HNSCC tissues compared with those in adjacent normal tissues. Meanwhile, this overexpression was close associated with tumor size but not with neck lymph node metastasis. Thus, this study mainly focuses on STIM1 function in HNSCC tumor growth. Three HNSCC cell lines, namely, TSCCA (oral cancer cell line) and Hep2 (laryngeal cell line) with high STIM1 expression levels and Tb3.1 (oral cancer cell line) with STIM1 expression level lower than previous two cell lines, were selected for in vitro study. Downregulated STIM1 expression levels in TSCCA and Hep2 arrested cells in G0/G1 stages, promoted cell apoptosis, and inhibited cell proliferation. By contrast, upregulated STIM1 expression in Tb3.1 inhibited cell apoptosis and promoted cell proliferation. Induced by thapsigargin (TG), ER stress was amplified when STIM1 expression was downregulated but was attenuated as STIM1 expression was upregulated. Furthermore, TSCCA cell xenograft models confirmed that STIM1 could promote HNSCC tumor growth in vivo. The present study provides new insight into HNSCC molecular mechanism and potential therapeutic target through targeting SOCE-dependent process. However, whether STIM1 participates in HNSCC metastasis requires further study.	[Li, Ping; Bian, Xue-yan; Yao, Xiao-feng; Wang, Xu-dong; Zhang, Wen-chao; Tao, Ying-jie; Jin, Rui; Zhang, Lun] Tianjin Med Univ, Canc Inst & Hosp, Dept Maxillofacial Oncol, Tianjin, Peoples R China; [Li, Ping; Bian, Xue-yan; Yao, Xiao-feng; Wang, Xu-dong; Zhang, Wen-chao; Tao, Ying-jie; Jin, Rui; Zhang, Lun] Tianjin Med Univ, Canc Inst & Hosp, Dept Otorhinolaryngol Oncol, Tianjin, Peoples R China; [Li, Ping; Bian, Xue-yan; Chen, Qing; Yao, Xiao-feng; Wang, Xu-dong; Zhang, Wen-chao; Tao, Ying-jie; Jin, Rui; Zhang, Lun] Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Bian, Xue-yan; Chen, Qing] Tianjin Med Univ, Canc Inst & Hosp, Cardiopulm Funct Lab, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Zhang, L (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Maxillofacial Oncol, Tianjin, Peoples R China.; Zhang, L (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Otorhinolaryngol Oncol, Tianjin, Peoples R China.; Zhang, L (corresponding author), Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	zhanglun16@126.com			National Natural Science Foundation of China [31400801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (grant no: 31400801).	Andruska N, 2015, ONCOGENE, V34, P3760, DOI 10.1038/onc.2014.292; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Birkeland AC, 2015, CANCERS, V7, P2094, DOI 10.3390/cancers7040879; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Cheng HY, 2016, ONCOTARGET, V7, P16866, DOI 10.18632/oncotarget.7619; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Jardin I, 2015, BIOCH BIOPHYS ACTA; Kamiya T, 2013, J CLIN BIOCHEM NUTR, V52, P101, DOI 10.3164/jcbn.12-46; Kamiya T, 2011, FREE RADICAL RES, V45, P692, DOI 10.3109/10715762.2011.567985; Li HY, 2014, INT J CLIN EXP PATHO, V7, P7989; Li P, 2012, ANN BIOMED ENG, V40, P1874, DOI 10.1007/s10439-012-0554-z; Li WD, 2013, SCI WORLD J, DOI 10.1155/2013/587284; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; St John MA, 2015, LARYNGOSCOPE, V125, pS1, DOI 10.1002/lary.24998; Sun YH, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0608-9; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Wang JY, 2015, ONCOGENE, V34, P4358, DOI 10.1038/onc.2014.366; Wu JT, 2015, INT J CLIN EXP MED, V8, P13628; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Zhang Y, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001838; [张志镇 Zhang Zhizhen], 2015, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V34, P1	33	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177484	10.1371/journal.pone.0177484	http://dx.doi.org/10.1371/journal.pone.0177484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494008	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300118
J	Taliercio, E; Eickholt, D; Rouf, R; Carter, T				Taliercio, Earl; Eickholt, David; Rouf, Rakin; Carter, Thomas			Changes in gene expression between a soybean F-1 hybrid and its parents are associated with agronomically valuable traits	PLOS ONE			English	Article							INBRED LINES; REGISTRATION; MAIZE; HETEROSIS; GENOME; YIELD	Soybean [Glycine max (L.) Merr.] genetic diversity is limited because domesticated soybean has undergone multiple genetic bottlenecks. Its progenitor, the wild soybean [Glycine soja Siebold & Zucc], has not undergone the same intense selection and is much more genetically diverse than domesticated soybean. However, the agronomic importance of diversity in wild soybean is unclear, and its weedy nature makes assessment difficult. To address this issue, we chose for study a highly selected, adapted F-4-derived progeny of wild soybean, NMS4-44-329. This breeding line is derived from the hybridization between G. max cultivar N7103 and G. soja PI 366122. Agronomic comparisons were made among N7103, NMS4-44-329 and their F-1 and F-2 progeny in replicated yield trials at two North Carolina locations. Significant F1 mid-parent heterosis was observed at each location for seed yield (189 and 223 kgha(-1), P<0.05 and P<0.10, respectively), seed protein content (1.1g/100g, P<0.01) and protein production per hectare (101 and 100 kgha(-1), P<0.01 and P<0.06, respectively). Increased yield, seed protein content and protein production per hectare in the hybrids suggested that wild soybean has the potential to improve agronomic traits in applied breeding. Comparisons of differentially-expressed genes in the hybrid vs. parents identified genes associated with N metabolism. Non-additive changes in gene expression in the hybrids relative to the parents could reasonably explain the improved protein levels in the F1 hybrids. Changes in gene expression were influenced by environmental effects; however, allele specific bias in the hybrids were well correlated between environments. We propose that changes in gene expression, both additive and non-additive, and changes in allele specific expression bias may explain agronomic traits, and be valuable tools for plant breeders in the assessment of breeding populations.	[Taliercio, Earl; Carter, Thomas] USDA ARS, Raleigh, NC 27695 USA; [Eickholt, David; Rouf, Rakin] North Carolina State Univ, Crop & Soil Sci Dept, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University	Taliercio, E (corresponding author), USDA ARS, Raleigh, NC 27695 USA.	Earl.Taliercio@ars.usda.gov			USDA research projects [6645-21000-028-00D]	USDA research projects	Funded by USDA research projects # 6645-21000-028-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandillo N, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.04.0024; Bernard R. L., 1973, Soybeans: improvement, production and uses., P117; Bi YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114827; BROWNIE C, 1993, AGRON J, V85, P1244, DOI 10.2134/agronj1993.00021962008500060028x; Burton JW, 2006, CROP SCI, V46, P2643, DOI 10.2135/cropsci2006.03.0156; Burton JW, 2005, CROP SCI, V45, P2654, DOI 10.2135/cropsci2005.0012; Carter T. E, 2004, SOYBEANS IMPROVEMENT, V3rd, DOI DOI 10.2134/AGRONMONOGR16.3ED.C8; Carter TE, 2016, J PLANT REGIST, V10, P238, DOI 10.3198/jpr2015.09.0057crc; Carter TE, 2011, J PLANT REGIST, V5, P309, DOI 10.3198/jpr2010.09.0565crc; CARTER TE, 1995, CROP SCI, V35, P1713, DOI 10.2135/cropsci1995.0011183X003500060042x; CARTER TE, 2003, CROP SCI, V43, P1128; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Delheimer J. C., 2012, THESIS; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fernandes EH, 2015, GENET MOL RES, V14, P6509, DOI 10.4238/2015.June.12.3; Friedrichs MR, 2016, CROP SCI, V56, P2072, DOI 10.2135/cropsci2015.11.0702; Gaufichon L, 2015, PLANT AND CELL PHYSI; GIZLICE Z, 1994, CROP SCI, V34, P1143, DOI 10.2135/cropsci1994.0011183X003400050001x; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Munir S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31772; Ndhlela T, 2015, EUPHYTICA, V204, P635, DOI 10.1007/s10681-015-1353-z; Pandurangan S, 2012, J EXP BOT, V63, P3173, DOI 10.1093/jxb/ers039; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Sun XL, 2016, PLANT J, V86, P514, DOI 10.1111/tpj.13187; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Thomsen HC, 2014, TRENDS PLANT SCI, V19, P656, DOI 10.1016/j.tplants.2014.06.002; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wegary D, 2013, EUPHYTICA, V191, P205, DOI 10.1007/s10681-012-0757-2; Wilson R. F, 2004, SOYBEANS IMPROV PROD, V16, P621, DOI DOI 10.2134/AGRONMONOGR16.3ED.C13; Yang HA, 2015, THEOR APPL GENET, V128, P779, DOI 10.1007/s00122-015-2499-8; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Zhai RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060668	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177225	10.1371/journal.pone.0177225	http://dx.doi.org/10.1371/journal.pone.0177225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493991	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300075
J	Zheng, YQ; Xu, SJ; Liu, J; Zhao, Y; Liu, JX				Zheng, Yiqi; Xu, Shaojun; Liu, Jing; Zhao, Yan; Liu, Jianxiu			Genetic diversity and population structure of Chinese natural bermudagrass [Cynodon dactylon (L.) Pers.] germplasm based on SRAP markers	PLOS ONE			English	Article							SOUTHWEST CHINA; ACCESSIONS; ISSR; CULTIVARS	Bermudagrass [Cynodon dactylon (L.) Pers.], an important turfgrass used in public parks, home lawns, golf courses and sports fields, is widely distributed in China. In the present study, sequence-related amplified polymorphism (SRAP) markers were used to assess genetic diversity and population structure among 157 indigenous bermudagrass genotypes from 20 provinces in China. The application of 26 SRAP primer pairs produced 340 bands, of which 328 (96.58%) were polymorphic. The polymorphic information content (PIC) ranged from 0.36 to 0.49 with a mean of 0.44. Genetic distance coefficients among accessions ranged from 0.04 to 0.61, with an average of 0.32. The results of STRUCTURE analysis suggested that 157 bermudagrass accessions can be grouped into three subpopulations. Moreover, according to clustering based on the unweighted pair-group method of arithmetic averages (UPGMA), accessions were divided into three major clusters. The UPGMA dendrogram revealed that accessions from identical or adjacent areas were generally, but not entirely, clustered into the same cluster. Comparison of the UPGMA dendrogram and the Bayesian STRUCTURE analysis showed general agreement between the population subdivisions and the genetic relationships among accessions. Principal coordinate analysis (PCoA) with SRAP markers revealed a similar grouping of accessions to the UPGMA dendrogram and STRUCTUE analysis. Analysis of molecular variance (AMOVA) indicated that 18% of total molecular variance was attributed to diversity among subpopulations, while 82% of variance was associated with differences within subpopulations. Our study represents the most comprehensive investigation of the genetic diversity and population structure of bermudagrass in China to date, and provides valuable information for the germplasm collection, genetic improvement, and systematic utilization of bermudagrass.	[Zheng, Yiqi; Xu, Shaojun; Liu, Jing; Zhao, Yan] Henan Univ Sci & Technol, Coll Forestry, Luoyang, Henan, Peoples R China; [Liu, Jianxiu] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China	Henan University of Science & Technology	Zheng, YQ (corresponding author), Henan Univ Sci & Technol, Coll Forestry, Luoyang, Henan, Peoples R China.	yiqi214@163.com			National natural science foundation of Chinese [31101754, 31101567]	National natural science foundation of Chinese(National Natural Science Foundation of China (NSFC))	This work was supported by National natural science foundation of Chinese (Grants No. 31101754 and 31101567) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, CHINESE FLORAL ACTA, V10; Assefa S, 1999, GENOME, V42, P465, DOI 10.1139/gen-42-3-465; Babu BK, 2014, MOL BIOL REP, V41, P4329, DOI 10.1007/s11033-014-3304-5; Beard J. B., 1972, TURFGRASS SCI CULTUR; Belamkar V, 2011, GENETICA, V139, P411, DOI 10.1007/s10709-011-9556-2; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Budak H, 2004, THEOR APPL GENET, V109, P280, DOI 10.1007/s00122-004-1630-z; CAETANOANOLLES G, 1995, THEOR APPL GENET, V91, P228, DOI 10.1007/BF00220882; Chen HL, 2015, GENE, V566, P175, DOI 10.1016/j.gene.2015.04.043; De Riek J, 2001, THEOR APPL GENET, V103, P1254, DOI 10.1007/s001220100710; Etemadi N., 2006, International Journal of Agriculture and Biology, V8, P198; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farsani TM, 2012, INT J MOL SCI, V13, P383, DOI 10.3390/ijms13010383; Ganesh S. K., 1995, Madras Agricultural Journal, V82, P263; Gulsen O, 2009, THEOR APPL GENET, V118, P1309, DOI 10.1007/s00122-009-0982-9; Hamrick J.L., 1983, GENETICS CONSERVATIO, P335, DOI DOI 10.1111/J.1471-8286.2004.00845.X; HARLAN J R, 1970, East African Agricultural and Forestry Journal, V36, P220; HARLAN J. R., 1970, Herbage Abstracts, V40, P233; HARLAN JR, 1969, CROP SCI, V9, P774, DOI 10.2135/cropsci1969.0011183X000900060031x; HARLAN JR, 1970, CROP SCI, V10, P288, DOI 10.2135/cropsci1970.0011183X001000030023x; HARLAN JR, 1970, EUPHYTICA, V19, P465, DOI 10.1007/BF01902921; Huang CQ, 2010, BIOCHEM SYST ECOL, V38, P993, DOI 10.1016/j.bse.2010.09.013; Huang CQ, 2014, INT J MOL SCI, V15, P19134, DOI 10.3390/ijms151019134; Juyo D, 2015, CROP SCI, V55, P760, DOI 10.2135/cropsci2014.07.0524; Kang SY, 2008, MOL CELLS, V25, P163; KNEEBONE W. R., 1967, Progress in Agriculture, Arizona, V19, P4; Li HY, 2011, SCI HORTIC-AMSTERDAM, V127, P555, DOI 10.1016/j.scienta.2010.12.001; Liang W, 2015, PLANT MOL BIOL REP, V33, P458, DOI 10.1007/s11105-014-0754-9; Ling Y, 2015, GENET MOL RES, V14, P1748, DOI 10.4238/2015.March.13.1; Ling Y, 2012, GENET MOL RES, V11, P4598, DOI 10.4238/2012.October.17.5; Linos A, 2014, SCI HORTIC-AMSTERDAM, V175, P33, DOI 10.1016/j.scienta.2014.05.034; Liu KJ, 2003, GENETICS, V165, P2117; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; MANTEL N, 1967, CANCER RES, V27, P209; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; RICHARDSON WL, 1978, CROP SCI, V18, P332, DOI 10.2135/cropsci1978.0011183X001800020035x; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; SOKAL RR, 1979, SYST ZOOL, V28, P227, DOI 10.2307/2412528; Tamaki I, 2014, TREE GENET GENOMES, V10, P989, DOI 10.1007/s11295-014-0737-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Wang ZY, 2013, BIOCHEM SYST ECOL, V46, P108, DOI 10.1016/j.bse.2012.09.001; Wang ZY, 2009, SCI HORTIC-AMSTERDAM, V122, P461, DOI 10.1016/j.scienta.2009.05.031; Wu YQ, 2006, CROP SCI, V46, P917, DOI 10.2135/cropsci2005.08.0256; Wu YQ, 2004, GENOME, V47, P689, DOI 10.1139/G04-032; Xie Y, 2015, PLANT SOIL, V390, P307, DOI 10.1007/s11104-015-2391-y; Yerramsetty PN, 2005, CROP SCI, V45, P772, DOI 10.2135/cropsci2005.0772; Zhang CM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0809-y; Zhang LH, 1999, THEOR APPL GENET, V98, P895, DOI 10.1007/s001220051148; Zong JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137528	54	28	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177508	10.1371/journal.pone.0177508	http://dx.doi.org/10.1371/journal.pone.0177508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493962	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300124
J	Bhamla, MS; Chai, C; Alvarez-Valenzuela, MA; Tajuelo, J; Fuller, GG				Bhamla, M. Saad; Chai, Chew; Alvarez-Valenzuela, Marco A.; Tajuelo, Javier; Fuller, Gerald G.			Interfacial mechanisms for stability of surfactant-laden films	PLOS ONE			English	Article							MARGINAL REGENERATION; ASYMMETRIC DRAINAGE; THIN; MODEL; DEPOSITION; FLOW	Thin liquid films are central to everyday life. They are ubiquitous in modern technology (pharmaceuticals, coatings), consumer products (foams, emulsions) and also serve vital biological functions (tear film of the eye, pulmonary surfactants in the lung). A common feature in all these examples is the presence of surface-active molecules at the air-liquid interface. Though they form only molecular-thin layers, these surfactants produce complex surface stresses on the free surface, which have important consequences for the dynamics and stability of the underlying thin liquid film. Here we conduct simple thinning experiments to explore the fundamental mechanisms that allow the surfactant molecules to slow the gravity-driven drainage of the underlying film. We present a simple model that works for both soluble and insoluble surfactant systems in the limit of negligible adsorption-desorption dynamics. We show that surfactants with finite surface rheology influence bulk flow through viscoelastic interfacial stresses, while surfactants with inviscid surfaces achieve stability through opposing surface-tension induced Marangoni flows.	[Bhamla, M. Saad] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chai, Chew; Fuller, Gerald G.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Alvarez-Valenzuela, Marco A.] Univ Carlos III Madrid, Dept Mech Engn, Leganes 28911, Spain; [Tajuelo, Javier] Univ Nacl Educ Distancia, Dept Fis Fundamental, Madrid 28040, Spain	Stanford University; Stanford University; Universidad Carlos III de Madrid; Universidad Nacional de Educacion a Distancia (UNED)	Bhamla, MS (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	saadbhamla@gmail.com	Bhamla, M. Saad/L-3174-2013; Bhamla, Saad/K-8398-2019	Bhamla, M. Saad/0000-0002-9788-9920; Bhamla, Saad/0000-0002-9788-9920; Tajuelo, Javier/0000-0002-4085-7610; Fuller, Gerald/0000-0002-2924-053X	UNED's Researchers Formation Program; MINECO [FIS2013-47350-C5-5-R]	UNED's Researchers Formation Program; MINECO(Spanish Government)	The authors received no specific funding for this work. However, J.T. acknowledges a personal grant from UNED's Researchers Formation Program and partial support from MINECO (Grant FIS2013-47350-C5-5-R).; The authors would like to thank Daniele Tammaro and John Frostad for useful discussions. J. T. acknowledges a grant from UNED's Researchers Formation Program and partial support from MINECO (Grant FIS2013-47350-C5-5-R).	Anton N, 2013, SOFT MATTER, V9, P10081, DOI 10.1039/c3sm51688a; Behera MR, 2014, IND ENG CHEM RES, V53, P18497, DOI 10.1021/ie503591v; Bhamla MS, 2015, J COLLOID INTERF SCI, V449, P428, DOI 10.1016/j.jcis.2015.01.002; Bhamla MS, 2014, SOFT MATTER, V10, P6917, DOI 10.1039/c3sm52934g; Bird JC, 2010, NATURE, V465, P759, DOI 10.1038/nature09069; Choi SQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1321; Cooper A, 2010, BIOPHYS CHEM, V151, P96, DOI 10.1016/j.bpc.2010.06.006; Debregeas G, 1998, SCIENCE, V279, P1704, DOI 10.1126/science.279.5357.1704; Feng J, 2014, NAT PHYS, V10, P606, DOI 10.1038/NPHYS3003; Hermans E, 2015, SOFT MATTER, V11, P8048, DOI 10.1039/c5sm01603g; Hermans E, 2014, SOFT MATTER, V10, P175, DOI 10.1039/c3sm52091a; HUDALES JBM, 1990, J COLLOID INTERF SCI, V138, P354, DOI 10.1016/0021-9797(90)90218-D; JOYE JL, 1994, LANGMUIR, V10, P3174, DOI 10.1021/la00021a046; Joye JL, 1996, J COLLOID INTERF SCI, V177, P542, DOI 10.1006/jcis.1996.0068; Kim K, 2013, P NATL ACAD SCI USA, V110, pE3054, DOI 10.1073/pnas.1303304110; Leal L, 2007, ADV TRANSPORT PHENOM, V1st; LYKLEMA J, 1965, J PHYS CHEM-US, V69, P116, DOI 10.1021/j100885a018; MYSELS KJ, 1962, J COLL SCI IMP U TOK, V17, P136, DOI 10.1016/0095-8522(62)90004-1; Naire S, 2000, J COLLOID INTERF SCI, V230, P91, DOI 10.1006/jcis.2000.7081; Naire S, 2004, J COMPUT APPL MATH, V166, P385, DOI 10.1016/j.cam.2003.08.039; Naire S, 2001, PHYS FLUIDS, V13, P2492, DOI 10.1063/1.1388540; Nierstrasz VA, 2001, J COLLOID INTERF SCI, V234, P162, DOI 10.1006/jcis.2000.7290; Nierstrasz VA, 1999, J COLLOID INTERF SCI, V215, P28, DOI 10.1006/jcis.1999.6226; Nierstrasz VA, 1998, J COLLOID INTERF SCI, V207, P209, DOI 10.1006/jcis.1998.5646; NIKOLOV AD, 1990, PROG COLL POL SCI S, V82, P87; Patist A, 2001, COLLOID SURFACE A, V176, P3, DOI 10.1016/S0927-7757(00)00610-5; RADOEV BP, 1983, J COLLOID INTERF SCI, V95, P254, DOI 10.1016/0021-9797(83)90094-2; Ramdane OO, 1997, LANGMUIR, V13, P2911; Shen AQ, 2002, PHYS FLUIDS, V14, P4055, DOI 10.1063/1.1512287; STEBE KJ, 1991, PHYS FLUIDS A-FLUID, V3, P3, DOI 10.1063/1.857862; STEIN HN, 1991, ADV COLLOID INTERFAC, V34, P175, DOI 10.1016/0001-8686(91)80050-T; Sureshbabu N, 2009, EUR BIOPHYS J BIOPHY, V38, P355, DOI 10.1007/s00249-008-0379-8; Zell ZA, 2014, P NATL ACAD SCI USA, V111, P3677, DOI 10.1073/pnas.1315991111	33	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175753	10.1371/journal.pone.0175753	http://dx.doi.org/10.1371/journal.pone.0175753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520734	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700007
J	Anderson, DJ; Rojas, LF; Watson, S; Knelson, LP; Pruitt, S; Lewis, SS; Moehring, RW; Bennett, EES; Weber, DJ; Chen, LF; Sexton, DJ				Anderson, Deverick J.; Rojas, Leoncio Flavio; Watson, Shera; Knelson, Lauren P.; Pruitt, Sohayla; Lewis, Sarah S.; Moehring, Rebekah W.; Bennett, Emily E. Sickbert; Weber, David J.; Chen, Luke F.; Sexton, Daniel J.		CDC Prevention Epicenters Program	Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HOSPITAL-ONSET; PCR RIBOTYPES; SWINE; DENSITY; OPERATIONS; ADMISSION; TIME; AIR		[Anderson, Deverick J.; Lewis, Sarah S.; Moehring, Rebekah W.; Chen, Luke F.; Sexton, Daniel J.] Duke Univ, Dept Med, Durham, NC USA; [Anderson, Deverick J.; Rojas, Leoncio Flavio; Watson, Shera; Knelson, Lauren P.; Lewis, Sarah S.; Moehring, Rebekah W.; Chen, Luke F.; Sexton, Daniel J.] Duke Univ, Duke Ctr Antimicrobial Stewardship & Infect Preve, Durham, NC 27706 USA; [Knelson, Lauren P.] Dana Farber Canc Inst, Breast Oncol Program, Susan F Smith Ctr Womens Canc, Boston, MA 02115 USA; [Pruitt, Sohayla] Duke Hlth Technol Solut, Durham, NC USA; [Pruitt, Sohayla] Forecast Hlth, Durham, NC USA; [Moehring, Rebekah W.] Durham VA Med Ctr, Durham, NC USA; [Bennett, Emily E. Sickbert; Weber, David J.] Univ North Carolina Chapel Hill, Dept Hosp Epidemiol, Chapel Hill, NC USA	Duke University; Duke University; Harvard University; Dana-Farber Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Anderson, DJ (corresponding author), Duke Univ, Dept Med, Durham, NC USA.; Anderson, DJ (corresponding author), Duke Univ, Duke Ctr Antimicrobial Stewardship & Infect Preve, Durham, NC 27706 USA.	dja@duke.edu		Anderson, Deverick/0000-0001-6882-5496; Sexton, Daniel J/0000-0001-9604-5948	CDC Prevention Epicenters Program [U54CK000164]; National Center for Advancing Translational Sciences (NCATS); National Institutes of Health [UL1TR001111]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023866] Funding Source: NIH RePORTER	CDC Prevention Epicenters Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the CDC Prevention Epicenters Program [U54CK000164] and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1TR001111]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the CDC.	Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940; Auguet OT, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001944; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bondo KJ, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0563-x; Carrel M, 2014, INFECT CONT HOSP EP, V35, P190, DOI 10.1086/674860; Casey JA, 2013, JAMA INTERN MED, V173, P1980, DOI 10.1001/jamainternmed.2013.10408; Centers for Disease Control and Prevention, ANTIBIOTIC RESISTANC; Centers for Disease Control and Prevention, MULT RES ORG CLOSTR; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dubberke ER, 2011, INFECT CONT HOSP EP, V32, P360, DOI 10.1086/658944; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Hopman NEM, 2011, VET MICROBIOL, V149, P186, DOI 10.1016/j.vetmic.2010.10.013; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Keessen EC, 2013, EMERG INFECT DIS, V19, P1032, DOI 10.3201/eid1906.121645; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Kwon JH, 2015, INFECT DIS CLIN N AM, V29, P123, DOI 10.1016/j.idc.2014.11.003; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Love DC, 2011, ENVIRON HEALTH PERSP, V119, P279, DOI 10.1289/ehp.1002625; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Naggie S, 2011, AM J MED, V124, P276, DOI 10.1016/j.amjmed.2010.10.013; Pelaez T, 2013, ANAEROBE, V22, P45, DOI 10.1016/j.anaerobe.2013.05.009; Pepin J, 2012, J INFECTION, V64, P387, DOI 10.1016/j.jinf.2011.12.011; Rodriguez-Palacios A, 2007, EMERG INFECT DIS, V13, P485, DOI 10.3201/eid1303.060988; Rodriguez-Palacios A, 2006, EMERG INFECT DIS, V12, P1730, DOI 10.3201/eid1211.051581; Schinasi L, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-54; Schneeberg A, 2012, ANAEROBE, V18, P484, DOI 10.1016/j.anaerobe.2012.08.002; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Tabak YP, 2015, INFECT CONT HOSP EP, V36, P695, DOI 10.1017/ice.2015.37; US Census Bureau, US CENS BUR CENS TRA; US Census Bureau, AM COMM SURV 2014; US Census Bureau, DAT WEB DATAFERRETT; Weese JS, 2010, CLIN MICROBIOL INFEC, V16, P3, DOI 10.1111/j.1469-0691.2009.03108.x; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; Zidaric V, 2008, ANAEROBE, V14, P325, DOI 10.1016/j.anaerobe.2008.10.001	42	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176285	10.1371/journal.pone.0176285	http://dx.doi.org/10.1371/journal.pone.0176285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510584	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500005
J	Magnusson, K; Holte, KB; Juel, NG; Brox, JI; Hagen, KB; Haugen, IK; Berg, TJ				Magnusson, Karin; Holte, Kristine Bech; Juel, Niels Gunnar; Brox, Jens Ivar; Hagen, Kare Birger; Haugen, Ida Kristin; Berg, Tore Julsrud			Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features - The Dialong hand study	PLOS ONE			English	Article							METABOLIC FACTORS; DISEASE; PROGRESSION; POPULATION; PREVALENCE; PHENOTYPE; ARTHROSIS; WEIGHT	Objective To explore whether having long-term type 1 diabetes (>45 years) is associated with a higher prevalence of radiographic hand OA, erosive hand OA and increased hand pain, disability and stiffness. Methods In total N = 96 persons with type 1 diabetes diagnosed before 1970 were included (mean [SD] age: 62.2 [7.4], mean [SD] HbA(1c): 7.43 [0.80] and N = 49 [51%] men). Regular measurements of their HbA1c were obtained till 2015. We included N = 69 healthy controls without any diabetes (mean [SD] age: 63.0 [7.0], mean [SD] HbA1c: 5.41 [0.32], N = 29 [42%] men). The groups were compared for radiographic hand OA (Kellgren-Lawrence grade >= 2 in >= 1 joint) and erosive hand OA (central erosions in >= 1 joint), Australian/Canadian index (AUSCAN) for hand pain, disability and stiffness using regression analyses adjusted for age, sex, educational level and waist circumference. Results We found no associations between having long term type 1 diabetes and more prevalent radiographic hand OA (OR = 0.83, 95% CI = 0.38-1.81). We found a trend towards higher prevalence of erosive hand OA in diabetes patients (OR = 2.96, 95% CI = 0.82-10.64). Strong and consistent associations were observed between long term type 1 diabetes and increased hand pain (B = 2.78, 95% CI = 1.65-3.91), disability (B = 5.30, 95% CI = 3.48-7.12) and stiffness (B = 2.00, 95% CI = 1.330-2.67). These associations were particularly strong for women and participants below the median age of 61 years. Conclusion Long-term type 1 diabetes was not associated with radiographic hand OA, but was strongly associated with hand pain, disability and stiffness. The association between diabetes and erosive hand OA warrants further investigation.	[Magnusson, Karin; Hagen, Kare Birger] Diakonhjemmet Hosp, Dept Rheumatol, Natl Advisory Unit Rehabil Rheumatol, Oslo, Norway; [Magnusson, Karin] Lund Univ, Dept Clin Sci Lund, Clin Epidemiol Unit, Orthopaed, Lund, Sweden; [Holte, Kristine Bech; Berg, Tore Julsrud] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Juel, Niels Gunnar; Brox, Jens Ivar] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Brox, Jens Ivar; Haugen, Ida Kristin] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [Berg, Tore Julsrud] Norwegian Diabet Ctr, Oslo, Norway; [Berg, Tore Julsrud] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway	Diakonhjemmet Hospital; Lund University; University of Oslo; University of Oslo; Diakonhjemmet Hospital; University of Oslo	Magnusson, K (corresponding author), Diakonhjemmet Hosp, Dept Rheumatol, Natl Advisory Unit Rehabil Rheumatol, Oslo, Norway.; Magnusson, K (corresponding author), Lund Univ, Dept Clin Sci Lund, Clin Epidemiol Unit, Orthopaed, Lund, Sweden.	magnusson_karin@outlook.com	Brox, Jens Ivar/N-1601-2018	Magnusson, Karin/0000-0003-4851-5794; Haugen, Ida Kristin/0000-0001-7810-2216	South-Eastern Norway Regional Health Authority; Oslo Diabetes Research Centre/Oslo University Hospital; Norwegian Diabetics' Centr research fund; Odd Fellow Research Fund; Norwegian Diabetes Association; Blix Family Foundation	South-Eastern Norway Regional Health Authority; Oslo Diabetes Research Centre/Oslo University Hospital; Norwegian Diabetics' Centr research fund; Odd Fellow Research Fund; Norwegian Diabetes Association; Blix Family Foundation	The data collection of the Dialong study has been funded from different sources through the Oslo Diabetes Research Centre/Oslo University Hospital, The Norwegian Diabetics' Centr research fund, the Odd Fellow Research Fund, The Norwegian Diabetes Association, and the Blix Family Foundation. The corresponding author (KM) was funded by the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1991, PRACTICAL STAT MED R, P440; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Banon S, 2013, Scand J Rheumatol, V42, P1, DOI 10.3109/03009742.2012.713983; BELLAMY N, 2007, INT MED J S2, V37, pA36; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Cleary PA, 2013, DIABETES TECHNOL THE, V15, P466, DOI 10.1089/dia.2012.0316; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Felson DT, 2013, OSTEOARTHR CARTILAGE, V21, P10, DOI 10.1016/j.joca.2012.09.012; Felson DT, 2004, ARTHRITIS RHEUM, V50, P3904, DOI 10.1002/art.20726; Frey N, 2016, OSTEOARTHRITIS CARTI; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Haugen IK, 2016, OSTEOARTHR CARTILAGE, V24, P647, DOI 10.1016/j.joca.2015.11.014; Haugen IK, 2015, ANN RHEUM DIS, V74, P74, DOI 10.1136/annrheumdis-2013-203789; Haugen IK, 2011, ANN RHEUM DIS, V70, P1581, DOI 10.1136/ard.2011.150078; Hopstock LA, 2015, HYPERTENSION, V66, P496, DOI 10.1161/HYPERTENSIONAHA.115.05925; JAMES TM, 1981, CLIN BIOCHEM, V14, P25, DOI 10.1016/0009-9120(81)90135-1; Jensen V, 1999, OCCUP MED-OXFORD, V49, P383, DOI 10.1093/occmed/49.6.383; Jungmann PM, 2013, ARTHRIT CARE RES, V65, P1942, DOI 10.1002/acr.22093; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kujala U M, 1999, Twin Res, V2, P196, DOI 10.1375/136905299320565861; Louati K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000077; Magnusson K, 2015, ARTHRIT CARE RES, V67, P187, DOI 10.1002/acr.22460; Marshall M, 2013, OSTEOARTHR CARTILAGE, V21, P1674, DOI 10.1016/j.joca.2013.08.004; NOKLUS, NAT NORW DIAB REG AN; Slatkowsky-Christensen B, 2005, OSTEOARTHR CARTILAGE, V13, P561, DOI 10.1016/j.joca.2005.02.013; Yusuf E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3894; Yusuf E, 2010, ANN RHEUM DIS, V69, P761, DOI 10.1136/ard.2008.106930	28	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177118	10.1371/journal.pone.0177118	http://dx.doi.org/10.1371/journal.pone.0177118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510594	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500013
J	Qu, XL; Hei, Y; Kang, L; Yang, XJ; Wang, Y; Lu, XZ; Xiao, LH; Yang, G				Qu, Xiao-Li; Hei, Yan; Kang, Li; Yang, Xin-Ji; Wang, Yi; Lu, Xiao-Zhong; Xiao, Li-Hua; Yang, Guang			Establishment of a combination scoring method for diagnosis of ocular adnexal lymphoproliferative disease	PLOS ONE			English	Article							REACTIVE LYMPHOID HYPERPLASIA; FOLLICULAR DENDRITIC CELLS; NON-HODGKIN-LYMPHOMA; MALT LYMPHOMA; HELICOBACTER-PYLORI; CLINICOPATHOLOGICAL FEATURES; MALIGNANT-LYMPHOMA; GERMINAL-CENTERS; DISORDERS; ORBIT	Lymphoproliferative diseases (LPDs) of the ocular adnexa encompass the majority of orbital diseases and include reactive follicular hyperplasia (RFH), atypical lymphoid hyperplasia (ALH), and mucosa-associated lymphoid tissue lymphoma (MALToma). Lymphoid follicles (LFs) are usually observed during the histological examination of LPDs. Currently, because there is a lack of specific clinical signs and diagnostic immunohistochemical biomarkers, it is difficult for pathologists to distinguish MALToma from ocular RFH and ALH, which makes the clinical management of these conditions difficult. Here, we analyzed the clinical features of patients with ocular adnexal LPDs (n = 125) and investigated the structure of LFs in paraffin-embedded tissue samples using anti-CD23 and anti-IgD immunochemistry. We found that some clinical features including age, sex, and laterality were different among RFH, LFH, and MALToma. Additionally, immunohistochemistry revealed that the expression of IgD and CD23 was higher in RFH patients and decreased in patients with ALH and MALToma. Moreover, LFs in RFH were intact, whereas the structures of most LFs were disrupted in ALH. In MALToma specimens, few intact LFs were observed. In a further investigation, we combined the results for CD23/IgD immunohistochemistry and the structure of LFs to establish a scoring method for the differential diagnosis of LPDs. According to the BIOMED-2 protocol, we further detected IgH gene monoclonal rearrangement in 73 cases (35 RFH, 17 ALH, and 21 MALToma cases). The sensitivity of our scoring method, based on a comparison with the results of IgH gene monoclonal rearrangement detection, was 85.7% (18/21) for MALToma and 35.3% (6/17) for ALH. Our study provides a method that may be useful for the differential diagnosis of RFH, ALH, and MALToma.	[Qu, Xiao-Li] Qianfoshan Hosp, Ophthalmol Dept, Jinan, Shandong, Peoples R China; [Hei, Yan; Kang, Li; Yang, Xin-Ji; Wang, Yi; Lu, Xiao-Zhong; Xiao, Li-Hua] Gen Hosp Chinese Peoples Armed Police Forces, Inst Orbital Dis, Beijing, Peoples R China; [Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Academy of Military Medical Sciences - China	Xiao, LH (corresponding author), Gen Hosp Chinese Peoples Armed Police Forces, Inst Orbital Dis, Beijing, Peoples R China.; Yang, G (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	xiaolihuawj@sina.com; yanggg@hotmail.com			General Hospital of Chinese People's Armed Police Forces [WZ2011001]	General Hospital of Chinese People's Armed Police Forces	The study was supported by the General Hospital of Chinese People's Armed Police Forces (WZ2011001). The funder had no role in study design, data collection an danalysis,decisionto publish,or preparation of the manuscript.	Al-Mujaini A, 2012, MIDDLE EAST AFR J OP, V19, P406, DOI 10.4103/0974-9233.102760; Aljurf MA, 2003, ANN ONCOL, V14, P1595, DOI 10.1093/annonc/mdg442; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Bilal JA, 2014, SAUDI MED J, V35, P699; Cahill M, 1999, BRIT J OPHTHALMOL, V83, P742, DOI 10.1136/bjo.83.6.742; Cai JP, 2012, MED SCI MONITOR, V18, pBR84, DOI 10.12659/MSM.882462; Collina F, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-8; Coupland SE, 2011, HISTOPATHOLOGY, V58, P69, DOI 10.1111/j.1365-2559.2010.03706.x; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Demirci H, 2002, OPHTHALMOLOGY, V109, P243, DOI 10.1016/S0161-6420(01)00932-0; Dong B, 2005, WORLD J GASTROENTERO, V11, P3595, DOI 10.3748/wjg.v11.i23.3595; Fujihara M, 2010, PATHOL INT, V60, P642, DOI 10.1111/j.1440-1827.2010.02574.x; Fukuhara J, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-194; GARNER A, 1983, BRIT J OPHTHALMOL, V67, P561, DOI 10.1136/bjo.67.9.561; GARNER A, 1992, BRIT J OPHTHALMOL, V76, P47, DOI 10.1136/bjo.76.1.47; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Good DJ, 2009, HEMATOL ONCOL CLIN N, V23, P729, DOI 10.1016/j.hoc.2009.04.005; Hamel KM, 2012, AUTOIMMUNITY, V45, P333, DOI 10.3109/08916934.2012.665524; Herwig MC, 2012, ACTA OPHTHALMOL, V90, pE331, DOI 10.1111/j.1755-3768.2011.02285.x; Hoshida Y, 2004, INT J CANCER, V108, P443, DOI 10.1002/ijc.11582; ISAACSON P, 1984, CANCER, V53, P2515, DOI 10.1002/1097-0142(19840601)53:11<2515::AID-CNCR2820531125>3.0.CO;2-C; Isaacson P G, 2003, Verh Dtsch Ges Pathol, V87, P116; Isaacson PG, 2005, BEST PRACT RES CL HA, V18, P57, DOI 10.1016/j.beha.2004.08.003; ISAACSON PG, 1990, HISTOPATHOLOGY, V16, P617, DOI 10.1111/j.1365-2559.1990.tb01173.x; Jin MK, 2011, HISTOPATHOLOGY, V58, P586, DOI 10.1111/j.1365-2559.2011.03779.x; Kasajima-Akatsuka N, 2006, HISTOCHEM CELL BIOL, V126, P261, DOI 10.1007/s00418-006-0157-6; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; KNOWLES DM, 1990, HUM PATHOL, V21, P959, DOI 10.1016/0046-8177(90)90181-4; Kojima M, 2005, INT J SURG PATHOL, V13, P267, DOI 10.1177/106689690501300306; Langerak AW, 1997, LEUKEMIA, V11, P2192, DOI 10.1038/sj.leu.2400887; Lee Jee-Young, 2005, J Clin Neurol, V1, P8, DOI 10.3988/jcn.2005.1.1.8; Li EY, 2015, ASIA-PAC J OPHTHALMO, V4, P106, DOI 10.1097/APO.0000000000000102; Maeda K, 2002, J HISTOCHEM CYTOCHEM, V50, P1475, DOI 10.1177/002215540205001107; Mannami T, 2001, MODERN PATHOL, V14, P641, DOI 10.1038/modpathol.3880366; MEDEIROS LJ, 1989, AM J SURG PATHOL, V13, P459, DOI 10.1097/00000478-198906000-00002; MURRAY PG, 1991, J PATHOL, V165, P125, DOI 10.1002/path.1711650207; NERI A, 1987, BLOOD, V70, P1519; NGUYEN DT, 1994, HISTOPATHOLOGY, V24, P437, DOI 10.1111/j.1365-2559.1994.tb00552.x; O'Malley DP, 2013, SEMIN DIAGN PATHOL, V30, P137, DOI 10.1053/j.semdp.2012.08.007; Oh DE, 2007, ARCH OPHTHALMOL-CHIC, V125, P1668, DOI 10.1001/archopht.125.12.1668; Pereira MI, 2014, WORLD J GASTROENTERO, V20, P684, DOI 10.3748/wjg.v20.i3.684; Piccaluga PP, 2011, ADV HEMATOL; Ponzoni M, 2013, ONCOLOGIST, V18, P876, DOI 10.1634/theoncologist.2012-0425; Rezk M, 2013, EXPERT REV HEMATOL, V6, P139, DOI [10.1586/ehm.13.4, 10.1586/EHM.13.4]; SCHROER KR, 1979, CANCER, V44, P1155, DOI 10.1002/1097-0142(197909)44:3<1155::AID-CNCR2820440354>3.0.CO;2-C; Shi Yun-fei, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P222, DOI 10.3760/cma.j.issn.0529-5807.2013.04.003; Stefanovic A, 2009, BLOOD, V114, P501, DOI 10.1182/blood-2008-12-195453; Ting DS, 2015, EYE LOND; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VANDERGAAG R, 1984, BRIT J OPHTHALMOL, V68, P892, DOI 10.1136/bjo.68.12.892; Verma V, 2008, SURV OPHTHALMOL, V53, P312, DOI 10.1016/j.survophthal.2008.04.008; Wang Qian, 2010, Chinese Journal of Pathology, V39, P296, DOI 10.3760/cma.j.issn.0529-5807.2010.05.003; Wilson J B, 1992, Curr Top Microbiol Immunol, V182, P375; Witkowska M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/523170; Zotos D, 2012, TRENDS IMMUNOL, V33, P281, DOI 10.1016/j.it.2012.04.003; Zucca E, 1998, NEW ENGL J MED, V338, P804, DOI 10.1056/NEJM199803193381205	56	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0160175	10.1371/journal.pone.0160175	http://dx.doi.org/10.1371/journal.pone.0160175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510589	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500001
J	Reardon, C; Tobin, DP; Tierney, P; Delahunt, E				Reardon, Cillian; Tobin, Daniel P.; Tierney, Peter; Delahunt, Eamonn			The worst case scenario: Locomotor and collision demands of the longest periods of gameplay in professional rugby union	PLOS ONE			English	Article							HIGH-INTENSITY EXERCISE; PHYSICAL DEMANDS; ELITE; RELIABILITY; VALIDITY; STRENGTH; PLAYERS; POWER; ACCELERATION; POSITION	A number of studies have used global positioning systems (GPS) to report on positional differences in the physical game demands of rugby union both on an average and singular bout basis. However, the ability of these studies to report quantitative data is limited by a lack of validation of certain aspects of measurement by GPS micro-technology. Furthermore no study has analyzed the positional physical demands of the longest bouts of ball-in-play time in rugby union. The aim of the present study is to compare the demands of the single longest period of ball-in-play, termed "worst case scenario" (WCS) between positional groups, which have previously been reported to have distinguishable game demands. The results of this study indicate that WCS periods follow a similar sporadic pattern as average demands but are played at a far higher pace than previously reported for average game demands with average meters per minute of 116.8 m. The positional differences in running and collision activity previously reported are perpetuated within WCS periods. Backs covered greater total distances than forwards (318 m vs 289 m), carried out more high-speed running (11.1 m.min(-1) vs 5.5 m.min(-1)) and achieved higher maximum velocities (MaxVel). Outside Backs achieved the highest MaxVel values (6.84 m.sec(-1)). Tight Five and Back Row forwards underwent significantly more collisions than Inside Back and Outside Backs (0.73 & 0.89 collisions.min(-1) vs 0.28 & 0.41 collisions.min(-1) respectively). The results of the present study provide information on the positional physical requirements of performance in prolonged periods involving multiple high intensity bursts of effort. Although the current state of GPS micro-technology as a measurement tool does not permit reporting of collision intensity or acceleration data, the combined use of video and GPS provides valuable information to the practitioner. This can be used to match and replicate game demands in training.	[Reardon, Cillian; Tobin, Daniel P.; Tierney, Peter] Leinster Rugby, Dublin, Ireland; [Reardon, Cillian; Delahunt, Eamonn] Univ Coll Dublin, Dublin, Ireland	University College Dublin	Reardon, C (corresponding author), Leinster Rugby, Dublin, Ireland.; Reardon, C (corresponding author), Univ Coll Dublin, Dublin, Ireland.	cillian.reardon@leinsterrugby.ie		Delahunt, Eamonn/0000-0001-5449-5932				Akenhead R, 2014, J SCI MED SPORT, V17, P562, DOI 10.1016/j.jsams.2013.08.005; Argus CK, 2012, J STRENGTH COND RES, V26, P2698, DOI 10.1519/JSC.0b013e318241382a; Austin D, 2011, J SPORT SCI, V29, P1105, DOI 10.1080/02640414.2011.582508; Austin D, 2011, J SCI MED SPORT, V14, P259, DOI 10.1016/j.jsams.2011.01.003; Austin DJ, 2011, J STRENGTH COND RES, V25, P1898, DOI 10.1519/JSC.0b013e3181e83a5b; Baker D, 1999, J STRENGTH COND RES, V13, P230; Black GM, 2014, INT J SPORT PHYSIOL, P556; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Duthie GM, 2006, J STRENGTH COND RES, V20, P208, DOI 10.1519/R-16784.1; Eaton C, 2006, PHYS THER SPORT, V7, P22, DOI 10.1016/j.ptsp.2005.08.006; Fontana FY, 2015, INT J SPORT PHYSIOL, V10, P674, DOI 10.1123/ijspp.2015-0014; Gabbett TJ, 2016, INT J SPORT PHYSIOL, V11, P530, DOI 10.1123/ijspp.2015-0266; Gabbett TJ, 2014, J SCI MED SPORT, V17, P556, DOI 10.1016/j.jsams.2013.08.002; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P1623, DOI 10.1519/JSC.0b013e318274f2af; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Quarrie KL, 2000, J SPORT SCI, V18, P237; Reardon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133410; Reardon CJ, 2016, COLLISION COUNT RUGB, P1; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Sirotic AC, 2009, J SPORT SCI, V27, P203, DOI 10.1080/02640410802520802; Smart DJ, 2013, J STRENGTH COND RES, V27, P3033, DOI 10.1519/JSC.0b013e31828c26d3; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Venter RE, 2010, AFRICAN J PHYS HLTH, V17, P1; Waldron M, 2011, J SPORT SCI, V29, P1223, DOI 10.1080/02640414.2011.587445	28	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177072	10.1371/journal.pone.0177072	http://dx.doi.org/10.1371/journal.pone.0177072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510582	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500011
J	de Paula, TG; Zanella, BTT; Fantinatti, BEDA; de Moraes, LN; Duran, BODS; de Oliveira, CB; Salomao, RAS; da Silva, RN; Padovani, CR; dos Santos, VB; Mareco, EA; Carvalho, RF; Dal-Pai-Silva, M				de Paula, Tassiana Gutierrez; Thomazini Zanella, Bruna Tereza; de Almeida Fantinatti, Bruno Evaristo; de Moraes, Leonardo Nazario; da Silva Duran, Bruno Oliveira; de Oliveira, Caroline Bredariol; Simoes Salomao, Rondinelle Artur; da Silva, Rafaela Nunes; Padovani, Carlos Roberto; dos Santos, Vander Bruno; Mareco, Edson Assuncao; Carvalho, Robson Francisco; Dal-Pai-Silva, Maeli			Food restriction increase the expression of mTORC1 complex genes in the skeletal muscle of juvenile pacu (Piaractus mesopotamicus)	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; TILAPIA OREOCHROMIS-NILOTICUS; TROUT ONCORHYNCHUS-MYKISS; GROWTH-RELATED GENES; RAINBOW-TROUT; ATLANTIC SALMON; FINE FLOUNDER; PLEURONECTES-PLATESSA; ENDURANCE EXERCISE; NUTRITIONAL-STATUS	Skeletal muscle is capable of phenotypic adaptation to environmental factors, such as nutrient availability, by altering the balance between muscle catabolism and anabolism that in turn coordinates muscle growth. Small noncoding RNAs, known as microRNAs (miRNAs), repress the expression of target mRNAs, and many studies have demonstrated that miRNAs regulate the mRNAs of catabolic and anabolic genes. We evaluated muscle morphology, gene expression of components involved in catabolism, anabolism and energetic metabolism and miRNAs expression in both the fast and slow muscle of juvenile pacu (Piaractus mesopotamicus) during food restriction and refeeding. Our analysis revealed that short periods of food restriction followed by refeeding predominantly affected fast muscle, with changes in muscle fiber diameter and miRNAs expression. There was an increase in the mRNA levels of catabolic pathways components (FBXO25, ATG12, BCL2) and energetic metabolism-related genes (PGC1 alpha and SDHA), together with a decrease in PPAR beta/delta mRNA levels. Interestingly, an increase in mRNA levels of anabolic genes (PI3K and mTORC1 complex: mTOR, mLST8 and RAPTOR) was also observed during food restriction. After refeeding, muscle morphology showed similar patterns of the control group; the majority of genes were slightly up-or down-regulated in fast and slow muscle, respectively; the levels of all miRNAs increased in fast muscle and some of them decreased in slow muscle. Our findings demonstrated that a short period of food restriction in juvenile pacu had a considerable impact on fast muscle, increasing the expression of anabolic (PI3K and mTORC1 complex: mTOR, mLST8 and RAPTOR) and energetic metabolism genes. The miRNAs (miR-1, miR-206, miR-199 and miR-23a) were more expressed during refeeding and while their target genes (IGF-1, mTOR, PGC1 alpha and MAFbx), presented a decreased expression. The alterations in mTORC1 complex observed during fasting may have influenced the rates of protein synthesis by using amino acids from protein degradation as an alternative mechanism to preserve muscle phenotype and metabolic demand maintenance.	[de Paula, Tassiana Gutierrez; Thomazini Zanella, Bruna Tereza; de Almeida Fantinatti, Bruno Evaristo; de Moraes, Leonardo Nazario; da Silva Duran, Bruno Oliveira; de Oliveira, Caroline Bredariol; Simoes Salomao, Rondinelle Artur; da Silva, Rafaela Nunes; Carvalho, Robson Francisco; Dal-Pai-Silva, Maeli] Sao Paulo State Univ, Inst Biosci Botucatu, Dept Morphol, Botucatu, SP, Brazil; [Simoes Salomao, Rondinelle Artur; Dal-Pai-Silva, Maeli] Sao Paulo State Univ, Aquaculture Ctr, Jaboticabal, SP, Brazil; [Padovani, Carlos Roberto] Sao Paulo State Univ, Inst Biosci Botucatu, Dept Biostat, Botucatu, SP, Brazil; [dos Santos, Vander Bruno] Sao Paulo Agcy Agribusiness Technol, Presidente Prudente, SP, Brazil; [Mareco, Edson Assuncao] Univ Western Sao Paulo UNOESTE, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade do Oeste Paulista	Dal-Pai-Silva, M (corresponding author), Sao Paulo State Univ, Inst Biosci Botucatu, Dept Morphol, Botucatu, SP, Brazil.; Dal-Pai-Silva, M (corresponding author), Sao Paulo State Univ, Aquaculture Ctr, Jaboticabal, SP, Brazil.	maeli@ibb.unesp.br	Bredariol de Oliveira, Caroline/D-8721-2019; Duran, Bruno/AAA-9977-2020; de Paula, Tassiana Gutierrez/L-2867-2017; Fantinatti, Bruno/B-2943-2013; de Moraes, Leonardo Nazario/F-8621-2012; Carvalho, Robson Francisco/AAE-4134-2020; Dal-Pai-Silva, Maeli/GLR-1413-2022	Bredariol de Oliveira, Caroline/0000-0002-3130-3907; Duran, Bruno/0000-0002-7920-8175; Carvalho, Robson Francisco/0000-0002-4901-7714; Moraes, Leonardo/0000-0003-4515-4137; Mareco, Edson/0000-0002-3504-6936; Santos, Vander Bruno/0000-0003-1816-169X	Sao Paulo Research Foundation (FAPESP) [2013/25915-1, 2014/16949-2, 2016/00725-3]; National Council for Scientific and Technological Development (CNPq) [447233/2014, 302656/2015-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo Research Foundation (FAPESP), http://www.fapesp.br/, Grants 2013/25915-1, 2014/16949-2 and 2016/00725-3; National Council for Scientific and Technological Development (CNPq), http://www.cnpq.br/, Grants 447233/2014 and 302656/2015-4; support to TGP, BTTZ, CBO and MDPS.	de Almeida FLA, 2010, MICRON, V41, P997, DOI 10.1016/j.micron.2010.06.012; Bodine SC, 2001, SCIENCE, P294; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bower NI, 2010, PHYSIOL GENOMICS, V42A, P114, DOI 10.1152/physiolgenomics.00065.2010; Bower NI, 2008, J EXP BIOL, V211, P3859, DOI 10.1242/jeb.024117; Brett J., 1979, ENV FACTORS GROWTH F; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Castagnolli N, 1986, PISCICULTURA NOS TRO; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; Chu WY, 2013, CURR MOL MED, V13, P1397, DOI 10.2174/15665240113139990059; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cleveland BM, 2010, AM J PHYSIOL-REG I, V298, pR341, DOI 10.1152/ajpregu.00516.2009; Desgeorges MM, 2014, INT J BIOCHEM CELL B, V54, P208, DOI 10.1016/j.biocel.2014.07.008; Dubowitz V., 1973, MUSCLE BIOPSY MODERN; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fuentes EN, 2013, GEN COMP ENDOCR, V186, P172, DOI 10.1016/j.ygcen.2013.02.009; Fuentes EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044256; Fuentes EN, 2012, GEN COMP ENDOCR, V177, P120, DOI 10.1016/j.ygcen.2012.02.019; Fuentes EN, 2012, ENDOCRINOLOGY, V153, P283, DOI 10.1210/en.2011-1313; FUENTES EN, 2011, AM J PHYSIOL-REG I, V300, P1532, DOI DOI 10.1152/AJPREGU.00535.2010; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Goodman L., 1965, SIMULTANEOUS CONFIDE; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hitachi K, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00408; Hoppeler H, 2016, J EXP BIOL, V219, P205, DOI 10.1242/jeb.128207; Jamart C, 2013, AM J PHYSIOL-ENDOC M, V305, pE964, DOI 10.1152/ajpendo.00270.2013; Jia L, 2014, INT J MOL SCI, V15, P296, DOI 10.3390/ijms15010296; JOHNSTON IA, 1973, MAR BIOL, V19, P348, DOI 10.1007/BF00348906; JOHNSTON IA, 1981, CELL TISSUE RES, V214, P369; Johnston IA, 2006, J EXP BIOL, V209, P2249, DOI 10.1242/jeb.02153; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leitao ND, 2011, AQUACULTURE, V315, P78, DOI 10.1016/j.aquaculture.2011.01.006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mareco EA, 2015, PLOS ONE, V10, P1; Mareco EA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1423-6; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Nakashima H, 2005, ACTA NEUROPATHOL, V110, P547, DOI 10.1007/s00401-005-1087-4; Nebo C, 2013, COMP BIOCHEM PHYS B, V164, P268, DOI 10.1016/j.cbpb.2013.02.003; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Steven A, 1990, THEORY PRACTICE HIST; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Terova G, 2007, J FISH BIOL, V70, P219, DOI 10.1111/j.1095-8649.2007.01402.x; URBINATI E.C., 2005, ESPECIES NATIVAS PIS; Valente LMP, 1999, J FISH BIOL, V55, P675, DOI 10.1111/j.1095-8649.1999.tb00710.x; Valente LMP, 2012, BRIT J NUTR, V108, P2148, DOI 10.1017/S0007114512000396; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vechetti IJ, 2016, J GERONTOL A-BIOL, V71, P601, DOI 10.1093/gerona/glv064; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wiberg R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142699; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamano K, 2016, EMBO REP, V17, P300, DOI 10.15252/embr.201541486; Yan BA, 2013, J EXP BIOL, V216, P1265, DOI 10.1242/jeb.079590; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	84	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177679	10.1371/journal.pone.0177679	http://dx.doi.org/10.1371/journal.pone.0177679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505179	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500032
J	Fu, Z; Epstein, B; Kelley, JL; Zheng, Q; Bergland, AO; Carrillo, CIC; Jensen, AS; Dahan, J; Karasev, AV; Snyder, WE				Fu, Zhen; Epstein, Brendan; Kelley, Joanna L.; Zheng, Qi; Bergland, Alan O.; Carrillo, Carmen I. Castillo; Jensen, Andrew S.; Dahan, Jennifer; Karasev, Alexander V.; Snyder, William E.			Using NextRAD sequencing to infer movement of herbivores among host plants	PLOS ONE			English	Article							INSECT VECTORS; POPULATIONS; MARKERS; LOCI; DIVERSITY; PATTERNS; DISEASE; ADAPTATION; MIGRATION; SELECTION	Herbivores often move among spatially interspersed host plants, tracking high-quality resources through space and time. This dispersal is of particular interest for vectors of plant pathogens. Existing molecular tools to track such movement have yielded important insights, but often provide insufficient genetic resolution to infer spread at finer spatiotemporal scales. Here, we explore the use of Nextera-tagmented reductively-amplified DNA (Nex-tRAD) sequencing to infer movement of a highly-mobile winged insect, the potato psyllid (Bactericera cockerelli), among host plants. The psyllid vectors the pathogen that causes zebra chip disease in potato (Solanum tuberosum), but understanding and managing the spread of this pathogen is limited by uncertainty about the insect's host plant(s) outside of the growing season. We identified 1,978 polymorphic loci among psyllids separated spatiotemporally on potato or in patches of bittersweet nightshade (S. dulcumara), a weedy plant proposed to be the source of potato-colonizing psyllids. A subset of the psyllids on potato exhibited genetic similarity to insects on nightshade, consistent with regular movement between these two host plants. However, a second subset of potato-collected psyllids was genetically distinct from those collected on bittersweet nightshade; this suggests that a currently unrecognized source, i.e., other nightshade patches or a third host-plant species, could be contributing to psyllid populations in potato. Oftentimes, dispersal of vectors of pathogens must be tracked at a fine scale in order to understand, predict, and manage disease spread. We demonstrate that emerging sequencing technologies that detect genome-wide SNPs of a vector can be used to infer such localized movement.	[Fu, Zhen; Carrillo, Carmen I. Castillo; Snyder, William E.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Epstein, Brendan; Kelley, Joanna L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Zheng, Qi] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Bergland, Alan O.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Jensen, Andrew S.] Northwest Potato Res Consortium, Lakeview, OR USA; [Dahan, Jennifer; Karasev, Alexander V.] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA; [Epstein, Brendan] Univ Minnesota, Coll Biol Sci, St Paul, MN 55108 USA; [Bergland, Alan O.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Carrillo, Carmen I. Castillo] Inst Nacl Invest Agr INIAP, Estn Expt Santa Catalina, Dept Protecc Vegetal, Panamericana Sur Km 1, Quito, Ecuador	Washington State University; Washington State University; University of Louisville; Stanford University; Idaho; University of Idaho; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia	Fu, Z (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	zhen.fu@wsu.edu	Kelley, Joanna L/H-1693-2012; Castillo Carrillo, Carmen/I-6752-2016	Kelley, Joanna L/0000-0002-7731-605X; Karasev, Alexander/0000-0001-8197-0639; Snyder, William/0000-0002-2747-3102; Castillo Carrillo, Carmen/0000-0001-7893-5218; Fu, Zhen/0000-0002-8120-590X	National Institute of Food and Agriculture, U.S. Department of Agriculture, Specialty Crop Research Initiative [2015-09273]; Northwest Potato Research Consortium; Washington State Commission on Pesticide Registration	National Institute of Food and Agriculture, U.S. Department of Agriculture, Specialty Crop Research Initiative; Northwest Potato Research Consortium; Washington State Commission on Pesticide Registration	This research was funded by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Specialty Crop Research Initiative (https://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) award number 2015-09273, along with grants from the Northwest Potato Research Consortium (http://www.nwpotatoresearch.com/) and the Washington State Commission on Pesticide Registration (http://wscpr.org/), all to WES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Barley AJ, 2015, MOL ECOL, V24, P1696, DOI 10.1111/mec.13151; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Canto T, 2009, GLOBAL CHANGE BIOL, V15, P1884, DOI 10.1111/j.1365-2486.2008.01820.x; Chasen EM, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM13014; Clement S. L., 2006, Plant Health Progress, P1; Coates BS, 2009, GENOME, V52, P57, DOI 10.1139/G08-104; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; Despland E, 2004, ECOGRAPHY, V27, P381, DOI 10.1111/j.0906-7590.2004.03779.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ebel ER, 2015, MOL ECOL, V24, P2392, DOI 10.1111/mec.13168; Eigenbrode SD, 2016, J APPL ECOL, V53, P1382, DOI 10.1111/1365-2664.12693; Emerson KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130773; EXCOFFIER L, 1992, GENETICS, V131, P479; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; FRASER D, 1984, CAN J ZOOL, V62, P80, DOI 10.1139/z84-014; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Greenway G, 2014, AM J POTATO RES, V91, P714, DOI 10.1007/s12230-014-9404-x; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Horton D. R., 2015, POTATO PROG, V15, P1; Horton David R., 2015, American Entomologist, V61, P234, DOI 10.1093/ae/tmv047; ILLIUS AW, 1992, J ANIM ECOL, V61, P183, DOI 10.2307/5521; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Keller I, 2013, MOL ECOL, V22, P2848, DOI 10.1111/mec.12083; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Koss AM, 2005, ENVIRON ENTOMOL, V34, P87, DOI 10.1603/0046-225X-34.1.87; Larson WA, 2013, CAN J FISH AQUAT SCI, V70, P128, DOI 10.1139/cjfas-2012-0233; Leebens-Mack J, 2004, J HERED, V95, P127, DOI 10.1093/jhered/esh025; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Long EY, 2015, OECOLOGIA, V177, P1067, DOI 10.1007/s00442-014-3194-1; Loxdale HD, 1998, B ENTOMOL RES, V88, P577, DOI 10.1017/S0007485300054250; Loxdale HD, 1999, PHILOS T R SOC B, V354, P1479, DOI 10.1098/rstb.1999.0492; Massonnet B, 2004, HEREDITY, V93, P577, DOI 10.1038/sj.hdy.6800559; MCELHANY P, 1995, ECOLOGY, V76, P444, DOI 10.2307/1941203; Meglecz E, 2007, INSECT MOL BIOL, V16, P175, DOI 10.1111/j.1365-2583.2006.00713.x; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Monteith KL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00096.1; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson MA, 1997, ECOLOGY, V78, P167, DOI 10.1890/0012-9658(1997)078[0167:HPPABD]2.0.CO;2; POWER AG, 1987, ECOLOGY, V68, P1658, DOI 10.2307/1939858; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; Reese Justin, 2014, J Genomics, V2, P54; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; ROSE DJW, 1979, PHILOS T ROY SOC B, V287, P393, DOI 10.1098/rstb.1979.0071; Russello MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1106; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shariatinajafabadi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108331; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Szulkin M, 2016, MOL ECOL, V25, P542, DOI 10.1111/mec.13486; Takahashi T, 2013, MOL ECOL, V22, P3049, DOI 10.1111/mec.12120; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Watt WB, 2003, MOL ECOL, V12, P1265, DOI 10.1046/j.1365-294X.2003.01804.x; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2015, AM NAT, V186, pS24, DOI 10.1086/682949; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223; Wink M, 2006, J ORNITHOL, V147, P234, DOI 10.1007/s10336-006-0065-5; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020; Zhu M, 2006, AGR FOREST METEOROL, V138, P192, DOI 10.1016/j.agrformet.2006.05.001	75	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177742	10.1371/journal.pone.0177742	http://dx.doi.org/10.1371/journal.pone.0177742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505182	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500038
J	Sumner, J; Harrison, A; Doherty, P				Sumner, Jennifer; Harrison, Alexander; Doherty, Patrick			The effectiveness of modern cardiac rehabilitation: A systematic review of recent observational studies in non-attenders versus attenders	PLOS ONE			English	Review							HEALTH-CARE PROFESSIONALS; LIFE-STYLE MODIFICATION; MYOCARDIAL-INFARCTION; SHORT-TERM; 1-YEAR; STATEMENT; PROGRAMS; OUTCOMES; IMPACT; TRIAL	Background The beneficial effects of cardiac rehabilitation (CR) have been challenged in recent years and there is now a need to investigate whether current CR programmes, delivered in the context of modern cardiology, still benefit patients. Methods A systematic review of non-randomised controlled studies was conducted. Electronic searches of Medline, Embase, CINAHL, science citation index (web of science), CIRRIE and Open Grey were undertaken. Non-randomised studies investigating the effects of CR were included when recruitment occurred from the year 2000 onwards in accordance with significant CR guidance changes from the late 1990' s. Adult patients diagnosed with acute myocardial infarction (AMI) were included. Non-English articles were considered. Two reviewers independently screened articles according to pre-defined selection criteria as reported in the PROSPERO database (CRD42015024021). Results Out of 2,656 articles, 8 studies involving 9,836 AMI patients were included. Studies were conducted in 6 countries. CR was found to reduce the risk of all-cause and cardiac-related mortality and improve Health-Related Quality of Life (HRQOL) significantly in at least one domain. The benefits of CR in terms of recurrent MI were inconsistent and no significant effects were found regarding re-vascularisation or re-hospitalisation following AMI. Conclusion Recent observational evidence draws different conclusions to the most current reviews of trial data with respect to total mortality and re-hospitalisation, questioning the representativeness of historic data in the modern cardiological era. Future work should seek to clarify which patient and service level factors determine the likelihood of achieving improved all-cause and cardiac mortality and reduced hospital re-admissions.	[Sumner, Jennifer; Harrison, Alexander; Doherty, Patrick] Univ York, Dept Hlth Sci, York, N Yorkshire, England	University of York - UK	Sumner, J (corresponding author), Univ York, Dept Hlth Sci, York, N Yorkshire, England.	Jenny.sumner@york.ac.uk	Sumner, Jennifer/AAT-3319-2021	Sumner, Jennifer/0000-0002-2200-3275; Doherty, Patrick Joseph/0000-0002-1887-0237				Alberti G, 2000, CORONARY HEART DIS N; Aldana SG, 2006, BEHAV MODIF, V30, P507, DOI 10.1177/0145445504267797; Aldana SG, 2003, HEART LUNG, V32, P374, DOI 10.1016/S0147-9563(03)00106-7; BALADY GJ, 1994, CIRCULATION, V90, P1602; Balady GJ, 2000, CIRCULATION, V102, P1069, DOI 10.1161/01.CIR.102.9.1069; Benzer W, 2017, INT J CARDIOL, V228, P58, DOI 10.1016/j.ijcard.2016.11.059; Bjarnason-Wehrens B, 2010, EUR J CARDIOV PREV R, V17, P410, DOI 10.1097/HJR.0b013e328334f42d; Boulay P, 2004, PREV MED, V38, P586, DOI 10.1016/j.ypmed.2003.11.028; British Association for Cardiovascular Prevention and Rehabilitation, 2012, BACPR STANDARDS CORE; British Heart Foundation, 2016, CARDIOVASCULAR DIS S; Caliani SE, 2004, REV ESP CARDIOL, V57, P53; Coll-Fernandez R, 2014, ARCH PHYS MED REHAB, V95, P322, DOI 10.1016/j.apmr.2013.09.020; Department of Health, 2013, CARD DIS OUTC STRAT; Doherty P, 2013, HEART, V99, P593, DOI 10.1136/heartjnl-2012-303365; Doherty P, 2012, HEART, V98, P605, DOI 10.1136/heartjnl-2012-301728; Giannuzzi P, 2003, EUR HEART J, V24, P1273, DOI 10.1016/S0195-668X(03)00198-2; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jolliffe JA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001800; Junger C, 2010, CURR MED RES OPIN, V26, P803, DOI 10.1185/03007991003604216; Karmali KN, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007131.pub3; Kim C, 2011, ANN REHABIL MED-ARM, V35, P375, DOI 10.5535/arm.2011.35.3.375; Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017; Listerman J, 2011, J CARDIOPULM REHABIL, V31, P342, DOI 10.1097/HCR.0b013e31822f189c; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Martin BJ, 2012, CIRCULATION, V126, P677, DOI 10.1161/CIRCULATIONAHA.111.066738; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; NICE, 2013, MI SEC PREV GUID 172; NICE, 2011, CARD REH SERV COMM G; Nielsen KM, 2008, EUR J PUBLIC HEALTH, V18, P479, DOI 10.1093/eurpub/ckn060; Piepoli MF, 2014, EUR J PREV CARDIOL, V21, P664, DOI 10.1177/2047487312449597; Rashid MA, 2012, HEART BRIT CARDIAC S, V98; Rauch B, 2016, EUR J PREV CARDIOL; Rauch B, 2014, EUR J PREV CARDIOL, V21, P1060, DOI 10.1177/2047487313486040; Salzwedel A, 2015, AGING CLIN EXP RES, V27, P315, DOI 10.1007/s40520-014-0283-2; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sumner JA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003930; Anderson Lindsey, 2017, Cochrane Database Syst Rev, V6, pCD007130, DOI [10.1002/14651858.CD007130.pub3, 10.1002/14651858.CD007130.pub4]; Taylor RS, 2012, HEART BRITISH CARDIA, V98; The National Audit of Cardiac Rehabilitation (NACR), 2016, NAT AUD CARD REH NAC; Wells GA, 2013, RES SYNTH METHODS, V4, P63, DOI 10.1002/jrsm.1077; West RR, 2012, HEART, V98, P637, DOI 10.1136/heartjnl-2011-300302; Wood D, 2012, HEART, V98, P607, DOI 10.1136/heartjnl-2012-301811; Zwisler AD, 2016, INT J CARDIOL, V221, P963, DOI 10.1016/j.ijcard.2016.06.207	44	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177658	10.1371/journal.pone.0177658	http://dx.doi.org/10.1371/journal.pone.0177658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498869	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000401314500039
J	Zhong, ZJ; Li, W; Deng, L; Song, Y; Wu, KJ; Tian, YN; Huang, XM; Hu, YC; Fu, HL; Geng, Y; Ren, ZH; Peng, GN				Zhong, Zhijun; Li, Wei; Deng, Lei; Song, Yuan; Wu, Kongju; Tian, Yinan; Huang, Xiangming; Hu, Yanchun; Fu, Hualin; Geng, Yi; Ren, Zhihua; Peng, Guangneng			Multilocus genotyping of Enterocytozoon bieneusi derived from nonhuman primates in southwest China	PLOS ONE			English	Article							GIARDIA-DUODENALIS; CAPTIVE WILDLIFE; CRYPTOSPORIDIUM; MICROSPORIDIOSIS; INFECTION; SEQUENCE; HUMANS	Enterocytozoon bieneusi has been increasingly reported in non-human primates (NHPs) in recent years, and this has garnered attention. However, reports of E. bieneusi infections in NHPs are limited worldwide. To appreciate the genetic diversity and assess the zoonotic potential during the transmission of human microsporidiosis, we examined a total of 369 fecal samples from NHPs and performed PCR amplification of the ITS gene of E. bieneusi. An infection rate of 12.5% (46/369) was detected in NHPs, with three known genotypes (D, PigEBITS7, and SC02) and a novel genotype (SCM01) characterized. Phylogenetic analysis indicated that all four genotypes in our study were classified as zoonotic group 1. Multilocus genotyping of positive E. bieneusi strains revealed that 36, 37, 30, and 29 specimens were successfully amplified and sequenced to generate 16, six, four, and five types of MS1, MS3, MS4, and MS7 loci, respectively. Twenty-four specimens were successfully amplified and sequenced at all four loci, forming 13 multilocus genotypes (MLGs). The occurrence of zoonotic genotypes suggests that zoonotic transmission of E. bieneusi between humans and NHPs has probably occurred and NHPs could be a source of human microspordiosis.	[Zhong, Zhijun; Li, Wei; Deng, Lei; Song, Yuan; Tian, Yinan; Hu, Yanchun; Fu, Hualin; Geng, Yi; Ren, Zhihua; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan, Sichuan Provinc, Peoples R China; [Wu, Kongju; Huang, Xiangming] Chengdu Res Base Giant Panda Breeding, Chengdu, Sichuan, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan, Sichuan Provinc, Peoples R China.	pgn.sicau@163.com	Deng, Lei/AAB-5622-2020	Deng, Lei/0000-0003-0391-6180	Chengdu Giant Panda Breeding Research Foundation [CPF2014-10, CPF2014-14, CPF2015-4]	Chengdu Giant Panda Breeding Research Foundation	The study was financially supported by the Chengdu Giant Panda Breeding Research Foundation (CPF2014-10; CPF2014-14; CPF2015-4).	Akinbo FO, 2012, AM J TROP MED HYG, V86, P441, DOI 10.4269/ajtmh.2012.11-0548; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Breton J, 2007, J CLIN MICROBIOL, V45, P2580, DOI 10.1128/JCM.02554-06; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; Feng YY, 2011, APPL ENVIRON MICROB, V77, P4822, DOI 10.1128/AEM.02803-10; Karim MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117991; Karim MR, 2014, APPL ENVIRON MICROB, V80, P1893, DOI 10.1128/AEM.03845-13; Li J, 2016, CHINA PARASIT VECTOR, V9, P1, DOI DOI 10.1016/J.IJPRT.2015.12.001; Li JQ, 2015, J EUKARYOT MICROBIOL, V62, P833, DOI 10.1111/jeu.12269; Li W, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1668-1; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Liguory O, 2001, J CLIN MICROBIOL, V39, P2672, DOI 10.1128/JCM.39.7.2672-2674.2001; Lobo ML, 2006, J EUKARYOT MICROBIOL, V53, pS61, DOI 10.1111/j.1550-7408.2006.00174.x; Maikai BV, 2012, EXP PARASITOL, V131, P452, DOI 10.1016/j.exppara.2012.05.011; Metge S, 2000, EUR J CLIN MICROBIOL, V19, P221, DOI 10.1007/s100960050463; Mynarova A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152771; Nkinin SW, 2007, J CLIN MICROBIOL, V45, P2841, DOI 10.1128/JCM.00328-07; Sadler F, 2002, J INFECTION, V44, P39, DOI 10.1053/jinf.2001.0934; Sak B, 2013, PLOS ONE, V8; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Singh I, 2006, J MED PRIMATOL, V35, P352, DOI 10.1111/j.1600-0684.2006.00181.x; Ten Hove RJ, 2009, J EUKARYOT MICROBIOL, V56, P388, DOI 10.1111/j.1550-7408.2009.00393.x; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Widmer G, 2013, APPL ENVIRON MICROB, V79, P5357, DOI 10.1128/AEM.01260-13; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11	29	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176926	10.1371/journal.pone.0176926	http://dx.doi.org/10.1371/journal.pone.0176926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498867	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314500007
J	Alam, MN; Garg, A; Munia, TTK; Fazel-Rezai, R; Tavakolian, K				Alam, Md Nafiul; Garg, Amanmeet; Munia, Tamanna Tabassum Khan; Fazel-Rezai, Reza; Tavakolian, Kouhyar			Vertical ground reaction force marker for Parkinson's disease	PLOS ONE			English	Article							TREADMILL WALKING; GAIT RHYTHM; CLASSIFICATION; VARIABILITY; PARAMETERS; SENSORS; PEOPLE	Parkinson's disease (PD) patients regularly exhibit abnormal gait patterns. Automated differentiation of abnormal gait from normal gait can serve as a potential tool for early diagnosis as well as monitoring the effect of PD treatment. The aim of current study is to differentiate PD patients from healthy controls, on the basis of features derived from plantar vertical ground reaction force (VGRF) data during walking at normal pace. The current work presents a comprehensive study highlighting the efficacy of different machine learning classifiers towards devising an accurate prediction system. Selection of meaningful feature based on sequential forward feature selection, the swing time, stride time variability, and center of pressure features facilitated successful classification of control and PD gaits. Support Vector Machine (SVM), K-nearest neighbor (KNN), random forest, and decision trees classifiers were used to build the prediction model. We found that SVM with cubic kernel outperformed other classifiers with an accuracy of 93.6%, the sensitivity of 93.1%, and specificity of 94.1%. In comparison to other studies, utilizing same dataset, our designed prediction system improved the classification performance by approximately 10%. The results of the current study underscore the ability of the VGRF data obtained non-invasively from wearable devices, in combination with a SVM classifier trained on meticulously selected features, as a tool for diagnosis of PD and monitoring effectiveness of therapy post pathology.	[Alam, Md Nafiul; Munia, Tamanna Tabassum Khan; Fazel-Rezai, Reza] Univ North Dakota, Dept Elect Engn, Grand Forks, ND 58201 USA; [Garg, Amanmeet; Tavakolian, Kouhyar] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada	University of North Dakota Grand Forks; Simon Fraser University	Alam, MN (corresponding author), Univ North Dakota, Dept Elect Engn, Grand Forks, ND 58201 USA.; Tavakolian, K (corresponding author), Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada.	mdnafiul.alam@und.edu; kouhyar.tavakolian@engr.und.edu						Abujaber SB, 2015, J ARTHROPLASTY, V30, P2027, DOI 10.1016/j.arth.2015.05.024; Alkhatib R, 2015, IEEE ENG MED BIO, P4186, DOI 10.1109/EMBC.2015.7319317; Alkhatib R, 2015, J COMPUTER COMMUNICA, V3, P13, DOI DOI 10.4236/JCC.2015.33003; Baratin E, 2015, GAIT POSTURE, V41, P634, DOI 10.1016/j.gaitpost.2015.01.012; Begg R, 2005, J BIOMECH, V38, P401, DOI 10.1016/j.jbiomech.2004.05.002; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; del Olmo MF, 2005, PARKINSONISM RELAT D, V11, P25, DOI 10.1016/j.parkreldis.2004.09.002; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Fernando ME, 2016, CLIN BIOMECH, V37, P98, DOI 10.1016/j.clinbiomech.2016.06.006; Foundation PD, 2016, STAT PARK PARK DIS F; Foundation PD, 2016, PRIM MOT SYMPT PARK; Frenkel-Toledo S, 2005, MOVEMENT DISORD, V20, P1109, DOI 10.1002/mds.20507; Frenkel-Toledo S., 2005, J NEUROENG REHABIL, P2; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hunt E.B., 1966, AM J PSYCHOL; Jolliffe I. T., 1990, Weather, V45, P375, DOI 10.1002/j.1477-8696.1990.tb05558.x; Kalron A, 2016, GAIT POSTURE, V47, P48, DOI 10.1016/j.gaitpost.2016.04.010; Kim HD, 2015, ANN REHABIL MED-ARM, V39, P409, DOI 10.5535/arm.2015.39.3.409; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Lozano-Ortiz CA, 2010, IEEE ENG MED BIO, P1413, DOI 10.1109/IEMBS.2010.5626715; Manap HH, 2011, IEEE INT SYMP SIGNAL, P60; Martinez-Manzanera O, 2016, IEEE T BIO-MED ENG, V63, P1016, DOI 10.1109/TBME.2015.2480242; Morris ME, 1999, HUM MOVEMENT SCI, V18, P461, DOI 10.1016/S0167-9457(99)00020-2; Murthy SK, 1998, DATA MIN KNOWL DISC, V2, P345, DOI 10.1023/A:1009744630224; Ota L., 2011, 2011 IEEE/SICE International Symposium on System Integration (SII 2011), P236, DOI 10.1109/SII.2011.6147452; Pamukoff DN, 2016, CLIN BIOMECH, V33, P61, DOI 10.1016/j.clinbiomech.2016.02.007; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peters J, 2017, ADAPT COMPUT MACH LE; Pietrosimone B, 2016, AM J SPORT MED, V44, P425, DOI 10.1177/0363546515618380; Plotnik M, 2013, GAIT POSTURE, V38, P864, DOI 10.1016/j.gaitpost.2013.04.011; Pohjalainen J, 2015, COMPUT SPEECH LANG, V29, P145, DOI 10.1016/j.csl.2013.11.004; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Tadano S, 2013, SENSORS-BASEL, V13, P9321, DOI 10.3390/s130709321; Tagliati M, 2008, NEUROLOGY, V71, P76, DOI 10.1212/01.wnl.0000316807.94657.e0; Tao WJ, 2012, SENSORS-BASEL, V12, P2255, DOI 10.3390/s120202255; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Yanci J, 2016, BIOL SPORT, V33, P173, DOI 10.5604/20831862.1198637; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Zhang YY, 2013, 2013 INTERNATIONAL CONFERENCE ON DIGITAL IMAGE COMPUTING: TECHNIQUES & APPLICATIONS (DICTA), P328	46	57	57	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0175951	10.1371/journal.pone.0175951	http://dx.doi.org/10.1371/journal.pone.0175951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493868	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300009
J	Buechter, M; Kahraman, A; Manka, P; Gerken, G; Dechene, A; Canbay, A; Wetter, A; Umutlu, L; Theysohn, JM				Buechter, Matthias; Kahraman, Alisan; Manka, Paul; Gerken, Guido; Dechene, Alexander; Canbay, Ali; Wetter, Axel; Umutlu, Lale; Theysohn, Jens M.			Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation	PLOS ONE			English	Article							PARTIAL SPLENIC EMBOLIZATION; RETROGRADE TRANSVENOUS OBLITERATION; INTRAHEPATIC PORTOSYSTEMIC SHUNT; GASTRIC VARICES; ARTERY EMBOLIZATION; CIRRHOTIC-PATIENTS; LIVER-CIRRHOSIS; SPLENECTOMY; PREVENTION; MANAGEMENT	Introduction Upper gastrointestinal bleeding (UGIB) is a severe and life-threatening complication among patients with portal hypertension (PH). Covered transjugular intrahepatic portosystemic shunt (TIPS) is the treatment of choice for patients with refractory or recurrent UGIB despite pharmacological and endoscopic therapy. In some patients, TIPS implantation is not possible due to co-morbidity or vascular disorders. Spleen embolization (SE) may be a promising alternative in this setting. Materials and methods We retrospectively analyzed 9 patients with PH-induced UGIB who underwent partial SE between 2012 and 2016. All patients met the following criteria: (i) upper gastrointestinal hemorrhage with primary or secondary failure of endoscopic interventions and (ii) TIPS implantation not possible. Each patient was followed for at least 6 months after embolization. Results Five patients (56%) suffered from cirrhotic PH, 4 patients (44%) from non-cirrhotic PH. UGIB occured in terms of refractory hemorrhage from gastric varices (3/9; 33%), hemorrhage from esophageal varices (3/9; 33%), and finally, hemorrhage from portal-hypertensive gastropathy (3/9; 33%). None of the patients treated with partial SE experienced re-bleeding episodes or required blood transfusions during a total follow-up time of 159 months, including both patients with cirrhotic-and non-cirrhotic PH. Discussion Partial SE, as a minimally invasive intervention with low procedure-associated complications, may be a valuable alternative for patients with recurrent PH-induced UGIB refractory to standard therapy.	[Buechter, Matthias; Kahraman, Alisan; Manka, Paul; Gerken, Guido; Dechene, Alexander; Canbay, Ali] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Manka, Paul] Fdn Liver Res, Inst Hepatol London, London, England; [Manka, Paul] Kings Coll London, Fac Life Sci & Med, London, England; [Wetter, Axel; Umutlu, Lale; Theysohn, Jens M.] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen; University of London; University College London; University of London; King's College London; University of Duisburg Essen	Theysohn, JM (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	jens.theysohn@uk-essen.de	Canbay, Ali/AAL-9620-2020; Manka, Paul/ABH-2421-2020; Manka, Paul/AAN-1261-2021	Manka, Paul/0000-0001-8589-7280; Canbay, Ali/0000-0001-6069-7899				Ahuja C, 2015, AM J ROENTGENOL, V205, P720, DOI 10.2214/AJR.15.14637; Akahoshi T, 2008, J GASTROEN HEPATOL, V23, P1702, DOI 10.1111/j.1440-1746.2008.05549.x; Buechter M, 2016, DIGESTION, V94, P138, DOI 10.1159/000450704; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; Garcia-Pagan JC, 2014, CLIN GASTROENTEROL H, V12, P919, DOI 10.1016/j.cgh.2013.07.015; Garcia-Pagan JC, 2012, SEMIN RESP CRIT CARE, V33, P46, DOI 10.1055/s-0032-1301734; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Cho H, 2016, HEPATOL RES OFF J JP; Chu HB, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0077-2; Copelan A, 2014, SEMIN INTERVENT RAD, V31, P235, DOI 10.1055/s-0034-1382790; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; DeLeve LD, 2009, HEPATOLOGY, V49, P1729, DOI 10.1002/hep.22772; Glowka Tim R, 2014, Viszeralmedizin, V30, P409, DOI 10.1159/000369575; Gu JJ, 2012, ACTA RADIOL, V53, P862, DOI 10.1258/ar.2012.110639; Hadduck TA, 2014, WORLD J RADIOL, V6, P160, DOI 10.4329/wjr.v6.i5.160; Holster IL, 2016, HEPATOLOGY, V63, P581, DOI 10.1002/hep.28318; Hong CH, 2009, J GASTROEN HEPATOL, V24, P372, DOI 10.1111/j.1440-1746.2008.05651.x; Jansen C, 2016, LIVER INT OFF J INT; Kanagawa H, 1996, J GASTROEN HEPATOL, V11, P51, DOI 10.1111/j.1440-1746.1996.tb00010.x; Karagul S, 2016, ANN TRANSPL, V21, P317, DOI 10.12659/AOT.898253; Kawanaka H, 2014, BRIT J SURG, V101, P1585, DOI 10.1002/bjs.9622; Kim H, 2012, TRANSPL P, V44, P755, DOI 10.1016/j.transproceed.2012.01.066; Kiyosue H, 2003, RADIOGRAPHICS, V23, P921, DOI 10.1148/rg.234025135; Koconis KG, 2007, J VASC INTERV RADIOL, V18, P463, DOI 10.1016/j.jvir.2006.12.734; Liu CL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004215; LOFTUS JP, 1993, ANN SURG, V217, P35, DOI 10.1097/00000658-199301000-00007; Luz JHM, 2016, CANCER MED-US, V5, P2715, DOI 10.1002/cam4.856; Ninoi T, 2005, AM J ROENTGENOL, V184, P1340, DOI 10.2214/ajr.184.4.01841340; Ohmoto K, 2003, HEPATO-GASTROENTEROL, V50, P1766; Palsson B, 2003, LANGENBECK ARCH SURG, V387, P421, DOI 10.1007/s00423-002-0342-6; Paramythiotis Daniel, 2010, J Med Case Rep, V4, P139, DOI 10.1186/1752-1947-4-139; Parker R, 2014, CLIN LIVER DIS, V18, P319, DOI 10.1016/j.cld.2013.12.004; Pedersen MR, 2016, ANN HEPATOL, V15, P127, DOI 10.5604/16652681.1184288; Saad Wael E A, 2012, Semin Intervent Radiol, V29, P118, DOI 10.1055/s-0032-1312573; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P339, DOI 10.1055/s-0031-1284461; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P283, DOI 10.1055/s-0031-1284454; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P333, DOI 10.1055/s-0031-1284460; Saif MW, 2016, CUREUS, V8, DOI 10.7759/cureus.689; Sauerbruch T, 2015, GASTROENTEROLOGY, V149, P660, DOI 10.1053/j.gastro.2015.05.011; Schouten JNL, 2011, HEPATOLOGY, V54, P1071, DOI 10.1002/hep.24422; Shimizu T, 2002, HEPATO-GASTROENTEROL, V49, P947; Smith Mitchell, 2012, Semin Intervent Radiol, V29, P135, DOI 10.1055/s-0032-1312575; Sunakawa H, 2015, CLIN J GASTROENTEROL, V8, P138, DOI 10.1007/s12328-015-0563-1; Taniai N, 1999, HEPATO-GASTROENTEROL, V46, P2849; Wang L, 2011, MED PRIN PRACT, V21, P20, DOI 10.1159/000329888; Xu RY, 2004, WORLD J GASTROENTERO, V10, P1072; Yang SC, 2013, HEPATOL INT, V7, P257, DOI 10.1007/s12072-012-9378-z; Yoshida H, 2005, AM J GASTROENTEROL, V100, P43, DOI 10.1111/j.1572-0241.2005.40559.x	48	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177401	10.1371/journal.pone.0177401	http://dx.doi.org/10.1371/journal.pone.0177401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494001	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300103
J	Javidi-Parsijani, P; Niu, GG; Davis, M; Lu, P; Atala, A; Lu, BS				Javidi-Parsijani, Parisa; Niu, Guoguang; Davis, Meghan; Lu, Pin; Atala, Anthony; Lu, Baisong			No evidence of genome editing activity from Natronobacterium gregoryi Argonaute (NgAgo) in human cells	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; INTRACELLULAR TRAFFICKING; MUSCLE; MODEL	The argonaute protein from the thermophilic bacterium Thermus thermophilus shows DNA-guided DNA interfering activity at high temperatures, complicating its application in mammalian cells. A recent work reported that the argonaute protein from Natronobacterium gregoryi (NgAgo) had DNA-guided genome editing activity in mammalian cells. We compared the genome editing activities of NgAgo and Staphylococcus aureus Cas9 (SaCas9) in human HEK293T cells side by side. EGFP reporter assays and DNA sequencing consistently revealed high genome editing activity from SaCas9. However, these assays did not demonstrate genome editing activity by NgAgo. We confirmed that the conditions allowed simultaneous transfection of the NgAgo expressing plasmid DNA and DNA guides, as well as heterologous expression of NgAgo in the HEK293T cells. Our data show that NgAgo is not a robust genome editing tool, although it may have such activity under other conditions.	[Javidi-Parsijani, Parisa; Niu, Guoguang; Davis, Meghan; Lu, Pin; Atala, Anthony; Lu, Baisong] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University School of Medicine	Lu, BS (corresponding author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.	blu@wakehealth.edu	Lu, Baisong/B-5837-2013	Lu, Baisong/0000-0001-9240-558X; lyu, pin/0000-0001-6841-1373	NCATS NIH HHS [UL1 TR001420] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bhattacharyya D, 2010, METHODS MOL BIOL, V619, P403, DOI 10.1007/978-1-60327-412-8_24; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Burgess S, 2016, PROTEIN CELL, V7, P913, DOI 10.1007/s13238-016-0343-9; Cardarelli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25879; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Green M. R., 2012, MOLECULAR CLONING A; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753; Li X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136630; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Naujok O, 2016, METHODS MOL BIOL, V1341, P67, DOI 10.1007/7651_2015_221; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Qi JL, 2016, CELL RES, V26, P1349, DOI 10.1038/cr.2016.134; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Ye S., 2017, BIORXIV, DOI [10.1101/101923, DOI 10.1101/101923]; Yonezawa M, 1996, INT J CANCER, V66, P347; Zander A, 2014, RNA BIOL, V11, P45, DOI 10.4161/rna.27446	32	21	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177444	10.1371/journal.pone.0177444	http://dx.doi.org/10.1371/journal.pone.0177444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494027	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300110
J	Zhao, R; Sun, JB; Zhang, XX; Wu, HJ; Liu, P; Yang, XJ; Qin, W				Zhao, Rui; Sun, Jinbo; Zhang, Xinxin; Wu, Huanju; Liu, Peng; Yang, Xuejuan; Qin, Wei			Sleep spindle detection based on non-experts: A validation study	PLOS ONE			English	Article							EEG; DENSITY; MEMORY; FINGERPRINT; INCREASES; DISORDER; DISEASE	Accurate and efficient detection of sleep spindles is a methodological challenge. The present study describes a method of using non-experts for manual detection of sleep spindles. We recruited five experts and 168 non-experts to manually identify spindles in stage N2 and stage N3 sleep data using a MATLAB interface. Scorers classified each spindle into definite and indefinite spindle (with weights of 1 and 0.5, respectively). First, a method of optimizing the thresholds of the expert/non-expert group consensus according to the results of experts and non-experts themselves is described. Using this method, we established expert and non-expert group standards from expert and non-expert scorers, respectively, and evaluated the performance of the non-expert group standards by compared with the expert group standard (termed EGS). The results indicated that the highest performance was the nonexpert group standard when definite spindles were only considered (termed nEGS-1; F1 score = 0.78 for N2; 0.68 for N3). Second, four automatic spindle detection methods were compared with the EGS. We found that the performance of nEGS-1 versus EGS was higher than that of the four automated methods. Our results also showed positive correlation between the mean F1 score of individual expert in EGS and the F1 score of nEGS-1 versus EGS across 30 segments of stage N2 data (r = 0.61, P < 0.001). Further, we found that six and nine non-experts were needed to manually identify spindles in stages N2 and N3, respectively, while maintaining acceptable performance of nEGS-1 versus EGS (F1 score = 0.79 for N2; 0.64 for N3). In conclusion, this study establishes a detailed process for detection of sleep spindles by non-experts in a crowdsourcing scheme.	[Zhao, Rui; Sun, Jinbo; Zhang, Xinxin; Wu, Huanju; Liu, Peng; Yang, Xuejuan; Qin, Wei] Xidian Univ, Sch Life Sci & Technol, Sleep & Neuroimage Grp, Xian, Shaanxi, Peoples R China	Xidian University	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Sleep & Neuroimage Grp, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn	秦, 伟/J-9770-2016; JinBo, Sun/GLT-2082-2022	秦, 伟/0000-0003-4583-0406; 	National Basic Research Program of China [2015CB856403, 2014CB543203, 2012CB518501]; National Natural Science Foundation of China [81271644, 81471811, 81471738, 61401346]; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financially supported by National Basic Research Program of China under Grant Nos. 2015CB856403, 2014CB543203 and 2012CB518501; the National Natural Science Foundation of China under Grant Nos. 81271644, 81471811, 81471738 and 61401346; and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acir N, 2004, EXPERT SYST APPL, V27, P451, DOI 10.1016/j.eswa.2004.05.007; Bodizs R, 2005, J SLEEP RES, V14, P285, DOI 10.1111/j.1365-2869.2005.00472.x; Bodizs R, 2009, J NEUROSCI METH, V178, P205, DOI 10.1016/j.jneumeth.2008.11.006; CAMPBELL K, 1980, ELECTROEN CLIN NEURO, V48, P602, DOI 10.1016/0013-4694(80)90296-5; Carskadon M.A., 2000, PRINCIPLES PRACTICE, V2, P16; Chen C, 2014, J SURG RES, V187, P65, DOI 10.1016/j.jss.2013.09.024; Christensen JAE, 2014, CLIN NEUROPHYSIOL, V125, P512, DOI 10.1016/j.clinph.2013.08.013; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; De Gennaro L, 2005, NEUROIMAGE, V26, P114, DOI 10.1016/j.neuroimage.2005.01.020; De Gennaro L, 2000, Sleep Res Online, V3, P155; Devuyst S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3883; Devuyst S, 2011, ENG MED BIOL SOC EMB; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Fogel SM, 2007, BEHAV NEUROSCI, V121, P1, DOI 10.1037/0735-7044.121.1.1; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; GAILLARD JM, 1981, SLEEP, V4, P385, DOI 10.1093/sleep/4.4.385; Gais S, 2002, J NEUROSCI, V22, P6830; Gorurr D., AUTOMATED DETECTION; Hagemann D, 2008, CLIN NEUROPHYSIOL, V119, P1271, DOI 10.1016/j.clinph.2008.02.010; Huupponen E, 2007, ARTIF INTELL MED, V40, P157, DOI 10.1016/j.artmed.2007.04.003; Latreille V, 2015, NEUROBIOL AGING, V36, P1083, DOI 10.1016/j.neurobiolaging.2014.09.009; Limoges E, 2005, BRAIN, V128, P1049, DOI 10.1093/brain/awh425; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; McCormick L, 1997, SLEEP, V20, P939, DOI 10.1093/sleep/20.11.939; Medicine AAoS, 2007, AASM MANUAL SCORING; Mitry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117401; Molle M, 2002, J NEUROSCI, V22, P10941; Montagna P, 2005, SLEEP MED REV, V9, P339, DOI 10.1016/j.smrv.2005.02.001; Montagna P, 2003, LANCET NEUROL, V2, P167, DOI 10.1016/S1474-4422(03)00323-5; Morin A, 2008, SLEEP, V31, P1149; Nguyen TB, 2012, RADIOLOGY, V262, P824, DOI 10.1148/radiol.11110938; Nicolas A, 2001, CLIN NEUROPHYSIOL, V112, P521, DOI 10.1016/S1388-2457(00)00556-3; Nowak S., 2010, INT C MULT INF RETR; Plante DT, 2013, J AFFECT DISORDERS, V146, P120, DOI 10.1016/j.jad.2012.06.016; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Ray LB, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00507; Ray LB, 2010, J SLEEP RES, V19, P374, DOI 10.1111/j.1365-2869.2009.00802.x; Rice JK, 2013, NEUROIMAGE, V64, P476, DOI 10.1016/j.neuroimage.2012.09.041; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; SCHIMICEK P, 1994, CLIN ELECTROENCEPHAL, V25, P26, DOI 10.1177/155005949402500108; Sitnikova E, 2009, J NEUROSCI METH, V180, P304, DOI 10.1016/j.jneumeth.2009.04.006; Ujma PP, 2014, J NEUROSCI, V34, P16358, DOI 10.1523/JNEUROSCI.1857-14.2014; Ventouras EM, 2005, COMPUT METH PROG BIO, V78, P191, DOI 10.1016/j.cmpb.2005.02.006; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wamsley EJ, 2012, BIOL PSYCHIAT, V71, P154, DOI 10.1016/j.biopsych.2011.08.008; Warby SC, 2014, NAT METHODS, V11, P385, DOI [10.1038/nmeth.2855, 10.1038/NMETH.2855]; Wendt SL, 2014, CLIN NEUROPHYSIOLOGY; Werth E, 1997, ELECTROEN CLIN NEURO, V103, P535, DOI 10.1016/S0013-4694(97)00070-9; Zeitlhofer J, 1997, J SLEEP RES, V6, P149, DOI 10.1046/j.1365-2869.1997.00046.x; Zygierewicz J, 1999, CLIN NEUROPHYSIOL, V110, P2136, DOI 10.1016/S1388-2457(99)00175-3	51	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177437	10.1371/journal.pone.0177437	http://dx.doi.org/10.1371/journal.pone.0177437			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493938	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300108
J	Hu, WJ; Pan, XL; Abbas, HMK; Li, FF; Dong, WB				Hu, Wenjin; Pan, Xinli; Abbas, Hafiz Muhammad Khalid; Li, Fengfeng; Dong, Wubei			Metabolites contributing to Rhizoctonia solani AG-1-IA maturation and sclerotial differentiation revealed by UPLC-QTOF-MS metabolomics	PLOS ONE			English	Article							CONTAINING AMINO-ACIDS; THIOL REDOX STATE; TENUAZONIC ACID; PROTEOMIC ANALYSIS; SPECTROMETRY DATA; NITRIC-OXIDE; GROWTH; BIOSYNTHESIS; COMPOUND; ROLFSII	Rhizoctonia solani is a causative agent of sheath blight, which results in huge economic losses every year. During its life cycle, the formation of sclerotia helps Rhizoctonia solani withstand a variety of unfavorable factors. Oxidative stress is a key factor that induces sclerotium formation. The differentiated and undifferentiated phenotypes of R. solani AG-1-IA were obtained by controlling aerial conditions. Metabolomics based on the mass spectrometry technique combined with multivariate and univariate analyses was used to investigate the metabolic variation in vegetative, differentiated and undifferentiated mycelia. Our results revealed that during maturation, the metabolic levels of N2-acetyl-L-ornithine,3,1'-( OH)2-Gamma-carotene, (5Z, 7E)-(1S, 3R)-24,24-difluoro-24a-homo-9,10-seco-5,7,10(19)cholestatrien-1,3,25-triol, stoloniferone O, PA(O-18: 0/12: 0), PA(P-16: 0/14: 0), PA(P-16: 0/16:( 19Z)) and PA(P-16: 0/17: 2(9Z, 12Z)) were suppressed in both differentiated and undifferentiated mycelia. The concentrations of PE(20: 1(11Z)/14: 1(9Z)), PE(P-16: 0/20: 4 (5Z, 8Z, 11Z, 13E)(15OH[ S])) and PS(12: 0/18: 1(9Z)) were increased in the differentiated group, while increased levels of N(gamma)-nitro-L-arginine, tenuazonic acid and 9S, 10S, 11R-trihydroxy-12Z, 15Z-octadecadienoic acid were found in the undifferentiated group. Our results suggest that different levels of these metabolites may act as biomarkers for the developmental stages of R. solani AG-1-IA. Moreover, the mechanisms of sclerotium formation and mycelium differentiation were elucidated at the metabolic level.	[Hu, Wenjin; Abbas, Hafiz Muhammad Khalid; Li, Fengfeng; Dong, Wubei] Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Pathol, Wuhan, Hubei Province, Peoples R China; [Hu, Wenjin; Abbas, Hafiz Muhammad Khalid; Li, Fengfeng; Dong, Wubei] Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Hubei Province, Peoples R China; [Pan, Xinli] Tech Univ Dortmund, Dept Biochem & Chem Engn, Dortmund, Germany	Huazhong Agricultural University; Huazhong Agricultural University; Dortmund University of Technology	Dong, WB (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Pathol, Wuhan, Hubei Province, Peoples R China.; Dong, WB (corresponding author), Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Hubei Province, Peoples R China.	dwb@mail.hzau.edu.cn	Abbas, Hafiz Muhammad Khalid/AAD-7630-2019	Abbas, Hafiz Muhammad Khalid/0000-0002-9355-7734; Dong, Wubei/0000-0001-8513-8751	National Major Project for Transgenic Organism Breeding [2011ZX08003-001, 2016ZX08003-001]; Hubei Provincial Technology Innovation Program [2016ABA093]	National Major Project for Transgenic Organism Breeding; Hubei Provincial Technology Innovation Program	This work was supported by the National Major Project for Transgenic Organism Breeding (2011ZX08003-001 and 2016ZX08003-001) and the Hubei Provincial Technology Innovation Program (2016ABA093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Drs. Guoying Wang and Yunjun Liu for comments and suggestions on the experimental design and data analysis. This work was supported by the National Major Project for Transgenic Organism Breeding (2011ZX08003-001 and 2016ZX08003-001) and the Hubei Provincial Technology Innovation Program (2016ABA093).	Akhtar J., 2009, Asian Journal of Agricultural Sciences, V1, P32; Aliferis KA, 2010, METABOLOMICS, V6, P96, DOI 10.1007/s11306-009-0180-4; Aliferis KA, 2010, J AGR FOOD CHEM, V58, P7604, DOI 10.1021/jf101029a; Anderson JP, 2016, MOL CELL PROTEOMICS, V15, P1188, DOI 10.1074/mcp.M115.054502; Baidya S, 2011, APPL ENVIRON MICROB, V77, P5524, DOI 10.1128/AEM.00638-11; Bernardes-de-Assis J, 2009, PHYTOPATHOLOGY, V99, P1090, DOI 10.1094/PHYTO-99-9-1090; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Calvo AM, 1999, APPL ENVIRON MICROB, V65, P3668; CHET I, 1966, J GEN MICROBIOL, V45, P541, DOI 10.1099/00221287-45-3-541; CHRISTIAS C, 1975, CAN J MICROBIOL, V21, P1541, DOI 10.1139/m75-226; COLEYSMI.JR, 1971, ANNU REV PHYTOPATHOL, V9, P65, DOI 10.1146/annurev.py.09.090171.000433; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Georgiou CD, 2001, PLANT PATHOL, V50, P594, DOI 10.1046/j.1365-3059.2001.00608.x; Georgiou CD, 2000, MYCOL RES, V104, P1191, DOI 10.1017/S0953756200002707; Georgiou CD, 1997, MYCOL RES, V101, P460, DOI 10.1017/S0953756296002882; Georgiou CD, 2006, INTEGR COMP BIOL, V46, P691, DOI 10.1093/icb/icj034; GITTERMA.CO, 1965, J MED CHEM, V8, P483, DOI 10.1021/jm00328a015; HENDRIX JW, 1970, ANNU REV PHYTOPATHOL, V8, P111, DOI 10.1146/annurev.py.08.090170.000551; Huan JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02303; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; KOSENKO E, 1995, NEUROCHEM RES, V20, P451, DOI 10.1007/BF00973101; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Kwon YS, 2014, FUNGAL BIOL-UK, V118, P433, DOI 10.1016/j.funbio.2014.02.001; LEBRUN MH, 1988, PHYTOCHEMISTRY, V27, P77, DOI 10.1016/0031-9422(88)80594-6; Liang Y, 2010, FUNGAL BIOL-UK, V114, P619, DOI 10.1016/j.funbio.2010.05.003; MILLER FA, 1963, NATURE, V200, P1338, DOI 10.1038/2001338a0; Mooney S, 2009, MOLECULES, V14, P329, DOI 10.3390/molecules14010329; Nes WD, 2009, ARCH BIOCHEM BIOPHYS, V481, P210, DOI 10.1016/j.abb.2008.11.003; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; Papapostolou I, 2010, FUNGAL BIOL-UK, V114, P387, DOI 10.1016/j.funbio.2010.01.010; Patsoukis N, 2008, MYCOL RES, V112, P602, DOI 10.1016/j.mycres.2007.10.006; Patsoukis N, 2007, MYCOPATHOLOGIA, V163, P335, DOI 10.1007/s11046-007-9008-9; Priyatmojo A, 2002, J PHYTOPATHOL, V150, P1, DOI 10.1046/j.1439-0434.2002.00707.x; Ritchie F, 2006, MYCOL RES, V110, P725, DOI 10.1016/j.mycres.2006.04.008; ROSETT T, 1957, BIOCHEM J, V67, P390, DOI 10.1042/bj0670390; Ruttkies C, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0115-9; Samsatly J, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01429; SHAPIRA R, 1989, J GEN MICROBIOL, V135, P1361; SHIGEURA HT, 1963, BIOCHEMISTRY-US, V2, P1132, DOI 10.1021/bi00905a039; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sonaimuthu V, 2011, MICROBIOL RES-ITALY, V2, DOI 10.4081/mr.2011.e17; STEYN PS, 1976, PHYTOCHEMISTRY, V15, P1977, DOI 10.1016/S0031-9422(00)88860-3; Sumner DR, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P207; TOWNSEND B. B., 1954, TRANS BRIT MYCOL SOC, V37, P213; TREVETHICK J, 1971, T BRIT MYCOL SOC, V57, P340, DOI 10.1016/S0007-1536(71)80017-7; UMETSU N, 1972, AGR BIOL CHEM TOKYO, V36, P859, DOI 10.1080/00021369.1972.10860315; Yun CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9758; Zervoudakis G, 2003, MYCOL RES, V107, P624, DOI 10.1017/S0953756203007822; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004	51	14	15	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177464	10.1371/journal.pone.0177464	http://dx.doi.org/10.1371/journal.pone.0177464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489938	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314100078
J	Pennisi, M; Lanza, G; Cantone, M; Ricceri, R; Ferri, R; D'Agate, CC; Pennisi, G; Di Lazzaro, V; Bella, R				Pennisi, Manuela; Lanza, Giuseppe; Cantone, Mariagiovanna; Ricceri, Riccardo; Ferri, Raffaele; D'Agate, Carmela Cinzia; Pennisi, Giovanni; Di Lazzaro, Vincenzo; Bella, Rita			Cortical involvement in celiac disease before and after long-term gluten-free diet: A Transcranial Magnetic Stimulation study	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR CORTEX EXCITABILITY; SLEEP-APNEA SYNDROME; INTRACORTICAL INHIBITION; SILENT PERIOD; DIAGNOSIS; ANTIBODIES; AUTOANTIBODIES; DISTURBANCES; VARIABILITY	Objective Transcranial Magnetic Stimulation in de novo patients with Celiac Disease previously revealed an imbalance in the excitability of cortical facilitatory and inhibitory circuits. After a median period of 16 months of gluten-free diet, a global increase of cortical excitability was reported, suggesting a glutamate-mediated compensation for disease progression. We have now evaluated cross-sectionally the changes of cortical excitability to TMS after a much longer gluten-free diet. Methods Twenty patients on adequate gluten-free diet for a mean period of 8.35 years were enrolled and compared with 20 de novo patients and 20 healthy controls. Transcranial Magnetic Stimulation measures, recorded from the first dorsal interosseous muscle of the dominant hand, consisted of: resting motor threshold, cortical silent period, motor evoked potentials, central motor conduction time, mean short-latency intracortical inhibition and intracortical facilitation. Results The cortical silent period was shorter in de novo patients, whereas in gluten-free diet participants it was similar to controls. The amplitude of motor responses was significantly smaller in all patients than in controls, regardless of the dietary regimen. Notwithstanding the diet, all patients exhibited a statistically significant decrease of mean short-latency intracortical inhibition and enhancement of intracortical facilitation with respect to controls; more intracortical facilitation in gluten-restricted compared to non-restricted patients was also observed. Neurological examination and celiac disease-related antibodies were negative. Conclusions In this new investigation, the length of dietary regimen was able to modulate the electrocortical changes in celiac disease. Nevertheless, an intracortical synaptic dysfunction, mostly involving excitatory and inhibitory interneurons within the motor cortex, may persist. The clinical significance of subtle neurophysiological changes in celiac disease needs to be further investigated.	[Pennisi, Manuela] Emergency Hosp Cannizzaro, Spinal Unit, Catania, Italy; [Lanza, Giuseppe; Cantone, Mariagiovanna; Ferri, Raffaele] IRCCS Oasi Maria SS, Dept Neurol IC, Troina, Enna, Italy; [Ricceri, Riccardo; Bella, Rita] Univ Catania, Dept Med & Surg Sci & Adv Technol, Sect Neurosci, Catania, Italy; [D'Agate, Carmela Cinzia] Univ Catania, Gastroenterol & Endoscopy Unit, Catania, Italy; [Pennisi, Giovanni] Univ Catania, Dept Specialita Med Chirurg, Catania, Italy; [Di Lazzaro, Vincenzo] Campus Biomed Univ, Inst Neurol, Rome, Italy	IRCCS Oasi Maria SS; University of Catania; University of Catania; University of Catania; University Campus Bio-Medico - Rome Italy	Lanza, G (corresponding author), IRCCS Oasi Maria SS, Dept Neurol IC, Troina, Enna, Italy.	glanza@oasi.en.it	Cantone, Mariagiovanna/C-9392-2017; Pennisi, Manuela/AAC-2362-2019; Lanza, Giuseppe/R-3065-2017; Di Lazzaro, Vincenzo/L-3731-2018; Ferri, Raffaele/B-5439-2013	Cantone, Mariagiovanna/0000-0002-9072-4971; Pennisi, Manuela/0000-0003-0776-1411; Lanza, Giuseppe/0000-0002-5659-662X; Di Lazzaro, Vincenzo/0000-0002-9113-5925; Ferri, Raffaele/0000-0001-6937-3065				Alaedini A, 2007, J IMMUNOL, V178, P6590, DOI 10.4049/jimmunol.178.10.6590; Bella R, 2016, BRAIN STIMUL, V9, P225, DOI 10.1016/j.brs.2015.09.013; Bella R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129218; Bella R, 2011, INT J PSYCHOPHYSIOL, V82, P248, DOI 10.1016/j.ijpsycho.2011.09.006; Benwell NM, 2007, EXP BRAIN RES, V179, P255, DOI 10.1007/s00221-006-0790-2; Biagi F, 2012, BRIT J NUTR, V108, P1884, DOI 10.1017/S0007114511007367; Bilgic B, 2013, NEUROL SCI, V34, P2199, DOI 10.1007/s10072-013-1448-z; Brown KJ, 2010, AM J NEURORADIOL, V31, P880, DOI 10.3174/ajnr.A1826; Cantello R, 2002, J CLIN NEUROPHYSIOL, V19, P272, DOI 10.1097/00004691-200208000-00003; Cantone M, 2014, CLIN NEUROPHYSIOL, V125, P1509, DOI 10.1016/j.clinph.2014.04.010; Chin Russell L, 2005, Curr Treat Options Neurol, V7, P43, DOI 10.1007/s11940-005-0005-3; Concerto C, 2015, INT J PSYCHIAT CLIN, V19, P253, DOI 10.3109/13651501.2015.1084329; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Currie S, 2012, J NEUROL NEUROSUR PS, V83, P1216, DOI 10.1136/jnnp-2012-303281; Di Lazzaro V, 2001, EXP BRAIN RES, V141, P121; Di Lazzaro V, 2014, J PHYSIOL-LONDON, V592, P4115, DOI 10.1113/jphysiol.2014.274316; Di Lazzaro V, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00018; Di Lazzaro V, 2010, LANCET, V376, P1798, DOI 10.1016/S0140-6736(10)61163-4; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Freeman HJ, 2008, CAN J GASTROENTEROL, V22, P273, DOI 10.1155/2008/905325; Gadoth A, 2015, JAMA NEUROL, V72, P676, DOI 10.1001/jamaneurol.2015.48; Giordano D, 2012, COMPUT METH PROG BIO, V107, P4, DOI 10.1016/j.cmpb.2011.10.008; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hadjivassiliou M, 2004, P 11 INT S CEL DIS B; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jackson JR, 2012, PSYCHIAT QUART, V83, P91, DOI 10.1007/s11126-011-9186-y; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lanza G, 2015, SLEEP MED REV, V19, P39, DOI 10.1016/j.smrv.2014.04.001; Lanza G, 2015, SLEEP MED, V16, P138, DOI 10.1016/j.sleep.2014.08.016; Ludvigsson JF, 2014, EUR J NEUROL, V21, P976, DOI 10.1111/ene.12419; Luostarinen L, 2003, J NEUROL NEUROSUR PS, V74, P490, DOI 10.1136/jnnp.74.4.490; Mavroudi A, 2005, PEDIATR NEUROL, V33, P292, DOI 10.1016/j.pediatrneurol.2005.05.010; Mesrati F, 2004, NEUROPHYSIOL CLIN, V34, P217, DOI 10.1016/j.neucli.2004.09.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Orth M, 2003, CLIN NEUROPHYSIOL, V114, P2362, DOI 10.1016/S1388-2457(03)00243-8; Parisi P, 2015, SEIZURE-EUR J EPILEP, V25, P181, DOI 10.1016/j.seizure.2014.09.016; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pennisi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102790; Pennisi M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8154969; Rigamonti A, 2007, MUSCLE NERVE, V35, P675, DOI 10.1002/mus.20727; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; Sanger TD, 2001, J PHYSIOL-LONDON, V530, P307, DOI 10.1111/j.1469-7793.2001.0307l.x; Spampinato C, 2013, IEEE T NEUR SYS REH, V21, P391, DOI 10.1109/TNSRE.2013.2256432; Takenoshita H, 2001, J NEUROL NEUROSUR PS, V70, P386, DOI 10.1136/jnnp.70.3.386; Tijssen MAJ, 2000, NEUROLOGY, V54, P1350, DOI 10.1212/WNL.54.6.1350; Turner MR, 2007, NAT CLIN PRACT NEURO, V3, P581, DOI 10.1038/ncpneuro0631; Turner MR, 2013, NEUROLOGY, V81, P1222, DOI 10.1212/WNL.0b013e3182a6cc13; Tursi A, 2006, DIGEST DIS SCI, V51, P1869, DOI 10.1007/s10620-005-9054-4; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; WILLIAMSON S, 1995, J AUTONOM NERV SYST, V55, P18, DOI 10.1016/0165-1838(95)00028-V; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 1996, EXP BRAIN RES, V109, P127; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028	65	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177560	10.1371/journal.pone.0177560	http://dx.doi.org/10.1371/journal.pone.0177560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489931	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100079
J	van Boekel, RLM; Vissers, KCP; van der Sande, R; Bronkhorst, E; Lerou, JGC; Steegers, MAH				van Boekel, Regina L. M.; Vissers, Kris C. P.; van der Sande, Rob; Bronkhorst, Ewald; Lerou, Jos G. C.; Steegers, Monique A. H.			Moving beyond pain scores: Multidimensional pain assessment is essential for adequate pain management after surgery	PLOS ONE			English	Article							SEVERE POSTOPERATIVE PAIN; PATIENT SATISFACTION; INTERNATIONAL PAIN; RATING-SCALES; PROFESSIONALS; PERSPECTIVES; PERCEPTIONS; VALIDATION; INPATIENTS; OPIOIDS	Background Clinical experience teaches us that patients are willing to accept postoperative pain, despite high pain intensity scores. Nevertheless, relationships between pain scores and other methods of pain assessment, e.g. acceptability of pain or its interference with physical functioning, are not fully established. Our aims were to examine these relationships. Methods A cross-sectional study was conducted on patients who underwent major surgery between January 2008 and August 2013. Using logistic regression, we quantified the relationships between movement-evoked pain scores on the numerical rating scale (NRS-MEP) and three dichotomous dependent variables: patient's opinion on acceptability of pain (PO: acceptable or unacceptable pain); nurses' observation of patient's performance of necessary activities to expedite recovery (NO: good or bad performance); a compound measure judging the presence of the clinically desirable situation of acceptable pain associated with good patients' performance (PONO: present or not). Using Receiver Operating Characteristics (ROC) analysis, NRS cut-off points were determined such that they best discriminate between patients having one versus the other outcome for PO, NO and PONO. Results 15,394 assessments were obtained in 9,082 patients in the first three postoperative days. Nine percent of the patients had unacceptable pain while having an NRS-MEP of 0-4. An estimated 47% (95% CI = 45%-49%) of patients with an NRS-MEP of 7 described their pain as acceptable on day one. Moreover, 33% (31%-35%) performed all required physical activities, and 22% (21%-24%) combined acceptable pain with appropriate movement. NRS cutoff points for PO, NO and PONO were five, four and four, respectively, but had insufficient discriminatory power. Conclusions Our results suggest pain management should be guided by the many dimensions of the patient's pain experience, not solely by NRS cut-off points. Future research should evaluate the impact of such multidimensional pain assessment on patients' functional outcome.	[van Boekel, Regina L. M.; Vissers, Kris C. P.; Lerou, Jos G. C.; Steegers, Monique A. H.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands; [van der Sande, Rob] HAN Univ Appl Sci, Fac Hlth, Nijmegen, Netherlands; [Bronkhorst, Ewald] Radboud Univ Nijmegen, Med Ctr, Dept Med Stat, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Boekel, RLM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands.	Rianne.vanBoekel@Radboudumc.nl	Vissers, Kris C.P./D-3569-2009; van Boekel, Regina/P-9452-2015; Bronkhorst, Ewald/AAR-2250-2020; Vissers, Kris/H-8110-2014; Steegers, M.A.H./L-4668-2015; Bronkhorst, Ewald/L-4230-2015	Vissers, Kris C.P./0000-0002-2919-6356; van Boekel, Regina/0000-0002-0962-2944; Bronkhorst, Ewald/0000-0003-0953-8053; Vissers, Kris/0000-0002-2919-6356; Lerou, Jos/0000-0003-4006-292X; van der Sande, Rob/0000-0003-1410-900X; Steegers, Monique/0000-0003-0812-5089				Anand KJS, 1996, PAIN, V67, P3, DOI 10.1016/0304-3959(96)03135-1; [Anonymous], ACUTE PAIN MANAGEMEN; Aubrun F, 2003, ANESTHESIOLOGY, V98, P1415, DOI 10.1097/00000542-200306000-00017; Bartlett JW, 2015, AM J EPIDEMIOL, V182, P730, DOI 10.1093/aje/kwv114; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Carr ECJ, 1997, J CLIN NURS, V6, P191, DOI 10.1111/j.1365-2702.1997.tb00304.x; Clark WC, 2002, PAIN, V98, P241, DOI 10.1016/S0304-3959(01)00474-2; Galley HF, 2004, BRIT J ANAESTH, V93, P623, DOI 10.1093/bja/aeh247; Gan TJ, 2014, CURR MED RES OPIN, V30, P149, DOI 10.1185/03007995.2013.860019; Gerbershagen HJ, 2011, BRIT J ANAESTH, V107, P619, DOI 10.1093/bja/aer195; Gerbershagen HJ, 2014, ANESTHESIOLOGY, V120, P1237, DOI 10.1097/ALN.0000000000000108; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Goesling J, 2016, PAIN, V157, P1259, DOI 10.1097/j.pain.0000000000000516; Gordon DB, 2015, CURR OPIN ANESTHESIO, V28, P565, DOI 10.1097/ACO.0000000000000225; Harting B, 2013, QUAL MANAG HEALTH CA, V22, P322, DOI 10.1097/QMH.0000000000000009; Helfand M, 2009, PAIN MED, V10, P1183, DOI 10.1111/j.1526-4637.2009.00718.x; Hosmer DW, 2005, APPL LOGISTIC REGRES, P1; Inspectorate DHC, BAS SET QUAL IND HOS; Ista E, 2013, INT J NURS STUD, V50, P552, DOI 10.1016/j.ijnurstu.2012.11.003; Janssen KJM, 2008, ANESTH ANALG, V107, P1330, DOI 10.1213/ane.0b013e31818227da; Liu SS, 2012, INT ORTHOP, V36, P2261, DOI 10.1007/s00264-012-1623-5; Macintyre P, 2008, CLIN PAIN MANAGEMENT, V1, P148; MacIntyre PE, 2009, COUSINS BRIDENBAUGHS, P1043; Maroney Catherine L, 2004, J Palliat Med, V7, P443, DOI 10.1089/1096621041349563; Massaron S, 2007, Hernia, V11, P517, DOI 10.1007/s10029-007-0267-7; McCaffery M., 1968, U CALIFORNIA PRINT O; MERSKEY H, 1991, European Psychiatry, V6, P153; MERSKEY H, 1994, QUAL LIFE RES, V3, pS69, DOI 10.1007/BF00433379; Oudejans L, 2016, PAIN, V157, P128, DOI 10.1097/j.pain.0000000000000338; RAWAL N, 1994, PAIN, V57, P117, DOI 10.1016/0304-3959(94)90115-5; Rothaug J, 2013, J PAIN, V14, P1361, DOI 10.1016/j.jpain.2013.05.016; Rothaug J, 2013, CLIN J PAIN, V29, P224, DOI 10.1097/AJP.0b013e31824c5d7a; Schiavenato M, 2010, CLIN J PAIN, V26, P667, DOI 10.1097/AJP.0b013e3181e72507; Schug SA, 2016, MED J AUSTRALIA, V204, P315, DOI 10.5694/mja16.00133; Schwenkglenks M, 2014, PAIN, V155, P1401, DOI 10.1016/j.pain.2014.04.021; Sloman R, 2006, PAIN MANAG NURS, V7, P153, DOI 10.1016/j.pmn.2006.09.001; Sommer M, 2008, EUR J ANAESTH, V25, P267, DOI 10.1017/S0265021507003031; Srikandarajah S, 2011, PAIN, V152, P1734, DOI 10.1016/j.pain.2011.02.008; van Boekel RLM, 2016, CLIN J PAIN, V32, P681, DOI 10.1097/AJP.0000000000000315; van Dijk JFM, 2016, INT J NURS STUD, V53, P260, DOI 10.1016/j.ijnurstu.2015.08.007; van Dijk JFM, 2015, PAIN PRACT, V15, P604, DOI 10.1111/papr.12217; van Dijk JFM, 2012, INT J NURS STUD, V49, P65, DOI 10.1016/j.ijnurstu.2011.07.009; White PF, 2010, ANESTHESIOLOGY, V112, P220, DOI 10.1097/ALN.0b013e3181c6316e; Wikstrom L, 2014, APPL NURS RES, V27, P53, DOI 10.1016/j.apnr.2013.11.001; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Wu CL, 2011, LANCET, V377, P2215, DOI 10.1016/S0140-6736(11)60245-6	46	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177345	10.1371/journal.pone.0177345	http://dx.doi.org/10.1371/journal.pone.0177345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489926	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100065
J	Bie, YM; Liu, ZY; Wang, YH				Bie, Yiming; Liu, Zhiyuan; Wang, Yinhai			A real-time traffic control method for the intersection with pre-signals under the phase swap sorting strategy	PLOS ONE			English	Article							BUS PRIORITY; TURN INTERSECTIONS; OPTIMIZATION; CAPACITY	To deal with the conflicts between left-turn and through traffic streams and increase the discharge capacity, this paper addresses the pre-signal which is implemented at a signalized intersection. Such an intersection with pre-signal is termed as a tandem intersection. For the tandem intersection, phase swap sorting strategy is deemed as the most effective phasing scheme in view of some exclusive merits, such as easier compliance of drivers, and shorter sorting area. However, a major limitation of the phase swap sorting strategy is not considered in previous studies: if one or more vehicle is left at the sorting area after the signal light turns to red, the capacity of the approach would be dramatically dropped. Besides, previous signal control studies deal with a fixed timing plan that is not adaptive with the fluctuation of traffic flows. Therefore, to cope with these two gaps, this paper firstly takes an in-depth analysis of the traffic flow operations at the tandem intersection. Secondly, three groups of loop detectors are placed to obtain the real-time vehicle information for adaptive signalization. The lane selection behavior in the sorting area is considered to set the green time for intersection signals. With the objective of minimizing the vehicle delay, the signal control parameters are then optimized based on a dynamic programming method. Finally, numerical experiments show that average vehicle delay and maximum queue length can be reduced under all scenarios.	[Bie, Yiming] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin, Peoples R China; [Liu, Zhiyuan] Southeast Univ, Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Jiangsu Key Lab Urban ITS, Nanjing, Jiangsu, Peoples R China; [Wang, Yinhai] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	Harbin Institute of Technology; Southeast University - China; University of Washington; University of Washington Seattle	Liu, ZY (corresponding author), Southeast Univ, Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Jiangsu Key Lab Urban ITS, Nanjing, Jiangsu, Peoples R China.	zhiyuanl@seu.edu.cn	Wang, Yinhai/B-5396-2012; 别, 一鸣/B-1070-2009	Wang, Yinhai/0000-0002-4180-5628; 别, 一鸣/0000-0003-4651-1570	National Natural Science Foundation of China [51638004, 51138003]; Postdoctoral Startup Foundation of Heilongjiang Province [LBHQ15050]; Opening Foundation of the Intelligent Traffic Engineering Technology Research Center of Yunan Province Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Startup Foundation of Heilongjiang Province; Opening Foundation of the Intelligent Traffic Engineering Technology Research Center of Yunan Province Universities	This study is supported by the National Natural Science Foundation of China (No. 51638004 & 51138003), the Postdoctoral Startup Foundation of Heilongjiang Province (LBHQ15050) and the Opening Foundation of the Intelligent Traffic Engineering Technology Research Center of Yunan Province Universities.	Bie YM, 2016, J ADV TRANSPORT, V50, P197, DOI 10.1002/atr.1316; Cai C, 2009, TRANSPORT RES C-EMER, V17, P456, DOI 10.1016/j.trc.2009.04.005; Gartner N.H., 1983, TRANSPORTATION RES R, V906, P75; Guler SI, 2016, TRANSPORT RES C-EMER, V63, P51, DOI 10.1016/j.trc.2015.12.005; Guler SI, 2014, TRANSPORT RES REC, P11, DOI 10.3141/2418-02; Guler SI, 2014, TRANSPORT RES B-METH, V64, P41, DOI 10.1016/j.trb.2014.03.004; Guler SI, 2012, TRANSPORT RES B-METH, V46, P1334, DOI 10.1016/j.trb.2012.09.002; He HT, 2016, TRANSPORT RES C-EMER, V64, P28, DOI 10.1016/j.trc.2016.01.009; Kuang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138617; Liu Z Bie Y., 2015, TRANSPORTMETRICA A, V11, P484; Ma WJ, 2013, TRANSPORT RES REC, P93, DOI 10.3141/2355-10; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Wu JP, 1998, TRANSPORT RES A-POL, V32, P563, DOI 10.1016/S0965-8564(98)00008-1; Xuan YG, 2011, TRANSPORT RES B-METH, V45, P769, DOI 10.1016/j.trb.2011.02.009; Yan CW, 2014, TRANSPORT RES B-METH, V60, P85, DOI 10.1016/j.trb.2013.12.001; Zhao J, 2015, TRANSPORT RES C-EMER, V61, P29, DOI 10.1016/j.trc.2015.10.012; Zhou HG, 2003, TRANSPORT RES REC, P36, DOI 10.3141/1847-05; Zhou YP, 2014, J ADV TRANSPORT, V48, P362, DOI 10.1002/atr.1222	18	9	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177637	10.1371/journal.pone.0177637	http://dx.doi.org/10.1371/journal.pone.0177637			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531198	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400020
J	Ginindza, TG; Sartorius, B; Dlamini, X; Ostensson, E				Ginindza, Themba G.; Sartorius, Benn; Dlamini, Xolisile; Ostensson, Ellinor			Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland	PLOS ONE			English	Article							ECONOMIC BURDEN; HPV VACCINE; CANCER PREVENTION; HERD-IMMUNITY; PROGRAM; BENEFITS; AGE	Background Human papillomavirus (HPV) has proven to be the cause of several severe clinical conditions on the cervix, vulva, vagina, anus, oropharynx and penis. Several studies have assessed the costs of cervical lesions, cervical cancer (CC), and genital warts. However, few have been done in Africa and none in Swaziland. Cost analysis is critical in providing useful information for economic evaluations to guide policymakers concerned with the allocation of resources in order to reduce the disease burden. Materials and methods A prevalence-based cost of illness (COI) methodology was used to investigate the economic burden of HPV-related diseases. We used a top-down approach for the cost associated with hospital care and a bottom-up approach to estimate the cost associated with outpatient and primary care. The current study was conducted from a provider perspective since the state bears the majority of the costs of screening and treatment in Swaziland. All identifiable direct medical costs were considered for cervical lesions, cervical cancer and genital warts, which were primary diagnoses during 2015. A mix of bottom up micro-costing ingredients approach and top-down approaches was used to collect data on costs. All costs were computed at the price level of 2015 and converted to dollars ($). Results The total annual estimated direct medical cost associated with screening, managing and treating cervical lesions, CC and genital warts in Swaziland was $ 16 million. The largest cost in the analysis was estimated for treatment of high-grade cervical lesions and cervical cancer representing 80% of the total cost ($ 12.6 million). Costs for screening only represented 5% of the total cost ($ 0.9 million). Treatment of genital warts represented 6% of the total cost ($ 1million). Conclusion According to the cost estimations in this study, the economic burden of HPV-related cervical diseases and genital warts represents a major public health issue in Swaziland. Prevention of HPV infection with a national HPV immunization programme for pre-adolescent girls would prevent the majority of CC related deaths and associated costs.	[Ginindza, Themba G.; Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth, Durban, South Africa; [Dlamini, Xolisile] Minist Hlth, Epidemiol Unit, Mbabane, Eswatini; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden	University of Kwazulu Natal; Karolinska Institutet; Karolinska Institutet	Ginindza, TG (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth, Durban, South Africa.	Ginindza@ukzn.ac.za	Gindza, Prof. Themba G/N-5762-2013	Ginindza, Themba G/0000-0002-0993-8308; , bennsartorius/0000-0001-6761-2325	Kingdom of Swaziland Ministry of Health; International Agency for Research on Cancer (IARC); Swedish Cancer Foundation [C8 30305153]; WHO-Swaziland local office and Ministry of Health Epidemiology Unit; Sexual and Reproductive Health Unit (SRH); The University of KwaZulu-Natal, College of Health Sciences Doctoral Research Scholarship; Health and Welfare Sector Education and Training Authority (HWSETA)	Kingdom of Swaziland Ministry of Health; International Agency for Research on Cancer (IARC)(World Health Organization); Swedish Cancer Foundation; WHO-Swaziland local office and Ministry of Health Epidemiology Unit; Sexual and Reproductive Health Unit (SRH); The University of KwaZulu-Natal, College of Health Sciences Doctoral Research Scholarship; Health and Welfare Sector Education and Training Authority (HWSETA)	The University of KwaZulu-Natal, College of Health Sciences Doctoral Research Scholarship Grant and funding was received from the Health and Welfare Sector Education and Training Authority (HWSETA), funded the study. The funder had no role in the study design, data collection and analysis and decision to publish.; We thank the Kingdom of Swaziland Ministry of Health for technical, logistic, and financial support and allowing us to implement the study, and we also received support from the International Agency for Research on Cancer (IARC), the Swedish Cancer Foundation (C8 30305153), (URL: www.cancerfonden.se), WHO-Swaziland local office and Ministry of Health Epidemiology Unit and Sexual and Reproductive Health Unit (SRH). We are grateful for the facilities support, Phalala office and to the HPV/Cervical cancer research team.	Annemans Lieven, 2008, J Med Econ, V11, P135, DOI 10.3111/13696990801961611; Armstrong EP, 2010, J MANAGE CARE PHARM, V16, P217, DOI 10.18553/jmcp.2010.16.3.217; Barnighausen T, 2012, CLIN MICROBIOL INFEC, V18, P70, DOI 10.1111/j.1469-0691.2012.03977.x; Baio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049699; Bayas JM, 2008, GYNECOL ONCOL, V110, pS11, DOI [10.1016/j.ygyno.2008.05.011, 10.1016/j.ygyno.2008.06.029]; Borget I, 2011, VACCINE, V29, P5245, DOI 10.1016/j.vaccine.2011.05.018; Cameron RL, 2016, EMERG INFECT DIS, V22, P56, DOI 10.3201/eid2201.150736; Campos NG, 2012, INT J CANCER, V130, P2672, DOI 10.1002/ijc.26269; Centers for Disease Control and Prevention, 2015, CDC VACCINE PRICE LI; Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 2015, CENT DIS CONTR PREV; Central Statistic office, 2007, SAWZ POP HOUS CENS; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Drummond O B., 2005, METHODS EVALUATION H; Elfstrom KM, 2013, CURR OPIN ONCOL; Ginindza TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170189; GlaxoSmithKline, HIGHL PRESCR INF; Goldhaber-Fiebert Jeremy D, 2006, Cost Eff Resour Alloc, V4, P13, DOI 10.1186/1478-7547-4-13; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2008, VACCINE, V26, pM17, DOI 10.1016/j.vaccine.2008.06.018; Harper DM, 2008, VACCINE, V26, pA7, DOI 10.1016/j.vaccine.2008.01.013; Harper DM, 2010, DISCOV MED, V10, P7; Herweijer E, 2016, INT J CANCER, V138, P2867, DOI 10.1002/ijc.30035; Herweijer E, 2014, JAMA-J AM MED ASSOC, V311, P597, DOI 10.1001/jama.2014.95; Hillemanns P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-76; Hopelands Cancer Centre, 2016, CERV CANC TREATM COS; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Insinga RP, 2005, PHARMACOECONOMICS, V23, P1107, DOI 10.2165/00019053-200523110-00004; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Legood R, 2005, INT J CANCER, V117, P981, DOI 10.1002/ijc.21220; Levin CE, 2010, INT J CANCER, V127, P1404, DOI 10.1002/ijc.25150; Lipsy Robert J, 2008, Am J Manag Care, V14, pS177; Low JJH, 2012, ASIAN PAC J CANCER P, V13, P305, DOI 10.7314/APJCP.2012.13.1.305; Mandelblatt JS, 2002, JNCI-J NATL CANCER I, V94, P1469, DOI 10.1093/jnci/94.19.1469; Mayeaux EJ, 2008, J AM OSTEOPATH ASSOC, V108, pS2; Merck & Co, HIGHL PRESCR INF; Ostensson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139062; Ostensson E, 2013, ACTA OBSTET GYN SCAN, V92, P830, DOI 10.1111/aogs.12143; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Phalala Fund Administration Office, 2015, ANN REP YEAR 2014 15; Quentin W, 2011, TROP MED INT HEALTH, V16, P379, DOI 10.1111/j.1365-3156.2010.02722.x; Rice D P, 1985, Health Care Financ Rev, V7, P61; Schwarz TF, 2009, VACCINE, V27, P581, DOI 10.1016/j.vaccine.2008.10.088; Shavit O, 2012, APPL HEALTH ECON HEA, V10, P87, DOI 10.2165/11594780-000000000-00000; Shi Ju-Fang, 2012, BMC Health Serv Res, V12, P123, DOI 10.1186/1472-6963-12-123; STIGMA, 2019, GUID MAN SEX TRANSM; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; The Clinic Group, PRIV HLTH CAR SERV C; The Kingdom of Swaziland, 2013, CERV CANC SCREEN GUI; The Kingdom of Swaziland, 2015, HLTH MAN INF SYST HM; The Kingdom of Swaziland, 2015, ANN NAT SEX REPR HLT; The Kingdom of Swaziland Gorvernment and UNFPA, 2007, SWAZ POP PROJ 2007 2; The Kingdom of Swaziland. Swaziland National Cancer Registry, 2016, REP CAS CANC SWAZ 20; TrADING Economics, 2016, SWAZ GDP PER CAP; UNAIDS, 2012, SWAZ COUNTR REP MON; United Nations Environment Programme (UNEP)/GRID, 2005, TOP MAPS SO AFR TOP; Vijayaraghavan A, 2009, GYNECOL ONCOL, V112, P377, DOI 10.1016/j.ygyno.2008.08.030; Weisberg E, 2009, AUST FAM PHYSICIAN, V38, P72; Wiley D, 2006, OBSTET GYNECOL SURV, V61, pS3, DOI 10.1097/01.ogx.0000221010.82943.8c; World Health Organization, 2016, WORLD HLTH REP EXC S; World Health Organization, 2014, EV BAS REC HUM PAP V	65	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177762	10.1371/journal.pone.0177762	http://dx.doi.org/10.1371/journal.pone.0177762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531205	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400028
J	Park, M; Park, J; Baek, YM; Macy, M				Park, Minsu; Park, Jaram; Baek, Young Min; Macy, Michael			Cultural values and cross-cultural video consumption on YouTube	PLOS ONE			English	Article							TECHNOLOGY	Video-sharing social media like YouTube provide access to diverse cultural products from all over the world, making it possible to test theories that the Web facilitates global cultural convergence. Drawing on a daily listing of YouTube's most popular videos across 58 countries, we investigate the consumption of popular videos in countries that differ in cultural values, language, gross domestic product, and Internet penetration rate. Although online social media facilitate global access to cultural products, we find this technological capability does not result in universal cultural convergence. Instead, consumption of popular videos in culturally different countries appears to be constrained by cultural values. Cross-cultural convergence is more advanced in cosmopolitan countries with cultural values that favor individualism and power inequality.	[Park, Minsu; Macy, Michael] Cornell Univ, Dept Informat Sci, Ithaca, NY 14850 USA; [Park, Jaram] Korea Adv Inst Sci & Technol, Grad Sch Culture Technol, Daejeon, South Korea; [Baek, Young Min] Yonsei Univ, Dept Commun, Seoul, South Korea; [Macy, Michael] Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA	Cornell University; Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Cornell University	Macy, M (corresponding author), Cornell Univ, Dept Informat Sci, Ithaca, NY 14850 USA.; Baek, YM (corresponding author), Yonsei Univ, Dept Commun, Seoul, South Korea.; Macy, M (corresponding author), Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA.	ymbaek@yonsei.ac.kr; mwm14@cornell.edu	Park, Jaram/AAL-2905-2021	Park, Jaram/0000-0003-2737-8647; Park, Minsu/0000-0002-9610-2938	National Research Foundation of Korea [NRF-2016S1A3A2925033]; US National Science Foundation (NSF) [SES1303533, SES1226483]; Minerva Initiative [FA9550-15-1-0162]	National Research Foundation of Korea(National Research Foundation of Korea); US National Science Foundation (NSF)(National Science Foundation (NSF)); Minerva Initiative	We acknowledge funding from the National Research Foundation of Korea (NRF-2016S1A3A2925033), the US National Science Foundation (NSF SES1303533, SES1226483), and the Minerva Initiative (FA9550-15-1-0162).	Allport GW, 1954, CANADIAN PSYCHOL; [Anonymous], 1984, DISTINCTION SOCIAL C; Baek YM, 2015, SOC SCI COMPUT REV, V33, P730, DOI 10.1177/0894439314562184; Bail CA, 2016, P NATL ACAD SCI USA, V113, P11823, DOI 10.1073/pnas.1607151113; Barnett G. A., 1996, J INT COMMUNICATION, V3, P19, DOI [DOI 10.1080/13216597.1996.9751833, 10.1080/13216597.1996.9751833]; Barnett George A., 2006, J COMPUT-MEDIAT COMM, V11, P217, DOI DOI 10.1111/J.1083-6101.2006.TB00311.X; Baskerville RF, 2003, HOFSTEDE NEVER STUDI, P1; Berry J. W., 2002, CROSS CULTURAL PSYCH, DOI DOI 10.1017/CBO9780511974274; Burnett Robert, 1996, GLOBAL JUKEBOX INT M; Cha M, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P1; Choi J, 2013, COMPUT HUM BEHAV, V29, P2665, DOI 10.1016/j.chb.2013.07.006; Cisco, 2016, GLOB IP TRAFF FOR; de Mooij M, 2011, J INT CONSUM MARK, V23, P181, DOI 10.1080/08961530.2011.578057; Dwyer S, 2005, J INT MARKETING, V13, P1, DOI 10.1509/jimk.13.2.1.64859; Eveland WP, 2015, INT J PUBLIC OPIN R, V27, P461, DOI 10.1093/ijpor/edv007; Feather NT, 1990, BRIDGING GAP VALUES; Garcia-Gavilanes R, 2014, P 17 ACM C COMPUTER, P1511, DOI DOI 10.1145/2531602.2531725; Garcia-Gavilanes R., 2013, P 7 INT AAAI C WEBL, P195; Geertz C., 1996, CONT SOCIOLOGY; Gillespie T, 2014, INSIDE TECHNOL, P167; Gudykunst W.B., 2000, INTERCULT COMMUN STU, V9, P1; Gudykunst WB, 1996, HUM COMMUN RES, V22, P510, DOI 10.1111/j.1468-2958.1996.tb00377.x; Gudykunst WB, 1999, INTERCULTURAL COMMUN, V9, P1; Hofstede G., 1980, CULTURES CONSEQUENCE; Hofstede G., 2010, CULTURES ORG SOFTWAR; Krishnan S, 2016, COMPUT HUM BEHAV, V54, P691, DOI 10.1016/j.chb.2015.07.055; Lee SG, 2013, J WORLD BUS, V48, P20, DOI 10.1016/j.jwb.2012.06.003; Leong CH, 2006, INT J INTERCULT REL, V30, P799, DOI 10.1016/j.ijintrel.2006.07.001; Maitland C.F., 2001, CULTURE TECHNOLOGY C, P87; Mooij M.D., 2003, INT J ADVERT, V22, P183, DOI [10.1080/02650487.2003.11072848, DOI 10.1080/02650487.2003.11072848, DOI 10.1016/S0022-4359(01)00067-7]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Norris Pippa, 2009, COSMOPOLITAN COMMUNI; Nye J., 2004, SOFT POWER MEANS SUC; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Park J, 2014, J COMMUN, V64, P333, DOI 10.1111/jcom.12086; Park M, 2015, P INT AAAI C WEB SOC; Park M, 2016, P INT AAAI C WEB SOC; Platt EL, 2015, P INT AAAI C WEB SOC; Rokeach M., 1973, NATURE HUMAN VALUES; Ronen S, 2014, P NATL ACAD SCI USA, V111; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; State B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122543; Stichele AV, 2006, POETICS, V34, P45, DOI 10.1016/j.poetic.2005.09.002; Stirling A, 2007, J R SOC INTERFACE, V4, P707, DOI 10.1098/rsif.2007.0213; STRAUBHAAR JD, 1991, CRIT STUD MASS COMM, V8, P39, DOI 10.1080/15295039109366779; Taneja H, 2016, J COMMUN, V66, P161, DOI 10.1111/jcom.12200; Wen G, 2009, CROSS CULT MANAG, V16, P83, DOI 10.1108/13527600910930059; World Bank Open Data, 2014, INT US PER 100 PEOPL; Zhou LX, 2003, J INT MARKETING, V11, P36, DOI 10.1509/jimk.11.2.36.20163	49	13	13	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177865	10.1371/journal.pone.0177865	http://dx.doi.org/10.1371/journal.pone.0177865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28531228	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400032
J	Weber, N; Bouwes, N; Pollock, MM; Volk, C; Wheaton, JM; Wathen, G; Wirtz, J; Jordan, CE				Weber, Nicholas; Bouwes, Nicolaas; Pollock, Michael M.; Volk, Carol; Wheaton, Joseph M.; Wathen, Gus; Wirtz, Jacob; Jordan, Chris E.			Alteration of stream temperature by natural and artificial beaver dams	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS; WATER TEMPERATURE; IMPACT ASSESSMENT; EASTERN OREGON; RIVER; DISTURBANCES; ECOSYSTEMS; UPSTREAM; DYNAMICS; PATTERNS	Beaver are an integral component of hydrologic, geomorphic, and biotic processes within North American stream systems, and their propensity to build dams alters stream and riparian structure and function to the benefit of many aquatic and terrestrial species. Recognizing this, beaver relocation efforts and/or application of structures designed to mimic the function of beaver dams are increasingly being utilized as effective and cost-efficient stream and riparian restoration approaches. Despite these verities, the notion that beaver dams negatively impact stream habitat remains common, specifically the assumption that beaver dams increase stream temperatures during summer to the detriment of sensitive biota such as salmonids. In this study, we tracked beaver dam distributions and monitored water temperature throughout 34 km of stream for an eight-year period between 2007 and 2014. During this time the number of natural beaver dams within the study area increased by an order of magnitude, and an additional 4 km of stream were subject to a restoration manipulation that included installing a high-density of Beaver Dam Analog (BDA) structures designed to mimic the function of natural beaver dams. Our observations reveal several mechanisms by which beaver dam development may influence stream temperature regimes; including longitudinal buffering of diel summer temperature extrema at the reach scale due to increased surface water storage, and creation of cool-water channel scale temperature refugia through enhanced groundwater-surface water connectivity. Our results suggest that creation of natural and/or artificial beaver dams could be used to mitigate the impact of human induced thermal degradation that may threaten sensitive species.	[Weber, Nicholas; Bouwes, Nicolaas; Wathen, Gus; Wirtz, Jacob] Ecolog Res Inc, Providence, UT 84332 USA; [Bouwes, Nicolaas; Wheaton, Joseph M.] Utah State Univ, Watershed Sci Dept, Logan, UT 84322 USA; [Pollock, Michael M.; Jordan, Chris E.] Northwest Fisheries Sci Ctr, Seattle, WA USA; [Volk, Carol] South Fork Res Inc, North Bend, WA USA	Utah System of Higher Education; Utah State University	Weber, N (corresponding author), Ecolog Res Inc, Providence, UT 84332 USA.	nick.weber@ecologicalresearch.net	Wheaton, Joseph Michael/F-1965-2010	Wheaton, Joseph Michael/0000-0002-8361-8150	Bonneville Power Administration (BPA) [2003-017]; National Oceanic and Atmospheric Administration as part of the Integrated Status and Effectiveness Monitoring Program; NOAA Western Regional Office	Bonneville Power Administration (BPA); National Oceanic and Atmospheric Administration as part of the Integrated Status and Effectiveness Monitoring Program; NOAA Western Regional Office	Financial support for this project was provided by the Bonneville Power Administration (BPA Project Number: 2003-017) and the National Oceanic and Atmospheric Administration as part of the Integrated Status and Effectiveness Monitoring Program, and by the NOAA Western Regional Office. The funder provided support in the form of salaries for authors affiliated with Eco-Logical Research and South Fork Research but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allan D., 2007, STREAM ECOLOGY STRUC; [Anonymous], 2019, MIDDLE COLUMBIA RIVE, P260; Arrigoni AS, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006480; Bledzki LA, 2011, ECOHYDROLOGY, V4, P698, DOI 10.1002/eco.163; Bouwes N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28581; Brewitt KS, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00036.1; Butler DR, 2005, GEOMORPHOLOGY, V71, P48, DOI 10.1016/j.geomorph.2004.08.016; Cleveland, 2009, ENCY EARTH; Collen P, 2001, REV FISH BIOL FISHER, V10, P439; Demmer R, 2008, NORTHWEST SCI, V82, P309, DOI 10.3955/0029-344X-82.4.309; Ebersole JL, 2001, ECOL FRESHW FISH, V10, P1, DOI 10.1034/j.1600-0633.2001.100101.x; Evans EC, 1997, HYDROLOG SCI J, V42, P199, DOI 10.1080/02626669709492020; Fanelli RM, 2008, GROUND WATER, V46, P671, DOI 10.1111/j.1745-6584.2008.00461.x; Feldhaus JW, 2010, ENVIRON BIOL FISH, V87, P277, DOI 10.1007/s10641-010-9580-6; Fuller MR, 2011, FRESHWATER BIOL, V56, P969, DOI 10.1111/j.1365-2427.2010.02548.x; Green K. C., 2009, BC Journal of Ecosystems and Management, V10, P68; Ham J, 2006, ENVIRON GEOL, V50, P55, DOI 10.1007/s00254-006-0186-4; Johnson SL, 2004, CAN J FISH AQUAT SCI, V61, P913, DOI [10.1139/f04-040, 10.1139/F04-040]; Johnston CA, 1987, LANDSCAPE ECOL, V1, P47, DOI 10.1007/BF02275265; Kammerer BD, 2013, ENVIRON BIOL FISH, V96, P823, DOI 10.1007/s10641-012-0078-2; Kemp PS, 2012, FISH FISH, V13, P158, DOI 10.1111/j.1467-2979.2011.00421.x; LI HW, 1994, T AM FISH SOC, V123, P627, DOI 10.1577/1548-8659(1994)123<0627:CEORDA>2.3.CO;2; Lowry M. M., 1993, THESIS OREGON STATE; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Majerova M., 2015, HYDROL EARTH SYST SC, V12, P839; Margolis BE, 2001, CAN J FISH AQUAT SCI, V58, P2271, DOI 10.1139/cjfas-58-11-2271; Mccullough DA, 2009, REV FISH SCI, V17, P90, DOI 10.1080/10641260802590152; MCRAE G, 1994, T AM FISH SOC, V123, P641, DOI 10.1577/1548-8659(1994)123<0641:TCOWHS>2.3.CO;2; NAIMAN RJ, 1988, BIOSCIENCE, V38, P753, DOI 10.2307/1310784; National Marine Fisheries Service, 2008, NMFS END SPEC ACT SE; Poff NL, 1998, CAN J FISH AQUAT SCI, V55, P201, DOI 10.1139/cjfas-55-S1-201; Pollock KM., 2012, NMFSNWFSC120 NOAA US, P47; Pollock MM, 2007, EARTH SURF PROC LAND, V32, P1174, DOI 10.1002/esp.1553; Pollock MM, 2014, BIOSCIENCE, V64, P279, DOI 10.1093/biosci/biu036; Pollock MM, 2015, BEAVER RESTORATION G; Pollock MM, 2003, AM FISHERIES SOC S, P22; Poole GC, 2001, ENVIRON MANAGE, V27, P787, DOI 10.1007/s002670010188; Reynolds SK, 2005, HYDROBIOLOGIA, V544, P69, DOI 10.1007/s10750-004-8334-x; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; SHETTER DAVID S., 1955, JOUR WILDLIFE MANAGEMENT, V19, P47, DOI 10.2307/3797551; Sigourney DB, 2006, T AM FISH SOC, V135, P1068, DOI 10.1577/T05-159.1; SMITH EP, 1993, CAN J FISH AQUAT SCI, V50, P627, DOI 10.1139/f93-072; Sowder C, 2012, WATER-SUI, V4, P597, DOI 10.3390/w4030597; Stewart-Oaten A, 2001, ECOL MONOGR, V71, P305, DOI 10.1890/0012-9615(2001)071[0305:TASVIE]2.0.CO;2; Stricker HK, 2010, FOREST COUNTY POTAWA; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Wagner R, 2005, ARCH HYDROBIOL, V163, P65, DOI 10.1127/0003-9136/2005/0163-0065; Westbrook CJ, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1359; Westbrook C.J., 2013, TREATISE GEOMORPHOLO, V12, P293; Williams J.E., 2015, REFERENCE MODULE EAR; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1	51	48	48	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176313	10.1371/journal.pone.0176313	http://dx.doi.org/10.1371/journal.pone.0176313			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520714	Green Published, gold			2022-12-27	WOS:000401487700013
J	Bhatnagar, M; Goel, I; Roy, T; Shukla, SD; Khurana, S				Bhatnagar, Maheep; Goel, Ishan; Roy, Tathagato; Shukla, Sunil Dutt; Khurana, Sukant			Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice	PLOS ONE			English	Article							NEURONAL DENDRITIC ARBORIZATION; GROWTH SPURT PERIOD; L-DOPA; OXIDATIVE STRESS; DISEASE; MOTOR; NEUROPROTECTION; NEUROTOXICITY; SYSTEM; ASSAY	Parkinson's disease remains as one of the most common debilitating neurodegenerative disorders. With the hopes of finding agents that can cure or reduce the pace of progression of the disease, we studied two traditional medicinal plants: Centella asiatica and Withania somnifera that have been explored in some recent studies. In agreement with the previous work on ethanol extracts of these two plants in mice model, we saw an improvement in oxidative stress profile as well as behavioral performance in 1-methyl-4-phenyl-1,2,3,6-tetrahy-dropyridine (MPTP) induced Parkinson-like symptoms in Balb/c mice. Given the known potential of both the herbal extracts in improving Parkinson-like symptoms, we expected the combination of the two to show better results than either of the two but surprisingly there was no additivity in either oxidative stress or behavioural recovery. In fact, in some assays, the combination performed worse than either of the two individual constituents. This effect of mixtures highlights the need of testing mixtures in supplements market using enthomedicine. The necessity of comparing multiple groups in this study to get most information from the experiments motivated us to design a ladder-like visualization to show comparison with different groups that we call complete comparison display (CCD). In summary, we show the potential of Centella asiatica and Withania somnifera to ameliorate Parkinson's disorder.	[Bhatnagar, Maheep; Shukla, Sunil Dutt] Mohanlal Sukhadia Univ, Dept Zool, Udaipur, Rajasthan, India; [Goel, Ishan; Khurana, Sukant] Cent Drug Res Inst, Pharmacol Dept, Lucknow, Uttar Pradesh, India; [Roy, Tathagato; Khurana, Sukant] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Haringhata Farm, W Bengal, India; [Shukla, Sunil Dutt] Govt Meera Girls Coll, Udaipur, Rajasthan, India	Mohanlal Sukhadia University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Indian Institute of Science Education & Research (IISER) - Kolkata	Shukla, SD (corresponding author), Mohanlal Sukhadia Univ, Dept Zool, Udaipur, Rajasthan, India.; Khurana, S (corresponding author), Cent Drug Res Inst, Pharmacol Dept, Lucknow, Uttar Pradesh, India.; Khurana, S (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Haringhata Farm, W Bengal, India.; Shukla, SD (corresponding author), Govt Meera Girls Coll, Udaipur, Rajasthan, India.	sukantkhurana@gmail.com; shuklasd@gmail.com	Shukla, Sunil Dutt/M-1182-2014; Shukla, Sunil Dutt/O-1443-2019	Shukla, Sunil Dutt/0000-0002-4467-3106; Shukla, Sunil Dutt/0000-0002-4467-3106				Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Ahmed D, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-243; Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; BARBEAU A, 1969, Canadian Medical Association Journal, V101, P59; Bastide MF, 2015, PROG NEUROBIOL, V132, P96, DOI 10.1016/j.pneurobio.2015.07.002; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Blesa J, 2012, NEUROBIOL DIS, V48, P79, DOI 10.1016/j.nbd.2012.05.018; Blesa J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00092; Brotchie JM, 2005, J NEURAL TRANSM, V112, P359, DOI 10.1007/s00702-004-0251-7; Cheng CW, 2015, J PHOTOCH PHOTOBIO B, V148, P262, DOI 10.1016/j.jphotobiol.2015.04.028; Cheng CL, 2000, LIFE SCI, V67, P2647, DOI 10.1016/S0024-3205(00)00848-1; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Datusalia AK, 2012, ACTA POL PHARM, V69, P699; Dhuley JN, 1998, J ETHNOPHARMACOL, V60, P173, DOI 10.1016/S0378-8741(97)00151-7; DONNAN GA, 1987, J NEUROL SCI, V77, P185, DOI 10.1016/0022-510X(87)90121-3; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; George M, 2010, AFR J TRAD COMPL ALT, V6; Gnanapragasam A, 2004, LIFE SCI, V76, P585, DOI 10.1016/j.lfs.2004.09.009; GODWINAUSTEN RB, 1969, LANCET, V2, P165; Haleagrahara N, 2010, J TOXICOL SCI, V35, P41, DOI 10.2131/jts.35.41; Horstink M, 2006, EUR J NEUROL, V13, P1186, DOI 10.1111/j.1468-1331.2006.01548.x; HYLAND K, 1992, CLIN CHEM, V38, P2405; Inamdar PK, 1996, J CHROMATOGR A, V742, P127, DOI 10.1016/0021-9673(96)00237-3; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jagmag SA, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00503; James JT, 2009, MOLECULES, V14, P3922, DOI 10.3390/molecules14103922; Jana U, 2010, Nepal Med Coll J, V12, P8; Jankovic J, 2005, MOVEMENT DISORD, V20, pS11, DOI 10.1002/mds.20458; Jansen RLM, 2014, PHYTOTHER RES, V28, P1789, DOI 10.1002/ptr.5199; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jeon W.K., 2012, EVID-BASED COMPL ALT, V2012, P1; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kumar Anil, 2011, Int J Alzheimers Dis, V2011, P347569, DOI 10.4061/2011/347569; Liu XX, 2000, LIFE SCI, V66, P2277, DOI 10.1016/S0024-3205(00)00557-9; MITRA N, 1992, BRAIN RES B, V28; Mohanakumar KP, 2000, BRAIN RES, V864, P281, DOI 10.1016/S0006-8993(00)02189-2; MOHANDAS J, 1984, BIOCHEM PHARMACOL, V33, P1801, DOI 10.1016/0006-2952(84)90353-8; Muralikrishnan D, 1998, FASEB J, V12, P905, DOI 10.1096/fasebj.12.10.905; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Panda Sunanda, 1997, Indian Journal of Physiology and Pharmacology, V41, P424; Ponnusamy K, 2008, Med J Malaysia, V63 Suppl A, P102; Prakash J, 2014, NEUROCHEM RES, V39, P2527, DOI 10.1007/s11064-014-1443-7; Prakash J, 2013, NEUROCHEM RES, V38, P972, DOI 10.1007/s11064-013-1005-4; Rao KGM, 2006, EVID-BASED COMPL ALT, V3, P349, DOI 10.1093/ecam/nel024; Rao KGM, 2009, EVID-BASED COMPL ALT, V6, P203, DOI 10.1093/ecam/nem079; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Shinomol GK, 2010, PHYTOTHER RES, V24, P885, DOI 10.1002/ptr.3042; Shinomol GK, 2008, NEUROTOXICOLOGY, V29, P948, DOI 10.1016/j.neuro.2008.09.009; Shukla SD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00112; Siddique YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/382124; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Tandon Neeraj, 2012, Toxicol Int, V19, P245, DOI 10.4103/0971-6580.103658; Ul Kabir A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-31; VARASTET M, 1994, NEUROSCIENCE, V63, P47, DOI 10.1016/0306-4522(94)90006-X; WEIHMULLER FB, 1989, PHARMACOL BIOCHEM BE, V34, P113, DOI 10.1016/0091-3057(89)90362-6; WEIHMULLER FB, 1988, NEUROSCI LETT, V85, P137, DOI 10.1016/0304-3940(88)90443-0; Whishaw IQ, 2003, J NEUROSCI METH, V126, P13, DOI 10.1016/S0165-0270(03)00049-9; Wijeweeraa P, PHYTOMEDICINE; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wong KS, 2003, J NEUROL SCI, V216, P81, DOI 10.1016/S0022-510X(03)00217-X; Xu CL, 2013, FITOTERAPIA, V90, P112, DOI 10.1016/j.fitote.2013.07.009; Xu CL, 2012, PHARMACOL BIOCHEM BE, V100, P413, DOI 10.1016/j.pbb.2011.09.014; Zaidan M R S, 2005, Trop Biomed, V22, P165; Zheng Cheng-jian, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P348	65	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177254	10.1371/journal.pone.0177254	http://dx.doi.org/10.1371/journal.pone.0177254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510600	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500018
J	Biswas, T; Garnett, SP; Pervin, S; Rawal, LB				Biswas, Tuhin; Garnett, Sarah P.; Pervin, Sonia; Rawal, Lal B.			The prevalence of underweight, overweight and obesity in Bangladeshi adults: Data from a national survey	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; POPULATION	Background Over the two last decades Bangladesh, a low-income country, has experienced a rapid demographic and epidemiological transition. The population has increased substantially with rapid urbanization and changing pattern of disease, which at least in part, can be explained by nutritional changes. However, the nutritional status of the adult population has not been previously described. Hence, the objective of this study was to estimate the prevalence and explore socio-demographic determinants of underweight, overweight and obesity among the Bangladeshi adult population. Methods This study is a secondary data analysis of the national 2011 Bangladesh Demographic and Health Survey. We determined the nutritional status of adults aged >= 35 years of age, who had a measured weight and height, using the Asian body mass index (BMI) cut-offs for underweight (BMI < 18.5 kg/m(2)), overweight (BMI 23 to < 27.5 kg/m(2)) and obesity (BMI >= 27.5 kg/m(2)). Logistic regression modeling was used to determine the association between socio-demographic factors and nutritional status. Result Of total sample (n = 5495), 30.4% were underweight, 18.9% were overweight and 4.6% were obese. Underweight was associated with age, education and wealth. The adjusted odd ratios for underweight were higher for older people (>= years) compared to younger, the least educated compared to the most educated and the poorest compared to the wealthiest were 2.51 (95% CI: 1.95-3.23, p < 0.001), 3.59 (95% CI: 2.30-5.61, p < 0.001) and 3.70 (95% CI: 2.76-4.96, p < 0.001), respectively. Younger age (35-44 years), being female, higher education, wealthier and living in urban areas were associated with overweight/obesity with adjusted odds ratios of 1.73 (95% CI: 1.24-2.41, p < 0.001), 2.48 (95% CI: 1.87-3.28, p < 0.001), 3.98 ( 95% CI: 2.96-5.33, p < 0.001), 7.14 ( 95% CI: 5.20-9.81, p < 0.001) 1.27 ( 95% CI: 1.05-1.55, p-0.02), respectively. Conclusion Underweight and overweight/obesity are prevalent in Bangladeshi adults. Both conditions are associated with increased morbidity and mortality and increase the risk of developing non-communicable diseases. Effective public health intervention approaches are necessary to address both these conditions.	[Biswas, Tuhin; Pervin, Sonia; Rawal, Lal B.] Icddr, Hlth Syst & Populat Studies Div, B 68 Shaheed Tajuddin Ahmed Sharani, Dhaka 22, Bangladesh; [Garnett, Sarah P.] Univ Sydney, Westmead Clin Sch, Childrens Hosp, Sydney, NSW, Australia; [Garnett, Sarah P.] Childrens Hosp Westmead Australia, Inst Endocrinol & Diabet, Westmead, NSW, Australia; [Rawal, Lal B.] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); University of Sydney; Bangladesh Rural Advancement Committee BRAC; BRAC University	Biswas, T (corresponding author), Icddr, Hlth Syst & Populat Studies Div, B 68 Shaheed Tajuddin Ahmed Sharani, Dhaka 22, Bangladesh.	tuhin.biswas@icddrb.org	Garnett, Sarah/D-8067-2012	Garnett, Sarah/0000-0001-7552-0789; Rawal, Lal/0000-0003-1106-0108; Biswas, Tuhin/0000-0002-7837-0306				Akter S, 2014, DIABETES CARE, V37, pE9, DOI 10.2337/dc13-1647; [Anonymous], 2011, PREL REP NIPORT 2013; [Anonymous], 2015, STAT FOOD INS WORLD; [Anonymous], 2000, OB PREV MAN GLOB EP; [Anonymous], 2011, PRELIMINARY REPORT; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Biswas T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167140; Gersh B, 2012, CIRCULATION, V126, pA606; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Islam A, 2014, CHRONIC NONCOMMUNICA, V1, P6; Kamal SMM, 2015, J HEALTH POPUL NUTR, V33, P92; Karar ZA, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1904; Khan MMH, 2011, B WORLD HEALTH ORGAN, V89, P583, DOI 10.2471/BLT.11.087429; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nube M, 2003, ANN HUM BIOL, V30, P520, DOI 10.1080/0301446031000119601; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Siddiquee T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2193-4; Smith LC, 2003, INTL FOOD POLICY RES, V131; Streatfield PK, 2008, J HEALTH POPUL NUTR, V26, P261; Subramanian S, 2010, PEDIATRICS; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456	25	80	82	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177395	10.1371/journal.pone.0177395	http://dx.doi.org/10.1371/journal.pone.0177395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510585	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500025
J	Chen, JG; Yu, XX; Bi, HX; Fu, YL				Chen, Jungang; Yu, Xinxiao; Bi, Huaxing; Fu, Yanlin			Indoor simulations reveal differences among plant species in capturing particulate matter	PLOS ONE			English	Article							ULTRAFINE PARTICLE DEPOSITION; VOLATILE ORGANIC-COMPOUNDS; URBAN STREET CANYON; DRY DEPOSITION; HEALTH IMPACTS; AEROSOL; TREE; FINE; VEGETATION; POLLUTION	A number of studies have focused on the capacity of urban trees and shrubs to serve as efficient biological filters to mitigate air pollution. In this study, five different tree species were assessed for this function. Kerria japonica, Sophora japonica, Philadelphus pekinensis, Gleditsia sinensis, and Prunus persica 'Atropurpurea' were tested in a deposition chamber using (NH4)(2)SO4 particles. We quantified and compared the capability of all tested trees to remove particles by assessing deposition velocity, a measure of the ability to remove particles. When placed in the deposition chamber, S. japonica had the greatest deposition velocity, followed by Philadelphus pekinensis, G. sinensis, Prunus persica 'Atropurpurea,' and K. japonica, in descending order. In addition, the comparison of deposition velocities among these species suggested that certain leaf geometries and surface characteristics of broad-leaf trees, such as trichomes and grooves, increased particle capture. However, these results change under a different simulation condition using ambient air, suggesting that some trees actually increase pollutant number concentrations more than reduce particle concentration. This outcome can be explained by the aerodynamic effect of trees exceeding the filtering capacity of vegetation under some conditions. This highlights the difficulty of generalizing species selection criteria for practice use. Accordingly, our results indicate that using vegetation to reduce particle pollution and improve the air quality is not a universally advisable and viable solution.	[Chen, Jungang; Yu, Xinxiao; Bi, Huaxing] Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China; [Chen, Jungang; Yu, Xinxiao; Bi, Huaxing] Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China; [Fu, Yanlin] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Bi, HX (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China.; Bi, HX (corresponding author), Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China.	bhx@bjfu.edu.cn		Chen, Jungang/0000-0002-5429-7079	forestry public welfare project of China [201304301]; Beijing Municipal Commission of Education [BLCXY201617]	forestry public welfare project of China; Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This study was supported by the research projects of forestry public welfare project of China (No.201304301) and Graduate Training and Development Program of Beijing Municipal Commission of Education (No.BLCXY201617) and Special Found for Beijing Common Construction Project. The authors are grateful to our partners in the program for their support and comments on the manuscript. We would like to express our gratitude to the authorities at the Beijing Olympic forest park and Beijing Forestry University for their help and giving us access to the park to conduct experiments.	[Anonymous], 2011, INT J PHYTOREMEDIAT, V13, P1037; Barima YSS, 2014, SCI TOTAL ENVIRON, V470, P975, DOI 10.1016/j.scitotenv.2013.10.082; BECKETT K.P., 2000, J ARBOR, V26, P12; Beckett KP, 2000, GLOBAL CHANGE BIOL, V6, P995, DOI 10.1046/j.1365-2486.2000.00376.x; Blanusa T, 2015, URBAN FOR URBAN GREE, V14, P1095, DOI 10.1016/j.ufug.2015.10.004; BURRI K, 2011, AEOLIAN RES, V3, P205, DOI DOI 10.1016/J.AEOLIA.2011.01.003; Ceulemans K, 2010, ATMOS ENVIRON, V44, P5434, DOI 10.1016/j.atmosenv.2010.05.001; Faiola CL, 2015, ATMOS CHEM PHYS, V15, P3629, DOI 10.5194/acp-15-3629-2015; Freer-Smith PH, 2004, WATER AIR SOIL POLL, V155, P173, DOI 10.1023/B:WATE.0000026521.99552.fd; Gens A, 2014, ATMOS ENVIRON, V84, P213, DOI 10.1016/j.atmosenv.2013.11.054; Goldstein A H, 2014, AGU FALL M, V1; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Gromke C, 2007, ATMOS ENVIRON, V41, P3287, DOI 10.1016/j.atmosenv.2006.12.043; Hao LQ, 2009, ATMOS CHEM PHYS, V9, P8121, DOI 10.5194/acp-9-8121-2009; Hofman J, 2013, ENVIRON POLLUT, V183, P123, DOI 10.1016/j.envpol.2012.09.015; Huang RJ, 2014, NATURE, V514, P218, DOI 10.1038/nature13774; Hwang HJ, 2011, ATMOS ENVIRON, V45, P6987, DOI 10.1016/j.atmosenv.2011.09.019; Inomata S, 2014, ATMOS ENVIRON, V97, P397, DOI 10.1016/j.atmosenv.2014.03.045; Keebaugh AJ, 2015, SCI TOTAL ENVIRON, V533, P69, DOI 10.1016/j.scitotenv.2015.06.048; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Lee H, 2014, J AEROSOL SCI, V67, P166, DOI 10.1016/j.jaerosci.2013.10.006; Lee H, 2015, ENVIRON POLLUT, V207, P43, DOI 10.1016/j.envpol.2015.08.036; Lin M, 2012, ATMOS ENVIRON, V51, P293, DOI 10.1016/j.atmosenv.2012.01.004; Lin MY, 2012, AEROSOL SCI TECH, V46, P465, DOI 10.1080/02786826.2011.638346; Litschke T, 2008, METEOROL Z, V17, P229, DOI 10.1127/0941-2948/2008/0284; McDonald AG, 2007, ATMOS ENVIRON, V41, P8455, DOI 10.1016/j.atmosenv.2007.07.025; McPherson G E, 1994, NE186 USDA; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Mitchell R, 2010, ENVIRON POLLUT, V158, P1472, DOI 10.1016/j.envpol.2009.12.029; Morawska L, 1998, ENVIRON SCI TECHNOL, V32, P2033, DOI 10.1021/es970826+; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Ottele M, 2010, ECOL ENG, V36, P154, DOI 10.1016/j.ecoleng.2009.02.007; Ould-Dada Z, 2001, ATMOS ENVIRON, V35, P3799, DOI 10.1016/S1352-2310(01)00161-3; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; PETERS K, 1992, ATMOS ENVIRON A-GEN, V26, P2555, DOI 10.1016/0960-1686(92)90108-W; Petroff A, 2008, ATMOS ENVIRON, V42, P3625, DOI 10.1016/j.atmosenv.2007.09.043; Pinto DM, 2007, ATMOS ENVIRON, V41, P4877, DOI 10.1016/j.atmosenv.2007.02.006; Rasanen JV, 2013, ENVIRON POLLUT, V183, P64, DOI 10.1016/j.envpol.2013.05.015; Roldin P, 2015, ATMOS CHEM PHYS, V15, P10777, DOI 10.5194/acp-15-10777-2015; Roupsard P, 2013, J AEROSOL SCI, V55, P12, DOI 10.1016/j.jaerosci.2012.07.006; Saebo A, 2012, SCI TOTAL ENVIRON, V427, P347, DOI 10.1016/j.scitotenv.2012.03.084; Song YS, 2016, J CLEAN PROD, V112, P1312, DOI 10.1016/j.jclepro.2015.05.006; Tallis M, 2011, LANDSCAPE URBAN PLAN, V103, P129, DOI 10.1016/j.landurbplan.2011.07.003; Teper E, 2009, ENVIRON MONIT ASSESS, V154, P383, DOI 10.1007/s10661-008-0405-4; Terzaghi E, 2013, ATMOS ENVIRON, V74, P378, DOI 10.1016/j.atmosenv.2013.04.013; Tiwary A, 2009, ENVIRON POLLUT, V157, P2645, DOI 10.1016/j.envpol.2009.05.005; Twomey S., 1976, SCI TOTAL ENVIRON, V13, P275; Vos PEJ, 2013, ENVIRON POLLUT, V183, P113, DOI 10.1016/j.envpol.2012.10.021; Wania A, 2012, J ENVIRON MANAGE, V94, P91, DOI 10.1016/j.jenvman.2011.06.036; WHO, 2006, EXPOSURE ASSESSMENT; YE Y, 1991, J AEROSOL SCI, V22, P63, DOI 10.1016/0021-8502(91)90093-W; Yook SJ, 2007, J AEROSOL SCI, V38, P211, DOI 10.1016/j.jaerosci.2006.11.010; Yook SJ, 2010, J AEROSOL SCI, V41, P911, DOI 10.1016/j.jaerosci.2010.06.003; Yook SJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3133343; Zhao DF, 2015, ATMOS CHEM PHYS, V15, P991, DOI 10.5194/acp-15-991-2015; Zhao Y, 2015, ENVIRON SCI TECHNOL, V49, P12153, DOI 10.1021/acs.est.5b02455	58	11	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177539	10.1371/journal.pone.0177539	http://dx.doi.org/10.1371/journal.pone.0177539			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520744	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500038
J	Maffioli, EM				Maffioli, Elisa M.			Is traditional male circumcision effective as an HIV prevention strategy? Evidence from Lesotho	PLOS ONE			English	Article							SOUTH-AFRICA; YOUNG MEN; KISUMU; KENYA	In many developing countries, male circumcision has been promoted as an effective HIV prevention strategy, and medical randomized controlled trials have indeed shown a causal link. However, there is limited empirical evidence to support this conclusion in countries where individuals can voluntary opt for different types of circumcision. The present study considers male circumcision in Lesotho, where HIV prevalence is among the highest in the world (23%). Here, men can opt for one of two types of circumcision: traditional male circumcision in initiation schools, or the medical option in health clinics. This paper investigates whether the former has medical effects on individual HIV status that are as beneficial as those shown for the latter. Controlling for the potential individual behavioral response after the operation, it was found that circumcision performed in initiation schools wholly offset the medical benefits of the surgical procedure. This supports anecdotal evidence that the operation performed by traditional circumcisers does not have the same protective effect against HIV transmission as the medical operation. No evidence of "disinhibition" behavior among circumcised men was found, nor differential risky sexual behavior among men circumcised, traditionally or medically. Considering that, in Lesotho, traditional male circumcision is undertaken by more than 90% of circumcised men, the findings highlight the need for further research into how the operation in initiation schools is performed and its medical benefits.	[Maffioli, Elisa M.] Duke Univ, Dept Econ, Durham, NC 27706 USA; [Maffioli, Elisa M.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA	Duke University; Duke University	Maffioli, EM (corresponding author), Duke Univ, Dept Econ, Durham, NC 27706 USA.; Maffioli, EM (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	elisa.maffioli@duke.edu						AKAIKE H, 1974, SELECTED PAPERS HIRO, V19, P716, DOI DOI 10.1007/978-1-4612-1694-0_16; Anderson C, 2011, IMPACT HIV ED UNPUB; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2008, B WORLD HEALTH ORGAN, V86, P669, DOI 10.2471/BLT.08.051482; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Cohen CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004573; Connolly C, 2008, SAMJ S AFR MED J, V98, P789; Corno L, 2007, POLICY RES WORKING P, V4421; De Paula A, 2014, J APPL ECONOMET, V29, P944, DOI 10.1002/jae.2342; de Walque D, 2009, WORKING PAPER; Delavande A, 2012, DEMOGRAPHY, V49, P1011, DOI 10.1007/s13524-012-0119-7; DHS, 2009, DEM HLTH SURV; Doyle D, 2005, J ROY COLL PHYS EDIN, V35, P279; Godlonton S, 2011, BEHAV RESPONSE UNPUB; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Peltzer K, 2012, INT J BEHAV MED, V19, P336, DOI 10.1007/s12529-011-9171-8; Peltzer K, 2011, J ASSOC NURSE AIDS C, V22, P397, DOI 10.1016/j.jana.2011.03.003; Quinn TC, 2007, CURR OPIN INFECT DIS, V20, P33, DOI 10.1097/QCO.0b013e328012c5bc; Sarvestani AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045316; Thomas AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027561; UNAIDS, 2015, FACT SHEET 2015 GLOB; USAID, 2003, MAL CIRC CURR EP FIE; Wilcken A, 2010, B WORLD HEALTH ORGAN, V88, P907, DOI 10.2471/BLT.09.072975; Wilson NL, 2014, J DEV ECON, V106, P78, DOI 10.1016/j.jdeveco.2013.08.012; World Health Organization, 2012, VOL MED MAL CIRC HIV; Zungu NP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3024-y	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177076	10.1371/journal.pone.0177076	http://dx.doi.org/10.1371/journal.pone.0177076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498835	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500010
J	Wu, Y; Ma, QH; Sun, HP; Xu, Y; Niu, ME; Pan, CW				Wu, Yin; Ma, Qinghua; Sun, Hong-Peng; Xu, Yong; Niu, Mei-E; Pan, Chen-Wei			Myopia and depressive symptoms among older Chinese adults	PLOS ONE			English	Article							VISUAL IMPAIRMENT; ASSOCIATIONS; DISORDERS; ANXIETY; IMPACT; COST; RISK	Purpose Few population-based data support the hypothesis that refractive errors are associated with depressive symptoms. We aim to assess the impact of myopia on the risk of having depressive symptoms in a community-based cohort of elderly Chinese. Methods A community-based cross-sectional study of 4611 Chinese adults aged 60 years or older was conducted. Depressive symptoms were measured using the 9-item Patient Health Questionnaire (PHQ-9) depression scale in 4597 adults. Refraction was determined by auto-refraction followed by subjective refraction. Myopia was defined as spherical equivalent (SE) < -0.50 diopters (D) and high myopia as SE < -6.00 D. Results After adjusting for age, gender, education, lifestyle-related exposures, presenting visual acuity and age-related cataract, myopic adults were more likely to have any depressive symptoms compared with non-myopic ones (odds ratio = 1.39; 95% confidence interval 1.04, 1.92). There were no significant differences in the risk of having any depressive symptoms between those with and without high myopia. Myopia or high myopia was not associated with having moderate depressive symptoms. The impact of myopia on depressive symptoms was stronger in adults with no formal education compared with those with formal education. Conclusions Myopia was related with the presence of depressive symptoms among older adults.	[Wu, Yin; Niu, Mei-E] Soochow Univ, Affiliated Hosp 1, Dept Nursing, Suzhou, Peoples R China; [Ma, Qinghua] 3rd Peoples Hosp Xiangcheng Dist, Suzhou, Peoples R China; [Sun, Hong-Peng; Xu, Yong; Pan, Chen-Wei] Soochow Univ, Med Coll, Sch Publ Hlth, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Niu, ME (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Nursing, Suzhou, Peoples R China.; Pan, CW (corresponding author), Soochow Univ, Med Coll, Sch Publ Hlth, Suzhou, Peoples R China.	meniu@suda.edu.cn; pcwonly@gmail.com	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613	Science and Technology Board of Xiangcheng District, Suzhou, China [XJ201655, XJ201454]	Science and Technology Board of Xiangcheng District, Suzhou, China	This study was funded by the Science and Technology Board of Xiangcheng District, Suzhou, China (Grant No. XJ201655 and No. XJ201454). The funding organization had no role in the design or conduct of this research.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Frick KD, 2007, ARCH OPHTHALMOL-CHIC, V125, P544, DOI 10.1001/archopht.125.4.544; Giloyan A, 2015, AGING MENT HEALTH, V19, P175, DOI 10.1080/13607863.2014.920298; Kang Hee-Ju, 2015, Chonnam Med J, V51, P8, DOI 10.4068/cmj.2015.51.1.8; Keeffe JE, 2009, ARCH OPHTHALMOL-CHIC, V127, P1377, DOI 10.1001/archophthalmol.2009.242; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Loprinzi PD, 2014, J AFFECT DISORDERS, V167, P8, DOI 10.1016/j.jad.2014.05.052; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Ong SY, 2013, INVEST OPHTH VIS SCI, V54, P799, DOI 10.1167/iovs.12-10460; Pan C-W, 2015, OPTOM VIS SCI; Pan CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142516; Pan CW, 2013, OPHTHALMOLOGY, V120, P284, DOI 10.1016/j.ophtha.2012.07.065; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pop-Jordanova Nada, 2014, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V35, P53; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sun HP, 2015, OPHTHALMIC PHYSL OPT; van der Aa HPA, 2015, INVEST OPHTH VIS SCI, V56, P849, DOI 10.1167/iovs.14-15848; Wong HB, 2009, AM J OPHTHALMOL, V147, P505, DOI 10.1016/j.ajo.2008.09.025; Zheng YF, 2013, INVEST OPHTH VIS SCI, V54, P7532, DOI 10.1167/iovs.13-12795; Zivin K, 2015, J PSYCHOSOM RES, V78, P324, DOI 10.1016/j.jpsychores.2015.01.014	21	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177613	10.1371/journal.pone.0177613	http://dx.doi.org/10.1371/journal.pone.0177613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498851	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500032
J	Yang, FQ; Xu, XP; Wang, W; Ma, JC; Wei, D; He, P; Pampolino, MF; Johnston, AM				Yang, Fuqiang; Xu, Xinpeng; Wang, Wei; Ma, Jinchuan; Wei, Dan; He, Ping; Pampolino, Mirasol F.; Johnston, Adrian M.			Estimating nutrient uptake requirements for soybean using QUEFTS model in China	PLOS ONE			English	Article							IRRIGATED LOWLAND RICE; FERTILIZER REQUIREMENTS; QUANTITATIVE-EVALUATION; YIELD GAPS; MAIZE; MANAGEMENT; WHEAT; EFFICIENCIES; PRODUCTIVITY; CORN	Estimating balanced nutrient requirements for soybean (Glycine max [L.] Merr) in China is essential for identifying optimal fertilizer application regimes to increase soybean yield and nutrient use efficiency. We collected datasets from field experiments in major soybean planting regions of China between 2001 and 2015 to assess the relationship between soybean seed yield and nutrient uptake, and to estimate nitrogen (N), phosphorus (P), and potassium (K) requirements for a target yield of soybean using the quantitative evaluation of the fertility of tropical soils (QUEFTS) model. The QUEFTS model predicted a linear -parabolic-plateau curve for the balanced nutrient uptake with a target yield increased from 3.0 to 6.0 t ha(-1) and the linear part was continuing until the yield reached about 60-70% of the potential yield. To produce 1000 kg seed of soybean in China, 55.4 kg N, 7.9 kg P, and 20.1 kg K (N: P: K = 7: 1: 2.5) were required in the above-ground parts, and the corresponding internal efficiencies (IE, kg seed yield per kg nutrient uptake) were 18.1, 126.6, and 49.8 kg seed per kg N, P, and K, respectively. The QUEFTS model also simulated that a balanced N, P, and K removal by seed which were 48.3, 5.9, and 12.2 kg per 1000 kg seed, respectively, accounting for 87.1%, 74.1%, and 60.8% of the total above-ground parts, respectively. These results were conducive to make fertilizer recommendations that improve the seed yield of soybean and avoid excessive or deficient nutrient supplies. Field validation indicated that the QUEFTS model could be used to estimate nutrient requirements which help develop fertilizer recommendations for soybean.	[Yang, Fuqiang; Xu, Xinpeng; Ma, Jinchuan; He, Ping] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China; [Wang, Wei; Wei, Dan] Heilongjiang Acad Agr Sci, Inst Soil Fertilizer & Environm Resources, Harbin, Peoples R China; [He, Ping] Int Plant Nutr Inst China Program, CAAS IPNI Joint Lab Plant Nutr Innovat Res, Beijing, Peoples R China; [Pampolino, Mirasol F.] Int Plant Nutr Inst Southeast Asia Program, George Town, Malaysia; [Johnston, Adrian M.] Int Plant Nutr Inst, Saskatoon, SK, Canada	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Heilongjiang Academy of Agricultural Sciences	He, P (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China.; He, P (corresponding author), Int Plant Nutr Inst China Program, CAAS IPNI Joint Lab Plant Nutr Innovat Res, Beijing, Peoples R China.	phe@ipni.net	He, Ping/HGD-5389-2022		National Key Research and Development Plan [2016YFD0200101]; Central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research [1610132016011, Y2017PT35]	National Key Research and Development Plan; Central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research	This research was supported by the National Key Research and Development Plan (2016YFD0200101) and Central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research (1610132016011, Y2017PT35). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Buresh R. J., 2007, Fertilizer best management practices: general principles, strategy for their adoption and voluntary initiatives vs regulations. Papers presented at the IFA International Workshop on Fertilizer Best Management Practices, Brussels, Belgium, 7-9 March, 2007, P47; Buresh RJ, 2010, PLANT SOIL, V335, P35, DOI 10.1007/s11104-010-0441-z; China National Knowledge Infrastructure, 2001, CHINA NATL KNOWLEDGE; Chinese Society of Soil Science, 2000, METH SOIL PLANT AN; Chuan LM, 2013, FIELD CROP RES, V146, P96, DOI 10.1016/j.fcr.2013.02.015; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Das D, 2009, NUTR CYCL AGROECOSYS, V83, P85, DOI 10.1007/s10705-008-9202-2; Dobermann A, 2004, INCREASING PRODUCTIVITY OF INTENSIVE RICE SYSTEMS THROUGH SITE-SPECIFIC NUTRIENT MANAGEMENT, P75; Dobermann A, 2002, PLANT SOIL, V247, P153, DOI 10.1023/A:1021197525875; FAO. FAOSTAT, 2013, DAT PROD; Fu C.F., 2011, HEILONGJIANG AGR SCI, V10, P33; Grassini P, 2015, FIELD CROP RES, V179, P150, DOI 10.1016/j.fcr.2015.04.015; Haefele SM, 2003, FIELD CROP RES, V80, P19, DOI 10.1016/S0378-4290(02)00152-1; Huang SW, 2006, NUTR CYCL AGROECOSYS, V75, P201, DOI 10.1007/s10705-006-9027-9; Ijgude M. B., 2008, Asian Journal of Soil Science, V3, P142; JANSSEN BH, 1990, GEODERMA, V46, P299, DOI 10.1016/0016-7061(90)90021-Z; Liu HL, 2011, NUTR CYCL AGROECOSYS, V89, P313, DOI 10.1007/s10705-010-9396-y; Liu MQ, 2006, NUTR CYCL AGROECOSYS, V74, P245, DOI 10.1007/s10705-006-9002-5; Liu XY, 2011, AGRON J, V103, P1452, DOI 10.2134/agronj2010.0476; Maiti Debtanu, 2006, Archives of Agronomy and Soil Science, V52, P403, DOI 10.1080/03650340600768706; Mowo JG, 2006, AGR ECOSYST ENVIRON, V116, P47, DOI 10.1016/j.agee.2006.03.021; Ni L., 2004, THESIS; Pampolino MF, 2012, COMPUT ELECTRON AGR, V88, P103, DOI 10.1016/j.compag.2012.07.007; Pathak H, 2003, NUTR CYCL AGROECOSYS, V65, P105, DOI 10.1023/A:1022177231332; Pierce FJ, 1999, ADV AGRON, V67, P1, DOI 10.1016/S0065-2113(08)60513-1; Saidou A, 2003, AGR ECOSYST ENVIRON, V100, P265, DOI 10.1016/S0167-8809(03)00184-1; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; Setiyono TD, 2010, FIELD CROP RES, V118, P158, DOI 10.1016/j.fcr.2010.05.006; SMALING EMA, 1993, GEODERMA, V59, P21, DOI 10.1016/0016-7061(93)90060-X; Tabi FO, 2008, NUTR CYCL AGROECOSYS, V80, P161, DOI 10.1007/s10705-007-9129-z; Tittonell P, 2008, PLANT SOIL, V313, P19, DOI 10.1007/s11104-008-9676-3; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Wang HuaiMing, 2011, Jiangsu Journal of Agricultural Sciences, V27, P199; [王寅 Wang Yin], 2016, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V22, P1441; [魏建军 Wei Jianjun], 2010, [大豆科学, Soybean Science], V29, P413; Witt C., 2006, Better Crops with Plant Food, V90, P28; Witt C, 1999, FIELD CROP RES, V63, P113, DOI 10.1016/S0378-4290(99)00031-3; Witt C., 2002, Better Crops International, V16, P20; Xu XP, 2015, FIELD CROP RES, V180, P37, DOI 10.1016/j.fcr.2015.05.008; Xu XP, 2014, FIELD CROP RES, V157, P27, DOI 10.1016/j.fcr.2013.12.013; Xu XP, 2013, FIELD CROP RES, V150, P115, DOI 10.1016/j.fcr.2013.06.006; Zhang BB, 2016, AGR WATER MANAGE, V177, P440, DOI 10.1016/j.agwat.2016.08.029; Zhang W.F., 2009, PHYTON BUENOS AIRES, VI, P147; Zhang Y, 2012, AGRON J, V104, P1436, DOI 10.2134/agronj2012.0125	44	27	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177509	10.1371/journal.pone.0177509	http://dx.doi.org/10.1371/journal.pone.0177509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498839	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500023
J	Kurtzer, GM; Sochat, V; Bauer, MW				Kurtzer, Gregory M.; Sochat, Vanessa; Bauer, Michael W.			Singularity: Scientific containers for mobility of compute	PLOS ONE			English	Article								Here we present Singularity, software developed to bring containers and reproducibility to scientific computing. Using Singularity containers, developers can work in reproducible environments of their choosing and design, and these complete environments can easily be copied and executed on other platforms. Singularity is an open source initiative that harnesses the expertise of system and software engineers and researchers alike, and integrates seam-lessly into common workflows for both of these groups. As its primary use case, Singularity brings mobility of computing to both users and HPC centers, providing a secure means to capture and distribute software and compute environments. This ability to create and deploy reproducible environments across these centers, a previously unmet need, makes Singularity a game changing development for computational science.	[Kurtzer, Gregory M.; Bauer, Michael W.] Lawrence Berkeley Natl Lab, High Performance Comp Serv, Berkeley, CA USA; [Sochat, Vanessa] Stanford Univ, Stanford Res Comp Ctr, Stanford, CA 94305 USA; [Sochat, Vanessa] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Bauer, Michael W.] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Bauer, Michael W.] GSI Helmholtzzentrum Schwerionenforsch, Expt Syst, Darmstadt, Germany	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stanford University; Stanford University; University of Michigan System; University of Michigan; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Sochat, V (corresponding author), Stanford Univ, Stanford Res Comp Ctr, Stanford, CA 94305 USA.; Sochat, V (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	vsochat@stanford.edu	Sochat, Vanessa/C-6893-2015	Sochat, Vanessa/0000-0002-4387-3819	Stanford Research Computing (IT); Stanford School of Medicine; Frankfurt Institute of Advanced Studies (FIAS); U.S. Department of Energy [DE-AC02-05CH11231]	Stanford Research Computing (IT); Stanford School of Medicine; Frankfurt Institute of Advanced Studies (FIAS); U.S. Department of Energy(United States Department of Energy (DOE))	Author VS is supported by Stanford Research Computing (IT) and the Stanford School of Medicine, and author MWB is supported by the Frankfurt Institute of Advanced Studies (FIAS). Author GMK is an employee of Lawrence Berkeley National Lab, the Department of Energy, and UC Regents. This manuscript has been authored by an author (GM K) at Lawrence Berkeley National Laboratory under Contract No. DE-AC02-05CH11231 with the U.S. Department of Energy. The U.S. Government retains, and the publisher, by accepting the article for publication, acknowledges, that the U.S. Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for U.S. Government purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AA, 2016, LECT N BIOINFORMAT, V9656, P587, DOI 10.1007/978-3-319-31744-1_52; Amazon Mechanical Turk, 2011, REQ BEST PRACT GUID; [Anonymous], 2015, DOCKER BASED SOLUTIO; [Anonymous], 2016, BIG DATA SEGMENTATIO; [Anonymous], 2015, WHAT IS DOCKER; [Anonymous], 2016, CONTAINER APP SINGUL; [Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Baker M., NATURE NEWS; Belmann P, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0087-0; Bockelman B., 2017, COMMUNICATION; Boettiger C, 2014, INTRO DOCKER REPRODU; Business Wire, 2016, BUSINESS WIRE; Ceruzzi P, 2003, HIST MODERN COMPUTIN; Furlani JL, 1996, PROCEEDINGS OF THE TENTH SYSTEMS ADMINISTRATION CONFERENCE (LISA X), P193; Gorgolewski KJ, 2016, BIDS APPS IMPROVING; Hale JS, 2016, CONTAINERS PRODUCTIV; Hosny A, 2016, BIOINFORMATICS, V32, P2396, DOI 10.1093/bioinformatics/btw120; Hyde D., SURVEY SECURITY VIRT; Jacobsen D.M., 2015, P CRAY US GROUP, P8; Layton J., CONTAINER HPC ADMIN; Layton J., COMMUNICATION; Merkel D, 2014, LINUX J, V2014; Priedhorsky R, 2016, CHARLIECLOUD UNPRIVI; Rushby J., 1981, ACM OPERATING SYSTEM, V15, P12, DOI DOI 10.1145/1067627.806586; Sklavos N, 2003, CIRC SYST 2003 ISCAS, V5, pV; Smith J. E., 2005, MORGAN KAUFMANN SERI, DOI 10.1016/B978-1-55860-910-5.X5000-9; Unwinding the'Long Tail' of Science &VERBAR; Computation Institute, UNW LONG TAIL SCI; Wallis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067332; Wilder B., 2012, CLOUD ARCHITECTURE P	29	475	485	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177459	10.1371/journal.pone.0177459	http://dx.doi.org/10.1371/journal.pone.0177459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494014	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300116
J	Li, ST; Wang, XN; Du, XH; Wu, Q				Li, Shu-ting; Wang, Xiang-ning; Du, Xin-hua; Wu, Qiang			Comparison of spectral-domain optical coherence tomography for intra-retinal layers thickness measurements between healthy and diabetic eyes among Chinese adults	PLOS ONE			English	Article							NERVE-FIBER LAYER; MACULAR THICKNESS; DISEASE SEVERITY; EARLY GLAUCOMA; NEURODEGENERATION; RETINOPATHY; OCT; SEGMENTATION; PATHOGENESIS; AGE	Purpose To compare intra-retinal layer thickness measurements between eyes with no or mild diabetic retinopathy (DR) and age-matched controls using Spectralis spectral-domain optical coherence tomography (SD-OCT). Methods Cross-sectional observational analysis study. High-resolution macular volume scans (30 degrees * 25 degrees) were obtained for 133 type 2 diabetes mellitus (T2DM) patients with no DR, 42 T2DM patients with mild DR and 115 healthy controls. The mean thickness was measured in all 9 Early Treatment Diabetic Retinopathy Study (ETDRS) sectors for 8 separate layers, inner retinal layer (IRL), outer retinal layer (ORL) and total retina (TR), after automated segmentation. The ETDRS grid consisted of three concentric circles of 1-, 3-, and 6-mm diameter. The superior, inferior, temporal, and nasal sectors of the 3- and 6-mm circles were respectively designated as S3, I3, T3, and N3 and S6, I6, T6, and N6. Linear regression analyses were conducted to evaluate the associations between the intra-retinal layer thicknesses, age, diabetes duration, fasting blood glucose and HbA1c. Results The mean age and duration of T2DM were 61.1 and 13.7 years, respectively. Although no significant differences in the average TR and ORL volumes were observed among the groups, significant differences were found in the volume and sectorial thicknesses of the inner plexiform layer (IPL), outer plexiform layer (OPL) and IRL among the groups. In particular, the thicknesses of the IPL (S3, T3, S6, I6 and T6 sectors) and the IRL (S6 sector) were decreased in the no-DR group compared with the controls (P < 0.05). The thickness of the OPL (S3, N3, S6 and N6 sectors) was thinner in the no-DR group than in mild DR (P < 0.05). The average IPL thickness was significantly negatively correlated with age and the duration of diabetes. Conclusion The assessment of the intra-retinal layer thickness showed a significant decrease in the IPL and IRL thicknesses in Chinese adults with T2DM, even in the absence of visible microvascular signs of DR.	[Li, Shu-ting; Wang, Xiang-ning; Du, Xin-hua; Wu, Qiang] Shanghai Jiao Tong Univ, Dept Ophthalmol, Affiliated Peoples Hosp 6, Shanghai, Peoples R China; [Wu, Qiang] Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wu, Q (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.; Wu, Q (corresponding author), Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China.	qiang.wu@shsmu.edu.cn			Science and Technology Commission of Shanghai Municipality [16DZ0501100]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Science and Technology Commission of Shanghai Municipality numbers: 16DZ0501100; URLs: http://www.stcsm. gov.cn/; http://images.stcsm.gov.cn/CMSstcsm/ 201702/201702131215051.pdf line 11. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2014, ANN NY ACAD SCI, V1311, P174, DOI 10.1111/nyas.12412; [Anonymous], 1991, Ophthalmology, V98, P786; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Asefzadeh B, 2008, CLIN EXP OPHTHALMOL, V36, P455, DOI 10.1111/j.1442-9071.2008.01769.x; Balasubramanian M, 2009, OPT EXPRESS, V17, P4019, DOI 10.1364/OE.17.004019; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Boynton GE, 2015, OPHTHALMOLOGY, V122, P957, DOI 10.1016/j.ophtha.2014.12.001; Chen YW, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0186-4; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chhablani J, 2015, INVEST OPHTH VIS SCI, V56, P6333, DOI 10.1167/iovs.15-17334; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Ctori I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129005; Demir M, 2014, INDIAN J OPHTHALMOL, V62, P719, DOI 10.4103/0301-4738.136234; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; Ferreira JT, 2016, INVEST OPHTH VIS SCI, V57, P6455, DOI 10.1167/iovs.16-20215; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Garcia-Martin E, 2016, ACTA OPHTHALMOL, V94, pE454, DOI 10.1111/aos.12977; Garcia-Martin E, 2011, INVEST OPHTH VIS SCI, V52, P4124, DOI 10.1167/iovs.10-6643; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Han IC, 2009, AM J OPHTHALMOL, V147, P847, DOI 10.1016/j.ajo.2008.11.019; Hernandez C, 2015, DIABETES, V25, P2569; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Kern TS, 2014, DIABETES METAB J, V38, P163, DOI 10.4093/dmj.2014.38.3.163; Lee HJ, 2015, AM J OPHTHALMOL, V160, P283, DOI 10.1016/j.ajo.2015.05.015; Lee KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147964; Leite MT, 2011, OPHTHALMOLOGY, V118, P1334, DOI 10.1016/j.ophtha.2010.11.029; Leung CKS, 2011, INVEST OPHTH VIS SCI, V52, P1539, DOI 10.1167/iovs.10-6012; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045264; Liu MM, 2014, INVEST OPHTH VIS SCI, V55, P1370, DOI 10.1167/iovs.13-13049; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Ng DSK, 2016, CLIN EXP OPHTHALMOL, V44, P243, DOI 10.1111/ceo.12724; Oberwahrenbrock T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137316; Padhy D, 2014, AM J OPHTHALMOL, V158, P211, DOI 10.1016/j.ajo.2014.04.014; Sato S, 2013, INVEST OPHTH VIS SCI, V54, P3046, DOI 10.1167/iovs.12-11173; Savastano MC, 2014, INVEST OPHTH VIS SCI, V55, P560, DOI 10.1167/iovs.13-12172; Silverman AL, 2016, OPHTHALMOLOGY, V123, P408, DOI 10.1016/j.ophtha.2015.09.047; Simo R, 2012, BRIT J OPHTHALMOL, V96, P1285, DOI 10.1136/bjophthalmol-2012-302005; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Stem MS, 2013, CURR MED CHEM, V20, P3241, DOI 10.2174/09298673113209990027; Stitt AW, 2016, PROG RETIN EYE RES, V51, P156, DOI 10.1016/j.preteyeres.2015.08.001; Terry L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162001; Usui V, 2015, J CLIN INVEST, V125, P2335, DOI 10.1172/JCI80297; Valverde AM, 2013, MOL VIS, V19, P47; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; van Dijk HW, 2010, INVEST OPHTH VIS SCI, V51, P3660, DOI 10.1167/iovs.09-5041; Vujosevic S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/905058; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; Wenner Y, 2014, GRAEF ARCH CLIN EXP, V252, P1195, DOI 10.1007/s00417-013-2560-8; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Yang JH, 2013, INVEST OPHTH VIS SCI, V54, P3844, DOI 10.1167/iovs.12-11309; Zhang XS, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046011; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	55	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177515	10.1371/journal.pone.0177515	http://dx.doi.org/10.1371/journal.pone.0177515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493982	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300126
J	Queloz, AC; Klymkowsky, MW; Stern, E; Hafen, E; Kohler, K				Queloz, Annie Champagne; Klymkowsky, Michael W.; Stern, Elsbeth; Hafen, Ernst; Kohler, Katja			Diagnostic of students' misconceptions using the Biological Concepts Instrument (BCI): A method for conducting an educational needs assessment	PLOS ONE			English	Article							CONCEPT INVENTORY; NATURAL-SELECTION; RANDOMNESS; KNOWLEDGE; ENERGY; DIFFUSION; GENETICS; OSMOSIS; DESIGN; TOOL	Concept inventories, constructed based on an analysis of students' thinking and their explanations of scientific situations, serve as diagnostics for identifying misconceptions and logical inconsistencies and provide data that can help direct curricular reforms. In the current project, we distributed the Biological Concepts Instrument (BCI) to 17-18-year-old students attending the highest track of the Swiss school system (Gymnasium). Students' performances on many questions related to evolution, genetics, molecular properties and functions were diverse. Important common misunderstandings were identified in the areas of evolutionary processes, molecular properties and an appreciation of stochastic processes in biological systems. Our observations provide further evidence that the BCI is efficient in identifying specific areas where targeted instruction is required. Based on these observations we have initiated changes at several levels to reconsider how biological systems are presented to university biology studies with the goal of improving student's foundational understanding.	[Queloz, Annie Champagne; Hafen, Ernst; Kohler, Katja] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Klymkowsky, Michael W.] Univ Colorado, Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Stern, Elsbeth] ETH, Inst Sci Educ, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Colorado System; University of Colorado Boulder; Swiss Federal Institutes of Technology Domain; ETH Zurich	Queloz, AC (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	champagne@imsb.biol.ethz.ch			Innovedum, ETH Zurich	Innovedum, ETH Zurich	This work was supported by Innovedum, ETH Zurich, to Prof Ernst Hafen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JK, 2014, CBE-LIFE SCI EDUC, V13, P349, DOI 10.1187/cbe.13-08-0160; Adedokun OA., 2012, J MULTIDISCIPLINARY, V8, P125; Allchin D, 2005, BIOL PHILOS, V20, P427, DOI 10.1007/s10539-005-2561-z; Anderson DL, 2002, J RES SCI TEACH, V39, P952, DOI 10.1002/tea.10053; Barbera J, 2013, J CHEM EDUC, V90, P546, DOI 10.1021/ed3004353; BISHOP BA, 1990, J RES SCI TEACH, V27, P415, DOI 10.1002/tea.3660270503; Bowling BV, 2008, GENETICS, V178, P15, DOI 10.1534/genetics.107.079533; Brandriet AR, 2014, J CHEM EDUC, V91, P1132, DOI 10.1021/ed500051n; Brasford J. D., 2000, PEOPLE LEARN MIND BR; Bretz SL, 2012, BIOCHEM MOL BIOL EDU, V40, P229, DOI 10.1002/bmb.20622; Champagne Queloz A, 2016, MATTERS SELECT, P1; Chi MT., 2013, INT HDB RES CONCEPTU; Coley JD, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-06-0094; Coley JD, 2012, CBE-LIFE SCI EDUC, V11, P209, DOI 10.1187/cbe.12-06-0074; Cooper MM, 2013, CBE-LIFE SCI EDUC, V12, P306, DOI 10.1187/cbe.12-10-0170; Couch BA, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-04-0071; Deane T, 2014, CBE-LIFE SCI EDUC, V13, P540, DOI 10.1187/cbe.13-11-0218; Demastes SS, 1996, J RES SCI TEACH, V33, P407, DOI 10.1002/(SICI)1098-2736(199604)33:4<407::AID-TEA4>3.0.CO;2-W; Duit R, 2003, INT J SCI EDUC, V25, P671, DOI 10.1080/09500690305016; Fisher KM, 2011, CBE-LIFE SCI EDUC, V10, P418, DOI 10.1187/cbe.11-04-0038; Garvin-Doxas K, 2008, CBE-LIFE SCI EDUC, V7, P227, DOI 10.1187/cbe.07-08-0063; Gonzalez Galli L., 2011, EVOL EDUC OUTREACH, V4, P145, DOI [DOI 10.1007/S12052-010-0272-7, 10.1007/s12052-010-0272-7]; Gray G. L., 2005, PROCEEDING OF THE 20; Henson K, 2012, BIOL OPEN, V1, P405, DOI 10.1242/bio.2012031; Hestenes D, 1992, PHYS TEACH, V30, P144; Kalas P, 2013, CBE-LIFE SCI EDUC, V12, P655, DOI 10.1187/cbe.12-10-0174; Kampourakis K, 2007, SCI ED, V17, P27; Kaufman R, 2002, INT J ED REFORM, V11, P77; Kelemen D, 2009, COGNITION, V111, P138, DOI 10.1016/j.cognition.2009.01.001; Klymkowsky MW, 2008, PLOS BIOL, V6, P14, DOI 10.1371/journal.pbio.0060003; Klymkowsky MW, 2010, ARXIV 1012 4501; Klymkowsky MW, 2016, BIORXIV; Klymkowsky MW, 2016, CBE LIFE SCIENCES ED, V15; Konicek-Moran R, 2015, TEACHING FOR CONCEPT; Lennox J. G., 2013, PHILOS BIOL COMPANIO, P421, DOI 10.1007/978-94-007-6537-5_20; Loertscher J, 2014, CBE-LIFE SCI EDUC, V13, P516, DOI 10.1187/cbe.14-04-0066; Marbach-Ad Gili, 2007, CBE Life Sci Educ, V6, P155, DOI 10.1187/cbe.06-12-0212; Metz KE, 1998, COGNITION INSTRUCT, V16, P285, DOI 10.1207/s1532690xci1603_3; Meysman P, 2012, BIOINFORM BIOL INSIG, V6, P155, DOI 10.4137/BBI.S9426; Nagel ML, 2015, CHEM EDUC RES PRACT, V16, P67, DOI 10.1039/c4rp00184b; Nehm RH, 2008, J RES SCI TEACH, V45, P1131, DOI 10.1002/tea.20251; Newman DL, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.15-06-0124; ODOM AL, 1995, J RES SCI TEACH, V32, P45, DOI 10.1002/tea.3660320106; Parker JM, 2012, CBE-LIFE SCI EDUC, V11, P47, DOI 10.1187/cbe.11-07-0054; Perez KE, 2013, CBE-LIFE SCI EDUC, V12, P665, DOI 10.1187/cbe.13-04-0079; Posner G.J., 1982, SCI ED, V66, P211, DOI [10.1002/sce.3730660207, https://doi.org/10.1002/sce.3730660207]; Price RM, 2014, CBE-LIFE SCI EDUC, V13, P65, DOI 10.1187/cbe.13-08-0159; Prince M, 2012, J ENG EDUC, V101, P412, DOI 10.1002/j.2168-9830.2012.tb00056.x; Sadler PM, 2013, CBE-LIFE SCI EDUC, V12, P553, DOI 10.1187/cbe.12-06-0078; Schneider M., 2010, NATURE LEARNING USIN, P69; Shi J, 2010, CBE-LIFE SCI EDUC, V9, P453, DOI 10.1187/cbe.10-04-0055; Skulmoski GJ, 2007, J INF TECHNOL EDUC-R, V6, P1; Smith J.P., 1993, J LEARN SCI, V3, P115, DOI [https://doi.org/10.1207/s15327809jls0302_1, DOI 10.1207/S15327809JLS0302_1, 10.1207/s15327809jls0302_1]; Smith JM, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-5; Smith MK, 2008, CBE-LIFE SCI EDUC, V7, P422, DOI 10.1187/cbe.08-08-0045; Southerland SA, 2001, SCI EDUC, V85, P328, DOI 10.1002/sce.1013; Stefanski KM, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.15-07-0162; Streveler RA, 2011, INT J ENG EDUC, V27, P968; TAMIR P, 1991, SCI EDUC, V75, P57, DOI 10.1002/sce.3730750106; Vosniadou S., 2013, SCI ED, V23, P1427; Vosniadou S, 2007, HUM DEV, V50, P47, DOI 10.1159/000097684; Waldrop MM, 2015, NATURE, V523, P272, DOI 10.1038/523272a; Wilensky U., 1999, J SCI EDUC TECHNOL, V8, P3, DOI DOI 10.1023/A:1009421303064; Wren D, 2013, J CHEM EDUC, V90, P1590, DOI 10.1021/ed400384g; Ziegler B, 2014, CBE-LIFE SCI EDUC, V13, P322, DOI 10.1187/cbe.13-09-0175; Ziegler L, 2013, TEACH STAT, V35, P2, DOI 10.1111/j.1467-9639.2012.00531.x; Zingaro D, 2014, COMPUT EDUC, V71, P87, DOI 10.1016/j.compedu.2013.09.015	67	12	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176906	10.1371/journal.pone.0176906	http://dx.doi.org/10.1371/journal.pone.0176906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493960	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300039
J	Schneider, T; Kuhne, JF; Bittrich, P; Schroeder, J; Magnus, T; Mohme, M; Grosser, M; Schoen, G; Fiehler, J; Siemonsen, S				Schneider, Tanja; Kuhne, Jan Felix; Bittrich, Paul; Schroeder, Julian; Magnus, Tim; Mohme, Malte; Grosser, Malte; Schoen, Gerhard; Fiehler, Jens; Siemonsen, Susanne			Edema is not a reliable diagnostic sign to exclude small brain metastases	PLOS ONE			English	Article							LUNG-CANCER; BREAST; TUMORS	No prior systematic study on the extent of vasogenic edema (VE) in patients with brain metastases (BM) exists. Here, we aim to determine 1) the general volumetric relationship between BM and VE, 2) a threshold diameter above which a BM shows VE, and 3) the influence of the primary tumor and location of the BM in order to improve diagnostic processes and understanding of edema formation. This single center, retrospective study includes 173 untreated patients with histologically proven BM. Semi-manual segmentation of 1416 BM on contrast-enhanced T1-weighted images and of 865 VE on fluid-attenuated inversion recovery/T2-weighted images was conducted. Statistical analyses were performed using a paired-samples t-test, linear regression/generalized mixed-effects model, and receiver-operating characteristic (ROC) curve controlling for the possible effect of non-uniformly distributed metastases among patients. For BM with non-confluent edema (n = 545), there was a statistically significant positive correlation between the volumes of the BM and the VE (P < 0.001). The optimal threshold for edema formation was a diameter of 9.4 mm for all BM. The primary tumors as interaction term in multivariate analysis had a significant influence on VE formation whereas location had not. Hence VE development is dependent on the volume of the underlying BM and the site of the primary neoplasm, but not from the location of the BM.	[Schneider, Tanja; Kuhne, Jan Felix; Bittrich, Paul; Grosser, Malte; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Schroeder, Julian; Magnus, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Mohme, Malte] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Schoen, Gerhard] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schneider, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	tan.schneider@uke.de						Aminoff A, 2014, AMINOFFS NEUROLOGY G; Berghoff AS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1057388; Bravo-RodroAiguez F, 2012, LEARNING NEUROIMAGIN; CRISCUOLO GR, 1993, YALE J BIOL MED, V66, P277; Drappatz J., UPTODATE; Ewing J, 1928, NEOPLASTIC DIS TREAT; Hengel K, 2013, INT J CLIN ONCOL, V18, P396, DOI 10.1007/s10147-012-0392-x; Kellie G., T MEDICOCHIRURGICAL, P84; Monro A, 1823, OBSERVATIONS STRUCTU; PAGET S, 1989, CANCER METAST REV, V8, P98; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Papadopoulos MC, 2001, NEUROPATH APPL NEURO, V27, P384, DOI 10.1046/j.0305-1846.2001.00341.x; Quattrocchi CC, 2012, J NEURO-ONCOL, V110, P79, DOI 10.1007/s11060-012-0937-x; Ramalho J, 2016, AM J NEURORADIOL, V37, P1192, DOI 10.3174/ajnr.A4615; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Rogne SG, 2014, ACTA NEUROL SCAND, V130, P1, DOI 10.1111/ane.12206; Roitbak T, 1999, GLIA, V28, P40, DOI 10.1002/(SICI)1098-1136(199910)28:1<40::AID-GLIA5>3.0.CO;2-6; Runge VM, 1997, CONTRAST ENHANCED CL; Schaefer PW, 1996, NEUROSURG CLIN N AM, V7, P393; Sekine A, 2012, LUNG CANCER, V77, P64, DOI 10.1016/j.lungcan.2011.12.017; WALKER AE, 1985, NEUROLOGY, V35, P219, DOI 10.1212/WNL.35.2.219; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8	22	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177217	10.1371/journal.pone.0177217	http://dx.doi.org/10.1371/journal.pone.0177217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493907	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300073
J	Christen, M; Del Medico, L; Christen, H; Christen, B				Christen, Matthias; Del Medico, Luca; Christen, Heinz; Christen, Beat			Genome Partitioner: A web tool for multi-level partitioning of large-scale DNA constructs for synthetic biology applications	PLOS ONE			English	Article							DESIGNER; YEAST; GENEDESIGN; STANDARDS; SEQUENCES; SOFTWARE; NETWORK	Recent advances in lower-cost DNA synthesis techniques have enabled new innovations in the field of synthetic biology. Still, efficient design and higher-order assembly of genome-scale DNA constructs remains a labor-intensive process. Given the complexity, computer assisted design tools that fragment large DNA sequences into fabricable DNA blocks are needed to pave the way towards streamlined assembly of biological systems. Here, we present the Genome Partitioner software implemented as a web-based interface that permits multi-level partitioning of genome-scale DNA designs. Without the need for specialized computing skills, biologists can submit their DNA designs to a fully automated pipeline that generates the optimal retrosynthetic route for higher-order DNA assembly. To test the algorithm, we partitioned a 783 kb Caulobacter crescentus genome design. We validated the partitioning strategy by assembling a 20 kb test segment encompassing a difficult to synthesize DNA sequence. Successful assembly from 1 kb subblocks into the 20 kb segment highlights the effectiveness of the Genome Partitioner for reducing synthesis costs and timelines for higher-order DNA assembly. The Genome Partitioner is broadly applicable to translate DNA designs into ready to order sequences that can be assembled with standardized protocols, thus offering new opportunities to harness the diversity of microbial genomes for synthetic biology applications. The Genome Partitioner web tool can be accessed at https://christenlab.ethz.ch/GenomePartitioner.	[Christen, Matthias; Del Medico, Luca; Christen, Heinz; Christen, Beat] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Del Medico, Luca] Life Sci Zurich PhD Program Syst Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Christen, M; Christen, B (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	matthias.christen@imsb.biol.ethz.ch; beat.christen@imsb.biol.ethz.ch	Christen, Beat/AAC-2974-2021	Del Medico, Luca/0000-0001-8248-5299; Christen, Beat/0000-0002-9528-3685; Christen, Matthias/0000-0001-7724-4562	Eidgenossische Technische Hochschule (ETH) Zurich [ETH-08 16-1]; Swiss National Science Foundation [31003A_166476]	Eidgenossische Technische Hochschule (ETH) Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Eidgenossische Technische Hochschule (ETH) Zurich [ETH-08 16-1] to BC and grant 31003A_166476 to BC from the Swiss National Science Foundation (SNSF, www.snt.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; [Anonymous], 2015, GLOBAL REGULATORY AR, V11; [Anonymous], 2011, WEBGESTER DB TRANSCR, V39, pD129; Auslander S, 2016, ANGEW CHEM INT ED EN; Awan AR, 2016, ADV DRUG DELIVER REV, V105, P96, DOI 10.1016/j.addr.2016.04.010; Bojar D, 2016, CURR OPIN CHEM BIOL, V34, P11, DOI 10.1016/j.cbpa.2016.05.012; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Casini A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt915; Chandran S, 2017, METHODS MOL BIOL, V1472, P187, DOI 10.1007/978-1-4939-6343-0_14; Chin JX, 2014, BIOINFORMATICS, V30, P2210, DOI 10.1093/bioinformatics/btu192; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Christen M, 2015, ACS SYNTH BIOL, V4, P927, DOI 10.1021/acssynbio.5b00087; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Eisenstein M, 2016, NATURE, V531, P401, DOI 10.1038/531401a; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; George KW, 2015, ADV BIOCHEM ENG BIOT, V148, P469, DOI 10.1007/10_2015_310; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hughes RA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023812; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Marillonnet S, 2015, METHODS MOL BIOL, V1321, P269, DOI 10.1007/978-1-4939-2760-9_19; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Oberortner E, 2016, ACS SYNTH BIOL; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pritchard L, 2006, BIOINFORMATICS, V22, P616, DOI 10.1093/bioinformatics/btk021; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rokke G, 2014, METHODS MOL BIOL, V1116, P1, DOI 10.1007/978-1-62703-764-8_1; Saxena P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11247; Schwander T, 2016, SCIENCE, V354, P900, DOI 10.1126/science.aah5237; Storch M, 2017, METHODS MOL BIOL, V1472, P79, DOI 10.1007/978-1-4939-6343-0_6; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Ye HF, 2013, P NATL ACAD SCI USA, V110, P141, DOI 10.1073/pnas.1216801110	40	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177234	10.1371/journal.pone.0177234	http://dx.doi.org/10.1371/journal.pone.0177234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531174	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400012
J	Zhang, D; Li, T; Chen, L; Zhang, XS; Zhao, GL; Liu, ZH				Zhang, Dai; Li, Ting; Chen, Lei; Zhang, Xiaosong; Zhao, Gengli; Liu, Zhaohui			Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; PELVIC-INFLAMMATORY-DISEASE; BACTERIAL VAGINOSIS; CERVICAL-CANCER; NEISSERIA-GONORRHOEAE; PREGNANT-WOMEN; HPV PREVALENCE; POPULATION; ABNORMALITIES; CLASSIFICATION	Background The incidence of lower genital tract infections in China has been increasing in recent years. The link between high-risk human papillomavirus (HR-HPV) and other sexually transmitted diseases (STDs) remains unclear. Methods From March to October 2014, gynecological examinations and questionnaires were conducted on 1218 married women. Cervical secretions and vaginal swab specimens were tested for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Ureaplasma urealyticum (UU), yeast, clue cells and HR-HPV. Results Laboratory results were available for 1195 of 1218 married women. HR-HPV was detected in 7.0% of participants. Forty-seven percent of women had lower genital tract infections (LGTIs). UU was the most common infection (35.5%), followed by bacterial vaginosis (BV) (10.5%), yeast infection (3.7%), CT (2.2%), and Trichomonas vaginalis (1.7%). BV was associated with an increased risk of HR-HPV (P < 0.0001; odds ratio, 3.0 [95% CI, 1.7 - 5.4]). There was a strong correlation between abnormal cervical cytology and HR-HPV infection (P < 0.0001). Conclusions The prevalence of LGTIs in Beijing is at a high level. It is clinically important to screen for the simultaneous presence of pathogens that cause co-infections with HR-HPV.	[Zhang, Dai; Li, Ting; Zhang, Xiaosong; Zhao, Gengli; Liu, Zhaohui] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing, Peoples R China; [Chen, Lei] Haidian Maternal & Child Hlth Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Peking University	Liu, ZH (corresponding author), Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing, Peoples R China.	17301255426@163.com	liu, zhao/GXV-6141-2022					Banhidy F, 2009, J MATERN-FETAL NEO M, V22, P410, DOI 10.1080/14767050902801645; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; DAWOOD MY, 1988, AM J MED, V84, P23, DOI 10.1016/0002-9343(88)90473-1; de Abreu ALP, 2016, AM J CANCER RES, V6, P1371; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Donders GGG, 2014, EXPERT OPIN PHARMACO, V15, P645, DOI 10.1517/14656566.2014.881800; Dubbink JH, 2016, J CLIN MICROBIOL, V54, P200, DOI 10.1128/JCM.02848-15; Franceschi S, 2007, SEX TRANSM DIS, V34, P563, DOI 10.1097/01.olq.0000258417.66619.0e; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; GOPLERUD C P, 1976, American Journal of Obstetrics and Gynecology, V126, P858; Goto A, 2005, J EPIDEMIOL, V15, P163, DOI 10.2188/jea.15.163; Guo YI, 2012, INT J STD AIDS, V23, P581, DOI 10.1258/ijsa.2012.011342; Huijsmans CJJ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2961-2; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Magana-Contreras M, 2015, J MED VIROL, V87, P2098, DOI 10.1002/jmv.24278; Manavi K, 2006, BEST PRACT RES CL OB, V20, P941, DOI 10.1016/j.bpobgyn.2006.06.003; Mao C, 2003, AM J OBSTET GYNECOL, V188, P677, DOI 10.1067/mob.2003.164; Markt SC, 2012, J INFECT DIS, V205, P498, DOI 10.1093/infdis/jir746; Marrazzo JM, 1997, SEX TRANSM DIS, V24, P131, DOI 10.1097/00007435-199703000-00003; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Pollock KGJ, 2014, BRIT J CANCER, V111, P1824, DOI 10.1038/bjc.2014.479; Rein DB, 2000, OBSTET GYNECOL, V95, P397, DOI 10.1016/S0029-7844(99)00551-7; Samoff E, 2005, AM J EPIDEMIOL, V162, P668, DOI 10.1093/aje/kwi262; Schwebke Jane R, 2009, Curr Infect Dis Rep, V11, P143, DOI 10.1007/s11908-009-0021-7; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Singh SM, 2015, INT J CLIN EXP PATHO, V8, P11901, DOI 10.5005/jp-journals-10005-1311; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P2148, DOI 10.1158/1055-9965.EPI-06-0556; Verteramo R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-16; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; WHO, 2012, GLOB INC PREV SEL CU; Wilson L, 2014, J INFECT DIS, V210, P448, DOI 10.1093/infdis/jiu104; Wu RF, 2007, INT J CANCER, V121, P1306, DOI 10.1002/ijc.22726; Xiaolei C, 2014, EUR J GYNAECOL ONCOL, V35, P571; Xu CY, 2012, J OBSTET GYNAECOL RE, V38, P310, DOI 10.1111/j.1447-0756.2011.01624.x; Yue XA, 2015, ARCH GYNECOL OBSTET, V292, P1285, DOI 10.1007/s00404-015-3774-2; Zekan Josko, 2014, Coll Antropol, V38, P779; Zhu HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003077	43	31	34	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178033	10.1371/journal.pone.0178033	http://dx.doi.org/10.1371/journal.pone.0178033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531212	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400051
J	He, ZZ; Zhang, JY; Yuan, XG; Liu, ZW; Liu, BB; Tuo, SH; Liu, YJ				He, Zongzhen; Zhang, Junying; Yuan, Xiguo; Liu, Zhaowen; Liu, Baobao; Tuo, Shouheng; Liu, Yajun			Network based stratification of major cancers by integrating somatic mutation and gene expression data	PLOS ONE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; MUTANT LUNG ADENOCARCINOMAS; CLASSIFICATION; PREDICTION; INHIBITOR; DISCOVERY; CETUXIMAB; DISEASE	The stratification of cancer into subtypes that are significantly associated with clinical outcomes is beneficial for targeted prognosis and treatment. In this study, we integrated somatic mutation and gene expression data to identify clusters of patients. In contrast to previous studies, we constructed cancer-type-specific significant co-expression networks (SCNs) rather than using a fixed gene network across all cancers, such as the network-based stratification (NBS) method, which ignores cancer heterogeneity. For each type of cancer, the gene expression data were used to construct the SCN network, while the gene somatic mutation data were mapped onto the network, propagated, and used for further clustering. For the clustering, we adopted an improved network-regularized non-negative matrix factorization (netNMF) (netNMF_HC) for a more precise classification. We applied our method to various datasets, including ovarian cancer (OV), lung adenocarcinoma (LUAD) and uterine corpus endometrial carcinoma (UCEC) cohorts derived from the TCGA (The Cancer Genome Atlas) project. Based on the results, we evaluated the performance of our method to identify survival-relevant subtypes and further compared it to the NBS method, which adopts priori networks and netNMF algorithm. The proposed algorithm outperformed the NBS method in identifying informative cancer subtypes that were significantly associated with clinical outcomes in most cancer types we studied. In particular, our method identified survival-associated UCEC subtypes that were not identified by the NBS method. Our analysis indicated valid subtyping of patient could be applied by mutation data with cancer-type-specific SCNs and netNMF_HC for individual cancers because of specific cancer co-expression patterns and more precise clustering.	[He, Zongzhen; Zhang, Junying; Yuan, Xiguo; Liu, Zhaowen; Liu, Baobao; Tuo, Shouheng; Liu, Yajun] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China	Xidian University	Zhang, JY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	jyzhang@mail.xidian.edu.cn	Liu, Zhaowen/AAM-6710-2021; liu, bb/GXA-2527-2022	Zhang, Junying/0000-0002-7511-0277	Natural Science Foundation of China [61571341, 61201312]; Natural Science Foundation of Shaanxi Province in China [2016JM6047, 2015JM6275]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province in China(Natural Science Foundation of Shaanxi Province)	This work was supported by the Natural Science Foundation of China under Grants 61571341, and 61201312, and the Natural Science Foundation of Shaanxi Province in China under Grants 2016JM6047 and 2015JM6275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl AA, 2015, COMPUT BIOL CHEM, V57, P3, DOI 10.1016/j.compbiolchem.2015.02.010; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cai D, 2008, IEEE DATA MINING, P63, DOI 10.1109/ICDM.2008.57; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chmielecki J, 2012, J THORAC ONCOL, V7, P434, DOI 10.1097/JTO.0b013e31823c5aee; Chuang CL, 2008, BIOINFORMATICS, V24, P1183, DOI 10.1093/bioinformatics/btn098; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hofree M., 2013, NATURE METHODS, V10; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Liu Z, 2015, BMC GENOMICS, V16, P1; Liu ZQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04002; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Olivier M, 2011, CURR OPIN ONCOL, V23, P88, DOI 10.1097/CCO.0b013e3283412dfa; Park S, 2010, IETE TECH REV, V27, P167, DOI 10.4103/0256-4602.60169; Pirazzoli V, 2014, CELL REP, V7, P999, DOI 10.1016/j.celrep.2014.04.014; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Van TL, 2016, BIOINFORMATICS, V32, P445, DOI 10.1093/bioinformatics/btw434; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xue Z, 2015, BMC GENOMICS, V16, P1; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231; Zhou DY, 2004, ADV NEUR IN, V16, P321	30	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177662	10.1371/journal.pone.0177662	http://dx.doi.org/10.1371/journal.pone.0177662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520777	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500053
J	Liao, JM; Ommerborn, MJ; Clark, CR				Liao, Joshua M.; Ommerborn, Mark J.; Clark, Cheryl R.			Association between features of patient-provider discussions and routine prostate-specific antigen testing	PLOS ONE			English	Article							SHARED DECISION-MAKING; PATTERNS	Introduction Although the US Preventive Services Task Force recommends against routine prostate cancer screening with prostate-specific antigen (PSA) testing, specialty organizations support screening via shared decision making between providers and selected patients. While discussions about advantages and disadvantages of testing are a feature of patient-centered care, it is unclear how provider recommendations and the presence of a personal doctor influence testing in the presence of such discussions. Materials and methods We used the 2013 Behavioral Risk Factor Surveillance System to identify 1,737 male respondents surveyed about their PSA testing decisions. We describe the prevalence of provider recommendations and utilize weighted multivariable logistic regression models to examine the impact of provider recommendations and presence of a personal doctor on routine testing while accounting for patient-provider discussions about advantages and disadvantages. Results The majority (70.4%) of respondents reported some form of discussion with providers about testing and most underwent screening in accordance with provider recommendations. In multivariable analyses, men whose providers had never recommended PSA test were less likely to receive screening [OR 0.03, 95% CI (0.02-0.05)], and patients who did not identify a personal doctor in their care were less likely to undergo testing [OR 0.12, 95% CI (0.04-0.32)]. Discussion Provider recommendations and having a personal doctor are associated with routine PSA testing. These findings suggest that providers and policymakers should be aware of how the content and context of communication with patients, beyond discussions of risks and benefits, can influence routine PSA testing behaviors.	[Liao, Joshua M.] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Ommerborn, Mark J.; Clark, Cheryl R.] Brigham & Womens Hosp, Ctr Community Hlth & Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Clark, Cheryl R.] Harvard Med Sch, Boston, MA USA; [Clark, Cheryl R.] Brigham & Womens Faulkner Hospitalist Program, Div Gen Internal Med & Primary Care, Boston, MA USA	University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liao, JM (corresponding author), Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA.	joshliao@upenn.edu						American Urological Association, EARLY DETECTION PROS; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Han PKJ, 2013, ANN FAM MED, V11, P306, DOI 10.1370/afm.1539; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; Li J, 2015, AM J PREV MED, V49, P259, DOI 10.1016/j.amepre.2015.02.007; Sammon JD, 2015, JAMA-J AM MED ASSOC, V314, P2075, DOI 10.1001/jama.2015.7273; Taneja SS, 2015, J UROLOGY, V193, P126, DOI 10.1016/j.juro.2014.10.073; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	8	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177687	10.1371/journal.pone.0177687	http://dx.doi.org/10.1371/journal.pone.0177687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520820	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500055
J	Rode, M; Lemoine, NP; Smith, MD				Rode, Madison; Lemoine, Nathan P.; Smith, Melinda D.			Prospective evidence for independent nitrogen and phosphorus limitation of grasshopper (Chorthippus curtipennis) growth in a tallgrass prairie	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; INSECT HERBIVORES; PLANT-QUALITY; NUTRITIONAL CONSTRAINTS; NATURAL ENEMIES; PREDATION RISK; MANDUCA-SEXTA; PERFORMANCE; ECOSYSTEM; TEMPERATURE	Insect herbivores play a pivotal role in regulating plant production and community composition, and their role in terrestrial ecosystems is partly determined by their feeding behavior and performance among plants of differing nutritional quality. Historically, nitrogen (N) has been considered the primary limiting nutrient of herbivorous insects, but N is only one of many potential nutrients important to insect performance. Of these nutrients, phosphorus (P) is perhaps the most important because somatic growth depends upon P-rich ribosomal RNA. Yet relatively few studies have assessed the strength of P-limitation for terrestrial insects and even fewer have simultaneously manipulated both N and P to assess the relative strengths of N- and P-limitation. Here, we tested for potential N and P limitation, as well as N: P co-limitation, on Chorthippis curtipennis (Orthoptera, Acrididae), an abundant member of arthropod communities of central US prairies. Our results demonstrate weak evidence for both N and P limitation of C. curtipennis growth rates in laboratory feeding assays. Importantly, P-limitation was just as strong as N-limitation, but we found no evidence for NP co-limitation in our study. Furthermore, nutrient limitation was not apparent in field studies, suggesting that insect growth rates may be predominately controlled by other factors, including temperature and predation. Our results suggest that P should be jointly considered, along with N, as a primary determinant of herbivore feeding behavior under both current and future climate conditions.	[Rode, Madison; Lemoine, Nathan P.; Smith, Melinda D.] Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA	Colorado State University	Lemoine, NP (corresponding author), Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	Nate.Lemoine@colostate.edu			United Stats Department of Agriculture - National Institute of Food and Agriculture - Agriculture and Food Research Initiative [2016-67012-25169]; Division Of Environmental Biology [1440484] Funding Source: National Science Foundation	United Stats Department of Agriculture - National Institute of Food and Agriculture - Agriculture and Food Research Initiative; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by a United Stats Department of Agriculture - National Institute of Food and Agriculture - Agriculture and Food Research Initiative postdoctoral fellowship (2016-67012-25169) to NPL (https://nifa.usda.gov/ program/afri-foundational-program). The USDA had no role in the study design, data collection, or manuscript preparation.	Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Bakker ES, 2009, OIKOS, V118, P1613, DOI 10.1111/j.1600-0706.2009.17199.x; Barton BT, 2010, ECOLOGY, V91, P2811, DOI 10.1890/09-2278.1; Bentz JA, 2001, ENVIRON ENTOMOL, V30, P533, DOI 10.1603/0046-225X-30.3.533; Bigger David S., 1998, Integrative Biology, V1, P60, DOI 10.1002/(SICI)1520-6602(1998)1:2<60::AID-INBI4>3.0.CO;2-Z; Bishop JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013598; BROWN VK, 1992, VEGETATIO, V101, P3, DOI 10.1007/BF00031910; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Burkepile DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01493; Busch JW, 1999, ECOL ENTOMOL, V24, P132, DOI 10.1046/j.1365-2311.1999.00185.x; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Carson WP, 1999, OECOLOGIA, V121, P260, DOI 10.1007/s004420050928; Cease AJ, 2016, DIETARY PHOSPHATE AF, P64; CLANCY KM, 1993, ECOLOGY, V74, P442, DOI 10.2307/1939306; Coley PD, 2006, OIKOS, V115, P219, DOI 10.1111/j.2006.0030-1299.14928.x; DAVIDSON DW, 1993, OIKOS, V68, P23, DOI 10.2307/3545305; De Bruyn L, 2002, OECOLOGIA, V130, P594, DOI 10.1007/s00442-001-0840-1; De Long JR, 2016, FUNCT ECOL, V30, P314, DOI 10.1111/1365-2435.12493; DeMalach N, 2017, ECOL LETT, V20, P60, DOI 10.1111/ele.12706; Elser JJ, 2006, FUNCT ECOL, V20, P846, DOI 10.1111/j.1365-2435.2006.01165.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, J EVOLUTION BIOL, V13, P845; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Joern A, 2004, ENVIRON ENTOMOL, V33, P1617, DOI 10.1603/0046-225X-33.6.1617; Joern A, 2012, ECOLOGY, V93, P1002, DOI 10.1890/11-1142.1; Johnson SN, 2013, J ANIM ECOL, V82, P1021, DOI 10.1111/1365-2656.12070; Kainulainen P, 1996, J CHEM ECOL, V22, P617, DOI 10.1007/BF02033574; KAROWE DN, 1989, J INSECT PHYSIOL, V35, P699, DOI 10.1016/0022-1910(89)90089-9; Kerslake JE, 1998, NEW PHYTOL, V140, P43, DOI 10.1046/j.1469-8137.1998.00244.x; Kingsolver JG, 1997, PHYSIOL ZOOL, V70, P631, DOI 10.1086/515872; La Pierre Kimberly J., 2015, Oikos, V124, P842, DOI 10.1111/oik.01869; La Pierre KJ, 2015, OECOLOGIA; Laws AN, 2013, OIKOS, V122, P977, DOI 10.1111/j.1600-0706.2012.20419.x; Lemoine NP, 2016, ECOLOGY, V97, P2554, DOI 10.1002/ecy.1506; Lemoine NP, 2016, PHYSIOL ENTOMOL, V41, P143, DOI 10.1111/phen.12138; Lemoine NP, 2014, OECOLOGIA, V174, P1367, DOI 10.1007/s00442-013-2860-z; Lemoine NP, 2013, OIKOS, V122, P1669, DOI 10.1111/j.1600-0706.2013.00457.x; Massey FP, 2007, OECOLOGIA, V152, P677, DOI 10.1007/s00442-007-0703-5; Massey FP, 2007, J ECOL, V95, P414, DOI 10.1111/j.1365-2745.2007.01223.x; Massey FP, 2006, J ANIM ECOL, V75, P595, DOI 10.1111/j.1365-2656.2006.01082.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Metcalfe DB, 2014, ECOL LETT, V17, P324, DOI 10.1111/ele.12233; Nabity PD, 2012, J ECON ENTOMOL, V105, P878, DOI 10.1603/EC11424; Parsons SMA, 2014, OECOLOGIA, V174, P379, DOI 10.1007/s00442-013-2785-6; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; POPP MP, 1989, ENVIRON ENTOMOL, V18, P795, DOI 10.1093/ee/18.5.795; Risch AC, 2015, ECOLOGY, V96, P3312, DOI 10.1890/15-0300.1; ROSSI AM, 1991, ENVIRON ENTOMOL, V20, P1349, DOI 10.1093/ee/20.5.1349; Rossi AM, 1996, J CHEM ECOL, V22, P653, DOI 10.1007/BF02033576; Ryalls JMW, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2016.0912; SALIM M, 1991, CROP SCI, V31, P797, DOI 10.2135/cropsci1991.0011183X003100030051x; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Tao LL, 2014, FUNCT ECOL, V28, P190, DOI 10.1111/1365-2435.12163; Tao LL, 2012, GLOBAL CHANGE BIOL, V18, P1843, DOI 10.1111/j.1365-2486.2012.02645.x; TILMAN D, 1981, LIMNOL OCEANOGR, V26, P1020, DOI 10.4319/lo.1981.26.6.1020; Visanuvimol L, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.6301; Wojewodzic MW, 2011, FUNCT ECOL, V25, P1154, DOI 10.1111/j.1365-2435.2011.01864.x	66	16	16	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177754	10.1371/journal.pone.0177754	http://dx.doi.org/10.1371/journal.pone.0177754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520785	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500066
J	Cai, W; Ma, ZX; Yang, CY; Wang, L; Wang, WZ; Zhao, GG; Geng, YP; Yu, DW				Cai, Wang; Ma, Zhuxin; Yang, Chunyan; Wang, Lin; Wang, Wenzhi; Zhao, Guigang; Geng, Yupeng; Yu, Douglas W.			Using eDNA to detect the distribution and density of invasive crayfish in the Honghe-Hani rice terrace World Heritage site	PLOS ONE			English	Article							ENVIRONMENTAL DNA; ORCONECTES-RUSTICUS; WATER; BIODIVERSITY; CAPTURE; SIZE; OCCUPANCY; IMPACT; SAMPLE	The Honghe-Hani landscape in China is a UNESCO World Natural Heritage site due to the beauty of its thousands of rice terraces, but these structures are in danger from the invasive crayfish Procambarus clarkii. Crayfish dig nest holes, which collapse terrace walls and destroy rice production. Under the current control strategy, farmers self-report crayfish and are issued pesticide, but this strategy is not expected to eradicate the crayfish nor to prevent their spread since farmers are not able to detect small numbers of crayfish. Thus, we tested whether environmental DNA (eDNA) from paddy-water samples could provide a sensitive detection method. In an aquarium experiment, Real-time Quantitative polymerase chain reaction (qPCR) successfully detected crayfish, even at a simulated density of one crayfish per average-sized paddy (with one false negative). In a field test, we tested eDNA and bottle traps against direct counts of crayfish. eDNA successfully detected crayfish in all 25 paddies where crayfish were observed and in none of the 7 paddies where crayfish were absent. Bottle-trapping was successful in only 68% of the crayfish-present paddies. eDNA concentrations also correlated positively with crayfish counts. In sum, these results suggest that single samples of eDNA are able to detect small crayfish populations, but not perfectly. Thus, we conclude that a program of repeated eDNA sampling is now feasible and likely reliable for measuring crayfish geographic range and for detecting new invasion fronts in the Honghe Hani landscape, which would inform regional control efforts and help to prevent the further spread of this invasive crayfish.	[Cai, Wang; Yang, Chunyan; Wang, Lin; Wang, Wenzhi; Yu, Douglas W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Cai, Wang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Ma, Zhuxin; Geng, Yupeng] Yunnan Univ, Inst Ecol & Geobot, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China; [Zhao, Guigang] Chinese Acad Sci, Kunming Inst Zool, Publ Tech Serv Ctr, Kunming, Yunnan, Peoples R China; [Zhao, Guigang] Chinese Acad Sci, Kunming Inst Zool, Kunming Biol Divers Reg Ctr Instruments, Kunming, Yunnan, Peoples R China; [Yu, Douglas W.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia	Yang, CY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.; Geng, YP (corresponding author), Yunnan Univ, Inst Ecol & Geobot, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China.	yangyahan@mail.kiz.ac.cn; ypgeng@ynu.edu.cn	Wang, Lin/ABF-8028-2021; Yu, Douglas W./D-2536-2009; Wang, Lin/AAA-2163-2022	Wang, Lin/0000-0001-5645-8991; Yu, Douglas W./0000-0001-8551-5609; 	National Natural Science Foundation of China; Ministry of Science and Technology of the People's Republic of China; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Support was provided by the National Natural Science Foundation of China [http://www.nsfc.gov.cn] to CYY and DWY; the Ministry of Science and Technology of the People's Republic of China [http://www.most.gov.cn] to DWY and GYP; and the Chinese Academy of Sciences [http://www.cas.cn] to DWY and YPG.	Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; CAPELLI GM, 1983, J CRUSTACEAN BIOL, V3, P548, DOI 10.2307/1547950; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Dougherty MM, 2016, J APPL ECOL, V53, P722, DOI 10.1111/1365-2664.12621; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Geiger W, 2005, BIOL INVASIONS, V7, P49, DOI 10.1007/s10530-004-9635-8; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Jane SF, 2014, MOL ECOL RESOUR, P216; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lodge DM, 2012, ANNU REV ECOL EVOL S, V43, P449, DOI 10.1146/annurev-ecolsys-111511-103919; Lucentini L, 2006, MOL ECOL NOTES, V6, P257, DOI 10.1111/j.1471-8286.2005.01142.x; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; OLSEN TM, 1991, CAN J FISH AQUAT SCI, V48, P1853, DOI 10.1139/f91-219; Paillisson JM, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011015; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Renshaw M A, 2014, MOL ECOL RESOUR, P168; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Seiler SM, 2004, FRESHWATER BIOL, V49, P870, DOI 10.1111/j.1365-2427.2004.01231.x; Smart AS, 2016, METHODS ECOL EVOL, V7, P1291, DOI 10.1111/2041-210X.12598; Smart AS, 2015, ECOL APPL, V25, P1944, DOI 10.1890/14-1751.1; Takahara T, 2015, BIOL CONSERV, V183, P64, DOI 10.1016/j.biocon.2014.11.014; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takazawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040154; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Twardochleb LA, 2013, FRESHW SCI, V32, P1367, DOI 10.1899/12-203.1; Zhang Gai P, 2015, YUNNAN XINHUA NET, V11, P1	38	27	33	10	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177724	10.1371/journal.pone.0177724	http://dx.doi.org/10.1371/journal.pone.0177724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505200	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000401473500036
J	Kahnert, K; Lucke, T; Huber, RM; Behr, J; Biertz, F; Vogel, A; Watz, H; Alter, P; Fahndrich, S; Bals, R; Holle, R; Karrasch, S; Sohler, S; Wacker, M; Ficker, JH; Parhofer, KG; Vogelmeier, C; Jorres, RA				Kahnert, Kathrin; Lucke, Tanja; Huber, Rudolf M.; Behr, Juergen; Biertz, Frank; Vogt, Anja; Watz, Henrik; Alter, Peter; Faehndrich, Sebastian; Bals, Robert; Holle, Rolf; Karrasch, Stefan; Sohler, Sandra; Wacker, Margarethe; Ficker, Joachim H.; Parhofer, Klaus G.; Vogelmeier, Claus; Joerres, Rudolf A.		COSYCONET Consortium	Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BODY-MASS INDEX; DIFFUSING-CAPACITY; METABOLIC SYNDROME; REFERENCE VALUES; RISK-FACTORS; MORTALITY; HEALTH; AGE	Although hyperlipidemia is common in COPD, its relationship to comorbidities, risk factors and lung function in COPD has not been studied in detail. Using the baseline data of the COSYCONET cohort we addressed this question. Data from 1746 COPD patients (GOLD stage 1-4; mean age 64.6 y, mean FEV1% pred 57%) were evaluated, focusing on the comorbidities hyperlipidemia, diabetes and cardiovascular complex (CVC; including arterial hypertension, cardiac failure, ischemic heart disease). Risk factors comprised age, gender, BMI, and packyears of smoking. The results of linear and logistic regression analyses were implemented into a path analysis model describing the multiple relationships between parameters. Hyperlipidemia (prevalence 42.9%) was associated with lower intrathoracic gas volume (ITGV) and higher forced expiratory volume in 1 second (FEV1) when adjusting for its multiple relationships to risk factors and other comorbidities. These findings were robust in various statistical analyses. The associations between comorbidities and risk factors were in accordance with previous findings, thereby underlining the validity of our data. In conclusion, hyperlipidemia was associated with less hyperinflation and airway obstruction in patients with COPD. This surprising result might be due to different COPD phenotypes in these patients or related to effects of medication.	[Kahnert, Kathrin; Huber, Rudolf M.; Behr, Juergen] Univ Munich, German Ctr Lung Res, Comprehens Pneumol Ctr, Dept Internal Med 5, Munich, Germany; [Lucke, Tanja; Karrasch, Stefan; Joerres, Rudolf A.] Ludwig Maximilians Univ Munchen, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Biertz, Frank] Hannover Med Sch, Inst Biostat, Hannover, Germany; [Vogt, Anja] Klin & Poliklin Univ Munchen, Stoffwechselambulanz, Munich, Germany; [Watz, Henrik] German Ctr Lung Res, LungenClin Grosshansdorf, Pulm Res Inst, Airway Res Ctr North, Grosshansdorf, Germany; [Alter, Peter; Vogelmeier, Claus] Philipps Univ Marburg, Dept Med Pulm & Crit Care Med, Univ Med Ctr Giessen & Marburg, German Ctr Lung Res DZL, Marburg, Germany; [Faehndrich, Sebastian; Bals, Robert] Saarland Univ Hosp, Dept Internal Med Pulmonol Allergol Resp Intens C, Homburg, Germany; [Holle, Rolf; Wacker, Margarethe] Helmholtz Zentrum Munchen GmbH, German Ctr Lung Res, CPC M, German Res Ctr Environm Hlth,Inst Hlth Econ & Hlt, Neuherberg, Germany; [Karrasch, Stefan] Helmholtz Zentrum Munchen, Inst Epidemiol 1, German Res Ctr Environm Hlth, Neuherberg, Germany; [Sohler, Sandra] Univ Marburg, ASCONET Study Coordinat Off, Marburg, Germany; [Ficker, Joachim H.] Paracelsus Med Univ, Gen Hosp Nuernberg, Dept Resp Med Allergol & Sleep Med, Nurnberg, Germany; [Parhofer, Klaus G.] Univ Munich, Dept Internal Med 4, Munich, Germany	University of Munich; University of Munich; Hannover Medical School; Grosshansdorf Hospital; Philipps University Marburg; University Hospital of Giessen & Marburg; Universitatsklinikum des Saarlandes; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg; University of Munich	Kahnert, K (corresponding author), Univ Munich, German Ctr Lung Res, Comprehens Pneumol Ctr, Dept Internal Med 5, Munich, Germany.	kathrin.kahnert@med.uni-muenchen.de	Ficker, Joachim H./A-1153-2015; Huber, Rudolf M./L-2464-2019; Kahnert, Kathrin/AAG-6564-2021; Holle, Rolf/D-9333-2013; Karrasch, Stefan/GQI-2691-2022; Deitsch, Haysha/C-2019-2017	Ficker, Joachim H./0000-0002-7175-5852; Huber, Rudolf M./0000-0001-7041-6368; Holle, Rolf/0000-0001-5395-2695; Deitsch, Haysha/0000-0002-0215-4340	BMBF Competence Network Asthma and COPD (ASCONET); German Federal Ministry of Education and Research (BMBF) [01 GI 0881]; AstraZeneca GmbH; Bayer Schering Pharma AG; Boehringer Ingelheim Pharma GmbH Co. KG; Chiesi GmbH; GlaxoSmithKline; Grifols Deutschland GmbH; MSD Sharp Dohme GmbH; Mundipharma GmbH; Novartis Deutschland GmbH; Pfizer Pharma GmbH; Takeda Pharma Vertrieb GmbH Co. KG	BMBF Competence Network Asthma and COPD (ASCONET)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); AstraZeneca GmbH(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim); Chiesi GmbH(Chiesi Pharmaceuticals Inc); GlaxoSmithKline(GlaxoSmithKline); Grifols Deutschland GmbH; MSD Sharp Dohme GmbH; Mundipharma GmbH; Novartis Deutschland GmbH; Pfizer Pharma GmbH(Pfizer); Takeda Pharma Vertrieb GmbH Co. KG	This work was supported by BMBF Competence Network Asthma and COPD (ASCONET) and performed in collaboration with the German Center for Lung Research (DZL). The project is funded by the German Federal Ministry of Education and Research (BMBF) with grant number 01 GI 0881; and is funded by unrestricted grants from AstraZeneca GmbH, Bayer Schering Pharma AG, Boehringer Ingelheim Pharma GmbH & Co. KG, Chiesi GmbH, GlaxoSmithKline, Grifols Deutschland GmbH, MSD Sharp & Dohme GmbH, Mundipharma GmbH, Novartis Deutschland GmbH, Pfizer Pharma GmbH, Takeda Pharma Vertrieb GmbH & Co. KG for patient investigations and laboratory measurements.	Akhabue E, 2014, AM J MED SCI, V347, P151, DOI 10.1097/MAJ.0b013e31828aab45; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; AVIRAM M, 1987, POSTGRAD MED J, V63, P91, DOI 10.1136/pgmj.63.736.91; Bando M, 2012, RESPIROLOGY, V17, P493, DOI 10.1111/j.1440-1843.2011.02116.x; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Chan MC, 2016, INT J CHRONIC OBSTR, V11, P1053, DOI 10.2147/COPD.S102708; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Chen WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108989; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Ford ES, 2014, J DIABETES, V6, P603, DOI 10.1111/1753-0407.12136; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Guerra S, 2002, CHEST, V122, P1256, DOI 10.1378/chest.122.4.1256; Hersh CP, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-164; Hoyle R.H, 2015, HDB STRUCTURAL EQUAT; Humayun Anjum, 2009, J Ayub Med Coll Abbottabad, V21, P141; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Karch A, 2016, RESP MED, V114, P27, DOI 10.1016/j.rmed.2016.03.008; Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; LOWE GDO, 1982, LANCET, V1, P472; Lucke T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163408; Negewo NA, 2015, RESPIR INVESTIG, V53, P249, DOI 10.1016/j.resinv.2015.02.004; NEWBALL HH, 1975, AM REV RESPIR DIS, V112, P83; PARTRIDGE MR, 1979, THORAX, V34, P265, DOI 10.1136/thx.34.2.265; Pintaric I, 2001, ATHEROSCLEROSIS, V154, P493, DOI 10.1016/S0021-9150(00)00505-0; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Santus P, 2014, RESP PHYSIOL NEUROBI, V197, P36, DOI 10.1016/j.resp.2014.03.012; Silove D, 2015, LANCET PSYCHIAT, V2, P161, DOI 10.1016/S2215-0366(14)00054-6; Soriano JB, 2015, LANCET RESP MED, V3, P443, DOI 10.1016/S2213-2600(15)00157-5; Tawakol A., 2017, LANCET; van der Lee I, 2007, RESP MED, V101, P1579, DOI 10.1016/j.rmed.2006.12.001; Yoshimura C, 2012, INTERNAL MED, V51, P2291, DOI 10.2169/internalmedicine.51.7427	33	26	26	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177501	10.1371/journal.pone.0177501	http://dx.doi.org/10.1371/journal.pone.0177501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505167	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500025
J	Murthy, SK; James, PD; Antonova, L; Chalifoux, M; Tanuseputro, P				Murthy, Sanjay K.; James, Paul D.; Antonova, Lilia; Chalifoux, Mathieu; Tanuseputro, Peter			High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study	PLOS ONE			English	Article							ADMINISTRATIVE DATA; VALIDATION; PREVALENCE; DATABASES; ONTARIO; ILLNESS; RECORDS; TRENDS	Background End of life (EOL) care is associated with greater costs, particularly for acute care services. In patients with inflammatory bowel disease (IBD), EOL costs may be accentuated due to reliance on hospital-based services and expensive diagnostic tests and treatments. We aimed to compare EOL health care use and costs between IBD and non-IBD decedents. Methods We conducted a retrospective cohort study of all decedents of Ontario, Canada between 2010 and 2013 using linked health administrative data. IBD (N = 2,214) and non-IBD (N = 262,540) decedents were compared on total direct health care costs in the last year of life and hospitalization time during the last 90 days of life. Results During the last 90 days of life, IBD patients spent an average of 16 days in hospital, equal to 2.1 greater adjusted hospital days (95% confidence interval [CI] 1.5-2.8 days) than non-IBD patients. IBD diagnosis was associated with $ 7,210 CAD (95% CI $ 5,005 -$ 9,464) higher adjusted per-patient cost in the last year of life, of which 76% was due to excess hospitalization costs. EOL cost of IBD care was higher than 15 of 16 studied chronic conditions. Health care costs rose sharply in the last 90 days of life, primarily due to escalating hospitalization costs. Conclusions IBD patients spend more time in hospital and incur substantially greater health care costs than other decedents as they approach the EOL. These excess costs could be curtailed through avoidance of unnecessary hospitalizations and expensive treatments in the setting of irreversible deterioration.	[Murthy, Sanjay K.; James, Paul D.; Tanuseputro, Peter] Ottawa Hosp, Dept Med, Div Gastroenterol, Ottawa, ON, Canada; [Murthy, Sanjay K.; James, Paul D.; Tanuseputro, Peter] Univ Ottawa, Ottawa, ON, Canada; [Murthy, Sanjay K.; James, Paul D.; Antonova, Lilia; Chalifoux, Mathieu; Tanuseputro, Peter] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Murthy, Sanjay K.; Chalifoux, Mathieu; Tanuseputro, Peter] Inst Clin Evaluat Sci ICES uOttawa, Ottawa, ON, Canada; [Tanuseputro, Peter] Bruyere Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Murthy, SK (corresponding author), Ottawa Hosp, Dept Med, Div Gastroenterol, Ottawa, ON, Canada.; Murthy, SK (corresponding author), Univ Ottawa, Ottawa, ON, Canada.; Murthy, SK (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Murthy, SK (corresponding author), Inst Clin Evaluat Sci ICES uOttawa, Ottawa, ON, Canada.	smurthy@toh.on.ca		Murthy, Sanjay/0000-0002-0128-7897; Tanuseputro, Peter/0000-0002-4409-0795	Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); Ontario Ministry of Health and Long-Term Care; Health System Performance Research Network Grant (HSPRN) [06034]	Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Health System Performance Research Network Grant (HSPRN)	This research was supported by a research grant from the Ontario Ministry of Health and Long-Term Care to the Health System Performance Research Network Grant [grant number HSPRN #06034]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was made possible with the support of the Institute for Clinical Evaluative Sciences (ICES) which receives funding from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Bassi A, 2004, GUT, V53, P1471, DOI 10.1136/gut.2004.041616; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Drummond D, 2012, COMMISSION REFORM ON; Felder S, 2000, J HEALTH ECON, V19, P679, DOI 10.1016/S0167-6296(00)00039-4; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jaakkimainen RL, 2016, J ALZHEIMERS DIS, V54, P337, DOI 10.3233/JAD-160105; Johnson SL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008597; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Longobardi T, 2006, CLIN GASTROENTEROL H, V4, P731, DOI 10.1016/j.cgh.2006.02.013; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Mondor L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002249; Niewiadomski O, 2015, J CROHNS COLITIS; Rocchi A, 2012, CAN J GASTROENTEROL, V26, P811, DOI 10.1155/2012/984575; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; Tanuseputro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121759; Tu Karen, 2007, Open Med, V1, pe18; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; Wodchis WP, 2013, GUIDELINES PERSON LE	23	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177211	10.1371/journal.pone.0177211	http://dx.doi.org/10.1371/journal.pone.0177211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498877	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314500012
J	Barchiesi, F; Orsetti, E; Mazzanti, S; Trave, F; Salvi, A; Nitti, C; Manso, E				Barchiesi, Francesco; Orsetti, Elena; Mazzanti, Sara; Trave, Francesca; Salvi, Aldo; Nitti, Cinzia; Manso, Esther			Candidemia in the elderly: What does it change?	PLOS ONE			English	Article							INVASIVE CANDIDIASIS; SEPTIC SHOCK; EPIDEMIOLOGY; SURVEILLANCE; MULTICENTER; CANDIDAEMIA; INFECTIONS; PREDICTORS; RESISTANCE; MORTALITY	Background Candidemia is a life-threatening fungal infection and it can affect patients of all ages. Characterization of candidemia in the elderly is lacking. Methods We performed a retrospective study of adults (>= 18 years) with candidemia diagnosed in our center in 2010-2015. Demographics, comorbidities, clinical and microbiologic characteristics, antifungal treatment and outcome were compared between older (<= 65 years) and younger (> 65 years) patients. Results Among 302 patients with candidemia identified during the study period, 188 (62%) belonged to the elderly group. Comorbidities were significantly more frequent in older patients and included chronic pulmonary diseases, cardiovascular diseases, diabetes mellitus, and chronic renal failure (p ranging from <0.0001 to 0.017). A significantly higher proportion of older patients had septic shock (p = 0.040) at the time of candidemia. Candida albicans accounted for 53% of isolates and there were no significant differences between patients' age and Candida species. Thirty-day mortality was significantly higher in older (45%) than in younger (28%) patients (p = 0.003). Factors associated with a significant higher proportion of death in the elderly included older age (i.e.: old-old), being hospitalized in ICU rather than in other wards, suffering from chronic pulmonary diseases, the presence of septic shock, multiple organ failure, dialysis and being infected with C. glabrata (p ranging from <0.0001 to 0.034). On multivariate analysis septic shock (HR 1.744 [CI95% 1.049-2.898], p = 0.032) and multiple organ failure (HR 2.242 [CI95% 1.070-4.698], p = 0.032) were independently associated with a higher risk of death. The probability of 30-days survival of older patients was significantly reduced when compared to that of younger patients (p = 0.005) who did not receive any treatment. In the elderly, there was a trend toward higher MICs for fluconazole/C. albicans, fluconazole/C. glabrata, amphotericin B/C. albicans, and caspofungin/C. glabrata. Conclusions In our study, we found that elderly patients with Candida bloodstream infections are characterized by a high mortality rate. In particular, the lack of any antifungal therapy as well as the occurrence of septic shock increased significantly the overall mortality. Additionally, we found that there was a trend of higher MIC for specific drug/Candida combination.	[Barchiesi, Francesco; Orsetti, Elena; Mazzanti, Sara; Trave, Francesca] Univ Politecn Marche, Clin Malattie Infett, Dipartimento Sci Biomed & Sanita Pubbl, Ancona, Italy; [Salvi, Aldo; Nitti, Cinzia] Azienda Osped Univ, Osped Riuniti Umberto IGM Lancisi G Salesi, Med Internist & Subintens, Ancona, Italy; [Manso, Esther] Azienda Osped Univ, Osped Riuniti Umberto IGM Lancisi G Salesi, Lab Microbiol, Ancona, Italy	Marche Polytechnic University	Barchiesi, F (corresponding author), Univ Politecn Marche, Clin Malattie Infett, Dipartimento Sci Biomed & Sanita Pubbl, Ancona, Italy.	f.barchiesi@univpm.it		nitti, cinzia/0000-0003-1655-8263; salvi, aldo/0000-0002-5601-8790				Al-Jasser AM, 2004, SAUDI MED J, V25, P566; Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P42, DOI 10.1111/1469-0691.12513; Arendrup MC, 2013, CLIN MICROBIOL INFEC, V19, pE343, DOI 10.1111/1469-0691.12212; Barchiesi F, 2016, INFECTION, V44, P205, DOI 10.1007/s15010-015-0845-z; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Blot S, 2001, J HOSP INFECT, V47, P308, DOI 10.1053/jhin.2000.0918; Chai YAL, 2007, MED MYCOL, V45, P435, DOI 10.1080/13693780701385868; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cheng Yu-Ren, 2006, Journal of Microbiology Immunology and Infection, V39, P155; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI, pM27; Diekema DJ, 2002, J CLIN MICROBIOL, V40, P1298, DOI 10.1128/JCM.40.4.1298-1302.2002; Flevari A, 2013, CLIN INTERV AGING, V8, P1199, DOI 10.2147/CIA.S39120; Guimaraes T, 2012, INT J INFECT DIS, V16, pE442, DOI 10.1016/j.ijid.2012.02.005; Hesstvedt L, 2015, CLIN MICROBIOL INFEC, V21, P938, DOI 10.1016/j.cmi.2015.06.008; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Luzzati R, 2016, INFECT 1 ONLINE 0711; Luzzati R, 2015, AGING CLIN EXP RES, V27, P131, DOI 10.1007/s40520-014-0251-x; Nucci M, 2010, CLIN INFECT DIS, V51, P887; Nucci M, 2007, DIAGN MICROBIOL INFE, V58, P82, DOI DOI 10.1016/J.DIAGMICR0BI0.2006.11.009; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2011, DRUG RESIST UPDATE, V14, P164, DOI 10.1016/j.drup.2011.01.004; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; Wang H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0609-x	29	41	46	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176576	10.1371/journal.pone.0176576	http://dx.doi.org/10.1371/journal.pone.0176576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493896	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300021
J	Date, SS; Fiori, MC; Altenberg, GA; Jansen, M				Date, Swapneeta S.; Fiori, Mariana C.; Altenberg, Guillermo A.; Jansen, Michaela			Expression in Sf9 insect cells, purification and functional reconstitution of the human proton-coupled folate transporter (PCFT, SLC46A1)	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-BASIS; PCFT-SLC46A1; PROTEIN; ACID; GLYCOSYLATION; MALABSORPTION; BIOSYNTHESIS; MECHANISM; RESIDUES	The proton-coupled folate transporter (PCFT) provides an essential uptake route for the vitamin folic acid (B9) in mammals. In addition, it is currently of high interest for targeting chemotherapeutic agents to tumors due to the increased folic acid requirement of rapidly dividing tumor cells as well as the upregulated PCFT expression in several tumors. To understand its function, determination of its atomic structure and molecular mechanism of transport are essential goals that require large amounts of functional PCFT. Here, we present a high-level heterologous expression system for human PCFT using a recombinant baculovirus and Spodoptera frugiperda (Sf9) insect cells. We demonstrate folate transport functionality along the PCFT expression, isolation, and purification process. Importantly, purified PCFT transports folic acid after reconstitution. We thus succeeded in overcoming heterologous expression as a major bottleneck of PCFT research. The availability of an overexpression system for human PCFT provides the basis for future biochemical, biophysical and structural studies.	[Date, Swapneeta S.; Fiori, Mariana C.; Altenberg, Guillermo A.; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Date, Swapneeta S.; Fiori, Mariana C.; Altenberg, Guillermo A.; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Date, Swapneeta S.] Oak Ridge Natl Lab, Oak Ridge, TN USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; United States Department of Energy (DOE); Oak Ridge National Laboratory	Jansen, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.; Jansen, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA.	Michaela.jansen@ttuhsc.edu		Jansen, Michaela/0000-0003-1325-9700; Altenberg, Guillermo/0000-0002-8932-740X	seed grants from the Laura W. Bush Institute for Women's Health and University Medical Center in Lubbock; Texas; Center for Membrane Protein Research; School of Medicine; TTUHSC; TTUHSC Office of Research	seed grants from the Laura W. Bush Institute for Women's Health and University Medical Center in Lubbock; Texas; Center for Membrane Protein Research; School of Medicine; TTUHSC; TTUHSC Office of Research	This work was supported in part by seed grants from the Laura W. Bush Institute for Women's Health and University Medical Center in Lubbock, Texas (to MJ and GAA), the Center for Membrane Protein Research, School of Medicine, TTUHSC (to MJ), and the TTUHSC Office of Research (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. A Pandhare, NT Phan, E Pirayesh and A Stuebler from Jansen's laboratory and Drs. MP Blanton, L Guan, and IL Urbatsch for discussion of experimental procedures. This work was supported in part by seed grants from the Laura W. Bush Institute for Women's Health and University Medical Center in Lubbock, Texas (to MJ and GAA), the Center for Membrane Protein Research, School of Medicine, TTUHSC (to MJ), and the TTUHSC Office of Research (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the TTUHSC Core Facilities: some of the images and data were generated in the Image Analysis Core Facility & Molecular Biology Core Facility supported by TTUHSC. The authors declare that they have no conflicts of interest with the contents of this article.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Alisio A, 2010, PROTEIN EXPRES PURIF, V70, P81, DOI 10.1016/j.pep.2009.10.011; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Chaptal V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41751; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Date SS, 2016, FEBS OPEN BIO, V6, P216, DOI 10.1002/2211-5463.12041; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Desmoulin SK, 2012, CANCER BIOL THER, V13, P1355, DOI 10.4161/cbt.22020; Desmoulin SK, 2012, MOL PHARMACOL, V82, P591, DOI 10.1124/mol.112.079004; Desmoulin SK, 2011, MOL PHARMACOL, V80, P1096, DOI 10.1124/mol.111.073833; Desmoulin SK, 2010, MOL PHARMACOL, V78, P577, DOI 10.1124/mol.110.065896; Duddempudi PK, 2013, FEBS J, V280, P2900, DOI 10.1111/febs.12293; Duddempudi PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078301; Eichholzer M, 2001, SWISS MED WKLY, V131, P539; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Golani LK, 2014, J MED CHEM, V57, P8152, DOI 10.1021/jm501113m; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holdsworth SR, 2012, BIOCHIMIE, V94, P1334, DOI 10.1016/j.biochi.2012.03.001; Huc-Brandt S, 2011, BBA-BIOMEMBRANES, V1808, P65, DOI 10.1016/j.bbamem.2010.08.013; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Pernstich C, 2014, PROTEIN EXPRES PURIF, V101, P68, DOI 10.1016/j.pep.2014.05.011; Qin TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep12044; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Shin D.S., 2012, AM J PHYSL CELL PHYS; Shin DS, 2012, AM J PHYSIOL-CELL PH, V303, pC834, DOI 10.1152/ajpcell.00171.2012; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Tao YY, 2015, NATURE, V527, P259, DOI 10.1038/nature15391; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Vinnicombe HG, 1999, BIOCHEM SOC T, V27, P53, DOI 10.1042/bst0270053; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Wisedchaisri G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5521; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	51	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177572	10.1371/journal.pone.0177572	http://dx.doi.org/10.1371/journal.pone.0177572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493963	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300138
J	Opoku-Acheampong, AB; Henningson, JN; Beck, AP; Lindshield, BL				Opoku-Acheampong, Alexander B.; Henningson, Jamie N.; Beck, Amanda P.; Lindshield, Brian L.			5 alpha-reductase 1 mRNA levels are positively correlated with TRAMP mouse prostate most severe lesion scores	PLOS ONE			English	Article							ANDROGEN RECEPTOR; TRANSGENIC MOUSE; STEROID 5-ALPHA-REDUCTASE; GENE-EXPRESSION; CANCER; MODEL; PROGRESSION; CARCINOMA; ENZYMES; TYPE-1	Background The contribution of 5 alpha-reductase 1 and 5 alpha-reductase 2 to prostate cancer development and progression is not clearly understood. TRAMP mice are a common prostate cancer model, in which 5 alpha-reductase 1 and 5 alpha-reductase 2 expression levels, along with prostate lesions scores, have not been investigated at different time points to further understand prostate carcinogenesis. Method/Principal findings To this end, 8-, 12-, 16-, and 20-week-old male C57BL/6TRAMP x FVB mice prostate most severe and most common lesion scores, 5 alpha-reductase 1 and 5 alpha-reductase 2 in situ hybridization expression, and Ki-67, androgen receptor, and apoptosis immunohistochemistry levels were measured. Levels of these markers were quantified in prostate epithelium, hyperplasia, and tumors sections. Mice developed low- to high-grade prostatic intraepithelial neoplasia at 8 weeks as the most severe and most common lesions, and moderate-and high-grade prostatic intraepithelial neoplasia at 12 and 16 weeks as the most severe lesion in all lobes. Moderately differentiated adenocarcinoma was observed at 20 weeks in all lobes. Poorly differentiated carcinoma was not observed in any lobe until 12-weeks-old. 5 alpha-reductase 1 and 5 alpha-reductase 2 were not significantly decreased in tumors compared to prostate epithelium and hyperplasia in all groups, while proliferation, apoptosis, and androgen receptor were either notably or significantly decreased in tumors compared with prostate epithelium and hyperplasia in most or all groups. Prostate 5 alpha R1 levels were positively correlated with adjusted prostate most severe lesion scores. Conclusion Downregulation of androgen receptor and 5 alpha-reductase 2, along with upregulation of 5 alpha-reductase 1 in tumors may promote prostatic intraepithelial neoplasia and prostate cancer development in TRAMP mice.	[Opoku-Acheampong, Alexander B.; Lindshield, Brian L.] Kansas State Univ, Dept Food Nutr Dietet & Hlth, Manhattan, KS 66506 USA; [Henningson, Jamie N.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Beck, Amanda P.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Kansas State University; Kansas State University; Yeshiva University; Albert Einstein College of Medicine	Lindshield, BL (corresponding author), Kansas State Univ, Dept Food Nutr Dietet & Hlth, Manhattan, KS 66506 USA.	blindsh@k-state.edu		Opoku-Acheampong, Alexander/0000-0002-4589-3776	National Institute of Health COBRE Epithelial Function in Health & Disease (NIH from NCRR) [P20-RR017686]; Johnson Center for Basic Cancer Research at Kansas State University	National Institute of Health COBRE Epithelial Function in Health & Disease (NIH from NCRR); Johnson Center for Basic Cancer Research at Kansas State University	This work was supported by National Institute of Health (https://www.nih.gov) COBRE Epithelial Function in Health & Disease (NIH-Grant No: P20-RR017686 from NCRR) and the Johnson Center for Basic Cancer Research at Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge Nicole M. Fiorentino of the Department of Food, Nutrition, Dietetics and Health, Kansas State University, and staff, especially Jennifer Phinney, of the Kansas State University Histology and Immunohistochemistry laboratory for their support during the immunohistochemistry and in situ hybridization experiments.	Andriole GL, 2004, UROLOGY, V64, P537, DOI 10.1016/j.urology.2004.04.084; BASSALYK LS, 1983, ARK PATOL, V45, P23; Berman-Booty LD, 2012, TOXICOL PATHOL, V40, P5, DOI 10.1177/0192623311425062; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Conlon LE, 2015, NUTR RES, V35, P882, DOI 10.1016/j.nutres.2015.07.003; derstro TG, 2001, J CLIN ENDOCR METAB, V86, P855; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1996, CANCER RES, V56, P4096; Gingrich JR, 1997, CANCER RES, V57, P4687; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Habib FK, 2003, CLIN CANCER RES, V9, P1815; Harris TJ, 2009, PROQUEST; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hurwitz Arthur A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2005s45; Iehle C, 1999, J STEROID BIOCHEM, V68, P189, DOI 10.1016/S0960-0760(99)00030-8; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Murti K, 2010, MED J INDONES, V19, P5; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; NILSSON S, 1991, ACTA ONCOL, V30, P177, DOI 10.3109/02841869109092346; Opoku-Acheampong AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077738; Parekh DJ, 2011, RECENT RESULTS CANC, V188, P109, DOI 10.1007/978-3-642-10858-7_9; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Shirakawa T, 2004, PROSTATE, V58, P33, DOI 10.1002/pros.10313; So AI, 2003, WORLD J UROL, V21, P325, DOI 10.1007/s00345-003-0373-9; Thomas LN, 2008, EUR UROL, V53, P244, DOI 10.1016/j.eururo.2007.10.052; Thomas LN, 2008, J UROLOGY, V179, P147, DOI 10.1016/j.juro.2007.08.155; Tien A. H., 2013, ANDROGEN RESPONSIVE, P135; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; Wang F, 2011, PROG MOL BIOL TRANSL, V100, P1, DOI 10.1016/B978-0-12-384878-9.00001-7; Wikstrom P, 2005, PROSTATE, V62, P148, DOI 10.1002/pros.20123; Xue LX, 1997, CARCINOGENESIS, V18, P995, DOI 10.1093/carcin/18.5.995; Zeng L, 2005, PROSTATE CANCER P D, V8, P7, DOI 10.1038/sj.pcan.4500757	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0175874	10.1371/journal.pone.0175874	http://dx.doi.org/10.1371/journal.pone.0175874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493878	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300008
J	Takahashi, M; Komine, K; Imai, H; Okada, Y; Saijo, K; Takahashi, M; Shirota, H; Ohori, H; Takahashi, S; Chiba, N; Mori, T; Shimodaira, H; Ishioka, C				Takahashi, Masanobu; Komine, Keigo; Imai, Hiroo; Okada, Yoshinari; Saijo, Ken; Takahashi, Masahiro; Shirota, Hidekazu; Ohori, Hisatsugu; Takahashi, Shin; Chiba, Natsuko; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi			Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis	PLOS ONE			English	Article							RANDOMIZED PHASE-II; COMBINATION CHEMOTHERAPY; REFRACTORY OSTEOSARCOMA; LEIOMYOSARCOMA; TRABECTEDIN; MULTICENTER; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; STANDARD	Background Combination therapy with gemcitabine and docetaxel has been reported to be a good therapeutic strategy for patients with soft tissue sarcoma. The aim of the present study was to analyze the efficacy and toxicity of gemcitabine with docetaxel in Japanese patients with advanced bone and soft tissue sarcoma. Patients and methods We retrospectively analyzed the effect of gemcitabine and docetaxel therapy on overall response, progression-free survival, overall survival, and toxicity in 42 patients with bone or soft tissue sarcoma who had received the therapy between October 2006 and September 2015, at Tohoku University Hospital. Results The median age was 55 years; 23 patients were men, and 19 were women. Eight had bone sarcoma and 34 had soft tissue sarcoma. Forty patients (95%) had previously been treated with one or more chemotherapeutic regimens. The overall response rate was 6.9% and the disease control rate was 55%. The median progression-free survival was 2.3 months and the median overall survival was 14.3 months. Grade 3 or more neutropenia and febrile neutropenia were observed in 74% and 4.8% of all patients, respectively. Conclusion The response rate was lower and myelosuppression was more frequently observed than in other previous reports. On the other hand, most of toxicities were enough manageable. In addition, some patients had long survival with a good response. Our study supports the notion that gemcitabine and docetaxel therapy is a good therapeutic option for treating patients with advanced soft tissue sarcoma as well as bone sarcoma, also in Asian populations.	[Takahashi, Masanobu; Komine, Keigo; Imai, Hiroo; Okada, Yoshinari; Saijo, Ken; Takahashi, Masahiro; Shirota, Hidekazu; Ohori, Hisatsugu; Takahashi, Shin; Chiba, Natsuko; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ Hosp, Dept Med Oncol, Aoba Ku, Sendai, Miyagi, Japan; [Takahashi, Masanobu; Komine, Keigo; Imai, Hiroo; Okada, Yoshinari; Saijo, Ken; Takahashi, Masahiro; Shirota, Hidekazu; Takahashi, Shin; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan; [Chiba, Natsuko] Tohoku Univ, Dept Canc Biol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Ishioka, C (corresponding author), Tohoku Univ Hosp, Dept Med Oncol, Aoba Ku, Sendai, Miyagi, Japan.; Ishioka, C (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan.	chikashi@tohoku.ac.jp	Imai, Hiroo/AFQ-7814-2022; Takahashi, Shin/AAE-5011-2019	Takahashi, Shin/0000-0001-6695-3099; Masahiro, Takahashi/0000-0001-6820-6011; qi wu, xiao feng/0000-0003-2502-3666; Ishioka, Chikashi/0000-0002-3023-1227; Mori, Takahiro/0000-0001-7324-8574	Ono Pharmaceutical Company; Grants-in-Aid for Scientific Research [16H04690, 15K08962] Funding Source: KAKEN	Ono Pharmaceutical Company; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M.T. reports receiving research funding from Ono Pharmaceutical Company. C.I. reports receiving lecture fees from Taiho, Chugai, Takeda, Byer, Pfeizer, Mochida, Asahikasei, Bristol-Myers Squibb, Daiichi-Sankyo, Merck Serono, and Novartis, and research funding from Chugai, Taiho, Bristol-Myers Squibb, Daiichi-Sankyo, Merck Serono, Yakult, Ono, and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTMAN K, 1993, J CLIN ONCOL, V11, P1276, DOI 10.1200/JCO.1993.11.7.1276; Bay JO, 2006, INT J CANCER, V119, P706, DOI 10.1002/ijc.21867; Bramwell V H, 2000, Sarcoma, V4, P103, DOI 10.1080/13577140020008066; Demetri GD, 2016, J CLIN ONCOL, V34, P786, DOI 10.1200/JCO.2015.62.4734; Dickson Mark A., 2015, Sarcoma, V2015, P532478, DOI 10.1155/2015/532478; Dileo P, 2007, CANCER-AM CANCER SOC, V109, P1863, DOI 10.1002/cncr.22609; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fox E, 2012, ONCOLOGIST, V17, P321, DOI 10.1634/theoncologist.2010-0265; Frustaci S, 2001, J CLIN ONCOL, V19, P1238, DOI 10.1200/JCO.2001.19.5.1238; He AN, 2013, INT J CLIN ONCOL, V18, P498, DOI [10.1007/s10147-012-0409-5, 10.1007/s10147-013-0561-6]; Hensley ML, 2002, J CLIN ONCOL, V20, P2824, DOI 10.1200/JCO.2002.11.050; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Kawai A, 2015, LANCET ONCOL, V16, P406, DOI 10.1016/S1470-2045(15)70098-7; Linch M, 2014, NAT REV CLIN ONCOL, V11, P187, DOI 10.1038/nrclinonc.2014.26; Maki RG, 2007, J CLIN ONCOL, V25, P2755, DOI 10.1200/JCO.2006.10.4117; MOURIDSEN HT, 1987, EUR J CANCER CLIN ON, V23, P1477, DOI 10.1016/0277-5379(87)90089-7; Navid F, 2008, CANCER, V113, P419, DOI 10.1002/cncr.23586; Palmerini E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2312-3; Patel SR, 2001, J CLIN ONCOL, V19, P3483, DOI 10.1200/JCO.2001.19.15.3483; Pautier P, 2012, ONCOLOGIST, V17, P1213, DOI 10.1634/theoncologist.2011-0467; Schoffski P, 2016, LANCET, V387, P1629, DOI 10.1016/S0140-6736(15)01283-0; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song BS, 2014, PEDIATR BLOOD CANCER, V61, P1376, DOI 10.1002/pbc.25035; Takano T, 2014, INT J CLIN ONCOL, V19, P897, DOI 10.1007/s10147-013-0627-5; Talbot SM, 2003, CANCER-AM CANCER SOC, V98, P1942, DOI 10.1002/cncr.11730; Tanaka K, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-1059-2; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645	28	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176972	10.1371/journal.pone.0176972	http://dx.doi.org/10.1371/journal.pone.0176972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489919	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314100039
J	Bachelier, K; Biehl, S; Schwarz, V; Kindermann, I; Kandolf, R; Sauter, M; Ukena, C; Yilmaz, A; Sliwa, K; Bock, CT; Klingel, K; Bohm, M				Bachelier, Katrin; Biehl, Susanne; Schwarz, Viktoria; Kindermann, Ingrid; Kandolf, Reinhard; Sauter, Martina; Ukena, Christian; Yilmaz, Ali; Sliwa, Karen; Bock, Claus-Thomas; Klingel, Karin; Boehm, Michael			Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOMYOCARDIAL BIOPSY; B19-ASSOCIATED MYOCARDITIS; PERIPARTUM CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; SUSPECTED MYOCARDITIS; EUROPEAN-SOCIETY; HIGH PREVALENCE; B19 INFECTION; REPLICATION	Background Diagnosis of viral myocarditis is difficult by clinical criteria but facilitated by detection of inflammation and viral genomes in endomyocardial biopsies. Parvovirus B19 (B19V) targets endothelial cells where viral nucleic acid is exclusively detected in the heart. Microparticles (MPs) are released after cell damage or activation of specific cells. We aimed to investigate whether circulating endothelial MPs (EMPs) in human and experimental models of myocarditis are associated with B19V myocarditis. Methods MPs were investigated in patients with myocarditis (n = 54), divided into two groups: B19V+ (n = 23) and B19V- (n = 31) and compared with healthy controls (HCTR, n = 25). MPs were also investigated in B19V transgenic mice (B19V-NS1+) and mice infected with coxsackievirus B3 (CVB3). MPs were analyzed with fluorescent activated cell sorting (FACS). Results In human samples, EMP subpopulation patterns were significantly different in B19V+ compared to B19V-and HCTR (p<0.001), with an increase of apoptotic but not activated EMPs. Other MPs such as platelet- (PMPs) leukocyte-(LMPs) and monocyte-derived MPs (MMPs) showed less specific patterns. Significantly different levels of EMPs were observed in transgenic B19V-NS1+ mice compared with CVB3-infected mice (p<0.001). Conclusion EMP subpopulations are different in B19V+ myocarditis in humans and transgenic B19V mice reflecting vascular damage. EMP profiles might permit differentiation between endothelial-cell-mediated diseases like myocardial B19V infection and other causes of myocarditis.	[Bachelier, Katrin; Biehl, Susanne; Schwarz, Viktoria; Kindermann, Ingrid; Ukena, Christian; Boehm, Michael] Univ Saarland, Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Homburg, Saarlandes, Germany; [Kandolf, Reinhard; Sauter, Martina; Bock, Claus-Thomas; Klingel, Karin] Univ Klinikum Tubingen, Abt Mol Pathol, Inst Pathol & Neuropathol, Tubingen, Germany; [Yilmaz, Ali] Univ Klinikum Munster, Dept Kardiol & Angiol, Munster, Germany; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, Cape Town, South Africa; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, MRC Inter Cape Heart Grp, Cape Town, South Africa	Saarland University; Universitatsklinikum des Saarlandes; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munster; University of Cape Town; University of Cape Town	Bohm, M (corresponding author), Univ Saarland, Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Homburg, Saarlandes, Germany.	michael.boehm@uks.eu	Kindermann, Ingrid/AAQ-3805-2020; Böhm, Michael/C-3638-2011; Ukena, Christian/AAA-4812-2019; Bock, C.-Thomas/A-3518-2012	Ukena, Christian/0000-0002-9810-4662; Bock, C.-Thomas/0000-0002-2773-486X	Ministry of Science and Economy of the Federal State of the Saarland; HOMFOR-program; Deutsche Forschungsgemeinschaft [KFO 196, SFB-TR19, KL 595/2-3]; South African National Research Foundation; South African Medical Research Foundation; BMBF on Cardiac disease in pregnancy	Ministry of Science and Economy of the Federal State of the Saarland; HOMFOR-program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); South African National Research Foundation(National Research Foundation - South Africa); South African Medical Research Foundation; BMBF on Cardiac disease in pregnancy	Katrin Bachelier, Ingrid Kindermann and Michael Bohm were supported by the Ministry of Science and Economy of the Federal State of the Saarland and the HOMFOR-program. Michael Bohm was supported by the Deutsche Forschungsgemeinschaft (KFO 196). Karen Sliwa receives support grants from the South African National Research Foundation, the South African Medical Research Foundation and the BMBF on Cardiac disease in pregnancy including various forms of cardiomyopathies. Karin Klingel was supported by the Deutsche Forschungsgemeinschaft (SFB-TR19 and KL 595/2-3).	Bock C, 2010, NEW ENGL J MED, V362, P1248, DOI 10.1056/NEJMc0911362; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; Bultmann BD, 2005, AM J OBSTET GYNECOL, V193, P363, DOI 10.1016/j.ajog.2005.01.022; Bultmann BD, 2003, VIRCHOWS ARCH, V442, P8, DOI 10.1007/s00428-002-0732-8; Bultmann BD, 2003, HUM PATHOL, V34, P92, DOI 10.1053/hupa.2003.48; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Duechting A, 2008, J VIROL, V82, P7942, DOI 10.1128/JVI.00891-08; Fuse K, 2001, CLIN EXP IMMUNOL, V124, P346, DOI 10.1046/j.1365-2249.2001.01510.x; Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Klingel K, 1998, LAB INVEST, V78, P1227; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; KLINGEL K, 1993, SCAND J INFECT DIS, P79; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Kuhl U, 2008, J MED VIROL, V80, P1243, DOI 10.1002/jmv.21187; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Mahfoud F, 2011, EUR HEART J, V32, P897, DOI 10.1093/eurheartj/ehq493; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; Pankuweit S, 2003, HUM PATHOL, V34, P497, DOI 10.1016/S0046-8177(03)00078-9; Pisetsky DS, 2010, NAT REV RHEUMATOL, V6, P368, DOI 10.1038/nrrheum.2010.66; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Schmidt-Lucke C, 2010, J INFECT DIS, V201, P936, DOI 10.1086/650700; Schultheiss HP, 2016, CLIN RES CARDIOL, V105, P763, DOI 10.1007/s00392-016-0986-9; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Tschope C, 2005, CIRCULATION, V111, P879, DOI 10.1161/01.CIR.0000155615.68924.B3; Vallbracht KB, 2004, CIRCULATION, V110, P2938, DOI 10.1161/01.CIR.0000146891.31481.CF; Vasina EM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.94; Walenta K, 2012, EUR HEART J, V33, P1469, DOI 10.1093/eurheartj/ehr485; WOOLF AD, 1989, ARCH INTERN MED, V149, P1153, DOI 10.1001/archinte.149.5.1153; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167	35	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176311	10.1371/journal.pone.0176311	http://dx.doi.org/10.1371/journal.pone.0176311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531186	Green Published, gold			2022-12-27	WOS:000402058400005
J	Gallandat, K; Lantagne, D				Gallandat, Karin; Lantagne, Daniele			Selection of a Biosafety Level 1 (BSL-1) surrogate to evaluate surface disinfection efficacy in Ebola outbreaks: Comparison of four bacteriophages	PLOS ONE			English	Article							REPLICATION CYCLE; FREE CHLORINE; VIRUS; INACTIVATION; PERSISTENCE; TRANSMISSION; ENVIRONMENT; ADENOVIRUS; FOMITES; RISK	The 2014 West African Ebola virus disease outbreak was the largest to date, and conflicting, chlorine-based surface disinfection protocols to interrupt disease transmission were recommended. We identified only one study documenting surface disinfection efficacy against the Ebola virus, showing a >6.6 log reduction after 5-minute exposure to 0.5% sodium hypochlorite (NaOCl) based on small-scale tests (Cook et al. (2015)). In preparation for future extensive, large-scale disinfection efficacy experiments, we replicated the Cook et al. experiment using four potential BSL-1 surrogates selected based on similarities to the Ebola virus: bacteriophages MS2, M13, Phi6, and PR772. Each bacteriophage was exposed to 0.1% and 0.5% NaOCl for 1, 5, and 10 minutes on stainless steel. MS2 and M13 were only reduced by 3.4 log and 3.5 log after a 10-minute exposure to 0.5% NaOCl, and would be overly conservative surrogates. Conversely, PR772 was too easily inactivated for surrogate use, as it was reduced by >4.8 log after only 1-minute exposure to 0.5% NaOCl. Phi6 was slightly more resistant than the Ebola virus, with 4.1 log reduction after a 5-minute exposure and not detected after a 10-minute exposure to 0.5% NaOCl. We therefore recommend Phi6 as a surrogate for evaluating the efficacy of chlorine-based surface disinfectants against the Ebola virus.	[Gallandat, Karin; Lantagne, Daniele] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA	Tufts University	Gallandat, K (corresponding author), Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA.	karin.gallandat@tufts.edu		Gallandat, Karin/0000-0001-6412-1483	United States Agency for International Development's Office of U.S. Foreign Disaster Assistance (USAID/OFDA); Fulbright Foreign Student Program; P.E.O. Foundation	United States Agency for International Development's Office of U.S. Foreign Disaster Assistance (USAID/OFDA)(United States Agency for International Development (USAID)); Fulbright Foreign Student Program; P.E.O. Foundation	The study was conducted with funding from the United States Agency for International Development's Office of U.S. Foreign Disaster Assistance (USAID/OFDA, https://www.usaid.gov/who-we-are/organization/bureaus/bureau-democracy-conflict-and-humanitarian-assistance/office-us). The authors gratefully acknowledge the Fulbright Foreign Student Program (http://foreign.fulbrightonline.org/) and the P.E.O. Foundation (http://www.peointernational.org/peo-foundation) for the partial support of this effort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Adcock NJ, 2009, J ENVIRON SCI HEAL A, V44, P1362, DOI 10.1080/10934520903217054; ASTM International, 2011, STAND QUANT DISK CAR; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bibby K, 2015, ENVIRON SCI TECH LET, V2, P2, DOI 10.1021/ez5003715; Brown KS, 2008, ENCY VIROLOGY, P57; Casanova LM, 2015, ENVIRON SCI TECH LET, V2, P76, DOI 10.1021/acs.estlett.5b00029; Centers for Disease Control and Prevention (CDC), 2015, INT GUID ENV INT CON; Centers for Disease Control and Prevention (CDC), 2014, INT REC CLEAN HOUS S; Centers for Disease Control and Prevention (CDC), 2014, EB EB VIR DIS INT GU; Chepurnov AA, 2003, ACTA TROP, V87, P315, DOI 10.1016/S0001-706X(03)00120-7; Cook BWM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38293; Cook BWM, 2015, VIRUSES-BASEL, V7, P1975, DOI 10.3390/v7041975; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Gall AM, 2016, ENVIRON SCI TECHNOL, V50, P2522, DOI 10.1021/acs.est.5b04713; Gall AM, 2015, ENVIRON SCI TECHNOL, V49, P4584, DOI 10.1021/acs.est.5b00301; Herzog AB, 2012, APPL ENVIRON MICROB, V78, P7915, DOI 10.1128/AEM.01370-12; JOHNSON KM, 1977, LANCET, V1, P569; KLENK HD, 1999, MARBURG EBOLA VIRUSE; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lee MT, 2016, ENVIRON SCI TECH LET, V3, P210, DOI 10.1021/acs.estlett.6b00105; Lucas W., 2010, ENCYCLOPEDIA OF LIFE; MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546; Mesquita MMF, 2010, WATER RES, V44, P1114, DOI 10.1016/j.watres.2009.11.017; Morin T, 2015, J APPL MICROBIOL, V119, P655, DOI 10.1111/jam.12870; Piercy TJ, 2010, J APPL MICROBIOL, V109, P1531, DOI 10.1111/j.1365-2672.2010.04778.x; Poranen MM, 2015, ELS; RASCHED I, 1986, MICROBIOL REV, V50, P401, DOI 10.1128/MMBR.50.4.401-427.1986; Rossi P., 1994, ADV BIOL TRACER TECH; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Sagripanti JL, 2010, ARCH VIROL, V155, P2035, DOI 10.1007/s00705-010-0791-0; Schuit M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148476; Sinclair RG, 2012, APPL ENVIRON MICROB, V78, P1969, DOI 10.1128/AEM.06582-11; Sobsey M.D., 2003, VIRUS SURVIVAL ENV S, V70, P19; Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P7769, DOI 10.1128/AEM.02144-12; Vaux DL, 2012, NATURE, V492, P180, DOI 10.1038/492180a; Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254; WHO, 2015, MAN CAR MAN PAT EB C; WHO & UNICEF, 2014, EB VIR DIS EVD KEY Q; Wigginton KR, 2015, ENVIRON SCI-WAT RES, V1, P735, DOI [10.1039/c5ew00125k, 10.1039/C5EW00125K]; Wigginton KR, 2012, ENVIRON SCI TECHNOL, V46, P12069, DOI 10.1021/es3029473; World Health Organisation, 2016, EB SIT REP 30 MARCH; Ye YY, 2016, ENVIRON SCI TECHNOL, V50, P5077, DOI 10.1021/acs.est.6b00876	43	31	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177943	10.1371/journal.pone.0177943	http://dx.doi.org/10.1371/journal.pone.0177943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531182	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000402058400042
J	Yuan, T; Zhang, F; Yao, QM; Liu, YX; Zhu, XJ; Wang, X				Yuan, Ting; Zhang, Feng; Yao, Qing-min; Liu, Yan-xia; Zhu, Xiao-juan; Wang, Xin			Weekly versus biweekly bortezomib given in patients with indolent non-Hodgkin lymphoma: A meta-analysis	PLOS ONE			English	Article							REFRACTORY FOLLICULAR LYMPHOMA; MANTLE CELL LYMPHOMA; PROTEASOME INHIBITOR BORTEZOMIB; NATIONAL-CANCER-INSTITUTE; CLINICAL-TRIALS GROUP; PHASE-II; RITUXIMAB; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE	Background Bortezomib is recently studied as a novel agent in indolent lymphoma. The optimal schedule of bortezomib used in indolent lymphoma is still uncertain. Methods We did a systematic review and meta-analysis of the clinical trials comparing the efficacy and toxicity of the weekly and biweekly schedules of bortezomib in patients with indolent lymphoma. We searched Pubmed, Cochrane Library and Emabase from inception to July 29, 2016. The primary outcome was the overall response rate including the complete response rate and the partial response rate. The secondary outcomes were the proportions of patients in each group experiencing the adverse events including the neutropathy, fatigue, diarrhea, nausea and neutropenia. Findings After final screening, six trials were considered eligible for analysis. The results showed that the overall response rate of biweekly schedule was higher than that of weekly schedule in indolent lymphoma (OR 1.691; 95% CI 1.02-2.80). Furthermore, there were no significant differences between the two schedules of bortezomib for the main adverse events. Interpretation The biweekly schedule of bortezomib was more effective than the weekly schedule in indolent lymphoma, with similar proportion of toxicities.	[Yuan, Ting; Zhang, Feng; Yao, Qing-min; Liu, Yan-xia; Zhu, Xiao-juan; Wang, Xin] Shandong Univ, Shandong Prov Hosp, Dept Hematol, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, X (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Hematol, Jinan, Shandong, Peoples R China.	xinw007@126.com		Yuan, Ting/0000-0003-0153-7611	National Natural Science Foundation [81270598, 31340009, 81100335]; Natural Science Foundations of Shandong Province [ZR2011HQ009, ZR2012HZ003]; Technology Development Projects of Shandong Province [2010GSF10250]; National Public Health Grand Research Foundation [201202017]; Program of Shandong Medical Leading Talent and Taishan Scholar Foundation of Shandong Province	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Shandong Province; Technology Development Projects of Shandong Province; National Public Health Grand Research Foundation; Program of Shandong Medical Leading Talent and Taishan Scholar Foundation of Shandong Province	This work was partly supported by National Natural Science Foundation (No. 81270598, No. 31340009, No. 81100335), Natural Science Foundations of Shandong Province (No. ZR2011HQ009, No. ZR2012HZ003), Technology Development Projects of Shandong Province (No. 2010GSF10250), National Public Health Grand Research Foundation (No. 201202017), Program of Shandong Medical Leading Talent and Taishan Scholar Foundation of Shandong Province.	Agathocleous A, 2010, BRIT J HAEMATOL, V151, P346, DOI 10.1111/j.1365-2141.2010.08340.x; Aguiar-Bujanda D, 2014, FUTURE ONCOL, V10, P1967, DOI 10.2217/fon.14.104; Aurora V, 2006, BLOOD REV, V20, P179, DOI 10.1016/j.blre.2005.11.003; Baiocchi RA, 2011, CANCER-AM CANCER SOC, V117, P2442, DOI 10.1002/cncr.25792; Belch A, 2007, ANN ONCOL, V18, P116, DOI 10.1093/annonc/mdl316; Bose P, 2014, EXPERT OPIN PHARMACO, V15, P2443, DOI 10.1517/14656566.2014.965142; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Cohen JB, 2015, BRIT J HAEMATOL, V171, P539, DOI 10.1111/bjh.13637; Coiffier B, 2011, LANCET ONCOL, V12, P773, DOI 10.1016/S1470-2045(11)70150-4; Craig M, 2014, BRIT J HAEMATOL, V166, P920, DOI 10.1111/bjh.12991; Crawford LJ, 2013, BLOOD REV, V27, P297, DOI 10.1016/j.blre.2013.10.002; de Vos S, 2009, J CLIN ONCOL, V27, P5023, DOI 10.1200/JCO.2008.17.7980; Di Bella N, 2010, BLOOD, V115, P475, DOI 10.1182/blood-2009-08-233155; Evens AM, 2014, BRIT J HAEMATOL, V166, P514, DOI 10.1111/bjh.12915; Fisher RI, 2005, J CLIN ONCOL, V23, P8447, DOI 10.1200/JCO.2005.03.1674; Fowler N, 2011, J CLIN ONCOL, V29, P3389, DOI 10.1200/JCO.2010.32.1844; Friedberg JW, 2011, BLOOD, V117, P2807, DOI 10.1182/blood-2010-11-314708; Gerecitano J, 2011, CLIN CANCER RES, V17, P2493, DOI 10.1158/1078-0432.CCR-10-1498; Gerecitano J, 2009, BRIT J HAEMATOL, V146, P652, DOI 10.1111/j.1365-2141.2009.07775.x; Goy A, 2005, J CLIN ONCOL, V23, P667, DOI 10.1200/JCO.2005.03.108; Jacobson CA, 2015, J NATL COMPR CANC NE, V13, P367, DOI 10.6004/jnccn.2015.0047; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kahl BS, 2016, BLOOD, V127, P2055, DOI 10.1182/blood-2015-11-624288; Kritharis Athena, 2015, Cancer Treat Res, V165, P197, DOI 10.1007/978-3-319-13150-4_8; Nabhan C, 2012, CL LYMPH MYELOM LEUK, V12, P26, DOI 10.1016/j.clml.2011.05.040; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; Ribrag V, 2013, EUR J CANCER, V49, P904, DOI 10.1016/j.ejca.2012.11.015; Sehn LH, 2011, J CLIN ONCOL, V29, P3396, DOI 10.1200/JCO.2010.33.6594; Sinha R, 2012, CANCER-AM CANCER SOC, V118, P3538, DOI 10.1002/cncr.26660; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; Ujjani C, 2015, ONCOLOGY-NY, V29, P760; Yun H, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0353-5; Zinzani PL, 2013, HEMATOL ONCOL, V31, P179, DOI 10.1002/hon.2036; Zinzani PL, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-67	35	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177950	10.1371/journal.pone.0177950	http://dx.doi.org/10.1371/journal.pone.0177950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531181	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058400045
J	Bonicelli, A; Xhemali, B; Kranioti, EF; Zioupos, P				Bonicelli, Andrea; Xhemali, Bledar; Kranioti, Elena F.; Zioupos, Peter			Rib biomechanical properties exhibit diagnostic potential for accurate ageing in forensic investigations	PLOS ONE			English	Article							ACID RACEMIZATION METHOD; AGE ESTIMATION; ASPARTIC-ACID; CORTICAL BONE; MECHANICAL-PROPERTIES; DEATH; MICRODAMAGE; ACCUMULATION; DENSITY; END	Age estimation remains one of the most challenging tasks in forensic practice when establishing a biological profile of unknown skeletonised remains. Morphological methods based on developmental markers of bones can provide accurate age estimates at a young age, but become highly unreliable for ages over 35 when all developmental markers disappear. This study explores the changes in the biomechanical properties of bone tissue and matrix, which continue to change with age even after skeletal maturity, and their potential value for age estimation. As a proof of concept we investigated the relationship of 28 variables at the macroscopic and microscopic level in rib autopsy samples from 24 individuals. Stepwise regression analysis produced a number of equations one of which with seven variables showed an R-2 = 0.949; a mean residual error of 2.13 yrs +/- 0.4 (SD) and a maximum residual error value of 2.88 yrs. For forensic purposes, by using only bench top machines in tests which can be carried out within 36 hrs, a set of just 3 variables produced an equation with an R-2 = 0.902 a mean residual error of 3.38 yrs +/- 2.6 (SD) and a maximum observed residual error 9.26yrs. This method outstrips all existing age-at-death methods based on ribs, thus providing a novel lab based accurate tool in the forensic investigation of human remains. The present application is optimised for fresh (uncompromised by taphonomic conditions) remains, but the potential of the principle and method is vast once the trends of the biomechanical variables are established for other environmental conditions and circumstances.	[Bonicelli, Andrea] Univ Edinburgh, Sch Hist Class & Archaeol, Edinburgh Unit Forens Anthropol, Edinburgh, Midlothian, Scotland; [Bonicelli, Andrea; Zioupos, Peter] Def Acad UK, Cranfield Forens Inst, Musculoskeletal & Medicolegal Res Grp, Shrivenham, England; [Xhemali, Bledar] Forens Inst, Dept Forens Med, Tirana, Albania; [Kranioti, Elena F.] Univ Crete, Dept Forens Sci, Fac Med, Iraklion, Crete, Greece	University of Edinburgh; University of Crete	Zioupos, P (corresponding author), Def Acad UK, Cranfield Forens Inst, Musculoskeletal & Medicolegal Res Grp, Shrivenham, England.	p.zioupos@cranfield.ac.uk	ZIOUPOS, PETER/S-4342-2019; Kranioti, Elena F./I-1923-2019; Bonicelli, Andrea/GNW-6422-2022	ZIOUPOS, PETER/0000-0002-0123-2706; Kranioti, Elena F./0000-0002-1627-5899; Bonicelli, Andrea/0000-0002-9518-584X				Abdel-Wahab AA, 2011, J MECH BEHAV BIOMED, V4, P807, DOI 10.1016/j.jmbbm.2010.10.001; Agnew A, 2014, TENSILE STRESS HUMAN, P397; Agnew AM, 2015, J MECH BEHAV BIOMED, V41, P302, DOI 10.1016/j.jmbbm.2014.09.002; Agnew AM, 2013, ANN BIOMED ENG, V41, P2501, DOI 10.1007/s10439-013-0875-6; Agnew AM, 2012, AM J PHYS ANTHROPOL, V148, P462, DOI 10.1002/ajpa.22048; Baccino E, 2006, FORENSIC ANTHROPOLOGY AND MEDICINE: COMPLEMENTARY SCIENCES FROM RECOVERY TO CAUSE OF DEATH, P259, DOI 10.1007/978-1-59745-099-7_11; Burr D, 2003, OSTEOPOROSIS INT, V14, pS67, DOI 10.1007/s00198-003-1476-2; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; Cho H, 2002, J FORENSIC SCI, V47, P12; Cornu O, 2000, J ORTHOPAED RES, V18, P426, DOI 10.1002/jor.1100180314; Currey JD, 2003, J BONE MINER RES, V18, P591, DOI 10.1359/jbmr.2003.18.4.591; Eleazer CD, 2016, AM J PHYS ANTHROPOL, V160, P317, DOI 10.1002/ajpa.22967; Franklin D, 2010, LEGAL MED-TOKYO, V12, P1, DOI 10.1016/j.legalmed.2009.09.001; Frost HM, 1960, H FORD HOSP B, V8, P25; Garamendi PM, 2011, J FORENSIC SCI, V56, pS3, DOI 10.1111/j.1556-4029.2010.01626.x; Garcia-Donas JG, 2016, J FORENSIC LEG MED, V38, P28, DOI 10.1016/j.jflm.2015.11.012; Garvin HM, 2012, J FORENSIC SCI, V57, P427, DOI 10.1111/j.1556-4029.2011.01979.x; Griffin RC, 2008, FORENSIC SCI INT, V175, P11, DOI 10.1016/j.forsciint.2007.04.226; ISCAN MY, 1984, AM J PHYS ANTHROPOL, V65, P147, DOI 10.1002/ajpa.1330650206; Jankauskas R, 2001, HOMO, V52, P59, DOI 10.1078/0018-442X-00020; Lee TC, 2000, INT J FATIGUE, V22, P847, DOI 10.1016/S0142-1123(00)00054-2; Li Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep16511; Martin RB, 2002, BONE, V30, P8, DOI 10.1016/S8756-3282(01)00620-2; Martin-de las Heras S, 1999, INT J LEGAL MED, V112, pe222; Miculescu F, 2011, UNIV POLITEH BUCHAR, V73, P203; Norman TL, 1998, BONE, V23, P303, DOI 10.1016/S8756-3282(98)00103-3; Obert M, 2013, FORENSIC SCI INT, V228, DOI 10.1016/j.forsciint.2013.02.006; Ohtani S, 2002, J FORENSIC SCI, V47, P32; Ohtani S, 2007, ARCH ORAL BIOL, V52, P233, DOI 10.1016/j.archoralbio.2006.08.011; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; PFEIFFER H, 1995, INT J LEGAL MED, V108, P19, DOI 10.1007/BF01845611; PFEIFFER H, 1995, INT J LEGAL MED, V108, P24, DOI 10.1007/BF01845612; Pfeiffer S, 2016, AM J PHYS ANTHR; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Ritz S, 1996, FORENSIC SCI INT, V77, P13, DOI 10.1016/0379-0738(95)01834-4; Ritz-Timme S, 2000, INT J LEGAL MED, V113, P129, DOI 10.1007/s004140050283; Sakuma A, 2012, FORENSIC SCI INT, V223, P198, DOI 10.1016/j.forsciint.2012.08.043; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Schmitt A, 2010, J FORENSIC SCI, V55, P590, DOI 10.1111/j.1556-4029.2010.01341.x; Skedros JG, 2013, AM J PHYS ANTHROPOL, V151, P230, DOI 10.1002/ajpa.22270; STOUT SD, 1994, J FORENSIC SCI, V39, P778; STOUT SD, 1992, AM J PHYS ANTHROPOL, V87, P111, DOI 10.1002/ajpa.1330870110; Thomas CDL, 2000, J ANAT, V196, P463, DOI 10.1046/j.1469-7580.2000.19630463.x; THOMPSON DD, 1983, FORENSIC SCI INT, V22, P203, DOI 10.1016/0379-0738(83)90015-4; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Verzeletti A, 2010, AM J FOREN MED PATH, V31, P27, DOI 10.1097/PAF.0b013e3181c0e7a5; Villa C, 2015, RES REP FORENSIC MED, V4, P3; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Xu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17788; Zioupos P, 2001, J BIOMATER APPL, V15, P187, DOI 10.1106/5JUJ-TFJ3-JVVA-3RJ0; Zioupos P, 1999, J BIOMED MATER RES, V45, P108, DOI 10.1002/(SICI)1097-4636(199905)45:2<108::AID-JBM5>3.3.CO;2-1; Zioupos P, 2014, J MECH BEHAV BIOMED, V33, P109, DOI 10.1016/j.jmbbm.2013.10.015; Zioupos P, 2001, J MICROSC-OXFORD, V201, P270, DOI 10.1046/j.1365-2818.2001.00783.x; Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025	55	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176785	10.1371/journal.pone.0176785	http://dx.doi.org/10.1371/journal.pone.0176785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520764	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000401487700030
J	Dorazio, RM; Karanth, KU				Dorazio, Robert M.; Karanth, K. Ullas			A hierarchical model for estimating the spatial distribution and abundance of animals detected by continuous-time recorders	PLOS ONE			English	Article							TIGER PANTHERA-TIGRIS; POPULATION-DENSITY; INFERENCE	Motivation Several spatial capture-recapture (SCR) models have been developed to estimate animal abundance by analyzing the detections of individuals in a spatial array of traps. Most of these models do not use the actual dates and times of detection, even though this information is readily available when using continuous-time recorders, such as microphones or motion-activated cameras. Instead most SCR models either partition the period of trap operation into a set of subjectively chosen discrete intervals and ignore multiple detections of the same individual within each interval, or they simply use the frequency of detections during the period of trap operation and ignore the observed times of detection. Both practices make inefficient use of potentially important information in the data. Model and data analysis We developed a hierarchical SCR model to estimate the spatial distribution and abundance of animals detected with continuous-time recorders. Our model includes two kinds of point processes: a spatial process to specify the distribution of latent activity centers of individuals within the region of sampling and a temporal process to specify temporal patterns in the detections of individuals. We illustrated this SCR model by analyzing spatial and temporal patterns evident in the camera-trap detections of tigers living in and around the Nagarahole Tiger Reserve in India. We also conducted a simulation study to examine the performance of our model when analyzing data sets of greater complexity than the tiger data. Benefits Our approach provides three important benefits: First, it exploits all of the information in SCR data obtained using continuous-time recorders. Second, it is sufficiently versatile to allow the effects of both space use and behavior of animals to be specified as functions of covariates that vary over space and time. Third, it allows both the spatial distribution and abundance of individuals to be estimated, effectively providing a species distribution model, even in cases where spatial covariates of abundance are unknown or unavailable. We illustrated these benefits in the analysis of our data, which allowed us to quantify differences between nocturnal and diurnal activities of tigers and to estimate their spatial distribution and abundance across the study area. Our continuous-time SCR model allows an analyst to specify many of the ecological processes thought to be involved in the distribution, movement, and behavior of animals detected in a spatial trapping array of continuous-time recorders. We plan to extend this model to estimate the population dynamics of animals detected during multiple years of SCR surveys.	[Dorazio, Robert M.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL 32653 USA; [Karanth, K. Ullas] Wildlife Conservat Soc, Bronx, NY USA; [Karanth, K. Ullas] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Karanth, K. Ullas] Ctr Wildlife Studies, Bangalore, Karnataka, India	United States Department of the Interior; United States Geological Survey; Wildlife Conservation Society; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Dorazio, RM (corresponding author), US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL 32653 USA.	bdorazio@usgs.gov		Dorazio, Robert/0000-0003-2663-0468	U.S. Geological Survey Wildlife Conservation Society	U.S. Geological Survey Wildlife Conservation Society	This work was supported by U.S. Geological Survey Wildlife Conservation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers D, 2014, METHODS ECOL EVOL, V5, P656, DOI 10.1111/2041-210X.12196; Borchers D, 2012, J ORNITHOL, V152, pS435, DOI 10.1007/s10336-010-0583-z; Brooks S, 2011, CH CRC HANDB MOD STA, pXIX; Cressie N. A. C., 2011, STAT SPATIO TEMPORAL; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; Dorazio RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084017; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford MG, 2009, ECOLOGY, V90, P2676, DOI 10.1890/08-1735.1; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Fuller AK, 2016, ECOL APPL, V26, P1125, DOI 10.1890/15-0315; Gardner B, 2010, ECOLOGY, V91, P3376, DOI 10.1890/09-0804.1; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Illian J, 2008, STAT ANAL MODELLING; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P97, DOI 10.1007/978-4-431-99495-4_7; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Karanth KU, 2000, J ZOOL, V250, P255; RCore Team, 2020, R LANG ENV STAT COMP; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Waagepetersen RP, 2004, STAT INFERENCE SIMUL	23	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176966	10.1371/journal.pone.0176966	http://dx.doi.org/10.1371/journal.pone.0176966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520796	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700033
J	Li, W; Fang, YH; Shen, HQ; Yang, DH; Shu, Q; Shang, SQ				Li, Wei; Fang, You-hong; Shen, Hong-qiang; Yang, De-hua; Shu, Qiang; Shang, Shi-qiang			Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of Mycoplasma pneumoniae infection in children with pneumonia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PCR DETECTION; SPECIMENS; ASSAYS; CHILDHOOD	Mycoplasma pneumoniae (M. pneumoniae) infection can cause community acquired pneumonia in children. A real-time method of simultaneous amplification and testing of M. pneumoniae (SAT-MP) was developed to diagnose M. pneumoniae targeting a region of the ribosomal RNA. The SAT-MP assay can accurately identify M. pneumoniae with a detection range from 10(1) to 10(7) CFU/ml. In this study, the specimens from 315 children with pneumonia were collected and analyzed by SAT-MP in parallel with real-time PCR method and IgM ELISA assay. The positive rates of these specimens examined by SAT-MP assay, real-time PCR method and IgM ELISA assay were 16.51%, 15.56% and 12.70% respectively. While there was statistical significance (p = 0.04) between SAT-MP assay and IgM ELISA assay, no statistical significance (p = 0.25) was found between SAT-MP assay and real-time PCR method and these two methods had high consistency (kappa value = 0.97). These findings indicate that the newly developed SAT-MP assay is a rapid, sensitive and specific method for identifying M. pneumoniae with potential clinical application in the early diagnosis of M. pneumoniae infection.	[Li, Wei; Fang, You-hong; Shen, Hong-qiang; Yang, De-hua; Shu, Qiang; Shang, Shi-qiang] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Shang, SQ (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China.	shangshiqiang33@163.com		Shen, Hongqiang/0000-0001-7188-5289	National Science & Technology Pillar Program [2012BAI04B05]; Medical Scientific Projects from Health Department of Zhejiang Province [2015KYA119]; Zhejiang Provincial Natural Science Foundation of China [LY15H080003]	National Science & Technology Pillar Program; Medical Scientific Projects from Health Department of Zhejiang Province; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by Key Projects of the National Science & Technology Pillar Program (2012BAI04B05), Medical Scientific Projects from Health Department of Zhejiang Province (2015KYA119) and Zhejiang Provincial Natural Science Foundation of China (LY15H080003).	Atkinson TP, 2014, PEDIATR INFECT DIS J, V33, P92, DOI 10.1097/INF.0000000000000171; Busson L, 2013, DIAGN MICR INFEC DIS, V76, P133, DOI 10.1016/j.diagmicrobio.2013.02.027; Daxboeck F, 2003, CLIN MICROBIOL INFEC, V9, P263, DOI 10.1046/j.1469-0691.2003.00590.x; Di Marco E, 2014, METHODS MOL BIOL, V1160, P99, DOI 10.1007/978-1-4939-0733-5_9; Diaz MH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00232; Dumke R, 2014, J CLIN MICROBIOL, V52, P4078, DOI 10.1128/JCM.02048-14; Harris M, 2011, THORAX, P66; Li W, 2016, IRAN J PEDIATR, V26, DOI 10.5812/ijp.3807; Li W, 2015, SCI REP-UK, V5, DOI 10.1038/srep15539; Loens K, 2010, EUR J CLIN MICROBIOL, V29, P1055, DOI 10.1007/s10096-010-0975-2; Ratliff AE, 2014, J CLIN MICROBIOL, V52, P1060, DOI 10.1128/JCM.02913-13; Schmitt BH, 2013, DIAGN MICR INFEC DIS, V77, P202, DOI 10.1016/j.diagmicrobio.2013.07.016; Touati A, 2009, J CLIN MICROBIOL, V47, P2269, DOI 10.1128/JCM.00326-09; Winchell JM, 2013, CURR PEDIATR REV, V9, P324, DOI 10.2174/15733963113099990009; Wu XC, 2016, ACAD RADIOL, V23, P696, DOI 10.1016/j.acra.2016.01.012; Xu YC, 2011, WORLD J PEDIATR, V7, P240, DOI 10.1007/s12519-011-0318-0; Yan LP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002597; Yan LP, 2016, TUBERCULOSIS, V96, P75, DOI 10.1016/j.tube.2015.11.005; Zhao F, 2012, BIOMED ENVIRON SCI, V25, P77, DOI 10.3967/0895-3988.2012.01.011	19	12	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177842	10.1371/journal.pone.0177842	http://dx.doi.org/10.1371/journal.pone.0177842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520818	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500078
J	Papanastasiou, SA; Bali, EMD; Ioannou, CS; Papachristos, DP; Zarpas, KD; Papadopoulos, NT				Papanastasiou, Stella A.; Bali, Eleftheria-Maria D.; Ioannou, Charalampos S.; Papachristos, Dimitrios P.; Zarpas, Kostas D.; Papadopoulos, Nikos T.			Toxic and hormetic-like effects of three components of citrus essential oils on adult Mediterranean fruit flies (Ceratitis capitata)	PLOS ONE			English	Article							DIPTERA TEPHRITIDAE; INDUCED HORMESIS; TRADE-OFF; FLY; CHRYSOMELIDAE; HYMENOPTERA	Plant essential oils (EOs) and a wide range of their individual components are involved in a variety of biological interactions with insect pests including stimulatory, deterrent, toxic and even hormetic effects. Both the beneficial and toxic properties of citrus EOs on the Mediterranean fruit fly (medfly) have been experimentally evidenced over the last years. However, no information is available regarding the toxic or beneficial effects of the major components of citrus EOs via contact with the adults of the Mediterranean fruit fly. In the present study, we explored the toxicity of limonene, linalool and alpha-pinene (3 of the main compounds of citrus EOs) against adult medflies and identified the effects of sub-lethal doses of limonene on fitness traits in a relaxed [full diet (yeast and sugar)] and in a stressful (sugar only) feeding environment. Our results demonstrate that all three compounds inferred high toxicity to adult medflies regardless of the diet, with males being more sensitive than females. Sublethal doses of limonene (LD20) enhanced the lifespan of adult medflies when they were deprived of protein. Fecundity was positively affected when females were exposed to limonene sub-lethal doses. Therefore, limonene, a major constituent of citrus EOs, induces high mortality at increased doses and positive effects on life history traits of medfly adults through contact at low sub-lethal doses. A hormetic-like effect of limonene to adult medflies and its possible underlying mechanisms are discussed.	[Papanastasiou, Stella A.; Bali, Eleftheria-Maria D.; Ioannou, Charalampos S.; Zarpas, Kostas D.; Papadopoulos, Nikos T.] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Nea Ionia, Magnisia, Greece; [Papachristos, Dimitrios P.] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Athens, Greece	University of Thessaly	Papadopoulos, NT (corresponding author), Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Nea Ionia, Magnisia, Greece.	nikopap@uth.gr	Papanastasiou, Stella/GRO-7360-2022; Papadopoulos, Nikos/AAJ-1721-2020; Papachristos, Dimitrios/AHC-0813-2022	Papadopoulos, Nikos/0000-0003-2480-8189; Papanastasiou, Stella/0000-0003-3975-7089; Zarpas, Kostas/0000-0003-1957-8681; Papachristos, Dimitrios/0000-0002-0524-0180				[Anonymous], 1992, FRUIT FLIES EC SIGNI; Arancibia M., 2013, J AGR FOOD TECHNOL, V3, P1; Back EA, 1915, J AGR RES, P311; Benelli G, 2013, IND CROP PROD, V50, P596, DOI 10.1016/j.indcrop.2013.08.006; Benelli G, 2012, CROP PROT, V42, P223, DOI 10.1016/j.cropro.2012.05.024; Chang CL, 2009, J ECON ENTOMOL, V102, P203, DOI 10.1603/029.102.0129; Diamantidis AD, 2008, ENTOMOL EXP APPL, V128, P389, DOI 10.1111/j.1570-7458.2008.00730.x; Escher Beate I., 2011, Integrated Environmental Assessment and Management, V7, P28, DOI 10.1002/ieam.100; Flatt T, 2007, EVOLUTION, V61, P1980, DOI 10.1111/j.1558-5646.2007.00151.x; Gerofotis CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28540; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Haddi K, 2015, J ECON ENTOMOL, V108, P2815, DOI 10.1093/jee/tov255; Jager T, 2013, ECOTOXICOLOGY, V22, P263, DOI 10.1007/s10646-012-1022-0; Khorram M. Safaei, 2011, Journal of Entomology, V8, P404, DOI 10.3923/je.2011.404.416; Kurdelas RR, 2012, IND CROP PROD, V40, P261, DOI 10.1016/j.indcrop.2012.03.024; Leonov A, 2015, MOLECULES, V20, P6544, DOI 10.3390/molecules20046544; LIQUIDO NJ, 1990, J ECON ENTOMOL, V83, P1863, DOI 10.1093/jee/83.5.1863; Liquido NJ, 1991, ENTOMOL SOC AM, P1863; Lopez SB, 2011, J AGR FOOD CHEM, V59, P5286, DOI 10.1021/jf104966b; Mallqui KSV, 2014, J ECON ENTOMOL, V107, P860, DOI 10.1603/EC13526; Miguel MG, 2010, J ESSENT OIL BEAR PL, V13, P191, DOI 10.1080/0972060X.2010.10643811; Moretti M. D. L., 1998, Journal of Essential Oil Research, V10, P405; Papachristos DP, 2009, ANN APPL BIOL, V155, P381, DOI 10.1111/j.1744-7348.2009.00350.x; Papachristos DP, 2004, PEST MANAG SCI, V60, P514, DOI 10.1002/ps.798; Papadopoulos NT, 2006, 7 INT S FRUIT FLIES; PROKOPY RJ, 1984, AM SCI, V72, P41; RATHMAN RJ, 1992, J ECON ENTOMOL, V85, P15, DOI 10.1093/jee/85.1.15; Renkema JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21432; RIVNAY E, 1950, B ENTOMOL RES, V41, P321, DOI 10.1017/S0007485300027656; ROESSLER Y, 1986, PHYTOPARASITICA, V14, P168; Salvatore A, 2004, J CHEM ECOL, V30, P323, DOI 10.1023/B:JOEC.0000017980.66124.d1; Sarakatsanou A, 2011, J APPL ENTOMOL, V135, P554, DOI 10.1111/j.1439-0418.2011.01610.x; Schoonhoven L. M., 2005, Insect-plant biology; Zou SG, 2010, J GERONTOL A-BIOL, V65, P41, DOI 10.1093/gerona/glp176; Zou SG, 2009, EXP GERONTOL, V44, P472, DOI 10.1016/j.exger.2009.02.011	36	28	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177837	10.1371/journal.pone.0177837	http://dx.doi.org/10.1371/journal.pone.0177837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520791	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500077
J	Sato, Y; Fujimoto, S; Konta, T; Iseki, K; Moriyama, T; Yamagata, K; Tsuruya, K; Narita, I; Kondo, M; Kasahara, M; Shibagaki, Y; Asahi, K; Watanabe, T				Sato, Yuji; Fujimoto, Shouichi; Konta, Tsuneo; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Narita, Ichiei; Kondo, Masahide; Kasahara, Masato; Shibagaki, Yugo; Asahi, Koichi; Watanabe, Tsuyoshi			Body shape index: Sex-specific differences in predictive power for all-cause mortality in the Japanese population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; MASS INDEX; ANTHROPOMETRIC MEASURES; CARDIOVASCULAR MORTALITY; METABOLIC SYNDROME; FOLLOW-UP; ASSOCIATION; RISK; OBESITY	Background While body mass index (BMI) is the most widely used anthropometric measure, its association with all-cause mortality is generally J-shaped or U-shaped. A body shape index (ABSI) is a recently formulated anthropometric measure that shows linear relationship to all-cause mortality, especially in Caucasian cohorts. We aimed to address the relationship between ABSI and all-cause mortality in Asians and to assess the influence of sex difference and of chronic kidney disease (CKD) on this relationship. Methods This was a longitudinal cohort study assessing the association of ABSI, BMI, waist circumference (WC), and waist-to-height ratio (WHtR) with all-cause mortality in a Japanese nationwide Specific Health Checkup database. The study enrolled 160,625 participants followed-up between 2008 and 2012. We calculated the all-cause mortality risk associated with a 1-standard deviation increase (+1SD) in ABSI, BMI, WC, or WHtR in cohorts stratified by sex and the presence of CKD. Results During the 4-year follow up, 1.3% of participants died. In men, ABSI (+1SD) significantly increased the risk for all-cause mortality after adjusting for other known risk factors including CKD; hazard ratio (HR) and 95% confidence intervals (CI) of non-CKD cohort, 1.30 (1.18 to 1.43), p<0.01; HR and 95% CI of CKD cohort, 1.16 (1.01 to 1.34), p = 0.04. In women, ABSI (+1SD) did not show significant association with all-cause mortality, especially in the CKD cohort; HR and 95% CI of non-CKD cohort, 1.07 (0.99 to 1.17), p = 0.09; HR and 95% CI of CKD cohort, 0.98 (0.84 to 1.14), p = 0.78. Conversely, BMI (+1SD) was associated with significantly lower risk in men, although minimal association was found in women. WC and WHtR showed little association with all-cause mortality. On stratification per ABSI quartiles, mortality risk increased linearly and significantly with ABSI in men, but not in women with CKD. Both BMI and WC showed significant but U-shaped association with mortality in the non-CKD cohort and in men with CKD. WHtR also showed significant U-shaped association with mortality in men. Conclusions In the Japanese population, ABSI showed significant and linear correlation with mortality risk in men but not in women, especially in the presence of CKD.	[Sato, Yuji] Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan; [Fujimoto, Shouichi] Miyazaki Univ, Dept Hemovasc Med & Artificial Organs, Fac Med, Miyazaki, Japan; [Konta, Tsuneo; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Narita, Ichiei; Kondo, Masahide; Kasahara, Masato; Shibagaki, Yugo; Asahi, Koichi; Watanabe, Tsuyoshi] Steering Comm Res Design Comprehens Hlth Care Sys, Fukushima, Japan	University of Miyazaki; University of Miyazaki	Sato, Y (corresponding author), Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan.	ysato@med.miyazaki-u.ac.jp	Narita, Ichiei/G-5204-2017; Konta, Tsuneo/AAO-9286-2021	Narita, Ichiei/0000-0001-7692-3096; 	Ministry of Health, Labor and Welfare of Japan; Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [16K08860] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health and Labor Sciences Research Grants for "Design of the Comprehensive Health Care System for Chronic Kidney Disease Based on the Individual Risk Assessment by Specific Health Check" from the Ministry of Health, Labor and Welfare of Japan and a Grant-in-Aid for "Research on Advanced Chronic Kidney Disease (REACH-J), Practical Research Project for Renal Disease" from Japan Agency for Medical Research and Development, AMED.	Abete I, 2015, EUR J NUTR, V54, P365, DOI 10.1007/s00394-014-0716-x; Afsar B, 2013, NUTRITION, V29, P1214, DOI 10.1016/j.nut.2013.03.012; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; Bozorgmanesh M, 2016, EUR J NUTR, V55, P147, DOI 10.1007/s00394-015-0833-1; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chang Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2150-2; Cheung YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085421; Cox BD, 1996, BRIT MED J, V313, P1487, DOI 10.1136/bmj.313.7070.1487; Dhana K, 2016, MATURITAS, V88, P96, DOI 10.1016/j.maturitas.2016.03.018; Dhana K, 2016, J EPIDEMIOL COMMUN H, V70, P90, DOI 10.1136/jech-2014-205257; Dhana K, 2015, HEART, V101, P377, DOI 10.1136/heartjnl-2014-306704; Evans M, 2005, AM J KIDNEY DIS, V46, P863, DOI 10.1053/j.ajkd.2005.07.040; Fujita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128972; Haghighatdoost F, 2014, NUTRITION, V30, P636, DOI 10.1016/j.nut.2013.10.021; He S, 2013, PLOS ONE, V8; Huang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126668; Iseki K, 2017, CLIN EXP NEPHROL; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kwan BCH, 2007, CLIN J AM SOC NEPHRO, V2, P992, DOI 10.2215/CJN.04221206; Madero M, 2007, AM J KIDNEY DIS, V50, P404, DOI 10.1053/j.ajkd.2007.06.004; Maessen MFH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107212; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Patel AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109153; Sardarinia M, 2017, NUTRITION, V33, P105, DOI 10.1016/j.nut.2016.05.004; Sasazuki S, 2011, J EPIDEMIOL, V21, P417, DOI 10.2188/jea.JE20100180; Sato Y, 2015, CLIN EXP NEPHROL, V19, P790, DOI 10.1007/s10157-014-1062-2; Sato Y, 2014, CLIN EXP NEPHROL, V18, P75, DOI 10.1007/s10157-013-0809-5; Sato Y, 2012, NEPHROL DIAL TRANSPL, V27, P3862, DOI 10.1093/ndt/gfs324; SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Song X, 2013, EUR J CLIN NUTR, V67, P1298, DOI 10.1038/ejcn.2013.203; Thomson CA, 2016, OBESITY, V24, P1061, DOI 10.1002/oby.21461; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Weiner DE, 2008, AM J KIDNEY DIS, V51, P212, DOI 10.1053/j.ajkd.2007.10.035	40	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177779	10.1371/journal.pone.0177779	http://dx.doi.org/10.1371/journal.pone.0177779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520811	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500070
J	Bedini, S; Braun, F; Weibel, L; Aussedat, M; Pereira, B; Dutheil, F				Bedini, Sarah; Braun, Francois; Weibel, Laurence; Aussedat, Michel; Pereira, Bruno; Dutheil, Frederic			Stress and salivary cortisol in emergency medical dispatchers: A randomized shifts control trial	PLOS ONE			English	Article							WORK-RELATED STRESS; QUALITY-OF-LIFE; IMPACT; SECRETION; RESPONSES; MODELS; CALL	Stress at work is a public health concern. Phone operators in emergency medical dispatch centers are particularly at risk. We aimed to demonstrate that the most stressful time for emergency medical dispatchers is the shift when they receive emergency incoming calls, with cortisol as a biomarker of stress. For each emergency medical dispatcher, we measured outcomes over a control day and during three types of shift: Incoming emergency call, Dispatch and Re-assessment. The pattern of shifts was randomized. Saliva was sampled every 15 minutes for 2 hours, i.e. 6 consecutive times, starting 15 minutes after the first life- and-death incoming emergency call between 2 and 5 pm during three types of shift. We measured saliva cortisol every 2 hours over a control day, from 7am to 9pm. Perceived stress was assessed by a visual analog scale. We recruited 22 phone operators aged 36.4 +/-10.8 years old (14 women and 8 men). Cortisol values were higher during the Incoming emergency call shift than during the Dispatch (p =.04) and Re-assessment (p =.04) shifts. The increase in cortisol levels was greater in men than in women (p =.009). There were no differences between control values and those of the three shifts. The kinetics of cortisol increased with greater perceived stress overall (p <.001) and for each type of shift (Incoming emergency call, p =.02; Dispatch p =.03; Re-assessment: p <.001). The kinetics of cortisol in response to incoming emergency calls was greater when the call was an absolute emergency (p =.03), and also tended to further increase when a subsequent absolute incoming emergency call was received (p = 0.07). In conclusion, the incoming emergency call shift carries particular risk for dispatchers, who have greater perceived stress and a greater increase in cortisol levels.	[Bedini, Sarah; Braun, Francois] Mercy Reg Hosp Ctr CHR MetzThionville, Emergency Dept, Ars Laquenexy, France; [Braun, Francois] SAMU Urgences France, Paris, France; [Weibel, Laurence] CARSAT Alsace, Strasbourg, France; [Pereira, Bruno] Univ Hosp Clermont Ferrand, Clin Res Direct, CHU Clermont Ferrand, Clermont Ferrand, France; [Dutheil, Frederic] Univ Hosp Clermont Ferrand, Univ Clermont Auvergne, CNRS, LaPSCo, Clermont Ferrand, France; [Dutheil, Frederic] Australian Catholic Univ, Sch Exercise Sci, Fac Hlth, Melbourne, Vic, Australia	CHR Metz-Thionville; CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Australian Catholic University	Bedini, S (corresponding author), Mercy Reg Hosp Ctr CHR MetzThionville, Emergency Dept, Ars Laquenexy, France.	sarah.bedini3@gmail.com	Dutheil, Frederic/O-9707-2014	Dutheil, Frederic/0000-0002-1468-6029	Mercy Regional Hospital Centre (CHR) of Metr-Thionville, Emergency department, Met, France	Mercy Regional Hospital Centre (CHR) of Metr-Thionville, Emergency department, Met, France	Recipient of the first prize of clinical research grant from the Mercy Regional Hospital Centre (CHR) of Metr-Thionville, Emergency department, Met, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backe EM, 2009, INT ARCH OCC ENV HEA, V82, P1057, DOI 10.1007/s00420-009-0428-3; Badrick E, 2008, J CLIN ENDOCR METAB, V93, P750, DOI 10.1210/jc.2007-0737; Bejean Sophie, 2005, Eur J Health Econ, V6, P16; Bellagamba G, 2015, INT J OCCUP MED ENV, V28, P357, DOI 10.13075/ijomeh.1896.00121; Bhui Kamaldeep S, 2012, J Environ Public Health, V2012, P515874, DOI 10.1155/2012/515874; Boudet G, 2016, EUR J PREV CARDIOL; Bozovic Djordje, 2013, Med Arch, V67, P374; Charbotel B, 2009, INT ARCH OCC ENV HEA, V82, P747, DOI 10.1007/s00420-008-0351-z; Choron G, 2016, INT J NURS STUD, V58, P80, DOI 10.1016/j.ijnurstu.2016.02.002; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLLINS KJ, 1979, J PHYSIOL-LONDON, V292, P1; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Doom Jenalee R, 2013, Dev Psychopathol, V25, P1359, DOI 10.1017/S0954579413000667; Dutheil F, 2011, POSTER COMP HEART RA; Dutheil F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007716; Dutheil F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071658; Dutheil F, 2012, INT J CARDIOL, V158, P322, DOI 10.1016/j.ijcard.2012.04.141; Fekedulegn D, 2012, IND HEALTH, V50, P476, DOI 10.2486/indhealth.2012-0043; Gatti R, 2011, SCAND J MED SCI SPOR, V21, P157, DOI 10.1111/j.1600-0838.2010.01252.x; Goldstone AR, 2004, BMJ-BRIT MED J, V328, P379, DOI 10.1136/bmj.37985.371343.EE; Granger DA, 2009, PSYCHONEUROENDOCRINO, V34, P1437, DOI 10.1016/j.psyneuen.2009.06.017; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Hasan MT, 2009, BIOMETRICAL J, V51, P946, DOI 10.1002/bimj.200900093; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Heuser I, 2003, NEUROBIOL AGING, V24, pS69, DOI 10.1016/S0197-4580(03)00048-4; Jones CB, 2008, J NURS ADMIN, V38, P11, DOI 10.1097/01.NNA.0000295636.03216.6f; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Knorr U, 2010, PSYCHONEUROENDOCRINO, V35, P1275, DOI 10.1016/j.psyneuen.2010.04.001; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lac G, 2012, BRAIN COGNITION, V80, P277, DOI 10.1016/j.bandc.2012.07.007; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Lesage FX, 2011, OCCUP MED-OXFORD, V61, P434, DOI 10.1093/occmed/kqr037; Liening SH, 2010, PHYSIOL BEHAV, V99, P8, DOI 10.1016/j.physbeh.2009.10.001; Looser RR, 2010, PSYCHOSOM MED, V72, P281, DOI 10.1097/PSY.0b013e3181d35065; Lovallo WR, 2010, PSYCHONEUROENDOCRINO, V35, P1253, DOI 10.1016/j.psyneuen.2010.02.015; Meewisse ML, 2007, BRIT J PSYCHIAT, V191, P387, DOI 10.1192/bjp.bp.106.024877; Meinlschmidt G, 2005, PSYCHONEUROENDOCRINO, V30, P568, DOI 10.1016/j.psyneuen.2005.01.006; Metzenthin P, 2009, PREV MED, V48, P462, DOI 10.1016/j.ypmed.2009.02.001; Meyer VJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00138; Miller R, 2013, PSYCHONEUROENDOCRINO, V38, P50, DOI 10.1016/j.psyneuen.2012.04.019; Min YY, 2005, STAT MODEL, V5, P1, DOI 10.1191/1471082X05st084oa; Moller TP, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0169-0; Montassier E, 2015, PREHOSP EMERG CARE, V19, P254, DOI 10.3109/10903127.2014.959217; Nakajima Y, 2012, J PHYSIOL SCI, V62, P191, DOI 10.1007/s12576-012-0197-8; Nakamura Y, 2016, STRESS, V19, P151, DOI 10.3109/10253890.2015.1121984; Ronda E, 2000, J EPIDEMIOL COMMUNIT, V54, P481; Roth SG, 2009, PREHOSP EMERG CARE, V13, P462, DOI 10.1080/10903120903144791; Rugless MJ, 2011, EMERG MED AUSTRALAS, V23, P39, DOI 10.1111/j.1742-6723.2010.01372.x; Shao MF, 2010, J ADV NURS, V66, P1565, DOI 10.1111/j.1365-2648.2010.05300.x; Teixeira RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119025; Torpy DJ, 2007, HORM METAB RES, V39, P439, DOI 10.1055/s-2007-980200; Trousselard M, 2016, INT ARCH OCC ENV HEA, V89, P221, DOI 10.1007/s00420-015-1065-7; Ulhoa MA, 2011, CHRONOBIOL INT, V28, P810, DOI 10.3109/07420528.2011.613136; Vaillancourt C, 2011, RESUSCITATION, V82, P1483, DOI 10.1016/j.resuscitation.2011.05.020; Weibel L, 2003, PRESSE MED, V32, P845; Weibel L, 2003, ANN EMERG MED, V41, P500, DOI 10.1067/mem.2003.109; Woda A, 2016, PSYCHONEUROENDOCRINO, V71, P127, DOI 10.1016/j.psyneuen.2016.05.017; Yang Y, 2001, J OCCUP ENVIRON MED, V43, P1011	59	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177094	10.1371/journal.pone.0177094	http://dx.doi.org/10.1371/journal.pone.0177094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505199	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500012
J	Koga, T; Okada, A; Fukuda, T; Hidaka, T; Ishii, T; Ueki, Y; Kodera, T; Nakashima, M; Takahashi, Y; Honda, S; Horai, Y; Watanabe, R; Okuno, H; Aramaki, T; Izumiyama, T; Takai, O; Miyashita, T; Sato, S; Kawashiri, S; Iwamoto, N; Ichinose, K; Tamai, M; Origuchi, T; Nakamura, H; Aoyagi, K; Eguchi, K; Kawakami, A				Koga, Tomohiro; Okada, Akitomo; Fukuda, Takaaki; Hidaka, Toshihiko; Ishii, Tomonori; Ueki, Yukitaka; Kodera, Takao; Nakashima, Munetoshi; Takahashi, Yuichi; Honda, Seiyo; Horai, Yoshiro; Watanabe, Ryu; Okuno, Hiroshi; Aramaki, Toshiyuki; Izumiyama, Tomomasa; Takai, Osamu; Miyashita, Taiichiro; Sato, Shuntaro; Kawashiri, Shin-ya; Iwamoto, Naoki; Ichinose, Kunihiro; Tamai, Mami; Origuchi, Tomoki; Nakamura, Hideki; Aoyagi, Kiyoshi; Eguchi, Katsumi; Kawakami, Atsushi		Japanese RA Patients RRP Study Grp	Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan	PLOS ONE			English	Article							JOINT DAMAGE; RISK MODEL; ULTRASONOGRAPHY; METHOTREXATE; MATRIX; KNEE; RECOMMENDATIONS; THERAPY	Objectives To determine prognostic factors of clinically relevant radiographic progression (CRRP) in patients with rheumatoid arthritis (RA) achieving remission or low disease activity (LDA) in clinical practice. Methods Using data from a nationwide, multicenter, prospective study in Japan, we evaluated 198 biological disease-modifying antirheumatic drug (bDMARD)-naive RA patients who were in remission or had LDA at study entry after being treated with conventional synthetic DMARDs (csDMARDs). CRRP was defined as the yearly progression of modified total Sharp score (mTSS) >3.0 U. We performed a multiple logistic regression analysis to explore the factors to predict CRRP at 1 year. We used receiver operating characteristic (ROC) curve to estimate the performance of relevant variables for predicting CRRP. Results The mean Disease Activity Score in 28 joints-erythrocyte sedimentation rate (DAS28-ESR) was 2.32-0.58 at study entry. During the 1-year observation, remission or LDA persisted in 72% of the patients. CRRP was observed in 7.6% of the patients. The multiple logistic regression analysis revealed that the independent variables to predict the development of CRRP were: anti-citrullinated peptide antibodies (ACPA) positivity at baseline (OR = 15.2, 95% CI 2.64-299), time-integrated DAS28-ESR during the 1 year post-baseline (7.85-unit increase, OR = 1.83, 95% CI 1.03-3.45), and the mTSS at baseline (13-unit increase, OR = 1.22, 95% CI 1.06-1.42). Conclusions ACPA positivity was the strongest independent predictor of CRRP in patients with RA in remission or LDA. Physicians should recognize ACPA as a poor-prognosis factor regarding the radiographic outcome of RA, even among patients showing a clinically favorable response to DMARDs.	[Koga, Tomohiro] Nagasaki Univ, Ctr Bioinformat & Mol Med, Grad Sch Biomed Sci, Sakamoto 1-7-1, Nagasaki, Japan; [Koga, Tomohiro; Horai, Yoshiro; Kawashiri, Shin-ya; Iwamoto, Naoki; Ichinose, Kunihiro; Tamai, Mami; Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Dept Immunol & Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Sakamoto 1-7-1, Nagasaki, Japan; [Okada, Akitomo; Nakashima, Munetoshi; Aramaki, Toshiyuki] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Rheumatol, Morimachi 3-15, Nagasaki, Japan; [Fukuda, Takaaki; Nakashima, Munetoshi] Kurume Univ, Med Ctr, Dept Rheumatol, Kokubun 155-1, Kurume, Fukuoka, Japan; [Hidaka, Toshihiko] Zenjinkai Shimin No Mori Hosp, Shioji 2783-37, Miyazaki, Japan; [Ishii, Tomonori; Watanabe, Ryu] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Aoba Ku, Seiryo 1-1, Sendai, Miyagi, Japan; [Ueki, Yukitaka; Aramaki, Toshiyuki] Sasebo Chuo Hosp, Rheumat & Collagen Dis Ctr, Yamato 15, Sasebo, Japan; [Kodera, Takao] Tohoku Med & Pharmaceut Univ Hosp, Aoba Ku, Komatsujima 4-4-1, Sendai, Miyagi, Japan; [Takahashi, Yuichi] Yu Family Clin, Rifu Aza Sinkan 2-5, Rifu, Miyagi, Japan; [Honda, Seiyo] Kurume Univ, Sch Med, Asahi Machi 67, Kurume, Fukuoka, Japan; [Okuno, Hiroshi] Tohoku Univ Hosp, Dept Orthopaed Surg, Hirase 9-3, Sasebo, Japan; [Izumiyama, Tomomasa] East Sendai Rheumatism & Internal Med Clin, Miyagino Ku, Nittahigashi 1-17-5, Sendai, Miyagi, Japan; [Takai, Osamu] Osaki Citizen Hosp, Furukawa Honami 3-8-1, Osaki, Japan; [Miyashita, Taiichiro] NHO Nagasaki Med Ctr, Kubara 2-1001-1, Omura, Nagasaki, Japan; [Sato, Shuntaro] Nagasaki Univ Hosp, Clin Res Ctr, Sakamoto 1-7-1, Nagasaki, Japan; [Kawashiri, Shin-ya; Aoyagi, Kiyoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Publ Hlth, Sakamoto 1-12-4, Nagasaki, Japan; [Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Rehabil Sci, Sakamoto 1-12-4, Nagasaki, Japan; [Eguchi, Katsumi] Sasebo City Gen Hosp, Hirase 9-3, Sasebo, Japan	Nagasaki University; Nagasaki University; Kurume University; Tohoku University; Tohoku Medical & Pharmaceutical University; Kurume University; Tohoku University; Nagasaki University; Nagasaki University; Nagasaki University	Koga, T (corresponding author), Nagasaki Univ, Ctr Bioinformat & Mol Med, Grad Sch Biomed Sci, Sakamoto 1-7-1, Nagasaki, Japan.; Koga, T (corresponding author), Nagasaki Univ, Dept Immunol & Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Sakamoto 1-7-1, Nagasaki, Japan.	tkoga@nagasaki-u.ac.jp	Koga, Tomohiro/V-9397-2019; Ichinose, Kunihiro/I-2126-2019; Watanabe, Ryu/AAL-2666-2021; Koga, Tomohiro/AAU-9697-2020; Sato, Shuntaro/AAN-8048-2020	Ichinose, Kunihiro/0000-0001-8794-7106; Watanabe, Ryu/0000-0002-1089-5296; Sato, Shuntaro/0000-0002-6055-3649; Koga, Tomohiro/0000-0003-2077-4428				Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; Aletaha D, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2014-000009; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Bohler C, 2013, ANN RHEUM DIS, V72, P241, DOI 10.1136/annrheumdis-2012-202297; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Bruynesteyn K, 2005, ANN RHEUM DIS, V64, P179, DOI 10.1136/ard.2003.018457; Bruynesteyn K, 2002, J RHEUMATOL, V29, P2306; Cohen G, 2007, ANN RHEUM DIS, V66, P358, DOI 10.1136/ard.2006.057497; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; Fautrel B, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4092; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Johnson K, 2002, CLIN RADIOL, V57, P466, DOI 10.1053/crad.2001.0876; Kane D, 2003, J RHEUMATOL, V30, P966; Karim Z, 2004, ARTHRITIS RHEUM-US, V50, P387, DOI 10.1002/art.20054; Koga T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003476; Lillegraven S, 2013, ARTHRIT CARE RES, V65, P526, DOI 10.1002/acr.21870; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120; Molenaar ETH, 2004, ARTHRITIS RHEUM, V50, P36, DOI 10.1002/art.11481; Salaffi F, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-120; Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201; Smolen JS, 2009, ANN RHEUM DIS, V68, P159, DOI 10.1136/ard.2008.099382; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Szkudlarek M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1904; Takahashi C, 2014, ANN RHEUM DIS, V73, P218, DOI 10.1136/annrheumdis-2014-eular.3527; Takeuchi T, 2014, ANN RHEUM DIS, V73, P536, DOI 10.1136/annrheumdis-2012-202433; Vastesaeger N, 2009, RHEUMATOLOGY, V48, P1114, DOI 10.1093/rheumatology/kep155; Visser K, 2010, ANN RHEUM DIS, V69, P1333, DOI 10.1136/ard.2009.121160; Yamanaka H, 2013, MOD RHEUMATOL, V23, P1, DOI [10.1007/s10165-012-0702-1, 10.1007/s10165-011-0510-z]	33	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0175281	10.1371/journal.pone.0175281	http://dx.doi.org/10.1371/journal.pone.0175281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505163	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500005
J	Wu, HY; Peng, CL; Chen, PC; Chiang, CK; Chang, CJ; Huang, JW; Peng, YS; Tu, YK; Chu, TS; Hung, KY; Chien, KL				Wu, Hon-Yen; Peng, Chiao-Ling; Chen, Pei-Chun; Chiang, Chih-Kang; Chang, Chee-Jen; Huang, Jenq-Wen; Peng, Yu-Sen; Tu, Yu-Kang; Chu, Tzong-Shinn; Hung, Kuan-Yu; Chien, Kuo-Liong			Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANTIHYPERTENSIVE DRUGS; TAIWAN SOCIETY; MANAGEMENT; NATIONWIDE; RISK; GUIDELINES; MORTALITY; BLOCKADE; HYPERTENSION	Background Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are considered to have similar renoprotective effects; so far there has been no consensus about their priorities. This study aimed to compare ACEIs and ARBs for major renal outcomes and survival in a 15-year cohort of adults with diabetes. Methods This study utilized Taiwan's medical and pharmacy claims data in the Longitudinal Cohort of Diabetes Patients. The primary outcome was long-term dialysis, and secondary outcomes were hospitalization for acute kidney injury, hospitalization for hyperkalemia, all-cause death, cardiovascular death, and non-cardiovascular death. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for outcomes comparing ACEIs with ARBs. We conducted subgroup analyses and interaction tests among patients with different age and comorbid diseases. Results A total of 34,043 patients received ACEIs and 23,772 patients received ARBs. No differences were found for primary or secondary outcomes in the main analyses. ACEIs showed significantly lower hazard than ARBs for long-term dialysis among patients with cardiovascular disease (HR 0.80, 95% CI 0.66-0.97, interaction P = 0.003) or chronic kidney disease (0.81, 0.71-0.93, interaction P = 0.001). Conclusions Our analyses show similar effects of ACEIs and ARBs in patients with diabetes. However, ACEIs might provide additional renoprotective effects among patients who have cardiovascular disease or chronic kidney disease.	[Wu, Hon-Yen; Peng, Yu-Sen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Wu, Hon-Yen; Chiang, Chih-Kang; Huang, Jenq-Wen; Peng, Yu-Sen; Chu, Tzong-Shinn; Hung, Kuan-Yu; Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Wu, Hon-Yen; Chiang, Chih-Kang; Huang, Jenq-Wen; Peng, Yu-Sen; Chu, Tzong-Shinn; Hung, Kuan-Yu; Chien, Kuo-Liong] Coll Med, Taipei, Taiwan; [Wu, Hon-Yen; Peng, Chiao-Ling; Tu, Yu-Kang; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Wu, Hon-Yen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Chen, Pei-Chun; Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Hung, Kuan-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Hung, KY; Chien, KL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Hung, KY; Chien, KL (corresponding author), Coll Med, Taipei, Taiwan.; Chien, KL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan.; Hung, KY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan.	kyhung@ntu.edu.tw; kichien@ntu.edu.tw	peng, yu/GXW-2071-2022	CHIANG, CHIH-KANG/0000-0001-9021-4616; Tu, Yu-Kang/0000-0002-2461-474X; CHIEN, KUO-LIONG/0000-0003-4979-8351; Wu, Hon-Yen/0000-0003-3121-3351; Chen, Pei-Chun/0000-0002-8713-8816; HUNG, KUAN-YU/0000-0003-3472-5512; HUANG, JENQ-WEN/0000-0001-8011-2317; Chang, Chee Jen/0000-0002-7725-7555	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-418-003-MY2]; National Health Research Institutes, Taiwan [NHRI-EX105-10510PC, NHRI-EX106-10510PC]; Far Eastern Memorial Hospital, New Taipei City, Taiwan [FEMH-EX105-10510PC, FEMH-EX106-10510PC]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Far Eastern Memorial Hospital, New Taipei City, Taiwan	This study was supported by research grants to Dr. Hon-Yen Wu from the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-418-003-MY2), the National Health Research Institutes, Taiwan (NHRI-EX105-10510PC, NHRI-EX106-10510PC), and the Far Eastern Memorial Hospital, New Taipei City, Taiwan (FEMH-EX105-10510PC, FEMH-EX106-10510PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sayed Nasreen A, 2013, Endocr Pract, V19, P579, DOI 10.4158/EP12272.OR; American Diabetes Association, 2017, Diabetes Care, V40, pS75; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Campbell HM, 2013, DIABETES RES CLIN PR, V102, P233, DOI 10.1016/j.diabres.2013.10.005; Carrero JJ, 2011, CLIN J AM SOC NEPHRO, V6, P1722, DOI 10.2215/CJN.11331210; Chang JW, 2015, KIDNEY INT, V87, P632, DOI 10.1038/ki.2014.299; Chen YC, 2015, KIDNEY INT, V87, P1030, DOI 10.1038/ki.2014.363; Chiang CE, 2015, J CHIN MED ASSOC, V78, P1, DOI 10.1016/j.jcma.2014.11.005; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fukuma S, CLIN EXP NEPHROL; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hayashi M, 2015, CLIN EXP NEPHROL, V19, P925, DOI 10.1007/s10157-015-1091-5; Hicks Karen A, 2015, J Nucl Cardiol, V22, P1041, DOI 10.1007/s12350-015-0209-1; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Hughes DR, 2015, JAMA INTERN MED, V175, P101, DOI 10.1001/jamainternmed.2014.6349; Iseki K, 2013, NEPHROL DIAL TRANSPL, V28, P1579, DOI 10.1093/ndt/gfs590; Izzo JL, 2011, J CLIN HYPERTENS, V13, P667, DOI 10.1111/j.1751-7176.2011.00508.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Patel Bimal V, 2007, J Clin Hypertens (Greenwich), V9, P692, DOI 10.1111/j.1524-6175.2007.07194.x; Pawluczyk IZA, 2004, KIDNEY INT, V65, P1240, DOI 10.1111/j.1523-1755.2004.00494.x; Seccia TM, 2006, J HYPERTENS, V24, P1419, DOI 10.1097/01.hjh.0000234124.94013.ac; STEINER JF, 1993, J GEN INTERN MED, V8, P306, DOI 10.1007/BF02600143; Tobe SW, 2011, CIRCULATION, V123, P1098, DOI 10.1161/CIRCULATIONAHA.110.964171; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Tsai WC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003013; Tsai WC, JAMA INT MED; Tung YC, 2010, STROKE, V41, P504, DOI 10.1161/STROKEAHA.109.568956; Van Wijk BLG, 2006, J CLIN EPIDEMIOL, V59, P11, DOI 10.1016/j.jclinepi.2005.05.005; Wu HY, 2014, JAMA INTERN MED, V174, P1108, DOI 10.1001/jamainternmed.2014.1363; Wu HY, 2014, J COMP EFFECT RES, V3, P213, DOI [10.2217/cer.14.10, 10.2217/CER.14.10]; Wu HY, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6008; Yang DC, 2012, DIABETES CARE, V35, P2279, DOI 10.2337/dc12-0545	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177654	10.1371/journal.pone.0177654	http://dx.doi.org/10.1371/journal.pone.0177654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505194	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500031
J	Howe, JR; Li, ES; Streeter, SE; Rahme, GJ; Chipumuro, E; Russo, GB; Litzky, JF; Hills, LB; Rodgers, KR; Skelton, PD; Luikart, BW				Howe, James R.; Li, Emily S.; Streeter, Sarah E.; Rahme, Gilbert J.; Chipumuro, Edmond; Russo, Grace B.; Litzky, Julia F.; Hills, L. Benjamin; Rodgers, Kyla R.; Skelton, Patrick D.; Luikart, Bryan W.			MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation	PLOS ONE			English	Article							DENTATE GYRUS; GRANULE CELLS; ADULT NEUROGENESIS; INCREASED FREQUENCY; CANCER-CELL; HIPPOCAMPAL; INTEGRATION; EXPRESSION; SURVIVAL; DIFFERENTIATION	Neurogenesis is a highly-regulated process occurring in the dentate gyrus that has been linked to learning, memory, and antidepressant efficacy. MicroRNAs (miRNAs) have been previously shown to play an important role in the regulation of neuronal development and neurogenesis in the dentate gyrus via modulation of gene expression. However, this mode of regulation is both incompletely described in the literature thus far and highly multifactorial. In this study, we designed sensors and detected relative levels of expression of 10 different miRNAs and found miR-338-3p was most highly expressed in the dentate gyrus. Comparison of miR-338-3p expression with neuronal markers of maturity indicates miR-338-3p is expressed most highly in the mature neuron. We also designed a viral "sponge" to knock down in vivo expression of miR-338-3p. When miR-338-3p is knocked down, neurons sprout multiple primary dendrites that branch off of the soma in a disorganized manner, cellular proliferation is upregulated, and neoplasms form spontaneously in vivo. Additionally, miR-338-3p overexpression in glioblastoma cell lines slows their proliferation in vitro. Further, low miR-338-3p expression is associated with increased mortality and disease progression in patients with glioblastoma. These data identify miR-338-3p as a clinically relevant tumor suppressor in glioblastoma.	[Howe, James R.; Li, Emily S.; Streeter, Sarah E.; Chipumuro, Edmond; Russo, Grace B.; Litzky, Julia F.; Hills, L. Benjamin; Rodgers, Kyla R.; Skelton, Patrick D.; Luikart, Bryan W.] Dartmouth Coll, Geisel Sch Med, Dept Physiol & Neurobiol, Lebanon, NH 03755 USA; [Rahme, Gilbert J.] Dartmouth Coll, Geisel Sch Med, Dept Genet, Lebanon, NH USA	Dartmouth College; Dartmouth College	Luikart, BW (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Physiol & Neurobiol, Lebanon, NH 03755 USA.	Bryan.W.Luikart@dartmouth.edu	Howe, James R./Q-8170-2018; Rodgers, Kyla/AAR-8045-2021	Howe, James R./0000-0002-7584-3577; Litzky, Julia/0000-0001-6767-5000; Luikart, Bryan/0000-0002-3181-6075; Rahme, Gilbert/0000-0001-6060-1279; Skelton, Patrick/0000-0002-6691-9904; Rodgers, Kyla/0000-0002-5844-1971	Department of Physiology and Neurobiology at the Geisel School of Medicine at Dartmouth (BWL); Optical Cellular Imaging Shared Resource; Norris Cotton Cancer Center at the Geisel School of Medicine at Dartmouth [P30 CA023108]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097949] Funding Source: NIH RePORTER	Department of Physiology and Neurobiology at the Geisel School of Medicine at Dartmouth (BWL); Optical Cellular Imaging Shared Resource; Norris Cotton Cancer Center at the Geisel School of Medicine at Dartmouth; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by startup funding provided by the Department of Physiology and Neurobiology at the Geisel School of Medicine at Dartmouth (BWL) and the Optical Cellular Imaging Shared Resource and the Norris Cotton Cancer Center at the Geisel School of Medicine at Dartmouth, P30 CA023108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Aldape K, 2015, ACTA NEUROPATHOL, V129, P829, DOI 10.1007/s00401-015-1432-1; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Aschrafi A, 2012, CELL MOL LIFE SCI, V69, P4017, DOI 10.1007/s00018-012-1064-8; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Chen H, 2006, NEUROREPORT, V17, P863, DOI 10.1097/01.wnr.0000221827.03222.70; Chen X, 2013, FEBS LETT, V587, P3729, DOI 10.1016/j.febslet.2013.09.044; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; De Falco M, 2004, J ANAT, V205, P405, DOI 10.1111/j.0021-8782.2004.00347.x; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fu XY, 2012, INT J MOL SCI, V13, P8514, DOI 10.3390/ijms13078514; Gartner A, 2014, J CELL SCI, V127, P4409, DOI 10.1242/jcs.149815; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Gould E, 1997, J NEUROSCI, V17, P2492; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hervey-Jumper S, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-134; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; Johansson A, 2003, NEUROSCI LETT, V340, P69, DOI 10.1016/S0304-3940(03)00051-X; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kos A, 2014, MOL NEUROBIOL; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Lau P, 2010, BRAIN RES, V1338, P14, DOI 10.1016/j.brainres.2010.04.002; Lauer M, 2003, PSYCHIAT RES-NEUROIM, V122, P89, DOI 10.1016/S0925-4927(02)00122-1; Lee Y, 2016, NEUROONCOL S, V18; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066782; Luikart BW, 2012, BEHAV BRAIN RES, V227, P348, DOI 10.1016/j.bbr.2011.03.048; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Rahme GJ, 2016, CANC RES; Sainath R, 2015, CELL TISSUE RES, V359, P267, DOI 10.1007/s00441-014-1955-0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Senitz D, 2003, J NEURAL TRANSM, V110, P317, DOI 10.1007/s00702-002-0776-6; Shang Chao, 2016, Med Sci Monit, V22, P710; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Sun K, 2013, WORLD J GASTROENTERO, V19, P2197, DOI 10.3748/wjg.v19.i14.2197; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Wang L, 2012, TRANSL ONCOL, V5, P1, DOI DOI 10.1016/J.FEBSLET.2012.03.035; West AB, 2005, TRENDS NEUROSCI, V28, P348, DOI 10.1016/j.tins.2005.05.002; Williams MR, 2015, J NEUROSCI, V35, P943, DOI 10.1523/JNEUROSCI.3144-14.2015; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	54	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177661	10.1371/journal.pone.0177661	http://dx.doi.org/10.1371/journal.pone.0177661			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493990	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300149
J	Lohner, V; Brookes, RL; Hollocks, MJ; Morris, RG; Markus, HS				Lohner, Valerie; Brookes, Rebecca L.; Hollocks, Matthew J.; Morris, Robin G.; Markus, Hugh S.			Apathy, but not depression, is associated with executive dysfunction in cerebral small vessel disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; VASCULAR DEPRESSION; BRIEF MEMORY; DEMENTIA; CLASSIFICATION; VALIDATION; MECHANISMS	Objective To determine the prevalence of apathy and depression in cerebral small vessel disease (SVD), and the relationships between both apathy and depression with cognition. To examine whether apathy is specifically related to impairment in executive functioning and processing speed. Methods 196 patients with a clinical lacunar stroke and an anatomically corresponding lacunar infarct on MRI were compared to 300 stroke-free controls. Apathy and depression were measured using the Geriatric Depression Scale, and cognitive functioning was assessed using an SVD cognitive screening tool, the Brief Memory and Executive Test, which measures executive functioning/processing speed and memory/orientation. Path analysis and binary logistic regression were used to assess the relation between apathy, depression and cognitive impairment. Results 31 participants with SVD (15.8%) met criteria for apathy only, 23 (11.8%) for both apathy and depression, and 2 (1.0%) for depression only. In the SVD group the presence of apathy was related to global cognition, and specifically to impaired executive functioning/processing speed, but not memory/orientation. The presence of depression was not related to global cognition, impaired executive functioning/processing speed or memory/orientation. Conclusions Apathy is a common feature of SVD and is associated with impaired executive functioning/processing speed suggesting the two may share biological mechanisms. Screening for apathy should be considered in SVD, and further work is required to develop and evaluate effective apathy treatment or management in SVD.	[Lohner, Valerie; Brookes, Rebecca L.; Hollocks, Matthew J.; Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England; [Morris, Robin G.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England	University of Cambridge; University of London; King's College London	Lohner, V (corresponding author), Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England.	valerie.lohner@gmail.com		Lohner, Valerie/0000-0001-5589-9701; Hollocks, Matthew/0000-0002-9513-6917	Priority Program Grant from the Stroke Association [TSA PPA 2015-02]; Stroke Association [TSA2008/10]; Stroke Association/British Heart Foundation Program [TSA BHF 2010/01]; BHF Project [PG/13/30/30005]; English National Institute of Health Research (NIHR) Clinical Stroke Research Network; NIHR Senior Investigator award; Cambridge University Hospital Comprehensive NIHR Biomedical Research Unit; British Heart Foundation [PG/13/30/30005] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10019] Funding Source: researchfish; Stroke Association [TSA2010/08] Funding Source: researchfish	Priority Program Grant from the Stroke Association; Stroke Association; Stroke Association/British Heart Foundation Program; BHF Project; English National Institute of Health Research (NIHR) Clinical Stroke Research Network; NIHR Senior Investigator award; Cambridge University Hospital Comprehensive NIHR Biomedical Research Unit; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association	This work was supported by a Priority Program Grant from the Stroke Association (TSA PPA 2015-02; www.stroke.org.uk). The BMET Study was supported by a grant from the Stroke Association (TSA2008/10). Valerie Lohner is supported by a Stroke Association/British Heart Foundation Program Grant (TSA BHF 2010/01; www.bhf.org.uk). Rebecca Brookes is supported by a BHF Project Grant (PG/13/30/30005). Recruitment to the BMET Study was supported by the English National Institute of Health Research (NIHR) Clinical Stroke Research Network (www. crn.nihr.ac.uk/stroke).Hugh Markus is supported by an NIHR Senior Investigator award (www.nihr.ac.uk) and his work is supported by the Cambridge University Hospital Comprehensive NIHR Biomedical Research Unit (www.cambridge-brc.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aizenstein HJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0720-5; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bonnelle V, 2015, J PHYSIOL-PARIS, V109, P16, DOI 10.1016/j.jphysparis.2014.04.002; Brookes RL, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0290-y; Brookes RL, 2014, NEUROPSYCHOLOGY, V28, P247, DOI 10.1037/neu0000015; Brookes RL, 2013, INT J STROKE, V8, P510, DOI 10.1111/j.1747-4949.2011.00763.x; Brookes RL, 2013, J NEUROPSYCHOL, V7, P19, DOI 10.1111/j.1748-6653.2012.02032.x; Brookes RL, 2012, AGE AGEING, V41, P212, DOI 10.1093/ageing/afr172; Charlton RA, 2006, NEUROLOGY, V66, P1523, DOI 10.1212/01.wnl.0000216270.02610.7e; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Herbert V, 2014, J INT NEUROPSYCH SOC, V20, P413, DOI 10.1017/S1355617714000101; Hollocks MJ, 2015, BRAIN, V138, P3803, DOI 10.1093/brain/awv304; Jacova C, 2012, ANN NEUROL, V72, P351, DOI 10.1002/ana.23733; Kline R.B., 2011, PRINCIPLES PRACTICE; Kuzis G, 1999, NEUROLOGY, V52, P1403, DOI 10.1212/WNL.52.7.1403; Lawrence AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135523; Lawrence AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061014; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Makin SDJ, 2013, J NEUROL NEUROSUR PS, V84, P893, DOI 10.1136/jnnp-2012-303645; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mitchell AJ, 2010, J AFFECT DISORDERS, V125, P10, DOI 10.1016/j.jad.2009.08.019; Moretti R, 2015, AM J ALZHEIMERS DIS, V30, P390, DOI 10.1177/1533317514550329; Nelson HE., 1991, REVISED NATL ADULT R; Pagonabarraga J, 2015, LANCET NEUROL, V14, P518, DOI 10.1016/S1474-4422(15)00019-8; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pohjasvaara T, 1998, STROKE, V29, P2311, DOI 10.1161/01.STR.29.11.2311; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Schinka JA, 2010, AM J GERIAT PSYCHIAT, V18, P684, DOI 10.1097/JGP.0b013e3181e56d5a; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Taylor WD, 2013, MOL PSYCHIATR, V18, P963, DOI 10.1038/mp.2013.20; Thobois S, 2010, BRAIN, V133, P1111, DOI 10.1093/brain/awq032; Tuladhar AM, 2015, NEUROIMAGE-CLIN, V7, P518, DOI 10.1016/j.nicl.2015.02.003; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	42	30	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176943	10.1371/journal.pone.0176943	http://dx.doi.org/10.1371/journal.pone.0176943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493898	Green Published, gold			2022-12-27	WOS:000401314300042
J	Tomobe, K; Yamamoto, E; Kholmurodov, K; Yasuoka, K				Tomobe, Katsufumi; Yamamoto, Eiji; Kholmurodov, Kholmirzo; Yasuoka, Kenji			Water permeation through the internal water pathway in activated GPCR rhodopsin	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; FORCE-FIELD; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; OPSIN; CHANNEL; CONFORMATION; RELEASE; LIGAND; SIMULATIONS	Rhodopsin is a light-driven G-protein-coupled receptor that mediates signal transduction in eyes. Internal water molecules mediate activation of the receptor in a rhodopsin cascade reaction and contribute to conformational stability of the receptor. However, it remains unclear how internal water molecules exchange between the bulk and protein inside, in particular through a putative solvent pore on the cytoplasmic. Using all-atom molecular dynamics simulations, we identified the solvent pore on cytoplasmic side in both the Meta II state and the Opsin. On the other hand, the solvent pore does not exist in the dark-adapted rhodopsin. We revealed two characteristic narrow regions located within the solvent pore in the Meta II state. The narrow regions distinguish bulk and the internal hydration sites, one of which is adjacent to the conserved structural motif "NPxxY". Water molecules in the solvent pore diffuse by pushing or sometimes jumping a preceding water molecule due to the geometry of the solvent pore. These findings revealed a total water flux between the bulk and the protein inside in the Meta II state, and suggested that these pathways provide water molecules to the crucial sites of the activated rhodopsin.	[Tomobe, Katsufumi; Yasuoka, Kenji] Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Yamamoto, Eiji] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Kholmurodov, Kholmirzo] Joint Inst Nucl Res, Frank Lab Neutron Phys, Dubna 141980, Russia; [Kholmurodov, Kholmirzo] Dubna State Univ, Dubna 141980, Russia	Keio University; Keio University; Joint Institute for Nuclear Research - Russia; Dubna State University	Yasuoka, K (corresponding author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	yasuoka@mech.keio.ac.jp	Yamamoto, Eiji/E-4926-2013	Yamamoto, Eiji/0000-0002-8813-5297; Kholmurodov, Kholmirzo/0000-0002-9415-8276	MEXT (Ministry of Education, Culture, Sports, Science and Technology); JSPS	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported in part by MEXT (Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for the Program for Leading Graduate Schools, Keio University Doctorate Student Grant-in-Aid Program, and a Bilateral Program JSPS. E.Y. was supported by MEXT Grant-in-Aid for the "Building of Consortia for the Development of Human Resources in Science and Technology".	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Bemporad D, 2004, J PHYS CHEM B, V108, P4875, DOI 10.1021/jp035260s; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BLAZYNSKI C, 1984, VISION RES, V24, P459, DOI 10.1016/0042-6989(84)90043-9; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dong H, 2013, P NATL ACAD SCI USA, V110, P17332, DOI 10.1073/pnas.1316969110; Espinoza-Fonseca LM, 2015, J AM CHEM SOC, V137, P7055, DOI 10.1021/jacs.5b03814; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Frutos LM, 2007, P NATL ACAD SCI USA, V104, P7764, DOI 10.1073/pnas.0701732104; Furutani Y, 2003, BIOCHEMISTRY-US, V42, P9619, DOI 10.1021/bi034592k; Gravelle S, 2013, P NATL ACAD SCI USA, V110, P16367, DOI 10.1073/pnas.1306447110; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Lim H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005135; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Mitchell DC, 2000, J BIOL CHEM, V275, P5355, DOI 10.1074/jbc.275.8.5355; Nakamichi H., 2006, ANGEW CHEM, V118, P4376, DOI DOI 10.1002/ANGE.200600595; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Ogata K, 2013, J AM CHEM SOC, V135, P15670, DOI 10.1021/ja404317d; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piechnick R, 2012, P NATL ACAD SCI USA, V109, P5247, DOI 10.1073/pnas.1117268109; Piechnick R, 2011, BIOCHEMISTRY-US, V50, P7168, DOI 10.1021/bi200675y; Rohrig UF, 2004, J AM CHEM SOC, V126, P15328, DOI 10.1021/ja048265r; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sun XQ, 2014, J PHYS CHEM B, V118, P10863, DOI 10.1021/jp505180t; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang T, 2011, J MOL RECOGNIT, V24, P350, DOI 10.1002/jmr.1087; Yamamoto E, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022718; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176876	10.1371/journal.pone.0176876	http://dx.doi.org/10.1371/journal.pone.0176876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493967	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300035
J	Viehmann, A; Kersting, C; Thielmann, A; Weltermann, B				Viehmann, Anja; Kersting, Christine; Thielmann, Anika; Weltermann, Birgitta			Prevalence of chronic stress in general practitioners and practice assistants: Personal, practice and regional characteristics	PLOS ONE			English	Article							JOB-SATISFACTION; PRIMARY-CARE; TRIER INVENTORY; PHYSICIANS; GERMANY; BURNOUT; STAFF; RISK; TICS	Background The majority of studies investigating stress in primary care have focused either on general practitioners (GPs) or practice assistants (PAs), but did not measure stress on a practice level. We analyzed the prevalence of chronic stress for both professional groups and on a practice level and investigated personal, practice, and regional characteristics. Methods Chronic stress was measured in GPs and PAs from 136 German practices using the standardized, self-administered TICS-SSCS questionnaire (12 items). Based on a sum-score, participants per professional group were categorized as having low or high strain due to chronic stress (<= 25th and >= 75th percentile of the study population's distribution, respectively). For a cluster-level analysis, the mean of all practice means was used to categorize low-and high-stress practices. The intra-class correlation coefficient (ICC) was calculated using ANOVA. Prevalence Ratios (PR) were used to compare low versus high strain due to stress, stratified for personal, practice and regional characteristics. Results The response rate was 74.1% (n = 137/185). Data from 214 GPs (34.1% female), 500 PAs (99.4% female), and 50 PAs in training (98.0% female) were analyzed. Chronic stress was highest in female GPs (median 19, IQR (interquartile range) 11.5), followed by PAs (16, IQR 12.25) and male GPs (15, IQR 10). On a practice level, 26.3% of the practice personnel reported a high stress level. We observed an overall ICC of 0.25, with higher ICCs when stratifying by professional group (PAs: ICC 0.36, GPs in group practices: ICC 0.51). High chronic stress was observed as the number of working hours per week increased (GPs: PR 2.03, 95% CI 1.16-3.56; PAs: PR 2.02, 95% CI 1.22-3.35). There were no differences for practice type (solo/group) and the various regional characteristics. Conclusion Personal and practice characteristics were associated with chronic stress in GPs, PAs, and on a practice level. The high ICCs indicate a need for stress-reduction strategies geared at both professions on a practice level.	[Viehmann, Anja; Kersting, Christine; Thielmann, Anika; Weltermann, Birgitta] Univ Duisburg Essen, Univ Hosp Essen, Inst Gen Med, Essen, Germany	University of Duisburg Essen	Weltermann, B (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Gen Med, Essen, Germany.	birgitta.weltermann@uk-essen.de		Kersting, Dr. Christine/0000-0001-9393-4766; Viehmann, Dr. Anja/0000-0003-1020-3680	Ministry of Innovation, Science and Research; North-Rhine Westphalia, Germany	Ministry of Innovation, Science and Research; North-Rhine Westphalia, Germany	Funding for this study was provided by the Ministry of Innovation, Science and Research, North-Rhine Westphalia, Germany.	[Anonymous], 2014, Z ALLG MED, DOI DOI 10.3238/ZFA.2014.0354-0359; Babbott S, 2014, J AM MED INFORM ASSN, V21, pE100, DOI 10.1136/amiajnl-2013-001875; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bauer J, 2013, DEUT MED WOCHENSCHR, V138, P2401, DOI 10.1055/s-0033-1359859; Behmann M, 2012, DTSCH ARZTEBL INT, V109, P193, DOI 10.3238/arztebl.2012.0193; Bernburg M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011369; Campbell MJ, 2007, STAT MED, V26, P2, DOI 10.1002/sim.2731; Ceccato S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02036; Frank E, 1999, AM J PSYCHIAT, V156, P1887; Gavartina A, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-110; Goetz K, 2013, FAM PRACT, V30, P411, DOI 10.1093/fampra/cmt015; Goetz K, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-137; Hapke U, 2013, BUNDESGESUNDHEITSBLA, V56, P749, DOI 10.1007/s00103-013-1690-9; Harris MF, 2007, MED J AUSTRALIA, V186, P570, DOI 10.5694/j.1326-5377.2007.tb01055.x; Killip S, 2004, ANN FAM MED, V2, P204, DOI 10.1370/afm.141; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Petrowski K, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-42; Philip Tucker, 2013, STRESS NR, P325; Schulz P, 1999, DIAGNOSTICA, V45, P8, DOI 10.1026//0012-1924.45.1.8; Schulz P., 2004, TRIERER INVENTAR CHR; Soler JK, 2008, FAM PRACT, V25, P245, DOI 10.1093/fampra/cmn038; Toyry S, 2004, STRESS HEALTH, V20, P213, DOI 10.1002/smi.1009; Visser MRM, 2003, CAN MED ASSOC J, V168, P271; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Williams ES, 2002, HEALTH SERV RES, V37, P121	25	28	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176658	10.1371/journal.pone.0176658	http://dx.doi.org/10.1371/journal.pone.0176658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489939	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100027
J	Guo, YT; Zhang, W; Chen, X; Fu, JH; Cheng, WB; Song, DS; Qu, XL; Yang, Z; Zhao, KX				Guo, Yatu; Zhang, Wei; Chen, Xia; Fu, Junhong; Cheng, Wenbo; Song, Desheng; Qu, Xiaolei; Yang, Zhuo; Zhao, Kanxing			Timing-dependent LTP and LTD in mouse primary visual cortex following different visual deprivation models	PLOS ONE			English	Article							LONG-TERM DEPRESSION; HOMEOSTATIC SYNAPTIC PLASTICITY; PRESYNAPTIC NMDA RECEPTORS; CORTICAL MAP PLASTICITY; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; IN-VIVO; SENSORY DEPRIVATION; SUBUNIT COMPOSITION; PYRAMIDAL NEURONS	Visual deprivation during the critical period induces long-lasting changes in cortical circuitry by adaptively modifying neuro-transmission and synaptic connectivity at synapses. Spike timing-dependent plasticity (STDP) is considered a strong candidate for experience-dependent changes. However, the visual deprivation forms that affect timing-dependent long-term potentiation(LTP) and long-term depression(LTD) remain unclear. Here, we demonstrated the temporal window changes of tLTP and tLTD, elicited by coincidental pre- and post-synaptic firing, following different modes of 6-day visual deprivation. Markedly broader temporal windows were found in robust tLTP and tLTD in the V1M of the deprived visual cortex in mice after 6-day MD and DE. The underlying mechanism for the changes seen with visual deprivation in juvenile mice using 6 days of dark exposure or monocular lid suture involves an increased fraction of NR2b-containing NMDAR and the consequent prolongation of NMDAR-mediated response duration. Moreover, a decrease in NR2A protein expression at the synapse is attributable to the reduction of the NR2A/2B ratio in the deprived cortex.	[Guo, Yatu; Zhang, Wei; Chen, Xia; Fu, Junhong; Cheng, Wenbo; Song, Desheng; Zhao, Kanxing] Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Fu, Junhong; Cheng, Wenbo; Song, Desheng] TEDA Int Hosp, Dept Ophthalmol, Tianjin, Peoples R China; [Qu, Xiaolei] Second Peoples Hosp Jinan, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Yang, Zhuo] Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, Minist Educ, Tianjin, Peoples R China; [Yang, Zhuo] Nankai Univ, Coll Med, Tianjin, Peoples R China	Tianjin Medical University; Nankai University; Nankai University	Guo, YT (corresponding author), Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China.	yatu.guo@gmail.com; zkx4260@163.com			National Natural Science Foundation of China [81300791]; Natural Science Foundation of Tianjin [14JCQNJC10500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by National Natural Science Foundation of China (No. 81300791) for Yatu Guo, https://isisn.nsfc.gov.cn/egrantweb/; Natural Science Foundation of Tianjin (No. 14JCQNJC10500) for Yatu Guo, http:/www.tstc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by grants from the National Natural Science Foundation of China (No. 81300791) and the Application foundation and advanced technology research project of Tianjin (No. 14JCQNJC10500).	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Beston Brett R, 2010, Front Synaptic Neurosci, V2, P138, DOI 10.3389/fnsyn.2010.00138; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blais BS, 2008, J NEUROPHYSIOL, V100, P2217, DOI 10.1152/jn.90411.2008; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; CARLSON M, 1986, DEV BRAIN RES, V25, P71, DOI 10.1016/0165-3806(86)90153-7; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; Cooke SF, 2010, J NEUROSCI, V30, P16304, DOI 10.1523/JNEUROSCI.4333-10.2010; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gabbott PL, 2012, NEUROSCIENCE, V207, P65, DOI 10.1016/j.neuroscience.2012.01.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guo YT, 2012, J NEUROSCI, V32, P15027, DOI 10.1523/JNEUROSCI.2545-12.2012; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Huang SY, 2015, J NEUROSCI, V35, P15916, DOI 10.1523/JNEUROSCI.1813-15.2015; Huang SY, 2013, J NEUROSCI, V33, P13171, DOI 10.1523/JNEUROSCI.5741-12.2013; Huang SY, 2012, NEURON, V73, P497, DOI 10.1016/j.neuron.2011.11.023; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kang E, 2013, J NEUROSCI, V33, P17789, DOI 10.1523/JNEUROSCI.1500-13.2013; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Larsen RS, 2014, NEURON, V83, P879, DOI 10.1016/j.neuron.2014.07.039; Larsen Rylan S, 2010, Front Synaptic Neurosci, V2, P9, DOI 10.3389/fnsyn.2010.00009; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LEVENTHAL AG, 1980, J NEUROPHYSIOL, V43, P1111, DOI 10.1152/jn.1980.43.4.1111; LEVENTHAL AG, 1977, P NATL ACAD SCI USA, V74, P1272, DOI 10.1073/pnas.74.3.1272; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Lunghi C, 2015, J PHYSIOL-LONDON, V593, P4361, DOI 10.1113/JP270950; Luz Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101109; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mainardi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004342; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Nahmani M, 2014, J NEUROSCI, V34, P2571, DOI 10.1523/JNEUROSCI.4600-13.2014; Nataraj K, 2011, J NEUROSCI, V31, P17932, DOI 10.1523/JNEUROSCI.4455-11.2011; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Storey GP, 2011, J NEUROSCI, V31, P6311, DOI 10.1523/JNEUROSCI.5553-10.2011; Tropea D, 2010, J NEUROSCI, V30, P11086, DOI 10.1523/JNEUROSCI.1661-10.2010; Whitt JL, 2014, NEUROPHARMACOLOGY, V78, P45, DOI 10.1016/j.neuropharm.2013.02.016; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Yoneda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053082; Zhou JW, 2015, RESTOR NEUROL NEUROS, V33, P381, DOI 10.3233/RNN-140472; Zilberter M, 2009, CEREB CORTEX, V19, P2308, DOI 10.1093/cercor/bhn247	72	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176603	10.1371/journal.pone.0176603	http://dx.doi.org/10.1371/journal.pone.0176603			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520739	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700024
J	Weng, LC; Huang, HL; Tsai, HH; Lee, WC				Weng, Li-Chueh; Huang, Hsiu-Li; Tsai, Hsiu-Hsin; Lee, Wei-Chen			Predictors of decision ambivalence and the differences between actual living liver donors and potential living liver donors	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIAL SUPPORT; TRANSPLANTATION; DONATION; STATEMENT; INTERVIEW; ATTITUDES; OUTCOMES; ETHICS	Background The decision to become a living liver donor is a stressful event. Ambivalence in decision making may result in psychological distress. Thus, the purpose of this study was to provide a description of the ambivalence of potential living liver donors, to examine the predictors of ambivalence, and to compare the ambivalence of potential living liver donors with that of actual living liver donors. Methods This descriptive and correlational study was conducted in a medical center from August 2013 to December 2015. Self-reported questionnaires were used to collect data. A total of 263 potential living liver donors who were assessed for donation to their parents were included in this study. Results The mean age of the total sample was 30.7 years (SD = 6.39, range = 20-47), and males comprised 53.6% of the sample. The majority of the potential donors had a college education (70.8%) and were single (63.5%). Of the total sample, the mean score for ambivalence was 4.27 (SD = 1.87, range = 0-7). Multivariate analysis revealed that the Mental Component Summary (MCS) of quality of life (beta = -0.24, p < 0.01), family support (beta = -0.17, p = 0.007), and intimacy (beta = -0.13, p = 0.04) were significant protective predictors of ambivalence. Actual living liver donors had significantly lower ambivalence (3.82 versus 4.60), higher intimacy with recipients (3.55 versus 3.34), higher MCS (45.26 versus 42.80), and higher family support (34.39 versus 29.79) than did the remaining potential living liver donors. Conclusion Ambivalence is common in potential living liver donors. The MCS of quality of life, family support, and intimacy were protective predictors in terms of ambivalence. Future research should explore other factors and design interventions targeted toward reducing ambivalence, promoting family support, and enhancing the mental dimensions of quality of life in potential living liver donors.	[Weng, Li-Chueh; Tsai, Hsiu-Hsin] Chang Gung Univ, Sch Nursing, Coll Med, Taoyuan, Taiwan; [Weng, Li-Chueh; Lee, Wei-Chen] Chang Gung Med Fdn Linkuo, Dept Gen Surg, Taoyuan, Taiwan; [Huang, Hsiu-Li] Natl Taipei Univ Nursing & Hlth Sci, Dept Long Term Care, Taipei, Taiwan; [Tsai, Hsiu-Hsin] Chang Gung Med Fdn Linkuo, Dept Psychiat, Taoyuan, Taiwan	Chang Gung University; National Taipei University of Nursing & Health Science (NTUNHS)	Weng, LC (corresponding author), Chang Gung Univ, Sch Nursing, Coll Med, Taoyuan, Taiwan.; Weng, LC (corresponding author), Chang Gung Med Fdn Linkuo, Dept Gen Surg, Taoyuan, Taiwan.	ax2488@mail.cgu.edu.tw		Weng, Li-Chueh/0000-0002-6926-988X; Tsai, Hsiu-Hsin/0000-0001-9678-8215	Ministry of Science and Technology of Taiwan	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study received a fund from the Ministry of Science and Technology of Taiwan. The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abdeldayem H, 2014, FRONT SURG, P1; Abecassis M, 2000, JAMA-J AM MED ASSOC, V284, P2919; Dai L., 2015, OPEN J SOC SCI, V3, P134, DOI [10.4236/jss.2015.312014, DOI 10.4236/JSS.2015.312014]; de Villa VH, 2003, TRANSPLANTATION, V75, pS2, DOI 10.1097/01.TP.0000046532.44975.57; Dew MA, 2012, PROG TRANSPLANT, V22, P280, DOI 10.7182/pit2012890; DiMartini A, 2012, AM J TRANSPLANT, V12, P136, DOI 10.1111/j.1600-6143.2011.03805.x; Dubay DA, 2009, AM J TRANSPLANT, V9, P1169, DOI 10.1111/j.1600-6143.2009.02614.x; Erim Y, 2008, CLIN TRANSPLANT, V22, P273, DOI 10.1111/j.1399-0012.2007.00782.x; Erim Y, 2012, LIVER TRANSPLANT, V18, P901, DOI 10.1002/lt.23466; Fredericks EM, 2012, PEDIATR TRANSPLANT, V16, P688, DOI 10.1111/j.1399-3046.2012.01775.x; Fujita M, 2006, LIVER TRANSPLANT, V12, P768, DOI 10.1002/lt.20689; Gordon EJ, 2011, TRANSPLANTATION, V92, P1285, DOI 10.1097/TP.0b013e31823817d5; Hair J. F., 1998, MULTIVAR DATA ANAL, P141; Hayashi A, 2007, TRANSPLANTATION, V84, P1255, DOI 10.1097/01.tp.0000287455.70815.9e; Jowsey Sheila G, 2008, Transplant Rev (Orlando), V22, P192, DOI 10.1016/j.trre.2008.04.008; Kusakabe T, 2008, GASTROENTEROL NURS, V31, P263, DOI 10.1097/01.SGA.0000334032.48629.c0; Lai YC, 2014, LIVER TRANSPLANT, V20, P1365, DOI 10.1002/lt.23952; Lee SG, 2015, AM J TRANSPLANT, V15, P17, DOI 10.1111/ajt.12907; Lee SH, 2005, TRANSPL P, V37, P1081, DOI 10.1016/j.transproceed.2005.01.032; Lee SG, 2010, BRIT MED BULL, V94, P33, DOI 10.1093/bmb/ldq003; Liao SC, 2005, J MED EDUC, V9, P80; Moos RH, 2009, FAMILY ENV SCALE MAN, P1; Muto K, 2010, INT J JPN SOCIOL, V19, P35, DOI 10.1111/j.1475-6781.2010.01135.x; Nohlen HU, 2014, SOC COGN AFFECT NEUR, V9, P924, DOI 10.1093/scan/nst074; Olbrisch M E, 2001, Prog Transplant, V11, P40; Papachristou C, 2004, TRANSPLANTATION, V78, P1506, DOI 10.1097/01.TP.0000142620.08431.26; Papaehristou C, 2009, CLIN TRANSPLANT, V23, P382, DOI 10.1111/j.1399-0012.2008.00948.x; Pruett TL, 2006, TRANSPLANTATION, V81, P1386, DOI 10.1097/01.tp.0000214976.36526.e3; Schulz KH, 2009, LIVER TRANSPLANT, V15, P1676, DOI 10.1002/lt.21917; Shrestha R, 2003, LIVER TRANSPLANT, V9, pS8, DOI 10.1053/jlts.2003.50225; Simmons RG, 1987, GIFT LIFE EFFECT ORG, P478; Simpson MA, 2011, LIVER TRANSPLANT, V17, P1226, DOI 10.1002/lt.22342; Steele CI, 1998, SOC WORK HLTH CARE, V13, P47; Tanaka K, 2004, HPB (Oxford), V6, P88, DOI 10.1080/13651820310020765; Tome S, 2008, J HEPATOL, V48, P567, DOI 10.1016/j.jhep.2007.12.013; Uehara M, 2011, TRANSPLANTATION, V92, P936, DOI 10.1097/TP.0b013e31822e0bb5; Walter M, 2004, J MED ETHICS, V30, P544, DOI 10.1136/jme.2003.004879; Walter M, 2006, CLIN TRANSPLANT, V20, P410, DOI 10.1111/j.1399-0012.2006.00464.x; Wang D, 2014, OPEN J SOCIAL SCI, V2, P132; Wang TH, 2016, TRANSPLANTATION, V100, P2235, DOI 10.1097/TP.0000000000001458; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wei J, 1998, J NURS RES, V6, P4, DOI DOI 10.7081/NR.199802.0004; Weng LC, 2012, NURS RES, V61, P141, DOI 10.1097/NNR.0b013e3182475688	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175672	10.1371/journal.pone.0175672	http://dx.doi.org/10.1371/journal.pone.0175672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520727	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700005
J	Karathedath, S; Rajamani, BM; Aalam, SMM; Abraham, A; Varatharajan, S; Krishnamurthy, P; Mathews, V; Velayudhan, SR; Balasubramanian, P				Karathedath, Sreeja; Rajamani, Bharathi M.; Aalam, Syed Mohammed Musheer; Abraham, Ajay; Varatharajan, Savitha; Krishnamurthy, Partha; Mathews, Vikram; Velayudhan, Shaji Ramachandran; Balasubramanian, Poonkuzhali			Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2	PLOS ONE			English	Article							OXIDATIVE STRESS; CANCER-CELLS; LUNG-CANCER; STEM-CELLS; ACTIVATION; EXPRESSION; PATHWAY; KEAP1; PROLIFERATION; APOPTOSIS	Cytarabine (Ara-C) and Daunorubicin (Dnr) forms the backbone of acute myeloid leukemia (AML) therapy. Drug resistance and toxic side effects pose a major threat to treatment success and hence alternate less toxic therapies are warranted. NF-E2 related factor-2 (Nrf2), a master regulator of antioxidant response is implicated in chemoresistance in solid tumors. However, little is known about the role of Nrf2 in AML chemoresistance and the effect of pharmacological inhibitor brusatol in modulating this resistance. Primary AML samples with high ex-vivo IC50 to Ara-C, ATO, Dnr had significantly high NRF2 RNA expression. Gene-specific knockdown of NRF2 improved sensitivity to these drugs in resistant AML cell lines by decreasing the expression of downstream antioxidant targets of Nrf2 by compromising the cell's ability to scavenge the ROS. Treatment with brusatol, a pharmacological inhibitor of Nrf2, improved sensitivity to Ara-C, ATO, and Dnr and reduced colony formation capacity. AML cell lines stably overexpressing NRF2 showed increased resistance to ATO, Dnr and Ara-C and increased expression of downstream targets. This study demonstrates that Nrf2 could be an ideal druggable target in AML, more so to the drugs that function through ROS, suggesting the possibility of using Nrf2 inhibitors in combination with chemotherapeutic agents to modulate drug resistance in AML.	[Karathedath, Sreeja; Rajamani, Bharathi M.; Abraham, Ajay; Varatharajan, Savitha; Mathews, Vikram; Velayudhan, Shaji Ramachandran; Balasubramanian, Poonkuzhali] Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India; [Aalam, Syed Mohammed Musheer; Velayudhan, Shaji Ramachandran] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India; [Krishnamurthy, Partha] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; University of Kansas; University of Kansas Medical Center	Balasubramanian, P (corresponding author), Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India.	bpoonkuzhali@cmcvellore.ac.in	Abraham, Ajay/AAK-8454-2020; Aalam, Syed Mohammed Musheer/AAR-2902-2021	Abraham, Ajay/0000-0003-4094-2476; Aalam, Syed Mohammed Musheer/0000-0002-8566-197X; Balasubramanian, Poonkuzhali/0000-0002-9443-439X; R Velayudhan, Shaji/0000-0002-8600-2933; Mathews, Vikram/0000-0001-9417-2353	Centre of Excellence grant from Department of Biotechnology India [BT/COE/34/SP13432/2015, BT/PR8742/AGR/36/773/2013]; University Grants Commission, Government of India; Indian Council of Medical Research; Wellcome DBT India Alliance, New Delhi, India [IN 5/11/2500267, IA/S/15/1/501842]	Centre of Excellence grant from Department of Biotechnology India; University Grants Commission, Government of India(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Wellcome DBT India Alliance, New Delhi, India(Wellcome Trust DBT India Alliance)	This study is supported by Centre of Excellence grant from Department of Biotechnology India: BT/COE/34/SP13432/2015 to Dr. Poonkuzhali Balasubramanian and BT/PR8742/AGR/36/773/2013 to Dr. Shaji R.V. SK and AA are supported by University Grants Commission, Government of India. SV is a recipient of a senior research fellowship from Indian Council of Medical Research. VM and PB are supported by Senior Fellowship from Wellcome DBT India Alliance (IN 5/11/2500267 and IA/S/15/1/501842), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Bhullar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071266; Biswas C, 2014, J BIOL CHEM, V289, P26882, DOI 10.1074/jbc.M114.567685; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Furukawa Y, 1998, Hum Cell, V11, P81; Gao AM, 2013, CARCINOGENESIS, V34, P1806, DOI 10.1093/carcin/bgt108; Hanada N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-66; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Hu XF, 2013, ASIAN PAC J CANCER P, V14, P5231, DOI 10.7314/APJCP.2013.14.9.5231; Kang KA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.149; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li MH, 2006, FREE RADICAL BIO MED, V41, P1079, DOI 10.1016/j.freeradbiomed.2006.06.010; Lien EC, 2016, NAT CELL BIOL, V18, P572, DOI 10.1038/ncb3341; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Liu QA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-37; Liu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.467; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; No Jae Hong, 2014, J Cancer Prev, V19, P111, DOI 10.15430/JCP.2014.19.2.111; Ofran Y, 2016, BLOOD, V128, P488, DOI 10.1182/blood-2016-01-635060; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Olayanju A, 2015, FREE RADICAL BIO MED, V78, P202, DOI 10.1016/j.freeradbiomed.2014.11.003; Peng HG, 2011, PROCED EARTH PLAN SC, V2, P7, DOI 10.1016/j.proeps.2011.09.002; Pulte D, 2010, ANN ONCOL, V21, P335, DOI 10.1093/annonc/mdp309; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Rushworth Stuart A, 2011, Cancers (Basel), V3, P1605, DOI 10.3390/cancers3021605; Takahashi T, 2010, J SURG ONCOL, V101, P500, DOI 10.1002/jso.21520; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Townsend DM, 2005, METHOD ENZYMOL, V401, P287, DOI 10.1016/S0076-6879(05)01019-0; Uras IZ, 2016, BLOOD; Walter RB, 2011, J CLIN ONCOL, V29, P4417, DOI 10.1200/JCO.2011.35.7525; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Yoon DS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.3	36	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177227	10.1371/journal.pone.0177227	http://dx.doi.org/10.1371/journal.pone.0177227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505160	Green Submitted, gold, Green Published			2022-12-27	WOS:000401473500015
J	Heo, JY; Seo, YB; Choi, WS; Lee, J; Noh, JY; Jeong, HW; Kim, WJ; Kim, MJ; Lee, HY; Song, JY				Heo, Jung Yeon; Seo, Yu Bin; Choi, Won Suk; Lee, Jacob; Noh, Ji Yun; Jeong, Hye Won; Kim, Woo Joo; Kim, Min Ja; Lee, Hee Young; Song, Joon Young			Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea	PLOS ONE			English	Article							AT-RISK ADULTS; CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; ECONOMIC BURDEN; PUBLIC-HEALTH; DISEASE; PNEUMONIA; INFLUENZA; OLDER; POPULATION	Background Although the 13-valent pneumococcal conjugate vaccine (PCV13) showed good efficacy against pneumococcal disease in the the CAPiTA trial, the 23-valent pneumococcal polysaccharide vaccination (PPSV23) program has been ongoing for older adults aged >= 65 years in Korea since May of 2013. This study aimed to evaluate the cost-effectiveness of the current vaccination strategy (a single-dose PPSV23 vaccination) compared to a single-dose PCV13 vaccination and sequential PCV13-PPSV23 vaccinations in the elderly population aged >= 65 years. Methods Using a Markov model, the incremental cost-effectiveness ratios (ICERs) of three vaccination strategies were assessed in a societal context. The transition probabilities, utility weights to estimate quality adjusted life year (QALY), and disease treatment costs were either calculated or cited from published data and the Health Insurance Review and Assessment Service. Simulations were performed in hypothetical cohorts of Korean adults aged >= 19 years. The vaccine effectiveness of PPSV23 was cited from a Cochrane Review report, while PCV13 effectiveness data were gathered from the CAPiTA trial. Results Current PPSV23 vaccination strategies were cost-effective (ICER, $ 25,786 per QALY). However, the administration of PCV13 as a substitute for PPSV23 was shown to be more cost-effective than PPSV23 vaccination (ICER, $ 797 per QALY). Sequential PCV13PPSV23 vaccination was also more cost-effective than PPSV23 for elderly people aged >= 65 years. In sensitivity analysis assuming significant PPSV23 effectiveness (50%) against non-bacteremic pneumococcal pneumonia, the PCV13 vaccination strategy was superior to the PPSV23 vaccination strategy in terms of cost-effectiveness. Conclusion The results suggest that PCV13 vaccination is more cost-effective in elderly subjects aged >= 65 years compared to the current PPSV23 vaccination strategy. When complete data is obtained in 2018 on the maximal herd effects of childhood PCV13 immunization, the incidence of pneumococcal pneumonia and the cost-effectiveness of vaccination strategies need to be reassessed.	[Heo, Jung Yeon; Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; [Heo, Jung Yeon; Jeong, Hye Won] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; [Seo, Yu Bin; Lee, Jacob] Hallym Univ, Coll Med, Dept Internal Med, Div Infect Dis, Chunchon, South Korea; [Choi, Won Suk; Noh, Ji Yun; Kim, Woo Joo; Kim, Min Ja; Song, Joon Young] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Lee, Hee Young] Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University Hospital; Hallym University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Song, JY (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Lee, HY (corresponding author), Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea.	wanderingstone@gmail.com; infection@korea.ac.kr	lee, hy/GRS-0797-2022; Choi, Won Suk/V-2730-2017	Choi, Won Suk/0000-0001-5874-4764; Song, Joon Young/0000-0002-0148-7194; KIM, MIN JA/0000-0002-2125-7521; Heo, Jung Yeon/0000-0002-6548-1939	Korea Centers for Disease Control and Prevention [2015-E32009-00]	Korea Centers for Disease Control and Prevention	This research was supported by funding (No. 2015-E32009-00) from the Korea Centers for Disease Control and Prevention.	[Anonymous], 2005, MMWR-MORBID MORTAL W, V54, P893; Boccalini S, 2013, HUM VACC IMMUNOTHER, V9, P699, DOI 10.4161/hv.23268; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Castiglia P, 2014, ADV THER, V31, P1011, DOI 10.1007/s12325-014-0157-1; Choi MJ, 2016, IDWEEK 2016; Christenson B, 2001, LANCET, V357, P1008, DOI 10.1016/S0140-6736(00)04237-9; Christenson B, 2004, EUR RESPIR J, V23, P363, DOI 10.1183/09031936.04.00063504; Department of Health and Human Services Centers for Disease Control and Prevention, 2012, 20091202 ACIP CDCP D; Diao WQ, 2016, VACCINE, V34, P1496, DOI 10.1016/j.vaccine.2016.02.023; Elston JWT, 2012, EPIDEMIOL INFECT, V140, P1252, DOI 10.1017/S0950268811001907; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Guevara M, 2009, CLIN MICROBIOL INFEC, V15, P1013, DOI 10.1111/j.1469-0691.2009.02904.x; Health Insurance Review and Assessment Service (HIRA), 2006, GUID EC EV PHARM KOR; Heo JY, 2016, 10 INT S PNEUM PNEUM; Hoshi SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139140; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Hutton J, 2002, ISPOR 5 ANN EUR C, P47; Jackson LA, 2013, VACCINE, V31, P3577, DOI 10.1016/j.vaccine.2013.04.085; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Jiang Y, 2014, EXPERT REV PHARM OUT, V14, P913, DOI 10.1586/14737167.2014.950232; Jiang YL, 2014, EXPERT REV PHARM OUT, V14, P901, DOI 10.1586/14737167.2014.953932; Jiang YL, 2012, EXPERT REV PHARM OUT, V12, P645, DOI [10.1586/erp.12.54, 10.1586/ERP.12.54]; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Kim MJ, 2015, PNEUMOCOCCAL DIS SER; Klugman KP, 2014, LANCET GLOB HEALTH, V2, pE365, DOI 10.1016/S2214-109X(14)70241-4; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Korean Centers for Disease Control and Prevention(KCDC), 2016, GUID NAT PNEUM IMM P, P83; Kraicer-Melamed H, 2016, VACCINE, V34, P1540, DOI 10.1016/j.vaccine.2016.02.024; Kuhlmann A, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-4; Lee SG., 2013, 2013E320010 KOR CTR; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; Moberley SA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub2; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; National Evidence- based Healthcare Collaborating Agency (NECA), 2015, HDB CLIN PRACT GUID; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Song JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-202; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; The Statistics Korea, 2016, KEY NAT IND KOR; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Vila-Corcoles A, 2006, CLIN INFECT DIS, V43, P860, DOI 10.1086/507340; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208; Weycker D, 2012, VACCINE, V30, P5437, DOI 10.1016/j.vaccine.2012.05.076; Yoo KH, 2013, J KOREAN MED SCI, V28, P888, DOI 10.3346/jkms.2013.28.6.888	50	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177342	10.1371/journal.pone.0177342	http://dx.doi.org/10.1371/journal.pone.0177342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498857	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500016
J	Kische, H; Gross, S; Wallaschofski, H; Grabe, HJ; Volzke, H; Nauck, M; Haring, R				Kische, Hanna; Gross, Stefan; Wallaschofski, Henri; Grabe, Hans Joergen; Voelzke, Henry; Nauck, Matthias; Haring, Robin			Associations of androgens with depressive symptoms and cognitive status in the general population	PLOS ONE			English	Article							FREE TESTOSTERONE LEVELS; OLDER MEN; SERUM TESTOSTERONE; DEHYDROEPIANDROSTERONE-SULFATE; REPRODUCTIVE HORMONES; RECEPTOR POLYMORPHISM; REFERENCE RANGES; WOMEN; MOOD; HEALTH	Objectives Associations between androgens and depressive symptoms were mostly reported from cross-sectional and patient-based studies. Study design/main outcome measures Longitudinal data from 4,110 participants of the Study of Health in Pomerania were used to assess sex-specific associations of baseline total and free testosterone, androstenedione and sex hormone-binding globulin with incident depressive symptoms and cognitive status at 5-and 10-year follow-up. Results Despite sex-specific differences in depressive symptoms prevalence at baseline (women: 17.4%, men: 8.1%), cross-sectional analyses showed no associations between sex hormones and depressive symptoms. In age-adjusted longitudinal analyses, total testosterone was associated with incident depressive symptoms (relative risk at 5-year follow-up: 0.73, 95% confidence interval: 0.58-0.92). Similarly, age-adjusted analyses showed a positive association between sex hormone-binding globulin and cognitive status in men (beta-coefficient per standard deviation: 0.44, 95% confidence interval: 0.13-0.74). In women, age-adjusted associations of androstenedione with baseline depressive symptoms (relative risk: 0.88, 95% confidence interval: 0.77-0.99) were found. None of the observed associations remained after multivariable adjustment. Conclusions The present population-based, longitudinal study revealed inverse associations between sex hormones and depressive symptoms. However, the null finding after multivariable adjustment suggests, that the observed associations were not independent of relevant confounders including body mass index, smoking and physical inactivity. Furthermore, the low number of incident endpoints in our non-clinical population-based sample limited the statistical power and reduced the chance to detect a statistically significant effect.	[Kische, Hanna; Wallaschofski, Henri; Nauck, Matthias; Haring, Robin] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Gross, Stefan; Voelzke, Henry; Nauck, Matthias] German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany; [Gross, Stefan] Univ Med Greifswald, Dept Cardiol, Greifswald, Germany; [Grabe, Hans Joergen] Univ Med Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Haring, Robin] European Univ Appl Sci, Fac Appl Publ Hlth, Rostock, Germany; [Haring, Robin] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Australia	Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Monash University	Kische, H (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.	kischeh@uni-greifswald.de	Wilkening, Robin/J-5535-2018	Wilkening, Robin/0000-0002-8332-5016	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	SHIP is part of the Community Medicine Research net of the University Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs, as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P283, DOI 10.1001/archgenpsychiatry.2007.33; Amiaz R, 2008, CURR OPIN ENDOCRINOL, V15, P278, DOI 10.1097/MED.0b013e3282fc27eb; Barrett-Connor E, 1999, J AM GERIATR SOC, V47, P685, DOI 10.1111/j.1532-5415.1999.tb01590.x; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P573, DOI 10.1210/jc.84.2.573; Barrett-Connor E, 1999, BIOAVAILABLE TESTOST, P573; Booth A, 1999, J HEALTH SOC BEHAV, V40, P130, DOI 10.2307/2676369; Bove RM, 2016, OBESITY, V24, P954, DOI 10.1002/oby.21415; Bromberger JT, 2010, ARCH GEN PSYCHIAT, V67, P598, DOI 10.1001/archgenpsychiatry.2010.55; Ebner Natalie C, 2014, Front Psychol, V5, P1595, DOI 10.3389/fpsyg.2014.01595; Ford AH, 2016, PSYCHONEUROENDOCRINO, V64, P57, DOI 10.1016/j.psyneuen.2015.11.012; Friedrich N, 2008, J ANDROL, V29, P610, DOI 10.2164/jandrol.108.005561; Grabe HJ, 2009, SOC PSYCH PSYCH EPID, V44, P835, DOI 10.1007/s00127-009-0005-9; Haring R, 2012, J CLIN ENDOCR METAB, V97, P408, DOI 10.1210/jc.2011-2134; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Heinemann L A, 2000, Aging Male, V3, P124, DOI 10.1080/13685530008500334; Hohlagschwandtner M, 2001, ACTA OBSTET GYN SCAN, V80, P326, DOI 10.1034/j.1600-0412.2001.080004326.x; Holland J, 2011, MATURITAS, V69, P322, DOI 10.1016/j.maturitas.2011.05.012; Hsu B, 2015, J CLIN ENDOCR METAB, V100, P2223, DOI 10.1210/jc.2015-1016; Huang G, 2016, LANCET DIABETES ENDO; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Joshi D, 2010, CLIN ENDOCRINOL, V72, P232, DOI 10.1111/j.1365-2265.2009.03641.x; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Margolese HC, 2000, J GERIATR PSYCH NEUR, V13, P93, DOI 10.1177/089198870001300208; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P525, DOI 10.1210/jc.2003-030680; Resnick SM, 2006, J CLIN ENDOCR METAB, V91, P1802, DOI 10.1210/jc.2005-2097; Rohr UD, 2002, MATURITAS, V41, pS25; Schule C, 2007, NERVENARZT, V78, P531, DOI 10.1007/s00115-007-2370-5; Schwarz S, 2007, MENOPAUSE, V14, P123, DOI 10.1097/01.gme.0000227860.58097.e9; Seidman SN, 2001, BIOL PSYCHIAT, V50, P371, DOI 10.1016/S0006-3223(01)01148-9; SHERWIN BB, 1988, PSYCHONEUROENDOCRINO, V13, P345, DOI 10.1016/0306-4530(88)90060-1; Shores MM, 2005, J CLIN PSYCHIAT, V66, P7, DOI 10.4088/JCP.v66n0102; T'Sjoen GG, 2005, J AM GERIATR SOC, V53, P636, DOI 10.1111/j.1532-5415.2005.53212.x; Takayanagi Y, 2015, AM J GERIAT PSYCHIAT, V23, P253, DOI 10.1016/j.jagp.2013.02.003; Thienpont LM, 2008, CLIN CHEM, V54, P1290, DOI 10.1373/clinchem.2008.105841; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Volzke H, 2010, INT J EPIDEMIOL; Wang C, 2004, LONG TERM TESTOSTERO, P2085; Zarrour FA, 2009, J PSYCHIATR PRACT, V15, P289, DOI 10.1097/01.pra.0000358315.88931.fc	38	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177272	10.1371/journal.pone.0177272	http://dx.doi.org/10.1371/journal.pone.0177272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498873	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500014
J	Fayon, M; Lacoste-Rodrigues, A; Barat, P; Helbling, JC; Nacka, F; Berger, P; Moisan, MP; Corcuff, JB				Fayon, Michael; Lacoste-Rodrigues, Aurelie; Barat, Pascal; Helbling, Jean-Christophe; Nacka, Fabienne; Berger, Patrick; Moisan, Marie-Pierre; Corcuff, Jean-Benoit			Nasal airway epithelial cell IL-6 and FKBP51 gene expression and steroid sensitivity in asthmatic children	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; SMOOTH-MUSCLE-CELLS; INFLAMMATION; BIOMARKERS; CYTOKINE; FUTURE	Background Many asthmatic patients exhibit uncontrolled asthma despite high-dose inhaled corticosteroids (ICS). Airway epithelial cells (AEC) have distinct activation profiles that can influence ICS response. Objectives A pilot study to identify gene expression markers of AEC dysfunction and markers of corticosteroid sensitivity in asthmatic and non-asthmatic control children, for comparison with published reports in adults. Methods AEC were obtained by nasal brushings and primary submerged cultures, and incubated in control conditions or in the presence of 10 ng/ml TNFalpha, 10(-8) M dexamethasone, or both. RT-PCR-based expression of FKBP51 (a steroid hormone receptor signalling regulator), NF-kB, IL-6, LIF (an IL-6 family neurotrophic cytokine), serpinB2 (which inhibits plasminogen activation and promotes fibrin deposition) and porin (a marker of mitochondrial mass) were determined. Results 6 patients without asthma (median age 11yr; min-max: 7-13), 8 with controlled asthma (11yr, 7-13; median daily fluticasone dose = 100 mu g), and 4 with uncontrolled asthma (12yr, 7-14; 1000 mu g fluticasone daily) were included. Baseline expression of LIF mRNA was significantly increased in uncontrolled vs controlled asthmatic children. TNFalpha significantly increased LIF expression in uncontrolled asthma. A similar trend was observed regarding IL-6. Dexamethasone significantly upregulated FKBP51 expression in all groups but the response was blunted in asthmatic children. No significant upregulation was identified regarding NF-kB, serpinB2 and porin. Conclusion LIF and FKBP51 expression in epithelial cells were the most interesting markers of AEC dysfunction/response to corticosteroid treatment.	[Fayon, Michael; Lacoste-Rodrigues, Aurelie; Berger, Patrick] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France; [Fayon, Michael; Lacoste-Rodrigues, Aurelie; Barat, Pascal; Nacka, Fabienne; Berger, Patrick] CHU Bordeaux, Ctr Invest Clin CIC 1401, Bordeaux, France; [Barat, Pascal; Helbling, Jean-Christophe; Moisan, Marie-Pierre; Corcuff, Jean-Benoit] Univ Bordeaux, Nutr & Integrat Neurobiol, Bordeaux, France; [Helbling, Jean-Christophe; Moisan, Marie-Pierre; Corcuff, Jean-Benoit] INRA, UMR1286, Nutr & Integrat Neurobiol, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Fayon, M (corresponding author), Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France.; Fayon, M (corresponding author), CHU Bordeaux, Ctr Invest Clin CIC 1401, Bordeaux, France.	michael.fayon@chu-bordeaux.fr	Moisan, Marie-Pierre/AAO-9971-2021; BARAT, Pascal/AAC-8948-2019; Berger, Patrick/D-8779-2012; Fayon, Michael/HDN-7887-2022; Corcuff, jb/GWM-4201-2022	Moisan, Marie-Pierre/0000-0001-7315-5319; BARAT, Pascal/0000-0001-5029-0200; Berger, Patrick/0000-0003-4702-0343; Fayon, Michael/0000-0002-1238-2128; Helbling, Jean-Christophe/0000-0001-7407-0114				Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Bucchieri F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120510; Bush Andrew, 2004, Paediatr Respir Rev, V5 Suppl A, pS93, DOI 10.1016/S1526-0542(04)90018-8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carayol N, 2002, AM J RESP CELL MOL, V26, P341, DOI 10.1165/ajrcmb.26.3.4684; Chaker AM, 2017, ORL J OTO-RHINO-LARY, V79, P72, DOI 10.1159/000455725; Chanez P, 2014, EUR RESPIR REV, V23, P405, DOI 10.1183/09059180.00009614; Desai D, 2010, RECENT PATENTS INFLA, V4, P193, DOI 10.2174/187221310793564218; Dietz K, 2016, J ALLERGY CLIN IMMUN; Fayon M, 2006, AM J PHYSIOL-LUNG C, V291, pL244, DOI 10.1152/ajplung.00474.2005; Fayon M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122446; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Giovannini-Chami L, 2012, EUR RESPIR J, V39, P1197, DOI 10.1183/09031936.00070511; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Hawkins GA, 2012, J ALLERGY CLIN IMMUN, V130, P510; Holgate ST, 2013, ALLERGY ASTHMA IMMUN, V5, P343, DOI 10.4168/aair.2013.5.6.343; Iosifidis T, 2016, RESPIROLOGY, V21, P438, DOI 10.1111/resp.12731; Kicic A, 2016, CLIN EXP ALLERGY; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Knight D, 2001, PULM PHARMACOL THER, V14, P169, DOI 10.1006/pupt.2001.0282; Konradova V, 1985, Pediatr Pulmonol, V1, P182, DOI 10.1002/ppul.1950010403; Le Souef PN, 2004, PEDIATR PULM, P34, DOI 10.1002/ppul.70040; Li MA, 2014, PATHOL RES PRACT, V210, P1038, DOI 10.1016/j.prp.2014.03.010; Lin Min-juan, 2005, Zhonghua Jiehe He Huxi Zazhi, V28, P820; Ling KM, 2016, RESPIROLOGY; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Martinez-Nunez RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111659; Matsumura Yasuhiro, 2010, Int J Biomed Sci, V6, P158; McDougall CM, 2015, RESP MED, V109, P689, DOI 10.1016/j.rmed.2015.04.001; McLellan K, 2015, PEDIAT PULMONOL; Muller GC, 2011, NEUROIMMUNOMODULAT, V18, P98, DOI 10.1159/000320343; Payne DNR, 1998, PEDIATR PULM, V25, P59, DOI 10.1002/(SICI)1099-0496(199801)25:1<59::AID-PPUL7>3.3.CO;2-9; Petrovic N, 2006, PROSTAG OTH LIPID M, V81, P126, DOI 10.1016/j.prostaglandins.2006.08.006; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Pringle EJ, 2012, PEDIATR PULM, V47, P1215, DOI 10.1002/ppul.22672; Ranganathan SC, 2001, PEDIATR PULM, V31, P114, DOI 10.1002/1099-0496(200102)31:2<114::AID-PPUL1018>3.0.CO;2-O; Sabbagh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107241; Sebag SC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88297; Singhania A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168680; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Trian T, 2015, AM J RESP CRIT CARE, V191, P538, DOI 10.1164/rccm.201409-1582OC; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Xiong WN, 2007, J HUAZHONG U SCI-MED, V27, P372, DOI 10.1007/s11596-007-0406-5; Yim RP, 2012, PAEDIATR RESPIR REV, V13, P172, DOI 10.1016/j.prrv.2011.05.002; Zissler UM, 2016, ALLERGY, V71, P475, DOI 10.1111/all.12828	47	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177051	10.1371/journal.pone.0177051	http://dx.doi.org/10.1371/journal.pone.0177051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493984	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300054
J	Rafacho, BPM; dos Santos, PP; Goncalves, AD; Fernandes, AAH; Okoshi, K; Chiuso-Minicucci, F; Azevedo, PS; Zornoff, LAM; Minicucci, MF; Wang, XD; de Paiva, SAR				Murino Rafacho, Bruna Paola; dos Santos, Priscila Portugal; Goncalves, Andrea de Freitas; Henrique Fernandes, Ana Angelica; Okoshi, Katashi; Chiuso-Minicucci, Fernanda; Azevedo, Paula S.; Mamede Zornoff, Leonardo Antonio; Minicucci, Marcos Ferreira; Wang, Xiang-Dong; Rupp de Paiva, Sergio Alberto			Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats	PLOS ONE			English	Article							OXIDATIVE STRESS; DIASTOLIC DYSFUNCTION; HEART-FAILURE; ANTIOXIDANT; ACID; SIZE; RECOMMENDATIONS; OFFICINALIS; ASSOCIATION; INHIBITION	Background Myocardial infarction (MI) is one of the leading causes of morbidity and mortality worldwide. Dietary intervention on adverse cardiac remodeling after MI has significant clinical relevance. Rosemary leaves are a natural product with antioxidant/anti-inflammatory properties, but its effect on morphology and ventricular function after MI is unknown. Methods and results To determine the effect of the dietary supplementation of rosemary leaves on cardiac remodeling after MI, male Wistar rats were divided into 6 groups after sham procedure or experimental induced MI: 1) Sham group fed standard chow (SR0, n = 23); 2) Sham group fed standard chow supplemented with 0.02% rosemary (R002) (SR002, n = 23); 3) Sham group fed standard chow supplemented with 0.2% rosemary (R02) (SR02, n = 22); 4) group submitted to MI and fed standard chow (IR0, n = 13); 5) group submitted to MI and fed standard chow supplemented with R002 (IR002, n = 8); and 6) group submitted to MI and fed standard chow supplemented with R02 (IR02, n = 9). After 3 months of the treatment, systolic pressure evaluation, echocardiography and euthanasia were performed. Left ventricular samples were evaluated for: fibrosis, cytokine levels, apoptosis, energy metabolism enzymes, and oxidative stress. Rosemary dietary supplementation attenuated cardiac remodeling by improving energy metabolism and decreasing oxidative stress. Rosemary supplementation of 0.02% improved diastolic function and reduced hypertrophy after MI. Regarding rosemary dose, 0.02% and 0.2% for rats are equivalent to 11 mg and 110 mg for humans, respectively. Conclusion Our findings support further investigations of the rosemary use as adjuvant therapy in adverse cardiac remodeling.	[Murino Rafacho, Bruna Paola; dos Santos, Priscila Portugal; Goncalves, Andrea de Freitas; Okoshi, Katashi; Chiuso-Minicucci, Fernanda; Azevedo, Paula S.; Mamede Zornoff, Leonardo Antonio; Minicucci, Marcos Ferreira; Rupp de Paiva, Sergio Alberto] UNESP, Internal Med Dept, Botucatu Med Sch, Botucatu, SP, Brazil; [Henrique Fernandes, Ana Angelica] UNESP, Dept Biochem, Botucatu Biosci Inst, Botucatu, SP, Brazil; [Chiuso-Minicucci, Fernanda] UNESP, Dept Microbiol & Immunol, Botucatu Biosci Inst, Botucatu, SP, Brazil; [Wang, Xiang-Dong] Tufts Univ, Nutr & Canc Biol Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Tufts University; United States Department of Agriculture (USDA)	Rafacho, BPM (corresponding author), UNESP, Internal Med Dept, Botucatu Med Sch, Botucatu, SP, Brazil.	bpmrafacho@alunos.fmb.unesp.br	Rafacho, Bruna Paola Murino/AGW-5794-2022; Minicucci, Fernanda C/A-9220-2015; Okoshi, Katashi/A-3955-2011; Zornoff, Leonardo/A-5612-2008; Rafacho, Bruna Paola Murino/B-5460-2013; Azevedo, Paula Schmidt/S-1597-2019; Paiva, Sergio AR/A-5101-2008; Fernandes, Ana Angelica Henrique/D-5291-2012; Minicucci, Marcos F/A-9094-2008; wang, xiao/HGB-7081-2022; dos Santos, Priscila Portugal/U-5345-2018	Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Minicucci, Fernanda C/0000-0002-4155-6414; Okoshi, Katashi/0000-0001-8980-8839; Zornoff, Leonardo/0000-0002-9831-8820; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Azevedo, Paula Schmidt/0000-0002-5843-6232; Paiva, Sergio AR/0000-0003-4412-1990; Minicucci, Marcos F/0000-0002-5980-4367; wang, xiao/0000-0002-4088-3341; dos Santos, Priscila Portugal/0000-0003-1159-5030	National Council of Technological and Scientific Development [CNPq 140262/2011-3]; Sao Paulo Research Foundation [FAPESP 2011/08956-0, 2011/15059-5]	National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by National Council of Technological and Scientific Development (CNPq 140262/2011-3) and Sao Paulo Research Foundation (FAPESP 2011/08956-0 and 2011/15059-5), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; Assalin HB, 2013, CIRC-HEART FAIL, V6, P809, DOI 10.1161/CIRCHEARTFAILURE.112.000298; Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Bai NS, 2010, J AGR FOOD CHEM, V58, P5363, DOI 10.1021/jf100332w; Botsoglou N, 2010, FOOD CHEM TOXICOL, V48, P944, DOI 10.1016/j.fct.2010.01.004; Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004; Buttros JB, 2009, PHARMACOLOGY, V84, P29, DOI 10.1159/000222245; Cheung S, 2007, ONCOL REP, V17, P1525; Chohan M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-578; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Csonka C, 2010, J PHARMACOL TOX MET, V61, P163, DOI 10.1016/j.vascn.2010.02.014; de Paiva SAR, 2003, AM J PHYSIOL-HEART C, V284, pH2242, DOI 10.1152/ajpheart.00646.2002; dos Santos PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098895; Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Genena AK, 2008, CIENCIA TECNOL ALIME, V28, P463, DOI 10.1590/S0101-20612008000200030; Gilbert B, 2003, CURR MED CHEM, V10, P13, DOI 10.2174/0929867033368583; Goncalves AF, 2015, CELL PHYSIOL BIOCHEM, V35, P259, DOI 10.1159/000369693; HARAGUCHI H, 1995, PLANTA MED, V61, P333, DOI 10.1055/s-2006-958094; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Idikio HA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/836806; Jeong EM, 2015, CIRC J, V79, P470, DOI 10.1253/circj.CJ-15-0064; Karthik D, 2011, J CARDIOVASC PHARM, V58, P514, DOI 10.1097/FJC.0b013e31822c265d; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Liu QF, 2016, J AGR FOOD CHEM, V64, P6716, DOI 10.1021/acs.jafc.6b03001; Liu TT, 2014, LIFE SCI, V101, P27, DOI 10.1016/j.lfs.2014.02.004; Lustosa BB, 2016, INT J CARDIOL, V225, P147, DOI 10.1016/j.ijcard.2016.09.092; Madamanchi NR, 2013, FREE RADICAL BIO MED, V61, P473, DOI 10.1016/j.freeradbiomed.2013.04.001; Minicucci MF, 2014, ARQ BRAS CARDIOL, V102, P549, DOI 10.5935/abc.20140051; Minicucci MF, 2011, INT J CARDIOL, V151, P242, DOI 10.1016/j.ijcard.2011.06.068; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Paiva SAR, 2005, J NUTR, V135, P2109, DOI 10.1093/jn/135.9.2109; Peng CH, 2007, BIOSCI BIOTECH BIOCH, V71, P2223, DOI 10.1271/bbb.70199; Perez-Fons L, 2010, J AGR FOOD CHEM, V58, P161, DOI 10.1021/jf9026487; Pfeffer JM, 2000, CARDIOVASC DRUG THER, V14, P579, DOI 10.1023/A:1007890126061; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Polegato BF, 2016, ARQ BRAS CARDIOL, V106, P105, DOI 10.5935/abc.20160015; Posadas SJ, 2009, EXP GERONTOL, V44, P383, DOI 10.1016/j.exger.2009.02.015; Punithavathi VR, 2010, LIFE SCI, V86, P178, DOI 10.1016/j.lfs.2009.11.021; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Retelny VS, 2008, NUTR CLIN PRACT, V23, P468, DOI 10.1177/0884533608323425; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793; Sadzuka Y, 1997, TOXICOL LETT, V92, P1, DOI 10.1016/S0378-4274(97)00028-3; Sahu BD, 2014, MOL CELL BIOCHEM, V394, P163, DOI 10.1007/s11010-014-2092-5; Saks V, 2006, J PHYSIOL-LONDON, V577, P769, DOI 10.1113/jphysiol.2006.120584; Scheckel KA, 2008, J NUTR, V138, P2098, DOI 10.3945/jn.108.090431; SPADARO J, 1980, ARCH PATHOL LAB MED, V104, P179; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Sun GB, 2012, TOXICOL APPL PHARM, V265, P229, DOI 10.1016/j.taap.2012.10.002; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Tamaki Y, 2010, PLANTA MED, V76, P683, DOI 10.1055/s-0029-1240622; van Deel ED, 2008, FREE RADICAL BIO MED, V44, P1305, DOI 10.1016/j.freeradbiomed.2007.12.007; WEBER KT, 1994, J MOL CELL CARDIOL, V26, P279, DOI 10.1006/jmcc.1994.1036; WOLFE CL, 1993, CIRCULATION, V87, P881, DOI 10.1161/01.CIR.87.3.881; Zhou SS, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/260429; Zhu YZ, 2004, NAT PROD REP, V21, P478, DOI 10.1039/b304821g; Zornoff LAM, 2006, NUTRITION, V22, P146, DOI 10.1016/j.nut.2005.05.008; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V93, P434, DOI 10.1590/S0066-782X2009001000018; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013	65	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177521	10.1371/journal.pone.0177521	http://dx.doi.org/10.1371/journal.pone.0177521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494028	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300128
J	St-Jean, M; Boudreau, F; Carpentier, AC; Hivert, MF				St-Jean, Matthieu; Boudreau, Francois; Carpentier, Andre C.; Hivert, Marie-France			HNF1 alpha defect influences post-prandial lipid regulation	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; HUMAN LIPOPROTEIN-LIPASE; GLUCAGON-LIKE PEPTIDE-1; INSULIN-SECRETION; BILE-ACID; GLUCOSE; GHRELIN; HUMANS; SENSITIVITY; RESISTANCE	Purpose Hepatocyte nuclear factor 1 alpha (HNF1 alpha) defects cause Mature Onset Diabetes of the Young type 3 (MODY3), characterized by defects in beta-cell insulin secretion. However, HNF1a is involved in many other metabolic pathways with relevance for monogenic or polygenic type 2 diabetes. We aimed to investigate gut hormones, lipids, and insulin regulation in response to a meal test in HNF1a defect carriers (MODY3) compared to non-diabetic subjects (controls) and type 2 diabetes (T2D). Methods We administered a standardized liquid meal to each participant. Over 6 hours, we measured post-meal responses of insulin regulation (blood glucose, c-peptide, insulin), gut hormones (ghrelin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1) and lipids (non-esterified fatty acids [NEFA] and triglycerides). Results We found that MODY3 participants had lower insulin secretion indices than controls and T2D participants, showing the expected beta-cell defect. MODY3 had similar glycated hemoglobin levels (HbA1c median [IQR]: 6.5 [5.6-7.6]%) compared to T2D (median: 6.6 [6.2- 6.9]%; P<0.05). MODY3 had greater insulin sensitivity (Matsuda index: 71.9 [29.6; 125.5]) than T2D (3.2 [4.0; 6.0]; P<0.05). MODY3 experienced a larger decrease in the ratio of NEFA to insulin (NEFA 30-0/insulin 3-0: -39 [-78; -30] x10(4)) in the early post-prandial period (0-30 minutes) compared to controls and to T2D (-2.0 [-0.6; -6.4] x10(4); P<0.05). MODY3 had lower fasting (0.66 [0.46; 1.2] mM) and post-meal triglycerides levels compared to T2D (fasting: 2.3 [1.7; 2.7] mM; P<0.05). We did not detect significant post-meal differences in ghrelin and incretins between MODY3 and other groups. Conclusion In response to a standard meal test, MODY3 showed greater early post-prandial NEFA diminution in response to relatively low early insulin secretion, and they maintained very low post-prandial triglycerides levels.	[St-Jean, Matthieu; Carpentier, Andre C.; Hivert, Marie-France] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Boudreau, Francois] Univ Sherbrooke, Dept Anat & Cellular Biol, Sherbrooke, PQ, Canada; [Hivert, Marie-France] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02115 USA; [Hivert, Marie-France] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	University of Sherbrooke; University of Sherbrooke; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hivert, MF (corresponding author), Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada.; Hivert, MF (corresponding author), Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02115 USA.; Hivert, MF (corresponding author), Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA.	mhivert@partners.org	St-Jean, Matthieu/AAR-9352-2021; Hivert, Marie-France/GWN-0455-2022	Hivert, Marie-France/0000-0001-7752-2585				Adamska E, 2014, GASTROENTEROL REV, V2, P69; Alssema M, 2013, EUR J ENDOCRINOL, V169, P421, DOI 10.1530/EJE-13-0487; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Babaya N, 2003, J CLIN ENDOCR METAB, V88, P2548, DOI 10.1210/jc.2002-021891; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Brassard P, 2008, J CLIN ENDOCR METAB, V93, P837, DOI 10.1210/jc.2007-1670; Brial F, 2015, DIABETES, V64, P3314, DOI 10.2337/db15-0124; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; Calanna S, 2013, DIABETES CARE, V36, P3346, DOI 10.2337/dc13-0465; Carpentier A, 1999, AM J PHYSIOL-ENDOC M, V276, pE1055, DOI 10.1152/ajpendo.1999.276.6.E1055; Carpentier AC, 2010, J CLIN ENDOCR METAB, V95, P1256, DOI 10.1210/jc.2009-1932; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; Ekholm E, 2013, J INTERN MED, V274, P263, DOI 10.1111/joim.12082; Ferreira LDMCB, 2001, DIABETES, V50, P1064, DOI 10.2337/diabetes.50.5.1064; Gardner DSL, 2012, DIABETES METAB SYNDR, V5, P101, DOI 10.2147/DMSO.S23353; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Green BD, 2004, CURR PHARM DESIGN, V10, P3651, DOI 10.2174/1381612043382774; Grenier-Larouche T, 2012, Int J Obes Suppl, V2, pS37, DOI 10.1038/ijosup.2012.21; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hegele RA, 2000, ARTERIOSCL THROM VAS, V20, P217, DOI 10.1161/01.ATV.20.1.217; Kong M, 2013, INT J IMMUNOGENET, V40, P120, DOI 10.1111/j.1744-313X.2012.01141.x; Kunach M, 2015, DIABETES, V64, P2432, DOI 10.2337/db14-1166; Labbe SM, 2012, DIABETES, V61, P2701, DOI 10.2337/db11-1805; Labbe SM, 2011, AM J PHYSIOL-ENDOC M, V300, pE445, DOI 10.1152/ajpendo.00579.2010; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; Lussier CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012378; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Nowak N, 2015, ENDOCRINE, V50, P643, DOI 10.1007/s12020-015-0627-5; Odom DT, 2010, TRANSCRIPTION FACTOR, V303, P1378; Ostoft SH, 2014, DIABETES, V63, P2838, DOI 10.2337/db13-1878; Pirro M, 2002, ATHEROSCLEROSIS, V160, P377, DOI 10.1016/S0021-9150(01)00588-3; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pramfalk C, 2005, J LIPID RES, V46, P1868, DOI 10.1194/jlr.M400450-JLR200; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; Sharifi F, 2013, ACYLATED GHRELIN LEP, P8; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; Tchernof A, PLASMA FREE FATTY AC; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yada T, 2014, OBES METAB, V16, P111; Yoh J, 2011, REGUL PEPTIDES, V167, P140, DOI 10.1016/j.regpep.2010.12.010	49	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177110	10.1371/journal.pone.0177110	http://dx.doi.org/10.1371/journal.pone.0177110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493909	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300061
J	Wang, MM; Xin, LH; Cai, GQ; Zhang, X; Yang, X; Li, XN; Xia, Q; Wang, L; Xu, SQ; Xu, JH; Shuai, ZW; Ding, CH; Pan, FM				Wang, Mengmeng; Xin, Lihong; Cai, Guoqi; Zhang, Xu; Yang, Xiao; Li, Xiaona; Xia, Qing; Wang, Li; Xu, Shengqian; Xu, Jianhua; Shuai, Zongwen; Ding, Changhai; Pan, Faming			Pathogenic variants screening in seventeen candidate genes on 2p15 for association with ankylosing spondylitis in a Han Chinese population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; SUSCEPTIBILITY; HLA-B27; USP34; ERAP1	Objectives Previous studies have found the association between rs10865331 in 2p15 area and ankylosing spondylitis (AS). This study aimed to identify additional functional genetic variants in 2p15 region associated with AS susceptibility. Methods We used next generation sequencing (NGS) in 100 AS cases and 100 healthy controls to screen AS susceptible genetic variants, and validated these variants in 620 cases and 620 controls by using imLDR (TM) technique for single nucleotide polymorphism (SNP) genotyping. Results Totally, we identified 12 SNPs that might confer susceptibility to AS. Of those SNPs, three (rs14170, rs2123111 and rs1729674) were nominally associated (P<0.05) with AS, but were no longer statistically significant after Bonferroni correction. After stratified by gender, another two SNPs (rs11428092 and rs10208769 in USP34) were associated with AS in males but not females, though this was not statistically significant after Bonferroni correction. In addition, rs1729674, rs14170, rs2123111 and rs10208769 were in strong linkage disequilibrium (LD) and were further enrolled in haplotype analysis. A novel haplotype TAGA was found to be associated with a decreased risk of AS (odds ratio (OR) (95% confidence interval (CI)) = 0.832 (0.705-0.982)). Beyond that, we also demonstrated a strong relationship between rs10865331 and AS susceptibility (OR (95% CI) = 1.303(1.111-1.526)). Conclusions rs14170 and rs2123111 inUSP34 and rs1729674 in C2orf74 may be associated with AS susceptibility in Han Chinese population. USP34 and C2orf74 in 2p15 region may be AS novel susceptibility genes.	[Wang, Mengmeng; Xin, Lihong; Cai, Guoqi; Zhang, Xu; Yang, Xiao; Li, Xiaona; Xia, Qing; Wang, Li; Pan, Faming] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Xu, Shengqian; Xu, Jianhua; Shuai, Zongwen; Ding, Changhai] Anhui Med Univ, Dept Rheumatism & Immun, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Ding, Changhai; Pan, Faming] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia	Anhui Medical University; Anhui Medical University; University of Tasmania; Menzies Institute for Medical Research	Pan, FM (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.; Pan, FM (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	famingpan@ahmu.edu.cn	zhang, xu/AAR-6231-2021; Cai, Guoqi/HGE-7097-2022; Xia, Qing/AAX-7441-2021; Ding, Changhai/J-7730-2014	Xia, Qing/0000-0002-8556-3456; Zhang, Xu/0000-0002-6217-6824; Ding, Changhai/0000-0002-9479-730X	National Natural Science Foundation of China [30771849, 30972530, 81273169, 81573218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from the National Natural Science Foundation of China (30771849, 30972530, 81273169 and 81573218). Faming Pan is supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang SY, 2011, J RHEUMATOL, V38, P322, DOI 10.3899/jrheum.100652; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Brown MA, 2011, BRIEF FUNCT GENOMICS, V10, P249, DOI 10.1093/bfgp/elr023; Cheng S, 2007, SEMIN ARTHRITIS RHEU, V37, P39, DOI 10.1016/j.semarthrit.2007.01.003; Davidson SI, 2013, ARTHRITIS RHEUM-US, V65, P1747, DOI 10.1002/art.37976; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; Duan ZH, 2012, SCAND J RHEUMATOL, V41, P219, DOI 10.3109/03009742.2011.625972; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fan D, 2014, SCAND J RHEUMATOL, V43, P374, DOI 10.3109/03009742.2014.882408; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; LIU Y, 2015, RHEUMATOL INT; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Poalas K, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-25; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sanchez A, 2010, J RHEUMATOL, V37, P2345, DOI 10.3899/jrheum.100211; Slobodin G, 2012, ISR MED ASSOC J, V14, P763; Smith JA, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0489-6; Sy SMH, 2013, NUCLEIC ACIDS RES, V41, P8572, DOI 10.1093/nar/gkt622; Thomas GP, 2010, DISCOV MED, V10, P263; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103618; Yang T, 2014, MOD RHEUMATOL, V24, P150, DOI 10.3109/14397595.2013.852856; Zeng Z, 2012, CLIN RHEUMATOL, V31, P1449, DOI 10.1007/s10067-012-2028-y; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130982; Zhao SG, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0158-y	31	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177080	10.1371/journal.pone.0177080	http://dx.doi.org/10.1371/journal.pone.0177080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493913	gold, Green Published, Green Accepted			2022-12-27	WOS:000401314300057
J	Yuan, Y; Liu, ZQ; Jin, H; Sun, S; Liu, TJ; Wang, X; Fan, HJ; Hou, SK; Ding, H				Yuan, Yao; Liu, Zi-Quan; Jin, Heng; Sun, Shi; Liu, Tian-Jun; Wang, Xue; Fan, Hao-Jun; Hou, Shi-Ke; Ding, Hui			Photodynamic antimicrobial chemotherapy with the novel amino acid-porphyrin conjugate 4I: In vitro and in vivo studies	PLOS ONE			English	Article							RESISTANT ACINETOBACTER-BAUMANNII; PHOTOINDUCED ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS INFECTION; METHICILLIN-RESISTANT; MULTIDRUG-RESISTANCE; WOUND INFECTIONS; RESCUES MICE; THERAPY; PHOTOSENSITIZERS; INACTIVATION	Photodynamic antimicrobial chemotherapy (PACT), as a novel and effective therapeutic modality to eradicate drug resistant bacteria without provoking multidrug resistance, has attracted increasing attention. This study examined the antimicrobial efficacy of the novel cationic amino acid-porphyrin conjugate 4I with four lysine groups against two different clinical isolated strains (drug sensitive and multidrug resistant) of the Acinetobacter baumannii species and its toxicity on murine dermal fibroblasts in vitro, as well as the therapeutic effect of PACT on acute, potentially lethal multidrug resistant strain excisional wound infections in vivo. The PACT protocol exposed 4I to illumination, exhibiting high antimicrobial efficacy on two different strains due to a high yield of reactive oxygen species (ROS) and non-selectivity to microorganisms. The photoinactivation effects of 4I against two different strains were dose-dependent. At 3.9 mu M and 7.8 mu M, PACT induced 6 log units of inactivation of sensitive and multidrug resistant strains. In contrast, 4I alone and illumination alone treatments had no visibly antimicrobial effect. Moreover, cytotoxicity tests revealed the great safety of the photosensitizer 4I in mice. In the in vivo study, we found 4I-mediated PACT was not only able to kill bacteria but also accelerated wound recovery. Compared with non-treated mice, over 2.89 log reduction of multidrug resistant Acinetobacter baumannii strain was reached in PACT treat mice at 24 h post-treatment. These results imply that 4I-mediated PACT therapy is an effective and safe alternative to conventional antibiotic therapy and has clinical potential for superficial drug-resistant bacterial infections.	[Yuan, Yao; Liu, Zi-Quan; Wang, Xue; Fan, Hao-Jun; Hou, Shi-Ke; Ding, Hui] Logist Univ Chinese Peoples Armed Police Force PA, Affiliated Hosp, Inst Disaster Med & Publ Hlth, Tianjin, Peoples R China; [Jin, Heng; Sun, Shi] Tianjin Med Univ, Dept Emergency Med, Gen Hosp, Tianjin, Peoples R China; [Liu, Tian-Jun] Chinese Acad Med Sci, Peking Union Med Coll, Tianjin Key Lab Biomed Mat, Inst Biomed Engn, Tianjin, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of BioMedical Engineering - CAMS; Peking Union Medical College	Ding, H (corresponding author), Logist Univ Chinese Peoples Armed Police Force PA, Affiliated Hosp, Inst Disaster Med & Publ Hlth, Tianjin, Peoples R China.	huidingah@163.com	Jin, Heng/S-7674-2019	Jin, Heng/0000-0001-9264-1187; YUAN, YAO/0000-0003-0351-2645	Major Projects of the National Health and Family Planning Commission of China [201302003]; Tianjin Natural Science Foundation of China [15JCYBJC28500, 15ZXLCSY00040]; Tianjin Health bureau science and technology Foundation of China [2015KZ123]; Basic Research Program of Logistics University of PAP [WHJ2016025]	Major Projects of the National Health and Family Planning Commission of China; Tianjin Natural Science Foundation of China; Tianjin Health bureau science and technology Foundation of China; Basic Research Program of Logistics University of PAP	This study was supported by the Major Projects of the National Health and Family Planning Commission of China (201302003 to ShikeHou), Tianjin Natural Science Foundation of China (15JCYBJC28500 to HuiDing, 15ZXLCSY00040 to ShikeHou), Tianjin Health bureau science and technology Foundation of China (2015KZ123 to ZiquanLiu), Basic Research Program of Logistics University of PAP (WHJ2016025 to ZiquanLiu). The funders provided support in study design.	Abrahamse H, 2016, BIOCHEM J, V473, P347, DOI 10.1042/BJ20150942; Alves E, 2014, FUTURE MED CHEM, V6, P141, DOI 10.4155/fmc.13.211; Cheon S, 2016, KOREAN J INTERN MED, V31, P367, DOI 10.3904/kjim.2015.178; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Dai TH, 2013, ANTIMICROB AGENTS CH, V57, P1238, DOI 10.1128/AAC.01652-12; Dai TH, 2010, LASER SURG MED, V42, P38, DOI 10.1002/lsm.20887; Dai TH, 2009, ANTIMICROB AGENTS CH, V53, P3929, DOI 10.1128/AAC.00027-09; Dosselli R, 2014, J MED CHEM, V57, P1403, DOI 10.1021/jm401653r; Dosselli R, 2013, J MED CHEM, V56, P1052, DOI 10.1021/jm301509n; Feng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24342; Fu XJ, 2014, J PHOTOCH PHOTOBIO B, V136, P72, DOI 10.1016/j.jphotobiol.2014.04.016; Garland MJ, 2009, FUTURE MED CHEM, V1, P667, DOI 10.4155/FMC.09.55; Grinholc M, 2015, APPL MICROBIOL BIOT, V99, P4031, DOI 10.1007/s00253-015-6539-8; Grinholc M, 2014, PHOTOMED LASER SURG, V32, P121, DOI 10.1089/pho.2013.3663; Hamblin MR, 2003, J INFECT DIS, V187, P1717, DOI 10.1086/375244; Hamblin MR, 2002, PHOTOCHEM PHOTOBIOL, V75, P51, DOI 10.1562/0031-8655(2002)075<0051:RCOWIB>2.0.CO;2; Hanakova A, 2014, MICROBIOL RES, V169, P163, DOI 10.1016/j.micres.2013.07.005; Huang LY, 2014, NANOMEDICINE-UK, V9, P253, DOI 10.2217/nnm.13.22; Lai MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153361; Lee H, 2016, CLIN EC EVALUATION M, V48, P174; Li K, 2014, LANGMUIR, V30, P14573, DOI 10.1021/la5028724; Lu ZS, 2010, NANOMEDICINE-UK, V5, P1525, DOI 10.2217/NNM.10.98; Luan YY, 2014, J INTERF CYTOK RES, V34, P2, DOI 10.1089/jir.2013.0042; Maisch T, 2011, J DTSCH DERMATOL GES, V9, P360, DOI 10.1111/j.1610-0387.2010.07577.x; Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582; Maraki S, 2016, 5 YEAR SURVEILLANCE, V48, P190; Meng S, 2015, EUR J MED CHEM, V92, P35, DOI 10.1016/j.ejmech.2014.12.029; Nakamizo S, 2013, SKIN PHARMACOL PHYS, V26, P22, DOI 10.1159/000343208; Orenstein A, 1997, FEMS IMMUNOL MED MIC, V19, P307, DOI 10.1016/S0928-8244(97)00097-7; Orlandi VT, 2013, J PHOTOCH PHOTOBIO B, V127, P123, DOI 10.1016/j.jphotobiol.2013.08.011; Pan T, 2016, EXP THER MED, V11, P1345, DOI 10.3892/etm.2016.3051; Prasanth CS, 2014, PHOTOCHEM PHOTOBIOL, V90, P628, DOI 10.1111/php.12198; Reginato Eleonora, 2014, World J Immunol, V4, P1; Sahu K, 2013, LASER MED SCI, V28, P465, DOI 10.1007/s10103-012-1083-6; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Sarmiento D, 2015, MICROVASC RES, V98, P187, DOI 10.1016/j.mvr.2014.02.001; Scrivens WA, 1994, SYNTHESIS C 14 LABEL; Sharma SK, 2011, CURR PHARM DESIGN, V17, P1303, DOI 10.2174/138161211795703735; Sharman WM, 2000, METHOD ENZYMOL, V319, P376; Sperandio Felipe F, 2013, Recent Pat Antiinfect Drug Discov, V8, P108; Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309; Tanaka T, 2016, IMMUNOTHERAPY-UK, V8, P959, DOI 10.2217/imt-2016-0020; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P196, DOI 10.1128/AAC.50.1.196-203.2006; Tsioutis C, 2016, INT J ANTIMICROB AG, V48, P492, DOI 10.1016/j.ijantimicag.2016.07.007; Vandepitte Warunee Punpanich, 2014, Journal of the Medical Association of Thailand, V97, pS129; Vecchio D, 2013, J BIOPHOTONICS, V6, P733, DOI 10.1002/jbio.201200121; Xu ZP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00242; Zhang YS, 2015, NANOMEDICINE-UK, V10, P603, DOI 10.2217/nnm.14.131; Zilberberg MD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1392-4	50	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176529	10.1371/journal.pone.0176529	http://dx.doi.org/10.1371/journal.pone.0176529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493985	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300020
J	Zmora, P; Molau-Blazejewska, P; Bertram, S; Walendy-Gnirss, K; Nehlmeier, I; Hartleib, A; Moldenhauer, AS; Konzok, S; Dehmel, S; Sewald, K; Brinkmann, C; Curths, C; Knauf, S; Gruber, J; Matz-Rensing, K; Dahlmann, F; Braun, A; Pohlmann, S				Zmora, Pawel; Molau-Blazejewska, Paulina; Bertram, Stephanie; Walendy-Gnirss, Kerstin; Nehlmeier, Inga; Hartleib, Anika; Moldenhauer, Anna-Sophie; Konzok, Sebastian; Dehmel, Susann; Sewald, Katherina; Brinkmann, Constantin; Curths, Christoph; Knauf, Sascha; Gruber, Jens; Maetz-Rensing, Kerstin; Dahlmann, Franziska; Braun, Armin; Poehlmann, Stefan			Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin	PLOS ONE			English	Article							ANCHORED SERINE PROTEASES; HUMAN AIRWAY EPITHELIUM; A VIRUSES; PROTEOLYTIC ACTIVATION; CELLS; REPLICATION; MATRIPTASE; TRYPSIN; ENTRY; MICE	The cellular serine protease TMPRSS2, a member of the type II transmembrane serine protease (TTSP) family, cleaves and activates the hemagglutinin of influenza A viruses (FLUAV) in cell culture and is essential for spread of diverse FLUAV in mice. Non-human primates (NHP), in particular rhesus and cynomolgus macaques, serve as animal models for influenza and experimental FLUAV infection of common marmosets has recently also been reported. However, it is currently unknown whether the NHP orthologues of human TMPRSS2 cleave and activate FLUAV hemagglutinin and contribute to viral spread in respiratory tissue. Here, we cloned and functionally analyzed the macaque and marmoset orthologues of human TMPRSS2. In addition, we analyzed the macaque orthologues of human TMPRSS4 and HAT, which also belong to the TTSP family. We found that all NHP orthologues of human TMPRSS2, TMPRSS4 and HAT cleave and activate HA upon directed expression and provide evidence that endogenous TMPRSS2 is expressed in the respiratory epithelium of rhesus macaques. Finally, we demonstrate that a serine protease inhibitor active against TMPRSS2 suppresses FLUAV spread in precision-cut lung slices of human, macaque and marmoset origin. These results indicate that FLUAV depends on serine protease activity for spread in diverse NHP and in humans. Moreover, our findings suggest that macaques and marmosets may serve as models to study FLUAV activation by TMPRSS2 in human patients.	[Zmora, Pawel; Molau-Blazejewska, Paulina; Bertram, Stephanie; Walendy-Gnirss, Kerstin; Nehlmeier, Inga; Hartleib, Anika; Moldenhauer, Anna-Sophie; Brinkmann, Constantin; Poehlmann, Stefan] Leibniz Inst, German Primate Ctr, Infect Biol Unit, Kellnerweg 4, Gottingen, Germany; [Konzok, Sebastian; Dehmel, Susann; Sewald, Katherina; Curths, Christoph; Dahlmann, Franziska; Braun, Armin] Fraunhofer Inst Toxicol & Expt Med, Div Preclin Pharmacol & In Vitro Toxicol, Nikolai Fuchs Str 1, Hannover, Germany; [Konzok, Sebastian; Dehmel, Susann; Sewald, Katherina; Curths, Christoph; Dahlmann, Franziska; Braun, Armin] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis Hannover, Nikolai Fuchs Str 1, Hannover, Germany; [Curths, Christoph; Knauf, Sascha; Maetz-Rensing, Kerstin; Dahlmann, Franziska] Leibniz Inst, Pathol Unit, German Primate Ctr, Kellnerweg 4, Gottingen, Germany; [Knauf, Sascha] Leibniz Inst, Workgrp Neglected Trop Dis, German Primate Ctr, Kellnerweg 4, Gottingen, Germany; [Gruber, Jens] Leibniz Inst, German Primate Ctr, Jr Res Grp Med RNA Biol, Primate Genet Lab, Gottingen, Germany; [Zmora, Pawel] Max Planck Inst Dynam Complex Tech Syst, Dept Bioproc Engn, Sandtorstr 1, Magdeburg, Germany; [Bertram, Stephanie] Leibniz Inst Expt Virol, Heinrich Pette Inst, Viral Zoonosis & Adaptat, Martinistr 52, Hamburg, Germany	Deutsches Primatenzentrum (DPZ); Fraunhofer Gesellschaft; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Max Planck Society; Heinrich Pette Institute	Pohlmann, S (corresponding author), Leibniz Inst, German Primate Ctr, Infect Biol Unit, Kellnerweg 4, Gottingen, Germany.	spoehlmann@dpz.eu	Zmora, Pawel/V-3843-2019; Braun, Armin/B-8750-2009; Pöhlmann, Stefan/H-2395-2011; Knauf, Sascha/F-1661-2017	Zmora, Pawel/0000-0002-2012-7223; Braun, Armin/0000-0002-1142-1463; Pöhlmann, Stefan/0000-0001-6086-9136; Knauf, Sascha/0000-0001-5744-4946	DFG [PO 716/6-1]; Leibniz Foundation (Graduate School Emerging Infectious Diseases)	DFG(German Research Foundation (DFG)); Leibniz Foundation (Graduate School Emerging Infectious Diseases)	This work was supported by DFG (PO 716/6-1 to SP) and Leibniz Foundation (Graduate School Emerging Infectious Diseases).	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2013, PATHOG DIS, V69, P87, DOI 10.1111/2049-632X.12053; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Cheng Z, 2015, J INFECT DIS; Davis AS, 2015, ANTIVIR RES, V117, P75, DOI 10.1016/j.antiviral.2015.02.011; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12; Kido H, 2007, CURR PHARM DESIGN, V13, P405, DOI 10.2174/138161207780162971; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; KLENK HD, 1973, J VIROL, V11, P823, DOI 10.1128/JVI.11.6.823-831.1973; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kuhn N, 2016, J VIROL, V90, P4298, DOI 10.1128/JVI.02693-15; LAZAROWI.SG, 1973, VIROLOGY, V52, P199, DOI 10.1016/0042-6822(73)90409-1; Marriott AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157887; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; Mooij P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126132; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sakai K, 2015, J VIROL, V89, P5154, DOI 10.1128/JVI.00124-15; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Seehase S, 2011, J APPL PHYSIOL, V111, P791, DOI 10.1152/japplphysiol.00162.2011; Switalla S, 2010, TOXICOL APPL PHARM, V246, P107, DOI 10.1016/j.taap.2010.04.010; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Trombetta C, 2015, VACCINES-BASEL, V3, P172, DOI 10.3390/vaccines3010172; Watanabe T, 2015, CURR OPIN VIROL, V14, P71, DOI 10.1016/j.coviro.2015.08.008; Winkler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043337; Yamada H, 2012, ANTIVIR RES, V96, P344, DOI 10.1016/j.antiviral.2012.09.012; Zmora P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138380; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	43	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176597	10.1371/journal.pone.0176597	http://dx.doi.org/10.1371/journal.pone.0176597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493964	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300022
J	Mattouk, M; Talhouk, SN				Mattouk, Miriam; Talhouk, Salma N.			A content analysis of nature photographs taken by Lebanese rural youth	PLOS ONE			English	Article							PHOTOVOICE; FAMILY; BIODIVERSITY	'Living in Harmony with Nature' is a 2050 vision put forth by the Convention on Biological Diversity (CBD) which takes into consideration culture and locality of perceptions of nature and aspirations for its use. Considering that 54% of the world population lives in cities, where nature has been decimated, the role of rural communities, living within or in proximity of natural and semi natural areas, will effectively influence the fate of the 'remaining' nature while they engage in local development. Reconciling between growth and development on the one hand, and nature conservation on the other, necessitates an understanding of how rural communities, especially the youth, imprint their own ideas on landscapes and develop ownership over natural spaces. In order to extend the understanding of how harmony with nature is perceived in different parts of the world, this paper presents the findings of primary research involving a group of young people who live in rural areas in Lebanon, a country in the Arab Middle East. Participatory research based on photovoice methodology was conducted with 77 young people aged 7-16 and residing in five rural villages located in different parts of Lebanon. Photographs taken by participants indicated that for many, nature was not perceived literally i.e. woodlands, forests, plants, animals, etc.... Instead, the participants saw nature as part of agriculture and local culture. Nature was also seen as symbolic expression of the participants' inner state of mind. Narratives written to explain the photographs shed light on the perception of harmony with nature which focused on positive family experiences and relayed personal emotions, abstract, and holistic yet functional view of nature. Another recurring theme that emerged from photographs and narratives was the role of family members, in particular grandparents, as having a strong influence on the positive perceptions of nature.	[Mattouk, Miriam; Talhouk, Salma N.] Amer Univ Beirut, Nat Conservat Ctr, Beirut, Lebanon; [Talhouk, Salma N.] Amer Univ Beirut, Dept Landscape Design & Ecosyst Management, Fac Agr & Food Sci, Beirut, Lebanon	American University of Beirut; American University of Beirut	Talhouk, SN (corresponding author), Amer Univ Beirut, Nat Conservat Ctr, Beirut, Lebanon.; Talhouk, SN (corresponding author), Amer Univ Beirut, Dept Landscape Design & Ecosyst Management, Fac Agr & Food Sci, Beirut, Lebanon.	ntsalma@aub.edu.lb			Coca Cola Foundation	Coca Cola Foundation	The study was partially funded by Coca Cola Foundation (SNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, RUR TOUR STRAT LEB; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; BARRANTI CCR, 1985, FAM RELAT, V34, P343, DOI 10.2307/583572; Bellin R., 2006, VISUAL STUD, V20, P56; Bengtson VL, 2001, J MARRIAGE FAM, V63, P1, DOI 10.1111/j.1741-3737.2001.00001.x; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Carlson ED, 2006, QUAL HEALTH RES, V16, P836, DOI 10.1177/1049732306287525; Castleden H, 2008, SOC SCI MED, V66, P1393, DOI 10.1016/j.socscimed.2007.11.030; Chawla L., 1998, J ENVIRON EDUC, V4, P369, DOI DOI 10.1080/00958969809599114; Dakin EK, 2014, QUALITATIVE SOCIAL W, P1; DENHAM TE, 1989, FAM RELAT, V38, P345, DOI 10.2307/585064; Djoundourian Salpie, 2009, Environment Development and Sustainability, V11, P427, DOI 10.1007/s10668-007-9122-3; Farina A, 2003, ECOL ECON, V45, P11, DOI 10.1016/S0921-8009(02)00255-0; King K, 2013, J RURAL STUD, V31, P67, DOI 10.1016/j.jrurstud.2013.02.004; MATTHEWS H, 1995, GEOGR J, V161, P285, DOI 10.2307/3059833; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; Mutamba E, 2004, ENVIRON MONIT ASSESS, V99, P105, DOI 10.1007/s10661-004-4010-x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nabhan G., 1994, GEOGRAPHY CHILDHOOD; Palmberg I.E., 2000, J ENVIRON EDUC, V31, P32, DOI [DOI 10.1080/00958960009598649, 10.1080/00958960009598649]; Payne PG, 2010, ENVIRON EDUC RES, V16, P209, DOI 10.1080/13504620903580545; Phenice L., 2003, CONT ISSUES EARLY CH, V4, P167, DOI [10.2304/ciec.2003.4.2.6, DOI 10.2304/CIEC.2003.4.2.6]; Potts SG, 2006, BIOL CONSERV, V129, P519, DOI 10.1016/j.biocon.2005.11.019; Sobel D., 1996, ECOPHOBIA RECLAIMING; State of the Environment Report (SOER), 2010, LEB ENV DEV OBS; Strack Robert W, 2004, Health Promot Pract, V5, P49, DOI 10.1177/1524839903258015; Tawk LY, 2014, THESIS; Wang C, 1996, SOC SCI MED, V42, P1391, DOI 10.1016/0277-9536(95)00287-1; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Wang CC, 2006, J COMMUNITY PRACT, V14, P147, DOI 10.1300/J125v14n01_09; Wang CC, 2004, MATERN CHILD HLTH J, V8, P95, DOI 10.1023/B:MACI.0000025732.32293.4f; Wesley A., 2011, DO YOU SEE WHAT I SE	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177079	10.1371/journal.pone.0177079	http://dx.doi.org/10.1371/journal.pone.0177079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489929	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100047
J	Goldansaz, SA; Guo, AC; Sajed, T; Steele, MA; Plastow, GS; Wishart, DS				Goldansaz, Seyed Ali; Guo, An Chi; Sajed, Tanvir; Steele, Michael A.; Plastow, Graham S.; Wishart, David S.			Livestock metabolomics and the livestock metabolome: A systematic review	PLOS ONE			English	Review							CHROMATOGRAPHY-MASS SPECTROMETRY; RESIDUAL FEED-INTAKE; DAIRY-COWS; MILK-PRODUCTION; BEEF-CATTLE; BIOMARKER DISCOVERY; ESCHERICHIA-COLI; IDENTIFICATION; CHALLENGES; DATABASE	Metabolomics uses advanced analytical chemistry techniques to comprehensively measure large numbers of small molecule metabolites in cells, tissues and biofluids. The ability to rapidly detect and quantify hundreds or even thousands of metabolites within a single sample is helping scientists paint a far more complete picture of system-wide metabolism and biology. Metabolomics is also allowing researchers to focus on measuring the end-products of complex, hard-to-decipher genetic, epigenetic and environmental interactions. As a result, metabolomics has become an increasingly popular "omics" approach to assist with the robust phenotypic characterization of humans, crop plants and model organisms. Indeed, metabolomics is now routinely used in biomedical, nutritional and crop research. It is also being increasingly used in livestock research and livestock monitoring. The purpose of this systematic review is to quantitatively and objectively summarize the current status of livestock metabolomics and to identify emerging trends, preferred technologies and important gaps in the field. In conducting this review we also critically assessed the applications of livestock metabolomics in key areas such as animal health assessment, disease diagnosis, bioproduct characterization and biomarker discovery for highly desirable economic traits (i.e., feed efficiency, growth potential and milk production). A secondary goal of this critical review was to compile data on the known composition of the livestock metabolome (for 5 of the most common livestock species namely cattle, sheep, goats, horses and pigs).	[Goldansaz, Seyed Ali; Steele, Michael A.; Plastow, Graham S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Goldansaz, Seyed Ali; Guo, An Chi; Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Guo, An Chi; Sajed, Tanvir; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Wishart, DS (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.; Wishart, DS (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.	david.wishart@ualberta.ca	Wishart, David Scott/ABI-3181-2020		Genome Canada; Genome Alberta; Alberta Livestock and Meat Agency; Agriculture Funding Consortium; Alberta Innovates [201201143] Funding Source: researchfish	Genome Canada(Genome Canada); Genome Alberta; Alberta Livestock and Meat Agency; Agriculture Funding Consortium; Alberta Innovates	Funding for this research has been provided by Genome Canada (to DSW), Genome Alberta (to DSW), Alberta Livestock and Meat Agency (to SAG) and Agriculture Funding Consortium (to SAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarghuei MJ, 2014, LIVEST SCI, V164, P72, DOI 10.1016/j.livsci.2014.03.021; Alves RDAM, 2015, METABOLOMICS, V11, P271, DOI 10.1007/s11306-014-0701-7; Andreas NJ, ELECTROPHORESIS; Bussche JV, 2015, ANAL CHEM, V87, P10927, DOI 10.1021/acs.analchem.5b02688; Castejon D, 2015, ANAL CHIM ACTA, V901, P1, DOI 10.1016/j.aca.2015.08.032; Cevallos-Cevallos JM, 2011, J FOOD SCI, V76, pM238, DOI 10.1111/j.1750-3841.2011.02132.x; Chapinal N, 2012, J DAIRY SCI, V95, P1301, DOI 10.3168/jds.2011-4724; Chen X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136612; Clark M, 2014, TRANSGENIC RES, V23, P245, DOI 10.1007/s11248-013-9768-6; Corona G, 2012, J CELL PHYSIOL, V227, P2827, DOI 10.1002/jcp.24003; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Escalona EE, 2015, EQUINE VET J, V47, P721, DOI 10.1111/evj.12333; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fontanesi L, 2016, ANIM FRONT, V6, P73, DOI 10.2527/af.2016-0011; Ganna A, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0893-5; Ghazi N, 2016, INT J REPROD BIOMED, V14, P1; Gilany K, 2014, MOL REPROD DEV, V81, P84, DOI 10.1002/mrd.22284; Gray DW, 2015, VET RES, V46, DOI 10.1186/s13567-014-0138-z; Hailemariam D, 2014, J DAIRY SCI, V97, P2680, DOI 10.3168/jds.2013-6803; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Imhasly S, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-122; Jalali A, 2016, IRAN J PHARM RES, V15, P221; Jewison T, 2012, NUCLEIC ACIDS RES, V40, pD815, DOI 10.1093/nar/gkr916; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Jones DP, 2012, ANNU REV NUTR, V32, P183, DOI 10.1146/annurev-nutr-072610-145159; Karisa B., 2013, SPRINGER SCI REV, V1, P73, DOI [10.1007/s40362-013-0005-8, DOI 10.1007/S40362-013-0005-8]; Karisa BK, 2014, LIVEST SCI, V165, P200, DOI 10.1016/j.livsci.2014.03.002; Karisa BK, 2013, CAN J ANIM SCI, V93, P295, DOI [10.4141/CJAS2012-136, 10.4141/cjas2012-136]; Kim S, 2016, CURR OPIN BIOTECH, V37, P16, DOI 10.1016/j.copbio.2015.09.004; Klein MS, 2012, J PROTEOME RES, V11, P1373, DOI 10.1021/pr201017n; Kordalewska M, 2015, J PHARMACEUT BIOMED, V113, P121, DOI 10.1016/j.jpba.2015.04.021; Kosmides Alyssa K., 2013, Critical Reviews in Biomedical Engineering, V41, P205; Kuhn C, 2014, PROC 10TH WORLD CONG, P1; LeBlanc SJ, 2005, J DAIRY SCI, V88, P159, DOI 10.3168/jds.S0022-0302(05)72674-6; Lu J, 2013, J PROTEOME RES, V12, P3288, DOI 10.1021/pr4001306; Mandavi V, 2016, ANAL BIOCHEM, V494, P31, DOI 10.1016/j.ab.2015.10.017; Mandavi V, 2015, ANAL BIOCHEM, V478, P65, DOI 10.1016/j.ab.2015.02.021; Mathew S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-161; May DH, 2013, BRIT J NUTR, V110, P1760, DOI 10.1017/S000711451300127X; McLaughlin MJ, FIELD CROP RES; Melzer N, 2013, J DAIRY SCI, V96, P1521, DOI 10.3168/jds.2012-5743; Melzer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070256; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Metzler-Zebeli BU, 2015, METABOLOMICS, V11, P545, DOI 10.1007/s11306-014-0714-2; Mickiewicz B, 2015, J ORTHOP RES, V33, P71, DOI 10.1002/jor.22743; Minai-Tehrani A, 2016, ANDROLOGIA, V48, P609, DOI 10.1111/and.12496; Mirsaeidi M, 2015, ANN AM THORAC SOC, V12, P1278, DOI 10.1513/AnnalsATS.201505-279PS; Moco S, 2013, PEDIATR RES, V73, P570, DOI 10.1038/pr.2013.1; Mohamad Nornazliya, 2015, J Clin Bioinforma, V5, P3, DOI 10.1186/s13336-015-0018-4; Monteiro MS, 2013, CURR MED CHEM, V20, P257, DOI 10.2174/092986713804806621; Moore RE, 2007, BIOMARK INSIGHTS, V2, P185; Moore SS, 2009, J ANIM SCI, V87, pE41, DOI 10.2527/jas.2008-1418; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Norris JL, 2013, CHEM REV, V113, P2309, DOI 10.1021/cr3004295; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Osorio MT, 2013, FOOD CHEM, V141, P2795, DOI 10.1016/j.foodchem.2013.05.118; Park YW, 2007, SMALL RUMINANT RES, V68, P88, DOI 10.1016/j.smallrumres.2006.09.013; Parveen I, 2007, J AGR FOOD CHEM, V55, P1129, DOI 10.1021/jf062995w; Pearson H, 2007, NATURE, V446, P8, DOI 10.1038/446008a; Peters RJB, 2010, TRAC-TREND ANAL CHEM, V29, P1250, DOI 10.1016/j.trac.2010.07.012; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Regal P, 2011, STEROIDS, V76, P365, DOI 10.1016/j.steroids.2010.12.005; Reinehr T, 2015, EUR J NUTR, V54, P173, DOI 10.1007/s00394-014-0698-8; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rompp A, 2015, ANAL BIOANAL CHEM, V407, P2329, DOI 10.1007/s00216-014-8410-7; Sajed T, 2016, NUCLEIC ACIDS RES, V44, pD495, DOI 10.1093/nar/gkv1060; Saleem F, 2012, J DAIRY SCI, V95, P6606, DOI 10.3168/jds.2012-5403; Saleem F, 2013, METABOLOMICS, V9, P360, DOI 10.1007/s11306-012-0458-9; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Shajahan-Haq AN, 2015, METABOLITES, V5, P100, DOI 10.3390/metabo5010100; Simo C, 2014, INT J MOL SCI, V15, P18941, DOI 10.3390/ijms151018941; Singh R, 2011, INDIAN J PHARMACOL, V43, P246, DOI 10.4103/0253-7613.81505; Skelton DM, 2014, ENVIRON SCI TECHNOL, V48, P2395, DOI 10.1021/es404021f; Srivastava A, 2016, METABOLITES, V6, DOI 10.3390/metabo6040032; Steinshamn H, 2014, SMALL RUMINANT RES, V122, P18, DOI 10.1016/j.smallrumres.2014.07.013; Sumner LW, 2015, NAT PROD REP, V32, P212, DOI 10.1039/c4np00072b; Sun HZ, 2015, J PROTEOME RES, V14, P1287, DOI 10.1021/pr501305g; Sundekilde UK, 2013, J DAIRY SCI, V96, P290, DOI [10.3168/jds.2012-5819, 10.3390/metabo3020204]; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Torii Y, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1011-z; Tweeddale H, 1998, J BACTERIOL, V180, P5109, DOI 10.1128/JB.180.19.5109-5116.1998; Verma M, 2013, CANCER EPIDEM BIOMAR, V22, P189, DOI 10.1158/1055-9965.EPI-12-1263; Viswanathan V, 2008, IEEE SOFTWARE, V25, P98, DOI 10.1109/MS.2008.156; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Weikard R, 2010, PHYSIOL GENOMICS, V42A, P79, DOI 10.1152/physiolgenomics.00120.2010; Widmann P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124574; Winter G, 2013, ENVIRON MICROBIOL, V15, P1901, DOI 10.1111/1462-2920.12064; Wishart DS, 2008, TRENDS FOOD SCI TECH, V19, P482, DOI 10.1016/j.tifs.2008.03.003; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, BIOANALYSIS, V1, P1579, DOI 10.4155/BIO.09.138; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wishart DS, 2016, METABOLITES, P6; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e	96	130	134	14	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177675	10.1371/journal.pone.0177675	http://dx.doi.org/10.1371/journal.pone.0177675			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531195	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400022
J	Nicholls, SB; Devos, SL; Commins, C; Nobuhara, C; Bennett, RE; Corjuc, DL; Maury, E; Eftekharzadeh, B; Akingbade, O; Fan, ZY; Roe, AD; Takeda, S; Wegmann, S; Hyman, BT				Nicholls, Samantha B.; DeVos, Sarah L.; Commins, Caitlin; Nobuhara, Chloe; Bennett, Rachel E.; Corjuc, Diana L.; Maury, Eduardo; Eftekharzadeh, Bahareh; Akingbade, Ololade; Fan, Zhanyun; Roe, Allyson D.; Takeda, Shuko; Wegmann, Susanne; Hyman, Bradley T.			Characterization of TauC3 antibody and demonstration of its potential to block tau propagation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; MOUSE MODEL; PROTEIN; TAUOPATHY; SEQUENCE; CLEAVAGE	The spread of neurofibrillary tangle (NFT) pathology through the human brain is a hallmark of Alzheimer's disease (AD), which is thought to be caused by the propagation of "seeding" competent soluble misfolded tau. "TauC3", a C-terminally truncated form of tau that is generated by caspase-3 cleavage at D421, has previously been observed in NFTs and has been implicated in tau toxicity. Here we show that TauC3 is found in the seeding competent high molecular weight (HMW) protein fraction of human AD brain. Using a specific TauC3 antibody, we were able to substantially block the HMW tau seeding activity of human AD brain extracts in an in vitro tau seeding FRET assay. We propose that TauC3 could contribute to the templated tau misfolding that leads to NFT spread in AD brains.	[Nicholls, Samantha B.; DeVos, Sarah L.; Commins, Caitlin; Nobuhara, Chloe; Bennett, Rachel E.; Corjuc, Diana L.; Maury, Eduardo; Eftekharzadeh, Bahareh; Akingbade, Ololade; Fan, Zhanyun; Roe, Allyson D.; Takeda, Shuko; Wegmann, Susanne; Hyman, Bradley T.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA.	bhyman@mgh.harvard.edu	Bennett, Rachel/AAU-6949-2020	Bennett, Rachel/0000-0001-9640-0575; Nicholls, Samantha/0000-0002-6001-7256	Intellect Neurosciences INC; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17H05080] Funding Source: KAKEN	Intellect Neurosciences INC; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a sponsored research agreement from Intellect Neurosciences INC (http://www.intellectns.com/). Intellect Neurosciences also provided the anti-TauC3 antibody. Intellect Neurosciences had no role in study design, data collection and analysis, or preparation of the manuscript. They did approve the manuscript to be published. The Massachusetts Alzheimer Disease Research Center Brain Bank provided tissue samples (P50AG005134).; This work was supported by a sponsored research agreement from Intellect Neurosciences INC. Intellect Neurosciences also provided the anti-TauC3 antibody. Thanks to Dr. Kelly Arnett and the HMS Center for Macromolecular Interactions for training and helpful discussions on Biacore experiments. The Massachusetts Alzheimer Disease Research Center Brain Bank provided tissue samples (P50AG005134).	Barghorn Stefan, 2004, V299, P35; Barthelemy NR, 2016, J PROTEOME RES, V15, P667, DOI 10.1021/acs.jproteome.5b01001; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Halfmann R., 2008, J VIS EXP, P838; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Kim Y, 2016, NEUROBIOL DIS, V87, P19, DOI 10.1016/j.nbd.2015.12.006; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Nobuhara CK, 2017, AM J PATHOL, V1; Ozcelik S., 2016, MOL PSYCHIAT; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takeda S, 2016, ANN NEUROL, V80, P355, DOI 10.1002/ana.24716; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	21	20	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177914	10.1371/journal.pone.0177914	http://dx.doi.org/10.1371/journal.pone.0177914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531180	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400038
J	Baez, PA; Lopez, MC; Duque-Jaramillo, A; Pelaez, D; Molina, F; Navas, MC				Baez, Paula A.; Lopez, Maria Camila; Duque-Jaramillo, Alejandra; Pelaez, Dioselina; Molina, Francisco; Navas, Maria-Cristina			First evidence of the Hepatitis E virus in environmental waters in Colombia	PLOS ONE			English	Article							NON-B-HEPATITIS; ENTERIC VIRUSES; HEV ANTIBODIES; FOOD-BORNE; GENOTYPE 3; A VIRUS; SEWAGE; INFECTION; SAMPLES; SWINE	Hepatitis E virus (HEV) is one of the main causes of acute viral hepatitis of enteric transmission. HEV has been detected in environmental samples in several countries from Europe and Asia, constituting a risk factor for waterborne infection. In Colombia, HEV has been identified in samples obtained from patients as well as from swine, but no environmental studies have been carried out. To determine if HEV is present in environmental waters, samples from the main source of drinking water plant and of wastewater system of eight municipalities and two villages of Antioquia state (North West Colombia), were collected between December 2012 and April 2014. The HEV genome was detected by RT-PCR in 23.3% (7/30) of the samples from the main source of drinking water plants and in 16.7% (5/30) from sewage. Viral concentrates obtained from three positive sewage samples were used to inoculate HepG2 cell cultures that were followed for one month; however, the viral genome was not detected in any cell culture. This study demonstrates the circulation of HEV in both source of drinking water plants and wastewater in Antioquia state, Colombia. The presence of HEV in environmental waters could be a risk for waterborne transmission in this population. The findings of the present study, together with the evidence of HEV circulation in human and swine in Colombia, should be consider by public health authorities for the development of surveillance programs and the inclusion of HEV infection diagnosis in the guidelines of viral hepatitis in the country. This is the first report of HEV in environmental samples in Colombia and the second one in Latin America.	[Baez, Paula A.; Lopez, Maria Camila; Duque-Jaramillo, Alejandra; Navas, Maria-Cristina] Univ Antioquia, Fac Med, Grp Gastrohepatol, Medellin, Colombia; [Pelaez, Dioselina] Inst Nacl Salud, Lab Virol, Bogota, Colombia; [Molina, Francisco] Univ Antioquia, Grp Invest Gest & Modelac Ambiental GAIA, Medellin, Colombia	Universidad de Antioquia; Instituto Nacional de Salud (Colombia); Universidad de Antioquia	Navas, MC (corresponding author), Univ Antioquia, Fac Med, Grp Gastrohepatol, Medellin, Colombia.	maria.navas@udea.edu.co	Navas, Maria Cristina/AAE-2528-2022; Jaramillo-Duque, Álvaro/AAU-9284-2021	Jaramillo-Duque, Álvaro/0000-0001-5281-7336; Molina, Francisco/0000-0002-3491-4586; Duque Jaramillo, Alejandra/0000-0002-7821-9737	Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias [111554531673]; Vicerrectoria de Investigacion, Universidad de Antioquia	Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Vicerrectoria de Investigacion, Universidad de Antioquia	The study was funded by Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias (Grant 111554531673) and Vicerrectoria de Investigacion, Universidad de Antioquia (Proyecto de Sosteni bilidad).	Baez PA, 2016, BIOMEDICA, V36, P135, DOI 10.7705/biomedica.v36i0.2979; Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12; Beji-Hamza A, 2015, ARCH VIROL, V160, P183, DOI 10.1007/s00705-014-2251-8; Betancur Carlos Alberto, 2013, Acta Med Colomb, V38, P68; Brassard J, 2012, APPL ENVIRON MICROB, V78, P3763, DOI 10.1128/AEM.00251-12; Calgua B, 2008, J VIROL METHODS, V153, P79, DOI 10.1016/j.jviromet.2008.08.003; Calgua B, 2013, J VIROL METHODS, V187, P215, DOI 10.1016/j.jviromet.2012.10.012; Gutierrez-Vergara CC, 2015, IATREIA, V28, P248, DOI 10.17533/udea.iatreia.v28n3a03; Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448; Cook N, 2015, FOOD ENVIRON VIROL, V7, P189, DOI 10.1007/s12560-015-9196-2; Dell'Amico MC, 2011, EMERG INFECT DIS, V17, P1488, DOI 10.3201/eid1708.100769; Direccion Seccional de Salud de Antioquia, 2000, CAS INC HEP SUBR MUN; Echevarria JM, 2013, J MED VIROL, V85, P1037, DOI 10.1002/jmv.23526; Fajardo S., 2012, PLAN DESARROLLO ANTI, P17; Fierro NA, 2016, WORLD J GASTROENTERO, V22, P2271, DOI 10.3748/wjg.v22.i7.2271; Forero J, 2013, HECHOS MICROBIOLO A, V4; Forero J. E, 2014, Rev. Med. Vet. Zoot., V61, P221, DOI 10.15446/rfmvz.v61n3.46868; Girones R, 2014, J WATER HEALTH, V12, P436, DOI 10.2166/wh.2014.027; González María M, 2006, Rev. salud pública, V8, P13; Greening GE, 2002, J APPL MICROBIOL, V93, P745, DOI 10.1046/j.1365-2672.2002.01741.x; Guerrero-Latorre L, 2016, INT J HYG ENV HLTH; Garcia CG, 2012, J MED VIROL, V84, P1025, DOI 10.1002/jmv.23277; Gutierrez Vergara CC, 2014, CES MED VET ZOOTECN, V9, P158; Gutierrez-Vergara C, 2015, GENET MOL RES, V14, P2890, DOI 10.4238/2015.March.31.20; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Iaconelli M, 2015, FOOD ENVIRON VIROL, V7, P316, DOI 10.1007/s12560-015-9207-3; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Ippagunta SK, 2007, J MED VIROL, V79, P1827, DOI 10.1002/jmv.21017; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kase JA, 2008, INT J ENVIRON HEAL R, V18, P165, DOI 10.1080/09603120701498311; Khuroo MS, 2011, VIRUS RES, V161, P3, DOI 10.1016/j.virusres.2011.02.007; Kitajima M, 2009, T ROY SOC TROP MED H, V103, P955, DOI 10.1016/j.trstmh.2009.04.004; Kokkinos P, 2012, FOOD ENVIRON VIROL, V4, P179, DOI 10.1007/s12560-012-9087-8; Li TC, 2014, AM J TROP MED HYG, V90, P764, DOI 10.4269/ajtmh.13-0562; dos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021; Lopes dos Santos DR, 2009, VET J LOND ENGL, V1997, P182; Lorenzo FR, 2008, VIRUS RES, V137, P86, DOI 10.1016/j.virusres.2008.06.005; Wassaf MGM, 2014, J CLIN VIROL, V61, P334, DOI 10.1016/j.jcv.2014.08.016; Masclaux FG, 2013, WATER RES, V47, P5101, DOI 10.1016/j.watres.2013.05.050; Mirazo S, 2014, EMERG INFECT DIS, V20, P171, DOI 10.3201/eid2001.131471; Mirazo S, 2013, VIRUS RES, V173, P364, DOI 10.1016/j.virusres.2013.01.005; Villalba MDM, 2013, INFECT GENET EVOL, V14, P335, DOI 10.1016/j.meegid.2012.12.022; Villallba MDM, 2008, EMERG INFECT DIS, V14, P1320, DOI 10.3201/eid1408.080049; Munne MS, 2006, J MED VIROL, V78, P1579, DOI 10.1002/jmv.20741; Myrmel M, 2015, FOOD ENVIRON VIROL, V7, P213, DOI 10.1007/s12560-015-9200-x; National Department of Statistics DANE, 2003, FICH TECN CENS ACT P; Okamoto H, 2013, J GASTROENTEROL, V48, P147, DOI 10.1007/s00535-012-0682-0; Okamoto H, 2011, VIRUS RES, V161, P65, DOI 10.1016/j.virusres.2011.01.015; Pelaez D, 2014, BIOMEDICA, V34, P354, DOI [10.7705/biomedica.v34i3.2236, 10.1590/S0120-41572014000300006]; Pelaez D, 2010, BIOMEDICA, V30, P276, DOI 10.7705/biomedica.v30i2.191; Pina S, 1998, APPL ENVIRON MICROB, V64, P4485; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Rendon J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148417; Rodriguez-Frias F, 2012, ENFERM INFEC MICR CL, V30, P624, DOI 10.1016/j.eimc.2012.01.014; Rusinol M, 2014, WATER RES, V59, P119, DOI 10.1016/j.watres.2014.04.013; Rutjes SA, 2009, EMERG INFECT DIS, V15, P381, DOI 10.3201/eid1503.071472; Smith DB, 2016, J MED VIROL, V88, P915, DOI 10.1002/jmv.24403; SOBSEY MD, 1985, APPL ENVIRON MICROB, V50, P1457, DOI 10.1128/AEM.50.6.1457-1463.1985; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Tobon F, 2011, REV MVZ CORDOBA, V16, P2605, DOI 10.21897/rmvz.1035; Tobon-Marulanda FA, 2012, REV SALUD PUBLICA, V12, P300, DOI DOI 10.1590/S0124-00642010000200013; Van der Poel WHM, 2014, CURR OPIN VIROL, V4, P91, DOI 10.1016/j.coviro.2014.01.006; VELAZQUEZ O, 1990, JAMA-J AM MED ASSOC, V263, P3281, DOI 10.1001/jama.263.24.3281; World Health Organization, 2012, PREV CONTR VIR HEP I; World Health Organization (WHO), 2015, HEP E FACT SHEET 280; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507	71	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177525	10.1371/journal.pone.0177525	http://dx.doi.org/10.1371/journal.pone.0177525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520759	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500036
J	Hajrah, NH; Obaid, AY; Atef, A; Ramadan, AM; Arasappan, D; Nelson, CA; Edris, S; Mutwakil, MZ; Alhebshi, A; Gadalla, NO; Makki, RM; Al-Kordy, MA; El-Domyati, FM; Sabir, JSM; Khiyami, MA; Hall, N; Bahieldin, A; Jansen, RK				Hajrah, Nahid H.; Obaid, Abdullah Y.; Atef, Ahmed; Ramadan, Ahmed M.; Arasappan, Dhivya; Nelson, Charllotte A.; Edris, Sherif; Mutwakil, Mohammed Z.; Alhebshi, Alawia; Gadalla, Nour O.; Makki, Rania M.; Al-Kordy, Madgy A.; El-Domyati, Fotouh M.; Sabir, Jamal S. M.; Khiyami, Mohammad A.; Hall, Neil; Bahieldin, Ahmed; Jansen, Robert K.			Transcriptomic analysis of salt stress responsive genes in Rhazya stricta	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; GENOME-WIDE ANALYSIS; ABIOTIC STRESS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; RNA; BIOSYNTHESIS; CHLOROPLASTS; METABOLISM; MITOCHONDRIA	Rhazya stricta is an evergreen shrub that is widely distributed across Western and South Asia, and like many other members of the Apocynaceae produces monoterpene indole alkaloids that have anti-cancer properties. This species is adapted to very harsh desert conditions making it an excellent system for studying tolerance to high temperatures and salinity. RNA-Seq analysis was performed on R. stricta exposed to severe salt stress (500 mM NaCl) across four time intervals (0, 2, 12 and 24 h) to examine mechanisms of salt tolerance. A large number of transcripts including genes encoding tetrapyrroles and pentatricopeptide repeat (PPR) proteins were regulated only after 12 h of stress of seedlings grown in controlled greenhouse conditions. Mechanisms of salt tolerance in R. stricta may involve the upregulation of genes encoding chaperone protein Dnaj6, UDP-glucosyl transferase 85a2, protein transparent testa 12 and respiratory burst oxidase homolog protein b. Many of the highly-expressed genes act on protecting protein folding during salt stress and the production of flavonoids, key secondary metabolites in stress tolerance. Other regulated genes encode enzymes in the porphyrin and chlorophyll metabolic pathway with important roles during plant growth, photosynthesis, hormone signaling and abiotic responses. Heme biosynthesis in R. stricta leaves might add to the level of salt stress tolerance by maintaining appropriate levels of photosynthesis and normal plant growth as well as by the participation in reactive oxygen species (ROS) production under stress. We speculate that the high expression levels of PPR genes may be dependent on expression levels of their targeted editing genes. Although the results of PPR gene family indicated regulation of a large number of transcripts under salt stress, PPR actions were independent of the salt stress because their RNA editing patterns were unchanged.	[Hajrah, Nahid H.; Atef, Ahmed; Ramadan, Ahmed M.; Edris, Sherif; Mutwakil, Mohammed Z.; Alhebshi, Alawia; Makki, Rania M.; Sabir, Jamal S. M.; Hall, Neil; Bahieldin, Ahmed; Jansen, Robert K.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah, Saudi Arabia; [Obaid, Abdullah Y.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Ramadan, Ahmed M.] ARC, AGERI, Giza, Egypt; [Arasappan, Dhivya; Jansen, Robert K.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Nelson, Charllotte A.] Inst Integrat Biol, Ctr Genom Res, Crown St, Liverpool, Merseyside, England; [Edris, Sherif; El-Domyati, Fotouh M.; Bahieldin, Ahmed] Ain Shams Univ, Fac Agr, Dept Genet, Cairo, Egypt; [Edris, Sherif] King Abdulaziz Univ, Fac Med, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Gadalla, Nour O.] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, Jeddah, Saudi Arabia; [Gadalla, Nour O.; Al-Kordy, Madgy A.] Natl Res Ctr, Genet Engn & Biotechnol Div, Genet & Cytol Dept, Dokki, Egypt; [Khiyami, Mohammad A.] KACST, Riyadh, Saudi Arabia; [Hall, Neil] Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England	King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; University of Texas System; University of Texas Austin; Egyptian Knowledge Bank (EKB); Ain Shams University; King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Abdulaziz City for Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute	Jansen, RK (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah, Saudi Arabia.; Jansen, RK (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	jansen@austin.utexas.edu	Alhebshi, Alawiah M/AAD-4587-2019; bahieldin, ahmed/I-9186-2012; Edris, Sherif/I-8070-2012; Edris, Sherif/GXZ-9995-2022; Hajrah, Nahid/AAT-2659-2021; Sabir, Jamal S M/C-8102-2014; atef, ahmed/B-7842-2013; Hajrah, Nahid/AAY-3196-2020; Ramadan, Ahmed/I-8241-2012	Edris, Sherif/0000-0002-2810-3736; Edris, Sherif/0000-0002-2810-3736; Hajrah, Nahid/0000-0001-6404-1627; Ramadan, Ahmed/0000-0002-2502-9921; Hall, Neil/0000-0003-2808-0009; Alhebshi, Alawiah/0000-0002-1751-8944; Atef, Ahmed/0000-0001-7530-2060	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [I-008-31]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no.I-008-31.r This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. I-008-31. The authors, therefore, acknowledge with thanks DSR technical and financial support. The authors also gratefully acknowledge the support from President of King Abdulaziz University. Prof. Dr. Abdulrahman O. Alyoubi.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arenas A, 2014, MITOCHONDRION, V19, P126, DOI 10.1016/j.mito.2014.08.006; Bahieldin A, 2015, CR BIOL, V338, P285, DOI 10.1016/j.crvi.2015.03.010; Blanco-Herrera F, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0525-2; Brehme N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140680; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Cao ZL, 2011, J INTEGR PLANT BIOL, V53, P258, DOI 10.1111/j.1744-7909.2011.01030.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng CX, 2013, INT J MOL SCI, V14, P24169, DOI 10.3390/ijms141224169; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; FREYER R, 1993, PLANT J, V4, P621, DOI 10.1046/j.1365-313X.1993.04040621.x; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Goyal E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27752; Grimm B, 1998, CURR OPIN PLANT BIOL, V1, P245, DOI 10.1016/S1369-5266(98)80112-X; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Hammani K, 2011, PLANT CELL, V23, P730, DOI 10.1105/tpc.110.081638; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hasan SS, 2013, P NATL ACAD SCI USA, V110, P4297, DOI 10.1073/pnas.1222248110; HIROSE T, 1994, PLANT MOL BIOL, V26, P509, DOI 10.1007/BF00039562; Jiang SC, 2015, PLANT MOL BIOL, V88, P369, DOI 10.1007/s11103-015-0327-9; Juhanningmeier U, 1984, J BIOL CHEM, V259, P13541; Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x; Khan N.A., 2014, J PLANT BIOCH PHYSL, V2, DOI [DOI 10.4172/2329-9029.1000120, 10.4172/2329-9029.1000120]; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu Y, 2010, J BUS RES, V63, P3, DOI 10.1016/j.jbusres.2009.01.005; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Lv HX, 2014, J PLANT BIOL, V57, P291, DOI 10.1007/s12374-014-0041-1; Martin M, 2009, BBA-BIOENERGETICS, V1787, P920, DOI 10.1016/j.bbabio.2009.03.001; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Murayama M, 2012, J EXP BOT, V63, P5301, DOI 10.1093/jxb/ers188; Obaid AY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0938-6; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Sabir JSM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33782; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Turan S, 2015, PHYSIOL PLANTARUM, V153, P477, DOI 10.1111/ppl.12250; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; Wahid A, 2006, J PLANT PHYSIOL, V163, P723, DOI 10.1016/j.jplph.2005.07.007; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; Zhang J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-228; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu Q, 2014, MOL PLANT, V7, P290, DOI 10.1093/mp/sst102; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260	63	17	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177589	10.1371/journal.pone.0177589	http://dx.doi.org/10.1371/journal.pone.0177589			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520766	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500041
J	Zhang, MX; Li, P; Wang, W				Zhang, Mingxi; Li, Pohan; Wang, Wei			An index-based algorithm for fast on-line query processing of latent semantic analysis	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; JACOBI SVD ALGORITHM; SIMILARITY SEARCH; RECOMMENDER; NETWORK	Latent Semantic Analysis (LSA) is widely used for finding the documents whose semantic is similar to the query of keywords. Although LSA yield promising similar results, the existing LSA algorithms involve lots of unnecessary operations in similarity computation and candidate check during on-line query processing, which is expensive in terms of time cost and cannot efficiently response the query request especially when the dataset becomes large. In this paper, we study the efficiency problem of on-line query processing for LSA towards efficiently searching the similar documents to a given query. We rewrite the similarity equation of LSA combined with an intermediate value called partial similarity that is stored in a designed index called partial index. For reducing the searching space, we give an approximate form of similarity equation, and then develop an efficient algorithm for building partial index, which skips the partial similarities lower than a given threshold.. Based on partial index, we develop an efficient algorithm called ILSA for supporting fast on-line query processing. The given query is transformed into a pseudo document vector, and the similarities between query and candidate documents are computed by accumulating the partial similarities obtained from the index nodes corresponds to non-zero entries in the pseudo document vector. Compared to the LSA algorithm, ILSA reduces the time cost of on-line query processing by pruning the candidate documents that are not promising and skipping the operations that make little contribution to similarity scores. Extensive experiments through comparison with LSA have been done, which demonstrate the efficiency and effectiveness of our proposed algorithm.	[Zhang, Mingxi] Univ Shanghai Sci & Technol, Coll Commun & Art Design, Shanghai, Peoples R China; [Zhang, Mingxi; Li, Pohan; Wang, Wei] Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China	University of Shanghai for Science & Technology; Fudan University	Zhang, MX (corresponding author), Univ Shanghai Sci & Technol, Coll Commun & Art Design, Shanghai, Peoples R China.; Zhang, MX (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China.	mingxizhang10@fudan.edu.cn			Natural Science Foundation of Shanghai grant [16ZR14228]; Innovation Program of Shanghai Municipal Education Commission [15ZZ073, 15ZZ074]; Training Project of University of Shanghai for Science and Technology grant [16HJPY-QN04]; Natural Science Foundation of Shanghai [16ZR14228]	Natural Science Foundation of Shanghai grant; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Training Project of University of Shanghai for Science and Technology grant; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by Natural Science Foundation of Shanghai grant 16ZR14228, http://www.stsm.gov.cn/; Innovation Program of Shanghai Municipal Education Commission grants 15ZZ073 and 15ZZ074, http://www.shmec.gov.cn/; and Training Project of University of Shanghai for Science and Technology grant 16HJPY-QN04, http://www.usst.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Natural Science Foundation of Shanghai grant 16ZR14228, http:// www.stcsm.gov.cn/: Innovation Program of Shanghai Municipal Education Commission grants 15ZZ073 and 15ZZ074, http://www.shmec.gov.cn/; and Training Project of University of Shanghai for Science and Technology grant 16HJPY-QN04, http://www.usst.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Haddou R, 2016, COMPUT AIDED GEOM D, V42, P23, DOI 10.1016/j.cagd.2015.12.003; Allioua S, 2012, NETWORKED DIGITAL TE, P297; An X, 2013, SCI WORLD J, DOI 10.1155/2013/213603; Anandkumar A, 2015, ALGORITHMICA, V72, P193, DOI 10.1007/s00453-014-9909-1; Balouchestani M, 2016, SIGNAL IMAGE VIDEO P, V10, P113, DOI 10.1007/s11760-014-0709-5; Balzano L, 2013, CORR; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boulares M, 2016, ARTIF INTELL REV, V46, P145, DOI 10.1007/s10462-016-9460-3; Bradford R. B., 2008, P 17 ACM C INF KNOWL, P153, DOI [10.1145/1458082.1458105, DOI 10.1145/1458082.1458105]; Brand M, 2003, SIAM PROC S, P37; Brand M, 2002, LECT NOTES COMPUT SC, V2350, P707; Celikkanat H, 2016, IEEE T COGN DEV SYST, V8, P42, DOI 10.1109/TAMD.2015.2476374; Chen JF, 2016, PROC VLDB ENDOW, V9, P744, DOI 10.14778/2977797.2977801; Chen KW, 2016, EXPERT SYST APPL, V66, P245, DOI 10.1016/j.eswa.2016.09.009; Dang A, 2016, COLING 2016; Domeniconi G, 2015, DATA 2015; Drinea E, 2001, PANH C INF PCI; Drmac Z, 2007, SIAM J MATRIX ANAL A, V29, P1322, DOI 10.1137/050639193; Drmac Z, 2007, SIAM J MATRIX ANAL A, V29, P1343, DOI 10.1137/05063920X; El Ghali B, 2017, KNOWL INF SYST, V50, P751, DOI 10.1007/s10115-016-0952-x; Elghazel H, 2016, EXPERT SYST APPL, V57, P1, DOI 10.1016/j.eswa.2016.03.041; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Ghoshdastidar D, 2015, AAAI CONF ARTIF INTE, P2610; Gonzalez J, 2016, J BIOINF COMPUT BIOL, V14, P1; Guan X, 2016, LECT NOTES ARTIF INT, V9652, P503, DOI 10.1007/978-3-319-31750-2_40; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Hofmann Thomas, 2013, CORR; Holmes M. P., 2008, ADV NEURAL INFORM PR, P673; Iwen MA, 2016, CORR; Jarvelin K, 2002, ACM T INFORM SYST, V20, P422, DOI 10.1145/582415.582418; Joachims T, 1997, 14 INT C MACH LEARN, P143; Kagie M, 2009, AI COMMUN, V22, P249, DOI 10.3233/AIC-2009-0467; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Layfield C., 2017, SEMANTIC KEYWORD BAS, V10151, P25, DOI [DOI 10.1007/978-3-319-53640-83, 10.1007/978-3-319-53640-83]; Lee M, 2014, IEEE T IMAGE PROCESS, V23, P4255, DOI 10.1109/TIP.2014.2346012; Levy A, 2000, IEEE T IMAGE PROCESS, V9, P1371, DOI 10.1109/83.855432; Li C, 2010, EDBT, P465, DOI DOI 10.1145/1739041.1739098; Luo X, 2016, IEEE T NEUR NET LEAR, V27, P524, DOI 10.1109/TNNLS.2015.2412037; Menon V, 2016, IEEE GEOSCI REMOTE S, V13, P1275, DOI 10.1109/LGRS.2016.2581172; Mingqing Zhang, 2014, Journal of Software, V9, P429, DOI 10.4304/jsw.9.2.429-436; Mirzal Andri, 2016, International Journal of Information and Decision Sciences, V8, P53; Nath C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153749; Ntalianis KS, 2015, VISAPP 2015, V2; Nugumanova A, 2013, COMM COM INF SC, V394, P92; Park J, 2016, 38 ANN INT C IEEE EN; Qin PD, 2016, NEUROCOMPUTING, V177, P257, DOI 10.1016/j.neucom.2015.11.028; Roy S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1223-2; Sammut C, 2010, ENCY MACHINE LEARNIN, P571; Strobach P, 2008, SIGNAL PROCESS, V88, P2651, DOI 10.1016/j.sigpro.2008.05.004; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Wang CCN, 2016, IEEE INT C BIOINF BI, P363, DOI 10.1109/BIBE.2016.71; Wu X, 2016, COMPUT MATH METHOD M, V2016; Yan M, 2016, INFORM SOFTWARE TECH, V73, P37, DOI 10.1016/j.infsof.2016.01.005; Ye Y, 2013, FRONT COMPUT SCI-CHI, V7, P526, DOI 10.1007/s11704-013-2360-7; Yuxia Huang, 2016, Annals of GIS, V22, P113, DOI 10.1080/19475683.2016.1144648; Zeng XX, 2016, IEEE INT C BIOINFORM, P682, DOI 10.1109/BIBM.2016.7822600; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang MX, 2015, EXPERT SYST APPL, V42, P8868, DOI 10.1016/j.eswa.2015.07.042; Zhang MX, 2015, EXPERT SYST APPL, V42, P699, DOI 10.1016/j.eswa.2014.08.039; Zhang W, 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.7554/ELIFE.11324; Zhang W, 2008, IEEE SYS MAN CYBERN, P108, DOI 10.1109/ICSMC.2008.4811259; Zhang Y, 2014, INFORM SCIENCES, V281, P687, DOI 10.1016/j.ins.2014.04.047; Zhou LF, 2016, IEEE ACCESS, V4, P869, DOI 10.1109/ACCESS.2016.2535103; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	65	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177523	10.1371/journal.pone.0177523	http://dx.doi.org/10.1371/journal.pone.0177523			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520747	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500035
J	Einaga, N; Yoshida, A; Noda, H; Suemitsu, M; Nakayama, Y; Sakurada, A; Kawaji, Y; Yamaguchi, H; Sasaki, Y; Tokino, T; Esumi, M				Einaga, Naoki; Yoshida, Akio; Noda, Hiroko; Suemitsu, Masaaki; Nakayama, Yuki; Sakurada, Akihisa; Kawaji, Yoshiko; Yamaguchi, Hiromi; Sasaki, Yasushi; Tokino, Takashi; Esumi, Mariko			Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation	PLOS ONE			English	Article							CROSS-LINKS; FORMALDEHYDE; EXTRACTION; EVOLUTION; URACIL; PROBE	Formalin-fixed, paraffin-embedded (FFPE) tissues used for pathological diagnosis are valuable for studying cancer genomics. In particular, laser-capture microdissection of target cells determined by histopathology combined with FFPE tissue section immunohistochemistry (IHC) enables precise analysis by next-generation sequencing (NGS) of the genetic events occurring in cancer. The result is a new strategy for a pathological tool for cancer diagnosis: 'microgenomics'. To more conveniently and precisely perform microgenomics, we revealed by systematic analysis the following three details regarding FFPE DNA compared with paired frozen tissue DNA. 1) The best quality of FFPE DNA is obtained by tissue fixation with 10% neutral buffered formalin for 1 day and heat treatment of tissue lysates at 95 degrees C for 30 minutes. 2) IHC staining of FFPE tissues decreases the quantity and quality of FFPE DNA to one-fourth, and antigen retrieval (at 120 degrees C for 15 minutes, pH 6.0) is the major reason for this decrease. 3) FFPE DNA prepared as described herein is sufficient for NGS. For non-mutated tissue specimens, no artifactual mutation occurs during FFPE preparation, as shown by precise comparison of NGS of FFPE DNA and paired frozen tissue DNA followed by validation. These results demonstrate that even FFPE tissues used for routine clinical diagnosis can be utilized to obtain reliable NGS data if appropriate conditions of fixation and validation are applied.	[Einaga, Naoki; Yoshida, Akio; Noda, Hiroko; Suemitsu, Masaaki; Nakayama, Yuki; Sakurada, Akihisa; Kawaji, Yoshiko; Yamaguchi, Hiromi; Esumi, Mariko] Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo, Japan; [Yoshida, Akio] Nihon Univ, Sch Med, Dept Orthopaed Surg, Itabashi Ku, Tokyo, Japan; [Suemitsu, Masaaki] Nihon Univ, Sch Dent Matsudo, Dept Oral Pathol, Matsudo, Chiba, Japan; [Sasaki, Yasushi; Tokino, Takashi] Sapporo Med Univ, Dept Med Genome Sci, Sapporo, Hokkaido, Japan	Nihon University; Nihon University; Nihon University; Sapporo Medical University	Esumi, M (corresponding author), Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo, Japan.	esumi.mariko@nihon-u.ac.jp	Tokino, Takashi/AAI-9887-2021; Sasaki, Yasushi/AAA-3079-2019	Sasaki, Yasushi/0000-0002-3500-8059	Ministry of Education, Culture, Sports, Science and Technology of Japan [25430142]; Scientific Support Programs for Cancer Research; Nihon University Multidisciplinary Research Grant [M14-012]; Grants-in-Aid for Scientific Research [17K09354] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Support Programs for Cancer Research; Nihon University Multidisciplinary Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (C) 25430142 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/) received by ME, Scientific Support Programs for Cancer Research Grant-in-Aid Scientific Research on Innovative Areas MEXT (http://ganshien.umin.jp/) received by TT, and Nihon University Multidisciplinary Research Grant (M14-012) from Nihon University (http://www.nihon-u.ac.jp/) received by ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1982-6; Avesson L, 2014, BBA-REV CANCER, V1845, P308, DOI 10.1016/j.bbcan.2014.03.001; Betge J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127146; CHAW YFM, 1980, BIOCHEMISTRY-US, V19, P5525, DOI 10.1021/bi00565a010; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kennedy-Darling J, 2014, ANAL CHEM, V86, P5678, DOI 10.1021/ac501354y; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lamy A, 2011, MODERN PATHOL, V24, P1090, DOI 10.1038/modpathol.2011.60; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; MCGHEE JD, 1977, BIOCHEMISTRY-US, V16, P3276, DOI 10.1021/bi00634a002; Munchel S, 2015, ONCOTARGET, V6, P25943, DOI 10.18632/oncotarget.4671; Nakayama Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150528; Oh E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144162; OHBA Y, 1979, EUR J BIOCHEM, V100, P285, DOI 10.1111/j.1432-1033.1979.tb02059.x; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; SEPP R, 1994, J CLIN PATHOL, V47, P318, DOI 10.1136/jcp.47.4.318; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Wong SQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03494; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	26	60	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176280	10.1371/journal.pone.0176280	http://dx.doi.org/10.1371/journal.pone.0176280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498833	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314500002
J	Gilbert, BM; Avenant-Oldewage, A				Gilbert, Beric M.; Avenant-Oldewage, Annemarie			Trace element and metal sequestration in vitellaria and sclerites, and reactive oxygen intermediates in a freshwater monogenean, Paradiplozoon ichthyoxanthon	PLOS ONE			English	Article							CHUB LEUCISCUS-CEPHALUS; LABEOBARBUS-KIMBERLEYENSIS GILCHRIST; POMPHORHYNCHUS-LAEVIS; AQUEOUS ALUMINUM; SOUTH-AFRICA; BOTHRIOCEPHALUS-ACHEILOGNATHI; LARGEMOUTH YELLOWFISH; GYRODACTYLUS NORDMANN; TRANSITION-METALS; CHEMICAL NATURE	Exposure to metals and other trace elements negatively affects infection dynamics of monogeneans, including diplozoids, but, physiological mechanisms linked to exposure have yet to be documented. In this study sequestration of trace elements and reactive oxygen intermediate production in the monogenean, Paradiplozoon ichthyoxanthon, was demonstrated. During dissection of host fish, Labeobarbus aeneus, the gills were excised and assessed for P. ichthyoxanthon, which were removed and frozen for fluorescence microscopy or fixed for transmission electron microscopy. Trace elements were sequestered in the vitellaria and sclerites in P. ichthyoxanthon, and the presence of reactive oxygen intermediates was observed predominantly in the tegument of the parasite. Trace elements and metals identified and ranked according to weight percentages (wt%) in the vitellaria were Cu > C > Au > O > Cr > Fe > Si while for the sclerites C > Cu > O > Au > Fe > Cr > Si were identified. For most element detected, readings were higher in the vitellaria than the sclerites, except for C and O which were higher in sclerites. Specifically for metals, all levels detected in the vitellaria were greater than in sclerites. Based on the proportion of trace elements present in the vitellaria and sclerites it appears that most trace elements including metals were sequestered in the vitellaria. The results of reactive oxygen intermediate production in the tegument of the parasite suggests either trace element accumulation takes place across the tegument or results from the action of the host's immune response on the parasite. The results serve as the first demonstration of trace element sequestration and reactive oxygen intermediates in a freshwater monogenean parasite.	[Gilbert, Beric M.; Avenant-Oldewage, Annemarie] Univ Johannesburg, Dept Zool, Johannesburg, Gauteng, South Africa	University of Johannesburg	Avenant-Oldewage, A (corresponding author), Univ Johannesburg, Dept Zool, Johannesburg, Gauteng, South Africa.	aoldewage@uj.ac.za	Avenant-Oldewage, Annemarie/A-7778-2011; Gilbert, Beric Michael/ABB-7255-2021	Avenant-Oldewage, Annemarie/0000-0001-8820-7679; Gilbert, Beric Michael/0000-0002-5681-8528	National Research Foundation South Africa [80789]; University of Johannesburg Faculty Research Committee [SASOLD-0107]	National Research Foundation South Africa(National Research Foundation - South AfricaSouth African Medical Research Council); University of Johannesburg Faculty Research Committee	Funding for this work was provided by the National Research Foundation South Africa (80789) and University of Johannesburg Faculty Research Committee (SASOLD-0107) to A-O. In both instances the funding was provided after proposal submission to the granting body. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Gaber R, 2016, J HELMINTHOL, V90, P742, DOI 10.1017/S0022149X15001054; Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P513, DOI 10.1007/s00436-014-4213-1; Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; Baptista-Farias MDD, 1998, MEM I OSWALDO CRUZ, V93, P543, DOI 10.1590/S0074-02761998000400023; Barus V, 2007, PARASITOL RES, V100, P929, DOI 10.1007/s00436-006-0384-8; Brabec J, 2015, INT J PARASITOL, V45, P761, DOI 10.1016/j.ijpara.2015.05.006; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; Cohen M, 2012, JOVE-J VIS EXP, DOI 10.3791/3928; Cribb BW, 2010, ACTA BIOMATER, V6, P3152, DOI 10.1016/j.actbio.2010.02.009; Degger N, 2009, AFR ZOOL, V44, P204, DOI 10.3377/004.044.0208; Dusek L, 1998, INT J PARASITOL, V28, P1555, DOI 10.1016/S0020-7519(98)00130-1; ERASMUS DA, 1975, EXP PARASITOL, V38, P240, DOI 10.1016/0014-4894(75)90027-2; Gagne F, 2004, COMP BIOCHEM PHYS C, V138, P33, DOI 10.1016/j.cca.2004.04.006; Gagne F, 2005, ENVIRON RES, V98, P89; Gheorghiu C, 2007, INT J PARASITOL, V37, P375, DOI 10.1016/j.ijpara.2006.09.004; Gilbert BM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1706-z; Gilbert BM, 2016, ACTA PARASITOL, V61, P52, DOI 10.1515/ap-2016-0005; HALTON DW, 1974, Z PARASITENKD, V45, P45, DOI 10.1007/BF00636526; Hauglund RP, 2005, HDB GUIDE FLUORESCEN; Hook SE, 2001, MAR BIOL, V138, P1131, DOI 10.1007/s002270000533; Hwang DS, 2010, COMP BIOCHEM PHYS C, V151, P360, DOI 10.1016/j.cbpc.2009.12.010; Jeffree RA, 2008, ARCH ENVIRON CON TOX, V55, P451, DOI 10.1007/s00244-007-9103-4; Jirsa F, 2008, ARCH ENVIRON CON TOX, V55, P619, DOI 10.1007/s00244-008-9154-1; Khalil M, 2009, INT J PARASITOL, V39, P1093, DOI 10.1016/j.ijpara.2009.02.023; Khan FR, 2010, AQUAT TOXICOL, V96, P124, DOI 10.1016/j.aquatox.2009.10.010; Khan R. A., 1991, Advances in Parasitology, V30, P201, DOI 10.1016/S0065-308X(08)60309-7; Knight DP, 1996, BIOL REV, V71, P81, DOI 10.1111/j.1469-185X.1996.tb00742.x; KRITSKY DC, 1978, J PARASITOL, V64, P172, DOI 10.2307/3279642; LYONS KM, 1966, PARASITOLOGY, V56, P63, DOI 10.1017/S0031182000071109; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Milne SJ, 2006, ONDERSTEPOORT J VET, V73, P149; Monserrat JM., 2003, COMMENTS TOXICOL, V9, P255, DOI [DOI 10.1080/08865140390450359, 10.1080/08865140390450359]; MONTORZI M, 1995, BIOCHEMISTRY-US, V34, P10851, DOI 10.1021/bi00034a018; Nachev M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-21; Ohashi H, 2007, PARASITOLOGY, V134, P229, DOI 10.1017/S0031182006001430; Oliva M, 2012, ECOTOX ENVIRON SAFE, V75, P151, DOI 10.1016/j.ecoenv.2011.08.017; Otachi EO, 2014, ENVIRON SCI POLLUT R, V21, P7339, DOI 10.1007/s11356-014-2602-8; Pettersen RA, 2006, SCI TOTAL ENVIRON, V369, P129, DOI 10.1016/j.scitotenv.2006.05.024; Poleo ABS, 2004, PARASITOLOGY, V128, P169, DOI 10.1017/S0031182003004396; RAMALING.K, 1973, EXP PARASITOL, V34, P115, DOI 10.1016/0014-4894(73)90069-6; Retief NR, 2006, PHYS CHEM EARTH, V31, P840, DOI 10.1016/j.pce.2006.08.004; Retief NR, 2007, PHYS CHEM EARTH, V32, P1384, DOI 10.1016/j.pce.2007.07.044; Rico D, 2009, COMP BIOCHEM PHYS C, V149, P90, DOI 10.1016/j.cbpc.2008.07.016; RIGGS MR, 1987, J PARASITOL, V73, P893, DOI 10.2307/3282507; SAKAI H, 1995, MAR POLLUT BULL, V30, P347, DOI 10.1016/0025-326X(94)00185-C; Scheef G, 2000, PARASITOL RES, V86, P688, DOI 10.1007/PL00008553; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; SHINN AP, 1995, INT J PARASITOL, V25, P797, DOI 10.1016/0020-7519(95)00008-P; SHINN AP, 1993, SYST PARASITOL, V25, P135, DOI 10.1007/BF00009983; Smyth J.D., 1989, PHYSL BIOCH CESTODES; Soleng A, 2005, AQUACULTURE, V250, P616, DOI 10.1016/j.aquaculture.2005.05.006; SUNDERMAN FW, 1995, MOL REPROD DEV, V42, P180, DOI 10.1002/mrd.1080420207; Sures B, 2007, J HELMINTHOL, V81, P191, DOI 10.1017/S0022149X07751465; Sures B, 1997, PARASITOL RES, V83, P618, DOI 10.1007/s004360050307; Sures B, 1997, B ENVIRON CONTAM TOX, V59, P14, DOI 10.1007/s001289900437; Sures B, 1999, EXP PARASITOL, V93, P66, DOI 10.1006/expr.1999.4437; Sures B, 2003, INT J PARASITOL, V33, P1617, DOI 10.1016/S0020-7519(03)00251-0; Sures B, 2003, INT J PARASITOL, V33, P65, DOI 10.1016/S0020-7519(02)00249-7; Sures B, 2002, ECOTOXICOLOGY, V11, P365, DOI 10.1023/A:1020561406624; SURES B, 1994, DIS AQUAT ORGAN, V19, P105, DOI 10.3354/dao019105; Sures Bernd, 2001, Aquatic Ecology, V35, P245, DOI 10.1023/A:1011422310314; Szefer P, 1998, SCI TOTAL ENVIRON, V220, P19, DOI 10.1016/S0048-9697(98)00221-6; Torres J, 2014, ACTA PARASITOL, V59, P580, DOI 10.2478/s11686-014-0293-4; Valtonen ET, 2003, PARASITOLOGY, V126, pS43, DOI 10.1017/S0031182003003494; Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g; Wallace WG, 2003, MAR ECOL PROG SER, V249, P183, DOI 10.3354/meps249183; Wang WY, 2005, AGR WATER MANAGE, V75, P1, DOI 10.1016/j.agwat.2004.12.009; WHARTON DA, 1983, PARASITOLOGY, V86, P85, DOI 10.1017/S003118200005085X; Wong WL, 1963, PARASITOLOGY, V2012, P1; Wu XY, 2011, J FOOD COMPOS ANAL, V24, P62, DOI 10.1016/j.jfca.2010.03.030	71	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177558	10.1371/journal.pone.0177558	http://dx.doi.org/10.1371/journal.pone.0177558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498876	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314500027
J	Kim, C; Kim, DS; Ahn, K; Choi, MY				Kim, Chansoo; Kim, Daniel S.; Ahn, Kwangwon; Choi, M. Y.			Dynamics of analyst forecasts and emergence of complexity: Role of information disparity	PLOS ONE			English	Article							EARNINGS FORECASTS; SECURITY ANALYSTS; CAREER CONCERNS; CROSS-SECTION; FLUCTUATIONS; RETURNS; LAW; EXPECTATIONS; EXPLANATION; UNCERTAINTY	We report complex phenomena arising among financial analysts, who gather information and generate investment advice, and elucidate them with the help of a theoretical model. Understanding how analysts form their forecasts is important in better understanding the financial market. Carrying out big-data analysis of the analyst forecast data from I/B/E/S for nearly thirty years, we find skew distributions as evidence for emergence of complexity, and show how information asymmetry or disparity affects financial analysts' forming their forecasts. Here regulations, information dissemination throughout a fiscal year, and interactions among financial analysts are regarded as the proxy for a lower level of information disparity. It is found that financial analysts with better access to information display contrasting behaviors: a few analysts become bolder and issue forecasts independent of other forecasts while the majority of analysts issue more accurate forecasts and flock to each other. Main body of our sample of optimistic forecasts fits a log-normal distribution, with the tail displaying a power law. Based on the Yule process, we propose a model for the dynamics of issuing forecasts, incorporating interactions between analysts. Explaining nicely empirical data on analyst forecasts, this provides an appealing instance of understanding social phenomena in the perspective of complex systems.	[Kim, Chansoo] Korea Inst Sci & Technol, Computat Sci Res Ctr, Computat Econ Lab, Seoul 02792, South Korea; [Kim, Chansoo] Seoul Natl Univ, Dept Econ, Seoul 08826, South Korea; [Kim, Daniel S.; Ahn, Kwangwon] Peking Univ, HSBC Business Sch, Shenzhen 518055, Peoples R China; [Ahn, Kwangwon] Korea Adv Inst Sci & Technol, Moon Soul Grad Sch Future Strategy, Daejeon 34141, South Korea; [Choi, M. Y.] Seoul Natl Univ, Dept Phys & Astron, Seoul 08826, South Korea; [Choi, M. Y.] Seoul Natl Univ, Ctr Theoret Phys, Seoul 08826, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Peking University; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU)	Ahn, K (corresponding author), Korea Adv Inst Sci & Technol, Moon Soul Grad Sch Future Strategy, Daejeon 34141, South Korea.; Choi, MY (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul 08826, South Korea.; Choi, MY (corresponding author), Seoul Natl Univ, Ctr Theoret Phys, Seoul 08826, South Korea.	k.ahn@kaist.ac.kr; mychoi@snu.ac.kr	Ahn, Kwangwon/Q-2015-2016	Ahn, Kwangwon/0000-0003-3611-183X; Choi, MooYoung/0000-0001-8070-7716; Kim, Daniel Sungyeon/0000-0002-4953-6258	Korea Institute of Science and Technology (Economic and Social Science Research Initiative [ESRI]) [2E27022]; Korea Institute of Science and Technology (Future Convergence) [2E26940]; Bridge Trust Asset Management Research Fund; National Research Foundation of Korea [2016R1D1A1A09917318]	Korea Institute of Science and Technology (Economic and Social Science Research Initiative [ESRI]); Korea Institute of Science and Technology (Future Convergence); Bridge Trust Asset Management Research Fund; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Korea Institute of Science and Technology (Economic and Social Science Research Initiative [ESRI] 2E27022 and Future Convergence 2E26940) (C.K.), by Bridge Trust Asset Management Research Fund (D.S.K. and K.A.), and by National Research Foundation of Korea (Grant No. 2016R1D1A1A09917318) (M.Y.C.).; This work was supported by Korea Institute of Science and Technology (Economic and Social Science Research Initiative (ESRI) 2E27022 and Future Convergence 2E26940) (C.K.), by Bridge Trust Asset Management Research Fund (D.S.K. and K.A.), and by National Research Foundation of Korea (Grant No. 2016R1D1A1A09917318) (M.Y.C.). C.K. is in Economic & Social Science Research Initiative, Materials and Life Science Research Division, Korea Institute of Science and Technology.	ABARBANELL JS, 1995, J ACCOUNT ECON, V20, P31, DOI 10.1016/0165-4101(94)00392-I; Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; Bak P, 1999, NATURE WORKS; Baran LC, 2014, APPL FINANCIAL EC, V24; Bartov E, 2002, J ACCOUNT ECON, V33, P173, DOI 10.1016/S0165-4101(02)00045-9; Bhojraj S, 2009, J FINANC, V64, P2361, DOI 10.1111/j.1540-6261.2009.01503.x; Bloom N, 2014, J ECON PERSPECT, V28, P153, DOI 10.1257/jep.28.2.153; Bloom N, 2009, ECONOMETRICA, V77, P623, DOI 10.3982/ECTA6248; Bradshaw MT, 2004, ACCOUNT REV, V79, P25, DOI 10.2308/accr.2004.79.1.25; Brown LD, 2015, J ACCOUNT RES, V53, P1, DOI 10.1111/1475-679X.12067; Brown LD, 2001, J ACCOUNTING RES, V39, P221, DOI 10.1111/1475-679X.00010; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Chaudhuri A, 2015, QUANTITATIVE MODELIN; Chen H., 2004, J EMPIR FINANC, V11, P483, DOI DOI 10.1016/J.JEMPFIN.2004.04.005; Choi MY, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/30006; Chopra V.K., 1998, FINANC ANAL J, V54, P35, DOI DOI 10.2469/FAJ.V54.N6.2223; Clement MB, 2005, J FINANC, V60, P307, DOI 10.1111/j.1540-6261.2005.00731.x; Diether KB, 2002, J FINANC, V57, P2113, DOI 10.1111/0022-1082.00490; Du Q, 2014, UNPUB, P1; Eleswarapu VR, 2004, J FINANC QUANT ANAL, V39, P209, DOI 10.1017/S0022109000003045; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gabaix X, 2007, PHYSICA A, V382, P81, DOI 10.1016/j.physa.2007.02.030; Gabaix X, 2006, Q J ECON, V121, P461, DOI 10.1162/qjec.2006.121.2.461; Gabaix X, 2009, ANNU REV ECON, V1, P255, DOI 10.1146/annurev.economics.050708.142940; Garfinkel JA, 2006, J ACCOUNT RES, V44, P85, DOI 10.1111/j.1475-679X.2006.00193.x; Gleason CA, 2003, ACCOUNT REV, V78, P193, DOI 10.2308/accr.2003.78.1.193; Goh S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061115; Goldenfeld N., 1992, LECT PHASE TRANSITIO, DOI DOI 10.1201/9780429493492; Graham JR, 2005, J ACCOUNT ECON, V40, P3, DOI 10.1016/j.jacceco.2005.01.002; Healy P.M., 1999, CONTEMP ACCOUNT RES, V16, P485, DOI [DOI 10.1111/J.1911-3846.1999.TB00592.X, 10.1111/j.1911-3846.1999.tb00592.x]; Heflin F, 2003, ACCOUNT REV, V78, P1, DOI 10.2308/accr.2003.78.1.1; Hong H, 2000, RAND J ECON, V31, P121, DOI 10.2307/2601032; Hong H, 2003, J FINANC, V58, P313, DOI 10.1111/1540-6261.00526; Hull J., 2018, RISK MANAGEMENT FINA, V5th; Johnson Neil F., 2007, SIMPLY COMPLEXITY CL; Johnson S., 2002, EMERGENCE CONNECTED; Johnson TC, 2004, J FINANC, V59, P1957, DOI 10.1111/j.1540-6261.2004.00688.x; Krause A., 2004, LECT NOTES EC MATH S, V531, P257; Lang MH, 1996, ACCOUNT REV, V71, P467; Loh R, 2014, IS SELL SIDE RES MOR, P1; Lux T., 1996, APPL FINANCIAL EC, V6, P463, DOI DOI 10.1080/096031096333917; Mainzer K., 2007, THINKING COMPLEXITY, V5th; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Nicolis G, 2012, WORLD SCI; OBRIEN PC, 1988, J ACCOUNT ECON, V10, P53, DOI 10.1016/0165-4101(88)90023-7; Park C, 2005, J BUS, V78, P2351, DOI 10.1086/497047; Plerou V, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.027104; Schelling T.C, 2006, MICROMOTIVES MACROBE; Welch I, 2000, J FINANC ECON, V58, P369, DOI 10.1016/S0304-405X(00)00076-3; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	51	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177071	10.1371/journal.pone.0177071	http://dx.doi.org/10.1371/journal.pone.0177071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498831	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314500009
J	Muhammad, N; Bibi, N; Mahmood, Z; Akram, T; Naqvi, SR				Muhammad, Nazeer; Bibi, Nargis; Mahmood, Zahid; Akram, Tallha; Naqvi, Syed Rameez			Reversible integer wavelet transform for blind image hiding method	PLOS ONE			English	Article							SCHEME; DECOMPOSITION	In this article, a blind data hiding reversible methodology to embed the secret data for hiding purpose into cover image is proposed. The key advantage of this research work is to resolve the privacy and secrecy issues raised during the data transmission over the internet. Firstly, data is decomposed into sub-bands using the integer wavelets. For decomposition, the Fresnelet transform is utilized which encrypts the secret data by choosing a unique key parameter to construct a dummy pattern. The dummy pattern is then embedded into an approximated sub-band of the cover image. Our proposed method reveals high-capacity and great imperceptibility of the secret embedded data. With the utilization of family of integer wavelets, the proposed novel approach becomes more efficient for hiding and retrieving process. It retrieved the secret hidden data from the embedded data blindly, without the requirement of original cover image.	[Muhammad, Nazeer] COMSATS Inst Informat Technol, Dept Math, Wah Cantt, Pakistan; [Bibi, Nargis] Fatima Jinnah Women Univ, Dept Comp Sci, Rawalpindi, Pakistan; [Mahmood, Zahid] COMSATS Inst Informat Technol, Dept Elect Engn, Abbotabad, Pakistan; [Akram, Tallha; Naqvi, Syed Rameez] COMSATS Inst Informat Technol, Dept Elect Engn, Wah Cantt, Pakistan	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Muhammad, N (corresponding author), COMSATS Inst Informat Technol, Dept Math, Wah Cantt, Pakistan.	nazeer@hanyang.ac.kr	Bibi, Nargis/ABE-6506-2021; Rameez Naqvi, Syed/Q-9336-2018; Muhammad, Nazeer/M-5653-2018	Muhammad, Nazeer/0000-0002-4056-9854; Mahmood, Zahid/0000-0003-4121-3558	Higher Education Commission (HEC) Pakistan [21-1399/SRGP/R-D/HEC/2016]	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan)	The author(s) received funding for this work from Higher Education Commission (HEC) Pakistan with following reference number: 21-1399/SRGP/R-D/HEC/2016.	Adams MD, 2002, REVERSIBLE INTEGER T; Anand D, 1998, ENG MED BIOL SOC 199; Bushra M, 2017, BIOMEDICAL RES IND, V28, P1; Chang CC, 2007, INFORM SCIENCES, V177, P2768, DOI 10.1016/j.ins.2007.02.019; Jung KH, 2009, COMPUT STAND INTER, V31, P465, DOI 10.1016/j.csi.2008.06.001; Lee S, 2007, IEEE T INF FOREN SEC, V2, P321, DOI 10.1109/TIFS.2007.905146; Liebling M, 2004, J OPT SOC AM A, V21, P2424, DOI 10.1364/JOSAA.21.002424; Lin C.C., 2010, J INF HIDING MULTIME, V1, P220; Lin C-C, 2009, P 3 INT C UB INF MAN; Lin CY, 2008, IEICE T INF SYST, VE91D, P836, DOI 10.1093/ietisy/e91-d.3.836; Luo LX, 2010, IEEE T INF FOREN SEC, V5, P187, DOI 10.1109/TIFS.2009.2035975; Mallat S, 2009, WAVELET TOUR OF SIGNAL PROCESSING: THE SPARSE WAY, P1; Muhammad N, 2013, IAENG T ENG TECHNOLO, P431; Muhammad N, 2012, WORLD C ENG, V2; Muhammad N, 2018, PATTERN ANAL APPL, V21, P997, DOI 10.1007/s10044-017-0613-z; Muhammad N, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1534-1; Muhammad N, 2015, IET IMAGE PROCESS, V9, P795, DOI 10.1049/iet-ipr.2014.0395; Nazeer M., 2012, Proceedings of the 2012 IEEE International Conference on Imaging Systems and Techniques (IST), P213, DOI 10.1109/IST.2012.6295590; Nazeer M, 2013, INT J ADV COMPUT SC, V4, P131; Olkkonen H, 2005, IEEE SIGNAL PROC LET, V12, P120, DOI 10.1109/LSP.2004.840904; Pan J-S, 2009, INFORM HIDING APPL, DOI 10.1007/978-3-642-02335-4; Peng F, 2012, SIGNAL PROCESS, V92, P54, DOI 10.1016/j.sigpro.2011.06.006; Sachnev V, 2009, IEEE T CIRC SYST VID, V19, P989, DOI 10.1109/TCSVT.2009.2020257; Sweldens W, 1998, SIAM J MATH ANAL, V29, P511, DOI 10.1137/S0036141095289051; Wang C, 2010, IM PROC ICIP 2010 17; Wang SY, 2013, IET IMAGE PROCESS, V7, P805, DOI 10.1049/iet-ipr.2012.0521; Wu HC, 2005, IEE P-VIS IMAGE SIGN, V152, P611, DOI 10.1049/ip-vis:20059022; Xuan GR, 2005, LECT NOTES COMPUT SC, V3304, P115; Yang CH, 2010, IET IMAGE PROCESS, V4, P223, DOI 10.1049/iet-ipr.2009.0316; Zaidan B. B., 2010, Journal of Applied Sciences, V10, P1650, DOI 10.3923/jas.2010.1650.1655	30	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176979	10.1371/journal.pone.0176979	http://dx.doi.org/10.1371/journal.pone.0176979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498855	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500008
J	Billingsley, MM; Riley, RS; Day, ES				Billingsley, Margaret M.; Riley, Rachel S.; Day, Emily S.			Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods	PLOS ONE			English	Article							FACTOR RECEPTOR EGFR; THERAPY	Accurate antigen detection is imperative for clinicians to diagnose disease, assess treatment success, and predict patient prognosis. The most common technique used for the detection of disease-associated biomarkers is the enzyme linked immunosorbent assay (ELISA). In an ELISA, primary antibodies are incubated with biological samples containing the biomarker of interest. Then, detectible secondary antibodies conjugated with horseradish peroxidase (HRP) bind the primary antibodies. Upon addition of a color-changing substrate, the samples provide a colorimetric signal that directly correlates to the targeted biomarker concentration. While ELISAs are effective for analyzing samples with high biomarker content, they lack the sensitivity required to analyze samples with low antigen levels. We hypothesized that the sensitivity of ELISAs could be enhanced by replacing freely delivered primary antibodies with antibody-nanoparticle conjugates that provide excess binding sites for detectible secondary antibodies, ultimately leading to increased signal. Here, we investigated the use of nanoshells (NS) decorated with antibodies specific to epidermal growth factor receptor (EGFR) as a model system (EGFR-NS). We incubated one healthy and two breast cancer cell lines, each expressing different levels of EGFR, with EGFR-NS, untargeted NS, or unconjugated EGFR antibodies, as well as detectable secondary antibodies. We found that EGFR-NS consistently increased signal intensity relative to unconjugated EGFR antibodies, with a substantial 13-fold enhancement from cells expressing high levels of EGFR. Additionally, 40x more unconjugated antibodies were required to detect EGFR compared to those conjugated to NS. Our results demonstrate that antibody-nanoparticle conjugates lower the detection limit of traditional ELISAs and support further investigation of this strategy with other antibodies and nanoparticles. Owing to their enhanced sensitivity, we anticipate that nanoparticle-modified ELISAs can be used to detect low levels of biomarkers found in various diseases, such as cancers, tuberculosis, and rheumatoid arthritis, and may ultimately enable earlier diagnosis, better prognostication, and improved treatment monitoring.	[Billingsley, Margaret M.; Riley, Rachel S.; Day, Emily S.] Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA; [Day, Emily S.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA; [Day, Emily S.] Helen F Graham Canc Ctr & Res Inst, Newark, DC 19713 USA	University of Delaware; University of Delaware; Helen F. Graham Cancer Center & Research Institute	Day, ES (corresponding author), Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.; Day, ES (corresponding author), Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.; Day, ES (corresponding author), Helen F Graham Canc Ctr & Res Inst, Newark, DC 19713 USA.	emilyday@udel.edu	Day, Emily/A-9026-2012	Day, Emily/0000-0002-8707-826X; Billingsley, Margaret/0000-0003-4499-9066	University of Delaware Research Foundation; American Cancer Society [IRG14-251-07-IRG]; National Institute of Health - National Institute of General Medical Sciences [R35GM119659, P20-GM103446]; state of Delaware; University of Delaware Summer Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446, R35GM119659] Funding Source: NIH RePORTER	University of Delaware Research Foundation; American Cancer Society(American Cancer Society); National Institute of Health - National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); state of Delaware; University of Delaware Summer Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Delaware Research Foundation provided funding for this project (https://www1.udel.edu/research/about/udrf.html). Research reported in this publication and funding for RSR was supported by Grant #IRG14-251-07-IRG from the American Cancer Society (http://www.cancer.org/index?_ga=1.211377937.58737158.1483112836) and by the National Institute of Health - National Institute of General Medical Sciences under Award Number R35GM119659 (hops://www.nigms.nih.gov/ Pages/default.aspx). Scanning electron microscopy was made possible by the Delaware IDeA Network of Biomedical Research Excellence program, supported by a grant from National Institute of Health - National Institute of General Medical Sciences (P20-GM103446) and the state of Delaware (http://de-inbre.org/ and https:/www.nigms.nih.gov/Pages/default.aspx). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. MMB received support from the University of Delaware Summer Scholars program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Ambrosi A, 2010, ANAL CHEM; Bidard F, 2010, SINGLE CIRCULATING T, P729; Bode GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126136; Buchholz TA, 2005, CORRELATES POOR SURV, P676; Chan WCW, 2016, PATIENTS HERE COMES; Chen H, 2013, SENSITIVE DETECTION, P431; Chen H, 2012, ANALYST, V137; Chung HH, 2013, ONE STEP DETECTION C, P2247; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Day ES, 2012, NANOMEDICINE-UK, V7, P1133, DOI [10.2217/NNM.11.189, 10.2217/nnm.11.189]; Day ES, 2010, INT J NANOMED, V5, P445; DUFF DG, 1993, LANGMUIR, V9, P2301, DOI 10.1021/la00033a010; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Hossain M, 2012, BIOSENS BIOELECTRON; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jo H, 2015, BIOSENS BIOELECTRON, V71, P129, DOI 10.1016/j.bios.2015.04.030; Kallergi G, 2008, BREAST CANCER RES, V10, P1; Kelley SO, ADV SPEED SENSITIVIT; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; LEBEAU J, 1987, INT J CANCER, V40, P189, DOI 10.1002/ijc.2910400210; Lee HWAY, 2010, BILE ACID REGULATES, P941; Li C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04893; Lowery AR, 2006, INT J NANOMED, V1, P149, DOI 10.2147/nano.2006.1.2.149; Ma HM, 2016, BIOSENS BIOELECTRON, V79, P379, DOI 10.1016/j.bios.2015.12.080; McKay JA, 2002, EUR J CANCER, V38, P2258, DOI 10.1016/S0959-8049(02)00234-4; Mehlen P, METASTASIS QUESTION; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Normanno N, 2006, EPIDERMAL GROWTH FAC; Oldenburg SJ, 1998, CHEM PHYS LETT, V288, P243, DOI 10.1016/S0009-2614(98)00277-2; Shen N, 2016, ONCOTARGET, P7; Wang L, 2013, NANOSTRUCTURED SUBST, V8, P1; Wang X, 2011, CANC RES; Wu X, IMPROVED SERS NANOPA; Yoon HJ, 2014, ACS NANO, V8, P1995, DOI 10.1021/nn5004277; Zhan L, 2014, NEW J CHEM, V38, P2935, DOI 10.1039/c4nj00253a; Zhang L, 2016, THERANOSTICS, P6	38	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177592	10.1371/journal.pone.0177592	http://dx.doi.org/10.1371/journal.pone.0177592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494030	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300142
J	Kindvall, SSI; Diaz, S; Svensson, J; Wollmer, P; Olsson, LE				Kindvall, Simon Sven Ivan; Diaz, Sandra; Svensson, Jonas; Wollmer, Per; Olsson, Lars E.			The change of longitudinal relaxation rate in oxygen enhanced pulmonary MRI depends on age and BMI but not diffusing capacity of carbon monoxide in healthy never-smokers	PLOS ONE			English	Article							LUNG-FUNCTION; PHYSICAL-ACTIVITY; TIME; BLOOD; T-1; IMPACT; LEVEL; T1	Objective Oxygen enhanced pulmonary MRI is a promising modality for functional lung studies and has been applied to a wide range of pulmonary conditions. The purpose of this study was to characterize the oxygen enhancement effect in the lungs of healthy, never-smokers, in light of a previously established relationship between oxygen enhancement and diffusing capacity of carbon monoxide in the lung (D-L,D-CO) in patients with lung disease. Methods In 30 healthy never-smoking volunteers, an inversion recovery with gradient echo read-out (Snapshot-FLASH) was used to quantify the difference in longitudinal relaxation rate, while breathing air and 100% oxygen Delta R1, at 1.5 Tesla. Measurements were performed under multiple tidal inspiration breath-holds. Results In single parameter linear models,Delta R1 exhibit a significant correlation with age (p = 0.003) and BMI (p = 0.0004), but not D-L,D-CO (p = 0.33). Stepwise linear regression of Delta R1 yields an optimized model including an age-BMI interaction term. Conclusion In this healthy, never-smoking cohort, age and BMI are both predictors of the change in MRI longitudinal relaxation rate when breathing oxygen. However, D-L,D-CO does not show a significant correlation with the oxygen enhancement. This is possibly because oxygen transfer in the lung is not diffusion limited at rest in healthy individuals. This work stresses the importance of using a physiological model to understand results from oxygen enhanced MRI.	[Kindvall, Simon Sven Ivan; Olsson, Lars E.] Lund Univ, Med Radiat Phys Translat Med, Malmo, Sweden; [Diaz, Sandra] Lund Univ, Med Radiol Translat Med, Malmo, Sweden; [Svensson, Jonas] Skane Univ Hosp, Med Imaging & Physiol, Lund, Sweden; [Wollmer, Per] Lund Univ, Clin Physiol Translat Med, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital; Lund University	Kindvall, SSI (corresponding author), Lund Univ, Med Radiat Phys Translat Med, Malmo, Sweden.	Simon.kindvall@med.lu.se	Wollmer, Per/S-5895-2019; Svensson, Jonas PO/B-8807-2013	Svensson, Jonas PO/0000-0003-1945-9594; Kindvall, Simon/0000-0003-2176-7529; Olsson, Lars E./0000-0001-6090-6697; Diaz Ruiz, Sandra/0000-0003-2016-4195	Allmanna Sjukhusets i Malmo stiftelse for bekampande av cancer; Stiftelsen for cancerforskning vid onkologiska kliniken vid Universitetsjukhuset MAS	Allmanna Sjukhusets i Malmo stiftelse for bekampande av cancer; Stiftelsen for cancerforskning vid onkologiska kliniken vid Universitetsjukhuset MAS	This work was supported by Allmanna Sjukhusets i Malmo stiftelse for bekampande av cancer and Stiftelsen for cancerforskning vid onkologiska kliniken vid Universitetsjukhuset MAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamidi FD, 2015, J CHRONIC OBSTRUCTIV, V2555, P1, DOI DOI 10.3109/15412555.2015.10488; Arnold JFT, 2004, MAGN RESON MATER PHY, V16, P246, DOI 10.1007/s10334-004-0034-z; Blockley NP, 2008, MAGN RESON MED, V60, P1313, DOI 10.1002/mrm.21792; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Hernan MA, 2011, INT J EPIDEMIOL, V40, P780, DOI 10.1093/ije/dyr041; Hueckel P., 2000, P INT SOC MAGNETIC R, V8, P1586; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; JENKINS SC, 1991, RESP MED, V85, P309, DOI 10.1016/S0954-6111(06)80102-2; Jensen RL, 1996, J INVEST MED, P44; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121520; Kershaw LE, 2010, MAGN RESON MED, V64, P1838, DOI 10.1002/mrm.22571; Kindvall SSI, 2016, J MAGN RESON IMAGING, V43, P1250, DOI 10.1002/jmri.25085; Kruger SJ, 2014, NMR BIOMED, V27, P1535, DOI 10.1002/nbm.3158; Ley S, 2007, INVEST RADIOL, V42, P283, DOI 10.1097/01.rli.0000258655.58753.5d; Li W, 2015, MAGN RESON MED; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; Meinel FG, 2013, EUR J RADIOL, V82, P1565, DOI 10.1016/j.ejrad.2013.04.019; Morgan AR, 2014, EUR J RADIOL, V83, P2093, DOI 10.1016/j.ejrad.2014.08.004; Muller CJ, 2002, RADIOLOGY, V222, P499, DOI 10.1148/radiol.2222000869; Nystad W, 2006, INT J TUBERC LUNG D, V10, P1399; Ohno Y, 2002, MAGN RESON MED, V47, P1139, DOI 10.1002/mrm.10168; Ohno Y, 2007, EUR J RADIOL, V64, P320, DOI 10.1016/j.ejrad.2007.08.006; Ohno Y, 2014, EUR J RADIOL, V83, P391, DOI 10.1016/j.ejrad.2013.11.001; Parsons TJ, 2005, INT J OBESITY, V29, P1212, DOI 10.1038/sj.ijo.0802932; Preisser AM, 2015, ADV EXP MED BIOL, V849, P65, DOI 10.1007/5584_2014_90; Renne J, 2015, RADIOLOGY, V276, P266, DOI 10.1148/radiol.15141486; Silvennoinen MJ, 2003, MAGNET RESON MED, V49, P568, DOI 10.1002/mrm.10370; Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319; Stanisz GJ, 2000, MAGNET RESON MED, V44, P665, DOI 10.1002/1522-2594(200011)44:5<665::AID-MRM1>3.0.CO;2-M; Triphan SMF, 2015, J MAGN RESON IMAGING, V42, P610, DOI 10.1002/jmri.24840; Triphan SMF, 2015, J MAGN RESON IMAGING, V41, P1708, DOI 10.1002/jmri.24692; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; West J.B., 2012, RESP PHYSL ESSENTIAL; Zaharchuk G, 2006, ACAD RADIOL, V13, P1016, DOI 10.1016/j.acra.2006.04.016; Zhang WJ, 2015, EUR J RADIOL, V84, P318, DOI 10.1016/j.ejrad.2014.10.021; Zheng SK, 2010, MAGN RESON MED, V63, P25, DOI 10.1002/mrm.22169; Zurek M, 2014, MAGN RESON MED, V71, P2180, DOI 10.1002/mrm.24876; Zurek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151211	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177670	10.1371/journal.pone.0177670	http://dx.doi.org/10.1371/journal.pone.0177670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494006	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300151
J	Liu, X; Shen, Y; Xie, JY; Bao, HH; Cao, Q; Wan, R; Xu, XM; Zhou, H; Huang, L; Xu, ZY; Zhu, WG; Hu, JZ; Cheng, XS; Hong, K				Liu, Xin; Shen, Yang; Xie, Jinyan; Bao, Huihui; Cao, Qing; Wan, Rong; Xu, Xiaoming; Zhou, Hui; Huang, Lin; Xu, Zhenyan; Zhu, Wengen; Hu, Jinzhu; Cheng, Xiaoshu; Hong, Kui			9 A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study	PLOS ONE			English	Article							IDIOPATHIC VENTRICULAR-FIBRILLATION; CHANNEL BLOCKADE; SCN5A MUTATIONS; SODIUM-CHANNEL; BRUGADA; ASSOCIATION; GUIDELINES; DEATH	Background Early repolarization syndrome (ERS) may be a near-Mendelian or an oligogenic disease; however, no direct evidence has been provided to support this theory. Methods and results We described a large Chinese family with nocturnal sudden cardiac death induced by ERS in most of the young male adults. One missense mutation (p.Q1916R) was found in the major subunit of the L-type calcium channel gene CACNA1C by the direct sequencing of candidate genes. A concomitant gain-of-function variant in the sodium channel gene SCN5A (p.R1193Q) was found to rescue the phenotype of the female CACNA1C-Q1916R mutation carriers, which led to the incomplete penetrance. The functional studies, via the exogenous expression approach, revealed that the CACNA1C-Q1916R mutation led to a decreasing L-type calcium current and the protein expression defect. The decreased calcium current produced by the mutant channel was improved by isoproterenol but exacerbated by testosterone. The effects of CACNA1C-Q1916R mutation and testosterone on cellular electrophysiology were further confirmed by the human ventricular action potential simulation. Conclusions Our results demonstrated that the loss-of-function CACNA1C-Q1916R mutation contributed to ERS-related sudden cardiac death, and the phenotypic incomplete penetrance was modified by the SCN5A-R1193Q variant and sex. These findings suggest that phenotypes of ERS are modified by multiple genetic factors, which supports the theory that ERS may be an oligogenic disease.	[Liu, Xin; Bao, Huihui; Zhou, Hui; Huang, Lin; Xu, Zhenyan; Zhu, Wengen; Hu, Jinzhu; Cheng, Xiaoshu; Hong, Kui] Nanchang Univ, Dept Cardiovasc Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Shen, Yang; Xie, Jinyan; Cao, Qing; Wan, Rong; Hong, Kui] Jiangxi Prov Key Lab Mol Med, Nanchang, Jiangxi, Peoples R China; [Xu, Xiaoming] Nanchang Univ, Dept Forens Med, Med Coll, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Hong, K (corresponding author), Nanchang Univ, Dept Cardiovasc Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China.; Hong, K (corresponding author), Jiangxi Prov Key Lab Mol Med, Nanchang, Jiangxi, Peoples R China.	hongkui88@163.com		Zhu, Wengen/0000-0002-1280-0158	National Natural Science Foundation of China [81530013]; Graduate Innovation Fund Project of Jiangxi Province [YC2012-B013, YC2013-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Innovation Fund Project of Jiangxi Province	The study design, data collection and analysis, decision to publish, or preparation of the manuscript were supported by grants from the National Natural Science Foundation of China (81530013), and Graduate Innovation Fund Project of Jiangxi Province (YC2012-B013 and YC2013-001).	Aizawa Y, 2013, J AM COLL CARDIOL, V62, P1015, DOI 10.1016/j.jacc.2013.05.030; Bezzina CR, 2015, CIRC RES, V116, P1919, DOI 10.1161/CIRCRESAHA.116.304030; Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Derval N, 2011, J AM COLL CARDIOL, V58, P722, DOI 10.1016/j.jacc.2011.04.022; Fukuyama M, 2013, CIRC J, V77, P1799, DOI 10.1253/circj.CJ-12-1457; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Giudicessi JR, 2012, NAT REV CARDIOL, V9, P319, DOI 10.1038/nrcardio.2012.3; Guo Q, 2016, INT J MOL MED, V37, P727, DOI 10.3892/ijmm.2016.2468; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Haissaguerre M, 2009, J CARDIOVASC ELECTR, V20, P93, DOI 10.1111/j.1540-8167.2008.01326.x; Hata Y, 2016, HEART RHYTHM, V13, P1544, DOI 10.1016/j.hrthm.2016.03.038; Hu D, 2014, INT J CARDIOL, V171, P431, DOI 10.1016/j.ijcard.2013.12.084; Hu ST, 2011, PHYSIOL RES, V60, P27, DOI 10.33549/physiolres.931948; Kawata H, 2012, HEART RHYTHM, V9, P77, DOI 10.1016/j.hrthm.2011.08.017; Koncz I, 2014, J MOL CELL CARDIOL, V68, P20, DOI 10.1016/j.yjmcc.2013.12.012; Kramer DB, 2011, CARDIOL REV, V19, P217, DOI 10.1097/CRD.0b013e3182203504; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li N, 2013, INT J MOL MED, V32, P661, DOI 10.3892/ijmm.2013.1422; Macfarlane PW, 2015, J AM COLL CARDIOL, V66, P470, DOI 10.1016/j.jacc.2015.05.033; Medeiros-Domingo A, 2010, HEART RHYTHM, V7, P1466, DOI 10.1016/j.hrthm.2010.06.016; Patton KK, 2016, CIRCULATION, V133, P1520, DOI 10.1161/CIR.0000000000000388; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Reinhard W, 2011, CIRC-CARDIOVASC GENE, V4, P134, DOI 10.1161/CIRCGENETICS.110.958298; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosso R, 2011, HEART RHYTHM, V8, P923, DOI 10.1016/j.hrthm.2011.01.037; Sager SJ, 2013, AM J CARDIOL, V112, P444, DOI 10.1016/j.amjcard.2013.03.052; Scragg JL, 2007, CELL CALCIUM, V42, P11, DOI 10.1016/j.ceca.2006.11.003; Shimizu W, 2005, NAT CLIN PRACT CARD, V2, P408, DOI 10.1038/ncpcardio0268; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Wang Q, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013300; Watanabe H, 2011, CIRC-ARRHYTHMIA ELEC, V4, P874, DOI 10.1161/CIRCEP.111.963983; Weiss S, 2013, CIRC RES, V113, P617, DOI 10.1161/CIRCRESAHA.113.301781; Xiong QM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001526	36	13	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177532	10.1371/journal.pone.0177532	http://dx.doi.org/10.1371/journal.pone.0177532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493952	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300130
J	Papendick, M; Bohner, G				Papendick, Michael; Bohner, Gerd			"Passive victim - strong survivor"? Perceived meaning of labels applied to women who were raped	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; JUDGMENTS; BLAME; RESPONSIBILITY; GENDER; CONSEQUENCES; DETERMINANTS; ATTRIBUTION; ACCEPTANCE; OBSERVER	Three experiments (total N = 464) were conducted in parallel with English- and German-speaking participants to examine the perceived meanings and effects of the labels "victim" versus "survivor" (and their German equivalents) when applied to a woman who was raped. In Study 1 (N = 179), participants read a rape vignette and then rated the meaning of the label it contained (either "victim" or "survivor") on a 15-item semantic differential. Independent of language and participant gender, "survivor" was perceived more positively overall (e.g., as strong, brave, active) than was "victim" (weak, passive, but also innocent). In Study 2 (N = 95), labels were varied within items assessing judgments of an acquaintance-rape case (e.g., "Does the victim [survivor]... carry a certain responsibility for what happened?"), focusing on short-term outcomes. Significant interaction effects of label and participants' gender emerged on case-related judgments. Participants in both language samples judged "survivor" to be a less appropriate term than "victim". In Study 3 (N = 190), participants read a text in which a woman who had been raped labeled herself as either "victim" or "survivor", focusing on the coping with sexual violence. As in Study 2, German-language participants showed no significant effects of the label on their case judgments but rejected the term "survivor" as inappropriate; English- language participants, by contrast, perceived the woman describing herself as "survivor" to be more psychologically stable and regarded the use of both labels as appropriate. Results are discussed in terms of their applied relevance for communicating about sexual violence.	[Papendick, Michael; Bohner, Gerd] Univ Bielefeld, Dept Psychol, Bielefeld, Germany	University of Bielefeld	Bohner, G (corresponding author), Univ Bielefeld, Dept Psychol, Bielefeld, Germany.	gerd.bohner@uni-bielefeld.de	Bohner, Gerd/B-2274-2008	Bohner, Gerd/0000-0002-0564-3625				Anderson KB, 1997, PERS SOC PSYCHOL B, V23, P295, DOI 10.1177/0146167297233008; Anderson Laura, 1994, WOMEN THER, V15, P5, DOI DOI 10.1300/J015V15N02_02; Auberle A, 2001, DUDEN DTSCH UNIVERSA; Barry Kathleen., 1979, FEMALE SEXUAL SLAVER; Black KA, 2008, VIOLENCE VICTIMS, V23, P115, DOI 10.1891/0886-6708.23.1.115; Bohner G, 2001, BRIT J SOC PSYCHOL, V40, P515, DOI 10.1348/014466601164957; Bohner G., 2009, RAPE CHALLENGING CON, P17, DOI DOI 10.4324/9781843927129; Bohner G, 2010, SEX ROLES, V62, P568, DOI 10.1007/s11199-009-9665-x; Boyle KS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1197; BRANSCOMBE NR, 1992, J SOC CLIN PSYCHOL, V11, P80, DOI 10.1521/jscp.1992.11.1.80; Cohen J.E., 1988, STAT POWER ANAL BEHA; Convery A., 2006, 2006 AUSTR POL STUD; Dunn JL, 2005, SOCIOL INQ, V75, P1, DOI 10.1111/j.1475-682X.2005.00110.x; Eyssel F, 2011, J INTERPERS VIOLENCE, V26, P1579, DOI 10.1177/0886260510370593; Gerger H, 2007, AGGRESSIVE BEHAV, V33, P422, DOI 10.1002/ab.20195; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Grubb A, 2008, AGGRESS VIOLENT BEH, V13, P396, DOI 10.1016/j.avb.2008.06.006; HENLEY NM, 1995, J LANG SOC PSYCHOL, V14, P60, DOI 10.1177/0261927X95141004; Hockett Jericho M., 2014, EXPRESSION INEQUALIT, P81; Hockett JM, 2013, THESIS; Hornby Albert Sydney, 2005, OXFORD ADV LEARNERS, P1620; KRAHE B, 1988, J APPL SOC PSYCHOL, V18, P50, DOI 10.1111/j.1559-1816.1988.tb00004.x; KRAHE B, 1991, J COMMUNITY APPL SOC, V1, P223, DOI 10.1002/casp.2450010305; LAMB S, 1991, AM J ORTHOPSYCHIAT, V61, P250, DOI 10.1037/h0079243; Lamb S., 1999, NEW VERSIONS VICTIMS; Leisenring A, 2006, SYMB INTERACT, V29, P307, DOI 10.1525/si.2006.29.3.307; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; LUGINBUHL J, 1981, SEX ROLES, V7, P547, DOI 10.1007/BF00288631; Mills T., 1985, QUALITATIVE SOCIOLOG, V8, P103, DOI DOI 10.1007/BF00989467; Morgan BL, 1996, SEX ROLES, V34, P359; Osgood C.E., 1957, MEASUREMENT MEANING; Park CL, 2009, J GEN INTERN MED, V24, P430, DOI 10.1007/s11606-009-0993-x; POLLARD P, 1992, BRIT J SOC PSYCHOL, V31, P307, DOI 10.1111/j.2044-8309.1992.tb00975.x; Rheinheimer DC, 2001, J EXP EDUC, V69, P373, DOI 10.1080/00220970109599493; Rogers P, 2007, J INTERPERS VIOLENCE, V22, P566, DOI 10.1177/0886260506298827; Skjelsbaek I, 2006, FEM PSYCHOL, V16, P373, DOI 10.1177/0959353506068746; Sussenbach P, 2017, PSYCHOL CRIME LAW, V23, P291, DOI 10.1080/1068316X.2016.1247160; Thompson Monica, 2000, SEX RELATSH THER, V15, P325, DOI DOI 10.1080/713697439; van der Bruggen M, 2014, AGGRESS VIOLENT BEH, V19, P523, DOI 10.1016/j.avb.2014.07.008	39	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177550	10.1371/journal.pone.0177550	http://dx.doi.org/10.1371/journal.pone.0177550			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493976	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300134
J	Tao, T; Zhou, CJ; Wang, Q; Chen, XR; Sun, Q; Zhao, TY; Ye, JC; Wang, Y; Zhang, ZY; Zhang, YL; Guo, ZJ; Wang, XB; Li, DW; Yu, JL; Han, CG				Tao, Tao; Zhou, Cui-Ji; Wang, Qian; Chen, Xiang-Ru; Sun, Qian; Zhao, Tian-Yu; Ye, Jian-Chun; Wang, Ying; Zhang, Zong-Ying; Zhang, Yong-Liang; Guo, Ze-Jian; Wang, Xian-Bing; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui			Rice black streaked dwarf virus P7-2 forms a SCF complex through binding to Oryza sativa SKP1-like proteins, and interacts with GID2 involved in the gibberellin pathway	PLOS ONE			English	Article							UBIQUITIN-LIGASE COMPLEX; F-BOX SUBUNIT; FUNCTIONAL-ANALYSIS; ANALYSIS REVEALS; COMPLETE GENOME; IN-VIVO; ARABIDOPSIS; GENES; DEGRADATION; EXPRESSION	As a core subunit of the SCF complex that promotes protein degradation through the 26S proteasome, S-phase kinase-associated protein 1 (SKP1) plays important roles in multiple cellular processes in eukaryotes, including gibberellin (GA), jasmonate, ethylene, auxin and light responses. P7-2 encoded by Rice black streaked dwarf virus (RBSDV), a devastating viral pathogen that causes severe symptoms in infected plants, interacts with SKP1 from different plants. However, whether RBSDV P7-2 forms a SCF complex and targets host proteins is poorly understood. In this study, we conducted yeast two-hybrid assays to further explore the interactions between P7-2 and 25 type I Oryza sativa SKP1-like (OSK) proteins, and found that P7-2 interacted with eight OSK members with different binding affinity. Co-immunoprecipitation assay further confirmed the interaction of P7-2 with OSK1, OSK5 and OSK20. It was also shown that P7-2, together with OSK1 and O. sativa Cullin-1, was able to form the SCF complex. Moreover, yeast two-hybrid assays revealed that P7-2 interacted with gibberellin insensitive dwarf2 (GID2) from rice and maize plants, which is essential for regulating the GA signaling pathway. It was further demonstrated that the N-terminal region of P7-2 was necessary for the interaction with GID2. Overall, these results indicated that P7-2 functioned as a component of the SCF complex in rice, and interaction of P7-2 with GID2 implied possible roles of the GA signaling pathway during RBSDV infection.	[Tao, Tao; Zhou, Cui-Ji; Chen, Xiang-Ru; Sun, Qian; Zhao, Tian-Yu; Ye, Jian-Chun; Wang, Ying; Zhang, Zong-Ying; Zhang, Yong-Liang; Guo, Ze-Jian; Wang, Xian-Bing; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Tao, Tao; Zhou, Cui-Ji; Chen, Xiang-Ru; Sun, Qian; Zhao, Tian-Yu; Ye, Jian-Chun; Wang, Ying; Zhang, Zong-Ying; Zhang, Yong-Liang; Guo, Ze-Jian; Wang, Xian-Bing; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wang, Qian] Chinese Acad Agr Sci, Tobacco Res Inst, Key Lab Tobacco Gene Resources, Qingdao, Shandong, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS	Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Han, CG (corresponding author), China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China.	hanchenggui@cau.edu.cn	Wang, Xianbing/E-4831-2013; Li, Dawei/I-8751-2016; Zhang, Yongliang/AAE-7639-2021	Li, Dawei/0000-0003-4133-1263; Zhang, Yongliang/0000-0002-6790-1044; Wang, Xian-Bing/0000-0003-3082-2462; Sun, Qian/0000-0003-4650-0257	National Natural Science Foundation of China [31201489]; National Department Public Benefit Research Funds [201303021]; 111 Project [613006]; Project of State Key Laboratory for Agrobiotechnology [2016SKLAB-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Funds; 111 Project(Ministry of Education, China - 111 Project); Project of State Key Laboratory for Agrobiotechnology	This research was supported by the National Natural Science Foundation of China (31201489, http://www.nsfc.gov.cn, QW received the funding), the National Department Public Benefit Research Funds (201303021, JLY received the funding), the 111 Project (613006, CGH received the funding), and The Project of State Key Laboratory for Agrobiotechnology (2016SKLAB-6, CGH received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; Akita F, 2012, J VIROL, V86, P746, DOI 10.1128/JVI.00826-11; Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Aronson MN, 2000, J VIROL, V74, P2967, DOI 10.1128/JVI.74.7.2967-2972.2000; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai FW, 2002, VIRUS GENES, V25, P201, DOI 10.1023/A:1020170020581; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Bragg JN, 2004, MOL PLANT PATHOL, V5, P465, DOI [10.1111/j.1364-3703.2004.00246.x, 10.1111/J.1364-3703.2004.00246.X]; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dantu SC, 2016, PROTEINS, V84, P159, DOI 10.1002/prot.24963; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; De V D, 2014, FRONT PLANT SCI, V5, P611; De Vleesschauwer D, 2013, TRENDS PLANT SCI, V18, P555, DOI 10.1016/j.tplants.2013.07.002; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Eltahir YM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-145; Fang S, 2001, ARCH VIROL, V146, P167, DOI 10.1007/s007050170200; Gomi K, 2004, PLANT J, V37, P626, DOI 10.1111/j.1365-313X.2003.01990.x; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hao Q, 2017, PLANT CELL REP, V36, P151, DOI 10.1007/s00299-016-2066-z; He P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-136; He Y, 2016, NEW PHYTOL; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Isogai M, 1998, J GEN VIROL, V79, P1487, DOI 10.1099/0022-1317-79-6-1487; Kahloul S, 2013, DNA RES, V20, P67, DOI 10.1093/dnares/dss034; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KAUFMAN RJ, 1987, EMBO J, V6, P187, DOI 10.1002/j.1460-2075.1987.tb04737.x; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kuroda H, 2002, PLANT CELL PHYSIOL, V43, P1073, DOI 10.1093/pcp/pcf151; Liu HJ, 2007, VIRUS RES, V127, P34, DOI 10.1016/j.virusres.2007.03.017; Liu HJ, 2007, FEBS LETT, V581, P2534, DOI 10.1016/j.febslet.2007.04.071; Liu YJ, 2011, IEEE SYS MAN CYBERN, P2011, DOI 10.1109/ICSMC.2011.6083967; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qian W, 2013, VIROL J, V10, P1; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SHIKATA E, 1977, VIROLOGY, V77, P826, DOI 10.1016/0042-6822(77)90502-5; SHINKAI A., 1962, Bull. natn. Inst. agric. Sci., Tokyo, V14, P1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Takahashi N, 2004, PLANT CELL PHYSIOL, V45, P83, DOI 10.1093/pcp/pch009; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang ZH, 2003, VIRUS GENES, V27, P163, DOI 10.1023/A:1025776527286; Wei TY, 2016, ANNU REV PHYTOPATHOL, V54, P99, DOI 10.1146/annurev-phyto-080615-095900; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Wu Z.Z., 2013, THESIS; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang J, 2014, ARCH VIROL, V159, P307, DOI 10.1007/s00705-013-1832-2; [张爱红 Zhang Aihong], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P217; Zhang CZ, 2008, J GEN VIROL, V89, P1770, DOI 10.1099/vir.0.2008/000109-0; Zhang HM, 2001, ARCH VIROL, V146, P2331, DOI 10.1007/s007050170006; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou YC, 2002, PLANT PHYSIOL, V128, P1098, DOI 10.1104/pp.010811; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306; Zhuo T, 2014, MOL PLANT MICROBE IN, V27, P515, DOI 10.1094/MPMI-08-13-0231-R	69	25	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177518	10.1371/journal.pone.0177518	http://dx.doi.org/10.1371/journal.pone.0177518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494021	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300127
J	He, C; Chen, YC; Yang, KX; Zhai, ZX; Zhao, WJ; Liu, SY; Ding, JM; Dai, RH; Yang, LY; Xu, K; Zhou, ZX; Gu, CJ; Huang, QZ; Meng, H				He, Chuan; Chen, Yongcan; Yang, Kaixuan; Zhai, Zhengxiao; Zhao, Wenjing; Liu, Shuyun; Ding, Jinmei; Dai, Ronghua; Yang, Lingyu; Xu, Ke; Zhou, Zhenxiang; Gu, Caiju; Huang, Qizhong; Meng, He			Genetic pattern and gene localization of polydactyly in Beijing fatty chicken	PLOS ONE			English	Article							RANGE SHH ENHANCER; SONIC HEDGEHOG; SNP DISCOVERY; EXPRESSION; LIMB; ASSOCIATION; LINKAGE; INHERITANCE; MUTATION; MOUSE	Polydactyly, a common heritable limb malformation in vertebrates, is characterized by supernumerary digits. In chickens, basic characteristics and rough dominant genes have been explored in past decades; however, the elaborate pattern of inheritance and the determinant gene remain obscure. In this study, different types of polydactylism were classified by the numbers and the shapes of toes, including the newly defined subtypes of B' and G, for the Beijing fatty chicken, a native breed of chicken from China. Through experiments on hybridization, we demonstrated a complete dominant inheritance of polydactyly instead of an incomplete penetrance or genetic modification of the previous conjecture. In particular, by using the F2 population of the five-digit purebred line of Beijing fatty chicken backcrossed to Shiqiza chicken and by using restriction-site associated DNA based markers, we performed a genome-wide association study on the trait of polydactyly. Furthermore, whole genome resequencing strategy was applied to sweep SNPs across the whole genome. An outlier-based F-st approach was employed to search for signatures of selection, and results indicated that the determinant mutation was found in the region ranging from 8.3 Mb to 8.7 Mb, where the polydactyly candidate gene LMBR1 was located. The G/T mutation of rs80659072 was identified to be highly associated with polydactyly in our resequencing and was validated in random samples from an expanded population. Thus, we confirmed that LMBR1 was the causative gene of polydactyly in the Beijing fatty chicken by using GWAS with restriction-site associated DNA based markers and resequencing.	[He, Chuan; Chen, Yongcan; Zhai, Zhengxiao; Zhao, Wenjing; Liu, Shuyun; Ding, Jinmei; Dai, Ronghua; Yang, Lingyu; Xu, Ke; Meng, He] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Anim Sci, Shanghai, Peoples R China; [He, Chuan; Chen, Yongcan; Zhai, Zhengxiao; Zhao, Wenjing; Liu, Shuyun; Ding, Jinmei; Dai, Ronghua; Yang, Lingyu; Xu, Ke; Meng, He] Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China; [Yang, Kaixuan; Zhou, Zhenxiang; Gu, Caiju; Huang, Qizhong] Shanghai Acad Agr Sci, Anim Husb & Vet Res Inst, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Academy of Agricultural Sciences	Meng, H (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Anim Sci, Shanghai, Peoples R China.; Meng, H (corresponding author), Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China.; Huang, QZ (corresponding author), Shanghai Acad Agr Sci, Anim Husb & Vet Res Inst, Shanghai, Peoples R China.	huangqizh@163.com; menghe@sjtu.edu.cn	ding, jin/GVT-5062-2022; He, Chuan/AAN-4356-2020	He, Chuan/0000-0002-8532-2898	National Science Foundation of China [31272430]; Agriculture Development through Science and Technology Key Project of Shanghai [2012, 2-3]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Development through Science and Technology Key Project of Shanghai	This work was supported by National Science Foundation of China (grant no. 31272430) and the Agriculture Development through Science and Technology Key Project of Shanghai (grant no. 2012, 2-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054454; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BERRY AJ, 1991, GENETICS, V129, P1111; Bond CJ, 1920, J GENET, V10, P87, DOI 10.1007/BF02983525; Bond CJ, 1926, J GENET, V16, P253, DOI 10.1007/BF02983001; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dundar M, 2001, J MED GENET, V38, P304, DOI 10.1136/jmg.38.5.304; Dunn IC, 2011, DEV DYNAM, V240, P1163, DOI 10.1002/dvdy.22623; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Gurnett CA, 2007, AM J MED GENET A, V143A, P27, DOI 10.1002/ajmg.a.31563; Harman MT, 1938, AM NAT, V72, P59, DOI 10.1086/280765; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hill RE, 2003, J ANAT, V202, P13, DOI 10.1046/j.1469-7580.2003.00148.x; Hohenlohe Paul A, 2012, Methods Mol Biol, V888, P235, DOI 10.1007/978-1-61779-870-2_14; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang YQ, 2006, GENE, V374, P10, DOI 10.1016/j.gene.2005.07.047; Hutchinson JB, 1931, AM NAT, V65, P376, DOI 10.1086/280381; Hutt FB, 1943, AM NAT, V77, P70, DOI 10.1086/281099; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Masuya H, 2007, GENOMICS, V89, P207, DOI 10.1016/j.ygeno.2006.09.005; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; Punnett RC, 1929, J GENET, V21, P341, DOI 10.1007/BF02984212; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SESGIN MZ, 1961, PLAST RECONSTR SURG, V27, P261, DOI 10.1097/00006534-196103000-00003; Sheng XH, 2015, GENE, V568, P176, DOI 10.1016/j.gene.2015.05.049; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Somes RG, 1990, POULTRY BREEDING GEN, P209; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sturkie PD, 1942, J GENET, V27, P172; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; Warren DC, 1944, GENETICS, V29, P217; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang K, 2013, ANIM GENET, V44, P118, DOI 10.1111/j.1365-2052.2012.02369.x; Zhai ZX, 2015, ANIM GENET, V46, P216, DOI 10.1111/age.12250; Zhang ZB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149010; Zhao G., 2005, CHINA POULTRY, V27, P49	42	3	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176113	10.1371/journal.pone.0176113	http://dx.doi.org/10.1371/journal.pone.0176113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489934	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314100014
J	Bettecken, K; Bernhard, F; Sartor, J; Hobert, MA; Hofmann, M; Gladow, T; van Uem, JMT; Liepelt-Scarfone, I; Maetzler, W				Bettecken, Kristina; Bernhard, Felix; Sartor, Jennifer; Hobert, Markus A.; Hofmann, Marc; Gladow, Till; van Uem, Janet M. T.; Liepelt-Scarfone, Inga; Maetzler, Walter			No relevant association of kinematic gait parameters with Health-related Quality of Life in Parkinson ' s disease	PLOS ONE			English	Article							MOTOR IMPAIRMENT; DETERMINANTS; DISABILITY; DEPRESSION; SYMPTOMS; DOMAINS; PEOPLE; ICF	Background Health-related Quality of Life (HrQoL) is probably the most important outcome parameter for the evaluation and management of chronic diseases. As this parameter is subjective and prone to bias, there is an urgent need to identify objective surrogate markers. Gait velocity has been shown to be associated with HrQoL in numerous chronic diseases, such as Parkinson's disease (PD). With the development and wide availability of simple-to-use wearable sensors and sophisticated gait algorithms, kinematic gait parameters may soon be implemented in clinical routine management. However, the association of such kinematic gait parameters with HrQoL in PD has not been assessed to date. Methods Kinematic gait parameters from a 20-meter walk from 43 PD patients were extracted using a validated wearable sensor system. They were compared with the Visual Analogue Scale of the Euro-Qol-5D (EQ-5D VAS) by performing a multiple regression analysis, with the International Classification of Functioning, Disability and Health (ICF) model as a framework. Results Use of assistive gait equipment, but no kinematic gait parameter, was significantly associated with HrQoL. Conclusion The widely accepted concept of a positive association between gait velocity and HrQoL may, at least in PD, be driven by relatively independent parameters, such as assistive gait equipment.	[Bettecken, Kristina; Bernhard, Felix; Sartor, Jennifer; Hobert, Markus A.; van Uem, Janet M. T.; Liepelt-Scarfone, Inga; Maetzler, Walter] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany; [Bettecken, Kristina; Bernhard, Felix; Sartor, Jennifer; Hobert, Markus A.; van Uem, Janet M. T.; Liepelt-Scarfone, Inga; Maetzler, Walter] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Bettecken, Kristina; Bernhard, Felix; Sartor, Jennifer; Hobert, Markus A.; van Uem, Janet M. T.; Liepelt-Scarfone, Inga; Maetzler, Walter] DZNE, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Hofmann, Marc; Gladow, Till] Hasomed, Magdeburg, Germany; [Gladow, Till] Jena Univ Hosp, Inst Physiotherapy, Dept Clin Res, Jena, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Friedrich Schiller University of Jena	van Uem, JMT (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany.; van Uem, JMT (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany.; van Uem, JMT (corresponding author), DZNE, German Ctr Neurodegenerat Dis, Tubingen, Germany.	janet.uem@uni-tuebingen.de	Maetzler, Walter/AAE-5831-2020; Hobert, Markus A./AAR-3234-2020; Maetzler, Walter/A-6796-2011	Maetzler, Walter/0000-0002-5945-4694; Hobert, Markus A./0000-0002-7558-8107; Maetzler, Walter/0000-0002-5945-4694	Hasomed	Hasomed	The authors received no specific funding for this work. Hasomed provided support in the form of salaries for authors MH and TG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bryant MS, 2012, DISABIL REHABIL-ASSI, V7, P149, DOI 10.3109/17483107.2011.602461; Buck PO, 2011, J PARKINSON DIS, V1, P253, DOI 10.3233/JPD-2011-11035; Carod-Artal FJ, 2008, PARKINSONISM RELAT D, V14, P102, DOI 10.1016/j.parkreldis.2007.06.011; Clarke CE, 2016, JAMA NEUROL, P1; Cubo E, 2003, PARKINSONISM RELAT D, V10, P9, DOI 10.1016/S1353-8020(03)00060-9; Cubo E, 2012, NEUROEPIDEMIOLOGY, V38, P48, DOI 10.1159/000334314; Debi R, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-127; Delbaere K, 2010, BMJ-BRIT MED J, V341, P4165, DOI DOI 10.1136/BMJ.C4165; Derlien S, 2010, MAN MED, V48, P254, DOI 10.1007/s00337-010-0766-y; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Donath L, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0115-z; Drapier S, 2016, J NEUROL; Ellis T, 2011, PARKINSONISM RELAT D, V17, P693, DOI 10.1016/j.parkreldis.2011.07.004; Espay AJ, 2016, MOV DISORD; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gobbens RJJ, 2012, GERONTOLOGIST, V52, P619, DOI 10.1093/geront/gnr135; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Greene T, 2007, J AM GERIATR SOC, V55, P1888, DOI 10.1111/j.1532-5415.2007.01384.x; Hammerla N.Y., 2015, PD DIS STATE ASSESSM; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kostanjsek N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S3; Kotagal V, 2014, MODIFIABLE CARDIOVAS; LACHS MS, 1990, ANN INTERN MED, V112, P699, DOI 10.7326/0003-4819-112-9-699; Levy G, 2000, NEUROLOGY, V55, P539, DOI 10.1212/WNL.55.4.539; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Maetzler W, 2016, MOV DISORD; Maetzler W, 2013, MOVEMENT DISORD, V28, P1628, DOI 10.1002/mds.25628; Maetzler W, 2012, MOVEMENT DISORD, V27, P627, DOI 10.1002/mds.24973; Marras C, 2008, MOVEMENT DISORD, V23, P653, DOI 10.1002/mds.21853; Martinez-Martin P, 2014, EUR J NEUROL, V21, P519, DOI 10.1111/ene.12349; Martinez-Martin P, 2004, MOVEMENT DISORD, V19, P312, DOI 10.1002/mds.10656; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Mayer L, INT J MS CARE, V17, P35; Muslimovic D, 2008, NEUROLOGY, V70, P2241, DOI 10.1212/01.wnl.0000313835.33830.80; Park K, 2016, CLIN BIOMECH, V33, P92, DOI 10.1016/j.clinbiomech.2016.02.012; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Richard Irene Hegeman, 2007, Neuropsychiatr Dis Treat, V3, P903; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P67, DOI 10.1136/jnnp.69.1.67; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Shearer J, 2012, J NEUROL, V259, P462, DOI 10.1007/s00415-011-6202-y; Slawek J, 2005, PARKINSONISM RELAT D, V11, P465, DOI 10.1016/j.parkreldis.2005.04.006; Soh SE, 2013, QUAL LIFE RES, V22, P1543, DOI 10.1007/s11136-012-0289-1; Toosizadeh N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124763; van Uem J, 2016, J PARKINSONS DIS; Van Uem JMT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151997; van Uem JMT, 2016, NEUROSCI BIOBEHAV R, V61, P26, DOI 10.1016/j.neubiorev.2015.11.014; Ward CD, 2000, J NEUROL NEUROSUR PS, V69, P289; Winter Y, 2011, PARKINSONISM RELAT D, V17, P265, DOI 10.1016/j.parkreldis.2011.01.003; Wood-Dauphinee S, 1999, J CLIN EPIDEMIOL, V52, P355, DOI 10.1016/S0895-4356(98)00179-6; Yoo Wonsuk, 2014, Int J Appl Sci Technol, V4, P9	55	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176816	10.1371/journal.pone.0176816	http://dx.doi.org/10.1371/journal.pone.0176816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28531171	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400008
J	Song, J; Hu, YJ; Li, JQ; Zheng, HW; Wang, JJ; Guo, L; Ning, RT; Li, HZ; Yang, ZN; Fan, HT; Liu, LD				Song, Jie; Hu, Yajie; Li, Jiaqi; Zheng, Huiwen; Wang, Jingjing; Guo, Lei; Ning, Ruotong; Li, Hongzhe; Yang, Zening; Fan, Haitao; Liu, Longding			Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing	PLOS ONE			English	Article							INACTIVATED ENTEROVIRUS 71; EPIDEMIOLOGY; VACCINE; EXPRESSION; IMMUNITY; THERAPEUTICS; BIOGENESIS; MIR-1246; DISEASES	Enterovirus 71 (EV71) and Coxsackievirus A16 (CA16) remain the predominant pathogens in hand, foot, and mouth disease (HFMD), but the factors underlying the pathogenesis of EV71 and CA16 infections have not been elucidated. Recently, the functions of microRNAs (miRNAs) in pathogen-host interactions have been highlighted. In the present study, we performed comprehensive miRNA profiling in EV71- and CA16-infected human umbilical vein endothelial cells (HUVECs) at multiple time points using high-throughput sequencing. The results showed that 135 known miRNAs exhibited remarkable differences in expression. Of these, 30 differentially expressed miRNAs presented opposite trends in EV71- and CA16-infected samples. Subsequently, we mainly focused on the 30 key differentially expressed miRNAs through further screening to predict targets. Gene ontology (GO) and pathway analysis of the predicted targets showed the enrichment of 14 biological processes, 9 molecular functions, 8 cellular components, and 85 pathways. The regulatory networks of these miRNAs with predicted targets, GOs, pathways, and co-expression genes were determined, suggesting that miRNAs display intricate regulatory mechanisms during the infection phase. Consequently, we specifically analyzed the hierarchical GO categories of the predicted targets involved in biological adhesion. The results indicated that the distinct changes induced by EV71 and CA16 infection may be partly linked to the function of the blood-brain barrier. Taken together, this is the first report describing miRNA expression profiles in HUVECs with EV71 and CA16 infections using high-throughput sequencing. Our data provide useful insights that may help to elucidate the different host-pathogen interactions following EV71 and CA16 infection and offer novel therapeutic targets for these infections.	[Liu, Longding] Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China; Peking Union Med Coll, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, LD (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China.	longdingl@gmail.com	Guo, Lei/AEU-0178-2022; wang, jing/GRS-7509-2022; Song, Jie/AAV-3499-2020; WANG, JINGYI/GSJ-1241-2022	Guo, Lei/0000-0003-1733-1802	CAMS Innovation Fund for Medical Sciences [2016-I2M-1-014, 2016-I2M-1-019]; National Natural Sciences Foundations of China [81373142]	CAMS Innovation Fund for Medical Sciences; National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported CAMS Innovation Fund for Medical Sciences (2016-12M1-014 and 2016-12M-1-019) (http://www.ac. cn/) and National Natural Sciences Foundations of China (81373142) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported CAMS Innovation Fund for Medical Sciences (2016-I2M-1-014 and 2016-I2M-1-019) and National Natural Sciences Foundations of China (81373142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Auvinen E, 2017, MOL DIAGN THER, V21, P45, DOI 10.1007/s40291-016-0236-x; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cai YC, 2014, VACCINE, V32, P2406, DOI 10.1016/j.vaccine.2014.03.012; Chai S, 2016, HEPATOLOGY, V64, P2062, DOI 10.1002/hep.28821; Chang C-Y, 2015, GLIA; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x; Chen Xiaojing, 2016, Zhejiang Da Xue Xue Bao Yi Xue Ban, V45, P342; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hu YJ, 2017, VIRUS RES, V228, P90, DOI 10.1016/j.virusres.2016.11.024; Hui YJ, 2016, INT J BIOCHEM CELL B, V81, P20, DOI 10.1016/j.biocel.2016.10.011; Koh WM, 2016, PEDIATR INFECT DIS J, V35, pE285, DOI 10.1097/INF.0000000000001242; Lee JJ, 2011, J PROTEOMICS, V74, P2018, DOI 10.1016/j.jprot.2011.05.022; Li JX, 2014, EXPERT REV VACCINES, V13, P609, DOI 10.1586/14760584.2014.897617; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Louten J, 2015, BIOMARK INSIGHTS, V10, P25, DOI 10.4137/BMI.S29512; Lugo D, 2016, CURR OPIN PEDIATR, V28, P107, DOI 10.1097/MOP.0000000000000303; Lui YLE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102997; Mao QY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.73; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169; Monastyrskaya K, 2013, AM J PATHOL, V182, P431, DOI 10.1016/j.ajpath.2012.10.020; Ng QY, 2015, VIRUSES-BASEL, V7, P6441, DOI 10.3390/v7122949; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ong KC, 2015, BRAIN PATHOL, V25, P614, DOI 10.1111/bpa.12279; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pathinayake PS, 2015, VIRUSES-BASEL, V7, P6613, DOI 10.3390/v7122961; Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059; Pons-Salort M, 2015, CURR OPIN INFECT DIS, V28, P479, DOI 10.1097/QCO.0000000000000187; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598; Sakha S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38750; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Tahamtan A, 2016, REV MED VIROL, V26, P389, DOI 10.1002/rmv.1894; Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003; Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786; Wang CY, 2015, J GEN VIROL, V96, P3010, DOI 10.1099/jgv.0.000235; Wang JJ, 2017, VIROLOGY, V500, P198, DOI 10.1016/j.virol.2016.10.031; Wang RYL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24149; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xu F, 2014, CLIN TRANSL ONCOL, V16, P980, DOI 10.1007/s12094-014-1183-9; Xu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095272; Xun M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0288-2; Yuan DX, 2016, ONCOTARGET, V7, P32707, DOI 10.18632/oncotarget.9017; Zhang WC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11702; Zhu Z, 2016, BIOMED RES INT, V2016	51	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177657	10.1371/journal.pone.0177657	http://dx.doi.org/10.1371/journal.pone.0177657			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531227	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400021
J	Bruce, MA; Martins, D; Duru, K; Beech, BM; Sims, M; Harawa, N; Vargas, R; Kermah, D; Nicholas, SB; Brown, A; Norris, KC				Bruce, Marino A.; Martins, David; Duru, Kenrik; Beech, Bettina M.; Sims, Mario; Harawa, Nina; Vargas, Roberto; Kermah, Dulcie; Nicholas, Susanne B.; Brown, Arleen; Norris, Keith C.			Church attendance, allostatic load and mortality in middle aged adults	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; RELIGIOUS SERVICES; RACIAL DISPARITIES; AMERICAN WOMEN; OLDER-ADULTS; ALL-CAUSE; FREQUENCY; SPIRITUALITY; MACARTHUR; STRESS	Importance Religiosity has been associated with positive health outcomes. Hypothesized pathways for this association include religious practices, such as church attendance, that result in reduced stress. Objective The objective of this study was to examine the relationship between religiosity (church attendance), allostatic load (AL) (a physiologic measure of stress) and all-cause mortality in middle-aged adults. Design, setting and participants Data for this study are from NHANES III (1988-1994). The analytic sample (n = 5449) was restricted to adult participants, who were between 40-65 years of age at the time of interview, had values for at least 9 out of 10 clinical/biologic markers used to derive AL, and had complete information on church attendance. Main outcomes and measures The primary outcomes were AL and mortality. AL was derived from values for metabolic, cardiovascular, and nutritional/inflammatory clinical/biologic markers. Mortality was derived from a probabilistic algorithm matching the NHANES III Linked Mortality File to the National Death Index through December 31, 2006, providing up to 18 years follow-up. The primary predictor variable was baseline report of church attendance over the past 12 months. Cox proportional hazard logistic regression models contained key covariates including socioeconomic status, self-rated health, co-morbid medical conditions, social support, healthy eating, physical activity, and alcohol intake. Results Churchgoers (at least once a year) comprised 64.0% of the study cohort (n = 3782). Non-churchgoers had significantly higher overall mean AL scores and higher prevalence of high-risk values for 3 of the 10 markers of AL than did churchgoers. In bivariate analyses non-churchgoers, compared to churchgoers, had higher odds of an AL score (2-3) under bar (OR 1.24; 95% CI 1.01, 1.50) or >= 4 (OR 1.38; 95% CI 1.11, 1.71) compared to AL score of 0-1. More frequent churchgoers (more than once a week) had a 55% reduction of all-cause mortality risk compared with non-churchgoers. (HR 0.45, CI 0.24-0.85) in the fully adjusted model that included AL. Conclusions and relevance We found a significant association between church attendance and mortality among middle-aged adults after full adjustments. AL, a measure of stress, only partially explained differences in mortality between church and non-church attendees. These findings suggest a potential independent effect of church attendance on mortality.	[Bruce, Marino A.] Vanderbilt Univ, Ctr Res Mens Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA; [Martins, David] Charles R Drew Univ Sch Med & Sci, Dept Internal Med, Los Angeles, CA USA; [Martins, David; Duru, Kenrik; Vargas, Roberto; Nicholas, Susanne B.; Brown, Arleen; Norris, Keith C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Beech, Bettina M.] Univ Mississippi, Med Ctr, John D Bower Sch Populat Hlth, Dept Populat Hlth Sci, Jackson, MS 39216 USA; [Sims, Mario] Univ Mississippi, Med Ctr, Dept Internal Med, Jackson, MS 39216 USA; [Harawa, Nina] Charles R Drew Univ Sch Med & Sci, Dept Psychiat, Los Angeles, CA USA; [Harawa, Nina] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Kermah, Dulcie] Charles R Drew Univ Sch Med & Sci, Dept Res, Los Angeles, CA USA; [Kermah, Dulcie] Charles R Drew Univ Sch Med & Sci, Inst Life Sci, Los Angeles, CA USA	Vanderbilt University; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; Charles R. Drew University of Medicine & Science; Charles R. Drew University of Medicine & Science	Bruce, MA (corresponding author), Vanderbilt Univ, Ctr Res Mens Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.	marino.bruce@vanderbilt.edu		Brown, Arleen/0000-0001-9948-8955; Harawa, Nina T./0000-0002-7486-8393	National Institutes of Health [UL1TR000445, 1K01HL88735, 1R25HL126145, P20MD000182, UL1TR000124, P30AG021684, P60MD002249]; Department of Health and Human Services' Office of Minority Health [1CPIMP091054-04]; NIH [UL1TR000445, 1K01HL88735, 1R25HL126145, P20MD000182, UL1TR000124, P30AG021684, P60MD002249, U54MD008176]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL126145, K01HL088735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008176, P20MD000182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services' Office of Minority Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by National Institutes of Health grants UL1TR000445 (MB), 1K01HL88735 (MB), 1R25HL126145 (BB), P20MD000182 (KN,DM), UL1TR000124 (KN,AB), P30AG021684 (KN,KD), P60MD002249 (MS), U54MD008176 (MS),and a grant from the Department of Health and Human Services' Office of Minority Health 1CPIMP091054-04 (BB).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no financial disclosures or conflicts of interest.; This work was supported in part by NIH grants UL1TR000445 (MB), 1K01HL88735 (MB), 1R25HL126145 (BB), P20MD000182 (KN, DM), UL1TR000124 (KN, AB), P30AG021684 (KN, KD), P60MD002249 (MS), U54MD008176 (MS), and a grant from the Department of Health and Human Services' Office of Minority Health 1CPIMP091054-04 (BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no financial disclosures or conflicts of interest.	[Anonymous], 1994, Vital Health Stat 1, P1; BANKS R, 1980, J SCHOOL HEALTH, V50, P195, DOI 10.1111/j.1746-1561.1980.tb07373.x; Bellingham R, 1989, Am J Health Promot, V4, P18, DOI 10.4278/0890-1171-4.1.18; Beydoun MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3744-z; Brown I., 1978, ETA SIGMA GAM, V10, P12; Buck AC, 2009, SOC SCI MED, V68, P314, DOI 10.1016/j.socscimed.2008.10.010; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Chapman L S, 1987, Am J Health Promot, V2, P12, DOI 10.4278/0890-1171-2.2.12; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Durkheim E, 1965, ELEMENTARY FORMS REL; Duru OK, 2012, J NATL MED ASSOC, V104, P89, DOI 10.1016/S0027-9684(15)30120-6; ELKINS DN, 1988, J HUMANIST PSYCHOL, V28, P5, DOI 10.1177/0022167888284002; Ernecoff NC, 2015, JAMA INTERN MED, V175, P1662, DOI 10.1001/jamainternmed.2015.4124; Ferraro KF, 2014, SOC SCI MED, V120, P92, DOI 10.1016/j.socscimed.2014.08.030; Ferraro KF, 1999, AM SOCIOL REV, V64, P303, DOI 10.2307/2657534; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; George LK, 2013, GERONTOLOGIST, V53, P898, DOI 10.1093/geront/gnt002; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Gillum RF, 2008, ANN EPIDEMIOL, V18, P124, DOI 10.1016/j.annepidem.2007.10.015; Gillum RF, 2006, ANN EPIDEMIOL, V16, P655, DOI 10.1016/j.annepidem.2005.11.002; Gillum RF, 2006, PSYCHOSOM MED, V68, P382, DOI 10.1097/01.psy.0000221253.90559.dd; Gillum RF, 2006, ANN BEHAV MED, V31, P30, DOI 10.1207/s15324796abm3101_6; Hatch SL, 2005, J GERONTOL B-PSYCHOL, V60, P130; Hummer RA, 1999, DEMOGRAPHY, V36, P273, DOI 10.2307/2648114; Jones SA, 2016, J SCI MED SPORT, V19, P1020, DOI 10.1016/j.jsams.2016.03.009; Karlamangla AS, 2006, PSYCHOSOM MED, V68, P500, DOI 10.1097/01.psy.0000221270.93985.82; Koenig H. G, 2001, HDB RELIG HLTH; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Koenig HG, 2004, J AM GERIATR SOC, V52, P554, DOI 10.1111/j.1532-5415.2004.52161.x; Koenig HG, 2012, HDB RELIG HLTH; Lawler-Row KA, 2009, J HEALTH PSYCHOL, V14, P43, DOI 10.1177/1359105308097944; Li SS, 2016, JAMA INTERN MED, V176, P777, DOI 10.1001/jamainternmed.2016.1615; Martins D, 2013, J HEALTH CARE POOR U, V24, P1235, DOI 10.1353/hpu.2013.0148; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; National Center for Health Statistics Centers for Disease Control and Prevention, 1998, PLAN OP 3 NAT HLTH N; National Center for Health Statistics. Office of Analysis and Epidemiology, 2009, 3 NAT HLTH NUTR EX S; Powell LH, 2003, AM PSYCHOL, V58, P36, DOI 10.1037/0003-066X.58.1.36; Russell R D, 1984, Health Educ, V15, P3; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Seeman TE, 2003, AM PSYCHOL, V58, P53, DOI 10.1037/0003-066X.58.1.53; Singh Darpan Kaur Mohinder, 2012, Indian J Psychol Med, V34, P399, DOI 10.4103/0253-7176.108234; Sprecher S, 2006, CURR RES SOC PSYCHOL, V11, P227; Steffen PR, 2005, ANN BEHAV MED, V30, P217, DOI 10.1207/s15324796abm3003_6; Stewart James A, 2006, J Physiol Anthropol, V25, P133, DOI 10.2114/jpa2.25.133; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; U.S. Department of Health and Human Services. National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL	46	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177618	10.1371/journal.pone.0177618	http://dx.doi.org/10.1371/journal.pone.0177618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520779	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500045
J	Moor, H				Moor, Helen			Life history trade-off moderates model predictions of diversity loss from climate change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DISTANCE SEED DISPERSAL; LONG-DISTANCE; ENVIRONMENTAL-CHANGE; COMMUNITY ECOLOGY; FUNCTIONAL TRAITS; SPATIAL-PATTERNS; EXTINCTION DEBT; RANGE SHIFTS; SIZE	Climate change can trigger species range shifts, local extinctions and changes in diversity. Species interactions and dispersal capacity are important mediators of community responses to climate change. The interaction between multispecies competition and variation in dispersal capacity has recently been shown to exacerbate the effects of climate change on diversity and to increase predictions of extinction risk dramatically. Dispersal capacity, however, is part of a species' overall ecological strategy and are likely to trade off with other aspects of its life history that influence population growth and persistence. In plants, a well-known example is the trade-off between seed mass and seed number. The presence of such a trade-off might buffer the diversity loss predicted by models with random but neutral (i.e. not impacting fitness otherwise) differences in dispersal capacity. Using a trait-based metacommunity model along a warming climatic gradient the effect of three different dispersal scenarios on model predictions of diversity change were compared. Adding random variation in species dispersal capacity caused extinctions by the introduction of strong fitness differences due an inherent property of the dispersal kernel. Simulations including a fitness-equalising trade-off based on empirical relationships between seed mass (here affecting dispersal distance, establishment probability, and seedling biomass) and seed number (fecundity) maintained higher initial species diversity and predicted lower extinction risk and diversity loss during climate change than simulations with variable dispersal capacity. Large seeded species persisted during climate change, but developed lags behind their climate niche that may cause extinction debts. Small seeded species were more extinction-prone during climate change but tracked their niches through dispersal and colonisation, despite competitive resistance from residents. Life history trade-offs involved in coexistence mechanisms may increase community resilience to future climate change and are useful guides for model development.	[Moor, Helen] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Moor, Helen] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden	Stockholm University; Swedish University of Agricultural Sciences	Moor, H (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.; Moor, H (corresponding author), Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden.	helen.moor@su.se		Moor, Helen/0000-0002-1340-2039	Strategic Research Programme EkoKlim, Stockholm University through the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)	Strategic Research Programme EkoKlim, Stockholm University through the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)	This research was financed by the Strategic Research Programme EkoKlim, Stockholm University (www.su.se/ekoklim), through the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, www.formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Ben-Hur E, 2012, ECOL LETT, V15, P1276, DOI 10.1111/j.1461-0248.2012.01850.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Coomes DA, 2003, TRENDS ECOL EVOL, V18, P283, DOI 10.1016/S0169-5347(03)00072-7; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Debain S, 2003, ECOSCIENCE, V10, P168, DOI 10.1080/11956860.2003.11682764; Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514; Ehrlen J, 2015, ECOL LETT, V18, P303, DOI 10.1111/ele.12410; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Gottfried M, 2012, NATURE CLIMATE CHANG, P5; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; Hodgson JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047141; Holt RD, 2005, OIKOS, V108, P18, DOI 10.1111/j.0030-1299.2005.13147.x; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Jeganmohan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088344; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; Levine JM, 2002, AM NAT, V160, P452, DOI 10.1086/342073; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lonnberg K, 2013, OIKOS, V122, P1080, DOI 10.1111/j.1600-0706.2012.00249.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Norberg J, 2012, NAT CLIM CHANGE, V2, P747, DOI [10.1038/NCLIMATE1588, 10.1038/nclimate1588]; Normand S, 2014, ECOGRAPHY, V37, P1149, DOI 10.1111/ecog.01490; Ozinga WA, 2005, OIKOS, V108, P555, DOI 10.1111/j.0030-1299.2005.13632.x; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Pearson RG, 2014, NAT CLIM CHANGE, V4, P217, DOI [10.1038/NCLIMATE2113, 10.1038/nclimate2113]; Singer A, 2016, ECOL MODEL, V326, P63, DOI 10.1016/j.ecolmodel.2015.11.007; Snell RS, 2014, GLOBAL ECOL BIOGEOGR, V23, P89, DOI 10.1111/geb.12106; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Thompson K, 1993, SEED SIZE SHAPE PRED; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Turnbull LA, 2004, J ECOL, V92, P97, DOI 10.1111/j.1365-2745.2004.00856.x; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; Turnbull LA, 2013, ECOL LETT, V16, P116, DOI 10.1111/ele.12056; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Urban MC, 2013, ANN NY ACAD SCI, V1297, P44, DOI 10.1111/nyas.12184; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; van Bodegom PM, 2014, P NATL ACAD SCI USA, V111, P13733, DOI 10.1073/pnas.1304551110; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; WESTOBY M, 1992, TRENDS ECOL EVOL, V7, P368, DOI 10.1016/0169-5347(92)90006-W; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zickfeld K, 2013, J CLIMATE, V26, P5782, DOI 10.1175/JCLI-D-12-00584.1; Zurell D, 2016, GLOBAL CHANGE BIOL, V22, P2651, DOI 10.1111/gcb.13251	70	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177778	10.1371/journal.pone.0177778	http://dx.doi.org/10.1371/journal.pone.0177778			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520770	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500069
J	Puglisi, G; Leonetti, A; Landau, A; Fornia, L; Cerri, G; Borroni, P				Puglisi, Guglielmo; Leonetti, Antonella; Landau, Ayelet; Fornia, Luca; Cerri, Gabriella; Borroni, Paola			The role of attention in human motor resonance	PLOS ONE			English	Article							HUMAN CORTICOSPINAL PROJECTIONS; SELECTIVE ATTENTION; EXCITABILITY CHANGES; MIRROR NEURONS; HAND; MOVEMENT; MUSCLES; REPRESENTATION; FACILITATION; SPECIFICITY	Observation of others' actions evokes in primary motor cortex and spinal circuits of observers a subliminal motor resonance response, which reflects the motor program encoding observed actions. We investigated the role of attention in human motor resonance with four experimental conditions, explored in different subject groups: in the first explicit condition, subjects were asked to observe a rhythmic hand flexion-extension movement performed live in front of them. In two other conditions subjects had to monitor the activity of a LED light mounted on the oscillating hand. The hand was clearly visible but it was not the focus of subjects' attention: in the semi-implicit condition hand movement was relevant to task completion, while in the implicit condition it was irrelevant. In a fourth, baseline, condition subjects observed the rhythmic oscillation of a metal platform. Motor resonance was measured with the H-reflex technique as the excitability modulation of cortico-spinal motorneurons driving a hand flexor muscle. As expected, a normal resonant response developed in the explicit condition, and no resonant response in the baseline condition. Resonant responses also developed in both semi-implicit and implicit conditions and, surprisingly, were not different from each other, indicating that viewing an action is, per se, a powerful stimulus for the action observation network, even when it is not the primary focus of subjects' attention and even when irrelevant to the task. However, the amplitude of these responses was much reduced compared to the explicit condition, and the phase-lock between the time courses of observed movement and resonant motor program was lost. In conclusion, different parameters of the response were differently affected by subtraction of attentional resources with respect to the explicit condition: time course and muscle selection were preserved while the activation of motor circuits resulted in much reduced amplitude and lost its kinematic specificity.	[Puglisi, Guglielmo; Leonetti, Antonella; Borroni, Paola] Univ Milan, Sch Med, Dept Hlth Sci, Milan, Italy; [Leonetti, Antonella; Fornia, Luca; Cerri, Gabriella] Univ Milan, Sch Med, Dept Med Biotechnol & Translat Med, Milan, Italy; [Landau, Ayelet] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Landau, Ayelet] Hebrew Univ Jerusalem, Dept Cognit Sci, Jerusalem, Israel; [Fornia, Luca; Cerri, Gabriella] Humanitas Clin & Res Ctr, Rozzano, Italy	University of Milan; University of Milan; Hebrew University of Jerusalem; Hebrew University of Jerusalem; IRCCS Humanitas Research Hospital	Puglisi, G (corresponding author), Univ Milan, Sch Med, Dept Hlth Sci, Milan, Italy.	guglielmo.puglisi@gmail.com	Fornia, Luca/AAS-3166-2020; PUGLISI, GUGLIELMO/ABC-9155-2020	PUGLISI, GUGLIELMO/0000-0002-7690-1679; BORRONI, PAOLA ALICE/0000-0001-8955-3645; FORNIA, LUCA/0000-0002-8332-2886; LEONETTI, ANTONELLA/0000-0002-5500-4901; CERRI, GABRIELLA/0000-0002-7202-3792	Dipartimento di Scienze della Salute, Universita degli studi di Milano; Regione Lombardia [SAL-53, 16970]; University degli Studi di Milano	Dipartimento di Scienze della Salute, Universita degli studi di Milano; Regione Lombardia(Regione Lombardia); University degli Studi di Milano	Support was provided by Dipartimento di Scienze della Salute, Universita degli studi di Milano; and by Regione Lombardia, SAL-53,16970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding from the University degli Studi di Milano and Project for International Scientific and Technological Cooperation (SAL-53, n.16970), from the Regione Lombardia.	Avenanti A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00185; Bach P, 2007, EXP BRAIN RES, V178, P509, DOI 10.1007/s00221-006-0756-4; Baldissera F, 2002, J PHYSIOL-LONDON, V539, P903, DOI 10.1113/jphysiol.2001.013282; BARGH JA, 1992, AM J PSYCHOL, V105, P181, DOI 10.2307/1423027; Bek J, 2016, EXP BRAIN RES, V234, P1819, DOI 10.1007/s00221-016-4570-3; Bien N, 2009, CEREB CORTEX, V19, P2338, DOI 10.1093/cercor/bhn251; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Borroni P, 2005, BRAIN RES; Borroni P, 2008, SOC NEUROSCI-UK, V3, P276, DOI 10.1080/17470910701515269; Borroni P, 2011, EUR J NEUROSCI, V34, P662, DOI 10.1111/j.1460-9568.2011.07779.x; Bortoletto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053248; Bourguignon M, 2013, NEUROIMAGE, V66, P500, DOI 10.1016/j.neuroimage.2012.10.038; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Cavallo A, 2012, CEREB CORTEX, V22, P710, DOI 10.1093/cercor/bhr157; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Chong TTJ, 2008, NEUROIMAGE, V40, P298, DOI 10.1016/j.neuroimage.2007.11.030; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Costantini M, 2008, EXP BRAIN RES, V188, P341, DOI 10.1007/s00221-008-1369-x; Cracco E, 2016, SOC COGN AFFECT NEUR; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Cross KA, 2014, NEUROIMAGE, V91, P228, DOI 10.1016/j.neuroimage.2014.01.027; DECETY J, 1988, EUR ARCH PSY CLIN N, V238, P33, DOI 10.1007/BF00381078; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eaves DL, 2016, BRAIN COGNITION, V106, P90, DOI 10.1016/j.bandc.2016.04.013; Eaves DL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00028; EPSTEIN M L, 1980, Journal of Sport Psychology, V2, P211; Esposti R, 2005, EXP BRAIN RES, V162, P436, DOI 10.1007/s00221-004-2120-x; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0177; Gallese V, 2009, PSYCHOL RES-PSYCH FO, V73, P486, DOI 10.1007/s00426-009-0232-4; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Georgopoulos A., 2000, CURRENT OPINION NEUR, P238; Gowen E, 2010, BRAIN COGNITION, V74, P288, DOI 10.1016/j.bandc.2010.08.010; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johansen-Berg H, 2002, EXP BRAIN RES, V142, P13, DOI 10.1007/s00221-001-0905-8; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kraskov a, 2014, CORTICOSPINAL MIRROR, DOI doi.org/10.1113/jphysiol; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Leonetti A, 2015, EXP BRAIN RES, V233, P3013, DOI 10.1007/s00221-015-4371-0; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mattiassi ADA, 2014, J COGNITIVE NEUROSCI, V26, P2028, DOI 10.1162/jocn_a_00619; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Mc Cabe SI, 2015, CEREB CORTEX, V25, P2229, DOI 10.1093/cercor/bhu029; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; Muthukumaraswamy SD, 2008, PSYCHOPHYSIOLOGY, V45, P896, DOI 10.1111/j.1469-8986.2008.00711.x; Naish KR, 2014, NEUROPSYCHOLOGIA, V64, P331, DOI 10.1016/j.neuropsychologia.2014.09.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Perry A, 2010, NEUROREPORT, V21, P1050, DOI 10.1097/WNR.0b013e32833fcb71; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0420; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sartori L, 2015, CORTEX, V70, P169, DOI 10.1016/j.cortex.2015.01.019; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Vigneswaran G, 2013, CURR BIOL, V23, P236, DOI 10.1016/j.cub.2012.12.006; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Woodruff CC, 2013, EXP BRAIN RES, V229, P507, DOI 10.1007/s00221-013-3612-3	77	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177457	10.1371/journal.pone.0177457	http://dx.doi.org/10.1371/journal.pone.0177457			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28510605	gold, Green Submitted, Green Published			2022-12-27	WOS:000401485500031
J	Singh, M; Kumar, M; Thilges, K; Cho, MJ; Cigan, AM				Singh, Manjit; Kumar, Manish; Thilges, Katherine; Cho, Myeong-Je; Cigan, A. Mark			MS26/CYP704B is required for anther and pollen wall development in bread wheat (Triticum aestivum L.) and combining mutations in all three homeologs causes male sterility	PLOS ONE			English	Article							SPOROPOLLENIN SYNTHESIS; EXINE FORMATION; CYTOCHROME-P450; ARABIDOPSIS; GENOME; GENES; HYDROXYLATION; BIOSYNTHESIS; EVOLUTION; MUTANTS	Development of anthers and pollen represents an important aspect of the life cycle in flowering plants. Genes contributing to anther and pollen development have been widely studied in many plant species. Ms26/CYP704B genes play an important role in pollen development through biosynthesis of sporopollenin for pollen exine formation. To investigate the role of Ms26/CYP704B genes in anther and pollen development of bread wheat, mutations in the A-, B-, and D-homeologs of the putative Ms26/CYP704B gene were analyzed. Single and double homozygous mutants in any of the homeologs did not affect pollen development and male fertility. Triple homozygous mutants resulted in completely male sterile plants that were defective in pollen and anther development. Additionally, double homozygous-single heterozygous mutants were also male sterile although with varying levels of residual fertility. The fertility of these triple mutants was dependent upon the homeolog contributing the wildtype allele. Two heterologous Ms26/CYP704B genes, when transformed into a triple homozygous mutant background, completely restored male fertility, whereas a single gene was unable to restore fertility. Functional analysis of Ms26/CYP704B furthers the understanding of male fertility genes which can be utilized for the development of novel hybrid seed production systems in wheat.	[Singh, Manjit; Kumar, Manish; Thilges, Katherine; Cho, Myeong-Je; Cigan, A. Mark] DuPont Pioneer, Johnston, IA 50131 USA; [Cho, Myeong-Je] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Cigan, A. Mark] Genus, De Forest, WI USA	DuPont; Pioneer Hi-Bred International, Inc.; University of California System; University of California Berkeley	Singh, M (corresponding author), DuPont Pioneer, Johnston, IA 50131 USA.	manjit.singh@pioneer.com	Singh, Manjit/GWM-3934-2022	Singh, Manjit/0000-0002-5451-3659	DuPont Pioneer	DuPont Pioneer	The authors received no external funding for this work.The authors, employees of DuPont Pioneer, designed, conducted experiments, performed data analysis and wrote the manuscript. DuPont Pioneer provided support in the form of salaries for authors [MS, MK, KT, MC and AMC] and provided research facilities and resources and supported the decision to publish. The specific roles of these authors are articulated in the 'author contributions' section	Ahlers F, 2000, Z NATURFORSCH C, V55, P129; Akhunova AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-505; Albertsen MC, 2009, INVENTORS NUCLEOTIDE; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Borrill P, 2015, NEW PHYTOL, V208, P1008, DOI 10.1111/nph.13533; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cigan AM, 2016, PLANT BIOTE IN PRESS; Colpitts CC, 2011, NEW PHYTOL, V192, P855, DOI 10.1111/j.1469-8137.2011.03858.x; Djukanovic V, 2013, PLANT J, V76, P888, DOI 10.1111/tpj.12335; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Duan H, 2005, PLANT PHYSIOL, V137, P1067, DOI 10.1104/pp.104.055715; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gomez JF, 2015, J INTEGR PLANT BIOL, V57, P876, DOI 10.1111/jipb.12425; GUILFORD WJ, 1988, PLANT PHYSIOL, V86, P134, DOI 10.1104/pp.86.1.134; HESS MW, 1993, PLANTA, V189, P139, DOI 10.1007/BF00201354; Klindworth DL, 2002, CROP SCI, V42, P1447, DOI 10.2135/cropsci2002.1447; Lei SL, 2007, THEOR APPL GENET, V115, P643, DOI 10.1007/s00122-007-0594-1; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; LOUKIDES CA, 1995, AM J BOT, V82, P1017, DOI 10.2307/2446231; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Quilichini TD, 2015, PHYTOCHEMISTRY, V113, P170, DOI 10.1016/j.phytochem.2014.05.002; SCOTT RJ, 1994, SOC EXP BIOL SEMIN S, V55, P49, DOI 10.1017/CBO9780511752339.006; Shi JX, 2015, TRENDS PLANT SCI, V20, P741, DOI 10.1016/j.tplants.2015.07.010; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wiermann R, 2001, BIOPOLYMERS, V1, P209, DOI DOI 10.1002/3527600035.BPOL1007; Wu YZ, 2016, PLANT BIOTECHNOL J, V14, P1046, DOI 10.1111/pbi.12477; Yang XJ, 2014, J INTEGR PLANT BIOL, V56, P979, DOI 10.1111/jipb.12212; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Yi B, 2010, PLANT J, V63, P925, DOI 10.1111/j.1365-313X.2010.04289.x; Zhang DB, 2016, SUBCELL BIOCHEM, V86, P315, DOI 10.1007/978-3-319-25979-6_13	38	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177632	10.1371/journal.pone.0177632	http://dx.doi.org/10.1371/journal.pone.0177632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520767	gold, Green Submitted, Green Published			2022-12-27	WOS:000401485500048
J	Tomasetti, C; Vogelstein, B				Tomasetti, Cristian; Vogelstein, Bert			On the slope of the regression between stem cell divisions and cancer risk, and the lack of correlation between stem cell divisions and environmental factors-associated cancer risk	PLOS ONE			English	Editorial Material							MUTATIONS		[Tomasetti, Cristian] Johns Hopkins Kimmel Canc Ctr, Div Biostat & Bioinformat, Baltimore, MD 21297 USA; [Tomasetti, Cristian] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr, Baltimore, MD USA; [Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Tomasetti, C (corresponding author), Johns Hopkins Kimmel Canc Ctr, Div Biostat & Bioinformat, Baltimore, MD 21297 USA.; Tomasetti, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.	ctomasetti@jhu.edu			John Templeton Foundation; Virginiaand D.K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; NIH [P30-CA006973, R37-CA43460, R01-CA57345, P50-CA62924]	John Templeton Foundation; Virginiaand D.K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The John Templeton Foundation, The Virginiaand D.K. Ludwig Fund for Cancer Research, The Lustgarten Foundation for Pancreatic Cancer Research, The Sol Goldman Center for Pancreatic Cancer Research, and NIH Grants P30-CA006973, R37-CA43460, R01-CA57345, and P50-CA62924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; Frank S. A., 2007, DYNAMICS CANC INCIDE; Little MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150335; Tomasetti C, 2015, ARXIV150105035V4STAT; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	9	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0175535	10.1371/journal.pone.0175535	http://dx.doi.org/10.1371/journal.pone.0175535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520721	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500003
J	Wilke, HJ; Herkommer, A; Werner, K; Liebsch, C				Wilke, Hans-Joachim; Herkommer, Andrea; Werner, Karin; Liebsch, Christian			In vitro analysis of the segmental flexibility of the thoracic spine	PLOS ONE			English	Article							LOAD-DISPLACEMENT CURVES; WHOLE LUMBAR SPINE; RIB CAGE; THORACOLUMBAR JUNCTION; MECHANICAL-PROPERTIES; INTERVERTEBRAL DISC; STEPWISE REDUCTION; CERVICAL-SPINE; SAGITTAL PLANE; STABILITY	Basic knowledge about the thoracic spinal flexibility is limited and to the authors' knowledge, no in vitro studies have examined the flexibility of every thoracic spinal segment under standardized experimental conditions using pure moments. In our in vitro study, 68 human thoracic functional spinal units including the costovertebral joints (at least n = 6 functional spinal units per segment from T1-T2 to T11-T12) were loaded with pure moments of +/- 7.5 Nm in flexion/extension, lateral bending, and axial rotation in a custom-built spine tester to analyze range of motion (ROM) and neutral zone (NZ). ROM and NZ showed symmetric motion behavior in all loading planes. In each loading direction, the segment T1-T2 exhibited the highest ROM. In flexion/extension, the whole thoracic region, with exception of T1-T2 (14 degrees), had an average ROM between 6 degrees and 8 degrees. In lateral bending, the upper thoracic region (T1-T7) was, with an average ROM between 10 degrees and 12 degrees, more flexible than the lower thoracic region (T7-T12) with an average ROM between 8 degrees and 9 degrees. In axial rotation, the thoracic region offered the highest overall flexibility with an average ROM between 10 degrees and 12 degrees in the upper and middle thoracic spine (T1-T10) and between 7 degrees and 8 degrees in the lower thoracic spine (T10-T12), while a trend of continuous decrease of ROM could be observed in the lower thoracic region (T7-T12). Comparing these ROM values with those in literature, they agree that ROM is lowest in flexion/extension and highest in axial rotation, as well as decreasing in the lower segments in axial rotation. Differences were found in flexion/extension and lateral bending in the lower segments, where, in contrast to the literature, no increase of the ROM from superior to inferior segments was found. The data of this in vitro study could be used for the validation of numerical models and the design of further in vitro studies of the thoracic spine without the rib cage, the verification of animal models, as well as the interpretation of already published human in vitro data.	[Wilke, Hans-Joachim; Herkommer, Andrea; Werner, Karin; Liebsch, Christian] Univ Ulm, Trauma Res Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany	Ulm University	Wilke, HJ (corresponding author), Univ Ulm, Trauma Res Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany.	hans-joachim.wilke@uni-ulm.de	Liebsch, Christian/AAY-9918-2020; Wilke, Hans-Joachim/M-6440-2014	Liebsch, Christian/0000-0003-1543-4728; Wilke, Hans-Joachim/0000-0001-6007-8844	German Research Council (DFG) [WI 1352/20-1]	German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Council (DFG), Project WI 1352/20-1 to (HJW).	Aebi M, 2003, EUR SPINE J, V12, pS202, DOI 10.1007/s00586-003-0609-9; ANDRIACCHI T, 1974, J BIOMECH, V7, P497, DOI 10.1016/0021-9290(74)90084-0; Aubin CE, 2008, SPINE, V33, P2143, DOI 10.1097/BRS.0b013e31817bd89f; Brasiliense LBC, 2011, SPINE, V36, pE1686, DOI 10.1097/BRS.0b013e318219ce84; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; FEIERTAG MA, 1995, SPINE, V20, P1604, DOI 10.1097/00007632-199507150-00009; Fujimori T, 2012, SPINE, V37, pE1318, DOI 10.1097/BRS.0b013e318267254b; GOEL VK, 1988, J ORTHOPAED RES, V6, P611, DOI 10.1002/jor.1100060419; GOEL VK, 1985, SPINE, V10, P543, DOI 10.1097/00007632-198507000-00008; GOODWIN RR, 1994, J BIOMECH, V27, P1049, DOI 10.1016/0021-9290(94)90221-6; GREGERSEN GG, 1967, J BONE JOINT SURG AM, VA 49, P247, DOI 10.2106/00004623-196749020-00003; Heuer F, 2007, J BIOMECH, V40, P795, DOI 10.1016/j.jbiomech.2006.03.016; Heuer F, 2007, J BIOMECH, V40, P271, DOI 10.1016/j.jbiomech.2006.01.007; Horton WC, 2005, SPINE, V30, P2014, DOI 10.1097/01.brs.0000180478.96494.88; Kettler A, 2011, EUR SPINE J, V20, P578, DOI 10.1007/s00586-010-1635-z; Liebsch C, 2016, EUR SPINE J, P1; Little JP, 2013, SCOLIOSIS, V8, P1; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Maiman DJ, 1991, CLIN NEUROSURG, V38, P296; Majdouline Y, 2009, MED BIOL ENG COMPUT, V47, P1143, DOI 10.1007/s11517-009-0509-1; MARKOLF KL, 1972, J BONE JOINT SURG AM, VA 54, P511, DOI 10.2106/00004623-197254030-00005; Meyer P. R., 1989, SURG SPINE TRAUMA; MIMURA M, 1994, SPINE, V19, P1371, DOI 10.1097/00007632-199406000-00011; Morita D, 2014, EUR SPINE J, V23, P673, DOI 10.1007/s00586-013-3088-7; Oda Itaru, 2002, Spine (Phila Pa 1976), V27, pE64, DOI 10.1097/00007632-200202010-00007; OXLAND TR, 1992, J ORTHOP RES, V10, P573, DOI 10.1002/jor.1100100412; PANJABI MM, 1977, ORTHOP CLIN N AM, V8, P169; PANJABI MM, 1993, SPINE, V18, P1298, DOI 10.1097/00007632-199308000-00009; PANJABI MM, 1976, J BONE JOINT SURG AM, V58, P642, DOI 10.2106/00004623-197658050-00011; PANJABI MM, 1981, ACTA ORTHOP SCAND, V52, P315, DOI 10.3109/17453678109050109; PANJABI MM, 1994, J BONE JOINT SURG AM, V76A, P413, DOI 10.2106/00004623-199403000-00012; Patwardhan AG, 2003, J ORTHOPAED RES, V21, P540, DOI 10.1016/S0736-0266(02)00202-4; POONI JS, 1986, SURG RADIOL ANAT, V8, P175, DOI 10.1007/BF02427846; SCHULTE K, 1989, SPINE, V14, P1116, DOI 10.1097/00007632-198910000-00015; Sham ML, 2005, BIOMED TECH, V50, P361, DOI 10.1515/BMT.2005.051; SINGER KP, 1988, SURG RADIOL ANAT, V10, P291, DOI 10.1007/BF02107901; Takeuchi T, 1999, SPINE, V24, P1414, DOI 10.1097/00007632-199907150-00005; Tawackoli W, 2004, SPINE, V29, P988, DOI 10.1097/00007632-200405010-00007; Volkheimer D, 2015, EUR SPINE J, V24, P1882, DOI 10.1007/s00586-015-4040-9; Wang XY, 2012, EUR SPINE J, V21, P1082, DOI 10.1007/s00586-011-2089-7; Watkins R, 2005, SPINE, V30, P1283, DOI 10.1097/01.brs.0000164257.69354.bb; Wen N, 1993, Eur Spine J, V2, P2, DOI 10.1007/BF00301048; White A.A., 1990, CLIN BIOMECH; WHITE AA, 1969, ACTA ORTHOP SCAND, VS, P7; Wilke H J, 1994, Eur Spine J, V3, P91, DOI 10.1007/BF02221446; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; Wilke HJ, 1998, ANAT REC, V251, P15, DOI 10.1002/(SICI)1097-0185(199805)251:1<15::AID-AR4>3.0.CO;2-D; WILKE HJ, 1995, SPINE, V20, P192, DOI 10.1097/00007632-199501150-00011; Willems JM, 1996, CLIN BIOMECH, V11, P311, DOI 10.1016/0268-0033(96)00017-4; WOOD KB, 1995, J BONE JOINT SURG AM, V77A, P1631, DOI 10.2106/00004623-199511000-00001; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020	51	32	33	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177823	10.1371/journal.pone.0177823	http://dx.doi.org/10.1371/journal.pone.0177823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520819	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500075
J	Al-Aama, JY; Shaik, NA; Banaganapalli, B; Salama, MA; Rashidi, O; Sahly, AN; Mohsen, MO; Shawoosh, HA; Shalabi, HA; Al Edreesi, M; Alharthi, SE; Wang, J; Elango, R; Saadah, OI				Al-Aama, Jumana Yousuf; Shaik, Noor Ahmad; Banaganapalli, Babajan; Salama, Mohammed A.; Rashidi, Omran; Sahly, Ahmed N.; Mohsen, Mohammed O.; Shawoosh, Harbi A.; Shalabi, Hebah Ahmad; Al Edreesi, Mohammad; Alharthi, Sameer E.; Wang, Jun; Elango, Ramu; Saadah, Omar I.			Whole exome sequencing of a consanguineous family identifies the possible modifying effect of a globally rare AK5 allelic variant in celiac disease development among Saudi patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADENYLATE KINASE-5; GENETIC-VARIATION; PROTEIN; DATABASE; REPLICATION; EXPRESSION; PROJECT; ARABIA; RISK	Celiac disease (CD), a multi-factorial auto-inflammatory disease of the small intestine, is known to occur in both sporadic and familial forms. Together HLA and Non-HLA genes can explain up to 50% of CD's heritability. In order to discover the missing heritability due to rare variants, we have exome sequenced a consanguineous Saudi family presenting CD in an autosomal recessive (AR) pattern. We have identified a rare homozygous insertion c. 1683_1684insATT, in the conserved coding region of AK5 gene that showed classical AR model segregation in this family. Sequence validation of 200 chromosomes each of sporadic CD cases and controls, revealed that this extremely rare (EXac MAF 0.000008) mutation is highly penetrant among general Saudi populations (MAF is 0.62). Genotype and allelic distribution analysis have indicated that this AK5 (c. 1683_1684insATT) mutation is negatively selected among patient groups and positively selected in the control group, in whom it may modify the risk against CD development [p<0.002]. Our observation gains additional support from computational analysis which predicted that Iso561 insertion shifts the existing H-bonds between 400th and 556th amino acid residues lying near the functional domain of adenylate kinase. This shuffling of amino acids and their H-bond interactions is likely to disturb the secondary structure orientation of the polypeptide and induces the gain-of-function in nucleoside phosphate kinase activity of AK5, which may eventually down-regulates the reactivity potential of CD4(+) T-cells against gluten antigens. Our study underlines the need to have population-specific genome databases to avoid false leads and to identify true candidate causal genes for the familial form of celiac disease.	[Al-Aama, Jumana Yousuf; Shaik, Noor Ahmad; Banaganapalli, Babajan; Elango, Ramu] King Abdulaziz Univ, Dept Genet Med, Fac Med, Jeddah, Saudi Arabia; [Al-Aama, Jumana Yousuf; Shaik, Noor Ahmad; Banaganapalli, Babajan; Salama, Mohammed A.; Rashidi, Omran; Sahly, Ahmed N.; Mohsen, Mohammed O.; Alharthi, Sameer E.; Wang, Jun; Elango, Ramu; Saadah, Omar I.] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Salama, Mohammed A.] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia; [Shawoosh, Harbi A.] King Fand Armed Forces Hosp, Dept Pediat, Jeddah, Saudi Arabia; [Shalabi, Hebah Ahmad] Minist Hlth, Primary Healthcare Ctr, Jeddah, Saudi Arabia; [Al Edreesi, Mohammad] Saudi Aramco Med Serv Org, Dhahran Hlth Ctr, Div Gastroenterol, Dept Pediat, Dhahran, Saudi Arabia; [Saadah, Omar I.] King Abdulaziz Univ, Div Pediat Gastroenterol, Dept Pediat, Fac Med, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; Ministry of Health - Saudi Arabia; Saudi Aramco; King Abdulaziz University	Elango, R (corresponding author), King Abdulaziz Univ, Dept Genet Med, Fac Med, Jeddah, Saudi Arabia.; Elango, R; Saadah, OI (corresponding author), King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia.; Saadah, OI (corresponding author), King Abdulaziz Univ, Div Pediat Gastroenterol, Dept Pediat, Fac Med, Jeddah, Saudi Arabia.	relango@ntlworld.com; osaddah@kau.edu.sa	Banaganapalli, Babajan/A-6282-2013; Saadah, Omar I/G-2068-2011; Elango, Ramu/C-7684-2014; Shaik, Noor ahmad/ABE-4084-2020; Al-aama, Jumana/AAA-8653-2021	Banaganapalli, Babajan/0000-0001-8089-2210; Saadah, Omar I/0000-0002-3744-9907; Elango, Ramu/0000-0003-4264-2135; Shaik, Noor ahmad/0000-0002-7133-656X; Al-Harthi, Sameer/0000-0003-4293-3215	Deanship of Scientific Research (DSR), King Abdulaziz University [HiCi-1434-140-1: OS]; Princess Al-Jawhara Al-Brahim Center of Excellence in Research of Hereditary Disorders (PACER-HD)	Deanship of Scientific Research (DSR), King Abdulaziz University; Princess Al-Jawhara Al-Brahim Center of Excellence in Research of Hereditary Disorders (PACER-HD)	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, under Grant no. HiCi-1434-140-1: OS Received the funding.; All authors sincerely extend their thanks to Princess Al-Jawhara Al-Brahim Center of Excellence in Research of Hereditary Disorders (PACER-HD) for its support in laboratory logistics required for this study. The authors sincerely appreciate Ms. Sana Khadir for her good effort in coordinating with patients and healthy volunteers for sampling and clinical data collection.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Owain M, 2012, AM J MED GENET A, V158A, P2629, DOI 10.1002/ajmg.a.35551; Alkhiary YM, SAUDI J BIOL SCI; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Annette K, 2008, CELIAC DIS; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Balasopoulou A, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0091-1; BEUTLER E, 1983, J CLIN INVEST, V72, P648, DOI 10.1172/JCI111014; Candi E, 2004, BIOCHEM J, V381, P313, DOI 10.1042/BJ20031474; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Erzurumluoglu AM, 2016, ANN HUM GENET, V80, P187, DOI 10.1111/ahg.12150; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Garcia-Etxebarria K, 2016, EUR J HUM GENET, V24, P1831, DOI 10.1038/ejhg.2016.120; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Gottenberg JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059868; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gutierrez-Achury J, 2015, NAT GENET, V47, P577, DOI 10.1038/ng.3268; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kuja-Halkola R., 2016, GUT; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumar V, 2012, SEMIN IMMUNOPATHOL, V34, P567, DOI 10.1007/s00281-012-0312-1; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Lundin KEA, 2015, NAT REV GASTRO HEPAT, V12, P507, DOI 10.1038/nrgastro.2015.136; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mistry V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116845; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Ng ASL, 2015, J NEUROIMMUNOL, V287, P31, DOI 10.1016/j.jneuroim.2015.08.009; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Saadah OI, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/351673; Saadah OI, 2011, ANN SAUDI MED, V31, P51, DOI 10.4103/0256-4947.75779; Samasca G, 2013, IMMUNOL INVEST, V42, P273, DOI 10.3109/08820139.2013.777074; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Solaroli N, 2009, FEBS LETT, V583, P2872, DOI 10.1016/j.febslet.2009.07.047; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Szperl AM, 2011, CLIN GENET, V80, P138, DOI 10.1111/j.1399-0004.2011.01714.x; Torinsson Naluai A., 2016, GUT; Trynka G, 2010, TRENDS MOL MED, V16, P537, DOI 10.1016/j.molmed.2010.09.003; Van Rompay AR, 1999, EUR J BIOCHEM, V261, P509, DOI 10.1046/j.1432-1327.1999.00294.x; Withoff S, 2016, TRENDS GENET, V32, P295, DOI 10.1016/j.tig.2016.02.003	48	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176664	10.1371/journal.pone.0176664	http://dx.doi.org/10.1371/journal.pone.0176664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505210	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500008
J	Kim, YK; Kim, SH; Yi, JM; Kang, CK; Short, F; Lee, KS				Kim, Young Kyun; Kim, Seung Hyeon; Yi, Joo Mi; Kang, Chang-Keun; Short, Frederick; Lee, Kun-Seop			Genetic identification and evolutionary trends of the seagrass Halophila nipponica in temperate coastal waters of Korea	PLOS ONE			English	Article							HYDROCHARITACEAE; DNA; ANGIOSPERMS; DIVERSITY; INSIGHTS; THOUARS; OVALIS; RATES	Although seagrass species in the genus Halophila are generally distributed in tropical or subtropical regions, H. nipponica has been reported to occur in temperate coastal waters of the northwestern Pacific. Because H. nipponica occurs only in the warm temperate areas influenced by the Kuroshio Current and shows a tropical seasonal growth pattern, such as severely restricted growth in low water temperatures, it was hypothesized that this temperate Halophila species diverged from tropical species in the relatively recent evolutionary past. We used a phylogenetic analysis of internal transcribed spacer (ITS) regions to examine the genetic variability and evolutionary trend of H. nipponica. ITS sequences of H. nipponica from various locations in Korea and Japan were identical or showed very low sequence divergence (less than 3-base pair, bp, difference), confirming that H. nipponica from Japan and Korea are the same species. Halophila species in the section Halophila, which have simple phyllotaxy (a pair of petiolate leaves at the rhizome node), were separated into five well-supported clades by maximum parsimony analysis. H. nipponica grouped with H. okinawensis and H. gaudichaudii from the subtropical regions in the same clade, the latter two species having quite low ITS sequence divergence from H. nipponica (7-15-bp). H. nipponica in Clade I diverged 2.95 +/- 1.08 million years ago from species in Clade II, which includes H. ovalis. According to geographical distribution and genetic similarity, H. nipponica appears to have diverged from a tropical species like H. ovalis and adapted to warm temperate environments. The results of divergence time estimates suggest that the temperate H. nipponica is an older species than the subtropical H. okinawensis and H. gaudichaudii and they may have different evolutionary histories.	[Kim, Young Kyun; Kim, Seung Hyeon; Lee, Kun-Seop] Pusan Natl Univ, Dept Biol Sci, Busan, South Korea; [Kim, Young Kyun; Kang, Chang-Keun] Gwangju Inst Sci & Technol, Sch Earth Sci & Environm Engn, Gwangju, South Korea; [Yi, Joo Mi] Dongnam Inst Radiol & Med Sci DIRAMS, Res Ctr, Busan, South Korea; [Short, Frederick] Univ New Hampshire, Jackson Estuarine Lab, Durham, NH 03824 USA	Pusan National University; Gwangju Institute of Science & Technology (GIST); Korea Institute of Radiological & Medical Sciences; University System Of New Hampshire; University of New Hampshire	Lee, KS (corresponding author), Pusan Natl Univ, Dept Biol Sci, Busan, South Korea.	klee@pusan.ac.kr	Kang, Chang-Keun/GLR-8512-2022		Ministry of Oceans and Fisheries, Korea; Pusan National University; National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2015R1A2A2A01004850]	Ministry of Oceans and Fisheries, Korea; Pusan National University(Pusan National University); National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by the Ministry of Oceans and Fisheries, Korea (Project title: Longterm changes in structure and function in the marine ecosystems of Korea) to KSL and CKK, Pusan National University to KSL, and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST; NRF-2015R1A2A2A01004850) to KSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; den Hartog C, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P1; DenHartog C, 1970, SEA GRASSES WORLD; Dubouzet JG, 1999, THEOR APPL GENET, V98, P422, DOI 10.1007/s001220051088; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Hershkovitz MA, 1999, SYST ASSOC SPEC VOL, V57, P268; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kim JB, 2009, AQUAT BOT, V90, P269, DOI 10.1016/j.aquabot.2008.10.007; Kim SH, 2012, MAR BIOL, V159, P255, DOI 10.1007/s00227-011-1804-6; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KROPF M., 2002, VERGLEICHENDE BIOGEO; Kuo John, 2006, Acta Phytotaxonomica et Geobotanica, V57, P129; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Makino T., 1912, BOT MAG TOKYO, V26, P208, DOI 10.15281/jplantres1887.26.307_208; McRoy C.P., 1997, SEAGRASS ECOSYSTEMS, P53; Miki S., 1934, BOT MAG TOKYO, V48, P131, DOI DOI 10.15281/JPLANTRES1887.48.131; MUKAI H, 1993, AUST J MAR FRESH RES, V44, P1; Nei M., 2000, MOL EVOLUTION PHYLOG; Nguyen VX, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-92; Vy NX, 2013, AQUAT BOT, V110, P6, DOI 10.1016/j.aquabot.2013.04.003; Osathanunkul M, 2015, AFR J BIOTECHNOL, V14, P649, DOI DOI 10.5897/AJB204.13855; Setchell WA, 1920, B TORREY BOT CLUB, V47, P563; SHIMADA S., 2012, COASTAL MARINE SCI, V35, P85; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 2010, AQUAT BOT, V93, P141, DOI 10.1016/j.aquabot.2010.05.001; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P5, DOI 10.1016/B978-044450891-1/50002-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uchimura M, 2006, BOT MAR, V49, P111, DOI 10.1515/BOT.2006.015; Uchimura Masayuki, 2006, Bulletin of the National Science Museum Series B (Botany), V32, P129; Uchimura M, 2008, BOT MAR, V51, P258, DOI 10.1515/BOT.2008.036; Waycott M, 2002, B MAR SCI, V71, P1299; Waycott M, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P25; WEST RJ, 1990, MAR POLLUT BULL, V21, P197, DOI 10.1016/0025-326X(90)90502-Y; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Nguyen XV, 2015, SYST BIODIVERS, V13, P496, DOI 10.1080/14772000.2015.1046408	37	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177772	10.1371/journal.pone.0177772	http://dx.doi.org/10.1371/journal.pone.0177772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505209	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500043
J	Smith, CA; Board, TN; Rooney, P; Eagle, MJ; Richardson, SM; Hoyland, JA				Smith, Christopher A.; Board, Tim N.; Rooney, Paul; Eagle, Mark J.; Richardson, Stephen M.; Hoyland, Judith A.			Human decellularized bone scaffolds from aged donors show improved osteoinductive capacity compared to young donor bone	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-I; OSTEOGENIC DIFFERENTIATION; POTENTIAL IMPLICATIONS; CORTICAL BONE; ALLOGRAFT; MATRIX; ARCHITECTURE; WOMEN; SITE	To improve the safe use of allograft bone, decellularization techniques may be utilized to produce acellular scaffolds. Such scaffolds should retain their innate biological and biomechanical capacity and support mesenchymal stem cell (MSC) osteogenic differentiation. However, as allograft bone is derived from a wide age-range, this study aimed to determine whether donor age impacts on the ability an osteoinductive, acellular scaffold produced from human bone to promote the osteogenic differentiation of bone marrow MSCs (BM-MSC). BM-MSCs from young and old donors were seeded on acellular bone cubes from young and old donors undergoing osteoarthritis related hip surgery. All combinations resulted in increased osteogenic gene expression, and alkaline phosphatase (ALP) enzyme activity, however BM-MSCs cultured on old donor bone displayed the largest increases. BM-MSCs cultured in old donor bone conditioned media also displayed higher osteogenic gene expression and ALP activity than those exposed to young donor bone conditioned media. ELISA and Luminex analysis of conditioned media demonstrated similar levels of bioactive factors between age groups; however, IGF binding protein 1 (IGFBP1) concentration was significantly higher in young donor samples. Additionally, structural analysis of old donor bone indicated an increased porosity compared to young donor bone. These results demonstrate the ability of a decellularized scaffold produced from young and old donors to support osteogenic differentiation of cells from young and old donors. Significantly, the older donor bone produced greater osteogenic differentiation which may be related to reduced IGFBP1 bioavailability and increased porosity, potentially explaining the excellent clinical results seen with the use of allograft from aged donors.	[Smith, Christopher A.; Richardson, Stephen M.; Hoyland, Judith A.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Board, Tim N.] Wrightington Hosp, Wigan, England; [Rooney, Paul; Eagle, Mark J.] NHS Blood & Tissue Transplant Serv, Liverpool, Merseyside, England; [Hoyland, Judith A.] Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England	University of Manchester; University of Manchester	Hoyland, JA (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England.; Hoyland, JA (corresponding author), Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England.	Judith.a.hoyland@manchester.ac.uk	Richardson, Stephen/A-4124-2009; Board, Tim/I-9296-2019; Smith, Christopher Andrew/A-7229-2015	Richardson, Stephen/0000-0002-7637-4135; Board, Tim/0000-0002-3295-2087; Smith, Christopher Andrew/0000-0001-6478-2310	John Charnley Trust; Joint Action; MRC CIC; NHSBT; Wrightington Hospital; National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit	John Charnley Trust; Joint Action; MRC CIC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHSBT; Wrightington Hospital; National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit	This work was funded by the John Charnley Trust, Joint Action, MRC CIC (http://www.johncharnleytrust.org/trust/index.html) to TB and JAH, the NHSBT, and Wrightington Hospital. Technical support for this project was funded by the National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkisson HD, 2000, J ORTHOPAED RES, V18, P503, DOI 10.1002/jor.1100180326; Aerssens J, 1997, J ENDOCRINOL, V155, P411, DOI 10.1677/joe.0.1550411; Boonen S, 1997, CALCIFIED TISSUE INT, V61, P173; Boskey A, 2003, OSTEOPOROSIS INT, V14, pS16, DOI 10.1007/s00198-003-1468-2; CAMPBELL PG, 1991, J CELL PHYSIOL, V149, P293, DOI 10.1002/jcp.1041490216; CHALMERS J, 1959, J BONE JOINT SURG BR, V41, P160, DOI 10.1302/0301-620X.41B1.160; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chen H, 2010, OSTEOPOROSIS INT, V21, P627, DOI 10.1007/s00198-009-0993-z; Chen L, 2015, BMB REPORTS; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chen PY, 2011, J MECH BEHAV BIOMED, V4, P961, DOI 10.1016/j.jmbbm.2011.02.006; Clough BH, 2015, J BONE MINER RES, V30, P83, DOI 10.1002/jbmr.2320; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; da Costa LC, 1999, J PERIODONTOL, V70, P562; daCosta FL, 1998, J PERIODONTOL, V69, P470; Delloye C, 2014, ACTA ORTHOP BELG, V80, P196; Dutra TF, 2010, EXP MOL PATHOL, V88, P58, DOI 10.1016/j.yexmp.2009.09.007; Ebraheim N A, 2001, J Am Acad Orthop Surg, V9, P210; Hashimoto Y, 2011, BIOMATERIALS, V32, P7060, DOI 10.1016/j.biomaterials.2011.06.008; JERGESEN HE, 1991, CLIN ORTHOP RELAT R, P253; Kurtz SM, 2014, J BONE JOINT SURG AM, V96A, P624, DOI 10.2106/JBJS.M.00285; Lochmuller EM, 2008, J BONE MINER RES, V23, P1964, DOI [10.1359/jbmr.080709, 10.1359/JBMR.080709]; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Marcos-Campos I, 2012, BIOMATERIALS, V33, P8329, DOI 10.1016/j.biomaterials.2012.08.013; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; NICOLAS V, 1994, J CLIN ENDOCR METAB, V78, P1011, DOI 10.1210/jc.78.5.1011; NyssenBehets C, 1996, ARCH ORTHOP TRAUM SU, V115, P303, DOI 10.1007/BF00420320; Pietrzak WS, 2006, J CRANIOFAC SURG, V17, P84, DOI 10.1097/01.scs.0000179745.91165.73; Pinholt EM, 1998, J CRANIOFAC SURG, V9, P142, DOI 10.1097/00001665-199803000-00011; Schwartz Z, 1998, J PERIODONTOL, V69, P470, DOI 10.1902/jop.1998.69.4.470; Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422; Smith CA, 2015, J TISSUE ENG REGEN M, V9, P595, DOI 10.1002/term.1934; Stauber M, 2006, OSTEOPOROSIS INT, V17, P616, DOI 10.1007/s00198-005-0025-6; Traianedes K, 2004, J BIOMED MATER RES B, V70B, P21, DOI 10.1002/jbm.b.30015; Turunen MJ, 2013, BONE, V54, P118, DOI 10.1016/j.bone.2013.01.045; Ueland T, 2003, J CLIN ENDOCR METAB, V88, P1014, DOI 10.1210/jc.2002-020977; Varettas K, 2011, CELL TISSUE BANK, V12, P37, DOI 10.1007/s10561-009-9154-z; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wilkinson A, 2011, ACTA BIOMATER, V7, P2919, DOI 10.1016/j.actbio.2011.03.026; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199	41	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177416	10.1371/journal.pone.0177416	http://dx.doi.org/10.1371/journal.pone.0177416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505164	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500020
J	Andersson, K; Dahllof, G; Lindahl, K; Kindmark, A; Grigelioniene, G; Astrom, E; Malmgren, B				Andersson, Kristofer; Dahllof, Goran; Lindahl, Katarina; Kindmark, Andreas; Grigelioniene, Giedre; Astrom, Eva; Malmgren, Barbro			Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - A retrospective cohort study	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATIONS; COLLAGEN STRUCTURAL GENES; I COLLAGEN; PAMIDRONATE THERAPY; SWEDISH POPULATION; HELICAL DOMAIN; 2ND MOLAR; BONE MASS; EXPRESSION; TEETH	Osteogenesis imperfecta (OI) is a heterogeneous group of disorders of connective tissue, caused mainly by mutations in the collagen I genes (COL1A1 and COL1A2). Dentinogenesis imperfecta (DGI) and other dental aberrations are common features of OI. We investigated the association between collagen I mutations and DGI, taurodontism, and retention of permanent second molars in a retrospective cohort of 152 unrelated children and adolescents with OI. The clinical examination included radiographic evaluations. Teeth from 81 individuals were available for histopathological evaluation. COL1A1/2 mutations were found in 104 individuals by nucleotide sequencing. DGI was diagnosed clinically and radiographically in 29% of the individuals (44/152) and through isolated histological findings in another 19% (29/152). In the individuals with a COL1A1 mutation, 70% (7/10) of those with a glycine substitution located C-terminal of p. Gly305 exhibited DGI in both dentitions while no individual (0/7) with a mutation N-terminal of this point exhibited DGI in either dentition (p = 0.01). In the individuals with a COL1A2 mutation, 80% (8/10) of those with a glycine substitution located C terminal of p. Gly211 exhibited DGI in both dentitions while no individual (0/5) with a mutation N-terminal of this point (p = 0.007) exhibited DGI in either dentition. DGI was restricted to the deciduous dentition in 20 individuals. Seventeen had missense mutations where glycine to serine was the most prevalent substitution (53%). Taurodontism occurred in 18% and retention of permanent second molars in 31% of the adolescents. Dental aberrations are strongly associated with qualitatively changed collagen I. The varying expressivity of DGI is related to the location of the collagen I mutation. Genotype information may be helpful in identifying individuals with OI who have an increased risk of dental aberrations.	[Andersson, Kristofer; Dahllof, Goran; Malmgren, Barbro] Karolinska Inst, Dept Dent Med, Div Pediat Dent, Huddinge, Sweden; [Dahllof, Goran] Ctr Pediat Oral Hlth Res, Stockholm, Sweden; [Lindahl, Katarina; Kindmark, Andreas] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Grigelioniene, Giedre] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Grigelioniene, Giedre] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Astrom, Eva] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Astrom, Eva] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Pediat Neurol & Musculoskeletal Disorders & Home, Stockholm, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Andersson, K (corresponding author), Karolinska Inst, Dept Dent Med, Div Pediat Dent, Huddinge, Sweden.	kristofer.andersson@ki.se	Grigelioniene, Giedre/N-6599-2013; Grigelioniene, Giedre/AAH-8408-2020	Grigelioniene, Giedre/0000-0001-9601-3137; Grigelioniene, Giedre/0000-0001-9601-3137; Dahllof, Goran/0000-0001-8536-5292	American Dental Society of Sweden (ADSS); Swedish Endocrine Society; Uppsala County Council; Stiftelsen Promobilia and Stockholm County Council; Stockholm County Council	American Dental Society of Sweden (ADSS); Swedish Endocrine Society; Uppsala County Council; Stiftelsen Promobilia and Stockholm County Council; Stockholm County Council(Stockholm County Council)	KA has been supported by grants from the American Dental Society of Sweden (ADSS) (http://www.adss.se/) and Svenska Tandlakare-Sallskapet (https://tandlakarforbundet.setforskning/svenska-tandlakare-sallskapet/); and KL was supported by the Swedish Endocrine Society (http://endokrinelogforeningen.se/). AK received grants from Uppsala County Council (ALF project). GG has been supported by Stiftelsen Promobilia (http://www.promobilia.se) and Stockholm County Council (ALF project). EA has been supported by Stockholm County Council (ALF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDUJAR MB, 1991, DEVELOPMENT, V111, P691; Astrom E, 1998, ACTA PAEDIATR, V87, P64; Axelsson Stefan, 2005, Swed Dent J Suppl, P3; Backman B, 2001, Int J Paediatr Dent, V11, P11, DOI 10.1046/j.1365-263x.2001.00205.x; Bardai G, 2016, OSTEOPOROS INT; Bondernark L, 2007, ANGLE ORTHOD, V77, P773, DOI 10.2319/072506-306.1; Chang PC, 2007, EUR J ORTHODONT, V29, P232, DOI 10.1093/ejo/cjl035; da Fontoura CSG, 2015, J DENT RES, V94, P913, DOI 10.1177/0022034515581643; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; Farman A G, 1978, Br J Orthod, V5, P93; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Gupta Saurabh K, 2011, J Oral Sci, V53, P231; Islam M, 2005, ORAL SURG ORAL MED O, V100, P736, DOI 10.1016/j.tripleo.2005.04.017; JASPERS MT, 1981, ORAL SURG ORAL MED O, V51, P632, DOI 10.1016/S0030-4220(81)80014-X; Jensen BL, 1997, J CRAN GENET DEV BIO, V17, P121; Joseph M, 2008, ORAL SURG ORAL MED O, V105, P670, DOI 10.1016/j.tripleo.2007.11.015; Lindahl K, 2015, EUR J HUM GENET, V23, P1042, DOI 10.1038/ejhg.2015.81; Lindahl K, 2011, HUM MUTAT, V32, P598, DOI 10.1002/humu.21475; Luder HU, 1996, J CRAN GENET DEV BIO, V16, P156; LUKINMAA PL, 1987, J CRAN GENET DEV BIO, V7, P115; LUKINMAA PL, 1987, J CRAN GENET DEV BIO, V7, P127; LUKINMAA PL, 1992, J DENT RES, V71, P36, DOI 10.1177/00220345920710010601; Lund AM, 1998, J CRAN GENET DEV BIO, V18, P30; Lund AM, 1996, CLIN GENET, V50, P304; Magnusson C, 2009, ANGLE ORTHOD, V79, P422, DOI 10.2319/021908-97.1; Malmgren B, 2017, ORAL DIS, V23, P42, DOI 10.1111/odi.12568; Malmgren B, 2002, ACTA ODONTOL SCAND, V60, P65, DOI 10.1080/000163502753509446; Malmgren Barbro, 2003, Acta Odontologica Scandinavica, V61, P72, DOI 10.1080/00016350310001398; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; O'Connell AC, 1999, ORAL SURG ORAL MED O, V87, P189, DOI 10.1016/S1079-2104(99)70272-6; ORMISTON IW, 1995, J CRANIO MAXILL SURG, V23, P261, DOI 10.1016/S1010-5182(05)80219-7; Rauch F, 2003, J BONE MINER RES, V18, P610, DOI 10.1359/jbmr.2003.18.4.610; Rauch F, 2003, J CLIN ENDOCR METAB, V88, P986, DOI 10.1210/jc.2002-021371; Rauch F, 2010, J BONE MINER RES, V25, P1367, DOI 10.1359/jbmr.091109; Rauch F, 2010, EUR J HUM GENET, V18, P642, DOI 10.1038/ejhg.2009.242; SCHWARTZ S, 1984, ORAL SURG ORAL MED O, V57, P161, DOI 10.1016/0030-4220(84)90206-8; Shaw JCM, 1928, J ANAT, V62, P476; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; STENVIK A, 1985, SCAND J DENT RES, V93, P56; SYKES B, 1986, LANCET, V2, P69; Thilander B, 2005, EUR J ORTHODONT, V27, P370, DOI 10.1093/ejo/cji033; VARPIO M, 1988, J DENT CHILD, V55, P114; WALLIS GA, 1993, J MED GENET, V30, P492, DOI 10.1136/jmg.30.6.492; Waltimo-Siren J, 2005, AM J MED GENET A, V133A, P142, DOI 10.1002/ajmg.a.30523; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; WILLING MC, 1992, AM J HUM GENET, V51, P508; Willing MC, 1996, AM J HUM GENET, V59, P799; WITKOP CJ, 1971, ORAL SURG ORAL MED O, V32, P278, DOI 10.1016/0030-4220(71)90232-5	50	44	46	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176466	10.1371/journal.pone.0176466	http://dx.doi.org/10.1371/journal.pone.0176466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498836	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500005
J	Birger, RB; Le, T; Kouyos, RD; Grenfell, BT; Hallett, TB				Birger, Ruthie B.; Thuy Le; Kouyos, Roger D.; Grenfell, Bryan T.; Hallett, Timothy B.			The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIGH-RISK; INFECTION; USERS; COINFECTION; EPIDEMIOLOGY; MEN; TRANSMISSION; REINFECTION; CLEARANCE	Background Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) coinfection is a major global health problem especially among people who inject drugs (PWID), with significant clinical implications. Mathematical models have been used to great effect to shape HIV care, but few have been proposed for HIV/HCV. Methods We constructed a deterministic compartmental ODE model that incorporated layers for HIV disease progression, HCV disease progression and PWID demography. Antiretroviral therapy (ART) and Methadone Maintenance Therapy (MMT) scale-ups were modeled as from 2016 and projected forward 10 years. HCV treatment roll-out was modeled beginning in 2026, after a variety of MMT scale-up scenarios, and projected forward 10 years. Results Our results indicate that scale-up of ART has a major impact on HIV though not on HCV burden. MMT scale-up has an impact on incidence of both infections. HCV treatment roll-out has a measurable impact on reductions of deaths, increasing multifold the mortality reductions afforded by just ART/MMT scale-ups. Conclusion HCV treatment roll-out can have major and long-lasting effects on averting PWID deaths on top of those averted by ART/MMT scale-up. Efficient intervention scale-up of HCV alongside HIV interventions is critical in Vietnam.	[Birger, Ruthie B.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Birger, Ruthie B.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Thuy Le] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Kouyos, Roger D.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Hallett, Timothy B.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England	Princeton University; Columbia University; University of Oxford; University of Zurich; University Zurich Hospital; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Imperial College London	Birger, RB (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.; Birger, RB (corresponding author), Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.	ruthie.birger@gmail.com	Birger, Ruthie/F-2416-2014; Kouyos, Roger/ABB-2291-2021; Kouyos, Roger/G-6226-2014	Birger, Ruthie/0000-0002-2960-5084; Kouyos, Roger/0000-0002-9220-8348; Kouyos, Roger/0000-0002-9220-8348; Hallett, Timothy/0000-0002-9681-0424	Princeton University Department of Ecology and Evolutionary Biology; Princeton University Center for Health and Well-Being; Wellcome Trust; Hawaii Center for AIDS; Bill and Melinda Gates Foundation; RAPIDD program of the Science and Technology Directorate, NIH; U.S. Department of Homeland Security, NIH; Fogarty International Center, NIH; Family Health International; Medical Research Council [G1100682, MR/K010174/1B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; MRC [G1100682] Funding Source: UKRI	Princeton University Department of Ecology and Evolutionary Biology(Princeton University); Princeton University Center for Health and Well-Being; Wellcome Trust(Wellcome TrustEuropean Commission); Hawaii Center for AIDS; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science and Technology Directorate, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Homeland Security, NIH; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Family Health International; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RBB was supported by the Princeton University Department of Ecology and Evolutionary Biology and the Princeton University Center for Health and Well-Being. TL is supported by the Wellcome Trust and the Hawaii Center for AIDS. BTG is supported by the Bill and Melinda Gates Foundation and the RAPIDD program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Masaya Kato, Nguyen To Nhu, and Family Health International for their support, and in particular their help with data acquisition. We also thank Maciej Boni, Jon Zelner, Jonathan Dushoff, David Wilson, Pejman Rohani, Andrea Graham, C. Jessica E. Metcalf, Simon Levin and the HIV Modelling Consortium for valuable insight and discussions.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Andreoni M, 2012, EUR REV MED PHARMACO, V16, P1473; [Anonymous], 2010, RES PROGR EV PAT IN; [Anonymous], 2014, NATURE MED, V20, P319, DOI 10.1038/nm.3538; Badri M, 2006, ANTIVIR THER, P63; Barth H, 2011, HEPATOLOGY, V54, P1135, DOI 10.1002/hep.24489; Birger R, 2015, EPIDEMICS-NETH, V12, P1, DOI 10.1016/j.epidem.2015.04.001; Birger RB, 2014, CLIN INFECT DIS, V58, P274, DOI 10.1093/cid/cit687; Chinh NT, 2010, CROI; Clatts MC, 2010, J URBAN HEALTH, V87, P278, DOI 10.1007/s11524-009-9417-9; Collins S., 2013, PIPELINE ORAL HCV DR; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Cunningham EB, 2015, NAT REV GASTRO HEPAT, V12, P218, DOI 10.1038/nrgastro.2015.36; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; de Vos AS, 2012, EPIDEMICS-NETH, V4, P57, DOI 10.1016/j.epidem.2012.01.001; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; Do TN, 2013, INT AIDS SOC C KUAL; Durier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034548; Fernandez-Montero J. V., 2013, Current Hepatitis Reports, V12, P269, DOI 10.1007/s11901-013-0179-1; FHI360 USAID, 2011, EFF EV PIOL PROGR OP; Foster GR, 2016, J HEPATOL, V64, P1224, DOI 10.1016/j.jhep.2016.01.029; Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Hirschler B, 2014, GILEAD OFFERS EGYPT; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Kamarulzaman A, 2015, INT J DRUG POLICY, V26, pS33, DOI 10.1016/j.drugpo.2014.11.011; Kato M, 1999, J ACQUIRED IMMUNE DE; Keating GM, 2014, DRUGS, V74, P273, DOI 10.1007/s40265-014-0179-7; Kwon JA, 2009, JAIDS-J ACQ IMM DEF, V51, P462, DOI 10.1097/QAI.0b013e3181a2539a; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mehta SJ, 2014, CLEV CLIN J MED, V81, P173, DOI 10.3949/ccjm.81a.14010; Mudecins du Monde and Treatment Action Group, 2016, MAPCROWD ONL GLOB DA; Nadol P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118304; NAKATA S, 1994, J GASTROEN HEPATOL, V9, P416, DOI 10.1111/j.1440-1746.1994.tb01265.x; National Committee for Aids Drugs Control and Prostitution Prevention UNAIDS, 2012, VIET NAM AIDS RESP P; [National Institute of Hygiene and Epidemiology Family Health International Viet Nam Administration of HIV/AIDS Control United States Agency for International Development], 2006, RES HIV STI INT BIOL; National Institute of Hygiene and Epidemiology and Family Health International Vietnam, 2009, RES HIV STI INT BIOL; Nguyen VT, 2008, ADDICTION, V103, P535, DOI 10.1111/j.1360-0443.2007.02122.x; Phan HTT, 2009, HEPATITIS C HUMAN IM; Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024; Quan VM, 2010, ADDICTION, V106, P583, DOI DOI 10.1111/J.1360-0443.2010.03175.X; Quan VM, 2008, PUBLIC HLTH ASPECTS, P457; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Rangarajan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108939; Rangsin R, 2004, JAIDS-J ACQ IMM DEF, V36, P622, DOI 10.1097/00126334-200405010-00011; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Sereno L, 2012, J INT ASS PHYS AIDS; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Khuat TH, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-25; Vuong T, 2012, INT J DRUG POLICY, V23, P319, DOI 10.1016/j.drugpo.2011.11.005; Hoang TV, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0075-9; VAAC UNAIDS World Bank University of New South Wales Partnership for Epidemic Analysis, 2011, PARTN EP AN EV EP IM; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; Vickerman P, 2009, SEX TRANSM INFECT, V85, P23, DOI 10.1136/sti.2008.034660; Vietnam Authority of HIV/AIDS Control, 2012, VIETN HIV AIDS DAT; Vietnam Ministry of Health, 2012, VIET NAM HIV AIDS ES; Vietnam Ministry of Health, 2016, ISS TECHN GUID HCV D; Vogel M, 2011, CURR OPIN INFECT DIS, V24, P1, DOI 10.1097/QCO.0b013e3283422e09; Wilson DP, 2011, EVALUATION EPIDEMIOL; World Health Organization, 2015, HEP C FACT SHEET	63	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177195	10.1371/journal.pone.0177195	http://dx.doi.org/10.1371/journal.pone.0177195			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493917	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000401314300070
J	Blair, DP; Blanchard, W; Banks, SC; Lindenmayer, DB				Blair, David P.; Blanchard, Wade; Banks, Sam C.; Lindenmayer, David B.			Non-linear growth in tree ferns, Dicksonia antarctica and Cyathea australis	PLOS ONE			English	Article							EUCALYPT FOREST; EPIPHYTIC FERNS; FIRE; ECOLOGY; AGE; PERSISTENCE; DISTURBANCE; DEMOGRAPHY; VICTORIA; HABITAT	Tree ferns are an important structural component of forests in many countries. However, because their regeneration is often unrelated to major disturbances, their age is often difficult to determine. In addition, rates of growth may not be uniform, which further complicates attempts to determine their age. In this study, we measured 5 years of growth of Cyathea australis and Dicksonia antarctica after a large wildfire in 2009 in south-eastern Australia. We found growth rates of these two species were unaffected by aspect and elevation but slope had a minor effect with D. antarctica growing 0.3mm faster for each additional degree of slope. Geographic location influenced growth in both species by up to 12 14mm/yr. The most consistent factor influencing growth rate, however, was initial height at the time of the 2009 fire; a finding consistent in both species and all geographic locations. For both tree fern species, individuals that were taller at the commencement of the study had greater overall growth for the duration of the study. This effect did not decrease even among the tallest tree ferns in our study (up to 6 metres tall). Overall, Cyathea australis averaged 73 (+/- 22) mm/year of growth (+/- 1SD), with the rate increasing 5mm/yr per metre of additional height. Dicksonia antarctica averaged 33 (+/- 13) mm/year, increasing by 6mm/yr/m. Growth rates dependent on initial height were unexpected and we discuss possible reasons for this finding. Variable growth rates also suggest that common age estimation methods of dividing height by average growth rate are likely to underestimate the age of short tree ferns, while overestimating the age of tall tree ferns, particularly if they have been subject to a fire.	[Blair, David P.; Blanchard, Wade; Banks, Sam C.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Blair, David P.; Blanchard, Wade; Banks, Sam C.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Long Term Ecol Res Network, Canberra, ACT, Australia	Australian National University; Australian National University	Blair, DP (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.; Blair, DP (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Long Term Ecol Res Network, Canberra, ACT, Australia.	david.blair@anu.edu.au	Lindenmayer, David B/P-7183-2017; /K-4907-2012	Lindenmayer, David B/0000-0002-4766-4088; /0000-0003-2415-0057	Australian Research Council; Victorian Government (Department of Environment, Land, Water and Planning); Victorian Government (Parks Victoria); Wood Foundation; Long Term Ecological Research Network (LTERN); Terrestrial Ecosystem Research Network (TERN)	Australian Research Council(Australian Research Council); Victorian Government (Department of Environment, Land, Water and Planning); Victorian Government (Parks Victoria); Wood Foundation; Long Term Ecological Research Network (LTERN); Terrestrial Ecosystem Research Network (TERN)	This work was funded by the Australian Research Council, Victorian Government (Department of Environment, Land, Water and Planning and Parks Victoria), Wood Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Academic Editor of PLOS ONE, Sergio Rossi and the four anonymous reviewers for their thoughtful comments which improved the manuscript. We also thank the Long Term Ecological Research Network (LTERN) and the Terrestrial Ecosystem Research Network (TERN) for their support of our research.	Arens NC, 2000, AM FERN J, V90, P1, DOI 10.2307/1547257; Arens NC, 2001, AM J BOT, V88, P545, DOI 10.2307/2657118; ASH J, 1987, AUST J BOT, V35, P331, DOI 10.1071/BT9870331; Ashton D, 1982, SPECIAL PUBLICATION; ASHTON DH, 1986, AUST J BOT, V34, P107, DOI 10.1071/BT9860107; ATTIWILL PM, 1987, FOREST SOILS NUTR CY; Australian Bureau of Meteorology, 2017, ANN AV SEAS MONTHL R; Australian Bureau of Meteorology, 2017, ANN AV MONTL DAYS RA; Australian Bureau of Meteorology, 2016, CLIM WEATH; Benyon RG, 2013, FOREST ECOL MANAG, V294, P197, DOI 10.1016/j.foreco.2012.04.003; Berry LE, 2015, ECOL APPL, V25, P2337, DOI [10.1890/14-1699.1.sm, 10.1890/14-1699.1]; BITTNER J, 1995, AM FERN J, V85, P37, DOI 10.2307/1547463; Blair D, 2016, UNPUB; Blair DP, 2016, ECOL APPL, V26, P2280, DOI 10.1002/eap.1369; Brock JMR, 2016, FOREST ECOL MANAG, V375, P112, DOI 10.1016/j.foreco.2016.05.030; Bystriakova N, 2011, J VEG SCI, V22, P72, DOI 10.1111/j.1654-1103.2010.01227.x; Conant DS, 1995, AM FERN J, V85, P328, DOI 10.2307/1547813; Coomes DA, 2005, J ECOL, V93, P918, DOI 10.1111/j.1365-2745.2005.01012.x; Dignan P, 2003, FOREST ECOL MANAG, V172, P161, DOI 10.1016/S0378-1127(01)00810-6; Fedrigo M, 2014, FOREST ECOL MANAG, V334, P129, DOI 10.1016/j.foreco.2014.08.025; FERWERDA F, 1981, Proceedings of the Royal Society of Victoria, V93, P1; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hunt MA, 2002, AUSTRAL ECOL, V27, P360, DOI 10.1046/j.1442-9993.2002.01190.x; Jemison M., 2012, ASSESSING IMPACT 200; Jones MM, 2007, J VEG SCI, V18, P13, DOI 10.1111/j.1654-1103.2007.tb02511.x; Korall P, 2014, J BIOGEOGR, V41, P402, DOI 10.1111/jbi.12222; Large MF., 2004, TREE FERNS; Lee PH, 2009, J PLANT RES, V122, P61, DOI 10.1007/s10265-008-0191-7; Lindenmayer D, 2015, MOUNTAIN ASH: FIRE, LOGGING AND THE FUTURE OF VICTORIA'S GIANT FORESTS, P1; Lindenmayer DB, 2006, CONSERV BIOL, V20, P1005, DOI 10.1111/j.1523-1739.2006.00501.x; LINDENMAYER DB, 1994, BIOL CONSERV, V68, P43, DOI 10.1016/0006-3207(94)90545-2; Lindenmayer DB, 2000, FOREST ECOL MANAG, V134, P189, DOI 10.1016/S0378-1127(99)00257-1; McCarthy MA, 1999, FOREST ECOL MANAG, V124, P193, DOI 10.1016/S0378-1127(99)00066-3; Moran RC, 2003, BIOTROPICA, V35, P48, DOI 10.1111/j.1744-7429.2003.tb00261.x; Mueck SG, 1996, AUST J ECOL, V21, P345, DOI 10.1111/j.1442-9993.1996.tb00619.x; Nagano T, 2007, TROPICS, V16, P47, DOI 10.3759/tropics.16.47; Neyland M.G., 1986, CONSERVATION MANAGEM; Ough K, 2004, FOREST ECOL MANAG, V199, P153, DOI 10.1016/j.foreco.2004.05.030; Page C, 1981, ECOLOGICAL BIOGEOGRA; Peacock R, 1995, DIVISION SILVICULTUR; Pharo EJ, 2013, FOREST ECOL MANAG, V296, P24, DOI 10.1016/j.foreco.2013.01.018; POPE AIRINI, 1926, NEW ZEALAND JOUR SCI & TECH, V8, P85; R Core Team, 2013, R LANG ENV STAT COMP; Roberts NR, 2005, AUSTRAL ECOL, V30, P146, DOI 10.1111/j.1442-9993.2005.01440.x; Schmitt JL, 2006, AM FERN J, V96, P103, DOI 10.1640/0002-8444(2006)96[103:GRAAEO]2.0.CO;2; Seebeck J.H., 1984, P145; TANNER EVJ, 1983, BOT J LINN SOC, V87, P213, DOI 10.1111/j.1095-8339.1983.tb00991.x; Volkova L, 2011, ENVIRON EXP BOT, V70, P11, DOI 10.1016/j.envexpbot.2010.06.001; Volkova L, 2009, AUST J BOT, V57, P562, DOI 10.1071/BT09153; Volkova L, 2009, FUNCT PLANT BIOL, V36, P1046, DOI 10.1071/FP09098; Walsh N.G., 1994, FLORA VICTORIA	51	11	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176908	10.1371/journal.pone.0176908	http://dx.doi.org/10.1371/journal.pone.0176908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493884	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300041
J	Gargallo-Garriga, A; Wright, SJ; Sardans, J; Perez-Trujillo, M; Oravec, M; Vecerova, K; Urban, O; Fernandez-Martinez, M; Parella, T; Penuelas, J				Gargallo-Garriga, Albert; Wright, S. Joseph; Sardans, Jordi; Perez-Trujillo, Miriam; Oravec, Michal; Vecerova, Kristyna; Urban, Otmar; Fernandez-Martinez, Marcos; Parella, Teodor; Penuelas, Josep			Long-term fertilization determines different metabolomic profiles and responses in saplings of three rainforest tree species with different adult canopy position	PLOS ONE			English	Article							PHOSPHORUS FERTILIZATION; ELEMENTAL COMPOSITION; NUTRIENT LIMITATION; LITTER PRODUCTION; YOUNG LEAVES; NITROGEN; LOWLAND; GROWTH; FOLIAR; LIGHT	Background Tropical rainforests are frequently limited by soil nutrient availability. However, the response of the metabolic phenotypic plasticity of trees to an increase of soil nutrient availabilities is poorly understood. We expected that increases in the ability of a nutrient that limits some plant processes should be detected by corresponding changes in plant metabolome profile related to such processes. Methodology/Principal findings We studied the foliar metabolome of saplings of three abundant tree species in a 15 year field NPK fertilization experiment in a Panamanian rainforest. The largest differences were among species and explained 75% of overall metabolome variation. The saplings of the large canopy species, Tetragastris panamensis, had the lowest concentrations of all identified amino acids and the highest concentrations of most identified secondary compounds. The saplings of the "mid canopy" species, Alseis blackiana, had the highest concentrations of amino acids coming from the biosynthesis pathways of glycerate-3P, oxaloacetate and alpha-ketoglutarate, and the saplings of the low canopy species, Heisteria concinna, had the highest concentrations of amino acids coming from the pyruvate synthesis pathways. Conclusions/Significance The changes in metabolome provided strong evidence that different nutrients limit different species in different ways. With increasing P availability, the two canopy species shifted their metabolome towards larger investment in protection mechanisms, whereas with increasing N availability, the sub-canopy species increased its primary metabolism. The results highlighted the proportional distinct use of different nutrients by different species and the resulting different metabolome profiles in this high diversity community are consistent with the ecological niche theory.	[Gargallo-Garriga, Albert; Sardans, Jordi; Fernandez-Martinez, Marcos; Penuelas, Josep] Global Ecol Unit CREAF CEAB CSIC UAB, CSIC, Cerdanyola Del Valles, Catalonia, Spain; [Gargallo-Garriga, Albert; Sardans, Jordi; Fernandez-Martinez, Marcos; Penuelas, Josep] CREAF, Cerdanyola Del Valles, Catalonia, Spain; [Gargallo-Garriga, Albert; Perez-Trujillo, Miriam; Parella, Teodor] Univ Autonoma Barcelona, Fac Sci & Biosci, Serv Ressonancia Magnet Nucl, Barcelona, Catalonia, Spain; [Wright, S. Joseph] Smithsonian Trop Res Inst, Balboa, Panama; [Oravec, Michal; Vecerova, Kristyna; Urban, Otmar] Czech Acad Sci, Global Change Res Inst, Brno, Czech Republic	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Smithsonian Institution; Smithsonian Tropical Research Institute; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Gargallo-Garriga, A (corresponding author), Global Ecol Unit CREAF CEAB CSIC UAB, CSIC, Cerdanyola Del Valles, Catalonia, Spain.; Gargallo-Garriga, A (corresponding author), CREAF, Cerdanyola Del Valles, Catalonia, Spain.; Gargallo-Garriga, A (corresponding author), Univ Autonoma Barcelona, Fac Sci & Biosci, Serv Ressonancia Magnet Nucl, Barcelona, Catalonia, Spain.	albert.gargallo@mail.com	Martínez, Marcos Fernández/I-7240-2012; Wright, Stuart Joseph/M-3311-2013; Penuelas, Josep/D-9704-2011; Oravec, Michal/G-9681-2014; PEREZ-TRUJILLO, MIRIAM/I-6349-2012; Urban, Otmar/J-7432-2012; Coll, Teodor Parella/A-5371-2008; Sardans, Jordi/AEM-0228-2022	Martínez, Marcos Fernández/0000-0002-5661-3610; Wright, Stuart Joseph/0000-0003-4260-5676; Penuelas, Josep/0000-0002-7215-0150; Oravec, Michal/0000-0002-2506-5826; PEREZ-TRUJILLO, MIRIAM/0000-0002-6919-7417; Urban, Otmar/0000-0002-1716-8876; Coll, Teodor Parella/0000-0002-1914-2709; Sardans, Jordi/0000-0003-2478-0219	European Research Council Synergy [ERC-2013SyG-610028 IMBALANCE-P]; Spanish Government [CGL2013-48074-P, CTQ2012-32436]; Catalan Government [SGR 2014-274]; Scholarly Studies program of the Smithsonian Institution; Academy of Sciences of the Czech Republic [M200871201]; Ministry of Education, Youth and Sports of the Czech Republic [LO1415]	European Research Council Synergy; Spanish Government(Spanish GovernmentEuropean Commission); Catalan Government; Scholarly Studies program of the Smithsonian Institution; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This research was supported by the European Research Council Synergy grant ERC-2013-SyG-610028 IMBALANCE-P, the Spanish Government grants CGL2013-48074-P, CTQ2012-32436, and the Catalan Government grant SGR 2014-274, the Scholarly Studies program of the Smithsonian Institution, the projects M200871201 (Academy of Sciences of the Czech Republic) and LO1415 (Ministry of Education, Youth and Sports of the Czech Republic).	Ameh SJ, 2012, ANEMIA, V2012, DOI 10.1155/2012/607436; BEGGS CJ, 1985, PLANT PHYSIOL, V79, P630, DOI 10.1104/pp.79.3.630; Beggs JJ, 1986, J IND RELAT, V2, P137; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Binkley D, 2000, FOREST ECOL MANAG, V128, P241, DOI 10.1016/S0378-1127(99)00138-3; Carreno-Quintero N, 2013, TRENDS GENET, V29, P41, DOI 10.1016/j.tig.2012.09.006; Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009; Coelho GC, 2007, BIOCHEM SYST ECOL, V35, P75, DOI 10.1016/j.bse.2006.09.001; Corre MD, 2010, ECOLOGY, V91, P1715, DOI 10.1890/09-0274.1; Eckert AJ, 2012, NEW PHYTOL, V193, P890, DOI 10.1111/j.1469-8137.2011.03976.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Estiarte M., 1999, ORSIS, V14, P159; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gargallo-Garriga A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0767-7; Gargallo-Garriga A, 2015, NEW PHYTOL, V207, P591, DOI 10.1111/nph.13377; Gargallo-Garriga A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06829; Ghasemzadeh A, 2011, J MED PLANTS RES, V5, P6697, DOI 10.5897/JMPR11.1404; Gianoli E, 2013, OECOLOGIA, V173, P13, DOI 10.1007/s00442-013-2590-2; Gil M, 2012, PHYTOCHEMISTRY, V77, P89, DOI 10.1016/j.phytochem.2011.12.011; Grassi G, 2000, TREE PHYSIOL, V20, P645; Gyimah R, 2007, NEW FOREST, V33, P217, DOI 10.1007/s11056-006-9028-1; HAHLBROCK K, 1981, PLANT PHYSIOL, V67, P768, DOI 10.1104/pp.67.4.768; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Kitajima K, 2002, FUNCT ECOL, V16, P433, DOI 10.1046/j.1365-2435.2002.00641.x; Klem K, 2015, PLANT PHYSIOL BIOCH, V93, P74, DOI 10.1016/j.plaphy.2015.01.001; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Leiss KA, 2011, PHYTOCHEM REV, V10, P205, DOI 10.1007/s11101-010-9175-z; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; LOIS R, 1994, PLANTA, V194, P498, DOI 10.1007/BF00714462; Lokvam J, 2005, J CHEM ECOL, V31, P2563, DOI 10.1007/s10886-005-7614-x; Lokvam J, 2004, PHYTOCHEMISTRY, V65, P351, DOI 10.1016/j.phytochem.2003.11.012; Marino G, 2010, FUNCT ECOL, V24, P263, DOI 10.1111/j.1365-2435.2009.01630.x; Martz F, 2010, J CHEM ECOL, V36, P1017, DOI 10.1007/s10886-010-9836-9; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; Montero-Vargas JM, 2013, MOL BIOSYST, V9, P693, DOI 10.1039/c3mb25509c; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Nguyen HTM, 2013, PLANT PHYSIOL BIOCH, V73, P23, DOI 10.1016/j.plaphy.2013.07.018; Niinemets U, 1997, FUNCT ECOL, V11, P518, DOI 10.1046/j.1365-2435.1997.00109.x; Paoli GD, 2007, ECOSYSTEMS, V10, P503, DOI 10.1007/s10021-007-9042-y; Pasquini SC, 2012, OECOLOGIA, V168, P311, DOI 10.1007/s00442-011-2099-5; Pasquini SC, 2014, ECOLOGY, V96; Penuelas J, 2010, GLOBAL CHANGE BIOL, V16, P2171, DOI 10.1111/j.1365-2486.2009.02054.x; Penuelas J, 2009, CHEM ECOL, V25, P305, DOI 10.1080/02757540903062517; Penuelas J, 2009, NATURE, V460, P803, DOI 10.1038/460803a; Randi AM, 2014, PHOTOSYNTHETICA, V52, P50, DOI 10.1007/s11099-014-0006-0; Rivas-Ubach A, 2012, P NATL ACAD SCI USA, V109, P4181, DOI 10.1073/pnas.1116092109; Robinson AR, 2005, J EXP BOT, V56, P2807, DOI 10.1093/jxb/eri273; Santiago LS, 2015, TREES-STRUCT FUNCT, V29, P1291, DOI 10.1007/s00468-015-1260-x; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Sardans J, 2014, PLANT ECOL, V215, P441, DOI 10.1007/s11258-014-0314-2; Sardans J, 2015, GLOBAL ECOL BIOGEOGR, V24, P261, DOI 10.1111/geb.12259; Sardans J, 2015, GLOBAL ECOL BIOGEOGR, V24, P240, DOI 10.1111/geb.12253; Sardans J, 2014, ECOHYDROLOGY, V7, P1, DOI 10.1002/eco.1459; Sardans J, 2013, GLOBAL ECOL BIOGEOGR, V22, P494, DOI 10.1111/geb.12015; Schweiger R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4886; Skillman JB, 2005, AM J BOT, V92, P1811, DOI 10.3732/ajb.92.11.1811; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; TANNER EVJ, 1992, ECOLOGY, V73, P78, DOI 10.2307/1938722; Tohge T, 2014, J CHROMATOGR B, V966, P7, DOI 10.1016/j.jchromb.2014.04.003; Tripler CE, 2006, ECOL LETT, V9, P451, DOI 10.1111/j.1461-0248.2006.00891.x; Turner BL, 2005, SCI TOTAL ENVIRON, V344, P27, DOI 10.1016/j.scitotenv.2005.02.003; Urbina I, 2015, ENVIRON EXP BOT, V111, P63, DOI 10.1016/j.envexpbot.2014.10.005; Vitousek, 2004, NUTR CYCLING LIMITAT; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wang WQ, 2015, PLANT ECOL, V216, P809, DOI 10.1007/s11258-015-0469-5; WILSON M, 1994, APPL ENVIRON MICROB, V60, P4468, DOI 10.1128/AEM.60.12.4468-4477.1994; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Wurzburger N, 2015, ECOLOGY, V96, P2137, DOI 10.1890/14-1362.1; Yavitt JB, 2009, AUST J SOIL RES, V47, P674, DOI 10.1071/SR08258; Yavitt JB, 2011, AUSTRAL ECOL, V36, P433, DOI 10.1111/j.1442-9993.2010.02157.x; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zavala JA, 2001, FIELD CROP RES, V69, P143, DOI 10.1016/S0378-4290(00)00136-2; Zhao HJ, 2002, PHOTOSYNTHETICA, V40, P523, DOI 10.1023/A:1024339716382	78	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177030	10.1371/journal.pone.0177030	http://dx.doi.org/10.1371/journal.pone.0177030			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493911	Green Published, gold			2022-12-27	WOS:000401314300051
J	Khomtchouk, BB; Hennessy, JR; Wahlestedt, C				Khomtchouk, Bohdan B.; Hennessy, James R.; Wahlestedt, Claes			shinyheatmap: Ultra fast low memory heatmap web interface for big data genomics	PLOS ONE			English	Article							MICROARRAY; VISUALIZATION	Background Transcriptomics, metabolomics, metagenomics, and other various next-generation sequencing (-omics) fields are known for their production of large datasets, especially across single-cell sequencing studies. Visualizing such big data has posed technical challenges in biology, both in terms of available computational resources as well as programming acumen. Since heatmaps are used to depict high-dimensional numerical data as a colored grid of cells, efficiency and speed have often proven to be critical considerations in the process of successfully converting data into graphics. For example, rendering interactive heatmaps from large input datasets (e.g., 100k+ rows) has been computationally infeasible on both desktop computers and web browsers. In addition to memory requirements, programming skills and knowledge have frequently been barriers-to-entry for creating highly customizable heatmaps. Results We propose shinyheatmap: an advanced user-friendly heatmap software suite capable of efficiently creating highly customizable static and interactive biological heatmaps in a web browser. shinyheatmap is a low memory footprint program, making it particularly well-suited for the interactive visualization of extremely large datasets that cannot typically be computed in-memory due to size restrictions. Also, shinyheatmap features a built-in high performance web plug-in, fastheatmap, for rapidly plotting interactive heatmaps of datasets as large as 10(5)-10(7) rows within seconds, effectively shattering previous performance benchmarks of heatmap rendering speed. Conclusions shinyheatmap is hosted online as a freely available web server with an intuitive graphical user interface: http://shinyheatmap.com. The methods are implemented in R, and are available as part of the shinyheatmap project at: https://github.com/Bohdan-Khomtchouk/ shinyheatmap. Users can access fastheatmap directly from within the shinyheatmap web interface, and all source code has been made publicly available on Github: https://github.com/Bohdan-Khomtchouk/fastheatmap.	[Khomtchouk, Bohdan B.; Wahlestedt, Claes] Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, 1501 NW 10th Ave, Miami, FL 33136 USA; [Khomtchouk, Bohdan B.; Wahlestedt, Claes] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, 1501 NW 10th Ave, Miami, FL 33136 USA; [Hennessy, James R.] Univ Miami, Dept Math, 1365 Mem Dr, Coral Gables, FL 33146 USA	University of Miami; University of Miami; University of Miami	Khomtchouk, BB (corresponding author), Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, 1501 NW 10th Ave, Miami, FL 33136 USA.; Khomtchouk, BB (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, 1501 NW 10th Ave, Miami, FL 33136 USA.	b.khomtchouk@med.miami.edu			United States Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program; NIH [DA035592, AA023781]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023781] Funding Source: NIH RePORTER	United States Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding for this project was provided to BBK by the United States Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program: this research was conducted with Government support under and awarded by DoD, Army Research Office (ARO), National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Relevant work in CW's laboratory is currently funded by NIH grants DA035592 and AA023781.	10X Genomics, 2022, SINGL CELL IMM PROF; [Anonymous], 2021, LANG ENV STAT COMP; BABICKI S, 2016, NUCLEIC ACIDS RES; Biostars, 2014, PLOT HEATM GEN EXPR; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chang W, 2015, SHINY WEB APPL FRAME; Cheng J, 2015, D3HEATMAP INTERACTIV; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Deu-Pons J, 2014, BIOINFORMATICS; Dowle M, 2015, DATA TABLE EXTENSION; Galili T, 2016, HEATMAPLY INTERACTIV; Google Groups, 2012, HEAT MAP 500 300 NOD; Gould J., GENE E SOFTWARE HOST; Hastie T., 2009, UNSUPERVISED LEARNIN; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Khomtchouk BB, 2016, FASTHEATMAP HIGH PER; Khomtchouk BB, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1260-x; Khomtchouk BB, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/s13029-014-0030-2; Kibbey C, 2005, J CHEM INF MODEL, V45, P523, DOI 10.1021/ci0496954; Kolde R., 2015, PHEATMAP PRETTY HEAT; Kolde R, 2015, PHEATMAP PRETTY HEAT, P4; Love M, 2016, RNA SEQ WORKFLOW GEN; Mango Information Systems, 2013, PRER D3 JS CHARTS SE; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Pavlopoulos GA, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0077-2; Pavlopoulos GA, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-13; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Plotly Technologies Inc, 2015, COLL DAT SCI; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakai R, 2014, F1000 RES, V3, p3246 ; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sievert C., 2016, PLOTLY CREATE INTERA; Skuta C, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/s13321-014-0044-4; SO, 2014, DRAW HEATM HUG DAT; SO, 2013, D3 SHOW LARG DAT; SO, 2011, HOW CAN I MAKE A HEA; SO, 2014, CLUST VER LARG DAT R; Sood S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw263; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Turkay C, 2014, IEEE COMPUT GRAPH, V34, P38, DOI 10.1109/MCG.2014.1; Verhaak RGW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-337; vida. io, 2014, BIGQUERY BIG DAT VIS; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Wu HM, 2010, COMPUT STAT DATA AN, V54, P767, DOI 10.1016/j.csda.2008.09.029; Yachdav Guy, 2014, F1000Res, V3, P48, DOI 10.12688/f1000research.3-48.v1; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	48	66	66	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176334	10.1371/journal.pone.0176334	http://dx.doi.org/10.1371/journal.pone.0176334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493881	gold, Green Published			2022-12-27	WOS:000401314300013
J	Morales, G; Llorente, I; Montesinos, E; Moragrega, C				Morales, Gerard; Llorente, Isidre; Montesinos, Emilio; Moragrega, Concepcio			A model for predicting Xanthomonas arboricola pv. pruni growth as a function of temperature	PLOS ONE			English	Article							VIABLE COUNT DATA; BACTERIAL-GROWTH; OPTICAL-DENSITY; LISTERIA-MONOCYTOGENES; 1ST REPORT; LAG PHASE; SPOT; PEACH; TIMES; FIREBLIGHT	A two-step modeling approach was used for predicting the effect of temperature on the growth of Xanthomonas arboricola pv. pruni, causal agent of bacterial spot disease of stone fruit. The in vitro growth of seven strains was monitored at temperatures from 5 to 35 degrees C with a Bioscreen C system, and a calibrating equation was generated for converting optical densities to viable counts. In primary modeling, Baranyi, Buchanan, and modified Gompertz equations were fitted to viable count growth curves over the entire temperature range. The modified Gompertz model showed the best fit to the data, and it was selected to estimate the bacterial growth parameters at each temperature. Secondary modeling of maximum specific growth rate as a function of temperature was performed by using the Ratkowsky model and its variations. The modified Ratkowsky model showed the best goodness of fit to maximum specific growth rate estimates, and it was validated successfully for the seven strains at four additional temperatures. The model generated in this work will be used for predicting temperature-based Xanthomonas arboricola pv. pruni growth rate and derived potential daily doublings, and included as the inoculum potential component of a bacterial spot of stone fruit disease forecaster.	[Morales, Gerard; Llorente, Isidre; Montesinos, Emilio; Moragrega, Concepcio] Univ Girona, CIDSAV, XaRTA, Inst Food & Agr Technol, Girona, Spain	Universitat de Girona	Moragrega, C (corresponding author), Univ Girona, CIDSAV, XaRTA, Inst Food & Agr Technol, Girona, Spain.	concepcio.moragrega@udg.edu	Llorente, Isidre/L-7211-2017; MORAGREGA, CONCEPCIÓ/H-4441-2017; MONTESINOS, EMILIO/H-5246-2015; Morales, Gerard/O-1522-2015	Llorente, Isidre/0000-0003-1893-8649; MORAGREGA, CONCEPCIÓ/0000-0001-6270-9611; MONTESINOS, EMILIO/0000-0003-4455-8332; Morales, Gerard/0000-0002-4535-3438	Ministerio de Educacion, Ciencia y Deporte [AGL2013-41405-R]; University of Girona [SING12/13, MPCUdG2016/085, BR 2013/31]; MECD from Spain [FPU13/04123]	Ministerio de Educacion, Ciencia y Deporte(Spanish Government); University of Girona; MECD from Spain	This research was supported, in part, by grants from the Ministerio de Educacion, Ciencia y Deporte (AGL2013-41405-R; https.//sede.rnteinn.gob.es) and from the University of Girona (SING12/13 and MPCUdG2016/085; http://www.udg.edu/).Gerard Morales was the recipient of predocotoral fellowships from the University of Girona (BR 2013/31; http://www.udg.edu) and from MECD (FPU13/04123; http://www.mecd.gob.es) from Spain.	Augustin JC, 1999, J MICROBIOL METH, V38, P137, DOI 10.1016/S0167-7012(99)00089-5; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Battilani P., 1999, Journal of Plant Pathology, V81, P161; Baty F, 2015, J STAT SOFTW, V66, P1; Begot C, 1997, FOOD MICROBIOL, V14, P403, DOI 10.1006/fmic.1997.0097; Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9; Biesta-Peters EG, 2010, APPL ENVIRON MICROB, V76, P1399, DOI 10.1128/AEM.02336-09; BILLING E, 1976, ANN APPL BIOL, V82, P259, DOI 10.1111/j.1744-7348.1976.tb00561.x; Billing E, 1999, ACTA HORTIC, V489, P399; BILLING E, 1974, J APPL BACTERIOL, V37, P643, DOI 10.1111/j.1365-2672.1974.tb00488.x; Boudon S, 2005, PHYTOPATHOLOGY, V95, P1081, DOI 10.1094/PHYTO-95-1081; Buchanan RL, 1997, FOOD MICROBIOL, V14, P313, DOI 10.1006/fmic.1997.0125; Bugiani R, 2008, IOBC WPRS B, V54, P565; Chorin E, 1997, INT J FOOD MICROBIOL, V38, P229, DOI 10.1016/S0168-1605(97)00110-4; DALGAARD P, 1994, INT J FOOD MICROBIOL, V23, P391, DOI 10.1016/0168-1605(94)90165-1; Dalgaard P, 2001, J MICROBIOL METH, V43, P183, DOI 10.1016/S0167-7012(00)00219-0; de Bernonville TD, 2014, FEMS MICROBIOL ECOL, V89, P527, DOI 10.1111/1574-6941.12345; EPPO, 2016, EPPO GLOB DAT; EPPO, 2006, EPPO B, V36, P129, DOI DOI 10.1111/J.1365-2338.2006.00925.X; Garcin A., 2011, INFOS CTIFL, V268, P26; HUDSON JA, 1994, J FOOD SAFETY, V14, P329, DOI 10.1111/j.1745-4565.1994.tb00604.x; Janse JD, 2012, J PLANT PATHOL, V94, pS5; Kim JH, 2014, PLANT PATHOLOGY J, V30, P125, DOI 10.5423/PPJ.OA.09.2013.0090; Kim J, 2013, FOODS, V2, P364, DOI 10.3390/foods2030364; Lalancette N, 2007, PLANT DIS, V91, P1122, DOI 10.1094/PDIS-91-9-1122; Lightner Gary W., 1992, Computers and Electronics in Agriculture, V7, P249, DOI 10.1016/S0168-1699(05)80023-7; Maniatis T., 1982, MOL CLONING; Marchi G, 2011, PLANT DIS, V95, P74, DOI 10.1094/PDIS-07-10-0529; MCCLURE PJ, 1993, J IND MICROBIOL, V12, P277, DOI 10.1007/BF01584203; McKellar RC, 1997, INT J FOOD MICROBIOL, V36, P179, DOI 10.1016/S0168-1605(97)01266-X; Morales G, 2016, ACTA HORTIC, V1149, P1, DOI [10.17660/ActaHortic.2016.1149.1, 10.1109/PESGM.2016.7741838]; Oscar TP, 2005, J FOOD PROTECT, V68, P2606, DOI 10.4315/0362-028X-68.12.2606; Palacio-Bielsa A, 2010, PLANT DIS, V94, P786, DOI 10.1094/PDIS-94-6-0786B; RATKOWSKY DA, 1983, J BACTERIOL, V154, P1222, DOI 10.1128/JB.154.3.1222-1226.1983; RATKOWSKY DA, 1982, J BACTERIOL, V149, P1; Ritchie D., 1999, FUNGICIDE NEMATICIDE, V54, P63; Ritchie D., 2005, SE PEACH GROWERS HDB; Ritchie D., 1995, COMPENDIUM STONE FRU, P50; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x; Ross T, 2000, INT J FOOD MICROBIOL, V62, P231, DOI 10.1016/S0168-1605(00)00340-8; Sant'Ana AS, 2012, FOOD MICROBIOL, V30, P267, DOI 10.1016/j.fm.2011.11.003; Scortichini M., 2010, J PLANT PATHOLOGY S1, V92; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SHEPARD DP, 1994, PLANT DIS, V78, P627, DOI 10.1094/PD-78-0627; Smith E., 1903, SCIENCE, V17, P456, DOI DOI 10.1126/SCIENCE.17.420.114-A; Smith IM, 1997, QUAR PESTS EUR, P1096; Smith T. J., 1993, ACTA HORTIC, V338, P153, DOI DOI 10.17660/ACTAHORTIC.1993.338.21; Socquet-Juglard D, 2012, J PLANT PATHOL, V94, DOI 10.4454/jpp.v94i1sup.015; Stefani E, 2010, J PLANT PATHOL, V92, pS99; Stephens PJ, 1997, J APPL MICROBIOL, V83, P445, DOI 10.1046/j.1365-2672.1997.00255.x; Swinnen IAM, 2004, INT J FOOD MICROBIOL, V94, P137, DOI 10.1016/j.ijfoodmicro.2004.01.006; Tjou-Tam-Sin NNA, 2012, PLANT DIS, V96, P759, DOI 10.1094/PDIS-04-11-0265-PDN; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; YOUNG JM, 1977, J APPL BACTERIOL, V42, P345, DOI 10.1111/j.1365-2672.1977.tb00702.x; Zehr EI, 1996, PLANT DIS, V80, P339, DOI 10.1094/PD-80-0339; ZWIETERING MH, 1991, APPL ENVIRON MICROB, V57, P1094, DOI 10.1128/AEM.57.4.1094-1101.1991; ZWIETERING MH, 1994, APPL ENVIRON MICROB, V60, P204, DOI 10.1128/AEM.60.1.204-213.1994; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	59	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							0177583	10.1371/journal.pone.0177583	http://dx.doi.org/10.1371/journal.pone.0177583			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493954	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300141
J	Castley, A; Sawleshwarkar, S; Varma, R; Herring, B; Thapa, K; Dwyer, D; Chibo, D; Nguyen, N; Hawke, K; Ratcliff, R; Garsia, R; Kelleher, A; Nolan, D				Castley, Alison; Sawleshwarkar, Shailendra; Varma, Rick; Herring, Belinda; Thapa, Kiran; Dwyer, Dominic; Chibo, Doris; Nam Nguyen; Hawke, Karen; Ratcliff, Rodney; Garsia, Roger; Kelleher, Anthony; Nolan, David		Australian Mol Epidemiology Networ	A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012	PLOS ONE			English	Article							VIRUS TYPE-1 SUBTYPES; DISEASE PROGRESSION; GENETIC DIVERSITY; IMMUNE-RESPONSES; TRANSMISSION; INFECTIONS; RISK; INDIVIDUALS; RESISTANCE; CRF01-AE	Introduction Rates of new HIV-1 diagnoses are increasing in Australia, with evidence of an increasing proportion of non-B HIV-1 subtypes reflecting a growing impact of migration and travel. The present study aims to define HIV-1 subtype diversity patterns and investigate possible HIV-1 transmission networks within Australia. Methods The Australian Molecular Epidemiology Network (AMEN) HIV collaborating sites in Western Australia, South Australia, Victoria, Queensland and western Sydney (New South Wales), provided baseline HIV-1 partial pol sequence, age and gender information for 4,873 patients who had genotypes performed during 2005-2012. HIV-1 phylogenetic analyses utilised MEGA V6, with a stringent classification of transmission pairs or clusters (bootstrap >= 98%, genetic distance <= 1.5% from at least one other sequence in the cluster). Results HIV-1 subtype B represented 74.5% of the 4,873 sequences (WA 59%, SA 68.4%, w-Syd 73.8%, Vic 75.6%, Qld 82.1%), with similar proportion of transmission pairs and clusters found in the B and non-B cohorts (23% vs 24.5% of sequences, p = 0.3). Significantly more subtype B clusters were comprised of =3 sequences compared with non-B clusters (45.0% vs 24.0%, p = 0.021) and significantly more subtype B pairs and clusters were male-only (88% compared to 53% CRF01_AE and 17% subtype C clusters). Factors associated with being in a cluster of any size included; being sequenced in a more recent time period (p<0.001), being younger (p<0.001), being male (p = 0.023) and having a B subtype (p = 0.02). Being in a larger cluster (>3) was associated with being sequenced in a more recent time period (p = 0.05) and being male (p = 0.008). Conclusion This nationwide HIV-1 study of 4,873 patient sequences highlights the increased diversity of HIV-1 subtypes within the Australian epidemic, as well as differences in transmission networks associated with these HIV-1 subtypes. These findings provide epidemiological insights not readily available using standard surveillance methods and can inform the development of effective public health strategies in the current paradigm of HIV prevention in Australia.	[Castley, Alison; Nolan, David] Royal Perth Hosp, Dept Clin Immunol, Perth, WA, Australia; [Sawleshwarkar, Shailendra; Varma, Rick] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Parramatta, NSW, Australia; [Sawleshwarkar, Shailendra; Varma, Rick] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Herring, Belinda; Thapa, Kiran; Dwyer, Dominic] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR Pathol West NSW Hlth Pathol, Westmead, NSW, Australia; [Herring, Belinda; Thapa, Kiran; Dwyer, Dominic] Univ Sydney, Westmead, NSW, Australia; [Chibo, Doris] Doherty Inst, HIV Characterisat Lab, Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Nam Nguyen] RBWH Herston, Div Immunol, HSQ Pathol Queensland Cent Lab, Herston, Qld, Australia; [Hawke, Karen] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Hawke, Karen] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia; [Ratcliff, Rodney] Royal Adelaide Hosp, Clin 275, Adelaide, SA, Australia; [Ratcliff, Rodney] SA Pathol, Dept Microbiol & Infect Dis, Adelaide, SA, Australia; [Garsia, Roger] Royal Prince Alfred Hosp, Clin Immunol Dept, Sydney, NSW, Australia; [Kelleher, Anthony] Univ New South Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia	Royal Perth Hospital; University of Western Australia; University of Sydney; University of Sydney; University of Sydney; Victorian Infectious Diseases Reference Laboratory; Royal Brisbane & Women's Hospital; South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia; Royal Adelaide Hospital; SA Pathology; University of Sydney; University of New South Wales Sydney; Kirby Institute	Castley, A (corresponding author), Royal Perth Hosp, Dept Clin Immunol, Perth, WA, Australia.	allison.castley@health.wa.gov.au	Hawke, Karen/AAD-6172-2022; Sawleshwarkar, Shailendra/AAB-3628-2020	Hawke, Karen/0000-0003-4118-0995; Sawleshwarkar, Shailendra/0000-0002-9399-0490; /0000-0001-8284-1505; Kelleher, Anthony/0000-0002-0009-3337; Chibo, Doris/0000-0002-6950-6910	Royal Perth Hospital (RPH)-Medical Research Foundation (MRF)	Royal Perth Hospital (RPH)-Medical Research Foundation (MRF)	Alison Castley gratefully acknowledges the Royal Perth Hospital (RPH)-Medical Research Foundation (MRF) for providing funding to complete this study.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Angelis K, 2015, J INFECT DIS, V211, P1735, DOI 10.1093/infdis/jiu666; [Anonymous], 2013, GLOBAL REPORT UNAIDS; [Anonymous], 2014, 34010 AUSTR BUR STAT; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Carlson JM, 2016, NAT MED, V22, P606, DOI 10.1038/nm.4100; Castley ASL, 2016, AIDS RES HUM RETROV, V32, P211, DOI [10.1089/aid.2015.0206, 10.1089/AID.2015.0206]; Castro-Nallar E, 2012, FUTURE VIROL, V7, P239, DOI 10.2217/FVL.12.4; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Chibo D, 2012, AIDS RES HUM RETROV, V28, P578, DOI [10.1089/aid.2011.0200, 10.1089/AID.2011.0200]; Combs BC, 2009, SEX HEALTH, V6, P35, DOI 10.1071/SH08010; Dunn D, 2014, AIDS, V28, P773, DOI 10.1097/QAD.0000000000000119; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Gisselquist D, 2003, INT J STD AIDS, V14, P162, DOI 10.1258/095646203762869160; Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawke KG, 2013, AIDS RES HUM RETROV, V29, P311, DOI 10.1089/aid.2012.0082; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Herring BL, 2003, J CLIN MICROBIOL, V41, P4600, DOI 10.1128/JCM.41.10.4600-4604.2003; Hocking J, 2004, AUST NZ J PUBL HEAL, V28, P217, DOI 10.1111/j.1467-842X.2004.tb00698.x; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Ivanov IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059666; Kirby Institute, HIV VIR HEP SEX TRAN; Kouri V, 2015, EBIOMEDICINE, V2, P244, DOI 10.1016/j.ebiom.2015.01.015; Lau KA, 2013, INFECT DIS REP, V5, P15, DOI 10.4081/idr.2013.s1.e4; Li X., 2015, 2015 IEEE 58 INT MID, P1, DOI DOI 10.1109/IJCNN.2015.7280320; Li Xiao-He, 2007, Virologica Sinica, V22, P426, DOI 10.1007/s12250-007-0043-y; Lihana RW, 2012, AIDS REV, V14, P83; Longosz AF, 2014, JAIDS-J ACQ IMM DEF, V65, P390, DOI 10.1097/QAI.0000000000000006; Luft LM, 2011, INT J INFECT DIS, V15, pE661, DOI 10.1016/j.ijid.2011.05.013; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Ng KY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-90; Oelrichs RB, 2000, J BIOMED SCI, V7, P128, DOI 10.1007/BF02256619; Palm AA, 2014, J INFECT DIS, V209, P721, DOI 10.1093/infdis/jit416; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Phanuphak N, 2015, AIDS RES HUM RETROV, V31, P1060, DOI 10.1089/aid.2015.0049; Phuphuakrat A, 2014, HIV MED, V15, P269, DOI 10.1111/hiv.12108; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Santoro M, 2013, ISRN MICROBIOL; Siemieniuk RAC, 2013, CAN J INFECT DIS MED, V24, P69, DOI 10.1155/2013/230380; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Vidal N, 2003, JAIDS-J ACQ IMM DEF, V33, P239, DOI 10.1097/00126334-200306010-00020; von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524	53	17	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0170601	10.1371/journal.pone.0170601	http://dx.doi.org/10.1371/journal.pone.0170601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489920	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100001
J	James, AW; Zhang, XL; Crisan, M; Hardy, WR; Liang, P; Meyers, CA; Lobo, S; Lagishetty, V; Childers, MK; Asatrian, G; Ding, C; Yen, YH; Zou, E; Ting, K; Peault, B; Soo, C				James, Aaron W.; Zhang, Xinli; Crisan, Mihaela; Hardy, Winters R.; Liang, Pei; Meyers, Carolyn A.; Lobo, Sonja; Lagishetty, Venu; Childers, Martin K.; Asatrian, Greg; Ding, Catherine; Yen, Yu-Hsin; Zou, Erin; Ting, Kang; Peault, Bruno; Soo, Chia			Isolation and characterization of canine perivascular stem/stromal cells for bone tissue engineering	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RAT SPINAL-FUSION; ADIPOSE-TISSUE; STROMAL CELLS; ADIPOGENIC DIFFERENTIATION; CHRONIC OSTEOARTHRITIS; SONIC HEDGEHOG; IN-VITRO; NELL-1; MODEL	For over 15 years, human subcutaneous adipose tissue has been recognized as a rich source of tissue resident mesenchymal stem/stromal cells (MSC). The isolation of perivascular progenitor cells from human adipose tissue by a cell sorting strategy was first published in 2008. Since this time, the interest in using pericytes and related perivascular stem/stromal cell (PSC) populations for tissue engineering has significantly increased. Here, we describe a set of experiments identifying, isolating and characterizing PSC from canine tissue (N = 12 canine adipose tissue samples). Results showed that the same antibodies used for human PSC identification and isolation are cross-reactive with canine tissue (CD45, CD146, CD34). Like their human correlate, canine PSC demonstrate characteristics of MSC including cell surface marker expression, colony forming unit-fibroblast (CFU-F) inclusion, and osteogenic differentiation potential. As well, canine PSC respond to osteoinductive signals in a similar fashion as do human PSC, such as the secreted differentiation factor NEL-Like Molecule-1 (NELL-1). Nevertheless, important differences exist between human and canine PSC, including differences in baseline osteogenic potential. In summary, canine PSC represent a multipotent mesenchymogenic cell source for future translational efforts in tissue engineering.	[James, Aaron W.; Meyers, Carolyn A.; Yen, Yu-Hsin; Zou, Erin] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [James, Aaron W.; Hardy, Winters R.; Liang, Pei; Lobo, Sonja; Lagishetty, Venu; Peault, Bruno; Soo, Chia] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [James, Aaron W.; Hardy, Winters R.; Liang, Pei; Lobo, Sonja; Lagishetty, Venu; Peault, Bruno; Soo, Chia] Orthoped Hosp, Dept Orthopaed Surg, Los Angeles, CA 90007 USA; [James, Aaron W.; Hardy, Winters R.; Liang, Pei; Lobo, Sonja; Lagishetty, Venu; Peault, Bruno; Soo, Chia] Orthoped Hosp, Res Ctr, Los Angeles, CA 90007 USA; [Zhang, Xinli; Asatrian, Greg; Ding, Catherine; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Div Growth & Dev, Los Angeles, CA 90024 USA; [Zhang, Xinli; Asatrian, Greg; Ding, Catherine; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Sect Orthodont, Los Angeles, CA 90024 USA; [Crisan, Mihaela; Peault, Bruno] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Crisan, Mihaela; Peault, Bruno] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Childers, Martin K.] UWMC, Rehabil Med Clin, Seattle, WA USA; [Soo, Chia] Univ Calif Los Angeles, David Geffen Sch Med, Div Plast & Reconstruct Surg, Dept Surg, Los Angeles, CA 90095 USA	Johns Hopkins University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Edinburgh; University of Edinburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	James, AW (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.; James, AW (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.; James, AW (corresponding author), Orthoped Hosp, Dept Orthopaed Surg, Los Angeles, CA 90007 USA.; James, AW (corresponding author), Orthoped Hosp, Res Ctr, Los Angeles, CA 90007 USA.	awjames@jhmi.edu	Lobo, Sonja/G-5151-2015; Lagishetty, Venu/C-8251-2009	Lobo, Sonja/0000-0002-5697-9858; Lagishetty, Venu/0000-0001-6500-8255; Zou, Erin/0000-0001-8614-1178; James, Aaron/0000-0002-2002-622X; Meyers, Carolyn/0000-0002-0734-029X	NIH/NIAMS [R01 AR061399, R01 AR066782, K08 AR068316]; California Institute of Regenerative Medicine (CIRM); Orthopaedic Research and Education Foundation; Musculoskeletal Transplant Foundation; The Catherine and Constantinos J. Limas Research Award; MRC [G1000816] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070773] Funding Source: NIH RePORTER; Medical Research Council [G1000816] Funding Source: researchfish	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Orthopaedic Research and Education Foundation; Musculoskeletal Transplant Foundation; The Catherine and Constantinos J. Limas Research Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The present work was supported by the NIH/NIAMS (grants R01 AR061399, R01 AR066782, K08 AR068316), California Institute of Regenerative Medicine (CIRM), and Orthopaedic Research and Education Foundation with funding provided by the Musculoskeletal Transplant Foundation, as well as The Catherine and Constantinos J. Limas Research Award.	Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Askarinam A, 2013, TISSUE ENG PT A, V19, P1386, DOI [10.1089/ten.tea.2012.0367, 10.1089/ten.TEA.2012.0367]; Black LL, 2007, VET THER, V8, P272; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014; Chen F, 2012, INT ORTHOP, V36, P2181, DOI 10.1007/s00264-012-1590-x; Cheung WK, 2010, CYTOTHERAPY, V12, P554, DOI 10.3109/14653241003709694; Chung CG, 2014, STEM CELL TRANSL MED, V3, P1231, DOI 10.5966/sctm.2014-0027; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; D'Alimonte I, 2013, STEM CELL REV REP, V9, P642, DOI 10.1007/s12015-013-9436-5; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Freeman FE, 2016, TISSUE ENG A; FRODEL JL, 1993, ARCH OTOLARYNGOL, V119, P17; GIBSON GJ, 1991, BIOCHEM J, V277, P513, DOI 10.1042/bj2770513; Guercio A, 2012, CELL BIOL INT, V36, P189, DOI 10.1042/CBI20110304; Harman R, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00081; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hindle P, 2016, STEM CELLS DEV; Hindle P., 2016, STEM CELLS TRANSL ME; Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024; James AW, 2016, TISSUE ENG PT A, V22, P840, DOI [10.1089/ten.tea.2015.0230, 10.1089/ten.TEA.2015.0230]; James AW, 2010, TISSUE ENG PT A, V16, P2605, DOI [10.1089/ten.tea.2010.0048, 10.1089/ten.TEA.2010.0048]; James AW, 2012, STEM CELL TRANSL MED, V1, P673, DOI 10.5966/sctm.2012-0053; James AW, 2012, STEM CELL TRANSL MED, V1, P510, DOI 10.5966/sctm.2012-0002; James AW, 2012, STEM CELLS DEV, V21, P2170, DOI 10.1089/scd.2011.0461; James AW, 2011, BIOCHEM BIOPH RES CO, V411, P126, DOI 10.1016/j.bbrc.2011.06.111; James AW, 2016, PHARM THER; Kang BJ, 2012, J VET SCI, V13, P299, DOI 10.4142/jvs.2012.13.3.299; Kang JW, 2008, STEM CELLS DEV, V17, P681, DOI 10.1089/scd.2007.0153; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; KLOTCH DW, 1995, OTOLARYNG HEAD NECK, V112, P291, DOI 10.1016/S0194-5998(95)70252-0; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kramann R., 2016, CELL STEM CELL; LARUE SM, 1989, J AM VET MED ASSOC, V195, P1734; Lee H, 2009, VET MED, P198; Levi B, 2011, PLAST RECONSTR SURG, V128, P373, DOI 10.1097/PRS.0b013e31821e6e49; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Li WM, 2010, TISSUE ENG PT A, V16, P2861, DOI 10.1089/ten.tea.2009.0550; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu GP, 2013, BIOMATERIALS, V34, P2655, DOI 10.1016/j.biomaterials.2013.01.004; Lu SS, 2007, SPINE J, V7, P50, DOI 10.1016/j.spinee.2006.04.020; Majesky MW, 2012, CELLS TISSUES ORGANS, V195, P73, DOI 10.1159/000331413; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Muller AM, 2010, EUR CELLS MATER, V19, P127; Murray IR, 2014, CELL MOL LIFE SCI, V71, P1353, DOI 10.1007/s00018-013-1462-6; Ostrander EA, 2000, TRENDS GENET, V16, P117, DOI 10.1016/S0168-9525(99)01958-7; Patterson DF, 2000, J VET INTERN MED, V14, P1, DOI 10.1892/0891-6640(2000)14[1:CAMITA]2.0.CO;2; Pham D, 2016, INT J ORTHOPAEDICS, P549; REHMAN I, 1995, J BIOMED MATER RES, V29, P1287, DOI 10.1002/jbm.820291016; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Russell KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167442; Shen J, 2016, AM J PATHOL, V186, P419, DOI 10.1016/j.ajpath.2015.10.011; Shen J, 2012, J CELL BIOCHEM, V113, P3620, DOI 10.1002/jcb.24253; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Tawonsawatruk T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22779; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; West CC, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0302-7; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; Yoon D, 2015, J VET SCI, V16, P397, DOI 10.4142/jvs.2015.16.4.397; Zhang X, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/765143; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013	65	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177308	10.1371/journal.pone.0177308	http://dx.doi.org/10.1371/journal.pone.0177308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489940	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100059
J	Armant, O; Gombeau, K; El Houdigui, SM; Floriani, M; Camilleri, V; Cavalie, I; Adam-Guillermin, C				Armant, Olivier; Gombeau, Kewin; El Houdigui, Sophia Murat; Floriani, Magali; Camilleri, Virginie; Cavalie, Isabelle; Adam-Guillermin, Christelle			Zebrafish exposure to environmentally relevant concentration of depleted uranium impairs progeny development at the molecular and histological levels	PLOS ONE			English	Article							HUMAN OSTEOBLAST CELLS; GENE-EXPRESSION; DANIO-RERIO; WATERBORNE URANIUM; HEAVY-METALS; BIOACCUMULATION; TRANSFORMATION; CONTAMINATION; METHYLATION; METABOLISM	Uranium is an actinide naturally found in the environment. Anthropogenic activities lead to the release of increasing amounts of uranium and depleted uranium (DU) in the environment, posing potential risks to aquatic organisms due to radiological and chemical toxicity of this radionucleide. Although environmental contaminations with high levels of uranium have already been observed, chronic exposures of non-human species to levels close to the environmental quality standards remain scarcely characterized. The present study focused on the identification of the molecular pathways impacted by a chronic exposure of zebrafish to 20 mu g/L of DU during 10 days. The transcriptomic effects were evaluated by the use of the mRNAseq analysis in three organs of adult zebrafish, the brain the testis and the ovaries, and two developmental stages of the adult fish progeny, two-cells embryo and four-days larvae. The results highlight generic effects on the cell adhesion process, but also specific transcriptomic responses depending on the organ or the developmental stage investigated. The analysis of the transgenerational effects of DU-exposure on the four-day zebrafish larvae demonstrate an induction of genes involved in oxidative response (cat, mpx, sod1 and sod2), a decrease of expression of the two hatching enzymes (he1a and he1b), the deregulation of the expression of gene coding for the ATPase complex and the induction of cellular stress. Electron microscopy analysis of skeletal muscles on the four-days larvae highlights significant histological impacts on the ultrastructure of both the mitochondria and the myofibres. In addition, the comparison with the transcriptomic data obtained for the acetylcholine esterase mutant reveals the induction of protein-chaperons in the skeletal muscles of the progeny of fish chronically exposed to DU, pointing towards long lasting effects of this chemical in the muscles. The results presented in this study support the hypothesis that a chronic parental exposure to an environmentally relevant concentration of DU could impair the progeny development with significant effects observed both at the molecular level and on the histological ultrastructure of organs. This study provides a comprehensive transcriptomic dataset useful for ecotoxicological studies on other fish species at the molecular level. It also provides a key DU responsive gene, egr1, which may be a candidate biomarker for monitoring aquatic pollution by heavy metals.	[Armant, Olivier; Gombeau, Kewin; El Houdigui, Sophia Murat; Floriani, Magali; Camilleri, Virginie; Cavalie, Isabelle; Adam-Guillermin, Christelle] PRP ENV SERIS LECO, IRSN, Cadarache, St Paul Lez Dur, France		Armant, O (corresponding author), PRP ENV SERIS LECO, IRSN, Cadarache, St Paul Lez Dur, France.	olivier.armant@irsn.fr		armant, olivier/0000-0001-7101-9209; Murat El Houdigui, Sophia/0000-0002-0106-1572; Gombeau, Kewin/0000-0003-3062-6365; Adam-Guillermin, christelle/0000-0002-8833-0762	IRSN; European project COMET; 7th PCRD EURATOM [Fission-2012-3.4.1-604794]; NEEDS-Environment	IRSN; European project COMET; 7th PCRD EURATOM; NEEDS-Environment	This work was supported by IRSN, the European project COMET, 7th PCRD EURATOM (Fission-2012-3.4.1-604794) and NEEDS-Environment.; We want to thank Christelle Etard and Volker Middel (KIT, Germany) for their help in the analysis of the electron microscopy results. We thank Jacqueline Garnier Laplace and Francois Paquet for the critical reading of the manuscript. We also thank Pr. Uwe Strahle and Victor Gourain (KIT, Germany) at the Institute of Toxicology and Genetics for the sequencing of the NGS libraries. This work was supported by IRSN, the European project COMET, 7th PCRD EURATOM (Fission-2012-3.4.1604794) and NEEDS-Environment.	Al Kaddissi S, 2016, ENVIRON TOXICOL, V31, P211, DOI 10.1002/tox.22036; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ansoborlo E, 2015, ENVIRON INT, V77, P1, DOI 10.1016/j.envint.2014.12.011; Anway MD, 2005, SCIENCE, P308; Armant O, 2016, DATA BRIEF, V8, P61, DOI 10.1016/j.dib.2016.05.007; Armant O, 2013, DEV BIOL, V380, P351, DOI 10.1016/j.ydbio.2013.05.006; Arzuaga X, 2010, J TOXICOL ENV HEAL B, V13, P527, DOI 10.1080/10937404.2010.509015; Augustine S, 2012, AQUAT TOXICOL, V118, P9, DOI 10.1016/j.aquatox.2012.02.029; Babb SG, 2001, DEV DYNAM, V221, P231, DOI 10.1002/dvdy.1132; Barillet S, 2007, ENVIRON TOXICOL CHEM, V26, P497, DOI 10.1897/06-243R.1; Barillet S, 2011, ENVIRON POLLUT, V159, P495, DOI 10.1016/j.envpol.2010.10.013; BEAUGELIN-SEILLER K. L., 2011, NEW URANIUM MINING B, P507; BETCHER RN, 1988, CAN J EARTH SCI, V25, P2089, DOI 10.1139/e88-193; Bourrachot S, 2008, AQUAT TOXICOL, V90, P29, DOI 10.1016/j.aquatox.2008.07.013; Bourrachot S, 2014, AQUAT TOXICOL, V154, P1, DOI 10.1016/j.aquatox.2014.04.018; Darolles C, 2010, TOXICOL LETT, V192, P337, DOI 10.1016/j.toxlet.2009.11.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Etard C, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0825-8; Fournier E, 2004, ENVIRON TOXICOL CHEM, V23, P1108, DOI 10.1897/02-604; Freeman JL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00268; Frelon S, 2010, AQUAT TOXICOL, V100, P66; Gagnaire B, 2011, ECOTOXICOLOGY, V20, P187, DOI 10.1007/s10646-010-0570-4; Gombeau K, 2017, AQUAT TOXICOL, V184, P14, DOI 10.1016/j.aquatox.2016.12.004; Gombeau K, 2016, J ENVIRON RADIOACTIV, V154, P25, DOI 10.1016/j.jenvrad.2016.01.004; Haberle V, 2014, NATURE, V507, P381, DOI 10.1038/nature12974; IAEA, 2012, UR 2011 RES PROD DEM; Ibrulj Slavica, 2004, Med Arh, V58, P335; Iqbal K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0619-z; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; KAZANTZIS G, 1979, EUR J CLIN INVEST, V9, P3, DOI 10.1111/j.1365-2362.1979.tb01660.x; Le Guernic A, 2016, ECOTOXICOLOGY, V25, P1234, DOI 10.1007/s10646-016-1677-z; Lerebours A, 2009, ENVIRON TOXICOL CHEM, V28, P1271, DOI 10.1897/08-357.1; Liu C, CANC GENE THER, V5, P3; Liu CT, 1999, J BIOL CHEM, V274, P4400, DOI 10.1074/jbc.274.7.4400; Liu YF, 2001, FRONT BIOSCI-LANDMRK, V6, pD12, DOI 10.2741/Liu; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Milacic S, 2009, J RADIAT RES, V50, P213, DOI 10.1269/jrr.08131; Miller AC, 2004, MOL CELL BIOCHEM, V255, P247, DOI 10.1023/B:MCBI.0000007280.72510.96; Miller AC, 2003, J ENVIRON RADIOACTIV, V64, P247, DOI 10.1016/S0265-931X(02)00053-X; Miller AC, 2002, J INORG BIOCHEM, V91, P246, DOI 10.1016/S0162-0134(02)00391-4; Miller AC, 1998, ENVIRON HEALTH PERSP, V106, P465, DOI 10.1289/ehp.98106465; Miller AC, 2009, BIOCHIMIE, V91, P1328, DOI 10.1016/j.biochi.2009.03.010; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Oliver J, 1916, J EXP MED, V23, P301, DOI 10.1084/jem.23.3.301; Pagel JI, 2012, INT J MOL SCI, V13, P13104, DOI 10.3390/ijms131013104; Papathanasiou K, 2005, Clin Exp Obstet Gynecol, V32, P58; Pereira S, 2012, AQUAT TOXICOL, V109, P11, DOI 10.1016/j.aquatox.2011.11.011; Racine R, 2009, J MOL NEUROSCI, V38, P159, DOI 10.1007/s12031-008-9145-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Do RP, 2012, REPROD TOXICOL, V34, P614, DOI 10.1016/j.reprotox.2012.09.006; Salonen L., 1994, FUTUR GROUNDW RESOUR; Senf SM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00330; Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Weber GJ, 2013, TOXICOL SCI, V132, P458, DOI 10.1093/toxsci/kft017; Zhang HH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05416; Zhang YY, 2016, CHEMOSPHERE, V144, P304, DOI 10.1016/j.chemosphere.2015.08.079; Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38	59	22	22	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177932	10.1371/journal.pone.0177932	http://dx.doi.org/10.1371/journal.pone.0177932			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531178	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058400040
J	Brondani, MA; Alan, R; Donnelly, L				Brondani, Mario A.; Alan, Rana; Donnelly, Leeann			Stigma of addiction and mental illness in healthcare: The case of patients' experiences in dental settings	PLOS ONE			English	Article								Objective To explore the ways in which stigma is experienced in healthcare and dental settings by patients with a history of addiction and mental illness. Methods Audio-recorded, semi-structured interviews with a purposefully selected convenience sample of residents from two community treatment centres in Vancouver, Canada were conducted. The interview guide contained questions about experiences while seeking health and dental care and was based on an existing framework of labeling, stereotyping, exclusion, discrimination, and power imbalance. Interviews were transcribed verbatim for coding and thematic analysis. Results Twenty-five participants between 23 and 67 years of age were interviewed; 17 were males. Most had a self-reported history of depression combined with use of alcohol and crack-cocaine; most of them only sought dental care for emergency purposes. Textual analysis of more than 300 pages of transcribed interviews revealed that participants perceived stigma when they were negatively stereotyped as 'unworthy', labeled as 'different', excluded from the decision-making process, discriminated against, 'treated unfairly', and felt powerless when interacting in the heath and dental care systems. Conversely, positive experiences were characterized by empathy, reassurance and good communication, which were empowering for patients. Conclusions When associated with stigma, mental illness and addictions have negative implications for accessing health and dental care. From our participants' perspectives, it seems that the lack of understanding about their life conditions by the healthcare professionals was the origin of stigma. We suggest that an increased social awareness of these health issues be enhanced among current and future health and dental care professionals to help improve care experiences for this marginalized population.	[Brondani, Mario A.; Donnelly, Leeann] Univ British Columbia, Fac Dent, Vancouver, BC, Canada; [Alan, Rana] Boston Univ, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA	University of British Columbia; Boston University	Brondani, MA (corresponding author), Univ British Columbia, Fac Dent, Vancouver, BC, Canada.	brondani@dentsitry.ubc.ca		Brondani, Mario/0000-0003-2437-4552				Adler NE, 2009, MILBANK Q, V87, P49, DOI 10.1111/j.1468-0009.2009.00547.x; Ahsan Ullah A K M, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P97, DOI 10.1177/1545109710381926; Alan R., STIGMA ADDICTION MEN; Bedos C, 2011, J CAN DENT ASSOC, V77; Brondani Mario, 2011, J Dent Hyg, V85, P92; Brondani MA, 2016, J CAN DENT ASSOC, V82; Brondani MA, 2013, J DENT EDUC, V77, P1108; Canadian Centre on Substance Abuse, 2005, CAN ADD SURV; (CCSA); CCoSA, 2013, 1 DO NO HARM RESP CA; Chandu A, 2011, AUST DENT J, V56, P240, DOI 10.1111/j.1834-7819.2011.01336_4.x; Charnock S, 2004, BRIT DENT J, V196, P385, DOI 10.1038/sj.bdj.4811193; Donnelly LR, 2016, JANAC, V26; Eijkman MAJ, 2011, INT DENT J, V47, P298; Fusch PI, 2015, QUAL REP, V20, P1408; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Huynh J, 2017, GERODONTOLGY; Kukla A, 2000, SOCIAL CONSTRUCTIVIS; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Loignon C, 2010, J DENT RES, V89, P991, DOI 10.1177/0022034510370822; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Ndetei DM, 2016, SOC PSYCH PSYCH EPID, V51, P73, DOI 10.1007/s00127-015-1090-6; Norberg AL, 2013, PSYCHO-ONCOLOGY, V22, P324, DOI 10.1002/pon.2091; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Rasinski KA, 2005, ON THE STIGMA OF MENTAL ILLNESS: PRACTICAL STRATEGIES FOR RESEARCH AND SOCIAL CHANGE, P219, DOI 10.1037/10887-010; Restum ZG, 2005, AM J PUBLIC HEALTH, V95, P1689, DOI 10.2105/AJPH.2004.055053; Rush B, 2008, CAN J PSYCHIAT, V53, P800, DOI 10.1177/070674370805301206; Shrivastava A, 2013, INDIAN J PSYCHIAT, V55, P178, DOI 10.4103/0019-5545.111459; Smith Greg, 2011, WIL BLACKW COMP MAJ, V2, P125; Stiefel Doris J, 2002, Spec Care Dentist, V22, p26S; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Wallace BB, 2013, J HEALTH CARE POOR U, V24, P943, DOI 10.1353/hpu.2013.0061; Weber M, 2013, CYBERPSYCH BEH SOC N, V16, P254, DOI 10.1089/cyber.2012.0328	33	39	39	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177388	10.1371/journal.pone.0177388	http://dx.doi.org/10.1371/journal.pone.0177388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28531176	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400016
J	Choi, J; Rajagopal, A; Xu, YF; Rabinowitz, JD; O'Shea, EK				Choi, Joonhyuk; Rajagopal, Abbhirami; Xu, Yi-Fan; Rabinowitz, Joshua D.; O'Shea, Erin K.			A systematic genetic screen for genes involved in sensing inorganic phosphate availability in Saccharomyces cerevisiae	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PHO4; CYCLIN-CDK COMPLEX; INOSITOL PYROPHOSPHATES; YEAST; PHOSPHORYLATION; PHO80-PHO85; KINASE; CASSETTES; PATHWAYS; MUTANTS	Saccharomyces cerevisiae responds to changes in extracellular inorganic phosphate (P-i) availability by regulating the activity of the phosphate-responsive (PHO) signaling pathway, enabling cells to maintain intracellular levels of the essential nutrient P-i. P-i-limitation induces upregulation of inositol heptakisphosphate (IP7) synthesized by the inositol hexakisphosphate kinase Vip1, triggering inhibition of the Pho80/Pho85 cyclin-cyclin dependent kinase (CDK) complex by the CDK inhibitor Pho81, which upregulates the PHO regulon through the CDK target and transcription factor Pho4. To identify genes that are involved in signaling upstream of the Pho80/Pho85/Pho81 complex and how they interact with each other to regulate the PHO pathway, we performed genome-wide screens with the synthetic genetic array method. We identified more than 300 mutants with defects in signaling upstream of the Pho80/Pho85/Pho81 complex, including AAH1, which encodes an adenine deaminase that negatively regulates the PHO pathway in a Vip1-dependent manner. Furthermore, we showed that even in the absence of VIP1, the PHO pathway can be activated under prolonged periods of P-i starvation, suggesting complexity in the mechanisms by which the PHO pathway is regulated.	[Choi, Joonhyuk; Rajagopal, Abbhirami; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Choi, Joonhyuk; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Choi, Joonhyuk; Rajagopal, Abbhirami; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Rajagopal, Abbhirami; O'Shea, Erin K.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Xu, Yi-Fan; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Xu, Yi-Fan; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Choi, Joonhyuk] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rajagopal, Abbhirami] Harris Cty Publ Hlth, Houston, TX USA; [O'Shea, Erin K.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Princeton University; Princeton University; California Institute of Technology; Howard Hughes Medical Institute	O'Shea, EK (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.; O'Shea, EK (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; O'Shea, EK (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; O'Shea, EK (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	erin_oshea@harvard.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	Howard Hughes Medical Institute; Samsung Scholarship; Mary Fieser fellowship; DOE Grant [DE-SC0012461]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Samsung Scholarship(Samsung); Mary Fieser fellowship; DOE Grant(United States Department of Energy (DOE))	Funded by Howard Hughes Medical Institute (http://www.hhmi.org): JC AR EKO. Samsung Scholarship (http://www.ssscholarship.com): JC. Mary Fieser fellowship (http://chemistry.harvard.edu): AR. DOE Grant DE-SC0012461 (https://science.energy.gov/): YX JDR.	AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Byrne M, 2004, J MOL BIOL, V335, P57, DOI 10.1016/j.jmb.2003.10.035; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; GANCEDO JM, 1973, BIOCHIMIE, V55, P205, DOI 10.1016/S0300-9084(73)80393-1; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SD, 2005, GENETICS, V169, P1859, DOI 10.1534/genetics.104.038695; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lin HY, 2010, METHODS MOL BIOL, V645, P103, DOI 10.1007/978-1-60327-175-2_7; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; Tong AHY, METHODS IN MOLECULAR, P171; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Wundenberg T, 2012, SYNTHESIS BIOL ACTIO, P979; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	43	12	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176085	10.1371/journal.pone.0176085	http://dx.doi.org/10.1371/journal.pone.0176085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520786	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700010
J	de Biase, D; Genestreti, G; Visani, M; Acquaviva, G; Di Battista, M; Cavallo, G; Paccapelo, A; Cancellieri, A; Trisolini, R; Esposti, RD; Bartolini, S; Pession, A; Tallini, G; Brandes, AA				de Biase, Dario; Genestreti, Giovenzio; Visani, Michela; Acquaviva, Giorgia; Di Battista, Monica; Cavallo, Giovanna; Paccapelo, Alexandro; Cancellieri, Alessandra; Trisolini, Rocco; Esposti, Roberta Degli; Bartolini, Stefania; Pession, Annalisa; Tallini, Giovanni; Brandes, Alba A.			The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma	PLOS ONE			English	Article							PAPILLARY THYROID CARCINOMAS; RANDOMIZED PHASE-3 TRIAL; EGFR MUTATIONS; KRAS MUTATIONS; 1ST-LINE TREATMENT; CANCER PATIENTS; TUMOR-CELLS; BRAF V600E; OPEN-LABEL; GEFITINIB	Background Epidermal Growth Factor Receptor (EGFR) molecular analysis is performed to assess the responsiveness to Tyrosine Kinase Inhibitors (TKIs) in patients with Non-Small Cell Lung Cancer (NSCLC). The existence of molecular intra-tumoral heterogeneity has been observed in lung cancers. The aim of the present study is to investigate if the percentage of mutated neoplastic cells within the tumor sample might influence the responsiveness to TKIs treatment. Material and methods A total of 931 cases of NSCLC were analyzed for EGFR mutational status (exon 18, 19, 20, 21) using Next Generation Sequencer. The percentage of mutated neoplastic cells was calculated after normalizing the percentage of mutated alleles obtained after next generation sequencer analysis with the percentage of neoplastic cells in each tumor. Results Next generation sequencing revealed an EGFR mutation in 167 samples (17.9%), mainly deletions in exon 19. In 18 patients treated with TKIs and with available follow-up, there was a significant correlation between the percentage of mutated neoplastic cells and the clinical response (P = 0.017). Patients with a percentage of mutated neoplastic cells greater than 56%, have a statistical trend (P = 0.081) for higher Overall Survival (26.3 months) when compared to those with a rate of mutated neoplastic cells lower than 56% (8.2 months). Conclusions The percentage of EGFR-mutated neoplastic cells in the tumor is associated with response to TKIs. A "quantitative result" of EGFR mutational status might provide useful information in order to recognize those patients which might have the greatest benefit from TKIs.	[de Biase, Dario; Pession, Annalisa] Univ Bologna, Azienda USL Bologna, Dept Pharm & Biotechnol, Mol Diagnost Unit, Bologna, Italy; [Genestreti, Giovenzio; Di Battista, Monica; Cavallo, Giovanna; Paccapelo, Alexandro; Esposti, Roberta Degli; Bartolini, Stefania; Brandes, Alba A.] AUSL Bologna, IRCCS Inst Neurol Sci, Dept Oncol, Bologna, Italy; [Visani, Michela; Acquaviva, Giorgia; Tallini, Giovanni] Univ Bologna, Azienda USL Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Dept Med,Mol Diagnost Unit,Sch Med, Bologna, Italy; [Cancellieri, Alessandra] Maggiore Hosp, AUSL Bologna, Anat Pathol Unit, Bologna, Italy; [Trisolini, Rocco] St Orsola Malpighi Hosp, Intervent Pulmol, Bologna, Italy	AUSL di Bologna; University of Bologna; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; University of Bologna; AUSL di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	de Biase, D (corresponding author), Univ Bologna, Azienda USL Bologna, Dept Pharm & Biotechnol, Mol Diagnost Unit, Bologna, Italy.; Genestreti, G (corresponding author), AUSL Bologna, IRCCS Inst Neurol Sci, Dept Oncol, Bologna, Italy.	dario.debiase@unibo.it; g.genestreti@ausl.bologna.it	Tallini, Giovanni/F-7850-2013; de Biase, Dario/B-9274-2012; Visani, Michela/K-5597-2016	Tallini, Giovanni/0000-0003-0113-6682; de Biase, Dario/0000-0002-0609-8817; Visani, Michela/0000-0002-9051-2231; Trisolini, Rocco/0000-0002-1067-4696	Italian Government-Ministero della Salute [RF-2011-02350857, GR-2011-02350937]	Italian Government-Ministero della Salute	This work was supported in part by an Italian Government-Ministero della Salute (http://www.salute.gov.it/portale/p5_11.jsp) [Grant No. RF-2011-02350857 to G.T]; in part by an Italian Government-Ministero della Salute (http://www.salute.gov.it/portale/p5_11.jsp) [Grant No. GR-2011-02350937 to D.d.B]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Bria E, 2015, ONCOTARGET, V6, P12783, DOI 10.18632/oncotarget.3727; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Biase D, 2014, J CLIN ENDOCR METAB, V99, pE1530, DOI 10.1210/jc.2013-4389; de Biase D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087651; de Biase D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083607; Di Maio M, 2012, J THORAC ONCOL, V7, P1830, DOI 10.1097/JTO.0b013e318275b327; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Gandolfi G, 2013, J CLIN ENDOCR METAB, V98, pE934, DOI 10.1210/jc.2012-3930; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gridelli C, 2012, J CLIN ONCOL, V30, P3002, DOI 10.1200/JCO.2011.41.2056; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Johnson BE, 2005, CANCER RES, V65, P7525, DOI 10.1158/0008-5472.CAN-05-1257; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mafficini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104979; Malapelle U, 2015, J CLIN PATHOL, V68, P739, DOI 10.1136/jclinpath-2015-203101; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Metro G, 2006, REV RECENT CLIN TRIA, V1, P1, DOI 10.2174/157488706775246157; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Ragazzi M, 2016, J CLIN PATHOL, V69, P440, DOI 10.1136/jclinpath-2015-203348; Rosell R, 2005, LUNG CANCER-J IASLC, V50, P25, DOI 10.1016/j.lungcan.2005.05.017; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Travis WD., 2004, TRAVIS WB WHO CLASSI; Visani M, 2013, INT J SURG PATHOL, V21, P546, DOI 10.1177/1066896912475073; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177822	10.1371/journal.pone.0177822	http://dx.doi.org/10.1371/journal.pone.0177822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520821	Green Published, gold			2022-12-27	WOS:000401485500074
J	Ricciardi, A; Gentilotti, E; Coppola, L; Maffongelli, G; Cerva, C; Malagnino, V; Mari, A; Di Veroli, A; Berrilli, F; Apice, F; Toschi, N; Di Cave, D; Parisi, SG; Andreoni, M; Sarmati, L				Ricciardi, Alessandra; Gentilotti, Elisa; Coppola, Luigi; Maffongelli, Gaetano; Cerva, Carlotta; Malagnino, Vincenzo; Mari, Alessia; Di Veroli, Ambra; Berrilli, Federica; Apice, Fabiana; Toschi, Nicola; Di Cave, David; Parisi, Saverio Giuseppe; Andreoni, Massimo; Sarmati, Loredana			Infectious disease ward admission positively influences P.jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients	PLOS ONE			English	Article							PNEUMOCYSTIS-JIROVECII PNEUMONIA; HUMAN-IMMUNODEFICIENCY-VIRUS; CELL TRANSPLANT RECIPIENTS; POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; HEMATOLOGICAL MALIGNANCIES; RESPIRATORY SPECIMENS; CARINII; DNA; EPIDEMIOLOGY	P. jiroveci (Pj) causes a potentially fatal pneumonia in immunocompromised patients and the factors associated with a bad outcome are poorly understood. A retrospective analysis on Pj pneumonia (PjP) cases occurring in Tor Vergata University Hospital, Italy, during the period 2011-2015. The patients' demographic, clinical and radiological characteristics and the Pj genotypes were considered. The study population included 116 patients, 37.9% of whom had haematological malignancy or underwent haematological stem cell transplantation (HSCT), 22.4% had HIV infection, 16.4% had chronic lung diseases (CLD), 7.8% had a solid cancer, and 3.4% underwent a solid organ transplant (SOT). The remaining 12.1% had a miscellaneous other condition. At univariate analysis, being older than 60 years was significantly correlated with a severe PjP (OR [95% CI] 2.52 [0.10-5.76]; p = 0.031) and death (OR [95% CI] 2.44 [1.05-5.70]; p = 0.036), while a previous trimethoprim/sulfamethoxazole (TMP/SMX) prophylaxis were significantly associated with a less severe pneumonia (OR [95% CI] 0.35 [0.15-0.84], p = 0.023); moreover, death due to PjP was significantly more frequent in patients with CLD (OR[95% CI] 3.26 [1.17-9.05]; p = 0.019) while, admission to the Infectious Diseases Unit was significantly associated with fewer deaths (OR[95% CI] 0.10 [0.03-0.36], p = 0.002). At multivariate analysis, a better PjP outcome was observed in patients taking TMP/ SMX prophylaxis and that were admitted to the Infectious Diseases Unit (OR[95% CI] 0.27 [0.07-1.03], p = 0.055, OR[95% CI] 0.16 [0.05-0.55]; p = 0.004, respectively).	[Ricciardi, Alessandra; Gentilotti, Elisa; Coppola, Luigi; Maffongelli, Gaetano; Cerva, Carlotta; Malagnino, Vincenzo; Andreoni, Massimo; Sarmati, Loredana] Tor Vergata Univ, Infect Dis, Rome, Italy; [Mari, Alessia] Tor Vergata Univ, Resp Dis Unit, Rome, Italy; [Di Veroli, Ambra] Tor Vergata Univ, Dept Haematol, Rome, Italy; [Berrilli, Federica; Apice, Fabiana; Di Cave, David] Tor Vergata Univ, Dept Clin Sci & Translat Med, Rome, Italy; [Toschi, Nicola] Tor Vergata Univ, Dept Biomed & Prevent, Rome, Italy; [Toschi, Nicola] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA USA; [Toschi, Nicola] Harvard Med Sch, Boston, MA USA; [Parisi, Saverio Giuseppe] Univ Padua, Dept Mol Med, Padua, Italy; [Parisi, Saverio Giuseppe] Padua Univ Hosp, Clin Microbiol & Virol Unit, Padua, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; Harvard University; Harvard Medical School; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova	Sarmati, L (corresponding author), Tor Vergata Univ, Infect Dis, Rome, Italy.	sarmati@med.uniroma2.it	Toschi, Nicola/J-2555-2012; Andreoni, Masimo/AAL-2214-2020; Maffongelli, Gaetano/AAB-8651-2022	Toschi, Nicola/0000-0003-1929-5833; MAFFONGELLI, GAETANO/0000-0001-7784-2511; Malagnino, Vincenzo/0000-0002-6561-5298; Gentilotti, Elisa/0000-0001-6018-5295; Cerva, Carlotta/0000-0001-9060-7313; sarmati, loredana/0000-0003-1452-0333	Abbvie; Bristol-Myers Squibb; Gilead Sciences; Merck Sharp Dohme; ViiV Healthcare; Janssen-Cilag; Gilead	Abbvie(AbbVie); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Merck Sharp Dohme(Merck & Company); ViiV Healthcare; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Gilead(Gilead Sciences)	MA and SGP have received speaker fees, travel grants, and consulting fees from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, ViiV Healthcare, and Janssen-Cilag. LS has received travel grants from Gilead Sciences and Merck Sharp & Dohme, payment for lectures from Gilead Sciences, Merck Sharp & Dohme and Abbvie and researcher funding from Gilead. This does not alter our adherence to PLOS ONE policies on sharing data and materials. All the other authors have no disclosures.	Alanio A, 2016, J ANTIMICROB CHEMOTH, V71, P2075, DOI 10.1093/jac/dkw036; Beard CB, 2000, EMERG INFECT DIS, V6, P265, DOI 10.3201/eid0603.000306; Bitar D, 2014, EMERG INFECT DIS, V20, P1149, DOI 10.3201/eid2007.140087; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Cordonnier C, 2016, J ANTIMICROB CHEMOTH, V71, P2379, DOI 10.1093/jac/dkw155; Crothers K, 2005, AIDS, V19, P801, DOI 10.1097/01.aids.0000168974.67090.70; Curtis JR, 2000, AM J RESP CRIT CARE, V162, P393, DOI 10.1164/ajrccm.162.2.9909014; Esteves F, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.03.013; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; Flori P, 2004, J MED MICROBIOL, V53, P603, DOI 10.1099/jmm.0.45528-0; Gupta R, 2009, DIAGN MICR INFEC DIS, V64, P381, DOI 10.1016/j.diagmicrobio.2009.04.008; Hardak E, 2012, RESPIROLOGY, V17, P681, DOI 10.1111/j.1440-1843.2012.02158.x; Hauser PM, 2011, J CLIN MICROBIOL, V49, P1872, DOI 10.1128/JCM.02390-10; Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; Kanne JP, 2012, AM J ROENTGENOL, V198, pW555, DOI 10.2214/AJR.11.7329; LEIBOVITZ E, 1995, J CLIN MICROBIOL, V33, P3004, DOI 10.1128/JCM.33.11.3004-3007.1995; Li MC, 2014, J MICROBIOL IMMUNOL, V47, P42, DOI 10.1016/j.jmii.2012.08.024; Lopez-Sanchez C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000681; Maini R, 2013, EMERG INFECT DIS, V19, P386, DOI 10.3201/eid1903.121151; Matos O, 2010, FUTURE MICROBIOL, V5, P1257, DOI [10.2217/fmb.10.75, 10.2217/FMB.10.75]; McQuillen DP, 2008, CLIN INFECT DIS, V47, P1051, DOI 10.1086/592067; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Morris A, 2008, COPD, V5, P43, DOI 10.1080/15412550701817656; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Procop GW, 2004, J CLIN MICROBIOL, V42, P3333, DOI 10.1128/JCM.42.7.3333-3335.2004; Roux A, 2014, EMERG INFECT DIS, V20, P1490, DOI 10.3201/eid2009.131668; Schmitt S, 2014, CLIN INFECT DIS, V58, P22, DOI 10.1093/cid/cit610; Sing A, 2000, J CLIN MICROBIOL, V38, P1461, DOI 10.1128/JCM.38.4.1461-1467.2000; Stern A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005590.pub3; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Wakefield AE, 1996, J CLIN MICROBIOL, V34, P1754, DOI 10.1128/JCM.34.7.1754-1759.1996; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778	33	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176881	10.1371/journal.pone.0176881	http://dx.doi.org/10.1371/journal.pone.0176881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505159	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500010
J	Tsompanas, MAI; Adamatzky, A; Sirakoulis, GC; Greenman, J; Ieropoulos, I				Tsompanas, Michail-Antisthenis I.; Adamatzky, Andrew; Sirakoulis, Georgios Ch.; Greenman, John; Ieropoulos, Ioannis			Towards implementation of cellular automata in Microbial Fuel Cells	PLOS ONE			English	Article								The Microbial Fuel Cell (MFC) is a bio-electrochemical transducer converting waste products into electricity using microbial communities. Cellular Automaton (CA) is a uniform array of finite-state machines that update their states in discrete time depending on states of their closest neighbors by the same rule. Arrays of MFCs could, in principle, act as massive-parallel computing devices with local connectivity between elementary processors. We provide a theoretical design of such a parallel processor by implementing CA in MFCs. We have chosen Conway's Game of Life as the 'benchmark' CA because this is the most popular CA which also exhibits an enormously rich spectrum of patterns. Each cell of the Game of Life CA is realized using two MFCs. The MFCs are linked electrically and hydraulically. The model is verified via simulation of an electrical circuit demonstrating equivalent behaviours. The design is a first step towards future implementations of fully autonomous biological computing devices with massive parallelism. The energy independence of such devices counteracts their somewhat slow transitions D compared to silicon circuitry D between the different states during computation.	[Tsompanas, Michail-Antisthenis I.; Adamatzky, Andrew] Univ West England, Unconvent Comp Ctr, Bristol, Avon, England; [Sirakoulis, Georgios Ch.] Democritus Univ Thrace, Dept Elect & Comp Engn, Xanthi, Greece; [Greenman, John; Ieropoulos, Ioannis] Univ West England, Bristol BioEnergy Ctr, Bristol, Avon, England	University of West England; Democritus University of Thrace; University of West England	Tsompanas, MAI (corresponding author), Univ West England, Unconvent Comp Ctr, Bristol, Avon, England.; Ieropoulos, I (corresponding author), Univ West England, Bristol BioEnergy Ctr, Bristol, Avon, England.	Antisthenis.Tsompanas@uwe.ac.uk; ioannis.ieropoulos@brl.ac.uk	Sirakoulis, Georgios/AAE-9654-2020; Ieropoulos, Ioannis Andrea/AAI-3669-2020	Sirakoulis, Georgios/0000-0001-8240-484X; Ieropoulos, Ioannis Andrea/0000-0002-9641-5504; Tsompanas, Michail Antisthenis/0000-0002-6607-7831	European Union's Horizon Research and Innovation Programme [686585]; EPSRC [EP/L002132/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L002132/1] Funding Source: researchfish	European Union's Horizon Research and Innovation Programme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 686585 (https://ec.europa.eu/programmes/harizan2020/).; This work was funded by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 686585. http://livingarchitecture-h2020.eu	Abrevaya XC, 2015, BIOSENS BIOELECTRON, V63, P591, DOI 10.1016/j.bios.2014.04.053; Adachi S, 2004, PHYSICA D, V198, P182, DOI 10.1016/j.physd.2004.04.010; Adamatzky A, 2010, GAME LIFE CELLULAR A, V1; Cheng SA, 2011, BIOSENS BIOELECTRON, V26, P1913, DOI 10.1016/j.bios.2010.05.016; Chopard B., 2009, ENCY COMPLEXITY SYST, P865, DOI [10.1007/978-0-387-30440-3_57, DOI 10.1007/978-0-387-30440-3_57]; Chouler J, 2016, ELECTROCHIM ACTA, V192, P89, DOI 10.1016/j.electacta.2016.01.112; Chua L. O., 1992, CNNA'92 Proceedings. Second International Workshop on Cellular Neural Networks and their Applications (Cat. No.92TH0498-6), P276, DOI 10.1109/CNNA.1992.274337; Chua L. O., 1998, CNN PARADIGM COMPLEX, V31; Conway J., 1970, SCI AM, V223, P4; Greenman J, 2006, INT J UNCONV COMPUT, V2, P249; Greenman J, 2006, UTOPIAN GENUINE UNCO, P67; Ieropoulos I, 2013, J WATER SANIT HYG DE, V3, P383, DOI 10.2166/washdev.2013.117; Koushanpour A, 2017, ELECTROANAL, V29, P950, DOI 10.1002/elan.201600706; Koushanpour A, 2016, ECS J SOLID STATE SC, V5, pM3037, DOI 10.1149/2.0071608jss; Kumlanghan A, 2007, BIOSENS BIOELECTRON, V22, P2939, DOI 10.1016/j.bios.2006.12.014; Ledezma P, 2013, BIORESOURCE TECHNOL, V134, P158, DOI 10.1016/j.biortech.2013.01.119; Lovley DR, 2017, ISME J, V11, P327, DOI 10.1038/ismej.2016.136; MacLennan B., 1990, CONTINUOUS SPATIAL A; Mardanpour MM, 2012, BIOSENS BIOELECTRON, V38, P264, DOI 10.1016/j.bios.2012.05.046; Mizas C, 2008, BIOSYSTEMS, V92, P61, DOI 10.1016/j.biosystems.2007.12.002; Ortiz-Martinez VM, 2016, CHEM ENG J, V291, P317, DOI 10.1016/j.cej.2016.01.084; Rendell P., 2002, COLLISION BASED COMP, P513, DOI [DOI 10.1007/978-1-4471-0129-1_18, 10.1007/978-1-4471-0129-1_18]; Santoro C, 2015, INT J HYDROGEN ENERG, V40, P14706, DOI 10.1016/j.ijhydene.2015.07.054; Sipper M, 1995, LECT NOTES ARTIF INT, V929, P544; Syiem MB, 2017, AGRO-ENVIRONMENTAL SUSTAINABILITY, VOL 1: MANAGING CROP HEALTH, P43, DOI 10.1007/978-3-319-49724-2_3; Tan Y, 2016, SMALL, V12, P4481, DOI 10.1002/smll.201601112; Walter XA, 2015, ALGAL RES, V11, P103, DOI 10.1016/j.algal.2015.06.003	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177528	10.1371/journal.pone.0177528	http://dx.doi.org/10.1371/journal.pone.0177528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498871	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000401314500026
J	Cors, JF; Kashyap, A; Khartchenko, AF; Schraml, P; Kaigala, GV				Cors, Julien F.; Kashyap, Aditya; Khartchenko, Anna Fomitcheva; Schraml, Peter; Kaigala, Govind V.			Tissue lithography: Microscale dewaxing to enable retrospective studies on formalin-fixed paraffin-embedded (FFPE) tissue sections	PLOS ONE			English	Article							MICROFLUIDIC PROBE; IMMUNOHISTOCHEMISTRY; BIOMARKERS; BIOBANKING	We present a new concept, termed tissue lithography (TL), and its implementation which enables retrospective studies on formalin-fixed paraffin-embedded tissue sections. Tissue lithography uses a microfluidic probe to remove microscale areas of the paraffin layer on formalin-fixed paraffin-embedded biopsy samples. Current practices in sample utilization for research and diagnostics require complete deparaffinization of the sample prior to molecular testing. This imposes strong limitations in terms of the number of tests as well as the time when they can be performed on a single sample. Microscale dewaxing lifts these constraints by permitting deprotection of a fraction of a tissue for testing while keeping the remaining of the sample intact for future analysis. After testing, the sample can be sent back to storage instead of being discarded, as is done in standard workflows. We achieve this microscale dewaxing by hydrodynamically confining nanoliter volumes of xylene on top of the sample with a probe head. We demonstrate micrometer-scale, chromogenic and fluorescencebased immunohistochemistry against multiple biomarkers ( p53, CD45, HER2 and beta-actin) on tonsil and breast tissue sections and microarrays. We achieve stain patterns as small as 100 mu m x 50 mu m as well as multiplexed immunostaining within a single tissue microarray core with a 20-fold time reduction for local dewaxing as compared to standard protocols. We also demonstrate a 10-fold reduction in the rehydration time, leading to lower processing times between different stains. We further show the potential of TL for retrospective studies by sequentially dewaxing and staining four individual cores within the same tissue microarray over four consecutive days. By combining tissue lithography with the concept of microimmunohistochemistry, we implement each step of the IHC protocol D dewaxing, rehydration and staining D with the same microfluidic probe head. Tissue lithography brings a new level of versatility and flexibility in sample processing and budgeting in biobanks, which may alleviate current sample limitations for retrospective studies in biomarker discovery and drug screening.	[Cors, Julien F.; Kashyap, Aditya; Khartchenko, Anna Fomitcheva; Kaigala, Govind V.] IBM Res Zurich, Ruschlikon, Switzerland; [Schraml, Peter] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland	International Business Machines (IBM); University of Zurich; University Zurich Hospital	Kaigala, GV (corresponding author), IBM Res Zurich, Ruschlikon, Switzerland.	gov@zurich.ibm.com	Fomitcheva-Khartchenko, Anna/AAS-8458-2021	Fomitcheva-Khartchenko, Anna/0000-0002-4846-3923; Kashyap, Aditya/0000-0002-5033-2826	European Research Council (ERC) Starting Grant, under the 7th Framework Program [311122]; IBM Research Zurich	European Research Council (ERC) Starting Grant, under the 7th Framework Program(European Research Council (ERC)); IBM Research Zurich(International Business Machines (IBM))	This work was supported by the European Research Council (ERC) Starting Grant, under the 7th Framework Program (Project No. 311122, BioProbe) (URL: http://www.bioprobe.eu/). IBM Research Zurich provided support in the form of salaries for authors JFC, AK, AFK, and GVK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baker M, 2012, NATURE, V486, P141, DOI 10.1038/486141a; Ciftlik AT, 2013, P NATL ACAD SCI USA, V110, P5363, DOI 10.1073/pnas.1211273110; Cors JF, 2016, CHEM COMMUN, V52, P13035, DOI 10.1039/c6cc08018a; Cors JF, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4866976; Economou M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-4; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Gannot G, 2005, J MOL DIAGN, V7, P427, DOI 10.1016/S1525-1578(10)60573-9; Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X; Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8; Huber D, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0064-0; Kaigala GV, 2011, LANGMUIR, V27, P5686, DOI 10.1021/la2003639; Kashyap A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29579; Kim MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010441; Lovchik RD, 2012, LAB CHIP, V12, P1040, DOI 10.1039/c2lc21016a; Massett Holly A., 2011, Journal of the National Cancer Institute Monographs, P8, DOI 10.1093/jncimonographs/lgr007; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Taylor DP, 2016, LANGMUIR, V32, P10537, DOI 10.1021/acs.langmuir.6b02983; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Womack C, 2014, METHODS, V70, P3, DOI 10.1016/j.ymeth.2014.01.014	19	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176691	10.1371/journal.pone.0176691	http://dx.doi.org/10.1371/journal.pone.0176691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493979	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000401314300026
J	Kobatake, E; Nakagawa, H; Seki, T; Miyazaki, T				Kobatake, Eiji; Nakagawa, Hisako; Seki, Takahiro; Miyazaki, Tadaaki			Protective effects and functional mechanisms of Lactobacillus gasseri SBT2055 against oxidative stress	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SIGNALING PATHWAY; HEME OXYGENASE-1; GENE-EXPRESSION; DEFENSE PATHWAY; NRF2; INHIBITION; INDUCTION; INFLUENZA	Lactobacillus gasseri SBT2055 (LG2055) is one of the probiotic lactic acid bacteria. Recently, we demonstrated that feeding with LG2055 extended the lifespan of Caenorhabditis elegans and that the prolongevity effect was dependent upon the regulation of oxidative stress response. In this study, we assessed whether LG2055 regulated the oxidative stress response of mammalian cells. In NIH-3T3 cells and primary mouse embryonic fibroblast cells, low cell proliferation rates and high reactive oxygen species levels were observed following paraquat treatment. LG2055 treatment suppressed these responses in paraquat-treated cells, indicating that LG2055 protected against oxidative stress in mammalian cells. The mRNA expression of oxidative stress-related genes, total nuclear factor-erythroid-2related factor 2 (Nrf2) protein levels, and the nuclear translocation of Nrf2 were increased by LG2055 treatment. These results suggested that the Nrf2-antioxidant response element (ARE) signaling pathway was activated by LG2055. Furthermore, c-Jun NH2-terminal kinase (JNK) was activated by LG2055 treatment and the inhibition of JNK suppressed the activation of the Nrf2-ARE signaling pathway in LG2055-treated cells. Together, these findings suggest that LG2055 activated the Nrf2-ARE signaling pathway by JNK activation, thus strengthening the defense system against oxidative stress in mammalian cells.	[Kobatake, Eiji; Seki, Takahiro] Megmilk Snow Brand Co Ltd, Milk Sci Res Inst, Saitama, Japan; [Nakagawa, Hisako; Miyazaki, Tadaaki] Hokkaido Univ, Inst Genet Med, Dept Probiot Immunol, Sapporo, Hokkaido, Japan	Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Inst Genet Med, Dept Probiot Immunol, Sapporo, Hokkaido, Japan.	miyazaki@pop.med.hokudai.ac.jp		Kobatake, Eiji/0000-0001-6599-6097	Megmilk Snow Brand Co., Ltd.	Megmilk Snow Brand Co., Ltd.	This study was funded by Megmilk Snow Brand Co., Ltd. The funder provided support in the form of salaries for Eiji Kobatake and Takahiro Seki, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Atia A, 2014, INT J MED RES HEALTH, V3, P428, DOI 10.5958/j.2319-5886.3.2.087; Blanco-Ayala T, 2014, FREE RADICAL RES, V48, P623, DOI 10.3109/10715762.2014.899694; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Choi SS, 2006, LETT APPL MICROBIOL, V42, P452, DOI 10.1111/j.1472-765X.2006.01913.x; FICHERA GA, 1994, CANCER LETT, V85, P93, DOI 10.1016/0304-3835(94)90244-5; Gao DW, 2013, FOOD FUNCT, V4, P982, DOI 10.1039/c3fo30316k; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Harata G, 2010, LETT APPL MICROBIOL, V50, P597, DOI 10.1111/j.1472-765X.2010.02844.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hosono A, 1997, BIOSCI BIOTECH BIOCH, V61, P312, DOI 10.1271/bbb.61.312; Hosoya T, 2014, PLOS ONE, V9; Howden R., 2013, OXID MED CELL LONGEV, V2013; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Jeong JH, 2015, IMMUNOBIOLOGY, V220, P460, DOI 10.1016/j.imbio.2014.11.002; Jones RM, 2015, CELL REP, V12, P1217, DOI 10.1016/j.celrep.2015.07.042; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Liu CC, 2015, MOL CARCINOGEN, V54, P889, DOI 10.1002/mc.22161; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Mann GE, 2009, CURR OPIN PHARMACOL, V9, P139, DOI 10.1016/j.coph.2008.12.012; Miyoshi M, 2014, EUR J NUTR, V53, P599, DOI 10.1007/s00394-013-0568-9; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nakagawa H, 2016, AGING CELL, V15, P227, DOI 10.1111/acel.12431; Nakayama Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04638; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Sakai F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105370; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; von Schillde MA, 2012, CELL HOST MICROBE, V11, P387, DOI 10.1016/j.chom.2012.02.006; Yang Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-48; You GE, 2013, J MICROBIOL BIOTECHN, V23, P1357, DOI 10.4014/jmb.1306.06026; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523	43	36	38	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177106	10.1371/journal.pone.0177106	http://dx.doi.org/10.1371/journal.pone.0177106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493927	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300060
J	Molina-Jijon, E; Rodriguez-Munoz, R; Gonzalez-Ramirez, R; Namorado-Tonix, C; Pedraza-Chaverri, J; Reyes, JL				Molina-Jijon, Eduardo; Rodriguez-Munoz, Rafael; Gonzalez-Ramirez, Ricardo; Namorado-Tonix, Carmen; Pedraza-Chaverri, Jose; Reyes, Jose L.			Aldosterone signaling regulates the overexpression of claudin-4 and-8 at the distal nephron from type 1 diabetic rats	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; PARACELLULAR CHLORIDE PERMEABILITY; INDUCED PODOCYTE INJURY; OXIDATIVE STRESS; MINERALOCORTICOID RECEPTOR; EPITHELIAL-CELLS; CL-PERMEABILITY; EXPRESSION; KIDNEY; SPIRONOLACTONE	Hyperglycemia in diabetes alters tight junction (TJ) proteins in the kidney. We evaluated the participation of aldosterone (ALD), and the effect of spironolactone (SPL), a mineralocorticoid receptor antagonist, on the expressions of claudin-2, -4, -5 and -8, and occludin in glomeruli, proximal and distal tubules isolated from diabetic rats. Type 1 diabetes was induced in female Wistar rats by a single tail vein injection of streptozotocin (STZ), and SPL was administrated daily by gavage, from days 3 - 21. Twenty-one days after STZ injection the rats were sacrificed. In diabetic rats, the serum ALD levels were increased, and SPLtreatment did not have effect on these levels or in hyperglycemia, however, proteinuria decreased in SPL-treated diabetic rats. Glomerular damage, evaluated by nephrin and Wilm's tumor 1 (WT1) protein expressions, and proximal tubular damage, evaluated by kidney injury molecule 1 (Kim-1) and heat shock protein 72 kDa (Hsp72) expressions, were ameliorated by SPL. Also, SPL prevented decrement in claudin-5 in glomeruli, and claudin2 and occludin in proximal tubules by decreasing oxidative stress, evaluated by superoxide anion (O-2(center dot-)) production, and oxidative stress markers. In distal tubules, SPL ameliorated increase in mRNA, protein expression, and phosphorylation in threonine residues of claudin- 4 and -8, through a serum and glucocorticoid-induced kinase 1 (SGK1), and with-nolysine kinase 4 (WNK4) signaling pathway. In conclusion, this is the first study that demonstrates that ALD modulates the expression of renal TJ proteins in diabetes, and that the blockade of its actions with SPL, may be a promising therapeutic strategy to prevent alterations of TJ proteins in diabetic nephropathy.	[Molina-Jijon, Eduardo; Rodriguez-Munoz, Rafael; Namorado-Tonix, Carmen; Reyes, Jose L.] CINVESTAV IPN, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Natl Polytech Inst, Mexico City, DF, Mexico; [Molina-Jijon, Eduardo] IPN, Dept Biociencias & Ingn, CIIEMAD, Mexico City, DF, Mexico; [Gonzalez-Ramirez, Ricardo] Dr Manuel Gea Gonzalez Gen Hosp, Dept Mol Biol & Histocompatibil, Mexico City, DF, Mexico; [Pedraza-Chaverri, Jose] Natl Autonomous Univ Mexico UNAM, Dept Biol, Fac Chem, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Reyes, JL (corresponding author), CINVESTAV IPN, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Natl Polytech Inst, Mexico City, DF, Mexico.	jreyes@fisio.cinvestav.mx	González-Ramírez, Ricardo/O-1792-2014; Molina-Jijon, Eduardo/AAY-2192-2021	González-Ramírez, Ricardo/0000-0003-1399-8036; Rodriguez-Munoz, Rafael/0000-0001-9668-052X; Reyes, Jose L./0000-0001-5830-2691	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [0179870, 220046, 252008, PAPIIT IN201316]; CONACyT [255413]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT) grants 0179870 to JLR and 220046 and 252008 and PAPIIT IN201316 to JPCh. EMJ thanks support by CONACyT (255413).	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Amasheh S, 2009, BIOCHEM BIOPH RES CO, V378, P45, DOI 10.1016/j.bbrc.2008.10.164; Angelow S, 2006, J PHYSIOL-LONDON, V571, P15, DOI 10.1113/jphysiol.2005.099135; Arreola-Mendoza L, 2006, TOXICOLOGY, V218, P237, DOI 10.1016/j.tox.2005.11.010; Arreola-Mendoza L, 2009, TOXICOL LETT, V191, P279, DOI 10.1016/j.toxlet.2009.09.011; Beesley AH, 1998, J PHYSIOL-LONDON, V509, P629, DOI 10.1111/j.1469-7793.1998.629bm.x; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Edelman I S, 1968, Recent Prog Horm Res, V24, P1; FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Fujisawa G, 2004, KIDNEY INT, V66, P1493, DOI 10.1111/j.1523-1755.2004.00913.x; Gilbert KC, 2010, CURR OPIN ENDOCRINOL, V17, P199, DOI 10.1097/MED.0b013e3283391989; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gonzalez-Mariscal L, 2006, NEPHROL DIAL TRANSPL, V21, P2391, DOI 10.1093/ndt/gfl255; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Hofni A, 2014, EUR J PHARMACOL, V744, P173, DOI 10.1016/j.ejphar.2014.10.021; Hollenberg NK, 2004, KIDNEY INT, V65, P1435, DOI 10.1111/j.1523-1755.2004.00524.x; Hou JH, 2013, ANNU REV PHYSIOL, V75, P479, DOI 10.1146/annurev-physiol-030212-183705; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P14877, DOI 10.1073/pnas.0406172101; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Ko B, 2013, AM J PHYSIOL-RENAL, V305, pF645, DOI 10.1152/ajprenal.00053.2013; Koda R, 2011, CELL TISSUE RES, V343, P637, DOI 10.1007/s00441-010-1117-y; Kolla V, 2000, MOL CELL BIOCHEM, V204, P35, DOI 10.1023/A:1007009700377; Le Moellic C, 2005, AM J PHYSIOL-CELL PH, V289, pC1513, DOI 10.1152/ajpcell.00314.2005; Matavelli LC, 2013, J CARDIOVASC PHARM, V61, P17, DOI 10.1097/FJC.0b013e318274d2ef; Molina-Jijon E, 2015, J NUTR BIOCHEM, V26, P441, DOI 10.1016/j.jnutbio.2014.11.018; Molina-Jijon E, 2014, FREE RADICAL BIO MED, V72, P162, DOI 10.1016/j.freeradbiomed.2014.03.040; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Muzzarelli S, 2012, AM J CARDIOL, V109, P693, DOI 10.1016/j.amjcard.2011.10.027; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; Ohta A, 2006, BIOCHEM BIOPH RES CO, V349, P804, DOI 10.1016/j.bbrc.2006.08.101; Patni H, 2007, AM J PHYSIOL-RENAL, V293, pF1065, DOI 10.1152/ajprenal.00147.2007; Reyes JL, 2002, KIDNEY INT, V62, P476, DOI 10.1046/j.1523-1755.2002.00479.x; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Siragy HM, 2003, ENDOCRINOLOGY, V144, P2229, DOI 10.1210/en.2003-0010; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; Tatum R, 2007, FEBS LETT, V581, P3887, DOI 10.1016/j.febslet.2007.07.014; Toyonaga J, 2011, NEPHROL DIAL TRANSPL, V26, P2475, DOI 10.1093/ndt/gfq750; Trujillo J, 2015, J BIOCHEM MOL TOXIC, V29, P149, DOI 10.1002/jbt.21679; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; WHITTEMBURY G, 1971, PFLUG ARCH EUR J PHY, V330, P302, DOI 10.1007/BF00588582; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xue C, 2005, HYPERTENSION, V46, P584, DOI 10.1161/01.HYP.0000175814.18550.c0; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Yu ASL, 2015, J AM SOC NEPHROL, V26, P11, DOI 10.1681/ASN.2014030284; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200; Yuan J, 2007, J RENIN-ANGIO-ALDO S, V8, P118, DOI 10.3317/jraas.2007.014; Yuan YG, 2015, LAB INVEST, V95, P1374, DOI 10.1038/labinvest.2015.118; Zhao LN, 2008, AM J PHYSIOL-REG I, V294, pR1856, DOI 10.1152/ajpregu.00862.2007; Zhou QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360; Zhu D, 2013, MOL CELL BIOCHEM, V380, P185, DOI 10.1007/s11010-013-1672-0	53	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177362	10.1371/journal.pone.0177362	http://dx.doi.org/10.1371/journal.pone.0177362			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493961	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300094
J	Sarabhai, T; Peter, C; Bar, AK; Windolf, J; Relja, B; Wesselborg, S; Wahlers, T; Paunel-Gorgulu, A				Sarabhai, Theresia; Peter, Christoph; Baer, Anne-Kathrin; Windolf, Joachim; Relja, Borna; Wesselborg, Sebastian; Wahlers, Thorsten; Paunel-Goerguelue, Adnana			Serum alpha-1 Antitrypsin (AAT) antagonizes intrinsic apoptosis induction in neutrophils from patients with systemic inflammatory response syndrome	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TRAUMA; ACTIVATION; INHIBITOR; SEPSIS; ALPHA; LEADS; GENE	Excessive neutrophil activation accompanied by delayed apoptotic cell death in inflammatory conditions causes progressive damage of cells and tissues, leading to life-threatening multiple organ dysfunction syndrome. Previous work suggested that circulating serum factors during inflammation are critically involved in the suppression of neutrophil cell death although the identity of these antiapoptotic mediators remained elusive. In this study, we identified the acute phase protein alpha-1 Antitrypsin (AAT) as a potent suppressor of stauros-porine (STS)-induced apoptosis in human neutrophils through a mechanism implicating cas-pases-independent pathways. We show here that serum levels of AAT, potentially in part released by stimulated neutrophils, are markedly elevated in major trauma patients suffering from systemic inflammatory response syndrome (SIRS). Notably, AAT depletion from serum increased sensitivity of human neutrophils for STS-induced cell death. In fact, AAT was demonstrated to confer intrinsic apoptosis resistance by preventing PKC/Akt inactivation and subsequent proteasomal degradation of antiapoptotic Mcl-1 protein in response to STS treatment. Neither MAP kinase ERK1/2 nor caspases were found to be involved in AAT-triggered antiapoptotic pathways in neutrophils. In summary, these results establish a novel pivotal role of circulating AAT in mediating survival by antagonizing the proapoptotic action of the PKC inhibitor STS and should be considered for AAT augmentation therapies in future.	[Sarabhai, Theresia; Windolf, Joachim] Univ Hosp Dusseldorf, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Peter, Christoph; Wesselborg, Sebastian] Heinrich Heine Univ Dusseldorf, Inst Mol Med 1, Dusseldorf, Germany; [Baer, Anne-Kathrin; Wahlers, Thorsten; Paunel-Goerguelue, Adnana] Univ Cologne, Dept Cardiothorac Surg, Heart Ctr, Cologne, Germany; [Relja, Borna] Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; University of Cologne; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Paunel-Gorgulu, A (corresponding author), Univ Cologne, Dept Cardiothorac Surg, Heart Ctr, Cologne, Germany.	adnana.paunel-goerguelue@uk-koeln.de	Relja, Borna/B-6642-2016; Peter, Christoph/ABB-4684-2020	Relja, Borna/0000-0002-5625-8823; Peter, Christoph/0000-0002-0048-2279; Wesselborg, Sebastian/0000-0002-5236-942X	German Research Foundation [PA2029/1-1]; Koein Fortune Program / Faculty of Medicine, University of Cologne [229/2016]	German Research Foundation(German Research Foundation (DFG)); Koein Fortune Program / Faculty of Medicine, University of Cologne	This study was supported in part by the German Research Foundation (PA2029/1-1, http://www.dfg.de, to APG) and by the Koein Fortune Program / Faculty of Medicine, University of Cologne (229/2016, www.uni-koeln.de/med-fak/dekanat/forschung/fortune, to APG and AKB). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Charles I, 2005, INVEST OPHTH VIS SCI, V46, P1330, DOI 10.1167/iovs.04-0363; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; COLOTTA F, 1992, BLOOD, V80, P2012; Di Martino M., 1995, Inflammation Research, V44, pS123; DUBOIS RM, 1991, BLOOD, V77, P2724; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gray RD, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-12; GREENE CM, 2010, THE EUROPEAN, V35, P1155, DOI DOI 10.1183/09031936.00191908; Hornstein T, 2016, J LEUKOCYTE BIOL, V99, P163, DOI 10.1189/jlb.3A1114-537RR; Hurley K, 2014, J IMMUNOL, V193, P3978, DOI 10.4049/jimmunol.1400132; JACOBSON PB, 1995, J PHARMACOL EXP THER, V275, P995; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jimenez MF, 1997, ARCH SURG-CHICAGO, V132, P1263; Kannan S, 2002, MED HYPOTHESES, V59, P266, DOI 10.1016/S0306-9877(02)00214-1; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Knoell DL, 1998, AM J RESP CRIT CARE, V157, P246, DOI 10.1164/ajrccm.157.1.9702033; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas CD, 2014, MUCOSAL IMMUNOL, V7, P857, DOI 10.1038/mi.2013.102; Matamala N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0585-y; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; Paunel-Gorgulu A, 2012, MOL MED, V18, P325, DOI 10.2119/molmed.2011.00380; Paunel-Gorgulu A, 2011, CRIT CARE, V15, DOI 10.1186/cc9965; Paunel-Gorgulu A, 2009, J IMMUNOL, V183, P6198, DOI 10.4049/jimmunol.0901264; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schamberger CJ, 2005, EXP CELL RES, V302, P115, DOI 10.1016/j.yexcr.2004.08.026; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Taneja R, 2004, CRIT CARE MED, V32, P1460, DOI 10.1097/01.CCM.0000129975.26905.77; Toldo S, 2011, J MOL CELL CARDIOL, V51, P244, DOI 10.1016/j.yjmcc.2011.05.003; Trager Karl, 2016, Case Rep Crit Care, V2016, P9852073, DOI 10.1155/2016/9852073; van 't Wout EFA, 2012, AM J RESP CELL MOL, V46, P607, DOI 10.1165/rcmb.2011-0231OC; Weir S, 2010, EXPERT REV PHARM OUT, V10, P187, DOI [10.1586/erp.10.8, 10.1586/ERP.10.8]; Zhang Y, 2013, IMMUNOLOGY, V140, P143, DOI 10.1111/imm.12123	40	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177450	10.1371/journal.pone.0177450	http://dx.doi.org/10.1371/journal.pone.0177450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493974	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300111
J	Shneider, BL; Moore, J; Kerkar, N; Magee, JC; Ye, W; Karpen, SJ; Kamath, BM; Molleston, JP; Bezerra, JA; Murray, KF; Loomes, KM; Whitington, PF; Rosenthal, P; Squires, RH; Guthery, SL; Arnon, R; Schwarz, KB; Turmelle, YP; Sherker, AH; Sokol, RJ				Shneider, Benjamin L.; Moore, Jeff; Kerkar, Nanda; Magee, John C.; Ye, Wen; Karpen, Saul J.; Kamath, Binita M.; Molleston, Jean P.; Bezerra, Jorge A.; Murray, Karen F.; Loomes, Kathleen M.; Whitington, Peter F.; Rosenthal, Philip; Squires, Robert H.; Guthery, Stephen L.; Arnon, Ronen; Schwarz, Kathleen B.; Turmelle, Yumirle P.; Sherker, Averell H.; Sokol, Ronald J.		Childhood Liver Dis Res Network	Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia?	PLOS ONE			English	Article							LOGISTIC-REGRESSION; DIAGNOSIS; HEPATITIS; OBSTRUCTION	Introduction Optimizing outcome in biliary atresia (BA) requires timely diagnosis. Cholestasis is a presenting feature of BA, as well as other diagnoses (Non-BA). Identification of clinical features of neonatal cholestasis that would expedite decisions to pursue subsequent invasive testing to correctly diagnose or exclude BA would enhance outcomes. The analytical goal was to develop a predictive model for BA using data available at initial presentation. Methods Infants at presentation with neonatal cholestasis (direct/conjugated bilirubin >2 mg/dl [34.2 mu M]) were enrolled prior to surgical exploration in a prospective observational multicentered study (PROBE-NCT00061828). Clinical features (physical findings, laboratory results, gallbladder sonography) at enrollment were analyzed. Initially, 19 features were selected as candidate predictors. Two approaches were used to build models for diagnosis prediction: a hierarchical classification and regression decision tree (CART) and a logistic regression model using a stepwise selection strategy. Results In PROBE April 2004-February 2014, 401 infants met criteria for BA and 259 for Non-BA. Univariate analysis identified 13 features that were significantly different between BA and Non-BA. Using a CART predictive model of BA versus Non-BA (significant factors: gamma-glutamyl transpeptidase, acholic stools, weight), the receiver operating characteristic area under the curve (ROC AUC) was 0.83. Twelve percent of BA infants were misclassified as Non-BA; 17% of Non-BA infants were misclassified as BA. Stepwise logistic regression identified seven factors in a predictive model (ROC AUC 0.89). Using this model, a predicted probability of >0.8 (n = 357) yielded an 81% true positive rate for BA; <0.2 (n = 120) yielded an 11% false negative rate. Conclusion Despite the relatively good accuracy of our optimized prediction models, the high precision required for differentiating BA from Non-BA was not achieved. Accurate identification of BA in infants with neonatal cholestasis requires further evaluation, and BA should not be excluded based only on presenting clinical features.	[Shneider, Benjamin L.] Baylor Coll Med, Pediat Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Moore, Jeff; Ye, Wen] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Kerkar, Nanda] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Kerkar, Nanda; Arnon, Ronen] Mt Sinai, New York, NY USA; [Magee, John C.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Karpen, Saul J.] Emory Univ, Sch Med Childrens Healthcare Atlanta, Pediat Gastroenterol Hepatol & Nutr, Atlanta, GA 30322 USA; [Kamath, Binita M.] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Toronto, ON, Canada; [Kamath, Binita M.] Univ Toronto, Toronto, ON, Canada; [Molleston, Jean P.] Indiana Univ, Sch Med, Riley Hosp Children, Pediat Gastroenterol Hepatol & Nutr, Indianapolis, IN 46204 USA; [Bezerra, Jorge A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Murray, Karen F.] Univ Washington Med Ctr, Seattle Childrens, Div Gastroenterol & Hepatol, Seattle, WA USA; [Loomes, Kathleen M.] Childrens Hosp Philadelphia, Pediat Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Whitington, Peter F.] Ann & Robert H Lurie Childrens Hosp Chicago, Pediat Div Gastroenterol Hepatol & Nutr, Chicago, IL USA; [Rosenthal, Philip] Univ Calif San Francisco, Dept Pediat, Div Gastroenterol Hepatol & Nutr, San Francisco, CA 94143 USA; [Squires, Robert H.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Guthery, Stephen L.] Univ Utah, Pediat Gastroenterol Hepatol & Nutr, Salt Lake City, UT USA; [Schwarz, Kathleen B.] Johns Hopkins Sch Med, Baltimore, MD USA; [Turmelle, Yumirle P.] Washington Univ, Sch Med, St Louis, MO USA; [Sherker, Averell H.] NIH, NIDDK, Liver Dis Res Branch, Bldg 10, Bethesda, MD 20892 USA; [Sokol, Ronald J.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat,Sect Pediat Gastroenterol Hepatol & N, Aurora, CO USA	Baylor College of Medicine; University of Michigan System; University of Michigan; Children's Hospital Los Angeles; University of Michigan System; University of Michigan; Children's Healthcare of Atlanta (CHOA); Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Cincinnati Children's Hospital Medical Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Ann & Robert H. Lurie Children's Hospital of Chicago; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins Medicine; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Shneider, BL (corresponding author), Baylor Coll Med, Pediat Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	Benjamin.Shneider@bcm.edu	Sherker, Averell H/A-2889-2013	Sherker, Averell H/0000-0003-0409-6938; Fredericks, Emily/0000-0002-3110-4983	National Institute of Diabetes and Digestive and Kidney Diseases [U01DK062456, U01DK062470, UL1TR000454, U01DK062453, UL1TR001082, U01DK062436, UL1TR000150, U01DK062503, UL1TR000424, U01DK062497, UL1TR000077];  [U01DK062500];  [UL1TR000004];  [U01DK062452];  [UL1TR000448];  [U01DK084536];  [UL1TR001108];  [U01DK084575];  [UL1TR000423];  [UL1RR025014];  [U01DK062466];  [UL1TR000005];  [U01DK103135];  [U01DK062481];  [U01DK103140];  [U01DK103149];  [U01DK062445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK103149, U01DK062481, U01DK062500, U01DK084536, P30DK078392, U01DK062466, U01DK103140, U01DK062436, U01DK062456, U01DK084575, U01DK062497] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by the following National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/) grants: U01DK103149 (BLS); U01DK062456 (JCM); U01DK062470 and UL1TR000454 (SJK); U01DK062453 and UL1TR001082 (RJS); U01DK062436 and UL1TR000150 (PFW); U01DK062503, UL1TR000424 (KS); U01DK062497 and UL1TR000077 (JAB); U01DK062445 (NK RA); U01DK062500 and UL1TR000004 (PR); U01DK062452 and UL1TR000448 (YPT); U01DK084536 and UL1TR001108 (JPM); U01DK084575, UL1TR000423 and UL1RR025014 (KFM); U01DK062466 and UL1TR000005 (RHS); U01DK103135 (BMK); U01DK062481 (KML); U01DK103140 (SLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institute of Diabetes and Digestive and Kidney Diseases, U01DK103149, Dr. Benjamin L. Shneider National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062445, Dr. Nanda Kerkar Dr. Ronen Arnon National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062456, Dr. John C. Magee National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062470, Dr. Saul J. Karpen National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR000454, Dr. Saul J. Karpen National Institute of Diabetes and Digestive and Kidney Diseases, U01DK103135, Dr. Binita M. Kamath National Institute of Diabetes and Digestive and Kidney Diseases, U01DK084536, Dr. Jean P. Molleston National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR001108, Dr. Jean P. Molleston National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062497, Dr. Jorge A. Bezerra National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR000077, Dr. Jorge A. Bezerra National Institute of Diabetes and Digestive and Kidney Diseases, U01DK084575, Dr. Karen F. Murray National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR000423, Dr. Karen F. Murray National Institute of Diabetes and Digestive and Kidney Diseases, UL1RR025014, Dr. Karen F. Murray National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062481, Dr. Kathleen M. Loomes National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062436, Dr. Peter F. Whitington National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR000150, Dr. Peter F. Whitington National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062500, Dr. Philip Rosenthal National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR000004, Dr. Philip Rosenthal National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062466, Dr. Robert H. Squires National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR000005, Dr. Robert H. Squires National Institute of Diabetes and Digestive and Kidney Diseases, U01DK103140, Dr. Stephen L. Guthery National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062503, Dr. Kathleen B. Schwarz National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR000424, Dr. Kathleen B. Schwarz National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062452, Dr. Yumirle P. Turmelle National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR000448, Dr. Yumirle P. Turmelle National Institute of Diabetes and Digestive and Kidney Diseases, U01DK062453, Dr. Ronald J. Sokol National Institute of Diabetes and Digestive and Kidney Diseases, UL1TR001082, Dr. Ronald J. Sokol	Ambler G, 2002, STAT MED, V21, P3803, DOI 10.1002/sim.1422; Backeljauw B, 2015, PEDIATRICS, V136, pE1, DOI 10.1542/peds.2014-3526; Bakshi B, 2012, ARCH DIS CHILD-FETAL, V97, pF385, DOI 10.1136/fetalneonatal-2010-209700; Breiman L., 1984, CLASSIFICATION REGRE; Chen X, 2016, J PEDIAT GASTROENTER; Choi SO, 1996, J PEDIATR SURG, V31, P363, DOI 10.1016/S0022-3468(96)90739-3; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; El-Guindi MAS, 2014, J HEPATOL, V61, P116, DOI 10.1016/j.jhep.2014.03.016; Farrant P, 2001, BRIT J RADIOL, V74, P952, DOI 10.1259/bjr.74.886.740952; FERRY GD, 1985, CLIN PEDIATR, V24, P305, DOI 10.1177/000992288502400601; Franciscovich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132270; Gilmour SM, 1997, J NUCL MED, V38, P1279; Gotze T, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00043; Gottesman LE, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0506-5; Greenholz SK, 1997, J PEDIATR SURG, V32, P175, DOI 10.1016/S0022-3468(97)90174-3; He JP, 2016, WORLD J PEDIATR, V12, P35, DOI 10.1007/s12519-015-0071-x; Jancelewicz T, 2015, J PEDIATR SURG, V50, P363, DOI 10.1016/j.jpedsurg.2014.08.014; Jimenez-Rivera C, 2013, J PEDIATR GASTR NUTR, V56, P344, DOI 10.1097/MPG.0b013e318282a913; Lee HP, 2015, PEDIATR GASTROENTERO, V18, P175, DOI 10.5223/pghn.2015.18.3.175; Lee JY, 2016, J PEDIAT SURG; Lee KI, 1997, COMMUN STAT-SIMUL C, V26, P559, DOI 10.1080/03610919708813397; MAGGIORE G, 1991, J PEDIATR GASTR NUTR, V12, P21, DOI 10.1097/00005176-199101000-00005; MANOLAKI AG, 1983, ARCH DIS CHILD, V58, P591, DOI 10.1136/adc.58.8.591; MARKOWITZ J, 1983, HEPATOLOGY, V3, P74; MOWAT AP, 1976, ARCH DIS CHILD, V51, P763, DOI 10.1136/adc.51.10.763; NORD KS, 1987, J PEDIATR-US, V111, P416, DOI 10.1016/S0022-3476(87)80470-5; Poddar U, 2009, ACTA PAEDIATR, V98, P1260, DOI 10.1111/j.1651-2227.2009.01338.x; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Russo P, 2011, CLIN GASTROENTEROL H, V9, P357, DOI 10.1016/j.cgh.2011.01.003; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Tang Kuo-Shu, 2007, Acta Paediatrica Taiwanica, V48, P196; THALER MM, 1968, AM J DIS CHILD, V116, P280, DOI 10.1001/archpedi.1968.02100020282008; TOLAYMAT N, 1989, J PEDIATR GASTR NUTR, V9, P256, DOI 10.1097/00005176-198908000-00020; Zhou L, 2016, AM J ROENTGENOL, pW1	35	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176275	10.1371/journal.pone.0176275	http://dx.doi.org/10.1371/journal.pone.0176275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493866	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300011
J	Smith, KE; Norman, GJ				Smith, Karen E.; Norman, Greg J.			Brief relaxation training is not sufficient to alter tolerance to experimental pain in novices	PLOS ONE			English	Article							MINDFULNESS-BASED INTERVENTIONS; PROGRESSIVE MUSCLE-RELAXATION; RANDOMIZED CONTROLLED-TRIAL; LOW-BACK-PAIN; BARORECEPTOR ACTIVATION; ANXIETY DISORDERS; MASSAGE THERAPY; AUTONOMIC SPACE; MEDITATION; BRAIN	Relaxation techniques, such as deep breathing and muscle relaxation, are aspects common to most forms of mindfulness training. There is now an abundance of research demonstrating that mindfulness training has beneficial effects across a wide range of clinical conditions, making it an important tool for clinical intervention. One area of extensive research is on the beneficial effects of mindfulness on experiences of pain. However, the mechanisms of these effects are still not well understood. One hypothesis is that the relaxation components of mindfulness training, through alterations in breathing and muscle tension, leads to changes in parasympathetic and sympathetic nervous system functioning which influences pain circuits. The current study seeks to examine how two of the relaxation subcomponents of mindfulness training, deep breathing and muscle relaxation, influence experiences of pain in healthy individuals. Participants were randomized to either a 10 minute deep breathing, progressive muscle relaxation, or control condition after which they were exposed to a cold pain task. Throughout the experiment, measures of parasympathetic and sympathetic nervous system activity were collected to assess how deep breathing and progressive muscle relaxation alter physiological responses, and if these changes moderate any effects of these interventions on responses to pain. There were no differences in participants' pain tolerances or self-reported pain ratings during the cold pain task or in participants' physiological responses to the task. Additionally, individual differences in physiological functioning were not related to differences in pain tolerance or pain ratings. Overall this study suggests that the mechanisms through which mindfulness exerts its effects on pain are more complex than merely through physiological changes brought about by altering breathing or muscle tension. This indicates a need for more research examining the specific subcomponents of mindfulness, and how these subcomponents might be acting, to better understand their utility as a clinical treatment.	[Smith, Karen E.; Norman, Greg J.] Univ Chicago, Dept Psychol, Integrat Neurosci Area, 5848 S Univ Ave, Chicago, IL 60637 USA; [Norman, Greg J.] Univ Chicago, Grossman Inst Neurosci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Smith, KE (corresponding author), Univ Chicago, Dept Psychol, Integrat Neurosci Area, 5848 S Univ Ave, Chicago, IL 60637 USA.	kelsmith@uchicago.edu						Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BERNTSON GG, 1994, PSYCHOPHYSIOLOGY, V31, P599, DOI 10.1111/j.1469-8986.1994.tb02352.x; BERNTSON GG, 1991, PSYCHOL REV, V98, P459, DOI 10.1037/0033-295X.98.4.459; Bisgaard T, 2001, PAIN, V90, P261, DOI 10.1016/S0304-3959(00)00406-1; Brown CA, 2013, CLIN J PAIN, V29, P233, DOI 10.1097/AJP.0b013e31824c5d9f; Brown CA, 2010, PAIN, V150, P428, DOI 10.1016/j.pain.2010.04.017; Busch V, 2012, PAIN MED, V13, P215, DOI 10.1111/j.1526-4637.2011.01243.x; Carson JW, 2005, J HOLIST NURS, V23, P287, DOI 10.1177/0898010105277651; Chiesa A, 2011, J ALTERN COMPLEM MED, V17, P83, DOI 10.1089/acm.2009.0546; CLARK WC, 1980, SCIENCE, V209, P410, DOI 10.1126/science.7384815; COGAN R, 1981, J PSYCHOSOM RES, V25, P535, DOI 10.1016/0022-3999(81)90107-0; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Conrad A, 2007, J ANXIETY DISORD, V21, P243, DOI 10.1016/j.janxdis.2006.08.001; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; de Wied M, 2001, PAIN, V90, P163, DOI 10.1016/S0304-3959(00)00400-0; Dolbier CL, 2012, INT J STRESS MANAGE, V19, P48, DOI 10.1037/a0027326; DWORKIN BR, 1994, P NATL ACAD SCI USA, V91, P6329, DOI 10.1073/pnas.91.14.6329; Emery CF, 2008, PAIN, V138, P375, DOI 10.1016/j.pain.2008.01.015; Gard T, 2012, CEREB CORTEX, V22, P2692, DOI 10.1093/cercor/bhr352; Grant JA, 2009, PSYCHOSOM MED, V71, P106, DOI 10.1097/PSY.0b013e31818f52ee; Gray MA, 2010, PAIN, V151, P853, DOI 10.1016/j.pain.2010.09.028; Gu J, 2015, CLIN PSYCHOL REV, V37, P1, DOI 10.1016/j.cpr.2015.01.006; HAPIDOU EG, 1988, PAIN, V34, P277, DOI 10.1016/0304-3959(88)90123-6; Heenan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099902; Hernandez-Reif M, 2001, INT J NEUROSCI, V106, P131, DOI 10.3109/00207450109149744; Hoffman JW, 2009, REDUCED SYMPATHETIC, V215, P190; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Johnson MH, 1997, PAIN, V69, P43, DOI 10.1016/S0304-3959(96)03272-1; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kakigi R, 2005, EUR J PAIN, V9, P581, DOI 10.1016/j.ejpain.2004.12.006; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; Kwekkeboom KL, 2006, J NURS SCHOLARSHIP, V38, P269, DOI 10.1111/j.1547-5069.2006.00113.x; Lancaster SL, 2016, MINDFULNESS, V7, P614, DOI 10.1007/s12671-016-0496-x; Liu XH, 2013, STRESS HEALTH, V29, P199, DOI 10.1002/smi.2446; Lucas SJE, 2013, J APPL PHYSIOL, V115, P202, DOI 10.1152/japplphysiol.00128.2013; Manzoni GM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-41; McClernon FJ, 2004, ADDICT BEHAV, V29, P765, DOI 10.1016/j.addbeh.2004.02.005; Porges, 1993, BODY PERCEPTION QUES; Preyde M, 2000, CAN MED ASSOC J, V162, P1815; Radloff LS, 1977, APPL PSYCH MEAS, V1, P385, DOI DOI 10.1177/014662167700100306; Reiner K, 2013, PAIN MED, V14, P230, DOI 10.1111/pme.12006; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; SHERWOOD A, 1990, PSYCHOPHYSIOLOGY, V27, P1, DOI 10.1111/j.1469-8986.1990.tb02171.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stabell N, 2013, PAIN, V154, P385, DOI 10.1016/j.pain.2012.11.012; Tang YY, 2012, CHILD DEV PERSPECT, V6, P361, DOI 10.1111/j.1750-8606.2012.00250.x; Travis F, 2009, INT J PSYCHOPHYSIOL, V71, P170, DOI 10.1016/j.ijpsycho.2008.09.007; Veehof MM, 2016, COGN BEHAV THERAPY, V45, P5, DOI 10.1080/16506073.2015.1098724; Vollestad J, 2012, BRIT J CLIN PSYCHOL, V51, P239, DOI 10.1111/j.2044-8260.2011.02024.x; Wanden-Berghe Rocio Guardiola, 2011, Eat Disord, V19, P34, DOI 10.1080/10640266.2011.533604; Zeidan F, 2012, NEUROSCI LETT, V520, P165, DOI 10.1016/j.neulet.2012.03.082; Zeidan F, 2010, J PAIN, V11, P199, DOI 10.1016/j.jpain.2009.07.015	55	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177228	10.1371/journal.pone.0177228	http://dx.doi.org/10.1371/journal.pone.0177228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493923	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300076
J	Tempest, N; McGuinness, N; Lane, S; Hapangama, DK				Tempest, Nicola; McGuinness, Naomi; Lane, Steven; Hapangama, Dharani K.			Neonatal and maternal outcomes of successful manual rotation to correct malposition of the fetal head; A retrospective and prospective observational study	PLOS ONE			English	Article							OPERATIVE DELIVERY; OCCIPUT POSTERIOR; 2ND-STAGE; FORCEPS; MORBIDITY; LABOR	Objective To evaluate the neonatal and maternal outcomes associated with successful operative vaginal births assisted by manual rotation. Design Prospective and retrospective observational study. Setting Delivery suite in a tertiary referral teaching hospital in England. Population A cohort of 2,426 consecutive operative births, in the second stage of labour, complicated with malposition of the fetal head during 2006-2013. Methods Outcomes of all births successfully assisted by manual rotation followed by direct traction instruments were compared with other methods of operative birth for fetal malposition in the second stage of labour (rotational ventouse, Kielland forceps and caesarean section). Main outcome measures Associated neonatal outcomes (admission to the special care baby unit, low cord pH, low Apgar and shoulder dystocia) and maternal outcomes (massive obstetric haemorrhage (blood loss of > 1500ml) and obstetric anal sphincter injury). Results Births successfully assisted with manual rotation followed by direct traction instruments, resulted in 10% (36/346) of the babies being admitted to the Special Care Baby Unit, 4.9% (17/349) shoulder dystocia, 2% (7/349) massive obstetric haemorrhage and 1.7% (6/349) obstetric anal sphincter injury, similar to other methods of rotational births. Conclusions Adverse neonatal and maternal outcomes associated with successful manual rotations followed by direct traction instruments were comparable to traditional methods of operative births. There is an urgent need to standardise the practice (guidance, training) and documentation of manual rotation followed by direct traction instrumental deliveries that will enable assessment of its efficacy and the absolute safety in achieving a vaginal birth.	[Tempest, Nicola; McGuinness, Naomi; Hapangama, Dharani K.] Liverpool Womens Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Tempest, Nicola; Hapangama, Dharani K.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England; [Lane, Steven] Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool	Hapangama, DK (corresponding author), Liverpool Womens Hosp NHS Fdn Trust, Liverpool, Merseyside, England.; Hapangama, DK (corresponding author), Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England.	dharani@liv.ac.uk	Tempest, Nicola/AAJ-5818-2021		Wellbeing of Women grant [RTF510]; Wellbeing of Women [RTF510] Funding Source: researchfish	Wellbeing of Women grant(Wellbeing of Women (WoW)); Wellbeing of Women(Wellbeing of Women (WoW))	Support was provided to NT by a Wellbeing of Women grant (RTF510), [http://www.wellbeingofwomen.org.uk/research/meet-the-researchers/] and also to include that there was no additional external funding received for this study.	Anim-Somuah M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000331.pub3; [Anonymous], 2014, OBSTET GYNECOL, V123, P693; Bahl R, 2013, BJOG-INT J OBSTET GY, V120, P1526, DOI 10.1111/1471-0528.12398; Bleich AT, 2012, AM J PERINAT, V29, P717, DOI 10.1055/s-0032-1314894; Chinnock M, 2009, AUST NZ J OBSTET GYN, V49, P515, DOI 10.1111/j.1479-828X.2009.01058.x; Le Ray C, 2013, OBSTET GYNECOL, V122, P634, DOI 10.1097/AOG.0b013e3182a10e43; Li WH, 2011, ASIAN PAC J TROP MED, V4, P409, DOI 10.1016/S1995-7645(11)60114-4; Majoko F, 2012, COCHRANE DB SYST REV, V17; Minas V, 2013, ARCH GYNECOL OBSTET, V287, P825, DOI 10.1007/s00404-012-2570-5; Murphy DJ, 2001, LANCET, V358, P1203, DOI 10.1016/S0140-6736(01)06341-3; Phipps H, 2014, COCHRANE DB SYST REV, V22; RANZCOG, 2012, RAT FORC; RCOG, 2011, OP VAG DEL GREEN TOP; RCOG, 2012, SHOULD DYST GREEN TO; Scott JR, 2003, DANFORTHS OBSTETRICS; Sen K, 2013, J OBSTET GYNAECOL RE, V39, P160, DOI 10.1111/j.1447-0756.2012.01935.x; Shaffer BL, 2011, J MATERN-FETAL NEO M, V24, P65, DOI 10.3109/14767051003710276; SOGC, 2004, GUID OP VAG BIRTH; Stock SJ, 2013, OBSTET GYNECOL, V121, P1032, DOI 10.1097/AOG.0b013e31828b72cb; Tempest N, 2013, BJOG-INT J OBSTET GY, V120, P1277, DOI 10.1111/1471-0528.12199; Tempest N, 2015, CURR OPIN OBSTET GYN, V27, P115, DOI 10.1097/GCO.0000000000000159; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	22	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176861	10.1371/journal.pone.0176861	http://dx.doi.org/10.1371/journal.pone.0176861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489924	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314100033
J	Carlin, DA; Hapig-Ward, S; Chan, BW; Damrau, N; Riley, M; Caster, RW; Bethards, B; Siegel, JB				Carlin, Dylan Alexander; Hapig-Ward, Siena; Chan, Bill Wayne; Damrau, Natalie; Riley, Mary; Caster, Ryan W.; Bethards, Bowen; Siegel, Justin B.			Thermal stability and kinetic constants for 129 variants of a family 1 glycoside hydrolase reveal that enzyme activity and stability can be separately designed	PLOS ONE			English	Article							DIRECTED EVOLUTION; FUNCTION TRADEOFFS; PROTEIN STABILITY; STRUCTURAL BASES; SPECIFICITY; LANDSCAPES; COMPLEXES	Accurate modeling of enzyme activity and stability is an important goal of the protein engineering community. However, studies seeking to evaluate current progress are limited by small data sets of quantitative kinetic constants and thermal stability measurements. Here, we report quantitative measurements of soluble protein expression in E. coli, thermal stability, and Michaelis-Menten constants (k(cat), K-M, and k(cat)/K-M) for 129 designed mutants of a glycoside hydrolase. Statistical analyses reveal that functional T-m is independent of k(cat), K-M, and k(cat)/K-M in this system, illustrating that an individual mutation can modulate these functional parameters independently. In addition, this data set is used to evaluate computational predictions of protein stability using the established Rosetta and FoldX algorithms. Predictions for both are found to correlate only weakly with experimental measurements, suggesting improvements are needed in the underlying algorithms.	[Carlin, Dylan Alexander] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA; [Hapig-Ward, Siena; Chan, Bill Wayne; Damrau, Natalie; Riley, Mary; Bethards, Bowen; Siegel, Justin B.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Caster, Ryan W.] Univ Calif Davis, Genet Grad Grp, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Siegel, JB (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Siegel, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	jbsiegel@ucdavis.edu			Defense Advanced Research Projects Agency (Energy) [DE-AR0000429]; Alfred P. Sloan Foundation [BR2014-012]; UC Davis start-up Funds	Defense Advanced Research Projects Agency (Energy); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); UC Davis start-up Funds	This work was supported by Defense Advanced Research Projects Agency (Energy) #DE-AR0000429, Alfred P. Sloan Foundation #BR2014-012 and UC Davis start-up Funds, all to JBS.	Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Carlin DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147596; Currin A, 2015, CHEM SOC REV, V44, P1172, DOI 10.1039/c4cs00351a; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; MEIERING EM, 1992, J MOL BIOL, V225, P585, DOI 10.1016/0022-2836(92)90387-Y; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Romero PA, 2015, P NATL ACAD SCI USA, V112, P7159, DOI 10.1073/pnas.1422285112; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schrodinger L., PYMOL MOL GRAPHICS S; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Sunden F, 2015, ELIFE, V4, DOI 10.7554/eLife.06181; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; van der Meer JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10911; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Wolf C, 2015, J AM CHEM SOC, V137, P13106, DOI 10.1021/jacs.5b08325; Wrenbeck EE, 2017, CURR OPIN STRUC BIOL, V45, P36, DOI 10.1016/j.sbi.2016.11.001	31	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176255	10.1371/journal.pone.0176255	http://dx.doi.org/10.1371/journal.pone.0176255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531185	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400004
J	Fuss, J; Spassov, N; Begun, DR; Bohme, M				Fuss, Jochen; Spassov, Nikolai; Begun, David R.; Boehme, Madelaine			Potential hominin affinities of Graecopithecus from the Late Miocene of Europe	PLOS ONE			English	Article							PAN-TROGLODYTES-VERUS; OURANOPITHECUS-MACEDONIENSIS; GREAT APE; SAHELANTHROPUS-TCHADENSIS; DENTAL MORPHOLOGY; ROOT MORPHOLOGY; AUSTRALOPITHECUS-BAHRELGHAZALI; PLIOPLEISTOCENE HOMINIDS; PLIOCENE HOMINIDS; ENAMEL THICKNESS	The split of our own clade from the Panini is undocumented in the fossil record. To fill this gap we investigated the dentognathic morphology of Graecopithecus freybergi from Pyrgos Vassilissis (Greece) and cf. Graecopithecus sp. from Azmaka (Bulgaria), using new mu CT and 3D reconstructions of the two known specimens. Pyrgos Vassilissis and Azmaka are currently dated to the early Messinian at 7.175 Ma and 7.24 Ma. Mainly based on its external preservation and the previously vague dating, Graecopithecus is often referred to as nomen dubium. The examination of its previously unknown dental root and pulp canal morphology confirms the taxonomic distinction from the significantly older northern Greek hominine Ouranopithecus. Furthermore, it shows features that point to a possible phylogenetic affinity with hominins. G. freybergi uniquely shares p4 partial root fusion and a possible canine root reduction with this tribe and therefore, provides intriguing evidence of what could be the oldest known hominin.	[Fuss, Jochen; Boehme, Madelaine] Eberhard Karls Univ Tubingen, Dept Geosci, Sigwartstr 10, Tubingen, Germany; [Fuss, Jochen; Boehme, Madelaine] Senckenberg Ctr Human Evolut & Palaeoenvironm HEP, Sigwartstr 10, Tubingen, Germany; [Spassov, Nikolai] Bulgarian Acad Sci, Natl Museum Nat Hist, 1 Blvd Tzar Osvoboditel, Sofia, Bulgaria; [Begun, David R.] Univ Toronto, Dept Anthropol, Toronto, ON, Canada	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Bulgarian Academy of Sciences; University of Toronto	Bohme, M (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci, Sigwartstr 10, Tubingen, Germany.; Bohme, M (corresponding author), Senckenberg Ctr Human Evolut & Palaeoenvironm HEP, Sigwartstr 10, Tubingen, Germany.	m.boehme@ifg.uni-tuebingen.de			German Science Foundation DFG [Bo 1550/19-1]	German Science Foundation DFG(German Research Foundation (DFG))	We acknowledge funding from the German Science Foundation DFG (grant Bo 1550/19-1 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For access to fossil collections, technical and scientific collaboration we thank Wieland Binczik, Wolfgang Gerber, Katerina Harvati, George D. Koufos, Veronika Kuhnert, Siegbert Schuffler, Henrik Stohr, Harald Stollhofen, and Adrian Troscher. We would like to thank the Academic Editor Roberto Macchiarelli for his careful handling of this publication. We also thank Brigitte Senut and 10 anonymous reviewers for their comments. We acknowledge funding from the German Science Foundation DFG (grant Bo 1550/19-1 to MB).	Abbott SA., 1984, COMP STUDY TOOTH ROO; Alpagut B, 1996, NATURE, V382, P349, DOI 10.1038/382349a0; Andrews Peter, 2005, P103; Beauvilain A, 2008, S AFR J SCI, V104, P165; Begun D., 2015, REAL PLANET APES NEW; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Begun DR, 2001, HOM EVOLUT CLIMAT CH, V2, P231; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; Begun DR, 1998, AM J PHYS ANTHROPOL, V105, P279, DOI 10.1002/(SICI)1096-8644(199803)105:3<279::AID-AJPA2>3.0.CO;2-N; BEGUN DR, 2015, HDB PALEOANTHROPOLOG, P1261, DOI DOI 10.1007/978-3-642-39979-4_32; Bohme M, PLOS ONE UNPUB; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Cobb SN, 2008, J ANAT, V212, P469, DOI 10.1111/j.1469-7580.2008.00866.x; de Bonis L, 1977, Geobios Lyon, V10, P849, DOI 10.1016/S0016-6995(77)80081-8; De Bonis Louis, 1997, P317; Emonet EG, 2014, ANAT REC, V297, P1927, DOI 10.1002/ar.22959; Emonet EG, 2014, AM J PHYS ANTHROPOL, V153, P116, DOI 10.1002/ajpa.22400; Emonet EG, 2012, J HUM EVOL, V62, P146, DOI 10.1016/j.jhevol.2011.11.011; Emonet EG, KHORATPITHECUS RAD H; Evans AR, 2016, NATURE, V530, P477, DOI 10.1038/nature16972; Giles E., 1963, J PHYSL ANTHR, V22, P129; Grine FE, 2002, S AFR J SCI, V98, P503; Gulec ES, 2007, ANTHROPOL SCI, V115, P153, DOI 10.1537/ase.070501; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Haile-Selassie Y, 2015, NATURE, V521, P483, DOI 10.1038/nature14448; Haile-Selassie Y, 2015, J HUM EVOL, V78, P44, DOI 10.1016/j.jhevol.2014.08.005; Haile-Selassie Yohannes, 2009, P159; Harris EF, 2001, AM J PHYS ANTHROPOL, V115, P223, DOI 10.1002/ajpa.1077; Hlusko LJ, 2004, AM J PHYS ANTHROPOL, V124, P223, DOI 10.1002/ajpa.10353; Humphrey LT, 1999, J ANAT, V195, P491, DOI 10.1046/j.1469-7580.1999.19540491.x; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; Koufos G. D., 2015, HDB PALEOANTHROPOLOG, V3, P1761; KOUFOS GD, 1993, AM J PHYS ANTHROPOL, V91, P225, DOI 10.1002/ajpa.1330910208; Koufos GD, 2016, GEOBIOS-LYON, V49, P45, DOI 10.1016/j.geobios.2016.01.008; Koufos George D., 2005, Annales de Paleontologie, V91, P227, DOI 10.1016/j.annpal.2005.05.001; Koufs GD, 2006, GEOBIOS-LYON, V39, P223, DOI 10.1016/j.geobios.2004.11.009; Kovacs I., 1971, DENT MORPHOLOGY EVOL, P211; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; Kupczik K, 2005, CURRENT TRENDS DENT, P257; Lague MR, 2008, J ANAT, V213, P670, DOI 10.1111/j.1469-7580.2008.00989.x; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Macchiarelli R, 2009, GEODIVERSITAS, V31, P851, DOI 10.5252/g2009n4a851; Manthi FK, 2012, S AFRICAN J SCI, V108; Martin L., 1984, Courier Forschungsinstitut Senckenberg, V69, P25; MARTIN LB, 1983, RELATIONSHIP LATER M; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Moore NC, 2016, J HUM EVOL, V93, P46, DOI 10.1016/j.jhevol.2015.12.002; Moore NC, 2015, AM J PHYS ANTHROPOL, V158, P209, DOI 10.1002/ajpa.22776; Moore NC, 2013, AM J PHYS ANTHROPOL, V150, P632, DOI 10.1002/ajpa.22239; Pickford M, 2009, CR PALEVOL, V8, P413, DOI 10.1016/j.crpv.2008.11.003; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Schaller M, 2015, QUAT GEOCHRONOL, V29, P6, DOI 10.1016/j.quageo.2015.05.012; Semaw S, 2005, NATURE, V433, P301, DOI 10.1038/nature03177; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Senut B., 2015, HDB PALEOANTHROPOLOG, P2043; Simpson SW, 2015, J HUM EVOL, V81, P68, DOI 10.1016/j.jhevol.2014.07.004; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Smith TM, 2004, J HUM EVOL, V46, P551, DOI 10.1016/j.jhevol.2004.01.006; Spassov N, 2012, J HUM EVOL, V62, P138, DOI 10.1016/j.jhevol.2011.10.008; Spencer MA, 2003, AM J PHYS ANTHROPOL, V122, P325, DOI 10.1002/ajpa.10288; Suwa G, 2005, ANTHROPOL SCI, V113, P237; Suwa G, 2016, 1 HOMINOID MARAGHEH; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Tobias PV, 1995, ASPECTS DENT BIOL PA, P283; TURNER CG, 1981, AM J PHYS ANTHROPOL, V54, P59, DOI 10.1002/ajpa.1330540108; Turner II C. G., 1991, ADV DENT ANTHR, P13; Uchida A., 1992, INTRASPECIES VARIATI; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; von FREYBERG B., 1951, ANN GEOL PAYS HELLTOIQUES, V3, P7; VONKOENIGSWALD GH, 1972, PROC K NED AKAD B-PH, V75, P385; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WOOD BA, 1987, J ANAT, V154, P121; WOOD BA, 1988, J ANAT, V156, P107	80	26	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177127	10.1371/journal.pone.0177127	http://dx.doi.org/10.1371/journal.pone.0177127			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531170	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400011
J	Rusciano, G; De Canditiis, C; Zito, G; Rubessa, M; Roca, MS; Carotenuto, R; Sasso, A; Gasparrini, B				Rusciano, Giulia; De Canditiis, Carolina; Zito, Gianluigi; Rubessa, Marcello; Roca, Maria Serena; Carotenuto, Rosa; Sasso, Antonio; Gasparrini, Bianca			Raman-microscopy investigation of vitrification-induced structural damages in mature bovine oocytes	PLOS ONE			English	Article							THAWED MOUSE OOCYTES; ZONA-PELLUCIDA; IN-VITRO; MEIOTIC SPINDLE; INVITRO FERTILIZATION; NONINVASIVE TOOL; OVINE OOCYTES; CRYOPRESERVATION; EMBRYOS; MICROSPECTROSCOPY	Although oocyte cryopreservation has great potentials in the field of reproductive technologies, it still is an open challenge in the majority of domestic animals and little is known on the biochemical transformation induced by this process in the different cellular compartments. Raman micro-spectroscopy allows the non-invasive evaluation of the molecular composition of cells, based on the inelastic scattering of laser photons by vibrating molecules. The aim of this work was to assess the biochemical modifications of both the zona pellucida and cytoplasm of vitrified/warmed in vitro matured bovine oocytes at different post-warming times. By taking advantage of Principal Component Analysis, we were able to shed light on the biochemical transformation induced by the cryogenic treatment, also pointing out the specific role of cryoprotective agents (CPs). Our results suggest that vitrification induces a transformation of the protein secondary structure from the alpha-helices to the beta-sheet form, while lipids tend to assume a more packed configuration in the zona pellucida. Both modifications result in a mechanical hardening of this cellular compartment, which could account for the reduced fertility rates of vitrified oocytes. Furthermore, biochemical modifications were observed at the cytoplasmic level in the protein secondary structure, with alpha-helices loss, suggesting cold protein denaturation. In addition, a decrease of lipid unsaturation was found in vitrified oocytes, suggesting oxidative damages. Interestingly, most modifications were not observed in oocytes exposed to CPs, suggesting that they do not severely affect the biochemical architecture of the oocyte. Nevertheless, in oocytes exposed to CPs decreased developmental competence and increased reactive oxygen species production were observed compared to the control. A more severe reduction of cleavage and blastocyst rates after in vitro fertilization was obtained from vitrified oocytes. Our experimental outcomes also suggest a certain degree of reversibility of the induced transformations, which renders vitrified oocytes more similar to untreated cells after 2 h warming.	[Rusciano, Giulia; Sasso, Antonio] Univ Naples Federico II, Dept Phys E Pancini, Via Cintia, I-80126 Naples, Italy; [Rusciano, Giulia; Sasso, Antonio] CNR, Natl Inst Opt INO, Via Campi Flegrei 34, I-80078 Pozzuoli, NA, Italy; [De Canditiis, Carolina; Gasparrini, Bianca] Univ Naples Federico II, Dept Vet Med & Anim Prod, Via F Delpino 1, I-80137 Naples, Italy; [Zito, Gianluigi] CNR, Inst Prot Biochem IBP, Via Pietro Castellino 111, I-80131 Naples, Italy; [Rubessa, Marcello] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Roca, Maria Serena] Ist Nazl Tumori Fdn G Pascale IRCCS, Expt Pharmacol Unit, Naples, Italy; [Carotenuto, Rosa] Univ Naples Federico II, Dept Biol, Via Cintia, I-80126 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Illinois System; University of Illinois Urbana-Champaign; IRCCS Fondazione Pascale; University of Naples Federico II	Rusciano, G (corresponding author), Univ Naples Federico II, Dept Phys E Pancini, Via Cintia, I-80126 Naples, Italy.; Rusciano, G (corresponding author), CNR, Natl Inst Opt INO, Via Campi Flegrei 34, I-80078 Pozzuoli, NA, Italy.	giulia.rusciano@unina.it	Zito, Gianluigi/AAY-2420-2020; roca, maria serena/AAZ-1071-2020; Zito, Gianluigi/P-9424-2018; Rusciano, Giulia/A-2079-2010	Zito, Gianluigi/0000-0003-2376-0080; Zito, Gianluigi/0000-0003-2376-0080; Rusciano, Giulia/0000-0002-7152-5352; roca, maria serena/0000-0002-9621-0939				AMAN RR, 1994, BIOL REPROD, V50, P103, DOI 10.1095/biolreprod50.1.103; Attanasio L, 2010, REPROD DOMEST ANIM, V45, P997, DOI 10.1111/j.1439-0531.2009.01475.x; Best BP, 2015, REJUV RES, V18, P422, DOI 10.1089/rej.2014.1656; Bogliolo L, 2015, J ASSIST REPROD GEN, V32, P185, DOI 10.1007/s10815-014-0389-7; Bogliolo L, 2013, J ASSIST REPROD GEN, V30, P877, DOI 10.1007/s10815-013-0046-6; Bogliolo L, 2012, CRYOBIOLOGY, V64, P267, DOI 10.1016/j.cryobiol.2012.02.010; CARROLL J, 1990, J REPROD FERTIL, V90, P547, DOI 10.1530/jrf.0.0900547; CARROLL J, 1989, J REPROD FERTIL, V85, P489, DOI 10.1530/jrf.0.0850489; Chaves Dowglish F., 2016, CRYOBIOLOGY, V73, P324; Chen SU, 2009, TAIWAN J OBSTET GYNE, V48, P15, DOI 10.1016/S1028-4559(09)60030-9; Davidson B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067972; Ferreira MS, 2014, ANAL CHIM ACTA, V807, P96, DOI 10.1016/j.aca.2013.11.033; FUKU E, 1995, CRYOBIOLOGY, V32, P139, DOI 10.1006/cryo.1995.1013; GABER BP, 1978, BIOPHYS J, V21, P161, DOI 10.1016/S0006-3495(78)85516-7; Gardner D. K., 2009, TXB ASSISTED REPROD; Gualtieri R, 2011, HUM REPROD, V26, P2452, DOI 10.1093/humrep/der210; Gupta MK, 2010, FERTIL STERIL, V93, P2602, DOI 10.1016/j.fertnstert.2010.01.043; Khajehpour M, 2006, ANAL BIOCHEM, V348, P40, DOI 10.1016/j.ab.2005.10.009; Ko CS, 2008, ANIM REPROD SCI, V105, P272, DOI 10.1016/j.anireprosci.2007.03.010; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Kuwayama M., 2000, J ASSIST REPROD GEN, P477, DOI DOI 10.1023/A:1017399518757; Larman MG, 2006, REPRODUCTION, V131, P53, DOI 10.1530/rep.1.00878; Le Gal F, 1999, CRYOBIOLOGY, V38, P290, DOI 10.1006/cryo.1999.2172; Ledda S, 2007, REPROD FERT DEVELOP, V19, P13, DOI 10.1071/RD06126; Leibo SP, 2008, THERIOGENOLOGY, V69, P37, DOI 10.1016/j.theriogenology.2007.10.006; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; MAGISTRINI M, 1980, EUR J CELL BIOL, V22, P699; Matson PL, 1997, HUM REPROD, V12, P1550, DOI 10.1093/humrep/12.7.1550; Matthaus C, 2008, METHOD CELL BIOL, V89, P275, DOI 10.1016/S0091-679X(08)00610-9; Mavrides A, 2005, EUR J OBSTET GYN R B, V118, P66, DOI 10.1016/j.ejogrb.2004.06.025; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; Moussa M, 2014, SCI CHINA LIFE SCI, V57, P903, DOI 10.1007/s11427-014-4689-z; Notingher I, 2006, EXPERT REV MED DEVIC, V3, P215, DOI 10.1586/17434440.3.2.215; Nottola SA, 2009, REPROD BIOMED ONLINE, V19, P17, DOI 10.1016/S1472-6483(10)60280-5; Odintsova NA, 2009, CRYOBIOLOGY, V59, P335, DOI 10.1016/j.cryobiol.2009.09.006; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Paynter SJ, 1999, HUM REPROD, V14, P2338, DOI 10.1093/humrep/14.9.2338; Prentice Jennifer R, 2010, Vet Med Int, V2011, DOI 10.4061/2011/146405; Rubessa M, 2011, THERIOGENOLOGY, V76, P1347, DOI 10.1016/j.theriogenology.2011.06.004; RUFFING NA, 1993, CRYOBIOLOGY, V30, P562, DOI 10.1006/cryo.1993.1059; Rusciano G, 2008, CARBON, V46, P335, DOI 10.1016/j.carbon.2007.11.052; Rusciano G, 2010, PHYS MEDICA, V26, P233, DOI 10.1016/j.ejmp.2010.02.001; Rusciano G, 2014, ACS NANO, V8, P12300, DOI 10.1021/nn504595k; Rusciano G, 2010, METHODS, V51, P27, DOI 10.1016/j.ymeth.2009.12.009; Saunders KM, 1999, BIOL REPROD, V61, P178, DOI 10.1095/biolreprod61.1.178; Somfai T, 2007, REPROD FERT DEVELOP, V19, P184, DOI 10.1071/RDv19n1Ab133; Sripunya N, 2010, J REPROD DEVELOP, V56, P176, DOI 10.1262/jrd.09-108H; Stachecki JJ, 2004, REPROD BIOMED ONLINE, V9, P152, DOI 10.1016/S1472-6483(10)62124-4; Succu S, 2010, MOL REPROD DEV, V74, P1337; Tamas S, 2007, CRYOBIOLOGY, V55, P115, DOI 10.1016/j.cryobiol.2007.06.008; TERVIT HR, 1972, J REPROD FERTIL, V30, P493, DOI 10.1530/jrf.0.0300493; Tian SJ, 2007, ANIM REPROD SCI, V101, P365, DOI 10.1016/j.anireprosci.2007.01.007; Topper EK, 1997, MOL REPROD DEV, V46, P344, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;344::AID-MRD13&gt;3.0.CO;2-Z; Vajta G, 2006, THERIOGENOLOGY, V65, P236, DOI 10.1016/j.theriogenology.2005.09.026; Vanroose G, 2000, BIOL REPROD, V62, P463, DOI 10.1095/biolreprod62.2.463; VINCENT C, 1990, J REPROD FERTIL, V89, P253, DOI 10.1530/jrf.0.0890253	56	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177677	10.1371/journal.pone.0177677	http://dx.doi.org/10.1371/journal.pone.0177677			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531193	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400023
J	Schmitz, AMT; Teixeira, SC; Pengel, KE; Loo, CE; Vogel, WV; Wesseling, J; Rutgers, EJT; Olmos, RAV; Sonke, GS; Rodenhuis, S; Peeters, MJTFDV; Gilhuijs, KGA				Schmitz, Alexander M. Th.; Teixeira, Suzana C.; Pengel, Kenneth E.; Loo, Claudette E.; Vogel, Wouter V.; Wesseling, Jelle; Rutgers, Emiel J. Th.; Olmos, Renato A. Valdes; Sonke, Gabe S.; Rodenhuis, Sjoerd; Peeters, Marie Jeanne T. F. D. Vrancken; Gilhuijs, Kenneth G. A.			Monitoring tumor response to neoadjuvant chemotherapy using MRI and F-18-FDG PET/CT in breast cancer subtypes	PLOS ONE			English	Article							PATHOLOGICAL RESPONSE; CONSENSUS CONFERENCE; EARLY PREDICTION; THERAPY; TRASTUZUMAB; PACLITAXEL; CARCINOMA; SURVIVAL; LESIONS; WOMEN	Purpose To explore guidelines on the use of MRI and PET/CT monitoring primary tumor response to neoadjuvant chemotherapy (NAC), taking breast cancer subtype into account. Materials and methods In this prospective cohort study, 188 women were included with stages II and III breast cancer. MRI and F-18-FDG-PET/CT were acquired before and during NAC. Baseline pathology was assessed from tumor biopsy. Tumors were stratified into HER2-positive, ER-positive/HER2-negative (ER-positive), and ER-negative/PR-negative/HER2-negative (triple-negative) subtypes, and treated according to subtype. Primary endpoint was pathological complete response (pCRmic) defined as no or only small numbers of scattered invasive tumor cells. We evaluated imaging scenarios using MRI only, PET/CT only, and combinations. Results pCRmic was found in 35/46 (76.1%) of HER2-positive, 11/87 (12.6%) of ER-positive, and 31/55 (56.4%) of triple-negative tumors. For HER2-positive tumors, MRI yielded the strongest predictor (AUC: 0.735; sensitivity 36.2%), outperforming PET/CT (AUC: 0.543; p = 0.04), and with comparable results to combined imaging (AUC: 0.708; p = 0.213). In ER-positive tumors, the combination of MRI and PET/CT was slightly superior (AUC: 0.818; sensitivity 55.8%) over MRI alone (AUC: 0.742; p = 0.117) and PET/CT alone (AUC: 0.791). However, even though relatively large numbers of ER-positive tumor patients were included, no significant differences were yet found. For triple-negative tumors, MRI (AUC: 0.855; sensitivity 45.4%), PET/CT (AUC: 0.844; p = 0.220) and combined imaging (AUC: 0.868; p = 0.213) yielded comparable results. Conclusions For HER2-positive tumors, MRI shows significant advantage over PET/CT. For triple-negative tumors, comparable results were seen for MRI, PET/CT and combined imaging. For ER-positive tumors, combining MRI with PET/CT may result in optimal response monitoring, although not yet significantly.	[Schmitz, Alexander M. Th.; Pengel, Kenneth E.; Loo, Claudette E.; Gilhuijs, Kenneth G. A.] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands; [Schmitz, Alexander M. Th.; Gilhuijs, Kenneth G. A.] Univ Med Ctr Utrecht, Dept Radiol, Image Sci Inst, Utrecht, Netherlands; [Teixeira, Suzana C.; Vogel, Wouter V.; Olmos, Renato A. Valdes] Netherlands Canc Inst, Dept Nucl Med, Amsterdam, Netherlands; [Wesseling, Jelle] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [Rutgers, Emiel J. Th.; Peeters, Marie Jeanne T. F. D. Vrancken] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands; [Sonke, Gabe S.; Rodenhuis, Sjoerd] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Schmitz, AMT (corresponding author), Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands.; Schmitz, AMT (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Image Sci Inst, Utrecht, Netherlands.	alexanderschmitz@outlook.com	peeters, marie jeanne vrancken/X-8866-2018; Teixeira, Suzana/GXM-3456-2022	peeters, marie jeanne vrancken/0000-0003-4472-4257; Wesseling, Jelle/0000-0002-8940-2676; Sonke, Gabe/0000-0001-8088-9628	project Breast CARE [03O-104]	project Breast CARE	This study was performed within the framework of CTMM, the center for Translational Molecular Medicine (www.ctmm.nl); project Breast CARE (grant 03O-104) to SR.; This study was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project Breast CARE (grant 03O-104).	Aukema TS, 2010, J NUCL MED TECHNOL, V38, P24, DOI 10.2967/jnmt.109.065557; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Dmitriev ID, 2013, PHYS MED BIOL, V58, P1221, DOI 10.1088/0031-9155/58/4/1221; Donker M, 2014, ANN SURG; Duch J, 2009, EUR J NUCL MED MOL I, V36, P1551, DOI 10.1007/s00259-009-1116-y; Fangberget A, 2011, EUR RADIOL, V21, P1188, DOI 10.1007/s00330-010-2020-3; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fitzal F, 2011, BREAST CANCER RES TR, V127, P121, DOI 10.1007/s10549-010-1164-9; Gilhuijs KGA, 2002, RADIOLOGY, V225, P907, DOI 10.1148/radiol.2253011582; Groheux D, 2015, RADIOLOGY, V277, P358, DOI 10.1148/radiol.2015141638; Groheux D, 2013, RADIOLOGY, V266, P388, DOI 10.1148/radiol.12110853; Hylton NM, 2012, RADIOLOGY, V263, P663, DOI 10.1148/radiol.12110748; Kaufmann M, 2012, ANN SURG ONCOL, V19, P1508, DOI 10.1245/s10434-011-2108-2; Koolen BB, 2014, EUR J NUCL MED MOL I, V41, P32, DOI 10.1007/s00259-013-2515-7; Koolen BB, 2013, BREAST, V22, P691, DOI 10.1016/j.breast.2012.12.020; Koolen BB, 2012, BREAST CANCER RES TR, V131, P117, DOI 10.1007/s10549-011-1767-9; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Kumar A, 2009, EUR RADIOL, V19, P1347, DOI 10.1007/s00330-009-1303-z; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Linden HM, 2006, J CLIN ONCOL, V24, P2793, DOI 10.1200/JCO.2005.04.3810; Loo CE, 2008, AM J ROENTGENOL, V191, P1331, DOI 10.2214/AJR.07.3567; Loo CE, 2011, J CLIN ONCOL, V29, P660, DOI 10.1200/JCO.2010.31.1258; Mieog JSD, 2007, BRIT J SURG, V94, P1189, DOI 10.1002/bjs.5894; Pengel KE, 2014, EUR J NUCL MED MOL I, V41, P1515, DOI 10.1007/s00259-014-2770-2; Pesce LL, 2007, ACAD RADIOL, V14, P814, DOI 10.1016/j.acra.2007.03.012; Rigter LS, 2013, BRIT J CANCER, V109, P2965, DOI 10.1038/bjc.2013.661; SATALOFF DM, 1995, J AM COLL SURGEONS, V180, P297; Schwartz GF, 2004, HUM PATHOL, V35, P781, DOI 10.1016/j.humpath.2004.02.006; Sharma U, 2009, NMR BIOMED, V22, P104, DOI 10.1002/nbm.1245; Sonke GS, 2013, BREAST J, V19, P419, DOI 10.1111/tbj.12124; Straver ME, 2009, EUR J CANCER, V45, P2284, DOI 10.1016/j.ejca.2009.04.029; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595	37	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176782	10.1371/journal.pone.0176782	http://dx.doi.org/10.1371/journal.pone.0176782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531188	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400007
J	Zemouri, C; de Soet, H; Crielaard, W; Laheij, A				Zemouri, Charifa; de Soet, Hans; Crielaard, Wim; Laheij, Alexa			A scoping review on bio-aerosols in healthcare and the dental environment	PLOS ONE			English	Review							AIRBORNE BACTERIA; CONTAMINATION; ANTIBODIES; PREVALENCE; INFECTION; AMEBAS	Background Bio-aerosols originate from different sources and their potentially pathogenic nature may form a hazard to healthcare workers and patients. So far no extensive review on existing evidence regarding bio-aerosols is available. Objectives This study aimed to review evidence on bio-aerosols in healthcare and the dental setting. The objectives were 1) What are the sources that generate bio-aerosols?; 2) What is the microbial load and composition of bio-aerosols and how were they measured?; and 3) What is the hazard posed by pathogenic micro-organisms transported via the aerosol route of transmission? Methods Systematic scoping review design. Searched in PubMed and EMBASE from inception to 09-03-2016. References were screened and selected based on abstract and full text according to eligibility criteria. Full text articles were assessed for inclusion and summarized. The results are presented in three separate objectives and summarized for an overview of evidence. Results The search yielded 5,823 studies, of which 62 were included. Dental hand pieces were found to generate aerosols in the dental settings. Another 30 sources from human activities, interventions and daily cleaning performances in the hospital also generate aerosols. Fifty-five bacterial species, 45 fungi genera and ten viruses were identified in a hospital setting and 16 bacterial and 23 fungal species in the dental environment. Patients with certain risk factors had a higher chance to acquire Legionella in hospitals. Such infections can lead to irreversible septic shock and death. Only a few studies found that bio-aerosol generating procedures resulted in transmission of infectious diseases or allergic reactions. Conclusion Bio-aerosols are generated via multiple sources such as different interventions, instruments and human activity. Bio-aerosols compositions reported are heterogeneous in their microbiological composition dependent on the setting and methodology. Legionella species were found to be a bio-aerosol dependent hazard to elderly and patients with respiratory complaints. But all aerosols can be can be hazardous to both patients and healthcare workers.	[Zemouri, Charifa] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; Vrije Univ Amsterdam, Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Zemouri, C (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands.	c.zemouri@acta.nl	Zemouri, Charifa/AEI-1259-2022	Zemouri, Charifa/0000-0002-9211-3744				Al Maghlouth A, 2007, QUAL QUANT, P91; Anderson K, 1996, ASPERGILLOSIS IMMUNO, P256; [Anonymous], 1995, Mater Manag Health Care, V4, P34; [Anonymous], 1995, MAT MANAG HLTH CARE, V4, P4; [Anonymous], 2015, METHODOLOGY JBI SCOP; ASHRAE, 2014, ASHRAE POS DOC AIRB; Augustowska M, 2006, VARIABILITY AIRBORNE, P99; Barker J, 2005, J APPL MICROBIOL, V99, P339, DOI 10.1111/j.1365-2672.2005.02610.x; Barlean, 2010, OHDMBSC, V9; Bennett AM, 2000, MICROBIAL AEROSOLS G, P664; Best Eike, 2012, Perspectives of System Informatics. 8th International Ershov Informatics Conference, PSI 2011. Revised Selected Papers, P1, DOI 10.1007/978-3-642-29709-0_1; Bischoff WE, DETECTION MEASLES VI; Borella P, 2008, J HOSP INFECT, V69, P148, DOI 10.1016/j.jhin.2008.03.004; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Browning WD, 2012, CASE SERIES HERPES S, P61; Cabo Verde S, 2015, MICROBIOLOGICAL ASSE, P557; Cadmus SI, 2010, EMERG INFECT DIS, V16, P1479, DOI 10.3201/eid1609.100447; Cellini L, 2000, QUANTITATIVE MICROBI, P301; Chen PS, 2007, CONCENTRATION PROFIL, P194; Chen PS, 2008, QUANTIFICATION AIRBO, P371; Duell RC, 1970, DROPLET NUCLEI PRODU, P711; Dutil S, 2007, AEROSOLIZATION MYCOB, P2836; Dutil S, 2009, J OCCUP ENVIRON HYG, V6, P121, DOI 10.1080/15459620802633957; Dutkiewicz J., 2008, CONCENTRATION SPECIE, P301; Fekadu S, 2015, MICROBIOLOGICAL ASSE, P117; Fennelly KP, 2012, VARIABILITY INFECT A, P450; Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010; Grenier D., 1995, QUANTITATIVE ANAL BA, P3165; Guida M, 2012, ENV MICROBIAL CONTAM, P207; Heimbuch BK, 2016, BIOAEROSOL EXPOSURE; Humphreys H, 1994, AIRBORNE DISSEMINATI, P1157; Huynh KN, 2008, NEW METHOD SAMPLING, P93; JoannaBriggsInstitute T, 2015, JOANN BRIGGS I REV M; Kadaifciler DG, 2013, MICROBIAL CONTAMINAT, P3431; Kedjarune U, 2000, INT DENT J, V50, P103, DOI 10.1002/j.1875-595X.2000.tb00807.x; Kimmerle H, 2012, AIRBORNE MICROBES DI, P689; Knibbs LD, 2014, VIABILITY PSEUDOMO N, P740; Kool JL, 1998, MORE 10 YEARS UNRECO, P898; Kulkarni H, 2016, AIRBORNE TRANSMISSIO; Kumar S, 2010, DENT UNIT WATERLINES, P99; Laheij A M G A, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.17659; Li CS, 2003, BIOAEROSOL CHARACTER, P169; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindsley WG, 2015, VIABLE INFLUENZA VIR, P107; Macintyre CR, 2013, QUANTIFYING RISK RES, P1802; MacIntyre R, 2014, HIGH RISK PROCEDURES, pe379; Martins-Diniz JN, 2005, MONITORING AIRBORNE, P398; Menzies D, 2003, EFFICACY ENV MEASURE, P483; Mirhoseini SH, 2015, ANN AGR ENV MED, V22, P670, DOI 10.5604/12321966.1185772; Mirzaei R, 2014, QUANTITATIVE QUALITA; Napoli C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-594; Nasir ZA, 2013, EVALUATION TOTAL CON, P269; Ortiz G, 2009, STUDY AIR MICROBE LE, P53; Palusinska-Szysz M, 2009, PATHOGENICITY FAMILY, P279; Pankhurst CL, 2007, J DENT, V35, P712, DOI 10.1016/j.jdent.2007.06.002; Pankhurst CL, 2003, BRIT DENT J, V195, P591, DOI 10.1038/sj.bdj.4810735; Pankhurst CL, 1995, EVALUATION CONTAMINA, P243; Pasquarella C, 2012, SCI TOTAL ENVIRON, V420, P289, DOI 10.1016/j.scitotenv.2012.01.030; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Rautemaa R, 2006, BACTERIAL AEROSOLS D, P76; REINTHALER FF, 1988, J DENT RES, V67, P942, DOI 10.1177/00220345880670061001; Ricci ML, 2012, LANCET, V379, P684, DOI 10.1016/S0140-6736(12)60074-9; Roberts K, 2006, BIOAEROSOL PRODUCTIO, P35; Schaffer K, 2015, J HOSP INFECT, V89, P309, DOI 10.1016/j.jhin.2015.02.005; Singh T, 2005, J HOSP INFECT, V61, P257, DOI 10.1016/j.jhin.2005.05.001; Stelzer-Braid S, 2009, EXHALATION RESP VIRU, P1674; Sudharsanam S, 2012, CHARACTERIZATION IND, P217; Szymanska J., 2007, DENT BIOAEROSOL OCCU, P203; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thompson K, 2013, TRANSMISSION INFLUEN, pS5; Thompson KA, 2013, INFLUENZA AEROSOLS U; Timmerman MF, 2004, J CLIN PERIODONTOL, V31, P458, DOI 10.1111/j.1600-051X.2004.00511.x; Trabelsi H, 2010, PARASITE, V17, P67, DOI 10.1051/parasite/2010171067; Tran K, 2012, AEROSOL GENERATING P; Tuttlebee CM, 2002, J HOSP INFECT, V52, P192, DOI 10.1053/jhin.2002.1282; TYNELIUSBRATTHALL G, 1985, J CLIN PERIODONTOL, V12, P762, DOI 10.1111/j.1600-051X.1985.tb01402.x; Vavricka SR, 2010, AIR SUCTIONING COLON, P736; Velez-Pereira A, 2014, STAPHYLOCOCCUS SP AI, P183; Verani M, 2014, VIRAL CONTAMINATION, P758; Wainwright CE, 2009, COUGH GENERATED AERO, P926; Wan GH, 2011, LONG TERM SURVEILLAN, P302; WHO, 2007, INT AG RES CANC MON, P39; Woo AH, 1986, POTENTIAL IN HOSP MO, P567; Yiallouros PK, 2013, 1 OUTBREAK NOSOCOMIA, P48	84	145	155	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178007	10.1371/journal.pone.0178007	http://dx.doi.org/10.1371/journal.pone.0178007			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531183	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400049
J	Durrer, KE; Allen, MS; von Herbing, IH				Durrer, Katherine E.; Allen, Michael S.; von Herbing, Ione Hunt			Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAH(enu2) mouse model of PKU	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; LACTOBACILLUS; COLONIZATION; CELLS; MICE; GUT; EXPRESSION; MICROBIOTA; STRAINS; FLORA	Phenylketonuria (PKU) is a genetic disease characterized by the inability to convert dietary phenylalanine to tyrosine by phenylalanine hydroxylase. Given the importance of gut microbes in digestion, a genetically engineered microbe could potentially degrade some ingested phenylalanine from the diet prior to absorption. To test this, a phenylalanine lyase gene from Anabaena variabilis (AvPAL) was codon-optimized and cloned into a shuttle vector for expression in Lactobacillus reuteri 100-23C (pHENOMMenal). Functional expression of AvPAL was determined in vitro, and subsequently tested in vivo in homozygous PAH(enu2) (PKU model) mice. Initial trials of two PAH(enu2) homozygous (PKU) mice defined conditions for freeze-drying and delivery of bacteria. Animals showed reduced blood phe within three to four days of treatment with pHENOMMenal probiotic, and blood phe concentrations remained significantly reduced (P < 0.0005) compared to untreated controls during the course of experiments. Although pHENOMMenal probiotic could be cultured from fecal samples at four months post treatment, it could no longer be cultivated from feces at eight months post treatment, indicating eventual loss of the microbe from the gut. Preliminary screens during experimentation found no immune response to AvPAL. Collectively these studies provide data for the use of a genetically engineered probiotic as a potential treatment for PKU.	[Durrer, Katherine E.; von Herbing, Ione Hunt] Univ North Texas, Dept Biol Sci, Denton, TX USA; [Allen, Michael S.] Univ North Texas, Hlth Sci Ctr, Ctr Med Genet, Inst Mol Med, Ft Worth, TX 76107 USA; [Durrer, Katherine E.] Univ North Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Allen, MS (corresponding author), Univ North Texas, Hlth Sci Ctr, Ctr Med Genet, Inst Mol Med, Ft Worth, TX 76107 USA.	Michael.Allen@unthsc.edu		Hunt von Herbing, Ione/0000-0003-4335-6878; Allen, Michael/0000-0003-2293-8078	National PKU Alliance; National Society for PKU (England)	National PKU Alliance; National Society for PKU (England)	This work was supported by National PKU Alliance, http://npkua.org/Research/Scientific-G rant-Requests, received scientific seed money grant for 2 years, 2012-2014; National Society for PKU (England), http://www.nspku.org/, donated $10,000.00 as supplement funds, not an official grant. The funders had no role in study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Bellier S, 2005, AM J PHYSIOL-GASTR L, V288, pG151, DOI 10.1152/ajpgi.00048.2004; Brumm VL, 2010, MOL GENET METAB, V99, pS59, DOI 10.1016/j.ymgme.2009.10.182; Gamez A, 2005, MOL THER, V11, P986, DOI 10.1016/j.ymthe.2005.02.013; Hale JDF, 2005, J BACTERIOL, V187, P5036, DOI 10.1128/JB.187.14.5036-5039.2005; Hamman K, 2005, MOL THER, V12, P337, DOI 10.1016/j.ymthe.2005.03.025; Harding CO, 2003, J GENE MED, V5, P984, DOI 10.1002/jgm.432; Heng NCK, 1999, APPL ENVIRON MICROB, V65, P5378; Hoffmann M, 2008, J NUTR, V138, P1684, DOI 10.1093/jn/138.9.1684; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; Kang TS, 2010, MOL GENET METAB, V99, P4, DOI 10.1016/j.ymgme.2009.09.002; Lehrer J, 2014, BOWEL TRANSIT TIME M; Levy HL, 1999, P NATL ACAD SCI USA, V96, P1811, DOI 10.1073/pnas.96.5.1811; Liu JZ, 2002, ARTIF CELL BLOOD SUB, V30, P243, DOI 10.1081/BIO-120006117; Livingston M, 2010, IMMUNOL CELL BIOL, V88, P99, DOI 10.1038/icb.2009.71; Lizier M, 2010, FEMS MICROBIOL LETT, V308, P8, DOI 10.1111/j.1574-6968.2010.01978.x; MCCAMAN MW, 1962, J LAB CLIN MED, V59, P885; McDonald JD, 1997, PEDIATR RES, V42, P103, DOI 10.1203/00006450-199707000-00016; Moffitt MC, 2007, BIOCHEMISTRY-US, V46, P1004, DOI 10.1021/bi061774g; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Porta F, 2008, J INHERIT METAB DIS, V31, pS339, DOI 10.1007/s10545-008-0907-9; Roato I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014167; Sarkissian CN, 2008, P NATL ACAD SCI USA, V105, P20894, DOI 10.1073/pnas.0808421105; Sarkissian CN, 1999, P NATL ACAD SCI USA, V96, P2339, DOI 10.1073/pnas.96.5.2339; Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342; TANNOCK GW, 1994, PLASMID, V31, P60, DOI 10.1006/plas.1994.1007; Tannock GW, 2005, APPL ENVIRON MICROB, V71, P8419, DOI 10.1128/AEM.71.12.8419-8425.2005; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004	28	30	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176286	10.1371/journal.pone.0176286	http://dx.doi.org/10.1371/journal.pone.0176286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520731	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700011
J	Yeung, SE; Thornton, WL				Yeung, Sophie E.; Thornton, Wendy Loken			"Do it-yourself" : Home blood pressure as a predictor of traditional and everyday cognition in older adults	PLOS ONE			English	Article							AGED 75 YEARS; PULSE PRESSURE; INTELLECTUAL ABILITY; ARTERIAL STIFFNESS; RELATIVE UTILITY; VASCULAR HEALTH; STROKE RISK; HYPERTENSION; PERFORMANCE; BRAIN	Background Hypertension guidelines recommend home blood pressure (HBP) monitoring in adjunct to office blood pressure (OBP) for its greater reproducibility and prognostic utility in the prevention of cardiovascular outcomes, especially stroke. To date, the relationship between HBP and cognitive function remains unexplored. Methods We examined HBP as a cognitive predictor in a multi-ethnic group of community-dwelling adults aged 60 and over (N = 133) using neuropsychological measures and analyzed the data using multiple regression analyses. We also employed "everyday cognition" measures that have been found to have higher prognostic utility for real-world functioning than traditional cognitive tasks. Results Good to perfect HBP monitoring compliance over seven days was achieved by 88.7% of the participants with superior reliability (ICC >=.96) to office readings. Higher home systolic BP and pulse pressure predicted worse processing speed, executive function, and everyday cognitive function, whereas lower home diastolic BP predicted worse everyday cognition. Office readings were similarly associated with everyday cognitive function but with no other cognitive measures. Conclusion Our findings are the first to validate HBP as a predictor of neuropsychological function in older adults beyond cognitive screening. Differential relationships among blood pressure variables and specific cognitive domains were observed. With proper standardization and training, we demonstrated that HBP can be obtained in a multi-ethnic community-dwelling older adult cohort. Our findings emphasize the importance of employing blood pressure and cognitive measures that are adequately sensitive to detect vascular-related cognitive impairment in a relatively healthy population. Implications regarding proper HBP measurement for hypertension management, cognitive health, and everyday function are discussed.	[Yeung, Sophie E.; Thornton, Wendy Loken] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada	Simon Fraser University	Thornton, WL (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.	wthornto@sfu.ca			Social Sciences and Humanities Research Council [SSHRC 410-2010-0407]; SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship Doctoral Award	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship Doctoral Award	This work was supported in part by a Social Sciences and Humanities Research Council (SSHRC 410-2010-0407) grant awarded to Dr. Wendy Loken Thornton. Dr. Sophie E. Yeung was supported by a SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyagari V, 2009, STROKE, V40, P2251, DOI 10.1161/STROKEAHA.108.531574; Allaire JC, 2006, AGING NEUROPSYCHOL C, V13, P207, DOI 10.1080/13825580490904228; Allaire JC, 2002, PSYCHOL AGING, V17, P101, DOI [10.1037//0882-7974.17.1.101, 10.1037/0882-7974.17.1.101]; Allaire JC, 1999, PSYCHOL AGING, V14, P627, DOI 10.1037/0882-7974.14.4.627; Artistico D, 2003, PSYCHOL AGING, V18, P68, DOI 10.1037/0882-7974.18.1.68; Asayama K, 2005, EUR HEART J, V26, P2026, DOI 10.1093/eurheartj/ehi330; Asayama K, 2004, STROKE, V35, P2356, DOI 10.1161/01.STR.0000141679.42349.9f; Beauchet O, 2010, REJUV RES, V13, P39, DOI 10.1089/rej.2009.0878; Birns J, 2009, J HUM HYPERTENS, V23, P86, DOI 10.1038/jhh.2008.80; Blankevoort CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070799; Bolli P, 2010, J HYPERTENS, V28, P1380, DOI 10.1097/HJH.0b013e32833ac964; Brown GG, 2009, NEUROPSYCHOLOGICAL A, P306; Campbell N, 2010, CANADIAN HYPERTENSIO; Campbell NRC, 2005, CAN J PUBLIC HEALTH, V96, P217, DOI 10.1007/BF03403694; Campo C, 2000, BLOOD PRESSURE, V9, P355; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen J., 2003, APPLIED MULTIPLE REG; Comrey A. L., 1992, A FIRST COURSE IN FA; Crichton GE, 2014, HYPERTENSION, V64, P1094, DOI 10.1161/HYPERTENSIONAHA.114.04282; Dahle CL, 2009, PSYCHOL AGING, V24, P154, DOI 10.1037/a0014283; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, THE CALIFORNIA VERBA; DENNEY NW, 1989, PSYCHOL AGING, V4, P438, DOI 10.1037/0882-7974.4.4.438; DENNEY NW, 1981, J GERONTOL, V36, P323, DOI 10.1093/geronj/36.3.323; Fischer AL, 2017, J GERONTOL B-PSYCHOL, V72, P71, DOI 10.1093/geronb/gbw088; Fischer AL, 2014, J GERONTOL B-PSYCHOL, V69, P219, DOI 10.1093/geronb/gbs120; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gelb SR, 2010, NEUROPSYCHOLOGY, V24, P514, DOI 10.1037/a0018670; Gorelick PB, 2012, J AM SOC HYPERTENS, V6, P309, DOI 10.1016/j.jash.2012.08.004; Hense HW, 2002, NEPHROL DIAL TRANSPL, V17, P1547, DOI 10.1093/ndt/17.9.1547; Iadecola C, 2016, HYPERTENSION; Imai Y, 2004, INTERNAL MED, V43, P771, DOI 10.2169/internalmedicine.43.771; Kanemaru A, 2001, HYPERTENS RES, V24, P19, DOI 10.1291/hypres.24.19; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Knecht S, 2008, HYPERTENSION, V51, P663, DOI 10.1161/HYPERTENSIONAHA.107.105577; Lee ATC, 2013, J ALZHEIMERS DIS, V35, P687, DOI 10.3233/JAD-122116; Mallick S, 2009, AM J MED, V122, P803, DOI 10.1016/j.amjmed.2009.02.028; Mario B, 2009, INT J GERIATR PSYCH, V24, P509, DOI 10.1002/gps.2145; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Muller M, 2010, J HYPERTENS, V28, P1498, DOI 10.1097/HJH.0b013e32833951ef; Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879; Nagai M, 2008, J HYPERTENS, V26, P1636, DOI 10.1097/HJH.0b013e3283018333; Nilsson SE, 2007, AGING CLIN EXP RES, V19, P41, DOI 10.1007/BF03325209; Nishinaga M, 2005, HYPERTENS RES, V28, P657, DOI 10.1291/hypres.28.657; Obisesan TO, 2008, J AM GERIATR SOC, V56, P501, DOI 10.1111/j.1532-5415.2007.01592.x; Ohkubo T, 2004, J HYPERTENS, V22, P1099, DOI 10.1097/00004872-200406000-00009; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Parati G, 2009, HYPERTENSION; Parati G, 2010, BLOOD PRESS MONIT, V15, P100, DOI 10.1097/MBP.0b013e328338c63b; Parati G, 2009, LANCET, V373, P876, DOI 10.1016/S0140-6736(09)60526-2; Peters R, 2013, J HYPERTENS, V31, P1868, DOI 10.1097/HJH.0b013e3283622cc6; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Plichart M, 2013, BLOOD PRESS MONIT, V18, P208, DOI 10.1097/MBP.0b013e3283631b45; Posner HB, 2002, NEUROLOGY, V58, P1175, DOI 10.1212/WNL.58.8.1175; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Qiu CX, 2003, STROKE, V34, P594, DOI 10.1161/01.STR.0000060127.96986.F4; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raz N, 2007, NEUROPSYCHOLOGY, V21, P149, DOI 10.1037/0894-4105.21.2.149; Reynolds M.W, 1999, PROFESSIONAL MANUAL; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Sakakura K, 2007, AM J HYPERTENS, V20, P720, DOI 10.1016/j.amjhyper.2007.02.001; Sharp SI, 2011, INT J GERIATR PSYCH, V26, P661, DOI 10.1002/gps.2572; Shimbo D, 2007, AM J HYPERTENS, V20, P476, DOI 10.1016/j.amjhyper.2006.12.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STEIGER JH, 1992, BEHAV RES METH INSTR, V24, P581, DOI 10.3758/BF03203611; Stergiou GS, 2002, J HYPERTENS, V20, P1987, DOI 10.1097/00004872-200210000-00018; Tadic M, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0386-0; Thornton AE, 2010, J CLIN EXP NEUROPSYC, V32, P299, DOI 10.1080/13803390903002209; Thornton WL, 2007, PSYCHOL AGING, V22, P470, DOI 10.1037/0882-7974.22.3.470; Thornton WL, 2013, INT J BEHAV DEV, V37, P13, DOI 10.1177/0165025412454028; Tsao CW, 2013, NEUROLOGY, V81, P984, DOI 10.1212/WNL.0b013e3182a43e1c; van Boxtel MPJ, 2006, J HUM HYPERTENS, V20, P5, DOI 10.1038/sj.jhh.1001934; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058; Wahlin A, 2006, PSYCHOL AGING, V21, P318, DOI 10.1037/0882-7974.21.2.318; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Wang W, 2011, BLOOD PRESS MONIT, V16, P277, DOI 10.1097/MBP.0b013e32834e3ba6; Weatherbee SR, 2008, PSYCHOL AGING, V23, P216, DOI 10.1037/0882-7974.23.1.216; Wechsler D., 1997, WECHSLER ADULT INTEL; Willis SL, 1993, MANUAL FOR THE EVERY; World Health Organisation (WHO), 2002, THE WORLD HEALTH REP; Yaneva-Sirakova T, 2012, J CARDIOVASC MED, V13, P735, DOI 10.2459/JCM.0b013e328357ba78; Yasui D, 2010, AM J HYPERTENS, V23, P508, DOI 10.1038/ajh.2010.15; Yeung SE, 2011, AGING NEUROPSYCHOL C, V18, P733, DOI 10.1080/13825585.2011.609882	83	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177424	10.1371/journal.pone.0177424	http://dx.doi.org/10.1371/journal.pone.0177424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DX	28520751	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700047
J	Franklin, SP; Burke, EE; Holmes, SP				Franklin, Samuel P.; Burke, Emily E.; Holmes, Shannon P.			The effect of platelet-rich plasma on osseous healing in dogs undergoing high tibial osteotomy	PLOS ONE			English	Article							LEVELING OSTEOTOMY; LONG BONES; BASIC SCIENCE; COMPLICATIONS; PROLIFERATION; MODEL; TIME	Objectives The purpose of this study was to investigate whether platelet-rich plasma (PRP) enhances osseous healing in conjunction with a high tibial osteotomy in dogs. Study design Randomized controlled trial. Methods Sixty-four client-owned pet dogs with naturally occurring rupture of the anterior cruciate ligament and that were to be treated with a high tibial osteotomy (tibial plateau leveling osteotomy) were randomized into the treatment or control group. Dogs in the treatment group received autologous platelet-rich plasma activated with calcium chloride and bovine thrombin to produce a well-formed PRP gel that was placed into the osteotomy at the time of surgery. Dogs in the control group received saline lavage of the osteotomy. All dogs had the osteotomy stabilized with identical titanium alloy implants and all aspects of the surgical procedure and post-operative care were identical among dogs of the two groups. Bone healing was assessed at exactly 28, 49, and 70 days after surgery with radiography and ultrasonography and with MRI at day 28. The effect of PRP on bone healing was assessed using a repeated measures analysis of covariance with radiographic and ultrasonographic data and using a t-test with the MRI data. Results Sixty dogs completed the study. There were no significant differences in age, weight, or gender distribution between the treatment and control groups. Twenty-seven dogs were treated with PRP and 33 were in the control group. The average platelet concentration of the PRP was 1.37x10(6) platelets/mu L (+/- 489x10(3)) with a leukocyte concentration of 5.45x10(3)/mu L (+/- 3.5x10(3)). All dogs demonstrated progressive healing over time and achieved clinically successful outcomes. Time since surgery and patient age were significant predictors of radiographic healing and time since surgery was a significant predictor of ultrasonographic assessment of healing. There was no significant effect of PRP treatment as assessed radio-graphically, ultrasonographically, or with MRI. Conclusion The PRP used in this study did not hasten osseous union in dogs treated with a high tibial osteotomy.	[Franklin, Samuel P.] Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA; [Franklin, Samuel P.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Burke, Emily E.; Holmes, Shannon P.] Univ Georgia, Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Franklin, SP (corresponding author), Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA.; Franklin, SP (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.	spfrank@uga.edu			AO Foundation; New Faculty Startup-Comparative Medical Research Donation Fund; Arthrex Vet Systems	AO Foundation; New Faculty Startup-Comparative Medical Research Donation Fund; Arthrex Vet Systems	Sam Franklin is a consultant for Arthrex Vet Systems. Sam Franklin is paid to consult on research investigations, products, and is paid (hourly) if teaching veterinary continuing education courses. Sam Franklin is not paid any salary and receives no royalties on any products and has no financial interest in any product. The PRP used in this study was produced using the Angel system (provided by Arthrex Vet Systems) and Arthrex Vet Systems provided materials support for this study. All financial support for this study was provided by the AO Foundation and by Sam Franklin using his New Faculty Startup-Comparative Medical Research Donation Fund; zero financial support was provided by Arthrex Vet Systems. No funding agency, including the AO Foundation or Arthrex, provided any support in the form of salaries for any authors of this study nor did any supporting/funding agency have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Arnoczky SP, 2013, SPORTS MED ARTHROSC, V21, P180, DOI 10.1097/JSA.0b013e3182999712; Barry S, 2010, VET COMP ORTHOPAED, V23, P385, DOI 10.3415/VCOT-10-01-0017; Bell A, 2016, ORTHOP CLIN N AM, V47, P365, DOI 10.1016/j.ocl.2015.09.010; Bergh MS, 2012, VET COMP ORTHOPAED, V25, P349, DOI 10.3415/VCOT-11-09-0122; Boswell SG, 2014, AM J SPORT MED, V42, P42, DOI 10.1177/0363546513507566; Brinker MR, 2016, ORTHOP CLIN N AM, V47, P67, DOI 10.1016/j.ocl.2015.08.009; Conkling AL, 2010, VET SURG, V39, P475, DOI 10.1111/j.1532-950X.2010.00656.x; Cook JL, 2010, VET SURG, V39, P905, DOI 10.1111/j.1532-950X.2010.00763.x; Silva Silmara Bonomi da, 2007, Cienc. Rural, V37, P1045, DOI 10.1590/S0103-84782007000400020; Diesen DL, 2008, VASCULAR, V16, pS29, DOI 10.2310/6670.2008.00031; Duerr FM, 2014, VET COMP ORTHOPAED, V27, P478, DOI 10.3415/VCOT-14-03-0047; Fitzpatrick N, 2010, VET SURG, V39, P460, DOI 10.1111/j.1532-950X.2010.00663.x; Franklin SP, 2015, AM J VET RES, V76, P822, DOI 10.2460/ajvr.76.9.822; Gianakos A, 2015, ORTHOPEDICS, V38, pE1079, DOI 10.3928/01477447-20151120-04; Hatakeyama I, 2014, TISSUE ENG PT A, V20, P874, DOI [10.1089/ten.tea.2013.0058, 10.1089/ten.TEA.2013.0058]; Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055; Iqbal Jameel, 2011, Curr Osteoporos Rep, V9, P258, DOI 10.1007/s11914-011-0080-1; Kieves NR, 2015, VET COMP ORTHOPAED, V28, P425, DOI 10.3415/VCOT-15-05-0084; Kim SE, 2012, VET SURG, V41, P465, DOI 10.1111/j.1532-950X.2012.00973.x; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Malhotra A, 2013, ARCH ORTHOP TRAUM SU, V133, P153, DOI 10.1007/s00402-012-1641-1; Rabillard M, 2009, VET COMP ORTHOPAED, V22, P460, DOI 10.3415/VCOT-09-04-0048; Risselada M, 2007, VET RADIOL ULTRASOUN, V48, P368, DOI 10.1111/j.1740-8261.2007.00258.x; Risselada M, 2006, VET RADIOL ULTRASOUN, V47, P301, DOI 10.1111/j.1740-8261.2006.00144.x; Risselada M, 2005, VET SURG, V34, P99, DOI 10.1111/j.1532-950X.2005.00017.x; Risselada M, 2003, VET RADIOL ULTRASOUN, V44, P214, DOI 10.1111/j.1740-8261.2003.tb01274.x; Rodriguez IA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/392398; Roffi A, 2016, INT ORTHOPAEDICS; Sabzevari S, 2016, ARCH BONE JT SURG-AB, V4, P204; Sadeghi-Ataabadi M, 2017, MAT SCI ENG C-MATER, V71, P372, DOI 10.1016/j.msec.2016.10.001; Souza TFB, 2012, VET COMP ORTHOPAED, V25, P445, DOI 10.3415/VCOT-10-10-0146; Visser LC, 2010, VET SURG, V39, P811, DOI 10.1111/j.1532-950X.2010.00739.x; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177597	10.1371/journal.pone.0177597	http://dx.doi.org/10.1371/journal.pone.0177597			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520812	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500042
J	Fantini, M; Pandolfini, L; Lisi, S; Chirichella, M; Arisi, I; Terrigno, M; Goracci, M; Cremisi, F; Cattaneo, A				Fantini, Marco; Pandolfini, Luca; Lisi, Simonetta; Chirichella, Michele; Arisi, Ivan; Terrigno, Marco; Goracci, Martina; Cremisi, Federico; Cattaneo, Antonino			Assessment of antibody library diversity through next generation sequencing and technical error compensation	PLOS ONE			English	Article							INTRACELLULAR ANTIBODIES; IMMUNOGLOBULIN GENES; ALLELIC EXCLUSION; IMMUNIZED MICE; SELECTION; REPERTOIRE; PHAGE; DISPLAY; HEAVY; LIGHT	Antibody libraries are important resources to derive antibodies to be used for a wide range of applications, from structural and functional studies to intracellular protein interference studies to developing new diagnostics and therapeutics. Whatever the goal, the key parameter for an antibody library is its complexity (also known as diversity), i.e. the number of distinct elements in the collection, which directly reflects the probability of finding in the library an antibody against a given antigen, of sufficiently high affinity. Quantitative evaluation of antibody library complexity and quality has been for a long time inadequately addressed, due to the high similarity and length of the sequences of the library. Complexity was usually inferred by the transformation efficiency and tested either by fingerprinting and/or sequencing of a few hundred random library elements. Inferring complexity from such a small sampling is, however, very rudimental and gives limited information about the real diversity, because complexity does not scale linearly with sample size. Next-generation sequencing (NGS) has opened new ways to tackle the antibody library complexity quality assessment. However, much remains to be done to fully exploit the potential of NGS for the quantitative analysis of antibody repertoires and to overcome current limitations. To obtain a more reliable antibody library complexity estimate here we show a new, PCR-free, NGS approach to sequence antibody libraries on Illumina platform, coupled to a new bioinformatic analysis and software (Diversity Estimator of Antibody Library, DEAL) that allows to reliably estimate the complexity, taking in consideration the sequencing error.	[Fantini, Marco; Pandolfini, Luca; Lisi, Simonetta; Chirichella, Michele; Terrigno, Marco; Goracci, Martina; Cremisi, Federico; Cattaneo, Antonino] Scuola Normale Super Pisa, Bio SNS Lab, Pisa, Italy; [Arisi, Ivan; Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Pandolfini, Luca] Univ Cambridge, Wellcome Trust, CRUK Gurdon Inst, Cambridge, England	Scuola Normale Superiore di Pisa; University of Cambridge; Wellcome Trust Sanger Institute	Cattaneo, A (corresponding author), Scuola Normale Super Pisa, Bio SNS Lab, Pisa, Italy.; Cattaneo, A (corresponding author), European Brain Res Inst, Rome, Italy.	antonino.cattaneo@sns.it	Cattaneo, Antonino/AAA-7252-2019; Pandolfini, Luca/AAK-4213-2021; cremisi, federico/AAI-2183-2020; Arisi, Ivan/AAM-1152-2021	Arisi, Ivan/0000-0002-0536-2508; Cremisi, Federico/0000-0003-4925-2703; Fantini, Marco/0000-0002-2195-3957; TERRIGNO, MARCO/0000-0001-8967-7269; Pandolfini, Luca/0000-0003-1444-8167; Goracci, Martina/0000-0002-2350-0724	European Union [604102]	European Union(European Commission)	Funded by European Union Seventh Framework Program [grant No. 604102 A.C.] (Human Brain Project). https://www.humanbrainproject.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andris-Widhopf J, 2011, COLD SPRING HARB PRO, V2011; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai XH, 1996, P NATL ACAD SCI USA, V93, P6280, DOI 10.1073/pnas.93.13.6280; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chirichella M, 2017, NAT METHODS, V14, P279, DOI [10.1038/NMETH.4144, 10.1038/nmeth.4144]; Daly J, 2007, EMBO J, V26, P4273, DOI 10.1038/sj.emboj.7601846; DAVIES EL, 1995, J IMMUNOL METHODS, V186, P125, DOI 10.1016/0022-1759(95)00143-X; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Glanville J, 2015, CURR OPIN STRUC BIOL, V33, P146, DOI 10.1016/j.sbi.2015.09.001; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Greiff V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0040-5; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; He MY, 1997, NUCLEIC ACIDS RES, V25, P5132, DOI 10.1093/nar/25.24.5132; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; KETTLEBOROUGH CA, 1994, EUR J IMMUNOL, V24, P952, DOI 10.1002/eji.1830240426; Koohapitagtam M, 2010, MOL BIOL REP, V37, P1677, DOI 10.1007/s11033-009-9583-6; Lang IM, 1996, GENE, V172, P295, DOI 10.1016/0378-1119(96)00021-2; Logan AC, 2011, P NATL ACAD SCI USA, V108, P21194, DOI 10.1073/pnas.1118357109; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Marks James D, 2004, Methods Mol Biol, V248, P117; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Meli G, 2009, J MOL BIOL, V387, P584, DOI 10.1016/j.jmb.2009.01.061; Milstein C., 1990, P R SOC LONDON B, V239; Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Tanaka T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng023; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Tanaka T, 2010, NAT PROTOC, V5, P67, DOI 10.1038/nprot.2009.199; Vettermann C, 2010, IMMUNOL REV, V237, P22, DOI 10.1111/j.1600-065X.2010.00935.x; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Visintin M, 2004, METHODS, V34, P200, DOI 10.1016/j.ymeth.2004.04.008; Visintin M, 2004, J IMMUNOL METHODS, V290, P135, DOI 10.1016/j.jim.2004.04.014; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	44	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177574	10.1371/journal.pone.0177574	http://dx.doi.org/10.1371/journal.pone.0177574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505201	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500030
J	Kan, HJ; Verrijp, FW; Hovius, SER; van Nieuwenhoven, CA; Selles, RW				Kan, Hester J.; Verrijp, Frank W.; Hovius, Steven E. R.; van Nieuwenhoven, Christianne A.; Selles, Ruud W.		Dupuytren Delphi Grp	Recurrence of Dupuytren's contracture: A consensus-based definition	PLOS ONE			English	Article							FOLLOW-UP; NONSURGICAL TREATMENT; DISEASE; DERMOFASCIECTOMY; MOTION; RANGE; HAND	Purpose One of the major determinants of Dupyutren disease (DD) treatment efficacy is recurrence of the contracture. Unfortunately, lack of agreement in the literature on what constitutes recurrence makes it nearly impossible to compare the multiple treatments alternatives available today. The aim of this study is to bring an unbiased pool of experts to agree upon what would be considered a recurrence of DD after treatment; and from that consensus establish a much-needed definition for DD recurrence. Methods To reach an expert consensus on the definition of recurrence we used the Delphi method and invited 43 Dupuytren's research and treatment experts from 10 countries to participate by answering a series of questionnaire rounds. After each round the answers were analyzed and the experts received a feedback report with another questionnaire round to further hone in of the definition. We defined consensus when at least 70% of the experts agreed on a topic. Results Twenty-one experts agreed to participate in this study. After four consensus rounds, we agreed that DD recurrence should be defined as "more than 20 degrees of contracture recurrence in any treated joint at one year post-treatment compared to six weeks post-treatment". In addition, "recurrence should be reported individually for every treated joint" and afterwards measurements should be repeated and reported yearly. Conclusion This study provides the most comprehensive to date definition of what should be considered recurrence of DD. These standardized criteria should allow us to better evaluate the many treatment alternatives.	[Kan, Hester J.; Verrijp, Frank W.; Hovius, Steven E. R.; van Nieuwenhoven, Christianne A.; Selles, Ruud W.] Erasmus MC, Dept Plast & Reconstruct Surg & Hand Surg, Rotterdam, Netherlands; [Selles, Ruud W.] Erasmus MC, Dept Rehabil Med & Physiotherapy, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Kan, HJ (corresponding author), Erasmus MC, Dept Plast & Reconstruct Surg & Hand Surg, Rotterdam, Netherlands.	h.kan@erasmusmc.nl	Selles, Ruud/N-9665-2019; Eaton, Charles/H-4666-2015; Zyluk, Andrzej/G-8377-2014	Selles, Ruud/0000-0002-2432-6756; Eaton, Charles/0000-0002-8186-3611; Degreef, Ilse/0000-0003-2464-2641; Jerosch-Herold, Christina/0000-0003-0525-1282; Zyluk, Andrzej/0000-0002-8299-4525				Abe Y, 2004, J HAND SURG-BRIT EUR, V29B, P427, DOI 10.1016/j.jhsb.2004.06.004; Becker GW, 2010, J HAND SURG-EUR VOL, V35E, P623, DOI 10.1177/1753193410376286; BROTHERSTON TM, 1994, BRIT J PLAST SURG, V47, P440, DOI 10.1016/0007-1226(94)90075-2; Cheng H S, 2008, J Orthop Surg (Hong Kong), V16, P88; Ellis B, 2002, CLIN REHABIL, V16, P562, DOI 10.1191/0269215502cr513oa; Gilpin D, 2010, J HAND SURG-AM, V35A, P2027, DOI 10.1016/j.jhsa.2010.08.007; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hovius SER, 2011, PLAST RECONSTR SURG, V128, P221, DOI 10.1097/PRS.0b013e31821741ba; HUESTON JT, 1976, MED J AUSTRALIA, V2, P189, DOI 10.5694/j.1326-5377.1976.tb134472.x; Kan HJ, 2013, J PLAST RECONSTR AES, V66, P95, DOI 10.1016/j.bjps.2012.08.019; KETCHUM LD, 1987, J HAND SURG-AM, V12A, P659, DOI 10.1016/S0363-5023(87)80043-6; LEA RD, 1995, J BONE JOINT SURG AM, V77A, P784, DOI 10.2106/00004623-199505000-00017; Pratt AL, 2009, J CLIN NURS, V18, P1793, DOI 10.1111/j.1365-2702.2008.02692.x; Skoff HD, 2004, PLAST RECONSTR SURG, V113, P540, DOI 10.1097/01.PRS.0000101054.80392.88; van Rijssen AL, 2006, J HAND SURG-AM, V31A, P717, DOI 10.1016/j.jhsa.2006.02.021; Watt AJ, 2010, J HAND SURG-AM, V35A, P534, DOI 10.1016/j.jhsa.2010.01.003; Werker PM, 2011, PLASTIC RECONSTRUCTI	17	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0164849	10.1371/journal.pone.0164849	http://dx.doi.org/10.1371/journal.pone.0164849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505187	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000401473500001
J	Myrick, DA; Christopher, MA; Scott, AM; Simon, AK; Donlin-Asp, PG; Kelly, WG; Katz, DJ				Myrick, Dexter A.; Christopher, Michael A.; Scott, Alyssa M.; Simon, Ashley K.; Donlin-Asp, Paul G.; Kelly, William G.; Katz, David J.			KDM1A/LSD1 regulates the differentiation and maintenance of spermatogonia in mice	PLOS ONE			English	Article							RETINOIC ACID; LSD1; METHYLATION; EXPRESSION; REPRESSION; COMPONENT; COREST; CELLS; CRE	The proper regulation of spermatogenesis is crucial to ensure the continued production of sperm and fertility. Here, we investigated the function of the H3K4me2 demethylase KDM1A/LSD1 during spermatogenesis in developing and adult mice. Conditional deletion of Kdm1a in the testis just prior to birth leads to fewer spermatogonia and germ cell loss before 3 weeks of age. These results demonstrate that KDM1A is required for spermatogonial differentiation, as well as germ cell survival, in the developing testis. In addition, inducible deletion of Kdm1a in the adult testis results in the abnormal accumulation of meiotic spermatocytes, as well as apoptosis and progressive germ cell loss. These results demonstrate that KDM1A is also required during adult spermatogenesis. Furthermore, without KDM1A, the stem cell factor OCT4 is ectopically maintained in differentiating germ cells. This requirement for KDM1A is similar to what has been observed in other stem cell populations, suggesting a common function. Taken together, we propose that KDM1A is a key regulator of spermatogenesis and germ cell maintenance in the mouse.	[Myrick, Dexter A.; Christopher, Michael A.; Scott, Alyssa M.; Simon, Ashley K.; Donlin-Asp, Paul G.; Katz, David J.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Myrick, Dexter A.; Christopher, Michael A.; Scott, Alyssa M.; Donlin-Asp, Paul G.] Emory Univ, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Kelly, William G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Katz, DJ (corresponding author), Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA.	djkatz@emory.edu			PREP post-baccalaureate program [5R25GM089615-04]; GMB [T32GM008490-21]; National Science Foundation [10S1354998]; BCDB [5T32GM008367]	PREP post-baccalaureate program; GMB; National Science Foundation(National Science Foundation (NSF)); BCDB	D. Myrick was a member of the PREP post-baccalaureate program (5R25GM089615-04). M. Christopher is supported by the GMB training grant (T32GM008490-21). P. Donlin-Asp was supported by the BCDB training grant (5T32GM008367). The work was supported by a grant to D.J.K from the National Science Foundation (10S1354998).	Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Brown JP, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-18; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Choi J, 2010, BIOCHEM BIOPH RES CO, V401, P327, DOI 10.1016/j.bbrc.2010.09.014; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Godmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012727; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Lambrot R, 2015, FASEB J; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; RUSSELL LD, 1990, AM J ANAT, V188, P21, DOI 10.1002/aja.1001880104; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang J, 2013, GENE DEV, V27, P749, DOI 10.1101/gad.210963.112; Zhu DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4174	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177473	10.1371/journal.pone.0177473	http://dx.doi.org/10.1371/journal.pone.0177473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498828	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314500018
J	Chen, Q; Hu, CY; Liu, Y; Liu, Y; Wang, W; Zheng, HC; Rong, LC; Jia, JY; Sun, SX; Yu, C; Liu, YM				Chen, Qian; Hu, Chaoying; Liu, Ye; Liu, Yun; Wang, Wei; Zheng, Hongchao; Rong, Lianchen; Jia, Jingying; Sun, Shixuan; Yu, Chen; Liu, Yan Mei			Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: A randomized, double-blind, placebo-controlled, ascending-dose study	PLOS ONE			English	Article							URINARY TRYPSIN-INHIBITOR; PROTEASE INHIBITOR; STRESS; INJURY; RATS	Ulinastatin, is a broad-spectrum protease inhibitor purified from human urine, inhibits endogenous proteases such as trypsin, a-chymotrypsin, hyaluronidase, and plasmin. It is widely being used at increasingly higher doses for the treatment of acute or chronic pancreatitis, severe infection, and acute organ failure. We aimed to evaluate the safety and tolerability of high-dose ulinastatin in healthy volunteers in our single center, randomized, double-blind, placebo-controlled, single-dose escalation study. Fifty-one healthy Chinese subjects were enrolled in 9 dose cohorts (3x10(5) U, 6x10(5) U, 12x10(5) U, 20x10(5) U, 30x10(5) U, 45x10(5) U, 60x10(5) U, 70x10(5) U, or 80x10(5) U of ulinastatin) and randomized to UTI or matching placebo (n = 1). Each dose cohort was composed of 3-7 subjects. All subjects were required to have 2 h of intravenous infusion. Safety and tolerability were assessed throughout the study via monitoring of vital signs, physical examinations, clinical laboratory tests, 12-lead electrocardiograms, and interviews with the subjects about adverse events. Fifty-one subjects (35 men and 16 women) completed the study. A total of 13 AEs were reported by 10 subjects: 11 adverse events in the ulinastatin groups and 2 adverse events in the placebo group. Twelve of the adverse events were possibly related to the study drug. The most common drug-related adverse events included dizziness, pain at injection site, and a decrease in white blood cell count. All adverse events were of mild severity; none were serious. In conclusion, 2 hours of intravenous infusion of ulinastatin (3x10(5) to 80x10(5) U) was well tolerated by healthy Chinese subjects.	[Chen, Qian; Hu, Chaoying; Liu, Ye; Liu, Yun; Jia, Jingying; Sun, Shixuan; Yu, Chen; Liu, Yan Mei] Fudan Univ, Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China; [Chen, Qian; Hu, Chaoying; Liu, Ye; Liu, Yun; Wang, Wei; Zheng, Hongchao; Jia, Jingying; Sun, Shixuan; Yu, Chen; Liu, Yan Mei] Fudan Univ, Zhongshan Xuhui Hosp, Shanghai, Peoples R China; [Wang, Wei] Fudan Univ, Shanghai Xuhui Cent Hosp, Dept Emergency, Shanghai, Peoples R China; [Zheng, Hongchao] Fudan Univ, Shanghai Xuhui Cent Hosp, Dept Cardiol, Shanghai, Peoples R China; [Rong, Lianchen] Techpool Biopharma Co Ltd, Clin Dev Dept, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Liu, YM (corresponding author), Fudan Univ, Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China.; Liu, YM (corresponding author), Fudan Univ, Zhongshan Xuhui Hosp, Shanghai, Peoples R China.	ymliu@shxh-centerlab.com		Jia, Jingying/0000-0002-2492-3219	Guangdong Techpool Bio-pharma Co., Ltd.; Techpool Bio-pharma Company, Limited	Guangdong Techpool Bio-pharma Co., Ltd.; Techpool Bio-pharma Company, Limited	This study was funded by Guangdong Techpool Bio-pharma Co., Ltd., who provided the study drug and financial support for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lianchen Rong is employed by Techpool Bio-pharma Company, Limited, Shanghai, China. Techpool Bio-pharma Company, Limited provided support in the form of salary for author LR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; All authors are grateful to the sponsor, Guangdong Techpool Bio-pharma Co., Ltd., who provided the study drug and financial support for this study. We would also like to thank Shanghai Clinical Research Center for performing the data analysis.	Bao PT, 2009, EUR J PHARMACOL, V603, P114, DOI 10.1016/j.ejphar.2008.12.007; [冯国辉 FENG Guo-hui], 2009, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V29, P296; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Jeong CW, 2012, KOREAN J ANESTHESIOL, V63, P120, DOI 10.4097/kjae.2012.63.2.120; Koga Y, 2010, NEUROL RES, V32, P925, DOI 10.1179/016164110X12645013515133; Pugia MJ, 2005, CLIN CHEM LAB MED, V43, P1, DOI 10.1515/CCLM.2005.001; Sato N, 2002, DIGEST SURG, V19, P300, DOI 10.1159/000064578; Song J, 2013, KOREAN J ANESTHESIOL, V64, P334, DOI 10.4097/kjae.2013.64.4.334; State Food and Drug Administration of China, GUID GOOD CLIN PRINC; Umeadi C, 2008, TRANSPL P, V40, P387, DOI 10.1016/j.transproceed.2008.01.034; WMA, 1964, WMA DECL HELS ETH PR; Wu CY, 2007, CHIN J CLIN PHARM, V12, P103; Yang HY, 2011, AM J SURG, V202, P151, DOI 10.1016/j.amjsurg.2010.07.044; [张安 ZHANG An], 2008, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V24, P104; [张献全 ZHANG Xianquan], 2008, [中国急救医学, Chinese Journal of Critical Care Medicine], V28, P1060; Zhong DF, 2011, CHIN J CLIN RATIONAL, V4, P41	16	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177425	10.1371/journal.pone.0177425	http://dx.doi.org/10.1371/journal.pone.0177425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493932	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300105
J	Choi, YH; Cho, SS; Simkhada, JR; Rahman, MS; Choi, YS; Kim, CS; Yoo, JC				Choi, Yun Hee; Cho, Seung Sik; Simkhada, Jaya Ram; Rahman, Md. Saifur; Choi, Yoon Seok; Kim, Chun Sung; Yoo, Jin Cheol			A novel multifunctional peptide oligomer of bacitracin with possible bioindustrial and therapeutic applications from a Korean food-source Bacillus strain	PLOS ONE			English	Article							NITRIC-OXIDE; RAW 264.7; BACTERIOCIN; PURIFICATION; THERMOTOLERANT; DEFENSE	Investigating the effects of a multifunctional microbial peptide possessing strong anti-inflammatory activity against pathogenic bacteria. The antimicrobial activity of the purified peptide (CSP32) against various multidrug-resistant as well as anaerobic pathogens was determined. Anti-inflammatory activity was determined by an enzyme-linked immunosorbent assay, western blotting, and RT-PCR in RAW 264.7 macrophages. Molecular weight and structural elucidation were performed by several analytical methods such as mass spectrometry and chemoinformatic analysis. CSP32, purified from newly isolated Bacillus sp. CS32, was active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant S. aureus, vancomycin-resistant enterococci, and anaerobic pathogens Propionibacterium acne and Clostridium difficile. Furthermore, CSP32 showed strong inhibitory effects on lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) expression in RAW 264.7 macrophages. At concentrations of 10, 50, and 100 mu g/mL, CSP32 treatment attenuated LPS-induced expression of nuclear factor kappa B (NF-kappa B)and mitogen-activated protein kinases (MAPKs) as well as other proinflammatory mediators such as tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL6), and IL-1 beta. CSP32 potently inhibited translocation of NF-kappa B into the nucleus by suppressing degradation of I.B kinase (I kappa Ba) and its phosphorylation, thereby causing NF-.B to remain inactive. CSP32 may be the first oligomer of bacitracin with anti-inflammatory properties. Conclusion CSP32 has stable characteristics and may find bio-industrial and therapeutic applications.	[Choi, Yun Hee; Simkhada, Jaya Ram; Rahman, Md. Saifur; Choi, Yoon Seok; Yoo, Jin Cheol] Chosun Univ, Dept Pharm, Coll Pharm, Gwangju, South Korea; [Cho, Seung Sik] Mokpo Natl Univ, Dept Pharm, Coll Pharm, Muan 5, Jeonnam, South Korea; [Kim, Chun Sung] Chosun Univ Gwangju, Dept Oral Biochem, Coll Dent, Gwangju, South Korea	Chosun University; Mokpo National University; Chosun University	Yoo, JC (corresponding author), Chosun Univ, Dept Pharm, Coll Pharm, Gwangju, South Korea.	jcyu@chosun.ac.kr	Rahman, Mohammad Sohelur/AAJ-7376-2020; SIMKHADA, JAYA RAM/AAK-1014-2020; Rahman, Mohammad Saifur/GZM-5483-2022; RAHMAN, MD SAIFUR/ABG-5140-2021	Rahman, Mohammad Sohelur/0000-0002-4489-2202; Rahman, Mohammad Saifur/0000-0002-9887-4456; 	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF- 2015R1A2A1A15056120, NRF- 2015R1D1A1A01059483]; Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs [115073-2]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs	Support was provided by: The National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF- 2015R1A2A1A15056120, NRF- 2015R1D1A1A01059483); and Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (115073-2).	Ahern M, 2003, FEMS MICROBIOL LETT, V220, P127, DOI 10.1016/S0378-1097(03)00086-7; Bizani D, 2002, J APPL MICROBIOL, V93, P512, DOI 10.1046/j.1365-2672.2002.01720.x; Chapman HD, 2010, POULTRY SCI, V89, P1788, DOI 10.3382/ps.2010-00931; Cherif A, 2001, LETT APPL MICROBIOL, V32, P243, DOI 10.1046/j.1472-765X.2001.00898.x; Cho SS, 2012, BIOPROC BIOSYST ENG, V35, P247, DOI 10.1007/s00449-011-0599-7; Choi YH, 2016, ARCH PHARM RES, V39, P429, DOI 10.1007/s12272-015-0679-3; Choi YH, 2012, INT J ANTIMICROB AG, V40, P80, DOI 10.1016/j.ijantimicag.2012.03.019; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Jorgensen J. H., 2015, MANUAL CLIN MICROBIO, P1253, DOI [DOI 10.1128/9781555817381.CH71, 10.1128/9781555817381]; Kayalvizhi N, 2008, LETT APPL MICROBIOL, V47, P600, DOI 10.1111/j.1472-765X.2008.02473.x; Khalil R, 2009, PAK J NUTR, V8, P242, DOI DOI 10.3923/PJN.2009.242.250; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Lee HJ, 1999, J BIOSCI BIOENG, V88, P153, DOI 10.1016/S1389-1723(99)80194-7; Lee HJ, 2009, ARCH PHARM RES, V32, P437, DOI 10.1007/s12272-009-1318-7; Mendo S, 2004, BIOTECHNOL LETT, V26, P115, DOI 10.1023/B:BILE.0000012888.72489.3f; NCCLS, 2004, METH ANT SUSC TEST A; Oscariz JC, 1999, FEMS MICROBIOL LETT, V178, P337, DOI 10.1111/j.1574-6968.1999.tb08696.x; Pattnaik P, 2001, J APPL MICROBIOL, V91, P636, DOI 10.1046/j.1365-2672.2001.01429.x; Rana M., 2006, Journal of Endocrinology and Reproduction, V10, P88; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Sarkar D, 2008, INT IMMUNOPHARMACOL, V8, P1264, DOI 10.1016/j.intimp.2008.05.003; Sumi CD, 2015, CAN J MICROBIOL, V61, P93, DOI 10.1139/cjm-2014-0613; Tamang J. P., 2016, FRONTIERS MICROBIOLO, V7; Wu SM, 2005, CURR MICROBIOL, V51, P292, DOI 10.1007/s00284-005-0004-3; Yoon WJ, 2012, ARCH PHARM RES, V35, P1421, DOI 10.1007/s12272-012-0812-5; Yoon WJ, 2009, POL J MICROBIOL, V58, P61; Yu HY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/637512	28	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176971	10.1371/journal.pone.0176971	http://dx.doi.org/10.1371/journal.pone.0176971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493903	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300045
J	Eriksson, S; Elbing, K; Soderman, O; Lindkvist-Petersson, K; Topgaard, D; Lasic, S				Eriksson, Stefanie; Elbing, Karin; Soderman, Olle; Lindkvist-Petersson, Karin; Topgaard, Daniel; Lasic, Samo			NMR quantification of diffusional exchange in cell suspensions with relaxation rate differences between intra and extracellular compartments	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; FIELD GRADIENT NMR; RED-BLOOD-CELLS; WATER DIFFUSION; SELF-DIFFUSION; POROUS-MEDIA; TRANSPORT; PERMEABILITY; MEMBRANE; ECHO	Water transport across cell membranes can be measured non-invasively with diffusion NMR. We present a method to quantify the intracellular lifetime of water in cell suspensions with short transverse relaxation times, T-2, and also circumvent the confounding effect of different T-2 values in the intra- and extracellular compartments. Filter exchange spectroscopy (FEXSY) is specifically sensitive to exchange between compartments with different apparent diffusivities. Our investigation shows that FEXSY could yield significantly biased results if differences in T-2 are not accounted for. To mitigate this problem, we propose combining FEXSY with diffusion-relaxation correlation experiment, which can quantify differences in T-2 values in compartments with different diffusivities. Our analysis uses a joint constrained fitting of the two datasets and considers the effects of diffusion, relaxation and exchange in both experiments. The method is demonstrated on yeast cells with and without human aquaporins.	[Eriksson, Stefanie; Soderman, Olle; Topgaard, Daniel] Lund Univ, Div Phys Chem, Dept Chem, Lund, Sweden; [Elbing, Karin; Lindkvist-Petersson, Karin] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Lasic, Samo] CR Dev AB, Lund, Sweden	Lund University; Lund University	Lasic, S (corresponding author), CR Dev AB, Lund, Sweden.	samo@crdev.se	Lasic, Samo/AAR-7539-2021	Lasic, Samo/0000-0002-9284-7182; Lindkvist, Karin/0000-0002-5209-3160; Topgaard, Daniel/0000-0001-9373-6348	Swedish Foundation for Strategic Research (SSF) [AM13-0090]; Cancer foundation [2010/1171, 2014/575]; Swedish Research Council (VR) [2011-2891, 2014-3910]; Organizing Molecular Matter (OMM) center of excellence and CR Development AB (Lund, Sweden)	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Cancer foundation; Swedish Research Council (VR)(Swedish Research Council); Organizing Molecular Matter (OMM) center of excellence and CR Development AB (Lund, Sweden)	The work was financially supported by the Swedish Foundation for Strategic Research (SSF) (AM13-0090), the Cancer foundation (2010/1171 and 2014/575), the Swedish Research Council (VR) (2011-2891, 2014-3910 and the Linnaeus grant), the Organizing Molecular Matter (OMM) center of excellence and CR Development AB (Lund, Sweden). The funder provided support in the form of salaries for authors [SL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; Allan EA, 1972, PURE APPL CHEM, V32; ANDRASKO J, 1976, BIOCHIM BIOPHYS ACTA, V428, P304, DOI 10.1016/0304-4165(76)90038-6; Aslund I, 2009, J MAGN RESON, V200, P291, DOI 10.1016/j.jmr.2009.07.015; BENGA G, 1988, PROG BIOPHYS MOL BIO, V51, P193, DOI 10.1016/0079-6107(88)90002-8; Benga G., 1989, WATER TRANSPORT BIOL; Benga G, 2013, EUR BIOPHYS J BIOPHY, V42, P33, DOI 10.1007/s00249-012-0868-7; Bernin D, 2013, CURR OPIN COLLOID IN, V18, P166, DOI 10.1016/j.cocis.2013.03.007; Callaghan P. T., 2011, TRANSLATIONAL DYNAMI; Callaghan PT, 2004, J CHEM PHYS, V120, P4032, DOI 10.1063/1.1642604; Callaghan PT, 2003, J MAGN RESON, V162, P320, DOI 10.1016/S1090-7807(03)00056-9; Chakraborty D, 2010, LANGMUIR, V26, P12940, DOI 10.1021/la101836a; Choudhury RP, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2807239; CONLON T, 1972, BIOCHIM BIOPHYS ACTA, V288, P354, DOI 10.1016/0005-2736(72)90256-8; Dyrby TB, 2014, MAGN RESON MED, V72, P756; Eden M, 2003, CONCEPTS MAGN RESO A, V18A, P24, DOI 10.1002/cmr.a.10065; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Fras-Zemljic L, 2015, REACT FUNCT POLYM, V97, p56 ; Gianolio E, 2016, BBA-BIOMEMBRANES, V1858, P627, DOI 10.1016/j.bbamem.2015.12.029; Godefroy S, 2003, MAGN RESON IMAGING, V21, P381, DOI 10.1016/S0730-725X(03)00144-9; HAINES TH, 1994, FEBS LETT, V346, P115, DOI 10.1016/0014-5793(94)00470-6; HERBST MD, 1989, AM J PHYSIOL, V256, pC1097, DOI 10.1152/ajpcell.1989.256.5.C1097; Hurlimann MD, 2002, J MAGN RESON, V157, P31, DOI 10.1006/jmre.2002.2567; Hurlimann MD, 2002, J CHEM PHYS, V117, P10223, DOI 10.1063/1.1518959; KARGER J, 1985, ADV COLLOID INTERFAC, V23, P129, DOI 10.1016/0001-8686(85)80018-X; Khrapitchev AA, 2001, J MAGN RESON, V152, P259, DOI 10.1006/jmre.2001.2402; Kuchel PW, 2006, CELL MOL BIOL, V52, P2, DOI 10.1170/T741; LABADIE C, 1994, J MAGN RESON SER B, V105, P99, DOI 10.1006/jmrb.1994.1109; Lampinen B, 2017, MAGN RESON MED, V77, P1104, DOI 10.1002/mrm.26195; Lasic S, 2016, NMR BIOMED, V29, P631, DOI 10.1002/nbm.3504; Lasic S, 2011, MAGN RESON MED, V66, P356, DOI 10.1002/mrm.22782; Maler L, 2018, NUCL SPIN RELAXATION, V2nd; Nilsson M, 2013, MAGN RESON MED, V69, P1572, DOI 10.1002/mrm.24395; Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007; Peled S, 1999, MAGNET RESON MED, V42, P911, DOI 10.1002/(SICI)1522-2594(199911)42:5<911::AID-MRM11>3.0.CO;2-J; Pfeuffer J, 1998, NMR BIOMED, V11, P19, DOI 10.1002/(SICI)1099-1492(199802)11:1<19::AID-NBM499>3.0.CO;2-O; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; PRICE HD, 1969, J MOL BIOL, V41, P443, DOI 10.1016/0022-2836(69)90287-3; Price W.S., 2009, NMR STUDIES TRANSLAT; Price WS, 1998, BIOPHYS J, V74, P2259, DOI 10.1016/S0006-3495(98)77935-4; REEVES LW, 1970, CAN J CHEMISTRY, V48, P3641, DOI 10.1139/v70-612; Roth Y, 2008, MAGN RESON IMAGING, V26, P88, DOI 10.1016/j.mri.2007.04.013; Schilling F, 2017, NAT BIOTECHNOL, V35, P75, DOI 10.1038/nbt.3714; Schonhoff M, 1997, J PHYS CHEM B, V101, P8237, DOI 10.1021/jp9711611; Shemesh N, 2016, MAGN RESON MED, V75, P82, DOI 10.1002/mrm.25901; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; TANNER JE, 1968, J CHEM PHYS, V49, P1768, DOI 10.1063/1.1670306; TANNER JE, 1970, J CHEM PHYS, V52, P2523, DOI 10.1063/1.1673336; Van Landeghem M, 2010, CONCEPT MAGN RESON A, V36A, P153, DOI 10.1002/cmr.a.20157; VANDUSSCHOTEN D, 1995, J MAGN RESON SER A, V116, P22, DOI 10.1006/jmra.1995.1185; vanDusschoten D, 1996, MAGN RESON MED, V36, P907, DOI 10.1002/mrm.1910360613; Waldeck AR, 1997, PROG NUCL MAG RES SP, V30, P39, DOI 10.1016/S0079-6565(96)01034-5; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhang YJ, 2011, BIOPHYS J, V101, P2833, DOI 10.1016/j.bpj.2011.10.035; ZIMMERMAN JR, 1957, J PHYS CHEM-US, V61, P1328, DOI 10.1021/j150556a015	58	33	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177273	10.1371/journal.pone.0177273	http://dx.doi.org/10.1371/journal.pone.0177273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493928	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300080
J	Sepulveda-Torres, LD; Rishishwar, L; Rogers, ML; Rios-Olivares, E; Boukli, N; Jordan, IK; Cubano, LA				Sepulveda-Torres, Lycely del C.; Rishishwar, Lavanya; Rogers, Maria Luisa; Rios-Olivares, Eddy; Boukli, Nawal; Jordan, I. King; Cubano, Luis A.			A decade of viral mutations and associated drug resistance in a population of HIV-1(+) Puerto Ricans: 2002-2011	PLOS ONE			English	Article							DNA-SEQUENCING SYSTEM; ANTIRETROVIRAL TREATMENT; GENOTYPING KIT; UNITED-STATES; HIV; IMPACT; PERFORMANCE; INFECTION; PROTEASE; THERAPY	Puerto Rico has one of the highest rates of HIV/AIDS seen for any US state or territory, and antiretroviral therapy has been a mainstay of efforts to mitigate the HIV/AIDS public health burden on the island. We studied the evolutionary dynamics of HIV-1 mutation and antiretroviral drug resistance in Puerto Rico by monitoring the population frequency of resistance-associated mutations from 2002 to 2011. Whole blood samples from 4,475 patients were analyzed using the TRUGENE HIV-1 Genotyping Kit and OpenGene DNA Sequencing System in the Immunoretrovirus Research Laboratory at Universidad Central del Caribe. Results show that 64.0% of female and 62.9% of male patients had HIV-1 mutations that confer resistance to at least one antiretroviral medication. L63P and M184V were the dominant mutations observed for the protease ( PRO) and reverse transcriptase ( RT) encoding genes, respectively. Specific resistance mutations, along with their associated drug resistance profiles, can be seen to form temporal clusters that reveal a steadily changing landscape of resistance trends over time. Both women and men showed resistance mutations for an average of 4.8 drugs over the 10-year period, further underscoring the strong selective pressure exerted by antiretrovirals along with the rapid adaptive response of HIV. Nevertheless, both female and male patients showed a precipitous decrease for overall drug resistance, and for PRO mutations in particular, over the entire course of the study, with the most rapid decrease in frequency seen after 2006. The reduced HIV-1 mutation and drug resistance trends that we observed are consistent with previous reports from multi-year studies conducted around the world. Reduced resistance can be attributed to the use of more efficacious antiretroviral drug therapy, including the introduction of multi-drug combination therapies, which limited the ability of the virus to mount rapid adaptive responses to antiretroviral selection pressure.	[Sepulveda-Torres, Lycely del C.; Rios-Olivares, Eddy; Boukli, Nawal; Cubano, Luis A.] Univ Cent Caribe, Dept Microbiol & Immunol, Bayamon, PR 00960 USA; [Rishishwar, Lavanya; Jordan, I. King] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Rishishwar, Lavanya; Jordan, I. King] PanAmer Bioinformat Inst, Cali, Valle Del Cauca, Colombia; [Rishishwar, Lavanya; Jordan, I. King] Appl Bioinformat Lab, Atlanta, GA USA; [Rogers, Maria Luisa] Sacred Heart Univ, Nat Sci Dept, San Juan, PR USA	University System of Georgia; Georgia Institute of Technology	Sepulveda-Torres, LD (corresponding author), Univ Cent Caribe, Dept Microbiol & Immunol, Bayamon, PR 00960 USA.	lycely.sepulveda@uccaribe.edu	Rishishwar, Lavanya/H-5587-2013	Rishishwar, Lavanya/0000-0002-2055-9392	Research Center in Minority Institution (RCMI) from the National Institutes of Health National Center for Research Resources [G12RR003035]; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	Research Center in Minority Institution (RCMI) from the National Institutes of Health National Center for Research Resources; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by a Research Center in Minority Institution (RCMI) grant number G12RR003035 from the National Institutes of Health National Center for Research Resources, https://www.nimhd.nih.gov/programs/extramural/coe/rcmi.html. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Alteri C, 2013, J ANTIMICROB CHEMOTH, V68, P2205, DOI 10.1093/jac/dkt173; Ammaranond P, 2012, FUND CLIN PHARMACOL, V26, P146, DOI 10.1111/j.1472-8206.2011.01009.x; Avila-Rios S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158560; Boyer PL, 2015, ANTIMICROB AGENTS CH, V59, P7184, DOI 10.1128/AAC.05069-14; *CDCP, 2002, HIV AIDS SURV REP 20; Centers for Disease Control and Prevention, 2012, HIV AIDS SURV REP 20; Centers for Disease Control and Prevention (CDC), 2014, EP HIV INF 2014; Charest H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109420; Chen NE, 2012, J IMMIGR MINOR HEALT, V14, P65, DOI 10.1007/s10903-011-9497-y; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Costa MGS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S5; Cubano Luis A, 2010, Bol Asoc Med P R, V102, P13; Cubano Luis A, 2008, Ethn Dis, V18, pS2; D'Aquila Richard T, 2003, Top HIV Med, V11, P92; D'Aquila Richard T., 2002, Top HIV Med, V10, P21; DAQUILA RT, 2001, TOP HIV MED, V9, P21; De Luca A, 2013, J INFECT DIS, V207, P1216, DOI 10.1093/infdis/jit017; Duani H, 2016, BRAZ J INFECT DIS; FDA, 2012, TRUGENE R HIV 1 GENO; Feder AF, 2016, ELIFE, V5, DOI 10.7554/eLife.10670; Franzetti M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-398; Gale HB, 2006, CLIN VACCINE IMMUNOL, V13, P235, DOI 10.1128/CVI.13.2.235-238.2006; Garcia D., 2015, STATE HIV AIDS HISPA; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Gupta A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S19-S10; Heron M., 2012, DEATHS LEADING CAUSE; Johnson Victoria A, 2008, Top HIV Med, V16, P62; Johnson Victoria A, 2007, Top HIV Med, V15, P119; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Johnson Victoria A, 2005, Top HIV Med, V13, P51; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Johnson Victoria A, 2004, Top HIV Med, V12, P119; Kuritzkes DR, 2003, J CLIN MICROBIOL, V41, P1594, DOI 10.1128/JCM.41.4.1594-1599.2003; Langs-Barlow A, 2014, VIRUSES-BASEL, V6, P3855, DOI 10.3390/v6103855; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; O'Brien William A 3rd, 2006, AIDS Read, V16, P38; Office of Epidemiological Research, 2016, PUERT RIC HIV AIDS S; Pennings PS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004000; Puerto Rico Department of Health, 2012, INT EP PROF HIV PREV; Richman DD, 2016, CLIN INFECT DIS, V62, P1318, DOI 10.1093/cid/ciw130; Scherrer AU, 2016, CLIN INFECT DIS, V62, P1310, DOI 10.1093/cid/ciw128; Sepulveda-Torres Ldel C, 2012, AIDS RES TREAT, V2012; Sheehan DM, 2015, INT J STD AIDS, V26, P1, DOI 10.1177/0956462414532242; Siliciano JD, 2013, CURR OPIN VIROL, V3, P487, DOI 10.1016/j.coviro.2013.08.007; Statistics N. C. F. H., 2013, HLTH US 2012 SPEC FE; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Tossas-Milligan KY, 2016, P R HEALTH SCI J, V35, P113; U. S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; US Department of Health Human Services, 2006, GUIDELINES USE ANTIR; Wensing AM, 2017, TOPICS ANTIVIRAL MED, V24	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177452	10.1371/journal.pone.0177452	http://dx.doi.org/10.1371/journal.pone.0177452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493944	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300112
J	Soleiman, AA; Thameem, F; Khan, I				Soleiman, Amal Ali; Thameem, Farook; Khan, Islam			Mechanism of down regulation of Na-H exchanger-2 in experimental colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NA+/H+ EXCHANGER; ELECTROLYTE TRANSPORT; COLONIC CRYPTS; EXPRESSION; NHE2; ISOFORM; RAT; LOCALIZATION; PROTEINS	Background The Na-H exchanger [NHE] performs an electroneutral uptake of NaCl and water from the lumen of the gastrointestinal tract. There are several distinct NHE isoforms, some of which show an altered expression in the inflammatory bowel diseases (IBD). In this study, we examined a role of NHE-2 in experimental colitis. Methods Colitis was induced in male Sprague-Dawley rats by intra-rectal administration of trinitroben-zenesulphonic acid (TNBS). On day 6 post-TNBS, the animals were sacrificed, colonic and ileal segments were taken out, cleaned with phosphate buffered saline and used in this study. Results There was a significant decrease in the level of NHE-2 protein as measured by ECL western blot analysis and confocal immunofluorescence microscopy. The levels of NHE-2 mRNA and heteronuclear RNA measured by an end-point RT-PCR and a real time PCR were also decreased significantly in the inflamed colon. However, there was no change in the level of NHE-2 protein in response to in vitro TNF-alpha treatment of uninflamed rat colonic segment. These changes were selective and localized to the colon as actin, an internal control, remained unchanged. Confocal immunofluorescence microscopy revealed co-localization of NHE-2 and NHE-3 in the brush borders of colonic epithelial cells. Inflamed colon showed a significant increase in myeloperoxidase activity and colon hypertrophy. In addition, there was a significant decrease in body weight and goblet cells' mucin staining in the TNBS treated colon. These changes were not conspicuous in the non-inflamed ileum. Conclusions These findings demonstrate suppression of NHE-2 expression on the brush borders in the colonic epithelial cells which is regulated transcriptionally. However a role of TNF-alpha in the regulation of NHE-2 is discounted in the present model of colitis. This decrease in the NHE-2 expression will lead to a loss of electrolyte and water uptake thus contributing to the symptoms associated with IBD.	[Soleiman, Amal Ali; Thameem, Farook; Khan, Islam] Kuwait Univ, Dept Biochem, Fac Med, Jabriya, Kuwait	Kuwait University	Khan, I (corresponding author), Kuwait Univ, Dept Biochem, Fac Med, Jabriya, Kuwait.	islam@hsc.edu.kw			Kuwait University Research Grant [YM 12/15]	Kuwait University Research Grant	This work was supported by the Kuwait University Research Administration through a grant (YM 12/15).; This work was supported by Kuwait University Research Grant No. [YM 12/15]. Dr James Craik for editing the manuscript. Prof Khan, Anatomy Department for allowing use of his laboratory for tissue block preparation and Histochemistry. Research Core Facility, Health Sciences Center, Kuwait University for providing technical support (Ms Gabriel J) and equipment for confocal immunofluorescence microscopy.	Al-Shamali A, 2011, SCAND J GASTROENTERO, V46, P20, DOI 10.3109/00365521.2010.521890; Amin MR, 2011, INFLAMM BOWEL DIS, V17, P720, DOI 10.1002/ibd.21419; Bachmann O, 2004, AM J PHYSIOL-GASTR L, V287, pG125, DOI 10.1152/ajpgi.00332.2003; Bou-Fersen AM, 2008, MED PRIN PRACT, V17, P190, DOI 10.1159/000117791; Chow CW, 1999, CLIN INVEST MED, V22, P195; COLLINS JF, 1993, P NATL ACAD SCI USA, V90, P3938, DOI 10.1073/pnas.90.9.3938; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Dudeja PK, 1996, AM J PHYSIOL-GASTR L, V271, pG483, DOI 10.1152/ajpgi.1996.271.3.G483; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Gawenis LR, 2002, AM J PHYSIOL-GASTR L, V282, pG776, DOI 10.1152/ajpgi.00297.2001; Goyal S, 2005, AM J PHYSIOL-RENAL, V288, pF530, DOI 10.1152/ajprenal.00229.2004; Guan YF, 2006, AM J PHYSIOL-GASTR L, V291, pG689, DOI 10.1152/ajpgi.00342.2005; HAWKER PC, 1980, GASTROENTEROLOGY, V79, P508; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Khan I, 1998, J PHARMACOL EXP THER, V285, P869; Khan I., 2006, NOVASCIENCE, P191; Kong JP, 2015, ONCOTARGET, V6, P32980, DOI 10.18632/oncotarget.5431; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Rajendran VM, 2015, J BIOL CHEM, V290, P25487, DOI 10.1074/jbc.M115.654277; Rocha F, 2001, AM J PHYSIOL-CELL PH, V280, pC1224, DOI 10.1152/ajpcell.2001.280.5.C1224; SANDLE GI, 1990, GASTROENTEROLOGY, V99, P97, DOI 10.1016/0016-5085(90)91235-X; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Siddique I, 2011, DIGEST DIS SCI, V56, P1656, DOI 10.1007/s10620-010-1524-7; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; TSE CM, 1994, BIOCHEMISTRY-US, V33, P12954, DOI 10.1021/bi00248a003; TSE CM, 1993, J BIOL CHEM, V268, P11917; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; WALLACE JL, 1995, J PHARMACOL TOXICOL, V33, P237, DOI 10.1016/1056-8719(95)00001-X; Xu H, 2005, AM J PHYSIOL-GASTR L, V289, pG36, DOI 10.1152/ajpgi.00552.2004; Yeruva S, 2010, INFLAMM BOWEL DIS, V16, P1149, DOI 10.1002/ibd.21183	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5								10.1371/journal.pone.0176767	http://dx.doi.org/10.1371/journal.pone.0176767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493993	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300032
J	Hsieh, YH				Hsieh, Ying-Hen			Ascertaining the impact of catastrophic events on dengue outbreak: The 2014 gas explosions in Kaohsiung, Taiwan	PLOS ONE			English	Article							VIRUS TRANSMISSION; INFECTIOUS-DISEASE; INTERVALS; THAILAND; ILLNESS; TSUNAMI; PATTERN; FLOODS; ASIA	Infectious disease outbreaks often occur in the aftermath of catastrophic events, either natural or man-made. While natural disasters such as typhoons/hurricanes, flooding and earthquakes have been known to increase the risk of infectious disease outbreak, the impact of anthropogenic disasters is less well-understood. Kaohsiung City is located in southern Taiwan, where most dengue outbreaks had occurred in the past two decades. It is also the center of petrochemical industry in Taiwan with pipelines running underneath city streets. Multiple underground gas explosions occurred in Kaohsiung in the evening of July 31, 2014 due to chemical leaks in the pipelines. The explosions caused 32 deaths, including five firefighters and two volunteer firefighters, and injured 321 persons. Historically, dengue outbreaks in southern Taiwan occurred mostly in small numbers of around 2000 cases or less, except in 2002 with over 5000 cases. However, in the months after the gas explosions, the city reported 14528 lab-confirmed dengue cases from August to December. To investigate the possible impact, if any, of the gas explosions on this record-breaking dengue outbreak, a simple mathematical model, the Richards model, is utilized to study the temporal patterns of the spread of dengue in the districts of Kaohsiung in the proximity of the explosion sites and to pinpoint the waves of infections that had occurred in each district in the aftermath of the gas explosions. The reproduction number of each wave in each district is also computed. In the aftermath of the gas explosions, early waves occurred 4-5 days (which coincides with the minimum of human intrinsic incubation period for dengue) later in districts with multiple waves. The gas explosions likely impacted the timing of the waves, but their impact on the magnitude of the 2014 outbreak remains unclear. The modeling suggests the need for public health surveillance and preparedness in the aftermath of future disasters.	[Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan	Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Hsieh, YH (corresponding author), China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan.	hsieh@mail.cmu.edu.tw	Hsieh, Ying-Hen/E-9685-2010		Taiwan Ministry of Science and Technology [103-2314-B-039- 010-MY3, 103-2115-M-039-002-MY2]	Taiwan Ministry of Science and Technology	This work was supported by the Taiwan Ministry of Science and Technology (https://www.most.gov.tw/), grants (103-2314-B-039- 010-MY3, 103-2115-M-039-002-MY2).	Akashi K., 1932, TAIWAN J MED, V31, P767; Aldstadt J, 2007, STOCH ENV RES RISK A, V21, P487, DOI 10.1007/s00477-007-0132-3; Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Caceres JLH, 2010, ELECT J BIOMEDICINE, V1, P87; CLARKE EJ, 1967, TROP GEOGR MED, V19, P326; de Ville de Goyet C, 1985, EMERGENCY DISASTER M; Fanany D, 2012, INT J COLLAB RES INT, V4, P673; Flores F. C., 2003, 131 ANN M NOV 15 19; Howard Michael J., 1996, Emergency Medicine Clinics of North America, V14, P413, DOI 10.1016/S0733-8627(05)70259-5; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Hsieh YH, 2013, TROP MED INT HEALTH, V18, P830, DOI 10.1111/tmi.12105; King Chwan-Chuen, 2000, Dengue Bulletin, V24, P1; Ko Y C, 1989, Gaoxiong Yi Xue Ke Xue Za Zhi, V5, P1; Kuno G, 2007, REV MED VIROL, V17, P327, DOI 10.1002/rmv.545; Oi T., 1943, TAIWAN J MED, V42, P734; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Saba H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1085; SHEARS P, 1988, LANCET, V2, P517, DOI 10.1016/S0140-6736(88)90173-0; SIDDIQUE AK, 1991, J DIARRHOEAL DIS RES, V9, P310; Taiwan Government Data Platform, 2016, DAIL CONF DENG CAS D; Tung TH, 2011, TAIWAN J PUBLIC HLTH, V30, P517; US Centers for Disease Control and Prevention (US CDC), LAB GUID DIAG TEST D; US Centers for Disease Control and Prevention (USCDC), 2016, EPIDEMIOLOGY; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang SF, 2016, AM J TROP MED HYG, V94, P193, DOI 10.4269/ajtmh.15-0422; Wang SF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.46; Wilder-Smith A, 2005, ANN ACAD MED SINGAP, V34, P625; Wiwanitkit V, 2007, TROP DOCT, V37, P194, DOI 10.1258/004947507781524575; World Health Organization, 2017, DENG SEV DENG	31	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177422	10.1371/journal.pone.0177422	http://dx.doi.org/10.1371/journal.pone.0177422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520740	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700046
J	Khoury, JM; de Freitas, AAC; Roque, MAV; Albuquerque, MR; das Neves, MDL; Garcia, FD				Khoury, Julia Machado; Correa de Freitas, Andre Augusto; Valente Roque, Marco Antonio; Albuquerque, Maicon Rodrigues; Lourenco das Neves, Maila de Castro; Garcia, Frederico Duarte			Assessment of the accuracy of a new tool for the screening of smartphone addiction	PLOS ONE			English	Article							COST-UTILITY; LIFE-STYLE; PHONE USE; DEPRESSION; ADOLESCENTS; ROC; METAANALYSIS; DISORDER; CRITERIA; ADULTS	Objective To translate, adapt and validate the Smartphone Addiction Inventory (SPAI) in a Brazilian population of young adults. Method We employed the translation and back-translation method for the adaptation of the Brazilian version SPAI (SPAI-BR). The sample consisted of 415 university students. Data was collected through an electronic questionnaire, which consisted of the SPAI-BR and the Goodman Criteria (gold standard). The retests were carried out 10-15 days after the initial tests with 130 individuals. Results The SPAI-BR maintained semantic, idiomatic and conceptual equivalences from the original scale. The Confirmatory Factor Analysis confirmed the One-factor model of the SPAI with good fit indexes (x(2) = 767.861, CFI = 0.913, TLI = 0.905, RMSE = 0.061, WRMR = 1.465). The Kuder-Richardson Coefficient showed good internal consistency. The analysis of the ROC curve established an area under the curve of 86.38%. The Intraclass-Correlation Coefficient of 0.926 between the test and the retest demonstrated an excellent temporal stability. The high correlation between SPAI-BR and the Goodman Criteria (rs = 0.750) established the convergent validity. Conclusion The SPAI-BR is a valid and reliable tool for the detection of Smartphone Addiction in Brazilian university students.	[Khoury, Julia Machado; Correa de Freitas, Andre Augusto; Valente Roque, Marco Antonio; Lourenco das Neves, Maila de Castro; Garcia, Frederico Duarte] Univ Fed Minas Gerais, Dept Mental Hlth, Belo Horizonte, MG, Brazil; [Khoury, Julia Machado; Garcia, Frederico Duarte] Univ Fed Minas Gerais, Sch Med, Postgrad Program Mol Med, Belo Horizonte, MG, Brazil; [Albuquerque, Maicon Rodrigues] Univ Fed Minas Gerais, Sch Phys Educ, Dept Sports, Belo Horizonte, MG, Brazil; [Garcia, Frederico Duarte] Univ Fed Minas Gerais, Natl Inst Sci & Technol Mol Med, Belo Horizonte, MG, Brazil; [Garcia, Frederico Duarte] Unite Inserm, Rouen, France	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Institut National de la Sante et de la Recherche Medicale (Inserm)	Garcia, FD (corresponding author), Univ Fed Minas Gerais, Dept Mental Hlth, Belo Horizonte, MG, Brazil.; Garcia, FD (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Program Mol Med, Belo Horizonte, MG, Brazil.; Garcia, FD (corresponding author), Univ Fed Minas Gerais, Natl Inst Sci & Technol Mol Med, Belo Horizonte, MG, Brazil.; Garcia, FD (corresponding author), Unite Inserm, Rouen, France.	frederico.garciad@gmail.com	Albuquerque, Maicon Rodrigues/I-6227-2013; Garcia, Frederico d/A-9402-2013; Garcia, Frederico/P-4646-2019	Albuquerque, Maicon Rodrigues/0000-0001-6021-8480; Garcia, Frederico d/0000-0003-1926-9053; Garcia, Frederico/0000-0003-1926-9053; Khoury, Julia/0000-0001-8842-4972				Abu-Jedy, 2008, JORDAN J ED SCI, V4, P137; Alavi SS, 2012, INTERNATIONAL JOURNA, V3; American Psychiatric Association (APA), 2014, MANUAL DIAGNOSTICO E, V5a; [Anonymous], 1996, PSYCHOL REP, V19, P3; [Anonymous], 2011, CLINICAL PRACTICE EP, V7; Babadi-Akashe Zahra, 2014, Addict Health, V6, P93; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Brown T, 1993, ALTERNATIVE WAYS OF; Capik C, 2015, PUBLIC HEALTH NURS, V32, P81, DOI 10.1111/phn.12156; Casey BM, 2012, LINKING PSYCHOLOGICA; Cassin SE, 2007, APPETITE, V49, P687, DOI 10.1016/j.appet.2007.06.012; Chen YF, 2006, J CYBERCULTURE INFOR, V11, P219; Choi SW, 2015, J BEHAV ADDICT, V4, P308, DOI 10.1556/2006.4.2015.043; Choliz M., 2012, PROG HLTH SCI, V2, P33, DOI DOI 10.3389/FPSYG.2016.00650; Choliz M, 2010, ADDICTION, V105, P373, DOI 10.1111/j.1360-0443.2009.02854.x; Davey S, 2014, INT J PREVENTIVE MED, V5, P1500; Del Favero S, 2015, DIABETES OBES METAB, V17, P468, DOI 10.1111/dom.12440; Demirci K, 2015, J BEHAV ADDICT, V4, P85, DOI 10.1556/2006.4.2015.010; Di Nicola M, 2015, DRUG ALCOHOL DEPEN, V148, P118, DOI 10.1016/j.drugalcdep.2014.12.028; Ezoe S, 2009, SOC BEHAV PERSONAL, V37, P231, DOI 10.2224/sbp.2009.37.2.231; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Finney S, 2006, A SECOND COURSE IN S; Flaskerud Jacquelyn H, 2012, Issues Ment Health Nurs, V33, P130, DOI 10.3109/01612840.2011.600510; Geneva WHO, 1993, CLASSIFICACAO DE TRA; GOODMAN A, 1990, BRIT J ADDICT, V85, P1403; Gras ME, 2007, ACCIDENT ANAL PREV, V39, P347, DOI 10.1016/j.aap.2006.08.006; Griffiths M, 1996, J Gambl Stud, V12, P471, DOI 10.1007/BF01539190; Ha JH, 2008, CYBERPSYCHOL BEHAV, V11, P783, DOI 10.1089/cpb.2008.0096; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Hakkaart-van Roijen L, 2006, BRIT J PSYCHIAT, V188, P323, DOI 10.1192/bjp.188.4.323; Halayem S, 2010, TUNISIE MED, P593; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hebden L, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-75; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Hye Hwang Kyung, 2012, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V12, P365, DOI 10.5392/JKCA.2012.12.10.365; James D, 2005, AUSTRALIAN AND NEW Z; Javid M, 2011, LANGUAGE INDIA, V11; Jeong SH, 2016, COMPUT HUM BEHAV, V54, P10, DOI 10.1016/j.chb.2015.07.035; Jospe MR, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3345; Kafka MP, 2013, SEX ADDICT COMPULS, V20, P19, DOI 10.1080/10720162.2013.768127; 김수미, 2014, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V53, P214, DOI 10.4306/jknpa.2014.53.4.214; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; Kline P., 1999, THE HANDBOOK OF PSYC; Kline R. B., 2015, PRINCIPLES AND PRACT; Kline R. B., 2011, PRINCIPLES AND PRACT; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lee KC, 2004, J BROADCAST ELECTRON, V48, P399, DOI 10.1207/s15506878jobem4803_4; Leung L., 2007, MEDIATED INTERPERS C, P359; Leung L, 2008, J CHILD MEDIA, V2, P93, DOI 10.1080/17482790802078565; Lin Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097838, 10.1371/journal.pone.0098312]; Lyzwinski LN, 2014, J PERS MED, V4, P311, DOI 10.3390/jpm4030311; Martinotti G, 2011, J PUBLIC HEALTH-HEID, V19, P545, DOI 10.1007/s10389-011-0422-6; Meule A, 2012, EUR EAT DISORD REV, V20, P419, DOI 10.1002/erv.2189; Park WK, 2005, COMP SUPP COMP W SER, P253; Pavia L, 2016, COMPUT HUM BEHAV, V63, P170, DOI 10.1016/j.chb.2016.05.039; Perry SD, 2007, COMMUNICAT-S AFR J C, V33, P63, DOI 10.1080/02500160701685417; Protegeles, 2005, SEGURIDAD INFANTIL Y; Puig DF, 2015, PREVENCION DEL USO P; Sanchez-Martinez M, 2009, CYBERPSYCHOL BEHAV, V12, P131, DOI 10.1089/cpb.2008.0164; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schulte M, 2016, J THORACIC ONCOLOGY, V12, DOI [DOI 10.1007/S11481016-96531, 10.1007/s11481016-96531]; Silveira Dartiu X., 2000, Revista Brasileira de Psiquiatria, V22, P4, DOI 10.1590/S1516-44462000000100003; Smetaniuk P, 2014, J BEHAV ADDICT, V3, P41, DOI 10.1556/JBA.3.2014.004; Smit F, 2006, JOURNAL OF MENTAL HE; Smits N, 2007, INT J METH PSYCH RES, V16, P219, DOI 10.1002/mpr.230; Speranza M, 2012, EUR EAT DISORD REV, V20, P182, DOI 10.1002/erv.1140; Streiner DL, 2007, CAN J PSYCHIAT, V52, P121, DOI 10.1177/070674370705200210; Targhetta R, 2013, J BEHAV ADDICT, V2, P179, DOI 10.1556/JBA.2.2013.007; Thomee S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-66; Toda M, 2006, SOC BEHAV PERSONAL, V34, P1277, DOI 10.2224/sbp.2006.34.10.1277; Trivedi D, 2015, PRIM HEALTH CARE RES, V16, P111, DOI 10.1017/S1463423615000018; Ubhi HK, 2015, J OF MEDICAL I, V17; Valenstein M, 2001, ANN INTERN MED, V134, P345, DOI 10.7326/0003-4819-134-5-200103060-00007; Walsh SP, 2008, J ADOLESCENCE, V31, P77, DOI 10.1016/j.adolescence.2007.04.004; Zhang MW, 2016, FRONTIERS IN PSYCHIA, V7	76	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176924	10.1371/journal.pone.0176924	http://dx.doi.org/10.1371/journal.pone.0176924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DX	28520798	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700032
J	Monforte, AD; Cozzi-Lepri, A; Ceccherini-Silberstein, F; De Luca, A; Lo Caputo, S; Castagna, A; Mussini, C; Cingolani, A; Tavelli, A; Shanyinde, M; Gori, A; Girardi, E; Andreoni, M; Antinori, A; Puoti, M				Monforte, Antonella d'Arminio; Cozzi-Lepri, Alessandro; Ceccherini-Silberstein, Francesca; De Luca, Andrea; Lo Caputo, Sergio; Castagna, Antonella; Mussini, Cristina; Cingolani, Antonella; Tavelli, Alessandro; Shanyinde, Milensu; Gori, Andrea; Girardi, Enrico; Andreoni, Massimo; Antinori, Andrea; Puoti, Massimo		Icona Fdn & Hepalcona Study Grp	Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort	PLOS ONE			English	Article							SOFOSBUVIR PLUS RIBAVIRIN; HEPATITIS-C; ANTIRETROVIRAL THERAPY; COINFECTED PATIENTS; GENOTYPE 1; HIV/HCV; VIRUS; BOCEPREVIR; LEDIPASVIR; CIRRHOSIS	Background Real-life data on access and response to direct antiviral agents (DAA) in HIV-HCV co-infected individuals are lacking. Methods HCV viremic, HIV-positive patients from Icona and Hepaicona cohorts naive to DAA by January 2013 were included. Access and predictors of starting DAA were evaluated. Switches of antiretroviral drugs at starting DAA were described. We calculated sustained virological response (SVR12) in those reaching 12 weeks after end-of-treatment (EOT), and defined treatment failure (TF) as discontinuation of DAA before EOT or non-SVR12. Statistical analyses included Kaplan-Meier curves, univariable and multivariable analyses evaluating predictors of access to DAA and of treatment outcome (non-SVR and TF). Results 2,607 patients included. During a median follow-up of 38 (IQR: 30-41) months, 920 (35.3%) patients started DAA. Eligibility for reimbursement was the strongest predictor to access to treatment: 761/1,090 (69.8%) eligible and 159/1,517 (10.5%) non-eligible to DAA reimbursement. Older age, HIV-RNA <= 50 copies/mL were associated to faster DAA initiation, higher CD4 count and HCV-genotype 3 with delayed DAA initiation in those eligible to DAA reimbursement. Up to 28% of patients (36% of those on ritonavir-boosted protease inhibitors, PI/r) underwent antiretroviral (ART) modification at DAA initiation. 545/595 (91.6%) patients reaching EOT achieved SVR12. Overall, TF occurred in 61/606 patients (10.1%), with 11 discontinuing DAA before EOT. Suboptimal DAA was the only independent predictor of both non-SVR12 (AHR 2.52, 95% CI: 1.24-5.12) and TF (AHR: 2.19; 95% CI: 1.13-4.22). Conclusions Only 35.3% had access to HCV treatment. Despite excellent rates of SVR12 rates (91.6%), only 21% (545/2,607) of our HIV-HCV co-infected patients are cured.	[Monforte, Antonella d'Arminio] Univ Milan, ASST St Paolo e Carlo, Dept Hlth Sci, Clin Infect & Trop Dis, Milan, Italy; [Cozzi-Lepri, Alessandro; Shanyinde, Milensu] UCL Med Sch, Div Populat Hlth, Dept Infect & Populat Hlth, Royal Free Campus, London, England; [Ceccherini-Silberstein, Francesca] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [De Luca, Andrea] Univ Siena, Dipartimento Biotecnol Med, UOC Infect Dis, Siena, Italy; [Lo Caputo, Sergio] Policlin Bari, UOC Infect Dis, Bari, Italy; [Castagna, Antonella] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Infect Dis, Milan, Italy; [Mussini, Cristina] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Infect Dis Clin, Modena, Italy; [Cingolani, Antonella] Catholic Univ Sacred Hearth, Dept Publ Hlth, Inst Clin Infect Dis, Rome, Italy; [Tavelli, Alessandro] Icona Fdn, Milan, Italy; [Gori, Andrea] Univ Milano Bicocca, ASST Monza Brianza San Gerardo Hosp, Div Infect Dis, Monza, Italy; [Girardi, Enrico] Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol, Rome, Italy; [Andreoni, Massimo] Univ Roma Tor Vergata, Clin Infect Dis, Dept Syst Med, Rome, Italy; [Antinori, Andrea] Natl Inst Infect Dis Lazzaro Spallanzani, HIV AIDS Dept, Rome, Italy; [Puoti, Massimo] ASST Grande Osped Metropolitano Niguarda, Dept Infect Dis, Milan, Italy	University of Milan; University of London; University College London; University of Rome Tor Vergata; University of Siena; Universita degli Studi di Bari Aldo Moro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Milano-Bicocca; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani	Monforte, AD (corresponding author), Univ Milan, ASST St Paolo e Carlo, Dept Hlth Sci, Clin Infect & Trop Dis, Milan, Italy.; Puoti, M (corresponding author), ASST Grande Osped Metropolitano Niguarda, Dept Infect Dis, Milan, Italy.	antonella.darminio@unimi.it; massimo.puoti@libero.it	Gori, Andrea/AAC-6078-2022; De Luca, Andrea/G-8810-2011; Mussini, Cristina/K-8672-2016; Castagna, Antonella/K-3280-2018; Antinori, Andrea/K-7125-2016; Di Maio, Velia Chiara/AGH-2628-2022; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; Puoti, Massimo/AAA-6580-2020; Ceccherini-Silberstein, Francesca/K-4762-2016; Andreoni, Masimo/AAL-2214-2020	De Luca, Andrea/0000-0002-9561-9193; Mussini, Cristina/0000-0002-6615-4198; Castagna, Antonella/0000-0002-8338-9714; Antinori, Andrea/0000-0003-2121-4684; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; Girardi, Enrico/0000-0001-8182-5896; Segala, Daniela/0000-0001-6133-0386; Lo Caputo, Sergio/0000-0002-4729-7548; Tavelli, Alessandro/0000-0001-5899-451X; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; Puoti, Massimo/0000-0003-3278-7138; d'Arminio Monforte, Antonella/0000-0003-0073-1789				Boerekamps A, 2017, CROI; Castera L, 2014, HIV MED, V15, P30, DOI 10.1111/hiv.12082; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Cope R, 2015, AIDS PATIENT CARE ST, V29, P379, DOI 10.1089/apc.2015.0004; EACS, 2016, HIV GUID; Harrington PR, 2015, CLIN INFECT DIS, V61, P974, DOI 10.1093/cid/civ419; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Piroth L, 2016, LANCET, V388, P1051, DOI 10.1016/S0140-6736(16)31540-9; Poizot-Martin I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141164; Saeed S, 2016, CLIN INFECT DIS, V62, P919, DOI 10.1093/cid/civ1222; Saxena V, 2015, HEPATOLOGY, V62, P715, DOI 10.1002/hep.27922; Sogni P, 2016, CLIN INFECT DIS, V63, P763, DOI 10.1093/cid/ciw379; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153	23	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177402	10.1371/journal.pone.0177402	http://dx.doi.org/10.1371/journal.pone.0177402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520749	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700045
J	Diem, JE; Stauber, CE; Rothenberg, R				Diem, Jeremy E.; Stauber, Christine E.; Rothenberg, Richard			Heat in the southeastern United States: Characteristics, trends, and potential health impact	PLOS ONE			English	Article							ATMOSPHERIC CIRCULATION PATTERNS; GROUND-LEVEL OZONE; CLIMATE-CHANGE; AMBIENT OZONE; VECTOR-BORNE; TEMPERATURE; MORTALITY; URBAN; PROJECTIONS; HUMIDITY	High summer temperatures in extratropical areas have an impact on the public's health, mainly through heat stress, high air pollution concentrations, and the transmission of tropical diseases. The purpose of this study is to examine the current characteristics of heat events and future projections of summer apparent temperature (AT)-and associated health concerns-throughout the southeastern United States. Synoptic climatology was used to assess the atmospheric characteristics of extreme heat days (EHDs) from 1979-2015. Ozone concentrations also were examined during EHDs. Trends in summer-season AT over the 37-year period and correlations between AT and atmospheric circulation were determined. Mid-century estimates of summer AT were calculated using downscaled data from an ensemble of global climate models. EHDs throughout the Southeast were characterized by ridging and anticyclones over the Southeast and the presence of moist tropical air masses. Exceedingly high ozone concentrations occurred on EHDs in the Atlanta area and throughout central North Carolina. While summer ATs did not increase significantly from 1979-2015, summer ATs are projected to increase substantially by mid-century, with most the Southeast having ATs similar to that of present-day southern Florida (i.e., a tropical climate). High ozone concentrations should continue to occur during future heat events. Large urban areas are expected to be the most affected by the future warming, resulting from intensifying and expanding urban heat islands, a large increase in heat-vulnerable populations, and climate conditions that will be highly suitable for tropical-disease transmission by the Aedes aegypti mosquito. This nexus of vulnerability creates the potential for heat-related morbidity and mortality, as well as the appearance of disease not previously seen in the region. These effects can be attenuated by policies that reduce urban heat (e.g., cool roofs and green roofs) and that improve infrastructure (e.g. emergency services, conditioned space).	[Diem, Jeremy E.] Georgia State Univ, Dept Geosci, Atlanta, GA 30303 USA; [Stauber, Christine E.] Georgia State Univ, Sch Publ Hlth, Div Environm Hlth, Atlanta, GA 30303 USA; [Rothenberg, Richard] Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Diem, JE (corresponding author), Georgia State Univ, Dept Geosci, Atlanta, GA 30303 USA.	jdiem@gsu.edu			National Institute of Minority Health and Health Disparities [1P20MD009572-01]	National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The study was supported by funding from a National Institute of Minority Health and Health Disparities 1P20MD009572-01 grant to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abatzoglou JT, 2012, INT J CLIMATOL, V32, P772, DOI 10.1002/joc.2312; Anderson GB, 2013, ENVIRON HEALTH PERSP, V121, P1111, DOI 10.1289/ehp.1206273; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Aneja P., 2000, CHEMOSPHERE GLOB CHA, V2, P157, DOI [10.1016/s1465-9972(00)00007-6, DOI 10.1016/S1465-9972(00)00007-6]; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bell ML, 2007, CLIMATIC CHANGE, V82, P61, DOI 10.1007/s10584-006-9166-7; Black E., 2004, WEATHER, V59, P217, DOI [10.1256/wea.74.04, DOI 10.1256/WEA.74.04]; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Butterworth MK, 2016, ENV HLTH PERSPECTIVE; Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114; Chen F, 2006, J APPL METEOROL CLIM, V45, P674, DOI 10.1175/JAM2345.1; Choudhary E, 2014, MMWR-MORBID MORTAL W, V63, P1; COMRIE AC, 1992, ATMOS ENVIRON B-URB, V26, P301, DOI 10.1016/0957-1272(92)90006-E; Cooper OR, 2000, J GEOPHYS RES-ATMOS, V105, P6855, DOI 10.1029/1999JD901015; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Davis JM, 1998, ATMOS ENVIRON, V32, P2505, DOI 10.1016/S1352-2310(98)00008-9; Davis RE, 2003, ENVIRON HEALTH PERSP, V111, P1712, DOI 10.1289/ehp.6336; Diem JE, 2006, J CLIMATE, V19, P613, DOI 10.1175/JCLI3645.1; Diem JE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006836; Diem JE, 2010, J APPL METEOROL CLIM, V49, P2185, DOI 10.1175/2010JAMC2454.1; Diem JE, 2009, ATMOS ENVIRON, V43, P3902, DOI 10.1016/j.atmosenv.2009.04.050; Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214; Environmental Protection Agency U. S, 2015, NAT AMB AIR QUAL STA; Fischer EM, 2013, NAT CLIM CHANGE, V3, P126, DOI [10.1038/nclimate1682, 10.1038/NCLIMATE1682]; Florida Department of Environmental Protection, 2012, FLOR OZ PART MATT QU; Georgescu M, 2014, P NATL ACAD SCI USA, V111, P2909, DOI 10.1073/pnas.1322280111; Giannini A, 2001, J CLIMATE, V14, P2867, DOI 10.1175/1520-0442(2001)014<2867:ICITET>2.0.CO;2; Greene S, 2011, WEATHER CLIM SOC, V3, P281, DOI 10.1175/WCAS-D-11-00055.1; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Helsel D. R., 2002, TECHNIQUES WATER RES, V4, pA3, DOI DOI 10.2307/1269385; Hou P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23792; Jia LW, 2016, J CLIMATE, V29, P4121, DOI 10.1175/JCLI-D-15-0471.1; Johnson DP, 2009, APPL GEOGR, V29, P419, DOI 10.1016/j.apgeog.2008.11.004; KALKSTEIN LS, 1989, ANN ASSOC AM GEOGR, V79, P44, DOI 10.1111/j.1467-8306.1989.tb00249.x; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Konrad C.E., 2013, CLIMATE SE US, P8, DOI DOI 10.5822/978-1-61091-509-0_7; Kunkel KE, 1996, B AM METEOROL SOC, V77, P1507, DOI 10.1175/1520-0477(1996)077<1507:TJHWIT>2.0.CO;2; Kunkel KE, 2010, J CLIMATE, V23, P4447, DOI 10.1175/2010JCLI3349.1; Li D, 2013, J APPL METEOROL CLIM, V52, P2051, DOI 10.1175/JAMC-D-13-02.1; Loikith PC, 2012, J CLIMATE, V25, P7266, DOI 10.1175/JCLI-D-11-00709.1; Maier G, 2014, WEATHER CLIM SOC, V6, P253, DOI 10.1175/WCAS-D-13-00037.1; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; McKinnon KA, 2016, NAT GEOSCI, V9, P389, DOI [10.1038/ngeo2687, 10.1038/NGEO2687]; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Monaghan AJ, 2016, PLOS CURRENT OUTBREA; National Weather Service, 2014, MET CONV CALC HEAT I; Oke TR, 1992, BOUNDARY LAYER CLIMA; Palecki MA, 2001, B AM METEOROL SOC, V82, P1353, DOI 10.1175/1520-0477(2001)082<1353:TNAIOT>2.3.CO;2; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pfister GG, 2014, J GEOPHYS RES-ATMOS, V119, P5559, DOI 10.1002/2013JD020932; Reid CE, 2012, ENVIRON HEALTH PERSP, V120, P1627, DOI 10.1289/ehp.1205251; Santer BD, 2003, J GEOPHYS RES, V301, P479; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Sheridan SC, 2002, INT J CLIMATOL, V22, P51, DOI 10.1002/joc.709; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; SILLMAN S, 1995, J GEOPHYS RES-ATMOS, V100, P11497, DOI 10.1029/94JD02146; STEADMAN RG, 1979, J APPL METEOROL, V18, P861, DOI 10.1175/1520-0450(1979)018<0861:TAOSPI>2.0.CO;2; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; U. S. Census Bureau, 2011, RES POP DAT INT; Wu SL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008917; Zhang YZ, 2016, P NATL ACAD SCI USA, V113, P10025, DOI 10.1073/pnas.1602563113	66	21	21	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177937	10.1371/journal.pone.0177937	http://dx.doi.org/10.1371/journal.pone.0177937			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520817	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500082
J	van der Hoeven, T; Browne, JL; Uiterwaal, CSPM; van der Ent, CK; Grobbee, DE; Dalmeijer, GW				van der Hoeven, Timothy; Browne, Joyce L.; Uiterwaal, Cuno S. P. M.; van der Ent, Cornelis K.; Grobbee, Diederick E.; Dalmeijer, Geertje W.			Antenatal coffee and tea consumption and the effect on birth outcome and hypertensive pregnancy disorders	PLOS ONE			English	Article							MATERNAL CAFFEINE INTAKE; FOLIC-ACID; RISK; WEIGHT; HOMOCYSTEINE; TRIMESTER; DRINKING; GROWTH	Background and objective Coffee and tea are commonly consumed during pregnancy. While several of their components, like caffeine, have strong pharmacological effects, the effect on the unborn fetus remains unclear. Caffeine intake has been associated with abortion, preterm birth and fetal growth restriction, but a general consensus on caffeine restriction is still lacking. We aimed to investigate antenatal coffee, tea and caffeine consumption and the effect on birth weight and length, gestational age at birth and hypertensive disorders in pregnancy. Methods A total of 936 healthy pregnancies from the WHISTLER birth cohort with data on coffee and tea consumption were included. Maternal and child characteristics as well as antenatal coffee and tea consumption were obtained through postpartum questionnaires. Reported consumption was validated using available preconceptional data. Caffeine intake was calculated from coffee and tea consumption. Linear and logistic regression was used to assess the association with birth outcome and hypertensive disorders. Results After adjustment for smoking and maternal age, a daily consumption of more than 300mg of caffeine compared to less than 100mg of caffeine was significantly associated with an increased gestational age (linear regression coefficient = 2.00 days, 95% CI = 0.12-4.21, P = 0.03). Tea consumption was significantly related to a higher risk of pregnancy induced hypertension (OR = 1.13, 95% CI = 1.04-1.23, P = 0.004). No associations concerning coffee consumption or birth weight and birth length were observed. Conclusions Daily caffeine consumption of more than 300mg is possibly associated with an increase in gestational age at birth. A possible relation between high tea consumption and increased risk for pregnancy induced hypertension warrants further research. For most outcomes, we found no significant associations with coffee or tea intake.	[van der Hoeven, Timothy; Browne, Joyce L.; Uiterwaal, Cuno S. P. M.; Grobbee, Diederick E.; Dalmeijer, Geertje W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Ent, Cornelis K.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	van der Hoeven, T (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	trvanderhoeven@gmail.com		Van der Ent, Cornelis/0000-0002-2501-4121	Netherlands Organization for Health Research and Development [2001-1-1322]; GlaxoSmithKline Netherlands	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); GlaxoSmithKline Netherlands(GlaxoSmithKline)	The authors received no specific funding for this article. The WHISTLER birth cohort was supported with a grant from the Netherlands Organization for Health Research and Development (Grant 2001-1-1322) and by an unrestricted grant from GlaxoSmithKline Netherlands. GlaxoSmithKline had no role in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the report for publication.	[Anonymous], 2010, Obstet Gynecol, V116, P467, DOI 10.1097/AOG.0b013e3181eeb2a1; Bakker R, 2011, AM J HYPERTENS, V24, P421, DOI 10.1038/ajh.2010.242; Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bech BH, 2007, BMJ-BRIT MED J, V334, P409, DOI 10.1136/bmj.39062.520648.BE; Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Centraal Bureau voor de Statistiek Nederland (CBS), 2013, BEV LENGT GEW BIJ GE; Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6; Chiaffarino F, 2006, EUR J CLIN NUTR, V60, P610, DOI 10.1038/sj.ejcn.1602358; Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Committee on Toxicity FSA UK, 2001, COT STAT REPR EFF CA; de la Calle M, 2003, EUR J OBSTET GYN R B, V107, P125, DOI 10.1016/S0301-2115(02)00305-6; DeJong-Potjer LC, 2011, HUISARTS WET, V54, P310; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Eskenazi B, 1999, EPIDEMIOLOGY, V10, P242, DOI 10.1097/00001648-199905000-00009; FENSTER L, 1991, AM J PUBLIC HEALTH, V81, P458, DOI 10.2105/AJPH.81.4.458; Goh YI, 2008, J OBSTET GYNAECOL, V28, P3, DOI 10.1080/01443610701814195; Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x; Grobbee DE, 2005, EUR J EPIDEMIOL, V20, P285, DOI 10.1007/s10654-004-5689-2; Grosso LM, 2001, EPIDEMIOLOGY, V12, P447, DOI 10.1097/00001648-200107000-00015; Hoyt AT, 2013, MATERN CHILD HLTH J; Infante-Rivard C, 2007, PAEDIATR PERINAT EP, V21, P300, DOI 10.1111/j.1365-3016.2007.00825.x; Jarosz M, 2012, EUR J OBSTET GYN R B, V160, P156, DOI 10.1016/j.ejogrb.2011.11.021; Katier N, 2004, EUR J EPIDEMIOL, V19, P895, DOI 10.1023/B:EJEP.0000040530.98310.0c; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32; MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718; Muhajarine N, 1997, CAN J PUBLIC HEALTH, V88, P375, DOI 10.1007/BF03403909; Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG), 2005, HYP DIS PREGN V2 0 N; Newman M, 2006, COFFEE CONSUMPTION; Oesterheld JR, 1998, J CHILD ADOL PSYCHOP, V8, P161, DOI 10.1089/cap.1998.8.161; Okubo H, 2015, NUTR RES, V35, P309, DOI 10.1016/j.nutres.2015.02.009; Olthof MR, 2001, AM J CLIN NUTR, V73, P532; Parazzini F, 2005, EUR J CLIN NUTR, V59, P299, DOI 10.1038/sj.ejcn.1602052; PEACOCK JL, 1991, J EPIDEMIOL COMMUN H, V45, P159, DOI 10.1136/jech.45.2.159; Pollack AZ, 2010, FERTIL STERIL, V93, P304, DOI 10.1016/j.fertnstert.2009.07.992; Roseboom T J, 2001, Twin Res, V4, P293, DOI 10.1375/1369052012605; Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42; Sharbaf F. R., 2013, Journal of Family and Reproductive Health, V7, P127; Stichting Perinatale Registratie Nederland, NETH PER REG; Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244; Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x; WEATHERSBEE PS, 1977, POSTGRAD MED, V62, P64, DOI 10.1080/00325481.1977.11714605; Wei SQ, 2009, INT J GYNECOL OBSTET, V105, P123, DOI 10.1016/j.ijgo.2008.12.003; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	48	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177619	10.1371/journal.pone.0177619	http://dx.doi.org/10.1371/journal.pone.0177619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520809	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500046
J	Palich, R; Irenge, LM; Sainte Fare, EBD; Augier, A; Malvy, D; Gala, JL				Palich, Romain; Irenge, Leonid M.; Fare, Eric Barte de Sainte; Augier, Augustin; Malvy, Denis; Gala, Jean-Luc			Ebola virus RNA detection on fomites in close proximity to confirmed Ebola patients; N'Zerekore, Guinea, 2015	PLOS ONE			English	Article							TRANSMISSION; FLUIDS; RISK	Objective Health care workers (HCWs) in contact with patients with Ebola virus disease (EVD) are exposed to a risk of viral contamination. Fomites contaminated with the patient's blood or body fluids represents this risk. Our study aims to detect Ebola virus (EBOV) RNA within the high-and low-risk areas of an Ebola treatment unit (ETU) located in inland Guinea during the 2014 - 2015 West African Ebola epidemics. For samples from patients' immediate vicinity, we aim to seek an association between viral RNA detectability and level of plasma viral load of patients (intermediate to high, or very high). Methods Swabbing was performed on immediate vicinity of Ebola patients, on surfaces of an ETU, and on personal protective equipment (PPE) of HCWs after patient care and prior to doffing. All samples were assessed by quantitative reverse-transcribed PCR (RT-qPCR). Results 32% (22/68) of swabs from high-risk areas were tested positive for EBOV RNA, including 42% (18/43) from patients' immediate vicinity, and 16% (4/25) from HCWs PPE. None of specimens from low-risk areas were tested positive (0/19). Swabs were much more often viral RNA positive in the vicinity of patients with a very high plasma viral load (OR 6.7, 95% CI [1.7 - 23.4]). Conclusion Our findings show the persistence of EBOV RNA in the environment of Ebola patients and of HCWs, in a Guinean ETU, despite strict infection prevention and control measures. This detection raises the possibility that patients' environment could be a potential source of contamination with the virus.	[Palich, Romain; Fare, Eric Barte de Sainte; Augier, Augustin] Alliance Int Med Act, Dakar, Senegal; [Irenge, Leonid M.; Gala, Jean-Luc] Louvain Catholic Univ, Ctr Appl Mol Technol, Brussels, Belgium; [Malvy, Denis] Univ Hosp Bordeaux, Dept Trop Med & Clin Int Hlth, Div Infect & Trop Dis, Bordeaux, France; [Malvy, Denis] Univ Bordeaux, INSERM1219, Bordeaux, France	Universite Catholique Louvain; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Palich, R (corresponding author), Alliance Int Med Act, Dakar, Senegal.	romain.palich@alima-ngo.org	MALVY, Denis/T-7930-2019; Palich, Romain/ABZ-1131-2022	Palich, Romain/0000-0003-0047-0101				Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Centers for Disease Control and Prevention (CDC), GEN HEALTHC SETT W A; Dowell SF, 1995, TRANSMISSION EBOLA H, V179, pS87; Fischer R, 2015, EMERG INFECT DIS, V21, P1243, DOI 10.3201/eid2107.150253; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Poliquin PG, 2016, J INFECT DIS, V214, pS145, DOI 10.1093/infdis/jiw198; Roels TH, 1999, J INFECT DIS, V179, pS92, DOI 10.1086/514286; Schuit M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148476; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Spengler JR, 2015, J INFECT DIS, V212, pS346, DOI 10.1093/infdis/jiv187; Wamala JF, 2010, EMERG INFECT DIS, V16, P1087, DOI 10.3201/eid1607.091525; WHO, 2015, EB SIT REP; Youkee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145167	13	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177350	10.1371/journal.pone.0177350	http://dx.doi.org/10.1371/journal.pone.0177350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493945	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300091
J	Cerri, CEP; You, X; Cherubin, MR; Moreira, CS; Raucci, GS; Castigioni, BD; Alves, PA; Cerri, DGP; Mello, FFD; Cerri, CC				Pellegrino Cerri, Carlos Eduardo; You, Xin; Cherubin, Mauricio Roberto; Moreira, Cindy Silva; Raucci, Guilherme Silva; Castigioni, Bruno de Almeida; Alves, Priscila Aparecida; Pellegrino Cerri, Domingos Guilherme; de Castro Mello, Francisco Fujita; Cerri, Carlos Clemente			Assessing the greenhouse gas emissions of Brazilian soybean biodiesel production	PLOS ONE			English	Article							SOIL CARBON STOCKS; FOOTPRINT; BIOFUEL; AGRICULTURE; BIOENERGY; CERRADO	Soybean biodiesel (B100) has been playing an important role in Brazilian energy matrix towards the national bio-based economy. Greenhouse gas (GHG) emissions is the most widely used indicator for assessing the environmental sustainability of biodiesels and received particular attention among decision makers in business and politics, as well as consumers. Former studies have been mainly focused on the GHG emissions from the soybean cultivation, excluding other stages of the biodiesel production. Here, we present a holistic view of the total GHG emissions in four life cycle stages for soybean biodiesel. The aim of this study was to assess the GHG emissions of Brazilian soybean biodiesel production system with an integrated life cycle approach of four stages: agriculture, extraction, production and distribution. Allocation of mass and energy was applied and special attention was paid to the integrated and non-integrated industrial production chain. The results indicated that the largest source of GHG emissions, among four life cycle stages, is the agricultural stage (42-51%) for B100 produced in integrated systems and the production stage (46-52%) for B100 produced in non-integrated systems. Integration of industrial units resulted in significant reduction in life cycle GHG emissions. Without the consideration of LUC and assuming biogenic CO2 emissions is carbon neutral in our study, the calculated life cycle GHG emissions for domestic soybean biodiesel varied from 23.1 to 25.8 gCO(2)eq. MJ(-1) B100 and those for soybean biodiesel exported to EU ranged from 26.5 to 29.2 gCO(2)eq. MJ(-1) B100, which represent reductions by 65% up to 72% (depending on the delivery route) of GHG emissions compared with the EU benchmark for diesel fuel. Our findings from a life cycle perspective contributed to identify the major GHG sources in Brazilian soybean biodiesel production system and they can be used to guide mitigation priority for policy and decisionmaking. Projected scenarios in this study would be taken as references for accounting the environmental sustainability of soybean biodiesel within a domestic and global level.	[Pellegrino Cerri, Carlos Eduardo; You, Xin] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Soil Sci, 11 Padua Dias Ave, Piracicaba, SP, Brazil; [You, Xin] Univ Hohenheim, Fac Agr Sci, Inst Soil Sci & Land Evaluat 310, Stuttgart, Germany; [Cherubin, Mauricio Roberto; Cerri, Carlos Clemente] Univ Sao Paulo, Ctr Nucl Energy Agr, 303 Centenario Ave, Piracicaba, SP, Brazil; [Moreira, Cindy Silva] Brazilian Vegetable Oil Ind Assoc, 3707 Vereador Jose Diniz Ave, Sao Paulo, SP, Brazil; [Raucci, Guilherme Silva] Espaco Eco Fdn, 230 Ribeirao do Soldado Rd, Sao Bernardo Do Campo, SP, Brazil; [Castigioni, Bruno de Almeida; Alves, Priscila Aparecida; Pellegrino Cerri, Domingos Guilherme] DeltaCO2 Sustentabilidade Ambiental, 600 Cezira Giovanoni Moretti St, Piracicaba, SP, Brazil; [de Castro Mello, Francisco Fujita] Minist Agr Livestock & Food Supply, Dept Dev Prod Chains & Sustainable Prod, Bl D Anexo 1 Aandar Ala B Sl 137, Brasilia, DF, Brazil	Universidade de Sao Paulo; University Hohenheim; Universidade de Sao Paulo	Cerri, CEP (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Soil Sci, 11 Padua Dias Ave, Piracicaba, SP, Brazil.	cepcerri@usp.br	Cherubin, Mauricio/A-6896-2016; Cerri, Carlos Eduardo p/C-5039-2012	Cherubin, Mauricio/0000-0001-7920-8362; Cerri, Carlos Eduardo p/0000-0002-4374-4056	National Council for Scientific and Technological Development (CNPq) Brazil; DAAD; BMBF; CSM (Brazilian Vegetable Oil Industries Association); GSR (Espaco Eco Foundation); BAC; PM; DGPC (DeltaCO2 - Sustentabilidade Ambiental)	National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); BMBF(Federal Ministry of Education & Research (BMBF)); CSM (Brazilian Vegetable Oil Industries Association); GSR (Espaco Eco Foundation); BAC; PM; DGPC (DeltaCO2 - Sustentabilidade Ambiental)	CEPC and CCC thank the National Council for Scientific and Technological Development (CNPq) Brazil for their productivity grants. XY thanks the Strategic Network Bio-based Economy (BECY) supported by DAAD and BMBF for providing his mobility research fellowship. The authors CSM (Brazilian Vegetable Oil Industries Association), GSR (Espaco Eco Foundation), BAC, PM and DGPC (DeltaCO2 - Sustentabilidade Ambiental) thank their respective companies for providing support in form of salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Almeida MC, 2008, EXTEMALIDADES ANALIS, P160; [Anonymous], 2016, BIOD STAT; ANP-Agencia Nacional de Petroleo Gas Natural e Biocombustiveis, 2016, AN DAD EST; Bjorklund AE, 2002, INT J LIFE CYCLE ASS, V7, P64, DOI 10.1065/lca2001.12/071; Brazil, 2015, FEDERATIVE REPUBLIC; Castanheira EG, 2013, J CLEAN PROD, V54, P49, DOI 10.1016/j.jclepro.2013.05.026; Cavalett O, 2010, J CLEAN PROD, V18, P55, DOI 10.1016/j.jclepro.2009.09.008; Cerri CEP, 2014, AGR ECOSYST ENVIRON, V183, P167; Cleary J, 2009, ENVIRON INT, V35, P1256, DOI 10.1016/j.envint.2009.07.009; Conab-Companhia Brasileira de Agricultura e Abastecimento, 2016, COMP BRAS AGR AB AC, V10; da Silva VP, 2010, J ENVIRON MANAGE, V91, P1831, DOI 10.1016/j.jenvman.2010.04.001; Davis SC, 2013, GCB BIOENERGY, V5, P623, DOI 10.1111/gcbb.12042; Davis SC, 2012, FRONT ECOL ENVIRON, V10, P69, DOI 10.1890/110003; Ecoinvent, 2010, LIF CYCL INV DAT BAS; European Commission, 2009, OFF J EUR UNION, V5, P16; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Finkbeiner M, 2009, INT J LIFE CYCLE ASS, V14, P91, DOI 10.1007/s11367-009-0064-x; Flach B, 2012, EU 27 OILSEEDS PRODU; de Alvarenga RAF, 2012, J CLEAN PROD, V28, P25, DOI 10.1016/j.jclepro.2011.06.023; Goldemberg J, 2014, ENERG POLICY, V69, P14, DOI 10.1016/j.enpol.2014.02.008; Grisoli R, 2015, J CLEAN PROD; Heijungs R., 1996, J CLEAN PROD, V4, P159, DOI [10.1016/S0959-6526(96)00042-X, DOI 10.1016/S0959-6526(96)00042-X]; IPCC, 2007, CLIMATE CHANGE 2007; ISO, 2006, 14044 ISO; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Kim S, 2009, INT J LIFE CYCLE ASS, V14, P540, DOI 10.1007/s11367-009-0106-4; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; Laurent A, 2010, CIRP ANN-MANUF TECHN, V59, P37, DOI 10.1016/j.cirp.2010.03.008; Lehuger S, 2009, J CLEAN PROD, V17, P616, DOI 10.1016/j.jclepro.2008.10.005; Macedo IC, 2008, BIOMASS BIOENERG, V32, P582, DOI 10.1016/j.biombioe.2007.12.006; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Maciel VG, 2016, J CLEAN PROD, V131, P747, DOI 10.1016/j.jclepro.2016.04.100; Miranda E, 2016, LAND DEGRAD DEV, V27, P1586, DOI 10.1002/ldr.2473; Neto MS, 2010, SOIL TILL RES, V110, P187, DOI 10.1016/j.still.2010.07.010; Ozturk I., 2015, GCB BIOENERGY, V8, P826; Ozturk I, 2016, BIOFUEL BIOPROD BIOR, V10, P150, DOI 10.1002/bbb.1628; Panichelli L, 2009, INT J LIFE CYCLE ASS, V14, P144, DOI 10.1007/s11367-008-0050-8; Esteves VPP, 2016, CLEAN TECHNOL ENVIR, V18, P1655, DOI 10.1007/s10098-016-1161-8; Persson UM, 2014, GLOBAL CHANGE BIOL, V20, P3482, DOI 10.1111/gcb.12635; Pradhan A, 2012, T ASABE, V55, P2257; Raucci GS, 2015, J CLEAN PROD, V96, P418, DOI 10.1016/j.jclepro.2014.02.064; Solomon BD, 2015, ENVIRON MANAGE, V56, P1276, DOI 10.1007/s00267-014-0424-6; United Soybean Board, 2009, APPL RECENT US SOYBE; US EPA-Environmental Protection Agency, 2010, FIN REG NAT REN FUEL; USDA, 2014, BRAZ BIOF ANN USDA F; Uusitalo V, 2014, RENEW ENERG, V69, P103, DOI 10.1016/j.renene.2014.03.020; Vigon B.W., 1993, LIFE CYCLE ASSESSMEN; Weidema BP, 2008, J IND ECOL, V12, P3, DOI 10.1111/j.1530-9290.2008.00005.x; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; Wolfram P, 2016, J CLEAN PROD, V124, P236, DOI 10.1016/j.jclepro.2016.02.080; WRI, 2001, GREENH GAS PROT CORP; Zamagni A, 2008, MAIN R D LINES IMPRO, P5	53	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176948	10.1371/journal.pone.0176948	http://dx.doi.org/10.1371/journal.pone.0176948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493965	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300043
J	Sanchez-Mendoza, EH; Bellver-Landete, V; Arce, C; Doeppner, TR; Hermann, DM; Oset-Gasque, MJ				Sanchez-Mendoza, Eduardo H.; Bellver-Landete, Victor; Arce, Carmen; Doeppner, Thorsten R.; Hermann, Dirk M.; Jesus Oset-Gasque, Maria			Vesicular glutamate transporters play a role in neuronal differentiation of cultured SVZ-derived neural precursor cells	PLOS ONE			English	Article							MURINE SUBVENTRICULAR ZONE; CEREBRAL-ISCHEMIA; NEUROPATHIC PAIN; STEM-CELLS; RAT-BRAIN; NEUROGENESIS; EXPRESSION; RECEPTORS; PROMOTES; PROLIFERATION	The role of glutamate in the regulation of neurogenesis is well-established, but the role of vesicular glutamate transporters (VGLUTs) and excitatory amino acid transporters (EAATs) in controlling adult neurogenesis is unknown. Here we investigated the implication of VGLUTs in the differentiation of subventricular zone (SVZ)-derived neural precursor cells (NPCs). Our results show that NPCs express VGLUT1-3 and EAAT1-3 both at the mRNA and protein level. Their expression increases during differentiation closely associated with the expression of marker genes. In expression analyses we show that VGLUT1 and VGLUT2 are preferentially expressed by cultured SVZ-derived doublecortin+ neuroblasts, while VGLUT3 is found on GFAP+ glial cells. In cultured NPCs, inhibition of VGLUT by Evans Blue increased the mRNA level of neuronal markers doublecortin, B3T and MAP2, elevated the number of NPCs expressing doublecortin protein and promoted the number of cells with morphological appearance of branched neurons, suggesting that VGLUT function prevents neuronal differentiation of NPCs. This survival-and differentiation-promoting effect of Evans blue was corroborated by increased AKT phosphorylation and reduced MAPK phosphorylation. Thus, under physiological conditions, VGLUT1-3 inhibition, and thus decreased glutamate exocytosis, may promote neuronal differentiation of NPCs.	[Sanchez-Mendoza, Eduardo H.; Bellver-Landete, Victor; Arce, Carmen; Jesus Oset-Gasque, Maria] Univ Complutense Madrid, Dept Biochem & Mol Biol, Fac Pharm, Madrid, Spain; [Sanchez-Mendoza, Eduardo H.; Hermann, Dirk M.] Univ Duisburg Essen, Dept Neurol, Essen, Germany; [Doeppner, Thorsten R.] Univ Gottingen, Dept Neurol, Med Sch, Gottingen, Germany; [Jesus Oset-Gasque, Maria] Univ Complutense Madrid, Inst Univ Invest Neuroquim, Madrid, Spain	Complutense University of Madrid; University of Duisburg Essen; University of Gottingen; Complutense University of Madrid	Oset-Gasque, MJ (corresponding author), Univ Complutense Madrid, Dept Biochem & Mol Biol, Fac Pharm, Madrid, Spain.; Oset-Gasque, MJ (corresponding author), Univ Complutense Madrid, Inst Univ Invest Neuroquim, Madrid, Spain.	mjoset@ucm.es	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk/GZB-9350-2022; Oset Gasque, Maria Jesus/I-1072-2015	Hermann, Dirk M./0000-0003-0198-3152; Oset Gasque, Maria Jesus/0000-0002-7223-0222	Ministry of Economy and Competitiveness (MINECO, Spain) [SAF2010-20337, BFU-2013-43163-R]; Complutense University of Madrid-Santander Bank [GR35/10-B and GR3/14]; Institute of Health Carlos III, ISCIII [RD06/0026/0012]	Ministry of Economy and Competitiveness (MINECO, Spain); Complutense University of Madrid-Santander Bank; Institute of Health Carlos III, ISCIII	This study was supported by the grants SAF2010-20337 and BFU-2013-43163-R from Ministry of Economy and Competitiveness (MINECO, Spain), GR35/10-B and GR3/14 (Complutense University of Madrid-Santander Bank) and RD06/0026/0012 (Institute of Health Carlos III, ISCIII). E. Sanchez-Mendoza has contract from RD06/0026/0012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the grants SAF2010-20337 from Ministry of Economy and Competitiveness (MINECO, Spain), GR35/10-B and GR3/14 (Complutense University of Madrid-Santander Bank) and RD06/0026/0012 (Institute of Health Carlos III, ISCIII) to MJ. Oset-Gasque. E. Sanchez-Mendoza has a contract from RD06/0026/0012.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Arranz AM, 2010, NEUROBIOL DIS, V37, P156, DOI 10.1016/j.nbd.2009.09.019; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bath KG, 2010, DEV NEUROBIOL, V70, P339, DOI 10.1002/dneu.20781; Castillo J, 2003, NEUROLOGIA, V18, P368; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Coronas V, 2004, J NEUROCHEM, V91, P1292, DOI 10.1111/j.1471-4159.2004.02823.x; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gu WG, 2010, STEM CELL RES, V4, P148, DOI 10.1016/j.scr.2009.12.001; Gundersen V, 2015, PHYSIOL REV, V95, P695, DOI 10.1152/physrev.00024.2014; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Islam MM, 2015, BBA-GENE REGUL MECH, V1849, P210, DOI 10.1016/j.bbagrm.2014.06.001; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kashani A, 2007, NEUROBIOL AGING, V28, P568, DOI 10.1016/j.neurobiolaging.2006.02.010; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kim Y, 2010, J NEUROCHEM, V114, P750, DOI 10.1111/j.1471-4159.2010.06799.x; Li L, 2006, J ENG FIBER FABR, V1, P1; Martinez-Lozada Z, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/787396; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Nakamichi N, 2009, J PHARMACOL SCI, V110, P133, DOI 10.1254/jphs.08R03CR; Perez-Rodriguez R, 2009, J NEUROCHEM, V108, P1083, DOI 10.1111/j.1471-4159.2008.05862.x; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3783, DOI 10.1113/jphysiol.2008.155879; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3739, DOI 10.1113/jphysiol.2008.155325; Platel JC, 2007, J MOL HISTOL, V38, P601, DOI 10.1007/s10735-007-9153-y; Platel JC, 2010, BRAIN RES REV, V63, P60, DOI 10.1016/j.brainresrev.2010.02.004; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Preobraschenski J, 2014, NEURON, V84, P1287, DOI 10.1016/j.neuron.2014.11.008; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Ransome MI, 2008, MOL CELL NEUROSCI, V38, P537, DOI 10.1016/j.mcn.2008.05.002; ROSETH S, 1995, J NEUROCHEM, V65, P96; Sanchez-Mendoza E, 2013, NEUROPATH APPL NEURO, V39, P722, DOI 10.1111/nan.12082; Sanchez-Mendoza E, 2010, J NEUROCHEM, V113, P1343, DOI 10.1111/j.1471-4159.2010.06707.x; Santos MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109824; Schramm J, 2014, NEUROSCI LETT, V562, P69, DOI 10.1016/j.neulet.2014.01.003; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Uda Y, 2016, STEM CELL REP, V6, P474, DOI 10.1016/j.stemcr.2016.02.007; Wallen-Mackenzie A, 2010, UPSALA J MED SCI, V115, P11, DOI 10.3109/03009730903572073; Wang ZT, 2015, BRAIN RES, V1624, P515, DOI 10.1016/j.brainres.2015.08.010; Weng HR, 2014, EXP NEUROL, V252, P18, DOI 10.1016/j.expneurol.2013.11.018; Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Xia WL, 2015, STEM CELL REP, V4, P795, DOI 10.1016/j.stemcr.2015.03.004; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhu GZ, 2015, EXP MOL PATHOL, V99, P474, DOI 10.1016/j.yexmp.2015.09.002	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177069	10.1371/journal.pone.0177069	http://dx.doi.org/10.1371/journal.pone.0177069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493916	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300056
J	Tilley, SK; Joseph, RM; Kuban, KCK; Dammann, OU; O'Shea, TM; Fry, RC				Tilley, Sloane K.; Joseph, Robert M.; Kuban, Karl C. K.; Dammann, Olaf U.; O'Shea, T. Michael; Fry, Rebecca C.			Genomic biomarkers of prenatal intrauterine inflammation in umbilical cord tissue predict later life neurological outcomes	PLOS ONE			English	Article							EXTREMELY PRETERM INFANTS; SYSTEMIC INFLAMMATION; CEREBRAL-PALSY; 28TH WEEK; GESTATION; RISK; AGE; PROTEINS; NEWBORNS; NEUROGENESIS	Background Preterm birth is a major risk factor for neurodevelopmental delays and disorders. This study aimed to identify genomic biomarkers of intrauterine inflammation in umbilical cord tissue in preterm neonates that predict cognitive impairment at 10 years of age. Study design Genome-wide messenger RNA (mRNA) levels from umbilical cord tissue were obtained from 43 neonates born before 28 weeks of gestation. Genes that were differentially expressed across four indicators of intrauterine inflammation were identified and their functions examined. Exact logistic regression was used to test whether expression levels in umbilical cord tissue predicted neurocognitive function at 10 years of age. Results Placental indicators of inflammation were associated with changes in the mRNA expression of 445 genes in umbilical cord tissue. Transcripts with decreased expression showed significant enrichment for biological signaling processes related to neuronal development and growth. The altered expression of six genes was found to predict neurocognitive impairment when children were 10 years old These genes include two that encode for proteins involved in neuronal development. Conclusion Prenatal intrauterine inflammation is associated with altered gene expression in umbilical cord tissue. A set of six of the differentially expressed genes predict cognitive impairment later in life, suggesting that the fetal environment is associated with significant adverse effects on neurodevelopment that persist into later childhood.	[Tilley, Sloane K.; Fry, Rebecca C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Joseph, Robert M.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Kuban, Karl C. K.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Dammann, Olaf U.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [O'Shea, T. Michael] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Fry, Rebecca C.] Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Boston University; Boston University; Massachusetts Department of Public Health; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fry, RC (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.; Fry, RC (corresponding author), Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC 27599 USA.	rfry@unc.edu		Fry, Rebecca/0000-0003-0899-9018; Joseph, Robert/0000-0001-6879-0254	National Institutes of Health [R01 ES019315, P42 ES005948, 5U01NS040069-05, 5U01NS040069-09, 1UG3OD023348-01]; National Institute for Occupational Safety and Health [T42/OH-008673]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS040069] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institutes of Health (http://www.nih.gov < http://www.nih.gov/>): R01 ES019315 (RF), P42 ES005948 (RF), 5U01NS040069-05 (KK), and 5U01NS040069-09 (KK), 1UG3OD023348-01 (TS) and from the National Institute for Occupational Safety and Health: T42/OH-008673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants from the National Institutes of Health (http://www.nih.gov): R01 ES019315, P42 ES005948, 5U01NS040069-05, 2R01NS040069-09, and 1UG3OD023348-01, and from the National Institute for Occupational Safety and Health: T42/OH-008673. The funders of this study had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Beran TN, 2007, CAN J SCH PSYCHOL, V22, P128, DOI 10.1177/0829573507302967; Bizzoca A, 2012, DEV BIOL, V365, P133, DOI 10.1016/j.ydbio.2012.02.011; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Chiquet BT, 2011, BIRTH DEFECTS RES A, V91, P44, DOI 10.1002/bdra.20737; Cohen J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r210; Costa D., 2015, PEDIATR RES, VXVI, P1; Dammann O, 2008, CLIN PERINATOL, V35, P643, DOI 10.1016/j.clp.2008.07.011; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Derr RE, 2000, ASYMPTOTIC ANAL, V254, P1; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Goldenberg RL, 2005, ARCH PEDIAT ADOL MED, V159, P89, DOI 10.1001/archpedi.159.1.89; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Guralnick M, 2004, J INTELL DISABIL RES, V48, P283; Hecht JL, 2008, PATHOLOGY, V40, P372, DOI 10.1080/00313020802035865; Helderman JB, 2012, PEDIATRICS, V129, P494, DOI 10.1542/peds.2011-1796; Ibrahim S.A., 2015, AM J OBSTET GYNECOL; Joseph RM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4343; Kilinc D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00282; Korkman M., 2007, NEPSY II CLIN INTERP; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kuban KCK, 2016, J PEDIATR-US, V173, P69, DOI 10.1016/j.jpeds.2016.02.048; Kuban KCK, 2015, PEDIATR NEUROL, V52, P42, DOI 10.1016/j.pediatrneurol.2014.10.005; Kuban KCK, 2014, J CHILD NEUROL, V29, P1692, DOI 10.1177/0883073813513335; Lee AWS, 2012, PLOS ONE, P7; Leviton A, 2011, EARLY HUM DEV, V87, P325, DOI 10.1016/j.earlhumdev.2011.01.043; Leviton A, 2010, EARLY HUM DEV, V86, P515, DOI 10.1016/j.earlhumdev.2010.07.001; Leviton A, 2010, PEDIATR RES, V67, P95, DOI 10.1203/PDR.0b013e3181bf5fab; Mathews TJ, 2013, NATL VITAL STAT REPO, V54, P0; McElrath TF, 2008, AM J EPIDEMIOL, V168, P980, DOI 10.1093/aje/kwn202; Mehren E., 2012, J PERINATOL, V13, P393; Money KM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00260; Nair RR, 2013, PLACENTA, V34, P824, DOI 10.1016/j.placenta.2013.06.307; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; O'Shea TM, 2014, PEDIATR RES, V75, P781, DOI 10.1038/pr.2014.41; O'Shea TM, 2012, J PEDIATR MOSBY, V160, P395; Paganoni S, 2005, J CELL SCI, V118, P433, DOI 10.1242/jcs.01622; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Swayne LA, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0089-5; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Zhang Qiang, 2015, Zhongguo Dang Dai Er Ke Za Zhi, V17, P217	47	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176953	10.1371/journal.pone.0176953	http://dx.doi.org/10.1371/journal.pone.0176953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493900	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300044
J	Wang, DD; Li, Y; Zhou, Y; Jin, C; Zhao, Q; Wang, AX; Wu, SL; Wei, WB; Zhao, XQ; Jonas, JB				Wang, Dandan; Li, Yang; Zhou, Yong; Jin, Cheng; Zhao, Qi; Wang, Anxin; Wu, Shouling; Wei, Wen Bin; Zhao, Xingquan; Jonas, Jost B.			Asymptomatic carotid artery stenosis and retinal nerve fiber layer thickness. A community-based, observational study	PLOS ONE			English	Article							SMALL VESSEL DISEASE; MICROVASCULAR ABNORMALITIES; ATHEROSCLEROSIS RISK; HYPERTENSION; DIAMETERS; STROKE; ENDARTERECTOMY; PREVENTION; PREVALENCE; DEFECTS	Purpose To examine whether an abnormally thin retinal nerve fiber layer (RNFL) is associated with cerebrovascular insufficiency. Design Community-based study. Methods The Asymptomatic Polyvascular Abnormalities in Community Study included Chinese aged 40+ years and without histories of cerebrovascular incidents or coronary heart disease. Using transcranial Doppler and carotid duplex ultrasound examination, we assessed presence and degree of an intracranial arterial stenosis (ICAS) and extracranial carotid arterial stenosis (ECAS) and we measured the RNFL thickness by spectral-domain optical coherence tomography. Results The study included 3,376 participants with a mean age of 54.3 +/- 10.3 years. Thinner RNFL was significantly correlated with a higher prevalence of ECAS (P = 0.035; standardized regression coefficient beta:- 0.04; non- standardized regression coefficient B:- 0.99; 95% confidence intervals(CI):- 1.90,-0.07), after adjusting for age (P<0.001; beta:-0.25; B:-0.26; 95% CI:-0.30,-0.22), gender (P = 0.001; beta:-0.07; B:-1.36; 95% CI:-2.14,- 0.58) and blood concentration of low- density lipoproteins (P = 0.03; beta: 0.04; B: 0.52; 95% CI: 0.05,0.98). In a reverse manner, prevalence of ECAS was associated with a thinner RNFL thickness (P = 0.007; odds ratio (OR): 0.99; 95% CI: 0.98,0.99) after adjusting for older age (P<0.001; OR: 1.06; 95% CI: 10.05,10.7), higher prevalence of ICAS (P = 0.01; OR: 1.34; 95% CI: 1.07,1.69) and higher prevalence of carotid artery plaques (P<0.001; OR: 9.18; 95% CI: 6.93,12.2), and higher blood concentration of total cholesterol (P = 0.03; OR: 1.12; 95% CI: 1.01,1.23). In univariate analysis, an increasing degree of ECAS was significantly correlated with a thinner RNFL. Conclusions Higher prevalence and degree of ECAS were correlated with thinner RNFL and vice versa. Patients with abnormally thin RNFL without ocular disease may undergo carotid artery examination to detect asymptomatic carotid artery stenosis. Examination of the RNFL is useful for the diagnosis of cerebrovascular disease.	[Wang, Dandan; Zhou, Yong; Wang, Anxin; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Dandan; Zhou, Yong; Wang, Anxin; Zhao, Xingquan] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Dandan; Zhou, Yong; Wang, Anxin; Zhao, Xingquan] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Wang, Dandan; Zhou, Yong; Wang, Anxin; Zhao, Xingquan] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Li, Yang; Zhao, Qi; Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China; [Jin, Cheng; Wu, Shouling] Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Key Lab Ophthalmol & Visual Sci, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Jonas, Jost B.] Ruprecht Karls Univ Heidelberg, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Zhao, XQ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.; Zhao, XQ (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Zhao, XQ (corresponding author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Zhao, XQ (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.; Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China.; Wu, SL (corresponding author), Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; tr_weiwenbin@163.com; zxq@vip.163.com	wei, wei/HHR-8613-2022	Jonas, Jost/0000-0003-2972-5227	Beijing Medical High Level Academic Leader	Beijing Medical High Level Academic Leader	This work was supported by a grant from Beijing Medical High Level Academic Leader (2014-2-010, 2015-2017, Xingquan Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascaso FJ, 2015, PSYCHIAT RES, V229, P230, DOI 10.1016/j.psychres.2015.07.028; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Halliday A, 2004, LANCET, V363, P1491; Ikram MK, 2006, BRAIN, V129, P182, DOI 10.1093/brain/awh688; Inzelberg R, 2004, VISION RES, V44, P2793, DOI 10.1016/j.visres.2004.06.009; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; Kim M, 2011, INVEST OPHTH VIS SCI, V52, P6882, DOI 10.1167/iovs.11-7276; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Lindley RI, 2009, LANCET NEUROL, V8, P628, DOI 10.1016/S1474-4422(09)70131-0; Mitchell P, 1997, STROKE, V28, P63, DOI 10.1161/01.STR.28.1.63; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; Tanabe Y, 2010, MICROCIRCULATION, V17, P94, DOI 10.1111/j.1549-8719.2009.00006.x; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wang D, 2015, EUR J NEUROL, V22, P533, DOI 10.1111/ene.12611; Wang DD, 2014, STROKE, V45, P1651, DOI 10.1161/STROKEAHA.113.004629; Wang J, 2014, EUR J NEUROL, V21, P512, DOI 10.1111/ene.12342; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Xu L, 2013, AM J HYPERTENS, V26, P511, DOI 10.1093/ajh/hps081; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685	26	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177277	10.1371/journal.pone.0177277	http://dx.doi.org/10.1371/journal.pone.0177277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493931	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300082
J	Bohme, M; Spassov, N; Ebner, M; Geraads, D; Hristova, L; Kirscher, U; Kotter, S; Linnemann, U; Prieto, J; Roussiakis, S; Theodorou, G; Uhlig, G; Winklhofer, M				Boehme, Madelaine; Spassov, Nikolai; Ebner, Martin; Geraads, Denis; Hristova, Latinka; Kirscher, Uwe; Koetter, Sabine; Linnemann, Ulf; Prieto, Jerome; Roussiakis, Socrates; Theodorou, George; Uhlig, Gregor; Winklhofer, Michael			Messinian age and savannah environment of the possible hominin Graecopithecus from Europe	PLOS ONE			English	Article							DEBRIS-FLOW DEPOSITS; DETRITAL ZIRCON AGES; LATE MIOCENE; CARBON ISOTOPES; SAHARA-DESERT; GRAIN-SIZE; CLIMATE; BULGARIA; LOESS; PROXY	Dating fossil hominids and reconstructing their environments is critically important for understanding human evolution. Here we date the potentially oldest hominin, Graecopithecus freybergi from Europe and constrain the environmental conditions under which it thrived. For the Graecopithecus-bearing Pikermi Formation of Attica/Greece, a saline aeolian dust deposit of North African (Sahara) provenance, we obtain an age of 7.37-7.11 Ma, which is coeval with a dramatic cooling in the Mediterranean region at the Tortonian-Messinian transition. Palaeobotanic proxies demonstrate C4-grass dominated wooded grassland-to-woodland habitats of a savannah biome for the Pikermi Formation. Faunal turnover at the Tortonian-Messinian transition led to the spread of new mammalian taxa along with Graecopithecus into Europe. The type mandible of G. freybergi from Pyrgos (7.175 Ma) and the single tooth (7.24 Ma) from Azmaka (Bulgaria) represent the first hominids of Messinian age from continental Europe. Our results suggest that major splits in the hominid family occurred outside Africa.	[Boehme, Madelaine; Ebner, Martin; Koetter, Sabine] Eberhard Karls Univ Tubingen, Dept Geosci, Tubingen, Germany; [Boehme, Madelaine; Koetter, Sabine] Senckenberg Ctr Human Evolut & Palaeoenvironm, Tubingen, Germany; [Spassov, Nikolai; Hristova, Latinka] Bulgarian Acad Sci, Natl Museum Nat Hist, Sofia, Bulgaria; [Geraads, Denis] Sorbonne Univ, CNRS, Museum Natl Hist Nat, CR2P,UMR 7207, CP 38, Paris, France; [Geraads, Denis] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, Leipzig, Germany; [Kirscher, Uwe] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Geophys, Munich, Germany; [Linnemann, Ulf] Museum Mineral & Geol, GeoPlasmaLab, Senckenberg Nat Hist Collect Dresden, Dresden, Germany; [Prieto, Jerome] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Palaeontol, Munich, Germany; [Roussiakis, Socrates; Theodorou, George] Univ Athens, Fac Geol & Geoenvironment, Athens, Greece; [Uhlig, Gregor] Leibniz Inst Polymer Res Dresden, Dresden, Germany; [Winklhofer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Sch Math & Sci, Oldenburg, Germany; [Kirscher, Uwe] Curtin Univ, Ctr Excellence Core Crust Fluid Syst, Earth Dynam Res Grp, Australian Res Council, Perth, WA, Australia; [Kirscher, Uwe] Curtin Univ, Western Australian Sch Mines, Dept Appl Geol, Inst Geosci Res, Perth, WA, Australia	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Bulgarian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; University of Munich; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Munich; National & Kapodistrian University of Athens; Leibniz Institut fur Polymerforschung Dresden; Carl von Ossietzky Universitat Oldenburg; Curtin University; Curtin University	Bohme, M (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci, Tubingen, Germany.; Bohme, M (corresponding author), Senckenberg Ctr Human Evolut & Palaeoenvironm, Tubingen, Germany.	m.boehme@ifg.uni-tuebingen.de	Winklhofer, Michael/B-7349-2009; Geraads, Denis/AAY-6051-2020; Roussiakis, Socrates/AAL-5449-2021; GERAADS, Denis/AAC-7241-2021; Kirscher, Uwe/GYI-8992-2022; Kirscher, Uwe/AAG-9960-2020; Hristova, Latinka/GLS-2172-2022	Winklhofer, Michael/0000-0003-1352-9723; GERAADS, Denis/0000-0003-2475-8011; Kirscher, Uwe/0000-0003-4203-1430	German Science Foundation [BO1550/19-1, WI1828/4-2]; United Bulgarian Bank; German Science Foundation DFG [Bo 1550/19-1, Wi 1828/4-2]; European Union (SYNTHESYS) [AT-TAF-2283, GB-TAF-1678]; Special Account for Research Grants of the National and Kapodistrian University of Athens [70/3/9494, 70/3/10437, 70/4/3570, 70/4/11078, 70/3/12977]	German Science Foundation(German Research Foundation (DFG)); United Bulgarian Bank; German Science Foundation DFG(German Research Foundation (DFG)); European Union (SYNTHESYS); Special Account for Research Grants of the National and Kapodistrian University of Athens	This work was supported by the German Science Foundation, BO1550/19-1, WI1828/4-2, http://www.dfg.de/ and the United Bulgarian Bank, https://www.ubb.bg/eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For access to fossil collections, laboratory assistance, and/or performance of measurements we thank: Fabian Bonitz, Agnes Fatz, Andreas Gartner, Wolfgang Gerber, Jurgen Hoflinger, Gottfried Hofbauer, Mandy Hofmann, George Koufos, Michael Marks, Hartmut Schulz, Bernd Steinhilber, Henrik Star, Ellen Struve, Heiner Taubald, Peter Weidenbach, Johannes Zieger, and Raphael Zimmermann. We would like to thank the Academic Editor Roberto Macchiarelli for his careful handling of this publication. We are grateful to Todd Ehlers and Andrew P. Roberts for critical reading of a previous version of the manuscript. We also thank Brigitte Senut and 14 anonymous reviewers for their comments. We acknowledge funding from the German Science Foundation DFG (grant Bo 1550/19-1 to MB and Wi 1828/4-2 to MW), the United Bulgarian Bank (grant to NS), and the European Union (SYNTHESYS grants AT-TAF-2283 and GB-TAF-1678 to LH). Research in Pikermi has been supported by the Special Account for Research Grants of the National and Kapodistrian University of Athens 70/3/9494, 70/3/10437, 70/4/3570, 70/4/11078 and 70/3/12977 (grants to GT).	Alcala FJ, 2008, J HYDROL, V359, P189, DOI 10.1016/j.jhydrol.2008.06.028; Altumi MM, 2013, J AFR EARTH SCI, V79, P74, DOI 10.1016/j.jafrearsci.2012.11.007; Barboni D, 2007, PALAEOGEOGR PALAEOCL, V246, P454, DOI 10.1016/j.palaeo.2006.10.012; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Bosmans JHC, 2015, QUATERNARY SCI REV, V123, P16, DOI 10.1016/j.quascirev.2015.06.008; BOUVRAIN G, 1988, Annales de Paleontologie, V74, P43; Bremond L, 2005, GLOBAL PLANET CHANGE, V45, P277, DOI 10.1016/j.gloplacha.2004.09.002; Burchfiel CB, 2000, GEOL SOC SPEC PUBL, V173, P325, DOI 10.1144/GSL.SP.2000.173.01.16; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Chen J, 2008, GEOMORPHOLOGY, V93, P493, DOI 10.1016/j.geomorph.2007.03.011; Dietze M, 2013, EGU GEN ASS C, P2779; Dominguez-Rodrigo M, 2014, CURR ANTHROPOL, V55, P59, DOI 10.1086/674530; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; DRAGOMANOV L, 1981, Paleontologiya Stratigrafiya i Litologiya, V14, P65; Eckelmann K, 2014, GONDWANA RES, V25, P1484, DOI 10.1016/j.gr.2013.05.018; Eisenmann V., 1988, STUDYING FOSSIL HORS; Fomba KW, 2014, ATMOS CHEM PHYS, V14, P8883, DOI 10.5194/acp-14-8883-2014; Fox DL, 2012, GEOL SOC AM BULL, V124, P444, DOI 10.1130/B30401.1; Freyberg Bv, 1950, ANN GEOLOGIQUES PAYS, V3, P65; Freyberg Bv, 1949, ANN GEOLOGIQUES PAYS, V3, P7; Fuss J, PLOS ONE UNPUB; GAMBELL AW, 1962, TELLUS, V14, P91; Gaudry A., 1862, ANIMAUX FOSSILES GEO, P2; Goudie A.S., 2006, DESERT DUST GLOBAL S; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Guerin C, 2001, VERTEBRES TUROLIEN M, V1, P1; Herbert TD, 2016, NATURE GEOSCIENCE; Hilgen FJ, 1995, EARTH PLANET SC LETT, V136, P495, DOI 10.1016/0012-821X(95)00207-S; Hilgen FJ, 2000, EARTH PLANET SC LETT, V182, P237, DOI 10.1016/S0012-821X(00)00247-8; Husing SK, 2009, EARTH PLANET SC LETT, V282, P140, DOI 10.1016/j.epsl.2009.03.010; Katoh S, 2016, NATURE, V530, P215, DOI 10.1038/nature16510; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Kojumdgieva E., 1979, PALEONTOL STRATIGR L, V11, P49; Komarek E.V., 1973, ECOLOGY SMOKE PARTIC; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Konidaris G. E., 2013, THESIS; Koufos George D., 2013, P595; Krinsley D.H, 2011, ATLAS QUARTZ SAND SU, Vsecond; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Liebens J, 1997, GEOMORPHOLOGY, V21, P53, DOI 10.1016/S0169-555X(97)00036-6; Linnemann U, 2014, PRECAMBRIAN RES, V244, P236, DOI 10.1016/j.precamres.2013.08.007; Linnemann U, 2012, EARTH-SCI REV, V112, P126, DOI 10.1016/j.earscirev.2012.02.007; Linnemann U, 2011, LITHOS, V123, P188, DOI 10.1016/j.lithos.2011.01.010; Madanipour S, 2013, TECTONOPHYSICS, V608, P440, DOI 10.1016/j.tecto.2013.09.003; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Mahaney W., 2002, ATLAS SAND GRAIN SUR; Marinos G, ANN GEOLOGIQUES PAYS; Marinos G., 1955, GEOLOGICAL RECONNAIS, V18, P1; Markov Georgi N., 2008, Historia Naturalis Bulgarica, V19, P153; MCFADDEN PL, 1988, EARTH PLANET SC LETT, V87, P161, DOI 10.1016/0012-821X(88)90072-6; MCFADDEN PL, 1990, GEOPHYS J INT, V103, P725, DOI 10.1111/j.1365-246X.1990.tb05683.x; Mettos AI, 1992, GEOLOGICAL PALEOGRAP; Ohneiser C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9765; Orgetta M., 1979, ANN GEOL PAYS HELL, P909; Papanikolaou D, 2007, B GEOLOGICAL SOC GRE, V40; Papanikolaou DJ, 2007, TECTONICS, V26, DOI 10.1029/2006TC002007; Papp A., 1979, ANN GEOLOGIQUES PAYS, V29, P664; Pausas JG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1074, DOI 10.1111/j.1466-8238.2012.00769.x; Pye K, 1995, QUATERNARY SCI REV, V14, P653, DOI 10.1016/0277-3791(95)00047-X; PYE K, 1983, J SEDIMENT PETROL, V53, P973; Rohling EJ, 2015, EARTH-SCI REV, V143, P62, DOI 10.1016/j.earscirev.2015.01.008; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schaller M, 2015, QUAT GEOCHRONOL, V29, P6, DOI 10.1016/j.quageo.2015.05.012; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Solounias N, 1999, PALEOECOLOGY PIKERMI, P436; Spassov N, 2012, J HUM EVOL, V62, P138, DOI 10.1016/j.jhevol.2011.10.008; Stamatis G, 2006, HYDROL PROCESS, V20, P2803, DOI 10.1002/hyp.6072; Stromberg CAE, 2007, PALAEOGEOGR PALAEOCL, V250, P18, DOI 10.1016/j.palaeo.2007.02.012; Stuchlik L., 2001, ATLAS POLLEN SPORES; SYMEONIDIS N, 1973, ANN NATURHISTORISCHE, V77, P125; Tassy P., 1986, NOUVEAUX ELEPHANTOID; Theodorou GE., 2010, P 19 C CARP BALK GEO, V99, P109; Tzanova A, 2015, EARTH PLANET SC LETT, V419, P71, DOI 10.1016/j.epsl.2015.03.016; Ujvari G, 2016, EARTH-SCI REV, V154, P247, DOI 10.1016/j.earscirev.2016.01.006; Vandenberghe J, 2013, EARTH-SCI REV, V121, P18, DOI 10.1016/j.earscirev.2013.03.001; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wack MR, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003985; Wagner A., 1839, GELEHRTE ANZEIGER BA, V8, P307; Watson G. S., 1956, GEOPHYS J INT, V7, P160, DOI [10.1111/j.1365-246X.1956.tb05561.x, DOI 10.1111/J.1365-246X.1956.TB05561.X]; Wynn JG, 2000, J HUM EVOL, V39, P411, DOI 10.1006/jhev.2000.0431; YAALON D. H., 1966, Sedi-mentology., V6, P315, DOI 10.1111/j.1365-3091.1966.tb01898.x; Zhang ZS, 2014, NATURE, V513, P401, DOI 10.1038/nature13705; Zijderveld J. D. A., 1967, METHODS PALEOMAGNETI, P254, DOI DOI 10.1016/B978-1-4832-2894-5.50049-5	84	47	47	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177347	10.1371/journal.pone.0177347	http://dx.doi.org/10.1371/journal.pone.0177347			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531204	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400014
J	Singh, N; Barnes, SJ; Kennedy, S; Adams, JH				Singh, Naresh; Barnes, Samantha J.; Kennedy, Sandra; Adams, John H.			Experimental evaluation of cryopreservative solutions to maintain in vitro and in vivo infectivity of P. berghei sporozoites	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MALARIA PARASITES; VACCINE; LINE	The rodent malaria parasite Plasmodium berghei is an excellent model organism for laboratory- based experimental evaluation of anti-malarial therapeutics prior to studies with human malaria parasites. The rodent model is especially important for evaluation of pre-erythrocytic ( PE) stage therapies, especially as current efforts to develop new PE vaccines and drugs is limited by access to P. falciparum and P. vivax sporozoites. Developing a more effective method for cryopreservation of sporozoites would help improve access to sporozoites for laboratories lacking suitable insectary facilities. In this study, P. berghei GFP-expressing sporozoites were purified from infected mosquitoes by manual dissection of salivary glands and different commercially-available, serum-free cryopreservative solutions were evaluated for efficient cryopreservation of the sporozoites. The cryopreservative solutions evaluated included CryoStor CS2, CryoSolutions DX5, CryoSolutions MC, Hestar 200, Voluven, Hetastarch, and Glycerolyte 57. The viability of fresh and post-thaw cryopreserved sporozoites was determined as a function of the relative sporozoite infectivity by infecting HC-04 cells in vitro, monitoring invasion and growth and development of liver stage parasites. Flow cytometer-based counting provided unbiased and fast quantitative assessment of parasite in vitro infection in infected HC-04 and in vivo infectivity was validated by injecting sporozoites IV into mice. CryoStor CS2 delivered the highest post-thaw recovery and infectivity of cryopreserved sporozoites. Sporozoites cryopreserved in CryoStor CS2 achieved 38% complete development of hepatic stages in HC-04 and 100% infectivity in mice. The cryopreservation method described here demonstrates a viable alternative for fresh Plasmodium sporozoites. The use of cryopreserved sporozoites should facilitate greater access to sporozoites for chemotherapeutic and vaccine research.	[Singh, Naresh; Barnes, Samantha J.; Kennedy, Sandra; Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Adams, JH (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.	jadams3@health.usf.edu	Adams, John H./ABB-8458-2020	Adams, John H./0000-0003-3707-7979	Bill and Melinda Gates Foundation [OPP1023643]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support was provided by the Bill and Melinda Gates Foundation Grant No. OPP1023643 (JHA).; This work was supported by a grant from Bill and Melinda Gates Foundation Grant No. OPP1023643 (JHA). We thank Ashley Souza for assistance with manuscript preparation.	[Anonymous], 2014, METHODS ANOPHELES RE, V4; COLLINS WE, 1994, J PARASITOL, V80, P512, DOI 10.2307/3283184; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HOLLINGDALE MR, 1985, T ROY SOC TROP MED H, V79, P206, DOI 10.1016/0035-9203(85)90335-9; Jeffery G. M., 1955, Experimental Parasitology, V4, P445, DOI 10.1016/0014-4894(55)90036-9; Kaushansky A, 2012, MOL BIOCHEM PARASIT, V183, P100, DOI 10.1016/j.molbiopara.2012.01.006; Leef J L, 1979, Bull World Health Organ, V57 Suppl 1, P87; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Sato Y, 2014, INFECT IMMUN, V82, P1164, DOI 10.1128/IAI.00758-13; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Singh N, 2015, PARASITOLOGY INT; TOURAY MG, 1992, J EXP MED, V175, P1607, DOI 10.1084/jem.175.6.1607; WALLIKER D, 1971, NATURE, V232, P561, DOI 10.1038/232561a0; WEATHERS.AB, 1967, J PARASITOL, V53, P638, DOI 10.2307/3276732; WHO, 2015, WORLD MAL REP 2015	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177304	10.1371/journal.pone.0177304	http://dx.doi.org/10.1371/journal.pone.0177304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531172	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400013
J	Booth, TC; Larkin, TJ; Yuan, Y; Kettunen, MI; Dawson, SN; Scoffings, D; Canuto, HC; Vowler, SL; Kirschenlohr, H; Hobson, MP; Markowetz, F; Jefferies, S; Brindle, KM				Booth, Thomas C.; Larkin, Timothy J.; Yuan, Yinyin; Kettunen, Mikko I.; Dawson, Sarah N.; Scoffings, Daniel; Canuto, Holly C.; Vowler, Sarah L.; Kirschenlohr, Heide; Hobson, Michael P.; Markowetz, Florian; Jefferies, Sarah; Brindle, Kevin M.			Analysis of heterogeneity in T-2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; NEWLY-DIAGNOSED GLIOBLASTOMA; GLIOMAS RESPONSE ASSESSMENT; HIGH-GRADE GLIOMAS; PROGNOSTIC-FACTORS; RADIATION-THERAPY; WHITE-MATTER; 3.0 T; PERFUSION; BRAIN	Purpose To develop an image analysis technique that distinguishes pseudoprogression from true progression by analyzing tumour heterogeneity in T-2-weighted images using topological descriptors of image heterogeneity called Minkowski functionals (MFs). Methods Using a retrospective patient cohort (n = 50), and blinded to treatment response outcome, unsupervised feature estimation was performed to investigate MFs for the presence of outliers, potential confounders, and sensitivity to treatment response. The progression and pseudoprogression groups were then unblinded and supervised feature selection was performed using MFs, size and signal intensity features. A support vector machine model was obtained and evaluated using a prospective test cohort. Results The model gave a classification accuracy, using a combination of MFs and size features, of more than 85% in both retrospective and prospective datasets. A different feature selection method (Random Forest) and classifier (Lasso) gave the same results. Although not apparent to the reporting radiologist, the T-2-weighted hyperintensity phenotype of those patients with progression was heterogeneous, large and frond-like when compared to those with pseudoprogression. Conclusion Analysis of heterogeneity, in T-2-weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required.	[Booth, Thomas C.; Larkin, Timothy J.; Kettunen, Mikko I.; Canuto, Holly C.; Kirschenlohr, Heide; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge, England; [Booth, Thomas C.; Larkin, Timothy J.; Yuan, Yinyin; Kettunen, Mikko I.; Canuto, Holly C.; Vowler, Sarah L.; Markowetz, Florian; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Dawson, Sarah N.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Clin Trials Unit, Cambridge, England; [Scoffings, Daniel] Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Hobson, Michael P.] Univ Cambridge, Cavendish Lab, Battock Ctr Expt Astrophys, Cambridge, England; [Jefferies, Sarah] Addenbrookes Hosp, Dept Oncol, Cambridge, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Brindle, KM (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.; Brindle, KM (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England.	kmb1001@cam.ac.uk	Scoffings, Daniel/GLS-1219-2022; Scoffings, Daniel/AAA-1649-2022; Kettunen, Mikko I/K-2299-2012	Kettunen, Mikko I/0000-0002-2004-660X; Dawson, Sarah/0000-0001-7401-2192; Yuan, Yinyin/0000-0002-8556-4707	Medical Research Council/Royal College of Radiologists (UK) Clinical Research Fellowship [G1000265]; Cancer Research UK Clinical Research Fellowship; Addenbrookes Charitable Trust Award; Cancer Research UK Programme grant [C197/A3514]; MRC [G1000265] Funding Source: UKRI; Cancer Research UK [17242, 16465, 19274, 22310] Funding Source: researchfish; Medical Research Council [G1000265] Funding Source: researchfish	Medical Research Council/Royal College of Radiologists (UK) Clinical Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Clinical Research Fellowship; Addenbrookes Charitable Trust Award; Cancer Research UK Programme grant(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by Medical Research Council/Royal College of Radiologists (UK) Clinical Research Fellowship (G1000265); Cancer Research UK Clinical Research Fellowship; Addenbrookes Charitable Trust Award to TCB. Cancer Research UK Programme grant (C197/A3514) to KM B. www.mrc.ac.uk; www.cancerresearchuk.org/;; http//www act4addenbrookes.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Linera J, 2008, EUR J RADIOL, V67, P415, DOI 10.1016/j.ejrad.2008.02.045; Bauchet L, 2010, NEURO-ONCOLOGY, V12, P725, DOI 10.1093/neuonc/noq030; BLEEHEN NM, 1991, BRIT J CANCER, V64, P769, DOI 10.1038/bjc.1991.396; Boss A, 2007, J MAGN RESON IMAGING, V25, P924, DOI 10.1002/jmri.20893; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Canuto HC, 2009, MAGN RESON MED, V61, P1218, DOI 10.1002/mrm.21946; Cerasa A, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/924814; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaskis C, 2009, SURG NEUROL, V72, P423, DOI 10.1016/j.surneu.2008.09.023; Chu HH, 2013, RADIOLOGY, V269, P831, DOI 10.1148/radiol.13122024; Chu RX, 2016, J NEUROIMAGING, V26, P62, DOI 10.1111/jon.12271; Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924; Dhermain FG, 2010, LANCET NEUROL, V9, P906, DOI 10.1016/S1474-4422(10)70181-2; Dydak U, 2006, NEUROIMAG CLIN N AM, V16, P269, DOI 10.1016/j.nic.2006.02.002; Ellingson BM, 2015, NEURO-ONCOLOGY, V17, P1188, DOI 10.1093/neuonc/nov095; Ellingson BM, 2014, NEURO-ONCOLOGY, V16, P2, DOI 10.1093/neuonc/nou224; Ellingson BM, 2012, NEURO-ONCOLOGY, V14, P333, DOI 10.1093/neuonc/nor220; European Medicines Agency, 2014, REF CHANG MARK AUTH; Filippini G, 2008, NEURO-ONCOLOGY, V10, P79, DOI 10.1215/15228517-2007-038; Gahramanov S, 2013, RADIOLOGY, V266, P842, DOI 10.1148/radiol.12111472; Galanis E, 2006, NEURO-ONCOLOGY, V8, P156, DOI 10.1215/15228517-2005-005; Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gutierrez DR, 2014, AM J NEURORADIOL, V35, P1009, DOI 10.3174/ajnr.A3784; Hamel L, KNOWLEDGE DISCOVERY; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Henson JW, 2008, AM J NEURORADIOL, V29, P419, DOI 10.3174/ajnr.A0963; Hockstein NG, 2004, LARYNGOSCOPE, V114, P1701, DOI 10.1097/00005537-200410000-00005; Hodgdon T, 2015, RADIOLOGY, V276, P787, DOI 10.1148/radiol.2015142215; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Hu LS, 2012, NEURO-ONCOLOGY, V14, P919, DOI 10.1093/neuonc/nos112; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Jain R, 2014, RADIOLOGY, V272, P484, DOI 10.1148/radiol.14131691; JOHNSON PC, 1989, RADIOLOGY, V170, P211, DOI 10.1148/radiology.170.1.2535765; Julesz B., 1962, IRE T INFORM THEOR, V8, P84, DOI [10.1109/TIT.1962.1057698, DOI 10.1109/TIT.1962.1057698]; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620; Larkin TJ, 2014, MAGN RESON MED, V71, P402, DOI 10.1002/mrm.24644; Lee MC, 2005, J MAGN RESON IMAGING, V21, P683, DOI 10.1002/jmri.20298; Liu HL, 2011, MED PHYS, V38, P802, DOI 10.1118/1.3534197; Lupo JM, 2006, J MAGN RESON IMAGING, V24, P520, DOI 10.1002/jmri.20673; Lupo JM, 2005, AM J NEURORADIOL, V26, P1446; Lutz K, 2011, CLIN NEURORADIOL, V21, P199, DOI 10.1007/s00062-011-0080-7; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440; Martin-Landrove M, 2007, P ANN INT IEEE EMBS, P1306, DOI 10.1109/IEMBS.2007.4352537; MECKE KR, 1994, ASTRON ASTROPHYS, V288, P697; Mehrkens JH, 2008, J NEURO-ONCOL, V88, P27, DOI 10.1007/s11060-008-9526-4; Michielsen K., 2001, Physics Reports, V347, P461, DOI 10.1016/S0370-1573(00)00106-X; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Nagesh V, 2008, INT J RADIAT ONCOL, V70, P1002, DOI 10.1016/j.ijrobp.2007.08.020; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Peters AM, 2007, MAGN RESON IMAGING, V25, P748, DOI 10.1016/j.mri.2007.02.014; Piroth MD, 2011, INT J RADIAT ONCOL, V80, P176, DOI 10.1016/j.ijrobp.2010.01.055; Polley MYC, 2010, NEURO-ONCOLOGY, V12, P274, DOI 10.1093/neuonc/nop034; Price SJ, 2003, CLIN RADIOL, V58, P455, DOI 10.1016/S0009-9260(03)00115-6; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Sanghera P, 2012, CLIN ONCOL-UK, V24, P216, DOI 10.1016/j.clon.2011.06.004; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Stivaros SM, 2016, PEDIATR RADIOL, V46, P73, DOI 10.1007/s00247-015-3444-3; Suh CH, 2013, AM J NEURORADIOL, V34, P2278, DOI 10.3174/ajnr.A3634; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Tsien C, 2010, J CLIN ONCOL, V28, P2293, DOI 10.1200/JCO.2009.25.3971; Tung GA, 2003, NEURORADIOLOGY, V45, P357, DOI 10.1007/s00234-003-0994-0; Ulmer S, 2012, NEURO-ONCOLOGY, V14, P482, DOI 10.1093/neuonc/nos003; Valery CA, 2001, J NEUROSURG, V94, P433, DOI 10.3171/jns.2001.94.3.0433; Vogelbaum MA, 2012, NEUROSURGERY, V70, P234, DOI 10.1227/NEU.0b013e318223f5a7; [王建锋 Wang Jianfeng], 2002, [中国工程科学, Engineering science], V4, P22; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7; Yongbi MN, 2002, RADIOLOGY, V222, P569, DOI 10.1148/radiol.2222001697; Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016	77	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176528	10.1371/journal.pone.0176528	http://dx.doi.org/10.1371/journal.pone.0176528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520730	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700020
J	Budnik, LT; Austel, N; Gadau, S; Kloth, S; Schubert, J; Jungnickel, H; Luch, A				Budnik, Lygia Therese; Austel, Nadine; Gadau, Sabrina; Kloth, Stefan; Schubert, Jens; Jungnickel, Harald; Luch, Andreas			Experimental outgassing of toxic chemicals to simulate the characteristics of hazards tainting globally shipped products	PLOS ONE			English	Article							HEALTH-RISK; EXPOSURE; DICHLOROMETHANE; CONTAINERS; EMISSIONS; FUMIGANTS; BENZENE; INDOOR; CANCER; RIOPA	Ambient monitoring analyses may identify potential new public health hazards such as residual levels of fumigants and industrial chemicals off gassing from products and goods shipped globally. We analyzed container air with gas chromatography coupled to mass spectrometry (TD-2D-GC-MS/FPD) and assessed whether the concentration of the volatiles benzene and 1,2-dichloroethane exceeded recommended exposure limits (REL). Products were taken from transport containers and analyzed for outgassing of volatiles. Furthermore, experimental outgassing was performed on packaging materials and textiles, to simulate the hazards tainting from globally shipped goods. The mean amounts of benzene in analyzed container air were 698-fold higher, and those of ethylene dichloride were 4.5-fold higher than the corresponding REL. More than 90% of all containers struck with toluene residues higher than its REL. For 1,2-dichloroethane 53% of containers, transporting shoes exceeded the REL. In standardized experimental fumigation of various products, outgassing of 1,2-dichloroethane under controlled laboratory conditions took up to several months. Globally produced transported products tainted with toxic industrial chemicals may contribute to the mixture of volatiles in indoor air as they are likely to emit for a long period. These results need to be taken into account for further evaluation of safety standards applying to workers and consumers.	[Budnik, Lygia Therese; Gadau, Sabrina; Kloth, Stefan] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Inst Occupat & Maritime Med ZfAM, Occupat Toxicol & Immunol Unit, Hamburg, Germany; [Austel, Nadine; Schubert, Jens; Jungnickel, Harald; Luch, Andreas] German Fed Inst Risk Assessment BfR, Dept Chem & Prod Safety, Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Federal Institute for Risk Assessment	Budnik, LT (corresponding author), Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Inst Occupat & Maritime Med ZfAM, Occupat Toxicol & Immunol Unit, Hamburg, Germany.	LBudnik@uke.de		Austel, Nadine/0000-0001-6380-3773	German Federal Ministry for Education and Research, BMBF; German Federal Institute for Risk Assessment, BfR [1329-501, 1322-433, 8124797, 7031564]; BMBF; BfR; State Department of Health; WHO	German Federal Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); German Federal Institute for Risk Assessment, BfR; BMBF(Federal Ministry of Education & Research (BMBF)); BfR; State Department of Health; WHO(World Health Organization)	The study was funded in parts by: the German Federal Ministry for Education and Research, BMBF (Project: OPTIMA, to LTB) and by the Strategic Research Program from the German Federal Institute for Risk Assessment, BfR (BfR Project 1329-501 to LTB; BfR Project 1322-433 to HJ; BfR Project 8124797 to LTB; BfR Project 7031564 to AL).; The authors would like to express our gratitude to our funding sources: BMBF, BfR and the State Department of Health for providing excellent laboratory facilities.; The study was a part of the WHO-GPA collaborating project "New chemical health risk hazards in transportation and warehousing of cargo due to the process of globalization" (LTB), the authors thank the WHO for support.	[Anonymous], 2012, HAZARD SURVEILLANCE; Barry KH, 2011, AM J EPIDEMIOL, V173, P404, DOI 10.1093/aje/kwq360; Batterman Stuart, 2014, Res Rep Health Eff Inst, P3; Baur X, 2015, HEALTH RISKS IN INTE; Baur X, 2014, INT MARIT HEALTH, V65, P142, DOI 10.5603/IMH.2014.0029; Baur X, 2010, OCCUP ENVIRON MED, V67, P207, DOI 10.1136/oem.2008.043893; Bolden AL, 2015, ENVIRON SCI TECHNOL, V49, P5261, DOI 10.1021/es505316f; Boor BE, 2014, ENVIRON SCI TECHNOL, V48, P3541, DOI 10.1021/es405625q; Budnik LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064413; Budnik LT, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-5; Budnik LT, 2010, J ENVIRON MONITOR, V12, P936, DOI 10.1039/b918428g; Carugno M, 2012, ENVIRON HEALTH PERSP, V120, P2010; Cooper GS, 2011, INT J ENV RES PUB HE, V8, P3380, DOI 10.3390/ijerph8083380; Delfino RJ., 2002, ENV HLTH, V110; Edokpolo B, 2014, INT J ENV RES PUB HE, V11, P6354, DOI 10.3390/ijerph110606354; Fahrenholtz S, 2010, J CHROMATOGR A, V1217, P8298, DOI 10.1016/j.chroma.2010.10.085; Freedman DM, 2001, AM J PUBLIC HEALTH, V91, P564, DOI 10.2105/AJPH.91.4.564; French JE, 2015, ENVIRON HEALTH PERSP, V123, P237, DOI 10.1289/ehp.1408202; Infante-Rivard C, ENV HLTH; Kloth S, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-110; Knol-de Vos T, 2005, REPORT 609021033 200; Lupo PJ, 2011, ENVIRON HEALTH PERSP, V119, P397, DOI 10.1289/ehp.1002212; New-Zealand-Customs-Service, 2012, REPORT ON THE OUTCOM; OEHHA, 2015, AIR TOXICS REFERENCE; Polito T, 2007, DEV PACKAGING MACHIN; Preisser AM, 2012, INT MARIT HEALTH, V63, P133; Preisser AM, 2011, SCI TOTAL ENVIRON, V409, P3106, DOI 10.1016/j.scitotenv.2011.04.053; Raw GJ, 2004, J EXPO ANAL ENV EPID, V14, pS85, DOI 10.1038/sj.jea.7500363; Safe-Work-Australia, 2006, VENTILATION OF FUMIG; Schlosser PM, 2015, ENVIRON HEALTH PERSP, V123, P114, DOI 10.1289/ehp.1308030; Su FC, 2013, ENVIRON RES, V126, P192, DOI 10.1016/j.envres.2013.08.005; Su FC, 2012, ATMOS ENVIRON, V62, P97, DOI 10.1016/j.atmosenv.2012.06.038; Svedberg U, 2013, ANN OCCUP HYG, V57, P1128, DOI 10.1093/annhyg/met033; UNCTAD, 2013, CONTAINER PORT THROU; Verberk MM, 2012, NEUROTOXICOLOGY, V33, P742, DOI 10.1016/j.neuro.2012.06.005; Vlaanderen J, 2010, ENVIRON HEALTH PERSP, V118, P526, DOI 10.1289/ehp.0901127; Wang G, 2013, HUM EXP TOXICOL, V32, P983, DOI 10.1177/0960327112470270; Weisel CP, 2002, ENVIRON HEALTH PERSP, V110, P527, DOI 10.1289/ehp.02110s4527; Wible B, 2014, SCIENCE, V344, P1100, DOI 10.1126/science.344.6188.1100; Wolkoff P, 2003, INDOOR AIR, V13, P5, DOI 10.1034/j.1600-0668.13.s.6.1.x	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177363	10.1371/journal.pone.0177363	http://dx.doi.org/10.1371/journal.pone.0177363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520742	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700043
J	Saragusty, J; Lemma, A; Hildebrandt, TB; Goritz, F				Saragusty, Joseph; Lemma, Alemayehu; Hildebrandt, Thomas Bernd; Goeritz, Frank			Follicular size predicts success in artificial insemination with frozen-thawed sperm in donkeys	PLOS ONE			English	Article							EQUUS-ASINUS; SEMINAL PLASMA; SEMEN CRYOPRESERVATION; SEXUAL-BEHAVIOR; FERTILITY; PREGNANCY; CRYOPROTECTANT; PARAMETERS; FREQUENCY; OVULATION	In asses, semen collection, cryopreservation, and artificial insemination (AI) with frozen thawed semen have been scarcely described and success rate, particularly following AI, is reportedly low. In the absence of reliable protocols, assisted reproductive technologies cannot support the conservation efforts aimed at endangered wild ass species and domestic donkey breeds. Two experiments were conducted in this study. In experiment 1 we evaluated freezing Abyssinian donkey (N = 5, 4 ejaculates each) spermatozoa using three freezing extenders (Berliner Cryomedium + glycerol, BC+G; BotuCrio, BOTU; INRAFreeze, INRA) and two cryopreservation techniques (liquid nitrogen vapour, LNV; directional freezing, DF). Post-thaw evaluation indicated that BOTU and INRA were similar and both superior to BC+G (P <= 0.004 for all motility tests), and that DF was superior to LNV (P < 0.002 for all evaluation parameters). In experiment 2, relying on these results, we used Abyssinian donkey sperm frozen in BOTU and INRA by DF for AI (N = 20). Prior to AI, thawed samples were diluted in corresponding centrifugation media or autologous seminal fluids at 1: 1 ratio. No difference was found between BOTU and INRA or between the addition of seminal fluids or media, all resulting in similar to 50% pregnancy, and no differences were noted between males (N = 4). The size of pre-ovulatory follicle was a significant (P = 0.001) predictor for AI success with 9/10 pregnancies occurring when follicular size ranged between 33.1-37.4 mm, no pregnancy when it was smaller, and only one when larger. A number of ass species face the risk of extinction. Knowledge gained in this study on the Abyssinian donkey can be customised and transferred to its closely related endangered species and breeds.	[Saragusty, Joseph; Hildebrandt, Thomas Bernd; Goeritz, Frank] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Lemma, Alemayehu] Addis Ababa Univ, Coll Vet Med & Agr, Debre Zeit, Ethiopia	Leibniz Institut fur Zoo und Wildtierforschung; Addis Ababa University	Saragusty, J (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	saragusty@gmail.com	Saragusty, Joseph/M-5030-2016	Saragusty, Joseph/0000-0002-9274-7800	Open Access Fund of the Leibniz Association	Open Access Fund of the Leibniz Association	Funding for this project was kindly provided by the Vienna Zoo - Tiergarten SchoEnbrunn, Vienna, Austria (http://www. zoovienna.at), as part of their support of a comprehensive study on reproduction and assisted reproduction of asses. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders or any body associated with them had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha D, 2016, REPROD FERT DEVELOP, V28, P1990, DOI 10.1071/RD14449; Alghamdi AS, 2005, ANIM REPROD SCI, V89, P242; Alvarez AL, 2006, ANIM REPROD SCI, V94, P89, DOI 10.1016/j.anireprosci.2006.04.026; Andrabi SMH, 2007, ANIM REPROD SCI, V99, P223, DOI 10.1016/j.anireprosci.2006.07.002; Arav A, 2014, REPROD FERT DEVELOP, V26, P83, DOI 10.1071/RD13295; BARKER C. A. V., 1957, CANADIAN JOUR COMP MED AND VET SCI, V21, P47; BLOTTNER S, 1998, ADV ETHOL S, V33, P9; Canisso IF, 2011, EQUINE VET J, V43, P179, DOI 10.1111/j.2042-3306.2010.00130.x; Canisso IF, 2010, THERIOGENOLOGY, V73, P56, DOI 10.1016/j.theriogenology.2009.07.026; Conforti VA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.105353; Contri A, 2012, ANIM REPROD SCI, V136, P74, DOI 10.1016/j.anireprosci.2012.10.022; Contri A, 2010, ANIM REPROD SCI, V120, P136, DOI 10.1016/j.anireprosci.2010.02.018; Cortes-Gutierrez EI, 2008, THERIOGENOLOGY, V69, P1022, DOI 10.1016/j.theriogenology.2008.02.002; de Cervantes M, 1605, DON QUIXOTE; FAO, 2007, STAT WORLDAN GEN R; Gacitua H., 2005, Reproduction in Domestic Animals, V40, P383; Gastal MO, 1997, THERIOGENOLOGY, V47, P627, DOI 10.1016/S0093-691X(97)00021-6; Gastal MO, 1996, THERIOGENOLOGY, V46, P593, DOI 10.1016/0093-691X(96)00211-7; Hayakawa H, 2007, REPROD FERT DEVELOP, V19, P176, DOI 10.1071/RDv19n1Ab118; Hermes R, 2009, THERIOGENOLOGY, V71, P393, DOI 10.1016/j.theriogenology.2008.10.008; Hermes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057616; Hildebrandt TB, 2012, THERIOGENOLOGY, V78, P1398, DOI 10.1016/j.theriogenology.2012.06.014; Hildebrandt TB, 2009, THERIOGENOLOGY, V72, P1065, DOI 10.1016/j.theriogenology.2009.06.026; Jepsen RJ, 2010, J EQUINE VET SCI, V30, P651, DOI 10.1016/j.jevs.2010.10.001; Lemma A, 2006, J VET MED A, V53, P1, DOI 10.1111/j.1439-0442.2006.00777.x; Lemma A, 2006, J EQUINE VET SCI, V26, P18, DOI 10.1016/j.jevs.2005.09.015; Loomis PR, 2001, ANIM REPROD SCI, V68, P191, DOI 10.1016/S0378-4320(01)00156-7; McDonnell SM, 2010, JHI; Miro J, 2005, THERIOGENOLOGY, V63, P1706, DOI 10.1016/j.theriogenology.2004.07.022; Moehlman P. D., 2008, IUCN RED LIST THREAT; Moehlman PD, 2008, EQUUS AFRICANUS IUCN; O'Brien JK, 2006, REPROD FERT DEVELOP, V18, P319, DOI 10.1071/RD05108; Okazaki T, 2012, J ANDROL, V33, P990, DOI 10.2164/jandrol.111.015115; Oliveira JV, 2006, ANIM REPROD SCI, V94, P82, DOI 10.1016/j.anireprosci.2006.04.010; Ortiz I, 2015, REPROD FERT DEVELOP, V27, P332, DOI 10.1071/RD13246; Pearson R.A., 2000, GUIDE LIVE WEIGHT ES; Perry GA, 2005, P NATL ACAD SCI USA, V102, P5268, DOI 10.1073/pnas.0501700102; Pablos MTP, 2015, J ZOO WILDLIFE MED, V46, P517, DOI 10.1638/2014-0243.1; Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076; Qeusada F, 2013, REPROD FERT DEVELOP, V25, P154, DOI 10.1071/RDv25n1Ab14; Rahman MS, 2012, J REPROD DEVELOP, V58, P219, DOI 10.1262/jrd.11-111T; Reid CE, 2009, THERIOGENOLOGY, V71, P275, DOI 10.1016/j.theriogenology.2008.07.009; Robeck TR, 2011, THERIOGENOLOGY, V76, P267, DOI 10.1016/j.theriogenology.2011.02.003; Robeck TR, 2010, THERIOGENOLOGY, V74, P989, DOI 10.1016/j.theriogenology.2010.04.028; Rota A, 2012, THERIOGENOLOGY, V78, P1846, DOI 10.1016/j.theriogenology.2012.07.015; Rota A, 2008, THERIOGENOLOGY, V69, P176, DOI 10.1016/j.theriogenology.2007.09.003; Sa MF, 2010, ANIM REPROD SCI, V120, P23, DOI 10.1016/j.anireprosci.2010.03.007; Sabatini C, 2014, REPROD DOMEST ANIM, V49, P989, DOI 10.1111/rda.12419; Sales JNS, 2011, THERIOGENOLOGY, V76, P427, DOI 10.1016/j.theriogenology.2011.02.019; Saragusty J, 2007, REPROD DOMEST ANIM, V42, P610, DOI 10.1111/j.1439-0531.2006.00831.x; Saragusty J, 2010, THERIOGENOLOGY, V74, P1256, DOI 10.1016/j.theriogenology.2010.05.031; Saragusty J, 2009, THERIOGENOLOGY, V71, P1425, DOI 10.1016/j.theriogenology.2009.01.019; Saragusty J, 2006, THERIOGENOLOGY, V66, P775, DOI 10.1016/j.theriogenology.2006.01.055; Saragusty Joseph, 2016, Zoo Biology, V34, P280, DOI 10.1002/zoo.21284; Saragusty J, 2015, METHODS MOL BIOL, V1257, P381, DOI 10.1007/978-1-4939-2193-5_19; Saragusty J, 2009, BIOTECHNOL BIOENG, V104, P719, DOI 10.1002/bit.22435; Saragusty J, 2009, ANIM REPROD SCI, V115, P255, DOI 10.1016/j.anireprosci.2008.11.010; Saragusty J, 2009, ANIM REPROD SCI, V115, P10, DOI 10.1016/j.anireprosci.2008.11.005; Tanco VM, 2011, BIOL REPROD, V85, P452, DOI 10.1095/biolreprod.111.091876; Trimeche A, 1998, THERIOGENOLOGY, V50, P793, DOI 10.1016/S0093-691X(98)00184-8; Trimeche A, 1996, THERIOGENOLOGY, V45, P1015, DOI 10.1016/0093-691X(96)00029-5; Trimeche A, 1997, CRYOBIOLOGY, V34, P385, DOI 10.1006/cryo.1997.2009; Vidament A, 2005, ANIM REPROD SCI, V89, P115, DOI 10.1016/j.anireprosci.2005.07.003; Vidament M, 2005, ANIM REPROD SCI, V89, P302; Vidament M, 2009, ANIM REPROD SCI, V112, P22, DOI 10.1016/j.anireprosci.2008.03.016	65	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175637	10.1371/journal.pone.0175637	http://dx.doi.org/10.1371/journal.pone.0175637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520723	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700004
J	Kaminska, M; Noel, F; Petrof, BJ				Kaminska, Marta; Noel, Francine; Petrof, Basil J.			Optimal method for assessment of respiratory muscle strength in neuromuscular disorders using sniff nasal inspiratory pressure (SNIP)	PLOS ONE			English	Article							DISEASE; VALUES	Background The ability to accurately determine respiratory muscle strength is vitally important in patients with neuromuscular disorders (NMD). Sniff nasal inspiratory pressure (SNIP), a test of inspiratory muscle strength, is easier to perform for many NMD patients than the more commonly used determination of maximum inspiratory pressure measured at the mouth (MIP). However, due to an inconsistent approach in the literature, the optimal technique to perform the SNIP maneuver is unclear. Therefore, we systematically evaluated the impact of performing the maneuver with nostril contralateral to the pressure-sensing probe open (SNIPOP) versus closed (SNIPCL), on determination of inspiratory muscle strength in NMD patients as well as control subjects with normal respiratory muscle function. Methods NMD patients (n = 52) and control subjects without respiratory dysfunction (n = 52) were studied. SNIPOP, SNIPCL, and MIP were measured during the same session and compared using ANOVA. Agreement and bias were assessed with intraclass correlation coefficients (ICC) and Bland-Altman plots. Results Mean MIP values were 58.2 and 94.0 cmH2O in NMD and control subjects, respectively (p<0.001). SNIPCL was greater than SNIPOP in NMD (51.9 +/- 31.0 vs. 36.9 +/- 25.4 cmH(2)O; p<0.001) as well as in controls (89.2 +/- 28.1 vs. 69.2 +/- 29.2 cmH(2)O; p<0.001). In both populations, the ICC between MIP and SNIPCL (NMD = 0.78, controls = 0.35) was higher than for MIP and SNIPOP (NMD = 0.53, controls = 0.06). In addition, SNIPCL was more often able to exclude inspiratory muscle weakness than SNIPOP. Conclusions SNIPCL values are systematically higher than SNIPOP in both normal subjects and NMD patients. Therefore, SNIPCL is a useful complementary test for ruling out inspiratory muscle weakness in individuals with low MIP values.	[Kaminska, Marta; Noel, Francine; Petrof, Basil J.] McGill Univ, Hlth Ctr, Resp Div, Montreal, PQ, Canada; [Kaminska, Marta; Noel, Francine; Petrof, Basil J.] McGill Univ, Hlth Ctr, Sleep Lab, Montreal, PQ, Canada; [Kaminska, Marta] McGill Univ, Hlth Ctr, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Kaminska, Marta; Noel, Francine; Petrof, Basil J.] McGill Univ, Hlth Ctr, Translat Res Resp Dis Program, Montreal, PQ, Canada; [Petrof, Basil J.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Kaminska, M (corresponding author), McGill Univ, Hlth Ctr, Resp Div, Montreal, PQ, Canada.; Kaminska, M (corresponding author), McGill Univ, Hlth Ctr, Sleep Lab, Montreal, PQ, Canada.; Kaminska, M (corresponding author), McGill Univ, Hlth Ctr, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.; Kaminska, M (corresponding author), McGill Univ, Hlth Ctr, Translat Res Resp Dis Program, Montreal, PQ, Canada.	marta.kaminska@mcgill.ca		Kaminska, Marta/0000-0001-6335-0938	Genzyme Inc.	Genzyme Inc.(Sanofi-AventisGenzyme Corporation)	This work was supported by Genzyme Inc. (https://www.genzyme.com/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Alexander C, 1966, Clin Radiol, V17, P79, DOI 10.1016/S0009-9260(66)80128-9; Beaussier M, 2009, REGION ANESTH PAIN M, V34, P393, DOI 10.1097/AAP.0b013e3181ae11c9; BRIDGER GP, 1970, ARCHIV OTOLARYNGOL, V92, P543; Capozzo R, 2015, J NEUROL, V262, P593, DOI 10.1007/s00415-014-7613-3; Chaudri MB, 2000, EUR RESPIR J, V15, P539, DOI 10.1034/j.1399-3003.2000.15.18.x; ESAU SA, 1983, J APPL PHYSIOL, V55, P731, DOI 10.1152/jappl.1983.55.3.731; Evans JA, 2009, RESP CARE, V54, P1348; Fitting JW, 2006, EUR RESPIR J, V27, P881, DOI 10.1183/09031936.06.00007906; Fitting JW, 1996, REV MAL RESPIR, V13, P479; GANDEVIA SC, 1992, J PHYSIOL-LONDON, V457, P167, DOI 10.1113/jphysiol.1992.sp019370; HAIGHT JSJ, 1983, LARYNGOSCOPE, V93, P49; Hart N, 2003, J NEUROL NEUROSUR PS, V74, P1685, DOI 10.1136/jnnp.74.12.1685; HERITIER F, 1994, AM J RESP CRIT CARE, V150, P1678, DOI 10.1164/ajrccm.150.6.7952632; Lofaso F, 2006, EUR RESPIR J, V27, P980, DOI 10.1183/09031936.06.00121305; Martinez-Llorens J, 2011, ARCH BRONCONEUMOL, V47, P169, DOI 10.1016/j.arbres.2011.01.002; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgan RK, 2005, AM J RESP CRIT CARE, V171, P269, DOI 10.1164/rccm.200403-314OC; NAVA S, 1993, THORAX, V48, P702, DOI 10.1136/thx.48.7.702; Nicot F, 2006, AM J RESP CRIT CARE, V174, P67, DOI 10.1164/rccm.200512-1841OC; POLKEY MI, 1995, THORAX, V50, P1131, DOI 10.1136/thx.50.11.1131; Prigent H, 2004, NEUROCRIT CARE, V1, P475, DOI 10.1385/NCC:1:4:475; Prigent H, 2012, NEUROCRIT CARE, V17, P236, DOI 10.1007/s12028-011-9575-y; Prigent H, 2008, RESP MED, V102, P1737, DOI 10.1016/j.rmed.2008.07.004; QUANJER PH, 1983, B EUR PHYSIOPATH RES, V19, P1; SIMILOWSKI T, 1993, AM REV RESPIR DIS, V147, P850, DOI 10.1164/ajrccm/147.4.850; Stefanutti D, 2000, AM J RESP CRIT CARE, V162, P1507, DOI 10.1164/ajrccm.162.4.9910034; Steier J, 2007, THORAX, V62, P975, DOI 10.1136/thx.2006.072884; Terzi N, 2008, EUR RESPIR J, V31, P93, DOI 10.1183/09031936.00094707; ULDRY C, 1995, THORAX, V50, P371, DOI 10.1136/thx.50.4.371; VINCKEN W, 1987, B EUR PHYSIOPATH RES, V23, P435; Walterspacher S, 2016, LUNG, V194, P821, DOI 10.1007/s00408-016-9929-5	32	15	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177723	10.1371/journal.pone.0177723	http://dx.doi.org/10.1371/journal.pone.0177723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520769	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500063
J	Liu, PF; Liu, QH; Wu, Y; Huang, J				Liu, Peng-fei; Liu, Qing-hui; Wu, Yin; Huang, Jie			Increased nucleoside diphosphate kinase activity induces white spot syndrome virus infection in Litopenaeus vannamei	PLOS ONE			English	Article							PENAEUS-MONODON; RNA INTERFERENCE; SHRIMP; HEMOCYTES; GENES; THIOREDOXIN	Nucleoside diphosphate kinase (NDK), which has the same sequence as oncoprotein (OP) in humans, can induce nucleoside triphosphates in DNA replication by maintenance of the deoxynucleotide triphosphate (dNTP's) and is known to be regulated by viral infection in the shrimp Litopenaeus vannamei. This paper describes the relationship between NDK and white spot syndrome virus (WSSV) infection. The recombinant NDK was produced by a prokaryotic expression system. WSSV copy numbers and mRNA levels of IE1 and VP28 were significantly increased in shrimp injected with recombinant NDK at 72 h after WSSV infection. After synthesizing dsRNA-NDK and confirming the efficacy of NDK silencing, we recorded the cumulative mortality of WSSV-infected shrimp injected with NDK and dsRNA-NDK. A comparison between the results demonstrated that silencing NDK delayed the death of shrimps. These findings indicate that NDK has an important role influencing the replication of WSSV replication in shrimp. Furthermore, NDK may have potential target as a new therapeutic strategy against WSSV infection in shrimp.	[Liu, Peng-fei; Liu, Qing-hui; Huang, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Liu, Peng-fei; Wu, Yin] Dalian Ocean Univ, Dalian, Peoples R China; [Liu, Qing-hui; Huang, Jie] Natl Lab Marine Sci & Technol, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Dalian Ocean University; Qingdao National Laboratory for Marine Science & Technology	Liu, QH (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.; Liu, QH (corresponding author), Natl Lab Marine Sci & Technol, Qingdao, Peoples R China.	liuqh@ysfri.ac.cn	Huang, Jie/GWQ-5005-2022	Huang, Jie/0000-0002-0348-6590	National Science Foundation of China [31672679]; National Basic Research Program (973 program) of China [2012CB114401]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 program) of China(National Basic Research Program of China)	This study was supported by the National Science Foundation of China (Grant: 31672679) and the National Basic Research Program (973 program) of China (Grant No: 2012CB114401).	Alday-Sanz V, 2002, DIS AQUAT ORGAN, V48, P91, DOI 10.3354/dao048091; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Chen X.Y., 2010, AQUACULT SCI ANHUI, V26, P14265; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Clavero-Salas A, 2007, FISH SHELLFISH IMMUN, V23, P459, DOI 10.1016/j.fsi.2007.01.010; de Lorgeril J, 2005, PHYSIOL GENOMICS, V21, P174, DOI 10.1152/physiolgenomics.00281.2004; Desvignes T, 2009, BMC EVOL BIOL, P249; Durand SV, 2002, J FISH DIS, V25, P381, DOI 10.1046/j.1365-2761.2002.00367.x; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu T, 2011, N-S ARCH PHARMACOL, V384, P363, DOI 10.1007/s00210-011-0607-0; Huang JY, 2012, ANTIOXID REDOX SIGN, V17, P914, DOI 10.1089/ars.2011.4264; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Liu PF, 2015, J INVERTEBR PATHOL, V129, P57, DOI 10.1016/j.jip.2015.05.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marino N, 2012, CANCER METAST REV, V31, P593, DOI 10.1007/s10555-012-9374-8; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Quintero-Reyes IE, 2012, J BIOENERG BIOMEMBR, V44, P325, DOI 10.1007/s10863-012-9436-1; Sambrook J., 2001, MOL CLONING LAB MANU; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Takacs-Vellai K, J MOL SIGNAL, V9, P42014; Van De Braak CB, 2002, FISH SHELLFISH IMMUN, V13, P293, DOI 10.1006/fsim.2002.0409; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; Zhou Q, 2007, J VIROL METHODS, V146, P288, DOI 10.1016/j.jviromet.2007.07.007	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0175741	10.1371/journal.pone.0175741	http://dx.doi.org/10.1371/journal.pone.0175741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505172	Green Submitted, gold, Green Published			2022-12-27	WOS:000401473500006
J	Mau-Moeller, A; Jacksteit, R; Jackszis, M; Feldhege, F; Weippert, M; Mittelmeier, W; Bader, R; Skripitz, R; Behrens, M				Mau-Moeller, Anett; Jacksteit, Robert; Jackszis, Mario; Feldhege, Frank; Weippert, Matthias; Mittelmeier, Wolfram; Bader, Rainer; Skripitz, Ralf; Behrens, Martin			Neuromuscular function of the quadriceps muscle during isometric maximal, submaximal and submaximal fatiguing voluntary contractions in knee osteoarthrosis patients	PLOS ONE			English	Article							FORCE STEADINESS; OLDER-ADULTS; STRENGTH; ACTIVATION; MECHANISMS; PERFORMANCE; WEAKNESS; ATROPHY; FEMORIS; HIP	Introduction Knee osteoarthrosis (KOA) is commonly associated with a dysfunction of the quadriceps muscle which contributes to alterations in motor performance. The underlying neuromuscular mechanisms of muscle dysfunction are not fully understood. The main objective of this study was to analyze how KOA affects neuromuscular function of the quadriceps muscle during different contraction intensities. Materials and methods The following parameters were assessed in 20 patients and 20 healthy controls: (i) joint position sense, i.e. position control (mean absolute error, MAE) at 30 degrees and 50 degrees of knee flexion, (ii) simple reaction time task performance, (iii) isometric maximal voluntary torque (IMVT) and root mean square of the EMG signal (RMS-EMG), (iv) torque control, i.e. accuracy (MAE), absolute fluctuation (standard deviation, SD), relative fluctuation (coefficient of variation, CV) and periodicity (mean frequency, MNF) of the torque signal at 20%, 40% and 60% IMVT, (v) EMG-torque relationship at 20%, 40% and 60% IMVT and (vi) performance fatigability, i.e. time to task failure (TTF) at 40% IMVT. Results Compared to the control group, the KOA group displayed: (i) significantly higher MAE of the angle signal at 30 degrees (99.3%; P = 0.027) and 50 degrees (147.9%; P < 0.001), (ii) no significant differences in reaction time, (iii) significantly lower IMVT (-41.6%; P = 0.001) and tendentially lower RMS-EMG of the rectus femoris (-33.7%; P = 0.054), (iv) tendentially higher MAE of the torque signal at 20% IMVT (65.9%; P = 0.068), significantly lower SD of the torque signal at all three torque levels and greater MNF at 60% IMVT (44.8%; P = 0.018), (v) significantly increased RMS-EMG of the vastus lateralis at 20% (70.8%; P = 0.003) and 40% IMVT (33.3%; P = 0.034), significantly lower RMS-EMG of the biceps femoris at 20% (-63.6%; P = 0.044) and 40% IMVT (-41.3%; P = 0.028) and tendentially lower at 60% IMVT (-24.3%; P = 0.075) and (vi) significantly shorter TTF (-51.1%; P = 0.049). Conclusion KOA is not only associated with a deterioration of IMVT and neuromuscular activation, but also with an impaired position and torque control at submaximal torque levels, an altered EMG-torque relationship and a higher performance fatigability of the quadriceps muscle. It is recommended that the rehabilitation includes strengthening and fatiguing exercises at maximal and submaximal force levels.	[Mau-Moeller, Anett; Jacksteit, Robert; Jackszis, Mario; Feldhege, Frank; Mittelmeier, Wolfram; Bader, Rainer; Skripitz, Ralf] Univ Med Rostock, Dept Orthopaed, Rostock, Germany; [Weippert, Matthias; Behrens, Martin] Univ Rostock, Inst Sports Sci, Rostock, Germany	University of Rostock; University of Rostock	Mau-Moeller, A (corresponding author), Univ Med Rostock, Dept Orthopaed, Rostock, Germany.	anett.mau-moeller@uni-rostock.de	Behrens, Martin/H-8443-2019; Weippert, Matthias/AAE-4048-2021	Behrens, Martin/0000-0003-1980-3260; Weippert, Matthias/0000-0003-2323-0047; Mau-Moeller, Anett/0000-0002-3097-1700	Deutsche Athrose-Hilfe e.V.	Deutsche Athrose-Hilfe e.V.	This study was supported by the Deutsche Athrose-Hilfe e.V. (http://www.arthrose.de/). The study sponsor was not involved in the study design, collection, analysis and interpretation of data as well as in the writing of the manuscript.	Alkner BA, 2000, MED SCI SPORT EXER, V32, P459, DOI 10.1097/00005768-200002000-00030; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bade MJ, 2010, J ORTHOP SPORT PHYS, V40, P559, DOI 10.2519/jospt.2010.3317; BARRETT DS, 1991, J BONE JOINT SURG BR, V73, P53, DOI 10.1302/0301-620X.73B1.1991775; Behrens M, 2016, J SCI MED SPORT, V19, P170, DOI 10.1016/j.jsams.2015.01.011; Behrens M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10209; Behrens M, 2015, EUR J APPL PHYSIOL, V115, P1075, DOI 10.1007/s00421-014-3089-1; Bennell KL, 2013, RHEUM DIS CLIN N AM, V39, P145, DOI 10.1016/j.rdc.2012.11.003; Berger MJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-199; Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; BOTWINICK J, 1966, J EXP PSYCHOL, V71, P9, DOI 10.1037/h0022634; Cohen J.E., 1988, STAT POWER ANAL BEHA; Elboim-Gabyzon M, 2013, CLIN INTERV AGING, V8, P1071, DOI 10.2147/CIA.S42094; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Fink B, 2007, ARTHRITIS RHEUM, V56, P3626, DOI 10.1002/art.22960; Fisher NM, 1997, DISABIL REHABIL, V19, P47, DOI 10.3109/09638289709166827; Fransen M, 2016, COCHRANE DB SYST REV, V1; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gapeyeva H, 2007, KNEE SURG SPORT TR A, V15, P202, DOI 10.1007/s00167-006-0166-y; GLASBERG M R, 1986, Henry Ford Hospital Medical Journal, V34, P37; Hiranaka T, 1995, Nihon Seikeigeka Gakkai Zasshi, V69, P675; Hopkins WG, 2011, NEW VIEW STAT; Hortobagyi T, 2001, J GERONTOL A-BIOL, V56, pB38, DOI 10.1093/gerona/56.1.B38; Hortobagyi T, 2004, ARTHRIT RHEUM-ARTHR, V51, P562, DOI 10.1002/art.20545; Hurley MV, 1999, RHEUM DIS CLIN N AM, V25, P283, DOI 10.1016/S0889-857X(05)70068-5; Hurley MV, 1997, ANN RHEUM DIS, V56, P641, DOI 10.1136/ard.56.11.641; Ikeda S, 2005, J ORTHOP SCI, V10, P121, DOI 10.1007/s00776-004-0876-2; Jerosch J, 1995, Sportverletz Sportschaden, V9, P72, DOI 10.1055/s-2007-993428; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Levinger P, 2011, KNEE SURG SPORT TR A, V19, P1082, DOI 10.1007/s00167-010-1325-8; Lewek MD, 2006, MUSCLE NERVE, V34, P767, DOI 10.1002/mus.20663; Lin DH, 2009, J ORTHOP SPORT PHYS, V39, P450, DOI 10.2519/jospt.2009.2923; Ling SM, 2007, OSTEOARTHR CARTILAGE, V15, P1134, DOI 10.1016/j.joca.2007.03.024; MARKS R, 1994, CLIN EXP RHEUMATOL, V12, P11; Mizner RL, 2005, J RHEUMATOL, V32, P1533; Mizner RL, 2005, J ORTHOP SPORT PHYS, V35, P424, DOI 10.2519/jospt.2005.35.7.424; Mizner RL, 2005, J BONE JOINT SURG AM, V87A, P1047, DOI 10.2106/JBJS.D.01992; Nakamura T, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P467; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Petterson SC, 2008, MED SCI SPORT EXER, V40, P422, DOI [10.1249/mss.0b013e31815ef285, 10.1249/MSS.0b013e31815ef285]; Pietrosimone BG, 2011, PM&R, V3, P153, DOI 10.1016/j.pmrj.2010.07.485; Ploutz-Snyder LL, 2002, J GERONTOL A-BIOL, V57, pB144, DOI 10.1093/gerona/57.4.B144; Rice DA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3467; Rice DA, 2010, SEMIN ARTHRITIS RHEU, V40, P250, DOI 10.1016/j.semarthrit.2009.10.001; Roos EM, 2011, NAT REV RHEUMATOL, V7, P57, DOI 10.1038/nrrheum.2010.195; SCHENAU GJV, 1994, HUM MOVEMENT SCI, V13, P495; Seynnes O, 2005, J AGING PHYS ACTIV, V13, P395, DOI 10.1123/japa.13.4.395; Singh NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082791; Singh NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048449; Singh NB, 2010, PHILOS T R SOC A, V368, P2783, DOI 10.1098/rsta.2010.0091; Smith JW, 2014, J ARTHROPLASTY, V29, P1143, DOI 10.1016/j.arth.2013.11.023; Stevens-Lapsley JE, 2010, CLIN ORTHOP RELAT R, V468, P2460, DOI 10.1007/s11999-009-1219-6; STOKES M, 1985, Physiotherapy Practice, V1, P71; Suelto MD, 1999, ANESTHESIOLOGY; Suetta C, 2007, J APPL PHYSIOL, V102, P942, DOI 10.1152/japplphysiol.00067.2006; Takacs J, 2013, AGING DIS, V4, P84; Tanaka R, 2016, CLIN REHABIL, V30, P36, DOI 10.1177/0269215515570098; Tanaka S, 1998, AM J PHYS MED REHAB, V77, P122, DOI 10.1097/00002060-199803000-00007; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Tracy BL, 2002, J APPL PHYSIOL, V92, P1004, DOI 10.1152/japplphysiol.00954.2001; Watanbe K, 2014, MUSCLE NERVE, V50; Winter SL, 2010, J APPL BIOMECH, V26, P45, DOI 10.1123/jab.26.1.45; WORRINGHAM CJ, 1985, EXP BRAIN RES, V61, P38; Zacharias A, 2014, OSTEOARTHR CARTILAGE, V22, P1752, DOI 10.1016/j.joca.2014.07.005	67	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176976	10.1371/journal.pone.0176976	http://dx.doi.org/10.1371/journal.pone.0176976			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505208	Green Submitted, gold, Green Published			2022-12-27	WOS:000401473500011
J	Zhan, ZX; Nwafor, CC; Hou, ZK; Gong, JF; Zhu, B; Jiang, YF; Zhou, YM; Wu, JS; Piao, ZY; Tong, Y; Liu, C; Zhang, CY				Zhan, Zongxiang; Nwafor, Chinedu Charles; Hou, Zhaoke; Gong, Jianfang; Zhu, Bin; Jiang, Yingfen; Zhou, Yongming; Wu, Jiangsheng; Piao, Zhongyun; Tong, Yue; Liu, Chao; Zhang, Chunyu			Cytological and morphological analysis of hybrids between Brassicoraphanus, and Brassica napus for introgression of clubroot resistant trait into Brassica napus L	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; RAPHANUS-SATIVUS; PLASMODIOPHORA-BRASSICAE; SOMATIC HYBRIDS; INTERSPECIFIC HYBRIDS; DURUM-WHEAT; GENE RFO; RAPA; RADISH; RECOMBINATION	Interspecific hybridization is a powerful tool for improvement of crop species, it has the potential to broaden the genetic base and create new plant forms for breeding programs. Synthetic allopolyploid is a widely-used model for the study of genetic recombination and fixed heterosis in Brassica. In Brassica napus breeding, identification and introgression of new sources of clubroot resistance trait from wild or related species into it by hybridization is a long-term crop management strategy for clubroot disease. Radish (Raphanus sativus L.) is a close relative of the Brassica and most radish accessions are immune to the clubroot disease. A synthesized allotetraploid Brassicoraphanus (RRCC, 2n = 36) between R. sativus cv. HQ-04 (2n = 18, RR) and Brassica oleracea var. alboglabra (L.H Bailey) (2n = 18, CC) proved resistant of multiple clubroot disease pathogen P. brassicae. To predict the possibility to transfer the clubroot resistance trait from the RR subgenome of allotetraploid Brassicoraphanus (RRCC, 2n = 36) into Brassica napus (AACC, 2n = 38), we analyzed the frequency of chromosome pairings in the F-1 hybrids produced from a cross between B. napus cv. HS5 and the allotetraploid, characterize the genomic composition of some back-crossed progeny (BC1) using GISH, BAC-FISH and AFLP techniques. The level of intergenomic pairing between A and R genomes in the F-1 hybrid was high, allosyndetic bivalents formed in 73.53% PMCs indicative of significant level of homeologous recombination between two genomes and high probability of incorporating chromosomal segments/genes from R-genome into A/C-genomes. The BC1 plants inherited variant extra R chromosomes or fragments from allotetraploid as revealed by GISH and AFLP analysis. 13.51% BC2 individuals were resistant to clubroot disease, and several resistance lines had high pollen fertility, Overall, the genetic material presented in this work represents a potential new genetic resource for practical use in breeding B. napus clubroot resistant cultivars.	[Zhan, Zongxiang; Nwafor, Chinedu Charles; Hou, Zhaoke; Gong, Jianfang; Zhou, Yongming; Wu, Jiangsheng; Liu, Chao; Zhang, Chunyu] Huazhong Agr Univ, Natl Res Ctr Rapeseed Engn & Technol, Wuhan, Peoples R China; [Zhan, Zongxiang; Nwafor, Chinedu Charles; Hou, Zhaoke; Gong, Jianfang; Zhou, Yongming; Wu, Jiangsheng; Liu, Chao; Zhang, Chunyu] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Zhu, Bin] Guizhou Normal Univ, Coll Life Sci, Guiyang, Peoples R China; [Jiang, Yingfen] Anhui Acad Agr Sci, Crop Res Inst, Hefei, Peoples R China; [Piao, Zhongyun] Shenyang Agr Univ, Dept Hort, Shenyang, Peoples R China; [Tong, Yue] Yichang Acad Agr Sci, Yichang, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Guizhou Normal University; Anhui Academy of Agricultural Sciences; Shenyang Agricultural University	Zhang, CY (corresponding author), Huazhong Agr Univ, Natl Res Ctr Rapeseed Engn & Technol, Wuhan, Peoples R China.; Zhang, CY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	zhchy@mail.hzau.edu.cn	Zhu, Bin/ABC-6740-2021; Zhang, Chun-yu/HDP-5776-2022		National Key Research and Development Program of China [2016YFD0101300]; Special Fund for Agroscientific Research in the Public Interest [201203026-6]; Technological innovation project of HuBei [2016ABA084]; China Agriculture Research System [nycytx00503]	National Key Research and Development Program of China; Special Fund for Agroscientific Research in the Public Interest; Technological innovation project of HuBei; China Agriculture Research System	This work was supported by the grants from the National Key Research and Development Program of China (no. 2016YFD0101300), Special Fund for Agroscientific Research in the Public Interest (201203026-6), Technological innovation project of HuBei (2016ABA084), and China Agriculture Research System (nycytx00503).	Arumugam N, 2002, PLANT BREEDING, V121, P168, DOI 10.1046/j.1439-0523.2002.00681.x; Chai AL, 2014, CAN J PLANT PATHOL, V36, P142, DOI 10.1080/07060661.2013.868829; Chandra A, 2004, THEOR APPL GENET, V108, P1620, DOI 10.1007/s00122-004-1592-1; Chen HG, 2008, GENET RESOUR CROP EV, V55, P143, DOI 10.1007/s10722-007-9223-8; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085307; Cifuentes M, 2010, CYTOGENET GENOME RES, V129, P124, DOI 10.1159/000313593; Cronn R, 2003, EVOLUTION, V57, P2475, DOI 10.1111/j.0014-3820.2003.tb01493.x; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Doyle JJ, 1993, AUSTR SYSTEMATIC BOT, V3, P125; Feng JH, 2009, GENOME, V52, P401, DOI [10.1139/G09-016, 10.1139/g09-016]; Grandont L, 2014, PLANT CELL, V26, P1448, DOI 10.1105/tpc.114.122788; Guttman B., 2001, ENCY GENETICS, V49, P663; HAGIMORI M, 1992, THEOR APPL GENET, V84, P819, DOI 10.1007/BF00227390; Han HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091066; He QY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0480-y; Heneen WK, 1995, HEREDITAS, V123, P251, DOI 10.1111/j.1601-5223.1995.00251.x; Hirai M, 2006, BREEDING SCI, V56, P223, DOI 10.1270/jsbbs.56.223; Hu XY, 2008, MOL BREEDING, V22, P663, DOI 10.1007/s11032-008-9207-1; Jauhar PP, 2009, J CROP IMPROV, V23, P319, DOI 10.1080/15427520902838648; Jenczewski E, 2003, GENETICS, V164, P645; Johnston TD, 2007, PLANT PATHOL, V17, P184; Kamei A, 2010, THEOR APPL GENET, V120, P1021, DOI 10.1007/s00122-009-1230-z; Kaneko Y, 2001, PLANT BREEDING, V120, P163, DOI 10.1046/j.1439-0523.2001.00576.x; Kato T, 2012, BREEDING SCI, V62, P282, DOI 10.1270/jsbbs.62.282; Ky CL, 2000, THEOR APPL GENET, V101, P669, DOI 10.1007/s001220051529; Lee YP, 2008, THEOR APPL GENET, V117, P905, DOI 10.1007/s00122-008-0830-3; Levin DA, 2012, NEW PHYTOL, V196, P666, DOI 10.1111/j.1469-8137.2012.04309.x; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li MT, 2004, CHROMOSOME RES, V12, P417, DOI 10.1023/B:CHRO.0000034722.66981.94; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; Mason AS, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-103; MCNAUGHTON IH, 1973, NATURE, V243, P547, DOI 10.1038/243547a0; Navabi ZK, 2011, GENETICS, V187, P659, DOI 10.1534/genetics.110.124925; PAULMANN W, 1988, PLANT BREEDING, V100, P299, DOI 10.1111/j.1439-0523.1988.tb00256.x; PELLANDELOURME R, 1987, PLANT BREEDING, V99, P89, DOI 10.1111/j.1439-0523.1987.tb01157.x; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Rahman H, 2017, CAN J PLANT SCI, V91, P447; Rahman H, 2013, CAN J PLANT SCI, V93, P363, DOI [10.4141/CJPS2012-074, 10.4141/cjps2012-074]; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rohlf FJ., 1988, NTSYS PC NUMERICAL T; Sakamoto K, 2008, THEOR APPL GENET, V117, P759, DOI 10.1007/s00122-008-0817-0; Schelfhout CJ, 2006, GENOME, V49, P1490, DOI 10.1139/G06-103; Suwabe K, 2003, THEOR APPL GENET, V107, P997, DOI 10.1007/s00122-003-1309-x; Tu YQ, 2008, PLANT CELL REP, V27, P873, DOI 10.1007/s00299-008-0513-1; VOORRIPS RE, 1995, EUPHYTICA, V83, P139, DOI 10.1007/BF01678041; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yamagishi H, 2014, BREEDING SCI, V64, P38, DOI 10.1270/jsbbs.64.38	48	22	25	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177470	10.1371/journal.pone.0177470	http://dx.doi.org/10.1371/journal.pone.0177470			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505203	gold, Green Submitted, Green Published			2022-12-27	WOS:000401473500022
J	Zhang, BB; Peng, B; Zhang, CH; Song, ZZ; Ma, RJ				Zhang, Binbin; Peng, Bin; Zhang, Chunhua; Song, Zhizhong; Ma, Ruijuan			Determination of fruit maturity and its prediction model based on the pericarp index of absorbance difference (I-AD) for peaches	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; TOTAL SOLUBLE SOLIDS; ON-TREE; HARVEST; ETHYLENE; FLESH; COLOR; NECTARINES; FIRMNESS; QUALITY	Harvest maturity is closely related to peach fruit quality and has a very important effect on the fresh fruit market. Unfortunately, at present, it is difficult to determine the maturity level of peach fruits by artificial methods. The objectives of this study were to develop quadratic polynomial regression models using near-infrared spectroscopy that could determine the peel color difference, fruit firmness, soluble solids content (SSC), soluble sugar, organic acid components, and their relationships with the absorbance of chlorophyll (index of absorbance difference, I-AD) in late maturing 'Xiahui 8' peach and 'Xiaguang' nectarine fruits. The analysis was based on data for fruits at veraison, fruits at harvesting maturity, and all fruits. The results showed that firmness has the highest correlation coefficient with I-AD. Prediction models for fruit maturity were established between firmness and the I-AD of the two cultivars using the quadratic polynomial regression method. Further variance analysis on the one degree term and quadratic term of each equation showed that every partial regression coefficient reached a significant or extremely significant level. No significant difference was observed between estimated and observed values after regression prediction. The regression equations seem to fit well. Other peach and nectarine varieties were used to test the feasibility of maturity prediction by this method, and it was found that maturity was successfully predicted in all the samples. The result indicated that the I-AD can be used as an index to predict peach fruit maturity.	[Zhang, Binbin; Peng, Bin; Zhang, Chunhua; Song, Zhizhong; Ma, Ruijuan] Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Ma, RJ (corresponding author), Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China.	marj311@163.com			China Agriculture Research System [CARS-31]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(15)1020]	China Agriculture Research System; Jiangsu Agriculture Science and Technology Innovation Fund	This work was supported by the earmarked fund of China Agriculture Research System (No.CARS-31), Ruijuan Ma (http//119.253.58.231/), and Jiangsu Agriculture Science and Technology Innovation Fund [No. CX(15)1020], Ruijuan Ma (http://www.jsnyzzcx.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonora E, 2013, SCI HORTIC-AMSTERDAM, V159, P166, DOI 10.1016/j.scienta.2013.05.011; Cantin CM, 2009, J SCI FOOD AGR, V89, P1909, DOI 10.1002/jsfa.3672; Crisosto C.H., 1994, POSTHARVEST NEWS INF, V5, P65; Dabbou S, 2016, PLANT PHYSIOL BIOCH, V100, P1, DOI 10.1016/j.plaphy.2015.12.015; Farneti B, 2015, SCI HORTIC-AMSTERDAM, V190, P110, DOI 10.1016/j.scienta.2015.04.023; Golding JB, 2006, ACTA HORTIC, P461, DOI 10.17660/ActaHortic.2006.713.69; Golic M, 2006, ANAL CHIM ACTA, V555, P286, DOI 10.1016/j.aca.2005.09.014; Goncalves RG, 2016, SCI HORTIC-AMSTERDAM, V209, P293, DOI 10.1016/j.scienta.2016.06.040; Herrero-Langreo A, 2012, J FOOD ENG, V108, P150, DOI 10.1016/j.jfoodeng.2011.07.004; Infante R, 2012, NEW ZEAL J CROP HORT, V40, P103, DOI 10.1080/01140671.2011.611149; Infante R, 2011, POSTHARVEST BIOL TEC, V61, P35, DOI 10.1016/j.postharvbio.2011.01.003; Infante R, 2011, CHIL J AGR RES, V71, P445, DOI 10.4067/S0718-58392011000300016; Koukounaras A, 2009, POSTHARVEST BIOL TEC, V54, P172, DOI 10.1016/j.postharvbio.2009.07.002; Lewallen KS, 2003, J AM SOC HORTIC SCI, V128, P163, DOI 10.21273/JASHS.128.2.0163; Liu MH, 2007, NEW ZEAL J AGR RES, V50, P601; Louw ED, 2010, POSTHARVEST BIOL TEC, V58, P176, DOI 10.1016/j.postharvbio.2010.07.001; Lurie S, 2013, POSTHARVEST BIOL TEC, V76, P10, DOI 10.1016/j.postharvbio.2012.08.007; Nascimento PAM, 2016, POSTHARVEST BIOL TEC, V111, P345, DOI 10.1016/j.postharvbio.2015.08.006; Matteoli S, 2015, IEEE SENS J, V15, P5455, DOI 10.1109/JSEN.2015.2442337; MITCHELL FG, 1974, CALIF AGR, V28, P12; Onelli E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145341; Pinto C, 2015, SCI HORTIC-AMSTERDAM, V192, P231, DOI 10.1016/j.scienta.2015.05.033; Rodrigo MJ, 2007, POSTHARVEST BIOL TEC, V43, P14, DOI 10.1016/j.postharvbio.2006.07.008; Shao YN, 2011, FOOD BIOPROCESS TECH, V4, P1376, DOI 10.1007/s11947-009-0227-6; Shinya P, 2013, POSTHARVEST BIOL TEC, V86, P472, DOI 10.1016/j.postharvbio.2013.07.038; Spadoni A, 2016, SCI HORTIC-AMSTERDAM, V201, P140, DOI 10.1016/j.scienta.2016.01.041; STEWART I, 1972, J AGR FOOD CHEM, V20, P448, DOI 10.1021/jf60180a024; Tiwari G, 2013, POSTHARVEST BIOL TEC, V86, P221, DOI 10.1016/j.postharvbio.2013.07.009; TONUTTI P, 1991, J AM SOC HORTIC SCI, V116, P274, DOI 10.21273/JASHS.116.2.274; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; VOSS DH, 1992, HORTSCIENCE, V27, P1256, DOI 10.21273/HORTSCI.27.12.1256; Ying YB, 2005, T ASAE, V48, P229, DOI 10.13031/2013.17922; Zerbini PE, 2006, POSTHARVEST BIOL TEC, V39, P223, DOI 10.1016/j.postharvbio.2005.10.011; Zhang BB, 2015, J HORTIC SCI BIOTECH, V90, P303, DOI 10.1080/14620316.2015.11513187; [张斌斌 Zhang Binbin], 2014, [食品科学, Food Science], V35, P68; Ziosi V, 2008, POSTHARVEST BIOL TEC, V49, P319, DOI 10.1016/j.postharvbio.2008.01.017	36	19	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177511	10.1371/journal.pone.0177511	http://dx.doi.org/10.1371/journal.pone.0177511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505165	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500026
J	Atassi, N; Xu, MS; Triantafyllou, C; Keil, B; Lawson, R; Cernasov, P; Ratti, E; Long, CJ; Paganoni, S; Murphy, A; Salibi, N; Seethamraju, R; Rosen, B; Ratai, EM				Atassi, Nazem; Xu, Maosheng; Triantafyllou, Christina; Keil, Boris; Lawson, Robert; Cernasov, Paul; Ratti, Elena; Long, Christopher J.; Paganoni, Sabrina; Murphy, Alyssa; Salibi, Nouha; Seethamraju, Ravi; Rosen, Bruce; Ratai, Eva-Maria			Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							VIVO H-1-NMR SPECTROSCOPY; MOTOR-NEURON INVOLVEMENT; IN-VIVO; MR SPECTROSCOPY; CEREBRAL DEGENERATION; PREDICTS SURVIVAL; DIFFUSION-TENSOR; HUMAN BRAIN; ALSFRS-R; GLUTAMATE	The main objective of this study was to utilize high field (7T) in vivo proton magnetic resonance imaging to increase the ability to detect metabolite changes in people with ALS, specifically, to quantify levels of glutamine and glutamine separately. The second objective of this study was to correlate metabolic markers with clinical outcomes of disease progression. 13 ALS participants and 12 age-matched healthy controls (HC) underwent 7 Tesla MRI and MRS. Single voxel MR spectra were acquired from the left precentral gyrus using a very short echo time (TE = 5 ms) STEAM sequence. MRS data was quantified using LCModel and correlated to clinical outcome markers. N-acetylaspartate (NAA) and total NAA (tNA, NAA + NAAG) were decreased by 17% in people with ALS compared to HC (P = 0.004 and P = 0.005, respectively) indicating neuronal injury and/or loss in the precentral gyrus. tNA correlated with disease progression as measured by forced vital capacity (FVC) (P = 0.014; R rho = 0.66) and tNA/tCr correlated with overall functional decline as measured by worsening of the ALS Functional Rating Scale-Revised (ALSFRS-R) (P = 0.004; R rho = -0.74). These findings underscore the importance of NAA as a reliable biomarker for neuronal injury and disease progression in ALS. Glutamate (Glu) was 15% decreased in people with ALS compared to HC (P = 0.02) while glutamine (Gln) concentrations were similar between the two groups. Furthermore, the decrease in Glu correlated with the decrease in FVC (P = 0.013; R rho = 0.66), a clinical marker of disease progression. The decrease in Glu is most likely driven by intracellular Glu loss due to neuronal loss and degeneration. Neither choline containing components (Cho), a marker for cell membrane turnover, nor myo-Inositol (ml), a suspected marker for neuroinflammation, showed significant differences between the two groups. However, ml/tNA was correlated with upper motor neuron burden (P = 0.004, R rho = 0.74), which may reflect a relative increase of activated microglia around motor neurons. In summary, 7T(1) H MRS is a powerful non-invasive imaging technique to study molecular changes related to neuronal injury and/or loss in people with ALS.	[Atassi, Nazem; Lawson, Robert; Cernasov, Paul; Ratti, Elena] Massachusetts Gen Hosp, NCRI, Dept Neurol, Boston, MA 02114 USA; [Atassi, Nazem; Lawson, Robert; Cernasov, Paul; Ratti, Elena; Murphy, Alyssa] Harvard Med Sch, Boston, MA 02114 USA; [Xu, Maosheng] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Triantafyllou, Christina; Keil, Boris; Rosen, Bruce; Ratai, Eva-Maria] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA; [Triantafyllou, Christina; Keil, Boris; Rosen, Bruce; Ratai, Eva-Maria] Harvard Med Sch, Charlestown, MA USA; [Long, Christopher J.] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Paganoni, Sabrina] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Salibi, Nouha] Siemens, Siemens Healthineers MR R&D, Auburn, AL USA; [Seethamraju, Ravi] Siemens, Siemens Healthineers MR R&D, Charlestown, MA USA; [Triantafyllou, Christina] Siemens Healthineers, Erlangen, Germany; [Keil, Boris] Mittelhessen Univ Appl Sci, Inst Med Phys & Radiat Safety, Dept Life Sci Engn, Giessen, Germany; [Ratti, Elena] Biogen, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Zhejiang Chinese Medical University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Spaulding Rehabilitation Hospital; Siemens AG; Siemens AG; Siemens AG; Biogen	Ratai, EM (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA.; Ratai, EM (corresponding author), Harvard Med Sch, Charlestown, MA USA.	ratai@nmr.mgh.harvard.edu	Keil, Boris/AAX-9557-2020; Keil, Boris/P-1411-2014	Keil, Boris/0000-0003-0805-8330; Seethamraju, Ravi Teja/0000-0002-2719-6854	Harvard NeuroDiscovery Center; Muscular Dystrophy Association Clinical Research Training Grant; Research fellowship from the American Academy of Neurology; Anne B. Young neuroscience translational medicine fellowship; Siemens Healtheneers	Harvard NeuroDiscovery Center; Muscular Dystrophy Association Clinical Research Training Grant(Muscular Dystrophy Association); Research fellowship from the American Academy of Neurology; Anne B. Young neuroscience translational medicine fellowship; Siemens Healtheneers	This work was conducted with support from the Harvard NeuroDiscovery Center, Muscular Dystrophy Association Clinical Research Training Grant, Research fellowship from the American Academy of Neurology, and the Anne B. Young neuroscience translational medicine fellowship. Siemens Healtheneers provided support in the form of salaries for authors CT, NS and RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted with support from the Harvard NeuroDiscovery Center, Muscular Dystrophy Association Clinical Research Training Grant, Research fellowship from the American Academy of Neurology, and the Anne B. Young neuroscience translational medicine fellowship. We like to thank Drs. Dinesh Deelchand and Gulin Oz from the Center for Magnetic Resonance Research at the University of Minnesota for providing us with the 7T-LCModel basis-set. In addition, we like to thank Dr. Merit Cudkowicz for insightful discussion on the study design. Lastly, we like to thank all participating patients and their families.	Abe K, 2001, NEURORADIOLOGY, V43, P537, DOI 10.1007/s002340000521; Block W, 1998, ARCH NEUROL-CHICAGO, V55, P931, DOI 10.1001/archneur.55.7.931; Bowen BC, 2000, AM J NEURORADIOL, V21, P647; Bradley WG, 1999, J NEUROL SCI, V169, P84, DOI 10.1016/S0022-510X(99)00221-X; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; da Rocha AJ, 2012, ARQ NEURO-PSIQUIAT, V70, P532, DOI 10.1590/S0004-282X2012000700012; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; Deelchand DK, 2012, MAGN RESON MED, V67, P891, DOI 10.1002/mrm.23080; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Foerster BR, 2013, NAT REV NEUROL, V9, P513, DOI 10.1038/nrneurol.2013.153; Foerster BR, 2013, JAMA NEUROL, V70, P1009, DOI 10.1001/jamaneurol.2013.234; Govind V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035607; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffith HR, 2008, NMR BIOMED, V21, P381, DOI 10.1002/nbm.1203; Han J, 2010, J MAGN RESON IMAGING, V31, P305, DOI 10.1002/jmri.22053; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Kalra S, 2006, J NEUROL NEUROSUR PS, V77, P1253, DOI 10.1136/jnnp.2006.090696; Kalra S, 2006, ARCH NEUROL-CHICAGO, V63, P1144, DOI 10.1001/archneur.63.8.1144; Kaufmann P, 2004, NEUROLOGY, V62, P1753, DOI 10.1212/01.WNL.0000125182.17874.59; Kaufmann Petra, 2002, Curr Neurol Neurosci Rep, V2, P55, DOI 10.1007/s11910-002-0054-x; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Liu CJ, 2015, INT J ANTENN PROPAG, V2015, DOI [10.1155/2015/252717, 10.1155/2015/256536]; Lombardo F, 2009, ARCH ITAL BIOL, V147, P69; Mitsumoto H, 2007, NEUROLOGY, V68, P1402, DOI 10.1212/01.wnl.0000260065.57832.87; Pioro EP, 1999, NEUROLOGY, V53, P71, DOI 10.1212/WNL.53.1.71; Pioro EP, 1997, J NEUROL SCI, V152, pS49, DOI 10.1016/S0022-510X(97)00244-X; Pohl C, 2001, ARCH NEUROL-CHICAGO, V58, P729, DOI 10.1001/archneur.58.5.729; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; Rule RR, 2004, AMYOTROPH LATERAL SC, V5, P141, DOI 10.1080/14660820410017109; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Schuff N, 2001, MAGN RESON MED, V45, P513, DOI 10.1002/1522-2594(200103)45:3<513::AID-MRM1067>3.0.CO;2-D; Shiino A, 2012, J CEREBR BLOOD F MET, V32, P805, DOI 10.1038/jcbfm.2012.9; Sivak S, 2010, NEURORADIOLOGY, V52, P1079, DOI 10.1007/s00234-010-0685-6; Sudharshan N, 2011, AM J NEURORADIOL, V32, P403, DOI 10.3174/ajnr.A2289; Tiret B, 2015, NEUROCHEM RES, V40, P2482, DOI 10.1007/s11064-015-1748-1; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tkac I, 2001, MAGNET RESON MED, V46, P451, DOI 10.1002/mrm.1213; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; Turner MR, 2013, AMYOTROPH LAT SCL FR, V14, P19, DOI 10.3109/21678421.2013.778554; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Turner Martin R, 2010, Expert Opin Med Diagn, V4, P483, DOI 10.1517/17530059.2010.536836; Unrath A, 2007, J NEUROL, V254, P1099, DOI 10.1007/s00415-006-0495-2; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; van der Graaff MM, 2010, AM J NEURORADIOL, V31, P1799, DOI 10.3174/ajnr.A2217; Verma G, 2013, RADIOLOGY, V267, P851, DOI 10.1148/radiol.13121148; Wang SM, 2006, RADIOLOGY, V239, P831, DOI 10.1148/radiol.2393050573; Wang SM, 2011, NEUROTHERAPEUTICS, V8, P63, DOI 10.1007/s13311-010-0011-3; Weiduschat N, 2014, NEUROSCI LETT, V570, P102, DOI 10.1016/j.neulet.2014.04.020; Zurcher NR, 2015, NEUROIMAGE-CLIN, V7, P409, DOI 10.1016/j.nicl.2015.01.009	58	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177680	10.1371/journal.pone.0177680	http://dx.doi.org/10.1371/journal.pone.0177680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498852	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500041
J	Wu, L; Feng, XQ; He, AX; Ding, Y; Zhou, XW; Xu, ZC				Wu, Lei; Feng, Xueqin; He, Axin; Ding, Yi; Zhou, Xiuwen; Xu, Zhice			Prenatal exposure to the Great Chinese Famine and mid-age hypertension	PLOS ONE			English	Article							DUTCH-HUNGER-WINTER; BLOOD-PRESSURE; RISK; DISEASE; HEALTH; PREVALENCE; ORIGIN; ADULTS; LIFE	Background One of the most terrible famines last century was Great Chinese Famine (GCF) in 1959-1961 when millions of people died from starving. Under-nutrition during famine between the Western and Eastern (Dutch Hungry vs. GCF) was similar, while cardiovascular consequences might not be the same. Addressing such questions may gain new insight into prevention of cardiovascular diseases. Methods A retrospective cohort of 18,593 participants aged 43-49 years of old, was from Suzhou, China. Logistic regression model was used to calculate the relative risk (RR) of hypertension and corresponding 95% confidence interval (CI). The multivariate RRs were adjusted for age, plasma glucose, triglyceride, and cholesterol. Results The multivariate RRs of systolic and diastolic pressure were not significantly elevated in the rural subgroups, but was higher in the urban population born in the famine (systolic pressure adjust RR 1.382, 95% CI 1.235-1.545, diastolic pressure adjust RR 1.569, 95% CI 1.415-1.740). The risks of hypertension were significantly higher among the urban subjects than that in the rural subgroups (systolic hypertension adjust RR 2.915, 95% CI 2.616-3.249, diastolic hypertension adjust RR 4.568, 95% CI 4.079-5.116). Percentile of optimal diastolic pressure at mid-age was significantly lower in the urban population prenatally exposed to the famine regardless of sexes. However, a similar reduction of percentage of optimal systolic pressure was only seen in the female, not the male population in the urban region. Conclusion The data suggest Asian genetic basis was not able to block famine-programmed vascular diseases as that happened in Europe, and the programmed problems due to under-nutrition could be reversed after birth. Protective mechanisms may be related to diet habits before age of 30 years old, which is important contribution to early prevention of hypertension.	[Wu, Lei; Feng, Xueqin; He, Axin; Zhou, Xiuwen; Xu, Zhice] Soochow Univ, Hosp 1, Inst Fetol, Suzhou, Jiangsu, Peoples R China; [Wu, Lei; Feng, Xueqin; He, Axin; Zhou, Xiuwen; Xu, Zhice] Soochow Univ, Hosp 1, Reprod Med Ctr, Suzhou, Jiangsu, Peoples R China; [Wu, Lei; Ding, Yi] Suzhou Ind Pk Ctr Dis Control & Prevent, Suzhou, Jiangsu, Peoples R China; [Xu, Zhice] Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA	Soochow University - China; Soochow University - China; Loma Linda University	Zhou, XW; Xu, ZC (corresponding author), Soochow Univ, Hosp 1, Inst Fetol, Suzhou, Jiangsu, Peoples R China.; Zhou, XW; Xu, ZC (corresponding author), Soochow Univ, Hosp 1, Reprod Med Ctr, Suzhou, Jiangsu, Peoples R China.; Xu, ZC (corresponding author), Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	xiuwen-z@163.com; xuzhice@suda.edu.cn			Ministry of Science and Technology of the People's Republic of China [81320108006]; Science and Technology Department of Jiangsu Province [BK20160297]; Bureau of Science and Technology of Suzhou Municipality [SYS201405]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Science and Technology Department of Jiangsu Province; Bureau of Science and Technology of Suzhou Municipality	This work was supported by the Ministry of Science and Technology of the People's Republic of China, 81320108006, (http://www.nsfc.gov.cn/) to ZX; Science and Technology Department of Jiangsu Province, BK20160297, (http://www.jstd.gov.cn/) to XZ and the Bureau of Science and Technology of Suzhou Municipality, SYS201405, (http://www.szkj.gov.cn/) to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D, 1999, PUBLIC HLTH, V113; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 2001, MONATSSCHR KINDERH, V149, pS2, DOI 10.1007/s001120170002; Barker DJP, 1998, MOTHERS BABIES HLTH; Baskar V, 2006, DIABETES OBES METAB, V8, P214, DOI 10.1111/j.1463-1326.2005.00485.x; BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601; Brown AS, 1997, EPIDEMIOLOGY, V8, P55, DOI 10.1097/00001648-199701000-00009; Brown AS, 2000, AM J PSYCHIAT, V157, P190, DOI 10.1176/appi.ajp.157.2.190; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Daliao X, 2009, HYPERTENSION, V53, P937; de Rooij SR, 2006, DIABETES CARE, V29, P1897, DOI 10.2337/dc06-0460; Edwards LJ, 2001, CLIN EXP PHARMACOL P, V28, P938, DOI 10.1046/j.1440-1681.2001.03553.x; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Franzek EJ, 2008, ADDICTION, V103, P433, DOI 10.1111/j.1360-0443.2007.02084.x; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Irwin B, 2014, PEDIATR ANN, V67, P738; Krupp D, 2015, EUR J NUTR, V54, P1269, DOI 10.1007/s00394-014-0804-y; Liu L.S., 2010, ZHONGHUA XIN XUE GUA, V39, P579; Lohmueller KE, 2006, ANN HUM GENET, V70, P27, DOI 10.1111/j.1529-8817.2005.00197.x; Painter RC, 2006, J HYPERTENS, V24, P1771, DOI 10.1097/01.hjh.0000242401.45591.e7; Patrick B, 2004, NATURE, V430, P419; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Roseboom TJ, 2003, PAEDIATR PERINAT EP, V17, P391, DOI 10.1046/j.1365-3016.2003.00516.x; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Smil V, 1999, BMJ-BRIT MED J, V319, P1619, DOI 10.1136/bmj.319.7225.1619; Somm E, 2009, MOL CELL ENDOCRINOL, V304, P69, DOI 10.1016/j.mce.2009.02.026; Stein AD, 2006, EUR J EPIDEMIOL, V21, P759, DOI 10.1007/s10654-006-9065-2; TRUSWELL AS, 1985, BRIT MED J, V291, P125, DOI 10.1136/bmj.291.6488.125; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z	30	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176413	10.1371/journal.pone.0176413	http://dx.doi.org/10.1371/journal.pone.0176413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498832	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500004
J	Agbadi, P; Urke, HB; Mittelmark, MB				Agbadi, Pascal; Urke, Helga Bjornoy; Mittelmark, Maurice B.			Household food security and adequacy of child diet in the food insecure region north in Ghana	PLOS ONE			English	Article							COMPLEMENTARY FEEDING PRACTICES; AGED 6-23 MONTHS; NUTRITIONAL-STATUS; ASSOCIATIONS; DETERMINANTS; INDICATORS; DIVERSITY; INFANT; INDEX	Background and objectives Adequate diet is of crucial importance for healthy child development. In food insecure areas of the world, the provision of adequate child diet is threatened in the many households that sometimes experience having no food at all to eat (household food insecurity). In the context of food insecure northern Ghana, this study investigated the relationship between level of household food security and achievement of recommended child diet as measured by WHO Infant and Young Child Feeding Indicators. Methods Using data from households and 6-23 month old children in the 2012 Feed the Future baseline survey (n = 871), descriptive analyses assessed the prevalence of minimum meal frequency; minimum dietary diversity, and minimum acceptable diet. Logistic regression analysis was used to examine the association of minimum acceptable diet with household food security, while accounting for the effects of child sex and age, maternal-age,-dietary diversity,-literacy and-education, household size, region, and urban-rural setting. Household food security was assessed with the Household Hunger Scale developed by USAID's Food and Nutrition Technical Assistance Project. Results Forty-nine percent of children received minimum recommended meal frequency, 31% received minimum dietary diversity, and 17% of the children received minimum acceptable diet. Sixty-four percent of the children lived in food secure households, and they were significantly more likely than children in food insecure households to receive recommended minimum acceptable diet [O.R = 0.53; 95% CI: 0.35, 0.82]. However, in 80% of food secure households, children did not receive a minimal acceptable diet by WHO standards. Conclusions Children living in food secure households were more likely than others to receive a minimum acceptable diet. Yet living in a food secure household was no guarantee of child dietary adequacy, since eight of 10 children in food secure households received less than a minimum acceptable diet. The results call for research into factors besides household food security in the search for determinants of child diet adequacy. In this study at least, household food security was a very weak marker of child diet adequacy. This finding is of significance to public health practice, since it calls into question any assumption that having enough food in a household necessarily results in adequately fed children.	[Agbadi, Pascal; Urke, Helga Bjornoy; Mittelmark, Maurice B.] Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway	University of Bergen	Urke, HB (corresponding author), Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway.	helga.urke@uib.no	Agbadi, Pascal/AAS-6842-2020	Agbadi, Pascal/0000-0001-5297-2512				Abafita J, 2013, J RURAL DEVELOP, V37, P129; Amanor-Boadu V., 2013, DISTRICT LEVEL ANAL; Amugsi D. A., 2014, British Journal of Medicine and Medical Research, V4, P4310, DOI 10.9734/BJMMR/2014/10014; Amugsi DA., 2015, CHILD CARE PRACTICES; Amugsi DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-960; Amugsi DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136748; [Anonymous], 2011, HOUSEHOLD HUNGER SCA; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Beyene A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1804-4; Bond T., 2001, APPL RASCH MODEL FUN; Deitchler M., 2010, VALIDATION MEASURE H; Dewey KG., 2003, GUIDING PRINCIPLES C; Disha A. D., 2012, African Journal of Food, Agriculture, Nutrition and Development, V12, P5895; Du Plessis LM, 2013, S AFR J CLIN NUTR, pS129; Faber M., 2009, International Journal of Food Safety, Nutrition and Public Health, V2, P1, DOI 10.1504/IJFSNPH.2009.026915; FAO, 2009, DECL WORLD SUMM FOOD; FAO, 1996, WORLD FOOD SUMMIT; FTF, 2010, FEED FUT GUID; GFSI, 2014, FOOD SEC FOC SUB SAH; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Humphries DL, 2015, J NUTR, V145, P1924, DOI 10.3945/jn.115.210229; Issaka AI, 2015, MATERN CHILD NUTR, V11, P14, DOI 10.1111/mcn.12194; Issaka AI, 2015, MATERN CHILD NUTR, V11, P31, DOI 10.1111/mcn.12193; Joshi N, 2012, MATERN CHILD NUTR, V8, P45, DOI 10.1111/j.1740-8709.2011.00384.x; Kennedy G., 2011, GUID MEAS HOUS IND D; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Matanda DJ, 2015, CHILD PHYS GROWTH CA; Maxwell D, 2013, DIFFERENT INDICATORS; Mensah O., 2013, GLOBAL ADV RES J AGR, V2; METSS-Ghana, 2012, FTF GHANA POP BAS SU; Ng CS, 2012, PUBLIC HEALTH NUTR, V15, P827, DOI 10.1017/S1368980011002485; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Nord M, 2007, J NUTR, V137, P533, DOI 10.1093/jn/137.3.533; Osei A, 2010, FOOD NUTR BULL, V31, P483, DOI 10.1177/156482651003100402; Reinbott A, 2015, PAEDIATR INT CHILD H, V35, P124, DOI 10.1179/2046905514Y.0000000155; Renzaho AMN, 2010, NUTRITION, V26, P1, DOI 10.1016/j.nut.2009.05.001; Rosas LG, 2009, J AM DIET ASSOC, V109, P2001, DOI 10.1016/j.jada.2009.09.004; Saaka M, 2015, BMC PUBLIC HEALTH, V15, P1; Sasson A, 2012, AGR FOOD SECURITY, V1, P1, DOI [10.1186/2048-7010-1-2, DOI 10.1186/2048-7010-1-2]; Sawadogo PS, 2006, J NUTR, V136, P656, DOI 10.1093/jn/136.3.656; Stanturf J. A., 2011, GHANA CLIMATE CHANGE; Stewart CP, 2013, MATERN CHILD NUTR, V9, P27, DOI 10.1111/mcn.12088; Tefera T., 2014, J FOOD SECURITY, V2, P92, DOI [10.12691/jfs-2-3-4, DOI 10.12691/JFS-2-3-4]; The Economist Group, 2017, GLOB FOOD SECUR-AGR; USAID, 2012, MAT DIET DIV IMPL CH; Victor R, 2014, MATERN CHILD NUTR, V10, P545, DOI 10.1111/j.1740-8709.2012.00435.x; WHO, 2009, INF YOUNG CHILD FEED; Zeitlin M, 1996, PARENTS CULTURAL BEL, P408; Zereyesus YA, 2014, BASELINE FEED FUTURE	51	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177377	10.1371/journal.pone.0177377	http://dx.doi.org/10.1371/journal.pone.0177377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494024	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300096
J	Armero, VES; Tremblay, MP; Allaire, A; Boudreault, S; Martenon-Brodeur, C; Duval, C; Durand, M; Lapointe, E; Thibault, P; Tremblay-Letourneau, M; Perreault, JP; Scott, MS; Bisaillon, M				Armero, Victoria E. S.; Tremblay, Marie-Pier; Allaire, Andrea; Boudreault, Simon; Martenon-Brodeur, Camille; Duval, Cyntia; Durand, Mathieu; Lapointe, Elvy; Thibault, Philippe; Tremblay-Letourneau, Maude; Perreault, Jean-Pierre; Scott, Michelle S.; Bisaillon, Martin			Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas	PLOS ONE			English	Article							MESSENGER-RNA; RIBONUCLEOPROTEIN-K; NUCLEAR EXPORT; PROTEIN; CANCER; EXPRESSION; MULTIPLE; IDENTIFICATION; PROLIFERATION; INHIBITION	Multiple human diseases including cancer have been associated with a dysregulation in RNA splicing patterns. In the current study, modifications to the global RNA splicing landscape of cellular genes were investigated in the context of Epstein-Barr virus-associated gastric cancer. Global alterations to the RNA splicing landscape of cellular genes was examined in a large-scale screen from 295 primary gastric adenocarcinomas using high-throughput RNA sequencing data. RT-PCR analysis, mass spectrometry, and co-immuno-precipitation studies were also used to experimentally validate and investigate the differential alternative splicing (AS) events that were observed through RNA-seq studies. Our study identifies alterations in the AS patterns of approximately 900 genes such as tumor suppressor genes, transcription factors, splicing factors, and kinases. These findings allowed the identification of unique gene signatures for which AS is misregulated in both Epstein-Barr virus-associated gastric cancer and EBV-negative gastric cancer. Moreover, we show that the expression of Epstein-Barr nuclear antigen 1 (EBNA1) leads to modifications in the AS profile of cellular genes and that the EBNA1 protein interacts with cellular splicing factors. These findings provide insights into the molecular differences between various types of gastric cancer and suggest a role for the EBNA1 protein in the dysregulation of cellular AS.	[Armero, Victoria E. S.; Tremblay, Marie-Pier; Allaire, Andrea; Boudreault, Simon; Martenon-Brodeur, Camille; Duval, Cyntia; Tremblay-Letourneau, Maude; Perreault, Jean-Pierre; Scott, Michelle S.; Bisaillon, Martin] Univ Sherbrooke, Fac Med & Sci Sante, Dept Med, Sherbrooke, PQ, Canada; [Durand, Mathieu; Lapointe, Elvy; Thibault, Philippe] Univ Sherbrooke, Plateforme RNom, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke	Bisaillon, M (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Med, Sherbrooke, PQ, Canada.	Martin.Bisaillon@USherbrooke.ca	Duval, Cyntia/AAF-7468-2021		Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; Universite de Sherbrooke Research Chair in Structure and Genomic RNA; Fonds de recherche du Quebec-Sante (FRQ-S)	Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; Universite de Sherbrooke Research Chair in Structure and Genomic RNA; Fonds de recherche du Quebec-Sante (FRQ-S)	This work was supported by grants from the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (M.B. and J.P.P.) and the Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke (M.B., M.S.S. and J. P.P.). J.P.P. holds the Universite de Sherbrooke Research Chair in Structure and Genomic RNA. M. B. is a Chercheur-boursier Senior from the Fonds de recherche du Quebec-Sante (FRQ-S).	Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; Bonomi S, 2013, INT J CELL BIOL; Borsi L, 1996, INT J CANCER, V66, P632, DOI 10.1002/(SICI)1097-0215(19960529)66:5<632::AID-IJC9>3.0.CO;2-U; Bozzetti F, 1999, ANN SURG, V230, P170, DOI 10.1097/00000658-199908000-00006; Brosseau JP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1287; Bryant HE, 2001, J VIROL, V75, P4376, DOI 10.1128/JVI.75.9.4376-4385.2001; Chen LC, 2008, CLIN CANCER RES, V14, P3807, DOI 10.1158/1078-0432.CCR-08-0155; Cidon Esther Una, 2011, J Gastrointest Cancer, V42, P127, DOI 10.1007/s12029-010-9161-0; Convertini P, 2014, NUCLEIC ACIDS RES, V42, P4947, DOI 10.1093/nar/gku151; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; da Cunha CB, 2010, LAB INVEST, V90, P1604, DOI 10.1038/labinvest.2010.155; Danan-Gotthold M, 2015, NUCLEIC ACIDS RES, V43, P5130, DOI 10.1093/nar/gkv210; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Drissi R, 2015, MOL CELL PROTEOMICS, V14, P2002, DOI 10.1074/mcp.M115.048991; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Geiser V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022929; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Ivarez E, 2013, PLOS ONE, V8; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kieff E, 2001, FIELDS VIROLOGY; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kumar M, 2015, J TRANSL MED, V13, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y, 2008, 2008 PROCEEDINGS OF INFORMATION TECHNOLOGY AND ENVIRONMENTAL SYSTEM SCIENCES: ITESS 2008, VOL 4, P1; Lindberg A, 2002, VIROLOGY, V294, P189, DOI 10.1006/viro.2001.1301; Line A, 2002, CANCER GENET CYTOGEN, V139, P78, DOI 10.1016/S0165-4608(02)00607-6; Liu XY, 2013, J NAT PROD, V76, P685, DOI 10.1021/np300913h; Lu J., 2011, J WIREL COMMUN NETWO, V1, P1, DOI DOI 10.1128/JVI.01531-10; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Mehta Sunali, 2010, Ther Adv Med Oncol, V2, P125, DOI 10.1177/1758834009360519; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; Petersen JM, 2000, MOL CELL BIOL, V20, P8590, DOI 10.1128/MCB.20.22.8590-8601.2000; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; Pimienta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124638; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Shinozaki-Ushiku A, 2015, INT J ONCOL, V46, P1421, DOI 10.3892/ijo.2015.2856; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Sivachandran N, 2011, J VIROL, V85, P10425, DOI 10.1128/JVI.05293-11; Smyth EC, 2014, ONCOTARGETS THER, V7, P1001, DOI 10.2147/OTT.S44941; Stamm S, 2012, ALTERNATIVE PREMRNA; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sturgeon CM, 2010, USE TUMOR MARKERS LI; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Wilson JB, 1996, EMBO J, V15, P3117, DOI 10.1002/j.1460-2075.1996.tb00674.x; Wu HH, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2013.16; Xiao YF, 2016, INT J NANOMED, V11, P3023, DOI 10.2147/IJN.S103648; Xu Jin-Heng, 2008, Ai Zheng, V27, P1271	76	18	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176880	10.1371/journal.pone.0176880	http://dx.doi.org/10.1371/journal.pone.0176880			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493890	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300036
J	Biri-Kovacs, B; Kiss, B; Vadaszi, H; Gogl, G; Palfy, G; Torok, G; Homolya, L; Bodor, A; Nyitray, L				Biri-Kovacs, Beata; Kiss, Bence; Vadaszi, Henrietta; Gogl, Gergo; Palfy, Gyula; Torok, Gyorgy; Homolya, Laszlo; Bodor, Andrea; Nyitray, Laszlo			Ezrin interacts with S100A4 via both its N- and C-terminal domains	PLOS ONE			English	Article							NONMUSCLE MYOSIN-IIA; METASTASIS-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR P53; ACTIN-BINDING-SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ERM PROTEINS; FERM DOMAIN; ANNEXIN-II; CELL-MIGRATION	Ezrin belongs to the ERM (ezrin, radixin, moesin) protein family that has a role in cell morphology changes, adhesion and migration as an organizer of the cortical cytoskeleton by linking actin filaments to the apical membrane of epithelial cells. It is highly expressed in a variety of human cancers and promotes metastasis. Members of the Ca2+-binding EF-hand containing S100 proteins have similar pathological properties; they are overexpressed in cancer cells and involved in metastatic processes. In this study, using tryptophan fluorescence and stopped-flow kinetics, we show that S100A4 binds to the N-terminal ERM domain (N-ERMAD) of ezrin with a micromolar affinity. The binding involves the F2 lobe of the N-ERMAD and follows an induced fit kinetic mechanism. Interestingly, S100A4 binds also to the unstructured C-terminal actin binding domain (C-ERMAD) with similar affinity. Using NMR spectroscopy, we characterized the complex of S100A4 with the C-ERMAD and demonstrate that no ternary complex is simultaneously formed with the two ezrin domains. Furthermore, we show that S100A4 co-localizes with ezrin in HEK-293T cells. However, S100A4 very weakly binds to full-length ezrin in vitro indicating that the interaction of S100A4 with ezrin requires other regulatory events such as protein phosphorylation and/or membrane binding, shifting the conformational equilibrium of ezrin towards the open state. As both proteins play an important role in promoting metastasis, the characterization of their interaction could shed more light on the molecular events contributing to this pathological process.	[Biri-Kovacs, Beata; Kiss, Bence; Vadaszi, Henrietta; Gogl, Gergo; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Palfy, Gyula; Bodor, Andrea] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, Budapest, Hungary; [Torok, Gyorgy; Homolya, Laszlo] Res Ctr Nat Sci, Mol Cell Biol Res Grp, Inst Enzymol, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Nyitray, L (corresponding author), Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary.	nyitray@elte.hu	Gogl, Gergo/ABH-4309-2020; Biri-Kovács, Beáta/A-8844-2016; Nyitray, László/AAE-5910-2020; Bodor, Andrea/G-1797-2018; Kiss, Bence/AAF-1808-2020; Homolya, Laszlo/N-1154-2016; Bodor, Andrea/AAL-7854-2020	Gogl, Gergo/0000-0002-8597-3711; Biri-Kovács, Beáta/0000-0001-5803-9969; Nyitray, László/0000-0003-4717-5994; Bodor, Andrea/0000-0002-7422-298X; Homolya, Laszlo/0000-0003-1639-8140; Bodor, Andrea/0000-0002-7422-298X; Palfy, Gyula/0000-0003-1590-5331; Kiss, Bence/0000-0001-5810-5858	National Research, Development and Innovation Office [K108437, K119359]; Momentum Program of the Hungarian Academy of Sciences [LP 2012-025]; MedlnProt program of the Hungarian Academy of Sciences; National Development Agency Grant [KMOP-4.2.1/B-10-2011]; New National Excellence Program of the Ministry of Human Capacities	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Momentum Program of the Hungarian Academy of Sciences; MedlnProt program of the Hungarian Academy of Sciences; National Development Agency Grant; New National Excellence Program of the Ministry of Human Capacities	This work was supported by the National Research, Development and Innovation Office K108437 and K119359 to Laszlo Nyitray and the Momentum Program of the Hungarian Academy of Sciences LP 2012-025 to Laszlo Homolya. We also acknowledge the support of the MedlnProt program of the Hungarian Academy of Sciences and the National Development Agency Grant (KMOP-4.2.1/B-10-2011). Beata Biri-Kovacs was supported through the New National Excellence Program of the Ministry of Human Capacities.	Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Biri B, 2016, BIOCHEM J, V473, P31, DOI 10.1042/BJ20150843; Bosk S, 2011, BIOPHYS J, V100, P1708, DOI 10.1016/j.bpj.2011.02.039; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Clucas J, 2015, J CELL SCI, V128, P1253, DOI 10.1242/jcs.170027; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Du M, 2012, J BIOL CHEM, V287, P15330, DOI 10.1074/jbc.M112.349787; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gingras AR, 2008, FEBS LETT, V582, P1651, DOI 10.1016/j.febslet.2008.04.017; Goddard TD, SPARKY 32000; Gogl G, 2016, J BIOL CHEM, V291, P11, DOI 10.1074/jbc.M115.684928; Granes F, 2000, J CELL SCI, V113, P1267; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kang BS, 2002, ACTA CRYSTALLOGR D, V58, P381, DOI 10.1107/S0907444901021175; Keller R., 2004, COMPUTER AIDED RESON, V1; Kiss B, 2016, FEBS J, V283, P2164, DOI 10.1111/febs.13728; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Liu YD, 2015, BRIT J PHARMACOL, V172, P1664, DOI 10.1111/bph.12978; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Palfy G, 2016, CHEMBIOCHEM, V17, P1829, DOI 10.1002/cbic.201600280; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Phang JM, 2016, BIOCHEM J, V473, P2763, DOI 10.1042/BCJ20160541; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rezvanpour A, 2011, J BIOL CHEM, V286, P40174, DOI 10.1074/jbc.M111.244038; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; van Dieck J, 2010, ONCOGENE, V29, P2024, DOI 10.1038/onc.2009.490; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; YOUNG RM, 1994, BIOPHYS J, V67, P881, DOI 10.1016/S0006-3495(94)80549-1; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zimmer D.B., 2010, CARDIOVASC PSYCHIAT, V2010	62	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177489	10.1371/journal.pone.0177489	http://dx.doi.org/10.1371/journal.pone.0177489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493957	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300120
J	Garcia-Jimenez, A; Teruel-Puche, JA; Berna, J; Rodriguez-Lopez, JN; Tudela, J; Garcia-Canovas, F				Garcia-Jimenez, Antonio; Antonio Teruel-Puche, Jose; Berna, Jose; Neptuno Rodriguez-Lopez, Jose; Tudela, Jose; Garcia-Canovas, Francisco			Action of tyrosinase on alpha and beta-arbutin: A kinetic study	PLOS ONE			English	Article							MUSHROOM TYROSINASE; DEPIGMENTING AGENT; CATALYZED HYDROXYLATION; MELANIN BIOSYNTHESIS; MICHAELIS CONSTANTS; HUMAN MELANOCYTES; ELLAGIC ACID; HYDROQUINONE; MECHANISM; INHIBITORS	The known derivatives from hydroquinone, a and beta-arbutin, are used as depigmenting agents. In this work, we demonstrate that the oxy form of tyrosinase (oxytyrosinase) hydroxylates a and beta-arbutin in ortho position of the phenolic hydroxyl group, giving rise to a complex formed by met-tyrosinase with the hydroxylated a or beta-arbutin. This complex could evolve in two ways: by oxidizing the originated o-diphenol to o-quinone and deoxy-tyrosinase, or by delivering the o-diphenol and met-tyrosinase to the medium, which would produce the self-activation of the system. Note that the quinones generated in both cases are unstable, so the catalysis cannot be studied quantitatively. However, if 3-methyl-2-benzothiazolinone hydrazone hydrochloride hydrate is used, the o-quinone is attacked, so that it becomes an adduct, which can be oxidized by another molecule of o-quinone, generating o-diphenol in the medium. In this way, the system reaches the steady state and originates a chromophore, which, in turn, has a high absorptivity in the visible spectrum. This reaction allowed us to characterize a and beta-arbutin kinetically as substrates of tyrosinase for the first time, obtaining a Michaelis constant values of 6.5 +/- 0.58 mM and 3 +/- 0.19 mM, respectively. The data agree with those from docking studies that showed that the enzyme has a higher affinity for beta-arbutin. Moreover, the catalytic constants obtained by the kinetic studies (catalytic constant = 4.43 +/- 0.33 s(-1) and 3.7 +/- 0.29 s(-1) for a and beta-arbutin respectively) agree with our forecast based on 13 C NMR considerations. This kinetic characterization of alpha and beta-arbutin as substrates of tyrosinase should be taken into account to explain possible adverse effects of these compounds.	[Garcia-Jimenez, Antonio; Neptuno Rodriguez-Lopez, Jose; Tudela, Jose; Garcia-Canovas, Francisco] Univ Murcia, GENZ Grp Res Enzymol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Antonio Teruel-Puche, Jose] Univ Murcia, Dept Biochem & Mol Biol A, Grp Mol Interact Membranes, Murcia, Spain; [Berna, Jose] Univ Murcia, Dept Organ Chem, Grp Synthet Organ Chem, Fac Chem, Murcia, Spain	University of Murcia; University of Murcia; University of Murcia	Garcia-Canovas, F (corresponding author), Univ Murcia, GENZ Grp Res Enzymol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	canovasf@um.es	Puche, José Antonio Teruel/R-4137-2018; Tudela, Jose/M-1278-2014; Berna, Jose/C-9334-2011; Garcia-Canovas, Francisco/M-1290-2014	Puche, José Antonio Teruel/0000-0003-2256-3368; Tudela, Jose/0000-0002-5528-4296; Berna, Jose/0000-0001-7775-3703; Garcia-Canovas, Francisco/0000-0002-8869-067X; Rodriguez-Lopez, Jose Neptuno/0000-0001-6863-1173	Fundacion Seneca (CARM, Murcia, Spain) [19545/PI/14, 19304/PI/14, 19240/PI/ 14]; MINECO (Fondos FEDER) [SAF2016-77241-R, CTQ2014-56887-P]; University of Murcia, Murcia [UMU15452, UMU17766]; University of Murci	Fundacion Seneca (CARM, Murcia, Spain)(Fundacion Seneca); MINECO (Fondos FEDER); University of Murcia, Murcia; University of Murci	This work was supported by the Fundacion Seneca (CARM, Murcia, Spain) under Projects 19545/PI/14, 19304/PI/14 and 19240/PI/ 14; MINECO under Projects SAF2016-77241-R and CTQ2014-56887-P (Co-financing with Fondos FEDER); and University of Murcia, Murcia under Projects UMU15452 and UMU17766. A. Garcia Jimenez has a FPU fellowship from the University of Murcia.	Alvarez-Parrilla E, 2007, FOOD CHEM, V101, P1346, DOI 10.1016/j.foodchem.2006.03.040; Maria-Solano MA, 2016, J MOL CATAL B-ENZYM, V125, P6, DOI 10.1016/j.molcatb.2015.12.008; Avonto C, 2016, INT J COSMETIC SCI, V38, P187, DOI 10.1111/ics.12275; Boissy RE, 2005, EXP DERMATOL, V14, P601, DOI 10.1111/j.0906-6705.2005.00337.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakraborty AK, 1998, PIGM CELL RES, V11, P206, DOI 10.1111/j.1600-0749.1998.tb00731.x; CHAVIN W, 1980, SCIENCE, V208, P408, DOI 10.1126/science.7367868; Chen WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07995; Couteau C., 2016, COSMETICS-BASEL, V3, P27, DOI [10.3390/cosmetics3030027, DOI 10.3390/COSMETICS3030027]; Degen GH, 2015, REGUL TOXICOL PHARM, V73, P866, DOI 10.1016/j.yrtph.2015.10.008; Garcia-Molina MD, 2014, REACT KINET MECH CAT, V112, P305, DOI 10.1007/s11144-014-0723-1; Garcia-Molina MD, 2014, BIOORGAN MED CHEM, V22, P3360, DOI 10.1016/j.bmc.2014.04.048; Deri B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34993; Espin JC, 1998, J AGR FOOD CHEM, V46, P2968, DOI 10.1021/jf971045v; Espin JC, 2000, EUR J BIOCHEM, V267, P1270, DOI 10.1046/j.1432-1327.2000.01013.x; Espin JC, 1996, J FOOD SCI, V61, P1177, DOI 10.1111/j.1365-2621.1996.tb10955.x; Fenoll LG, 2002, INT J BIOCHEM CELL B, V34, P332, DOI 10.1016/S1357-2725(01)00133-9; Fenoll LG, 2001, BBA-PROTEIN STRUCT M, V1548, P1, DOI 10.1016/S0167-4838(01)00207-2; FUNAYAMA M, 1995, BIOSCI BIOTECH BIOCH, V59, P143, DOI 10.1271/bbb.59.143; Garcia-Jimenez A, 2017, REACT KINET MECH CAT, V120, P1, DOI 10.1007/s11144-016-1106-6; Garcia-Jimenez A, 2016, BIOORGAN MED CHEM, V24, P4434, DOI 10.1016/j.bmc.2016.07.048; Garcia-Jimenez A, 2016, IUBMB LIFE, V68, P663, DOI 10.1002/iub.1528; Garcia-Molina F, 2007, J AGR FOOD CHEM, V55, P9739, DOI 10.1021/jf0712301; Garcia-Molina F, 2005, J AGR FOOD CHEM, V53, P3702, DOI 10.1021/jf048340h; Hamed SH, 2006, J COSMET SCI, V57, P291; Hori I, 2004, PHYTOTHER RES, V18, P475, DOI 10.1002/ptr.1456; Hsiao NW, 2014, J CHEM INF MODEL, V54, P3099, DOI 10.1021/ci500370x; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kolbe L, 2013, J EUR ACAD DERMATOL, V27, P19, DOI 10.1111/jdv.12051; Lim YJ, 2009, ARCH PHARM RES, V32, P367, DOI 10.1007/s12272-009-1309-8; Liu C-Q, 2013, J MICROBIOL BIOTECHN, V29, P1391; Maeda K, 1996, J PHARMACOL EXP THER, V276, P765; Makino ET, 2013, J DRUGS DERMATOL, V12, pS16; Mary Sea Garcia-Molina, 2013, BIOSCI BIOTECH BIOCH, V77, P2383, DOI 10.1271/bbb.130500; Migas P, 2015, PHYTOCHEM LETT, V13, P35, DOI 10.1016/j.phytol.2015.05.015; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Munoz JL, 2006, ANAL BIOCHEM, V351, P128, DOI 10.1016/j.ab.2006.01.011; Nakajima M, 1998, PIGM CELL RES, V11, P12, DOI 10.1111/j.1600-0749.1998.tb00705.x; Nihei KI, 2003, BIOORG MED CHEM LETT, V13, P2409, DOI 10.1016/S0960-894X(03)00395-0; PENNEY KB, 1984, J INVEST DERMATOL, V82, P308, DOI 10.1111/1523-1747.ep12260588; Pillaiyar T, 2015, EXPERT OPIN THER PAT, V25, P775, DOI 10.1517/13543776.2015.1039985; Qin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109398; Qiu L, 2009, FOOD CHEM, V112, P609, DOI 10.1016/j.foodchem.2008.06.021; Rodriguez-Lopez JN, 2000, BIOCHEMISTRY-US, V39, P10497, DOI 10.1021/bi000539+; RODRIGUEZLOPEZ JN, 1993, BIOCHEM J, V293, P859, DOI 10.1042/bj2930859; RODRIGUEZLOPEZ JN, 1994, ANAL BIOCHEM, V216, P205, DOI 10.1006/abio.1994.1026; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCCS Degen GH, 2016, REGUL TOXICOL PHARM, V74, P75; Scientific J., 2006, SIGMA PLOT 9 0 WINDO; Seo DH, 2012, APPL MICROBIOL BIOT, V95, P1417, DOI 10.1007/s00253-012-4297-4; Stratford MRL, 2012, BIOORGAN MED CHEM, V20, P4364, DOI 10.1016/j.bmc.2012.05.041; Sugimoto K, 2003, CHEM PHARM BULL, V51, P798; Tokiwa Y, 2007, BIOTECHNOL LETT, V29, P481, DOI 10.1007/s10529-006-9267-4; Ortiz-Ruiz CV, 2016, J DERMATOL SCI, V82, P115, DOI 10.1016/j.jdermsci.2016.02.004; Ortiz-Ruiz CV, 2015, IUBMB LIFE, V67, P828, DOI 10.1002/iub.1439; Ortiz-Ruiz CV, 2015, IUBMB LIFE, V67, P757, DOI 10.1002/iub.1432; Ortiz-Ruiz CV, 2015, J AGR FOOD CHEM, V63, P7032, DOI 10.1021/acs.jafc.5b02523; Ortiz-Ruiz CV, 2015, J AGR FOOD CHEM, V63, P2162, DOI 10.1021/jf5051816; Yoshikawa M, 2016, J DERMATOL IN PRESS; Yoshimura M, 2005, BIOSCI BIOTECH BIOCH, V69, P2368, DOI 10.1271/bbb.69.2368; Zheng ZP, 2011, FOOD FUNCT, V2, P259, DOI 10.1039/c1fo10033e	64	37	39	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177330	10.1371/journal.pone.0177330	http://dx.doi.org/10.1371/journal.pone.0177330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493937	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300088
J	Yu, WY; Chen, HP; Lv, YP; Deng, QY; Kang, P; Zhang, LL				Yu, Wenya; Chen, Haiping; Lv, Yipeng; Deng, Qiangyu; Kang, Peng; Zhang, Lulu			Comparison of influencing factors on outcomes of single and multiple road traffic injuries: A regional study in Shanghai, China (2011-2014)	PLOS ONE			English	Article							PREVENTABLE DEATHS; TRAUMA DEATHS; SEVERITY; CRASHES; EPIDEMIOLOGY; PEDESTRIANS; LEVEL	Introduction To identify key intervention factors and reduce road traffic injury (RTI)-associated mortality, this study compared outcomes and influencing factors of single and multiple road traffic injuries (RTIs) in Shanghai. Methods Based on the design of National Trauma Data Bank, this study collected demographic, injury, and outcome data from RTI patients treated at the four largest trauma centers in Shanghai from January 2011 to January 2015. Data were analyzed with descriptive statistics, univariate analysis, and hierarchical logistic regression analysis. Results Among 2397 participants, 59.4% had a single injury, and 40.6% had multiple injuries. Most patients' outcome was cure or improvement. For single-RTI patients, length of stay, body region, central nervous system injury, acute renal failure, multiple organ dysfunction syndrome, bacterial infection, and coma were significantly related to outcome. For multiple-RTI patients, age, admission pathway, prehospital time, length of stay, number of body regions, body region, injury condition, injury severity score, and coma were significantly related to outcome. Conclusions Emergency rescue in road traffic accidents should focus on high-risk groups (the elderly), high-incidence body regions (head, thorax, pelvis) and number of injuries, injury condition (central nervous system injury, coma, complications, admission pathway), injury severity (critically injured patients), and time factors (particularly prehospital time).	[Yu, Wenya; Chen, Haiping; Lv, Yipeng; Deng, Qiangyu; Kang, Peng; Zhang, Lulu] Second Mil Med Univ, Coll Mil Hlth Serv Management, Dept Mil Hlth Serv Management, Shanghai, Peoples R China	Naval Medical University	Zhang, LL (corresponding author), Second Mil Med Univ, Coll Mil Hlth Serv Management, Dept Mil Hlth Serv Management, Shanghai, Peoples R China.	zllrmit@aliyun.com			National Natural Science Foundation of China [71233008, 71603271]; Important Disease Joint Research Project in Health Systems of Shanghai [2013ZYJB0006]; Military Health Support Strategy andKey Technology Research for Special Injuries in the South China Sea Region [AWS12J002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important Disease Joint Research Project in Health Systems of Shanghai; Military Health Support Strategy andKey Technology Research for Special Injuries in the South China Sea Region	The project was supported by National Natural Science Foundation of China (71233008, 71603271), which supported the study design, data collection and publication. It was also supported by Important Disease Joint Research Project in Health Systems of Shanghai (2013ZYJB0006), and Military Health Support Strategy and Key Technology Research for Special Injuries in the South China Sea Region (AWS12J002), which played a role in the process of data analysis and preparation of this manuscript.	Alemany R, 2013, ACCIDENT ANAL PREV, V60, P95, DOI 10.1016/j.aap.2013.08.016; An S, 2013, CHINESE MED J-PEKING, V126, P2859, DOI 10.3760/cma.j.issn.0366-6999.20130039; [Anonymous], 1971, JAMA, V215, P277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boniface R, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.46.7487; CAYTEN CG, 1991, ANN SURG, V214, P510, DOI 10.1097/00000658-199110000-00015; Chalya Phillipo L, 2012, J Trauma Manag Outcomes, V6, P1, DOI 10.1186/1752-2897-6-1; Chen C., 2016, INT J ADV MANUF TECH, V5, P1, DOI DOI 10.1080/2162402X.2016.1176653; China NHaFPCotPsRo, 2014, STAT YB NAT HLTH FAM; China NHaFPCotPsRo, 2013, STAT YB NAT HLTH FAM; China NHaFPCotPsRo, 2012, STAT YB NAT HLTH FAM; Daurka JS, 2015, INJURY, V46, P340, DOI 10.1016/j.injury.2014.11.018; Decker S, 2016, ACCIDENT ANAL PREV, V94, P46, DOI 10.1016/j.aap.2016.05.010; Durusu M, 2010, ULUS TRAVMA ACIL CER, V16, P357; Eluru N, 2008, ACCIDENT ANAL PREV, V40, P1033, DOI 10.1016/j.aap.2007.11.010; Gholipour C, 2016, WORLD J EMERG MED, V7, P135, DOI 10.5847/wjem.j.1920-8642.2016.02.009; Haghparast-Bidgoli Hassan, 2013, J Inj Violence Res, V5, P28, DOI 10.5249/jivr.v5i1.195; Huang L, 2013, OCCUPATION HLTH, V11; Kim YJ, 2012, NURS CRIT CARE, V17, P138, DOI 10.1111/j.1478-5153.2012.00498.x; Li YC, 2013, CHINESE J DIS CONTRO, V17, P837; Liu L, 2002, CHINESE J DIS CONTRO, V3; Ma S, 2012, TRAFFIC INJ PREV, V13, P57, DOI 10.1080/15389588.2011.633945; Motomura T, 2014, J NIPPON MED SCH, V81, P320, DOI 10.1272/jnms.81.320; Nunn S, 2011, J FORENSIC SCI, V56, P429, DOI 10.1111/j.1556-4029.2010.01657.x; Osifo OD, 2012, INJURY, V43, P1861, DOI 10.1016/j.injury.2011.07.016; Patel A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3359-4; Pour-Rouholamin M, 2016, J SAFETY RES, V57, P9, DOI 10.1016/j.jsr.2016.03.004; Sciortino S., 2005, AAP, V37, P357; Verzosa N, 2016, ACCIDENT ANAL PREV, V94, P216, DOI 10.1016/j.aap.2016.06.006; Wang LG, 2014, SURG TRAUMA SURG; Wang S, 2013, CHINA J EMERGENCY RE, P881; Watanabe Ryosuke, 2012, Stapp Car Crash J, V56, P269; Wesson HKH, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30728; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2015, WORLD REP ROAD TRAFF; Xiong LL, 2013, CHINESE J DIS CONTRO, V17, P845; Yang YJ, 2013, J PREVENTIVE MED INF, V29, P884; Ye Pengpeng, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P7; Yeung JH, 2010, GUIDELINES TRAUMA QU; Zhang HQ, DISASTER MED; Zhang YC, 2015, CHINESE J PRACTICAL, V42, P73; Zhao H, 2012, CHIN J TRAUMATOL, V15, P170, DOI 10.3760/cma.j.issn.1008-1275.2012.03.009; [周继红 Zhou Jihong], 2005, [中华创伤杂志, Chinese Journal of Traumatology], V21, P71	43	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176907	10.1371/journal.pone.0176907	http://dx.doi.org/10.1371/journal.pone.0176907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493893	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300040
J	Siegmund, K; Thuille, N; Wachowicz, K; Hermann-Kleiter, N; Baier, G				Siegmund, Kerstin; Thuille, Nikolaus; Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Baier, Gottfried			Protein kinase C theta is dispensable for suppression mediated by CD25(+) CD4(+) regulatory T cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PKC-THETA; IN-VIVO; TRANSCRIPTION FACTOR; IMMUNOLOGICAL SYNAPSE; IL-17 PRODUCTION; ACTIVATION; RECEPTOR; DIFFERENTIATION; FOXP3	The activation of conventional T cells upon T cell receptor stimulation critically depends on protein kinase C theta (PKC theta). However, its role in regulatory T (Treg) cell function has yet to be fully elucidated. Using siRNA or the potent and PKC family-selective pharmacological inhibitor AEB071, we could show that murine Treg-mediated suppression in vitro is independent of PKC theta function. Likewise, Treg cells of PKC theta-deficient mice were fully functional, showing a similar suppressive activity as wild-type CD25(+) CD4(+) T cells in an in vitro suppression assay. Furthermore, in vitro-differentiated wild-type and PKC theta-deficient iTreg cells showed comparable Foxp3 expression as well as suppressive activity. However, we observed a reduced percentage of Foxp3(+) CD25(+) CD4(+) T cells in the lymphatic organs of PKC theta-deficient mice. Taken together, our results suggest that while PKC. is involved in Treg cell differentiation in vivo, it is dispensable for Treg-mediated suppression.	[Siegmund, Kerstin; Thuille, Nikolaus; Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria	Medical University of Innsbruck	Siegmund, K; Baier, G (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria.	kerstin.siegmund@i-med.ac.at; Gottfried.Baier@i-med.ac.at	Kleiter, Natascha/I-5101-2018; Bellaire-Siegmund, Kerstin/AAA-9702-2021; Bellaire-Siegmund, Kerstin/D-4774-2018	Kleiter, Natascha/0000-0003-4389-9813; Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Thuille, Nikolaus/0000-0002-2253-3946; Baier, Gottfried/0000-0002-2085-8325	FWF Austrian Science Fund [M1636-B23, 25044-B21, P28694-B30]; Medical University Innsbruck for young scientists MUI-START [2013042002]; Austrian Science Fund (FWF) [M 1636] Funding Source: researchfish	FWF Austrian Science Fund(Austrian Science Fund (FWF)); Medical University Innsbruck for young scientists MUI-START; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the FWF Austrian Science Fund ("Lise-Meitner" M1636-B23 to KS, 25044-B21 to GB, and P28694-B30 to NH-K) and by the intramural funding program of the Medical University Innsbruck for young scientists MUI-START, project 2013042002 (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2006, AUTOIMMUNITY, V39, P469, DOI 10.1080/08916930600907954; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gruber T, 2009, MOL IMMUNOL, V46, P2071, DOI 10.1016/j.molimm.2009.02.030; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; He XH, 2014, J INVEST DERMATOL, V134, P975, DOI 10.1038/jid.2013.459; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Iype T, 2010, J IMMUNOL, V185, P6115, DOI 10.4049/jimmunol.1000622; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006580; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Kwon MJ, 2012, J IMMUNOL, V188, P5887, DOI 10.4049/jimmunol.1102941; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Ma J, 2012, J IMMUNOL, V188, P5337, DOI 10.4049/jimmunol.1102979; Marsland BJ, 2007, J IMMUNOL, V178, P3466, DOI 10.4049/jimmunol.178.6.3466; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Martin B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3209; Meisel M, 2013, IMMUNITY; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Ohayon A, 2010, INFECT IMMUN, V78, P4195, DOI 10.1128/IAI.00465-10; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Salek-Ardakani S, 2005, J IMMUNOL, V175, P7635, DOI 10.4049/jimmunol.175.11.7635; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidt AM, 2015, J IMMUNOL, V194, P4362, DOI 10.4049/jimmunol.1402384; Shen SD, 2010, J BIOL CHEM, V285, P35393, DOI 10.1074/jbc.M110.145052; Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; von Essen M, 2006, J IMMUNOL, V176, P7502, DOI 10.4049/jimmunol.176.12.7502; Wachowicz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096401; Yan DP, 2015, P NATL ACAD SCI USA, V112, P14942, DOI 10.1073/pnas.1520393112; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	54	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0175463	10.1371/journal.pone.0175463	http://dx.doi.org/10.1371/journal.pone.0175463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531229	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058400002
J	Garcia-Martin, E; Pablo, LE; Bambo, MP; Alarcia, R; Polo, V; Larrosa, JM; Vilades, E; Cameo, B; Orduna, E; Ramirez, T; Satue, M				Garcia-Martin, Elena; Pablo, Luis E.; Bambo, Maria P.; Alarcia, Raquel; Polo, Vicente; Larrosa, Jose M.; Vilades, Elisa; Cameo, Beatriz; Orduna, Elvira; Ramirez, Teresa; Satue, Maria			Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson's disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LINEAR DISCRIMINANT FUNCTION; NORMAL-TENSION GLAUCOMA; LAYER ATROPHY; EYES; IMPAIRMENT; DISABILITY; DIAGNOSIS; SEVERITY; ABILITY	Purpose To study peripapillary choroidal thickness (PPCT) in healthy subjects using swept-source optical coherence tomography (SS-OCT), and to evaluate PPCT differences between Parkinson's disease (PD) patients, and age-and sex-matched healthy controls. Design Case-control study Methods 80 healthy subjects and 40 PD patients were consecutively recruited in this single institution study. The healthy subjects were divided into two populations: a teaching population (n = 40, used to establish choroidal zones) and a validating population (n = 40, used to compare measurements with PD patients). An optic disc 6.0x6.0 mm three-dimensional scan was obtained using Deep Range Imaging (DRI) OCT Triton. A 26x26 cube-grid centered on the optic disc was generated to automatically measure choroidal thickness. Five concentric choroidal zones were established and used to compare PPCT between healthy and PD patients. Results PPCT was significantly thicker in PD patients compared with controls in all four concentric zones evaluated (p <= 0.0001). PPCT followed a similar pattern in controls and PD; it was thicker in the temporosuperior region, followed by the superior, temporal, nasal, and inferior regions. Conclusion PD patients presented with an increased PPCT in all zones surrounding the optic disc compared with healthy subjects. The peripapillary choroidal tissue showed a concentric pattern, with the thickness increasing with increasing distance from the optic nerve. SS-OCT could be useful for evaluating choroidal thinning in clinical practice.	[Garcia-Martin, Elena; Pablo, Luis E.; Bambo, Maria P.; Polo, Vicente; Larrosa, Jose M.; Vilades, Elisa; Cameo, Beatriz; Orduna, Elvira; Satue, Maria] Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain; [Garcia-Martin, Elena; Pablo, Luis E.; Bambo, Maria P.; Alarcia, Raquel; Polo, Vicente; Larrosa, Jose M.; Vilades, Elisa; Cameo, Beatriz; Orduna, Elvira; Ramirez, Teresa; Satue, Maria] Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain; [Alarcia, Raquel] Miguel Servet Univ Hosp, Neurol Dept, Zaragoza, Spain; [Ramirez, Teresa] Lozano Blesa Univ Hosp, Anat Pathol Dept, Zaragoza, Spain	Miguel Servet University Hospital; University of Zaragoza; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital	Garcia-Martin, E (corresponding author), Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain.; Garcia-Martin, E (corresponding author), Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain.	egmvivax@yahoo.com		Pablo, Luis/0000-0003-2389-8282; GARCIA-MARTIN, ELENA/0000-0001-6258-2489; Larrosa Poves, Jose Manuel/0000-0002-6745-7668; Satue, Maria/0000-0002-1609-5994; Bambo, Maria Pilar/0000-0001-5320-7839; Polo Llorens, Vicente/0000-0002-1402-3129; Perez-Olivan, Susana/0000-0003-3513-4714; Larrosa, Jose Manuel/0000-0003-4403-4854				Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P7813, DOI 10.1167/iovs.12-10483; Banitt M, 2013, CURR OPIN OPHTHALMOL, V24, P125, DOI 10.1097/ICU.0b013e32835d9245; Bodis-Wollner I, 2009, J NEURAL TRANSM, V116, P1493, DOI 10.1007/s00702-009-0292-z; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Chen FK, 2012, INVEST OPHTH VIS SCI, V53, P975, DOI 10.1167/iovs.11-8771; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Cubo E, 2010, MOVEMENT DISORD, V25, P2461, DOI 10.1002/mds.23215; Edwards ME, 2001, BIOTECHNOL PROGR, V17, P760, DOI 10.1021/bp010040m; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; Eraslan M, 2016, ACTA OPHTHALMOL, V94, pE68, DOI 10.1111/aos.12809; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Garcia-Martin E, 2014, INVEST OPHTH VIS SCI, V55, P696, DOI 10.1167/iovs.13-13062; Garcia-Martin E, 2014, AM J OPHTHALMOL, V157, P470, DOI 10.1016/j.ajo.2013.09.028; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P1705, DOI 10.1016/j.ophtha.2012.01.046; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Jiang R, 2015, INVEST OPHTH VIS SCI, V56, P4045, DOI 10.1167/iovs.15-16521; Larrosa JM, 2014, INVEST OPHTH VIS SCI, V55, P3043, DOI 10.1167/iovs.13-13629; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Park A, 2009, J NEUROL, V256, pS293, DOI 10.1007/s00415-009-5240-1; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Pinto LA, 2016, ACTA OPHTHALMOL, V94, P592, DOI 10.1111/aos.12962; Polo V, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009658; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Satue M, 2014, BRIT J OPHTHALMOL, V98, P350, DOI 10.1136/bjophthalmol-2013-304152; Satue M, 2013, EYE, V27, P507, DOI 10.1038/eye.2013.4; Schwartz RS, 2012, MOVEMENT DISORD, V27, P1506, DOI 10.1002/mds.25112; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Usui S, 2012, AM J OPHTHALMOL, V153, P10, DOI 10.1016/j.ajo.2011.05.037; Vale TC, 2015, J NEUROL NEUROSUR PS, V86, P547, DOI 10.1136/jnnp-2014-307867; Yang P, 2015, J PARKINSON DIS, V5, P821, DOI 10.3233/JPD-140454; Zhang X, SURV OPHTHALMOL, V60, P547	43	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177163	10.1371/journal.pone.0177163	http://dx.doi.org/10.1371/journal.pone.0177163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510576	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500015
J	Rhee, EJ; Cho, JH; Lee, DY; Kwon, H; Park, SE; Park, CY; Oh, KW; Park, SW; Lee, WY				Rhee, Eun-Jung; Cho, Jung Hwan; Lee, Da Young; Kwon, Hyemi; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young			Insulin resistance contributes more to the increased risk for diabetes development in subjects with low lipoprotein(a) level than insulin secretion	PLOS ONE			English	Article							GLYCEMIC CONTROL; NIDDM PATIENTS; ASSOCIATION; MELLITUS; GLUCOSE; HOMEOSTASIS; DISEASE; SIZE	Background Recent studies suggest an association between Lipoprotein(a) [Lp(a)] and the development of diabetes mellitus. We analyzed the association between baseline Lp(a) levels and diabetes development after 4 years of follow-up, in a population of apparently healthy Korean subjects. Methods A total of 2,536 non-diabetic participants (mean age: 41 years, men: 92%) of a health checkup program were included in the study. Diabetes development was defined by fasting blood glucose >= 126 mg/ dL, HbA1c >= 6.5%, and self-reported treatment of diabetes. Homeostasis model assessment (HOMA) indices were used to assess insulin resistance (IR) and insulin secretion (IS). Presence of IR and impaired IS was defined by being in the highest quartile of HOMA-IR and in the lowest quartile HOMA-IS. Results After four years, 3.4% of the participants developed diabetes. The odds ratio (OR) of developing diabetes was lowest in the 4th quartile group of baseline Lp(a) (0.323 [95% CI 0.153-0.685]) with the 1st quartile group as the reference. The subjects with both IR & impaired IS plus baseline Lp(a)<50 mg/dL showed the higher OR for diabetes development compared with those without IR and normal IS as the reference (67.277 [20.218-223.871], and those with IR plus Lp(a)<50 mg/ dL showed higher OR for diabetes than in those with impaired IS and Lp(a)<50 mg/ dL (3.811 [1.938-7.495] vs. 3.452 [1.620-7.353]). Conclusions The subjects with low baseline Lp(a) level showed higher risk for development of diabetes compared with high baseline Lp(a) level, and this was prominent in those with IR than in those with impaired IS.	[Rhee, Eun-Jung; Cho, Jung Hwan; Lee, Da Young; Kwon, Hyemi; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; , Da Young Lee/AAA-1843-2021; LEE, WON-YOUNG/C-7249-2018	Rhee, Eun-Jung/0000-0002-6108-7758; , Da Young Lee/0000-0002-8211-2393; LEE, WON-YOUNG/0000-0002-1082-7592				[Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; Bacova Z, 2012, MED CHEM, V8, P65; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Bonfleur ML, 2010, BBA-MOL CELL BIOL L, V1801, P183, DOI 10.1016/j.bbalip.2009.10.012; BRUCKERT E, 1990, JAMA-J AM MED ASSOC, V263, P35, DOI 10.1001/jama.1990.03440010033016; Bustos P, 2005, J PEDIATR ENDOCR MET, V18, P257; CHANG CJ, 1995, DIABETES CARE, V18, P1191, DOI 10.2337/diacare.18.8.1191; Ding L, 2015, J LIPID RES, V56, P920, DOI 10.1194/jlr.P049015; DUELL PB, 1994, DIABETES CARE, V17, P1135, DOI 10.2337/diacare.17.10.1135; Habib SS, 2009, ARQ BRAS CARDIOL, V93, P28, DOI 10.1590/S0066-782X2009000700006; HAFFNER SM, 1991, DIABETES CARE, V14, P302, DOI 10.2337/diacare.14.4.302; HIRAGA T, 1995, DIABETES CARE, V18, P241, DOI 10.2337/diacare.18.2.241; Kamstrup PR, 2013, LANCET DIABETES ENDO, V1, P220, DOI 10.1016/S2213-8587(13)70064-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mora S, 2010, CLIN CHEM, V56, P1252, DOI 10.1373/clinchem.2010.146779; Neele DM, 1999, DIABETOLOGIA, V42, P41, DOI 10.1007/s001250051110; Nielsen LB, 1997, ARTERIOSCL THROM VAS, V17, P905, DOI 10.1161/01.ATV.17.5.905; Rainwater DL, 1998, ARTERIOSCL THROM VAS, V18, P1335, DOI 10.1161/01.ATV.18.8.1335; RAINWATER DL, 1994, DIABETES, V43, P942, DOI 10.2337/diabetes.43.7.942; RUIZ J, 1994, DIABETOLOGIA, V37, P585, DOI 10.1007/s001250050151; SCANU AM, 1992, J INTERN MED, V231, P679, DOI 10.1111/j.1365-2796.1992.tb01257.x; Schwartz Kendra L, 2005, BMC Fam Pract, V6, P28, DOI 10.1186/1471-2296-6-28; Seo MH, 2011, J CLIN ENDOCR METAB, V96, pE2050, DOI 10.1210/jc.2011-1857; Wada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149452; Ye Z, 2014, DIABETES, V63, P332, DOI 10.2337/db13-1144	26	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177500	10.1371/journal.pone.0177500	http://dx.doi.org/10.1371/journal.pone.0177500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510610	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500032
J	Tavares, WC; Seuanez, HN				Tavares, William Correa; Seuanez, Hector N.			Disease-associated mitochondrial mutations and the evolution of primate mitogenomes	PLOS ONE			English	Article							DNA MUTATIONS; PURIFYING SELECTION; POSITIVE SELECTION; SEQUENCE ALIGNMENT; GENE; GENOME; DIVERSIFICATION; INFERENCE; VARIANTS; SUBUNITS	Several human diseases have been associated with mutations in mitochondrial genes comprising a set of confirmed and reported mutations according to the MITOMAP database. An analysis of complete mitogenomes across 139 primate species showed that most confirmed disease-associated mutations occurred in aligned codon positions and gene regions under strong purifying selection resulting in a strong evolutionary conservation. Only two confirmed variants (7.1%), coding for the same amino acids accounting for severe human diseases, were identified without apparent pathogenicity in non-human primates, like the closely related Bornean orangutan. Conversely, reported disease-associated mutations were not especially concentrated in conserved codon positions, and a large fraction of them occurred in highly variable ones. Additionally, 88 (45.8%) of reported mutations showed similar variants in several non-human primates and some of them have been present in extinct species of the genus Homo. Considering that recurrent mutations leading to persistent variants throughout the evolutionary diversification of primates are less likely to be severely damaging to fitness, we suggest that these 88 mutations are less likely to be pathogenic. Conversely, 69 (35.9%) of reported disease-associated mutations occurred in extremely conserved aligned codon positions which makes them more likely to damage the primate mitochondrial physiology.	[Tavares, William Correa; Seuanez, Hector N.] Inst Nacl Canc, Programa Genet, Rio De Janeiro, RJ, Brazil; [Tavares, William Correa; Seuanez, Hector N.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil; [Tavares, William Correa] Univ Fed Rio de Janeiro, Inst Biol, Dept Zool, Rio De Janeiro, RJ, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Seuanez, HN (corresponding author), Inst Nacl Canc, Programa Genet, Rio De Janeiro, RJ, Brazil.; Seuanez, HN (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.	hseuanez@inca.gov.br	Tavares, William Corrêa/AAM-3362-2021	Tavares, William Corrêa/0000-0003-3385-7265; Seuanez, Hector/0000-0003-3355-8003	Conselho Nacional de Desenvolvimento, CNPq-Brazil [303306/2010-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES-Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-Brazil-FAPERJ; William Tavares with post-doctoral grant [209101/E_44/2014]	Conselho Nacional de Desenvolvimento, CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-Brazil-FAPERJ; William Tavares with post-doctoral grant	Conselho Nacional de Desenvolvimento, CNPq-Brazil (www.npq.r) provided funding for computing facilities (grant 303306/2010-6). Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES-Brazil (www.capes.gov.br) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-Brazil-FAPERJ (www.faperj.br) supported William Tavares with post-doctoral grant 209101/E_44/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work supported by Conselho Nacional de Desenvolvimento, CNPq-Brazil, grant 303306/2010-6. WCT was supported by a post-doctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Brazil (FAPERJ; 209101/E_44/2014).	Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Aristide L, 2015, MOL PHYLOGENET EVOL, V82, P375, DOI 10.1016/j.ympev.2013.11.008; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Bi R, 2012, MOL VIS, V18, P3087; Bridges HR, 2011, BIOCHEM SOC T, V39, P799, DOI 10.1042/BST0390799; Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; de Magalhaes JP, 2005, J MOL EVOL, V61, P491, DOI 10.1007/s00239-004-0258-6; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dubot A, 2004, BIOCHEM BIOPH RES CO, V313, P687, DOI 10.1016/j.bbrc.2003.12.013; Echave J, 2016, NAT REV GENET, V17, P109, DOI 10.1038/nrg.2015.18; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eo SH, 2010, P ROY SOC B-BIOL SCI, V277, P3587, DOI 10.1098/rspb.2010.0965; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Fleming MA, 2003, P NATL ACAD SCI USA, V100, P1151, DOI 10.1073/pnas.0237285100; Ghelli A, 2013, HUM MOL GENET, V22, P2141, DOI 10.1093/hmg/ddt067; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hashimoto T, 2001, ANN NEUROL, V50, P528, DOI 10.1002/ana.1229; Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kistler L, 2015, J HUM EVOL, V79, P45, DOI 10.1016/j.jhevol.2014.06.016; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Liedigk R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0176-1; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lloyd RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069003; Lott M. T., 2013, CURR PROTOC BIOINFOR, V123, P1, DOI [10.1002/0471250953.bi0123s44, DOI 10.1002/0471250953.BI0123S44]; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Matsumoto M, 1999, Ophthalmic Genet, V20, P153, DOI 10.1076/opge.20.3.153.2281; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McClellan David A, 2010, Int J Bioinform Res Appl, V6, P120, DOI 10.1504/IJBRA.2010.032116; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Menezes AN, 2013, MITOCHONDRION, V13, P846, DOI 10.1016/j.mito.2013.06.001; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Nabholz B, 2013, MOL BIOL EVOL, V30, P272, DOI 10.1093/molbev/mss238; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Niroula A, 2017, HUM MUTAT, P1; Paradis E., 2014, MODERN PHYLOGENETIC, P3; Pecon-Slattery J, 2014, ANNU REV ANIM BIOSCI, V2, P41, DOI 10.1146/annurev-animal-022513-114217; Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pontzer H, 2010, P NATL ACAD SCI USA, V107, P14048, DOI 10.1073/pnas.1001031107; Popadin KY, 2013, MOL BIOL EVOL, V30, P347, DOI 10.1093/molbev/mss219; Pozzi L, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-72; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1; Schrago CG, 2014, GENOME BIOL EVOL, V6, P3105, DOI 10.1093/gbe/evu244; Shin SH, 2015, GENES GENOM, V37, P365, DOI 10.1007/s13258-015-0265-6; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Springer MS, 2012, PLOS ONE, P7; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Tomasco IH, 2014, GENE, V534, P371, DOI 10.1016/j.gene.2013.09.097; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xia Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-691; Zeng S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-455; Zuo L, 2016, MITOCHONDRIAL MECH D, P49	85	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177403	10.1371/journal.pone.0177403	http://dx.doi.org/10.1371/journal.pone.0177403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510580	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500026
J	Li, P; Becker, JB; Heitzeg, MM; McClellan, ML; Reed, BG; Zucker, RA				Li, Pin; Becker, Jill B.; Heitzeg, Mary M.; McClellan, Michele L.; Reed, Beth Glover; Zucker, Robert A.			Gender differences in the transmission of risk for antisocial behavior problems across generations	PLOS ONE			English	Article							PARENTAL PROBLEM DRINKING; EXTERNALIZING BEHAVIOR; SUBTYPE VARIATIONS; FAMILY CONFLICT; SOCIAL SUPPORT; ALCOHOLISM; CHILDREN; SONS; LIFE; DEPENDENCE	Previous studies have shown that children of alcohol use disorder (AUD) parents are more likely to develop alcohol problems as well as antisocial and other behavior problems. The purpose of this study was to examine gender discordance in the effect of early maternal and paternal influences on antisocial behaviors of boys and girls, as well as the environmental factors that moderate the parental effects. Specifically, we examined the effects of childhood and adulthood antisocial behavior of the parents on offspring antisocial behavior as young adults. We also examined whether mothers' and fathers' drinking problems when offspring were young children (6-8 years) affected offspring antisocial behavior as young adults (18-21 years). We evaluated 655 children from 339 families in the Michigan Longitudinal Study (MLS), a prospective study of AUD and non-AUD families. Path models were constructed in order to test for the parental contributions to offspring outcomes. We found that both mothers' and fathers' antisocial behavior contributed to the children's young adult antisocial behavior. Only mothers' drinking problems while their children were little had a significant effect on their sons' later drinking, but not on their daughters'. These different parental effects suggest that maternal and paternal influences may be mediated by different mechanisms.	[Li, Pin] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Becker, Jill B.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Becker, Jill B.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Becker, Jill B.; Heitzeg, Mary M.; Zucker, Robert A.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [McClellan, Michele L.] Univ Michigan, Dept Hist, Ann Arbor, MI 48109 USA; [McClellan, Michele L.] Univ Michigan, Residential Coll, Ann Arbor, MI 48109 USA; [Reed, Beth Glover] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA; [Reed, Beth Glover] Univ Michigan, Dept Womens Studies, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Becker, JB (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.; Becker, JB (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.; Becker, JB (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	jbbecker@umich.edu	Li, Pin/AAZ-3048-2020; Heitzeg, Mary/M-7154-2017	LI, PIN/0000-0003-4508-3762; Heitzeg, Mary/0000-0002-6737-2971; Becker, Jill/0000-0003-3880-6408	National Institute on Alcohol Abuse and Alcoholism [R37 AA 07065, R01 M 07065]; MCubed grant; Sloan Foundation; National Institute on Drug Abuse [R01DA039952]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007065, R37AA007065] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MCubed grant; Sloan Foundation(Alfred P. Sloan Foundation); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by grants from the National Institute on Alcohol Abuse and Alcoholism (R37 AA 07065 to RAZ, R01 M 07065 to RAZ and MMH, and by an MCubed grant to JBB, MLM, BGR, MMH, and RAZ funded by a parent grant from the Sloan Foundation to Carl Lagoze. JBB is supported in part by a grant from the National Institute on Drug Abuse R01DA039952.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, TOWN ABANDONED FLINT; [Anonymous], 1969, MONOGRAPHS RUTGERS C; BALLARD M, 1990, J GENET PSYCHOL, V151, P195, DOI 10.1080/00221325.1990.9914654; Bierut LJ, 1998, ARCH GEN PSYCHIAT, V55, P982, DOI 10.1001/archpsyc.55.11.982; Blazei RW, 2006, APPL PREV PSYCHOL, V11, P230, DOI 10.1016/j.appsy.2006.07.001; Buu A, 2008, PARENT FAMILY NEIGHB; Buu A, 2007, ALCOHOL CLIN EXP RES, V31, P1545, DOI 10.1111/j.1530-0277.2007.00449.x; Cranford JA, 2010, PSYCHOL ADDICT BEHAV, V24, P386, DOI 10.1037/a0019801; Curran GM, 1999, GENDER DIFFERENCES R; DiGaetano A, 1999, URBAN AFF REV, V34, P546, DOI 10.1177/10780879922184077; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; El-Sheikh M, 2001, J ABNORM CHILD PSYCH, V29, P417, DOI 10.1023/A:1010447503252; Ellis DA, 1997, ALCOHOL HEALTH RES W, V21, P218; Enoch MA, 2011, PSYCHOPHARMACOLOGY, V214, P17, DOI 10.1007/s00213-010-1916-6; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; Finan LJ, 2015, J ADOLESCENCE, V43, P100, DOI 10.1016/j.adolescence.2015.05.001; FITZGERALD HE, 1993, CHILD DEV, V64, P110, DOI 10.2307/1131440; Floyd FJ, 2006, J ABNORM PSYCHOL, V115, P121, DOI 10.1037/0021-843X.115.1.121; Formoso D, 2000, AM J COMMUN PSYCHOL, V28, P175, DOI 10.1023/A:1005135217449; Fuller BE, 2003, J STUD ALCOHOL, V64, P472, DOI 10.15288/jsa.2003.64.472; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; HALL RL, 1983, BEHAV GENET, V13, P373, DOI 10.1007/BF01065775; Ham H, 1993, ANN M AM PSYCH SOC; Hedden S.L., 2015, HHS PUBLICATION; Heitzeg MM, 2014, NEUROPSYCHOPHARMACOL, V39, P3077, DOI 10.1038/npp.2014.161; Hicks BM, 2007, J ABNORM PSYCHOL, V116, P433, DOI 10.1037/0021-843X.116.3.433; Hussong AM, 2008, J FAM PSYCHOL, V22, P819, DOI 10.1037/a0013704; Jacobson KC, 2002, DEV PSYCHOPATHOL, V14, P395, DOI 10.1017/S0954579402002110; Jaffee SR, 2003, CHILD DEV, V74, P109, DOI 10.1111/1467-8624.t01-1-00524; Johnston L. D., 1979, DRUGS CLASS 78 BEHAV; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Leonard KE, 1999, J STUD ALCOHOL, P130, DOI 10.15288/jsas.1999.s13.130; Loukas A, 2001, J ABNORM CHILD PSYCH, V29, P91, DOI 10.1023/A:1005281011838; Loukas A, 2001, FAM RELAT, V50, P293, DOI 10.1111/j.1741-3729.2001.00293.x; Martinez JJC, 2017, FRONT PSYCHOL, P8; MCCORD J, 1988, J STUD ALCOHOL, V49, P357, DOI 10.15288/jsa.1988.49.357; Meier MH, 2011, J ABNORM PSYCHOL, V120, P377, DOI 10.1037/a0022303; Moffitt T. E., 2001, SEX DIFFERENCES ANTI; Moos R., 1974, FAMILY ENV SCALE, P31; MULLER RT, 1994, CAN J BEHAV SCI, V26, P438, DOI 10.1037/0008-400X.26.3.438; NORBECK JS, 1981, NURS RES, V30, P264; Poon E, 2000, ALCOHOL CLIN EXP RES, V24, P1020, DOI 10.1097/00000374-200007000-00012; Puttler LI, 1998, ALCOHOL CLIN EXP RES, V22, P1962, DOI 10.1111/j.1530-0277.1998.tb05904.x; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Sarkar DK, 2015, ADDICTION BIOL; Schuckit M, 1978, RES QUESTIONNAIRE AL; Seglem KB, 2016, ADDICTION; Sher KJ, 1997, ALCOHOL HEALTH RES W, V21, P247; Shukla SD, 2008, ALCOHOL CLIN EXP RES, V32, P1525, DOI 10.1111/j.1530-0277.2008.00729.x; Sugrue Thomas J, 2005, ORIGINS URBAN CRISIS, V1st Princeton Classic, DOI DOI 10.1515/9781400851218; Thompson Heather Ann, 2013, JL SOC, V15, P41; TOLAN P, 1988, J ABNORM CHILD PSYCH, V16, P317, DOI 10.1007/BF00913803; VELLEMAN R, 1990, BRIT J CLIN PSYCHOL, V29, P297, DOI 10.1111/j.2044-8260.1990.tb00887.x; Werner EE, 2004, SUBST USE MISUSE, V39, P699, DOI 10.1081/JA-120034012; WEST MO, 1987, PSYCHOL BULL, V102, P204, DOI 10.1037/0033-2909.102.2.204; Wolfe JD, 2016, SOC PSYCH PSYCH EPID, V51, P1439, DOI 10.1007/s00127-016-1264-x; Zheng Y, 2015, EVALUATION REV, V39, P229, DOI 10.1177/0193841X14567313; Zucker R. A., 1990, DRINKING DRUG UNPUB; Zucker R. A., 2000, CHILDREN ADDICTION R, P109; Zucker RA, 1996, DEV PSYCHOPATHOL, V8, P831, DOI 10.1017/S0954579400007458; ZUCKER RA, 1980, ANTISOCIAL BEHAV CHE; ZUCKER RA, 1991, ALCOHOL HEALTH RES W, V15, P18	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177288	10.1371/journal.pone.0177288	http://dx.doi.org/10.1371/journal.pone.0177288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505162	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500017
J	Li, SP; Peng, Q; Liao, SY; Li, WR; Ma, Q; Lu, XM				Li, Siping; Peng, Qi; Liao, Shengyun; Li, Wenrui; Ma, Qiang; Lu, Xiaomei			A reverse dot blot assay for the screening of twenty mutations in four genes associated with NSHL in a Chinese population	PLOS ONE			English	Article							NONSYNDROMIC HEARING-LOSS; MOLECULAR ETIOLOGY; DEAFNESS; IMPAIRMENT; SLC26A4; GJB2; CHILDHOOD; MONGOLIA	Background Congenital deafness is one of the most distressing disorders affecting humanity and exhibits a high incidence worldwide. Most cases of congenital deafness in the Chinese population are caused by defects in a limited number of genes. A convenient and reliable method for detecting common deafness-related gene mutations in the Chinese population is required. Methods We developed a PCR-reverse dot blot (RDB) assay for screening 20 hotspot mutations of GJB2, GJB3, SLC26A4, and MT-RNR1, which are common non-syndromic hearing loss (NSHL)-associated genes in the Chinese population. The PCR-RDB assay consists of multiplex PCR amplifications of 10 fragments in the target sequence of the four above-mentioned genes in wild-type and mutant genomic DNA samples followed by hybridization to a test strip containing allele-specific oligonucleotide probes. We applied our method to a set of 225 neonates with deafness gene mutations and 30 normal neonates. Results The test was validated through direct sequencing in a blinded study with 100% concordance. Conclusions The results demonstrated that our reverse dot blot assay is a reliable and effective genetic screening method for identifying carriers and individuals with NSHL among the Chinese population.	[Li, Siping; Li, Wenrui; Lu, Xiaomei] Dongguan Childrens Hosp, Dept Lab, Dongguan, Guangdong, Peoples R China; [Peng, Qi; Ma, Qiang; Lu, Xiaomei] Dongguan Inst Pediat, Dept Med & Mol Genet, Dongguan, Guangdong, Peoples R China; [Liao, Shengyun] Shenzhen Yilifang Biotech CO LTD, Shenzhen, Peoples R China		Lu, XM (corresponding author), Dongguan Childrens Hosp, Dept Lab, Dongguan, Guangdong, Peoples R China.; Lu, XM (corresponding author), Dongguan Inst Pediat, Dept Med & Mol Genet, Dongguan, Guangdong, Peoples R China.	lxm020@126.com			Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology [2013108101018]; Science and Technology Planning Project of Guangdong Province [2014A020213001]	Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology; Science and Technology Planning Project of Guangdong Province	This work was supported by the Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology (Project Number: 2013108101018) and the Science and Technology Planning Project of Guangdong Province (Project Number: 2014A020213001). We also thank all the neonates and their parents for their cooperation during this work.	Alves RM, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0303-5; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Dai P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-74; Du W, 2014, GENOMICS, V104, P264, DOI 10.1016/j.ygeno.2014.07.009; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Huang SW, 2016, GENE, V591, P119, DOI 10.1016/j.gene.2016.07.019; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; Lappin S, 2001, J MOL DIAGN, V3, P178, DOI 10.1016/S1525-1578(10)60670-8; Lerer I, 2000, AM J MED GENET, V95, P53, DOI 10.1002/1096-8628(20001106)95:1<53::AID-AJMG11>3.0.CO;2-2; Lin D, 2001, HUM MUTAT, V18, P42, DOI 10.1002/humu.1148; Lu YJ, 2011, J BIOMED RES, V25, P309, DOI 10.1016/S1674-8301(11)60042-0; Ma YL, 2016, ACTA OTO-LARYNGOL, V136, P800, DOI 10.3109/00016489.2016.1164893; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Pandya A, 1997, J MED GENET, V34, P169, DOI 10.1136/jmg.34.2.169; Peng Q, 2016, GENET TEST MOL BIOMA, V20, P603, DOI 10.1089/gtmb.2016.0055; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; Wu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151909; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Xin F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-312; Yao GD, 2014, EXP THER MED, V7, P218, DOI 10.3892/etm.2013.1406; Yao GD, 2013, ACTA OTO-LARYNGOL, V133, P833, DOI 10.3109/00016489.2013.777160; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zhang J, INT J PEDIAT OTORHIN, V77, P1929; Zhang JQ, 2013, INT J PEDIATR OTORHI, V77, P1929, DOI 10.1016/j.ijporl.2013.08.038	27	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177196	10.1371/journal.pone.0177196	http://dx.doi.org/10.1371/journal.pone.0177196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505178	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500013
J	Pava, Z; Noviyanti, R; Handayuni, I; Trimarsanto, H; Trianty, L; Burdam, FH; Kenangalem, E; Utami, RAS; Tirta, YK; Coutrier, F; Poespoprodjo, JR; Price, RN; Marfurt, J; Auburn, S				Pava, Zuleima; Noviyanti, Rintis; Handayuni, Irene; Trimarsanto, Hidayat; Trianty, Leily; Burdam, Faustina H.; Kenangalem, Enny; Utami, Retno A. S.; Tirta, Yusrifar K.; Coutrier, Farah; Poespoprodjo, Jeanne R.; Price, Ric N.; Marfurt, Jutta; Auburn, Sarah			Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P-vivax diversity and a distinct subpopulation of asymptomatic P-falciparum infections	PLOS ONE			English	Article							POPULATION-STRUCTURE; MICROSATELLITE DIVERSITY; TRANSMISSION DYNAMICS; P.-VIVAX; CHLOROQUINE; PREVALENCE; RESISTANCE; MARKERS	Background Genetic analyses of Plasmodium have potential to inform on transmission dynamics, but few studies have evaluated this on a local spatial scale. We used microsatellite genotyping to characterise the micro-epidemiology of P. vivax and P. falciparum diversity to inform malaria control strategies in Timika, Papua Indonesia. Methods Genotyping was undertaken on 713 sympatric P. falciparum and P. vivax isolates from a cross-sectional household survey and clinical studies conducted in Timika. Standard population genetic measures were applied, and the data was compared to published data from Kalimantan, Bangka, Sumba and West Timor. Results Higher diversity (H-E = 0.847 vs 0.625; p = 0.017) and polyclonality (46.2% vs 16.5%, p<0.001) were observed in P. vivax versus P. falciparum. Distinct P. falciparum substructure was observed, with two subpopulations, K1 and K2. K1 was comprised solely of asymptomatic infections and displayed greater relatedness to isolates from Sumba than to K2, possibly reflecting imported infections. Conclusions The results demonstrate the greater refractoriness of P. vivax versus P. falciparum to control measures, and risk of distinct parasite subpopulations persisting in the community undetected by passive surveillance. These findings highlight the need for complimentary new surveillance strategies to identify transmission patterns that cannot be detected with traditional malariometric methods.	[Pava, Zuleima; Handayuni, Irene; Price, Ric N.; Marfurt, Jutta; Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Noviyanti, Rintis; Trianty, Leily; Utami, Retno A. S.; Tirta, Yusrifar K.; Coutrier, Farah] Eijkman Inst Mol Biol, Malaria Pathogenesis Unit, Jakarta, Indonesia; [Trimarsanto, Hidayat] Eijkman Inst Mol Biol, Bioinformat Lab, Jakarta, Indonesia; [Trimarsanto, Hidayat] Agcy Assessment & Applicat Technol, Jakarta, Indonesia; [Burdam, Faustina H.; Kenangalem, Enny; Poespoprodjo, Jeanne R.] Mimika Dist Hlth Author, Timika, Papua, Indonesia; [Burdam, Faustina H.; Kenangalem, Enny; Poespoprodjo, Jeanne R.] Papuan Hlth & Community Dev Fdn, Timika Malaria Res Programme, Timika, Papua, Indonesia; [Burdam, Faustina H.; Poespoprodjo, Jeanne R.] Univ Gadjah Mada, Fac Med, Dept Child, Pediat Res Off, Yogyakarta, Indonesia; [Price, Ric N.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England	Charles Darwin University; Menzies School of Health Research; Eijkman Institute; Eijkman Institute; Agency for the Assessment & Application of Technology (BPPT); Gadjah Mada University; University of Oxford	Auburn, S (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	sarah.auburn@menzies.edu.au	Poespoprodjo, Jeanne/AAF-1698-2020; Auburn, Sarah/N-2266-2013	Poespoprodjo, Jeanne/0000-0003-1573-734X; Pava, Zuleima/0000-0002-4802-0647; Price, Richard/0000-0003-2000-2874; Noviyanti, Rintis/0000-0003-1383-3274; Tirta, Yusrifar Kharisma/0000-0001-7592-9445; Auburn, Sarah/0000-0002-4638-536X; Trimarsanto, Hidayat/0000-0003-2436-8283	Wellcome Trust [200909, 099875, 512-2010]; DFAT (Australian Department of Foreign Affairs and Trade); NHMRC [1037304]	Wellcome Trust(Wellcome TrustEuropean Commission); DFAT (Australian Department of Foreign Affairs and Trade); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the Wellcome Trust (a Senior Fellowship in Clinical Science awarded to RNP - 200909) and Fellowships to: JRP (Wellcome Trust - 099875) and ZP (Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias - 512-2010). The Timika Research Facility and Papuan Health and Community Development Foundation were supported by DFAT (Australian Department of Foreign Affairs and Trade) and the NHMRC (Program Grant 1037304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], 2015, WORLD MALARIA REPORT; Auburn S, 2016, INT J PARASITOL; Barry AE, 2015, PATHOG GLOB HEALTH, V109, P142, DOI 10.1179/2047773215Y.0000000012; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413; Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Ferreira MU, 2014, TRENDS PARASITOL, V30, P465, DOI 10.1016/j.pt.2014.08.003; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Hamedi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166124; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Jennison C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003634; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Koepfli Cristian, 2014, P N G Med J, V57, P75; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Laufer MK, 2004, DRUG RESIST UPDATE, V7, P279, DOI 10.1016/j.drup.2004.08.003; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pava Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165340; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Pritchard JK, 2000, GENETICS, V155, P945; Pumpaibool T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-155; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Sumawinata IW, 2003, AM J TROP MED HYG, V68, P416, DOI 10.4269/ajtmh.2003.68.416; Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447; WHO, 2016, EL MAL, V24	36	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177445	10.1371/journal.pone.0177445	http://dx.doi.org/10.1371/journal.pone.0177445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498860	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314500017
J	Sakai, H; Fukuda, S; Nakamura, M; Uezumi, A; Noguchi, Y; Sato, T; Morita, M; Yamada, H; Tsuchida, K; Tajbakhsh, S; Fukada, S				Sakai, Hiroshi; Fukuda, Sumiaki; Nakamura, Miki; Uezumi, Akiyoshi; Noguchi, Yu-taro; Sato, Takahiko; Morita, Mitsuhiro; Yamada, Harumoto; Tsuchida, Kunihiro; Tajbakhsh, Shahragim; Fukada, So-ichiro			Notch ligands regulate the muscle stem-like state ex vivo but are not sufficient for retaining regenerative capacity	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; HUMAN SKELETAL-MUSCLE; SATELLITE CELL NICHE; SELF-RENEWAL; PROGENITOR CELLS; MESENCHYMAL PROGENITORS; EXPANSION; GENE; MYOD; TRANSPLANTATION	Myogenic stem cells are a promising avenue for the treatment of muscular disorders. Freshly isolated muscle stem cells have a remarkable engraftment ability in vivo, but their cell number is limited. Current conventional culture conditions do not allow muscle stem cells to expand in vitro with their bona fide engraftment efficiency, requiring the improvement of culture procedures for achieving successful cell-therapy for muscle disorders. Here we expanded mouse muscle stem cells and human myoblasts with Notch ligands, DLL1, DLL4, and JAG1 to activate Notch signaling in vitro and to investigate whether these cells could retain their engraftment efficiency. Notch signaling promotes the expansion of Pax7+MyoD-mouse muscle stem-like cells and inhibits differentiation even after passage in vitro. Treatment with Notch ligands induced the Notch target genes and generated PAX7+MYOD-stem-like cells from human myoblasts previously cultured on conventional culture plates. However, cells treated with Notch ligands exhibit a stem cell-like state in culture, yet their regenerative ability was less than that of freshly isolated cells in vivo and was comparable to that of the control. These unexpected findings suggest that artificial maintenance of Notch signaling alone is insufficient for improving regenerative capacity of mouse and human donor-muscle cells and suggest that combinatorial events are critical to achieve muscle stem cell and myoblast engraftment potential.	[Sakai, Hiroshi; Tajbakhsh, Shahragim] CNRS, Inst Pasteur, Dept Dev & Stem Cell Biol, Stem Cells & Dev,UMR 3738, Paris, France; [Fukuda, Sumiaki; Nakamura, Miki; Noguchi, Yu-taro; Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol Grad, Osaka, Japan; [Uezumi, Akiyoshi; Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Aichi, Japan; [Sato, Takahiko] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Yamada, Harumoto] Fujita Hlth Univ, Dept Orthopaed Surg, Aichi, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Osaka University; Fujita Health University; Kyoto Prefectural University of Medicine; Fujita Health University	Tajbakhsh, S (corresponding author), CNRS, Inst Pasteur, Dept Dev & Stem Cell Biol, Stem Cells & Dev,UMR 3738, Paris, France.; Fukada, S (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol Grad, Osaka, Japan.	shahragim.tajbakhsh@pasteur.fr; fukada@phs.osaka-u.ac.jp	Uezumi, Akiyoshi/ABF-7359-2020; Hiroshi, SAKAI/B-1450-2016; Tsuchida, Kunihiro/A-4501-2012; Fukada, So-ichiro/AAI-9151-2020	Uezumi, Akiyoshi/0000-0003-4294-0116; Hiroshi, SAKAI/0000-0001-9456-0911; Tsuchida, Kunihiro/0000-0002-3983-5756; Fukada, So-ichiro/0000-0003-4051-5108	Japan Agency for Medical Research and Development; Institut Pasteur; Centre National pour la Recherche Scientific; Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir) [ANR-10-LABX-73]; European Research Council [332893]; Grants-in-Aid for Scientific Research [16K08599] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Institut Pasteur(European Commission); Centre National pour la Recherche Scientific; Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir)(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	So-ichiro F. and A.U. were supported by Japan Agency for Medical Research and Development. S.T. was funded by Institut Pasteur, Centre National pour la Recherche Scientific, the Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir; ANR-10-LABX-73) and the European Research Council (Advanced Research Grant 332893).	Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Ikemoto M, 2007, MOL THER, V15, P2178, DOI 10.1038/sj.mt.6300295; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Law P K, 1992, Cell Transplant, V1, P235; Le Roux I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9528; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Motohashi N, 2008, AM J PATHOL, V173, P781, DOI 10.2353/ajpath.2008.070902; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Parker MH, 2012, STEM CELLS, V30, P2212, DOI 10.1002/stem.1181; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sakai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063016; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Sun DQ, 2008, J CELL SCI, V121, P3815, DOI 10.1242/jcs.035493; TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203; Uezumi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.161; Uezumi A, 2016, STEM CELL REP, V7, P263, DOI 10.1016/j.stemcr.2016.07.004; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vieira NM, 2015, CELL, V163, P1204, DOI 10.1016/j.cell.2015.10.049; Wertz K, 1998, DEV DYNAM, V212, P229, DOI 10.1002/(SICI)1097-0177(199806)212:2<229::AID-AJA7>3.0.CO;2-J; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800; Zucconi E, 2010, NEUROMUSCULAR DISORD, V20, P64, DOI 10.1016/j.nmd.2009.10.011	39	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177516	10.1371/journal.pone.0177516	http://dx.doi.org/10.1371/journal.pone.0177516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498863	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500024
J	Durda, K; Kaklewski, K; Gupta, S; Szydlowski, M; Baszuk, P; Jaworska-Bieniek, K; Sukiennicki, G; Kaczmarek, K; Waloszczyk, P; Narod, S; Lubinski, J; Jakubowska, A				Durda, Katarzyna; Kaklewski, Krzysztof; Gupta, Satish; Szydlowski, Michal; Baszuk, Piotr; Jaworska-Bieniek, Katarzyna; Sukiennicki, Grzegorz; Kaczmarek, Katarzyna; Waloszczyk, Piotr; Narod, Steven; Lubinski, Jan; Jakubowska, Anna			Serum folate concentration and the incidence of lung cancer	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; B-VITAMINS; RISK; POLYMORPHISMS; REDUCTASE; ASSOCIATION; SMOKING; MTHFR; MTR	Background Lung cancer is a leading cause of cancer-related mortality globally. Folate helps to maintain DNA integrity and to regulate gene expression. Serum folate levels may affect the risk of several cancers, including lung cancer. In this study we evaluated the association between serum folate concentration and variations in genes involved in folate metabolism with lung cancer incidence in Poland. Methods The study included 366 lung cancer patients and 366 control subjects. We measured serum folate concentration and genotyped six variants in MTHFR, MTR and MTRR genes. The odds ratios of being diagnosed with lung cancer were calculated using conditional univariable and multivariable logistic regression with respect to folate level and genotypes. Results The mean serum folate level was lower in lung cancer cases than in control group (20.07 nmol/l vs. 22.52 nmol/l, p = 0.002). The odds ratio for lung cancer declined with increasing serum content of the folate. The folate concentration of >25.71 nmol/l (IVth quartile) in comparison to < 15.92 nmol/l (Ist quartile) was associated with an odds ratio of 0.61 (95% CI 0.40-0.95, p = 0.03). The analysis of variations in MTHFR, MTR and MTRR genes did not reveal any significant difference between lung cancer cases and controls in univariable and multivariable analyses. Conclusion In this case-control study, lower serum folate concentrations were associated with a higher risk of lung cancer diagnosis. Although previous findings have been somewhat mixed, our results add to the evidence that circulating folate levels may be an indicator of lung cancer risk.	[Durda, Katarzyna; Kaklewski, Krzysztof; Gupta, Satish; Baszuk, Piotr; Jaworska-Bieniek, Katarzyna; Sukiennicki, Grzegorz; Kaczmarek, Katarzyna; Lubinski, Jan; Jakubowska, Anna] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Polabska 4, Szczecin, Poland; [Szydlowski, Michal] West Pomeranian Univ Technol, Fac Mech Engn & Mechatron, Al Piastow 19, Szczecin, Poland; [Waloszczyk, Piotr] Zdunomed, Independent Lab Pathol, Szczecin, Poland; [Narod, Steven] Womens Coll Res Inst, Toronto, ON, Canada	Pomeranian Medical University; West Pomeranian University of Technology; University of Toronto; University Toronto Affiliates; Womens College Hospital	Durda, K (corresponding author), Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Polabska 4, Szczecin, Poland.	k.durda@onet.pl	Jakubowska, Anna/O-8050-2014; Szydlowski, Michal/ABI-1376-2020; Szydlowski, Michal J./AAZ-3809-2020; Narod, Steven A/AAA-6112-2022; Szydłowski, Michał J/B-4472-2017	Jakubowska, Anna/0000-0002-5650-0501; Szydłowski, Michał J/0000-0003-4723-6726; Kaklewski, Krzysztof/0000-0002-0846-2619; Bialkowska, Katarzyna/0000-0001-8489-6665; Lubinski, Jan/0000-0003-2931-3003	National Science Centre [DEC-2013/09/N/NZ4/02225]	National Science Centre(National Science Centre, Poland)	This work was supported by National Science Centre (https://www.ncn.gov.pl/) grant DEC-2013/09/N/NZ4/02225 (KD). The funder (National Science Center; NCN) provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LB, 2015, J NUTR, V145, P1636, DOI 10.3945/jn.114.206599; Bandera EV, 1997, CANCER CAUSE CONTROL, V8, P828, DOI 10.1023/A:1018456127018; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Cui LH, 2011, PHARMACOGENOMICS, V12, P797, DOI [10.2217/pgs.11.27, 10.2217/PGS.11.27]; Dai WM, 2013, CHINESE MED J-PEKING, V126, P1957, DOI 10.3760/cma.j.issn.0366-6999.20130391; Drammeh BS, 2008, CLIN CHEM, V54, P1883, DOI 10.1373/clinchem.2008.108761; Dutkowska A, 2013, MOLBIOL REP, V40; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jansen EHJM, 2012, CLIN CHEM LAB MED, V50, P1761, DOI 10.1515/cclm-2012-0108; Jatoi A, 2001, J SURG ONCOL, V77, P247, DOI 10.1002/jso.1104; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kiyohara C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-459; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Langevin SM, 2015, TRANSL RES, V165, P74, DOI 10.1016/j.trsl.2014.03.001; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; LEMARCHAND L, 1989, JNCI-J NATL CANCER I, V81, P1158, DOI 10.1093/jnci/81.15.1158; Li H, 2015, NUTRIENTS, V7; Liu Chiu-Shong, 2009, Cancer Genomics & Proteomics, V6, P325; Pfeiffer CM, 2010, FOLATE HLTH DIS, P179; Roswall N, 2010, LUNG CANCER, V67, P275, DOI 10.1016/j.lungcan.2009.11.010; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shi QL, 2005, CANCER EPIDEM BIOMAR, V14, P1477, DOI 10.1158/1055-9965.EPI-04-0905; Shi QL, 2005, PHARMACOGENET GENOM, V15, P547, DOI 10.1097/01.fpc.0000170916.96650.70; Slatore CG, 2008, AM J RESP CRIT CARE, V177, P524, DOI 10.1164/rccm.200709-1398OC; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Suzuki T, 2007, CARCINOGENESIS, V28, P1718, DOI 10.1093/carcin/bgm104; Takata Y, 2013, NUTR CANCER, V65, P51, DOI 10.1080/01635581.2013.741757; Tastekin D., 2015, Experimental Oncology, V37, P218; Wettergren Y, 2010, MOL MED, V16, P425, DOI 10.2119/molmed.2009.00156	32	21	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177441	10.1371/journal.pone.0177441	http://dx.doi.org/10.1371/journal.pone.0177441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493936	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300109
J	Gutierrez, J; Albuquerque, ALA; Falzon, L				Gutierrez, Jose; Albuquerque, Ana Leticia A.; Falzon, Louise			HIV infection as vascular risk: A systematic review of the literature and meta-analysis	PLOS ONE			English	Review							ACTIVE ANTIRETROVIRAL THERAPY; ACUTE MYOCARDIAL-INFARCTION; INTIMA-MEDIA THICKNESS; ISCHEMIC-STROKE; HEART-DISEASE; INDIVIDUALS; COHORT; AIDS; INFLAMMATION; ASSOCIATION	Importance The vascular risk attributable to HIV infection is rising. The heterogeneity of the samples studied is an obstacle to understanding whether HIV is a vascular risk across geographic regions. Objective To test the hypothesis that HIV infection is a vascular risk factor, and that the risk conferred by HIV varies by geographical region. Data sources A systematic search of publications was carried out in seven electronic databases: PubMed, The Cochrane Library, EMBASE, Web of Science, LILACS, ClinicalTrials. gov, and WHO International Clinical Trials Registry Platform from inception to July 2015. Study selection We included longitudinal studies of HIV+ individuals and their risk of vascular outcomes of >= 50 HIV+ cases and excluded studies on biomarkers of vascular disease as well as clinical trials. Data extraction and synthesis Data was extracted by one of the authors and independently confirmed by the other two authors. We used incidence rate (IR), incidence risk ratio (IRR) and hazard ratio (HR) with their 95% confidence intervals as measures of risk. Main outcome All-death, myocardial infarction (MI), coronary heart disease (CHD), any stroke, ischemic stroke (IS) or intracranial hemorrhage (ICH). Results We screened 11,482 references for eligibility, and selected 117 for analysis. Forty-four cohorts represented 334,417 HIV+ individuals, 49% from the United States. Compared with their European counterparts, HIV+ individuals in the United States had higher IR of death (IRR 1.78, 1.69-1.88), MI (IRR 1.61, 1.29-2.01), CHD (IRR 2.27, 1.92-2.68), any stroke (IRR 1.94, 1.59-2.38), IS (IRR 1.56, 1.23-1.98), and ICH (IRR 4.03, 2.72-6.14). Compared with HIV- controls and independent of geographical region, HIV was a risk for death (HR 4.77, 4.55-5.00), MI (HR 1.60, 1.49-1.72), any CHD (HR 1.20, 1.15-1.25), any stroke (HR 1.82, 1.53-2.16), IS (HR 1.27, 1.15-1.39) and ICH (HR 2.20, 1.61-3.02). Use of antiretroviral therapy was a consistent risk for cardiac outcomes, while immunosuppression and unsuppressed viral load were consistent risks for cerebral outcomes. Conclusions HIV should be considered a vascular risk, with varying magnitudes across geographical and anatomical regions. We think that strategies to reduce the HIV-related vascular burden are urgent, and should incorporate the disparities noted here.	[Gutierrez, Jose] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA; [Albuquerque, Ana Leticia A.] Univ Fed Alagoas, Sch Med, Maceio, AL, Brazil; [Falzon, Louise] Columbia Univ, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY USA	Columbia University; Universidade Federal de Alagoas; Columbia University	Gutierrez, J (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.	jg3233@cumc.columbia.edu	Gutiérrez, José/GSJ-1846-2022; Falzon, Louise/AAG-2404-2019; Falzon, Louise/HCI-2175-2022	Falzon, Louise/0000-0002-9449-6056; Gutierrez, Jose/0000-0002-2175-8078	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [NIH-U24AG052175]; Value Institute of New York Presbyterian Hospital [S15-0142]; NATIONAL INSTITUTE ON AGING [U24AG052175] Funding Source: NIH RePORTER	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Value Institute of New York Presbyterian Hospital; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Brazil Scientific Mobility Program, sponsored by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). NIH-U24AG052175 and Value Institute of New York Presbyterian Hospital S15-0142. Role of funding agent: Funding salary support, no direct role in this research.	Bejot Y, 2014, J NEUROL NEUROSUR PS, V85, P509, DOI 10.1136/jnnp-2013-306203; Bozzette SA, 2008, JAIDS-J ACQ IMM DEF, V47, P338, DOI 10.1097/QAI.0b013e31815e7251; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Brouwer ES, 2014, EPIDEMIOLOGY, V25, P406, DOI 10.1097/EDE.0000000000000041; Carballo D, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0045-z; Centre for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Connor MD, 2000, STROKE, V31, P2117, DOI 10.1161/01.STR.31.9.2117; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; Falcone EL, 2011, ANTIVIR THER, V16, P1, DOI 10.3851/IMP1682; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Gillis J, 2014, ANTIVIR THER, V19, P309, DOI 10.3851/IMP2724; Gutierrez J, 2016, AIDS, V30, P415, DOI 10.1097/QAD.0000000000000927; Gutierrez J, 2015, NEUROLOGY, V85, P1139, DOI 10.1212/WNL.0000000000001976; Helleberg M, 2012, INFECTION, V40, P627, DOI 10.1007/s15010-012-0293-y; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Howard G, 2011, STROKE, V42, P3369, DOI 10.1161/STROKEAHA.111.625277; Howard VJ, 2011, ANN NEUROL, V69, P619, DOI 10.1002/ana.22385; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Jensen-Fangel S, 2004, AIDS, V18, P89, DOI 10.1097/00002030-200401020-00011; Klein DB, 2015, CLIN INFECT DIS, V60, P1278, DOI 10.1093/cid/civ014; Marcus JL, 2014, AIDS, V28, P1911, DOI 10.1097/QAD.0000000000000352; Mateen FJ, 2013, NEUROLOGY, V81, P2094, DOI 10.1212/01.wnl.0000437296.97946.73; Mateen FJ, 2012, NEUROLOGY, V79, P1873, DOI 10.1212/WNL.0b013e318271f7b8; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Ortiz G, 2007, NEUROLOGY, V68, P1257, DOI 10.1212/01.wnl.0000259515.45579.1e; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pellowski JA, 2013, AM PSYCHOL, V68, P197, DOI 10.1037/a0032694; Rasmussen LD, 2015, CLIN INFECT DIS, V60, P1415, DOI 10.1093/cid/civ013; Rasmussen LD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-169; Sabin CA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0588-4; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Shrestha S, 2014, ARTERIOSCL THROM VAS, V34, P244, DOI 10.1161/ATVBAHA.113.302191; Sico JJ, 2015, NEUROLOGY, V84, P1933, DOI 10.1212/WNL.0000000000001560; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Vinikoor MJ, 2013, AIDS RES HUM RETROV, V29, P1068, DOI [10.1089/aid.2012.0334, 10.1089/AID.2012.0334]; Volpe GE, 2013, JAIDS-J ACQ IMM DEF, V64, P51, DOI 10.1097/QAI.0b013e31829ed726; Whitmore Suzanne K., 2012, Morbidity and Mortality Weekly Report, V61, P971; World Health Organization, 2014, HIV AIDS	45	71	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176686	10.1371/journal.pone.0176686	http://dx.doi.org/10.1371/journal.pone.0176686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493892	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000401314300025
J	Hopkins, JB; Ferguson, JM; Tyers, DB; Kurle, CM				Hopkins, John B., III; Ferguson, Jake M.; Tyers, Daniel B.; Kurle, Carolyn M.			Selecting the best stable isotope mixing model to estimate grizzly bear diets in the Greater Yellowstone Ecosystem	PLOS ONE			English	Article							AMERICAN BLACK BEARS; MOUNTAIN PINE-BEETLE; DELTA-N-15; DELTA-C-13; NITROGEN; SULFUR; CONSUMPTION; COMPONENTS; BROWN; SEX	Past research indicates that whitebark pine seeds are a critical food source for Threatened grizzly bears (Ursus arctos) in the Greater Yellowstone Ecosystem (GYE). In recent decades, whitebark pine forests have declined markedly due to pine beetle infestation, invasive blister rust, and landscape-level fires. To date, no study has reliably estimated the contribution of whitebark pine seeds to the diets of grizzlies through time. We used stable isotope ratios (expressed as delta C-13, delta(15) N, and delta(34) S values) measured in grizzly bear hair and their major food sources to estimate the diets of grizzlies sampled in Cooke City Basin, Montana. We found that stable isotope mixing models that included different combinations of stable isotope values for bears and their foods generated similar proportional dietary contributions. Estimates generated by our top model suggest that whitebark pine seeds (35 +/- 10%) and other plant foods (56 +/- 10%) were more important than meat (9 +/- 8%) to grizzly bears sampled in the study area. Stable isotope values measured in bear hair collected elsewhere in the GYE and North America support our conclusions about plant-based foraging. We recommend that researchers consider model selection when estimating the diets of animals using stable isotope mixing models. We also urge researchers to use the new statistical framework described here to estimate the dietary responses of grizzlies to declines in whitebark pine seeds and other important food sources through time in the GYE (e.g., cutthroat trout), as such information could be useful in predicting how the population will adapt to future environmental change.	[Hopkins, John B., III] Unity Coll, Sch Biodivers Conservat, Unity, ME 04988 USA; [Hopkins, John B., III; Kurle, Carolyn M.] Univ Calif San Diego, Ecol Behav & Evolut Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Ferguson, Jake M.] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA; [Tyers, Daniel B.] US Forest Serv, Northern Rocky Mt Sci Ctr, Bozeman, MT USA	University of California System; University of California San Diego; Idaho; University of Idaho; United States Department of Agriculture (USDA); United States Forest Service	Hopkins, JB (corresponding author), Unity Coll, Sch Biodivers Conservat, Unity, ME 04988 USA.; Hopkins, JB (corresponding author), Univ Calif San Diego, Ecol Behav & Evolut Sect, Div Biol Sci, La Jolla, CA 92093 USA.	jhopkins@unity.edu		Ferguson, Jake/0000-0002-5034-9089	National Institute for Mathematical and Biological Synthesis at University of Tennessee Knoxville (NSF Award) [DBI-130042,6]; Center for Modeling Complex Interactions (NIH Award) [GM104420]; D. Ohman; G. Bennett; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104420] Funding Source: NIH RePORTER	National Institute for Mathematical and Biological Synthesis at University of Tennessee Knoxville (NSF Award); Center for Modeling Complex Interactions (NIH Award); D. Ohman; G. Bennett; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the U.S. Forest Service, Federal Highway Administration-Western Federal Lands, University of California San Diego, the National Institute for Mathematical and Biological Synthesis at University of Tennessee Knoxville (NSF Award \#DBI-130042,6), the Center for Modeling Complex Interactions (NIH Award \#GM104420), D. Ohman, and G. Bennett.	[Anonymous], 2021, LANG ENV STAT COMP; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Bockino NK, 2012, NAT AREA J, V32, P31, DOI 10.3375/043.032.0105; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Costello CM, 2014, ECOL EVOL, V4, P2004, DOI 10.1002/ece3.1082; Day NE, 1969, BIOMETRIKA; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Ferguson J., 2016, ISOTOPER STABLE ISOT; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Fortin JK, 2013, J WILDLIFE MANAGE, V77, P270, DOI 10.1002/jwmg.483; FRENCH S.P., 1994, INT C BEAR RES MANAG, V9, P389; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Gunther KA, 2014, URSUS, V25, P61, DOI 10.2192/URSUS-D-13-00008.1; Haroldson M. A., 2006, WILDLIFE MONOGR, V161, P33; Haroldson MA, 2013, YELLOWSTONE GRIZZLY, P48; Haroldson MA, 2010, URSUS, V21, P1, DOI 10.2192/09GR022.1; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; Hopkins JB, 2016, METHODS ECOL EVOL, V7, P210, DOI 10.1111/2041-210X.12446; Hopkins JB, 2014, FRONT ECOL ENVIRON, V12, P107, DOI 10.1890/130276; Hopkins JB, 2012, J WILDLIFE MANAGE, V76, P703, DOI 10.1002/jwmg.318; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Koch PL, 2002, OECOLOGIA, V133, P14, DOI 10.1007/s00442-002-0977-6; Kurle CM, 2014, ISOT ENVIRON HEALT S, V50, P307, DOI 10.1080/10256016.2014.908872; Lopez-Alfaro C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128088; Mahalovich MF, 2016, FOREST ECOL MANAG, V359, P174, DOI 10.1016/j.foreco.2015.09.047; Mattson D.J., 2000, THESIS; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; Mattson DJ, 1998, URSUS-SERIES, V10, P129; MATTSON DJ, 1992, J WILDLIFE MANAGE, V56, P432, DOI 10.2307/3808855; Middleton AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0870; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; Ripple WJ, 2014, J ANIM ECOL, V83, P223, DOI 10.1111/1365-2656.12123; Rossi J. L, 2016, THESIS; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Schwartz CC, 2014, WILDLIFE SOC B, V38, P664, DOI 10.1002/wsb.426; Schwartz CC, 2014, J WILDLIFE MANAGE, V78, P68, DOI 10.1002/jwmg.633; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Teisberg JE, 2014, J WILDLIFE MANAGE, V78, P369, DOI 10.1002/jwmg.667; van Manen FT, 2013, RESPONSE YELLOWSTONE, P1; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Woods JG, 1999, WILDLIFE SOC B, V27, P616	49	11	12	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0174903	10.1371/journal.pone.0174903	http://dx.doi.org/10.1371/journal.pone.0174903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493929	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300005
J	Khatri, RB; Dangi, TP; Gautam, R; Shrestha, KN; Homer, CSE				Khatri, Resham Bahadur; Dangi, Tara Prasad; Gautam, Rupesh; Shrestha, Khadka Narayan; Homer, Caroline S. E.			Barriers to utilization of childbirth services of a rural birthing center in Nepal: A qualitative study	PLOS ONE			English	Article							MATERNAL MORTALITY; CARE SERVICES; HEALTH; PROGRAM; DELIVERY; WOMEN; ATTENDANTS; IMPACT; GHANA; PERSPECTIVES	Background Maternal mortality and morbidity are public health problems in Nepal. In rural communities, many women give birth at home without the support of a skilled birth attendant, despite the existence of rural birthing centers. The aim of this study was to explore the barriers and provide pragmatic recommendations for better service delivery and use of rural birthing centers. Methods We conducted 26 in-depth interviews with service users and providers, and three focus group discussions with community key informants in a rural community of Rukum district. We used the Adithya Cattamanchi logic model as a guiding framework for data analysis. Results Irregular and poor quality services, inadequate human and capital resources, and poor governance were health system challenges which prevented service delivery. Contextual barriers including difficult geography, poor birth preparedness practices, harmful culture practices and traditions and low level of trust were also found to contribute to underutilization of the birthing center. Conclusion The rural birthing center was not providing quality services when women were in need, which meant women did not use the available services properly because of systematic and contextual barriers. Approaches such as awareness-raising activities, local resource mobilization, ensuring access to skilled providers and equipment and other long-term infrastructure development works could improve the quality and utilization of childbirth services in the rural birthing center. This has resonance for other centers in Nepal and similar countries.	[Khatri, Resham Bahadur] Ctr Res & Dev, Kathmandu, Nepal; [Dangi, Tara Prasad] Govt Nepal, Minist Home Affairs, Kathmandu, Nepal; [Gautam, Rupesh] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Shrestha, Khadka Narayan] Tribhuvan Univ, Dept Sociol & Anthropol, Kathmandu, Nepal; [Homer, Caroline S. E.] Univ Technol Sydney, Fac Hlth, Sydney, NSW, Australia; [Khatri, Resham Bahadur] Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld, Australia	Aarhus University; Tribhuvan University; University of Technology Sydney; University of Queensland	Khatri, RB (corresponding author), Ctr Res & Dev, Kathmandu, Nepal.; Khatri, RB (corresponding author), Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld, Australia.	rkchettri@gmail.com	Dangal, Ganesh/O-1989-2017; Khatri, Resham B/R-1532-2016	Dangal, Ganesh/0000-0002-5834-5525; Khatri, Resham B/0000-0001-5216-606X				Adegoke AA, 2013, MIDWIFERY, V29, pE64, DOI 10.1016/j.midw.2012.08.009; Adhikari SR, 2014, NEPAL HEALTH SECTOR, P1; Adongo PB, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-16; Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Ahmed SM, 2016, B WORLD HEALTH ORGAN, V94, P351, DOI 10.2471/BLT.15.168450; Andersen K, 2013, GLOB HEALTH-SCI PRAC, V1, P372, DOI 10.9745/GHSP-D-12-00026; Awoonor-Williams JK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S3; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Borrell C, 2014, EPIDEMIOL REV, V36, P31, DOI 10.1093/epirev/mxt002; Brunson J, 2010, SOC SCI MED, V71, P1719, DOI 10.1016/j.socscimed.2010.06.013; Cattamanchi A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0668-0; Chaturvedi S, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27427; Choe MK, 2005, J BIOSOC SCI, V37, P143, DOI 10.1017/S0021932003006527; Devkota M, 2011, READINESS OF COMPREH; Ensor T, 2009, HEALTH POLICY, V90, P247, DOI 10.1016/j.healthpol.2008.06.009; Ferdous J, 2012, J HEALTH POPUL NUTR, V30, P143, DOI 10.3329/jhpn.v30i2.11308; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; GURUNG G, 2016, THE INTERNATIONAL JO, V31, P167; Head R, 2015, LANCET, V386, P97, DOI 10.1016/S0140-6736(14)61649-4; Hipgrave DB, 2014, HEALTH POLICY PLANN, V29, P703, DOI 10.1093/heapol/czt053; Hossain SK, 2014, OBSTET GYNECOL, V123, p149S, DOI 10.1097/01.AOG.0000447136.92802.2a; Idowu AE, 2013, THE SOCIO CULTURAL C; Iyer HS, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28365; Joshi SR, 2010, DISTRICT AND VDC PRO; Kaphle S, 2013, MIDWIFERY, V29, P1173, DOI 10.1016/j.midw.2013.06.002; Karkee R, 2013, HEALTH POLICY AND PL; Karkee R, 2015, HEALTH POLICY PLANN, V30, P1, DOI 10.1093/heapol/czt090; Karkee R, 2013, MIDWIFERY, V29, P1206, DOI 10.1016/j.midw.2013.05.002; Lama S, 2015, KATHMANDU UNIVERSITY, V12, P253; Leap Nicky, 2002, Aust J Midwifery, V15, P15, DOI 10.1016/S1031-170X(02)80004-6; Mahato PK., 2016, J ASIAN MIDWIVES, V3, P18; Milne L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0564-6; Ministry of Health and Population, 2011, ANNUAL REPORT 2010 2; Ministry of Health and Population, 2009, ANN REPORT; Ministry of Health and Population (MOHP) [Nepal] New ERA and ICF International Inc, 2012, NEPAL DEMOGRAPHIC AN; Ministry of Health & Population, 2011, NEPAL DEMOGRAPHIC AN; Morgan A, 2014, TROP MED INT HEALTH, V19, P1457, DOI 10.1111/tmi.12390; Morrison J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-89; Nawal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060957; Nonyane BA, 2015, HLTH POLICY PLANNING; Onta S, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24580; Pandey S., 2016, CHILDREN AND YOUTH S; Paudel NR, 2007, NFU CONFERENCE; Perrott SB, 2014, CAN J DEV STUD, V35, P304, DOI 10.1080/02255189.2014.899893; Powell-Jackson T, 2012, J HEALTH ECON, V31, P271, DOI 10.1016/j.jhealeco.2011.10.010; Powell-Jackson T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-97; Pradhan R., 2016, SCHOOL OF PUBLIC HEA; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Sakeah E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-344; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Shah R, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1848-x; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Subba NR, 2015, AMERICAN JOURNAL OF, V3, P310; Suvedi B. K., 2009, NEPAL MATERNAL MORTA; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; Uzochukwu B S C, 2004, East Afr Med J, V81, P293; Viterna J, 2014, HANDBOOK OF THE SOCI; Wagle Rajendra Raj, 2004, BMC Pregnancy Childbirth, V4, P8, DOI 10.1186/1471-2393-4-8; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wild K, 2012, B WORLD HEALTH ORGAN, V90, P97, DOI 10.2471/BLT.11.088955; Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010508	62	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177602	10.1371/journal.pone.0177602	http://dx.doi.org/10.1371/journal.pone.0177602			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493987	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300143
J	Nemeth, B; Ajtay, Z; Hejjel, L; Ferenci, T; Abram, Z; Muranyi, E; Kiss, I				Nemeth, Balazs; Ajtay, Zeno; Hejjel, Laszlo; Ferenci, Tamas; Abram, Zoltana; Muranyi, Edit; Kiss, Istvan			The issue of plasma asymmetric dimethylarginine reference range - A systematic review and meta-analysis	PLOS ONE			English	Review							MASS-SPECTROMETRY; ADMA; ARGININE; HEALTH; VALUES; LEVEL; SDMA	Background Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase, marker and mediator of endothelial dysfunction. Several studies have demonstrated its value in cardiovascular risk stratification and all-cause mortality prediction. The aim was to determine the reference range of plasma ADMA in healthy adults. Methods and results Taking into account the most widely used ADMA measurement methods, only studies using either high performance liquid chromatography (HPLC) -with fluorescence or mass spectrometric detection-, or enzyme-linked immunosorbent assay (ELISA) to quantify plasma ADMA concentrations were enrolled. 66 studies were included in the quantitative analysis (24 using ELISA and 42 using HPLC) reporting a total number of 5528 non-diabetic, non-hypertensive, non-obese adults without any medication (3178 men and 2350 women, 41.6 +/- 16.9 years old). The reference range of ADMA (in mu mol/l with 95% confidence interval in parenthesis) was 0.34 (0.29-0.38)-1.10 (0.85-1.35) with a mean of 0.71 (0.57-0.85) (n = 4093) measured by HPLC and 0.25 (0.18-0.31)-0.92 (0.76-1.09) with a mean of 0.57 (0.48-0.66) (n = 1435) by ELISA. Conclusions Numerous publications suggested that asymmetric dimethylarginine is not only an outstanding tool of disease outcome prediction but also a new potential therapeutic target substance; the reference range provided by this meta-analysis can become of great importance and aid to further investigations. However, developing a standard measurement method would be beneficial to facilitate the clinical usage of ADMA.	[Nemeth, Balazs; Muranyi, Edit; Kiss, Istvan] Univ Pecs, Med Sch, Dept Publ Hlth Med, Pecs, Hungary; [Ajtay, Zeno; Hejjel, Laszlo] Univ Pecs, Heart Inst, Med Sch, Pecs, Hungary; [Ferenci, Tamas] Obudai Univ, John von Neumann Fac Informat, Physiol Controls Grp, Budapest, Hungary; [Abram, Zoltana] Univ Med & Pharm Tirgu Mures, Dept Hyg, Targu Mures, Romania	University of Pecs; University of Pecs; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures	Nemeth, B (corresponding author), Univ Pecs, Med Sch, Dept Publ Hlth Med, Pecs, Hungary.	balazs.nemeth@aok.pte.hu	Hejjel, László/GYI-8861-2022; Ferenci, Tamás/H-4682-2012; Nemeth, Balazs/AAP-1660-2021	Hejjel, László/0000-0002-1820-5560; Ferenci, Tamás/0000-0001-6791-3080; Nemeth, Balazs/0000-0002-4914-9872; Kiss, Istvan/0000-0002-7558-1300	New National Excellence Program of the Ministry of Human Capacities [UNKP16-4/III]	New National Excellence Program of the Ministry of Human Capacities	Tamas Ferenci was supported by UNKP16-4/III New National Excellence Program of the Ministry of Human Capacities (http://www. kormany.hu/hu/ernberi eroforrasok-miniszteriurna). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Blackwell S, 2007, EUR J CLIN INVEST, V37, P364, DOI 10.1111/j.1365-2362.2007.01798.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Borenstein M, 2009, INTRO META ANAL; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Deneva-Koycheva Tanya I, 2011, Folia Med (Plovdiv), V53, P28; Furuki K, 2008, HYPERTENS RES, V31, P1185, DOI 10.1291/hypres.31.1185; Horowitz JD, 2007, J CHROMATOGR B, V851, P42, DOI 10.1016/j.jchromb.2006.09.023; Hov GG, 2007, SCAND J CLIN LAB INV, V67, P868, DOI 10.1080/00365510701429836; Jin RC, 2010, J BLOOD MED, V1, P147; Kaushik Nitin, 2014, MLO Med Lab Obs, V46, P26; Korkmaz GG, 2013, METABOLISM, V62, P828, DOI 10.1016/j.metabol.2013.01.002; Leong T, 2008, ARTERIOSCL THROM VAS, V28, P961, DOI 10.1161/ATVBAHA.107.156596; Lu TM, 2003, EUR HEART J, V24, P1912, DOI 10.1016/j.ehj.2003.08.013; Martens-Lobenhoffer J, 2005, CLIN CHEM, V51, P2188, DOI 10.1373/clinchem.2005.056788; Owczarek D, 2010, INFLAMM BOWEL DIS, V16, P52, DOI 10.1002/ibd.20994; Riccioni G, 2014, INT J MOL SCI, V15, P6391, DOI 10.3390/ijms15046391; Sakyi AS, 2015, ANN MED HEALTH SCI R, V5, P8, DOI 10.4103/2141-9248.149763; Schnabel Renate, 2005, Circ Res, V97, pe53, DOI 10.1161/01.RES.0000181286.44222.61; Schulze F, 2004, CLIN CHEM LAB MED, V42, P1377, DOI 10.1515/CCLM.2004.257; Schulze F, 2005, EUR J CLIN INVEST, V35, P622, DOI 10.1111/j.1365-2362.2005.01561.x; Schulze F, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.005; Schwedhelm E, 2009, CLIN CHEM, V55, P1539, DOI 10.1373/clinchem.2009.124263; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Siroka R, 2007, J CHROMATOGR B, V850, P586, DOI 10.1016/j.jchromb.2006.12.009; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Sydow K, 2010, CLIN CHEM, V56, P111, DOI 10.1373/clinchem.2009.136200; Turkcuoglu I, 2011, GYNECOL ENDOCRINOL, V27, P609, DOI 10.3109/09513590.2010.507291; Vassiliadis E, 2012, BIOMARK INSIGHTS, V7, P45, DOI 10.4137/BMI.S9536; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Willeit P, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001833; Zincir S, 2014, PSYCHIAT RES, V220, P76, DOI 10.1016/j.psychres.2014.07.013	34	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177493	10.1371/journal.pone.0177493	http://dx.doi.org/10.1371/journal.pone.0177493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494019	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300122
J	Pols, TWH; Puchner, T; Korkmaz, HI; Vos, M; Soeters, MR; de Vries, CJM				Pols, Thijs W. H.; Puchner, Teresa; Korkmaz, H. Inci; Vos, Mariska; Soeters, Maarten R.; de Vries, Carlie J. M.			Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor	PLOS ONE			English	Article							BILE-ACIDS; TGR5; CELLS; ATHEROSCLEROSIS; EXPRESSION; INDUCE; ERK; DIFFERENTIATION; INFLAMMATION; MECHANISMS	Bile acids are established signaling molecules next to their role in the intestinal emulsification and uptake of lipids. We here aimed to identify a potential interaction between bile acids and CD4(+) Th cells, which are central in adaptive immune responses. We screened distinct bile acid species for their potency to affect T cell function. Primary human and mouse CD4+ Th cells as well as Jurkat T cells were used to gain insight into the mechanism underlying these effects. We found that unconjugated lithocholic acid (LCA) impedes Th1 activation as measured by i) decreased production of the Th1 cytokines IFN gamma. and TNF alpha alpha, ii) decreased expression of the Th1 genes T-box protein expressed in T cells (T-bet), Stat-1 and Stat4, and iii) decreased STAT1 alpha/beta phosphorylation. Importantly, we observed that LCA impairs Th1 activation at physiological relevant concentrations. Profiling of MAPK signaling pathways in Jurkat T cells uncovered an inhibition of ERK-1/2 phosphorylation upon LCA exposure, which could provide an explanation for the impaired Th1 activation. LCA induces these effects via Vitamin D receptor (VDR) signaling since VDR RNA silencing abrogated these effects. These data reveal for the first time that LCA controls adaptive immunity via inhibition of Th1 activation. Many factors influence LCA levels, including bile acid-based drugs and gut microbiota. Our data may suggest that these factors also impact on adaptive immunity via a yet unrecognized LCA-Th cell axis.	[Pols, Thijs W. H.; Puchner, Teresa; Korkmaz, H. Inci; Vos, Mariska; de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Soeters, Maarten R.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pols, TWH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.	Thijs.pols@amc.uva.nl			Netherlands Organization of Scientific Research [NWO VENI] [016.136.083]; Federation of European Biochemical Societies (FEBS); Dutch Diabetes Research Foundation	Netherlands Organization of Scientific Research [NWO VENI]; Federation of European Biochemical Societies (FEBS); Dutch Diabetes Research Foundation	TWHP was supported by a personal grant from the Netherlands Organization of Scientific Research [NWO VENI grant number 016.136.083] as well as by a Follow-up Research Fund from the Federation of European Biochemical Societies (FEBS). MRS was funded by the Dutch Diabetes Research Foundation.	ATTILI AF, 1986, MED HYPOTHESES, V19, P57, DOI 10.1016/0306-9877(86)90137-4; Cantorna MT, 2015, NUTRIENTS, V7, P3011, DOI 10.3390/nu7043011; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duboc H, 2012, HEPATOLOGY, V56, P2426, DOI 10.1002/hep.25839; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070667; Glicksman C, 2010, ANN CLIN BIOCHEM, V47, P482, DOI 10.1258/acb.2010.010040; Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Haselow K, 2013, J LEUKOCYTE BIOL, V94, P1253, DOI 10.1189/jlb.0812396; Hashimoto S, 1996, LIPIDS, V31, P601, DOI 10.1007/BF02523830; Hayes CE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00100; Hogenauer K, 2014, J MED CHEM, V57, P10343, DOI 10.1021/jm501052c; Ichikawa R, 2012, IMMUNOLOGY, V136, P153, DOI 10.1111/j.1365-2567.2012.03554.x; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Kongsbak M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00148; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Li N, 2010, J IMMUNOL, V185, P3041, DOI 10.4049/jimmunol.1000993; Lou GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093567; Ma HJ, 2014, BEST PRACT RES CL GA, V28, P573, DOI 10.1016/j.bpg.2014.07.004; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Mobraten K, 2015, J RECEPT SIG TRANSD, V35, P402, DOI 10.3109/10799893.2014.986744; O'Kelly J, 2002, J CLIN INVEST, V109, P1091, DOI 10.1172/JCI200212392; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Perino A, 2014, J CLIN INVEST, V124, P5424, DOI 10.1172/JCI76289; Pols TWH, 2014, BIOCHEM SOC T, V42, P244, DOI 10.1042/BST20130279; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yoneno K, 2013, IMMUNOLOGY, V139, P19, DOI 10.1111/imm.12045; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176715	10.1371/journal.pone.0176715	http://dx.doi.org/10.1371/journal.pone.0176715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493883	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300027
J	Rivera-Millot, A; Lesne, E; Solans, L; Coutte, L; Bertrand-Michel, J; Froguel, P; Dhennin, V; Hot, D; Locht, C; Antoine, R; Jacob-Dubuisson, F				Rivera-Millot, Alex; Lesne, Elodie; Solans, Luis; Coutte, Loic; Bertrand-Michel, Justine; Froguel, Philippe; Dhennin, Veronique; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise			Characterization of a Bvg-regulated fatty acid methyl-transferase in Bordetella pertussis	PLOS ONE			English	Article							FILAMENTOUS HEMAGGLUTININ; CRYSTAL-STRUCTURE; ADHESIN; REGULON; PROTEIN; METHYLTRANSFERASE; PHAGOCYTOSIS; PATHOGENESIS; PALMITATE; SEQUENCE	The whooping cough agent Bordetella pertussis controls the expression of its large virulence regulon in a coordinated manner through the two-component signal transduction system BvgAS. In addition to the genes coding for bona fide virulence factors, the Bvg regulon comprises genes of unknown function. In this work, we characterized a new Bvg-activated gene called BP2936. Homologs of BP2936 are found in other pathogenic Bordetellae and in several other species, including plant pathogens and environmental bacteria. We showed that the gene product of BP2936 is a membrane-associated methyl-transferase of free fatty acids. We thus propose to name it FmtB, for (f) under bar atty acid (m) under bar ethyl-(t) under bar ransferase of (B) under bar ordetella. The role of this protein was tested in cellular and animal models of infection, but the loss of BP2936 did not appear to affect host-pathogen interactions in those assays. The high level of conservation of BP2936 among B. pertussis isolates nevertheless argues that it probably plays a role in the life cycle of this pathogen.	[Rivera-Millot, Alex; Lesne, Elodie; Solans, Luis; Coutte, Loic; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Univ Lille, CNRS, INSERM, CHU Lille,Inst Pasteur Lille,U1019,UMR 8204,CIIL, Lille, France; [Bertrand-Michel, Justine] INSERM, U1048, MetaboHUB MetaToul Lipid Core Facil, Toulouse, France; [Froguel, Philippe; Dhennin, Veronique] Univ Lille, CNRS, Inst Pasteur Lille, UMR 8199,European Genom Inst Diabet, Lille, France; [Froguel, Philippe] Imperial Coll London, Dept Genom Common Dis, Sch Publ Hlth, Hammersmith Hosp, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London	Antoine, R; Jacob-Dubuisson, F (corresponding author), Univ Lille, CNRS, INSERM, CHU Lille,Inst Pasteur Lille,U1019,UMR 8204,CIIL, Lille, France.	rudy.antoine@pasteur-lille.fr; francoise.jacob@ibl.cnrs.fr	Antoine, Rudy/CAH-6653-2022; Rivera-Millot, Alex/P-6776-2019; coutte, loic/B-2566-2019; Jacob-Dubuisson, Françoise/F-1610-2018; Locht, Camille/L-3516-2018; FROGUEL, Philippe/O-6799-2017; Antoine, Rudy/L-1630-2018; Coutte, Loïc/G-4379-2012; Rivera-Millot, Alex/AAA-9668-2021; Hot, David/M-6775-2016	Antoine, Rudy/0000-0002-7369-0626; Rivera-Millot, Alex/0000-0001-8431-5509; coutte, loic/0000-0002-8626-8109; Jacob-Dubuisson, Françoise/0000-0002-5102-1704; FROGUEL, Philippe/0000-0003-2972-0784; Antoine, Rudy/0000-0002-7369-0626; Coutte, Loïc/0000-0002-8626-8109; Solans, Luis/0000-0002-5841-4754; Hot, David/0000-0002-2361-0616; Locht, Camille/0000-0001-7295-7336	laboratory (INSERM, Lille University); LIGAN-PM Genomics platform (Lille, France) [UMR 8199]; European Genomics Institute for Diabetes [ANR-10-LABX-46]; ANR Equipex session [ANR-10-EQPX-07-01]; FEDER; Region Nord-Pas-de-Calais-Picardie	laboratory (INSERM, Lille University); LIGAN-PM Genomics platform (Lille, France); European Genomics Institute for Diabetes; ANR Equipex session(French National Research Agency (ANR)); FEDER(European Commission); Region Nord-Pas-de-Calais-Picardie(Region Hauts-de-France)	This work was supported by the recurrent funding of our laboratory (INSERM, Lille University). We also acknowledge the participation of the UMR 8199 LIGAN-PM Genomics platform (Lille, France), which belongs to the 'Federation de Recherche' 3508 Labex EGID (European Genomics Institute for Diabetes; ANR-10-LABX-46) and was supported by the ANR Equipex 2010 session (ANR-10-EQPX-07-01; 'LIGAN-PM'). The LIGAN-PM Genomics platform (Lille, France) is also supported by the FEDER and the Region Nord-Pas-de-Calais-Picardie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2011, J BACTERIOL, V193, P3473, DOI 10.1128/JB.01539-10; Alonso S, 2001, INFECT IMMUN, V69, P6038, DOI 10.1128/IAI.69.10.6038-6043.2001; ANTOINE R, 1990, INFECT IMMUN, V58, P1518, DOI 10.1128/IAI.58.6.1518-1526.1990; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cai P, 2005, TOXICOLOGY, V210, P197, DOI 10.1016/j.tox.2005.02.001; Chatterjee T, 2015, ARCH BIOCHEM BIOPHYS, V583, P140, DOI 10.1016/j.abb.2015.08.001; Coote JG, 2001, ADV MICROB PHYSIOL, V44, P141, DOI 10.1016/S0065-2911(01)44013-6; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; Coutte L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32774; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Danne L, 2015, MOL MICROBIOL, V95, P313, DOI 10.1111/mmi.12870; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; EFTIMIADI C, 1990, J INFECT DIS, V161, P138, DOI 10.1093/infdis/161.1.138; Frohlich BT, 1996, J BIOTECHNOL, V45, P137, DOI 10.1016/0168-1656(95)00155-7; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Im HN, 2016, J STRUCT BIOL, V193, P172, DOI 10.1016/j.jsb.2016.01.002; Jacob-Dubuisson F, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P57; KAWAI Y, 1982, J BACTERIOL, V151, P996, DOI 10.1128/JB.151.2.996-1005.1982; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Kumar V, 2011, J STRUCT BIOL, V176, P409, DOI 10.1016/j.jsb.2011.08.007; Lamberti Y, 2016, J PROTEOMICS, V136, P55, DOI 10.1016/j.jprot.2016.02.002; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; Locht C, 2001, CURR OPIN MICROBIOL, V4, P82, DOI 10.1016/S1369-5274(00)00169-7; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; MENOZZI FD, 1994, INFECT IMMUN, V62, P769, DOI 10.1128/IAI.62.3.769-778.1994; Nakamura MM, 2006, INFECT IMMUN, V74, P5537, DOI 10.1128/IAI.00781-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; PORTER JF, 1991, APPL ENVIRON MICROB, V57, P1202, DOI 10.1128/AEM.57.4.1202-1206.1991; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Sarkar S, 2006, J BIOCHEM MOL TOXIC, V20, P302, DOI 10.1002/jbt.20150; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; STIBITZ S, 1994, METHOD ENZYMOL, V235, P458; Stibitz S, 2007, BORDETELLA MOL MICRO, P47; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; THIELE O W, 1973, European Journal of Biochemistry, V34, P333, DOI 10.1111/j.1432-1033.1973.tb02764.x; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; Vandebriel RJ, 2003, MICROB PATHOGENESIS, V35, P19, DOI 10.1016/S0882-4010(03)00087-1; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Williamson YM, 2012, J MICROBIOL METH, V90, P119, DOI 10.1016/j.mimet.2012.04.007	50	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176396	10.1371/journal.pone.0176396	http://dx.doi.org/10.1371/journal.pone.0176396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493897	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300014
J	Rojas, SV; Kensah, G; Rotaermel, A; Baraki, H; Kutschka, I; Zweigerdt, R; Martin, U; Haverich, A; Gruh, I; Martens, A				Rojas, Sebastian V.; Kensah, George; Rotaermel, Alexander; Baraki, Hassina; Kutschka, Ingo; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Gruh, Ina; Martens, Andreas			Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; VENTRICULAR ASSIST DEVICE; MOUSE MODEL; HEART; DIFFERENTIATION; GENERATION; THERAPY; SURVIVAL; MURINE; REPAIR	Background Induced pluripotent stem cells (iPSC) can be differentiated into cardiomyocytes and represent a possible autologous cell source for myocardial repair. We analyzed the engraftment and functional effects of murine iPSC-derived cardiomyocytes (iPSC-CMs) in a murine model of myocardial infarction. Methods and results To maximize cardiomyocyte yield and purity a genetic purification protocol was applied. Murine iPSCs were genetically modified to express a Zeocin T resistance gene under control of the cardiac-specific a-myosin heavy chain (alpha-MHC, MYH6) promoter. Thus, CM selection was performed during in vitro differentiation. iPSC-CM aggregates ("cardiac bodies ", CBs) were transplanted on day 14 after LAD ligation into the hearts of previously LADligated mice (800 CBs/animal; 2-3x10(6) CMs). Animals were treated with placebo (PBS, n = 14) or iPSC-CMs (n = 35). Myocardial remodeling and function were evaluated by magnetic resonance imaging (MRI), conductance catheter (CC) analysis and histological morphometry. In vitro and in vivo differentiation was investigated. Follow up was 28 days (including histological assessment and functional analysis). iPSC-CM purity was >99%. Transplanted iPSC-CMs formed mature grafts within the myocardium, expressed cardiac markers and exhibited sarcomeric structures. Intramyocardial transplantation of iPSC-CMs significantly improved myocardial remodeling and left ventricular function 28 days after LAD-ligation. Conclusions We conclude that iPSCs can effectively be differentiated into cardiomyocytes and genetically enriched to high purity. iPSC derived cardiomyocytes engraft within the myocardium of LAD-ligated mice and contribute to improve left ventricular function.	[Rojas, Sebastian V.; Kensah, George; Rotaermel, Alexander; Baraki, Hassina; Kutschka, Ingo; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Gruh, Ina; Martens, Andreas] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Hannover, Germany; [Rojas, Sebastian V.; Kensah, George; Rotaermel, Alexander; Baraki, Hassina; Kutschka, Ingo; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Gruh, Ina; Martens, Andreas] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Rojas, Sebastian V.; Kensah, George; Rotaermel, Alexander; Baraki, Hassina; Kutschka, Ingo; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Gruh, Ina; Martens, Andreas] Hannover Med Sch, REBIRTH Cluster Excellence, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Rojas, SV (corresponding author), Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Hannover, Germany.; Rojas, SV (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany.; Rojas, SV (corresponding author), Hannover Med Sch, REBIRTH Cluster Excellence, Hannover, Germany.	Rojas.Sebastian@mh-hannover.de	Haverich, Axel/AAC-7552-2022; Martin, Ulrich/F-4888-2017; Rojas, Sebastian V/AFR-1536-2022; Martens, Andreas/AAG-2746-2020	Martin, Ulrich/0000-0003-1058-4540; Rojas, Sebastian V/0000-0002-9505-1358; Martens, Andreas/0000-0002-7953-2645	German Research Foundation [KU 2752/2-1]; Federal Ministry of Education and Research [RTC, University of Rostock, Germany] [01GN0958, 01E00802]; CORTISS Foundation (Heinz and lngeburg Wille Trust); REBIRTH Cluster of Excellence [DFG EXC 62/1, DFG EXC 62/2]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research [RTC, University of Rostock, Germany]; CORTISS Foundation (Heinz and lngeburg Wille Trust); REBIRTH Cluster of Excellence	This work was supported by the German Research Foundation [KU 2752/2-1; grant to AM, RZ, UM, IK], the Federal Ministry of Education and Research [RTC, University of Rostock, Germany, 01GN0958, grant to AM, IK, AH; IFB-TX, 01E00802, grant to AM, IK, IG], the CORTISS Foundation (Heinz and lngeburg Wille Trust, grant to IG) and the REBIRTH Cluster of Excellence (DFG EXC 62/1, 62/2).	Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Carpenter L, 2012, STEM CELLS DEV, V21, P977, DOI 10.1089/scd.2011.0075; Cheng YT, 2015, INT J CARDIOL, V201, P441, DOI 10.1016/j.ijcard.2015.08.118; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Kensah G, 2013, EUR HEART J, V34, P1134, DOI 10.1093/eurheartj/ehs349; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Logan SJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0471-z; Ma J, 2011, AM J PHYSIOL-HEART C, pH2006; Marban E, 2010, CIRCULATION, V121, P1981, DOI 10.1161/CIRCULATIONAHA.110.952580; Martens A, 2014, ARTIF ORGANS, V38, P978, DOI 10.1111/aor.12268; Martens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101775; Martens A, 2011, CYTOTHERAPY, V13, P864, DOI 10.3109/14653249.2011.571247; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Mollmann H, 2009, HEART, V95, P508, DOI 10.1136/hrt.2007.125054; Moon SH, 2013, INT J CARDIOL, V168, P41, DOI 10.1016/j.ijcard.2012.09.077; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Nsair A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045603; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olmer R, 2012, TISSUE ENG PART C-ME, V18, P772, DOI 10.1089/ten.tec.2011.0717; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Rojas SV, 2015, MINERVA CHIR, V70, P63; Rojas SV, 2015, TISSUE ENG PT A, V21, P1991, DOI [10.1089/ten.tea.2014.0537, 10.1089/ten.TEA.2014.0537]; Rojas SV, 2015, ARTIF ORGANS, V39, P473, DOI 10.1111/aor.12422; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; So KH, 2011, INT J CARDIOL, V153, P277, DOI 10.1016/j.ijcard.2010.08.052; Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016; Strueber M, 2011, J AM COLL CARDIOL, V57, P1375, DOI 10.1016/j.jacc.2010.10.040; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Uribarri A, 2015, INT J CARDIOL, V197, P128, DOI 10.1016/j.ijcard.2015.04.046; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; van Laake LW, 2010, CIRC RES, V107, P340, DOI 10.1161/CIRCRESAHA.109.215434; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Xu XQ, 2009, STEM CELLS, V27, P2163, DOI 10.1002/stem.166; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zweigerdt R, 2007, SEMIN CELL DEV BIOL, V18, P794, DOI 10.1016/j.semcdb.2007.09.014; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318; Zwi-Dantsis L, 2012, CELL MOL LIFE SCI, V69, P3285, DOI 10.1007/s00018-012-1078-2	47	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0173222	10.1371/journal.pone.0173222	http://dx.doi.org/10.1371/journal.pone.0173222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493867	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300003
J	Wang, D; Li, QP; Gong, YH; Yuan, Y				Wang, Dan; Li, Qiuping; Gong, Yuehua; Yuan, Yuan			The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: A meta-analysis	PLOS ONE			English	Article							VIRULENCE FACTORS; PEPTIC-ULCER; TREATMENT FAILURE; CONTROLLED-TRIAL; GASTRIC-CANCER; TRIPLE THERAPY; RESISTANCE; EFFICACY; STRAINS; MUTATIONS	Background H. pylori virulence factors, especially vacA and cagA are important in gastroduodenal disease pathogenesis and affect cure rates. This meta-analysis aimed to clarify the association between vacA or cagA status and eradication outcome of H. pylori infection. Methods A literature search was performed using electronic databases to identify studies. Twenty-six prospective studies were determined eligible. Meta-analytical techniques were conducted to calculate eradication rates and pooled relative ratios (RR). Results The eradication rate was greater approximately 10% in vacA s1 compared with vacA s2 infected patients, and the pooled RR was 1.164 (95% CI: 1.040-1.303, P = 0.008). A significant association existed between vacA s1 and higher eradication rates in Europe (RR: 1.203, 95% CI: 1.003-1.442, P = 0.046) and Asia (RR: 1.187, 95% CI: 1.028-1.371, P = 0.020), in triple therapy patients (RR: 1.175, 95% CI: 1.012-1.365, P = 0.035). Eradication rates were similar for vacA m1 and m2 genotypes (RR: 0.981, 95% CI: 0.891-1.080, P = 0.690), whereas they were higher by approximately 8% in cagA-positive compared with cagA-negative infected patients, with a pooled RR of 1.094 (95% CI: 1.025-1.168, P = 0.007). A significant association existed between cagA-positive and increased eradication rates in Europe (RR: 1.138, 95% CI: 1.000-1.295, P = 0.049) and Asia (RR: 1.118, 95% CI: 1.051-1.190, P<0.001), in using PCR (RR: 1.232, 95% CI: 1.142-1.329, P<0.001) and protein chips (RR: 1.200, 95% CI: 1.060-1.359, P = 0.004), in triple therapy patients (RR: 1.090, 95% CI: 1.006-1.181, P = 0.034). Conclusions Evidence indicates that infection with vacA s1, cagA-positive strains, but not vacA s2, cagA-negative, is more conducive to H. pylori eradication.	[Gong, Yuehua; Yuan, Yuan] China Med Univ, Tumor Etiol & Screening Dept, Canc Inst, Affiliated Hosp 1, Shenyang, Peoples R China; China Med Univ, Affiliated Hosp 1, Gen Surg, Shenyang, Peoples R China; China Med Univ, Key Lab Canc Etiol & Prevent, Liaoning Prov Educ Dept, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Gong, YH; Yuan, Y (corresponding author), China Med Univ, Tumor Etiol & Screening Dept, Canc Inst, Affiliated Hosp 1, Shenyang, Peoples R China.	yhgong@cmu.edu.cn; yuanyuan@cmu.edu.cn	Yuan, Yuan/GVS-5120-2022					Baryshnikova NV, 2012, HELICOBACTER, V17, P105; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boyanova L, 2016, MICROB DRUG RESIST, V22, P227, DOI 10.1089/mdr.2015.0199; Broutet N, 2001, J CLIN MICROBIOL, V39, P1319, DOI 10.1128/JCM.39.4.1319-1322.2001; Cen C, 2009, GUANG XI MED J, V01; Chaudhuri S, 2003, J GASTROEN HEPATOL, V18, P190, DOI 10.1046/j.1440-1746.2003.02944.x; Cui MH, 2013, CHINESE GEN PRACTICE, V08; De Francesco V, 2004, ALIMENT PHARM THER, V19, P407, DOI 10.1046/j.1365-2036.2004.01818.x; De Francesco V, 2002, AM J GASTROENTEROL, V97, P2686, DOI 10.1016/S0002-9270(02)04420-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Greenberg PD, 1999, ARCH INTERN MED, V159, P2283, DOI 10.1001/archinte.159.19.2283; Hajimahmoodi M, 2011, NAT PROD RES, V25, P1059, DOI 10.1080/14786419.2010.501763; He CY, 2014, MUTAT RES-REV MUTAT, V759, P14, DOI 10.1016/j.mrrev.2013.09.002; [何兴祥 He Xingxiang], 2002, [中国抗生素杂志, Chinese Journal of Antibiotics], V27, P427; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang YN, 2012, CLIN OBSERVATION ECA; Kim IJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00037; Lerro P, 2000, ACTA PAEDIAT, V89; Liu JW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-555; Lopez-Brea M, 1999, FEMS IMMUNOL MED MIC, V24, P183, DOI 10.1016/S0928-8244(99)00024-3; Magalhaes A F Novaes de, 2005, Gastroenterol Hepatol, V28, P441; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mao HV, 2000, ALIMENT PHARM THER, V14, P97; Niu S, 2014, CHINESE J PRACT MED, V2; Queiroz DMM, 2002, J CLIN GASTROENTEROL, V35, P315, DOI 10.1097/00004836-200210000-00007; Rudi J, 2002, DIGESTION, V65, P11, DOI 10.1159/000051925; Russo F, 2003, ALIMENT PHARM THER, V17, P421, DOI 10.1046/j.1365-2036.2003.01443.x; Saruc M, 2001, BRAZ J MED BIOL RES, V34, P1435, DOI 10.1590/S0100-879X2001001100010; Scholte GHA, 2002, AM J GASTROENTEROL, V97, P1687, DOI 10.1111/j.1572-0241.2002.05775.x; Shiota S, 2012, J CLIN GASTROENTEROL, V46, P297, DOI 10.1097/MCG.0b013e318243201c; Spiller RC, 1999, EUR J GASTROEN HEPAT, V11, pS25; Spiller RC, 1999, EUR J GASTROEN HEPAT, V11, pS43; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sugimoto M, 2009, EUR J CLIN MICROBIOL, V28, P1227, DOI 10.1007/s10096-009-0772-y; Suzuki T, 2006, ALIMENT PHARM THER, V24, P273, DOI 10.1111/j.1365-2036.2006.02994.x; Take S, 2015, J GASTROENTEROL, V50, P638, DOI 10.1007/s00535-014-1004-5; Treiber G, 2002, ARCH INTERN MED, V162, P153, DOI 10.1001/archinte.162.2.153; Uotani T, 2015, EXPERT OPIN THER TAR, V19, P1637, DOI 10.1517/14728222.2015.1073261; van Doorn LJ, 2000, GUT, V46, P321, DOI 10.1136/gut.46.3.321; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; van Doorn LJ, 2001, ANTIMICROB AGENTS CH, V45, P1500, DOI 10.1128/AAC.45.5.1500-1504.2001; vanderHulst RWM, 1997, GASTROENTEROLOGY, V113, P25, DOI 10.1016/S0016-5085(97)70076-3; Wu J, 2012, CLIN FOCUS, V19; Xia HHX, 2003, ALIMENT PHARM THER, V17, P935, DOI 10.1046/j.1365-2036.2003.01525.x; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Zhao JJ, 2007, J GASTROEN HEPATOL, V22, P2251, DOI 10.1111/j.1440-1746.2007.04836.x	47	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177455	10.1371/journal.pone.0177455	http://dx.doi.org/10.1371/journal.pone.0177455			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493953	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300114
J	Wegrzyn, M; Vogt, M; Kireclioglu, B; Schneider, J; Kissler, J				Wegrzyn, Martin; Vogt, Maria; Kireclioglu, Berna; Schneider, Julia; Kissler, Johanna			Mapping the emotional face. How individual face parts contribute to successful emotion recognition	PLOS ONE			English	Article							FACIAL EXPRESSIONS; NORMAL ADULTS; REPRESENTATION; EYES	Which facial features allow human observers to successfully recognize expressions of emotion? While the eyes and mouth have been frequently shown to be of high importance, research on facial action units has made more precise predictions about the areas involved in displaying each emotion. The present research investigated on a fine-grained level, which physical features are most relied on when decoding facial expressions. In the experiment, individual faces expressing the basic emotions according to Ekman were hidden behind a mask of 48 tiles, which was sequentially uncovered. Participants were instructed to stop the sequence as soon as they recognized the facial expression and assign it the correct label. For each part of the face, its contribution to successful recognition was computed, allowing to visualize the importance of different face areas for each expression. Overall, observers were mostly relying on the eye and mouth regions when successfully recognizing an emotion. Furthermore, the difference in the importance of eyes and mouth allowed to group the expressions in a continuous space, ranging from sadness and fear (reliance on the eyes) to disgust and happiness (mouth). The face parts with highest diagnostic value for expression identification were typically located in areas corresponding to action units from the facial action coding system. A similarity analysis of the usefulness of different face parts for expression recognition demonstrated that faces cluster according to the emotion they express, rather than by low-level physical features. Also, expressions relying more on the eyes or mouth region were in close proximity in the constructed similarity space. These analyses help to better understand how human observers process expressions of emotion, by delineating the mapping from facial features to psychological representation.	[Wegrzyn, Martin; Vogt, Maria; Kireclioglu, Berna; Schneider, Julia; Kissler, Johanna] Bielefeld Univ, Dept Psychol, Bielefeld, Germany; [Wegrzyn, Martin; Kissler, Johanna] Bielefeld Univ, Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Wegrzyn, M (corresponding author), Bielefeld Univ, Dept Psychol, Bielefeld, Germany.; Wegrzyn, M (corresponding author), Bielefeld Univ, Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany.	martin.wegrzyn@uni-bielefeld.de	Kissler, Johanna/B-7361-2019	Kissler, Johanna/0000-0002-4567-1997	Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence 277 "Cognitive Interaction Technology"	Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence 277 "Cognitive Interaction Technology"(German Research Foundation (DFG))	Research was funded by the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de), Cluster of Excellence 277 "Cognitive Interaction Technology". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Edelman S, 1998, BEHAV BRAIN SCI, V21, P449, DOI 10.1017/S0140525X98001253; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Ekman P., 2002, MANUAL INVESTIGATORS; Feng R, 2013, P 21 ACM INT C MULT, P793; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Jack RE, 2015, CURR BIOL, V25, pR621, DOI 10.1016/j.cub.2015.05.052; Kontsevich LL, 2004, VISION RES, V44, P1493, DOI 10.1016/j.visres.2003.11.027; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Matsumoto D., 2008, SCHOLARPEDIA, V3, P4237, DOI [10.4249/scholarpedia.4237, DOI 10.4249/SCHOLARPEDIA.4237]; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plutchik R.E., 1997, CIRCUMPLEX MODELS PE; Pochedly JT, 2012, EMOTION, V12, P1315, DOI 10.1037/a0027998; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Taigman Y, 2014, PROC CVPR IEEE, P1701, DOI 10.1109/CVPR.2014.220; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vinyals O, 2015, PROC CVPR IEEE, P3156, DOI 10.1109/CVPR.2015.7298935; Wegrzyn M, 2015, CORTEX, V69, P131, DOI 10.1016/j.cortex.2015.05.003	38	144	145	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177239	10.1371/journal.pone.0177239	http://dx.doi.org/10.1371/journal.pone.0177239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493921	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300077
J	Lakatos, E; Salehi-Reyhani, A; Barclay, M; Stumpf, MPH; Klug, DR				Lakatos, Eszter; Salehi-Reyhani, Ali; Barclay, Michael; Stumpf, Michael P. H.; Klug, David R.			Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; PHOSPHORYLATION; EXPRESSION; MDM2; QUANTIFICATION	We determine p53 protein abundances and cell to cell variation in two human cancer cell lines with single cell resolution, and show that the fractional width of the distributions is the same in both cases despite a large difference in average protein copy number. We developed a computational framework to identify dominant mechanisms controlling the variation of protein abundance in a simple model of gene expression from the summary statistics of single cell steady state protein expression distributions. Our results, based on single cell data analysed in a Bayesian framework, lends strong support to a model in which variation in the basal p53 protein abundance may be best explained by variations in the rate of p53 protein degradation. This is supported by measurements of the relative average levels of mRNA which are very similar despite large variation in the level of protein.	[Lakatos, Eszter; Stumpf, Michael P. H.] Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London, England; [Salehi-Reyhani, Ali; Barclay, Michael; Klug, David R.] Imperial Coll London, Dept Chem, Inst Chem Biol, London, England	Imperial College London; Imperial College London	Salehi-Reyhani, A (corresponding author), Imperial Coll London, Dept Chem, Inst Chem Biol, London, England.	ali.salehi-reyhani@imperial.ac.uk	Klug, David R/F-3357-2011	Klug, David R/0000-0001-9301-1654; Salehi-Reyhani, Ali/0000-0002-1084-2012; Lakatos, Eszter/0000-0002-7221-6850	UK Engineering and Physical Sciences Research Council [EP/1017887/1]; Imperial College London Junior Research Fellowship; Schrodinger Scholarship; Imperial College London; Engineering and Physical Sciences Research Council [1232251, EP/I017887/1] Funding Source: researchfish; EPSRC [EP/I017887/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Imperial College London Junior Research Fellowship; Schrodinger Scholarship; Imperial College London(General Electric); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the UK Engineering and Physical Sciences Research Council [grant number EP/1017887/1]; Imperial College London Junior Research Fellowship to ASR; and the Schrodinger Scholarship to EL. Funding for open access charge: Imperial College London.	Ananiev J., 2011, Acta Medica Bulgarica, V38, P72; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Burgin E, 2014, ANALYST, V139, P3235, DOI 10.1039/c4an00091a; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Fox JG, 2002, CANCER RES, V62, P696; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gilkes DM, 2007, CELL CYCLE, V6, P151, DOI 10.4161/cc.6.2.3719; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jingyi JL, 2015, AM ASSOC ADV SCI PUB, V347, P1066; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lenive O, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0324-x; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Li XL, 2015, WORLD J GASTROENTERO, V21, P84, DOI 10.3748/wjg.v21.i1.84; Liepe J, 2010, BIOINFORMATICS, V26, P1797, DOI 10.1093/bioinformatics/btq278; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Moll UM, 2003, MOL CANCER RES, V1, P1001; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Poyurovsky MV, 2006, GENE DEV, V20, P125, DOI 10.1101/gad.1397506; Salehi-Reyhani A, 2011, LAB CHIP, V11, P1256, DOI [10.1039/c0lc00613k, 10.1039/c01c00613k]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Stadler C, 2010, J PROTEOMICS, V73, P1067, DOI 10.1016/j.jprot.2009.10.012; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Wilkinson D.J., 2012, STOCHASTIC MODELLING; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhou YX, 2011, BIOINFORMATICS, V27, P874, DOI 10.1093/bioinformatics/btr015	38	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177336	10.1371/journal.pone.0177336	http://dx.doi.org/10.1371/journal.pone.0177336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489927	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100064
J	Liu, ZY; He, KW; Ma, QH; Yu, Q; Liu, CY; Ndege, I; Wang, XZ; Yu, ZY				Liu, Zhaoyun; He, Kewen; Ma, Qinghua; Yu, Qian; Liu, Chenyu; Ndege, Isabella; Wang, Xinzhao; Yu, Zhiyong			Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; TYROSINE KINASE INHIBITOR; OXYGEN SPECIES ROS; ENHANCED AUTOPHAGY; CYCLE ARREST; EGFR; GROWTH; RESISTANCE; SURVIVAL; FAMILY	Epidermal growth factor receptor (EGFR) is over-expressed in about 50% of Triple negative breast cancers (TNBCs), but EGFR inhibitors have not been effective in treating TNBC patients. Increasing evidence supports that autophagy was related to drug resistance at present. However, the role and the mechanism of autophagy to the treatment of TNBC remain unknown. In the current study, we investigated the effect of autophagy inhibitor to gefitinib (Ge) in TNBC cells in vitro and in nude mice vivo. Our study demonstrated that inhibition of autophagy by 3-Methyladenine or bafilomycin A1 improved Ge's sensitivity to MDA-MB-231 and MDA-MB-468 cells, as evidence from stronger inhibition of cell vitality and colony formation, higher level of G0/G1 arrest and DNA damage, and these effects were verified in nude mice vivo. Our data showed that the mitochondrial-dependent apoptosis pathway was activated in favor of promoting apoptosis in the therapy of Ge combined autophagy inhibitor, as the elevation of BAX/Bcl-2, Cytochrome C, and CASP3. These results demonstrated that targeting autophagy should be considered as an effective therapeutic strategy to enhance the sensitivity of EGFR inhibitors on TNBC.	[Liu, Zhaoyun; He, Kewen; Ndege, Isabella] Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Shandong, Peoples R China; [Liu, Zhaoyun; He, Kewen; Ma, Qinghua; Ndege, Isabella; Wang, Xinzhao; Yu, Zhiyong] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Dept Oncol, Jinan, Shandong, Peoples R China; [Yu, Qian] Univ Kentucky, Coll Med, Lexington, KY USA; [Liu, Chenyu] Emory Univ, Dept Biol, Winship Canc Inst, Atlanta, GA 30322 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan; University of Kentucky; Emory University	Yu, ZY (corresponding author), Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Dept Oncol, Jinan, Shandong, Peoples R China.	drzhiyongyu@aliyun.com			Natural Science Foundation of Shandong Province [ZR2015HM055]; key research and development plan of Shandong Province [2016GSF201185]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); key research and development plan of Shandong Province	The reagents were supported by the Grants from the Natural Science Foundation of Shandong Province (ZR2015HM055). The URL is http://jihIx.sdste.gov.cn/STDPMS/ZR/ ProjectAppitcation/MyProjectList.aspx, and ZYY received the funding; Laboratory supplies was supported by the Grants from the key research and development plan of Shandong Province (2016GSF201185). The URL is http://jihIx.sdstc. gov.cniSTDPMS/GG/ProtectApplication/MyProjectList.aspx, and ZYY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anido J, 2003, CLIN CANCER RES, V9, P1274; Bao PP, 2015, EPIDEMIOLOGY, V26, P909, DOI 10.1097/EDE.0000000000000373; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Bellizzi A, 2015, INT J ONCOL, V46, P1214, DOI 10.3892/ijo.2014.2805; Chen M, 2014, INT J MOL MED, V34, P276, DOI 10.3892/ijmm.2014.1772; Cufi S, 2012, ONCOTARGET, V3, P1600; Dragowska WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076503; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; He JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129842; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Hsin-Ling Y, 2016, INT J MOL SCI, V17; Huang J, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.22; Huang SW, 2013, TOXICOL APPL PHARM, V267, P113, DOI 10.1016/j.taap.2012.12.016; Janmaat ML, 2003, ONCOLOGIST, V8, P576, DOI 10.1634/theoncologist.8-6-576; Jeong Chul-Ho, 2016, J Cancer Prev, V21, P13, DOI 10.15430/JCP.2016.21.1.13; Kang M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020321; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Kavitha N, 2017, J ETHNOPHARMACOL, V201, P42, DOI 10.1016/j.jep.2017.02.041; Kim SJ, 2015, INT J MOL SCI, V16, P21486, DOI 10.3390/ijms160921486; Lee JG, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0285-4; Li M, 2016, INT J MOL SCI, V17; Li YY, 2013, LUNG CANCER, V81, P354, DOI 10.1016/j.lungcan.2013.05.012; Liu DL, 2014, J FORMOS MED ASSOC, V113, P141, DOI 10.1016/j.jfma.2012.10.017; Liu TR, 2011, MOL CANCER THER, V10, P1460, DOI 10.1158/1535-7163.MCT-10-0925; Masui A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162786; Moulder SL, 2001, CANCER RES, V61, P8887; Mukai S, 2016, INT J ONCOL, V48, P45, DOI 10.3892/ijo.2015.3237; Pawlowska E, 2015, INT J MOL SCI, V16, P27535, DOI 10.3390/ijms161126049; Renault TT, 2014, J BIOL CHEM, V289, P26481, DOI 10.1074/jbc.M114.569632; Ribback S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101618; Sakuma Y, 2013, LAB INVEST, V93, P1137, DOI 10.1038/labinvest.2013.102; Schointuch MN, 2014, GYNECOL ONCOL, V134, P346, DOI 10.1016/j.ygyno.2014.05.015; Sharma K, 2014, AUTOPHAGY, V10, P2346, DOI 10.4161/15548627.2014.993283; Shen H, 2017, ONCOL RES; Shi YG, 2006, CURR OPIN CELL BIOL, V18, P677, DOI 10.1016/j.ceb.2006.09.006; Sickmier EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163366; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Smith PM, 2016, F1000RESEARCH, V5; Sobhakumari A, 2013, TOXICOL APPL PHARM, V272, P736, DOI 10.1016/j.taap.2013.07.013; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Sugita S, 2015, BIOCHEM BIOPH RES CO, V461, P28, DOI 10.1016/j.bbrc.2015.03.162; Sui XB, 2014, MOL CLIN ONCOL, V2, P8, DOI 10.3892/mco.2013.187; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tang MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119135; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tricarico PM, 2015, INT J MOL SCI, V16, P16067, DOI 10.3390/ijms160716067; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Wang XD, 2001, GENE DEV, V15, P2922; Williams CB, 2015, ADV CANCER RES, V127, P253, DOI 10.1016/bs.acr.2015.04.008; Xie L, 2016, ONCOTARGET, V7, P1651, DOI 10.18632/oncotarget.6410; Xu H, 2005, MOL CANCER THER, V4, P435; Yang ZY, 2015, CURR CANCER DRUG TAR, V15, P215, DOI 10.2174/1568009615666150126161939; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang LH, 2016, APOPTOSIS, V21, P473, DOI 10.1007/s10495-016-1214-9; Zhu YX, 2016, CELL PHYSIOL BIOCHEM, V40, P297, DOI 10.1159/000452546; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	58	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177694	10.1371/journal.pone.0177694	http://dx.doi.org/10.1371/journal.pone.0177694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531218	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058400025
J	Nordmann, S; Vilotitch, A; Lions, C; Michel, L; Mora, M; Spire, B; Maradan, G; Bendiane, MK; Morel, A; Roux, P; Carrieri, P				Nordmann, Sandra; Vilotitch, Antoine; Lions, Caroline; Michel, Laurent; Mora, Marion; Spire, Bruno; Maradan, Gwenaelle; Bendiane, Marc-Karim; Morel, Alain; Roux, Perrine; Carrieri, Patrizia		ANRS Methaville Study Gp	Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial)	PLOS ONE			English	Article							USE DISORDER PATIENTS; SELF-REPORT SCALE; MAINTENANCE TREATMENT; SUBSTANCE USE; CANCER PAIN; DEPENDENT PATIENTS; PERSISTENT PAIN; FRENCH VERSION; PRIMARY-CARE; ADULT ADHD	Background Pain in opioid-dependent patients is common but data measuring the course of pain (and its correlates) using validated scales in patients initiating methadone treatment are sparse. We aimed to assess pain and its interference in daily life, associated correlates, and undertreatment before and during methadone treatment. Methods This is a secondary analysis using longitudinal data of a randomized trial comparing two methadone initiation models. We assessed the effect of methadone initiation and other correlates on pain intensity and interference (using the Brief Pain Inventory) at months 0, 6 and 12 using a mixed multinomial logistic regression model. Results The study group comprised 168 patients who had data for either pain intensity or interference for at least one visit. Moderate to severe pain was reported in 12.9% of patients at M0, 5.4% at M6 and 7.3% at M12. Substantial interference with daily functioning was reported in 36.0% at M0, 14.5% at M6 and 17.1% at M12. Of the 98 visits where patients reported moderate to severe pain or substantial interference, 55.1% reported no treatment for pain relief, non-opioid analgesics were reported by 34.7%, opioid analgesics by 3.1% and both opioid and non-opioid analgesics by 7.1%. Methadone was associated with decreased pain intensity at 6 months (OR = 0.29, p = 0.04) and 12 months (OR = 0.30, p = 0.05) of follow-up and tended to be associated with substantial pain interference. Suicide risk was associated with both pain intensity and pain interference. Conclusions Methadone in opioid-dependent patients can reduce pain. However, undertreatment of pain in methadone patients remains a major clinical concern. Patients with pain are at higher risk of suicide. Adequate screening and management of pain in this population is a priority and needs to be integrated into routine comprehensive care.	[Nordmann, Sandra; Vilotitch, Antoine; Lions, Caroline; Mora, Marion; Spire, Bruno; Maradan, Gwenaelle; Bendiane, Marc-Karim; Roux, Perrine; Carrieri, Patrizia] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France; [Nordmann, Sandra; Vilotitch, Antoine; Lions, Caroline; Mora, Marion; Spire, Bruno; Maradan, Gwenaelle; Bendiane, Marc-Karim; Roux, Perrine; Carrieri, Patrizia] ORS PACA, Marseille, France; [Michel, Laurent] INSERM, UMR S 669, Paris, France; [Michel, Laurent] Univ Paris Sud, Paris, France; [Michel, Laurent] Univ Paris 05, UMR S 669, Paris, France; [Michel, Laurent] Ctr Pierre Nicole, Paris, France; [Morel, Alain] Oppelia, Paris, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Carrieri, P (corresponding author), Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France.; Carrieri, P (corresponding author), ORS PACA, Marseille, France.	maria-patrizia.carrieri@inserm.fr	Spire, Bruno/F-5546-2013; Bendiane, Marc-Karim K/F-5414-2010; Bendiane, Marc-Karim/M-7060-2019	Spire, Bruno/0000-0002-3546-8020; Bendiane, Marc-Karim K/0000-0003-4329-8807; MICHEL, laurent/0000-0002-2000-7838; Carrieri, Patrizia/0000-0002-6794-4837	French National Agency for Research on Aids and Viral Hepatitis (ANRS); French Ministry of Health	French National Agency for Research on Aids and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); French Ministry of Health	This study received external funding from the French National Agency for Research on Aids and Viral Hepatitis (ANRS) and the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barry DT, 2009, J CLIN PSYCHIAT, V70, P1213, DOI 10.4088/JCP.08m04367; Barry DT, 2009, AM J ADDICTION, V18, P117, DOI 10.1080/10550490902772470; Beck A T, 1990, Crisis, V11, P22; Blinderman Craig D, 2009, J Opioid Manag, V5, P107; Bounes V, 2013, PAIN PHYSICIAN, V16, pE739; Breitbart W, 1997, PAIN, V72, P235, DOI 10.1016/S0304-3959(97)00039-0; Caldeiro RM, 2008, ADDICTION, V103, P1996, DOI 10.1111/j.1360-0443.2008.02358.x; Carrieri PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112328; Center for Substance Abuse Treatment, 2011, TREATMENT IMPROVEMEN, V54; Center for Substance Abuse Treatment, 2005, TREATM IMPR PROT TIP, V43; Center for Substance Abuse Treatment, 2004, TREATMENT IMPROVEMEN, V40; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cleeland CS, 1996, PAIN, V67, P267, DOI 10.1016/0304-3959(96)03131-4; Daigre C, 2015, J ATTEN DISORD, V19, P328, DOI 10.1177/1087054714529819; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; Darke S, 1991, OPIATE TREATMENT IND, P1; Dhingra L, 2015, DRUG ALCOHOL DEPEN, V149, P285, DOI 10.1016/j.drugalcdep.2015.02.007; Dhingra L, 2013, DRUG ALCOHOL DEPEN, V128, P161, DOI 10.1016/j.drugalcdep.2012.08.003; Dunn KE, 2014, PAIN MED, V15, P1540, DOI 10.1111/pme.12430; Edwards RR, 2006, PAIN, V126, P272, DOI 10.1016/j.pain.2006.07.004; Eisenberger NI, 2012, PSYCHOSOM MED, V74, P126, DOI 10.1097/PSY.0b013e3182464dd1; Eyler ECH, 2013, AM J ADDICTION, V22, P75, DOI 10.1111/j.1521-0391.2013.00308.x; Fishman SM, 2002, PAIN MED, V3, P339, DOI 10.1046/j.1526-4637.2002.02047.x; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; HANDELSMAN L, 1987, AM J DRUG ALCOHOL AB, V13, P293, DOI 10.3109/00952998709001515; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hines S, 2008, DRUG ALCOHOL REV, V27, P519, DOI 10.1080/09595230802245519; Jamison RN, 2000, J PAIN SYMPTOM MANAG, V19, P53, DOI 10.1016/S0885-3924(99)00144-X; Karasz A, 2004, J PAIN SYMPTOM MANAG, V28, P517, DOI 10.1016/j.jpainsymman.2004.02.025; Keane H, 2013, INT J DRUG POLICY, V24, P189, DOI [10.1016/j.drugpo.2013.05.007, 10.1016/j.drugpo.2013.01.011]; Larson MJ, 2007, ADDICTION, V102, P752, DOI 10.1111/j.1360-0443.2007.01759.x; Michel L, 2015, COMPR PSYCHIAT, V62, P123, DOI 10.1016/j.comppsych.2015.07.004; Miller LR, 2009, J PAIN, V10, P619, DOI 10.1016/j.jpain.2008.12.007; Nielsen S, 2013, DRUG ALCOHOL REV, V32, P489, DOI 10.1111/dar.12041; Nordmann S, 2016, PSYCHOPHARMACOLOGY, V233, P1203, DOI 10.1007/s00213-016-4202-4; Peles E, 2005, PAIN, V113, P340, DOI 10.1016/j.pain.2004.11.011; Potter JS, 2008, AM J DRUG ALCOHOL AB, V34, P101, DOI 10.1080/00952990701523706; Poundja J, 2007, J PAIN SYMPTOM MANAG, V33, P720, DOI 10.1016/j.jpainsymman.2006.09.031; Rosenblum A, 2003, JAMA-J AM MED ASSOC, V289, P2370, DOI 10.1001/jama.289.18.2370; Roux P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-488; Rowley D, 2011, AM J HOSP PALLIAT ME, V28, P183, DOI 10.1177/1049909110380897; Santiago-Palma J, 2001, CANCER, V92, P1919, DOI 10.1002/1097-0142(20011001)92:7<1919::AID-CNCR1710>3.0.CO;2-G; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Sheu R, 2008, PAIN MED, V9, P911, DOI 10.1111/j.1526-4637.2008.00420.x; St Marie B, 2014, PAIN MED, V15, P2075, DOI 10.1111/pme.12493; Stickley A, 2016, PSYCHIAT RES, V246, P326, DOI 10.1016/j.psychres.2016.10.004; Tang NKY, 2016, CLIN J PAIN, V32, P411, DOI 10.1097/AJP.0000000000000276; Trafton JA, 2004, DRUG ALCOHOL DEPEN, V73, P23, DOI 10.1016/j.drugalcdep.2003.08.007; Turner JA, 2002, PAIN, V98, P127, DOI 10.1016/S0304-3959(02)00045-3; van de Glind G, 2013, DRUG ALCOHOL DEPEN, V132, P587, DOI 10.1016/j.drugalcdep.2013.04.010; Voon P, 2015, J PAIN, V16, P887, DOI 10.1016/j.jpain.2015.06.003; Voon P, 2015, DRUG ALCOHOL REV, V34, P221, DOI 10.1111/dar.12226	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176288	10.1371/journal.pone.0176288	http://dx.doi.org/10.1371/journal.pone.0176288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520735	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700012
J	Ramachandran, SK; Thompson, A; Pandit, JJ; Devine, S; Shanks, AM				Ramachandran, Satya Krishna; Thompson, Aleda; Pandit, Jaideep J.; Devine, Scott; Shanks, Amy M.			Retrospective observational evaluation of postoperative oxygen saturation levels and associated postoperative respiratory complications and hospital resource utilization	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; PERIOPERATIVE-OUTCOMES-GROUP; NATIONWIDE INPATIENT SAMPLE; RANDOMIZED CONTROLLED-TRIAL; PULSE OXIMETRY; CONSTANT HYPOXEMIA; SUPPLEMENTAL OXYGEN; NONCARDIAC SURGERY; EPISODIC HYPOXEMIA; RISK	Introduction The clinical importance of postoperative episodic hypoxemia is still unclear, and therefore largely under-studied. As a result, there is limited understanding of its relationship with early postoperative respiratory complications (PRC, defined as intubation within three days of surgery) and hospital resource utilization. Materials and methods This single center study was performed using a retrospective observational design. We described population based definitions of desaturation from continuous SpO(2) monitoring data captured in the post anesthesia care unit (PACU), namely median SpO(2) in PACU, duration of desaturation below median, nadir desaturation, and length of oxygen therapy relative to PACU duration. These measures were evaluated against the occurrence of early PRC in logistic regression models. Measures that were independently associated with early PRC were accepted as the primary study exposures. Stratified logistic regression models were planned if significant interaction occurred with high risk surgical procedures. Models were adjusted by including several patient conditions, procedural, and anesthesia risk factors. Propensity matching on desaturation occurrence was planned to evaluate the relationship with postoperative resource utilization. Results Among 125,740 patients included in the univariate analyses, 351 patients (0.3%) developed early PRC. Nadir desaturation < 89% [14.3% of patients; adjusted odds ratio 2.02; 95% CI 1.52, 2.68; p < 0.001] and PACU oxygen therapy requirements greater than 60 min [adjusted odds ratio 1.92 (> 60 min) to 3.04 (> 90 min); p < 0.001] were identified as independent predictors of early PRC occurrence. A modest interaction was observed between desaturation and higher surgical risk. Propensity matching for postoperative oxygen requirement was performed in 37,354 matched patients. Matched analysis demonstrated significant increase in day of surgery charges, respiratory charges, total charges, hospital length of stay, reintubation and use of invasive or non-invasive ventilatory support. Conclusions In summary, we report that prolonged PACU oxygen therapy and nadir desaturation < 89% in PACU as captured in a retrospective database are independently associated with early PRC. This study describes resource implications of PACU desaturation in a large academic medical center in North America.	[Ramachandran, Satya Krishna] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA; [Ramachandran, Satya Krishna] Harvard Med Sch, Boston, MA 02115 USA; [Thompson, Aleda; Shanks, Amy M.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Pandit, Jaideep J.] Nuffield Dept Anaesthesia, Oxford, Oxon, England; [Devine, Scott] Merck Sharpe & Dohme, Ctr Observat & Real World Evidence US Evidence &, Whitehouse Stn, NJ USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Oxford	Ramachandran, SK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA.; Ramachandran, SK (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	skrama@bidmc.harvard.edu	Ramachandran, Satya Krishna/P-6636-2016; (Thompson) Leis, Aleda/J-1066-2016	Ramachandran, Satya Krishna/0000-0002-7176-6375; (Thompson) Leis, Aleda/0000-0003-2867-9062	Merck; Sharpe and Dohme; White house Station, NJ, USA, through the University of Michigan	Merck(Merck & Company); Sharpe and Dohme; White house Station, NJ, USA, through the University of Michigan	This research project was funded by Merck, Sharpe and Dohme, White house Station, NJ, USA, through the University of Michigan. No funds were paid directly to any of the authors. The funder provided support in the form of salaries for authors [SKR, SD, AS], but did not have any additional role in the study design, data collection and analysis, decision to publish,or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amer Soc Anesthesiologists, 2006, ANESTHESIOLOGY, V104, P1081; Bateman BT, 2013, ANESTH ANALG, V116, P1380, DOI 10.1213/ANE.0b013e318251daed; Belcher AW, 2016, ANESTH ANALG, V123, P1471, DOI 10.1213/ANE.0000000000001534; Bender SP, 2015, ANESTH ANALG, V121, P1231, DOI 10.1213/ANE.0000000000000940; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; CANET J, 1989, ANESTH ANALG, V69, P207; Cashman JN, 2004, BRIT J ANAESTH, V93, P212, DOI 10.1093/bja/aeh180; Chung F, 2014, ANESTHESIOLOGY, V120, P287, DOI 10.1097/ALN.0000000000000040; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Fu ES, 2004, CHEST, V126, P1552, DOI 10.1378/chest.126.5.1552; Gami AS, 2013, J AM COLL CARDIOL, V62, P610, DOI 10.1016/j.jacc.2013.04.080; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Gogenur I, 2008, BRIT J ANAESTH, V100, P45, DOI 10.1093/bja/aem340; Isono S, 1998, BRIT J ANAESTH, V80, P602, DOI 10.1093/bja/80.5.602; Kheterpal S, 2013, ANESTHESIOLOGY, V119, P1360, DOI 10.1097/ALN.0000435832.39353.20; Kheterpal Sachin, 2011, Anesthesiol Clin, V29, P377, DOI 10.1016/j.anclin.2011.06.002; Liao P, 2017, CHEST, V151, P597, DOI 10.1016/j.chest.2016.12.005; Loredo JS, 2006, SLEEP, V29, P564, DOI 10.1093/sleep/29.4.564; Mashour GA, 2009, J CLIN MONIT COMPUT, V23, P273, DOI 10.1007/s10877-009-9193-9; Mathis MR, 2013, ANESTHESIOLOGY, V119, P1310, DOI 10.1097/ALN.0000000000000005; McLean DJ, 2015, ANESTHESIOLOGY, V122, P1201, DOI 10.1097/ALN.0000000000000674; Mokhlesi B, 2013, OBES SURG, V23, P1842, DOI 10.1007/s11695-013-0991-2; Mokhlesi B, 2013, CHEST, V144, P903, DOI 10.1378/chest.12-2905; MOLLER JT, 1993, ANESTHESIOLOGY, V78, P445, DOI 10.1097/00000542-199303000-00007; Mutter TC, 2014, ANESTHESIOLOGY, V121, P707, DOI 10.1097/ALN.0000000000000407; Netzer N, 2001, CHEST, V120, P625, DOI 10.1378/chest.120.2.625; Pedersen T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002013.pub3; Ramachandran SK, 2011, ANESTHESIOLOGY, V115, P44, DOI 10.1097/ALN.0b013e31821cf6de; Raval MV, 2010, J AM COLL SURGEONS, V211, P715, DOI 10.1016/j.jamcollsurg.2010.07.021; ROSENBERG J, 1994, EUR J SURG, V160, P137; Rosenberg J, 1999, ANAESTHESIA, V54, P323, DOI 10.1046/j.1365-2044.1999.00744.x; ROSENBERG J, 1990, ACTA CHIR SCAND, V156, P585; ROSENBERG J, 1990, BRIT J ANAESTH, V65, P684, DOI 10.1093/bja/65.5.684; ROSENBERG J, 1992, BRIT J ANAESTH, V68, P18, DOI 10.1093/bja/68.1.18; ROSENBERG J, 1994, BRIT J ANAESTH, V72, P145, DOI 10.1093/bja/72.2.145; ROSENBERG J, 1994, J CLIN ANESTH, V6, P212, DOI 10.1016/0952-8180(94)90061-2; RosenbergAdamsen S, 1997, ANAESTHESIA, V52, P589; SHEPARD JW, 1985, CHEST, V88, P335, DOI 10.1378/chest.88.3.335; Tarassenko L, 2006, BRIT J ANAESTH, V97, P64, DOI 10.1093/bja/ael113; Taylor S, 2005, AM J SURG, V190, P752, DOI 10.1016/j.amjsurg.2005.07.015; Valencia-Flores M, 2000, OBES RES, V8, P262, DOI 10.1038/oby.2000.31; Voepel-Lewis T, 2013, INT J NURS STUD, V50, P1351, DOI 10.1016/j.ijnurstu.2013.02.006; Watkinson PJ, 2006, ANAESTHESIA, V61, P1031, DOI 10.1111/j.1365-2044.2006.04818.x; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	44	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175408	10.1371/journal.pone.0175408	http://dx.doi.org/10.1371/journal.pone.0175408			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520718	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700003
J	Baragli, P; Demuru, E; Scopa, C; Palagi, E				Baragli, Paolo; Demuru, Elisa; Scopa, Chiara; Palagi, Elisabetta			Are horses capable of mirror self-recognition? A pilot study	PLOS ONE			English	Article							STEREOTYPIC WEAVING BEHAVIOR; MODAL INDIVIDUAL RECOGNITION; PHYSIOLOGICAL-RESPONSES; ISOLATION STRESS; CHIMPANZEES; STIMULATION; LATERALITY; STIMULUS; ANIMALS; ORIGINS	Mirror Self-Recognition (MSR) unveils complex cognitive, social and emotional skills and it has been found only in humans and few other species, such as great apes, dolphins, elephants and magpies. In this pilot study, we tested if horses show the capacity of MSR. Four subjects living socially under naturalistic conditions were selected for the experiment. We adopted the classical mark test, which consists in placing a coloured mark on an out-of-view body part, visible only through mirror inspection. If the animal considers the image as its own, it will use its reflection to detect the mark and will try to explore it. We enhanced the classical paradigm by introducing a double-check control. Only in the presence of the reflecting surface, animals performed tactile and olfactory exploration of the mirror and looked behind it. These behaviors suggest that subjects were trying to associate multiple sensory cues (visual, tactile and olfactory) to the image in the mirror. The lack of correspondence between the collected stimuli in front of the mirror and the response to the colored mark lead us to affirm that horses are able to perceive that the reflected image is incongruent when compared with the memorized information of a real horse. However, without replication of data, the self-directed behavior towards the colored marks showed by our horses cannot be sufficient per se to affirm that horses are capable of self-recognition.	[Baragli, Paolo; Scopa, Chiara] Univ Pisa, Dipartimento Sci Vet, Pisa, Italy; [Baragli, Paolo; Demuru, Elisa; Scopa, Chiara; Palagi, Elisabetta] Univ Pisa, Museo Storia Nat, Calci, Italy; [Palagi, Elisabetta] ISTC CNR, Unita Primatol Cognit, Rome, Italy	University of Pisa; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Baragli, P (corresponding author), Univ Pisa, Dipartimento Sci Vet, Pisa, Italy.; Baragli, P (corresponding author), Univ Pisa, Museo Storia Nat, Calci, Italy.	paolo.baragli@unipi.it	Demuru, Elisa/ABD-8569-2020; Scopa, Chiara/P-7882-2019; Demuru, Elisa/ABE-6920-2021; Baragli, Paolo/AAZ-1020-2021	Scopa, Chiara/0000-0002-1519-9556; Baragli, Paolo/0000-0001-5221-5714				Anderson JR, 2015, PRIMATES, V56, P317, DOI 10.1007/s10329-015-0488-9; Anderson JR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001024; Baragli P, 2014, BEHAVIOUR, V151, P1513, DOI 10.1163/1568539X-00003197; Basile M, 2009, ANIM COGN, V12, P611, DOI 10.1007/s10071-009-0220-5; Bischof-Kohler D, 2012, EMOT REV, V4, P40, DOI 10.1177/1754073911421377; Blackmore TL, 2008, BEHAV PROCESS, V78, P387, DOI 10.1016/j.beproc.2008.02.003; Briefer EF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09989; Broom DM, 2010, APPL ANIM BEHAV SCI, V126, P1, DOI 10.1016/j.applanim.2010.05.001; Chang LT, 2015, CURR BIOL, V25, P212, DOI 10.1016/j.cub.2014.11.016; Chelazzi L, 2013, VISION RES, V85, P58, DOI 10.1016/j.visres.2012.12.005; Cirulli F, 2011, ANN I SUPER SANITA, V47, P341, DOI 10.4415/ANN_11_04_04; Cozzi A, 2010, BEHAV PROCESS, V85, P185, DOI 10.1016/j.beproc.2010.07.007; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal FBM, 2008, PLOS BIOL, V6, P1621, DOI 10.1371/journal.pbio.0060201; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Fuss J, 2013, BEHAV BRAIN RES, V243, P191, DOI 10.1016/j.bbr.2013.01.015; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gallup GG, 1995, ANIM BEHAV, V50, P1525, DOI 10.1016/0003-3472(95)80008-5; Gallup GG, 2002, COGNITIVE ANIMAL, P325; GALLUP GG, 1983, ANIMAL COGNITION BEH, P473; Hanggi EB, 2009, ANIM COGN, V12, P451, DOI 10.1007/s10071-008-0205-9; Jones SE, 2005, ANIM WELFARE, V14, P195; Kay R, 2009, APPL ANIM BEHAV SCI, V116, P237, DOI 10.1016/j.applanim.2008.08.013; Kondo N, 2012, P R SOC B; Lanata A, 2016, 2016 38 ANN INT C IE; Larose C, 2006, LATERALITY, V11, P355, DOI 10.1080/13576500600624221; Lesimple C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00306; Liljenstolpe C., 2009, HORSES EUROPE UPPSAL; Lovrovich P, 2015, APPL ANIM BEHAV SCI, V166, P80, DOI 10.1016/j.applanim.2015.02.017; McAfee LM, 2002, APPL ANIM BEHAV SCI, V78, P159, DOI 10.1016/S0168-1591(02)00086-2; Mills DS, 2002, ANIM SCI, V74, P95, DOI 10.1017/S1357729800052255; Momozawa Y, 2005, APPL ANIM BEHAV SCI, V92, P77, DOI 10.1016/j.applanim.2004.11.006; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; PARROTT RF, 1988, APPL ANIM BEHAV SCI, V19, P331, DOI 10.1016/0168-1591(88)90015-9; Piller CA, 1999, APPL ANIM BEHAV SCI, V63, P93, DOI 10.1016/S0168-1591(99)00010-6; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Poulin-Dubois D, 2009, ADV CHILD DEV BEHAV, V37, P55, DOI 10.1016/S0065-2407(09)03702-1; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; Povinelli DJ, 1997, ANIM BEHAV, V53, P1083, DOI 10.1006/anbe.1996.0303; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; Proops L, 2012, P ROY SOC B-BIOL SCI, V279, P3131, DOI 10.1098/rspb.2012.0626; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Sankey C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018331; Saslow CA, 1999, APPL ANIM BEHAV SCI, V61, P273, DOI 10.1016/S0168-1591(98)00205-6; Schwartz B, 2008, J INTEGR BIOSCI, V5, P19; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Smith AV, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0907; Soler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086193; SUAREZ SD, 1981, J HUM EVOL, V10, P175, DOI 10.1016/S0047-2484(81)80016-4; Suddendorf T, 2013, TRENDS COGN SCI, V17, P121, DOI 10.1016/j.tics.2013.01.004; Toda K, 2015, CURR BIOL, V25, pR64, DOI 10.1016/j.cub.2014.12.005; Wathan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131738; Wathan J, 2014, CURR BIOL, V24, pR677, DOI 10.1016/j.cub.2014.06.023; Wells DL, 2009, APPL ANIM BEHAV SCI, V118, P1, DOI 10.1016/j.applanim.2009.01.002; Westergaard G.C., 1994, Human Evolution, V9, P273, DOI 10.1007/BF02435514; Whalen CN, 2012, PHYS OCCUP THER PEDI, V32, P229, DOI 10.3109/01942638.2011.619251; Yarnell K, 2015, PHYSIOL BEHAV, V143, P51, DOI 10.1016/j.physbeh.2015.02.040	60	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176717	10.1371/journal.pone.0176717	http://dx.doi.org/10.1371/journal.pone.0176717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28510577	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500009
J	Brocklehurst, P; Ni, HB; Zhang, HG; Ye, JQ				Brocklehurst, Paul; Ni, Haibo; Zhang, Henggui; Ye, Jianqiao			Electro-mechanical dynamics of spiral waves in a discrete 2D model of human atrial tissue	PLOS ONE			English	Article							MECHANOELECTRIC FEEDBACK; CONTRACTILE DYSFUNCTION; POTASSIUM CURRENT; IONIC MECHANISMS; CARDIAC-MUSCLE; ACTIVATION; INSIGHTS; CURRENTS; CALCIUM; LENGTH	We investigate the effect of mechano-electrical feedback and atrial fibrillation induced electrical remodelling (AFER) of cellular ion channel properties on the dynamics of spiral waves in a discrete 2D model of human atrial tissue. The tissue electro-mechanics are modelled using the discrete element method (DEM). Millions of bonded DEM particles form a network of coupled atrial cells representing 2D cardiac tissue, allowing simulations of the dynamic behaviour of electrical excitation waves and mechanical contraction in the tissue. In the tissue model, each cell is modelled by nine particles, accounting for the features of individual cellular geometry; and discrete inter-cellular spatial arrangement of cells is also considered. The electro-mechanical model of a human atrial single-cell was constructed by strongly coupling the electrophysiological model of Colman et al. to the mechanical myofilament model of Rice et al., with parameters modified based on experimental data. A stretch-activated channel was incorporated into the model to simulate the mechano-electrical feedback. In order to investigate the effect of mechano-electrical feedback on the dynamics of spiral waves, simulations of spiral waves were conducted in both the electromechanical model and the electrical-only model in normal and AFER conditions, to allow direct comparison of the results between the models. Dynamics of spiral waves were characterized by tracing their tip trajectories, stability, excitation frequencies and meandering range of tip trajectories. It was shown that the developed DEM method provides a stable and efficient model of human atrial tissue with considerations of the intrinsically discrete and anisotropic properties of the atrial tissue, which are challenges to handle in traditional continuum mechanics models. This study provides mechanistic insights into the complex behaviours of spiral waves and the genesis of atrial fibrillation by showing an important role of the mechano-electrical feedback in facilitating and promoting atrial fibrillation.	[Brocklehurst, Paul; Ye, Jianqiao] Univ Lancaster, Engn Dept, Lancaster, England; [Ni, Haibo; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England	Lancaster University; University of Manchester	Ye, JQ (corresponding author), Univ Lancaster, Engn Dept, Lancaster, England.; Zhang, HG (corresponding author), Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England.	henggui.zhang@manchester.ac.uk; j.ye2@lancaster.ac.uk	Zhang, Henggui/D-6712-2011; Ye, Jianqiao/D-1521-2013; Zhang, Henggui/AAM-1043-2020	Ye, Jianqiao/0000-0002-1039-1944; Ni, Haibo/0000-0003-0083-4286	Engineering and Physical Sciences Research Council [EP/J009482/1, EP/J00958X/1]; EPSRC [EP/J009482/1, EP/J00958X/1]; University of Manchester; British Heart Foundation [FS/14/5/30533] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Manchester; British Heart Foundation(British Heart Foundation)	JY was funded by EP/J009482/1; Engineering and Physical Sciences Research Council, https://www.epsrc.ac.uk/; HZ was funded by EP/J00958X/1; Engineering and Physical Sciences Research Council, https://www.epsrc.ac.uk/.; The authors are grateful for financial support provided to the project by EPSRC (EP/J009482/1; EP/J00958X/1). HN would like to thank the University of Manchester for financial support of his study.	Adeniran I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142397; Adeniran I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00166; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Brocklehurst P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/854953; Cave DM, 2010, CIRCULATION, V122, pS720, DOI 10.1161/CIRCULATIONAHA.110.970970; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; DANIELS M, 1984, J PHYSIOL-LONDON, V355, P367, DOI 10.1113/jphysiol.1984.sp015424; Dobrev D, 2002, CARDIOVASC RES, V54, P397, DOI 10.1016/S0008-6363(01)00555-7; Dorn A, 2012, BIOMED TECH BERL S, V57, P1; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Franz MR, 2003, PROG BIOPHYS MOL BIO, V82, P163, DOI 10.1016/S0079-6107(03)00013-0; Harada M, 2015, J AM COLL CARDIOL, V66, P47, DOI 10.1016/j.jacc.2015.04.056; HOFMANN PA, 1987, AM J PHYSIOL, V253, pC90; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Inc. ICG, 2014, PART FLOW COD VERS 5; Kamkin A, 2003, PFLUG ARCH EUR J PHY, V446, P339, DOI 10.1007/s00424-002-0948-0; Keldermann RH, 2010, AM J PHYSIOL-HEART C, V299, pH134, DOI 10.1152/ajpheart.00862.2009; Khan IA, 2003, AM HEART J, V145, P787, DOI 10.1016/S0002-8703(03)00086-3; Kohl P, 2001, CARDIOVASC RES, V50, P280, DOI 10.1016/S0008-6363(01)00194-8; Kohl P, 1999, PROG BIOPHYS MOL BIO, V71, P91, DOI 10.1016/S0079-6107(98)00038-8; Kohl P, 2001, PHILOS T R SOC A, V359, P1173, DOI 10.1098/rsta.2001.0824; Koo SH, 2010, EUROPACE, V12, P1490, DOI 10.1093/europace/euq280; Kuijpers NHL, 2007, AM J PHYSIOL-HEART C, V292, pH2832, DOI 10.1152/ajpheart.00923.2006; Lunze K, 2010, IFMBE PROC, V25, P740; Narolska NA, 2005, J MUSCLE RES CELL M, V26, P39, DOI 10.1007/s10974-005-9005-x; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nobile F, 2012, INT J NUMER METH BIO, V28, P52, DOI 10.1002/cnm.1468; Qi XY, 2015, CIRC RES, V116, P836, DOI 10.1161/CIRCRESAHA.116.305326; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; RUDY Y, 1987, CIRC RES, V61, P815, DOI 10.1161/01.RES.61.6.815; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; SANO T, 1970, CIRC RES, V26, P201, DOI 10.1161/01.RES.26.2.201; Schotten U, 2001, CIRCULATION, V103, P691; Schotten U, 2007, CARDIOVASC RES, V73, P37, DOI 10.1016/j.cardiores.2006.11.024; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Severs NJ, 2004, CARDIOVASC RES, V62, P368, DOI 10.1016/j.cardiores.2003.12.007; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wakili R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P530, DOI 10.1161/CIRCEP.109.933036; Weise LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059317; Youm J.B., 2005, MECHANOSENSITIVITY C; Zhang DL, 2014, CIRCULATION, V129, P346, DOI 10.1161/CIRCULATIONAHA.113.005300; Zhang HG, 2009, PHYSICA D, V238, P976, DOI 10.1016/j.physd.2008.06.012	48	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176607	10.1371/journal.pone.0176607	http://dx.doi.org/10.1371/journal.pone.0176607			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510575	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000401485500007
J	Yang, C; Yang, SJ; Xu, WW; Zhang, JH; Fu, WG; Feng, CH				Yang, Chao; Yang, Shujuan; Xu, Weiwei; Zhang, Junhui; Fu, Wenguang; Feng, Chunhong			Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study	PLOS ONE			English	Article							SERUM URIC-ACID; METABOLIC SYNDROME; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; HEPATIC STEATOSIS; URATE TRANSPORT; NATURAL-HISTORY; OBESE CHILDREN; UNITED-STATES	Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease associated with high levels of serum uric acid (SUA). However, whether this relationship applies in obese subjects has been unclear, and no cohort study has previously been conducted in non-obese subjects. We therefore performed a retrospective cohort study among employees of seven companies in China to investigate whether hyperuricemia was independently associated with NAFLD in obese and non-obese subjects, respectively. A total of 2383 initially NAFLD-free subjects were followed up for four years, and 15.2% (363/2383) developed NAFLD. Hyperuricemia subjects had a higher cumulative incidence than did those with normouricemia (29.0% vs. 12.9%, P<0.001). Cox proportional hazard regression analyses showed that baseline hyperuricemia was significantly associated with risk of developing NAFLD in nonobese subjects. This relationship was significantly independent of baseline age, gender, metabolic syndrome components, and other clinical variables (RR = 1.389, 95% CI: 1.051-2.099). However, this association did not exist in obese subjects (RR = 1.010, 95% CI: 0.649-1.571). The independent effect of hyperuricemia on NAFLD was stronger in females (RR = 2.138, 95% CI: 1.050-4.355) than in males (RR = 1.435, 95% CI: 1.021-2.018). In conclusion, further studies are needed to explore the different mechanisms between obese and non-obese subjects, and the reason hyperuricemia raises NAFLD risk in females more than in males.	[Yang, Chao; Zhang, Junhui] Southwest Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Luzhou, Peoples R China; [Yang, Shujuan] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Peoples R China; [Xu, Weiwei; Feng, Chunhong] Southwest Med Univ, Affiliated Hosp 1, Hlth Management Dept, Coll Med, Luzhou, Peoples R China; [Fu, Wenguang] Southwest Med Univ, Affiliated Hosp 1, Coll Med, Dept Hepatobiliary Surg, Luzhou, Peoples R China	Southwest Medical University; Sichuan University; Southwest Medical University; Southwest Medical University	Feng, CH (corresponding author), Southwest Med Univ, Affiliated Hosp 1, Hlth Management Dept, Coll Med, Luzhou, Peoples R China.	chunhongf@tom.com	fu, wenguang/ABI-7883-2020; WENGUANG, FU/AAI-1142-2019					Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Argo CK, 2017, AM J GASTROENTEROL, V112, P111, DOI 10.1038/ajg.2016.527; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Cai W, 2014, SCI WORLD J, DOI 10.1155/2014/393628; Cardoso AS, 2013, J PEDIAT-BRAZIL, V89, P412, DOI 10.1016/j.jped.2012.12.008; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; Cho HC, 2016, GUT LIVER, V10, P117, DOI 10.5009/gnl14444; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Das K, 2010, HEPATOLOGY, V51, P1593, DOI 10.1002/hep.23567; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Feldman A, 2017, AM J GASTROENTEROL, V112, P102, DOI 10.1038/ajg.2016.318; Feng RN, 2014, WORLD J GASTROENTERO, V20, P17932, DOI 10.3748/wjg.v20.i47.17932; Gong SL, 2016, EUR J GASTROEN HEPAT, V28, P132, DOI 10.1097/MEG.0000000000000507; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hwang IC, 2011, J KOREAN MED SCI, V26, P386, DOI 10.3346/jkms.2011.26.3.386; Jaruvongvanich V, 2017, EUR J GASTROENTEROL; Jian-gao Fan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P163; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Kuo CF, 2010, SCAND J RHEUMATOL, V39, P466, DOI 10.3109/03009741003742797; Lanaspa MA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047948, 10.1371/journal.pone.0048801]; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Liu CQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38605; Liu J, 2016, HEPATOLOGY RES OFFIC; Liu PJ, 2014, CLIMACTERIC, V17, P692, DOI 10.3109/13697137.2014.926323; Liu Pengju, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P53, DOI 10.3760/cma.j.issn.1007-3418.2014.01.012; Lombardi R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040548; Lonardo A, 2002, DIGEST LIVER DIS, V34, P204, DOI 10.1016/S1590-8658(02)80194-3; Lonardo A, 2000, J GASTROEN HEPATOL, V15, P775, DOI 10.1046/j.1440-1746.2000.02226.x; Lonardo A, 2017, DIGESTIVE LIVER DIS; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Miyake T, 2013, J GASTROENTEROL, V48, P413, DOI 10.1007/s00535-012-0650-8; Moon SS, 2013, ANN NUTR METAB, V62, P158, DOI 10.1159/000346202; Mosca A, 2017, J HEPATOLOGY; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ozcelik F, 2016, LIVER INT, V36, P768, DOI 10.1111/liv.13063; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Ryu S, 2011, METABOLISM, V60, P860, DOI 10.1016/j.metabol.2010.08.005; Sartorio A, 2007, EUR J CLIN NUTR, V61, P877, DOI 10.1038/sj.ejcn.1602588; Serfaty L, 2008, DIABETES METAB, V34, P634, DOI 10.1016/S1262-3636(08)74597-X; Shen HC, 2014, CLIN INTERV AGING, V9, P501, DOI 10.2147/CIA.S59538; Sirota JC, 2013, METABOLISM, V62, P392, DOI 10.1016/j.metabol.2012.08.013; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a; Wan XY, 2016, J HEPATOL, V64, P925, DOI 10.1016/j.jhep.2015.11.022; Wijarnpreecha K, 2016, LIVER INT OFFICIAL J; Wu SJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000802; Xie YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067152; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49; Zhang SJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006381; Zhao CC, 2016, J DIABETES COMPLICAT, V30, P1074, DOI 10.1016/j.jdiacomp.2016.04.017; Zhou YL, 2016, ACTA ASTRONAUT, V127, P209, DOI 10.1016/j.actaastro.2016.05.027; Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080; Zoppini G, 2014, AM J GASTROENTEROL, V109, P1020, DOI 10.1038/ajg.2014.132	64	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177249	10.1371/journal.pone.0177249	http://dx.doi.org/10.1371/journal.pone.0177249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510581	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500017
J	Li, HH; Ding, N; Zhang, YY; Liu, Y; Wen, DL				Li, Honghe; Ding, Ning; Zhang, Yuanyuan; Liu, Yang; Wen, Deliang			Assessing medical professionalism: A systematic review of instruments and their measurement properties	PLOS ONE			English	Review							MINI-EVALUATION EXERCISE; CLINICAL-EVALUATION EXERCISE; DIRECTORS EVALUATION FORM; UPDATED METHOD GUIDELINES; PROGRAM DIRECTORS; METHODOLOGICAL QUALITY; COMMUNICATION-SKILLS; STUDENTS PERCEPTIONS; ATTENDING PHYSICIANS; INITIAL VALIDATION	Background Over the last three decades, various instruments were developed and employed to assess medical professionalism, but their measurement properties have yet to be fully evaluated. This study aimed to systematically evaluate these instruments' measurement properties and the methodological quality of their related studies within a universally acceptable standardized framework and then provide corresponding recommendations. Methods A systematic search of the electronic databases PubMed, Web of Science, and PsycINFO was conducted to collect studies published from 1990-2015. After screening titles, abstracts, and full texts for eligibility, the articles included in this study were classified according to their respective instrument's usage. A two-phase assessment was conducted: 1) methodological quality was assessed by following the COnsensus-based Standards for the selection of health status Measurement INstruments (COSMIN) checklist; and 2) the quality of measurement properties was assessed according to Terwee's criteria. Results were integrated using best-evidence synthesis to look for recommendable instruments. Results After screening 2,959 records, 74 instruments from 80 existing studies were included. The overall methodological quality of these studies was unsatisfactory, with reasons including but not limited to unknown missing data, inadequate sample sizes, and vague hypotheses. Content validity, cross-cultural validity, and criterion validity were either unreported or negative ratings in most studies. Based on best-evidence synthesis, three instruments were recommended: Hisar's instrument for nursing students, Nurse Practitioners' Roles and Competencies Scale, and Perceived Faculty Competency Inventory. Conclusion Although instruments measuring medical professionalism are diverse, only a limited number of studies were methodologically sound. Future studies should give priority to systematically improving the performance of existing instruments and to longitudinal studies.	[Li, Honghe; Ding, Ning; Wen, Deliang] China Med Univ, Res Ctr Med Educ, Shenyang, Liaoning, Peoples R China; [Zhang, Yuanyuan] Dalian Med Univ, Sch Publ Hlth, Dalian, Liaoning, Peoples R China; [Liu, Yang] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China	China Medical University; Dalian Medical University; China Medical University	Wen, DL (corresponding author), China Med Univ, Res Ctr Med Educ, Shenyang, Liaoning, Peoples R China.	dlwen@cmu.edu.cn	Li, Honghe/AAA-5808-2020; zhang, yuanyuan/GYA-4428-2022; Li, Honghe/AAZ-2490-2020		Social Science Foundation of Chinese Ministry of Education [14YJAZH085]	Social Science Foundation of Chinese Ministry of Education(Ministry of Education, China)	This study was supported by The Social Science Foundation of Chinese Ministry of Education (Funding Number: 14YJAZH085) URLs: http://www.sinoss.net/2014/0704/50699.htrnl. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research team would like to thank Terwee CB for providing permission to use the COSMIN checklist. This study was supported by The Social Science Foundation of Chinese Ministry of Education (Funding Number: 14YJAZH085) URLs: http://www.sinoss.net/2014/0704/50699.html. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to express their gratitude to Nan Jiang for her critical review and Haolin Zhang for language editing.	Abadel FT, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-28; Abma IL, 2016, SLEEP MED REV, V28, P18, DOI 10.1016/j.smrv.2015.07.006; Accreditation Council for Graduate Medical Education, 2002, ACGME COMM PROGR REQ; Afonso P, 2014, PSYCHIAT RES, V217, P210, DOI 10.1016/j.psychres.2014.03.044; Akhund Saima, 2014, BMC Res Notes, V7, P150, DOI 10.1186/1756-0500-7-150; Al Ansari A, 2015, ADV MED EDUC PRACT, V6, P509, DOI 10.2147/AMEP.S86068; Al-Eraky MM, 2013, MED TEACH, V35, pS56, DOI 10.3109/0142159X.2013.765553; ALBUAM G, 1993, J MARKETING RES, V30, P393, DOI 10.2307/3172892; Aramesh K, 2009, MED TEACH, V31, pE356, DOI 10.1080/01421590802638022; Arnold EL, 1998, ACAD MED, V73, P1119, DOI 10.1097/00001888-199810000-00025; Arnold L, 2002, ACAD MED, V77, P502, DOI 10.1097/00001888-200206000-00006; Artino AR, 2015, MIL MED, V180, P104, DOI 10.7205/MILMED-D-14-00554; Baumann A, 2009, J ADV NURS, V65, P2216, DOI 10.1111/j.1365-2648.2009.05104.x; Blackall GF, 2007, MED TEACH, V29, pE58, DOI 10.1080/01421590601044984; Blue AV, 2009, MED TEACH, V31, P928, DOI 10.3109/01421590802574565; Brasel KJ, 2004, AM J SURG, V188, P9, DOI 10.1016/j.amjsurg.2003.11.036; Brennan T, 2002, LANCET, V359, P520, DOI 10.1016/s0140-6736(02)07684-5; Bustamante E, 2014, BIOMEDICA, V34, P291, DOI [10.1590/S0120-41572014000200015, 10.7705/biomedica.v34i2.1807]; Campbell JL, 2008, QUAL SAF HEALTH CARE, V17, P187, DOI 10.1136/qshc.2007.024679; Chandratilake M, 2010, CLIN MED, V10, P364, DOI 10.7861/clinmedicine.10-4-364; Clauser BE, 2012, ADV HEALTH SCI EDUC, V17, P165, DOI 10.1007/s10459-010-9219-6; Comert M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152717; Colletti JE, 2010, J EMERG MED, V39, P662, DOI 10.1016/j.jemermed.2009.09.001; Collins NJ, 2016, OSTEOARTHR CARTILAGE, V24, P1317, DOI 10.1016/j.joca.2016.03.010; Cordier R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132299; Cottrell S., 2006, MED ED ONLINE, V11, P4587, DOI [10.3402/meo.v11i.4587, DOI 10.3402/meo.v11i.4587]; Crossley J, 2009, MED TEACH, V31, pE603, DOI 10.3109/01421590903193547; Cruess R, 2006, ACAD MED, V81, pS74, DOI 10.1097/00001888-200610001-00019; Cruess SR, 2006, CLIN ORTHOP RELAT R, P170, DOI 10.1097/01.blo.0000229275.66570.97; De Champlain AF, 2010, MED EDUC, V44, P109, DOI 10.1111/j.1365-2923.2009.03425.x; de Oliveira GR, 2008, ANESTH ANALG, V107, P1316, DOI 10.1213/ane.0b013e318182fbdd; Deemer ED, 2011, TRAIN EDUC PROF PSYC, V5, P38, DOI 10.1037/a0021940; DeLisa JA, 2001, AM J PHYS MED REHAB, V80, P225, DOI 10.1097/00002060-200103000-00015; Dong T, 2015, MIL MED, V180, P97, DOI 10.7205/MILMED-D-14-00551; Donnon T, 2014, ACAD MED, V89, P511, DOI 10.1097/ACM.0000000000000147; Durning SJ, 2005, ACAD MED, V80, P964, DOI 10.1097/00001888-200510000-00018; Dwyer T, 2014, CAN J SURG, V57, P229, DOI 10.1503/cjs.018813; Egerton T, 2015, QUAL LIFE RES, V24, P2239, DOI 10.1007/s11136-015-0963-1; Ephgrave K, 2006, AM J SURG, V191, P701, DOI 10.1016/j.amjsurg.2006.02.002; Frohna A, 2005, MED EDUC, V39, P763, DOI 10.1111/j.1365-2929.2005.02234.x; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Garratt AM, 2014, RHEUMATOLOGY, V53, P1161, DOI 10.1093/rheumatology/ket374; Gauger PG, 2005, AM J SURG, V189, P479, DOI 10.1016/j.amjsurg.2004.09.020; Gillespie Colleen, 2009, J Grad Med Educ, V1, P208, DOI 10.4300/JGME-D-09-00018.1; Goldie J, 2013, MED TEACH, V35, pE952, DOI 10.3109/0142159X.2012.714888; Golnik KC, 2005, OPHTHALMOLOGY, V112, P1649, DOI 10.1016/j.ophtha.2005.06.006; Golnik KC, 2004, OPHTHALMOLOGY, V111, P1271, DOI 10.1016/j.ophtha.2004.04.014; Hafferty F, 2012, AM BOARD MED SPECIAL; Hanratty J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144649; Hawkins RE, 2009, MED TEACH, V31, P385, DOI 10.1080/01421590902887404; Hays R, 2013, OXFORD TXB MED ED, P500; Hisar F, 2010, NURS EDUC TODAY, V30, P726, DOI 10.1016/j.nedt.2010.01.013; Hodges Brian David, 2011, Med Teach, V33, P354, DOI 10.3109/0142159X.2011.577300; Hojat M, 2007, MED EDUC, V41, P982, DOI 10.1111/j.1365-2923.2007.02841.x; Horwitz LI, 2013, J HOSP MED, V8, P191, DOI 10.1002/jhm.2023; Horwitz LI, 2013, J CLIN NURS, V22, P1477, DOI 10.1111/j.1365-2702.2012.04131.x; Irvine D, 1999, LANCET, V353, P1174, DOI 10.1016/S0140-6736(99)91160-1; Jefferies A, 2007, MED TEACH, V29, P183, DOI 10.1080/01421590701302290; Jha V, 2007, MED EDUC, V41, P822, DOI 10.1111/j.1365-2923.2007.02804.x; Jiang S, 2010, MED TEACH, V32, P961, DOI 10.3109/0142159X.2010.497827; Karayurt O, 2009, J CLIN NURS, V18, P1123, DOI 10.1111/j.1365-2702.2008.02417.x; Kassam A, 2014, CAN J EMERG MED, V16, P144, DOI 10.2310/8000.2013.130958; Klemenc-Ketis Z, 2014, INT J MED EDUC, V5, P205, DOI 10.5116/ijme.544b.7972; Lesser CS, 2010, JAMA-J AM MED ASSOC, V304, P2732, DOI 10.1001/jama.2010.1864; Liao JM, 2014, ACAD MED, V89, P343, DOI 10.1097/ACM.0000000000000124; Lidwine BM, 2012, COSMIN CHECKLIST MAN; Lin LC, 2016, J CLIN NURS, V25, P99, DOI 10.1111/jocn.13001; Lin YH, 2010, NURS EDUC TODAY, V30, P492, DOI 10.1016/j.nedt.2009.10.016; Lockyer J, 2006, MED EDUC, V40, P340, DOI 10.1111/j.1365-2929.2006.02410.x; Lockyer JM, 2006, CAN J ANAESTH, V53, P33, DOI 10.1007/BF03021525; Lockyer JM, 2006, ACAD EMERG MED, V13, P1296, DOI 10.1197/j.aem.2006.07.030; Lockyer JM, 2009, ARCH PATHOL LAB MED, V133, P1301, DOI 10.1043/1543-2165-133.8.1301; Lombarts KMJMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097069; Lynch DC, 2004, MED TEACH, V26, P366, DOI 10.1080/01421590410001696434; Miller B K, 1993, J Prof Nurs, V9, P290, DOI 10.1016/8755-7223(93)90055-H; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Muller E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106844; Musick DW, 2010, AM J PHYS MED REHAB, V89, P235, DOI 10.1097/PHM.0b013e3181cf1b30; Musick DW, 2003, AM J PHYS MED REHAB, V82, P394, DOI 10.1097/01.PHM.0000064737.97937.45; Sang NM, 2015, GLOB PUBLIC HEALTH, V10, pS131, DOI 10.1080/17441692.2014.981830; Overeem K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-80; Park YS, 2014, MED EDUC, V48, P614, DOI 10.1111/medu.12408; Ponton-Carss A, 2011, AM J SURG, V202, P433, DOI 10.1016/j.amjsurg.2010.07.045; Qu B, 2012, INT J MED SCI, V9, P228, DOI 10.7150/ijms.3353; Qu B, 2010, SAUDI MED J, V31, P1260; Quaintance JL, 2008, ACAD MED, V83, pS5, DOI 10.1097/ACM.0b013e318183e3d4; Reimers AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-461; Reisdorff EJ, 2004, ACAD EMERG MED, V11, P881, DOI 10.1197/j.aem.2004.01.009; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2668, DOI 10.1001/jama.298.22.2668; Roberts C, 2009, MED EDUC, V43, P350, DOI 10.1111/j.1365-2923.2009.03292.x; Rodriguez E, 2012, ACAD EMERG MED, V19, P1372, DOI 10.1111/acem.12031; Royal College of Physicians and Surgeons of Canada(RCPSC), 2005, CANMEDS 2005 PHYS CO; Senol Y, 2009, KUWAIT MED J, V41, P205; Shayne P, 2006, ACAD EMERG MED, V13, P727, DOI 10.1197/j.aem.2006.01.030; Silber CG, 2004, ACAD MED, V79, P549, DOI 10.1097/00001888-200406000-00010; Smith CA, 2004, J GEN INTERN MED, V19, P766, DOI 10.1111/j.1525-1497.2004.30269.x; Swick HM, 2000, ACAD MED, V75, P612, DOI 10.1097/00001888-200006000-00010; Symons AB, 2009, BMC MED EDUC, V9, P7; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Terwee CB, COSMIN CONSENSUS BAS; Thrush CR, 2011, MED TEACH, V33, pE683, DOI 10.3109/0142159X.2011.611194; Tiffin PA, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-43; Tijssen M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-117; Tromp F, 2007, MED TEACH, V29, P150, DOI 10.1080/01421590601178014; Tromp F, 2012, PATIENT EDUC COUNS, V89, P199, DOI 10.1016/j.pec.2012.06.028; Tromp F, 2010, MED TEACH, V32, pE161, DOI 10.3109/01421590903544728; Tsai TC, 2007, MED TEACH, V29, P128, DOI 10.1080/01421590701310889; Tsugawa Y, 2011, ACAD MED, V86, P1026, DOI 10.1097/ACM.0b013e3182222ba0; Tsugawa Y, 2009, MED EDUC, V43, P968, DOI 10.1111/j.1365-2923.2009.03437.x; Valentine MA, 2015, MED CARE, V53, pE16, DOI 10.1097/MLR.0b013e31827feef6; van de Camp K, 2006, MED EDUC, V40, P43, DOI 10.1111/j.1365-2929.2005.02346.x; van Mook Walther N K A, 2009, Eur J Intern Med, V20, pe90, DOI 10.1016/j.ejim.2008.11.011; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; van Zanten M, 2005, MED EDUC, V39, P20, DOI 10.1111/j.1365-2929.2004.02029.x; Veloski JJ, 2005, ACAD MED, V80, P366, DOI 10.1097/00001888-200504000-00014; Violato C, 2008, MED EDUC, V42, P1007, DOI 10.1111/j.1365-2923.2008.03127.x; Violato C, 2008, CAN J PSYCHIAT, V53, P525, DOI 10.1177/070674370805300807; Nhan VT, 2014, TEACH LEARN MED, V26, P72, DOI 10.1080/10401334.2013.857333; Weis D, 2009, J NURS MEAS, V17, P221, DOI 10.1891/1061-3749.17.3.221; Wilkinson TJ, 2009, ACAD MED, V84, P551, DOI 10.1097/ACM.0b013e31819fbaa2; Wittich CM, 2013, ANAT SCI EDUC, V6, P232, DOI 10.1002/ase.1329; Wood J, 2004, ACAD RADIOL, V11, P931, DOI 10.1016/j.acra.2004.04.015; WOOLLISCROFT JO, 1994, ACAD MED, V69, P216, DOI 10.1097/00001888-199403000-00017; Yang YY, 2013, J CHIN MED ASSOC, V76, P186, DOI 10.1016/j.jcma.2012.12.002; Yang YY, 2011, J CHIN MED ASSOC, V74, P198, DOI 10.1016/j.jcma.2011.03.003; Young ME, 2014, ADV HEALTH SCI EDUC, V19, P99, DOI 10.1007/s10459-013-9466-4; Yudkowsky R, 2006, ACAD MED, V81, P1115, DOI 10.1097/01.ACM.0000246752.00689.bf; Zhao YH, 2013, J SURG EDUC, V70, P628, DOI 10.1016/j.jsurg.2013.04.004; Zill JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112637	133	44	44	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177321	10.1371/journal.pone.0177321	http://dx.doi.org/10.1371/journal.pone.0177321			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498838	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500015
J	Akombi, BJ; Agho, KE; Merom, D; Renzaho, AM; Hall, JJ				Akombi, Blessing J.; Agho, Kingsley E.; Merom, Dafna; Renzaho, Andre M.; Hall, John J.			Child malnutrition in sub-Saharan Africa: A meta-analysis of demographic and health surveys (2006-2016)	PLOS ONE			English	Article							INCOME	Background Sub-Saharan Africa has one of the highest levels of child malnutrition globally. Therefore, a critical look at the distribution of malnutrition within its sub-regions is required to identify the worst affected areas. This study provides a meta-analysis of the prevalence of malnutrition indicators (stunting, wasting and underweight) within four sub-regions of sub-Saharan Africa. Methods Cross-sectional data from the most recent Demographic and Health Surveys (2006-2016) of 32 countries in sub-Saharan Africa were used. The countries were grouped into four subregions (East Africa, West Africa, Southern Africa and Central Africa), and a meta-analysis was conducted to estimate the prevalence of each malnutrition indicator within each of the sub-regions. Significant heterogeneity was detected among the various surveys (I-2 > 50%), hence a random effect model was used, and sensitivity analysis was performed, to examine the effects of outliers. Stunting was defined as HAZ<-2; wasting as WHZ<-2 and underweight as WAZ<-2. Results Stunting was highest in Burundi (57.7%) and Malawi (47.1%) in East Africa; Niger (43.9%), Mali (38.3%), Sierra Leone (37.9%) and Nigeria (36.8%) in West Africa; Democratic Republic of Congo (42.7%) and Chad (39.9%) in Central Africa. Wasting was highest in Niger (18.0%), Burkina Faso (15.50%) and Mali (12.7%) in West Africa; Comoros (11.1%) and Ethiopia (8.70%) in East Africa; Namibia (6.2%) in Southern Africa; Chad (13.0%) and Sao Tome & Principle (10.5%) in Central Africa. Underweight was highest in Burundi (28.8%) and Ethiopia (25.2%) in East Africa; Niger (36.4%), Nigeria (28.7%), Burkina Faso (25.7%), Mali (25.0%) in West Africa; and Chad (28.8%) in Central Africa. Conclusion The prevalence of malnutrition was highest within countries in East Africa and West Africa compared to the WHO Millennium development goals target for 2015. Appropriate nutrition interventions need to be prioritised in East Africa and West Africa if sub-Saharan Africa is to meet the WHO global nutrition target of improving maternal, infant and young child nutrition by 2025.	[Akombi, Blessing J.; Agho, Kingsley E.; Merom, Dafna] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Renzaho, Andre M.] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Hall, John J.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	Western Sydney University; Western Sydney University; University of New South Wales Sydney	Akombi, BJ (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	B.Akombi@westernsydney.edu.au	Agho, Kingsley/AAW-5622-2021; Merom, Dafna/AAW-5357-2021; Renzaho, Andre M.N./AAH-7679-2021; Agho, Kingsley/AAE-9971-2020; Akombi-Inyang, Blessing/AAT-6507-2020	Agho, Kingsley/0000-0003-4111-3207; Merom, Dafna/0000-0001-6459-8628; Akombi-Inyang, Blessing/0000-0002-6410-4154; RENZAHO, ANDRE/0000-0002-6844-0833; Hall, John/0000-0001-9839-5626	ARC Future Fellowship [FT110100345]	ARC Future Fellowship(Australian Research Council)	Professor Andre M. Renzaho is supported by an ARC Future Fellowship (FT110100345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is part of the first author's thesis for a doctoral dissertation with the School of Science and Health at the Western Sydney University, Australia. We are grateful to Measure DHS, ORC Macro, Calverton, MD, USA for providing all the DHS data for this analysis. Professor Andre M. Renzaho<SUP>2</SUP> is supported by an ARC Future Fellowship (FT110100345).	Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; De Onis M, 2006, WHO CHILD GROWTH STA; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; European Commission, 2016, NUTR FICH BUR; Fanzo J.., 2012, NUTR CHALLENGE SUBSA; FAO, 2015, REG OV FOOD INS AFR; Gillespie S, 2017, GLOBAL CHALLENG 0301; Hackett M, 2009, REV PANAM SALUD PUBL, V25, P506, DOI 10.1590/S1020-49892009000600006; Hollinger F., 2015, AGR GROWTH W AFRICA; Hunger Notes, 2016, HUNGER NOTES WORLD H; International Federation of Red Cross and Red Crescent Societies IFRCS, 2011, TACKL MALN NIG CAS S; Leroy JL, 2014, J NUTR, V144, P1460, DOI 10.3945/jn.114.191981; Lopriore C., 2003, FOOD SECURITY NUTR T; Mukhebi A., 2011, OVERVIEW FOOD SECURI; Mutisya M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2403-0; Nkunzimana T., 2016, POVERTY WELL BEING E, P61; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Ruel M. T., 2008, SCN News, P21; Salami A., 2010, SMALLHOLDER AGR E AF; Saxena NC, 2011, HUNGER NUTR FOOD SEC; Smith M., 1997, POPUL B WASHINGTON, V51, P1; StataCorp, 2015, STAT REL 14; UN, 2015, MILLENNIUM DEV GOALS; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; United Nations International Children's Fund, 2015, STAT WORLDS CHILDR S; WHO, 2010, WOR HEALT REP, P1	27	164	168	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177338	10.1371/journal.pone.0177338	http://dx.doi.org/10.1371/journal.pone.0177338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494007	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300090
J	Berruezo, F; de Souza, FSJ; Picca, PI; Nemirovsky, SI; Tosar, LM; Rivero, M; Mentaberry, AN; Zelada, AM				Berruezo, Florencia; de Souza, Flavio S. J.; Picca, Pablo I.; Nemirovsky, Sergio I.; Martinez Tosar, Leandro; Rivero, Mercedes; Mentaberry, Alejandro N.; Zelada, Alicia M.			Sequencing of small RNAs of the fern Pleopeltis minima (Polypodiaceae) offers insight into the evolution of the microrna repertoire in land plants	PLOS ONE			English	Article							MARCHANTIA-POLYMORPHA; GENOME; TARGETS; IDENTIFICATION; EXPRESSION; LIVERWORT; ORIGIN; MIRNAS; ALGAE; SIRNA	MicroRNAs (miRNAs) are short, single stranded RNA molecules that regulate the stability and translation of messenger RNAs in diverse eukaryotic groups. Several miRNA genes are of ancient origin and have been maintained in the genomes of animal and plant taxa for hundreds of millions of years, playing key roles in development and physiology. In the last decade, genome and small RNA (sRNA) sequencing of several plant species have helped unveil the evolutionary history of land plants. Among these, the fern group (monilophytes) occupies a key phylogenetic position, as it represents the closest extant cousin taxon of seed plants, i.e. gymno- and angiosperms. However, in spite of their evolutionary, economic and ecological importance, no fern genome has been sequenced yet and few genomic resources are available for this group. Here, we sequenced the small RNA fraction of an epiphytic South American fern, Pleopeltis minima (Polypodiaceae), and compared it to plant miRNA databases, allowing for the identification of miRNA families that are shared by all land plants, shared by all vascular plants (tracheophytes) or shared by euphyllophytes (ferns and seed plants) only. Using the recently described transcriptome of another fern, Lygodium japonicum, we also estimated the degree of conservation of fern miRNA targets in relation to other plant groups. Our results pinpoint the origin of several miRNA families in the land plant evolutionary tree with more precision and are a resource for future genomic and functional studies of fern miRNAs.	[Berruezo, Florencia; Martinez Tosar, Leandro; Mentaberry, Alejandro N.; Zelada, Alicia M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Agrobiotecnol, Buenos Aires, DF, Argentina; [de Souza, Flavio S. J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet Biol Mol Dr Hector N Torre, Buenos Aires, DF, Argentina; [de Souza, Flavio S. J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Picca, Pablo I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Nemirovsky, Sergio I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Inst Quim Biol,IQUIBICEN, Buenos Aires, DF, Argentina; [Martinez Tosar, Leandro; Mentaberry, Alejandro N.; Zelada, Alicia M.] Univ Buenos Aires, CONICET, IBBEA, Buenos Aires, DF, Argentina; [Rivero, Mercedes] Inst Agrobiotecnol Rosario INDEAR, Rosario, Santa Fe, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Zelada, AM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Agrobiotecnol, Buenos Aires, DF, Argentina.; Zelada, AM (corresponding author), Univ Buenos Aires, CONICET, IBBEA, Buenos Aires, DF, Argentina.	azelada@fbmc.fcen.uba.ar	de Souza, Flavio S J/H-7974-2013	de Souza, Flavio S J/0000-0002-6725-2873; Nemirovsky, Sergio I./0000-0003-4501-7052	National Agency for the Promotion of Science and Technology [ANPCyT-PICT 08-1481]; National Council for Scientific and Technological Research of Argentina [CONICET-PIP 11220110100715/12]	National Agency for the Promotion of Science and Technology(ANPCyT); National Council for Scientific and Technological Research of Argentina	This study was supported by the National Agency for the Promotion of Science and Technology (ANPCyT-PICT 08-1481) and the National Council for Scientific and Technological Research (CONICET-PIP 11220110100715/12) of Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Alaba S, 2015, NEW PHYTOL, V206, P352, DOI 10.1111/nph.13220; Arazi T, 2012, PLANT MOL BIOL, V80, P55, DOI 10.1007/s11103-011-9761-5; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Aya K, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu184; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Coruh C, 2015, PLANT CELL, V27, P2148, DOI 10.1105/tpc.15.00228; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Jagtap S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1049; Jones-Rhoades MW, 2012, PLANT MOL BIOL, V80, P3, DOI 10.1007/s11103-011-9829-2; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Koi S, 2016, CURR BIOL, V26, P1775, DOI 10.1016/j.cub.2016.05.013; Koszegi D, 2011, PLANT J, V67, P280, DOI 10.1111/j.1365-313X.2011.04592.x; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krasnikova MS, 2013, SCI WORLD J, DOI 10.1155/2013/924153; Li Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-122; Lin PC, 2016, PLANT CELL PHYSIOL, V57, P339, DOI 10.1093/pcp/pcw020; Llorente B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19036; Mai Morente P., 2014, THESIS U REPUBLICA U; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Morea EGO, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0716-5; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Pires ND, 2012, PHILOS T R SOC B, V367, P508, DOI 10.1098/rstb.2011.0252; Plavskin Y, 2012, Cold Spring Harb Symp Quant Biol, V77, P221, DOI 10.1101/sqb.2013.77.014878; Prado J, 2010, AM FERN J, V100, P189, DOI 10.1640/0002-8444-100.4.189; Proctor MCF, 2002, NEW PHYTOL, V156, P327, DOI 10.1046/j.1469-8137.2002.00526.x; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rodriguez RE, 2014, WIRES DEV BIOL, V3, P41, DOI 10.1002/wdev.115; Rovekamp M, 2016, CURR BIOL, V26, P1782, DOI 10.1016/j.cub.2016.05.028; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Sessa EB, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-15; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Taylor RS, 2014, TRENDS PLANT SCI, V19, P175, DOI 10.1016/j.tplants.2013.11.008; Tsuzuki M, 2016, PLANT CELL PHYSIOL, V57, P359, DOI 10.1093/pcp/pcv182; Vanneste K, 2015, PLANT CELL, V27, P1567, DOI 10.1105/tpc.15.00157; Vasco A, 2016, NEW PHYTOL, V212, P745, DOI 10.1111/nph.14075; Vasco A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00345; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Wan LC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-146; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wolf PG, 2015, GENOME BIOL EVOL, V7, P2533, DOI 10.1093/gbe/evv163; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Xia R, 2015, MOL BIOL EVOL, V32, P2905, DOI 10.1093/molbev/msv164; Zhang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127184; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	60	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							0177573	10.1371/journal.pone.0177573	http://dx.doi.org/10.1371/journal.pone.0177573			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494025	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300139
J	Rusterholz, PM; Hansen, PJ; Daugbjerg, N				Rusterholz, Pernille Moller; Hansen, Per Juel; Daugbjerg, Niels			Evolutionary transition towards permanent chloroplasts? - Division of kleptochloroplasts in starved cells of two species of Dinophysis (Dinophyceae)	PLOS ONE			English	Article							MIXOTROPHIC DINOFLAGELLATE; FOOD AVAILABILITY; CILIATE PREY; ACUMINATA; GROWTH; KLEPTOPLASTIDY; PHOTOSYNTHESIS; MESODINIUM; SURVIVAL; CAUDATA	Species within the marine toxic dinoflagellate genus Dinophysis are phagotrophic organisms that exploit chloroplasts (kleptochloroplasts) from other protists to perform photosynthesis. Dinophysis spp. acquire the kleptochloroplasts from the ciliate Mesodinium rubrum, which in turn acquires the chloroplasts from a unique clade of cryptophytes. Dinophysis spp. digest the prey nuclei and all other cell organelles upon ingestion (except the kleptochloroplasts) and they are therefore believed to constantly acquire new chloroplasts as the populations grow. Previous studies have, however, indicated that Dinophysis can keep the kleptochloroplasts active during long term starvation and are able to produce photosynthetic pigments when exposed to prey starvation. This indicates a considerable control over the kleptochloroplasts and the ability of Dinophysis to replicate its kleptochloroplasts was therefore re- investigated in detail in this study. The kleptochloroplasts of Dinophysis acuta and Dinophysis acuminata were analyzed using confocal microscopy and 3D bioimaging software during long term starvation experiments. The cell concentrations were monitored to confirm cell divisions and samples were withdrawn each time a doubling had occurred. The results show direct evidence of kleptochloroplastidic division and that the decreases in total kleptochloroplast volume, number of kleptochloroplasts and number of kleptochloroplast centers were not caused by dilution due to cell divisions. This is the first report of division of kleptochloroplasts in any protist without the associated prey nuclei. This indicates that Dinophysis spp. may be in a transitional phase towards possessing permanent chloroplasts, which thereby potentially makes it a key organism to understand the evolution of phototrophic protists.	[Rusterholz, Pernille Moller; Hansen, Per Juel; Daugbjerg, Niels] Univ Copenhagen, Marine Biol Sect, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Daugbjerg, N (corresponding author), Univ Copenhagen, Marine Biol Sect, Dept Biol, Copenhagen, Denmark.	n.daugbjerg@bio.ku.dk	Hansen, Per Juel/AAX-6193-2020; Hansen, Per J/E-9969-2011; Daugbjerg, Niels/D-3521-2014	Hansen, Per Juel/0000-0003-0228-9621; Hansen, Per J/0000-0003-0228-9621; Daugbjerg, Niels/0000-0002-0397-3073	Danish Council for Independent Research, grant [4181-00484]	Danish Council for Independent Research, grant	This study was partly supported by the Danish Council for Independent Research, grant number 4181-00484 to PJH. ND thanks the Villum Kann Rasmussen Foundation for an equipment grant.	Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Bhattacharya D, 2008, J PHYCOL, V44, P7, DOI 10.1111/j.1529-8817.2007.00433.x; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Garcia-Cuetos L, 2010, HARMFUL ALGAE, V9, P25, DOI 10.1016/j.hal.2009.07.002; Guillard RRL, 1983, CULTURE MARINE INVER, P123; Hansen PJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00785; Hansen PJ, 2013, HARMFUL ALGAE, V28, P126, DOI 10.1016/j.hal.2013.06.004; Hattenrath-Lehmann T, 2015, LIMNOL OCEANOGR, V60, P1588, DOI 10.1002/lno.10119; Kim M, 2012, J PHYCOL, V48, P569, DOI 10.1111/j.1529-8817.2012.01150.x; Koike K, 2005, PROTIST, V156, P225, DOI 10.1016/j.protis.2005.04.002; LUCAS IAN, 1990, J PHYCOL, V26, P345, DOI 10.1111/j.0022-3646.1990.00345.x; Minnhagen S, 2008, ENVIRON MICROBIOL, V10, P2411, DOI 10.1111/j.1462-2920.2008.01666.x; Minnhagen S, 2011, AQUAT MICROB ECOL, V62, P99, DOI 10.3354/ame01459; Nielsen LT, 2013, HARMFUL ALGAE, V23, P34, DOI 10.1016/j.hal.2012.12.004; Nielsen LT, 2012, MAR ECOL PROG SER, V471, P37, DOI 10.3354/meps10027; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; Riisgaard K, 2009, MAR ECOL PROG SER, V381, P51, DOI 10.3354/meps07953; Sanchez-Puerta MV, 2007, PROTIST, V158, P105, DOI 10.1016/j.protis.2006.09.004; Slamovits CH, 2008, MOL BIOL EVOL, V25, P1297, DOI 10.1093/molbev/msn075; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Stoecker DK, 2016, ANNU REV MAR SCI, V9, P1; Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Tong MM, 2015, AQUAT MICROB ECOL, V75, P169, DOI 10.3354/ame01757; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366	24	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177512	10.1371/journal.pone.0177512	http://dx.doi.org/10.1371/journal.pone.0177512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493958	Green Published, gold			2022-12-27	WOS:000401314300125
J	Jensen, EM; Sevatdal, S; Bakke, MJ; Kaur, K; Horsberg, TE				Jensen, Elena Myhre; Sevatdal, Sigmund; Bakke, Marit Jorgensen; Kaur, Kiranpreet; Horsberg, Tor Einar			A selection study on a laboratory-designed population of salmon lic (Lepeophtheirus salmonis) using organophosphate and pyrethroid pesticides	PLOS ONE			English	Article							SEA LICE; ATLANTIC SALMON; ACETYLCHOLINESTERASE; DELTAMETHRIN; SALAR; INFECTIONS; RESISTANCE; CRUSTACEA; BIOMARKER; EXPOSURE	Resistance towards antiparasitic agents in the salmon louse (Lepeophtheirus salmonis) is a widespread problem along the Norwegian coast, reducing treatments efficacies and slowing down the envisioned expansion of Norwegian salmon production. The present study was conducted in order to assess the efficacies of two of the most widely used anti-parasitic substances -azamethiphos and deltamethrin-as well as assessing the benefit of having a resistant genotype compared to being fully sensitive when exposed to one of these substances. Atlantic salmon were exposed to a mix of salmon lice copepodids from a fully sensitive, a double resistant and a multi-resistant strain. Once the lice reached pre-adult stages, one group was exposed to 100 mu g/L azamethiphos for 60 minutes, the other to 2 mu g/L deltamethrin for 30 minutes, and the last was kept in a seawater control. Detached lice were collected at a series of time points following exposure, and all lice (immobilized and surviving) were analysed for both pyrethroid (sensitive "S" and resistant "R") and azamethiphos (fully sensitive "SS", heterozygous resistant "RS" and fully resistant "RR") resistance markers. We found that the efficacies of deltamethrin on parasites with genotype S and R were 70.3 and 13.2%, respectively. The overall efficacy of the deltamethrin treatment was 32.3%. The efficacies of azamethiphos on parasites with genotype SS, RS and RR were 100, 80 and 19.1%, respectively. The overall efficacy of the azamethiphos treatment was 80.4%. Survival analyses revealed that the median survival time in deltamethrin-sensitive and-resistant parasites were 16.8 and > 172 hours, respectively. The differences were even more pronounced in the azamethiphos-treated group, where SS, RS and RR parasites survived for 0.26, 6.6 and > 172 hours, respectively. The substantial differences in survival between sensitive and resistant lice following treatment demonstrate the ability of medicinal treatments to drive genetic selection towards a much more resistant salmon lice population within a very short time span if there is no influx of sensitive genotypes.	[Jensen, Elena Myhre; Bakke, Marit Jorgensen; Kaur, Kiranpreet; Horsberg, Tor Einar] Norwegian Univ Life Sci, Sea Lice Res Ctr, Fac Vet Med, Oslo, Norway; [Sevatdal, Sigmund] VESO, Oslo, Norway	Norwegian University of Life Sciences	Jensen, EM (corresponding author), Norwegian Univ Life Sci, Sea Lice Res Ctr, Fac Vet Med, Oslo, Norway.	elena.myhre.jensen@nmbu.no	Kaur, Kiran/R-3535-2018	Kaur, Kiran/0000-0002-7285-5513	Norwegian Seafood Research Fund - FHF [900838]; Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre [NFR 203513/030]	Norwegian Seafood Research Fund - FHF; Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre	The study was financially supported by the Norwegian Seafood Research Fund - FHF, grant number 900838. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The financial support was provided as support for rental of vet-lab capacities. The study was also financially supported by the Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre, grant number NFR 203513/030. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and provided only financial support in the form of salaries to [EMJ, KK & MJB]. One of the authors of the study [SS] is employed by the commercial company VESO, Oslo, Norway, and contributed to study design, data collection and preparation of the manuscript. The company VESO, however, had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific role of each author is articulated in the 'author contributions' section.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Altman DG, 1992, PRACTICAL STAT MED R, P365; [Anonymous], 2016, STATUS NORSKE LAKSEB; Badiou A, 2008, CHEM-BIOL INTERACT, V175, P406, DOI 10.1016/j.cbi.2008.05.040; Bjorn PA, 1998, CAN J ZOOL, V76, P970, DOI 10.1139/cjz-76-5-970; Corbett JR, 1974, BIOCH MODE ACTION PE; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Fallang A, 2004, PEST MANAG SCI, V60, P1163, DOI 10.1002/ps.932; Fast MD, 2006, FISH SHELLFISH IMMUN, V21, P228, DOI 10.1016/j.fsi.2005.11.010; Grimnes A, 1996, J FISH BIOL, V48, P1179, DOI 10.1111/j.1095-8649.1996.tb01813.x; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Hartl DL, 2006, PRINCIPLES POPULATIO; Heuch PA, 2003, J FISH DIS, V26, P539, DOI 10.1046/j.1365-2761.2003.00490.x; Hossain MM, 2004, NEUROTOXICOLOGY, V25, P825, DOI 10.1016/j.neuro.2004.01.002; Tu HT, 2012, CHEMOSPHERE, V86, P83, DOI 10.1016/j.chemosphere.2011.09.022; Jansen PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149006; Kaur K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149264; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Liu YJ, 2014, PREV VET MED, V117, P469, DOI 10.1016/j.prevetmed.2014.08.018; Mattilsynet, RETH MIDL RED GODKJ; McEwan GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139128; Nilsen F. E., 2013, Patent application, Patent No. [CA2920588A1, 2920588]; Nolan DT, 1999, CAN J FISH AQUAT SCI, V56, P947, DOI 10.1139/cjfas-56-6-947; Sevatdal S, 2005, PEST MANAG SCI, V61, P772, DOI 10.1002/ps.1057; Sevatdal S, 2003, AQUACULTURE; SHI MA, 2004, BMC EVOLUT BIOL, V4, P1; Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x; Tarpai R. N, 2016, SURVEILLANCE PROGRAM; Toumi H, 2015, CHEMOSPHERE, V120, P351, DOI 10.1016/j.chemosphere.2014.07.087	32	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178068	10.1371/journal.pone.0178068	http://dx.doi.org/10.1371/journal.pone.0178068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531206	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000402058400056
J	Lv, FS; Yang, XP; Cui, CJ; Su, CH				Lv, Fengshou; Yang, Xiaopeng; Cui, Chuanju; Su, Chunhe			Exogenous expression of Drp1 plays neuroprotective roles in the Alzheimer ' s disease in the A beta 42 transgenic Drosophila model	PLOS ONE			English	Article							INDUCED MITOCHONDRIAL DYSFUNCTION; AMYLOID PRECURSOR PROTEIN; DYNAMIN-RELATED PROTEIN-1; ABNORMAL INTERACTION; SYNAPTIC DAMAGE; FISSION; BETA; TAU; PHOSPHORYLATION; INHIBITION	Background Alzheimer's disease (AD) is one of the most common neurodegenerative disorders. Recent studies have shown that mitochondrial dysfunction is a causative factor of AD. Drp1 (Dynamin- related protein 1), a regulator of mitochondrial fission, shows neuroprotective effects on Parkinson's disease. In this study, we investigate the effect and mechanism of Drp1 on A beta 42 transgenic Drosophila. Methods Elav-gal4/UAS>A beta 42 transgenic Drosophila model was constructed using Elav-gal4 promoter. The effects of Drp1 on the lifespan, motor ability and neuronal degeneration of the transgenic Drosophila were explored by over-expressing Drp1 in the A beta 42 transgenic Drosophila. ATP levels in the brain tissues of A beta 42 transgenic Drosophila were detected using high performance liquid chromatography (HPLC). Results Exogenous expression of Drp1 promoted crawling ability, reduced the levels of ATP in Drosophila brain and suppressed the neuronal degeneration. Conclusion The protective effect of Drp1 on the A beta 42 transgenic Drosophila was achieved by protecting the mitochondrial function, suggesting that Drp1 may be a potential therapeutic strategies for AD.	[Lv, Fengshou] Henan Med Coll, Dept Pathol, Zhengzhou, Peoples R China; [Yang, Xiaopeng; Su, Chunhe] Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou, Peoples R China; [Cui, Chuanju] Zhengzhou First Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China	Henan Medical College; Zhengzhou University	Yang, XP (corresponding author), Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou, Peoples R China.	xiaopengyang1233@163.com						Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Filichia E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32656; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; Kandimalla RJL, 2011, CURR ALZHEIMER RES, V8, P187; Kandimalla R, 2016, HUM MOL GENET, V25, P4881, DOI 10.1093/hmg/ddw312; Kandimalla R, 2016, BBA-MOL BASIS DIS, V1862, P814, DOI 10.1016/j.bbadis.2015.12.018; Kandimalla RJ, 2014, CURR ALZHEIMER RES, V11, P340, DOI 10.2174/1567205011666140331161027; Kandimalla RJ PS, 2013, BIOL OPEN; Kim B, 2016, FREE RADICAL BIO MED, V90, P184, DOI 10.1016/j.freeradbiomed.2015.11.015; Kim DI, 2016, BBA-MOL CELL RES, V1863, P2820, DOI 10.1016/j.bbamcr.2016.09.003; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Manczak M, 2016, HUM MOL GENET, V25, P5148, DOI 10.1093/hmg/ddw330; Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244; Verri M, 2012, INT J IMMUNOPATH PH, V25, P345, DOI 10.1177/039463201202500204; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Xie N, 2014, NEUROSCIENCE, V256, P36, DOI 10.1016/j.neuroscience.2013.10.011; Yan J, 2015, NEUROBIOL AGING, V36, P211, DOI 10.1016/j.neurobiolaging.2014.08.005	26	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176183	10.1371/journal.pone.0176183	http://dx.doi.org/10.1371/journal.pone.0176183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531191	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400003
J	Tzeng, HP; Lan, KC; Yang, TH; Chung, MN; Liu, SH				Tzeng, Huei-Ping; Lan, Kuo-Cheng; Yang, Ting-Hua; Chung, Min-Ni; Liu, Shing Hwa			Benzo[a] pyrene activates interleukin-6 induction and suppresses nitric oxide-induced apoptosis in rat vascular smooth muscle cells	PLOS ONE			English	Article							NF-KAPPA-B; POLYCYCLIC AROMATIC-HYDROCARBONS; NECROSIS-FACTOR-ALPHA; ANGIOTENSIN-II; UP-REGULATION; IN-VITRO; EXPRESSION; ATHEROSCLEROSIS; GENE; PROLIFERATION	Benzo[a] pyrene, a ubiquitous environmental pollutant, has been suggested to be capable of initiating and/or accelerating atherosclerosis. Accumulation of vascular smooth muscle cells (VSMCs) in vessel intima is a hallmark of atherosclerosis. Nitric oxide (NO) can suppress VSMCs proliferation and induce VSMCs apoptosis. NO plays a compensatory role in the vascular lesions to reduce proliferation and/or accelerate apoptosis of VSMCs. The aim of this study was to investigate whether benzo[a] pyrene can affect VSMCs growth and apoptosis induced by NO. Benzo[a] pyrene (1-30 mu mol/L) did not affect the cell number and cell cycle distribution in VSMCs under serum deprivation condition. Sodium nitroprusside (SNP), a NO donor, decreased cell viability and induced apoptosis in VSMCs. Benzo[a] pyrene significantly suppressed SNP-induced cell viability reduction and apoptosis. VSMCs cultured in conditioned medium from cells treated with benzo[a] pyrene could also prevent SNP-induced apoptosis. Benzo[a] pyrene was capable of inducing the activation of nuclear factor (NF)-kappa B and phosphorylation of p38 mitogen-activated protein kinase (MAPK) in VSMCs. Both NF-kappa B inhibitor and p38 MAPK inhibitor significantly reversed the anti-apoptotic effect of benzo[a] pyrene on SNP-treated VSMCs. Incubation of VSMCs with benzo[a] pyrene significantly and dose-dependently increased interleukin (IL)-6 production. A neutralizing antibody to IL-6 effectively reversed the anti-apoptotic effect of benzo[a] pyrene on SNP-treated VSMCs. Taken together, these results demonstrate for the first time that benzo[a] pyrene activates IL-6 induction and protects VSMCs from NO-induced apoptosis. These findings propose a new mechanism for the atherogenic effect of benzo[a] pyrene.	[Tzeng, Huei-Ping; Chung, Min-Ni; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan; [Lan, Kuo-Cheng] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Yang, Ting-Hua] Natl Taiwan Univ, Coll Med, Dept Otolaryngol, Taipei, Taiwan; [Yang, Ting-Hua] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan.; Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan.; Liu, SH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	shinghwaliu@ntu.edu.tw		LIU, SHING-HWA/0000-0002-9976-1197	Ministry of Science and Technology of Taiwan [MOST103-2314-B-002-035]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grant from the Ministry of Science and Technology of Taiwan (MOST103-2314-B-002-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Amrani Y, 2001, MOL PHARMACOL, V60, P646; Andres V, 1998, INT J MOL MED, V2, P81; Bangia KS, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0039-2; Baraldi E, 1997, J PEDIATR-US, V131, P381, DOI 10.1016/S0022-3476(97)80062-5; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Browatzki M, 2000, BASIC RES CARDIOL, V95, P98, DOI 10.1007/s003950050170; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Curfs DMJ, 2005, FASEB J, V19, P1290, DOI 10.1096/fj.04-2269fje; Funakoshi Y, 1999, HYPERTENSION, V34, P118, DOI 10.1161/01.HYP.34.1.118; Geng YJ, 1996, ARTERIOSCL THROM VAS, V16, P19, DOI 10.1161/01.ATV.16.1.19; HANSSON GK, 1994, J EXP MED, V180, P733, DOI 10.1084/jem.180.2.733; Hardonniere K, 2015, TOXICOL IN VITRO, V29, P1597, DOI 10.1016/j.tiv.2015.06.010; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; HOUGH JL, 1993, ARTERIOSCLER THROMB, V13, P1721, DOI 10.1161/01.ATV.13.12.1721; Hu TT, 2016, ENVIRON TOXICOL PHAR, V43, P54, DOI 10.1016/j.etap.2016.02.011; Hung MJ, 2010, J HYPERTENS, V28, P940, DOI 10.1097/HJH.0b013e32833992ef; Inanaga K, 2009, HYPERTENS RES, V32, P466, DOI 10.1038/hr.2009.47; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; Ito T, 2000, CIRCULATION, V102, P2522, DOI 10.1161/01.CIR.102.20.2522; Kapadia MR, 2009, NITRIC OXIDE-BIOL CH, V20, P279, DOI 10.1016/j.niox.2009.02.005; Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1; Kim YM, 1999, CIRC RES, V84, P253, DOI 10.1161/01.RES.84.3.253; KWON NS, 1994, FASEB J, V8, P529, DOI 10.1096/fasebj.8.8.8181671; Lau HKF, 2003, ATHEROSCLEROSIS, V166, P223, DOI 10.1016/S0021-9150(02)00333-7; Lee WY, 2007, AM J CARDIOL, V99, P99, DOI 10.1016/j.amjcard.2006.07.070; Li CH, 2010, TOXICOL SCI, V118, P544, DOI 10.1093/toxsci/kfq279; Li H, 2014, EXP BIOL MED, V239, P954, DOI 10.1177/1535370214527903; LOPPNOW H, 1990, J CLIN INVEST, V85, P731, DOI 10.1172/JCI114498; MAJESKY MW, 1990, TOXICOL PATHOL, V18, P554; Sanmarco LM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00626; Mehrhof FB, 2005, CIRC RES, V96, P958, DOI 10.1161/01.RES.0000166924.31219.49; Mikhailenko V. M., 2013, Experimental Oncology, V35, P318; MONCADA S, 1991, PHARMACOL REV, V43, P109; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Nicotera P, 1997, TRENDS PHARMACOL SCI, V18, P189, DOI 10.1016/S0165-6147(97)90619-2; Nishio E, 1996, BIOCHEM BIOPH RES CO, V221, P163, DOI 10.1006/bbrc.1996.0563; Oesterling E, 2008, TOXICOL APPL PHARM, V232, P309, DOI 10.1016/j.taap.2008.07.001; Park H, 2003, ANN NY ACAD SCI, V1005, P242, DOI 10.1196/annals.1288.036; Popowich DA, 2010, AM J PHYSIOL-HEART C, V298, pH2192, DOI 10.1152/ajpheart.00535.2009; Ramachandran A, 2002, P NATL ACAD SCI USA, V99, P6643, DOI 10.1073/pnas.102019899; Ramos KS, 1996, ARCH BIOCHEM BIOPHYS, V332, P213, DOI 10.1006/abbi.1996.0335; Ratajczak-Wrona W, 2013, INT J ORAL SCI, V5, P141, DOI 10.1038/ijos.2013.59; Sato S, 2014, SCI WORLD J, V2014; SCHWARZE MMK, 1995, CANCER RES, V55, P2262; SEINO Y, 1994, CYTOKINE, V6, P87, DOI 10.1016/1043-4666(94)90013-2; Snyder CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007059; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; TANABE O, 1988, J IMMUNOL, V141, P3875; Tokunou T, 2001, ARTERIOSCL THROM VAS, V21, P1759, DOI 10.1161/hq1101.098489; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Tzeng HP, 2003, TOXICOL SCI, V75, P66, DOI 10.1093/toxsci/kfg164; VONDERLEYEN HE, 1995, P NATL ACAD SCI USA, V92, P1137, DOI 10.1073/pnas.92.4.1137; Wang G, 2015, J PHYSIOL-LONDON, V593, P3013, DOI 10.1113/JP270033; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Xia P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9583268; Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949; Yan ZQ, 1996, CIRC RES, V79, P38, DOI 10.1161/01.RES.79.1.38; Zahradka P, 2002, J MOL CELL CARDIOL, V34, P1609, DOI 10.1006/jmcc.2002.2111; Zhao M, 2002, ARCH BIOCHEM BIOPHYS, V400, P199, DOI 10.1016/S0003-9861(02)00028-0	66	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178063	10.1371/journal.pone.0178063	http://dx.doi.org/10.1371/journal.pone.0178063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531207	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400055
J	Angelini, O; Cristelli, M; Zaccaria, A; Pietronero, L				Angelini, Orazio; Cristelli, Matthieu; Zaccaria, Andrea; Pietronero, Luciano			The complex dynamics of products and its asymptotic properties	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; SOPHISTICATION	We analyse global export data within the Economic Complexity framework. We couple the new economic dimension Complexity, which captures how sophisticated products are, with an index called logPRODY, a measure of the income of the respective exporters. Products' aggregate motion is treated as a 2-dimensional dynamical system in the Complexity-logPRODY plane. We find that this motion can be explained by a quantitative model involving the competition on the markets, that can be mapped as a scalar field on the Complexity-logPRODY plane and acts in a way akin to a potential. This explains the movement of products towards areas of the plane in which the competition is higher. We analyse market composition in more detail, finding that for most products it tends, over time, to a characteristic configuration, which depends on the Complexity of the products. This market configuration, which we called asymptotic, is characterized by higher levels of competition.	[Angelini, Orazio; Cristelli, Matthieu; Zaccaria, Andrea; Pietronero, Luciano] CNR, Inst Complex Syst, ISC, Rome, Italy; [Pietronero, Luciano] Sapienza Univ Rome, Phys Dept, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome	Angelini, O (corresponding author), CNR, Inst Complex Syst, ISC, Rome, Italy.	angelini.orazio@gmail.com	Pietronero, Luciano/O-4473-2018; Zaccaria, Andrea/F-8476-2018	Pietronero, Luciano/0000-0001-6424-8863; Zaccaria, Andrea/0000-0002-4478-3292	CNR Progetto di Interesse CRISIS LAB; EU [611272 GROWTHCOM]	CNR Progetto di Interesse CRISIS LAB; EU(European Commission)	This work was supported by CNR Progetto di Interesse CRISIS LAB http://www.crisislab.it) and EU Project nr. 611272 GROWTHCOM (http://www.growthcom.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Battiston C., 2014, COMPLEXECONOMIC TIME, V41, P1; Cadot O, 2011, REV ECON STAT, V93, P590, DOI 10.1162/REST_a_00078; Caldarelli G, 2013, NAT PHYS, V9, P125, DOI 10.1038/nphys2580; Cristelli M, 2014, GROWTH SCENARI UNPUB; Cristelli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117174; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Dominguez-Garcia V, 2015, SCI REP-UK, V5, DOI 10.1038/srep08182; DOSI G, 1988, J ECON LIT, V26, P1120; Feenstra R. C., 2005, WORLD TRADE FLOWS 19; Gaulier G, 2010, SSRN ELECT J; Ghani E, 2011, CAN SERVICES NEXT GR; Goldstein H., 2007, CLASSICAL MECH; Hausmann R, 2007, J ECON GROWTH, V12, P1, DOI 10.1007/s10887-006-9009-4; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Jarreau J., 2009, J ECON SURV, V7, P149; Jarreau J, 2012, J DEV ECON, V97, P281, DOI 10.1016/j.jdeveco.2011.04.001; KELLY WA, 1981, SOUTHERN ECON J, V48, P50, DOI 10.2307/1058595; Kim WC, 2005, CALIF MANAGE REV, V47, P105, DOI 10.2307/41166308; Klimek P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038924; Lall S, 2006, WORLD DEV, V34, P222, DOI 10.1016/j.worlddev.2005.09.002; LORENZ EN, 1969, J ATMOS SCI, V26, P636, DOI 10.1175/1520-0469(1969)26<636:APARBN>2.0.CO;2; Mariani MS, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60298-7; Minondo A., EMPIRICAL EC LETT, P331; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; OECD, OECD TRAD VAL ADD DA; Page L., 1998, PAGERANK CITATION RA, DOI [10.1007/978-3-319-08789-4_10, DOI 10.1007/978-3-319-08789-4_10]; Pugliese E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168540; Pugliese E, 2016, EUR PHYS J-SPEC TOP, V225, P1893, DOI 10.1140/epjst/e2015-50118-1; Ranganathan S, 2014, PLOS ONE, V9; Rhoades S., 1993, FEDERAL RES B, V79, P188; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; TEECE DJ, 1994, J ECON BEHAV ORGAN, V23, P1, DOI 10.1016/0167-2681(94)90094-9; United Nations Statistics Division, CLASS REG; Wu RJ, 2016, PHYSICA A, V460, P254, DOI 10.1016/j.physa.2016.05.023; Zaccaria A, 2016, J ECON INTERACT COOR, V11, P151, DOI 10.1007/s11403-015-0145-9; Zaccaria A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113770	40	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177360	10.1371/journal.pone.0177360	http://dx.doi.org/10.1371/journal.pone.0177360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520794	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700042
J	Chen, YC; Chen, KD; Su, MC; Chin, CH; Chen, CJ; Liou, CW; Chen, TW; Chang, YC; Huang, KT; Wang, CC; Wang, TY; Chang, JC; Lin, YY; Zheng, YX; Lin, MC; Hsiao, CC				Chen, Yung-Che; Chen, Kuang-Den; Su, Mao-Chang; Chin, Chien-Hung; Chen, Chung-Jen; Liou, Chia-Wei; Chen, Ting-Wen; Chang, Ya-Chun; Huang, Kuo-Tung; Wang, Chin-Chou; Wang, Ting-Ya; Chang, Jen-Chieh; Lin, Yong-Yong; Zheng, Yi-Xin; Lin, Meng-Chih; Hsiao, Chang-Chun			Genome-wide gene expression array identifies novel genes related to disease severity and excessive daytime sleepiness in patients with obstructive sleep apnea	PLOS ONE			English	Article							NEUTROPHIL APOPTOSIS; INTERMITTENT HYPOXIA; ENDOTHELIAL FUNCTION; GALIG; CELLS; RISK	We aimed to identify novel molecular associations between chronic intermittent hypoxia with re-oxygenation and adverse consequences in obstructive sleep apnea (OSA). We analyzed gene expression profiles of peripheral blood mononuclear cells from 48 patients with sleep-disordered breathing stratified into four groups: primary snoring (PS), moderate to severe OSA (MSO), very severe OSA (VSO), and very severe OSA patients on long-term continuous positive airway pressure treatment (VSOC). Comparisons of the microarray gene expression data identified eight genes up-regulated with OSA and down-regulated with CPAP treatment, and five genes down-regulated with OSA and up-regulated with CPAP treatment. Protein expression levels of two genes related to endothelial tight junction (AMOT P130, and PLEKHH3), and three genes related to anti-or pro-apoptosis (BIRC3, ADAR1 P150, and LGALS3) were all increased in the VSO group, while AMOT P130 was further increased, and PLEKHH3, BIRC3, and ADAR1 P150 were all decreased in the VSOC group. Subgroup analyses revealed that AMOT P130 protein expression was increased in OSA patients with excessive daytime sleepiness, BIRC3 protein expression was decreased in OSA patients with hypertension, and LGALS3 protein expression was increased in OSA patients with chronic kidney disease. In vitro short-term intermittent hypoxia with re-oxygenation experiment showed immediate over-expression of ADAR1 P150. In conclusion, we identified a novel association between AMOT/PLEKHH3/BIRC3/ADAR1/LGALS3 over-expressions and high severity index in OSA patients. AMOT and GALIG may constitute an important determinant for the development of hypersomnia and kidney injury, respectively, while BIRC3 may play a protective role in the development of hypertension.	[Chen, Yung-Che; Su, Mao-Chang; Chin, Chien-Hung; Chang, Ya-Chun; Huang, Kuo-Tung; Wang, Chin-Chou; Wang, Ting-Ya; Lin, Yong-Yong; Zheng, Yi-Xin; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Chen, Yung-Che; Chen, Kuang-Den; Su, Mao-Chang; Chin, Chien-Hung; Chen, Chung-Jen; Liou, Chia-Wei; Chang, Ya-Chun; Huang, Kuo-Tung; Wang, Chin-Chou; Wang, Ting-Ya; Chang, Jen-Chieh; Lin, Yong-Yong; Zheng, Yi-Xin; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Yung-Che; Su, Mao-Chang; Chin, Chien-Hung; Chang, Ya-Chun; Huang, Kuo-Tung; Wang, Chin-Chou; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Sleep Ctr, Kaohsiung, Taiwan; [Chen, Yung-Che; Lin, Meng-Chih] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Chen, Kuang-Den; Chang, Jen-Chieh] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Su, Mao-Chang; Wang, Chin-Chou] Chang Gung Univ Sci & Technol, Chiayi, Taiwan; [Chen, Chung-Jen] Kaohsiung Chang Gung Mem Hosp, Div Rheumatol, Kaohsiung, Taiwan; [Liou, Chia-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chen, Ting-Wen] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Chen, Ting-Wen] Chang Gung Univ, Bioinformat Ctr, Taoyuan, Taiwan; [Hsiao, Chang-Chun] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Hsiao, Chang-Chun] Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Sleep Ctr, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Chang Gung Univ, Dept Med, Taoyuan, Taiwan.; Hsiao, CC (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.; Hsiao, CC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Kaohsiung, Taiwan.	mengchihlin@hotmail.com; cchsiao@mail.cgu.edu.tw	Chen, Ting-Wen/AAY-8473-2020; Chen, Yung-Che/AAL-5167-2020	Chen, Ting-Wen/0000-0003-4028-2375; Chen, Yung-Che/0000-0001-8695-5227; Hsiao, Chang-Chun/0000-0002-7275-4675	Ministry of Science and Technology, Taiwan [NMRPG8D6131/103-2314-B-182A-094-MY2, NMRPG8B6192/101-2314-B-182A-130-MY2]; Chang Gung Memorial Hospital [CMRPG8C1181-1182]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the Ministry of Science and Technology, Taiwan (NMRPG8D6131/103-2314-B-182A-094-MY2 & NMRPG8B6192/101-2314-B-182A-130-MY2 to M. C. Lin) and grants from Chang Gung Memorial Hospital (CMRPG8C1181-1182 to M.C. Lin), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bruno RM, 2013, J HYPERTENS, V31, P1456, DOI 10.1097/HJH.0b013e328360f773; Calandria JM, 2015, CELL DEATH DIFFER; Chen YC, 2015, SLEEP BREATH, V19, P873, DOI 10.1007/s11325-014-1116-4; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057053; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Duneau M, 2005, EXP CELL RES, V302, P194, DOI 10.1016/j.yexcr.2004.08.041; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Dyugovskaya L, 2008, AM J RESP CRIT CARE, V177, P544, DOI 10.1164/rccm.200705-675OC; Dyugovskaya L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-211; Dyugovskaya L, 2011, AM J RESP CELL MOL, V45, P154, DOI 10.1165/rcmb.2010-0025OC; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; George CX, 2014, J INTERF CYTOK RES, V34, P437, DOI 10.1089/jir.2014.0001; Hoffmann MS, 2007, ANTIOXID REDOX SIGN, V9, P661, DOI 10.1089/ars.2007.1589; Jennum P, 2015, NAT SCI SLEEP, V7, P43, DOI 10.2147/NSS.S75166; Khalyfa A, 2010, AM J RESP CRIT CARE, V181, P1114, DOI 10.1164/rccm.200909-1398OC; Khalyfa A, 2009, SLEEP MED, V10, P75, DOI 10.1016/j.sleep.2007.11.006; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Mollet L, 2013, MOL IMMUNOL, V56, P123, DOI 10.1016/j.molimm.2013.04.012; Nigita G, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00037; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Robinet P, 2010, BIOCHEM BIOPH RES CO, V392, P53, DOI 10.1016/j.bbrc.2009.12.162; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Scheffzek K, 2012, FEBS LETT, V586, P2662, DOI 10.1016/j.febslet.2012.06.006; Song CM, 2012, ACTA OTO-LARYNGOL, V132, pS63, DOI 10.3109/00016489.2012.660729; Uyar M, 2015, SLEEP BREATH; Xia Y, 2015, ONCOTARGET, V6, P5426, DOI 10.18632/oncotarget.3101; Xu HJ, 2015, RESP CARE, V60, P749, DOI 10.4187/respcare.03739; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zaniewska M, 2015, J NEUROCHEM	32	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176575	10.1371/journal.pone.0176575	http://dx.doi.org/10.1371/journal.pone.0176575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520763	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700022
J	Loch, G; Zinke, I; Mori, T; Carrera, P; Schroer, J; Takeyama, H; Hoch, M				Loch, Gerrit; Zinke, Ingo; Mori, Tetsushi; Carrera, Pilar; Schroer, Jonas; Takeyama, Haruko; Hoch, Michael			Antimicrobial peptides extend lifespan in Drosophila	PLOS ONE			English	Article							INNATE IMMUNE HOMEOSTASIS; STEM-CELL PROLIFERATION; HOST-DEFENSE; BACTERIAL-INFECTION; TISSUE HOMEOSTASIS; ORAL INFECTION; GUT; MELANOGASTER; SYSTEM; EXPRESSION	Antimicrobial peptides (AMPs) are important defense molecules of the innate immune system. High levels of AMPs are induced in response to infections to fight pathogens, whereas moderate levels induced by metabolic stress are thought to shape commensal microbial communities at barrier tissues. We expressed single AMPs in adult flies either ubiquitously or in the gut by using the inducible GeneSwitch system to tightly regulate AMP expression. We found that activation of single AMPs, including Drosocin, resulted in a significant extension of Drosophila lifespan. These animals showed reduced activity of immune pathways over lifetime, less intestinal regenerative processes, reduced stress response and a delayed loss of gut barrier integrity. Furthermore, intestinal Drosocin induction protected the animals against infections with the natural Drosophila pathogen Pseudomonas entomophila, whereas a germ-reduced environment prevented the lifespan extending effect of Drosocin. Our study provides new insights into the crosstalk of innate immunity, intestinal homeostasis and ageing.	[Loch, Gerrit; Carrera, Pilar; Schroer, Jonas; Hoch, Michael] Univ Bonn, Life & Med Sci Inst LIMES, Mol Dev Biol, Bonn, Germany; [Zinke, Ingo] Univ Bonn, Life & Med Sci Inst LIMES, Mol Brain Physiol & Behav, Bonn, Germany; [Mori, Tetsushi; Takeyama, Haruko] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	University of Bonn; University of Bonn; Waseda University	Hoch, M (corresponding author), Univ Bonn, Life & Med Sci Inst LIMES, Mol Dev Biol, Bonn, Germany.	m.hoch@uni-bonn.de	Mori, Tetsushi/C-1973-2017; Mori, Tetsushi/AAN-5656-2020	Mori, Tetsushi/0000-0001-7096-4161; 	DFG [SFB 645, SFB 704]; DFG (cluster of excellence ImmunoSensation); Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by Oversees Training Program Division, International Program Department, Japan Society for the Promotion of Science	DFG(German Research Foundation (DFG)); DFG (cluster of excellence ImmunoSensation)(German Research Foundation (DFG)); Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by Oversees Training Program Division, International Program Department, Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the DFG to M.H. (SFBs 645, 704 and cluster of excellence ImmunoSensation) (www.dfg.de) and the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by Oversees Training Program Division, International Program Department, Japan Society for the Promotion of Science to T.M. and H.T. (www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhouayri IG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077619; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bonnay F, 2013, P NATL ACAD SCI USA, V110, P2957, DOI 10.1073/pnas.1221910110; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Fink C, 2016, MUCOSAL IMMUNOL, V9, P927, DOI 10.1038/mi.2015.112; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Landis GN, 2015, AGING-US, V7, P53, DOI 10.18632/aging.100721; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Poirier L, 2008, AGING CELL, V7, P758, DOI 10.1111/j.1474-9726.2008.00421.x; Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rera M, 2013, AGEING RES REV, V12, P436, DOI 10.1016/j.arr.2012.05.003; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Varma D, 2014, J INSECT PHYSIOL, V69, P80, DOI 10.1016/j.jinsphys.2014.04.006; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zhao HW, 2011, J BIOL CHEM, V286, P6211, DOI 10.1074/jbc.M110.181206	47	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176689	10.1371/journal.pone.0176689	http://dx.doi.org/10.1371/journal.pone.0176689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520752	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700027
J	Carrel, M; Zahrieh, D; Young, SG; Oleson, J; Ryckman, KK; Wels, B; Simmons, DL; Saftlas, A				Carrel, Margaret; Zahrieh, David; Young, Sean G.; Oleson, Jacob; Ryckman, Kelli K.; Wels, Brian; Simmons, Donald L.; Saftlas, Audrey			High prevalence of elevated blood lead levels in both rural and urban Iowa newborns: Spatial patterns and area-level covariates	PLOS ONE			English	Article							NEW-ORLEANS; SOIL LEAD; PRENATAL EXPOSURE; MERCURY LEVELS; CHILDREN; HEALTH; SYRACUSE; CADMIUM; ASSOCIATIONS; ENVIRONMENT	Lead in maternal blood can cross the placenta and result in elevated blood lead levels in newborns, potentially producing negative effects on neurocognitive function, particularly if combined with childhood lead exposure. Little research exists, however, into the burden of elevated blood lead levels in newborns, or the places and populations in which elevated lead levels are observed in newborns, particularly in rural settings. Using similar to 2300 dried bloods spots collected within 1-3 days of birth among Iowa newborns, linked with the area of mother's residence at the time of birth, we examine the spatial patterns of elevated (>5 mu g/dL) blood lead levels and the ecological-level predictors of elevated blood lead levels. We find that one in five newborns exceed the 5 mu g/dL action level set by the US Centers for Disease Control & Prevention (CDC). Bayesian spatial zero inflated regression indicates that elevated blood lead in newborns is associated with areas of increased pre- 1940s housing and childbearing-age women with low educational status in both rural and urban settings. No differences in blood lead levels or the proportion of children exceeding 5 mu g/dL are observed between urban and rural maternal residence, though a spatial cluster of elevated blood lead is observed in rural counties. These characteristics can guide the recommendation for testing of infants at well-baby appointments in places where risk factors are present, potentially leading to earlier initiation of case management. The findings also suggest that rural populations are at as great of risk of elevated blood lead levels as are urban populations. Analysis of newborn dried blood spots is an important tool for lead poisoning surveillance in newborns and can direct public health efforts towards specific places and populations where lead testing and case management will have the greatest impact.	[Carrel, Margaret; Young, Sean G.] Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA; [Carrel, Margaret; Ryckman, Kelli K.; Saftlas, Audrey] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Zahrieh, David; Oleson, Jacob] Univ Iowa, Dept Biostat, Iowa City, IA USA; [Ryckman, Kelli K.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Wels, Brian; Simmons, Donald L.] Univ Iowa, State Hygien Lab, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carrel, M (corresponding author), Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA.; Carrel, M (corresponding author), Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.	Margaret-carrel@uiowa.edu	Young, Sean G/H-6469-2014	Young, Sean G/0000-0002-0054-0627; Ryckman, Kelli/0000-0002-9496-4147	University of Iowa Center for Health Effects of Environmental Contaminants (CHEEC)	University of Iowa Center for Health Effects of Environmental Contaminants (CHEEC)	This study was supported by a seed grant from the University of Iowa Center for Health Effects of Environmental Contaminants (CHEEC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelion CM, 2012, HEALTH PLACE, V18, P774, DOI 10.1016/j.healthplace.2012.04.005; Agarwal DK, 2002, ENVIRON ECOL STAT, V9, P341, DOI 10.1023/A:1020910605990; ASCHENGRAU A, 1994, ENVIRON RES, V67, P125, DOI 10.1006/enrs.1994.1069; Banerjee S., 2014, HIERARCHICAL MODELIN; BELLINGER D, 1986, PEDIATRICS, V77, P826; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Bellinger DC, 2003, COMMENT NEW ENGLAND, V349; Best N., 2007, MESQUITE MODULAR SYS, V3; Brown MJ, 2011, ENVIRON RES, V111, P67, DOI 10.1016/j.envres.2010.10.003; Burm E, 2016, INT J HYG ENVIR HEAL, V219, P412, DOI 10.1016/j.ijheh.2016.04.004; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; CAPRIO RJ, 1974, ARCH ENVIRON HEALTH, V28, P195, DOI 10.1080/00039896.1974.10666468; Chiodo LM, 2004, NEUROTOXICOL TERATOL, V26, P359, DOI 10.1016/j.ntt.2004.01.010; CLARK S, 1991, Chemical Speciation and Bioavailability, V3, P163; COHEN CJ, 1973, JAMA-J AM MED ASSOC, V226, P1430, DOI 10.1001/jama.226.12.1430; DAVIES DJA, 1990, SCI TOTAL ENVIRON, V90, P13, DOI 10.1016/0048-9697(90)90182-T; Davis AM, 2011, J PEDIATR PSYCHOL, V36, P669, DOI 10.1093/jpepsy/jsq117; Ettinger Adrienne S., 2010, BREAST FEEDING; Garcia-Esquinas E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-841; Gilbert SG, 2006, NEUROTOXICOLOGY, V27, P693, DOI 10.1016/j.neuro.2006.06.008; Goyer RA, 1996, ENVIRON HEALTH PERSP, V104, P1050, DOI 10.2307/3433116; Harville EW, 2005, OCCUP ENVIRON MED, V62, P263, DOI 10.1136/oem.2003.012492; HAYES EB, 1994, PEDIATRICS, V93, P195; Hazards CoE, 1987, PEDIATRICS, V79, P457; Hertz-Picciotto I, 2000, AM J EPIDEMIOL, V152, P829, DOI 10.1093/aje/152.9.829; Hinwood A, 2014, CHEMOSPHERE, V108, P125, DOI 10.1016/j.chemosphere.2014.02.071; Holtrop TG, 1998, ARCH PEDIAT ADOL MED, V152, P455; Hruba F, 2012, ENVIRON INT, V41, P29, DOI 10.1016/j.envint.2011.12.001; HUBERMONT G, 1978, INT ARCH OCC ENV HEA, V41, P117, DOI 10.1007/BF00381796; Jacobs DE, 2006, ENVIRON RES, V102, P352, DOI 10.1016/j.envres.2005.12.015; Jacobs DE, 2002, ENVIRON HEALTH PERSP, V110, pA599, DOI 10.1289/ehp.021100599; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Johnson DL, 1996, ENVIRON GEOCHEM HLTH, V18, P81, DOI 10.1007/BF01771136; Johnson DL, 2002, ENVIRON GEOCHEM HLTH, V24, P375, DOI 10.1023/A:1020500504167; Jones EA, 2010, ENVIRON INT, V36, P649, DOI 10.1016/j.envint.2010.04.007; Jones RL, 2009, PEDIATRICS, V123, pe376, DOI 10.1542/peds.2007-3608; Kennedy C., 2016, MMWR-MORBID MORTAL W, P65; Laidlaw MAS, 2012, ATMOS ENVIRON, V49, P302, DOI 10.1016/j.atmosenv.2011.11.030; Laidlaw MAS, 2005, ENVIRON HEALTH PERSP, V113, P793, DOI 10.1289/ehp.7759; Lanphear BP, 1998, PEDIATRICS, V101, P264, DOI 10.1542/peds.101.2.264; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lanphear BP, 1997, ENVIRON RES, V74, P67, DOI 10.1006/enrs.1997.3726; Lead Ayotte P., 1999, ARCH ENVIRON HEALTH, P54; LEPOW ML, 1975, ENVIRON RES, V10, P415, DOI 10.1016/0013-9351(75)90037-7; Levallois P, 2014, J EXPO SCI ENV EPID, V24, P185, DOI 10.1038/jes.2012.129; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; McLaine P, 2013, PEDIATRICS, V131, P1081, DOI 10.1542/peds.2012-2277; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Mielke HW, 1999, ENVIRON RES, V81, P117, DOI 10.1006/enrs.1999.3966; Mielke HW, 1997, ENVIRON HEALTH PERSP, V105, P950, DOI 10.1289/ehp.97105950; Moyer TP, 1999, CLIN CHEM, V45, P2055; National Center for Environmental Health DoEaEHS, 2016, CDCS CHILDH LEAD POI; National Center for Environmental Health DoEaEHS, 2016, IOW DAT STAT SURV 20; NEEDLEMAN HL, 1990, JAMA-J AM MED ASSOC, V263, P673, DOI 10.1001/jama.263.5.673; NEEDLEMAN HL, 1979, NEW ENGL J MED, V300, P689, DOI 10.1056/NEJM197903293001301; NORMAN EH, 1994, PEDIATRICS, V94, P59; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; Parajuli RP, 2013, ENVIRON RES, V121, P45, DOI 10.1016/j.envres.2012.10.010; Pueschel SM., 1974, ENVIRON HEALTH PERSP, V7, P13, DOI [DOI 10.1289/EHP.74713, 10.1289/ehp.74713]; RABINOWITZ M, 1984, ARCH ENVIRON HEALTH, V39, P74, DOI 10.1080/00039896.1984.10545838; RHAINDS M, 1993, ARCH ENVIRON HEALTH, V48, P421, DOI 10.1080/00039896.1993.10545964; Riddell TJ, 2007, B WHO, V85; Robinson W., 1950, AM SOCIOLOGICAL REV; Rothenberg S, 1995, J EXPO ANAL ENV EPID, V6, P211; RUMMO JH, 1979, ARCH ENVIRON HEALTH, V34, P120, DOI 10.1080/00039896.1979.10667381; Sarkar M., 2011, AM HOMES VARY YEAR T; Schell LM, 2003, ENVIRON HEALTH PERSP, V111, P195, DOI 10.1289/ehp.5592; Schober SE, 2006, ENVIRON HEALTH PERSP, V114, P1538, DOI 10.1289/ehp.9123; SCHONFELD DJ, 1995, ARCH PEDIAT ADOL MED, V149, P447, DOI 10.1001/archpedi.1995.02170160101015; Scott LLF, 2011, INT ARCH OCC ENV HEA, V84, P513, DOI 10.1007/s00420-011-0624-9; SELVIN HC, 1958, AM J SOCIOL, V63, P607, DOI 10.1086/222356; Silver MK, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0148-6; Spielman SE, 2014, APPL GEOGR, V46, P147, DOI 10.1016/j.apgeog.2013.11.002; Srivuthana K, 1996, ARCH PEDIAT ADOL MED, V150, P498, DOI 10.1001/archpedi.1996.02170300052010; Stanton NV, 1999, CLIN CHEM, V45, P2229; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; Tellez-Rojo MM, 2004, AM J EPIDEMIOL, V160, P668, DOI 10.1093/aje/kwh271; VEREBEY K, 1995, CLIN CHEM, V41, P469; Verebey K, 2000, CLIN CHEM, V46, P1024; Walkowiak J, 1998, NEUROTOXICOL TERATOL, V20, P511, DOI 10.1016/S0892-0362(98)00010-5; Wang CH, 2004, INT J HYG ENVIR HEAL, V207, P431, DOI 10.1078/1438-4639-00311; WEITZMAN M, 1993, JAMA-J AM MED ASSOC, V269, P1647, DOI 10.1001/jama.269.13.1647; Wengrovitz Anne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Wong Y, 1995, CLIN CHEM 1995 AM AS; Yiin LM, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.2307/3454518; Zahran S, 2013, ENVIRON SCI TECHNOL, V47, P2839, DOI 10.1021/es303854c	86	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177930	10.1371/journal.pone.0177930	http://dx.doi.org/10.1371/journal.pone.0177930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520816	Green Published, gold			2022-12-27	WOS:000401485500081
J	Lin, YC; Seo, DC				Lin, Yi-Ching; Seo, Dong-Chul			Cumulative family risks across income levels predict deterioration of children's general health during childhood and adolescence	PLOS ONE			English	Article							MATERNAL EDUCATION; RESILIENCE; STRESS; POVERTY; DISADVANTAGE	Family is considered an important agent in the health development of children. This process is significant but quite complex because the prevalence of potential risk factors in the family can hinder children's health. This study examined if multiple family risks might have cumulative effect on children and youth's health across various levels of household income. The data in this study were drawn from the 2011-2012 U.S. National Survey of Children's Health (N = 79,601). A cumulative family risk (CFR) index was developed, which included such constructs as single-parenthood, unstable employment, large family, parenting stress, poor maternal education, poor maternal general health and poor maternal mental health. Multiple logistic regression analyses showed that CFR level was significantly related to children and youth's poor health outcome (p < .001). When poverty levels were considered, however, the impact of CFRs on children and youth's health was attenuated. The impact of CFRs was higher on children and youth from affluent families than on those from poor families. Overall there was a consistent pattern of trend in the point estimate as well as confidence limits as levels of affluence and numbers of family risk increased although some of the confidence intervals overlapped. Living in disadvantaged families might serve as a protective factor against CFRs possibly through repeated exposure to hardships and subsequent formation of resilience among some of the disadvantaged children.	[Lin, Yi-Ching] Natl Taipei Univ Educ, Coll Educ, Dept Early Childhood & Family Educ, Taipei, Taiwan; [Seo, Dong-Chul] Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN 47405 USA	National Taipei University of Education; Indiana University System; Indiana University Bloomington	Seo, DC (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN 47405 USA.	seo@indiana.edu	Seo, Dong-Chul/A-6935-2009	Seo, Dong-Chul/0000-0002-1972-6237				Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; Akter S, 2013, ECOL ECON, V96, P114, DOI 10.1016/j.ecolecon.2013.10.008; [Anonymous], 2007, 1 BRONF C CHAOS CHIL; Appleyard K, 2005, J CHILD PSYCHOL PSYC, V46, P235, DOI 10.1111/j.1469-7610.2004.00351.x; Association AP, 2010, ROAD RES; Atkinson L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127650; Bacikova-Sleskova M, 2015, PSYCHOL HEALTH, V30, P400, DOI 10.1080/08870446.2014.976645; Bauman LJ, 2006, PEDIATRICS, V117, P1321, DOI 10.1542/peds.2005-1647; Bethell CD, 2014, HEALTH AFFAIR, V33, P2106, DOI 10.1377/hlthaff.2014.0914; Bingham B, 2011, NEUROPSYCHOPHARMACOL, V36, P896, DOI 10.1038/npp.2010.229; Bloom B, 2011, VITAL HLTH STAT, V2012, P10; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Buehler C, 2013, J YOUTH ADOLESCENCE, V42, P905, DOI 10.1007/s10964-012-9806-3; CDC National Center for Health Statistics., 2013, STAT LOC AR INT TEL; Coleman M, 2002, FAM RELAT, V51, P101, DOI 10.1111/j.1741-3729.2002.00101.x; Conger RD, 2002, J MARRIAGE FAM, V64, P361, DOI 10.1111/j.1741-3737.2002.00361.x; Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85; Corder K, 2012, PREV MED, V55, P201, DOI 10.1016/j.ypmed.2012.06.021; Crosnoe R, 2002, J MARRIAGE FAM, V64, P690, DOI 10.1111/j.1741-3737.2002.00690.x; Davey TM, 2015, MATERN CHILD HLTH J, V19, P2501, DOI 10.1007/s10995-015-1771-5; Drotar D., 2014, MEASURING HLTH RELAT; Eamon MK, 2001, SOC WORK, V46, P256, DOI 10.1093/sw/46.3.256; Edin K., 1997, MAKING ENDS MEET SIN; Evans GW, 2013, CHILD DEV PERSPECT, V7, P43, DOI 10.1111/cdep.12013; Evans GW, 2003, DEV PSYCHOL, V39, P924, DOI 10.1037/0012-1649.39.5.924; Felner RD, 2013, HANDBOOK OF RESILIENCE IN CHILDREN, SECOND EDITION, P105, DOI 10.1007/978-1-4614-3661-4_7; Fergus S, 2005, ANNU REV PUBL HEALTH, V26, P399, DOI 10.1146/annurev.publhealth.26.021304.144357; Frasquilho D, 2015, CHILD PSYCHIAT HUMAN; Furstenberg FF, 2005, J MARRIAGE FAM, V67, P809, DOI 10.1111/j.1741-3737.2005.00177.x; Gunes PM, 2015, ECON EDUC REV, V47, P1, DOI 10.1016/j.econedurev.2015.02.008; Heath CL, 2015, CHILD PSYCHIAT HUM D, V46, P118, DOI 10.1007/s10578-014-0458-2; Hesketh KR, 2013, BMC PUBLIC HEALTH, V13, P1; Huston AC, 2010, ANNU REV PSYCHOL, V61, P411, DOI 10.1146/annurev.psych.093008.100442; Jones DJ, 2002, J MARRIAGE FAM, V64, P105, DOI 10.1111/j.1741-3737.2002.00105.x; Juby C, 2004, FAM SOC-J CONTEMP H, V85, P581, DOI 10.1606/1044-3894.1847; Kaiser KL, 2016, PUBLIC HEALTH NURS, V33, P21, DOI 10.1111/phn.12228; Kingston D, 2014, MATERN CHILD HLTH J, V18, P1728, DOI 10.1007/s10995-013-1418-3; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; KRAEMER HC, 2005, TO YOUR HLTH; Krueger PM, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0038-0; Larson K, 2008, PEDIATRICS, V121, P337, DOI 10.1542/peds.2007-0447; Larson K, 2010, MATERN CHILD HLTH J, V14, P332, DOI 10.1007/s10995-009-0477-y; Lee C-T, 2016, PEDIAT NEONATOLOGY; Lin C., 2016, ANN TELECOMMUN, p1 ; Lin YC, 2015, INT J PUBLIC HEALTH, V60, P691, DOI 10.1007/s00038-015-0701-z; Lundberg U., 1993, TIME PRESSURE STRESS, P41; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Masten AS, 2014, CHILD DEV, V85, P6, DOI 10.1111/cdev.12205; McClain DB, 2012, ADOLESCENT DEV SCH A, V48, P227; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Morris P.A, 2006, HDB CHILD PSYCHOL, V6th ed; Mullin WJ, 2008, J FAM SOC WORK, V11, P424, DOI 10.1080/10522150802424565; NSCH. National Survey of Children's Health, 2016, OV SURV DAT RES CTR; O'Donnell M, 2015, J EPIDEMIOL COMMUN H, V69, P1175, DOI 10.1136/jech-2014-205240; Orthner DK, 2004, FAM RELAT, V53, P159, DOI 10.1111/j.0022-2445.2004.00006.x; Panter-Brick C, 2013, J CHILD PSYCHOL PSYC, V54, P333, DOI 10.1111/jcpp.12057; Patterson JM, 2002, J MARRIAGE FAM, V64, P349, DOI 10.1111/j.1741-3737.2002.00349.x; Rahman A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001442; Sameroff A., 2014, DIALECTIC INTEGRATIO, P25; Sameroff A. J., 2004, HDB INFANT TODDLER P, P61; Sameroff AJ, 1998, FAMILIES, RISK, AND COMPETENCE, P161; Sapienza JK, 2011, CURR OPIN PSYCHIATR, V24, P267, DOI 10.1097/YCO.0b013e32834776a8; Scharte M, 2013, EUR J PUBLIC HEALTH, V23, P469, DOI 10.1093/eurpub/cks062; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; Spear LP, 2009, DEV PSYCHOPATHOL, V21, P87, DOI 10.1017/S0954579409000066; Strong C, 2016, CHILD PSYCHIAT HUM D, V47, P347, DOI 10.1007/s10578-015-0570-y; Su CT, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-206; Thompson RA, 2014, FUTURE CHILD, V24, P41, DOI 10.1353/foc.2014.0004; Trentacosta CJ, 2008, J CHILD PSYCHOL PSYC, V49, P1211, DOI 10.1111/j.1469-7610.2008.01941.x; Tsai MC, 2015, J ADOLESCENCE, V42, P87, DOI 10.1016/j.adolescence.2015.03.016; Tsai MC, 2015, RES DEV DISABIL, V36, P376, DOI 10.1016/j.ridd.2014.10.026; Turner K, 2013, SOC SCI MED, V95, P1, DOI 10.1016/j.socscimed.2013.07.015; Udry J. R., 1998, NEW PERSPECTIVES ADO, P241, DOI [10.1017/CBO9780511571138.009, DOI 10.1017/CBO9780511571138.009]; Vanderlaan DP, 2010, J GAY LESBIAN MENT H, V15, P30, DOI 10.1080/19359705.2011.530570; Veronneau MH, 2010, J EARLY ADOLESC, P1; Walsh F., 2015, STRENGTHENING FAMILY; Wells NM, 2010, AM J PUBLIC HEALTH, V100, P2507, DOI 10.2105/AJPH.2009.184291; Wood BL, 2015, FAM PROCESS, V54, P376, DOI 10.1111/famp.12139; World Health Organization, 2012, GLOB REP RES INF DIS; Zill N, 2014, CHILD YOUTH SERV REV, V40, P29, DOI 10.1016/j.childyouth.2014.02.008; Zolkoski SM, 2012, CHILD YOUTH SERV REV, V34, P2295, DOI 10.1016/j.childyouth.2012.08.009	81	7	7	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177531	10.1371/journal.pone.0177531	http://dx.doi.org/10.1371/journal.pone.0177531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520758	gold, Green Submitted, Green Published			2022-12-27	WOS:000401485500037
J	Odgers-Jewell, K; Isenring, EA; Thomas, R; Reidlinger, DP				Odgers-Jewell, Kate; Isenring, Elisabeth A.; Thomas, Rae; Reidlinger, Dianne P.			Group participants' experiences of a patient-directed group-based education program for the management of type 2 diabetes mellitus	PLOS ONE			English	Article							SELF-MANAGEMENT; CHRONIC DISEASE; SOCIAL SUPPORT; PEOPLE; METAANALYSIS; CARE	Objective The objective of this study was to explore the experiences of individuals who participated in a group-based education program, including their motivators in relation to their diabetes management, and the perceived impact of group interactions on participants' experiences and motivation for self-management. Understanding individuals diagnosed with diabetes experiences of group-based education for the management of type 2 diabetes mellitus may guide the development and facilitation of these programs. Methods Semi-structured interviews were conducted with all individuals who participated in the intervention. Using thematic analysis underpinned by self-determination theory, we developed themes that explored participants' motivators in relation to diabetes management and the impact of group interactions on their experiences and motivation. Results The key themes included knowledge, experience, group interactions and motivation. Participants perceived that the group interactions facilitated further learning and increased motivation, achieved through normalization, peer identification or by talking with, and learning from the experience of others. Conclusions The results support the use of patient-centred programs that prioritize group interactions over the didactic presentation of content, which may address relevant psychological needs of people diagnosed with type 2 diabetes mellitus, and improve their motivation and health behaviours. Future group-based education programs may benefit from the use of self-determination theory as a framework for intervention design to enhance participant motivation.	[Odgers-Jewell, Kate; Isenring, Elisabeth A.; Reidlinger, Dianne P.] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Thomas, Rae] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia	Bond University; Bond University	Odgers-Jewell, K (corresponding author), Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld, Australia.	kodgersj@bond.edu.au	Odgers-Jewell, Kate/AAA-8667-2019; Reidlinger, Dianne/E-1456-2016	Reidlinger, Dianne/0000-0002-9993-8239; Isenring, Elizabeth/0000-0002-4478-9707				Adolfsson ET, 2008, INT J NURS STUD, V45, P986, DOI 10.1016/j.ijnurstu.2007.07.007; [Anonymous], 2008, DIABETES VOICE, V53, P45; [Anonymous], 2014, EUR HLTH PSYCHOL, DOI DOI 10.1186/1479-5868-9-20; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Barr E. L. M., 2005, AUSDIAB 2005 AUSTR D; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Cable TA, 1999, SCAND J PUBLIC HEALT, V27, P206, DOI 10.1177/14034948990270031301; Carolan M, 2015, J CLIN NURS, V24, P1011, DOI 10.1111/jocn.12724; Cavanagh S, 1997, Nurse Res, V4, P5, DOI 10.7748/nr.4.3.5.s2; Cooper HC, 2003, HEALTH EDUC RES, V18, P191, DOI 10.1093/her/18.2.191; Costello JF, 2013, DIABETES ED; Deakin T, 2005, COCHRANE DB SYST REV, V1, P1; Dietitians Association of Australia (DAA), 2007, TYP 2 DIAB MED GROUP; Eigenmann C, 2007, OUTCOMES INDICATORS; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Flick U., 2013, SAGE HDB QUALITATIVE, P467; Funnell MM, 2005, DIABETES EDUCATOR, V31, P53, DOI 10.1177/0145721704273166; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Holman H, 2004, JAMA-J AM MED ASSOC, V292, P1057, DOI 10.1001/jama.292.9.1057; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Mensing CR, 2003, DIABETES SPECTR, V16, P96, DOI [10.2337/diaspect.16.2.96, DOI 10.2337/DIASPECT.16.2.96]; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Odgers-Jewell K, 2016, NUTR DIETETICS; Odgers-Jewell K, 2017, DIABETIC MED; Odgers-Jewell K, 2015, NUTR DIET, V72, P347, DOI 10.1111/1747-0080.12190; Parry O, 2006, HEALTH EDUC RES, V21, P97, DOI 10.1093/her/cyh044; Ryan R. M., 2008, EUROPEAN HLTH PSYCHO, V10, P2, DOI DOI 10.1080/17509840701827437; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Skinner TC, 2006, PATIENT EDUC COUNS, V64, P369, DOI 10.1016/j.pec.2006.04.007; Steinsbekk A., 2013, PLOS ONE, V8; Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213; Stopford R, 2013, PATIENT EDUC COUNS, V93, P549, DOI 10.1016/j.pec.2013.08.016; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Trento M, 2004, DIABETES CARE, V27, P670, DOI 10.2337/diacare.27.3.670; van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; *WHO, 1998, THER PAT ED CONT ED; World Health Organization, 2007, PEER SUPP PROGR DIAB	40	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177688	10.1371/journal.pone.0177688	http://dx.doi.org/10.1371/journal.pone.0177688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520801	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500056
J	Okumu, DO; East, MP; Levine, M; Herring, LE; Zhang, R; Gilbert, TSK; Litchfield, DW; Zhang, Y; Graves, LM				Okumu, Denis O.; East, Michael P.; Levine, Merlin; Herring, Laura E.; Zhang, Raymond; Gilbert, Thomas S. K.; Litchfield, David W.; Zhang, Yanping; Graves, Lee M.			BIRC6 mediates imatinib resistance independently of Mcl-1	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; PROTEIN-KINASE CK2; MYELOGENOUS LEUKEMIA; ACQUIRED-RESISTANCE; APOPTOSIS PROTEIN; CANCER-CELLS; BCR-ABL; INHIBITORS; SURVIVIN; IDENTIFICATION	Baculoviral IAP repeat containing 6 (BIRC6) is a member of the inhibitors of apoptosis proteins (IAPs), a family of functionally and structurally related proteins that inhibit apoptosis. BIRC6 has been implicated in drug resistance in several different human cancers, however mechanisms regulating BIRC6 have not been extensively explored. Our phosphoproteomic analysis of an imatinib-resistant chronic myelogenous leukemia (CML) cell line (MYL-R) identified increased amounts of a BIRC6 peptide phosphorylated at S480, S482, and S486 compared to imatinib-sensitive CML cells (MYL). Thus we investigated the role of BIRC6 in mediating imatinib resistance and compared it to the well-characterized anti-apoptotic protein, Mcl-1. Both BIRC6 and Mcl-1 were elevated in MYL-R compared to MYL cells. Lentiviral shRNA knockdown of BIRC6 in MYL-R cells increased imatinib-stimulated caspase activation and resulted in a similar to 20-25-fold increase in imatinib sensitivity, without affecting Mcl1. Treating MYL-R cells with CDK9 inhibitors decreased BIRC6 mRNA, but not BIRC6 protein levels. By contrast, while CDK9 inhibitors reduced Mcl-1 mRNA and protein, they did not affect imatinib sensitivity. Since the Src family kinase Lyn is highly expressed and active in MYL-R cells, we tested the effects of Lyn inhibition on BIRC6 and Mcl-1. RNAi-mediated knockdown or inhibition of Lyn (dasatinib/ponatinib) reduced BIRC6 protein stability and increased caspase activation. Inhibition of Lyn also increased formation of an N-terminal BIRC6 fragment in parallel with reduced amount of the BIRC6 phosphopeptide, suggesting that Lyn may regulate BIRC6 phosphorylation and stability. In summary, our data show that BIRC6 stability is dependent on Lyn, and that BIRC6 mediates imatinib sensitivity independently of Mcl-1 or CDK9. Hence, BIRC6 may be a novel target for the treatment of drug-resistant CML where Mcl-1 or CDK9 inhibitors have failed.	[Okumu, Denis O.; East, Michael P.; Herring, Laura E.; Zhang, Raymond; Gilbert, Thomas S. K.; Zhang, Yanping; Graves, Lee M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Okumu, Denis O.; East, Michael P.; Zhang, Yanping; Graves, Lee M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA; [Levine, Merlin] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Herring, Laura E.; Gilbert, Thomas S. K.; Graves, Lee M.] Univ N Carolina, UNC Michael Hooker Prote Ctr, Chapel Hill, NC 27514 USA; [Litchfield, David W.] Western Univ, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Zhang, Yanping] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario); University of North Carolina; University of North Carolina Chapel Hill	Graves, LM (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA.; Graves, LM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA.; Graves, LM (corresponding author), Univ N Carolina, UNC Michael Hooker Prote Ctr, Chapel Hill, NC 27514 USA.	lmg@med.unc.edu	Graves, Lee/AAG-5470-2021; , Proteomics Core UNC/AAH-3777-2022; Core, Vector/CAF-4832-2022; , Proteomics Core UNC/AFQ-7201-2022	Zhang, Raymond/0000-0001-6329-7225; Gilbert, Thomas/0000-0002-6833-6788	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007040] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Arend KC, 2017, MOL CELL PROTEOMICS, V16, pS263, DOI 10.1074/mcp.M116.065375; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; Bhamidipati PK, 2013, THER ADV HEMATOL, V4, P103, DOI 10.1177/2040620712468289; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683; Borgo C, 2013, MOL ONCOL, V7, P1103, DOI 10.1016/j.molonc.2013.08.006; Bose Prithviraj, 2013, Leuk Res Rep, V2, P12; Bose P, 2013, EXPERT OPIN INV DRUG, V22, P723, DOI 10.1517/13543784.2013.789859; Carter BZ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1180; Carter BZ, 2006, BLOOD, V107, P1555, DOI 10.1182/blood-2004-12-4704; Cassuto O, 2012, ONCOTARGET, V3, P1557; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; Chen LJ, 2017, EXPERT OPIN THER PAT, V27, P163, DOI 10.1080/13543776.2017.1249848; Chen X, 2016, J CANCER, V7, P314, DOI 10.7150/jca.13332; Cooper MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066755; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deveraux QL, 1999, GENES DEV; Dong X, 2013, J THORAC ONCOL, V8, P161, DOI 10.1097/JTO.0b013e31827d5237; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Foo J, 2014, J THEOR BIOL, V355, P10, DOI 10.1016/j.jtbi.2014.02.025; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Ge CM, 2015, P NATL ACAD SCI USA, V112, pE1210, DOI 10.1073/pnas.1418335112; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Gringeri E, 2010, BIOCHEM J, V425, P401, DOI 10.1042/BJ20090902; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hitz C, 2005, GENESIS, V42, P91, DOI 10.1002/gene.20128; Huang JC, 2015, AM J CANCER RES, V5, P20; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Hussain SRA, 2007, CLIN CANCER RES, V13, P2144, DOI 10.1158/1078-0432.CCR-06-2294; Ito T, 2007, EUR J HAEMATOL, V78, P417, DOI 10.1111/j.1600-0609.2007.00835.x; Jabbour EJ, 2013, CL LYMPH MYELOM LEUK, V13, P515, DOI 10.1016/j.clml.2013.03.018; Kantarjian H, 2012, BLOOD, V119, P1981, DOI 10.1182/blood-2011-08-358135; Kelly KR, 2011, J CELL MOL MED, V15, P2057, DOI 10.1111/j.1582-4934.2010.01218.x; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; Kim A, 2015, ONCOTARGET, V6, P38225, DOI 10.18632/oncotarget.5425; Lamers F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-285; Lee S, 2016, NAT STRUCT MOL BIOL, V23, P600, DOI 10.1038/nsmb.3223; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lopergolo A, 2009, BRIT J CANCER, V100, P739, DOI 10.1038/sj.bjc.6604927; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Lu HS, 2015, ELIFE, V4, DOI 10.7554/eLife.06535; Luk SUI, 2014, ONCOTARGET, V5, P6896, DOI 10.18632/oncotarget.2229; Ma L, 2014, SCI TRANSLATIONAL; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; Mobahat M, 2014, INT J MOL SCI, V15, P2494, DOI 10.3390/ijms15022494; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; Oberoi-Khanuja TK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.311; Okabe S, 2013, BIOCHEM BIOPH RES CO, V435, P506, DOI 10.1016/j.bbrc.2013.05.022; Pasic I, 2017, LEUKEMIA RES, V55, P65, DOI 10.1016/j.leukres.2017.01.005; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Polier G, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.66; Polier G, 2014, INT J CANC; Qiu XB, 2005, J BIOL CHEM, V280, P174, DOI 10.1074/jbc.M411430200; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schwarz LJ, 2014, J CLIN INVEST, V124, P5490, DOI 10.1172/JCI72573; Sharma A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.155; Sung KW, 2007, CLIN CANCER RES, V13, P5109, DOI 10.1158/1078-0432.CCR-07-0693; Tang W, 2014, J CANC; Thomas D, 2013, BLOOD, V122, P738, DOI 10.1182/blood-2012-08-447441; Van Houdt WJ, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011353-1, 10.1074/mcp.M111.011353]; Wang L, 2014, TUMOR BIOL, V35, P4891, DOI 10.1007/s13277-014-1641-6; Wang QZ, 2010, ACS CHEM BIOL, V5, P887, DOI 10.1021/cb100099h; Wang ZX, 2005, CANCER RES, V65, P8224, DOI 10.1158/0008-5472.CAN-05-0303; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Yeh YY, 2015, ONCOTARGET, V6, P2667, DOI 10.18632/oncotarget.2096; Zhang MY, 2011, PROTEOMICS, V11, P4632, DOI 10.1002/pmic.201100339; Zimmerman EI, 2010, MOL PHARMACOL, V78, P811, DOI 10.1124/mol.110.066258	84	13	15	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177871	10.1371/journal.pone.0177871	http://dx.doi.org/10.1371/journal.pone.0177871			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520795	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500079
J	Owili, PO; Muga, MA; Mendez, BR; Chen, B				Owili, Patrick Opiyo; Muga, Miriam Adoyo; Mendez, Bomar Rojas; Chen, Bradley			Quality of maternity care and its determinants along the continuum in Kenya: A structural equation modeling analysis	PLOS ONE			English	Article							JANANI SURAKSHA YOJANA; OF-CARE; NEWBORN HEALTH; CHILD HEALTH; MORTALITY; COUNTRIES; SURVIVAL; DELIVERY; PROGRAM; AGENDA	Background Improving access to delivery services does not guarantee access to quality obstetric care and better survival, and therefore, concerns for quality of maternal and newborn care in low- and middle-income countries have been raised. Our study explored characteristics associated with the quality of initial assessment, intrapartum, and immediate postpartum and newborn care, and further assessed the relationships along the continuum of care. Methods The 2010 Service Provision Assessment data of Kenya for 627 routine deliveries of women aged 15-49 were used. Quality of care measures were assessed using recently validated quality of care measures during initial assessment, intrapartum, and postpartum periods. Data were analyzed with negative binomial regression and structural equation modeling technique. Results The negative binomial regression results identified a number of determinants of quality, such as the level of health facilities, managing authority, presence of delivery fee, central electricity supply and clinical guideline for maternal and neonatal care. Our structural equation modeling (SEM) further demonstrated that facility characteristics were important determinants of quality for initial assessment and postpartum care, while characteristics at the provider level became more important in shaping the quality of intrapartum care. Furthermore we also noted that quality of initial assessment had a positive association with quality of intrapartum care (beta = 0.71, p < 0.001), which in turn was positively associated with the quality of newborn and immediate postpartum care (beta = 1.29, p = 0.004). Conclusions A continued focus on quality of care along the continuum of maternity care is important not only to mothers but also their newborns. Policymakers should therefore ensure that required resources, as well as adequate supervision and emphasis on the quality of obstetric care, are available.	[Owili, Patrick Opiyo] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan; [Owili, Patrick Opiyo; Muga, Miriam Adoyo] Univ Eastern Africa, Dept Publ Hlth, Baraton, Eldoret, Kenya; [Muga, Miriam Adoyo] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Mendez, Bomar Rojas; Chen, Bradley] Natl Yang Ming Univ, Int Hlth Program, Taipei, Taiwan; [Chen, Bradley] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, B (corresponding author), Natl Yang Ming Univ, Int Hlth Program, Taipei, Taiwan.; Chen, B (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.	bradleychen@ym.edu.tw	Owili, Patrick Opiyo/J-8948-2019	Owili, Patrick Opiyo/0000-0002-9417-8947; Chen, Bradley/0000-0001-6024-673X; Muga, Miriam/0000-0002-9180-5394	Ministry of Science and Technology [104-2410-H-010-021]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study is supported by Ministry of Science and Technology Grant #104-2410-H-010-021 to BC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NEON MORT; Arregoces L, 2015, LANCET GLOB HEALTH, V3, pE410, DOI 10.1016/S2214-109X(15)00057-1; Brenner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123968; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Choi YJ, 2004, YONSEI MED J, V45, P829, DOI 10.3349/ymj.2004.45.5.829; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Davidson R, 1993, ESTIMATION INFERENCE; Demographic and Health Surveys (DHS) Program, 2012, SERV PROV ASS SPA; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Enders CK, 2004, STRUCT EQU MODELING, V11, P1, DOI 10.1207/S15328007SEM1101_1; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; Joreskog K.G., 1993, LISREL 8 STRUCTURAL; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; McBryde-Foster M, 2005, J ADV NURS, V50, P624, DOI 10.1111/j.1365-2648.2005.03447.x; Miller S, 2003, INT J GYNECOL OBSTET, V82, P89, DOI 10.1016/S0020-7292(03)00148-6; Owili PO, 2016, WOMEN HLTH, P1; Pittrof R, 2002, ACTA OBSTET GYN SCAN, V81, P277, DOI 10.1034/j.1600-0412.2002.810401.x; Powell-Jackson T, 2009, ADV HEALTH ECON HEAL, V21, P221, DOI 10.1108/S0731-2199(2009)0000021012; Powell-Jackson T, 2015, J HEALTH ECON, V43, P154, DOI 10.1016/j.jhealeco.2015.07.001; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Raven JH, 2012, MIDWIFERY, V28, pE676, DOI 10.1016/j.midw.2011.09.003; Roberts M., 2008, GETTING HLTH REFORM, DOI DOI 10.1093/ACPROF:OSO/9780195371505.001.0001; Salinas AM, 1997, INT J QUAL HEALTH C, V9, P93, DOI 10.1093/intqhc/9.2.93; Smith SL, 2016, SOC SCI MED, V166, P86, DOI 10.1016/j.socscimed.2016.08.013; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stanton C, 2009, B WORLD HEALTH ORGAN, V87, P207, DOI 10.2471/BLT.08.052597; StataCorp, 2013, STAT STAT SOFTW; Tripathi V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129491; UNICEF, 2019, MAT MORT; United Nations, 2022, SUSTAIN DEV, DOI DOI 10.1002/SD.2445; United Nations, MILL DEV GOALS REP 2; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; World Health Organization UNFPA UNICEF Averting Maternal Death and Disability (AMDD), 2009, AV MAT DEATH DIS AMD	37	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177756	10.1371/journal.pone.0177756	http://dx.doi.org/10.1371/journal.pone.0177756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520771	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500067
J	Popinako, A; Antonov, M; Tikhonov, A; Tikhonova, T; Popov, V				Popinako, Anna; Antonov, Mikhail; Tikhonov, Alexey; Tikhonova, Tamara; Popov, Vladimir			Structural adaptations of octaheme nitrite reductases from haloalkaliphilic Thioalkalivibrio bacteria to alkaline pH and high salinity	PLOS ONE			English	Article							SP NOV.; PROTEIN; DEHYDROGENASE; STABILITY; INSIGHTS; TOOL	Bacteria Tv. nitratireducens and Tv. paradoxus from soda lakes grow optimally in sodium carbonate/NaCl brines at pH range from 9.5 to 10 and salinity from 0.5 to 1.5 M Na+. Octaheme nitrite reductases (ONRs) from haloalkaliphilic bacteria of genus Thioalkalivibrio are stable and active in a wide range of pH (up to 11) and salinity (up to 1 M NaCl). To establish adaptation mechanisms of ONRs from haloalkaliphilic bacteria a comparative analysis of amino acid sequences and structures of ONRs from haloalkaliphilic bacteria and their homologues from non-halophilic neutrophilic bacteria was performed. The following adaptation strategies were observed: (1) strategies specific for halophilic and alkaliphilic proteins (an increase in the number of aspartate and glutamate residues and a decrease in the number of lysine residues on the protein surface), (2) strategies specific for halophilic proteins (an increase in the arginine content and a decrease in the number of hydrophobic residues on the solvent-accessible protein surface), (3) strategies specific for alkaliphilic proteins (an increase in the area of intersubunit hydrophobic contacts). Unique adaptation mechanism inherent in the ONRs from bacteria of genus Thioalkalivibrio was revealed (an increase in the core in the number of tryptophan and phenylalanine residues, and an increase in the number of small side chain residues, such as alanine and valine, in the core).	[Popinako, Anna; Tikhonov, Alexey; Tikhonova, Tamara; Popov, Vladimir] Russian Acad Sci, Res Ctr Biotechnol, Bach Inst Biochem, Leninsky Prospekt 33,Bld 2, Moscow, Russia; [Antonov, Mikhail] MK Ammosov North Eastern Fed Univ, Suite 312, Yakutsk, Yakutia, Russia; [Popov, Vladimir] Natl Res Ctr, Kurchatov Inst, Akad Kurchatova Sqr 1, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; North-Eastern Federal University in Yakutsk; National Research Centre - Kurchatov Institute	Popinako, A (corresponding author), Russian Acad Sci, Res Ctr Biotechnol, Bach Inst Biochem, Leninsky Prospekt 33,Bld 2, Moscow, Russia.	popinakoav@gmail.com	Antonov, Mikhail/B-4703-2014	Antonov, Mikhail/0000-0003-3674-0863; Popov, Vladimir/0000-0002-0133-7962; Tikhonova, Tamara/0000-0003-4264-8676	Russian Science Foundation [14-24-00172]; Russian Foundation for Basic Research [16-34-60252]; Russian Science Foundation [17-24-00022] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The bioinformatics analysis was supported by the Russian Science Foundation (grant 14-24-00172) (http://www.rscf.ru/en/enprjcard?rid=17-24-00022). The improvement of the protocol for the structural analysis of proteins from poliextremophiles was supported by the Russian Foundation for Basic Research (grant 16-34-60252)(http://www.rfbr.ru/rffi/ru/project_search/o_2038468)	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bezsudnova EY, 2015, BIOCHIMIE, V118, P82, DOI 10.1016/j.biochi.2015.08.010; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Dubnovitsky AP, 2005, ENZYME ADAPTATION AL, P97; DYM O, 1995, SCIENCE, V267, P1344, DOI 10.1126/science.267.5202.1344; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Filimonenkov AA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P744, DOI 10.1134/S000629791006009X; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Graziano G, 2014, BBA-PROTEINS PROTEOM, V1844, P850, DOI 10.1016/j.bbapap.2014.02.018; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Karyagina Anna, 2006, Journal of Bioinformatics and Computational Biology, V4, P357, DOI 10.1142/S0219720006001837; Kassner BRJ, 1973, BIOCHEM J, P283; Kastritis PL, 2007, INT J BIOL MACROMOL, V41, P447, DOI 10.1016/j.ijbiomac.2007.06.005; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Madern D, 2004, EXTREMOPHILES, V8, P377, DOI 10.1007/s00792-004-0398-z; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oguchi Y, 2006, BIOTECHNOL LETT, V28, P1383, DOI 10.1007/s10529-006-9100-0; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pica A, 2013, BBA-PROTEINS PROTEOM, V1834, P149, DOI 10.1016/j.bbapap.2012.09.014; Poidevin L, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-44; Polyakov KM, 2009, J MOL BIOL, V389, P846, DOI 10.1016/j.jmb.2009.04.037; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Reed C. J., 2013, ARCHAEA, V2013, DOI DOI 10.1155/2013/373275; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Sadovnichy V., 2013, LOMONOSOV SUPERCOMPU, P283; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Shifman JM, 2000, BIOCHEMISTRY-US, V39, P14813, DOI 10.1021/bi000927b; Siddiqui K.S., 2008, PROTEIN ADAPTATIONS, P250; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; Sorokin DY, 2012, INT J SYST EVOL MICR, V62, P1884, DOI 10.1099/ijs.0.034504-0; Sorokin DY, 2003, INT J SYST EVOL MICR, V53, P1779, DOI 10.1099/ijs.0.02615-0; Suplatov D, 2014, J BIOMOL STRUCT DYN, V32, P1752, DOI 10.1080/07391102.2013.834514; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tamura K, MEGA5 MOL EVOLUTIONA; Tikhonova T, COMP STRUCTURAL FUNC; Tikhonova T, 2012, FEBS J, V279, P4052, DOI 10.1111/j.1742-4658.2012.08811.x; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Warden AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10278; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang GS, 2016, ACTA CRYSTALLOGR B, V72, P20, DOI 10.1107/S2052520615018582; ZWEIG MH, 1993, CLIN CHEM, V39, P561	51	10	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177392	10.1371/journal.pone.0177392	http://dx.doi.org/10.1371/journal.pone.0177392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510595	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500024
J	Schunter, S; Villa, R; Flynn, V; Heidelberger, JB; Classen, AK; Beli, P; Becker, PB				Schunter, Sarah; Villa, Raffaella; Flynn, Victoria; Heidelberger, Jan B.; Classen, Anne-Kathrin; Beli, Petra; Becker, Peter B.			Ubiquitylation of the acetyltransferase MOF in Drosophila melanogaster	PLOS ONE			English	Article							DOSAGE COMPENSATION COMPLEX; X-CHROMOSOME; ACETYL TRANSFERASE; MSL COMPLEX; LETHAL; PHOSPHORYLATION; UBIQUITINATION; IDENTIFICATION; REVEALS; DOMAIN	The nuclear acetyltransferase MOF (KAT8 in mammals) is a subunit of at least two multicomponent complexes involved in transcription regulation. In the context of complexes of the 'Non-Specific-Lethal' (NSL) type it controls transcription initiation of many nuclear housekeeping genes and of mitochondrial genes. While this function is conserved in metazoans, MOF has an additional, specific function in Drosophila in the context of dosage compensation. As a subunit of the male-specific-lethal dosage compensation complex (MSLDCC) it contributes to the doubling of transcription output from the single male X chromosome by acetylating histone H4. Proper dosage compensation requires finely tuned levels of MSL-DCC and an appropriate distribution of MOF between the regulatory complexes. The amounts of DCC formed depends directly on the levels of the male-specific MSL2, which orchestrates the assembly of the DCC, including MOF recruitment. We found earlier that MSL2 is an E3 ligase that ubiquitylates most MSL proteins, including MOF, suggesting that ubiquitylation may contribute to a quality control of MOF's overall levels and folding state as well as its partitioning between the complex entities. We now used mass spectrometry to map the lysines in MOF that are ubiquitylated by MSL2 in vitro and identified in vivo ubiquitylation sites of MOF in male and female cells. MSL2-specific ubiquitylation in vivo could not be traced due to the dominance of other, sex-independent ubiquitylation events and conceivably may be rare or transient. Expressing appropriately mutated MOF derivatives we assessed the importance of the ubiquitylated lysines for dosage compensation by monitoring DCC formation and X chromosome targeting in cultured cells, and by genetic complementation of the male-specific-lethal mof 2 allele in flies. Our study provides a comprehensive analysis of MOF ubiquitylation as a reference for future studies.	[Schunter, Sarah; Villa, Raffaella; Flynn, Victoria; Becker, Peter B.] Ludwig Maximilians Univ Munchen, Mol Biol Div, Biomed Ctr, Munich, Germany; [Schunter, Sarah; Villa, Raffaella; Flynn, Victoria; Becker, Peter B.] Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci, Munich, Germany; [Heidelberger, Jan B.; Beli, Petra] IMB, Mainz, Germany; [Classen, Anne-Kathrin] Ctr Biol Syst Anal ZSBA, Freiburg, Germany	University of Munich; University of Munich; Institute of Molecular Biology (IMB)	Becker, PB (corresponding author), Ludwig Maximilians Univ Munchen, Mol Biol Div, Biomed Ctr, Munich, Germany.; Becker, PB (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci, Munich, Germany.	pbecker@bmc.med.lmu.de	Classen, Anne-Kathrin/L-6164-2018; Villa, Raffaella/D-5223-2018	Classen, Anne-Kathrin/0000-0001-5157-0749; Becker, Peter/0000-0001-7186-0372	European Research Council under the European Union's Seventh Framework Programme/ERC [293948]; European Commission [630763]	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 293948 (P.B. B.),https://erc.europa.eu/. P.B. is supported by the Emmy Noether Program (BE 5342/1-1) from the German Research Foundation, http://www.dgr.de/foerderung/programme/einzelfoerderung/emmy_noether/ and the Marie Curie Career Integration Grant from the European Commission (630763), http://ec.europa.eu/research/mariecurieactions/ funded-projects/career-integration-grants_en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Azevedo Cristina, 2015, Advances in Biological Regulation, V60, P144, DOI 10.1016/j.jbior.2015.09.008; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chatterjee A, 2016, CELL, V167, P722, DOI 10.1016/j.cell.2016.09.052; Chatterjee RN, 2012, NUCLEUS CALCUTTA, V55, P3, DOI 10.1007/s13237-012-0054-4; Conrad T, 2012, DEV CELL, V22, P610, DOI 10.1016/j.devcel.2011.12.016; Corn JE, 2014, NAT STRUCT MOL BIOL, V21, P297, DOI 10.1038/nsmb.2808; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Du J., 2011, PLOS ONE, V6; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fauth T, 2010, NUCLEIC ACIDS RES, V38, P3209, DOI 10.1093/nar/gkq026; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Gu WG, 1998, DEV GENET, V22, P56, DOI 10.1002/(SICI)1520-6408(1998)22:1<56::AID-DVG6>3.0.CO;2-6; Izzo A, 2008, NUCLEIC ACIDS RES, V36, P950, DOI 10.1093/nar/gkm1108; Jaffrey X, 2013, BIOTECHNOL GENET ENG, V29, P73; Johansson AM, 2011, NUCLEIC ACIDS RES, V39, P6428, DOI 10.1093/nar/gkr236; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kosik I, 2015, PLOS ONE, V10; Kuroda MI, 2016, GENETICS, V204, P435, DOI 10.1534/genetics.115.185108; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Prestel M, 2010, MOL CELL, V38, P815, DOI 10.1016/j.molcel.2010.05.022; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ristic M, 2016, METHODS MOL BIOL, V1449, P279, DOI 10.1007/978-1-4939-3756-1_17; Straub T, 2005, STABLE CHROMOSOMAL A, P352; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Thomae AW, 2013, DEV CELL, V27, P412, DOI 10.1016/j.devcel.2013.10.001; Vaughan L, 2015, CELL REP, V10, P88, DOI 10.1016/j.celrep.2014.12.012; Villa R, 2016, NATURE, V537, P244, DOI 10.1038/nature19338; Villa R, 2012, MOL CELL, V48, P647, DOI 10.1016/j.molcel.2012.09.012; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Zheng S, 2014, STRUCTURAL BASIS X C, P2652	47	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177408	10.1371/journal.pone.0177408	http://dx.doi.org/10.1371/journal.pone.0177408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510597	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500027
J	Tallmadge, RL; Miller, SC; Parry, SA; Felippe, MJB				Tallmadge, Rebecca L.; Miller, Steven C.; Parry, Stephen A.; Felippe, Maria Julia B.			Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate	PLOS ONE			English	Article							B-CELL RESPONSES; MATERNAL ANTIBODIES; EXPERIMENTAL-INFECTION; SEROLOGICAL RESPONSE; PERIPHERAL-BLOOD; HEALTHY FOALS; ADULT HORSES; HEPATITIS-A; GENE; INFLUENZA	The value of prophylactic neonatal vaccination is challenged by the interference of passively transferred maternal antibodies and immune competence at birth. Taken our previous studies on equine B cell ontogeny, we hypothesized that the equine neonate generates a diverse immunoglobulin repertoire in response to vaccination, independently of circulating maternal antibodies. In this study, equine neonates were vaccinated with 3 doses of keyhole limpet hemocyanin (KLH) or equine influenza vaccine, and humoral immune responses were assessed using antigen-specific serum antibodies and B cell Ig variable region sequencing. An increase (p<0.0001) in serum KLH-specific IgG level was measured between days 21 and days 28, 35 and 42 in vaccinated foals from non-vaccinated mares. In vaccinated foals from vaccinated mares, serum KLH-specific IgG levels tended to increase at day 42 (p = 0.07). In contrast, serum influenza-specific IgG levels rapidly decreased (p <= 0.05) in vaccinated foals from vaccinated mares within the study period. Nevertheless, IGHM and IGHG sequences were detected in KLH- and influenza-sorted B cells of vaccinated foals, independently of maternal vaccination status. Immunoglobulin nucleotide germline identity, IGHV gene usage and CDR length of antigen-specific IGHG sequences in B cells of vaccinated foals revealed a diverse immunoglobulin repertoire with isotype switching that was comparable between groups and to vaccinated mares. The low expression of CD27 memory marker in antigen-specific B cells, and of cytokines in peripheral blood mononuclear cells upon in vitro immunogen stimulation indicated limited lymphocyte population expansion in response to vaccine during the study period.	[Tallmadge, Rebecca L.; Miller, Steven C.; Felippe, Maria Julia B.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Equine Immunol Lab, Ithaca, NY 14853 USA; [Parry, Stephen A.] Cornell Univ, Cornell Stat Consulting Unit, Ithaca, NY USA	Cornell University; Cornell University	Felippe, MJB (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Equine Immunol Lab, Ithaca, NY 14853 USA.	mbf6@cornell.edu		Felippe, Maria Julia B./0000-0002-6440-5272; Tallmadge, Rebecca/0000-0002-7466-5449	Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture [2012-67015-19459]; Empire State Stem Cell Fund through New York State Department of Health [C026718]	Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture; Empire State Stem Cell Fund through New York State Department of Health	This project was supported by the Agriculture and Food Research Initiative competitive grant number 2012-67015-19459 of the USDA National Institute of Food and Agriculture (MJBF, RLT) https://nifa.usda.gov/program/agriculture-and-food-research-initative-afri. The Cornell Biomedical Sciences Flow Cytometry core lab acknowledges support by the Empire State Stem Cell Fund through New York State Department of Health Contract #C026718. Opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Board, the New York State Department of Health, or the State of New York https://stemcell.ny.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu Kazunaga, 2004, Nihon Rinsho Meneki Gakkai Kaishi, V27, P309; AGHOMO HO, 1990, VET RES COMMUN, V14, P415, DOI 10.1007/BF00343220; Ainsworth DM, 2002, VET IMMUNOL IMMUNOP, V84, P169, DOI 10.1016/S0165-2427(01)00400-7; Avanzini MA, 2010, INT J IMMUNOPATH PH, V23, P247, DOI 10.1177/039463201002300122; Badial PR, 2015, CLIN VACCINE IMMUNOL, V22, P1133, DOI 10.1128/CVI.00374-15; Banks EMS, 1999, J COMP PATHOL, V120, P1, DOI 10.1053/jcpa.1998.0250; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Battista JM, 2014, IMMUNOGENETICS, V66, P635, DOI 10.1007/s00251-014-0799-9; Bergmann-Leitner ES, 2014, VACCINES-BASEL, V2, P252, DOI 10.3390/vaccines2020252; Blasco E, 2001, VACCINE, V19, P4805, DOI 10.1016/S0264-410X(01)00211-0; Bordin AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105367; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; BURSTYN DG, 1983, INFECT IMMUN, V41, P1150, DOI 10.1128/IAI.41.3.1150-1156.1983; CLAESSON BA, 1989, J PEDIATR-US, V114, P97, DOI 10.1016/S0022-3476(89)80611-0; Clarke E, 2016, EXPERT REV VACCINES, V15, P1305, DOI 10.1586/14760584.2016.1167602; Dagan R, 2000, PEDIATR INFECT DIS J, V19, P1045, DOI 10.1097/00006454-200011000-00004; DAUM RS, 1991, J INFECT DIS, V164, P1154, DOI 10.1093/infdis/164.6.1154; Davis EG, 2015, EQUINE VET J, V47, P667, DOI 10.1111/evj.12350; Edmonds JD, 2001, EQUINE VET J, V33, P658, DOI 10.2746/042516401776249282; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Endsley JJ, 2003, BIOLOGICALS, V31, P123, DOI 10.1016/S1045-1056(03)00027-7; ENGLUND JA, 1995, PEDIATRICS, V96, P580; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Flaminio MJBF, 2009, CLIN VACCINE IMMUNOL, V16, P176, DOI 10.1128/CVI.00336-08; Flaminio MJBF, 1999, J VET INTERN MED, V13, P206, DOI 10.1892/0891-6640(1999)013&lt;0206:PBLSAI&gt;2.3.CO;2; Flaminio MJBF, 2000, VET IMMUNOL IMMUNOP, V73, P267, DOI 10.1016/S0165-2427(00)00149-5; Galson Jacob D, 2015, EBioMedicine, V2, P2070, DOI 10.1016/j.ebiom.2015.11.034; Galson JD, 2015, IMMUNOL CELL BIOL, V93, P885, DOI 10.1038/icb.2015.57; Hara Y, 2015, MOL IMMUNOL, V68, P617, DOI 10.1016/j.molimm.2015.10.003; Holbrook BC, 2016, VACCINE, V34, P4712, DOI 10.1016/j.vaccine.2016.08.010; Holmes MA, 2006, VET IMMUNOL IMMUNOP, V111, P67, DOI 10.1016/j.vetimm.2006.01.010; Ibrahim S, 2012, VET IMMUNOL IMMUNOP, V145, P7, DOI 10.1016/j.vetimm.2011.07.021; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P669, DOI 10.1128/CVI.00042-07; JEFFCOTT LB, 1975, J REPROD FERTIL, P727; JEONG HD, 1988, J EXP MED, V168, P589, DOI 10.1084/jem.168.2.589; Kanra G, 2000, TURKISH J PEDIATR, V42, P105; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KLOBASA F, 1981, RES VET SCI, V31, P195, DOI 10.1016/S0034-5288(18)32494-9; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; LAVOIE JP, 1989, AM J VET RES, V50, P1598; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Littel-van den Hurk SV, 1999, VIRAL IMMUNOL, V12, P67, DOI 10.1089/vim.1999.12.67; Lohmann KL, 2013, CAN J VET RES, V77, P161; Lopez AM, 2003, VACCINE, V21, P3815, DOI 10.1016/S0264-410X(03)00329-3; MARTIN BR, 1973, AM J VET RES, V34, P1363; Merant C, 2009, VET IMMUNOL IMMUNOP, V131, P1, DOI 10.1016/j.vetimm.2009.03.002; Minke JM, 2007, J COMP PATHOL, V137, pS76, DOI 10.1016/j.jcpa.2007.04.016; MORGAN DO, 1975, J REPROD FERTIL, P735; Muirhead TL, 2008, J VET INTERN MED, V22, P654, DOI 10.1111/j.1939-1676.2008.0091.x; Mumford EL, 2003, EQUINE VET J, V35, P72, DOI 10.2746/042516403775467379; Mwila K, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00405-16; Nguyen TV, 2006, CLIN VACCINE IMMUNOL, V13, P475, DOI 10.1128/CVI.13.4.475-485.2006; Nguyen TV, 2006, VACCINE, V24, P2302, DOI 10.1016/j.vaccine.2005.11.043; Opriessnig T, 2008, CLIN VACCINE IMMUNOL, V15, P397, DOI 10.1128/CVI.00416-07; Pei Y, 2007, VET MICROBIOL, V125, P100, DOI 10.1016/j.vetmic.2007.05.007; PERLMUTTER RM, 1985, SCIENCE, V227, P1597, DOI 10.1126/science.3975629; PERRYMAN LE, 1980, AM J VET RES, V41, P1197; Pichichero ME, 2014, VACCINE, V32, P3886, DOI 10.1016/j.vaccine.2014.05.008; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; Prieto JMB, 2017, VET IMMUNOL IMMUNOP, V183, P60, DOI 10.1016/j.vetimm.2016.12.004; Pusterla N, 2011, J PARASITOL, V97, P281, DOI 10.1645/GE-2657.1; R Core Team, 2021, R LANGUAGE ENV STAT; Ryan C, 2010, CLIN VACCINE IMMUNOL, V17, P1896, DOI 10.1128/CVI.00328-10; Sheoran AS, 2000, AM J VET RES, V61, P1099, DOI 10.2460/ajvr.2000.61.1099; Shiokawa S, 1999, J IMMUNOL, V162, P6060; Souto-Carneiro MM, 1950, J IMMUNOL BALTIM MD, V175, P7425; Sturgill TL, 2014, VACCINE, V32, P1362, DOI 10.1016/j.vaccine.2014.01.032; Sturgill TL, 2010, J EQUINE VET SCI, V30, P359, DOI 10.1016/j.jevs.2010.05.008; Sun LS, 2012, DEV COMP IMMUNOL, V36, P534, DOI 10.1016/j.dci.2011.09.009; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Tallmadge RL, 2014, DEV COMP IMMUNOL, V46, P171, DOI 10.1016/j.dci.2014.04.001; Tallmadge RL, 2013, DEV COMP IMMUNOL, V41, P33, DOI 10.1016/j.dci.2013.03.020; Tallmadge RL, 2009, DEV COMP IMMUNOL, V33, P1027, DOI 10.1016/j.dci.2009.05.002; VANMAANEN C, 1992, VET QUART, V14, P13, DOI 10.1080/01652176.1992.9694319; Varga J, 1997, VET MICROBIOL, V56, P205, DOI 10.1016/S0378-1135(97)00089-8; Walther S, 2015, DEV COMP IMMUNOL, V53, P303, DOI 10.1016/j.dci.2015.07.017; Wang HS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00099; Weitkamp JH, 2005, HUM IMMUNOL, V66, P666, DOI 10.1016/j.humimm.2005.02.008; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Williams JV, 2009, MOL IMMUNOL, V47, P407, DOI 10.1016/j.molimm.2009.08.024; Wilson WD, 2001, EQUINE VET J, V33, P644, DOI 10.2746/042516401776249435; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; ZINK MC, 1984, AM J VET RES, V45, P893	83	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177831	10.1371/journal.pone.0177831	http://dx.doi.org/10.1371/journal.pone.0177831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520789	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500076
J	Herrmann, WJ; Haarmann, A; Baerheim, A				Herrmann, Wolfram J.; Haarmann, Alexander; Baerheim, Anders			A sequential model for the structure of health care utilization	PLOS ONE			English	Article							LOW-INCOME; SERVICES	Traditional measurement models of health care utilization are not able to represent the complex structure of health care utilization. In this qualitative study, we, therefore, developed a new model to represent the health care utilization structure. In Norway and Germany, we conducted episodic interviews, participant observation and a concurrent context analysis. Data was analyzed by thematic coding in the framework of grounded theory. Consultations do very often not only have one single reason for encounter. They are usually not independent events but form part of consultation sequences. We could find structural differences between Norway and Germany regarding the flow of information between consultations and which providers are involved in health care in what way. This leads to a sequential model, in which health care utilization is seen as sequences of consultations. Such health care utilization sequences consist of nodes which are connected by edges. Nodes represent patientprovider contacts and edges depict the flow of information. Time and the level of health care providers are dimensions in the model. These sequences can be described by different measures and aggregated on population level. Thus, the sequential model can be further used in analyzing health care utilization quantitatively, e.g., by using routine data.	[Herrmann, Wolfram J.] Charite, Inst Gen Practice, Berlin, Germany; [Herrmann, Wolfram J.; Haarmann, Alexander] Otto von Guericke Univ, Inst Gen Practice & Family Med, Magdeburg, Germany; [Baerheim, Anders] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Haarmann, Alexander] Univ Bremen, Bremen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Otto von Guericke University; University of Bergen; University of Bremen	Herrmann, WJ (corresponding author), Charite, Inst Gen Practice, Berlin, Germany.; Herrmann, WJ (corresponding author), Otto von Guericke Univ, Inst Gen Practice & Family Med, Magdeburg, Germany.	wolfram.herrmann@charite.de	Herrmann, Wolfram/C-8972-2013	Herrmann, Wolfram/0000-0002-9505-4911	Deutsche Forschungsgemeinschaft (DFG) [HE 6399/1-1, HE 6399/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de), grant numbers HE 6399/1-1 and HE 6399/1-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2009, SACHVERSTANDIGENRAT; Babitsch Birgit, 2012, Psychosoc Med, V9, pDoc11, DOI 10.3205/psm000089; Bartley M., 2004, HLTH INEQUALITY INTR; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Burt RS, 2005, BROKERAGE CLOSURE IN; Busse Reinhard., 2014, GERMANY HLTH SYSTEM; CONNELLY JE, 1989, MED CARE, V27, pS99, DOI 10.1097/00005650-198903001-00009; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Flick U., 2000, QUALITATIVE RES TEXT, P75; Garrido MV, 2011, SCAND J PRIM HEALTH, V29, P28, DOI 10.3109/02813432.2010.537015; Gatrell A, 2002, HEALTH PLACE, V8, P147, DOI 10.1016/S1353-8292(01)00044-2; Glaser B.G., 1968, DISCOV GROUNDED THEO; Alvarez MLG, 2009, SOC SCI MED, V69, P793, DOI 10.1016/j.socscimed.2009.06.037; Herrmann WJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002952; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P791, DOI 10.1016/j.jclinepi.2005.12.008; Karsch-Volk M, 2010, Z ALLGEMEINMED, V86, P468; Kulu-Glasgow I, 1998, HEALTH POLICY, V45, P221, DOI 10.1016/S0168-8510(98)00045-1; Mangano A, 2010, HEALTH PLACE, V16, P301, DOI 10.1016/j.healthplace.2009.10.013; Mason T, 2015, SOC SCI MED, V132, P11, DOI 10.1016/j.socscimed.2015.03.005; McKernan SC, 2015, HEALTH PLACE, V34, P150, DOI 10.1016/j.healthplace.2015.05.002; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; Reijneveld SA, 2000, J CLIN EPIDEMIOL, V53, P267, DOI 10.1016/S0895-4356(99)00138-9; Riens B, 2012, ARZTKONTAKTE JAHR 20; Ringard Sagan A, 2013, WHO REGIONAL OFFICE; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Roovali L, 2006, HEALTH PLACE, V12, P195, DOI 10.1016/j.healthplace.2004.12.001; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; Schei E, 2000, Tidsskr Nor Laegeforen, V120, P2258; Sofianopoulou E, 2012, HEALTH PLACE, V18, P1248, DOI 10.1016/j.healthplace.2012.08.006; Terraneo M, 2015, SOC SCI MED, V126, P154, DOI 10.1016/j.socscimed.2014.12.028; World Health Organization, 2014, EUR HLTH ALL DAT	33	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176657	10.1371/journal.pone.0176657	http://dx.doi.org/10.1371/journal.pone.0176657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498872	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500006
J	Yi, L; Liu, ZQ; Qiao, LN; Wan, CM; Mu, DZ				Yi, Ling; Liu, Zhongqiang; Qiao, Lina; Wan, Chaomin; Mu, Dezhi			Does stroke volume variation predict fluid responsiveness in children: A systematic review and meta-analysis	PLOS ONE			English	Review							CARDIAC-OUTPUT MONITOR; CRITICALLY-ILL CHILDREN; CENTRAL VENOUS-PRESSURE; BIOREACTANCE; ACCURACY; THERAPY; INFANTS; ARTERY	Objective Stroke volume variation (SVV) is a reliable predictor of fluid responsiveness in adult patients. However, the predictive value of SVV is uncertain in pediatric patients. We performed the first systematic meta-analysis to evaluate the diagnostic value of SVV in predicting fluid responsiveness in children. Methods PUBMED, EMBASE, and Cochrane Central Register of Controlled Trials were searched up to December 2016. Original studies assessing the diagnostic accuracy of SVV in predicting fluid responsiveness in children were considered to be eligible. A random-effects model was used to calculate pooled values of sensitivity, specificity and diagnostic odds ratio with 95% CI. The summary receiver operating characteristic curve was estimated and area under the curve was calculated. Quality of the studies was assessed with the QUADAS-2 tool. Results Six studies with a total of 279 fluid boluses in 224 children were included. The analysis demonstrated a pooled sensitivity of 0.68 (95% CI, 0.59-0.76), pooled specificity of 0.65 (95% CI, 0.57-0.73), pooled diagnostic odds ratio of 8.24 (95% CI, 2.58-26.30), and the summary area under the summary receiver operating characteristic curve of 0.81. However, significant inter-study heterogeneity was found (p<0.05, rho = 61.3%), likely due to small sample size and diverse study characteristics. Conclusions Current evidence suggests that SVV was of diagnostic value in predicting fluid responsiveness in children under mechanical ventilation. Given the high heterogeneity of published data, further studies are needed to confirm the diagnostic accuracy of SVV in predicting fluid responsiveness in pediatric patients.	[Yi, Ling] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance China, Chengdu, Sichuan, Peoples R China; [Yi, Ling; Liu, Zhongqiang; Qiao, Lina; Wan, Chaomin; Mu, Dezhi] Sichuan Univ, Key Lab Obstetr & Gynecol & Pediat Dis & Birth De, Minist Educ, Chengdu, Sichuan, Peoples R China; [Liu, Zhongqiang; Qiao, Lina] Sichuan Univ, West China Univ Hosp 2, Dept Pediat Intens Care Unit, Chengdu, Sichuan, Peoples R China; [Wan, Chaomin; Mu, Dezhi] Sichuan Univ, West China Univ 2, Dept Pediat, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wan, CM; Mu, DZ (corresponding author), Sichuan Univ, Key Lab Obstetr & Gynecol & Pediat Dis & Birth De, Minist Educ, Chengdu, Sichuan, Peoples R China.; Wan, CM; Mu, DZ (corresponding author), Sichuan Univ, West China Univ 2, Dept Pediat, Chengdu, Sichuan, Peoples R China.	wcm0220@sina.com; Mudz@scu.edu.cn		Mu, Dezhi/0000-0002-2599-7041; Qu, Yi/0000-0002-9993-8810	National Science Foundation of China [81630038]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (no. 81630038).; This work was supported by the National Science Foundation of China (No. 81630038).	Akao M, 2013, J NIPPON MED SCH, V80, P260, DOI 10.1272/jnms.80.260; [Anonymous], 2009, J INTENSIVE CARE MED, V24, P35; Ansari BM, 2016, ANAESTHESIA, V71, P94, DOI 10.1111/anae.13246; Antonelli M, 2007, INTENS CARE MED, V33, P575, DOI 10.1007/s00134-007-0531-4; Auler JOC, 2008, SHOCK, V30, P18, DOI 10.1097/SHK.0b013e3181818708; Biais M, 2008, BRIT J ANAESTH, V101, P761, DOI 10.1093/bja/aen277; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Navarro LHC, 2015, PERIOPER MED, V4, DOI 10.1186/s13741-015-0014-z; Carsetti A, 2015, CURR OPIN CRIT CARE, V21, P388, DOI 10.1097/MCC.0000000000000240; Chand R, 2006, J CARDIOTHOR VASC AN, V20, P315, DOI 10.1053/j.jvca.2005.05.024; De Backer D, 2005, INTENS CARE MED, V31, P517, DOI 10.1007/s00134-005-2586-4; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Desgranges FP, 2016, PEDIATR ANESTH, V26, P37, DOI 10.1111/pan.12803; Eskesen TG, 2016, INTENS CARE MED, V42, P324, DOI 10.1007/s00134-015-4168-4; Gan H, 2013, ANESTH ANALG, V117, P1380, DOI 10.1213/ANE.0b013e3182a9557e; Hasanin A, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0117-0; Hett D A, 2004, Intensive Crit Care Nurs, V20, P103, DOI 10.1016/j.iccn.2004.01.002; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofer Christoph K, 2011, Acta Anaesthesiol Taiwan, V49, P59, DOI 10.1016/j.aat.2011.05.001; Kang WS, 2014, KOREAN J ANESTHESIOL, V66, P358, DOI 10.4097/kjae.2014.66.5.358; Lee JH, 2015, BRIT J ANAESTH, V115, P38, DOI 10.1093/bja/aev109; Lee JY, 2014, PEDIATR CARDIOL, V35, P289, DOI 10.1007/s00246-013-0772-7; Li C, 2013, INT J MED SCI, V10, P148, DOI 10.7150/ijms.5293; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; Marik PE, 2013, J CARDIOTHOR VASC AN, V27, P121, DOI 10.1053/j.jvca.2012.03.022; Marque S, 2009, CRIT CARE, V13, DOI 10.1186/cc7884; MATTHAY MA, 1988, ANN INTERN MED, V109, P826, DOI 10.7326/0003-4819-109-10-826; McLean JRL, 2014, INTENS CARE MED, V40, P288, DOI 10.1007/s00134-013-3171-x; Miller-Hance WWI, 2012, GREGORYS PEDIAT ANES, P60; Min JJ, 2016, J CLIN MONITORING CO; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Renner J, 2012, BRIT J ANAESTH, V108, P108, DOI 10.1093/bja/aer371; Sandroni C, 2012, INTENS CARE MED, V38, P1429, DOI 10.1007/s00134-012-2621-1; Saxena R, 2015, INTENS CARE MED, V41, P2161, DOI 10.1007/s00134-015-4075-8; Senzaki H, 2002, EUR J PEDIATR, V161, P547, DOI 10.1007/s00431-002-1025-6; Sharp MK, 2000, J APPL PHYSIOL, V88, P2227, DOI 10.1152/jappl.2000.88.6.2227; Suehiro K, 2011, J ANESTH, V25, P777, DOI 10.1007/s00540-011-1200-x; Tan HL, 2005, BRIT J ANAESTH, V94, P287, DOI 10.1093/bja/aei054; Thiele RH, 2015, CRIT CARE MED, V43, P177, DOI 10.1097/CCM.0000000000000608; Vergnaud E, 2015, BRIT J ANAESTH, V114, P103, DOI 10.1093/bja/aeu361; Weisz DE, 2012, NEONATOLOGY, V102, P61, DOI 10.1159/000337295; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wiesenack C, 2005, EUR J ANAESTH, V22, P658, DOI 10.1017/S0265021505001092; Wolf AR, 2014, PEDIATR ANESTH, V24, P5, DOI 10.1111/pan.12290; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang ZH, 2011, J ANESTH, V25, P904, DOI 10.1007/s00540-011-1217-1	46	22	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177590	10.1371/journal.pone.0177590	http://dx.doi.org/10.1371/journal.pone.0177590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498858	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500030
J	Benavente, ED; Ward, Z; Chan, W; Mohareb, FR; Sutherland, CJ; Roper, C; Campino, S; Clark, TG				Benavente, Ernest Diez; Ward, Zoe; Chan, Wilson; Mohareb, Fady R.; Sutherland, Colin J.; Roper, Cally; Campino, Susana; Clark, Taane G.			Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RESISTANCE-CONFERRING MUTATIONS; GENETIC DIVERSITY; DRUG-RESISTANCE; POPULATIONS; EVOLUTION; CHLOROQUINE; ORIGINS; PVMDR1; ASIA	Background Although Plasmodium vivax contributes to almost half of all malaria cases outside Africa, it has been relatively neglected compared to the more deadly P. falciparum. It is known that P. vivax populations possess high genetic diversity, differing geographically potentially due to different vector species, host genetics and environmental factors. Results We analysed the high-quality genomic data for 46 P. vivax isolates spanning 10 countries across 4 continents. Using population genetic methods we identified hotspots of selection pressure, including the previously reported MRP1 and DHPS genes, both putative drug resistance loci. Extra copies and deletions in the promoter region of another drug resistance candidate, MDR1 gene, and duplications in the Duffy binding protein gene (PvDBP) potentially involved in erythrocyte invasion, were also identified. For surveillance applications, continental-informative markers were found in putative drug resistance loci, and we show that organellar polymorphisms could classify P. vivax populations across continents and differentiate between Plasmodia spp. Conclusions This study has shown that genomic diversity that lies within and between P. vivax populations can be used to elucidate potential drug resistance and invasion mechanisms, as well as facilitate the molecular barcoding of the parasite for surveillance applications.	[Benavente, Ernest Diez; Ward, Zoe; Chan, Wilson; Sutherland, Colin J.; Roper, Cally; Campino, Susana; Clark, Taane G.] London Sch Hyg & Trop Med, Keppel St, London, England; [Ward, Zoe] Cranfield Univ, Sch Water Energy & Environm, Bioinformat Grp, Cranfield, Beds, England; [Chan, Wilson; Mohareb, Fady R.] Univ Calgary, Dept Pathol & Lab Med, Diagnost & Sci Ctr, Fac Med, Calgary, AB, Canada	University of London; London School of Hygiene & Tropical Medicine; Cranfield University; University of Calgary	Clark, TG (corresponding author), London Sch Hyg & Trop Med, Keppel St, London, England.	taane.clark@lshtm.ac.uk	Mohareb, Fady/O-1952-2019; Sutherland, Colin/AAN-3939-2020; Campino, Susana/AAM-2577-2020; Clark, Taane G./AAM-2570-2020; Roper, Cally/K-2989-2013	Mohareb, Fady/0000-0002-7880-2519; Sutherland, Colin/0000-0003-1592-6407; Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Diez Benavente, Ernest/0000-0002-4313-4290; Ward, Zoe/0000-0003-0334-6659; Roper, Cally/0000-0002-6545-309X	Medical Research Council UK [MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103]; MRC UK; MRC [MR/M01360X/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TGC receives funding from the Medical Research Council UK (grant numbers MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103). CR and SC are funded by the Medical Research Council UK (grant no. MR/M01360X/1). The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.; We thank Samuel Assefa, Francesc Coll, and Mark Preston for providing computing support. Sequence data were analysed using the MRC UK funded eMedlab computing resource.	Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Assefa SA, 2014, BIOINFORMATICS, V30, P1292, DOI 10.1093/bioinformatics/btu005; Auburn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053160; Baniecki ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003539; Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830; Bright AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-262; Campino S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1254-1; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cornejo OE, 2015, GENOME BIOL EVOL, V7, P106, DOI 10.1093/gbe/evu267; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Flannery EL, 2015, ACS INFECT DIS, V1, P367, DOI 10.1021/acsinfecdis.5b00049; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004639, 10.1371/journal.pntd.0005091]; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Hawkins VN, 2007, TRENDS PARASITOL, V23, P213, DOI 10.1016/j.pt.2007.03.002; Hawkins VN, 2009, AM J TROP MED HYG, V81, P348, DOI 10.4269/ajtmh.2009.81.348; Hawkins VN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-72; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hupalo DN, 2016, NAT GENET, V48, P953, DOI 10.1038/ng.3588; Imwong M, 2006, MOL BIOL EVOL, V23, P1016, DOI 10.1093/molbev/msj116; Imwong M, 2008, ANTIMICROB AGENTS CH, V52, P2657, DOI 10.1128/AAC.01459-07; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Kim JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151514; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lu F, 2010, AM J TROP MED HYG, P83; Lu F, 2011, ACTA TROP, V117, P69, DOI 10.1016/j.actatropica.2010.08.011; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Ocholla H, 2014, J INFECT DIS, V210, P1991, DOI 10.1093/infdis/jiu349; Ord R, 2005, MOL BIOCHEM PARASIT, V144, P86, DOI 10.1016/j.molbiopara.2005.08.005; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Parobek CM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002796; Pearson RD, 2016, NAT GENET, V48, P959, DOI 10.1038/ng.3599; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Rungsihirunrat K, 2007, AM J TROP MED HYG, V76, P1057, DOI 10.4269/ajtmh.2007.76.1057; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Samad H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005131; Saralamba N, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1543-8; Schousboe ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004196; Shen HX, 2015, MATER RES-IBERO-AM J, V18, P66, DOI 10.1590/1516-1439.325514; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Tachibana M, 2015, VACCINE, V33, P1901, DOI 10.1016/j.vaccine.2015.03.008; TAJIMA F, 1989, GENETICS, V123, P585; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Vallejo AF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1263-0; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WHO, WORLD MAL REP 2013; Winter DJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004252	53	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177134	10.1371/journal.pone.0177134	http://dx.doi.org/10.1371/journal.pone.0177134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493919	Green Published, Green Accepted, gold			2022-12-27	WOS:000401314300063
J	Canizares, M; Hogg-Johnson, S; Gignac, MAM; Glazier, RH; Badley, EM				Canizares, Mayilee; Hogg-Johnson, Sheilah; Gignac, Monique A. M.; Glazier, Richard H.; Badley, Elizabeth M.			Changes in the use practitioner-based complementary and alternative medicine over time in Canada: Cohort and period effects	PLOS ONE			English	Article							HEALTH-CARE; CAM USE; UNITED-STATES; AGE; ADULTS; PAIN; THERAPIES; TRENDS; SELF; PREVALENCE	Background The use of complementary and alternative medicine (CAM) is growing. However the factors contributing to changes over time and to birth cohort differences in CAM use are not well understood. Setting We used data from 10186 participants, who were aged 20-69 years at the first cycle of data collection in the longitudinal component of the Canadian National Population Health Survey (1994/95-2010/11). We examined chiropractic and other practitioner-based CAM use with a focus on five birth cohorts: pre-World War II (born 1925-1934); World War II (born 1935-1944); older baby boomers (born 1945-1954); younger baby boomers (born 1955-1964); and Gen Xers (born 1965-1974). The survey collected data every two years on predisposing (e.g., sex, education), enabling (e.g., income), behavior-related factors (e.g., obesity), need (e.g., chronic conditions), and use of conventional care (primary care and specialists). Results The findings suggest that, at corresponding ages, more recent cohorts reported greater CAM (OR = 25.9, 95% CI: 20.0; 33.6 for Gen Xers vs. pre-World War) and chiropractic use than their predecessors (OR = 2.2, 95% CI: 1.7; 2.8 for Gen Xers vs. pre-World War). There was also a secular trend of increasing CAM use, but not chiropractic use, over time (period effect) across all ages. Factors associated with cohort differences were different for CAM and chiropractic use. Cohort differences in CAM use were partially related to a period effect of increasing CAM use over time across all ages while cohort differences in chiropractic use were related to the higher prevalence of chronic conditions among recent cohorts. The use of conventional care was positively related to greater CAM use (OR = 1.8, 95% CI: 1.6; 2.0)	[Canizares, Mayilee] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Canizares, Mayilee; Gignac, Monique A. M.; Badley, Elizabeth M.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Hogg-Johnson, Sheilah; Gignac, Monique A. M.; Glazier, Richard H.; Badley, Elizabeth M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hogg-Johnson, Sheilah; Gignac, Monique A. M.] Inst Work & Hlth, Toronto, ON, Canada; [Glazier, Richard H.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Glazier, Richard H.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Glazier, Richard H.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada	University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Institute for Work & Health; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Canizares, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Canizares, M (corresponding author), Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada.	mcanizar@uhnres.utoronto.ca		Badley, Elizabeth/0000-0002-6045-2549	CIHR Operating Grant Secondary Analysis of Databases [SEC 117113]	CIHR Operating Grant Secondary Analysis of Databases	Access to the data is through the Statistics Canada Research Data Centres (RDC) Program. RDCs are operated under the provisions of the Statistics Act in accordance with all the confidentiality rules. The findings and conclusions of this paper are those of the authors and do not represent the official position of Statistics Canada. This study was partially supported by a CIHR Operating Grant Secondary Analysis of Databases (SEC 117113). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2008-7; Ahn AC, 2006, AM J PUBLIC HEALTH, V96, P647, DOI 10.2105/AJPH.2004.048496; Astin JA, 1998, ARCH INTERN MED, V158, P2303, DOI 10.1001/archinte.158.21.2303; Ayers SL, 2012, HEALTH SERV RES, V47, P2081, DOI 10.1111/j.1475-6773.2012.01406.x; Ayers SL, 2010, HEALTH-LONDON, V14, P234, DOI 10.1177/1363459309347491; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bell A, 2014, SOC SCI MED, V120, P21, DOI 10.1016/j.socscimed.2014.09.008; Bell A, 2013, SOC SCI MED, V93, P163, DOI 10.1016/j.socscimed.2013.04.029; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Brown C, 2009, J ALTERN COMPLEM MED, V15, P911, DOI 10.1089/acm.2008.0561; Busse JW, 2005, MAYO CLIN P, P80; Canadian Institute for Health Information, CANADAS HEALTH CARE; Canizares M, 2017, J GERONTOL B-PSYCHOL; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Clarke TC, 2015, NATL HLTH STAT REPOR, P1; Coulter ID, 2004, MED J AUSTRALIA, V180, P587, DOI 10.5694/j.1326-5377.2004.tb06099.x; Davis MA, 2011, HEALTH SERV RES, V46, P1402, DOI 10.1111/j.1475-6773.2011.01270.x; Deloitte Center for Health Solutions, THE QUEST FOR VALUE; Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Esmail N, 2007, COMPLEMENTARY AND AL; Faith J, 2015, ALTERN THER HEALTH M, V21, P30; Feinglass J, 2007, CLIN J PAIN, V23, P744, DOI 10.1097/AJP.0b013e31815349d4; Foster MM, 2010, HEALTH POLICY, V97, P105, DOI 10.1016/j.healthpol.2010.04.005; Fries C. J., 2012, Issues in health and health care related to race/ethnicity, immigration, SES and gender, P113; Fries CJ, 2013, HEALTH SOCIOL REV, V22, P37, DOI 10.5172/hesr.2013.22.1.37; Grzywacz JG, 2008, AM J HEALTH BEHAV, V32, P650, DOI 10.5555/ajhb.2008.32.6.650; Grzywacz JG, 2007, J HEALTH SOC BEHAV, V48, P84, DOI 10.1177/002214650704800106; Harris PE, 2012, INT J CLIN PRACT, V66, P924, DOI 10.1111/j.1742-1241.2012.02945.x; Hirschkorn KA, 2009, CAN REV SOCIOL, V46, P143, DOI 10.1111/j.1755-618X.2009.01208.x; Ho TF, 2014, J AM BOARD FAM MED, V27, P465, DOI 10.3122/jabfm.2014.04.130238; Kelner M, 1997, SOC SCI MED, V45, P203, DOI 10.1016/S0277-9536(96)00334-6; Kessler RC, 2001, ANN INTERN MED, V135, P262, DOI 10.7326/0003-4819-135-4-200108210-00011; Lapane KL, 2012, OSTEOARTHR CARTILAGE, V20, P22, DOI 10.1016/j.joca.2011.10.005; Lawrence Dana J, 2007, Chiropr Osteopat, V15, P2, DOI 10.1186/1746-1340-15-2; Lind BK, 2010, J ALTERN COMPLEM MED, V16, P411, DOI 10.1089/acm.2009.0261; McFarland B, 2002, AM J PUBLIC HEALTH, V92, P1616, DOI 10.2105/AJPH.92.10.1616; Metcalfe A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-58; Mior SA, 2008, J MANIP PHYSIOL THER, V31, P104, DOI 10.1016/j.jmpt.2007.12.007; Moffatt S, 2012, AGEING SOC, V32, P725, DOI 10.1017/S0144686X11000602; Murthy V, 2014, CLIN RHEUMATOL, V33, P253, DOI 10.1007/s10067-013-2357-5; Nahin RL, 2010, BMC HEALTH SERV RES, P10; Neiberg RH, 2011, J ALTERN COMPLEM MED, V17, P363, DOI 10.1089/acm.2009.0157; Pagan JA, 2005, HEALTH AFFAIR, V24, P255, DOI 10.1377/hlthaff.24.1.255; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Redwood D, 2008, J ALTERN COMPLEM MED, V14, P361, DOI 10.1089/acm.2007.0766; Reither EN, 2015, SOC SCI MED, V128, P356, DOI 10.1016/j.socscimed.2015.01.011; Rochelle TL, 2010, BRIT J HEALTH PSYCH, V15, P715, DOI 10.1348/135910709X479195; Rosenthal M, 2002, MILBANK Q, V80, P41, DOI 10.1111/1468-0009.00003; SAS Institute Inc, 2013, SAS STAT 9 3 US GUID; Sirois FM, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-16; Statistics Canada, 2011, INFORMATION ABOUT TH; Sulik GA, 2008, NO LONGER PATIENT SO, P3; Suzuki E, 2012, SOC SCI MED, V75, P452, DOI 10.1016/j.socscimed.2012.03.036; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; Vallerand AH, 2003, AM J PUBLIC HEALTH, V93, P923, DOI 10.2105/AJPH.93.6.923; Ventola C Lee, 2010, P T, V35, P461; Villanueva-Russell Y, 2011, SOC SCI MED, V72, P1826, DOI 10.1016/j.socscimed.2011.03.038; Votova K, 2010, J ALTERN COMPLEM MED, V16, P995, DOI 10.1089/acm.2009.0628; Weigel P, 2010, CHIROPR OSTEO, V18, P1; Yang SB, 2013, CLIN THER, V35, P1690, DOI 10.1016/j.clinthera.2013.09.022; Yang Y, 2013, AGE PERIOD COHORT AN, Vxiii	62	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177307	10.1371/journal.pone.0177307	http://dx.doi.org/10.1371/journal.pone.0177307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28494011	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300084
J	D'Aquila, PS; Galistu, A				D'Aquila, Paolo S.; Galistu, Adriana			Within-session decrement of the emission of licking bursts following reward devaluation in rats licking for sucrose	PLOS ONE			English	Article							MEDIATED BEHAVIORAL ACTIVATION; NUCLEUS-ACCUMBENS DOPAMINE; D2-LIKE RECEPTORS; DEPRIVED RATS; MICROSTRUCTURAL ANALYSIS; INCENTIVE SALIENCE; INGESTIVE BEHAVIOR; NACL SOLUTIONS; D1-LIKE; PIMOZIDE	We previously observed that dopamine D2-like receptor blockade in rats licking for sucrose produced a within-session decrement of the emission of licking bursts similar to the effect of either reward devaluation, or neuroleptics, on operant responding for different rewards, which, accordingly, we interpreted as an extinction-like effect. This implies that exposing animals to reward devaluation would result in a drop of burst number taking place only after the contact with the devalued reward. To test this prediction, we compared the difference in the within-session time course of burst number in response to high (10%) versus low (2%) concentration sucrose solutions, either in a condition of reward devaluation (exposure to 2% after daily 10%), or in a condition which does not involve changes in the reward value (two groups of subjects each repeatedly exposed to only one of the two concentrations). Reward devaluation resulted in a within-session decrement of the burst number, with the response rate dropping only after the contact with the devalued reward, as predicted. This response pattern was reliably observed only in subjects at their first devaluation experience. In contrast, exposure of separate groups of animals to the two different concentrations yielded lower levels of burst number in the low concentration group apparent since the beginning of the session, as previously observed with dopamine D1-like receptor blockade. These results show that the analysis of burst number, but not of burst size, reveals a specific activation pattern in response to reward devaluation, which differs from the pattern observed comparing the response to two different sucrose concentrations in separate groups of subjects, i.e. in a condition not involving reward devaluation. Finally, the characterisation of the experimental measures of the analysis of licking microstructure in behaviourally (and psychologically) meaningful functional terms, might be relevant for the investigation of the mechanisms underlying behavioural activation and the related evaluation processes.	[D'Aquila, Paolo S.; Galistu, Adriana] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy	University of Sassari	D'Aquila, PS (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy.	dsfpaolo@uniss.it	D'Aquila, Paolo S./H-5389-2011	D'Aquila, Paolo S./0000-0002-7885-9988	Fondazione Banco di Sardegna, Italy [U5002013/A.I.424MGB]	Fondazione Banco di Sardegna, Italy(Fondazione Banco di Sardegna)	This work was funded by Fondazione Banco di Sardegna, Italy (www.fondazionedisardegna.it, Grant N. U5002013/A.I.424MGB to PSD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen JM, 2016, PHYSIOL BEHAV, V167, P92, DOI 10.1016/j.physbeh.2016.09.001; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Canu ME, 2010, PHARMACOL BIOCHEM BE, V96, P194, DOI 10.1016/j.pbb.2010.05.004; D'Aquila PS, 2012, PHARMACOL BIOCHEM BE, V101, P99, DOI 10.1016/j.pbb.2011.12.004; D'Aquila PS, 2012, NEUROPHARMACOLOGY, V62, P1717, DOI 10.1016/j.neuropharm.2011.11.018; D'Aquila PS, 2010, NEUROPHARMACOLOGY, V58, P1085, DOI 10.1016/j.neuropharm.2010.01.017; DAVIS JD, 1989, ANN NY ACAD SCI, V575, P106; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; Frisina PG, 2002, PHARMACOL BIOCHEM BE, V74, P163, DOI 10.1016/S0091-3057(02)00995-4; Galistu A, 2013, PSYCHOPHARMACOLOGY, V229, P357, DOI 10.1007/s00213-013-3110-0; Galistu A, 2012, PHYSIOL BEHAV, V105, P230, DOI 10.1016/j.physbeh.2011.08.006; Galistu A, 2011, PSYCHOPHARMACOLOGY, V216, P411, DOI 10.1007/s00213-011-2237-0; GEARY N, 1985, PHARMACOL BIOCHEM BE, V22, P787, DOI 10.1016/0091-3057(85)90528-3; Genn RF, 2003, BEHAV PHARMACOL, V14, P609, DOI 10.1097/00008877-200312000-00005; GRAMLING SE, 1986, PHARMACOL BIOCHEM BE, V25, P219, DOI 10.1016/0091-3057(86)90256-X; GRAMLING SE, 1984, PHARMACOL BIOCHEM BE, V21, P617, DOI 10.1016/S0091-3057(84)80047-7; GRIGSON PS, 1993, PHYSIOL BEHAV, V54, P909, DOI 10.1016/0031-9384(93)90301-U; Higgs S, 1998, PSYCHOPHARMACOLOGY, V139, P342, DOI 10.1007/s002130050725; Jimenez-Garcia AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164331; Liao R M, 1995, Chin J Physiol, V38, P65; Lin JY, 2012, PHYSIOL BEHAV, V106, P515, DOI 10.1016/j.physbeh.2012.03.029; Moore JD, 2014, TRENDS NEUROSCI, V37, P370, DOI 10.1016/j.tins.2014.05.001; Robles CF, 2017, BEHAV BRAIN RES, V320, P431, DOI 10.1016/j.bbr.2016.10.043; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Salamone JD, 2016, BRAIN, V139, P1325, DOI 10.1093/brain/aww050; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; SANGER DJ, 1986, PSYCHOPHARMACOLOGY, V89, P98; SCHNEIDER LH, 1990, EUR J PHARMACOL, V186, P61, DOI 10.1016/0014-2999(90)94060-B; Schneider LH, 1989, APPETITE, V12, P236; Sclafani A, 2004, PHYSIOL BEHAV, V82, P89, DOI 10.1016/j.physbeh.2004.04.045; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P169, DOI 10.1016/S0149-7634(87)80022-2; Smith GP, 2004, APPETITE, V43, P11, DOI 10.1016/j.appet.2004.02.006; Smith GP, 2001, APPETITE, V36, P84, DOI 10.1006/appe.2000.0371; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; WEINGARTEN HP, 1982, PHYSIOL BEHAV, V28, P401, DOI 10.1016/0031-9384(82)90131-7; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469	39	10	10	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177705	10.1371/journal.pone.0177705	http://dx.doi.org/10.1371/journal.pone.0177705			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493981	Green Published, gold			2022-12-27	WOS:000401314300152
J	Douglas, SM; Chubiz, LM; Harcombe, WR; Marx, CJ				Douglas, Sarah M.; Chubiz, Lon M.; Harcombe, William R.; Marx, Christopher J.			Identification of the potentiating mutations and synergistic epistasis that enabled the evolution of inter-species cooperation	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; ESCHERICHIA-COLI POPULATION; METHIONINE BIOSYNTHESIS; SALMONELLA-TYPHIMURIUM; BENEFICIAL MUTATIONS; MICROBIAL MUTUALISM; KEY INNOVATION; ADAPTATION; MUTANTS; DYNAMICS	Microbes often engage in cooperation through releasing biosynthetic compounds required by other species to grow. Given that production of costly biosynthetic metabolites is generally subjected to multiple layers of negative feedback, single mutations may frequently be insufficient to generate cooperative phenotypes. Synergistic epistatic interactions between multiple coordinated changes may thus often underlie the evolution of cooperation through overproduction of metabolites. To test the importance of synergistic mutations in cooperation we used an engineered bacterial consortium of an Escherichia coli methionine auxotroph and Salmonella enterica. S. enterica relies on carbon by-products from E. coli if lactose is the only carbon source. Directly selecting wild-type S. enterica in an environment that favored cooperation through secretion of methionine only once led to a methionine producer, and this producer both took a long time to emerge and was not very effective at cooperating. On the other hand, when an initial selection for resistance of S. enterica to a toxic methionine analog, ethionine, was used, subsequent selection for cooperation with E. coli was rapid, and the resulting double mutants were much more effective at cooperation. We found that potentiating mutations in metJ increase expression of metA, which encodes the first step of methionine biosynthesis. This increase in expression is required for the previously identified actualizing mutations in metA to generate cooperation. This work highlights that where biosynthesis of metabolites involves multiple layers of regulation, significant secretion of those metabolites may require multiple mutations, thereby constraining the evolution of cooperation.	[Douglas, Sarah M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Douglas, Sarah M.; Chubiz, Lon M.; Harcombe, William R.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Chubiz, Lon M.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Harcombe, William R.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Marx, Christopher J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA	Harvard University; Harvard University; University of Missouri System; University of Missouri Saint Louis; University of Minnesota System; University of Minnesota Twin Cities; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Marx, CJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA.	cmarx@uidaho.edu			US Department of Energy [DE-SC0006731]	US Department of Energy(United States Department of Energy (DOE))	CJM recognizes funding from the US Department of Energy (DE-SC0006731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Brown KM, 2009, MOL BIOL EVOL, V26, P2455, DOI 10.1093/molbev/msp151; Bull JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004115; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Chou HH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004149; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Douglas SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161837; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; GREENE RC, 1970, BIOCHEM BIOPH RES CO, V38, P1120, DOI 10.1016/0006-291X(70)90355-4; HALL BG, 1993, METHOD ENZYMOL, V224, P603, DOI 10.1016/0076-6879(93)24045-V; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; HEGEMAN GD, 1970, ANNU REV MICROBIOL, V24, P429, DOI 10.1146/annurev.mi.24.100170.002241; Hillesland KL, 2014, P NATL ACAD SCI USA, V111, P14822, DOI 10.1073/pnas.1407986111; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; HOBSON AC, 1973, MOL GEN GENET, V126, P7, DOI 10.1007/BF00333477; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kryazhimskiy S, 2014, SCIENCE, V344, P1519, DOI 10.1126/science.1250939; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; LaMonte BL, 2006, MICROBIOL-SGM, V152, P1451, DOI 10.1099/mic.0.28489-0; LAWRENCE DA, 1968, GENETICS, V58, P473; LAWRENCE DA, 1972, J BACTERIOL, V109, P8, DOI 10.1128/JB.109.1.8-11.1972; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Na D, 2011, J BIOTECHNOL, V153, P35, DOI 10.1016/j.jbiotec.2011.03.004; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Pande S, 2016, ISME J, V10, P1413, DOI 10.1038/ismej.2015.212; Pande S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7238; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Quandt EM, 2015, ELIFE, V4, DOI 10.7554/eLife.09696; Quandt EM, 2014, P NATL ACAD SCI USA, V111, P2217, DOI 10.1073/pnas.1314561111; Rakoff-Nahoum S, 2016, NATURE, V533, P255, DOI 10.1038/nature17626; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; SU CH, 1971, P NATL ACAD SCI USA, V68, P367, DOI 10.1073/pnas.68.2.367; UMBARGER HE, 1969, ANNU REV BIOCHEM, V38, P323, DOI 10.1146/annurev.bi.38.070169.001543; URBANOWSKI ML, 1985, NUCLEIC ACIDS RES, V13, P673, DOI 10.1093/nar/13.3.673; Usuda Y, 2005, APPL ENVIRON MICROB, V71, P3228, DOI 10.1128/AEM.71.6.3228-3234.2005; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilson K., 2001, CURRENT PROTOCOLS MO, P241; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112	57	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0174345	10.1371/journal.pone.0174345	http://dx.doi.org/10.1371/journal.pone.0174345			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493869	Green Published, gold			2022-12-27	WOS:000401314300004
J	Khalid, M; Hassani, D; Bilal, M; Liao, JL; Huang, DF				Khalid, Muhammad; Hassani, Danial; Bilal, Muhammad; Liao, Jianli; Huang, Danfeng			Elevation of secondary metabolites synthesis in Brassica campestris ssp chinensis L. via exogenous inoculation of Piriformospora indica with appropriate fertilizer	PLOS ONE			English	Article							LETTUCE LACTUCA-SATIVA; ANTIOXIDANT ACTIVITY; PLANT-GROWTH; MEDICINAL-PLANT; ARABIDOPSIS; LEAVES; POLYPHENOLS; EXPRESSION; PHENOLICS; IMPACT	This work evaluated the impact of exogenous soil inoculation of beneficial fungal strain Piriformospora indica on phytochemical changes and the related genes expression of Chinese cabbage (Brassica campestris ssp. chinensis L.) by greenhouse pot experiments. High performance liquid chromatography (HPLC) affirmed that among the different combinations of fungal and organic fertilizer treatments, the phenolic acids and flavonoids were considerably enriched in organic fertilizer and fungi (OP) followed by organic fertilizer, biochar, fungi (OBP) treated plants. The antiradical activity was higher in OP (61.29%) followed by P (60%) and organic fertilizer (OF) (53.84%) inoculated plants which positively correlated with chlorophyll, carotenoids and flavonoids level (P<0.05). Furthermore, results showed that the exogenous application of P. indica significantly (P<0.05) enhanced plant growth, as well as stimulating the activation of chlorophyll, carotenoids and other antioxidant related pathways. The RT-qPCR analysis indicated that key FLS gene triggering the synthesis of kaemferol was up-regulated by the inoculation of P. indica. In conclusion, the results revealed that organic fertilizer and P. indica (OP) is the most appropriate combination for improving phytochemical and antiradical properties in Pakchoi.	[Khalid, Muhammad; Hassani, Danial; Liao, Jianli; Huang, Danfeng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Bilal, Muhammad] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China.	hdf@sjtu.edu.cn	Khalid, Muhammad/AAU-4383-2021; Hassani, Danial/AGZ-8246-2022; Bilal, Muhammad/AAH-6461-2020	Hassani, Danial/0000-0001-8024-0837; Bilal, Muhammad/0000-0001-5388-3183	National High-tech R&D Program of China (863 Program) [2013AA103000]; Shanghai Agriculture Applied Technology Development Program, China [T20140502]	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Shanghai Agriculture Applied Technology Development Program, China	This research was supported in part by the National High-tech R&D Program of China (863 Program) (Grant No. 2013AA103000) and Shanghai Agriculture Applied Technology Development Program, China (Grant No. T20140502).	Abadi VAJM, 2016, SYMBIOSIS, V69, P9, DOI 10.1007/s13199-015-0361-z; Achatz B, 2010, PLANT SOIL, V333, P59, DOI 10.1007/s11104-010-0319-0; Ackland ML, 2005, IN VIVO, V19, P69; Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Bagheri A. A., 2013, International Journal of Advanced Biological and Biomedical Research, V1, P1337; Baishya D, 2015, SYMBIOSIS, V66, P37, DOI 10.1007/s13199-015-0331-5; Baltruschat H, 2008, NEW PHYTOL, V180, P501, DOI 10.1111/j.1469-8137.2008.02583.x; Baslam M, 2011, J AGR FOOD CHEM, V59, P5504, DOI 10.1021/jf200501c; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Caldwell CR, 2006, J FOOD COMPOS ANAL, V19, P637, DOI 10.1016/j.jfca.2005.12.016; Camehl I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002051; Cartea ME, 2011, MOLECULES, V16, P251, DOI 10.3390/molecules16010251; Ceccarelli N, 2010, PLANT SOIL, V335, P311, DOI 10.1007/s11104-010-0417-z; Chu YH, 2000, J SCI FOOD AGR, V80, P561, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;561::AID-JSFA574&gt;3.0.CO;2-#; Das A, 2012, PLANT SIGNAL BEHAV, V7, P103, DOI 10.4161/psb.7.1.18472; Duthie GG, 2000, NUTR RES REV, V13, P79, DOI 10.1079/095442200108729016; Francisco M, 2010, FOOD RES INT, V43, P1455, DOI 10.1016/j.foodres.2010.04.024; Fresco P, 2010, CURR PHARM DESIGN, V16, P114, DOI 10.2174/138161210789941856; Gawlik-Dziki U, 2011, ACTA SCI POL-HORTORU, V10, P15; GianinazziPearson V, 1996, PLANT CELL, V8, P1871, DOI 10.1105/tpc.8.10.1871; Gil MI, 1999, J AGR FOOD CHEM, V47, P2213, DOI 10.1021/jf981200l; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gould W. D., 1990, Biotechnology of plant-microbe interactions., P287; Harbaum B, 2008, FOOD CHEM, V110, P838, DOI 10.1016/j.foodchem.2008.02.069; Hassani D, 2015, GENET MOL RES, V14, P13425, DOI 10.4238/2015.October.28.4; Hause B, 2005, PLANTA, V221, P184, DOI 10.1007/s00425-004-1436-x; Hegde DM, 1999, INDIAN J AGR SCI, V69, P73; Holm G., 1954, Acta Agriculturae Scandinavica, V4, P457; Jogawat A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26891; Johnson J.M., 2011, ENDOCYT CELL RES, V21, P101; Jugran AK, 2015, J SOIL SCI PLANT NUT, V15, P1035; Khan AG, 2000, CHEMOSPHERE, V41, P197, DOI 10.1016/S0045-6535(99)00412-9; Kilam D, 2015, SYMBIOSIS, V66, P149, DOI 10.1007/s13199-015-0347-x; Kim HJ, 2006, J AGR FOOD CHEM, V54, P7263, DOI 10.1021/jf060568c; Kim JD, 2006, J NUTR BIOCHEM, V17, P165, DOI 10.1016/j.jnutbio.2005.06.006; Krishna K, 1991, CURRENT RES, V20, P173; Kumar M, 2011, PLANT SIGNAL BEHAV, V6, P723, DOI 10.4161/psb.6.5.15106; LAMAISON JL, 1990, PHARM ACTA HELV, V65, P315; Lee YC, 2011, MOL PLANT MICROBE IN, V24, P421, DOI 10.1094/MPMI-05-10-0110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Middleton Jr E, 1994, IMPACT PLANT FLAVONO; Mulabagal V, 2010, FOOD CHEM, V118, P300, DOI 10.1016/j.foodchem.2009.04.119; Oelmuller R, 2009, SYMBIOSIS, V49, P1, DOI 10.1007/s13199-009-0009-y; Pant AP, 2009, J SCI FOOD AGR, V89, P2383, DOI 10.1002/jsfa.3732; Podsedek A, 2007, LWT-FOOD SCI TECHNOL, V40, P1, DOI 10.1016/j.lwt.2005.07.023; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prasad R, 2013, J BASIC MICROB, V53, P1016, DOI 10.1002/jobm.201200367; Rochfort SJ, 2006, J AGR FOOD CHEM, V54, P4855, DOI 10.1021/jf060154j; Sarwat M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00869; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Seeram NP, 2008, J AGR FOOD CHEM, V56, P627, DOI 10.1021/jf071988k; Shen DZ, 1997, AGR ECOSYST ENVIRON, V62, P237, DOI 10.1016/S0167-8809(96)01132-2; Sherameti I, 2005, J BIOL CHEM, V280, P26241, DOI 10.1074/jbc.M500447200; Sherameti I, 2008, MOL PLANT MICROBE IN, V21, P799, DOI 10.1094/MPMI-21-6-0799; SHETTY KG, 1994, ENVIRON POLLUT, V86, P181, DOI 10.1016/0269-7491(94)90189-9; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Smith SE., 1996, MYCORRHIZAL SYMBIOSI; Strasser R. J., 2007, V11, P319; Sun CA, 2010, J PLANT PHYSIOL, V167, P1009, DOI 10.1016/j.jplph.2010.02.013; Swieca M, 2012, SCI HORTIC-AMSTERDAM, V140, P87, DOI 10.1016/j.scienta.2012.04.005; Szaufer-Hajdrych M., 2004, Herba Polonica, V50, P50; Unnikumar KR, 2013, SYMBIOSIS, V60, P107, DOI 10.1007/s13199-013-0246-y; Vadassery J, 2008, MOL PLANT MICROBE IN, V21, P1371, DOI 10.1094/MPMI-21-10-1371; Vadassery J, 2009, J PLANT PHYSIOL, V166, P1263, DOI 10.1016/j.jplph.2008.12.016; Vahabi K, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1136763; VARMA A, 1994, ANGEW BOT, V68, P108; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Varma A, 2001, PIRIFORMOSPORA INDIC, P125; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Waller F, 2008, J PLANT PHYSIOL, V165, P60, DOI 10.1016/j.jplph.2007.05.017; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; Yochum L, 1999, AM J EPIDEMIOL, V149, P943, DOI 10.1093/oxfordjournals.aje.a009738; Zlotek U, 2014, FOOD CHEM, V148, P253, DOI 10.1016/j.foodchem.2013.10.031	76	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177185	10.1371/journal.pone.0177185	http://dx.doi.org/10.1371/journal.pone.0177185			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493970	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300069
J	Vahia, MN; Yadav, N; Ladiwala, U; Mathur, D				Vahia, Mayank N.; Yadav, Nisha; Ladiwala, Uma; Mathur, Deepak			A diffusion based study of population dynamics: Prehistoric migrations into South Asia	PLOS ONE			English	Article							GENETIC-EVIDENCE; MODERN HUMANS; HOMO-SAPIENS; INDIA; CLIMATE; DISPERSAL; COMPONENTS; SETTLEMENT; LANDSCAPE; DIVERSITY	A diffusion equation has been used to study migration of early humans into the South Asian subcontinent. The diffusion equation is tempered by a set of parameters that account for geographical features like proximity to water resources, altitude, and flatness of land. The ensuing diffusion of populations is followed in time-dependent computer simulations carried out over a period of 10,000 YBP. The geographical parameters are determined from readily-available satellite data. The results of our computer simulations are compared to recent genetic data so as to better correlate the migratory patterns of various populations; they suggest that the initial populations started to coalesce around 4,000 YBP before the commencement of a period of relative geographical isolation of each population group. The period during which coalescence of populations occurred appears consistent with the established timeline associated with the Harappan civilization and also, with genetic admixing that recent genetic mapping data reveal. Our results may contribute to providing a timeline for the movement of prehistoric people. Most significantly, our results appear to suggest that the Ancestral Austro-Asiatic population entered the subcontinent through an easterly direction, potentially resolving a hitherto-contentious issue.	[Vahia, Mayank N.; Yadav, Nisha; Ladiwala, Uma; Mathur, Deepak] Tata Inst Fundamental Res, Bombay, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Vahia, MN (corresponding author), Tata Inst Fundamental Res, Bombay, Maharashtra, India.	vahia@tifr.res.in	Mathur, Deepak/K-5000-2019	Mathur, Deepak/0000-0002-2322-6331				Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Allchin B., 1982, RISE CIVILIZATION IN; Alves I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002837; Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Barcelo A JA, 2016, SIMULATING PREHISTOR; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Basu A, 2016, P NATL ACAD SCI USA, V113, P1594, DOI 10.1073/pnas.1513197113; Brahmachari SK, 2008, J GENET, V87, P3; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Chakravarti A, 2009, NATURE, V461, P487, DOI 10.1038/461487a; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Culotta E, 2016, SCIENCE, V353, P1352, DOI 10.1126/science.353.6306.1352; deMenocal PB, 2016, NATURE, V538, P49, DOI 10.1038/nature19471; Dennell R, 2012, QUATERNARY SCI REV, V47, P15, DOI 10.1016/j.quascirev.2012.05.002; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P16089, DOI 10.1073/pnas.1209494109; Field JS, 2007, J ANTHROPOL ARCHAEOL, V26, P88, DOI 10.1016/j.jaa.2006.06.001; Finlayson C, 2005, TRENDS ECOL EVOL, V20, P457, DOI 10.1016/j.tree.2005.05.019; Gangal K, 2010, CURR SCI INDIA, V98, P846; Hastings D. A., 1998, GROUP, V4, P218; Hong YT, 2003, EARTH PLANET SC LETT, V211, P371, DOI 10.1016/S0012-821X(03)00207-3; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Korisettar R, 2007, VERTEBR PALEOBIOL PA, P69, DOI 10.1007/1-4020-5562-5_4; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Kummu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020578; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Morrison KD, 2007, VERTEBR PALEOBIOL PA, P321, DOI 10.1007/1-4020-5562-5_14; Normile D, 2009, SCIENCE, V326, P1470, DOI 10.1126/science.326.5959.1470; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Paddayya K, 2007, VERTEBR PALEOBIOL PA, P97, DOI 10.1007/1-4020-5562-5_5; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Perry CA, 2000, P NATL ACAD SCI USA, V97, P12433, DOI 10.1073/pnas.230423297; Petraglia MD, 2007, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/1-4020-5562-5_1; Possehl GL, 2007, VERTEBR PALEOBIOL PA, P447, DOI 10.1007/1-4020-5562-5_19; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Sharma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032546; Sharma S, J HUMAN GENET; Tamang Rakesh, 2012, Investig Genet, V3, P20, DOI 10.1186/2041-2223-3-20; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Thapar Romila, 2004, EARLY INDIA ORIGINS; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Vahia MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154641; WAGLE BG, 1994, MAR GEOL, V117, P207, DOI 10.1016/0025-3227(94)90016-7	52	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176985	10.1371/journal.pone.0176985	http://dx.doi.org/10.1371/journal.pone.0176985			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493906	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300048
J	Wang, Y; Yin, Y; Lan, X; Ye, F; Tian, K; Zhao, XL; Yin, HD; Li, DY; Xu, HY; Liu, YP; Zhu, Q				Wang, Yan; Yin, Yue; Lan, Xi; Ye, Fei; Tian, Kai; Zhao, Xiaoling; Yin, Huadong; Li, Diyan; Xu, Hengyong; Liu, Yiping; Zhu, Qing			Molecular characterization, expression of chicken TBK1 gene and its effect on IRF3 signaling pathway	PLOS ONE			English	Article							KAPPA-B KINASE; TANK-BINDING KINASE-1; VIRUS-INFECTION; IKK-EPSILON; INNATE IMMUNITY; RIG-I; INTERFERON; ACTIVATION; PHOSPHORYLATION; RECOGNITION	TRAF family member-associated NF-kappa B activator (TANK)-binding kinase1 (TBK1) is a serine- threonine kinase at the crossroads of multiple interferon (IFN)-inducing signaling pathways in innate immunity. The importance of TBK1 in antiviral immunity is well established in mammal models, but in chicken, the molecular characterization and potential function of TBK1 remain unclear. In the present study, the open-reading frame (ORF) of chicken TBK1 (chTBK1) was cloned and characterized. The sequencing results revealed that the chTBK1 ORF consists of 2190 base pairs (bp) encoding a deduced protein of 729 amino acid residues. Multiple sequence alignment analysis demonstrated chTBK1 similarity to other birds and mammals, which indicates that it is evolutionarily conserved. Quantitative real-time PCR (qRT-PCR) results showed that chTBK1 was ubiquitously expressed in chicken tissues and expression was especially high in immune tissues. In addition, the expression of chTBK1 was significantly up-regulated by infection with avian leukosis virus subgroup J (ALV-J) both in vivo and in chicken embryo fibroblasts (CEFs) challenged with ALV-J or stimulated with poly I:C in vitro. Consistent with the activation of chTBK1, the interferon regulatory factor 3 (IRF3) and IFN beta gene in CEFs were also up-regulated after challenge with ALV-J or polyI:C. In contrast, the expression of IRF3 and IFN beta in CEFs was significantly reduced by siRNA targeting the chTBK1 gene compared with a negative control (NC) during ALV-J infection or polyI:C transfection. In conclusion, our results demonstrated that chTBK1 may be an important immunoregulator for IRF3 and IFN beta induction in response to viral stimulation in chicken.	[Wang, Yan; Lan, Xi; Ye, Fei; Tian, Kai; Zhao, Xiaoling; Yin, Huadong; Li, Diyan; Xu, Hengyong; Liu, Yiping; Zhu, Qing] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China; [Yin, Yue] Sichuan Acad Med Sci, Inst Lab Anim, Chengdu, Peoples R China; [Yin, Yue] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Zhu, Q (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China.	zhuqing5959@163.com		Li, Diyan/0000-0001-7490-3550	Twelfth Five Year Plan for Breeding Program in Sichuan [2011NZ0099-7]; thirteenth Five Year Plan for Breeding Program in Sichuan [2016NYZ0050]; China Agriculture Research System [CARS-41]; National Natural Science Foundation of China [31601936]	Twelfth Five Year Plan for Breeding Program in Sichuan; thirteenth Five Year Plan for Breeding Program in Sichuan; China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Twelfth Five Year Plan for Breeding Program in Sichuan (No. 2011NZ0099-7), the thirteenth Five Year Plan for Breeding Program in Sichuan (No. 2016NYZ0050), the China Agriculture Research System (No. CARS-41) and National Natural Science Foundation of China (No. 31601936).	Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Brown CC, 1999, J COMP PATHOL, V120, P383, DOI 10.1053/jcpa.1998.0286; Chau TL, 2008, TRENDS BIOCHEM SCI, P33171; Chi H, 2011, FISH SHELLFISH IMMUN, V30, P1055, DOI 10.1016/j.fsi.2011.02.002; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Feng ZQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/419256; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; GRANT CE, 1995, NUCLEIC ACIDS RES, V23, P2137, DOI 10.1093/nar/23.12.2137; Hang BL, 2014, VIRUS RES, V188, P8, DOI 10.1016/j.virusres.2014.03.009; Huang B, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-22; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Larabi A, 2013, CELL REPORTS, P3734; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Li XJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P23, DOI 10.1016/j.abb.2009.06.008; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Liu HX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-196; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; May DL, 2000, DNA CELL BIOL, V19, P555, DOI 10.1089/104454900439782; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Nociari M, 2009, J VIROL, V83, P4081, DOI 10.1128/JVI.02591-08; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Rue CA, 2011, J GEN VIROL, V92, P931, DOI 10.1099/vir.0.025486-0; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; TBK1, 1999, EMBO J, V18, P6694; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	40	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177608	10.1371/journal.pone.0177608	http://dx.doi.org/10.1371/journal.pone.0177608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493975	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300144
J	Zhang, P; Li, XM; Zhao, XK; Song, X; Yuan, L; Shen, FF; Fan, ZM; Wang, LD				Zhang, Peng; Li, Xin-Min; Zhao, Xue-Ke; Song, Xin; Yuan, Ling; Shen, Fang-Fang; Fan, Zong-Min; Wang, Li-Dong			Novel genetic locus at MHC region for esophageal squamous cell carcinoma in Chinese populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; RISK; EXPRESSION; CANCER	Background Our previous genome-wide association study (GWAS) identified three independent single nucleotide polymorphisms (SNPs) in human major histocompatibility complex (MHC) region showing association with esophageal squamous cell carcinoma (ESCC). In this study, we increased GWAS sample size on MHC region and performed validation in an independent ESCC cases and normal controls with aim to find additional loci at MHC region showing association with an increased risk to ESCC. Methods The 1,077 ESCC cases and 1,733 controls were genotyped using Illumina Human 610-Quad Bead Chip, and 451 cases and 374 controls were genotyped using Illumina Human 660W-Quad Bead Chip. After quality control, the selected SNPs were replicated by TaqMan genotyping assay on another 2,026 ESCC cases and 2,384 normal controls. Results By excluding low quality SNPs in primary GWAS screening, we selected 2,533 SNPs in MHC region for association analysis, and identified 5 SNPs with p < 10(-4). Further validation analysis in an independent case-control cohort confirmed one of the 5 SNPs (rs911178) that showed significant association with ESCC. rs911178 (P-GWAS = 6.125E-04, OR = 0.644 and P-replication = 1.406E-22, OR = 0.489) was located at upstream of SCAND3. Conclusion The rs911178 (SCAND3 gene) in MHC region is significantly associated with high risk of ESCC. This study not only reveal the potential role of MHC region for the pathogenesis of ESCC, but also provides important clues for the establishment of tools and methods for screening high risk population of ESCC.	[Zhang, Peng; Li, Xin-Min; Zhao, Xue-Ke; Song, Xin; Fan, Zong-Min; Wang, Li-Dong] Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Li, Xin-Min] Maternal & Child Hlth Care Hosp Zhengzhou, Dept Pathol, Zhengzhou, Henan, Peoples R China; [Yuan, Ling] Zhengzhou Univ, Henan Canc Hosp, Dept Radiotherapy, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China; [Shen, Fang-Fang] Xinxiang Med Univ, Key Lab Tumor Translat Med, Affiliated Hosp 3, Xinxiang, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Xinxiang Medical University	Wang, LD (corresponding author), Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	ldwang2007@126.com			National Natural Science Foundation of China [81472323]; NSFC-Guangdong Joint Fund [U1301227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong Joint Fund	This study was funded by the National Natural Science Foundation of China (No. 81472323, http://www.nsfc.gov.cn/) and the NSFC-Guangdong Joint Fund (No. U1301227, http://www.nsfc.gov.cn/) for LDW.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Chen J, 2015, DIS ESOPHAGUS, V28, P84, DOI 10.1111/dote.12088; Chen W, 2011, CHIN J CANCER, V34, P502, DOI DOI 10.1186/S40880-015-0042-6; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Ko JM, 2014, ONCOL REP, V32, P860, DOI 10.3892/or.2014.3222; Lin J, 2003, WORLD J GASTROENTERO, V9, P412, DOI 10.3748/wjg.v9.i3.412; Llorens Carlos, 2012, Mob Genet Elements, V2, P205; Makeyev AV, 2009, BIOCHEM BIOPH RES CO, V386, P554, DOI 10.1016/j.bbrc.2009.06.045; Matejcic M, 2015, CRIT REV CL LAB SCI, V52, P211, DOI 10.3109/10408363.2015.1020358; Mizuki N, 1997, GENOMICS, V42, P55, DOI 10.1006/geno.1997.4708; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROCKETT JC, 1995, J CLIN PATHOL, V48, P539, DOI 10.1136/jcp.48.6.539; Schwartz M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0145-x; Shen FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090438; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Urayama KY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00300; Urayama KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072557; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2014, NAT GENET, V46, P1001, DOI 10.1038/ng.3064; Wu M, 2009, INT J CANCER, V124, P1907, DOI 10.1002/ijc.24142; Yang Y, 2008, TISSUE ANTIGENS, V72, P105, DOI 10.1111/j.1399-0039.2008.01078.x; Zhao X., 2011, SINGAPORE MANAGEMENT, V10, P2011	27	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e177494	10.1371/journal.pone.0177494	http://dx.doi.org/10.1371/journal.pone.0177494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493959	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300123
J	Chen, FP; Zhou, GQ; Qi, ZY; Lin, L; Hu, J; Wang, XJ; Sun, Y				Chen, Fo-Ping; Zhou, Guan-Qun; Qi, Zhen-Yu; Lin, Li; Hu, Jiang; Wang, Xiao-Ju; Sun, Ying			Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: Analysis of 1230 patients with positive cervical nodal metastasis	PLOS ONE			English	Article							STAGING SYSTEM; PATTERNS; NECROSIS	Purpose To investigate the variability and prognostic value of nodal tumor volume (NTV) in nasopharyngeal carcinoma (NPC). Methods and materials Data on 1230 patients with newly diagnosed stage T1-4N1-3M0 NPC treated with definitive radiation therapy with or without chemotherapy at a single cancer center were reviewed. NTV was determined from dose volume histogram (DVH) data. X-tile analysis was applied to identify the optimal cut-off points for the NTV with respect to regional recurrence-free survival (RRFS). Correlations between the TNM classification system, NTV and RRFS were assessed using a Cox regression model. Cross-validation based on receiver operating characteristic (ROC) curve analysis was applied to compare the prognostic predictive validity of NTV and N categories. Results Within a median follow-up of 49.9 (range, 1.27-76.40) months, 61/1230 (5%) patients developed regional recurrence and 154 (12.5%) developed distant metastasis. NTV values of 7.2 cc and 35.7 cc were identified as the optimal cut-off points. Patients with larger NTV had poorer prognosis. Compared with the N category, NTV was better at determining RRFS for patients with NPC. Hazard ratios increased with NTV, ranging from 1.86 (95% confidence interval [95% CI], 0.92-3.78) for NTV between 7.2 cc to 35.7 cc, and 3.67 (95% CI, 1.58-8.50) for NTV > 35.7 cc. With both NTV and N category in the same Cox regression model, only NTV remained statistically significant in the RRFS of NPC. The validation results with ROC curves also revealed that, NTV was superior to N category for predicting RRFS with significantly larger area under the ROC curve. Conclusions NTV offers important prognostic value for treatment outcomes in NPC, especially regional control. Volumetric analysis of nodal involvement may assist selection of patients with poor prognosis.	[Chen, Fo-Ping; Zhou, Guan-Qun; Qi, Zhen-Yu; Lin, Li; Hu, Jiang; Wang, Xiao-Ju; Sun, Ying] Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Sun, Y (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou, Guangdong, Peoples R China.	sunying@sysucc.org.cn						[Anonymous], 2010, ICRU REP, V83; [Anonymous], 1999, ICRU REP, V62; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Chen MK, 2004, CANCER-AM CANCER SOC, V100, P2160, DOI 10.1002/cncr.20210; Chua DTT, 2004, INT J RADIAT ONCOL, V58, P1437, DOI 10.1016/j.ijrobp.2003.09.075; Chua DTT, 1997, INT J RADIAT ONCOL, V39, P711, DOI 10.1016/S0360-3016(97)00374-X; Cooper JS, 1998, CANCER-AM CANCER SOC, V83, P213, DOI 10.1002/(SICI)1097-0142(19980715)83:2<213::AID-CNCR3>3.0.CO;2-R; GATENBY RA, 1988, INT J RADIAT ONCOL, V14, P831, DOI 10.1016/0360-3016(88)90002-8; Groebe K, 1996, INT J RADIAT ONCOL, V34, P395, DOI 10.1016/0360-3016(95)02065-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Ho FCH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-98; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; King AD, 2004, RADIOLOGY, V230, P720, DOI 10.1148/radiol.2303030157; Lan M, 2015, RADIOLOGY, V276, P536, DOI 10.1148/radiol.15141251; Liu LZ, 2006, INT J RADIAT ONCOL, V66, P721, DOI 10.1016/j.ijrobp.2006.05.054; Loong HH, 2008, HEMATOL ONCOL CLIN N, V22, P1267, DOI 10.1016/j.hoc.2008.08.012; Ma J, 2001, INT J RADIAT ONCOL, V50, P1181, DOI 10.1016/S0360-3016(01)01537-1; Mao YP, 2008, CLIN CANCER RES, V14, P7497, DOI 10.1158/1078-0432.CCR-08-0271; Ng SH, 2004, EUR J NUCL MED MOL I, V31, P1073, DOI 10.1007/s00259-004-1498-9; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Tang LL, 2009, CANCER-AM CANCER SOC, V115, P680, DOI 10.1002/cncr.24049	23	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176995	10.1371/journal.pone.0176995	http://dx.doi.org/10.1371/journal.pone.0176995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489930	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100042
J	Li, WJ; Xu, ST; Zhang, B; Zhu, YL; Hua, Y; Kong, X; Sun, LH; Hong, J				Li, Wenjie; Xu, Shouteng; Zhang, Biao; Zhu, Yelin; Hua, Yan; Kong, Xin; Sun, Lianhong; Hong, Jiong			Directed evolution to improve the catalytic efficiency of urate oxidase from Bacillus subtilis	PLOS ONE			English	Article							ASPERGILLUS-FLAVUS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; URICASE GENE; SP TB-90; HYPERURICEMIA; EXPRESSION; PURIFICATION; RASBURICASE; RESOLUTION	Urate oxidase is a key enzyme in purine metabolism and catalyzes the oxidation of uric acid to allantoin. It is used to treat hyperuricemia and gout, and also in a diagnostic kit. In this study, error-prone polymerase chain reaction and staggered extension process was used to generate a mutant urate oxidase with improved enzyme activity from Bacillus subtilis. After several rounds of mutagenesis and screening, two mutants 6E9 and 8E279 were obtained which exhibited 2.99 and 3.43 times higher catalytic efficiency, respectively. They also exhibited lower optimal reaction temperature and higher thermo-stability. D44V, Q268R and K285Q were identified as the three most beneficial amino acid substitutions introduced by site-directed mutagenesis. D44V/Q268R, which was obtained through random combination of the three mutants, displayed the highest catalytic activity. The Km, kcat/Km and enzyme activity of D44V/Q268R increased by 68%, 83% and 129% respectively, compared with that of wild-type urate oxidase. Structural modeling indicated that mutations far from the active site can have significant effects on activity. For many of them, the underlying mechanisms are still difficult to explain from the static structural model. We also compared the effects of the same set of single point mutations on the wild type and on the final mutant. The results indicate strong effects of epistasis, which may imply that the mutations affect catalysis through influences on protein dynamics besides equilibrium structures.	[Li, Wenjie; Xu, Shouteng; Zhang, Biao; Zhu, Yelin; Hua, Yan; Kong, Xin; Sun, Lianhong; Hong, Jiong] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hong, J (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China.	hjiong@ustc.edu.cn	HONG, Jiong/N-1996-2013	HONG, Jiong/0000-0002-4592-7083; Kong, Xin/0000-0002-3734-2763	National Natural Science Foundation of China [31570082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China [31570082] (JH) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balci H, 2014, APPL MICROBIOL BIOT, V98, P4467, DOI 10.1007/s00253-013-5476-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Chen ZY, 2008, APPL MICROBIOL BIOT, V79, P545, DOI 10.1007/s00253-008-1472-8; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; Dabbagh F, 2016, CURR PHARM BIOTECHNO, V17, P141, DOI 10.2174/1389201016666150907113055; Fan YH, 2007, APPL MICROBIOL BIOT, V76, P135, DOI 10.1007/s00253-007-0996-7; Feng J, 2015, APPL MICROBIOL BIOT, V99, P7973, DOI 10.1007/s00253-015-6520-6; Gabison L, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-32; Goldman SC, 2001, BLOOD, V97, P2998, DOI 10.1182/blood.V97.10.2998; Hibi T, 2016, BIOCHEMISTRY-US, V55, P724, DOI 10.1021/acs.biochem.5b01119; Jeha S, 2005, LEUKEMIA, V19, P34, DOI 10.1038/sj.leu.2403566; LEGOUX R, 1992, J BIOL CHEM, V267, P8565; Li JM, 2006, PROTEIN EXPRES PURIF, V49, P55, DOI 10.1016/j.pep.2006.02.003; Liu XJ, 2011, APPL MICROBIOL BIOT, V92, P529, DOI 10.1007/s00253-011-3244-0; Liu ZX, 2009, PHYS CHEM CHEM PHYS, V11, P333, DOI 10.1039/b811496j; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Oue S, 1999, J BIOL CHEM, V274, P2344, DOI 10.1074/jbc.274.4.2344; Pfrimer P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/674908; Pui CH, 1997, LEUKEMIA, V11, P1813, DOI 10.1038/sj.leu.2400850; Pui CH, 2001, SEMIN HEMATOL, V38, P13, DOI 10.1053/shem.2001.29018; Retailleau P, 2004, ACTA CRYSTALLOGR D, V60, P453, DOI 10.1107/S0907444903029718; Shaaban MI, 2015, J MICROBIOL BIOTECHN, V25, P887, DOI 10.4014/jmb.1410.10041; van der Veen BA, 2004, FEBS LETT, V560, P91, DOI 10.1016/S0014-5793(04)00077-8; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Xu H-f, 2009, BIOCATAL BIOTRANSFOR, V21, P41; Yamamoto K, 1996, J BIOCHEM-TOKYO, V119, P80; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou SH, 2016, APPL MICROBIOL BIOT, V100, P10443, DOI 10.1007/s00253-016-7672-8; Zhu L, 2016, APPL MICROBIOL BIOT, V100, P5805, DOI 10.1007/s00253-016-7371-5	33	15	15	8	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177877	10.1371/journal.pone.0177877	http://dx.doi.org/10.1371/journal.pone.0177877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531234	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400034
J	Zhang, LF; Cheng, XH; Bian, SN; Song, YH; Li, Q; Gao, MQ; Zhang, YQ; Shi, XC; Liu, XQ				Zhang, Lifan; Cheng, Xinhe; Bian, Sainan; Song, Yanhua; Li, Qiang; Gao, Mengqiu; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing			Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; LATENT TUBERCULOSIS; DIAGNOSIS; INFECTION; METAANALYSIS; CELLS	Currently available Interferon-gamma release assay (IGRA) cannot reliably differentiate active TB (ATB) from non-active TB (non-ATB). A study was performed to evaluate the value of Mycobacterium tuberculosis (MTB) specific Th1 cell immune responses which test IFN-gamma and IL-2 simultaneous for differentiating ATB from non-ATB. Forty-nine newly diagnosed inpatients with ATB (26 pulmonary TB and 23 extrapulmonary TB) were enrolled as the ATB group. Forty-five volunteers with latent tuberculosis infection (LTBI) and twenty with evidence of previous TB were enrolled during the same period as the non-ATB group. Clinical examination and MTB specific Th1 cell immune responses were performed for all participants. After being stimulated with ESAT-6 and CFP-10, the median frequencies of single IL-2-, single IFN-gamma-, and dual IFN-gamma/ IL-2-secreting T-cells were all higher in the ATB group than in the non-ATB group (20(8-45) vs. 7(3-13), P<0.001; 131(44-308) vs. 10(6-27), P<0.001; 25(9- 74) vs. 7(3-23), P = 0.001, respectively). Evaluation of the diagnostic performance of detecting single IFN-gamma-secreting T cells for pulmonary TB employed a cutoff value of 35 iSFCs/ 250,000 PBMC. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) were 92.3%, 80.0%, 64.9%, 96.3%, 4.62, and 0.10, respectively. For extrapulmonary TB, using a cutoff value of 23 iSFCs/ 250,000 PBMC, the sensitivity, specificity, PPV, NPV, PLR, and NLR were 91.3%, 76.9%, 58.3%, 96.2%, 3.96, and 0.11, respectively. When combining frequencies and proportion of single IFN-gamma-secreting T cells, the test sensitivity was 100% in parallel tests and the specificity was 87.7% in serial tests for pulmonary TB. MTB specific Th1 cell immune responses (FluoroSpot) had value for the differentiation of ATB and non-ATB. Further confirmatory studies are indicated.	[Zhang, Lifan; Cheng, Xinhe; Bian, Sainan; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Div Infect Dis, Beijing, Peoples R China; [Zhang, Lifan; Cheng, Xinhe; Bian, Sainan; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Lifan; Liu, Xiaoqing] Chinese Acad Med Sci, Clin Epidemiol Unit, Int Epidemiol Network, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Zhang, Lifan; Shi, Xiaochun; Liu, Xiaoqing] Chinese Acad Med Sci, Ctr TB Res, Beijing, Peoples R China; [Song, Yanhua; Li, Qiang; Gao, Mengqiu] Capital Med Univ, TB Dept, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University	Liu, XQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Div Infect Dis, Beijing, Peoples R China.; Liu, XQ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Liu, XQ (corresponding author), Chinese Acad Med Sci, Clin Epidemiol Unit, Int Epidemiol Network, Peking Union Med Coll Hosp, Beijing, Peoples R China.; Liu, XQ (corresponding author), Chinese Acad Med Sci, Ctr TB Res, Beijing, Peoples R China.	liuxq@pumch.cn			Beijing Municipal Science and Technology Commission [Z111107058811105]; Ministry of Science and Technology of the People's Republic of China [2014ZX10003003]; Chinese Academy of Medical Sciences (CAMS) Fund for Tuberculosis Research [2016ZX310183-4]; National Health and Family Planning Commission of the People's Republic of China [201402001]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2016-I2M-1-013]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Medical Sciences (CAMS) Fund for Tuberculosis Research; National Health and Family Planning Commission of the People's Republic of China; Chinese Academy of Medical Sciences Initiative for Innovative Medicine	This work was supported by Beijing Municipal Science and Technology Commission (grant number Z111107058811105, http://www.bjkw.gov.cn/); Ministry of Science and Technology of the Peoples Republic of China (grant number 2014ZX10003003, http://www.most.gov.cn/); Chinese Academy of Medical Sciences (CAMS) Fund for Tuberculosis Research (grant number 2016ZX310183-4, http://www.pumc.edu.cn/); National Health and Family Planning Commission of the People's Republic of China (grant number 201402001, http://www.nhfpc.gov.cn/); and Chinese Academy of Medical Sciences Initiative for Innovative Medicine (grant number 2016-I2M-1-013, http://www.cams.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal AN, 2015, J CLIN MICROBIOL, V53, P2451, DOI 10.1128/JCM.00823-15; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Bittel P, 2014, INFECTION, V42, P539, DOI 10.1007/s15010-014-0588-2; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chesov D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120006; Essone PN, 2014, RESPIRATION, V88, P251, DOI 10.1159/000365816; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Janssens JP, 2007, EUR RESPIR J, V30, P722, DOI 10.1183/09031936.00028507; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Liu XQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005200; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Ruan QL, 2016, CLIN RHEUMATOL, V35, P417, DOI 10.1007/s10067-014-2817-6; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; WANG L X, 2012, CHIN J ANTITUBERC, V34, P485; World Health Organization, 2015, GLOB TUB REP 2015; Zhang L, 2014, PLOS ONE, V9	19	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177850	10.1371/journal.pone.0177850	http://dx.doi.org/10.1371/journal.pone.0177850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531231	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400031
J	Caspell-Garcia, C; Simuni, T; Tosun-Turgut, D; Wu, IW; Zhang, Y; Nalls, M; Singleton, A; Shaw, LA; Kang, JH; Trojanowski, JQ; Siderowf, A; Coffey, C; Lasch, S; Aarsland, D; Burn, D; Chahine, LM; Espay, AJ; Foster, ED; Hawkins, KA; Litvan, I; Richard, I; Weintraub, D				Caspell-Garcia, Chelsea; Simuni, Tanya; Tosun-Turgut, Duygu; Wu, I-Wei; Zhang, Yu; Nalls, Mike; Singleton, Andrew; Shaw, Leslie A.; Kang, Ju-Hee; Trojanowski, John Q.; Siderowf, Andrew; Coffey, Christopher; Lasch, Shirley; Aarsland, Dag; Burn, David; Chahine, Lana M.; Espay, Alberto J.; Foster, Eric D.; Hawkins, Keith A.; Litvan, Irene; Richard, Irene; Weintraub, Daniel		Parkinson's Progression Marker	Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; PLANNING ABILITY; INITIATIVE PPMI; LEWY BODIES; DEMENTIA; INCIDENT; DECLINE; POLYMORPHISM; DISORDER	Objectives To assess the neurobiological substrate of initial cognitive decline in Parkinson's disease (PD) to inform patient management, clinical trial design, and development of treatments. Methods We longitudinally assessed, up to 3 years, 423 newly diagnosed patients with idiopathic PD, untreated at baseline, from 33 international movement disorder centers. Study outcomes were four determinations of cognitive impairment or decline, and biomarker predictors were baseline dopamine transporter (DAT) single photon emission computed tomography (SPECT) scan, structural magnetic resonance imaging (MRI; volume and thickness), diffusion tensor imaging (mean diffusivity and fractional anisotropy), cerebrospinal fluid (CSF; amyloid beta [A beta], tau and alpha synuclein), and 11 single nucleotide polymorphisms (SNPs) previously associated with PD cognition. Additionally, longitudinal structural MRI and DAT scan data were included. Univariate analyses were run initially, with false discovery rate = 0.2, to select biomarker variables for inclusion in multivariable longitudinal mixed-effect models. Results By year 3, cognitive impairment was diagnosed in 15-38% participants depending on the criteria applied. Biomarkers, some longitudinal, predicting cognitive impairment in multivariable models were: (1) dopamine deficiency (decreased caudate and putamen DAT availability); (2) diffuse, cortical decreased brain volume or thickness (frontal, temporal, parietal, and occipital lobe regions); (3) co-morbid Alzheimer's disease A beta amyloid pathology (lower CSF A beta 1-42); and (4) genes (COMT val/val and BDNF val/val genotypes). Conclusions Cognitive impairment in PD increases in frequency 50-200% in the first several years of disease, and is independently predicted by biomarker changes related to nigrostriatal or cortical dopaminergic deficits, global atrophy due to possible widespread effects of neurodegenerative disease, co-morbid Alzheimer's disease plaque pathology, and genetic factors.	[Caspell-Garcia, Chelsea; Coffey, Christopher] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Simuni, Tanya] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Tosun-Turgut, Duygu; Wu, I-Wei; Zhang, Yu] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Nalls, Mike; Singleton, Andrew] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Shaw, Leslie A.; Kang, Ju-Hee; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kang, Ju-Hee] Inha Univ, Sch Med, Dept Pharmacol & Clin Pharmacol, Incheon, South Korea; [Siderowf, Andrew] Avid Radiopharmaceut, Philadelphia, PA USA; [Lasch, Shirley] Inst Neurodegenerat Disorders, New Haven, CT USA; [Lasch, Shirley] Mol NeuroImaging LLC MNI, New Haven, CT USA; [Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England; [Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway; [Burn, David] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Chahine, Lana M.; Weintraub, Daniel] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Espay, Alberto J.] Univ Cincinnati, Acad Hlth Ctr, Dept Neurol, Cincinnati, OH USA; [Hawkins, Keith A.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Litvan, Irene] Univ Calif San Diego, Dept Neurosci, UCSD Movement Disorder Ctr, San Diego, CA 92103 USA; [Richard, Irene] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Richard, Irene] Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA; [Weintraub, Daniel] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Philadelphia Vet Affairs Med Ctr, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Philadelphia Vet Affairs Med Ctr, MIRECC, Philadelphia, PA 19104 USA	University of Iowa; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; Inha University; University of London; King's College London; Stavanger University Hospital; Newcastle University - UK; University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; University of Cincinnati; Yale University; University of California System; University of California San Diego; University of Rochester; University of Rochester; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Weintraub, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.; Weintraub, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.; Weintraub, D (corresponding author), Philadelphia Vet Affairs Med Ctr, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Philadelphia, PA 19104 USA.; Weintraub, D (corresponding author), Philadelphia Vet Affairs Med Ctr, MIRECC, Philadelphia, PA 19104 USA.	Daniel.Weintraub@uphs.upenn.edu	Singleton, Andrew B/C-3010-2009; Espay, Alberto J./AAC-4255-2020; Litvan, Irene/X-9319-2018; Weintraub, Daniel/AAD-8309-2020; Weintraub, Daniel/AAC-5232-2020; Burn, David/ABD-6052-2021	Espay, Alberto J./0000-0002-3389-136X; Litvan, Irene/0000-0002-3485-3445; Weintraub, Daniel/0000-0003-0633-7168; Hawkins, Keith/0000-0003-3494-2103; Chahine, Lana/0000-0003-2521-7196; Tosun, Duygu/0000-0001-8644-7724; Aarsland, Dag/0000-0001-6314-216X; Burn, David/0000-0001-7658-1209; Zhang, Yu/0000-0001-8066-7275	Michael J. Fox Foundation; Abbvie; Avid Radiopharmaceuticals; Biogen; Bristol-Myers Squibb; Covance; GE Healthcare; Genentech; GlaxoSmithKline; Lilly; Lundbeck; Merck; Meso Scale Discovery; Pfizer; Piramal; Roche; Servier; UCB; NINDS [P50 NS053488]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER	Michael J. Fox Foundation; Abbvie(AbbVie); Avid Radiopharmaceuticals; Biogen(Biogen); Bristol-Myers Squibb(Bristol-Myers Squibb); Covance; GE Healthcare(General ElectricGE Healthcare); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Merck(Merck & Company); Meso Scale Discovery; Pfizer(Pfizer); Piramal; Roche(Roche Holding); Servier(Servier); UCB(UCB Pharma SA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Michael J Fox Foundation for Parkinson's Research (michaeljtokorg) study design, data collection, decision to publish, preparation of manuscript. PPMI a public-private partnership is funded by the Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbvie, Avid Radiopharmaceuticals, Biogen, Bristol-Myers Squibb, Covance, GE Healthcare, Genentech, GlaxoSmithKline, Lilly, Lundbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Servier, and UCB. Dr. Andrew Siderowf is an employee of Avid Radiopharmaceuticals. Avid Radiopharmaceuticals provided support in the form of salary for Dr. Siderowf, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Siderowf's specific role is articulated in the 'author contributions' section. Also supported by NINDS P50 NS053488 (Trojanowski JQ-PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; Adler CH, 2010, ACTA NEUROPATHOL, V120, P827, DOI 10.1007/s00401-010-0744-4; Alves G, 2014, NEUROLOGY, V82, P1784, DOI 10.1212/WNL.0000000000000425; Bohnen NI, 2015, JAMA NEUROL, V72, P194, DOI 10.1001/jamaneurol.2014.2757; Bohnen NI, 2009, NEUROLOGY, V73, P256, DOI 10.1212/WNL.0b013e3181b0bd3d; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duncan GW, 2016, MOVEMENT DISORD, V31, P103, DOI 10.1002/mds.26312; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Evans A. C., 1993, NUCL SCI S MED IM C; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Foltynie T, 2005, J NEUROL, V252, P833, DOI 10.1007/s00415-005-0756-5; Foltynie T, 2004, MOVEMENT DISORD, V19, P885, DOI 10.1002/mds.20118; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Jellinger KA, 2002, J NEURAL TRANSM, V109, P329, DOI 10.1007/s007020200027; Kaasinen V, 2002, NEUROSCI BIOBEHAV R, V26, P785, DOI 10.1016/S0149-7634(02)00065-9; Kang JH, 2016, ACTA NEUROPATHOL, V131, P935, DOI 10.1007/s00401-016-1552-2; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; Morley JF, 2012, MOVEMENT DISORD, V27, P512, DOI 10.1002/mds.24946; Nalls MA, 2016, MOVEMENT DISORD, V31, P79, DOI 10.1002/mds.26374; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Pigott K, 2015, NEUROLOGY, V85, P1276, DOI 10.1212/WNL.0000000000002001; Poletti M, 2013, THER ADV PSYCHOPHARM, V3, P101, DOI 10.1177/2045125312470130; Ravina B, 2012, MOVEMENT DISORD, V27, P1392, DOI 10.1002/mds.25157; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Schuff N, 2015, MOVEMENT DISORD, V30, P1885, DOI 10.1002/mds.26325; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tsuang D, 2013, JAMA NEUROL, V70, P223, DOI 10.1001/jamaneurol.2013.600; Uribe C, 2016, MOVEMENT DISORD, V31, P699, DOI 10.1002/mds.26590; van der Kolk NM, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.08.023; Weintraub D, 2015, MOVEMENT DISORD, V30, P919, DOI 10.1002/mds.26170; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Weintraub D, 2011, MOVEMENT DISORD, V26, P1022, DOI 10.1002/mds.23664; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Williams-Gray CH, 2008, BRAIN, V131, P397, DOI 10.1093/brain/awm313; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Yarnall AJ, 2014, NEUROLOGY, V82, P308, DOI 10.1212/WNL.0000000000000066; ZWEIG RM, 1993, NEUROLOGY, V43, P986, DOI 10.1212/WNL.43.5.986	47	87	87	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175674	10.1371/journal.pone.0175674	http://dx.doi.org/10.1371/journal.pone.0175674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520803	Green Published, gold			2022-12-27	WOS:000401487700006
J	Mulak, KE; Bonn, CD; Chladkova, K; Aslin, RN; Escudero, P				Mulak, Karen E.; Bonn, Cory D.; Chladkova, Katerina; Aslin, Richard N.; Escudero, Paola			Indexical and linguistic processing by 12-month-olds: Discrimination of speaker, accent and vowel differences	PLOS ONE			English	Article							AMERICAN ENGLISH VOWELS; SPEECH-PERCEPTION; REGIONAL ACCENT; EARLY INFANCY; VARIABILITY; INFORMATION; CONSEQUENCES; RECOGNITION; CONSTANCY; DIMENSION	Infants preferentially discriminate between speech tokens that cross native category boundaries prior to acquiring a large receptive vocabulary, implying a major role for unsupervised distributional learning strategies in phoneme acquisition in the first year of life. Multiple sources of between-speaker variability contribute to children's language input and thus complicate the problem of distributional learning. Adults resolve this type of indexical variability by adjusting their speech processing for individual speakers. For infants to handle indexical variation in the same way, they must be sensitive to both linguistic and indexical cues. To assess infants' sensitivity to and relative weighting of indexical and linguistic cues, we familiarized 12-month-old infants to tokens of a vowel produced by one speaker, and tested their listening preference to trials containing a vowel category change produced by the same speaker (linguistic information), and the same vowel category produced by another speaker of the same or a different accent (indexical information). Infants noticed linguistic and indexical differences, suggesting that both are salient in infant speech processing. Future research should explore how infants weight these cues in a distributional learning context that contains both phonetic and indexical variation.	[Mulak, Karen E.; Escudero, Paola] Western Sydney Univ, MARCS Inst Brain Behav & Dev, Penrith, NSW, Australia; [Mulak, Karen E.; Escudero, Paola] Western Sydney Univ, Australian Res Council, Ctr Excellence Dynam Language, Penrith, NSW, Australia; [Bonn, Cory D.; Aslin, Richard N.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Chladkova, Katerina] Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands; [Bonn, Cory D.] Univ Paris 05, Lab Psychol Percept, Paris, France; [Chladkova, Katerina] Univ Leipzig, Inst Psychol, Cognit & Biol Psychol, Leipzig, Germany	Western Sydney University; Western Sydney University; University of Rochester; University of Amsterdam; UDICE-French Research Universities; Universite Paris Cite; Leipzig University	Mulak, KE (corresponding author), Western Sydney Univ, MARCS Inst Brain Behav & Dev, Penrith, NSW, Australia.; Mulak, KE (corresponding author), Western Sydney Univ, Australian Res Council, Ctr Excellence Dynam Language, Penrith, NSW, Australia.	k.mulak@westernsydney.edu.au	Escudero, Paola/Q-5310-2019; Bonn, Cory/I-1282-2019; Chládková, Kateřina/K-2039-2015	Escudero, Paola/0000-0002-8071-7663; Chládková, Kateřina/0000-0003-2009-1897	Australian Research Council [DP130102181, CE140100041]	Australian Research Council(Australian Research Council)	This research was supported by Australian Research Council grants DP130102181 and CE140100041 (CI Paola Escudero).	Adank P, 2004, J ACOUST SOC AM, V116, P1729, DOI 10.1121/1.1779271; Adank P, 2007, 16 INT C PHONETIC SC, P1925; Adank P, 2009, J EXP PSYCHOL HUMAN, V35, P520, DOI 10.1037/a0013552; Alispahic S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00052; Allen JS, 2003, J ACOUST SOC AM, V113, P544, DOI 10.1121/1.1528172; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Clayards M, 2008, COGNITION, V108, P804, DOI 10.1016/j.cognition.2008.04.004; Cox Felicity, 2006, PROSPECT, V21, P3; Csibra G, 2016, DEV PSYCHOL, V52, P521, DOI 10.1037/dev0000083; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Dehaene-Lambertz G, 2001, NEUROREPORT, V12, P3155, DOI 10.1097/00001756-200110080-00034; Escudero P, 2015, P 18 INT C PHON SCI; Escudero P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01059; Feldman NH, 2013, COGNITION, V127, P427, DOI 10.1016/j.cognition.2013.02.007; Floccia C, 2006, J EXP PSYCHOL HUMAN, V32, P1276, DOI 10.1037/0096-1523.32.5.1276; Floccia C, 2000, DEVELOPMENTAL SCI, V3, P333, DOI 10.1111/1467-7687.00128; Gabry J., 2016, RSTANARM BAYESIAN AP; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Houston DM, 2000, J EXP PSYCHOL HUMAN, V26, P1570, DOI 10.1037/0096-1523.26.5.1570; JUSCZYK PW, 1992, COGNITION, V43, P253, DOI 10.1016/0010-0277(92)90014-9; Kleinschmidt DF, 2015, PSYCHOL REV, V122, P148, DOI 10.1037/a0038695; Kriengwatana B, 2014, P 15 AUSTR INT C SPE, P76; Kriengwatana B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156870; KUHL PK, 1983, INFANT BEHAV DEV, V6, P263, DOI 10.1016/S0163-6383(83)80036-8; KUHL PK, 1979, J ACOUST SOC AM, V66, P1668, DOI 10.1121/1.383639; Liu R, 2015, J EXP PSYCHOL HUMAN, V41, P1783, DOI 10.1037/xhp0000092; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; McMurray B, 2011, PSYCHOL REV, V118, P219, DOI 10.1037/a0022325; MILLER JD, 1989, J ACOUST SOC AM, V85, P2114, DOI 10.1121/1.397862; Mulak KE, 2013, CHILD DEV, V84, P2064, DOI 10.1111/cdev.12087; Newman RS, 2001, J ACOUST SOC AM, V109, P1181, DOI 10.1121/1.1348009; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rost GC, 2010, INFANCY, V15, P608, DOI 10.1111/j.1532-7078.2010.00033.x; Rost GC, 2009, DEVELOPMENTAL SCI, V12, P339, DOI 10.1111/j.1467-7687.2008.00786.x; Schmale R, 2010, INFANCY, V15, P650, DOI 10.1111/j.1532-7078.2010.00032.x; Stager CL, 1997, NATURE, V388, P381, DOI 10.1038/41102; Stan Development Team, 2016, RSTAN R INT STAN R P; Swingley D, 2009, PHILOS T R SOC B, V364, P3617, DOI 10.1098/rstb.2009.0107; SYRDAL AK, 1986, J ACOUST SOC AM, V79, P1086, DOI 10.1121/1.393381; TRAUNMULLER H, 1981, J ACOUST SOC AM, V69, P1465, DOI 10.1121/1.385780; van Heugten M, 2014, LANG LEARN DEV, P1; van Heugten M, 2012, J SPEECH LANG HEAR R, V55, P554, DOI 10.1044/1092-4388(2011/10-0347); Wanrooij K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00077; White KS, 2011, DEVELOPMENTAL SCI, V14, P372, DOI 10.1111/j.1467-7687.2010.00986.x	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176762	10.1371/journal.pone.0176762	http://dx.doi.org/10.1371/journal.pone.0176762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DX	28520762	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700029
J	Schwarz, NG; Mertens, E; Winter, D; Maiga-Ascofare, O; Dekker, D; Jansen, S; Tappe, D; Randriamampionona, N; May, J; Rakotozandrindrainy, R; Schmidt-Chanasit, J				Schwarz, Norbert Georg; Mertens, Eva; Winter, Doris; Maiga-Ascofare, Oumou; Dekker, Denise; Jansen, Stephanie; Tappe, Dennis; Randriamampionona, Njary; May, Juergen; Rakotozandrindrainy, Raphael; Schmidt-Chanasit, Jonas			No serological evidence for Zika virus infection and low specificity for anti-Zika virus ELISA in malaria positive individuals among pregnant women from Madagascar in 2010	PLOS ONE			English	Article							SEROPREVALENCE; OUTBREAK; DENGUE; CHIKUNGUNYA; ANTIBODIES	It was previously reported that a malaria infection may interfere with the specificity of a commercial ELISA test against Zika virus (ZIKV). We analyzed 1,216 plasma samples from healthy, pregnant women collected in two sites in Madagascar in 2010 for ZIKV antibodies using a commercial ELISA and for Plasmodium infection by PCR. This screen revealed six putative ZIKV-positive samples by ELISA. These results could not be confirmed by indirect immunofluorescence assays or virus neutralization tests. Four of these six samples were also positive for P. falciparum. We noted that the frequency of malaria positivity was higher in ZIKV-ELISA positive samples (50% and 100% in the two study sites) than ZIKV-negative samples (17% and 10%, respectively), suggesting that malaria may have led to false ZIKV-ELISA positives.	[Schwarz, Norbert Georg; Mertens, Eva; Winter, Doris; Maiga-Ascofare, Oumou; Dekker, Denise; May, Juergen] Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Hamburg, Germany; [Mertens, Eva; Winter, Doris; Maiga-Ascofare, Oumou; Dekker, Denise; May, Juergen] German Ctr Infect Res, Hamburg Borstel Lubeck, Germany; [Maiga-Ascofare, Oumou] Kumasi Ctr Collaborat Res, Res Grp Med Trop, Kumasi, Ghana; [Jansen, Stephanie; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Hamburg, Germany; [Tappe, Dennis] Bernhard Nocht Inst Trop Med, Res Grp Zoonoses, Hamburg, Germany; [Randriamampionona, Njary; Rakotozandrindrainy, Raphael] Univ Antananarivo, Dept Microbiol & Parasitol, Antananarivo, Madagascar	Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research; Kumasi Center for Collaborative Research; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; University Antananarivo	Mertens, E (corresponding author), Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Hamburg, Germany.; Mertens, E (corresponding author), German Ctr Infect Res, Hamburg Borstel Lubeck, Germany.	mertens@bnitm.de	Schwarz, Norbert G/C-8797-2012; amsalu, ribka/G-8780-2019	Schwarz, Norbert G/0000-0002-8387-2837; Maiga Ascofare, Oumou/0000-0003-2947-5651; May, Jurgen/0000-0001-7831-8420	Bernhard Nocht Institute for Tropical Medicine	Bernhard Nocht Institute for Tropical Medicine	This study was financed by in house resources of the Bernhard Nocht Institute for Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; FONTENILLE D, 1989, J AM MOSQUITO CONTR, V5, P219; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203; Maiga-Ascofare O, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0704-5; Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Pan American Health Organization WHO, 2016, ZIK EP UPD; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036; Steinhagen K, 2016, EUROSURVEILLANCE; Tappe D, 2010, J CLIN VIROL, V49, P148, DOI 10.1016/j.jcv.2010.05.012; Tappe D, 2009, MED MICROBIOL IMMUN, V198, P271, DOI 10.1007/s00430-009-0122-9; Van Esbroeck M, 2016, EUROSURVEILLANCE, V21; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010	25	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176708	10.1371/journal.pone.0176708	http://dx.doi.org/10.1371/journal.pone.0176708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510593	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500008
J	Shakya, P; Kunieda, MK; Koyama, M; Rai, SS; Miyaguchi, M; Dhakal, S; Sandy, S; Sunguya, BF; Jimba, M				Shakya, Prakash; Kunieda, Mika Kondo; Koyama, Momoko; Rai, Sarju Sing; Miyaguchi, Moe; Dhakal, Sumi; Sandy, Su; Sunguya, Bruno Fokas; Jimba, Masamine			Effectiveness of community-based peer support for mothers to improve their breastfeeding practices: A systematic review and meta-analysis	PLOS ONE			English	Review							LOW-INCOME; WOMENS GROUPS; INTERVENTION; HEALTH; COUNSELORS; DURATION; PROGRAM; BANGLADESH; INITIATION; NUTRITION	Breastfeeding is associated with reduced mortality in children aged less than 5 years. We conducted a systematic review and meta-analysis (registered as PROSPERO 2015: CRD42015019105) to examine the effectiveness of community-based peer support for mothers on their breastfeeding practices as compared to mothers who have not received such a support. Methods We searched for evidence regarding community-based peer support for mothers in databases, such as PubMed/MEDLINE, the Cochrane Library, CINAHL, Web of Science, SocINDEX, and PsycINFO. We selected three outcome variables for breastfeeding practices, namely, exclusive breastfeeding duration, breastfeeding within the first hour of life, and prelacteal feeding. We conducted meta-analyses of the included randomized controlled trials and quasi-experimental studies. Results For our review, we selected 47 articles for synthesis out of 1,855 retrieved articles. In low-and middle-income countries, compared to usual care, community-based peer support increased exclusive breastfeeding at 3 months (RR: 1.90, 95% CI: 1.62-2.22), at 5 months (RR: 9.55, 95% CI: 6.65-13.70) and at 6 months (RR: 3.53, 95% CI: 2.49-5.00). In high-income countries, compared to usual care, peer support increased exclusive breastfeeding at 3 months (RR: 2.61, 95% CI: 1.15-5.95). In low-and middle-income countries, compared to usual care, peer support increased the initiation of breastfeeding within the first hour of life (RR: 1.51, 95% CI: 1.04-2.21) and decreased the risk of prelacteal feeding (RR: 0.38, 95% CI: 0.33-0.45). Conclusions Community-based peer support for mothers is effective in increasing the duration of exclusive breastfeeding, particularly for infants aged 3-6 months in low-and middle-income countries. Such support also encourages mothers to initiate breastfeeding early and prevents newborn prelacteal feeding.	[Shakya, Prakash; Kunieda, Mika Kondo; Koyama, Momoko; Rai, Sarju Sing; Miyaguchi, Moe; Dhakal, Sumi; Sandy, Su; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Sunguya, Bruno Fokas] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania	University of Tokyo; Muhimbili University of Health & Allied Sciences	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	mjimba@m.u-tokyo.ac.jp	S, Sarju/AAU-5893-2021; Jimba, Masamine/AAF-5630-2020; S, Sarju/AAT-6149-2020	S, Sarju/0000-0001-5914-1471; S, Sarju/0000-0001-5914-1471; Kunieda, Mika/0000-0002-3412-9860; Dhakal, Sumi/0000-0002-5003-5530; Sunguya, Bruno/0000-0003-3625-0725				Acharya A, 2015, AM J PUBLIC HEALTH, V105, P144, DOI 10.2105/AJPH.2014.302092; Agrasada GV, 2005, ACTA PAEDIATR, V94, P1109, DOI 10.1080/08035250510025752; Ahluwalia IB, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e85; Aksu H, 2011, J MATERN-FETAL NEO M, V24, P354, DOI 10.3109/14767058.2010.497569; Anderson AK, 2005, ARCH PEDIAT ADOL MED, V159, P836, DOI 10.1001/archpedi.159.9.836; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bhandari N, 2004, J NUTR, V134, P2342; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Brown A, 2011, MIDWIFERY, V27, P53, DOI 10.1016/j.midw.2009.09.004; Chapman DJ, 2004, ARCH PEDIAT ADOL MED, V158, P897, DOI 10.1001/archpedi.158.9.897; Dennis CL, 2002, CAN MED ASSOC J, V166, P21; Desclaux A, 2009, SOC SCI MED, V69, P821, DOI 10.1016/j.socscimed.2009.06.007; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Fairbank L., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/hta4250; Graffy J, 2004, BRIT MED J, V328, P26, DOI 10.1136/bmj.328.7430.26; Gross SM, 2009, J HUM LACT, V25, P435, DOI 10.1177/0890334409342070; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Hoddinott P, 2006, BIRTH-ISS PERINAT C, V33, P27, DOI 10.1111/j.0730-7659.2006.00071.x; Ingram J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-192; Jolly K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8287; Jolly K, 2012, MIDWIFERY, V28, P740, DOI 10.1016/j.midw.2011.08.005; Khan AI, 2013, ACTA PAEDIATR, V102, P815, DOI 10.1111/apa.12282; Khanal V, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-9; Kim SY, 2013, J CLIN EPIDEMIOL, V66, P408, DOI 10.1016/j.jclinepi.2012.09.016; Kistin N, 1994, J Hum Lact, V10, P11, DOI 10.1177/089033449401000121; Kushwaha KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109181; Leite AJM, 2005, ACTA PAEDIATR, V94, P741, DOI 10.1080/08035250410023854; Lewycka S, 2013, LANCET, V381, P1721, DOI 10.1016/S0140-6736(12)61959-X; Lovera D, 2010, J AM DIET ASSOC, V110, P1696, DOI 10.1016/j.jada.2010.08.001; McInnes RJ, 2000, J PUBLIC HEALTH MED, V22, P138, DOI 10.1093/pubmed/22.2.138; Merewood A, 2006, ARCH PEDIAT ADOL MED, V160, P681, DOI 10.1001/archpedi.160.7.681; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; More NS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001257; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Muirhead PE, 2006, BRIT J GEN PRACT, V56, P191; Mullany LC, 2008, J NUTR, V138, P599, DOI 10.1093/jn/138.3.599; Navarro JI, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-212; Ochola SA, 2013, PUBLIC HEALTH NUTR, V16, P1732, DOI 10.1017/S1368980012004405; Pugh LC, 2002, BIRTH-ISS PERINAT C, V29, P95, DOI 10.1046/j.1523-536X.2002.00169.x; Sudfeld CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045143; Taveras EM, 2011, MATERN CHILD HLTH J, V15, P1217, DOI 10.1007/s10995-010-0696-2; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO UNICEF, 1989, PROT PROM SUPP BREAS; Younes L, 2015, J EPIDEMIOL COMMUN H, V69, P374, DOI 10.1136/jech-2014-204271	48	64	68	41	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177434	10.1371/journal.pone.0177434	http://dx.doi.org/10.1371/journal.pone.0177434			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28510603	gold, Green Published			2022-12-27	WOS:000401485500029
J	Chanda, A; Chan, A; Deng, LL; Kornaga, EN; Enwere, EK; Morris, DG; Bonni, S				Chanda, Ayan; Chan, Angela; Deng, Lili; Kornaga, Elizabeth N.; Enwere, Emeka K.; Morris, Donald G.; Bonni, Shirin			Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; SNON; SUMOYLATION; TIF1-GAMMA; TUMOR; EXPRESSION; PROTEINS	Metastasis is the ultimate cause of breast cancer related mortality. Epithelial-mesenchymal transition (EMT) is thought to play a crucial role in the metastatic potential of breast cancer. Growing evidence has implicated the SUMO E3 ligase PIAS1 in the regulation of EMT in mammary epithelial cells and breast cancer metastasis. However, the relevance of PIAS1 in human cancer and mechanisms by which PIAS1 might regulate breast cancer metastasis remain to be elucidated. Using tissue-microarray analysis (TMA), we report that the protein abundance and subcellular localization of PIAS1 correlate with disease specific overall survival of a cohort of breast cancer patients. In mechanistic studies, we find that PIAS1 acts via sumoylation of the transcriptional regulator SnoN to suppress invasive growth of MDA-MB-231 human breast cancer cell-derived organoids. Our studies thus identify the SUMO E3 ligase PIAS1 as a prognostic biomarker in breast cancer, and suggest a potential role for the PIAS1-SnoN sumoylation pathway in controlling breast cancer metastasis.	[Chanda, Ayan; Deng, Lili; Bonni, Shirin] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada; [Chanda, Ayan; Deng, Lili; Bonni, Shirin] Univ Calgary, Biochem & Mol Biol, Calgary, AB, Canada; [Chan, Angela; Kornaga, Elizabeth N.; Enwere, Emeka K.; Morris, Donald G.] Alberta Hlth Serv, Tom Baker Canc Ctr, Translat Labs, Calgary, AB, Canada; [Morris, Donald G.] Alberta Hlth Serv, Dept Oncol, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); Tom Baker Cancer Clinic; University of Calgary; Alberta Health Services (AHS); University of Calgary	Bonni, S (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada.; Bonni, S (corresponding author), Univ Calgary, Biochem & Mol Biol, Calgary, AB, Canada.	sbonni@ucalgary.ca		Chanda, Ayan/0000-0002-2692-8558	University of Calgary, Achievers in Medical Sciences Recruitment Award; Eyes High Recruitment Award; Breast Cancer Society of Canada Grant; Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Canadian Breast Cancer Foundation Prairies/NWT	University of Calgary, Achievers in Medical Sciences Recruitment Award; Eyes High Recruitment Award; Breast Cancer Society of Canada Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Canadian Breast Cancer Foundation Prairies/NWT	This work was supported by the University of Calgary, Achievers in Medical Sciences Recruitment Award and Eyes High Recruitment Award; the Breast Cancer Society of Canada Grant; the Canadian Institutes of Health Research; Alberta Innovates Health Solutions and the Canadian Breast Cancer Foundation Prairies/NWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareeda AT, 2014, BREAST CANCER RES TR, V144, P519, DOI 10.1007/s10549-014-2897-7; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bonni S, 2012, FEBS LETT, V586, P1977, DOI 10.1016/j.febslet.2012.02.048; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chandhoke AS, 2016, CELL DEATH DIFFER, V23, P876, DOI 10.1038/cdd.2015.152; Coppola D, 2009, J CANCER RES CLIN, V135, P1287, DOI 10.1007/s00432-009-0570-z; Creighton Chad J, 2013, Cancer Manag Res, V5, P187, DOI 10.2147/CMAR.S35171; Dadakhujaev Shorafidinkhuja, 2014, Oncoscience, V1, P229; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Feng XL, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0575-2; Gonzalez-Prieto R, 2015, CELL CYCLE, V14, P1859, DOI 10.1080/15384101.2015.1040965; Gur I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099503; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Ikeuchi Y, 2014, J BIOL CHEM, V289, P25067, DOI 10.1074/jbc.M114.575878; Jahchan NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055794; Jain S, 2011, WORLD J GASTROENTERO, V17, P3994, DOI 10.3748/wjg.v17.i35.3994; Ji S., 2012, ADV DIFFER EQU, V2012, P1, DOI DOI 10.1016/J.CAGE0.2012.01.004; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kassem L, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1471-y; Kornaga EN, 2016, MOD PATHOL; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Liu B, 2014, PLOS ONE, V9; Malinen M, 2015, MOL CELL ENDOCRINOL, V414, P91, DOI 10.1016/j.mce.2015.07.024; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; Netherton SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013971; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Puhr M, 2016, ONCOGENE, V35, P2322, DOI 10.1038/onc.2015.292; Remotti Helen, 2013, Methods Mol Biol, V980, P13, DOI 10.1007/978-1-62703-287-2_2; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vinci M, 2015, JOVE-J VIS EXP, DOI 10.3791/52686; Weber S, 2009, GENE DEV, V23, P118, DOI 10.1101/gad.489409; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Yin X, 2016, ONCOL REP; Zhang F, 2003, CANCER RES, V63, P5005	43	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177639	10.1371/journal.pone.0177639	http://dx.doi.org/10.1371/journal.pone.0177639			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493978	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300146
J	Frank, MR; Cebrian, M; Pickard, G; Rahwan, I				Frank, Morgan R.; Cebrian, Manuel; Pickard, Galen; Rahwan, Iyad			Validating Bayesian truth serum in large-scale online human experiments	PLOS ONE			English	Article							ARTIFICIAL CULTURAL MARKET; INCENTIVES; DISHONESTY; QUALITY; PEOPLE	Bayesian truth serum (BTS) is an exciting new method for improving honesty and information quality in multiple-choice survey, but, despite the method's mathematical reliance on large sample sizes, existing literature about BTS only focuses on small experiments. Combined with the prevalence of online survey platforms, such as Amazon's Mechanical Turk, which facilitate surveys with hundreds or thousands of participants, BTS must be effective in large-scale experiments for BTS to become a readily accepted tool in real-world applications. We demonstrate that BTS quantifiably improves honesty in large-scale online surveys where the honest distribution of answers is known in expectation on aggregate. Furthermore, we explore a marketing application where honest answers cannot be known, but find that BTS treatment impacts the resulting distributions of answers.	[Frank, Morgan R.; Cebrian, Manuel; Rahwan, Iyad] MIT, Media Lab, Cambridge, MA 02139 USA; [Cebrian, Manuel] CSIRO, Unit Data61, Melbourne, Vic, Australia; [Pickard, Galen] Google Inc, Mountain View, CA USA	Massachusetts Institute of Technology (MIT); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Google Incorporated	Rahwan, I (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	irahwan@mit.edu	Frank, Morgan R/L-3124-2016; Rahwan, Iyad/ABB-2422-2020	Rahwan, Iyad/0000-0002-1796-4303; /0000-0001-9487-9359	Google Inc.	Google Inc.(Google Incorporated)	This research is supported by a grant from Google Inc. The funding organization provided support in the form of funds used to reward participants in the study. A Google employee is a coauthor on this study and he aided in the study design, data collection, data analysis, and the preparation of the manuscript. Any opinions, findings, conclusions, or recommendations expressed here are those of the authors alone.	Abeler J, 2012, IZA DISCUSSION PAPER; Abeliuk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121934; Berinsky AJ, 2014, AM J POLIT SCI, V58, P739, DOI 10.1111/ajps.12081; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Bucciol A, 2011, J ECON PSYCHOL, V32, P73, DOI 10.1016/j.joep.2010.12.001; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cohn A., 2014, NATURE; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Evrenk H, 2015, PUBLIC CHOICE, V162, P405, DOI 10.1007/s11127-015-0241-3; Fischbacher U, 2013, J EUR ECON ASSOC, V11, P525, DOI 10.1111/jeea.12014; Gino F, 2010, PSYCHOLOGICAL SCIENC; Heath A, 2005, ANNU REV POLIT SCI, V8, P297, DOI 10.1146/annurev.polisci.8.090203.103000; Hippler HJ, 2012, SOCIAL INFORMATION P; Hopmann DN, 2012, PARTY POLIT, V18, P173, DOI 10.1177/1354068810380097; Hu M., 2004, P 10 ACM SIGKDD INT, P168, DOI DOI 10.1145/1014052.1014073; Huff C, 2014, WHO ARE THESE PEOPLE; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kim YK, 2011, TOURISM MANAGE, V32, P235, DOI 10.1016/j.tourman.2009.12.008; Krumme C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033785; Malhotra N, 2008, PUBLIC OPIN QUART, V72, P914, DOI 10.1093/poq/nfn050; Mannes AE, 2014, J PERS SOC PSYCHOL, V107, P276, DOI 10.1037/a0036677; Mason W., 2010, SIGKDD EXPLORATIONS, V11, P100, DOI [DOI 10.1145/1809400.1809422, 10.1145/1600150.1600175]; Mazar N, 2006, J PUBLIC POLICY MARK, V25, P117, DOI 10.1509/jppm.25.1.117; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Morton RB, 2015, EUR ECON REV, V77, P65, DOI 10.1016/j.euroecorev.2015.03.012; MURRY JW, 1995, REV HIGH EDUC, V18, P423, DOI 10.1353/rhe.1995.0008; Prelec D, 2004, SCIENCE, V306, P462, DOI 10.1126/science.1102081; Randolph-Seng Brandon, 2007, INT J PSYCHOL RELIG, V17, P303, DOI [DOI 10.1080/10508610701572812, 10.1080/10508610701572812]; Rose S, 2012, J RETAILING, V88, P308, DOI 10.1016/j.jretai.2012.03.001; Salganik MJ, 2009, TOP COGN SCI, V1, P439, DOI 10.1111/j.1756-8765.2009.01030.x; Salganik MJ, 2008, SOC PSYCHOL QUART, V71, P338, DOI 10.1177/019027250807100404; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Shariff AF, 2011, INT J PSYCHOL RELIG, V21, P85, DOI 10.1080/10508619.2011.556990; Skippon SM, 2014, TRANSPORT RES F-TRAF, V23, P15, DOI 10.1016/j.trf.2013.12.008; Smith SM, 2016, J BUS RES, V69, P3139, DOI 10.1016/j.jbusres.2015.12.002; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Veenhoven R, 2002, SOC INDIC RES, V58, P33, DOI 10.1023/A:1015723614574; Wang W, 2015, INT J FORECASTING, V31, P980, DOI 10.1016/j.ijforecast.2014.06.001; Weaver R, 2013, J MARKETING RES, V50, P289, DOI 10.1509/jmr.09.0039; Witkowski J., 2012, AAAI	40	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177385	10.1371/journal.pone.0177385	http://dx.doi.org/10.1371/journal.pone.0177385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28494000	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300099
J	Hussein, AA; Leow, CY; Rahman, TA				Hussein, Ahmed Abdulqader; Leow, Chee Yen; Rahman, Tharek A.			Robust multiple frequency multiple power localization schemes in the presence of multiple jamming attacks	PLOS ONE			English	Article							WIRELESS SENSOR NETWORKS; CLOCK SYNCHRONIZATION; CHANNEL; ACCURACY; SECURITY; PROTOCOL; NODE	Localization of the wireless sensor network is a vital area acquiring an impressive research concern and called upon to expand more with the rising of its applications. As localization is gaining prominence in wireless sensor network, it is vulnerable to jamming attacks. Jamming attacks disrupt communication opportunity among the sender and receiver and deeply impact the localization process, leading to a huge error of the estimated sensor node position. Therefore, detection and elimination of jamming influence are absolutely indispensable. Range-based techniques especially Received Signal Strength (RSS) is facing severe impact of these attacks. This paper proposes algorithms based on Combination Multiple Frequency Multiple Power Localization (C-MFMPL) and Step Function Multiple Frequency Multiple Power Localization (SF-MFMPL). The algorithms have been tested in the presence of multiple types of jamming attacks including capture and replay, random and constant jammers over a log normal shadow fading propagation model. In order to overcome the impact of random and constant jammers, the proposed method uses two sets of frequencies shared by the implemented anchor nodes to obtain the averaged RSS readings all over the transmitted frequencies successfully. In addition, three stages of filters have been used to cope with the replayed beacons caused by the capture and replay jammers. In this paper the localization performance of the proposed algorithms for the ideal case which is defined by without the existence of the jamming attack are compared with the case of jamming attacks. The main contribution of this paper is to achieve robust localization performance in the presence of multiple jamming attacks under log normal shadow fading environment with a different simulation conditions and scenarios.	[Hussein, Ahmed Abdulqader; Leow, Chee Yen; Rahman, Tharek A.] Univ Teknol Malaysia, WCC, Fac Elect Engn, Utm Skudai 81310, Johor, Malaysia; [Hussein, Ahmed Abdulqader] Univ Technol Baghdad, Baghdad 10066, Iraq	Universiti Teknologi Malaysia; University of Technology- Iraq	Hussein, AA (corresponding author), Univ Teknol Malaysia, WCC, Fac Elect Engn, Utm Skudai 81310, Johor, Malaysia.; Hussein, AA (corresponding author), Univ Technol Baghdad, Baghdad 10066, Iraq.	ahmedabdulqaderhussein@gmail.com	LEOW, CHEE YEN/J-9206-2018; HUSSEIN, AHMED ABDULQADER/O-8158-2019	LEOW, CHEE YEN/0000-0001-6418-0184; HUSSEIN, AHMED ABDULQADER/0000-0002-7929-8668	Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia [4F818, 4J210, 12H35]	Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia	The work of C.Y. Leow is jointly supported by the Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia under vote number 4F818, 4J210 and 12H35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; "The work of C.Y. Leow is jointly supported by the Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia under vote number 4F818, 4J210 and 12H35."	Aalsalem MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158072; Acs G, 2006, P 4 ACM WORKSH SEC A, P49; Ahsan Faraz, 2011, Journal of Theoretical and Applied Information Technology, V30, P55; Akyildiz IF, 2002, IEEE COMMUN MAG, V40, P102, DOI 10.1109/MCOM.2002.1024422; Ashraf QM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160311; Bao Hua Liu, 2008, International Journal of Sensor Networks, V3, P211, DOI 10.1504/IJSNET.2008.019006; Bao QR, 2016, INT CONF INFO SCI, P443, DOI 10.1109/ICIST.2016.7483455; Chen Y, 2011, P 9 ACM C EMB NETW S, P26; Chen YY, 2010, IEEE T VEH TECHNOL, V59, P2418, DOI 10.1109/TVT.2010.2044904; Chen YY, 2009, ACM T SENSOR NETWORK, V5, DOI 10.1145/1464420.1464422; Chuku N., 2013, P IEEE SOUTHEASTCON, P1; Do Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138449; Donlan BM, 2006, IEEE T WIREL COMMUN, V5, P2863, DOI 10.1109/TWC.2006.04482; Gao Y, 2014, 2014 TENTH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P633, DOI 10.1109/CIS.2014.147; Ge MM, 2014, LECT NOTES COMPUT SC, V8792, P462, DOI 10.1007/978-3-319-11698-3_35; Huang Y, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/587318; Hussein Ahmed Abdulqader, 2015, Journal of Theoretical and Applied Information Technology, V78, P53; HUSSEIN AA, 2015, JOURNAL OF THEORETIC, V71; Hussein AA, 2015, SENSORS-BASEL, V15, P30545, DOI 10.3390/s151229817; Jiang X, 2010, LECT NOTES COMPUT SC, V6476, P140, DOI 10.1007/978-3-642-17650-0_11; Jiuqiang Xu, 2010, Wireless Sensor Network, V2, P606, DOI 10.4236/wsn.2010.28072; Kim YY, 1999, IEEE J SEL AREA COMM, V17, P888, DOI 10.1109/49.768203; Kumari S, 2016, CONCURRENCY AND COMP; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049141; Li MY, 2007, IEEE INFOCOM SER, P1307, DOI 10.1109/INFCOM.2007.155; Lin L, 2014, SENSORS-BASEL, V14, P14744, DOI 10.3390/s140814744; Liu H, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/263540; Ma D, 2009, IEEE NETWORK, V23, P43, DOI 10.1109/MNET.2009.4804335; Mao G., 2009, LOCALIZATION ALGORIT, DOI [10.4018/978-1-60566-396-8, DOI 10.4018/978]; Mao GQ, 2007, COMPUT NETW, V51, P2467, DOI 10.1016/j.comnet.2006.11.007; Mpitziopoulos A, 2009, SECUR COMMUN NETW, V2, P145, DOI 10.1002/sec.81; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Obaidat M, 2014, PRINCIPLES OF WIRELE; Pu C. C., 2014, P INT C FRONT COMM N, P1; Rhee IK, 2009, SENSORS-BASEL, V9, P56, DOI 10.3390/s90100056; Sen J, 2010, ARXIV PREPRINT ARXIV; Shim KA, 2016, IEEE COMMUN SURV TUT, V18, P577, DOI 10.1109/COMST.2015.2459691; Sookhak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115324; Tague P, 2008, ANN ALLERTON CONF, P1221, DOI 10.1109/ALLERTON.2008.4797699; Tian F, 2008, WIRELESS COMMUNICATI, P1; Xing K, 2010, NETWORK SECURITY, P251, DOI 10.1007/978-0-387-73821-5_11; Xu W., 2005, P INT S MOBILE AD HO, P46, DOI [10.1145/1062689.1062697, DOI 10.1145/1062689.1062697]; Xu W., 2004, P 2004 ACM WORKSHOP, P80, DOI DOI 10.1145/1023646.1023661; Xu W., 2007, P 2007 8 INT C EL ME, DOI [10.1109/ICEMI.2007.4350524, DOI 10.1109/ICEMI.2007.4350524]; Xu WY, 2006, IEEE NETWORK, V20, P41, DOI 10.1109/MNET.2006.1637931; Xu WY, 2008, ACM T SENSOR NETWORK, V4, DOI 10.1145/1387663.1387664; Yu Seung Kim, 2012, IEEE International Conference on Communications (ICC 2012), P949, DOI 10.1109/ICC.2012.6364441; Zeng P, 2010, IEEE T CONSUM ELECTR, V56, P566, DOI 10.1109/TCE.2010.5505971; Zhang H, 2016, IEEE T CONTR SYST T, V24, P843, DOI 10.1109/TCST.2015.2462741; Zhang H, 2015, IEEE T AUTOMAT CONTR, V60, P3023, DOI 10.1109/TAC.2015.2409905; Zheng XY, 2014, IEEE T PARALL DISTR, V25, P1955, DOI 10.1109/TPDS.2013.281; Zhu Y, 2012, INTERNATIONAL JOURNA, V2012	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177326	10.1371/journal.pone.0177326	http://dx.doi.org/10.1371/journal.pone.0177326			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493977	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300087
J	Morrison, JM; Baker, KD; Zamor, RM; Nikolai, S; Elshahed, MS; Youssef, NH				Morrison, Jessica M.; Baker, Kristina D.; Zamor, Richard M.; Nikolai, Steve; Elshahed, Mostafa S.; Youssef, Noha H.			Spatiotemporal analysis of microbial community dynamics during seasonal stratification events in a freshwater lake (Grand Lake, OK, USA)	PLOS ONE			English	Article							GROWTH-PROMOTING BACTERIUM; SP-NOV.; POLYNUCLEOBACTER-NECESSARIUS; ORGANIC-MATTER; GEN.-NOV.; BACTERIOPLANKTON COMMUNITY; MARINE BACTERIOPLANKTON; EUTROPHIC LAKE; DIVERSITY; SEDIMENT	Many freshwater lakes undergo seasonal stratification, where the formation of phototrophic blooms in the epilimnion and subsequent sedimentation induces hypoxia/anoxia in the thermocline and hypolimnion. This autochthonously produced biomass represents a major seasonal organic input that impacts the entire ecosystem. While the limnological aspects of this process are fairly well documented, relatively little is known regarding the microbial community response to such events, especially in the deeper anoxic layers of the water column. Here, we conducted a spatiotemporal survey of the particle-associated and free-living microbial communities in a warm monomictic freshwater reservoir (Grand Lake O' the Cherokees) in northeastern Oklahoma, USA. Pre-stratification samples (March) harbored a homogeneous community throughout the oxygenated water column dominated by typical oligotrophic aquatic lineages (acl clade within Actinobacteria, and Flavobacterium within the Bacteroidetes). The onset of phototrophic blooming in June induced the progression of this baseline community into two distinct trajectories. Within the oxic epilimnion, samples were characterized by the propagation of phototrophic (Prochlorococcus), and heterotrophic (Planctomycetes, Verrucomicrobia, and Beta-Proteobacteria) lineages. Within the oxygen-deficient thermocline and hypolimnion, the sedimentation of surface biomass induced the development of a highly diverse community, with the enrichment of Chloroflexi, "Latescibacteria", Armatimonadetes, and Delta-Proteobacteria in the particle-associated fraction, and Gemmatimonadetes and "Omnitrophica" in the free-living fraction. Our work documents the development of multiple spatially and temporally distinct niches during lake stratification, and supports the enrichment of multiple yet-uncultured and poorly characterized lineages in the lake's deeper oxygen-deficient layers, an ecologically relevant microbial niche that is often overlooked in lakes diversity surveys.	[Morrison, Jessica M.; Baker, Kristina D.; Elshahed, Mostafa S.; Youssef, Noha H.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Zamor, Richard M.; Nikolai, Steve] Grand River Dam Author, Vinita, OK USA	Oklahoma State University System; Oklahoma State University - Stillwater	Youssef, NH (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	Noha@Okstate.edu	Youssef, Noha H./T-5198-2019; M.Zamor, Richard/AAG-7504-2019	Youssef, Noha H./0000-0001-9159-3785; M.Zamor, Richard/0000-0003-3512-2940; Baker, Kristina/0000-0003-2812-5502	Oklahoma State University	Oklahoma State University	This work was funded by Oklahoma State University startup-funds to N. H. Youssef.	Bahr M, 1996, AQUAT MICROB ECOL, V11, P271, DOI 10.3354/ame011271; Baltar F, 2012, MICROBIOLOGYOPEN, V1, P214, DOI 10.1002/mbo3.25; Beck DAC, 2013, PEERJ, V1, DOI 10.7717/peerj.23; Bendall ML, 2016, ISME J, V10, P1589, DOI 10.1038/ismej.2015.241; Bowman J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P266, DOI 10.1007/0-387-30745-1_15; Bresciani M, 2013, EUR J REMOTE SENS, V46, P445, DOI 10.5721/EuJRS20134626; Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Cebron A, 2004, APPL ENVIRON MICROB, V70, P6726, DOI 10.1128/AEM.70.11.6726-6737.2004; Chauhan A, 2006, APPL ENVIRON MICROB, V72, P2400, DOI 10.1128/AEM.72.4.2400-2406.2006; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Chistoserdova L, 2011, APPL ENVIRON MICROB, V77, P4705, DOI 10.1128/AEM.00314-11; Cho DH, 2015, BIORESOURCE TECHNOL, V175, P578, DOI 10.1016/j.biortech.2014.10.159; DIAPOULIS A, 1987, Acta Adriatica, V28, P85; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eiler A, 2014, ENVIRON MICROBIOL, V16, P2682, DOI 10.1111/1462-2920.12301; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fukunaga Y., 2014, PROKARYOTES OTHER MA, V4, P683; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gallina N, 2011, J LIMNOL, V70, P186, DOI 10.4081/jlimnol.2011.186; Garcia SL, 2014, ENV MICROBIOL REP, V6, P21, DOI 10.1111/1758-2229.12104; Garcia SL, 2013, ISME J, V7, P137, DOI 10.1038/ismej.2012.86; Ghai R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00490; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Ghylin TW, 2014, ISME J, V8, P2503, DOI 10.1038/ismej.2014.135; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Glockner J, 2010, ENVIRON MICROBIOL, V12, P1218, DOI 10.1111/j.1462-2920.2010.02164.x; Gonzalez LE, 2000, APPL ENVIRON MICROB, V66, P1527, DOI 10.1128/AEM.66.4.1527-1531.2000; Gregoire P, 2011, INT J SYST EVOL MICR, V61, P1436, DOI 10.1099/ijs.0.025676-0; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hahn MW, 2007, INT J SYST EVOL MICR, V57, P936, DOI 10.1099/ijs.0.64807-0; Hahn MW, 2016, ISME J, V10, P1642, DOI 10.1038/ismej.2015.237; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; Hanert HH., 2006, PROKARYOTES, P990, DOI [DOI 10.1007/0-387-30747-8_46, 10.1007/0-387-30747-8_46]; Hedlund B. P., 2015, PROSTHECOBACTER BERG; Herren CM, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00013-16; Hiller KA, 2015, APPL ENVIRON MICROB, V81, P7114, DOI 10.1128/AEM.01986-15; Hugerth LW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0834-7; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Imazaki I, 2010, CAN J MICROBIOL, V56, P333, DOI [10.1139/W10-019, 10.1139/w10-019]; Jackson CR, 2014, APPL ENVIRON MICROB, V80, P7186, DOI 10.1128/AEM.01844-14; Jezberova J, 2010, ENVIRON MICROBIOL, V12, P658, DOI 10.1111/j.1462-2920.2009.02106.x; Kalyuhznaya MG, 2009, ENV MICROBIOL REP, V1, P385, DOI 10.1111/j.1758-2229.2009.00046.x; Kalyuzhnaya MG, 2006, INT J SYST EVOL MICR, V56, P2819, DOI 10.1099/ijs.0.64191-0; Kan JJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00210; Kant R, 2011, J BACTERIOL, V193, P2900, DOI 10.1128/JB.00299-11; Kent AD, 2004, MICROB ECOL, V48, P550, DOI 10.1007/s00248-004-0244-y; Kent AD, 2006, ENVIRON MICROBIOL, V8, P1448, DOI 10.1111/j.1462-2920.2006.01039.x; Kim BH, 2014, BIOMASS BIOENERG, V69, P95, DOI 10.1016/j.biombioe.2014.07.015; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Klindworth A, 2014, MAR GENOM, V18, P185, DOI 10.1016/j.margen.2014.08.007; Kojima H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05728; Kormas KA, 2001, MAR ECOL-P S Z N I, V22, P201, DOI 10.1046/j.1439-0485.2001.01720.x; Kuever J., 2014, PROKARYOTES DELTAPRO, P45, DOI DOI 10.1007/978-3-642-39044-9_266; Lage OM, 2011, FEMS MICROBIOL ECOL, V78, P366, DOI 10.1111/j.1574-6941.2011.01168.x; Lage OM, FRONT MICROBIOL, V5, P1; Lee J, 2013, BIORESOURCE TECHNOL, V131, P195, DOI 10.1016/j.biortech.2012.11.130; Lee KCY, 2011, INT J SYST EVOL MICR, V61, P2482, DOI 10.1099/ijs.0.027235-0; Li N, 2015, ANTON LEEUW INT J G, V107, P305, DOI 10.1007/s10482-014-0327-9; Logue JB, 2004, LIMNOL OCEANOGR, V49, P2001, DOI 10.4319/lo.2004.49.6.2001; Logue JB, 2008, BIOSCIENCE, V58, P103, DOI 10.1641/B580205; Louati I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140614; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Methe BA, 1998, LIMNOL OCEANOGR, V43, P368, DOI 10.4319/lo.1998.43.2.0368; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Miller TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074933; Mulamattathil S. G., 2014, J PATHOGENS, V2014, P11; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01028; Nunez M, 2003, BIOPHYS J, V84, P3379, DOI 10.1016/S0006-3495(03)70061-7; Oestreicher Z, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00406; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Okazaki Y, 2016, ENV MICROBIOL REP, V8, P780, DOI 10.1111/1758-2229.12439; Oksanen J., 2017, VEGAN INTRO ORDINATI; OWRB, 2009, STAT OKL WAT RES BOA; OWRB, STAT OKL WAT RES BOA; Page KA, 2004, APPL ENVIRON MICROB, V70, P6542, DOI 10.1128/AEM.70.11.6542-6550.2004; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Perry KA, 1990, CHEM LIMNOLOGY 2 MER; Ramanan R, 2016, BIOTECHNOL ADV, V34, P14, DOI 10.1016/j.biotechadv.2015.12.003; Ramanan R, 2015, ALGAL RES, V8, P140, DOI 10.1016/j.algal.2015.02.003; Reichenbach H., 2015, MYXOCOCCALES BERGEYS; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rinta-Kanto JM, 2012, ENVIRON MICROBIOL, V14, P228, DOI 10.1111/j.1462-2920.2011.02602.x; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schiaffino MR, 2016, J PLANKTON RES, V38, P64, DOI 10.1093/plankt/fbv105; Sack ELW, 2011, APPL ENVIRON MICROB, V77, P6931, DOI 10.1128/AEM.00372-11; SALEEM S., 2011, JES, V2, P185; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Schauer M, 2006, APPL ENVIRON MICROB, V72, P4704, DOI 10.1128/AEM.02935-05; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Shade A, 2011, ENVIRON MICROBIOL, V13, P2752, DOI 10.1111/j.1462-2920.2011.02546.x; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; Sison-Mangus MP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01433; Smalley NE, 2015, INT J SYST EVOL MICR, V65, P2227, DOI 10.1099/ijs.0.000190; Spring S, 2000, FEMS MICROBIOL REV, V24, P573, DOI 10.1016/S0168-6445(00)00046-2; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Tamaki H, 2011, INT J SYST EVOL MICR, V61, P1442, DOI 10.1099/ijs.0.025643-0; Taylor CB, 1942, J HYG-CAMBRIDGE, V42, P284, DOI 10.1017/S0022172400035488; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; Uyaguari-Diaz MI, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0166-1; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Watanabe K, 2009, FEMS MICROBIOL ECOL, V67, P57, DOI 10.1111/j.1574-6941.2008.00606.x; Wells ML, 2015, HARMFUL ALGAE, V49, P68, DOI 10.1016/j.hal.2015.07.009; White RA, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01531; Williams TJ, 2013, ENVIRON MICROBIOL, V15, P1302, DOI 10.1111/1462-2920.12017; Woodhouse JN, 2013, J APPL PHYCOL, V25, P1039, DOI 10.1007/s10811-012-9909-y; Wu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101837; Xie CH, 2005, INT J SYST EVOL MICR, V55, P2419, DOI 10.1099/ijs.0.63733-0; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Yannarell AC, 2004, APPL ENVIRON MICROB, V70, P214, DOI 10.1128/AEM.70.1.214-223.2004; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Ye WJ, 2011, HARMFUL ALGAE, V10, P472, DOI 10.1016/j.hal.2011.03.002; Youssef NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127499; Zaremba-Niedzwiedzka K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r130; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	131	28	31	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177488	10.1371/journal.pone.0177488	http://dx.doi.org/10.1371/journal.pone.0177488			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493994	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300119
J	Provencio, M; Sabin, P; Gomez-Codina, J; Torrente, M; Calvo, V; Llanos, M; Guma, J; Quero, C; Blasco, A; Cruz, MA; Aguiar, D; Garcia-Arroyo, F; Lavernia, J; Martinez, N; Morales, M; Saez-Cusi, A; Rodriguez, D; de la Cruz, L; Sanchez, JJ; Rueda, A				Provencio, Mariano; Sabin, Pilar; Gomez-Codina, Jose; Torrente, Maria; Calvo, Virginia; Llanos, Marta; Guma, Josep; Quero, Cristina; Blasco, Ana; Angel Cruz, Miguel; Aguiar, David; Garcia-Arroyo, Francisco; Lavernia, Javier; Martinez, Natividad; Morales, Manuel; Saez-Cusi, Alvaro; Rodriguez, Delvys; de la Cruz, Luis; Javier Sanchez, Jose; Rueda, Antonio		GOTEL Spanish Lymphoma Oncology Gr	Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMAS; PROGNOSTIC-FACTORS; TRANSFORMATION; OUTCOMES; TIME	Background Follicular lymphoma is the second most common non-Hodgkin lymphoma in the United States and Europe. However, most of the prospective randomized studies have very little follow-up compared to the long natural history of the disease. The primary aim of this study was to investigate the long-term survival of our series of patients with follicular lymphoma. Patients and methods A total of 1074 patients with newly diagnosed FL were enrolled. Patients diagnosed were prospectively enrolled from 1980 to 2013. Results Median follow-up was 54.9 months and median overall survival is over 20 years in our series. We analyzed the patients who are still alive beyond 10 years from diagnosis in order to fully assess the prognostic factors that condition this group. Out of 166 patients who are still alive after more than 10 years of follow-up, 118 of them (73%) are free of evident clinical disease. Variables significantly associated with survival at 10 years were stage < II (p <0.03), age < 60 years (p <0.0001), low FLIPI (p <0.002), normal beta 2 microglobulin (p <0.005), no B symptoms upon diagnosis (p <0.02), Performance Status 0-1 (p <0.03) and treatment with anthra-cyclines and rituximab (p <0.001), or rituximab (p <0.0001). Conclusions A longer follow-up and a large series demonstrated a substantial population of patients with follicular lymphoma free of disease for more than 10 years.	[Provencio, Mariano; Torrente, Maria; Calvo, Virginia] Hosp Univ Puerta de Hierro Majadahonda, Dept Med Oncol, Madrid, Spain; [Sabin, Pilar] Hosp Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain; [Gomez-Codina, Jose] Hosp Univ La Fe, Dept Med Oncol, Valencia, Spain; [Llanos, Marta] Hosp Univ Canarias, Dept Med Oncol, Tenerife, Spain; [Guma, Josep] Hosp Univ San Joan de Reus, Dept Med Oncol, Tarragona, Spain; [Quero, Cristina] Hosp Univ Virgen de la Victoria, Dept Med Oncol, Malaga, Spain; [Blasco, Ana] Hosp Gen Univ, Dept Med Oncol, Valencia, Spain; [Angel Cruz, Miguel] Hosp Virgen de la Salud, Dept Med Oncol, Toledo, Spain; [Aguiar, David] Hosp Univ Gran Canaria Doctor Negrin, Dept Med Oncol, Las Palmas Gran Canaria, Spain; [Garcia-Arroyo, Francisco] Complejo Hosp Pontevedra, Dept Med Oncol, Pontevedra, Spain; [Lavernia, Javier] Inst Valenciano Oncol, Dept Oncol, Valencia, Spain; [Martinez, Natividad] Hosp Gen Univ Elche, Dept Med Oncol, Alicante, Spain; [Morales, Manuel] Hosp Univ Nuestra Senora de Candelaria, Dept Med Oncol, Santa Cruz De Tenerife, Spain; [Saez-Cusi, Alvaro] Hosp Clin Univ Lozano Blesa, Dept Med Oncol, Zaragoza, Spain; [Rodriguez, Delvys] Hosp Univ Insular Gran Canaria, Dept Med Oncol, Las Palmas Gran Canaria, Spain; [de la Cruz, Luis] Hosp Univ Virgen de la Macarena, Dept Med Oncol, Seville, Spain; [Javier Sanchez, Jose] Univ Autonoma Nuevo Leon, Monterrey, Mexico; [Rueda, Antonio] Hosp Costa Sol, Dept Med Oncol, Marbella, Spain	Hospital Puerta de Hierro-Majadahonda; General University Gregorio Maranon Hospital; Hospital Universitari i Politecnic La Fe; Universidad de la Laguna; Hospital Virgen de la Victoria; Universidad de Malaga; Hospital Clinic Universitari de Valencia; Complejo Hospitalario de Toledo; Complexo Hospitalario Universitario de Pontevedra; Instituto Valenciano De Oncologia; Lozano Blesa University Clinical Hospital; Universidad Autonoma de Nuevo Leon	Provencio, M (corresponding author), Hosp Univ Puerta de Hierro Majadahonda, Dept Med Oncol, Madrid, Spain.	mariano.provencio@salud.madrid.org	Provencio, Mariano/ABE-8586-2020; de Juan, Virginia Calvo/AAD-4505-2021; Blasco, Ana/D-7970-2018; Morales, Manuel/ABG-4659-2021; Martínez Madrid, Natividad/Y-2636-2018	Provencio, Mariano/0000-0001-9053-9197; Blasco, Ana/0000-0002-5625-235X; Martínez Madrid, Natividad/0000-0003-1965-9481; Blasco Cordellat, Ana/0000-0001-5889-0382; Martinez-Banaclocha, Natividad/0000-0002-7515-5037; Calvo de Juan, Virginia/0000-0002-3503-4847; Provencio Pulla, Mariano/0000-0001-6315-7919; TORRENTE, MARIA/0000-0001-8791-7660				Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Chan WC, 1997, BLOOD, V89, P3909; Chau I, 2003, BRIT J CANCER, V89, P36, DOI 10.1038/sj.bjc.6601006; COIFFIER B, 1993, SEMIN ONCOL, V20, P89; Conconi A, 2015, ANN ONCOL, V26, P2317, DOI 10.1093/annonc/mdv376; Conconi A, 2010, LEUKEMIA LYMPHOMA, V51, P1028, DOI 10.3109/10428191003743460; CULLEN MH, 1979, CANCER, V44, P645, DOI 10.1002/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y; Curado M., 2009, CANC INCIDENCE 5 CON, VIX; De Sanjose S., 2008, MED CLIN BARC S1, V131, p72 ; Denham JW, 1996, EUR J CANCER, V32A, P480, DOI 10.1016/0959-8049(95)00635-4; Dreyling M, 2014, ANN ONCOL, V25, P76, DOI [10.1093/annonc/mdu200, 10.1093/annonc/mdx020]; Federico M, 2013, J CLIN ONCOL, V31, P1506, DOI 10.1200/JCO.2012.45.0866; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Fisher RI, 2005, J CLIN ONCOL, V23, P8447, DOI 10.1200/JCO.2005.03.1674; Gangatharan SA, 2015, BRIT J HAEMATOL, V170, P384, DOI 10.1111/bjh.13451; GARVIN AJ, 1983, CANCER-AM CANCER SOC, V52, P393, DOI 10.1002/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M; HORNING SJ, 1984, NEW ENGL J MED, V311, P1471, DOI 10.1056/NEJM198412063112303; Nabhan C, 2014, AM J HEMATOL, V89, P633, DOI 10.1002/ajh.23708; Nastoupil LJ, 2014, CANCER-AM CANCER SOC, V120, P1830, DOI 10.1002/cncr.28659; Provencio M, 2012, CLIN TRANSL ONCOL, V14, P386, DOI 10.1007/s12094-012-0813-3; Relander T, 2010, J CLIN ONCOL, V28, P2902, DOI 10.1200/JCO.2009.26.1693; Sarkozy C, 2016, J CLIN ONCOL, V34, P2575, DOI 10.1200/JCO.2015.65.7163; Sebban C, 2008, J CLIN ONCOL, V26, P3614, DOI 10.1200/JCO.2007.15.5358; Solal-Celigny P, 2012, J CLIN ONCOL, V30, P3848, DOI 10.1200/JCO.2010.33.4474; SOUBEYRAN P, 1991, EUR J CANCER, V27, P1606, DOI 10.1016/0277-5379(91)90425-D; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; Swerdlow SH, 2008, WHO CLASSIFICATION T, P200; van de Schans SAM, 2009, ANN ONCOL, V20, P1697, DOI 10.1093/annonc/mdp053; YOUNG RC, 1988, SEMIN HEMATOL, V25, P11	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177204	10.1371/journal.pone.0177204	http://dx.doi.org/10.1371/journal.pone.0177204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493986	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300071
J	Ha, TMH; Yong, D; Lee, EMY; Kumar, P; Lee, YK; Zhou, WBA				Thi Mai Hoa Ha; Yong, Derrick; Lee, Elizabeth Mei Yin; Kumar, Prathab; Lee, Yuan Kun; Zhou, Weibiao			Activation and inactivation of Bacillus pumilus spores by kiloelectron volt X-ray irradiation	PLOS ONE			English	Article							RELATIVE BIOLOGICAL EFFECTIVENESS; PHASE-CONTRAST MICROSCOPY; ESCHERICHIA-COLI O157H7; DNA-REPAIR; IONIZING-RADIATION; RAMAN-SPECTROSCOPY; HEAT ACTIVATION; HIGH-PRESSURE; GERMINATION; RESISTANCE	In this study, we investigated the inactivation efficacy of endospore-forming bacteria, Bacillus pumilus, irradiated by low-energy X-rays of different beam qualities. The different low-energy X-rays studied had cut-off energies of 50, 100 and 150 keV. Bacillus pumilus spores (in biological indicator strips) were irradiated at step doses between 6.5 to 390 Gy. The resulting bacteria populations were then quantified by a pour plate method. Results showed that X-rays of lower energies were more effective in inactivating bacterial spores. In addition, an increment in bacterial population was observed at doses below 13Gy. We attributed this increase to a radiation-induced activation of bacterial spores. Four kinetic models were then evaluated for their prediction of bacterial spore behavior under irradiation. This included: (i) first-order kinetics model; (ii) Shull model; (iii) Sapru model; and (iv) probabilistic model. From R-2 and AIC analyses, we noted that the probabilistic model performed the best, followed by the Sapru model. We highlighted that for simplicity in curve fitting the Sapru model should be used instead of the probabilistic model. A 12-log reduction in bacterial population (corresponding to a sterility assurance level of 10-6 as required in the sterilization of medical devices) was computed to be achievable at doses of 1000, 1600 and 2300 Gy for the three different X-ray cut-off energies respectively. These doses are an order in magnitude lesser than that required in gamma irradiation. This highlights the applicability of cheaper and safer table-top X-ray sources for sterilization application.	[Thi Mai Hoa Ha; Yong, Derrick; Lee, Elizabeth Mei Yin] Singapore Inst Mfg Technol, Singapore, Singapore; [Lee, Elizabeth Mei Yin] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore; [Kumar, Prathab; Zhou, Weibiao] Natl Univ Singapore, Dept Chem, Food Sci & Technol Programme, Singapore, Singapore; [Lee, Yuan Kun] Natl Univ Singapore, Dept Microbiol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute of Manufacturing Technology (SIMTech); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore	Ha, TMH (corresponding author), Singapore Inst Mfg Technol, Singapore, Singapore.	tmhha@simtech.a-star.edu.sg	Zhou, Weibiao/AAG-8840-2020; Lee, Elizabeth/Q-9074-2019	Zhou, Weibiao/0000-0002-4990-9835; Yong, Derrick/0000-0001-6806-8472	Agency of Science Technology and Research (A*STAR), as well as its Graduate Scholarship	Agency of Science Technology and Research (A*STAR), as well as its Graduate Scholarship(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency of Science Technology and Research (A*STAR), as well as its Graduate Scholarship.; This work was supported by the Agency of Science Technology and Research (A*STAR) as well as its Graduate Scholarship. The authors also wish to thank NGUYEN Thi Quynh Ngoc at Singapore Center for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University for her help on phase-contrast microscopy of spores.	AGENCY IAE, 2008, TRENDS RAD STERILIZA; AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aleid SM, 2013, INT J FOOD SCI TECH, V48, P1453, DOI 10.1111/ijfs.12112; Alpen EL, 1998, RAD BIOPHYSICS, P365; Bacq ZM, 1961, PERGAMON, P239; Brenner DJ, 1999, PHYS MED BIOL, V44, P323, DOI 10.1088/0031-9155/44/2/002; Cavanaugh JE, 1997, STAT PROBABIL LETT, V33, P201, DOI 10.1016/S0167-7152(96)00128-9; Eijlander RT, 2011, CURR OPIN BIOTECH, V22, P180, DOI 10.1016/j.copbio.2010.11.009; ESTAR PSTAR and ASTAR, 2005, COMP PROGR CALC STOP; Ghosh S, 2012, J BACTERIOL, V194, P2221, DOI 10.1128/JB.00151-12; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Hill MA, 2004, RADIAT PROT DOSIM, V112, P471, DOI 10.1093/rpd/nch091; Horneck G, 1989, Adv Space Res, V9, P105, DOI 10.1016/0273-1177(89)90428-6; Hornstra LM, 2009, INT J FOOD MICROBIOL, V134, P9, DOI 10.1016/j.ijfoodmicro.2009.02.011; Horowitz J, 2010, APPL ENVIRON MICROB, V76, P230, DOI 10.1128/AEM.01527-09; Hunter N, 2009, J RADIOL PROT, V29, P5, DOI 10.1088/0952-4746/29/1/R01; Jeong S, 2012, INT J FOOD MICROBIOL, V153, P365, DOI 10.1016/j.ijfoodmicro.2011.11.028; Jeong S, 2010, J FOOD PROTECT, V73, P547, DOI 10.4315/0362-028X-73.3.547; Kong LB, 2014, APPL ENVIRON MICROB, V80, P345, DOI 10.1128/AEM.03043-13; Kong LB, 2011, NAT PROTOC, V6, P625, DOI 10.1038/nprot.2011.307; Kong LB, 2010, ANAL CHEM, V82, P3840, DOI 10.1021/ac1003322; Leuschner RGK, 1999, LETT APPL MICROBIOL, V29, P228, DOI 10.1046/j.1365-2672.1999.00604.x; LING CC, 1995, INT J RADIAT ONCOL, V32, P373, DOI 10.1016/0360-3016(95)00530-C; Mahmoud BSM, 2010, FOOD MICROBIOL, V27, P24, DOI 10.1016/j.fm.2009.07.004; Mahmoud BSM, 2009, FOOD MICROBIOL, V26, P860, DOI 10.1016/j.fm.2009.05.013; Mahmoud BSM, 2009, INT J FOOD MICROBIOL, V130, P135, DOI 10.1016/j.ijfoodmicro.2009.01.023; Moeller R, 2005, FEMS MICROBIOL ECOL, V51, P231, DOI 10.1016/j.femsec.2004.08.008; Moeller R, 2008, J BACTERIOL, V190, P1134, DOI 10.1128/JB.01644-07; Moeller R, 2014, APPL ENVIRON MICROB, V80, P104, DOI 10.1128/AEM.03136-13; Moosekian SR, 2014, FOOD CONTROL, V36, P243, DOI 10.1016/j.foodcont.2013.08.024; Motulsky Harvey J., 2004, P1; Nagler K, 2014, APPL ENVIRON MICROB, V80, P1314, DOI 10.1128/AEM.03293-13; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Pandey R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058972; SAPRU V, 1992, J FOOD SCI, V57, P1248, DOI 10.1111/j.1365-2621.1992.tb11310.x; Setlow B, 1996, J BACTERIOL, V178, P3486, DOI 10.1128/jb.178.12.3486-3495.1996; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2013, J APPL MICROBIOL, V115, P1251, DOI 10.1111/jam.12343; Setlow P, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.TBS-0003-2012; SHULL JJ, 1963, APPL MICROBIOL, V11, P485, DOI 10.1128/AEM.11.6.485-487.1963; SYMONS MCR, 1994, RADIAT PHYS CHEM, V43, P403, DOI 10.1016/0969-806X(94)90035-3; Tirumalai RS, 2006, PHARMACOPEIAL FORUM, V27; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wei J, 2010, J BACTERIOL, V192, P1455, DOI 10.1128/JB.01497-09	46	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177571	10.1371/journal.pone.0177571	http://dx.doi.org/10.1371/journal.pone.0177571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493969	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300137
J	Nyiro, JU; Kombe, IK; Sande, CJ; Kipkoech, J; Kiyuka, PK; Onyango, CO; Munywoki, PK; Kinyanjui, TM; Nokes, DJ				Nyiro, Joyce U.; Kombe, Ivy K.; Sande, Charles J.; Kipkoech, James; Kiyuka, Patience K.; Onyango, Clayton O.; Munywoki, Patrick K.; Kinyanjui, Timothy M.; Nokes, D. James			Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya	PLOS ONE			English	Article							ANTIBODY-RESPONSE; BIRTH COHORT; INFECTION; PARAINFLUENZA; INFANTS; MEASLES; DISEASE; LIVE; REINFECTION; PARAMETERS	Background Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract disease in early life and a target for vaccine prevention. Data on the age-prevalence of RSV specific antibodies will inform on optimizing vaccine delivery. Methods Archived plasma samples were randomly selected within age strata from 960 children less than 145 months of age admitted to Kilifi County Hospital pediatric wards between 2007 and 2010. Samples were tested for antibodies to RSV using crude virus IgG ELISA. Seroprevalence (and 95% confidence intervals) was estimated as the proportion of children with specific antibodies above a defined cut-off level. Nested catalytic models were used to explore different assumptions on antibody dynamics and estimate the rates of decay of RSV specific maternal antibody and acquisition of infection with age, and the average age of infection. Results RSV specific antibody prevalence was 100% at age 0-<1month, declining rapidly over the first 6 months of life, followed by an increase in the second half of the first year of life and beyond. Seroprevalence was lowest throughout the age range 5-11 months; all children were seropositive beyond 3 years of age. The best fit model to the data yielded estimates for the rate of infection of 0.78/person/year (95% CI 0.65-0.97) and 1.69/person/year (95% CI 1.27-2.04) for ages 0-<1 year and 1-<12 years, respectively. The rate of loss of maternal antibodies was estimated as 2.54/year (95% CI 2.30-2.90), i.e. mean duration 4.7 months. The mean age at primary infection was estimated at 15 months (95% CI 13-18). Conclusions The rate of decay of maternal antibody prevalence and subsequent age-acquisition of infection are rapid, and the average age at primary infection early. The vaccination window is narrow, and suggests optimal targeting of vaccine to infants 5 months and above to achieve high seroconversion.	[Nyiro, Joyce U.; Kombe, Ivy K.; Sande, Charles J.; Kipkoech, James; Kiyuka, Patience K.; Munywoki, Patrick K.; Nokes, D. James] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Sande, Charles J.] Univ Oxford, Dept Paediat, Oxford, England; [Onyango, Clayton O.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent, Kisumu, Kenya; [Kinyanjui, Timothy M.] Univ Manchester, Sch Math, Manchester, Lancs, England; [Nokes, D. James] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Nokes, D. James] Univ Warwick, WIDER, Coventry, W Midlands, England	University of Oxford; Kenya Medical Research Institute; University of Manchester; University of Warwick; University of Warwick	Kombe, IK (corresponding author), Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	ikombe@kemri-wellcome.org	Kinyanjui, Timothy/S-8489-2019; Munywoki, Patrick K./GQP-4775-2022	Munywoki, Patrick K./0000-0001-9419-7155; Kiyuka, Patience/0000-0002-3257-5920; Kombe, Ivy/0000-0003-1228-8227; Sande, Charles/0000-0002-8364-6063; Kinyanjui, Timothy/0000-0001-5461-4946	Wellcome Trust UK [102975, 084633]	Wellcome Trust UK(Wellcome Trust)	This work is supported by the Wellcome Trust UK,Grant ref: [102975]; [084633] (https://wellcome.ac.uki) to DJN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaku M, 2009, MEM I OSWALDO CRUZ, V104, P897, DOI 10.1590/S0074-02762009000600013; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; BRUSSOW H, 1991, J INFECT DIS, V163, P679, DOI 10.1093/infdis/163.3.679a; CHANOCK R, 1967, B WORLD HEALTH ORGAN, V37, P363; COONEY MK, 1975, AM J EPIDEMIOL, V101, P532, DOI 10.1093/oxfordjournals.aje.a112125; Cox MJ, 1998, J MED VIROL, V55, P234, DOI 10.1002/(SICI)1096-9071(199807)55:3&lt;234::AID-JMV9&gt;3.0.CO;2-2; Faneye Adedayo, 2014, Afr J Infect Dis, V8, P36; FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Karron RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8463; KATZMANN W, 1984, THEOR POPUL BIOL, V25, P125, DOI 10.1016/0040-5809(84)90016-9; Kinyanjui TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138018; Kucharski AJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002082; Kutsaya A, 2016, EPIDEMIOL INFECT, V144, P1622, DOI 10.1017/S0950268815003143; Lee MS, 2005, HUM VACCINES, V1, P6, DOI 10.4161/hv.1.1.1424; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; Mossong J, 2004, EPIDEMIOL INFECT, V132, P1121, DOI 10.1017/S0950268804002754; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Noyola DE, 2005, PEDIATR INFECT DIS J, V24, P1049, DOI 10.1097/01.inf.0000190026.58557.93; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Ohuma EO, 2012, AM J EPIDEMIOL, V176, P794, DOI 10.1093/aje/kws257; Sande CJ, 2013, J MED VIROL, V85, P2020, DOI 10.1002/jmv.23696; Siegrist C A, 1998, Dev Biol Stand, V95, P133; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; WELLIVER RC, 1980, J PEDIATR-US, V96, P808, DOI 10.1016/S0022-3476(80)80547-6; Williams BG, 1995, EPIDEMIOL INFECT, V115, P603, DOI 10.1017/S0950268800058763; WILLIAMS BG, 1994, PARASITOL TODAY, V10, P489, DOI 10.1016/0169-4758(94)90163-5; Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859; Zoubir AM, 1998, IEEE SIGNAL PROC MAG, V15, P56, DOI 10.1109/79.647043	34	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177803	10.1371/journal.pone.0177803	http://dx.doi.org/10.1371/journal.pone.0177803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531224	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400029
J	Yoshimoto, T; Oka, H; Katsuhira, J; Fujii, T; Masuda, K; Tanaka, S; Matsudaira, K				Yoshimoto, Takahiko; Oka, Hiroyuki; Katsuhira, Junji; Fujii, Tomoko; Masuda, Katsuhiko; Tanaka, Sakae; Matsudaira, Ko			Prognostic psychosocial factors for disabling low back pain in Japanese hospital workers	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; EPIDEMIOLOGIC-RESEARCH; QUESTIONNAIRE FABQ; NEW-ONSET; PREVALENCE; DISABILITY; INSTRUMENTS; PERFORMANCE	Background Although the occupational health field has identified psychosocial factors as risk factors for low back pain that causes disability, the association between disabling low back pain and psychosocial factors has not been examined adequately in Japanese hospital workers. Therefore, this study examined the association between low back pain, which interfered with work, and psychosocial factors in Japanese hospital workers. Method This cross-sectional study was conducted at a hospital in Japan. In total, 280 hospital workers were recruited from various occupational settings. Of these, 203 completed a self-administered questionnaire that included items concerning individual characteristics, severity of low back pain, fear-avoidance beliefs (Fear-Avoidance Beliefs Questionnaire), somatic symptoms (Somatic Symptom Scale-8), psychological distress (K6), workaholism, and work-related psychosocial factors (response rate: 72.5%). Logistic regression was used to explore risk factors associated with disabling low back pain. Results Of the 203 participants who completed questionnaires, 36 (17.7%) reported low back pain that interfered with their work. Multivariate analyses with individual factors and occupations adjusted for showed statistically significant associations between disabling low back pain and fear-avoidance beliefs (adjusted odds ratio [OR]: 2.619, 95% confidence interval [CI]: 1.003-6.538], somatic symptoms (OR: 4.034, 95% CI: 1.819-9.337), and interpersonal stress at work (OR: 2.619, 95% CI: 1.067-6.224). Conclusions Psychosocial factors, such as fear-avoidance beliefs, somatic symptoms, and interpersonal relationships at work, were important risk factors in low back pain that interfered with work in Japanese hospital workers. With respect to occupational health, consideration of psychosocial factors is required to reduce disability related to low back pain.	[Yoshimoto, Takahiko] Kameda Med Ctr, Dept Rehabil, Chiba, Japan; [Oka, Hiroyuki; Fujii, Tomoko; Matsudaira, Ko] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Tokyo, Japan; [Katsuhira, Junji] Niigata Univ Hlth & Welf, Dept Prosthet & Orthot & Assist Technol, Fac Med Technol, Niigata, Japan; [Masuda, Katsuhiko] Inc Med Inst Yoseikai, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Tokyo, Japan	University of Tokyo; Niigata University; University of Tokyo	Oka, H (corresponding author), Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Tokyo, Japan.	okah-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Industrial Disease Clinical Research Grants [14020301]	Industrial Disease Clinical Research Grants	KM (Matsudaira) reports grants from Industrial Disease Clinical Research Grants (No. 14020301). URL: http://www.mhlw.go.jp/seisakunitsuite/bunya/koyou_roudou/roudoukijun/rousai/hojokin/0000051021.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Obaidi SM, 2005, SPINE, V30, P1051, DOI 10.1097/01.brs.0000160848.94706.83; Bener A, 2013, J PAIN RES, V6, P95, DOI 10.2147/JPR.S40740; Black J.T, 1992, MULTIVARIATE DATA AN; Coggon D, 2013, PAIN, V154, P1769, DOI 10.1016/j.pain.2013.05.039; Coggon D, 2013, OCCUP ENVIRON MED, V70, P575, DOI 10.1136/oemed-2012-101316; Coggon D, 2013, PAIN, V154, P856, DOI 10.1016/j.pain.2013.02.008; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Davis KG, 2002, SPINE, V27, P2645, DOI 10.1097/00007632-200212010-00003; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Fritz JM, 2001, PAIN, V94, P7, DOI 10.1016/S0304-3959(01)00333-5; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gierk B, 2014, JAMA INTERN MED, V174, P399, DOI 10.1001/jamainternmed.2013.12179; Harkness EF, 2003, RHEUMATOLOGY, V42, P959, DOI 10.1093/rheumatology/keg265; Hilfiker R, 2007, EUR SPINE J, V16, P1755, DOI 10.1007/s00586-007-0433-8; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Katsuhira J, 2013, SPINE, V38, pE832, DOI 10.1097/BRS.0b013e31829360e5; Kawakami N, 2005, PREV MED, V41, P471, DOI 10.1016/j.ypmed.2005.01.001; Kendall NAS, 2009, TACKLING MUSCULOSKEL; Kent PM, 2005, CHIROPR OSTEOPAT, P1313; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kikuchi S, 2008, EUR SPINE J, V17, pS421, DOI 10.1007/s00586-008-0747-1; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Linton SJ, 2001, J OCCUP REHABIL, V11, P53, DOI 10.1023/A:1016656225318; Matsudaira K., 2016, JPN PSYCHOSOM MED, V56, P931; Matsudaira K, 2015, IND HEALTH, V53, P368, DOI 10.2486/indhealth.2014-0260; Matsudaira K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093924; Matsudaira K, 2014, J ORTHOP SCI, V19, P26, DOI 10.1007/s00776-013-0471-5; Matsudaira K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075140; Matsudaira K, 2012, SPINE, V37, P1324, DOI 10.1097/BRS.0b013e3182498382; Matsudaira K, 2011, OCCUP ENVIRON MED, V68, P191, DOI 10.1136/oem.2009.053645; Melloh M, 2009, INT ORTHOP, V33, P301, DOI 10.1007/s00264-008-0707-8; Ministry of Health Labour and Welfare, 2015, OCCUPATIONAL DISEASE; Muto S, 2006, IND HEALTH, V44, P123, DOI 10.2486/indhealth.44.123; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Sakakibara T, 2013, PAIN PHYSICIAN, V16, P603; Schaufeli WB, 2009, CROSS-CULT RES, V43, P320, DOI 10.1177/1069397109337239; Shaw WS, 2013, BEST PRACT RES CL RH, V27, P637, DOI 10.1016/j.berh.2013.09.012; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; Steffens D, 2016, JAMA INTERN MED, V176, P199, DOI 10.1001/jamainternmed.2015.7431; Takura T, 2015, J ORTHOP SCI, V20, P750, DOI 10.1007/s00776-015-0730-8; Vargas-Prada S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153748; Vargas-Prada S, 2013, OCCUP ENVIRON MED, V70, P57, DOI 10.1136/oemed-2011-100637; Vlaeyen JWS, 2002, CLIN J PAIN, V18, P251, DOI 10.1097/00002508-200207000-00006; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wada K, 2013, IND HEALTH, V51, P482, DOI 10.2486/indhealth.2013-0016; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Werneke MW, 2009, ARCH PHYS MED REHAB, V90, P768, DOI 10.1016/j.apmr.2008.11.008; Wertli MM, 2014, SPINE J, V14, P816, DOI 10.1016/j.spinee.2013.09.036; Wood PB, 2006, PAIN, V120, P230, DOI 10.1016/j.pain.2005.12.014	55	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177908	10.1371/journal.pone.0177908	http://dx.doi.org/10.1371/journal.pone.0177908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28531194	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400037
J	Zeng, FQ; Biligetu, B; Coulman, B; Schellenberg, MP; Fu, YB				Zeng, Fangqin; Biligetu, Bill; Coulman, Bruce; Schellenberg, Michael P.; Fu, Yong-Bi			RNA-Seq analysis of gene expression for floral development in crested wheatgrass (Agropyron cristatum L.)	PLOS ONE			English	Article							FLOWERING-TIME GENE; DISRUPTS CIRCADIAN-RHYTHMS; LOCUS-T; MOLECULAR CHARACTERIZATION; DIFFERENTIAL EXPRESSION; PHOTOPERIODIC CONTROL; TRANSCRIPTION FACTOR; ALLELIC VARIATION; ARABIDOPSIS; VERNALIZATION	Crested wheatgrass [Agropyron cristatum L. (Gaertn.)] is widely used for early spring grazing in western Canada and the development of late maturing cultivars which maintain forage quality for a longer period is desired. However, it is difficult to manipulate the timing of floral transition, as little is known about molecular mechanism of plant maturity in this species. In this study, RNA-Seq and differential gene expression analysis were performed to investigate gene expression for floral initiation and development in crested wheatgrass. Three cDNA libraries were generated and sequenced to represent three successive growth stages by sampling leaves at the stem elongation stage, spikes at boot and anthesis stages. The sequencing generated 25,568,846; 25,144,688 and 25,714,194 qualified Illumina reads for the three successive stages, respectively. De novo assembly of all the reads generated 311,671 transcripts with a mean length of 487 bp, and 152,849 genes with an average sequence length of 669 bp. A total of 48,574 (31.8%) and 105,222 (68.8%) genes were annotated in the Swiss-Prot and NCBI non-redundant (nr) protein databases, respectively. Based on the Kyoto Encyclopedia of Genes and Genome (KEGG) pathway database, 9,723 annotated sequences were mapped onto 298 pathways, including plant circadian clock pathway. Specifically, 113 flowering time-associated genes, 123 MADS-box genes and 22 CONSTANS-LIKE (COL) genes were identified. A COL homolog DN52048-c0-g4 which was clustered with the flowering time genes AtCO and OsHd1 in Arabidopsis (Arabidopsis thaliana L.) and rice (Oryza sativa L.), respectively, showed specific expression in leaves and could be a CONSTANS (CO) candidate gene. Taken together, this study has generated a new set of genomic resources for identifying and characterizing genes and pathways involved in floral transition and development in crested wheatgrass. These findings are significant for further understanding of the molecular basis for late maturity in this grass species.	[Zeng, Fangqin; Biligetu, Bill; Coulman, Bruce] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Schellenberg, Michael P.] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Fu, Yong-Bi] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Plant Gene Resources Canada, Saskatoon, SK, Canada	University of Saskatchewan; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Biligetu, B (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.; Fu, YB (corresponding author), Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Plant Gene Resources Canada, Saskatoon, SK, Canada.	bill.biligetu@usask.ca; yong-bi.fu@agr.gc.ca		Coulman, Bruce/0000-0001-9813-8435	Beef Cattle Research Council; AAFC GF2 funds	Beef Cattle Research Council; AAFC GF2 funds	This work was supported by Beef Cattle Research Council and AAFC GF2 funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Mr. Gregory Peterson and Ms. Carolee Horbach for their technical assistance in the research project; Dr. Dwayne Hegedus and Ms. Cathy Coutu at Agriculture and Agri-Food Canada-Saskatoon Research and Development Centre for the access to the Blast2go software; Mr. Brian J. Haas at Klarman Cell Observatory, Broad Institute, USA, for his kind help and suggestions of Trinity; and Drs. Sateesh Kagale and Yifang Tan at National Research Council, Saskatoon, Saskatchewan, and Dr. Jihua Xu at the University of Saskatchewan for their critical reading and valuable comments on the early version of the manuscript. Thanks also go to the three anonymous reviewers and editor for their helpful comments to improve the manuscript. The research was funded by the Beef Cattle Research Council of Canada and AAFC GF2 funds.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Benjamini Y, 2001, ANN STAT, V29, P1165; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; Dennis Elizabeth S., 2009, Journal of Biology (London), V8, P57, DOI 10.1186/jbiol156; Devlin PF, 1999, PLANT PHYSIOL, V119, P909, DOI 10.1104/pp.119.3.909; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; DEWEY D R, 1984, P209; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Dornelas M. C., 2006, Floriculture, ornamental and plant biotechnology, P272; Dornelas Marcelo Carnier, 2005, Braz. J. Plant Physiol., V17, P255, DOI 10.1590/S1677-04202005000200009; Dubcovsky J, 2005, MOL BREEDING, V15, P395, DOI 10.1007/s11032-005-0084-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; MOORE KJ, 1991, AGRON J, V83, P1073, DOI 10.2134/agronj1991.00021962008300060027x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Pankievicz VCS, 2016, PLANT MOL BIOL, V90, P589, DOI 10.1007/s11103-016-0430-6; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Preston JC, 2006, GENETICS, V174, P421, DOI 10.1534/genetics.106.057125; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; Somers DE, 1998, DEVELOPMENT, P125; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x; Zhang JP, 2015, GENOMICS, V106, P129, DOI 10.1016/j.ygeno.2015.04.003; Zhao P, 2016, FRONT PLANT SCI, V7	70	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177417	10.1371/journal.pone.0177417	http://dx.doi.org/10.1371/journal.pone.0177417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531235	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400017
J	Weber, E; Birkenfeld, J; Franz, J; Gritzan, U; Linden, L; Trautwein, M				Weber, Ernst; Birkenfeld, Jorg; Franz, Jurgen; Gritzan, Uwe; Linden, Lars; Trautwein, Mark			Modular Protein Expression Toolbox (MoPET), a standardized assembly system for defined expression constructs and expression optimization libraries	PLOS ONE			English	Article							GOLDEN GATE CLONING; ONE-POT; DNA; BIOLOGY	The design and generation of an optimal expression construct is the first and essential step in in the characterization of a protein of interest. Besides evaluation and optimization of process parameters (e.g. selection of the best expression host or cell line and optimal induction conditions and time points), the design of the expression construct itself has a major impact. However, the path to this final expression construct is often not straight forward and includes multiple learning cycles accompanied by design variations and retesting of construct variants, since multiple, functional DNA sequences of the expression vector backbone, either coding or non-coding, can have a major impact on expression yields. To streamline the generation of defined expression constructs of otherwise difficult to express proteins, the Modular Protein Expression Toolbox (MoPET) has been developed. This cloning platform allows highly efficient DNA assembly of pre-defined, standardized functional DNA modules with a minimal cloning burden. Combining these features with a standardized cloning strategy facilitates the identification of optimized DNA expression constructs in shorter time. The MoPET system currently consists of 53 defined DNA modules divided into eight functional classes and can be flexibly expanded. However, already with the initial set of modules, 792,000 different constructs can be rationally designed and assembled. Furthermore, this starting set was used to generate small and mid-sized combinatorial expression optimization libraries. Applying this screening approach, variants with up to 60-fold expression improvement have been identified by MoPET variant library screening.	[Weber, Ernst; Birkenfeld, Jorg] Bayer AG, Antibody Lead Discovery, Biol Res, Cologne, Germany; [Franz, Jurgen; Linden, Lars; Trautwein, Mark] Bayer AG, Cell & Prot Sci, Biol Res, Wuppertal, Germany; [Gritzan, Uwe] Bayer AG, Prot Engn & Assays, Biol Res, Cologne, Germany; [Birkenfeld, Jorg] Sanofi Aventis Deutschland GmbH, R&D Biol Res Prot Therapeut, Frankfurt, Germany	Bayer AG; Bayer AG; Bayer AG; Sanofi-Aventis	Weber, E (corresponding author), Bayer AG, Antibody Lead Discovery, Biol Res, Cologne, Germany.	ernst.weber@bayer.com						Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2014, ACS SYNTH BIOL, V3, P839, DOI 10.1021/sb4001504; Engler C, 2014, METHODS MOL BIOL, V1116, P119, DOI 10.1007/978-1-62703-764-8_9; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GIL A, 1987, CELL, V49, P399, DOI 10.1016/0092-8674(87)90292-3; Knight T., IDEMPOTENT VECTOR DE; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Mitchell LA, 2015, NUCLEIC ACIDS RES, V43, P6620, DOI 10.1093/nar/gkv466; Moore SJ, 2016, ACS SYNTH BIOL, V5, P1059, DOI 10.1021/acssynbio.6b00031; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Post LE, 1992, USE BGH GDNA POLYADE; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Tom R., 2007, METHODS EXPRESS EXPR, P203; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; Zhang F, 2011, NATURE BIOTECHNOLOGY	27	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176314	10.1371/journal.pone.0176314	http://dx.doi.org/10.1371/journal.pone.0176314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520717	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700014
J	Zyszka, B; Aniol, M; Lipok, J				Zyszka, Beata; Aniol, Miroslaw; Lipok, Jacek			Modulation of the growth and metabolic response of cyanobacteria by the multifaceted activity of naringenin	PLOS ONE			English	Article							NATURAL FLAVONOIDS; SUBSTANCES; MICROALGAE; GENE	The interactions between the plant-derived bioflavonoid, naringenin, and prokaryotic microalgae representatives (cyanobacteria), were investigated with respect to its influence on the growth and metabolic response of these microorganisms. To achieve reliable results, the growth of cyanobacteria was determined based on measurements of chlorophyll content, morphological changes were assessed through microscopic observations, and the chemical response of cells was determined using liquid and gas chromatography (HPLC; GC-FID). The results show that micromolar levels of naringenin stimulated the growth of cyanobacteria. Increased growth was observed for halophilic strains at naringenin concentrations below 40 mg L-1, and in freshwater strains at concentrations below 20 mg L-1. The most remarkable stimulation was observed for the freshwater species Nostoc muscorum, which had a growth rate that was up to 60% higher than in the control. When naringenin was examined at concentrations above 40 mg L-1, the growth of the tested microorganisms was inhibited. Simultaneously, an intensive excretion of exopolysaccharides was observed. Microscopic observations strongly suggest that these effects resulted from a structural disturbance of cyanobacterial cell walls that was exerted by naringenin. This phenomenon, in combination with the absorption of naringenin into cell wall structures, influenced cell permeability and thus the growth of bacteria. Fortunately, almost all the naringenin added to the culture was incorporated into to cell substructures and could be recovered through extraction, raising the possibility that this modulator could be recycled.	[Zyszka, Beata; Lipok, Jacek] Univ Opole, Fac Chem, Dept Analyt & Ecol Chem, Opole, Poland; [Aniol, Miroslaw] Wroclaw Univ Environm & Life Sci, Fac Food Sci, Dept Chem, Wroclaw, Poland	University of Opole; Wroclaw University of Environmental & Life Sciences	Lipok, J (corresponding author), Univ Opole, Fac Chem, Dept Analyt & Ecol Chem, Opole, Poland.	jacek.lipok@uni.opole.pl		Zyszka-Haberecht, Beata/0000-0002-3232-8815; Lipok, Jacek/0000-0002-8567-5351	National Centre for Research and Development in Poland [PBS3/B8/25/2015]	National Centre for Research and Development in Poland(National Centre for Research & Development, Poland)	This work was financially supported in the frame of the project PBS3/B8/25/2015, granted by the National Centre for Research and Development in Poland.	Ahmad A, 2015, FOOD RES INT, V77, P221, DOI 10.1016/j.foodres.2015.06.021; Ahmad A, 2013, J AGR FOOD CHEM, V61, P8039, DOI 10.1021/jf402145u; Andersen O. M., 2006, FLAVONOIDS CHEM BIOC; Babic O, 2016, J APPL PHYCOL, V28, P2333, DOI 10.1007/s10811-015-0773-4; Becker-Ritt AB, 2007, TOXICON, V50, P971, DOI 10.1016/j.toxicon.2007.07.008; Bugianesi R, 2002, J NUTR, V132, P3349, DOI 10.1093/jn/132.11.3349; Cohen MF, 2002, MOL PLANT MICROBE IN, V15, P875, DOI 10.1094/MPMI.2002.15.9.875; Cohen MF, 2000, J BACTERIOL, V182, P4644, DOI 10.1128/JB.182.16.4644-4646.2000; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Forlani G, 2011, ENZYME MICROB TECH, V48, P299, DOI 10.1016/j.enzmictec.2010.12.005; Goiris K, 2014, J PHYCOL, V50, P483, DOI 10.1111/jpy.12180; Goldstein J., 1981, SCANNING ELECT MICRO; Hossain MF, 2016, FOOD SCI NUTR, V4, P753, DOI 10.1002/fsn3.340; Huang HM, 2015, TOXINS, V7, P66, DOI 10.3390/toxins7010066; Jain V, 1999, FOLIA MICROBIOL, V44, P311, DOI 10.1007/BF02818553; Lee KA, 2010, FOOD SCI BIOTECHNOL, V19, P257, DOI 10.1007/s10068-010-0037-7; Lin CC, 1999, BIOL FERT SOILS, V30, P83, DOI 10.1007/s003740050591; Martinia S, 2009, INT J ANTIMICROB AG, V34, P50, DOI 10.1016/j.ijantimicag.2009.01.010; McSwain BS, 2005, APPL ENVIRON MICROB, V71, P1051, DOI 10.1128/AEM.71.2.1051-1057.2005; Mirzoeva OK, 1997, MICROBIOL RES, V152, P239, DOI 10.1016/S0944-5013(97)80034-1; Moon SH, 2013, INT J ENV RES PUB HE, V10, P5459, DOI 10.3390/ijerph10115459; Nychas G., 1995, NEW METHODS FOOD PRE, P58, DOI [DOI 10.1007/978-1-4615-2105-1_4, 10.1007/978-1-4615-2105-1_4]; Plaper A, 2003, BIOCHEM BIOPH RES CO, V306, P530, DOI 10.1016/S0006-291X(03)01006-4; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; RECOURT K, 1989, J BACTERIOL, V171, P4370, DOI 10.1128/JB.171.8.4370-4377.1989; Scholz B, 2006, PHARM BIOL, V44, P544, DOI 10.1080/13880200600883114; Sharathchandra K., 2013, INT J PHARM BIO SCI, V4, P275; Sheng GP, 2006, WATER RES, V40, P1233, DOI 10.1016/j.watres.2006.01.023; Shin SY, 2007, LWT-FOOD SCI TECHNOL, V40, P1515, DOI 10.1016/j.lwt.2006.12.005; Singh D. P., 2014, American Journal of Plant Sciences, V5, P726; Snedecor G.W., 1989, AMES IOWA STATE U PR; Ultee A, 2000, ARCH MICROBIOL, V174, P233, DOI 10.1007/s002030000199; Wang MJ, 2006, J FOOD DRUG ANAL, V14, P247; WANG YC, 1995, J CHEM TECHNOL BIOT, V63, P215, DOI 10.1002/jctb.280630304; Wenig P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-405; Yan R, 2011, FRESEN ENVIRON BULL, V20, P18	36	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177631	10.1371/journal.pone.0177631	http://dx.doi.org/10.1371/journal.pone.0177631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498848	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314500037
J	Arai, KY; Hara, T; Nagatsuka, T; Kudo, C; Tsuchiya, S; Nomura, Y; Nishiyama, T				Arai, Koji Y.; Hara, Takuya; Nagatsuka, Toyofumi; Kudo, Chikako; Tsuchiya, Sho; Nomura, Yoshihiro; Nishiyama, Toshio			Postnatal changes and sexual dimorphism in collagen expression in mouse skin	PLOS ONE			English	Article							ANDROGEN RECEPTOR; III COLLAGENS; TISSUE-REPAIR; GROWTH; AGE; FIBRILLOGENESIS; ACTIVIN; MICE; IDENTIFICATION; FIBROBLASTS	To investigate sexual dimorphism and postnatal changes in skin collagen expression, mRNA levels of collagens and their regulatory factors in male and female skin were examined during the first 120 days of age by quantitative realtime PCR. Levels of mRNAs encoding extracellular matrices did not show any differences between male and female mice until day 15. Col1a1 and Col1a2 mRNAs noticeably increased at day 30 and remained at high levels until day 120 in male mice, while those in female mice remained at low levels during the period. Consistent with the mRNA expression, pepsin-soluble type I collagen contents in skin was very high in mature male as compared to female. Col3a1 mRNA in male mice also showed significantly high level at day 120 as compared to female. On the other hand, expression of mRNAs encoding TGF-beta s and their receptors did not show apparent sexual dimorphism although small significant differences were observed at some points. Castration at 60 days of age resulted in a significant decrease in type I collagen mRNA expression within 3 days, and noticeably decreased expression of all fibril collagen mRNAs examined within 14 days, while administration of testosterone tube maintained the mRNA expression at high levels. Despite the in vivo effect of testosterone, administration of physiological concentrations of testosterone did not affect fibril collagen mRNA expression in either human or mouse skin fibroblasts in vitro, suggesting that testosterone does not directly affect collagen expression in fibroblasts. In summary, present study demonstrated dynamic postnatal changes in expression of collagens and their regulatory factors, and suggest that testosterone and its effects on collagen expression are responsible for the skin sexual dimorphism but the effects of testosterone is not due to direct action on dermal fibroblasts.	[Arai, Koji Y.; Hara, Takuya; Nagatsuka, Toyofumi; Kudo, Chikako; Tsuchiya, Sho; Nomura, Yoshihiro; Nishiyama, Toshio] Tokyo Univ Agr & Technol, Fac Agr, Scleroprotein Res Inst, Fuchu, Tokyo, Japan	Tokyo University of Agriculture & Technology	Arai, KY (corresponding author), Tokyo Univ Agr & Technol, Fac Agr, Scleroprotein Res Inst, Fuchu, Tokyo, Japan.	kojiarai@cc.tuat.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19580336]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant No. 19580336). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Satoshi Amano (Shiseido Ltd.) for providing CGS27023A. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant No. 19580336).	Arai KY, 2011, ENDOCRINOLOGY, V152, P3779, DOI 10.1210/en.2011-0255; Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; BIRK DE, 1990, J CELL SCI, V95, P649; BLAUER M, 1991, J INVEST DERMATOL, V97, P264, DOI 10.1111/1523-1747.ep12480373; DUMAS M, 1994, MECH AGEING DEV, V73, P179, DOI 10.1016/0047-6374(94)90050-7; EPSTEIN EH, 1974, J BIOL CHEM, V249, P3225; Foley CJ, 2014, J CELL PHYSIOL, V229, P1875, DOI 10.1002/jcp.24650; HAYASHI T, 1979, J BIOCHEM-TOKYO, V86, P453, DOI 10.1093/oxfordjournals.jbchem.a132544; Hibino T, 2004, J DERMATOL SCI, V35, P9, DOI 10.1016/j.jdermsci.2003.12.003; Inui S, 2003, J INVEST DERM SYMP P, V8, P69, DOI 10.1046/j.1523-1747.2003.12174.x; JEANFAUCHER C, 1978, ACTA ENDOCRINOL-COP, V89, P780, DOI 10.1530/acta.0.0890780; KLEIN L, 1977, P NATL ACAD SCI USA, V74, P1436, DOI 10.1073/pnas.74.4.1436; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; LONGAKER MT, 1990, J PEDIATR SURG, V25, P63, DOI 10.1016/S0022-3468(05)80165-4; Markiewicz M, 2007, J DERMATOL SCI, V47, P217, DOI 10.1016/j.jdermsci.2007.05.008; Markova MS, 2004, J INVEST DERMATOL, V123, P1052, DOI 10.1111/j.0022-202X.2004.23494.x; MAYS PK, 1988, MECH AGEING DEV, V45, P203, DOI 10.1016/0047-6374(88)90002-4; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; SEIDENARI S, 1994, SKIN PHARMACOL, V7, P201; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; SMITH LT, 1986, AM J ANAT, V175, P507, DOI 10.1002/aja.1001750409; Son ED, 2005, J INVEST DERMATOL, V124, P1149, DOI 10.1111/j.0022-202X.2005.23736.x; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V225, P1, DOI 10.1016/j.mce.2004.02.006; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Tur E, 1997, CLIN DERMATOL, V15, P5, DOI 10.1016/S0738-081X(96)00105-8; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Vazquez F, 1996, MATURITAS, V25, P209, DOI 10.1016/S0378-5122(96)01066-3; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177534	10.1371/journal.pone.0177534	http://dx.doi.org/10.1371/journal.pone.0177534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494009	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300131
J	Boissiere, M; Herold, M; Atmadja, S; Sheil, D				Boissiere, Manuel; Herold, Martin; Atmadja, Stibniati; Sheil, Douglas			The feasibility of local participation in Measuring, Reporting and Verification (PMRV) for REDD	PLOS ONE			English	Article							PLUS; OPPORTUNITIES	The studies in this PLOS ONE collection investigated the feasibility of community participation in Measuring, Reporting and Verifying (Participatory MRV-PMRV) initiatives in the context of national programs to reduce emissions from deforestation and forest degradation (REDD+). While such participation is desirable, its feasibility has been uncertain. This collection builds the empirical foundations for putting PMRV into practice. The authors of this article identified five crucial considerations: (1) clarify the stakeholders, (2) understand their motivation to participate, (3) integrate knowledge and information from multiple disciplines and sources, (4) convey knowledge and information across multiple levels of governance, and (5) clarify and enable the links to REDD+ safeguards. We conclude that local communities and other local actors can play a major role in achieving REDD+ MRV, however, this requires attention to their needs and motivations. Future activities should include assessment of past PMRV experiences, costs and benefits, operationalization of reporting and verification, formalization of PMRV and full scale testing on the ground.	[Boissiere, Manuel] Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France; [Boissiere, Manuel; Atmadja, Stibniati] Ctr Int Forestry Res CIFOR Ethiopia, Addis Ababa, Ethiopia; [Herold, Martin] Wageningen Univ, Dept Environm Sci, Ctr Geoinformat, Wageningen, Netherlands; [Sheil, Douglas] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, NO-1432 As, Norway	CIRAD; CGIAR; Center for International Forestry Research (CIFOR); Wageningen University & Research; Norwegian University of Life Sciences	Boissiere, M (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France.; Boissiere, M (corresponding author), Ctr Int Forestry Res CIFOR Ethiopia, Addis Ababa, Ethiopia.	m.boissiere@cgiar.org	Herold, Martin/F-8553-2012; Sheil, Douglas/A-3867-2015; Sheil, Douglas/N-3291-2019; Atmadja, Stibniati S./AGY-3388-2022	Herold, Martin/0000-0003-0246-6886; Sheil, Douglas/0000-0002-1166-6591; BOISSIERE, Manuel/0000-0002-2552-7664	European Community's Seventh Framework Research Programme; DANIDA, IKI; Latin American Investment Facility (LAIF); Google Earth Engine Research Award; Norad; USAID; AUSAID; Norwegian Agency for Development Cooperation (Norad); International Climate Initiative (IKI); German Federal Ministry for the Environment; Nature Conservation, Building and Nuclear Safety (BMUB); Building and Nuclear Safety (BMUB); CGIAR Research Program on Forests; Trees and Agroforestry (CRP-FTA)	European Community's Seventh Framework Research Programme; DANIDA, IKI; Latin American Investment Facility (LAIF); Google Earth Engine Research Award(Google Incorporated); Norad(CGIAR); USAID(United States Agency for International Development (USAID)); AUSAID(Australian Aid (AusAID)); Norwegian Agency for Development Cooperation (Norad)(CGIAR); International Climate Initiative (IKI); German Federal Ministry for the Environment; Nature Conservation, Building and Nuclear Safety (BMUB); Building and Nuclear Safety (BMUB); CGIAR Research Program on Forests(CGIAR); Trees and Agroforestry (CRP-FTA)	Eight papers in this collection (including this introduction paper) were research under the CIFOR's Global Comparative Study on REDD+ (with funding from USAID, AUSAID, the Norwegian Agency for Development Cooperation (Norad), the International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB)), and the CGIAR Research Program on Forests, Trees and Agroforestry (CRP-FTA). These include six papers from: the "Participatory M RV: addressing the scale research project. The other four papers were funded by the European Community's Seventh Framework Research Programme, DANIDA, IKI, Latin American Investment Facility (LAIF), Google Earth Engine Research Award and Norad.	Atmadja S, 2016, PLOS ONE, P1; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Beaudoin G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166592; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Bong I, 2016, PLOS ONE, P1; Bossiere M, 2015, ECOLOGY SOC, V20, P1; Brockhaus M, 2014, FOREST POLICY ECON, V49, P23, DOI 10.1016/j.forpol.2013.07.003; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Brown D, 2008, MOVING AHEAD REDD IS, P107; Danielsen F, 2013, ECOLOGY SOC, V18, P1; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; DeVries B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147121; Ekowati D, 2016, PLOS ONE, P1; Felker L, 2014, PERSPECTIVE, P1; Felker ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167943; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; GOFC-GOLD, 2015, SOURC METH PROC MON; HawthorneS M, 2016, PLOS ONE, P1; Jagger P, 2014, FORESTS, V5, P2136, DOI 10.3390/f5092136; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Luttrell C, 2013, ECOL SOC, V18, DOI 10.5751/ES-05834-180452; McCarty MA, 2016, PORTS 2016: PORT PLANNING AND DEVELOPMENT, P1; Murdiyarso D., 2006, COMMUNITY FOREST MAN; Pratihast A, 2016, PLOS ONE, P1; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Roe S, 2013, CLIMATEFOCUS, P1; Skutsch MM, 2010, FOREST POLICY ECON, V12, P264, DOI 10.1016/j.forpol.2009.12.003; Turnhout E, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.425; UNFCCC, 2014, HDB MEAS REP VER DEV; United Nations, 2015, PAR AGR, P1; Vega Praputra A, 2016, PLOS ONE, P1; Zhao M., 2016, PROC IFIPIEEE INT C, P1	32	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176897	10.1371/journal.pone.0176897	http://dx.doi.org/10.1371/journal.pone.0176897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493901	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300038
J	Caulley, L; Sawada, M; Hinther, K; Ko, YTI; Crowther, JA; Kontorinis, G				Caulley, Lisa; Sawada, Michael; Hinther, Kelsey; Ko, Ya-tung Iris; Crowther, John A.; Kontorinis, Georgios			Geographic distribution of vestibular schwannomas in West Scotland between 2000-2015	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; QUALITY-OF-LIFE; ACOUSTIC NEUROMA; EPIDEMIOLOGY; ASSOCIATION; INDICATORS; HISTORY; TRENDS	Background Although the natural history of vestibular schwannomas (VS) has been previously studied, few studies have investigated associated epidemiological factors, primarily because of the lack of large available cohorts. Objective The objective of this study was to perform a multi-scale geographical analysis of the period prevalence of VS in West Scotland from 2000 to 2015. Methods Adults diagnosed with sporadic VS were identified through the National Health Services of West Scotland database and geocoded to the unit postcode. To assess whether the cohort of VS cases could be pooled into a period prevalence measure, the locations of VS cases were analyzed by sex using Cross-L and Difference-K functions. VS period prevalence was examined at two aggregate spatial scales: the postcode district and a coarser scale of NHS Health Boards. The spatial structure of period prevalence within each level of spatial aggregation was measured using univariate global and local Moran's I. Bivariate local Moran's I was used to examine the between-scale variability in period prevalence from the postcode district level to the NHS Health Boards levels. Prior to spatial autocorrelation analyses, the period prevalence at the postcode district was tested for stratified spatial heterogeneity within the NHS Health Boards using Wang's q-Statistic. Results A total of 512 sporadic VS were identified in a population of over 3.1 million. Between 2000 and 2015, VS period prevalence was highest within the NHS Health Boards of Greater Glasgow and Clyde, Ayrshire and Arran and the Western Isles. However, at the NHS scale, period prevalence exhibited no spatial autocorrelation globally or locally. At the district scale, Highland exhibited the most unusual local spatial autocorrelation. Bivariate local Moran's I results indicated general stability of period prevalence across the postcode district to Health Boards scales. However, locally, some postcode districts in Greater Glasgow and Clyde, Ayrshire and Arran exhibited unusually low district to zone spatial autocorrelation in period prevalence, as did the southern parts of the Western Isles. Some unusually high period prevalence values between the postcode district to Health Board scale were found in Tayside, Forth Valley and Dumfries and Galloway. Conclusion Geographic variability in VS in West Scotland was identified in this patient population, showing that there are areas, even remote, with unusually high or low period prevalence. This can be partially attributed to links between primary and tertiary care. Potential genetic or environmental risk factors that may contribute to geographic variation in this disease within Scotland are also a possibility but require further investigation.	[Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp, Ottawa, ON, Canada; [Sawada, Michael] Univ Ottawa, Dept Geog Environm & Geomat, LAGGISS, Ottawa, ON, Canada; [Hinther, Kelsey] Univ Saskatchewan, Undergrad Med Program, Saskatoon, SK, Canada; [Ko, Ya-tung Iris; Crowther, John A.; Kontorinis, Georgios] Queen Elizabeth Univ Hosp, Dept Otolaryngol Head & Neck Surg, Glasgow, Lanark, Scotland	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Saskatchewan; Queen Elizabeth University Hospital (QEUH)	Kontorinis, G (corresponding author), Queen Elizabeth Univ Hosp, Dept Otolaryngol Head & Neck Surg, Glasgow, Lanark, Scotland.	gkontorinis@gmail.com	Sawada, Michael/O-8457-2019	Sawada, Michael/0000-0001-5180-5325; Caulley, Lisa/0000-0002-9661-4634				Andersen JF, 2015, OTOL NEUROTOL, V36, P647, DOI 10.1097/MAO.0000000000000668; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Babu R, 2013, J NEUROSURG, V119, P121, DOI 10.3171/2013.1.JNS121370; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2014, ECOL MONOGR, V84, P477, DOI 10.1890/13-2042.1; Berkowitz O, 2015, WORLD NEUROSURG, V84, P1674, DOI 10.1016/j.wneu.2015.07.007; Bivand R, 2015, J STAT SOFTW, V63, P1; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; Brenner AV, 2002, INT J CANCER, V99, P252, DOI 10.1002/ijc.10320; Carlson ML, 2016, J NEURO-ONCOL, V129, P269, DOI 10.1007/s11060-016-2170-5; Carlson ML, 2015, OTOLARYNG HEAD NECK, V153, P202, DOI 10.1177/0194599815585508; Carlson ML, 2015, J NEUROSURG, V122, P833, DOI 10.3171/2014.11.JNS14594; Carlson ML, 2014, OTOLARYNGOL HEAD NEC, V151, P1028; Census Ss, 2011, CENS RES SCOTL CENS; Del Pero MM, 2009, SKULL BASE-INTERD AP, V19, P159, DOI 10.1055/s-0028-1096203; ESRI, 2016, INVENTORARCGIS DESKT; Grubesic T.H., 2008, SOCIOECON PLAN SCI, V42, P129, DOI [DOI 10.1016/j.seps.2006.09.001, 10.1016/j.seps.2006.09.001, DOI 10.1016/J.SEPS.2006.09.001]; Inskip PD, 2003, INT J EPIDEMIOL, V32, P225, DOI 10.1093/ije/dyg051; Jeyakumar A, 2007, ACTA OTO-LARYNGOL, V127, P1051, DOI 10.1080/00016480701200210; Klenke C, 2013, HEAD NECK ONCOLOGY, V16; Kontorinis G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3601; Kshettry VR, 2015, J NEURO-ONCOL, V124, P223, DOI 10.1007/s11060-015-1827-9; Larjavaara S, 2011, BRIT J CANCER, V105, P1069, DOI 10.1038/bjc.2011.344; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Matisziw TC, 2008, COMPUT ENVIRON URBAN, V32, P81, DOI 10.1016/j.compenvurbsys.2007.06.002; Neff BA, 2006, OTOL NEUROTOL, V27, P197, DOI 10.1097/01.mao.0000180484.24242.54; Nelson JK, 2017, CARTOGR GEOGR INF SC, V44, P35, DOI 10.1080/15230406.2015.1093431; Nieters A, 2004, CLIN EXP ALLERGY, V34, P346, DOI 10.1111/j.1365-2222.2004.01889.x; Parenteau MP, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-58; R Core Team, 2021, R LANGUAGE ENV STAT; Rey SJ, 2010, PYSAL A PYTHON LIBRA; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Saman Y, 2009, LARYNGOSCOPE, V119, P2085, DOI 10.1002/lary.20648; Schlehofer B, 2007, EUR J CANCER, V43, P1741, DOI 10.1016/j.ejca.2007.05.008; Schoemaker MJ, 2007, INT J CANCER, V120, P103, DOI 10.1002/ijc.22272; Scottish Government MS, 2013, SCOTL NAT MAR PLAN C; Statistics OfN, POST GEOGR; Stepanidis K, 2014, ACTA OTO-LARYNGOL, V134, P551, DOI 10.3109/00016489.2014.890293; Streiner D, 2009, PDQ EPIDEMIOLOGY; Torres-Martin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065868; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; [王婧宇 Wang Jingyu], 2010, [华东师范大学学报. 自然科学版, Journal of East China Normal University. Natural Science], P101; Wong BYW, 2012, J LARYNGOL OTOL, V126, P658, DOI 10.1017/S0022215112000680; Zygourakis CC, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14435	49	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0175489	10.1371/journal.pone.0175489	http://dx.doi.org/10.1371/journal.pone.0175489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493872	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300007
J	Parikh, JD; Hollingsworth, KG; Wallace, D; Blamire, AM; MacGowan, GA				Parikh, Jehill D.; Hollingsworth, Kieren G.; Wallace, Dorothy; Blamire, Andrew M.; MacGowan, Guy A.			Left ventricular functional, structural and energetic effects of normal aging: Comparison with hypertension	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; DIASTOLIC FUNCTION; FIBER; AGE; DEFORMATION; HYPERTROPHY; RELAXATION; COMMUNITY; STIFFNESS	Objectives Both aging and hypertension are significant risk factors for heart failure in the elderly. The purpose of this study was to determine how aging, with and without hypertension, affects left ventricular function. Methods Cross-sectional study of magnetic resonance imaging and P-31 spectroscopy-based measurements of left ventricular structure, global function, strains, pulse wave velocity, high energy phosphate metabolism in 48 normal subjects and 40 treated hypertensive patients (though no other cardiovascular disease or diabetes) stratified into 3 age deciles from 50-79 years. Results Normal aging was associated with significant increases in systolic blood pressure, vascular stiffness, torsion, and impaired diastolic function (all P<0.05). Age-matched hypertension exacerbated the effects of aging on systolic pressure, and diastolic function. Hypertension alone, and not aging, was associated with increased left ventricular mass index, reduced energetic reserve, reduced longitudinal shortening and increased endocardial circumferential shortening (all P<0.05). Multiple linear regression analysis showed that these unique hypertensive features were significantly related to systolic blood pressure (P<0.05). Conclusions 1) Hypertension adds to the age-related changes in systolic blood pressure and diastolic function; 2) hypertension is uniquely associated with changes in several aspects of left ventricular structure, function, systolic strains, and energetics; and 3) these uniquely hypertensive-associated parameters are related to the level of systolic blood pressure and so are potentially modifiable.	[Parikh, Jehill D.; Hollingsworth, Kieren G.; Wallace, Dorothy; Blamire, Andrew M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Parikh, Jehill D.; Hollingsworth, Kieren G.; Wallace, Dorothy; Blamire, Andrew M.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Parikh, Jehill D.; Hollingsworth, Kieren G.; Wallace, Dorothy; Blamire, Andrew M.; MacGowan, Guy A.] Newcastle Univ, Ctr In Vivo Imaging, Newcastle Upon Tyne, Tyne & Wear, England; [MacGowan, Guy A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [MacGowan, Guy A.] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	MacGowan, GA (corresponding author), Newcastle Univ, Ctr In Vivo Imaging, Newcastle Upon Tyne, Tyne & Wear, England.; MacGowan, GA (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.; MacGowan, GA (corresponding author), Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England.	guy.macgowan@nuth.nhs.uk	Blamire, Andrew/AAU-6100-2021; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Blamire, Andrew/0000-0002-8749-1257	British Heart Foundation, Clinical Leave Research Fellowship [FS/11/89/29162]; British Heart Foundation [FS/11/89/29162] Funding Source: researchfish	British Heart Foundation, Clinical Leave Research Fellowship; British Heart Foundation(British Heart Foundation)	British Heart Foundation, Clinical Leave Research Fellowship to GMG (FS/11/89/29162) (https://www.bhf.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MI, 2012, JACC-CARDIOVASC IMAG, V5, P273, DOI 10.1016/j.jcmg.2011.11.013; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; Bauer R, 2008, CARDIOVASC RES, V79, P652, DOI 10.1093/cvr/cvn131; BRUTSAERT DL, 1978, J PHYSIOL-LONDON, V283, P469, DOI 10.1113/jphysiol.1978.sp012513; BUCHALTER MB, 1990, CIRCULATION, V81, P1236, DOI 10.1161/01.CIR.81.4.1236; Chantler PD, 2008, J APPL PHYSIOL, V105, P1342, DOI 10.1152/japplphysiol.90600.2008; Chantler PD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00090; Cheng SS, 2014, J HYPERTENS, V32, P174, DOI 10.1097/HJH.0b013e32836586da; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; de Santi D, 2005, EUR J HEART FAIL, V7, P829, DOI 10.1016/j.ejheart.2004.09.008; Hollingsworth KG, 2013, EUR J HEART FAIL, V15, P986, DOI 10.1093/eurjhf/hft057; Hollingsworth KG, 2012, AM J PHYSIOL-HEART C, V302, pH885, DOI 10.1152/ajpheart.00985.2011; Ibrahim ESH, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-26; Jones DEJ, 2010, AM J PHYSIOL-GASTR L, V298, pG764, DOI 10.1152/ajpgi.00501.2009; Kannel W B, 1987, J Cardiovasc Pharmacol, V10 Suppl 6, pS135, DOI 10.1097/00005344-198706106-00018; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lee WH, 2016, J HYPERTENS, V34, P1195, DOI 10.1097/HJH.0000000000000903; LEVY D, 1990, NEW ENGL J MED, V0322; Lumens J, 2006, AM J PHYSIOL-HEART C, V291, pH1573, DOI 10.1152/ajpheart.00074.2006; MacGowan GA, 1997, CIRCULATION, V96, P535; Melenovsky V, 2007, J AM COLL CARDIOL, V49, P198, DOI 10.1016/j.jacc.2006.08.050; Mitchell GF, 2007, CIRCULATION, V115, P2628, DOI 10.1161/CIRCULATIONAHA.106.667733; Narayanan A, 2009, CIRC-CARDIOVASC IMAG, V2, P382, DOI 10.1161/CIRCIMAGING.108.811620; Neubauer S, 1997, CIRCULATION, V96, P2190; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; PALMON LC, 1994, CIRCULATION, V89, P122, DOI 10.1161/01.CIR.89.1.122; Parikh JD, 2016, INT J CARDIOL, V223, P306, DOI 10.1016/j.ijcard.2016.07.252; Parikh JD, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0224-4; Pavlopoulos H, 2008, EUR J ECHOCARDIOGR, V9, P741, DOI 10.1093/ejechocard/jen133; PEARLMAN ES, 1982, LAB INVEST, V46, P158; RADEMAKERS FE, 1994, CIRCULATION, V89, P1174, DOI 10.1161/01.CIR.89.3.1174; Solomon SD, 2010, HYPERTENSION, V55, P241, DOI 10.1161/HYPERTENSIONAHA.109.138529; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Van der Toorn A, 2002, AM J PHYSIOL-HEART C, V283, pH1609, DOI 10.1152/ajpheart.00239.2002; WEISS RG, 1990, NEW ENGL J MED, V323, P1593, DOI 10.1056/NEJM199012063232304	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177404	10.1371/journal.pone.0177404	http://dx.doi.org/10.1371/journal.pone.0177404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493996	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300104
J	Rosa, DF; Sarandy, MM; Novaes, RD; da Matta, SLP; Goncalves, RV				Rosa, Daiane Figueiredo; Sarandy, Mariaurea Matias; Novaes, Romulo Dias; Pinto da Matta, Sergio Luis; Goncalves, Reggiani Vilela			Effect of a high-fat diet and alcohol on cutaneous repair: A systematic review of murine experimental models	PLOS ONE			English	Review							ACUTE ETHANOL EXPOSURE; INFLAMMATORY RESPONSE; EXTRACELLULAR-MATRIX; FIBROBLAST FUNCTION; OXIDATIVE STRESS; WOUND REPAIR; TISSUE; ANGIOGENESIS; RAT; ASSOCIATION	Background and purpose Chronic alcohol intake associated with an inappropriate diet can cause lesions in multiple organs and tissues and complicate the tissue repair process. In a systematic review, we analyzed the relevance of alcohol and high fat consumption to cutaneous and repair, compared the main methodologies used and the most important parameters tested. Preclinical investigations with murine models were assessed to analyze whether the current evidence support clinical trials. Methods The studies were selected from MEDLINE/PubMed and Scopus databases, according to Fig 1. All 15 identified articles had their data extracted. The reporting bias was investigated according to the ARRIVE (Animal Research: Reporting of in Vivo Experiments) strategy. Results In general, animals offered a high-fat diet and alcohol showed decreased cutaneous wound closure, delayed skin contraction, chronic inflammation and incomplete re-epithelialization. Conclusion In further studies, standardized experimental design is needed to establish comparable study groups and advance the overall knowledge background, facilitating data translatability from animal models to human clinical conditions.	[Rosa, Daiane Figueiredo; Sarandy, Mariaurea Matias; Pinto da Matta, Sergio Luis] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Novaes, Romulo Dias] Univ Fed Alfenas, Dept Cell Tissue & Dev Biol, Alfenas, MG, Brazil; [Goncalves, Reggiani Vilela] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Alfenas; Universidade Federal de Vicosa	Goncalves, RV (corresponding author), Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil.	reggiani.goncalves@ufv.br	Novaes, Romulo D/F-1210-2015; SOUZA, MARIAUREA/GQP-7833-2022; Gonçalves, Reggiani V/J-1550-2016	Novaes, Romulo D/0000-0002-3186-5328; Gonçalves, Reggiani V/0000-0002-5831-3590	Fundagao de Amparo a Pesquisa do estado de Minas Gerais (Fapemig)	Fundagao de Amparo a Pesquisa do estado de Minas Gerais (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors received funding of the Fundagao de Amparo a Pesquisa do estado de Minas Gerais (Fapemig).	Aghdam SY, 2012, BIOCHEM BIOPH RES CO, V421, P197, DOI 10.1016/j.bbrc.2012.03.134; Altman DG, 2010, J ANTIMICROB CHEMOTH, V65, P1, DOI 10.1093/jac/dkp410; Amar MB, 2014, ROY SOC INTERFACE, V11, P1; Blum KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094713; Bogl LH, 2013, NUTR METAB CARDIOVAS, V23, P1071, DOI 10.1016/j.numecd.2012.11.007; Campbell L, 2010, J EXP MED, V207, P1825, DOI 10.1084/jem.20100500; Chang WJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008540; Choudhry MA, 2000, ALCOHOL, V21, P239, DOI 10.1016/S0741-8329(00)00093-8; Das SK, 2010, OXID MED CELL LONGEV, V3, P414, DOI 10.4161/oxim.3.6.14417; Ding J, 2015, ADV WOUND CARE, V4, P673, DOI 10.1089/wound.2014.0550; do Nascimento AP, 2011, BRIT J NUTR, V106, P603, DOI [10.1017/80007114511000468, 10.1017/S0007114511000468]; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Emmerson E, 2013, MOL CELL ENDOCRINOL, V375, P149, DOI 10.1016/j.mce.2013.05.015; Faunce DE, 2003, ALCOHOL CLIN EXP RES, V27, P1199, DOI 10.1097/01.ALC.0000075833.92139.35; Fitzgerald DJ, 2007, ALCOHOL CLIN EXP RES, V31, P317, DOI 10.1111/j.1530-0277.2006.00307.x; Flegg JA, 2015, FRONT PHYSIOL, V6, P1; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gallardo CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041161; Gantwerker EA, 2011, FACIAL PLAST SURG CL, V19, P441, DOI 10.1016/j.fsc.2011.06.009; GENTILELLO LM, 1993, J TRAUMA, V34, P669, DOI 10.1097/00005373-199305000-00009; Gupta M, 2015, J DIABETES, V7, P573, DOI 10.1111/1753-0407.12223; Halici M, 2010, EKLEM HAST CERRAHISI, V21, P172; Hiebert PR, 2013, CELL DEATH DIFFER, V20, P1404, DOI 10.1038/cdd.2013.96; Holcomb VB, 2009, VIVO, V23, P15; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Jung MK, 2011, ALCOHOL CLIN EXP RES, V35, P392, DOI 10.1111/j.1530-0277.2010.01356.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leite SN, 2015, LASER MED SCI, V30, P1481, DOI 10.1007/s10103-015-1745-2; Masuda R, 2009, WOUND REPAIR REGEN, V17, P127, DOI 10.1111/j.1524-475X.2008.00450.x; McCutcheon JE, 2009, EUR J NEUROSCI, V29, P997, DOI 10.1111/j.1460-9568.2009.06648.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Nascimento AP, 2006, BRIT J NUTR, V96, P1069, DOI 10.1017/BJN20061955; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Olczyk Pawel, 2014, Biomed Res Int, V2014, P747584, DOI 10.1155/2014/747584; Otranto M, 2013, WOUND REPAIR REGEN, V21, P464, DOI 10.1111/wrr.12042; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; Pence BD, 2012, MED SCI SPORT EXER, V44, P1846, DOI 10.1249/MSS.0b013e31825a5971; Potz BA, 2016, J SURG RES, V203, P154, DOI 10.1016/j.jss.2016.03.009; Radek KA, 2005, AM J PHYSIOL-HEART C, V289, pH1084, DOI 10.1152/ajpheart.00080.2005; Radek KA, 2009, J LEUKOCYTE BIOL, V86, P1125, DOI 10.1189/jlb.0209103; Ram M, 2015, EUR J PHARMACOL, V764, P9, DOI 10.1016/j.ejphar.2015.06.029; Randi AM, 2017, J THROMB HAEMOST, V15, P13, DOI 10.1111/jth.13551; Ranzer MJ, 2011, ALCOHOL CLIN EXP RES, V35, P83, DOI 10.1111/j.1530-0277.2010.01324.x; Renaud HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088584; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Seitz O, 2010, EXP DIABETES RES, DOI 10.1155/2010/476969; Silva MLS, 2016, ACTA TROP, V154, P133, DOI 10.1016/j.actatropica.2015.11.010; Slavkovsky R, 2011, WOUND REPAIR REGEN, V19, P515, DOI 10.1111/j.1524-475X.2011.00703.x; Stephens P, 1996, INT J ORAL MAX SURG, V25, P161, DOI 10.1016/S0901-5027(96)80065-8; Su YJ, 2015, ADV WOUND CARE, V4, P631, DOI 10.1089/wound.2014.0559; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Tang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092082; Tepole AB, 2013, PEDIATR RES, V73, P553, DOI 10.1038/pr.2013.3; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Tracy LE, 2016, ADV WOUND CARE, V5, P119, DOI 10.1089/wound.2014.0561; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang H, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0270-0; Wang JH, 2014, INTERNATIONAL CONFERENCE ON MECHANISM SCIENCE AND CONTROL ENGINEERING (MSCE 2014), P1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yonehiro L, 2013, WOUNDS, V25, P340	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176240	10.1371/journal.pone.0176240	http://dx.doi.org/10.1371/journal.pone.0176240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493875	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300010
J	Lee, JH; Shin, MS; Kim, EJ; Ahn, YB; Kim, HD				Lee, Jung-Hoo; Shin, Myung-Seop; Kim, Eun-Jeong; Ahn, Yoo-Been; Kim, Hyun-Duck			The association of dietary vitamin C intake with periodontitis among Korean adults: Results from KNHANES IV	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; ASCORBIC-ACID; NATIONAL-HEALTH; DISEASE; INFECTION; SMOKING; PLASMA; STROKE; NHANES; RISK	Backgrounds The association of dietary vitamin C (vit C) on periodontitis requires more valid evidence from large representative samples to enable sufficient adjustments. This study aimed to evaluate the association between dietary vit C intake and periodontitis after controlling for various confounders in the representative Korean adult population Method A total of 10,930 Korean adults (>= 19 years) from the fourth Korean National Health and Nutrition Examination Survey data set were included in this cross-sectional study. Periodontitis was defined as community periodontal index score of 3 or 4. Dietary vit C intake was estimated from a 24-hour dietary record, and categorized into adequate and inadequate according to the Korean Estimated Average Requirement value. Potential confounders included age, sex, income, frequency of tooth brushing, use of floss, dental visit, drinking, smoking, diabetes, hypercholesterolemia, hypertension, and obesity. A multivariable logistic regression analysis and stratified analysis were applied. Results Those with inadequate dietary vit C intake were more likely by 1.16 times to have periodontitis than those with adequate dietary vit C intake (adjusted odds ratio [aOR] = 1.16, 95% confidence interval = 1.04-1.29). Lowest and middle-low quartile of dietary vit C intake, compared to highest quartile of dietary vit C intake, showed significant association (aOR = 1.28 and 1.22 respectively), which was in a biological-gradient relationship (trendp < 0.05). Conclusions Our data showed that inadequate dietary vit C intake was independently associated with periodontitis among Korean adults. Hence, adequate intake of dietary vitamin C could be substantially important on the promotion of periodontal health among Korean adults.	[Lee, Jung-Hoo; Shin, Myung-Seop; Kim, Eun-Jeong; Ahn, Yoo-Been; Kim, Hyun-Duck] Seoul Natl Univ, Sch Dent, Dept Prevent & Social Dent, 101 Daehak Ro, Seoul, South Korea; [Kim, Hyun-Duck] Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, HD (corresponding author), Seoul Natl Univ, Sch Dent, Dept Prevent & Social Dent, 101 Daehak Ro, Seoul, South Korea.; Kim, HD (corresponding author), Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea.	hyundkim@snu.ac.kr			National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University, Korea [2015-048003]	National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University, Korea	This work was supported by a grant from the National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly (No. 2015-048003) at Seoul National University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly (No. 2015-048003) at Seoul National University, Korea.	Abou Sulaiman AE, 2010, J PERIODONTOL, V81, P1547, DOI 10.1902/jop.2010.100173; Ahn YB, 2015, J CLIN PERIODONTOL, V42, P998, DOI 10.1111/jcpe.12471; AINAMO J, 1982, INT DENT J, V32, P281; Amaliya, 2007, J CLIN PERIODONTOL, V34, P299, DOI 10.1111/j.1600-051X.2007.01053.x; Amaliya A, 2014, JAVA PROJECT PERIODO; Amarasena N, 2005, J CLIN PERIODONTOL, V32, P93, DOI 10.1111/j.1600-051X.2004.00643.x; [Anonymous], 1997, Nutr Rev, V55, P319; Balwant Rai, 2008, Advances in Medical and Dental Sciences, V2, P26; Bartold PM, 2010, PERIODONTOL 2000, V53, P55, DOI 10.1111/j.1600-0757.2010.00347.x; Chapple ILC, 2007, J NUTR, V137, P657, DOI 10.1093/jn/137.3.657; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Ciol MA, 2006, ARCH PHYS MED REHAB, V87, P299, DOI 10.1016/j.apmr.2005.09.021; CLARK DE, 1990, J DENT RES, V69, P890, DOI 10.1177/00220345900690031201; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Dwyer J, 2003, J NUTR, V133, p609S; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Gelskey SC, 1999, COMMUNITY DENT ORAL, V27, P16, DOI 10.1111/j.1600-0528.1999.tb01987.x; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Han DH, 2013, J PERIODONTOL, V84, P776, DOI 10.1902/jop.2012.120237; Han DH, 2012, J CLIN PERIODONTOL, V39, P30, DOI 10.1111/j.1600-051X.2011.01806.x; Haytac MC, 2013, PERIODONTOL 2000, V61, P252, DOI 10.1111/j.1600-0757.2011.00410.x; ISMAIL AI, 1983, J AM DENT ASSOC, V107, P927, DOI 10.14219/jada.archive.1983.0365; Iwasaki M, 2012, J DENT RES, V91, P167, DOI 10.1177/0022034511431702; Jang AY, 2016, KOREAN J FAM MED, V37, P117, DOI 10.4082/kjfm.2016.37.2.117; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Kaye EK, 2012, PERIODONTOL 2000, V58, P93, DOI 10.1111/j.1600-0757.2011.00418.x; Kim DW, 2014, ORAL DIS, V20, P551, DOI 10.1111/odi.12168; Kim HD, 2010, J PERIODONTOL, V81, P658, DOI 10.1902/jop.2010.090614; Korea Health Industry Development Institute (KHIDI), 2019, KOR NAT HLTH NUTR EX; Kuzmanova D, 2012, J CLIN PERIODONTOL, V39, P905, DOI 10.1111/j.1600-051X.2012.01927.x; LEGGOTT PJ, 1991, J DENT RES, V70, P1531, DOI 10.1177/00220345910700121101; Llambes F, 2015, WORLD J DIABETES, V6, P927, DOI 10.4239/wjd.v6.i7.927; Merchant Anwar T, 2008, J Evid Based Dent Pract, V8, P103, DOI 10.1016/j.jebdp.2008.03.005; Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2014, KOR HLTH STAT 2013 K; Murphy SP, 2002, PUBLIC HEALTH NUTR, V5, P843, DOI 10.1079/PHN2002389; Nishida M, 2000, J PERIODONTOL, V71, P1215, DOI 10.1902/jop.2000.71.8.1215; Park JB, 2014, J PERIODONTOL, V85, P1521, DOI 10.1902/jop.2014.130782; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Pfeiffer CM, 2013, J NUTR, V143, p957S, DOI 10.3945/jn.112.173021; Pussinen PJ, 2003, CLIN DIAGN LAB IMMUN, V10, P897, DOI 10.1128/CDLI.10.5.897-902.2003; Castell GS, 2015, NUTR HOSP, V31, P46, DOI 10.3305/nh.2015.31.sup3.8750; Sim SJ, 2008, J PERIODONTOL, V79, P1652, DOI [10.1902/jop.2008.080015, 10.1902/jop.2008.080015 ]; The Korean Nutrition Society, 2010, DIET REF INT KOR 201; Van der Velden U, 2011, J CLIN PERIODONTOL, V38, P142, DOI 10.1111/j.1600-051X.2010.01663.x; VOGEL RI, 1986, J PERIODONTOL, V57, P472, DOI 10.1902/jop.1986.57.8.472; Yan Y, 2013, PROTEIN CELL, V4, P620, DOI 10.1007/s13238-013-3030-0	47	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177074	10.1371/journal.pone.0177074	http://dx.doi.org/10.1371/journal.pone.0177074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489936	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100046
J	Mashauri, FM; Manjurano, A; Kinung'hi, S; Martine, J; Lyimo, E; Kishamawe, C; Ndege, C; Ramsan, MM; Chan, A; Mwalimu, CD; Changalucha, J; Magesa, S				Mashauri, Fabian M.; Manjurano, Alphaxard; Kinung'hi, Safari; Martine, Jackline; Lyimo, Eric; Kishamawe, Coleman; Ndege, Chacha; Ramsan, Mahdi M.; Chan, Adeline; Mwalimu, Charles D.; Changalucha, John; Magesa, Stephen			Indoor residual spraying with micro-encapsulated pirimiphos-methyl (Actellic (R) 300CS) against malaria vectors in the Lake Victoria basin, Tanzania	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE COMPLEX; BED NETS; TRANSMISSION; RESISTANCE; COMMUNITY; MOSQUITOS; AREA; SUSCEPTIBILITY; PREVALENCE	Background The indoor residual spraying programme for malaria vectors control was implemented in four districts of the Lake Victoria basin of Tanzania namely Ukerewe, Sengerema, Rorya andSerengeti. Entomological monitoring activities were implemented in one sentinel village in each district to evaluate the efficacy of pirimiphos-methyl 300 CS sprayed on different wall surfaces and its impact against malaria vectors post-IRS intervention. Methods The residual decay rate of p-methyl 300 CS applied at a target dosage of 1g a.i./m(2) on the-sprayed wall surfaces was monitored for a period of 43 weeks post-IRSusing the WHO cone wall bioassay method. The bioassays were performed by exposing 2-5 days old unfed susceptible female Anopheles gambiae s.s. (Kisumu strain) to sprayed wall surfaces for a period of 30 minutes. In each sentinel village, mosquito collection was carried out by trained community mosquito collectors. Monthly mosquito collections were carried out from 6.00pm to 6.00am using CDC light traps and clay pot methods for indoors host seekingand outdoors resting mosquitoes respectively. Six traps (2 CDC light traps and 4 clay pots) were set per sentinel village per night for28 consecutive days in a moon. PCR and ELISA were used for mosquito species identification and sporozoite detection, respectively. Results Based on the WHOPES recommendation, insecticides should have a minimum efficacy of >= 80% mosquito mortality at 24 hours post exposure on the sprayed wall surfaces to be considered effective. In this study, p-methyl 300 CS was demonstrated to have a long residual efficacy of 21-43 weeks post-IRS on mud, cement, painted and wood wall surfaces. Number of anopheline mosquitoes decreased post-IRS interventions in all sentinel villages. The highest numbers ofanopheline mosquitoes were collected in November-December, 38-43 weeks post-IRS. A total of 270 female anopheline mosquitoes were analyzed by PCR; out of which 236 (87.4%) were An. gambiae s.l. and 34 (12.6%) were An. funestus group. Of the 236 An. gambiae s.l. identified 12.6% (n = 34) were An. gambiae s. s. and 68.6% (n = 162) were An. arabiensis. Ofthe 34 An. funestus group indentified 91.2% (n = 31) were An. parensis and 8.8% (n = 3) were An. rivulorum. The overall Plasmodium falciparum sporozoite rate was 0.7% (n = 2,098). Conclusions Pirimiphos-methyl 300 CS was found to be effective for IRS in the Lake Victoria basin, Tanzania. P-methyl 300 CShas a long residual efficacy on sprayed wall surfaces and therefore it is effective in controlling principal malaria vectors of An. gambiae s.l and An. funestus which rest on wall surfaces after and before feeding.	[Mashauri, Fabian M.; Manjurano, Alphaxard; Kinung'hi, Safari; Martine, Jackline; Lyimo, Eric; Kishamawe, Coleman; Ndege, Chacha; Changalucha, John] Mwanza Ctr, Natl Inst Med Res, Mwanza, Tanzania; [Ramsan, Mahdi M.; Magesa, Stephen] Res Triangle Inst RTI Int, Dar Es Salaam, Tanzania; [Chan, Adeline] Ctr Dis Control & Prevent, Atlanta, GA USA; [Mwalimu, Charles D.] Minist Hlth Community Dev Gender Elderly & Childr, Natl Malaria Control Program, Dar Es Salaam, Tanzania	National Institute of Medical Research; Research Triangle Institute; Centers for Disease Control & Prevention - USA	Mashauri, FM (corresponding author), Mwanza Ctr, Natl Inst Med Res, Mwanza, Tanzania.	mashauri@hotmail.com		Lyimo, Eric/0000-0002-1904-7410	US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International [6-330-0212555]; US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International; Ministry of Health, Community Development, Gender, Elderly and Children of the United Republic of Tanzania	US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International; US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International; Ministry of Health, Community Development, Gender, Elderly and Children of the United Republic of Tanzania	This research was funded by the US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International, Grant number 6-330-0212555.; We are grateful to Michael Sadataley and Epiphany Michael for assistance to conductcone wall bioassay, rearing and maintaining a colony of susceptible Anopheles gambiae (Kisumu strain). We are thankful for the financial support extended to the project by the US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International and the Ministry of Health, Community Development, Gender, Elderly and Children of the United Republic of Tanzania. We also acknowledge the logistic support provided to the project by the management of NIMR-Mwanza Centre. We thank the District Medical team in particular District Vector Control Officers (DVCOs) from all selected districts for field support and supervision of entomological monitoring activities. Last but not least we extend our sincere appreciation to the community mosquito collectors and communities from all selected sentinel villages for the support and cooperation during fieldwork implementation.	Abbott F F, 1925, Cal West Med, V23, P758; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-190; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; BEIER JC, 1990, J MED ENTOMOL, V27, P377, DOI 10.1093/jmedent/27.3.377; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; Chanda E, 2013, J MED ENTOMOL, V50, P1275, DOI 10.1603/ME13041; Chiu Chen, 2008, Proc Natl Acad Sci U S A, V105, P13116, DOI 10.1073/pnas.0804408105; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; DAS M, 1987, MED VET ENTOMOL, V1, P289, DOI 10.1111/j.1365-2915.1987.tb00357.x; Eze IC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-196; Frohlich F., 1966, BRIT J AESTHET, V6, P17; Fuseini G, 2011, J MED ENTOMOL, V48, P437, DOI 10.1603/ME09286; Gaiger J, 2001, BRIT J AESTHET, V41, P455, DOI 10.1093/bjaesthetics/41.4.455; Haji KA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1239-x; Hamusse SD, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.11619; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Holland RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001676; Ishengoma DS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-338; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Kabula B, 2014, MED VET ENTOMOL, V28, P244, DOI 10.1111/mve.12036; Kabula B, 2012, TROP MED INT HEALTH, V17, P742, DOI 10.1111/j.1365-3156.2012.02986.x; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kim MJ, 2015, KOREAN J PARASITOL, V53, P571, DOI 10.3347/kjp.2015.53.5.571; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76; Kolaczinski K, 2007, T ROY SOC TROP MED H, V101, P852, DOI 10.1016/j.trstmh.2007.04.003; Mashauri FM, 2013, AM J TROP MED HYG, V88, P841, DOI 10.4269/ajtmh.12-0412; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Matowo J, 2015, MED VET ENTOMOL, V29, P51, DOI 10.1111/mve.12090; Meyrowitsch DW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-188; Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8; Motherwell R, 1952, MODERN ARTISTS AM; Muturi EJ, 2006, J VECTOR ECOL, V31, P129, DOI 10.3376/1081-1710(2006)31[129:MSDAAI]2.0.CO;2; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; N'Guessan R, 2012, LANCET INFECT DIS, V12, P581, DOI 10.1016/S1473-3099(12)70139-1; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; NASIR SM, 1982, J TROP MED HYG, V85, P239; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; OSBORNE H, 1976, BRIT J AESTHET, V16, P291, DOI 10.1093/bjaesthetics/16.4.291; Oxborough RM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-37; Porter JI, 2009, BRIT J AESTHET, V49, P1, DOI 10.1093/aesthj/ayn054; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rowland M, 1997, B WORLD HEALTH ORGAN, V75, P23; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; Russell TL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1195-8; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Seyoum A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-101; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Tia E, 2006, Bull Soc Pathol Exot, V99, P278; Trigg PI, 1998, B WORLD HEALTH ORGAN, V76, P11; Wakabi W, 2007, LANCET, V370, P1895, DOI 10.1016/S0140-6736(07)61796-6; West PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115661; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; Whitney JR, 1997, NEW DIRECTIONS PALEO, P24; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2006, IND RES SPRAYING US; WHOPES, 2013, REP 16 WHOPES WORK G; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; Wort UU, 2004, INT J EPIDEMIOL, V33, P1311, DOI 10.1093/ije/dyh256; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67	68	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176982	10.1371/journal.pone.0176982	http://dx.doi.org/10.1371/journal.pone.0176982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489935	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100040
J	Sandri, TL; Adukpo, S; Giang, DP; Nguetse, CN; Andrade, FA; Tong, HV; Toan, NL; Song, LH; Elumalai, P; Thangaraj, K; Valluri, VL; Ntoumi, F; Meyer, CG; Reason, IJD; Kremsner, PG; Velavan, TP				Sandri, Thaisa Lucas; Adukpo, Selorme; Dao Phuong Giang; Nguetse, Christian N.; Andrade, Fabiana Antunes; Hoang Van Tong; Nguyen Linh Toan; Le Huu Song; Elumalai, Preetham; Thangaraj, Kumarasamy; Valluri, Vijaya Lakshmi; Ntoumi, Francine; Meyer, Christian G.; de Messias Reason, Iara Jose; Kremsner, Peter G.; Velavan, Thirumalaisamy P.			Geographical distribution of complement receptor type 1 variants and their associated disease risk	PLOS ONE			English	Article							CANDIDATE GENE POLYMORPHISMS; C3B/C4B RECEPTOR; CR-1; MALARIA; IDENTIFICATION; BINDING; SUSCEPTIBILITY; ACTIVATION; MECHANISMS; EXPRESSION	Background Pathogens exert selective pressure which may lead to substantial changes in host immune responses. The human complement receptor type 1 (CR1) is an innate immune recognition glycoprotein that regulates the activation of the complement pathway and removes opsonized immune complexes. CR1 genetic variants in exon 29 have been associated with expression levels, C1q or C3b binding and increased susceptibility to several infectious diseases. Five distinct CR1 nucleotide substitutions determine the Knops blood group phenotypes, namely Kn(a/b), McC(a/b), Sl1/Sl2, Sl4/Sl5 and KCAM+/-. Methods CR1 variants were genotyped by direct sequencing in a cohort of 441 healthy individuals from Brazil, Vietnam, India, Republic of Congo and Ghana. Results The distribution of the CR1 alleles, genotypes and haplotypes differed significantly among geographical settings (p <= 0.001). CR1 variants rs17047660A/G (McC(a/b)) and rs17047661A/G (Sl1/Sl2) were exclusively observed to be polymorphic in African populations compared to the groups from Asia and South-America, strongly suggesting that these two SNPs may be subjected to selection. This is further substantiated by a high linkage disequilibrium between the two variants in the Congolese and Ghanaian populations. A total of nine CR1 haplotypes were observed. The CR1* AGAATA haplotype was found more frequently among the Brazilian and Vietnamese study groups; the CR1* AGAATG haplotype was frequent in the Indian and Vietnamese populations, while the CR1* AGAGTG haplotype was frequent among Congolese and Ghanaian individuals. Conclusion The African populations included in this study might have a selective advantage conferred to immune genes involved in pathogen recognition and signaling, possibly contributing to disease susceptibility or resistance.	[Sandri, Thaisa Lucas; Adukpo, Selorme; Nguetse, Christian N.; Hoang Van Tong; Meyer, Christian G.; Kremsner, Peter G.; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Sandri, Thaisa Lucas; Andrade, Fabiana Antunes; de Messias Reason, Iara Jose] Univ Fed Parana, Lab Mol mmunopathol, Curitiba, Parana, Brazil; [Adukpo, Selorme] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Dao Phuong Giang; Le Huu Song] 108 Mil Cent Hosp, Hanoi, Vietnam; [Dao Phuong Giang; Hoang Van Tong; Nguyen Linh Toan; Le Huu Song; Meyer, Christian G.; Velavan, Thirumalaisamy P.] Vietnamese German Ctr Med Res, Hanoi, Vietnam; [Nguyen Linh Toan] Vietnam Mil Med Univ, Hanoi, Vietnam; [Elumalai, Preetham] Kerala Univ Fisheries & Ocean Studies, Kochi, Kerala, India; [Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Prades, India; [Valluri, Vijaya Lakshmi] LEPRA Blue Peter Publ Hlth & Res Ctr, Hyderabad, Andhra Prades, India; [Ntoumi, Francine; Velavan, Thirumalaisamy P.] Fdn Congolaise Rech Med, Brazzaville, Rep Congo; [Meyer, Christian G.; Velavan, Thirumalaisamy P.] Duy Tan Univ, Da Nang, Vietnam	Eberhard Karls University of Tubingen; Universidade Federal do Parana; University of Ghana; Kerala University of Fisheries & Ocean Studies; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Duy Tan University	Velavan, TP (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.; Velavan, TP (corresponding author), Vietnamese German Ctr Med Res, Hanoi, Vietnam.; Velavan, TP (corresponding author), Fdn Congolaise Rech Med, Brazzaville, Rep Congo.; Velavan, TP (corresponding author), Duy Tan Univ, Da Nang, Vietnam.	velavan@medizin.uni-tuebingen.de	van Tong, Hoang/E-9448-2011; Valluri, Vijaya Lakshmi/S-9219-2019; Velavan, Thirumalaisamy P/C-1223-2010	van Tong, Hoang/0000-0002-7170-8810; Velavan, Thirumalaisamy P/0000-0002-9809-9883; Andrade, Fabiana/0000-0003-4116-2324; Jose de Messias Reason, Iara/0000-0002-5573-260X	CAPES (Coordenagao de Aperfeigoamento de Pessoal Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil); BMBF [BMBF BRA11/A33, 01DN11001]; CANTAM (Central Africa Network on Tuberculosis, HIV/AIDS and Malaria); EDCTP; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Tuebingen University	CAPES (Coordenagao de Aperfeigoamento de Pessoal Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BMBF(Federal Ministry of Education & Research (BMBF)); CANTAM (Central Africa Network on Tuberculosis, HIV/AIDS and Malaria); EDCTP; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This work was supported by research grants from CAPES (Coordenagao de Aperfeigoamento de Pessoal Superior) for Thaisa Lucas Sandri and from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil) for lara Jose de Messias Reason. Also, bilateral cooperation support from BMBF to TPV (BMBF BRA11/A33; 01DN11001) for Thirumalaisamy P. Velavan is acknowledged. TPV and FN acknowledge the support from CANTAM (Central Africa Network on Tuberculosis, HIV/AIDS and Malaria), a network of excellence supported by EDCTP. The authors greatly acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. Other authors received no specific funding for this work. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyaz M, 2012, IMMUNOBIOLOGY, V217, P204, DOI 10.1016/j.imbio.2011.07.023; Apinjoh TO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-236; Backes C, 2015, ONCOTARGET, V6, P5918, DOI 10.18632/oncotarget.2950; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; Chakraborty P, 2001, J PARASITOL, V87, P1023, DOI 10.1645/0022-3395(2001)087[1023:MOMMRA]2.0.CO;2; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Diakite M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-250; Dominguez M, 2003, MICROBES INFECT, V5, P507, DOI 10.1016/S1286-4579(03)00071-6; Dominguez M, 2002, J EXP MED, V195, P451, DOI 10.1084/jem.20011319; Duru KC, 2015, EVOL BIOINFORM, V11, DOI 10.4137/EBO.S23132; Eid NA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-119; Erdei A, 2009, MOL IMMUNOL, V46, P2767, DOI 10.1016/j.molimm.2009.05.181; Fang YF, 1998, J IMMUNOL, V160, P5273; Fernie-King B, 2002, ANN RHEUM DIS, V61, P8; Fitness J, 2002, GENES IMMUN, V3, P441, DOI 10.1038/sj.gene.6363926; Fonseca MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149792; Gomes JAS, 2012, IMMUNOBIOLOGY, V217, P1005, DOI 10.1016/j.imbio.2012.01.014; Haas KM, 2004, J IMMUNOL, V172, P5833, DOI 10.4049/jimmunol.172.10.5833; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Holton P, 2013, ANN HUM GENET, V77, P85, DOI 10.1111/ahg.12000; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; HOURCADE D, 1988, J EXP MED, V168, P1255, DOI 10.1084/jem.168.4.1255; Jacquet M, 2013, J IMMUNOL, V190, P3721, DOI 10.4049/jimmunol.1202451; Jiao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144898; Kariuki SM, 2013, EPILEPSIA, V54, P990, DOI 10.1111/epi.12173; Keenan BT, 2012, HUM MOL GENET, V21, P2377, DOI 10.1093/hmg/dds054; KLICKSTEIN LB, 1988, J EXP MED, V168, P1699, DOI 10.1084/jem.168.5.1699; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Klop B, 2014, J BIOL CHEM, V289, P35421, DOI 10.1074/jbc.M114.573840; Krych-Goldberg M, 2002, TRENDS MOL MED, V8, P531, DOI 10.1016/S1471-4914(02)02419-X; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Kullo IJ, 2011, AM J HUM GENET, V89, P131, DOI 10.1016/j.ajhg.2011.05.019; Liu D, 2009, IMMUNOPHARM IMMUNOT, V31, P524, DOI 10.3109/08923970902845768; Malik M, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0048-1; McElroy JJ, 2013, HUM GENET, V132, P935, DOI 10.1007/s00439-013-1304-5; Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005; Moulds J M, 2010, Immunohematology, V26, P2; Moulds JM, 2000, GENES IMMUN, V1, P325, DOI 10.1038/sj.gene.6363676; Moulds JM, 2004, TRANSFUSION, V44, P164, DOI 10.1111/j.1537-2995.2004.00615.x; Moulds JM, 2002, TRANSFUSION, V42, P251, DOI 10.1046/j.1537-2995.2002.00002.x; Moulds JM, 2001, BLOOD, V97, P2879, DOI 10.1182/blood.V97.9.2879; Noumsi GT, 2011, TRANSFUSION, V51, P2462, DOI 10.1111/j.1537-2995.2011.03161.x; Ogembo JG, 2013, CELL REP, V3, P371, DOI 10.1016/j.celrep.2013.01.023; Ren N, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001681; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Saranya B, 2016, INTERDISCIP SCI, V8, P35, DOI 10.1007/s12539-015-0279-4; Seregin SS, 2009, GENE THER, V16, P1245, DOI 10.1038/gt.2009.77; Sherif Fayroz F., 2015, Advances in Bioinformatics, V2015, P639367, DOI 10.1155/2015/639367; Sinha S, 2009, HUM IMMUNOL, V70, P244, DOI 10.1016/j.humimm.2009.02.001; Tettey R, 2015, PATHOG GLOB HEALTH, V109, P247, DOI 10.1179/2047773215Y.0000000011; Toure O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043987; Van Cauwenberghe C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.03.008; Wang FS, 2005, CLIN EXP IMMUNOL, V139, P112, DOI 10.1111/j.1365-2249.2005.02681.x; WEIS JH, 1987, J IMMUNOL, V138, P312; Weiss L, 1989, Adv Nephrol Necker Hosp, V18, P249; Yu XF, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-56; Zhao L, 2015, J CANCER, V6, P525, DOI 10.7150/jca.10749; Zimmerman PA, 2003, GENES IMMUN, V4, P368, DOI 10.1038/sj.gene.6363980	60	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175973	10.1371/journal.pone.0175973	http://dx.doi.org/10.1371/journal.pone.0175973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520715	Green Submitted, gold, Green Published			2022-12-27	WOS:000401487700009
J	Abdulrahman, SA; Rampal, L; Ibrahim, F; Radhakrishnan, AP; Shahar, HK; Othman, N				Abdulrahman, Surajudeen Abiola; Rampal, Lekhraj; Ibrahim, Faisal; Radhakrishnan, Anuradha P.; Shahar, Hayati Kadir; Othman, Norlijah			Mobile phone reminders and peer counseling improve adherence and treatment outcomes of patients on ART in Malaysia: A randomized clinical trial	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; TERM; CARE; THERAPY	Background Adherence to treatment remains the cornerstone of long term viral suppression and successful treatment outcomes among patients receiving Antiretroviral Therapy (ART). Objective(s) Evaluate the effectiveness of mobile phone reminders and peer counseling in improving adherence and treatment outcomes among HIV positive patients on ART in Malaysia. Methods A single-blind, parallel group RCT conducted in Hospital Sungai Buloh, Malaysia in which 242 adult Malaysian patients were randomized to intervention or control groups. Intervention consisted of a reminder module delivered through SMS and telephone call reminders by trained research assistants for 24 consecutive weeks (starting from date of ART initiation), in addition to adherence counseling at every clinic visit. The length of intended follow up for each patient was 6 months. Data on adherence behavior of patients was collected using specialized, pre-validated Adult AIDS Clinical Trial Group (AACTG) adherence questionnaires. Data on weight, clinical symptoms, CD4 count and viral load tests were also collected. Data was analyzed using SPSS version 22 and R software. Repeated measures ANOVA, Friedman's ANOVA and Multivariate regression models were used to evaluate efficacy of the intervention. Results The response rate after 6 months follow up was 93%. There were no significant differences at baseline in gender, employment status, income distribution and residential location of respondents between the intervention and control group. After 6 months follow up, the mean adherence was significantly higher in the intervention group (95.7; 95% CI: 94.39-96.97) as compared to the control group (87.5; 95% CI: 86.14-88.81). The proportion of respondents who had Good (>95%) adherence was significantly higher in the intervention group (92.2%) compared to the control group (54.6%). A significantly lower frequency in missed appointments (14.0% vs 35.5%) (p = 0.001), lower viral load (p = 0.001), higher rise in CD4 count (p = 0.017), lower incidence of tuberculosis (p = 0.001) and OIs (p = 0.001) at 6 months follow up, was observed among patients in the intervention group. Conclusion Mobile phone reminders (SMS and telephone call reminders) and peer counseling are effective in improving adherence and treatment outcomes among HIV positive patients on ART in Malaysia. These findings may be of potential benefit for collaborative adherence planning between patients and health care providers at ART commencement.	[Abdulrahman, Surajudeen Abiola; Rampal, Lekhraj; Ibrahim, Faisal; Shahar, Hayati Kadir] Univ Putra Malaysia, Dept Community Hlth, Fac Med & Hlth Sci, Upm Serdang, Selangor Darul, Malaysia; [Abdulrahman, Surajudeen Abiola] Penang Med Coll, Dept Publ Hlth Med, George Town, Penang, Malaysia; [Radhakrishnan, Anuradha P.] Hosp Sungai Buloh, Infect Dis Clin, Sungai Buloh, Selangor Darul, Malaysia; [Othman, Norlijah] Univ Putra Malaysia, Dept Pediat, Fac Med & Hlth Sci, Upm Serdang, Selangor Darul, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Rampal, L (corresponding author), Univ Putra Malaysia, Dept Community Hlth, Fac Med & Hlth Sci, Upm Serdang, Selangor Darul, Malaysia.	lekhraj@upm.edu.my		Abdulrahman, Surajudeen/0000-0003-4445-1295				Collier AC, 2005, J INFECT DIS, V192, P1398, DOI 10.1086/466526; da Costa TM, 2012, INT J MED INFORM, V81, P257, DOI 10.1016/j.ijmedinf.2011.10.002; Downer SR, 2005, MED J AUSTRALIA, V183, P366, DOI 10.5694/j.1326-5377.2005.tb07085.x; Egbewale Bolaji Emmanuel, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P354, DOI 10.1016/S2221-1691(15)30367-1; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; Hardy H, 2011, AIDS PATIENT CARE ST, V25, P153, DOI 10.1089/apc.2010.0006; Hovart T, 2012, COCHRANE DB SYST REV; Jani A.A., 2004, ADHERENCE HIV TREATM, P3; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Kunutsor S, 2010, AIDS BEHAV, V14, P1347, DOI 10.1007/s10461-010-9780-2; Lemeshow S., 1990, TITLE ADEQUACY SAMPL; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; March K, 2007, AM J HEALTH-SYST PH, V64, P2574, DOI 10.2146/ajhp070048; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Ndubuka NO, 2011, INT J NURS STUD, V48, P1323, DOI 10.1016/j.ijnurstu.2011.04.006; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Preininger L, 2011, CURR HIV RES, V9, P253, DOI 10.2174/157016211796320351; Reynolds NR, 2007, JAIDS-J ACQ IMM DEF, V46, P402, DOI 10.1097/QAI.0b013e318158a44f; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Roberts C, 1999, BRIT MED J, V319, P185, DOI 10.1136/bmj.319.7203.185; Sabin LL, 2015, JAIDS-J ACQ IMM DEF, V69, P551, DOI 10.1097/QAI.0000000000000651; Sabin LL, 2010, AIDS BEHAV, V14, P580, DOI 10.1007/s10461-009-9615-1; Saple D., 2005, INDIA J DERMATOLOGY; Sarna A, 2008, JAIDS-J ACQ IMM DEF, V48, P611, DOI 10.1097/QAI.0b013e3181806bf1; van Velthoven MHMMT, 2013, PSYCHOL HEALTH MED, V18, P182, DOI 10.1080/13548506.2012.701310; World Health Organization, 2007, WHO WORK GROUP M 21	27	32	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177698	10.1371/journal.pone.0177698	http://dx.doi.org/10.1371/journal.pone.0177698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520768	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500058
J	Kowitt, SD; Schmidt, AM; Hannan, A; Goldstein, AO				Kowitt, Sarah D.; Schmidt, Allison M.; Hannan, Anika; Goldstein, Adam O.			Awareness and trust of the FDA and CDC: Results from a national sample of US adults and adolescents	PLOS ONE			English	Article							VACCINE UPTAKE; CONFIDENCE; GOVERNMENT; NUMERACY; PERCEPTIONS; A(H1N1)	Trust in government agencies plays a key role in advancing these organizations' agendas, influencing behaviors, and effectively implementing policies. However, few studies have examined the extent to which individuals are aware of and trust the leading United States agencies devoted to protecting the public's health. Using two national samples of adolescents (N = 1,125) and adults (N = 5,014), we examined demographic factors, with a focus on vulnerable groups, as correlates of awareness of and trust in the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and the federal government. From nine different weighted and adjusted logistic regression models, we found high levels of awareness of the existence of the FDA and CDC (ranging from 55.7% for adolescents' awareness of the CDC to 94.3% for adults' awareness of the FDA) and moderate levels of trust (ranging from a low of 41.8% for adults' trust in the federal government and a high of 78.8% for adolescents' trust of the FDA). In the adolescent and adult samples, awareness was higher among non-Hispanic Blacks and respondents with low numeracy. With respect to trust, few consistent demographic differences emerged. Our findings provide novel insights regarding awareness and trust in the federal government and specific United States public health agencies. Our findings suggest groups to whom these agencies may want to selectively communicate to enhance trust and thus facilitate their communication and regulatory agendas.	[Kowitt, Sarah D.; Schmidt, Allison M.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA; [Hannan, Anika; Goldstein, Adam O.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Goldstein, Adam O.] Univ North Carolina Chapel Hill, Dept Family Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kowitt, SD (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA.	kowitt@email.unc.edu		Hannan, Anika/0000-0002-8830-5719	National Cancer Institute [P50 CA180907]; FDA Center for Tobacco Products (CTP); NATIONAL CANCER INSTITUTE [P50CA180907] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by grant number P50 CA180907 from the National Cancer Institute and the FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Boynton MH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3151-5; Byrne S, 2012, J HEALTH COMMUN, V17, P1119, DOI 10.1080/10810730.2012.665425; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Hanoch Y, 2010, CHILD CARE HLTH DEV, V36, P795, DOI 10.1111/j.1365-2214.2010.01075.x; Huang H, 2012, LIT NUMER STUD, V20, P3, DOI 10.5130/lns.v20i2.3082; Huang LL, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010042; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Lee C, 2016, VACCINE; Lee JG, 2016, AM J PREV MED; Levi M, 2000, ANNU REV POLIT SCI, V3, P475, DOI 10.1146/annurev.polisci.3.1.475; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Lipkus IM, 2009, HEALTH EDUC BEHAV, V36, P1065, DOI 10.1177/1090198109341533; Mandrola J, 2015, PUBLIC TRUST CDC TAM; Marlow LAV, 2007, HUM VACCINES, V3, P171, DOI 10.4161/hv.3.5.4310; Meredith LS, 2007, J HEALTH COMMUN, V12, P217, DOI 10.1080/10810730701265978; Mesch GS, 2015, HEALTH PROMOT INT, V30, P213, DOI 10.1093/heapro/dau094; Meyer SB, 2013, AUST HEALTH REV, V37, P11, DOI 10.1071/AH11073; Pew Research Center, 2013, TRUST GOV NEARS REC; Pew Research Center, 2015, DISTR AM VIEW THEIR; Pew Research Center, 2010, PUBL KNOWS BAS FACTS; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Pollard WE, 2003, J HEALTH COMMUN, V8, P93, DOI 10.1080/10810730390224893; Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048; Rothstein M, 2015, RESTORING TRUST US C; Rutten LJF, 2011, J CANCER EDUC, V26, P465, DOI 10.1007/s13187-011-0201-7; SAS Institute Inc, SAS VERS 9 3; Schmidt Allison M, 2016, Tob Regul Sci, V2, P31; Taylor-Clark K, 2005, BIOSECUR BIOTERROR, V3, P138, DOI 10.1089/bsp.2005.3.138; Twenge JM, 2014, PSYCHOL SCI, V25, P1914, DOI 10.1177/0956797614545133; U.S. Food and Drug Administration, 2014, MEM UND FOOD DRUG AD; United States Census Bureau, 2015, REG DIV 2015; Us Department of Health and Human Services, 2016, REAL COST 2016; US Department of Health Human Services, 2014, HLTH CONSMOK 50 YE, P17, DOI DOI 10.1037/E510072014-001; Waldrop-Valverde D, 2010, AIDS BEHAV, V14, P799, DOI 10.1007/s10461-009-9604-4; Whetten K, 2006, AM J PUBLIC HEALTH, V96, P716, DOI 10.2105/AJPH.2005.063255	36	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177546	10.1371/journal.pone.0177546	http://dx.doi.org/10.1371/journal.pone.0177546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520750	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500040
J	Neuditschko, M; Raadsma, HW; Khatkar, MS; Jonas, E; Steinig, EJ; Flury, C; Signer-Hasler, H; Frischknecht, M; von Niederhausem, R; Leeb, T; Rieder, S				Neuditschko, Markus; Raadsma, Herman W.; Khatkar, Mehar S.; Jonas, Elisabeth; Steinig, Eike J.; Flury, Christine; Signer-Hasler, Heidi; Frischknecht, Mirjam; von Niederhausem, Ruedi; Leeb, Tosso; Rieder, Stefan			Identification of key contributors in complex population structures	PLOS ONE			English	Article							GENOME SEQUENCE DATA; GENOTYPE IMPUTATION; CATTLE BREEDS; ACCURACY; INFORMATION; FRAMEWORK; INFERENCE; LINKAGE; HORSE; LOCI	Evaluating the genetic contribution of individuals to population structure is essential to select informative individuals for genome sequencing, genotype imputation and to ascertain complex population structures. Existing methods for the selection of informative individuals for genomic imputation solely focus on the identification of key ancestors, which can lead to a loss of phasing accuracy of the reference population. Currently many methods are independently applied to investigate complex population structures. Based on the Eigenvalue Decomposition (EVD) of a genomic relationship matrix we describe a novel approach to evaluate the genetic contribution of individuals to population structure. We combined the identification of key contributors with model-based clustering and population network visualization into an integrated three-step approach, which allows identification of high-resolution population structures and substructures around such key contributors. The approach was applied and validated in four disparate datasets including a simulated population (5,100 individuals and 10,000 SNPs), a highly structured experimental sheep population (1,421 individuals and 44,693 SNPs) and two large complex pedigree populations namely horse (1,077 individuals and 38,124 SNPs) and cattle (2,457 individuals and 45,765 SNPs). In the simulated and experimental sheep dataset, our method, which is unsupervised, successfully identified all known key contributors. Applying our three-step approach to the horse and cattle populations, we observed high-resolution population substructures including the absence of obvious important key contributors. Furthermore, we show that compared to commonly applied strategies to select informative individuals for genotype imputation including the computation of marginal gene contributions (PEDIG) and the optimization of genetic relatedness (wREL), the selection of key contributors provided the highest phasing accuracies within the selected reference populations. The presented approach opens new perspectives in the characterization and informed management of populations in general, and in areas such as conservation genetics and selective animal breeding in particular, where assessing the genetic contribution of influential and admixed individuals is crucial for research and management applications. As such, this method provides a valuable complement to common applied tools to visualize complex population structures and to select individuals for resequencing.	[Neuditschko, Markus; Frischknecht, Mirjam; von Niederhausem, Ruedi; Rieder, Stefan] Agroscope, Swiss Natl Stud Farm, Avenches, Switzerland; [Neuditschko, Markus; Raadsma, Herman W.; Khatkar, Mehar S.; Jonas, Elisabeth] Univ Sydney, Fac Vet Sci, Reprogen Anim Biosci Grp, Camden, NSW, Australia; [Jonas, Elisabeth] SLU, Dept Anim Breeding & Genet, Uppsala, Sweden; [Steinig, Eike J.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Flury, Christine; Signer-Hasler, Heidi] Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland; [Frischknecht, Mirjam; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland	Swiss Federal Research Station Agroscope; University of Sydney; Swedish University of Agricultural Sciences; James Cook University; University of Bern	Neuditschko, M (corresponding author), Agroscope, Swiss Natl Stud Farm, Avenches, Switzerland.; Neuditschko, M (corresponding author), Univ Sydney, Fac Vet Sci, Reprogen Anim Biosci Grp, Camden, NSW, Australia.	markus.neuditschko@agroscope.admin.ch	Leeb, Tosso/G-3187-2014; Jonas, Elisabeth/F-1764-2017	Leeb, Tosso/0000-0003-0553-4880; Jonas, Elisabeth/0000-0003-4950-2549; Flury, Christine/0000-0002-8649-5571; Khatkar, Mehar/0000-0002-4554-1404				Alexander D. H., 2009, GENOME RES; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Boichard D, 2002, P 7 WORLD C GEN APPL; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Brownrigg S, 2011, NY TIMES BK REV, P12; Coster A, 2011, PEDIGREE PEDIGREE FU; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Druet T, 2014, HEREDITY, V112, P39, DOI 10.1038/hdy.2013.13; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Frischknecht M, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0063-7; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; Goddard M. E., 2009, Matching genetics and environment: a new look at an old topic. Proceedings of the 18th Conference of the Association for the Advancement of Animal Breeding and Genetics, Barossa Valley, South Australia, Australia, 28 September-1 October, 2009, P26; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hoze C, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-33; Khatkar MS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-538; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Neuditschko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048375; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pausch H, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-3; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; Raadsma HW, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-34; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Sarkissian CD, 2015, CURR BIOL, V25, P2577, DOI 10.1016/j.cub.2015.08.032; Shakhsi-Niaei M, 2012, ANIM GENET, V43, P627, DOI 10.1111/j.1365-2052.2011.02315.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Steinig EJ, 2016, MOL ECOL RESOUR, V16, P216, DOI 10.1111/1755-0998.12442; USAI M G, 2014, BMC PROCEEDING, V8, P1; van Binsbergen R, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-41; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177638	10.1371/journal.pone.0177638	http://dx.doi.org/10.1371/journal.pone.0177638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520805	Green Published, gold, Green Accepted			2022-12-27	WOS:000401485500050
J	Sieiro, D; Veron, N; Marcelle, C				Sieiro, Daniel; Veron, Nadege; Marcelle, Christophe			The chicken embryo as an efficient model to test the function of muscle fusion genes in amniotes	PLOS ONE			English	Article							CELL-CELL FUSION; MYOBLAST FUSION; DROSOPHILA; MYOGENESIS; GTPASES; REGENERATION; VERTEBRATES; MYOMAKER; FIBERS; FISH	The fusion of myoblasts into multinucleated myotubes is a crucial step of muscle growth during development and of muscle repair in the adult. While multiple genes were shown to play a role in this process, a vertebrate model where novel candidates can be tested and analyzed at high throughput and relative ease has been lacking. Here, we show that the early chicken embryo is a fast and robust model in which functional testing of muscle fusion candidate genes can be performed. We have used known modulators of muscle fusion, Rac1 and Cdc42, along with the in vivo electroporation of integrated, inducible vectors, to show that the chicken embryo is a suitable model in which their function can be tested and quantified. In addition to nuclei content, specific characteristics of the experimental model allow a fine characterization of additional morphological features that are nearly impossible to assess in other model organisms. This study should establish the chicken embryo as a cheap, reliable and powerful model in which novel vertebrate muscle fusion candidates can be evaluated.	[Sieiro, Daniel; Veron, Nadege; Marcelle, Christophe] Monash Univ, ARMI, Clayton, Vic, Australia; [Sieiro, Daniel; Marcelle, Christophe] Univ Claude Bernard Lyon1, Inst NeuroMyoGene INMG, Fac Med Laennec, Lyon, France	Australian Regenerative Medicine Institute; Monash University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Marcelle, C (corresponding author), Monash Univ, ARMI, Clayton, Vic, Australia.; Marcelle, C (corresponding author), Univ Claude Bernard Lyon1, Inst NeuroMyoGene INMG, Fac Med Laennec, Lyon, France.	christophe.marcelle@monash.edu		Sieiro Mosti, Daniel/0000-0001-5750-5163; Marcelle, Christophe/0000-0002-9612-7609	National Health and Medical Research Council (NHMRC, Australia); Programme Avenir Lyon Saint-Etienne (PALSE) from the University of Lyon; State Government of Victoria; Australian Government; Association Francaise contre les Myopathies (AFM)	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Programme Avenir Lyon Saint-Etienne (PALSE) from the University of Lyon; State Government of Victoria; Australian Government(Australian GovernmentCGIAR); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by grants from the National Health and Medical Research Council (NHMRC, Australia) to C.M. and N.V. and by the Programme Avenir Lyon Saint-Etienne (PALSE) from the University of Lyon to C.M. and D.S. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The NeuroMyoGene Institute is supported by grants from the Association Francaise contre les Myopathies (AFM).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Bruusgaard JC, 2003, J PHYSIOL-LONDON, V551, P467, DOI 10.1113/jphysiol.2003.045328; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HALL ZW, 1989, CELL, V59, P771, DOI 10.1016/0092-8674(89)90597-7; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Rios AC, 2011, NATURE, V473, P532, DOI 10.1038/nature09970; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Serralbo O, 2013, GENESIS, V51, P372, DOI 10.1002/dvg.22388; SHIMADA Y, 1971, J CELL BIOL, V48, P128, DOI 10.1083/jcb.48.1.128; Sieiro-Mosti D, 2014, DEVELOPMENT, V141, P3605, DOI 10.1242/dev.114546; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; Sung BH, 2011, CURR BIOL, V21, pR121, DOI 10.1016/j.cub.2010.12.024; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tixier V, 2010, EXP CELL RES, V316, P3019, DOI 10.1016/j.yexcr.2010.07.013; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007	37	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177681	10.1371/journal.pone.0177681	http://dx.doi.org/10.1371/journal.pone.0177681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520772	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500054
J	Murray, DL; Peers, MJL; Majchrzak, YN; Wehtje, M; Ferreira, C; Pickles, RSA; Row, JR; Thornton, DH				Murray, Dennis L.; Peers, Michael J. L.; Majchrzak, Yasmine N.; Wehtje, Morgan; Ferreira, Catarina; Pickles, Rob S. A.; Row, Jeffrey R.; Thornton, Daniel H.			Continental divide: Predicting climate-mediated fragmentation and biodiversity loss in the boreal forest	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; HABITAT LOSS; RANGE SHIFTS; PHENOTYPIC PLASTICITY; RELATIVE INFLUENCE; GENETIC-STRUCTURE; CHANGE IMPACTS; SAMPLING BIAS; MODELS; NORTH	Climate change threatens natural landscapes through shifting distribution and abundance of species and attendant change in the structure and function of ecosystems. However, it remains unclear how climate-mediated variation in species' environmental niche space may lead to large-scale fragmentation of species distributions, altered meta-population dynamics and gene flow, and disrupted ecosystem integrity. Such change may be especially relevant when species distributions are restricted either spatially or to a narrow environmental niche, or when environments are rapidly changing. Here, we use range-wide environmental niche models to posit that climate-mediated range fragmentation aggravates the direct effects of climate change on species in the boreal forest of North America. We show that climate change will directly alter environmental niche suitability for boreal-obligate species of trees, birds and mammals (n = 12), with most species ranges becoming smaller and shifting northward through time. Importantly, species distributions will become increasingly fragmented, as characterized by smaller mean size and greater isolation of environmentally-suitable landscape patches. This loss is especially pronounced along the Ontario-Quebec border, where the boreal forest is narrowest and roughly 78% of suitable niche space could disappear by 2080. Despite the diversity of taxa surveyed, patterns of range fragmentation are remarkably consistent, with our models predicting that spruce grouse (Dendragapus canadensis), boreal chickadee (Poecile hudsonicus), moose (Alces americanus) and caribou (Rangifer tarandus) could have entirely disjunct east-west population segments in North America. These findings reveal potentially dire consequences of climate change on population continuity and species diversity in the boreal forest, highlighting the need to better understand: 1) extent and primary drivers of anticipated climate-mediated range loss and fragmentation; 2) diversity of species to be affected by such change; 3) potential for rapid adaptation in the most strongly-affected areas; and 4) potential for invasion by replacement species.	[Murray, Dennis L.; Wehtje, Morgan; Ferreira, Catarina; Pickles, Rob S. A.] Trent Univ, Dept Biol, Peterborough, ON, Canada; [Peers, Michael J. L.; Majchrzak, Yasmine N.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Ferreira, Catarina] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Pickles, Rob S. A.] Panthera, New York, NY USA; [Row, Jeffrey R.] Univ Waterloo, Environm & Resource Studies, Waterloo, ON, Canada; [Thornton, Daniel H.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA	Trent University; University of Alberta; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Waterloo; Washington State University	Murray, DL (corresponding author), Trent Univ, Dept Biol, Peterborough, ON, Canada.	dennismurray@trentu.ca	Ferreira, Catarina Campos/A-3898-2011	Ferreira, Catarina Campos/0000-0002-5093-0789	Natural Sciences and Engineering Research Council (Canada); Canada Research Chairs program; European Union [PIOF-GA-2013-621571]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs); European Union(European Commission)	This work was supported by grants from the Natural Sciences and Engineering Research Council (Canada) and the Canada Research Chairs program. C.F. is supported by a Marie Curie Outgoing International Fellowship for Career Development (PIOF-GA-2013-621571) within the 7th Framework Programme of the European Union.; We are grateful to the various organizations and museums that provided presence records and digitized maps used in our analyses. We also thank the Integrative Wildlife Conservation lab for discussions on previous versions of this manuscript, and anonymous reviewers for helpful comments. This work was supported by grants from the Natural Sciences and Engineering Research Council (Canada) and the Canada Research Chairs program. C.F. is supported by a Marie Curie Outgoing International Fellowship from the European Union.	Anderson RP, 2012, ANN NY ACAD SCI, V1260, P66, DOI 10.1111/j.1749-6632.2011.06440.x; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Andrello M, 2015, DIVERS DISTRIB, V21, P139, DOI 10.1111/ddi.12250; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Araujo MB, 2014, ECOGRAPHY, V37, P406, DOI 10.1111/j.1600-0587.2013.00643.x; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Cannone N, 2008, ECOL APPL, V18, P637, DOI 10.1890/07-1188.1; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cushman SA, 2012, LANDSCAPE ECOL, V27, P369, DOI 10.1007/s10980-011-9693-0; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feldman RE, 2017, GLOB ECOL CONSERV, V9, P1, DOI 10.1016/j.gecco.2016.10.001; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Gagnon AS, 2005, CLIMATIC CHANGE, V69, P269, DOI 10.1007/s10584-005-1815-8; Gamache I, 2005, J BIOGEOGR, V32, P849, DOI 10.1111/j.1365-2699.2004.01182.x; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; GROISMAN PY, 1994, J CLIMATE, V7, P184, DOI 10.1175/1520-0442(1994)007<0184:VATOTP>2.0.CO;2; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Ipcc, 2014, INT PAN CLIM CHANG 5; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Krebs CJ, 2011, P ROY SOC B-BIOL SCI, V278, P481, DOI 10.1098/rspb.2010.1992; Kupfer JA, 2012, PROG PHYS GEOG, V36, P400, DOI 10.1177/0309133312439594; Lee-Yaw JA, 2016, ECOL LETT, V19, P710, DOI 10.1111/ele.12604; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; McGarigal K., 2012, TECH REP; McGuire JL, 2016, P NATL ACAD SCI USA, V113, P7195, DOI 10.1073/pnas.1602817113; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Milanovich JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012189; Millette KL, 2015, ECOL EVOL, V5, P73, DOI 10.1002/ece3.1325; Murray DL, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)166[1:PNDACI]2.0.CO;2; Murray DL, 2015, BIOL CONSERV, V192, P174, DOI 10.1016/j.biocon.2015.09.017; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Normand S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0479; Otis JA, 2017, DIVERS DISTRIB; Ovaskainen O, 2002, J THEOR BIOL, V215, P95, DOI 10.1006/jtbi.2001.2502; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peers MJL, 2014, GLOBAL CHANGE BIOL, V20, P1126, DOI 10.1111/gcb.12469; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pilliod DS, 2015, ECOL EVOL, V5, P3979, DOI 10.1002/ece3.1634; Price DT, 2013, ENVIRON REV, V21, P322, DOI 10.1139/er-2013-0042; Pyke CR, 2004, FRONT ECOL ENVIRON, V2, P178, DOI 10.1890/1540-9295(2004)002[0178:HLCCCI]2.0.CO;2; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Ralston J, 2013, CONSERV GENET, V14, P543, DOI 10.1007/s10592-012-0418-y; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Row JR, 2014, GLOBAL CHANGE BIOL, V20, P2076, DOI 10.1111/gcb.12526; Ruhland KM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1887; Ruffell J, 2016, OIKOS, V125, P117, DOI 10.1111/oik.01948; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Searcy CA, 2016, AM NAT, V187, P423, DOI 10.1086/685387; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stocks BJ, 1998, CLIMATIC CHANGE, V38, P1, DOI 10.1023/A:1005306001055; Stralberg D, 2015, ECOL APPL, V25, P52, DOI 10.1890/13-2289.1; Stralberg D, 2017, ECOGRAPHY; Strickland D, 2011, OECOLOGIA, V167, P943, DOI 10.1007/s00442-011-2040-y; Sultaire SM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3104; Tape KD, 2016, GLOBAL CHANGE BIOL, V22, P208, DOI 10.1111/gcb.13058; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornton DH, 2011, ECOL APPL, V21, P2324, DOI 10.1890/10-2124.1; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Venier LA, 2014, ENVIRON REV, V22, P457, DOI 10.1139/er-2013-0075; Villard MA, 2014, J APPL ECOL, V51, P309, DOI 10.1111/1365-2664.12190; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Wright AN, 2016, CLIMATIC CHANGE, V134, P579, DOI 10.1007/s10584-015-1552-6; Zhang X, 2011, 5 CAN COUNC RES MIN; Zimova M, 2016, ECOL LETT, V19, P299, DOI 10.1111/ele.12568	91	19	19	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176706	10.1371/journal.pone.0176706	http://dx.doi.org/10.1371/journal.pone.0176706			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505173	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500009
J	von Reyn, CF; Lahey, T; Arbeit, RD; Landry, B; Kailani, L; Adams, LV; Haynes, BC; Mackenzie, T; Wieland-Alter, W; Connor, RI; Tvaroha, S; Hokey, DA; Ginsberg, AM; Waddell, R				von Reyn, C. Fordham; Lahey, Timothy; Arbeit, Robert D.; Landry, Bernard; Kailani, Leway; Adams, Lisa V.; Haynes, Brenda C.; Mackenzie, Todd; Wieland-Alter, Wendy; Connor, Ruth I.; Tvaroha, Sue; Hokey, David A.; Ginsberg, Ann M.; Waddell, Richard			Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901	PLOS ONE			English	Article							HIV-ASSOCIATED TUBERCULOSIS; MYCOBACTERIAL VACCINE; INFECTED ADULTS; PREVENTION	Background Development of a tuberculosis vaccine to boost BCG is a major international health priority. SRL172, an inactivated whole cell booster derived from a non-tuberculous mycobacterium, is the only new vaccine against tuberculosis to have demonstrated efficacy in a Phase 3 trial. In the present study we sought to determine if a three-dose series of DAR-901 manufactured from the SRL172 master cell bank by a new, scalable method was safe and immunogenic. Methods We performed a single site, randomized, double-blind, controlled, Phase 1 dose escalation trial of DAR-901 at Dartmouth-Hitchcock Medical Center in the United States. Healthy adult subjects age 18-65 with prior BCG immunization and a negative interferon-gamma release assay (IGRA) were enrolled in cohorts of 16 subjects and randomized to three injections of DAR-901 (n = 10 per cohort), or saline placebo (n = 3 per cohort), or two injections of saline followed by an injection of BCG (n = 3 per cohort; 1-8 x 10(6) CFU). Three successive cohorts were enrolled representing DAR-901 at 0.1, 0.3, and 1 mg per dose. Randomization was performed centrally and treatments were masked from staff and volunteers. Subsequent open label cohorts of HIV-negative/IGRA-positive subjects (n = 5) and HIV-positive subjects (n = 6) received three doses of 1 mg DAR-901. All subjects received three immunizations at 0, 2 and 4 months administered as 0.1 mL injections over the deltoid muscle alternating between right and left arms. The primary outcomes were safety and immunogenicity. Subjects were followed for 6 months after dose 3 for safety and had phlebotomy performed for safety studies and immune assays before and after each injection. Immune assays using peripheral blood mononuclear cells included cell-mediated IFN-gamma. responses to DAR-901 lysate and to Mycobacterium tuberculosis (MTB) lysate; serum antibody to M. tuberculosis lipoarabinomannan was assayed by ELISA. Results DAR-901 had an acceptable safety profile and was well-tolerated at all dose levels in all treated subjects. No serious adverse events were reported. Median (range) 7-day erythema and induration at the injection site for 1 mg DAR-901 were 10 (4-20) mm and 10 (4-16) mm, respectively, and for BCG, 30 (10-107) mm and 38 (15-55) mm, respectively. Three mild AEs, all headaches, were considered possibly related to DAR-901. No laboratory or vital signs abnormalities were related to immunization. Compared to pre-vaccination responses, three 1 mg doses of DAR-901 induced statistically significant increases in IFN-gamma. response to DAR-901 lysate and MTB lysate, and in antibody responses to M. tuberculosis lipoarabinomannan. Ten subjects who received 1 mg DAR-901 remained IFN-gamma. release assay (IGRA) negative after three doses of vaccine. Conclusions A three-injection series of DAR-901 was well-tolerated, had an acceptable safety profile, and induced cellular and humoral immune responses to mycobacterial antigens. DAR-901 is advancing to efficacy trials.	[von Reyn, C. Fordham; Lahey, Timothy; Kailani, Leway; Adams, Lisa V.; Haynes, Brenda C.; Mackenzie, Todd; Wieland-Alter, Wendy; Connor, Ruth I.; Tvaroha, Sue; Waddell, Richard] Geisel Sch Med Dartmouth, Hanover, NH 03755 USA; [Arbeit, Robert D.] Tufts Univ, Sch Med, Boston, MA USA; [Landry, Bernard; Hokey, David A.; Ginsberg, Ann M.] Aeras, Rockville, MD USA; [von Reyn, C. Fordham] DHMC, Geisel Sch Med, Infect Dis & Int Hlth, Lebanon, NH 03766 USA	Dartmouth College; Tufts University; Dartmouth College	von Reyn, CF (corresponding author), Geisel Sch Med Dartmouth, Hanover, NH 03755 USA.; von Reyn, CF (corresponding author), DHMC, Geisel Sch Med, Infect Dis & Int Hlth, Lebanon, NH 03766 USA.	fvr@dartmouth.edu			Dartmouth College - university grant; Aeras Foundation - supporting grant; Jack and Dorothy Byrne Foundation	Dartmouth College - university grant; Aeras Foundation - supporting grant; Jack and Dorothy Byrne Foundation	Support was provided by Dartmouth College - university grant (no number), Aeras Foundation - supporting grant (no number), and Jack and Dorothy Byrne Foundation (no number).	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; EDWARDS LB, 1973, AM REV RESPIR DIS, V108, P1334; Evans TG, 2016, VACCINE, V34, P2911, DOI 10.1016/j.vaccine.2016.02.079; FDA, 2007, FDA GUID IND TOX GRA; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111; Lahey T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022074; Lahey T, 2010, VACCINE, V28, P7652, DOI 10.1016/j.vaccine.2010.09.041; Medical Research Council, 1963, BRIT MED J, V1, P973; Opie EL, 1939, AM J HYG, V29, P155, DOI 10.1093/oxfordjournals.aje.a118486; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Sakai S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005667; von Reyn CF, 2014, CLIN INFECT DIS, V59, P608, DOI 10.1093/cid/ciu331; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Vuola JM, 2003, AIDS, V17, P2351, DOI 10.1097/00002030-200311070-00010; Waddell RD, 2000, CLIN INFECT DIS, V30, pS309, DOI 10.1086/313880; WEISS DW, 1959, AM REV RESPIR DIS, V80, P676, DOI 10.1164/arrd.1959.80.5.676	21	33	33	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0175215	10.1371/journal.pone.0175215	http://dx.doi.org/10.1371/journal.pone.0175215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498853	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500001
J	Al-Jarallah, A; Oriowo, M				Al-Jarallah, Aishah; Oriowo, Mabayoje			The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis	PLOS ONE			English	Article							PROTEIN-KINASE-C; INFLAMMATORY-BOWEL-DISEASE; SPHINGOSINE 1-PHOSPHATE; ULCERATIVE-COLITIS; CEREBRAL-ARTERIES; DOWN-REGULATION; MOTOR-ACTIVITY; CA2+ CHANNELS; RAT MODEL; MOTILITY	Aim Increased levels of circulating sphingosine-1-phosphate (S1P) have been reported in ulcerative colitis. The objective of this study was to examine the effect of S1P on colonic smooth muscle contractility and how is it affected by colitis. Methods Colonic inflammation was induced by intrarectal administration of trinitrobenzene sulfonic acid. Five days later colon segments were isolated and used for contractility experiments and immunoblotting. Results S1P contracted control and inflamed colon segments and the contraction was significantly greater in inflamed colon segments. S1P-induced contraction was mediated by S1PR1 and S1PR2 in control and S1PR2 in inflamed colon segments. S1PR3 did not play a significant role in S1P-induced contractions in control or inflamed colon. S1PR1, S1PR2 and S1PR3 proteins were expressed in colon segments from both groups. The expression of S1PR1 and S1PR2 was significantly enhanced in control and inflamed colon segments, respectively. S1PR3 levels however were not significantly different between the two groups. Nifedipine significantly reduced S1P-induced contraction in control but not inflamed colon segments. Thapsigargin significantly reduced S1P-induced contraction of the inflamed colon. GF 109203X and Y-27632, alone abolished S1P-induced contraction of the control but not inflamed colon segments. Combination of GF 109203X, Y-27632 and thapsigargin abolished S1P-induced contraction of inflamed colon segments. Conclusion S1P contracted control colon via S1PR1 and S1PR2 and inflamed colon exclusively via S1PR2. Calcium influx (control) or release (inflamed) and calcium sensitization are involved in S1P-induced contraction. Exacerbated response to S1P in colitic colon segments may explain altered colonic motility reported in patients and experimental models of inflammatory bowel disease.	[Al-Jarallah, Aishah] Kuwait Univ, Dept Biochem, Hlth Sci Ctr, Fac Med, Jabreya, Kuwait; [Oriowo, Mabayoje] Kuwait Univ, Dept Pharmacol & Toxicol, Hlth Sci Ctr, Fac Med, Jabreya, Kuwait	Kuwait University; Kuwait University	Al-Jarallah, A (corresponding author), Kuwait Univ, Dept Biochem, Hlth Sci Ctr, Fac Med, Jabreya, Kuwait.	a.jarallah@hsc.edu.kw			Kuwait University [MB01/12]	Kuwait University	This work was supported by the Research Sector, Kuwait University, Grant No. MB01/12. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jarallah A, 2007, MOL CELL BIOCHEM, V298, P169, DOI 10.1007/s11010-006-9363-8; Al-Jarallah A, 2008, EUR J PHARMACOL, V579, P365, DOI 10.1016/j.ejphar.2007.10.069; Al-Saffar A, 2001, SCAND J GASTROENTERO, V36, P485; Auli M, 2008, AUTON NEUROSCI-BASIC, V141, P10, DOI 10.1016/j.autneu.2008.04.005; Aydin M, 2010, BJU INT, V106, P562, DOI 10.1111/j.1464-410X.2009.09156.x; Bassotti G, 2004, INT J COLORECTAL DIS, V19, P493, DOI 10.1007/s00384-004-0604-6; Bianca RDD, 2006, J PHARMACOL EXP THER, V316, P703, DOI 10.1124/jpet.105.093419; Cao WB, 2004, AM J PHYSIOL-GASTR L, V286, pG833, DOI 10.1152/ajpgi.00414.2003; Cheon GJ, 2012, KOREAN J PHYSIOL PHA, V16, P437, DOI 10.4196/kjpp.2012.16.6.437; Chiba Y, 2010, PHARMACOL RES, V62, P357, DOI 10.1016/j.phrs.2010.05.005; Choi SK, 2009, CARDIOVASC RES, V82, P324, DOI 10.1093/cvr/cvp054; Coulie B, 2001, ALIMENT PHARM THERAP, V15, P653, DOI 10.1046/j.1365-2036.2001.00959.x; Coussin F, 2002, CIRC RES, V91, P151, DOI 10.1161/01.RES.0000028150.51130.36; Hu W, 2006, BIOCHEM BIOPH RES CO, V343, P1038, DOI 10.1016/j.bbrc.2006.03.079; Hu WH, 2006, AM J PHYSIOL-GASTR L, V291, pG605, DOI 10.1152/ajpgi.00147.2006; Ikeda H, 2004, BIOCHEM BIOPH RES CO, V320, P754, DOI 10.1016/j.bbrc.2004.04.207; Jolly PS, 2002, MOL IMMUNOL, V38, P1239, DOI 10.1016/S0161-5890(02)00070-6; Jouet P, 1995, AM J PHYSIOL-GASTR L, V269, pG913, DOI 10.1152/ajpgi.1995.269.6.G913; Kamiya T, 2014, EXP EYE RES, V121, P94, DOI 10.1016/j.exer.2014.01.011; Kandabashi T, 2003, ARTERIOSCL THROM VAS, V23, P2209, DOI 10.1161/01.ATV.0000104010.87348.26; Kegeyama Y, 2012, HEPATOLOGY; Kendig DM, 2013, EUR J PHARMACOL, V720, P355, DOI 10.1016/j.ejphar.2013.10.004; Khan I, 1999, DIGEST DIS SCI, V44, P1525, DOI 10.1023/A:1026694406446; Kim YS, 2007, ARCH PHARM RES, V30, P1608, DOI 10.1007/BF02977331; Kinoshita K, 2003, AM J PHYSIOL-GASTR L, V285, pG483, DOI 10.1152/ajpgi.00038.2003; Kume H, 2007, J PHARMACOL EXP THER, V320, P766, DOI 10.1124/jpet.106.110718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leiber D, 2007, AM J PHYSIOL-CELL PH, V292, pC240, DOI 10.1152/ajpcell.00023.2006; Liu XR, 2001, GASTROENTEROLOGY, V120, P480, DOI 10.1053/gast.2001.21167; LOENINGBAUCKE V, 1989, AM J GASTROENTEROL, V84, P892; Lundberg S, 2006, ACTA PHYSIOL, V187, P489, DOI 10.1111/j.1748-1716.2006.01576.x; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mair KM, 2010, BRIT J PHARMACOL, V161, P176, DOI 10.1111/j.1476-5381.2010.00878.x; Makino Y, 2012, ALLERGOL INT, V61, P311, DOI 10.2332/allergolint.11-OA-0350; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Nakayama K, 2003, BIORHEOLOGY, V40, P307; Ohama T, 2008, J GASTROENTEROL, V43, P858, DOI 10.1007/s00535-008-2241-2; Ohama Takashi, 2007, Journal of Smooth Muscle Research, V43, P43, DOI 10.1540/jsmr.43.43; Ohama T, 2007, AM J PHYSIOL-GASTR L, V292, pG1429, DOI 10.1152/ajpgi.00315.2006; Oriowo MA, 2004, EUR J PHARMACOL, V506, P157, DOI 10.1016/j.ejphar.2004.11.008; Pfaff M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-48; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Rosenfeldt HM, 2003, FASEB J, V17, P1789, DOI 10.1096/fj.02-0836com; Ross GR, 2007, J PHARMACOL EXP THER, V322, P948, DOI 10.1124/jpet.107.123075; Roviezzo F, 2007, AM J RESP CELL MOL, V36, P757, DOI 10.1165/rcmb.2006-0383OC; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Salomone S, 2003, EUR J PHARMACOL, V469, P125, DOI 10.1016/S0014-2999(03)01731-X; Salomone S, 2010, PHARMACOL RES, V62, P465, DOI 10.1016/j.phrs.2010.09.002; SETHI AK, 1991, GASTROENTEROLOGY, V100, P954, DOI 10.1016/0016-5085(91)90269-Q; Shi XZ, 2000, AM J PHYSIOL-GASTR L, V278, pG234, DOI 10.1152/ajpgi.2000.278.2.G234; SNAPE W J JR, 1991, Keio Journal of Medicine, V40, P6; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Song HJ, 2006, MOL CELLS, V21, P42; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Wang TC, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00083; Wang TC, 2009, AM J PHYSIOL-RENAL, V297, pF1534, DOI 10.1152/ajprenal.00095.2009; Watterson KR, 2007, FASEB J, V21, P2818, DOI 10.1096/fj.06-7326com; Zhang YZ, 2014, WORLD J GASTROENTERO, V20, P91, DOI 10.3748/wjg.v20.i1.91; Zhou HP, 2004, AM J PHYSIOL-CELL PH, V286, pC1130, DOI 10.1152/ajpcell.00429.2003	60	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0170792	10.1371/journal.pone.0170792	http://dx.doi.org/10.1371/journal.pone.0170792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493876	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300002
J	Niskanen, J; Dillard, K; Arumilli, M; Salmela, E; Anttila, M; Lohi, H; Hytonen, MK				Niskanen, Julia; Dillard, Kati; Arumilli, Meharji; Salmela, Elina; Anttila, Marjukka; Lohi, Hannes; Hytonen, Marjo K.			Nonsense variant in COL7A1 causes recessive dystrophic epidermolysis bullosa in Central Asian Shepherd dogs	PLOS ONE			English	Article							VII COLLAGEN; GENE-THERAPY; ANIMAL-MODEL; SKIN; TRANSPLANTATION; MUTATIONS	A rare hereditary mechanobullous disorder called epidermolysis bullosa (EB) causes blistering in the skin and the mucosal membranes. To date, nineteen EB-related genes have been discovered in human and other species. We describe here a novel EB variant in dogs. Two newborn littermates of Central Asian Shepherd dogs with severe signs of skin blistering were brought to a veterinary clinic and euthanized due to poor prognosis. In post-mortem examination, the puppies were shown to have findings in the skin and the mucosal membranes characteristic of EB. A whole-genome sequencing of one of the affected puppies was performed to identify the genetic cause. The resequencing data were filtered under a recessive model against variants from 31 other dog genomes, revealing a homozygous case-specific nonsense variant in one of the known EB-causing genes, COL7A1 (c.4579C> T, p.R1527*). The variant results in a premature stop codon and likely absence of the functional protein in the basement membrane of the skin in the affected dogs. This was confirmed by immunohistochemistry using a COL7A1 antibody. Additional screening of the variant indicated full penetrance and breed specificity at similar to 28% carrier frequency. In summary, this study reveals a novel COL7A1 variant causing recessive dystrophic EB and provides a genetic test for the eradication of the disease from the breed.	[Niskanen, Julia; Arumilli, Meharji; Salmela, Elina; Lohi, Hannes; Hytonen, Marjo K.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Niskanen, Julia; Arumilli, Meharji; Salmela, Elina; Lohi, Hannes; Hytonen, Marjo K.] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Niskanen, Julia; Arumilli, Meharji; Salmela, Elina; Lohi, Hannes; Hytonen, Marjo K.] Folkhalsan Inst Genet, Helsinki, Finland; [Dillard, Kati; Anttila, Marjukka] Finnish Food Safety Author, Pathol Unit, Helsinki, Finland; [Salmela, Elina] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki; Finnish Food Authority; University of Helsinki	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.; Lohi, H (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland.; Lohi, H (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.	Hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011; Niskanen, Julia/AAH-7917-2020; Niskanen, Julia/U-7837-2017	Lohi, Hannes/0000-0003-1087-5532; Niskanen, Julia/0000-0002-2871-6890; Niskanen, Julia/0000-0002-2871-6890; Salmela, Elina/0000-0003-1326-4462; Arumilli, Meharji/0000-0003-4072-0996; Hytonen, Marjo/0000-0003-1976-5874	Academy of Finland [1268091]; Jane and Aatos Erkko Foundation; Biocentrum Helsinki; Orion Research Foundation; Morris Animal Foundation [D13CA-403]; Jenny and Antti Wihuri Foundation	Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; Biocentrum Helsinki; Orion Research Foundation; Morris Animal Foundation; Jenny and Antti Wihuri Foundation	This work was supported by the Academy of Finland, grant number 1268091 (http://www.aka.fi/) (HL); the Jane and Aatos Erkko Foundation (http://jaes.fi/) (HL); Biocentrum Helsinki (http://www.helsinki.fi/biocentrum/) (HL); the Orion Research Foundation (http://www.orion.fi/en/rd) (HL); the Morris Animal Foundation-D13CA-403 (http://www.morrisanimalfoundation.org) (MKH); and the Jenny and Antti Wihuri Foundation (http://wihurinrahasto.fi/) (ES)	Baldeschi C, 2003, HUM MOL GENET, V12, P1897, DOI 10.1093/hmg/ddg200; Capt A, 2005, J INVEST DERMATOL, V124, P530, DOI 10.1111/j.0022-202X.2004.23584.x; Conget P, 2010, CYTOTHERAPY, V12, P429, DOI 10.3109/14653241003587637; Dang NN, 2008, EXP DERMATOL, V17, P553, DOI 10.1111/j.1600-0625.2008.00723.x; Fine JD, 2008, J PEDIATR GASTR NUTR, V46, P147, DOI 10.1097/MPG.0b013e31812f5667; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Fine JD, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-12; Gache Y, 2011, J INVEST DERMATOL, V131, P2069, DOI 10.1038/jid.2011.172; Hytonen MK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006037; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; Lin ZM, 2016, NAT GENET, V48, P1508, DOI 10.1038/ng.3701; Magnol JP, 2005, B ACAD NAT MED PARIS, V189, P107, DOI 10.1016/S0001-4079(19)33609-X; Mauldin EA, 2017, VET DERMATOL, V28, P10, DOI 10.1111/vde.12394; Medeiros GX, 2015, VET DERMATOL, V26, P3, DOI 10.1111/vde.12176; Niskanen J, 2017, J OPEN SOURCE SOFTW, V2; Olivry T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032072; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Palazzi X, 2000, J INVEST DERMATOL, V115, P135, DOI 10.1046/j.1523-1747.2000.00031-5.x; Siprashvili Z, 2010, HUM GENE THER, V21, P1299, DOI 10.1089/hum.2010.023; Uitto J, 2017, MATRIX BIOL; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Woodley DT, 2013, J INVEST DERMATOL, V133, P1910, DOI 10.1038/jid.2013.10; Woodley DT, 2004, NAT MED, V10, P693, DOI 10.1038/nm1063	24	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177527	10.1371/journal.pone.0177527	http://dx.doi.org/10.1371/journal.pone.0177527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493971	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300129
J	Petushkova, NA; Zgoda, VG; Pyatnitskiy, MA; Larina, OV; Teryaeva, NB; Potapov, AA; Lisitsa, AV				Petushkova, Natalia A.; Zgoda, Victor G.; Pyatnitskiy, Mikhail A.; Larina, Olesya V.; Teryaeva, Nadezhda B.; Potapov, Alexander A.; Lisitsa, Andrey V.			Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROTEIN-PHOSPHORYLATION; DATABASE SEARCH; STRATEGY; IDENTIFICATION; ACETYLATION; CANCER; CELLS; SERUM	Liquid chromatography-tandem mass spectrometry was used to analyze plasma proteins of volunteers (control) and patients with glioblastoma multiform (GBM). A database search was pre-set with a variable post-translational modification (PTM): phosphorylation, acetylation or ubiquitination. There were no significant differences between the control and the GBM groups regarding the number of protein identifications, sequence coverage or number of PTMs. However, in GBM plasma, we unambiguously observed a decreased fraction in post-translationally modified peptides identified with high quality. The disease-specific PTM patterns were extracted and mapped to the set of FDA-approved plasma protein markers. Decreases of 46% and 24% in the number of acetylated and ubiquitinated peptides, respectively, were observed in the GBM samples. Significance of capturing disease-associated patterns of protein modifications was envisaged.	[Petushkova, Natalia A.; Zgoda, Victor G.; Pyatnitskiy, Mikhail A.; Larina, Olesya V.; Lisitsa, Andrey V.] VN Orekhovich Res Inst Biomed Chem, Moscow, Russia; [Teryaeva, Nadezhda B.; Potapov, Alexander A.] NN Burdenko Res Inst Neurosurg, Moscow, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery	Petushkova, NA (corresponding author), VN Orekhovich Res Inst Biomed Chem, Moscow, Russia.	cyp450@mail.ru	Лисица, Андрей/ABD-2934-2020; Zgoda, Victor G/F-1791-2017; Petushkova, Natalia/E-9951-2017	Zgoda, Victor G/0000-0002-4532-4274; Petushkova, Natalia/0000-0002-4101-4607; Potapov, Alexander/0000-0001-8343-3511	RSF [16-44-03007]	RSF(Russian Science Foundation (RSF))	Mass spectrometric measurements and bioinformatics processing of the results were supported by the RSF grant No. 16-44-03007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Pavel Pogodin for his contribution to the statistical analysis. Mass spectrometric measurements and bioinformatics processing of the results were supported by the RSF grant No. 16-44-03007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Bonilla LE, 2008, BIOTECHNIQUES, V44, P671, DOI 10.2144/000112800; Cappadona S, 2012, AMINO ACIDS, V43, P1087, DOI 10.1007/s00726-012-1289-8; Cesnik AJ, 2016, J PROTEOME RES, V15, P800, DOI 10.1021/acs.jproteome.5b00817; Chick JM, 2015, NAT BIOTECHNOL, V33, P743, DOI 10.1038/nbt.3267; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Froelich JM, 2008, PROTEOMICS, V8, P1334, DOI 10.1002/pmic.200700792; Geyer PE, 2016, CELL SYST, V2, P185, DOI 10.1016/j.cels.2016.02.015; Han S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1125-0; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Kalvik TV, 2013, ONCOGENE, V32, P269, DOI 10.1038/onc.2012.82; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Langton SD, 2002, INT J FOOD MICROBIOL, V79, P175, DOI 10.1016/S0168-1605(02)00107-1; Lee P, 2015, ANTICANCER RES, V35, P615; Matsuura H, 1985, NEUROL NEUROSURG PSY, V48, P835; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Melo-Braga MN, 2015, METHODS MOL BIOL, V1295, P275, DOI 10.1007/978-1-4939-2550-6_21; Mughal AA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0432-z; Narushima Y, 2016, MOL CELL PROTEOMICS, V15, P1017, DOI 10.1074/mcp.M115.049999; Pan SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11066; Rodchenkova M., 2013, ANALITIKA, V3, P40; Ryslava H, 2013, J PROTEOMICS, V92, P80, DOI 10.1016/j.jprot.2013.03.025; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shortreed MR, 2015, J PROTEOME RES, V14, P4714, DOI 10.1021/acs.jproteome.5b00599; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Walker J M, 1994, Methods Mol Biol, V32, P5; Wu SL, 2007, J PROTEOME RES, V6, P4230, DOI 10.1021/pr070313u; Zhao YM, 2009, PROTEOMICS, V9, P4632, DOI 10.1002/pmic.200900398	33	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177427	10.1371/journal.pone.0177427	http://dx.doi.org/10.1371/journal.pone.0177427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493947	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300106
J	Raviv, B; Granot, G; Chalifa-Caspi, V; Grafi, G				Raviv, Buzi; Granot, Gila; Chalifa-Caspi, Vered; Grafi, Gideon			The dead, hardened floral bracts of dispersal units of wild wheat function as storage for active hydrolases and in enhancing seedling vigor	PLOS ONE			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; LATERAL ROOT DEVELOPMENT; EMMER WHEAT; DNA; DOMESTICATION; ENDONUCLEASES; EVOLUTION; NITRATE; PLANT; DEFICIENCY	It is commonly assumed that the dead, hardened floral bracts of the dispersal unit of grasses have been evolved to protect seeds from predation and / or assist in fruit/caryopsis dispersal. While these structures have important agronomical and economical implications, their adaptive value has not been fully explored. We investigated the hypothesis that the maternally derived hardened floral bracts have been evolved not just as a means for caryopsis protection and dispersal, but also as storage for substances that might affect seed germination and seedling vigor. Dead glumes as well as lemmas and paleas of wild emmer wheat (Triticum turgidum var dicoccoides) were found to store and release upon hydration active hydrolases including nucleases and chitinases. High nuclease activity was released upon hydration from glumes derived from wild strains of wheat including Triticum urartu and wild emmer wheat, while very low nuclease activity was detected in glumes derived from domesticated, free- threshing wheat cultivars (e.g., durum wheat). Germination from the intact dispersal unit of wild emmer wheat was delayed, but post germination growth was better than those of separated caryopses. Most notable was a significant increase in lateral root production on seedlings germinated from the intact dispersal unit. Proteome analysis of wild emmer wheat glumes revealed many proteins stored and released upon hydration including S1-type nucleases, peptidases, antifungal hydrolases such as chitinases and beta-1,3-glucanase as well as pectin acetylesterase, a protein involved in cell wall degradation and remodeling. Also, reactive oxygen species (ROS)-detoxifying enzymes such as superoxide dismutase and ascorbate peroxidase were overrepresented in dead glumes of wild emmer wheat. Thus our study highlighted previously unknown features of the dispersal unit in wild wheat in which the dead, hardened floral bracts enclosing the caryopsis store active hydrolases and nutritional elements and probably growth promoting substances that facilitate seed longevity and germination and increase seedling vigor.	[Raviv, Buzi; Granot, Gila; Grafi, Gideon] Ben Gurion Univ Negev, Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel; [Chalifa-Caspi, Vered] Ben Gurion Univ Negev, Natl Inst Biotechnol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Grafi, G (corresponding author), Ben Gurion Univ Negev, Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel.	ggrafi@bgu.ac.il		Chalifa-Caspi, Vered/0000-0001-6030-5816	Harbour Foundation; Margolin foundation	Harbour Foundation; Margolin foundation	This work was supported by the Harbour Foundation to B.R., and the Margolin foundation to G. Grafi.; We thank Z. Peleg for providing dispersal units of wild and domesticated wheat lines. We thank the Harbour Foundation for supporting B.R. research. The work was supported in part by the Margolin foundation to G. Grafi.	Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Balasubramanian V, 2012, BIOTECHNOL LETT, V34, P1983, DOI 10.1007/s10529-012-1012-6; BEARD P, 1973, J VIROL, V12, P1303, DOI 10.1128/JVI.12.6.1303-1313.1973; BENHAM CJ, 1979, P NATL ACAD SCI USA, V76, P3870, DOI 10.1073/pnas.76.8.3870; Bertini L, 2009, FEBS LETT, V583, P2865, DOI 10.1016/j.febslet.2009.07.045; Bhatt I, 2011, BIOTECHNOL ADV, V29, P850, DOI 10.1016/j.biotechadv.2011.07.002; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; Booth D. T., 1990, Journal of Seed Technology, V14, P61; BOOTH DT, 1983, J RANGE MANAGE, V36, P387, DOI 10.2307/3898495; BOOTH DT, 1984, J RANGE MANAGE, V37, P222, DOI 10.2307/3899141; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Cao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046944; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Ceasar SA, 2012, BIOTECHNOL LETT, V34, P995, DOI 10.1007/s10529-012-0871-1; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Elbaum R, 2008, J STRUCT BIOL, V164, P101, DOI 10.1016/j.jsb.2008.06.008; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; Eriksson O, 2008, INT J PLANT SCI, V169, P863, DOI 10.1086/589888; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Galiana E, 1997, PLANT PHYSIOL, V115, P1557, DOI 10.1104/pp.115.4.1557; Gartemann KH, 2003, J BIOTECHNOL, V106, P179, DOI 10.1016/j.jbiotec.2003.07.011; Grafi G, 1995, PLANT MOL BIOL, V29, P703, DOI 10.1007/BF00041161; Granot G, 2015, BBA-GENE REGUL MECH, V1849, P239, DOI 10.1016/j.bbagrm.2014.12.003; Hugot K, 2002, MOL PLANT MICROBE IN, V15, P243, DOI 10.1094/MPMI.2002.15.3.243; Ko CY, 2012, J AGR FOOD CHEM, V60, P5169, DOI 10.1021/jf300945c; Kohli P., 2015, J BIOPROCESSING BIOT, V5, P1, DOI DOI 10.4172/2155-9821.1000227; Kumar SPJ, 2015, ANN BOT-LONDON, V116, P663, DOI 10.1093/aob/mcv098; Lu JJ, 2015, SEED SCI RES, V25, P276, DOI 10.1017/S0960258515000215; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Pulido P, 2009, PLANT J, V57, P132, DOI 10.1111/j.1365-313X.2008.03675.x; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; RUDALL PJ, 2005, ECDEIOCOLEACEAE AM J, V92, P1432, DOI DOI 10.3732/AJB.92.9.1432; Sharma N., 2011, Asian Journal of Biochemistry, V6, P29, DOI 10.3923/ajb.2011.29.37; Simpson DJ, 2003, J CEREAL SCI, V37, P111, DOI 10.1006/jcrs.2002.0488; Song WJ, 2015, PLANT SOIL, V396, P163, DOI 10.1007/s11104-015-2579-1; Sugiyama M, 2000, PLANT MOL BIOL, V44, P387, DOI 10.1023/A:1026504911786; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; TRUDEL J, 1989, ANAL BIOCHEM, V178, P362, DOI 10.1016/0003-2697(89)90653-2; Vercauteren I, 2002, MOL PLANT MICROBE IN, V15, P404, DOI 10.1094/MPMI.2002.15.4.404; Wilkes H.G., 1967, TEOSINTE CLOSEST REL; Wurzburger J., 1969, BIOSS NEW PHYTOL, V68, P337, DOI DOI 10.1111/J.1469-8137.1969.TB06445.X; Zhang HM, 2000, J EXP BOT, V51, P51, DOI 10.1093/jexbot/51.342.51; Zhu JM, 2005, PLANT SOIL, V270, P299, DOI 10.1007/s11104-004-1697-y	48	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177537	10.1371/journal.pone.0177537	http://dx.doi.org/10.1371/journal.pone.0177537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493968	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300132
J	Rosholm, M; Mikkelsen, MB; Gumede, K				Rosholm, Michael; Mikkelsen, Mai Bjornskov; Gumede, Kamilla			Your move: The effect of chess on mathematics test scores	PLOS ONE			English	Article							ACHIEVEMENT EMOTIONS; ACADEMIC-PERFORMANCE; FAR TRANSFER; HIGH-SCHOOL; METAANALYSIS; INTELLIGENCE; OUTCOMES; FAILURE; PLAYERS	We analyse the effect of substituting a weekly mathematics lesson in primary school grades 1-3 with a lesson in mathematics based on chess instruction. We use data from the City of Aarhus in Denmark, combining test score data with a comprehensive data set obtained from administrative registers. We use two different methodological approaches to identify and estimate treatment effects and we tend to find positive effects, indicating that knowledge acquired through chess play can be transferred to the domain of mathematics. We also find larger impacts for unhappy children and children who are bored in school, perhaps because chess instruction facilitates learning by providing an alternative approach to mathematics for these children. The results are encouraging and suggest that chess may be an important and effective tool for improving mathematical capacity in young students.	[Rosholm, Michael; Gumede, Kamilla] Aarhus Univ, TrygFondens Ctr Child Res, Aarhus, Denmark; [Rosholm, Michael] IZA, Bonn, Germany; [Mikkelsen, Mai Bjornskov] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark	Aarhus University; IZA Institute Labor Economics; Aarhus University	Rosholm, M (corresponding author), Aarhus Univ, TrygFondens Ctr Child Res, Aarhus, Denmark.; Rosholm, M (corresponding author), IZA, Bonn, Germany.	rom@econ.au.dk		Mikkelsen, Mai Bjornskov/0000-0002-9730-913X; Rosholm, Michael/0000-0001-8360-2127	TrygFonden	TrygFonden	TrygFonden (www.trygfonden.dk) has financed TrygFonden's Centre for Child Research, which pays the wage of one co-author (Gumede), and Rosholm was the PI on the original centre application and head of centre until 2016.	Ahmed W, 2013, J EDUC PSYCHOL, V105, P150, DOI 10.1037/a0030160; Alexander P. A., 1999, INT J EDUC RES, V31, P561, DOI DOI 10.1016/S0883-0355(99)00024-5; Almlund M., 2011, HDB EC ED; Andersen S. C, 2016, POLITICA IN PRESS; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Bart WM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00762; Bench SW, 2013, BEHAV SCI-BASEL, V3, P459, DOI 10.3390/bs3030459; Berkman R.M., 2004, MATH TEACHING MIDDLE, V9, P246, DOI [https://doi.org/10.5951/MTMS.9.5.0246, DOI 10.5951/MTMS.9.5.0246]; Bherer L, 2005, PSYCHOL AGING, V20, P695, DOI 10.1037/0882-7974.20.4.695; Bilalic M, 2007, INTELLIGENCE, V35, P457, DOI 10.1016/j.intell.2006.09.005; Blair C, 2008, DEV PSYCHOPATHOL, V20, P899, DOI 10.1017/S0954579408000436; Bransford J. D, 1999, PEOPLE LEARN BRAIN M; Campitelli G, 2008, LEARN INDIVID DIFFER, V18, P446, DOI 10.1016/j.lindif.2007.11.006; Caprara GV, 2011, BRIT J EDUC PSYCHOL, V81, P78, DOI 10.1348/2044-8279.002004; Casillas A, 2012, J EDUC PSYCHOL, V104, P407, DOI 10.1037/a0027180; Cook P. J., 2014, 19862 NBER; Costa A. L., 2009, DISPOSITIONS REFRAMI; Csikszentmihalyi M., 2014, APPL FLOW HUMAN DEV, DOI [10.1007/978-94-017-9094-9, DOI 10.1007/978-94-017-9094-9]; Cunha F, 2007, AM ECON REV, V97, P31, DOI 10.1257/aer.97.2.31; DAWID AP, 1979, J ROY STAT SOC B MET, V41, P1; DETTERMAN DK, 1993, TRANSFER TRIAL INTEL; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Eren A., 2016, J EDUC RES, P1; ERICSSON KA, 1994, AM PSYCHOL, V49, P725, DOI 10.1037/0003-066X.49.8.725; FRYDMAN M, 1992, BRIT J PSYCHOL, V83, P233, DOI 10.1111/j.2044-8295.1992.tb02437.x; Gobet F., 2006, CHESS ED SELECTED ES, P124; Goetz T., 2003, LEARNING EMOTIONS IN; Grabner RH, 2007, ACTA PSYCHOL, V124, P398, DOI 10.1016/j.actpsy.2006.07.008; Hayes J. R., 1977, IND S COGN POT MAR; Heckman J, 1998, ECONOMETRICA, V66, P1017, DOI 10.2307/2999630; HOLYOAK KJ, 1987, MEM COGNITION, V15, P332, DOI 10.3758/BF03197035; Hong S, 2007, INT J SPEC EDUC, V22, P89; Isikgoz E., 2016, ANAL MATH SUCCESS SE, V13, p1689 ; Joensen JS, 2009, J HUM RESOUR, V44, P171, DOI 10.3368/jhr.44.1.171; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kwon K., 2016, SCH PSYCHOL Q; Lichtenfeld S, 2012, LEARN INDIVID DIFFER, V22, P190, DOI 10.1016/j.lindif.2011.04.009; Liew J, 2012, CHILD DEV PERSPECT, V6, P105, DOI 10.1111/j.1750-8606.2011.00196.x; Lipsey M. W., 2012, TRANSLATING STAT REP; McKeough A., 2013, TEACHING TRANSFER FO; Mega C, 2014, J EDUC PSYCHOL, V106, P121, DOI 10.1037/a0033546; Minear M, 2008, MEM COGNITION, V36, P1470, DOI 10.3758/MC.336.8.1470; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; OECD, 2014, PISA, DOI 10.1787/9789264208780-en; Pekrun R, 2002, EDUC PSYCHOL-US, V37, P91, DOI 10.1207/S15326985EP3702_4; Pekrun R., 2002, COPING M GOALS VISIO, P149, DOI DOI 10.1093/MED:PSYCH/9780198508144.003.0008; Pekrun R, 2014, EDUC PSYCHOL HANDB, P120; Pi Y., 2008, THEORY COGNITIVE PAT; Poropat AE, 2009, PSYCHOL BULL, V135, P322, DOI 10.1037/a0014996; Sala G, 2016, EDUC RES REV-NETH, V18, P46, DOI 10.1016/j.edurev.2016.02.002; Singley M.K., 1989, TRANSFER COGNITIVE S; Trinchero R, 2016, EURASIA J MATH SCI T, V12, P655; Tze VMC, 2016, EDUC PSYCHOL REV, V28, P119, DOI 10.1007/s10648-015-9301-y; WAGNER MM, 1995, FUTURE CHILD, V5, P90, DOI 10.2307/1602359	54	12	12	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177257	10.1371/journal.pone.0177257	http://dx.doi.org/10.1371/journal.pone.0177257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28494023	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300078
J	Simion, V; Sobilo, J; Clemoncon, R; Natkunarajah, S; Ezzine, S; Abdallah, F; Lerondel, S; Pichon, C; Baril, P				Simion, Viorel; Sobilo, Julien; Clemoncon, Rudy; Natkunarajah, Sharuja; Ezzine, Safia; Abdallah, Florence; Lerondel, Stephanie; Pichon, Chantal; Baril, Patrick			Positive radionuclide imaging of miRNA expression using RILES and the human sodium iodide symporter as reporter gene is feasible and supports a protective role of miRNA-23a in response to muscular atrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; THYROID-CANCER; NA+/I-SYMPORTER; PROTEIN; THERAPY; SYSTEM; INVOLVEMENT; TRANSPORT; MICRORNAS; MECHANISM	MicroRNAs (miRNAs) are key players in many biological processes and are considered as an emerging class of pharmacology drugs for diagnosis and therapy. However to fully exploit the therapeutic potential of miRNAs, it is becoming crucial to monitor their expression pattern using medical imaging modalities. Recently, we developed a method called RILES, for RNAi-Inducible Luciferase Expression System that relies on an engineered regulatable expression system to switch-ON the expression of the luciferase gene when a miRNA of interest is expressed in cells. Here we investigated whether replacing the luciferase reporter gene with the human sodium iodide symporter (hNIS) reporter gene will be also suited to monitor the expression of miRNAs in a clinical setting context. We provide evidence that radionuclide imaging of miRNA expression using hNIS is feasible although it is not as robust as when the luciferase reporter gene is used. However, under appropriate conditions, we monitored the expression of several miRNAs in cells, in the liver and in the tibialis anterior muscle of mice undergoing muscular atrophy. We demonstrated that radiotracer accumulation in transfected cells correlated with the induction of hNIS and with the expression of miRNAs detected by real time PCR. We established the kinetic of miRNA-23a expression in mice and demonstrated that this miRNA follows a biphasic expression pattern characterized by a loss of expression at a late time point of muscular atrophy. At autopsy, we found an opposite expression pattern between miRNA-23a and one of the main transcriptional target of this miRNA, APAF-1, and as downstream target, Caspase 9. Our results report the first positive monitoring of endogenously expressed miRNAs in a nuclear medicine imaging context and support the development of additional work to establish the potential therapeutic value of miRNA-23 to prevent the damaging effects of muscular atrophy.	[Simion, Viorel; Clemoncon, Rudy; Ezzine, Safia; Abdallah, Florence; Pichon, Chantal; Baril, Patrick] CNRS, UPR4301, Ctr Biophys Mol, Orleans, France; [Sobilo, Julien; Natkunarajah, Sharuja; Lerondel, Stephanie] CNRS Orleans, PHENOMIN TAAM UPS44, CIPA, Orleans, France; [Pichon, Chantal; Baril, Patrick] Univ Orleans, Coll Sci & Tech, Orleans, France; [Ezzine, Safia] Synthelis, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans	Baril, P (corresponding author), CNRS, UPR4301, Ctr Biophys Mol, Orleans, France.; Baril, P (corresponding author), Univ Orleans, Coll Sci & Tech, Orleans, France.	patrick.baril@cnrs.fr	Simion, Viorel/M-3355-2019	Simion, Viorel/0000-0002-2683-2871; PICHON, Chantal/0000-0003-3161-3937; BARIL, Patrick/0000-0001-8290-9899	French National Cancer Institute (INCA) [2014-168]; Marengo INCA funding	French National Cancer Institute (INCA)(Institut National du Cancer (INCA) France); Marengo INCA funding	This work was supported by the French National Cancer Institute (INCA, No 2014-168, MARENGO project). Viorel Simion is supported by a postdoctoral fellowship from the Marengo INCA funding.	Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Arano Y, 2002, ANN NUCL MED, V16, P79, DOI 10.1007/BF02993710; Aumiller JJ, 2012, GLYCOBIOLOGY, V22, P417, DOI 10.1093/glycob/cwr160; Baril P, 2016, METHODS MOL BIOL, V1372, P193, DOI 10.1007/978-1-4939-3148-4_15; Baril P, 2010, BRIT J PHARMACOL, V159, P761, DOI 10.1111/j.1476-5381.2009.00412.x; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Billiet L, 2012, BIOMATERIALS, V33, P2980, DOI 10.1016/j.biomaterials.2011.12.027; Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Castro MR, 2001, J CLIN ENDOCR METAB, V86, P5627, DOI 10.1210/jc.86.11.5627; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Chisholm EJ, 2009, CANCER RES, V69, P2655, DOI 10.1158/0008-5472.CAN-08-2657; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; Chung T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142984; Dayem M, 2008, J ENDOCRINOL, V197, P95, DOI 10.1677/JOE-07-0455; DEUTSCH E, 1987, J NUCL MED, V28, P1491; Dobrowolny G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-3; Dohan O, 2006, MOL ENDOCRINOL, V20, P1121, DOI 10.1210/me.2005-0376; Ezzine S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt797; Galanis E, 2015, CANCER RES, V75, P22, DOI 10.1158/0008-5472.CAN-14-2533; Grohmann M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-301; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Jo MH, 2013, BIOMATERIALS, V34, P4803, DOI 10.1016/j.biomaterials.2013.03.032; Jung KH, 2008, J NUCL MED, V49, P1966, DOI 10.2967/jnumed.108.055764; Kim YH, 2015, THERANOSTICS, V5, P86, DOI 10.7150/thno.10062; Ko HY, 2009, NAT PROTOC, V4, P1663, DOI 10.1038/nprot.2009.119; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Le Guiner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102538; Liu N, 2015, DIGEST DIS SCI, V60, P2000, DOI 10.1007/s10620-015-3588-x; Ma GD, 2015, INT J BIOL SCI, V11, P345, DOI 10.7150/ijbs.10921; Merron A, 2010, EUR J NUCL MED MOL I, V37, P1377, DOI 10.1007/s00259-009-1379-3; Miller A, 2016, EXPERT OPIN BIOL TH, V16, P15, DOI 10.1517/14712598.2016.1100162; Mitrofanova E, 2006, GENE THER, V13, P1052, DOI 10.1038/sj.gt.3302758; Mullick A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-43; Neumann S, 2004, THYROID, V14, P99, DOI 10.1089/105072504322880337; Nicola JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4948; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Portulano C, 2014, ENDOCR REV, V35, P106, DOI 10.1210/er.2012-1036; Pugliese M, 2013, THYROID, V23, P838, DOI 10.1089/thy.2012.0359; Rajecki M, 2011, MOL THER, V19, P629, DOI 10.1038/mt.2011.31; Russell SJ, 2014, MAYO CLIN PROC, V89, P926, DOI 10.1016/j.mayocp.2014.04.003; Sekar TV, 2013, THERANOSTICS, V3, P953, DOI 10.7150/thno.4928; Singh TD, 2015, J NUCL MED, V56, P1690, DOI 10.2967/jnumed.115.160366; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; Tonacchera M, 2002, J CLIN ENDOCR METAB, V87, P352, DOI 10.1210/jc.87.1.352; Vadysirisack DD, 2006, J NUCL MED, V47, P182; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yong FL, 2014, INT J MOL SCI, V15, P11713, DOI 10.3390/ijms150711713; ZHANG XF, 2015, J INEQUAL APPL, V2015, P1, DOI DOI 10.3892/0L.2015.3238	54	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177492	10.1371/journal.pone.0177492	http://dx.doi.org/10.1371/journal.pone.0177492			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493972	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300121
J	Wang, B; Guo, X; Zhao, PJ; Ruan, MB; Yu, XL; Zou, LP; Yang, YL; Li, X; Deng, DL; Xiao, JX; Xiao, YW; Hu, CJ; Wang, X; Wang, XL; Wang, WQ; Peng, M				Wang, Bin; Guo, Xin; Zhao, Pingjuan; Ruan, Mengbin; Yu, Xiaoling; Zou, Liangping; Yang, Yiling; Li, Xiao; Deng, Deli; Xiao, Jixiang; Xiao, Yiwei; Hu, Chunji; Wang, Xue; Wang, Xiaolin; Wang, Wenquan; Peng, Ming			Molecular diversity analysis, drought related marker-traits association mapping and discovery of excellent alleles for 100-day old plants by EST-SSRs in cassava germplasms (Manihot esculenta Cranz)	PLOS ONE			English	Article							FIBER QUALITY; STRESS TOLERANCE; LINKAGE MAP; GENE; ARABIDOPSIS; DEHYDRATION; RESISTANCE; LANDRACES; LOCI; HEAT	Cassava is the third largest food crop of the world and has strong ability of drought tolerance. In order to evaluate the molecular diversity and to discover novel alleles for drought tolerance in cassava germplasms, we examined a total of 107 abiotic stress related expressed sequence tags-simple sequence repeat (EST-SSR) markers in 134 cassava genotypes coming from planting regions worldwide and performed drought related marker-traits association mapping. As results, we successfully amplified 98 of 107 markers in 97 polymorphic loci and 279 alleles, with 2.87 alleles per locus, gene diversity of 0.48 and polymorphic information content (PIC) of 0.41 on average. The genetic coefficient between every two lines was 0.37 on average, ranging from 0.21 to 0.82. According to our population structure analysis, these samples could be divided into three sub-populations showing obvious gene flow between them. We also performed water stress experiments using 100-day old cassava plants in two years and calculated the drought tolerance coefficients (DTCs) and used them as phenotypes for marker-trait association mapping. We found that 53 markers were significantly associated with these drought-related traits, with a contribution rate for trait variation of 8.60% on average, ranging between 2.66 and 28.09%. Twenty-four of these 53 associated genes showed differential transcription or protein levels which were confirmed by qRT-PCR under drought stress when compared to the control conditions in cassava. Twelve of twenty-four genes were the same differential expression patterns in omics data and results of qRT-PCR. Out of 33 marker-traits combinations on 24 loci, 34 were positive and 53 negative alleles according to their phenotypic effects and we also obtained the typical materials which carried these elite alleles. We also found 23 positive average allele effects while 10 loci were negative according to their allele effects (AAEs). Our results on molecular diversity, locus association and differential expression under drought can prove beneficial to select excellent materials through marker assisted selection and for functional genes research in the future.	[Wang, Bin; Guo, Xin; Yang, Yiling] Huazhong Agricultrural Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Wang, Bin; Guo, Xin; Zhao, Pingjuan; Ruan, Mengbin; Yu, Xiaoling; Zou, Liangping; Yang, Yiling; Li, Xiao; Deng, Deli; Xiao, Jixiang; Xiao, Yiwei; Hu, Chunji; Wang, Xue; Wang, Xiaolin; Wang, Wenquan; Peng, Ming] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China; [Wang, Bin; Guo, Xin; Zhao, Pingjuan; Ruan, Mengbin; Yu, Xiaoling; Zou, Liangping; Yang, Yiling; Li, Xiao; Deng, Deli; Xiao, Jixiang; Xiao, Yiwei; Hu, Chunji; Wang, Xue; Wang, Xiaolin; Wang, Wenquan; Peng, Ming] Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Peng, M (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China.; Peng, M (corresponding author), Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China.	pengming@itbb.org.cn	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Wang, Wenquan/0000-0002-7603-3437	National Natural Science Foundation of China NSFC-CGIAR Project [31561143012]; National Science Foundation of China [31501378]; national key technology RAMP;D program of China [2015BAD15B01]; Hainan province innovative research team foundation [2016CXTD013]	National Natural Science Foundation of China NSFC-CGIAR Project(CGIAR); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); national key technology RAMP;D program of China; Hainan province innovative research team foundation	This work was financially supported by National Natural Science Foundation of China NSFC-CGIAR Project (grant no. 31561143012), the National Science Foundation of China (grant No. 31501378), the national key technology R&D program of China (grant no. 2015BAD15B01) and the Hainan province innovative research team foundation (grant no. 2016CXTD013).	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; [Anonymous], 2009, BMC PLANT BIOL, DOI DOI 10.1186/1471-2229-9-118; Ashraf M, 2008, ADV AGRON, V97, P45, DOI 10.1016/S0065-2113(07)00002-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; BOUSLAMA M, 1984, CROP SCI, V24, P933, DOI 10.2135/cropsci1984.0011183X002400050026x; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Soto JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1397-4; Chen X, 2012, EUPHYTICA, V187, P227, DOI 10.1007/s10681-012-0662-8; [邓德力 Deng Deli], 2015, [热带作物学报, Chinese Journal of Tropical Crops], V36, P1986; Ding Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-229; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferguson ME, 2012, THEOR APPL GENET, V124, P685, DOI 10.1007/s00122-011-1739-9; Fregene MA, 2003, THEOR APPL GENET, V107, P1083, DOI 10.1007/s00122-003-1348-3; Gaviria J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143955; Guerinier T, 2013, PLANT J, V75, P515, DOI 10.1111/tpj.12218; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Haq SU, 2016, GENET RES INT; Hernandez A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00085; Howeler RN, 2013, SAVA GROW CASSAVA; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Khadilkar AS, 2016, PLANT PHYSIOL, V170, P401, DOI 10.1104/pp.15.01409; Kim DH, 2013, PLANT CELL REP, V32, P1953, DOI 10.1007/s00299-013-1506-2; Kizito EB, 2007, HEREDITAS, V144, P129, DOI 10.1111/j.2007.0018-0661.01975.x; Kunkeaw S, 2011, MOL BREEDING, V27, P67, DOI 10.1007/s11032-010-9414-4; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu ML, 2013, PLANT PHYSIOL BIOCH, V73, P161, DOI 10.1016/j.plaphy.2013.09.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lokko Y, 2007, PLANT CELL REP, V26, P1605, DOI 10.1007/s00299-007-0378-8; Lopez CE, 2007, GENOME, V50, P1078, DOI 10.1139/G07-087; Min HW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01080; Nie XH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2662-x; Nie XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141064; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pootakham W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116028; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Qie LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101868; Rabbi I, 2012, THEOR APPL GENET, V125, P329, DOI 10.1007/s00122-012-1836-4; Raji AAJ, 2009, ANN APPL BIOL, V155, P187, DOI 10.1111/j.1744-7348.2009.00329.x; Rodriguez PL, 1998, PLANT MOL BIOL, V38, P919, DOI 10.1023/A:1006054607850; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakurai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074056; Sakurai T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-66; Sautron E, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150065; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Siqueira MVBM, 2009, GENET MOL BIOL, V32, P104, DOI 10.1590/S1415-47572009005000010; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Thanyasiriwat T, 2014, PLANT BIOLOGY, V16, P197, DOI 10.1111/plb.12022; Tomar RSS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156528; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang B, 2012, THEOR APPL GENET, V125, P1263, DOI 10.1007/s00122-012-1911-x; Wang XL, 2016, NAT GENET, V48, P1233, DOI 10.1038/ng.3636; Wang XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165733; Wang XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19643; Wang Y, 2003, DEV BIOL, V264, P228, DOI 10.1016/j.ydbio.2003.07.017; Wei YX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00025; Wen ZiXiang, 2008, Acta Agronomica Sinica, V34, P1339, DOI 10.3724/SP.J.1006.2008.01339; Whankaew S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-266; Xu J, 2012, EMBO J, V31, P1975, DOI 10.1038/emboj.2012.56; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao PJ, 2015, J EXP BOT; Zhong LL, 2013, PLANT CELL, V25, P2925, DOI 10.1105/tpc.113.111229; Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146242	69	24	26	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177456	10.1371/journal.pone.0177456	http://dx.doi.org/10.1371/journal.pone.0177456			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493955	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300115
J	Wang, X; Xue, JY; Wang, XY; Liu, XH				Wang, Xin; Xue, Jianyue; Wang, Xinyun; Liu, Xiaoheng			Heterogeneous Ag-TiO2-SiO2 composite materials as novel catalytic systems for selective epoxidation of cyclohexene by H2O2	PLOS ONE			English	Article							LEAF EXTRACT; OXIDATION; NANOCOMPOSITE; TS-1; AG; REDUCTION; COMPLEXES; STYRENE; OXIDE	TiO2-SiO2 composites were synthesized using cetyl trimethyl ammonium bromide (CTAB) as the structure directing template. Self-assembly hexadecyltrimethyl-ammonium bromide TiO2-SiO2/(CTAB) were soaked into silver nitrate (AgNO3) aqueous solution. The Ag-TiO2-SiO2(Ag-TS) composite were prepared via a precipitation of AgBr in soaking process and its decomposition at calcination stage. Structural characterization of the materials was carried out by various techniques including X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), N-2 adsorption-desorption and ultraviolet visible spectroscopy (UV-Vis). Characterization results revealed that Ag particles were incorporated into hierarchical TiO2-SiO2 without significantly affecting the structures of the supports. Further heating-treatment at 723 K was more favorable for enhancing the stability of the Ag-TS composite. The cyclohexene oxide was the major product in the epoxidation using H2O2 as the oxidant over the Ag-TS catalysts. Besides, the optimum catalytic activity and stability of Ag-TS catalysts were obtained under operational conditions of calcined at 723 K for 2 h, reaction time of 120 min, reaction temperature of 353 K, catalyst amount of 80 mg, aqueous H2O2 (30 wt.%) as oxidant and chloroform as solvent. High catalytic activity with conversion rate up to 99.2% of cyclohexene oxide could be obtainable in water-bathing. The catalyst was found to be stable and could be reused three times without significant loss of catalytic activity under the optimized reaction conditions.	[Wang, Xin; Xue, Jianyue; Wang, Xinyun] Chaohu Univ, Coll Chem & Mat Engn, Chaohu, Anhui, Peoples R China; [Wang, Xin; Xue, Jianyue; Wang, Xinyun] Chaohu Univ, Inst Novel Funct Mat & Fine Chem, Chaohu, Anhui, Peoples R China; [Liu, Xiaoheng] Nanjing Univ Sci & Technol, Key Lab Soft Chem & Funct Mat, Minist Educ, Nanjing, Jiangsu, Peoples R China	Chaohu University; Chaohu University; Nanjing University of Science & Technology	Wang, X (corresponding author), Chaohu Univ, Coll Chem & Mat Engn, Chaohu, Anhui, Peoples R China.; Wang, X (corresponding author), Chaohu Univ, Inst Novel Funct Mat & Fine Chem, Chaohu, Anhui, Peoples R China.	wangxin@chu.edu.cn	Xiaoheng, LIU/GNP-3359-2022		Natural Science Foundation of Anhui Province [KJ2013B161]; Special Project of the Scientific Research Institute Foundation [XLY-201319]; Dr. Scientific Research Foundation of Chaohu University	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Special Project of the Scientific Research Institute Foundation; Dr. Scientific Research Foundation of Chaohu University	This work was supported by the Natural Science Foundation of Anhui Province (No. KJ2013B161) to XW, the Special Project of the Scientific Research Institute Foundation (No. XLY-201319) to XW and the Dr. Scientific Research Foundation of Chaohu University to XW. The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hardan NH, 2016, SENSOR ACTUAT A-PHYS, V242, P50, DOI 10.1016/j.sna.2016.02.036; Behera GC, 2013, APPL CATAL A-GEN, V464, P364, DOI 10.1016/j.apcata.2013.06.012; Belaidi N, 2015, APPL CLAY SCI, V107, P14, DOI 10.1016/j.clay.2015.01.026; Berube F, 2010, CHEM MATER, V22, P1988, DOI 10.1021/cm9030667; Bet-Moushoul E, 2016, RENEW ENERG, V92, P12, DOI 10.1016/j.renene.2016.01.070; Bradley CA, 2007, J PHYS CHEM C, V111, P17570, DOI 10.1021/jp074512c; Cao D, 2016, CHEMOSPHERE, V159, P23, DOI 10.1016/j.chemosphere.2016.05.080; Cao YH, 2014, ACS CATAL, V4, P1617, DOI 10.1021/cs500187q; Chen JJ, 2016, INT J HYDROGEN ENERG, V41, P11441, DOI 10.1016/j.ijhydene.2016.05.022; Doi Y, 2014, J MOL CATAL A-CHEM, V383, P70, DOI 10.1016/j.molcata.2013.11.033; Garcia AM, 2016, J MOL CATAL A-CHEM, V416, P10, DOI 10.1016/j.molcata.2016.01.034; He W, 2016, IND ENG CHEM RES, V55, P1373, DOI 10.1021/acs.iecr.5b04187; Hereijgers BPC, 2011, ACS CATAL, V1, P1183, DOI 10.1021/cs200354c; Hosseini-Sarvari M, 2015, MATER RES BULL, V72, P98, DOI 10.1016/j.materresbull.2015.07.019; Kwon S, 2015, J CATAL, V326, P107, DOI 10.1016/j.jcat.2015.04.005; Liu JH, 2009, CATAL COMMUN, V10, P868, DOI 10.1016/j.catcom.2008.12.013; Liu S, 2016, J CATAL, V337, P188, DOI 10.1016/j.jcat.2016.01.019; Mantri Y, 2007, J AM CHEM SOC, V129, P5023, DOI 10.1021/ja067631z; Moosavifar M, 2015, CHINESE J CATAL, V36, P1719, DOI 10.1016/s1872-2067(15)60908-1; Muratsugu S, 2013, ACS CATAL, V3, P2020, DOI 10.1021/cs400053f; Notari B, 1996, ADV CATAL, V41, P253, DOI 10.1016/S0360-0564(08)60042-5; Peng C, 2016, J MOL CATAL A-CHEM, V423, P393, DOI 10.1016/j.molcata.2016.07.038; Qiu CJ, 2009, J ORGANOMET CHEM, V694, P3418, DOI 10.1016/j.jorganchem.2009.06.034; Rayati S, 2016, J MOL CATAL A-CHEM, V423, P105, DOI 10.1016/j.molcata.2016.06.012; Reddy AS, 2010, J MOL CATAL A-CHEM, V318, P60, DOI 10.1016/j.molcata.2009.11.008; SING KSW, 1982, PURE APPL CHEM, V54, P2201, DOI 10.1351/pac198254112201; Sun DL, 2015, APPL CATAL A-GEN, V505, P422, DOI 10.1016/j.apcata.2015.03.047; Tajbakhsh M, 2016, J ALLOY COMPD, V685, P258, DOI 10.1016/j.jallcom.2016.05.278; Tekla J, 2016, MICROPOR MESOPOR MAT, V233, P16, DOI 10.1016/j.micromeso.2016.06.031; Wang AL, 2010, APPL SURF SCI, V256, P2611, DOI 10.1016/j.apsusc.2009.11.003; Williams FJ, 2004, J AM CHEM SOC, V126, P8509, DOI 10.1021/ja039378y; Yan YB, 2016, CATAL TODAY, V259, P292, DOI 10.1016/j.cattod.2015.07.021; Yang Q, 2016, APPL CATAL A-GEN, V518, P213, DOI 10.1016/j.apcata.2015.10.023; Zhan WC, 2009, J PHYS CHEM C, V113, P7181, DOI 10.1021/jp8101095; Zhuang JQ, 2004, ANGEW CHEM INT EDIT, V43, P6377, DOI 10.1002/anie.200461113	35	3	3	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176332	10.1371/journal.pone.0176332	http://dx.doi.org/10.1371/journal.pone.0176332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493879	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300012
J	Zhang, XP; Devlin, HM; Smith, B; Imperatore, G; Thomas, W; Lobelo, F; Ali, MK; Norris, K; Gruss, S; Bardenheier, B; Cho, P; de Quevedo, IG; Mudaliar, U; Jones, CD; Durthaler, JM; Saaddine, J; Geiss, LS; Gregg, EW				Zhang, Xuanping; Devlin, Heather M.; Smith, Bryce; Imperatore, Giuseppina; Thomas, William; Lobelo, Felipe; Ali, Mohammed K.; Norris, Keri; Gruss, Stephanie; Bardenheier, Barbara; Cho, Pyone; de Quevedo, Isabel Garcia; Mudaliar, Uma; Jones, Christopher D.; Durthaler, Jeffrey M.; Saaddine, Jinan; Geiss, Linda S.; Gregg, Edward W.			Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis	PLOS ONE			English	Review							FASTING PLASMA-GLUCOSE; HEALTHY-LIVING PARTNERSHIPS; RANDOMIZED CONTROLLED-TRIAL; OBESE POSTMENOPAUSAL WOMEN; CORONARY-HEART-DISEASE; HIGH-CARBOHYDRATE DIET; WEIGHT-LOSS; PRIMARY-CARE; CARDIOMETABOLIC RISK; PREVENTION PROGRAM	Structured lifestyle interventions can reduce diabetes incidence and cardiovascular disease (CVD) risk among persons with impaired glucose tolerance (IGT), but it is unclear whether they should be implemented among persons without IGT. We conducted a systematic review and meta-analyses to assess the effectiveness of lifestyle interventions on CVD risk among adults without IGT or diabetes. We systematically searched MEDLINE, EMBASE, CINAHL, Web of Science, the Cochrane Library, and PsychInfo databases, from inception to May 4, 2016. We selected randomized controlled trials of lifestyle interventions, involving physical activity (PA), dietary (D), or combined strategies (PA+D) with follow-up duration >= 12 months. We excluded all studies that included individuals with IGT, confirmed by 2-hours oral glucose tolerance test (75g), but included all other studies recruiting populations with different glycemic levels. We stratified studies by baseline glycemic levels: (1) low-range group with mean fasting plasma glucose (FPG) <5.5mmol/L or glycated hemoglobin (A1C) <5.5%, and (2) high-range group with FPG >= 5.5mmol/L or A1C >= 5.5%, and synthesized data using random-effects models. Primary outcomes in this review included systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Totally 79 studies met inclusion criteria. Compared to usual care (UC), lifestyle interventions achieved significant improvements in SBP (-2.16mmHg[95% CI, -2.93, -1.39]), DBP (-1.83mmHg[-2.34, -1.31]), TC (-0.10mmol/L[-0.15, -0.05]), LDL-C (-0.09mmol/L [-0.13, -0.04]), HDL-C (0.03mmol/L[0.01, 0.04]), and TG (-0.08mmol/L[-0.14, -0.03]). Similar effects were observed among both low-and high-range study groups except for TC and TG. Similar effects also appeared in SBP and DBP categories regardless of follow-up duration. PA+D interventions had larger improvement effects on CVD risk factors than PA alone interventions. In adults without IGT or diabetes, lifestyle interventions resulted in significant improvements in SBP, DBP, TC, LDL-C, HDL-C, and TG, and might further reduce CVD risk.	[Zhang, Xuanping; Devlin, Heather M.; Smith, Bryce; Imperatore, Giuseppina; Gruss, Stephanie; Bardenheier, Barbara; Cho, Pyone; Saaddine, Jinan; Geiss, Linda S.; Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Thomas, William] Ctr Dis Control & Prevent, Off Publ Hlth Sci Serv, Atlanta, GA USA; [Lobelo, Felipe; Ali, Mohammed K.; Mudaliar, Uma] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Norris, Keri] Fulton DeKalb Hosp Author, Hlth Policy & Adm, Atlanta, GA USA; [de Quevedo, Isabel Garcia] Ctr Dis Control & Prevent, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Jones, Christopher D.; Durthaler, Jeffrey M.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Zhang, XP (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	xbz2@cdc.gov	Lobelo, R.L Felipe/AAB-2264-2021; Ali, Mohammed K/N-9833-2013	Lobelo, R.L Felipe/0000-0003-4185-7193; Ali, Mohammed/0000-0001-7266-2503; Gregg, Edward/0000-0003-2381-6822	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the Centers for Disease Control and Prevention in the form of salaries for XZ, HMD, BS, GI, WT, SG, BB, PC, IGQ, CDJ, JMD, JS, LSG, EWG.; This study was supported by the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.	Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Almeida LB, 2011, AIDS CARE, V23, P755, DOI 10.1080/09540121.2010.525789; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anderson AS, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1823; Anderssen SA, 1998, SCAND J MED SCI SPOR, V8, P109; Anderssen SA, 1996, J INTERN MED, V240, P203, DOI 10.1046/j.1365-2796.1996.22848000.x; [Anonymous], 2015, DIABETES CARE, V38, pS49, DOI 10.2337/dc15-S011; [Anonymous], 1993, CONTROL CLIN TRIALS, V14, P229; [Anonymous], 1999, Diabetologia, V42, P647; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Arguin H, 2012, MENOPAUSE, V19, P870, DOI 10.1097/gme.0b013e318250a287; Bazzano LA, 2014, ANN INTERN MED, V161, P309, DOI 10.7326/M14-0180; Bo S, 2007, J GEN INTERN MED, V22, P1695, DOI 10.1007/s11606-007-0399-6; Bo S, 2009, AM J CLIN NUTR, V90, P1502, DOI 10.3945/ajcn.2009.28379; Bouchonville M, 2014, INT J OBESITY, V38, P423, DOI 10.1038/ijo.2013.122; Brinkworth GD, 2004, INT J OBESITY, V28, P661, DOI 10.1038/sj.ijo.0802617; Broekhuizen Karen, 2012, BMC Res Notes, V5, P181, DOI 10.1186/1756-0500-5-181; Burke V, 2008, NUTR METAB CARDIOVAS, V18, P198, DOI 10.1016/j.numecd.2006.10.004; Burke V, 2007, J CLIN EPIDEMIOL, V60, P133, DOI 10.1016/j.jclinepi.2006.05.012; Burtscher M, 2012, EXP CLIN ENDOCR DIAB, V120, P445, DOI 10.1055/s-0032-1311642; Burtscher M, 2009, CLIN J SPORT MED, V19, P394, DOI 10.1097/JSM.0b013e3181b8b6dc; Fernandez AC, 2012, NUTR HOSP, V27, P2093, DOI 10.3305/nh.2012.27.6.6133; Chirinos DA, 2016, J BEHAV MED, V39, P483, DOI 10.1007/s10865-016-9721-2; Choo J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-82; Clifton PM, 2008, AM J CLIN NUTR, V87, P23, DOI 10.1093/ajcn/87.1.23; Cole RE, 2013, DIABETES EDUCATOR, V39, P344, DOI 10.1177/0145721713484812; COON PJ, 1989, METABOLISM, V38, P1201, DOI 10.1016/0026-0495(89)90160-1; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Cox KL, 2008, PREV MED, V46, P511, DOI 10.1016/j.ypmed.2008.01.010; Cox KL, 2010, METABOLISM, V59, P1562, DOI 10.1016/j.metabol.2010.02.001; Cox KL, 2006, J HYPERTENS, V24, P307, DOI 10.1097/01.hjh.0000200514.25571.20; Craigie AM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-184; Delgadillo AT, 2010, DIABETES EDUCATOR, V36, P640, DOI 10.1177/0145721710374368; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ditschuneit HH, 1999, AM J CLIN NUTR, V69, P198; Ditschuneit HH, 2001, OBES RES, V9, p284S, DOI 10.1038/oby.2001.132; Donnelly JE, 2000, INT J OBESITY, V24, P566, DOI 10.1038/sj.ijo.0801198; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Esposito K, 2004, JAMA-J AM MED ASSOC, V291, P2978, DOI 10.1001/jama.291.24.2978; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Esposito K, 2009, J SEX MED, V6, P243, DOI 10.1111/j.1743-6109.2008.01030.x; Fager G, 1997, ARTERIOSCL THROM VAS, V17, P3527, DOI 10.1161/01.ATV.17.12.3527; Fatouros IG, 2005, J CLIN ENDOCR METAB, V90, P5970, DOI 10.1210/jc.2005-0261; Ferrara AL, 2012, J CLIN HYPERTENS, V14, P767, DOI 10.1111/jch.12016; Fischer HH, 2016, DIABETES CARE, V39, P1364, DOI 10.2337/dc15-2137; Fisher G, 2012, J APPL PHYSIOL, V112, P688, DOI 10.1152/japplphysiol.00843.2011; Fiuza-Luces C, 2013, PHYSIOLOGY, V28, P330, DOI 10.1152/physiol.00019.2013; Fogelholm M, 2000, ARCH INTERN MED, V160, P2177, DOI 10.1001/archinte.160.14.2177; Fonolla J, 2009, NUTRITION, V25, P408, DOI 10.1016/j.nut.2008.10.008; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Frank LL, 2005, OBES RES, V13, P615, DOI 10.1038/oby.2005.66; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Groeneveld IF, 2010, PREV MED, V51, P240, DOI 10.1016/j.ypmed.2010.07.021; Groeneveld IF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-1; Haskell William L, 2003, J Cardiovasc Nurs, V18, P245; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; Imayama I, 2013, PREV MED, V57, P525, DOI 10.1016/j.ypmed.2013.07.006; Jacobs DR, 2009, AM J CLIN NUTR, V89, P509, DOI 10.3945/ajcn.2008.26371; Juul L, 2016, PRIM CARE DIABETES, V10, P111, DOI 10.1016/j.pcd.2015.07.002; Kanaya AM, 2014, J DIABETES COMPLICAT, V28, P406, DOI 10.1016/j.jdiacomp.2013.12.001; Kanaya AM, 2012, AM J PUBLIC HEALTH, V102, P1551, DOI 10.2105/AJPH.2011.300456; Katula JA, 2013, AM J PREV MED, V44, pS324, DOI 10.1016/j.amepre.2012.12.015; Katula JA, 2011, DIABETES CARE, V34, P1451, DOI 10.2337/dc10-2115; Katula JA, 2010, CONTEMP CLIN TRIALS, V31, P71, DOI 10.1016/j.cct.2009.09.002; Kawano M, 2009, INTERNAL MED, V48, P25, DOI 10.2169/internalmedicine.48.1527; Keogh JB, 2007, BRIT J NUTR, V98, P852, DOI 10.1017/S0007114507747815; Kim C, 2011, DIABETES CARE, V34, P1949, DOI 10.2337/dc11-0269; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kuller LH, 2006, J WOMENS HEALTH, V15, P962, DOI 10.1089/jwh.2006.15.962; Kuller Lewis H, 2012, Obesity (Silver Spring), V20, P636, DOI 10.1038/oby.2011.80; Kuller LH, 2001, CIRCULATION, V103, P32; Lawton BA, 2009, BRIT J SPORT MED, V43, P120, DOI 10.1136/bmj.a2509; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Lim SS, 2010, NUTR METAB CARDIOVAS, V20, P599, DOI 10.1016/j.numecd.2009.05.003; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lombard C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3215; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; Ma J, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-71; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marcus BH, 2006, CIRCULATION, V114, P2739, DOI 10.1161/CIRCULATIONAHA.106.179683; Marrero DG, 2016, AM J PUBLIC HEALTH, V106, P949, DOI 10.2105/AJPH.2015.303035; Marsh KA, 2010, AM J CLIN NUTR, V92, P83, DOI 10.3945/ajcn.2010.29261; Mason AE, 2016, J BEHAV MED, V39, P201, DOI 10.1007/s10865-015-9692-8; Mason C, 2013, OBESITY, V21, pE549, DOI 10.1002/oby.20509; Mason C, 2011, AM J PREV MED, V41, P366, DOI 10.1016/j.amepre.2011.06.042; Mayega RW, 2014, DIABETES RES CLIN PR, V104, P112, DOI 10.1016/j.diabres.2013.12.030; McAuley KA, 2006, INT J OBESITY, V30, P342, DOI 10.1038/sj.ijo.0803075; McAuley KA, 2005, DIABETOLOGIA, V48, P8, DOI 10.1007/s00125-004-1603-4; Mellberg C, 2014, EUR J CLIN NUTR, V68, P350, DOI 10.1038/ejcn.2013.290; Merriam PA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-20; Muto T, 2001, PREV MED, V33, P571, DOI 10.1006/pmed.2001.0923; Narayan KMV, 1998, DIABETIC MED, V15, P66; NILSSON PM, 1992, J HYPERTENS, V10, P1071; Nilsson PM, 2001, SCAND J WORK ENV HEA, V27, P57, DOI 10.5271/sjweh.587; Ockene IS, 2012, AM J PUBLIC HEALTH, V102, P336, DOI 10.2105/AJPH.2011.300357; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Poston WSC, 2006, J INTERN MED, V260, P388, DOI 10.1111/j.1365-2796.2006.01702.x; Potteiger JA, 2003, METABOLISM, V52, P1175, DOI 10.1016/S0026-0495(03)00146-X; Potteiger JA, 2002, INT J OBESITY, V26, P87, DOI 10.1038/sj.ijo.0801839; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Reboldi G, 2011, J HYPERTENS, V29, P1253, DOI 10.1097/HJH.0b013e3283469976; Reid RD, 2014, CAN MED ASSOC J, V186, P23, DOI 10.1503/cmaj.130550; Rossner S, 1997, INT J OBESITY, V21, P22, DOI 10.1038/sj.ijo.0800355; Ryttig KR, 1997, INT J OBESITY, V21, P574, DOI 10.1038/sj.ijo.0800444; Sartorelli DS, 2005, PUBLIC HEALTH NUTR, V8, P820, DOI 10.1079/PHN2005737; Sattin RW, 2016, J COMMUN HEALTH, V41, P87, DOI 10.1007/s10900-015-0071-8; Schwarz UV, 2008, SCAND J WORK ENV HEA, V34, P179, DOI 10.5271/sjweh.1227; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Simkin-Silverman L R, 1998, Womens Health, V4, P255; Simkin-Silverman LR, 2003, ANN BEHAV MED, V26, P212, DOI 10.1207/S15324796ABM2603_06; SIMKINSILVERMAN L, 1995, PREV MED, V24, P509, DOI 10.1006/pmed.1995.1081; Siu PM, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0034-3; Staten LK, 2004, J WOMENS HEALTH, V13, P547, DOI 10.1089/1540999041281133; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; Tapsell LC, 2014, EUR J CLIN NUTR, V68, P778, DOI 10.1038/ejcn.2014.39; ter Bogt NCW, 2009, AM J PREV MED, V37, P270, DOI 10.1016/j.amepre.2009.06.011; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Thompson WG, 2005, OBES RES, V13, P1344, DOI 10.1038/oby.2005.163; Torjesen PA, 1997, DIABETES CARE, V20, P26, DOI 10.2337/diacare.20.1.26; Toth PP, 2005, AM J CARDIOL, V96, p50K, DOI 10.1016/j.amjcard.2005.08.008; Tsai AG, 2010, OBESITY, V18, P1614, DOI 10.1038/oby.2009.457; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vainionpaa A, 2007, MED SCI SPORT EXER, V39, P756, DOI 10.1249/mss.0b013e318031c039; Vetter ML, 2013, INT J OBESITY, V37, pS19, DOI 10.1038/ijo.2013.92; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Watanabe M, 2003, DIABETES CARE, V26, P3209, DOI 10.2337/diacare.26.12.3209; Weinstock RS, 1998, ARCH INTERN MED, V158, P2477, DOI 10.1001/archinte.158.22.2477; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; WING RR, 1995, INT J OBESITY, V19, P67; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350; Wycherley TP, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.11; Yeh MC, 2016, DIABETIC MED, V33, P547, DOI 10.1111/dme.12848; Zhang XP, 2017, DIABETES RES CLIN PR, V123, P149, DOI 10.1016/j.diabres.2016.11.020; Zhuo XH, 2013, DIABETES CARE, V36, P3992, DOI 10.2337/dc13-0497; Zhuo XH, 2012, AM J PREV MED, V42, P374, DOI 10.1016/j.amepre.2012.01.003	140	64	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176436	10.1371/journal.pone.0176436	http://dx.doi.org/10.1371/journal.pone.0176436			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493887	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300019
J	Hsieh, JH; Huang, RL; Lin, JA; Sedykh, A; Zhao, JH; Tice, RR; Paules, RS; Xia, MH; Auerbach, SS				Hsieh, Jui-Hua; Huang, Ruili; Lin, Ja-An; Sedykh, Alexander; Zhao, Jinghua; Tice, Raymond R.; Paules, Richard S.; Xia, Menghang; Auerbach, Scott S.			Real-time cell toxicity profiling of Tox21 10K compounds reveals cytotoxicity dependent toxicity pathway linkage	PLOS ONE			English	Article							CHEMICALS; MECHANISM; ASSAYS; PERTURBATIONS; DEATH	Cytotoxicity is a commonly used in vitro endpoint for evaluating chemical toxicity. In support of the U. S. Tox21 screening program, the cytotoxicity of similar to 10K chemicals was interrogated at 0, 8, 16, 24, 32, & 40 hours of exposure in a concentration dependent fashion in two cell lines (HEK293, HepG2) using two multiplexed, real-time assay technologies. One technology measures the metabolic activity of cells (i.e., cell viability, glo) while the other evaluates cell membrane integrity (i.e., cell death, flor). Using glo technology, more actives and greater temporal variations were seen in HEK293 cells, while results for the flor technology were more similar across the two cell types. Chemicals were grouped into classes based on their cytotoxicity kinetics profiles and these classes were evaluated for their associations with activity in the Tox21 nuclear receptor and stress response pathway assays. Some pathways, such as the activation of H2AX, were associated with the fast-responding cytotoxicity classes, while others, such as activation of TP53, were associated with the slow-responding cytotoxicity classes. By clustering pathways based on their degree of association to the different cytotoxicity kinetics labels, we identified clusters of pathways where active chemicals presented similar kinetics of cytotoxicity. Such linkages could be due to shared underlying biological processes between pathways, for example, activation of H2AX and heat shock factor. Others involving nuclear receptor activity are likely due to shared chemical structures rather than pathway level interactions. Based on the linkage between androgen receptor antagonism and Nrf2 activity, we surmise that a subclass of androgen receptor antagonists cause cytotoxicity via oxidative stress that is associated with Nrf2 activation. In summary, the real-time cytotoxicity screen provides informative chemical cytotoxicity kinetics data related to their cytotoxicity mechanisms, and with our analysis, it is possible to formulate mechanism-based hypotheses on the cytotoxic properties of the tested chemicals.	[Hsieh, Jui-Hua] Kelly Govt Solut, Durham, NC 27560 USA; [Huang, Ruili; Zhao, Jinghua; Xia, Menghang] NIH, Natl Ctr Advancing Translat Sci, Rockville, MD USA; [Lin, Ja-An] US FDA, Silver Spring, MD USA; [Sedykh, Alexander] Sciome, Durham, NC USA; [Tice, Raymond R.; Paules, Richard S.; Auerbach, Scott S.] NIEHS, Div Natl Toxicol Program, NIH, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hsieh, JH (corresponding author), Kelly Govt Solut, Durham, NC 27560 USA.	jui-hua.hsieh@nih.gov		Paules, Richard S/0000-0001-9106-7486; Hsieh, Jui-Hua/0000-0003-1620-1571	Intramural Research Programs [Y2-ES-7020-01]; National Toxicology Program, NIEHS [ZIA ES103318-01]; NIEHS [HHSN273201700001C, HHSN271201500007I]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000040, ZIATR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103318] Funding Source: NIH RePORTER	Intramural Research Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Toxicology Program, NIEHS; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by the Intramural Research Programs (Y2-ES-7020-01), National Toxicology Program, NIEHS (ZIA ES103318-01), and NIEHS contracts including Bioinformatics Support with Sciome (HHSN273201700001C) and with Kelly (HHSN271201500007I). Except J-HH (Kelly) and AS (Sciome) received salary through corresponding contracting company, the other authors are federal employees. The funder provided support in the form of salaries for authors [J-HH, RH, J-AL, AS, JZ, RRT, RSP, MX, and SSA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Behl M, NEUROTOXICOL TERATOL; Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641; Bruni G, 2016, NAT CHEM BIOL; Duellman SJ, 2015, ASSAY DRUG DEV TECHN, V13, P456, DOI 10.1089/adt.2015.669; Everitt BS., 2010, CAMBRIDGE DICT STAT, DOI [10.1017/CBO9780511779633, DOI 10.1017/CBO9780511779633]; Gray L, ANTI ANDROGENIC ACTI; Hsieh JH, 2015, J BIOMOL SCREEN, V20, P887, DOI 10.1177/1087057115581317; Huang R, 2014, SCI REP, P4; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Kaneko H, 2005, BIOCHEM BIOPH RES CO, V328, P1101, DOI 10.1016/j.bbrc.2005.01.073; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kim MT, 2016, ENVIRON HEALTH PERSP, V124, P634, DOI 10.1289/ehp.1509763; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Laszlo A, 2009, CANCER RES, V69, P2042, DOI 10.1158/0008-5472.CAN-08-1639; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; McDonald JH, 2015, HDB BIOL STAT; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Pohlert T., 2016, R PACKAGE TREND NONP; Rotroff DM, 2014, ENVIRON SCI TECHNOL, V48, P8706, DOI 10.1021/es502676e; Rotroff DM, 2013, CHEM RES TOXICOL, V26, P1097, DOI 10.1021/tx400117y; Sedykh A, 2011, ENVIRON HEALTH PERSP, V119, P364, DOI 10.1289/ehp.1002476; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sharma PM, 2015, PLOS ONE, P10; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sipes NS, ENV SCI TECHNOL; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; Vittinghoff E, 2012, REGRESSION METHODS B, P261; Wang YH, 2016, METHODS MOL BIOL, V1473, P123, DOI 10.1007/978-1-4939-6346-1_13; Xi ZK, 2014, COMPUT BIOL CHEM, V49, P23, DOI 10.1016/j.compbiolchem.2013.12.004; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Yu CN, 2016, NAT BIOTECHNOL, V34, P419, DOI 10.1038/nbt.3460; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099863	37	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177902	10.1371/journal.pone.0177902	http://dx.doi.org/10.1371/journal.pone.0177902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531190	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400036
J	Tun, STT; Lubell, Y; Dondorp, AM; Fieldman, T; Tun, KM; Celhay, O; Chan, XH; Saralamba, S; White, LJ				Tun, Sai Thein Than; Lubell, Yoel; Dondorp, Arjen M.; Fieldman, Tom; Tun, Kyaw Myo; Celhay, Olivier; Chan, Xin Hui; Saralamba, Sompob; White, Lisa J.			Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application	PLOS ONE			English	Article								The emergence of artemisinin-resistant Plasmodium falciparum malaria is a major threat to malaria elimination. New tools for supporting the surveillance of artemisinin resistance are critical for current and future malaria control and elimination strategies. We have developed an open-access, user-friendly, web-based tool to analyse parasite clearance half-life data of P. falciparum infected patients after treatment with artemisinin derivatives, so that resistance to artemisinin can be identified. The tool can be accessed at bit.ly/id_artemisinin_resistance.	[Tun, Sai Thein Than; Lubell, Yoel; Dondorp, Arjen M.; Celhay, Olivier; Chan, Xin Hui; Saralamba, Sompob; White, Lisa J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Lubell, Yoel; Dondorp, Arjen M.; Chan, Xin Hui; White, Lisa J.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Fieldman, Tom] Univ Cambridge, Sch Clin Med, Cambridge, England; [Tun, Kyaw Myo] Def Serv Med Acad, Yangon, Myanmar	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Cambridge	Tun, STT (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	theinthantun.sai@gmail.com	Chan, Xin Hui S/ABA-5004-2021	Chan, Xin Hui S/0000-0002-9941-6975; White, Lisa/0000-0002-6523-185X; Saralamba, Sompob/0000-0002-5460-8447; Lubell, Yoel/0000-0002-0237-1070; Celhay, Olivier/0000-0002-2971-9110; Tun, Sai Thein Than/0000-0001-9733-8304	Bill and Melinda Gates Foundation [OPP1110500]; Wellcome-Trust Major Overseas Programme in SE Asia [106698/Z/14/Z]; MRC [1790394] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome-Trust Major Overseas Programme in SE Asia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Bill and Melinda Gates Foundation Investment number OPP1110500 awarded to LJW. It was also a part of the Wellcome-Trust Major Overseas Programme in SE Asia (grant number 106698/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaglia T, 2009, J STAT SOFTW, V32, P1; Chang W, SHINYDASHBOARD CREAT; Chang W, shinythemes: Themes for Shiny; Chang W., Shiny: Web Application Framework for R2020 R Package Version 1.4.0.2 2021; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; R Core Team, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Venables WN., 2002, MODERN APPL STAT S 4; White LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001823; White LJ, 2015, PDPHENO MIXTURE SOUR; World Health Organization, 2016, UPD ART ACT RES OCT	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177840	10.1371/journal.pone.0177840	http://dx.doi.org/10.1371/journal.pone.0177840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531230	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400030
J	Katano, I; Harada, K; Doi, H; Souma, R; Minamoto, T				Katano, Izumi; Harada, Ken; Doi, Hideyuki; Souma, Rio; Minamoto, Toshifumi			Environmental DNA method for estimating salamander distribution in headwater streams, and a comparison of water sampling methods	PLOS ONE			English	Article							JAPONICUS; ABUNDANCE; TOOL	Environmental DNA (eDNA) has recently been used for detecting the distribution of macroor-ganisms in various aquatic habitats. In this study, we applied an eDNA method to estimate the distribution of the Japanese clawed salamander, Onychodactylus japonicus, in headwater streams. Additionally, we compared the detection of eDNA and hand-capturing methods used for determining the distribution of O. japonicus. For eDNA detection, we designed a qPCR primer/probe set for O. japonicus using the 12S rRNA region. We detected the eDNA of O. japonicus at all sites (with the exception of one), where we also observed them by hand-capturing. Additionally, we detected eDNA at two sites where we were unable to observe individuals using the hand-capturing method. Moreover, we found that eDNA concentrations and detection rates of the two water sampling areas (stream surface and under stones) were not significantly different, although the eDNA concentration in the water under stones was more varied than that on the surface. We, therefore, conclude that eDNA methods could be used to determine the distribution of macroorganisms inhabiting headwater systems by using samples collected from the surface of the water.	[Katano, Izumi; Harada, Ken] Univ Hyogo, Sch Human Sci & Environm, 1-1-12 Shinzaike Honcho, Himeji, Hyogo, Japan; [Katano, Izumi] Nara Womens Univ, Fac Sci, Nara, Japan; [Doi, Hideyuki] Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, 7-1-28 Minatojima Minamimachi, Kobe, Hyogo, Japan; [Souma, Rio] Univ Hyogo, Grad Sch Human Sci & Environm, 1-1-12 Shinzaike Honcho, Himeji, Hyogo, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo, Japan	University of Hyogo; Nara Womens University; University of Hyogo; University of Hyogo; Kobe University	Doi, H (corresponding author), Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, 7-1-28 Minatojima Minamimachi, Kobe, Hyogo, Japan.	hideyuki.doi@icloud.com	Minamoto, Toshifumi/C-6453-2009	Minamoto, Toshifumi/0000-0002-5379-1622; Katano, Izumi/0000-0002-1657-619X; Doi, Hideyuki/0000-0002-2701-3982	Environment Research and Technology Development Fund [4RF1302, 4- 1602]; Ministry of the Environment, Japan; JSPS KAKENHI [15K00596]	Environment Research and Technology Development Fund; Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Environment Research and Technology Development Fund (4RF1302 and 4- 1602) of the Ministry of the Environment, Japan, and JSPS KAKENHI Grant Numbers 15K00596 for IK.; We thank H. Mitsuhashi, University of Hyogo, for suggesting field sampling sites. This study was supported by the Environment Research and Technology Development Fund (4RF1302 and 4-1602) of the Ministry of the Environment, Japan and JSPS KAKENHI Grant Numbers 15K00596 for IK.	Akita Y., 1996, ENCY ANIMAL JAPAN, V5, P23; [Anonymous], 2021, LANG ENV STAT COMP; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Doi H, 2017, FRESHWATER BIOL, V62, P30, DOI 10.1111/fwb.12846; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Dunker KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162277; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Hartman LJ, 2005, MOL CELL PROBE, V19, P51, DOI 10.1016/j.mcp.2004.07.006; HAYASE N, 1982, Japanese Journal of Ecology, V32, P395; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ikeda K, 2016, CONSERV GENET RESOUR, V8, P231, DOI 10.1007/s12686-016-0541-z; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2016, ENVIRON SCI TECHNOL, V50, P8770, DOI 10.1021/acs.est.6b01761; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Lacoursiere-Roussel A, 2016, MOL ECOL RESOUR, V16, P1401, DOI 10.1111/1755-0998.12522; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Poyarkov NA, 2012, ZOOTAXA, P1; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Uchii K, 2016, MOL ECOL RESOUR, V16, P415, DOI 10.1111/1755-0998.12460; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786; Yamanaka H, 2016, ECOL INDIC, V62, P147, DOI 10.1016/j.ecolind.2015.11.022; Yoshikawa N, 2008, MOL PHYLOGENET EVOL, V49, P249, DOI 10.1016/j.ympev.2008.07.016	34	31	34	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176541	10.1371/journal.pone.0176541	http://dx.doi.org/10.1371/journal.pone.0176541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520733	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700021
J	Shehab, A; Zubaid, M; Bhagavathula, AS; Rashed, WA; Alsheikh-Ali, AA; AlMahmeed, W; Sulaiman, K; Al-Zakwani, I; AlQudaimi, A; Asaad, N; Amin, H				Shehab, Abdulla; Zubaid, Mohammad; Bhagavathula, Akshaya Srikanth; Rashed, Wafa A.; Alsheikh-Ali, Alawi A.; AlMahmeed, Wal; Sulaiman, Kadhim; Al-Zakwani, Ibrahim; AlQudaimi, Ahmed; Asaad, Nidal; Amin, Haitham		Gulf Survey Atrial Fibrillation E	Sex differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Gulf SAFE)	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; EURO HEART SURVEY; RISK STRATIFICATION; PREDICTING STROKE; COHORT; THROMBOEMBOLISM; PREVALENCE; VALIDATION; GUIDELINES; HEALTH	Differences in the management of atrial fibrillation (AF) between men and women were investigated by using Gulf SAFE data in the Middle East. The study included 2,043 patients presenting with AF to emergency room (ER) were prospectively enrolled and followed for one-year. Women were older, have higher body mass index (BMI), comorbidities, and health complications than men. With regard to management of AF, cardioversion was recommended more often for men (16.7% vs. 9.3%), and underwent electrical cardioversion (2.2% vs. 1.1%). Women were prescribed digoxin more frequently than men (25.6% vs. 17.4%) and a significant number women received warfarin alone (31.1% vs. 8.7%). No difference between the sexes was noticed in One-year rates of stroke/transient ischemic attacks (TIA) and all-cause of mortality after one-year follow-up (3.1% men vs. 3.3% women, and 7.5% vs. 7.4%). Older age (>= 65 years), smoking, alcohol use, CHADS2 scores >= 5 were some of the significant risk factors in men with AF. Suboptimal use of anticoagulants, higher mortality and stroke/TIA events at one year are high but similar between the sexes. ER management revealed high use of rate control strategy and high rate of hospital admission was noticed in women.	[Shehab, Abdulla] UAE Univ, Dept Internal Med, Fac Med, Al Ain, U Arab Emirates; [Zubaid, Mohammad] Kuwait Univ, Dept Med, Fac Med, Kuwait, Kuwait; [Bhagavathula, Akshaya Srikanth] Univ Gondar, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia; [Rashed, Wafa A.] Kuwait Univ, Mubarak Al Kabeer Hosp, Dept Med, Minist Hlth, Kuwait, Kuwait; [Alsheikh-Ali, Alawi A.; AlMahmeed, Wal] Sheikh Khalifa Med City, Div Cardiol, Abu Dhabi, U Arab Emirates; [Sulaiman, Kadhim] Royal Hosp, Muscat, Oman; [Al-Zakwani, Ibrahim] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Pharmacol & Clin Pharm, Muscat, Oman; [Al-Zakwani, Ibrahim] Gulf Hlth Res, Muscat, Oman; [AlQudaimi, Ahmed] Al Thawra Hosp, Sanaa, Yemen; [Asaad, Nidal] Hamad Med Corp, Dept Cardiol & Cardiovasc Surg, Doha, Qatar; [Amin, Haitham] Mohammed Bin Khalifa Cardiac Ctr, Manama, Bahrain	United Arab Emirates University; Kuwait University; University of Gondar; Kuwait University; Mubarak Al-Kabeer Hospital; The Royal Hospital, Sultanate of Oman; Sultan Qaboos University; Hamad Medical Corporation	Shehab, A (corresponding author), UAE Univ, Dept Internal Med, Fac Med, Al Ain, U Arab Emirates.	A.Shehab@uaeu.ac.ae	Bhagavathula, Akshaya Srikanth/G-6649-2015; Al-Zakwani, Ibrahim/ABI-2951-2020; Bhagavathula, Akshaya/GQH-1302-2022	Bhagavathula, Akshaya Srikanth/0000-0002-0581-7808; Al-Zakwani, Ibrahim/0000-0002-3626-4230	Sanofi Aventis	Sanofi Aventis(Sanofi-Aventis)	This research was supported by Sanofi Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065795; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; Friberg L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3522; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Heeringa J, 2010, EUROPACE, V12, P451, DOI 10.1093/europace/euq056; JCS Joint Working Group, 2014, CIRC J, V78, P1997; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Madias C, 2011, WOMENS HEALTH, V7, P375, DOI [10.2217/whe.11.29, 10.2217/WHE.11.29]; Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Potpara TS, 2012, INT J CARDIOL, V161, P39, DOI 10.1016/j.ijcard.2011.04.022; Riesgo A, 2011, REV ESP CARDIOL, V64, P233, DOI 10.1016/j.recesp.2010.04.002; Scheuermeyer FX, 2015, ACAD EMERG MED, V22, P1067, DOI 10.1111/acem.12750; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Verma A, 2014, CAN J CARDIOL, V30, P1114, DOI 10.1016/j.cjca.2014.08.001; Wagstaff AJ, 2014, QJM-INT J MED, V107, P955, DOI 10.1093/qjmed/hcu054; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304; Zhu W, 2016, CLIN CARDIOL; Zubaid M, 2015, ANGIOLOGY, V66, P464, DOI 10.1177/0003319714536980; Zubaid M, 2011, CIRC-CARDIOVASC QUAL, V4, P477, DOI 10.1161/CIRCOUTCOMES.110.959700	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175405	10.1371/journal.pone.0175405	http://dx.doi.org/10.1371/journal.pone.0175405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520719	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700002
J	Zhang, XH; Ruan, ZQ; You, XX; Wang, JT; Chen, JM; Peng, C; Shi, Q				Zhang, Xinhui; Ruan, Zhiqiang; You, Xinxin; Wang, Jintu; Chen, Jieming; Peng, Chao; Shi, Qiong			De novo assembly and comparative transcriptome analysis of the foot from Chinese green mussel (Perna viridis) in response to cadmium stimulation	PLOS ONE			English	Article							RNA-SEQ; MYTILUS-EDULIS; HEAVY-METALS; ASPERGILLUS-FLAVUS; GENE-EXPRESSION; BYSSUS; BINDING; PROTEIN; TYROSINASE; COLLAGEN	The Chinese green mussel, Perna viridis, is a marine bivalve with important economic values as well as biomonitoring roles for aquatic pollution. Byssus, secreted by the foot gland, has been proved to bind heavy metals effectively. In this study, using the RNA sequencing technology, we performed comparative transcriptomic analysis on the mussel feet with or without inducing by cadmium (Cd). Our current work is aiming at providing insights into the molecular mechanisms of byssus binding to heavy metal ions. The transcriptome sequencing generated a total of 26.13-Gb raw data. After a careful assembly of clean data, we obtained a primary set of 105,127 unigenes, in which 32,268 unigenes were annotated. Based on the expression profiles, we identified 9,048 differentially expressed genes (DEGs) between Cd treatment (50 or 100 mu g/L) at 48 h and the control, suggesting an extensive transcriptome response of the mussels during the Cd stimulation. Moreover, we observed that the expression levels of 54 byssus protein coding genes increased significantly after the 48-h Cd stimulation. In addition, 16 critical byssus protein coding genes were picked for profiling by quantitative real-time PCR (qRT-PCR). Finally, we reached a primary conclusion that high content of tyrosine (Tyr), cysteine (Cys), histidine (His) residues or the special motif plays an important role in the accumulation of heavy metals in byssus. We also proposed an interesting model for the confirmed byssal Cd accumulation, in which biosynthesis of byssus proteins may play simultaneously critical roles since their transcription levels were significantly elevated.	[Zhang, Xinhui; Shi, Qiong] Shenzhen Univ, Coll Life Sci & Oceanog, Lab Aquat Genom, Shenzhen, Peoples R China; [Zhang, Xinhui; Ruan, Zhiqiang; You, Xinxin; Chen, Jieming; Peng, Chao; Shi, Qiong] BGI, BGI Acad Marine Sci, Shenzhen Key Lab Marine Genom,BGI Fisheries, Guangdong Prov Key Lab Mol Breeding Marine Econ A, Shenzhen, Peoples R China; [Wang, Jintu] BGI, BGI Shenzhen, Shenzhen, Peoples R China	Shenzhen University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Shi, Q (corresponding author), Shenzhen Univ, Coll Life Sci & Oceanog, Lab Aquat Genom, Shenzhen, Peoples R China.; Shi, Q (corresponding author), BGI, BGI Acad Marine Sci, Shenzhen Key Lab Marine Genom,BGI Fisheries, Guangdong Prov Key Lab Mol Breeding Marine Econ A, Shenzhen, Peoples R China.	shiqiong@genomics.cn	You, Xinxin/AAL-2095-2020		BGI-Shenzhen; Special Fund For State Oceanic Administration Scientific Research in the Public Interest [201305018]; Shenzhen Special Program for Future Industrial Development [JSGG20141020113728803]; Zhenjiang Leading Talent Program for Innovation and Entrepreneurship;  [2014AA093501]	BGI-Shenzhen; Special Fund For State Oceanic Administration Scientific Research in the Public Interest; Shenzhen Special Program for Future Industrial Development; Zhenjiang Leading Talent Program for Innovation and Entrepreneurship; 	BGI-Shenzhen provided support in the form of salaries for authors for authors X. Zhang, Z. Ruan, J. Wang, J. Chen, CP, X. You and Q. Shi but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The work is supported by China Project (No. 2014AA093501), Special Fund For State Oceanic Administration Scientific Research in the Public Interest (No. 201305018), Shenzhen Special Program for Future Industrial Development (No. JSGG20141020113728803), and Zhenjiang Leading Talent Program for Innovation and Entrepreneurship.	Acosta V, 2004, CIENC MAR, V30, P323, DOI 10.7773/cm.v30i2.183; Aguilera F, 2014, ACTA BIOMATER, V10, P3855, DOI 10.1016/j.actbio.2014.03.031; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAKER DH, 1987, J NUTR, V117, P1003, DOI 10.1093/jn/117.6.1003; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Choi YS, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-139; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830; Ferreira A. G, 2005, Braz. J. Biol., V65, P67, DOI 10.1590/S1519-69842005000100010; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Goswami P, 2014, J ENVIRON SCI HEAL A, V49, P1564, DOI 10.1080/10934529.2014.938534; Guerette PA, 2013, NAT BIOTECHNOL, V31, P908, DOI 10.1038/nbt.2671; Hedlund J, 2009, BIOMACROMOLECULES, V10, P845, DOI 10.1021/bm801325j; HOLT GD, 1989, J BIOL CHEM, V264, P12138; Huang L, 2015, ENVIRON POLLUT, V196, P350, DOI 10.1016/j.envpol.2014.10.019; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004; INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698; Iseli C, 1999, ESTSCAN PROGRAM DETE; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Leung PTY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-804; Lin JQ, 2013, FUNGAL GENET BIOL, V56, P78, DOI 10.1016/j.fgb.2013.04.007; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0759; Lucas JM, 2002, J EXP BIOL, V205, P1807; Mejare M, 2001, TRENDS BIOTECHNOL, V19, P67, DOI 10.1016/S0167-7799(00)01534-1; Miao Y, 2015, MAR BIOTECHNOL, V17, P523, DOI 10.1007/s10126-015-9635-y; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicholson S, 2005, ENVIRON INT, V31, P121, DOI 10.1016/j.envint.2004.05.007; Numata K, 2014, BIOMACROMOLECULES, V15, P3206, DOI 10.1021/bm5009052; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pinto R, 2015, MAR POLLUT BULL, V91, P418, DOI 10.1016/j.marpolbul.2014.09.059; Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623; Quig D, 1998, Altern Med Rev, V3, P262; Rebl A, 2014, MAR BIOTECHNOL, V16, P333, DOI 10.1007/s10126-013-9552-x; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Spritz RA, 1997, J INVEST DERMATOL, V109, P207, DOI 10.1111/1523-1747.ep12319351; Suarez-Ulloa V, 2013, MAR DRUGS, V11, P4370, DOI 10.3390/md11114370; Suhre MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4392; Sun CJ, 2002, BIOMACROMOLECULES, V3, P1240, DOI 10.1021/bm0255903; Swann CP, 1998, COMP BIOCHEM PHYS B, V119, P755, DOI 10.1016/S0305-0491(98)00052-2; Szefer P, 1997, ARCH ENVIRON CON TOX, V32, P184, DOI 10.1007/s002449900173; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3; WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Yap CK, 2006, ECOTOX ENVIRON SAFE, V63, P413, DOI 10.1016/j.ecoenv.2005.02.005; Yap CK, 2003, HYDROBIOLOGIA, V498, P151, DOI 10.1023/A:1026221930811; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu JJ, 2011, FEMS MICROBIOL LETT, V322, P145, DOI 10.1111/j.1574-6968.2011.02345.x; Zhao H, 2006, BIOCHEMISTRY-US, V45, P14223, DOI 10.1021/bi061677n; Zhao X. K., 1994, TROPIC OCEANOLOGY, P62	60	10	10	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176677	10.1371/journal.pone.0176677	http://dx.doi.org/10.1371/journal.pone.0176677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520756	Green Submitted, gold, Green Published			2022-12-27	WOS:000401487700026
J	Laeremans, M; Dons, E; Avila-Palencia, I; Carrasco-Turigas, G; Orjuela, JP; Anaya, E; Brand, C; Cole-Hunter, T; de Nazelle, A; Gotschi, T; Kahlmeier, S; Nieuwenhuijsen, M; Standaert, A; De Boever, P; Panis, LI				Laeremans, Michelle; Dons, Evi; Avila-Palencia, Ione; Carrasco-Turigas, Gloria; Pablo Orjuela, Juan; Anaya, Esther; Brand, Christian; Cole-Hunter, Tom; de Nazelle, Audrey; Gotschi, Thomas; Kahlmeier, Sonja; Nieuwenhuijsen, Mark; Standaert, Arnout; De Boever, Patrick; Panis, Luc Int			Physical activity and sedentary behaviour in daily life: A comparative analysis of the Global Physical Activity Questionnaire (GPAQ) and the SenseWear armband	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; SELF-REPORT MEASURES; METABOLIC SYNDROME; VALIDITY; RELIABILITY; VALIDATION; RECALL; EXERCISE; MONITORS; WALKING	Reduction of sedentary time and an increase in physical activity offer potential to improve public health. However, quantifying physical activity behaviour under real world conditions is a major challenge and no standard of good practice is available. Our aim was to compare the results of physical activity and sedentary behaviour obtained with a self-reported instrument (Global Physical Activity Questionnaire (GPAQ)) and a wearable sensor (SenseWear) in a repeated measures study design. Healthy adults (41 in Antwerp, 41 in Barcelona and 40 in London) wore the SenseWear armband for seven consecutive days and completed the GPAQ on the final day. This was repeated three times. We used the Wilcoxon signed rank sum test, Spearman correlation coefficients, mixed effects regression models and Bland-Altman plots to study agreement between both methods. Mixed models were used to assess the effect of personal characteristics on the absolute and relative difference between estimates obtained with the GPAQ and SenseWear. Moderate to vigorous energy expenditure and duration derived from the GPAQ were significantly lower (p<0.05) compared to the SenseWear, yet these variables showed significant correlations ranging from 0.45 to 0.64. Estimates of vigorous-intensity physical activity in particular showed high similarity (r>0.59). Results for sedentary behaviour did not differ, yet were poorly correlated (r<0.25). The differences between all variables were reproducible across repeated measurements. In addition, we observed a relationship between these differences and BMI, body fat and physical activity domain. Due to the lack of a standardized protocol, results from different studies measuring physical activity and sedentary behaviour are difficult to compare. Therefore, we suggested an easy-to-implement approach for future studies adding the GPAQ to the wearable of choice as a basis for comparisons.	[Laeremans, Michelle; Dons, Evi; Standaert, Arnout; De Boever, Patrick; Panis, Luc Int] Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit MRG, Mol, Belgium; [Laeremans, Michelle; Panis, Luc Int] Hasselt Univ, Transportat Res Inst IMOB, Diepenbeek, Belgium; [Dons, Evi; De Boever, Patrick] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Avila-Palencia, Ione; Carrasco-Turigas, Gloria; Cole-Hunter, Tom; Nieuwenhuijsen, Mark] Ctr Res Environm Epidemiol, ISGlobal, Barcelona, Spain; [Avila-Palencia, Ione; Carrasco-Turigas, Gloria; Cole-Hunter, Tom; Nieuwenhuijsen, Mark] Univ Pompeu Fabra, Barcelona, Spain; [Avila-Palencia, Ione; Carrasco-Turigas, Gloria; Cole-Hunter, Tom; Nieuwenhuijsen, Mark] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Pablo Orjuela, Juan; Anaya, Esther; de Nazelle, Audrey] Imperial Coll London, CEP, London, England; [Brand, Christian] Univ Oxford, Transport Studies Unit, Oxford, England; [Cole-Hunter, Tom] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Gotschi, Thomas; Kahlmeier, Sonja] Univ Zurich, Epidemiol Biostat & Prevent Inst, Phys Act & Hlth Unit, Zurich, Switzerland	VITO; Hasselt University; Hasselt University; ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of London; London School Economics & Political Science; University of Oxford; Colorado State University; University of Zurich	Panis, LI (corresponding author), Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit MRG, Mol, Belgium.; Panis, LI (corresponding author), Hasselt Univ, Transportat Res Inst IMOB, Diepenbeek, Belgium.	luc.intpanis@vito.be	Gotschi, Thomas/AAL-4108-2021; Cole-Hunter, Thomas Anthony/N-4063-2014; De Boever, Patrick/AAA-8387-2019; Avila-Palencia, Ione/J-1062-2018; Boig, Esther Anaya/K-5395-2015; Kahlmeier, Sonja/B-8141-2014; Dons, Evi/H-7913-2019; Brand, Christian/ABF-1401-2020; Nieuwenhuijsen, Mark J/C-3914-2017; Panis, Luc Int/C-8717-2009	Cole-Hunter, Thomas Anthony/0000-0002-6827-6084; De Boever, Patrick/0000-0002-5197-8215; Avila-Palencia, Ione/0000-0002-4353-2256; Boig, Esther Anaya/0000-0002-9204-534X; Kahlmeier, Sonja/0000-0001-6905-9244; Dons, Evi/0000-0002-6745-7246; Brand, Christian/0000-0002-1535-5328; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Panis, Luc Int/0000-0002-2558-4351; de Nazelle, Audrey/0000-0002-1092-3971; Laeremans, Michelle/0000-0002-1406-7893	European Union [602624]; VITO PhD scholarship; FWO Research Foundation Flanders [12L8815N]; Colciencias (Administrative Department of Science, Technology and Innovation of the Colombian Government) [646]; EPSRC [EP/L024756/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L024756/1] Funding Source: researchfish	European Union(European Commission); VITO PhD scholarship; FWO Research Foundation Flanders(FWO); Colciencias (Administrative Department of Science, Technology and Innovation of the Colombian Government)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research received funding from the European Union's Seventh Framework Program to the PASTA project under grant agreement No. 602624 (FP7-HEALTH-2013-INNOVATION-1) (Physical Activity through Sustainable Transport Approaches). Michelle Laeremans is supported by a VITO PhD scholarship (no grant number; www.vito.be). Evi Dons holds a postdoctoral scholarship from FWO Research Foundation Flanders (grant number: 12L8815N; www.fwo.be). Juan Pablo Orjuela received a beneficiary grant from Colciencias (Administrative Department of Science, Technology and Innovation of the Colombian Government) (grant number 646; www.colciencias.gov.co). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107039; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2014, HLTH EC ASSESSMENT T; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Berntsen S, 2010, BRIT J SPORT MED, V44, P657, DOI 10.1136/bjsm.2008.048868; Bland J.M., 1996, BMJ-BRIT MED J, V312, p572a; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Brazeau AS, 2016, J SCI MED SPORT, V19, P46, DOI 10.1016/j.jsams.2014.11.001; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Cleland CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1255; Clemes SA, 2012, J PHYS ACT HEALTH, V9, P533, DOI 10.1123/jpah.9.4.533; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dons E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2453-3; Durante R, 1996, MED SCI SPORT EXER, V28, P1282, DOI 10.1097/00005768-199610000-00012; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Gerike R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009924; Gomersall SR, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5531; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Herrmann SD, 2013, MEAS PHYS EDUC EXERC, V17, P221, DOI 10.1080/1091367X.2013.805139; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; John D, 2013, SENSORS-BASEL, V13, P14754, DOI 10.3390/s131114754; Keadle SK, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-12; Koehler K, 2011, MED SCI SPORT EXER, V43, P1328, DOI 10.1249/MSS.0b013e31820750f5; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mackey DC, 2011, J GERONTOL A-BIOL, V66, P1108, DOI 10.1093/gerona/glr101; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Peterman JE, 2016, EUR J APPL PHYSIOL, V116, P1565, DOI 10.1007/s00421-016-3408-9; Philippaerts RM, 2001, INT J SPORTS MED, V22, P34, DOI 10.1055/s-2001-11359; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Scheers T, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-71; Sjostrom M., 2002, SCAND J NUTR, V46, P123, DOI [DOI 10.1080/11026480260363251, 10.1080/11026480260363251]; Sperlich B, 2012, EUR J APPL PHYSIOL, V112, P4015, DOI 10.1007/s00421-012-2382-0; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Strath SJ, 2003, MED SCI SPORT EXER, V35, P2112, DOI 10.1249/01.MSS.0000099091.38917.76; Van Hoye A, 2014, SCI SPORT, V29, P78, DOI 10.1016/j.scispo.2013.01.010; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624; Welk GJ, 2014, MED SCI SPORT EXER, V46, P2014, DOI 10.1249/MSS.0000000000000314; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Health Organization, GLOB PHYS ACT QUEST; World Health Organization, WHO STEPWISE APPR NO	50	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177765	10.1371/journal.pone.0177765	http://dx.doi.org/10.1371/journal.pone.0177765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520781	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000401485500068
J	Lam, HV; Nguyen, DT; Nguyen, CD				Lam, Hoang V.; Nguyen, Dat T.; Nguyen, Cao D.			Sibling method increases risk assessment estimates for type 1 diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL; PATHOGENESIS; NEPHROPATHY; CONCORDANCE; PREVENTION; MELLITUS; LINKAGE; COHORT	We presented a risk assessment model to distinguish between type 1 diabetes (T1D) affected and unaffected siblings using only three single nucleotide polymorphism (SNP) genotypes. In addition we calculated the heritability from genome-wide identity-by-descent (IBD) sharing between full siblings. We analyzed 1,253 pairs of affected individuals and their unaffected siblings (750 pairs from a discovery set and 503 pairs from a validation set) from the T1D Genetics Consortium (T1DGC), applying a logistic regression to analyze the area under the receiver operator characteristic (ROC) curve (AUC). To calculate the heritability of T1D we used the Haseman-Elston regression analysis of the squared difference between the phenotypes of the pairs of siblings on the estimate of their genome-wide IBD proportion. The model with only 3 SNPs achieving an AUC of 0.75 in both datasets outperformed the model using the presence of the high-risk DR3/4 HLA genotype, namely AUC of 0.60. The heritability on the liability scale of T1D was approximately from 0.53 to 0.92, close to the results obtained from twin studies, ranging from 0.4 to 0.88.	[Lam, Hoang V.] Cho Ray Hosp, Dept Endocrinol, Ho Chi Minh City, Vietnam; [Nguyen, Dat T.] Hoa Sen Univ, Dept Sci & Technol, Ho Chi Minh City, Vietnam; [Nguyen, Cao D.] Econ Univ, Dept Business & Informat Syst, Ho Chi Minh City, Vietnam; [Nguyen, Cao D.] Clin Anal & Modelling Dept Hlth, Perth, WA, Australia	Hoa Sen University; Vietnam National University Hochiminh City	Nguyen, CD (corresponding author), Econ Univ, Dept Business & Informat Syst, Ho Chi Minh City, Vietnam.; Nguyen, CD (corresponding author), Clin Anal & Modelling Dept Hlth, Perth, WA, Australia.	cao.nguyen@health.wa.gov.au						Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bates D., 2014, IME4 LINEAR MIXED EF; Bjornstad P, 2014, CURR OPIN ENDOCRINOL, V21, P279, DOI 10.1097/MED.0000000000000074; Bjornstad P, 2013, DIABETES CARE, V36, P3678, DOI 10.2337/dc13-0631; Bresson D, 2009, DIABETES CARE, V32, P1753, DOI 10.2337/dc09-0373; Cameron FJ, 2014, DIABETES CARE, V37, P1554, DOI 10.2337/dc13-1904; Efron B., 1992, BREAKTHROUGHS STAT, P569, DOI DOI 10.1007/978-1-4612-4380-9_41; Epstein CJ, 2006, AM J HUM GENET, V79, P434, DOI 10.1086/507610; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gillespie KM, 2006, CAN MED ASSOC J, V175, P165, DOI 10.1503/cmaj.060244; Hagopian WA, 2006, ANN NY ACAD SCI, V1079, P320, DOI 10.1196/annals.1375.049; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hyttinen V., 2003, DIABETES, V52, P1052; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Krischer J, 2007, PEDIATR DIABETES, V8, P117, DOI 10.1111/j.1399-5448.2007.00239.x; KYVIK KO, 1995, BRIT MED J, V311, P913; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lu Q, 2010, BIOMETRICS, V66, P586, DOI 10.1111/j.1541-0420.2009.01278.x; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Morahan G, 2010, HLA COMPLEX BIOL MED, P205; Morahan G, 2012, CURR OPIN ENDOCRINOL, V19, P263, DOI 10.1097/MED.0b013e328355b7fe; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Nguyen C, 2013, DIABETES, V62, P2135; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P14, DOI 10.1196/annals.1447.054; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Virtanen SM, 2006, DIABETOLOGIA, V49, P1512, DOI 10.1007/s00125-006-0236-1; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Ziegler AG, 2016, DIABETES, V65, P3233, DOI 10.2337/db16-0687	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176341	10.1371/journal.pone.0176341	http://dx.doi.org/10.1371/journal.pone.0176341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510587	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500006
J	Hammond, NE; Taylor, C; Finfer, S; Machado, FR; An, YZ; Billot, L; Bloos, F; Bozza, F; Cavalcanti, AB; Correa, M; Du, B; Hjortrup, PB; Li, Y; McIntryre, L; Saxena, M; Schortgen, F; Watts, NR; Myburgh, J				Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Machado, Flavia R.; An, YouZhong; Billot, Laurent; Bloos, Frank; Bozza, Fernando; Cavalcanti, Alexandre Biasi; Correa, Maryam; Du, Bin; Hjortrup, Peter B.; Li, Yang; McIntryre, Lauralyn; Saxena, Manoj; Schortgen, Frederique; Watts, Nicola R.; Myburgh, John		Fluid-TRIPS Fluidos Investigators; George Inst Global Hlth; ANZICS Clinical Trials Grp; BRICNet; REVA Res Network	Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; HYDROXYETHYL STARCH 130/0.4; CRITICALLY-ILL ADULTS; KIDNEY INJURY; ASSOCIATION; SEPSIS; SALINE; CHOICE; SCORE; SHOCK	Background In 2007, the Saline versus Albumin Fluid Evaluation D Translation of Research Into Practice Study (SAFE-TRIPS) reported that 0.9% sodium chloride (saline) and hydroxyethyl starch (HES) were the most commonly used resuscitation fluids in intensive care unit (ICU) patients. Evidence has emerged since 2007 that these fluids are associated with adverse patient-centred outcomes. Based on the published evidence since 2007, we sought to determine the current type of fluid resuscitation used in clinical practice and the predictors of fluid choice and determine whether these have changed between 2007 and 2014. Methods In 2014, an international, cross-sectional study was conducted (Fluid-TRIPS) to document current patterns of intravenous resuscitation fluid use and determine factors associated with fluid choice. We examined univariate and multivariate associations between patients and prescriber characteristics, geographical region and fluid type. Additionally, we report secular trends of resuscitation fluid use in a cohort of ICUs that participated in both the 2007 and 2014 studies. Regression analysis were conducted to determine changes in the administration of crystalloid or colloid between 2007 and 2014. Findings In 2014, a total of 426 ICUs in 27 countries participated. Over the 24 hour study day, 1456/ 6707 (21.7%) patients received resuscitation fluid during 2716 resuscitation episodes. Crystalloids were administered to 1227/1456 (84.3%) patients during 2208/2716 (81.3%) episodes and colloids to 394/1456 (27.1%) patients during 581/2716 (21.4%) episodes. In multivariate analyses, practice significantly varied between geographical regions. Additionally, patients with a traumatic brain injury were less likely to receive colloid when compared to patients with no trauma (adjusted OR 0.24; 95% CI 0.1 to 0.62; p = 0.003). Patients in the ICU for one or more days where more likely to receive colloid compared to patients in the ICU on their admission date (adjusted OR 1.75; 95% CI 1.27 to 2.41; p = < 0.001). For secular trends in fluid resuscitation, 84 ICUs in 17 countries contributed data. In 2007, 527/1663 (31.7%) patients received fluid resuscitation during 1167 episodes compared to 491/1763 (27.9%) patients during 960 episodes in 2014. The use of crystalloids increased from 498/1167 (42.7%) in 2007 to 694/960 (72.3%) in 2014 (odds ratio (OR) 3.75, 95% confidence interval (CI) 2.95 to 4.77; p = < 0.001), primarily due to a significant increase in the use of buffered salt solutions. The use of colloids decreased from 724/1167 (62.0%) in 2007 to 297/960 (30.9%) in 2014 (OR 0.29, 95% CI 0.19 to 0.43; p = < 0.001), primarily due to a decrease in the use of HES, but an overall increase in the use of albumin. Conclusions Clinical practices of intravenous fluid resuscitation have changed between 2007 and 2014. Geographical location remains a strong predictor of the type of fluid administered for fluid resuscitation. Overall, there is a preferential use of crystalloids, specifically buffered salt solutions, over colloids. There is now an imperative to conduct a trial determining the safety and efficacy of these fluids on patient-centred outcomes.	[Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Correa, Maryam; Li, Yang; Saxena, Manoj; Watts, Nicola R.; Myburgh, John] George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia; [Hammond, Naomi E.; Finfer, Simon] Royal North Shore Hosp, Malcolm Fisher Dept Intens Care Med, Sydney, NSW, Australia; [Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Billot, Laurent] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Hammond, Naomi E.; Saxena, Manoj; Myburgh, John] Univ New South Wales, Fac Med, St George Clin Sch, Sydney, NSW, Australia; [Machado, Flavia R.] Univ Fed Sao Paulo, Pain & Intens Care Dept, Anesthesiol, Sao Paulo, Brazil; Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing, Peoples R China; George Inst Global Hlth, Stat Div, Sydney, NSW, Australia; Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; DOr Inst Res & Educ, Rio De Janeiro, Brazil; Hosp Coracao, Res Inst, Sao Paulo, Brazil; Peking Union Med Coll Hosp, Med Intens Care Unit, Beijing, Peoples R China; Copenhagen Univ Hosp, Rigshosp, Dept Intens Care, Copenhagen, Denmark; Ottawa Hosp, Res Inst, Dept Med Crit Care, Ottawa, ON, Canada; St George Hosp, Dept Intens Care Med, Sydney, NSW, Australia; Reanimat Med Grp Hosp Henri Mondor, Assistance Publ Hop Paris, Creteil, France	George Institute for Global Health; University of Sydney; Royal North Shore Hospital; University of Sydney; University of New South Wales Sydney; Universidade Federal de Sao Paulo (UNIFESP); Peking University; George Institute for Global Health; University of Sydney; Friedrich Schiller University of Jena; IDOR - Instituto D'Or de Ensino e Pesquisa; Hospital do Coracao - HCor; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Rigshospitalet; University of Copenhagen; University of Ottawa; Ottawa Hospital Research Institute; St George Hospital; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Hammond, NE (corresponding author), George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Royal North Shore Hosp, Malcolm Fisher Dept Intens Care Med, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Univ New South Wales, Fac Med, St George Clin Sch, Sydney, NSW, Australia.	nhammond@georgeinstitute.org.au	Bozza, Fernando A/A-2618-2013; Colombo, Riccardo/AAK-9081-2020; Billot, Laurent/Y-1241-2019; Biondi, Rodrigo S/H-5212-2016; Christian, Michael/AAZ-4452-2020; Bloos, Frank/AAY-8265-2020; Christian, Mike/AAO-6338-2020; Cavalcanti, Alexandre/K-5529-2013; Du, Bin/K-4283-2013	Bozza, Fernando A/0000-0003-4878-0256; Colombo, Riccardo/0000-0002-9616-803X; Billot, Laurent/0000-0002-4975-9793; Biondi, Rodrigo S/0000-0002-9242-6062; Christian, Michael/0000-0001-9644-9950; Bloos, Frank/0000-0002-0767-7941; Christian, Mike/0000-0001-9644-9950; Cavalcanti, Alexandre/0000-0003-2798-6263; da Costa Nunes Bosso, Carlos Eduardo/0000-0001-8216-4372; Micallef, Sharon/0000-0002-8496-2324; Hammond, Naomi/0000-0002-6559-7747; Saxena, Manoj/0000-0002-0385-6731; Finfer, Simon/0000-0002-2785-5864; Banner-Goodspeed, Valerie/0000-0002-7644-2521; Schortgen, Frederique/0000-0003-1756-7508; Deeb, Ahmad/0000-0002-3680-7338; Du, Bin/0000-0001-6237-2895; Myburgh, John/0000-0003-4088-7016	Baxter Healthcare; CSL Behring; National Health and Medical Research Council of Australia [APP1039312]	Baxter Healthcare; CSL Behring; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was partially supported by unrestricted fluid grants from Baxter Healthcare and CSL Behring paid to The George Institute for Global Health. NH received a National Health and Medical Research Council of Australia Postgraduate Scholarship (2012-2014) that has supported part of this work [APP1039312]. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation of the manuscript; or decision to submit the manuscript for publication.	Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Cecconi M, 2015, INTENS CARE MED, V41, P1529, DOI 10.1007/s00134-015-3850-x; EMA, 2013, PRAC REC SUSP MARK A; FDA, 2013, HYDR STARCH SOL FDA; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Hammond NE, 2015, INTENS CARE MED, V41, P1611, DOI 10.1007/s00134-015-3878-y; Hammond Naomi, 2015, Rev. bras. ter. intensiva, V27, P309, DOI 10.5935/0103-507X.20150053; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krajewski ML, 2015, BRIT J SURG, V102, P24, DOI 10.1002/bjs.9651; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MHRA, 2013, HYDR STARCH HES PROD; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; R Core Team, 2013, R LANG ENV STAT COMP; Raghunathan K, 2015, ANESTHESIOLOGY, V123, P1385, DOI 10.1097/ALN.0000000000000861; Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305; Shaw AD, 2014, INTENS CARE MED, V40, P1897, DOI 10.1007/s00134-014-3505-3; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; TGA, 2014, HYDR STRACH VOL VOL; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	30	64	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176292	10.1371/journal.pone.0176292	http://dx.doi.org/10.1371/journal.pone.0176292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498856	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314500003
J	Sadeh, D; Nitzan, N; Shachter, A; Chaimovitsh, D; Dudai, N; Ghanim, M				Sadeh, Dganit; Nitzan, Nadav; Shachter, Alona; Chaimovitsh, David; Dudai, Nativ; Ghanim, Murad			Whitefly attraction to rosemary (Rosmarinus officinialis L.) is associated with volatile composition and quantity	PLOS ONE			English	Article							BEMISIA-TABACI; INSECTICIDES; OFFICINALIS; BIOTYPES	Whitefly (Bemisia tabaci) is an important insect pest, causing severe damage to agricultural crops. The pest was recorded in a commercial rosemary (Rosmarinus officinalis, Lamiaceae) field, colonizing rosemary variety (var.) '2', but not '11'. A series of field and controlled laboratory choice bioassays confirmed the observed phenomenon. Mature potted plants of the two varieties were randomly organized in a lemon verbena (Lippia citrodora) and lemon grass (Cymbopogon spp.) fields. Seven days later var. '2'was significantly more colonized by whiteflies than var. '11'. Under lab conditions, whiteflies were significantly more attracted to var. '2'plantlets than to var. '11'following choice bioassays. Furthermore, cotton plants dipped in an essential oil emulsion of var. '2'had significantly greater colonization than cotton plants dipped in the essential oil emulsion of var. '11'. Similar results were obtained in 'plant-plant', 'plant-no plant'as well as, 'essential oil D essential oil'choice bioassay designs. Analyses of the essential oils of the two varieties identified a set of common and unique volatiles in each variety. Among these volatiles were beta-caryophyllene and limonene, two compounds known to be associated with plantinsect interactions. The attraction of B. tabaci to pure (> 95%) beta-caryophyllene and limonene using a range of concentrations was examined in vitro by choice bioassays. The compounds were attractive to the insect at moderate concentration, but not at the lowest or highest concentrations used, where the insect was not attracted or repelled, respectively. Limonene attracted the insects at rates that were 10-fold lower than beta-caryophyllene. The results emphasized the role of host plant volatiles in shaping the structure of B. tabaci populations in nature and in agricultural systems, and provided insights into the factors that contribute to the development of insect populations with unique characteristics. The results could also serve for future development of bio-pesticides and in breeding programs.	[Sadeh, Dganit; Nitzan, Nadav; Shachter, Alona; Chaimovitsh, David; Dudai, Nativ] ARO, Newe Yaar Res Ctr, Unit Aromat & Med plants, Ramat Yishay, Israel; [Sadeh, Dganit; Ghanim, Murad] ARO, Volcani Ctr, Dept Entomol, Bet Dagan, Israel; [Sadeh, Dganit; Dudai, Nativ; Ghanim, Murad] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Dudai, N (corresponding author), ARO, Newe Yaar Res Ctr, Unit Aromat & Med plants, Ramat Yishay, Israel.; Ghanim, M (corresponding author), ARO, Volcani Ctr, Dept Entomol, Bet Dagan, Israel.; Dudai, N; Ghanim, M (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel.	ghanim@agri.gov.il; nativdud@agri.gov.il						Ahn YJ, 2006, ADV PHYTOMED, V3, P269; Alvarez A, 2012, FOOD CHEM, V132, P1395, DOI 10.1016/j.foodchem.2011.11.127; Apel MA, 2009, PARASITOL RES, V105, P863, DOI 10.1007/s00436-009-1455-4; Baldin ELL, 2013, J PEST SCI, V86, P301, DOI 10.1007/s10340-012-0462-x; Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK, 1994, FAO PLANT PROTECT B, V42, P2; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Caspi-Fluger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021096; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Delatte H, 2009, BIOL INVASIONS, V11, P1059, DOI 10.1007/s10530-008-9328-9; Deletre E, 2016, PEST MANAG SCI, V72, P179, DOI 10.1002/ps.3987; Dudai N, 2012, ACTA HORTIC, V955, P175, DOI 10.17660/ActaHortic.2012.955.25; Dudai N, 2007, ISRAEL PLANT BREEDER, V69, P23; El Omari A, 2012, J ETHNOPHARMACOL, V131, P451; Firdaus S, 2013, INSECT SCI, V20, P723, DOI 10.1111/1744-7917.12001; Horowitz AR, 2014, PEST MANAG SCI, V70, P1568, DOI 10.1002/ps.3752; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huang M, 2012, NEW PHYTOL, V193, P997, DOI 10.1111/j.1469-8137.2011.04001.x; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Li YF, 2014, ARTHROPOD-PLANT INTE, V8, P183, DOI 10.1007/s11829-014-9302-7; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Mahmoodi Leila, 2014, Journal of Plant Protection Research, V54, P294, DOI 10.2478/jppr-2014-0044; McCormick AC, 2014, PLANT CELL ENVIRON, V37, P1836, DOI 10.1111/pce.12357; Mena P, 2016, MOLECULES, V21, DOI 10.3390/molecules21111576; Navarrete A, 2011, J FOOD ENG, V104, P196, DOI 10.1016/j.jfoodeng.2010.10.033; Ngo SNT, 2011, CRIT REV FOOD SCI, V51, P946, DOI 10.1080/10408398.2010.490883; Pengelly A, 2012, J MED FOOD, V15, P10, DOI 10.1089/jmf.2011.0005; Raiciu AD, 2010, FARMACIA, V58, P735; Ravid U, 1994, ISRAEL AGRESEARCH, V7, P85; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Soliman MM, 2007, ARCH PHYTOPATHOL PLA, V40, P128; Sun DB, 2013, B ENTOMOL RES, V103, P344, DOI 10.1017/S0007485312000788; Tan XL, 2014, ENTOMOL EXP APPL, V151, P259, DOI 10.1111/eea.12190; Tosh CR, 2015, AGRON SUSTAIN DEV, V35, P183, DOI 10.1007/s13593-014-0219-4; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Yanishlieva NV, 2006, EUR J LIPID SCI TECH, V108, P776, DOI 10.1002/ejlt.200600127; Zavala Jorge A., 2004, BMC Ecology, V4, P11, DOI 10.1186/1472-6785-4-11; Zoubiri S, 2014, J SAUDI CHEM SOC, V18, P925, DOI 10.1016/j.jscs.2011.11.015	48	22	23	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177483	10.1371/journal.pone.0177483	http://dx.doi.org/10.1371/journal.pone.0177483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498837	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314500021
J	Zhang, HH; Peng, Y; Tian, GD; Wang, DQ; Xie, PP				Zhang, Honghao; Peng, Yong; Tian, Guangdong; Wang, Danqi; Xie, Pengpeng			Green material selection for sustainability: A hybrid MCDM approach	PLOS ONE			English	Article							DECISION-MAKING METHODOLOGY; MODEL COMBINING DANP; VIKOR METHOD; CONSTRUCTION-INDUSTRY; RELATIONAL ANALYSIS; COMPROMISE RANKING; OPTIMIZATION MODEL; MULTIPLE CRITERIA; FUZZY VIKOR; AHP	Green material selection is a crucial step for the material industry to comprehensively improve material properties and promote sustainable development. However, because of the subjectivity and conflicting evaluation criteria in its process, green material selection, as a multi-criteria decision making (MCDM) problem, has been a widespread concern to the relevant experts. Thus, this study proposes a hybrid MCDM approach that combines decision making and evaluation laboratory (DEMATEL), analytical network process (ANP), grey relational analysis (GRA) and technique for order performance by similarity to ideal solution (TOPSIS) to select the optimal green material for sustainability based on the product's needs. A nonlinear programming model with constraints was proposed to obtain the integrated closeness index. Subsequently, an empirical application of rubbish bins was used to illustrate the proposed method. In addition, a sensitivity analysis and a comparison with existing methods were employed to validate the accuracy and stability of the obtained final results. We found that this method provides a more accurate and effective decision support tool for alternative evaluation or strategy selection.	[Zhang, Honghao; Peng, Yong; Xie, Pengpeng] Cent S Univ, Sch Traff & Transportat Engn, Key Lab Traff Safety Track, Minist Educ, Changsha, Hunan, Peoples R China; [Tian, Guangdong] Jilin Univ, Transportat Coll, Changchun, Peoples R China; [Wang, Danqi] Jilin Univ, Coll Automot Engn, Changchun, Peoples R China	Central South University; Jilin University; Jilin University	Peng, Y (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Key Lab Traff Safety Track, Minist Educ, Changsha, Hunan, Peoples R China.; Tian, GD (corresponding author), Jilin Univ, Transportat Coll, Changchun, Peoples R China.	yong_peng@csu.edu.cn; tiangd2013@163.com	Wang, Danqi/GSN-5245-2022	PENG, Yong/0000-0003-0101-0342	National Natural Science Foundation of China [51405517, U1334208, 51405075]; Natural Science Foundation of Hunan [2015JJ3155]; National Natural Science Foundation of China [51405517, U1334208, 51405075]; Natural Science Foundation of Hunan [2015JJ3155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province)	This work was supported by the National Natural Science Foundation of China (No. 51405517, U1334208 and No. 51405075) and the Natural Science Foundation of Hunan (2015JJ3155).	Ahmadi MH, 2016, RENEW SUST ENERG REV, V60, P784, DOI 10.1016/j.rser.2015.12.181; Akadiri PO, 2013, AUTOMAT CONSTR, V30, P113, DOI 10.1016/j.autcon.2012.10.004; Altuntas S, 2014, INT J ADV MANUF TECH, V73, P749, DOI 10.1007/s00170-014-5826-3; Aly M.F., 2013, INT J INNOV RES SCI, V2, P6464; Anojkumar L, 2015, INT J MATER PROD TEC, V51, P102, DOI 10.1504/IJMPT.2015.071770; Anojkumar L, 2014, EXPERT SYST APPL, V41, P2964, DOI 10.1016/j.eswa.2013.10.028; [Anonymous], 2015, PLOS ONE; [Anonymous], 1981, MULTIPLE ATTRIBUTES; Athawale VM, 2011, INT J ADV MANUF TECH, V57, P11, DOI 10.1007/s00170-011-3293-7; Behzadian M, 2012, EXPERT SYST APPL, V39, P13051, DOI 10.1016/j.eswa.2012.05.056; Bissoli-Dalvi M, 2016, CONSTR BUILD MATER, V106, P357, DOI 10.1016/j.conbuildmat.2015.12.030; Blackstock KL, 2007, ECOL ECON, V60, P726, DOI 10.1016/j.ecolecon.2006.05.014; Brundiers K, 2011, INNOV HIGH EDUC, V36, P107, DOI 10.1007/s10755-010-9161-9; Caliskan H, 2013, MATER DESIGN, V45, P473, DOI 10.1016/j.matdes.2012.09.042; Castellano J, 2014, BUILD ENVIRON, V82, P618, DOI 10.1016/j.buildenv.2014.09.016; Castro-Lacouture D, 2009, BUILD ENVIRON, V44, P1162, DOI 10.1016/j.buildenv.2008.08.009; Chan JWK, 2006, INT J COMPUT APPL T, V26, P210, DOI 10.1504/IJCAT.2006.010766; Chan JWK, 2007, MATER DESIGN, V28, P1539, DOI 10.1016/j.matdes.2006.02.016; Chatterjee P, 2011, MATER DESIGN, V32, P851, DOI 10.1016/j.matdes.2010.07.010; Chatterjee P, 2009, MATER DESIGN, V30, P4043, DOI 10.1016/j.matdes.2009.05.016; Chiu WY, 2013, KNOWL-BASED SYST, V37, P48, DOI 10.1016/j.knosys.2012.06.017; Coelho CRV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160397; Corazza M, 2013, APPL MATH COMPUT, V224, P611, DOI 10.1016/j.amc.2013.07.091; Dagdeviren M, 2009, EXPERT SYST APPL, V36, P8143, DOI 10.1016/j.eswa.2008.10.016; Desai S, 2012, EUR J IND ENG, V6, P322, DOI 10.1504/EJIE.2012.046666; Do JY, 2012, INT J CONCR STRUCT M, V6, P87, DOI 10.1007/s40069-012-0009-9; Florez Laura, 2013, Construction Innovation, V13, P217, DOI 10.1108/14714171311322174; Florez L, 2013, MATER DESIGN, V46, P310, DOI 10.1016/j.matdes.2012.10.013; Girubha RJ, 2012, MATER DESIGN, V37, P478, DOI 10.1016/j.matdes.2012.01.022; Govindan K, 2015, RENEW SUST ENERG REV, V55, p1274 , DOI DOI 10.1016/J.RSER.2015.07.100; Govindan K, 2016, RENEW SUST ENERG REV, V55, P1274, DOI 10.1016/j.rser.2015.07.100; Tzeng GH, 2007, EXPERT SYST APPL, V32, P1028, DOI 10.1016/j.eswa.2006.02.004; Hakkinen T, 2007, CIV ENG ENVIRON SYST, V24, P247, DOI 10.1080/10286600701315880; Hosseinijou SA, 2014, INT J LIFE CYCLE ASS, V19, P620, DOI 10.1007/s11367-013-0658-1; Hsu CH, 2012, RESOUR CONSERV RECY, V66, P95, DOI 10.1016/j.resconrec.2012.02.009; Huang HH, 2011, INT J ADV MANUF TECH, V52, P421, DOI 10.1007/s00170-010-2745-9; Huang HH, 2009, INT J ADV MANUF TECH, V44, P1073, DOI 10.1007/s00170-009-1935-9; Jahan A, 2011, MATER DESIGN, V32, P1215, DOI 10.1016/j.matdes.2010.10.015; Kou G, 2016, TECHNOL ECON DEV ECO, V22, P738, DOI 10.3846/20294913.2016.1210694; Kou G, 2014, INFORM SCIENCES, V275, P1, DOI 10.1016/j.ins.2014.02.137; Kou G, 2014, EUR J OPER RES, V235, P225, DOI 10.1016/j.ejor.2013.10.019; Kou G, 2014, EUR J OPER RES, V236, P261, DOI 10.1016/j.ejor.2013.11.035; Kou G, 2012, INT J INF TECH DECIS, V11, P197, DOI 10.1142/S0219622012500095; Kumar R, 2015, RENEW SUST ENERG REV, V52, P240, DOI 10.1016/j.rser.2015.07.018; Kuo TC, 2015, SUSTAINABILITY-BASEL, V7, P1661, DOI 10.3390/su7021661; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Li GX, 2015, J OPER RES SOC, V66, P1793, DOI 10.1057/jors.2015.1; Liu HC, 2017, ENG APPL ARTIF INTEL, V60, P45, DOI 10.1016/j.engappai.2017.01.012; Liu HC, 2015, APPL SOFT COMPUT, V28, P579, DOI 10.1016/j.asoc.2014.11.036; Liu HC, 2015, RENEW SUST ENERG REV, V41, P932, DOI 10.1016/j.rser.2014.08.061; Liu HC, 2014, MATER DESIGN, V60, P380, DOI 10.1016/j.matdes.2014.03.071; Liu HC, 2013, MATER DESIGN, V52, P158, DOI 10.1016/j.matdes.2013.05.054; Liu HC, 2013, APPL MATH MODEL, V37, P6325, DOI 10.1016/j.apm.2013.01.026; Maity SR, 2013, MATER MANUF PROCESS, V28, P408, DOI 10.1080/10426914.2012.700159; Maniya K, 2010, MATER DESIGN, V31, P1785, DOI 10.1016/j.matdes.2009.11.020; Mayyas A, 2016, INT J SUSTAIN ENG, V9, P292, DOI 10.1080/19397038.2016.1153168; Mayyas A, 2012, RENEW SUST ENERG REV, V16, P1845, DOI 10.1016/j.rser.2012.01.012; Ng CY, 2014, IEEE SYST J, V8, P1182, DOI 10.1109/JSYST.2013.2258217; Nguyen BK, 2011, PROCEDIA ENGINEER, V21, P387, DOI 10.1016/j.proeng.2011.11.2030; Nguyen HT, 2015, PLOS ONE, V10; Onut S, 2009, INT J ADV MANUF TECH, V44, P818, DOI 10.1007/s00170-008-1897-3; Ortiz O, 2009, CONSTR BUILD MATER, V23, P28, DOI 10.1016/j.conbuildmat.2007.11.012; Oztaysi B, 2014, KNOWL-BASED SYST, V70, P44, DOI 10.1016/j.knosys.2014.02.010; Patil SK, 2014, EXPERT SYST APPL, V41, P679, DOI 10.1016/j.eswa.2013.07.093; Prendeville S, 2014, J CLEAN PROD, V85, P31, DOI 10.1016/j.jclepro.2014.05.023; Rahman S, 2012, EXPERT SYST APPL, V39, P6857, DOI 10.1016/j.eswa.2012.01.010; Rao RV, 2008, INT J ADV MANUF TECH, V35, P751, DOI 10.1007/s00170-006-0752-7; Rao RV, 2008, MATER DESIGN, V29, P1949, DOI 10.1016/j.matdes.2008.04.019; Rathod MK, 2011, MATER DESIGN, V32, P3578, DOI 10.1016/j.matdes.2011.02.040; Rezaei J, 2015, OMEGA-INT J MANAGE S, V53, P49, DOI 10.1016/j.omega.2014.11.009; Roth R, 1993, J COMPUTER AIDED MAT, V1, p325 , DOI DOI 10.1007/BF00712855; Saaty T.L., 1996, DECISION MAKING DEPE, VVolume 4922; Shanian A, 2006, MATER DESIGN, V27, P329, DOI 10.1016/j.matdes.2004.10.027; Shanian A, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4006461; Singh S, 2016, INT J ADV MANUF TECH, V84, P547, DOI 10.1007/s00170-015-7553-9; Sun Y, 2009, ENG OPTIMIZ, V41, P989, DOI 10.1080/03052150902787955; Tavana M, 2016, EXPERT SYST APPL, V50, P17, DOI 10.1016/j.eswa.2015.11.007; Tavana M, 2016, APPL SOFT COMPUT, V40, P544, DOI 10.1016/j.asoc.2015.12.005; Tian G, 2016, 2016 IEEE 13 INT C N, P1; Tsai CY, 2012, J CLEAN PROD, V20, P127, DOI 10.1016/j.jclepro.2011.08.009; Turkay M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147502; Tuzkaya G, 2010, EXPERT SYST APPL, V37, P2853, DOI 10.1016/j.eswa.2009.09.004; Tzeng, 2008, INT J OPER RES, V3, P160, DOI DOI 10.1080/14783361003606852; Viegas CV, 2016, J CLEAN PROD, V126, P260, DOI 10.1016/j.jclepro.2016.02.106; Wang YL, 2012, EXPERT SYST APPL, V39, P5600, DOI 10.1016/j.eswa.2011.11.057; Yang YPO, 2013, INFORM SCIENCES, V232, P482, DOI 10.1016/j.ins.2011.09.012; Zhao R, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010079	87	40	42	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177578	10.1371/journal.pone.0177578	http://dx.doi.org/10.1371/journal.pone.0177578			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498864	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500028
J	Charvet, LE; Yang, J; Shaw, MT; Sherman, K; Haider, L; Xu, JJ; Krupp, LB				Charvet, Leigh E.; Yang, Jie; Shaw, Michael T.; Sherman, Kathleen; Haider, Lamia; Xu, Jianjin; Krupp, Lauren B.			Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial	PLOS ONE			English	Article							VERBAL MEMORY; REHABILITATION; SCHIZOPHRENIA; IMPAIRMENT; ADULTS; RISK	Cognitive impairment affects more than half of all individuals living with multiple sclerosis (MS). We hypothesized that training at home with an adaptive online cognitive training program would have greater cognitive benefit than ordinary computer games in cognitively-impaired adults with MS. This was a double-blind, randomized, active-placebo-controlled trial. Participants with MS were recruited through Stony Brook Medicine and randomly assigned to either the adaptive cognitive remediation (ACR) program or active control of ordinary computer games for 60 hours over 12 weeks. Training was remotely-supervised and delivered through a study-provided laptop computer. A computer generated, blocked stratification table prepared by statistician provided the randomization schedule and condition was assigned by a study technician. The primary outcome, administered by study psychometrician, was measured by change in a neuropsychological composite measure from baseline to study end. An intent-to-treat analysis was employed and missing primary outcome values were imputed via Markov Chain Monte Carlo method. Participants in the ACR (n = 74) vs. active control (n = 61) training program had significantly greater improvement in the primary outcome of cognitive functioning (mean change in composite z score +/- SD: 0.25 +/- 0.45 vs. 0.09 +/- 0.37, p = 0.03, estimated difference = 0.16 with 95% CI: 0.02-0.30), despite greater training time in the active control condition (mean +/- SD: 56.9 +/- 34.6 vs. 37.7 +/- 23.8 hours played, p = 0.006). This study provides Class I evidence that adaptive, computer-based cognitive remediation accessed from home can improve cognitive functioning in MS. This telerehabilitation approach allowed for rapid recruitment and high compliance, and can be readily applied to other neurological conditions associated with cognitive dysfunction.	[Charvet, Leigh E.; Shaw, Michael T.; Sherman, Kathleen; Krupp, Lauren B.] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Yang, Jie] Stony Brook Med, Dept Family Populat & Prevent Med, New York, NY USA; [Haider, Lamia] Columbia Univ, Med Ctr, Taub Inst, New York, NY USA; [Xu, Jianjin] Stony Brook Med, Dept Appl Math & Stat, Stony Brook, NY USA	New York University; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Charvet, LE (corresponding author), NYU, Sch Med, Dept Neurol, New York, NY 10016 USA.	leigh.charvet@nyumc.org		Shaw, Michael/0000-0003-4755-4484; krupp, lauren/0000-0001-7003-807X; Charvet, Leigh/0000-0003-4429-9713	National Multiple Sclerosis Society [RG4808A81]; Biostatistical Consulting Core at School of Medicine, Stony Brook University	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Biostatistical Consulting Core at School of Medicine, Stony Brook University	This study was supported by the National Multiple Sclerosis Society, award number: RG4808A81.; We would like to thank Maria Amella, Wendy Fang, Ariana Frontario, Patricia Melville, William Scherl and Colleen Schwarz for their support of this study. We acknowledge the biostatistical consultation and support provided by the Biostatistical Consulting Core at School of Medicine, Stony Brook University.	Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; Benedict RH, 2007, BRIEF VISUOSPATIAL M; Brain HQ, 2015, POSIT SCI; Charvet LMS, 2015, MULTSCLER J EXP TRAN, V1, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1177/2055217315609629; Chiaravalloti ND, 2013, NEUROLOGY, V81, P2066, DOI 10.1212/01.wnl.0000437295.97946.a8; Delis D. C., 2001, DELIS KAPLAN EXECUTI; Fisher M, 2015, SCHIZOPHRENIA BULL, V41, P250, DOI 10.1093/schbul/sbt232; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Gaming H., 2008, LLC; Hancock LM, 2015, J CLIN EXP NEUROPSYC, V37, P113, DOI 10.1080/13803395.2014.989818; Hartman David E, 2009, Appl Neuropsychol, V16, P85, DOI 10.1080/09084280802644466; Keefe RSE, 2012, J CLIN PSYCHIAT, V73, P1016, DOI 10.4088/JCP.11m07100; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Little R. J. A., 1987, STAT ANAL MISSING DA; Loewy R, 2016, SCHIZOPHRENIA BULL, V42, pS118, DOI 10.1093/schbul/sbw009; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; McCabe JA, 2016, PSYCHOL SCI PUBL INT, V17, P187, DOI 10.1177/1529100616664716; Merzenich MM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00385; Mishra J, 2014, NEURON, V84, P1091, DOI 10.1016/j.neuron.2014.10.034; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rocca M. A., 2015, LANCET NEUROLOGY; Rosti-Otajarvi EM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub2; Rubin DB, 2004, MULTIPLE IMPUTATION; Scherl WF, 2004, PSYCHOL REP, V95, P593, DOI 10.2466/PR0.95.6.593-603; Smith A., 1982, SYMBOL DIGIT MODALIT; Stuifbergen AK, 2012, CLIN REHABIL, V26, P882, DOI 10.1177/0269215511434997; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; University V, 2016, REDCAP RES EL DAT CA; Vinogradov S, 2012, NEUROPSYCHOPHARMACOL, V37, P43, DOI 10.1038/npp.2011.251	32	66	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177177	10.1371/journal.pone.0177177	http://dx.doi.org/10.1371/journal.pone.0177177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493924	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300068
J	Kshettry, A; Vaidyanathan, S; Athreya, V				Kshettry, Aritra; Vaidyanathan, Srinivas; Athreya, Vidya			Leopard in a tea-cup: A study of leopard habitat-use and human-leopard interactions in north-eastern India	PLOS ONE			English	Article							PANTHERA-PARDUS; LARGE CARNIVORES; NATIONAL-PARK; CONSERVATION; SELECTION; CONFLICT; TIGER; MODEL; RECOVERY; ATTACKS	There is increasing evidence of the importance of multi-use landscapes for the conservation of large carnivores. However, when carnivore ranges overlap with high density of humans, there are often serious conservation challenges. This is especially true in countries like India where loss of peoples' lives and property to large wildlife are not uncommon. The leopard (Panthera pardus) is a large felid that is widespread in India, often sharing landscapes with high human densities. In order to understand the ecology of leopards in a human use landscape and the nature of human-leopard interactions, we studied (i) the spatial and temporal distribution and the characteristics of leopard attacks on people, (ii) the spatial variability in the pattern of habitat use by the leopard, and (iii) the spatial relationship between attack locations and habitat use by leopards. The study site, located in northern West Bengal, India, is a densely populated mixed-use landscape of 630 km 2, comprising of forests, tea plantations, agriculture fields, and human settlements. A total of 171 leopard attacks on humans were reported between January 2009 and March 2016, most of which occurred within the tea-gardens. None of the attacks was fatal. We found significant spatial clustering of locations of leopard attacks on humans. However, most of the attacks were restricted to certain tea estates and occurred mostly between January and May. Analysis of habitat use by leopards showed that the probability of use of areas with more ground vegetation cover was high while that of areas with high density of buildings was low. However, locations of leopard attacks on people did not coincide with areas that showed a higher probability of use by leopards. This indicates that an increased use of an area by leopards, by itself, does not necessarily imply an increase in attacks on people. The spatial and temporal clustering of attack locations allowed us to use this information to prioritize areas to focus mitigation activities in order reduce negative encounters between people and leopards in this landscape which has had a long history of conflict.	[Kshettry, Aritra] GKVK, Natl Ctr Biol Sci, Wildlife Conservat Soc India, Post Grad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India; [Vaidyanathan, Srinivas] Fdn Ecol Res Advocacy & Learning, Villupuram, Tamil Nadu, India; [Athreya, Vidya] Wildlife Conservat Soc India, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Kshettry, A (corresponding author), GKVK, Natl Ctr Biol Sci, Wildlife Conservat Soc India, Post Grad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India.	aritra.kshettry@gmail.com		Vaidyanathan, Srinivas/0000-0003-3642-0309	Department of Science and Technology, Government of India; Science and Engineering Research Board [SERB/F/2235/2012-2013]; Rufford Foundation [168271]; IdeaWild	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Science and Engineering Research Board; Rufford Foundation; IdeaWild	This work was supported by Department of Science and Technology, Government of India, Science and Engineering Research Board grant number SERB/F/2235/2012-2013, the Rufford Foundation grant number 168271 (http://www.rufford.org/projects/aritra_kshettry) and IdeaWild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LEOPARD INDIA NATURA; Athreya V, 2016, ORYX, V50, P156, DOI 10.1017/S0030605314000106; Athreya V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142647; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Baddeley A, 2014, ECOL MONOGR, V84, P477, DOI 10.1890/13-2042.1; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Bhattacharjee Anushree, 2013, Human Dimensions of Wildlife, V18, P20, DOI 10.1080/10871209.2012.698403; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Champion S.H., 1968, REVISED SURVEY FORES; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chatterjee Piya, 2001, TIME TEA WOMEN LABOR; Corbett J, 1946, MAN EATERS OF KUMAON; Dellinger JA, 2013, BIOL CONSERV, V157, P324, DOI 10.1016/j.biocon.2012.09.004; Dhanwatey HS, 2013, ORYX, V47, P221, DOI 10.1017/S0030605311001803; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Ghosal S, 2013, BIODIVERS CONSERV, V22, P2665, DOI 10.1007/s10531-013-0549-6; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines J. E., 2006, PROGRAM PRESENCE; Inskip C, 2013, HUM ECOL, V41, P169, DOI 10.1007/s10745-012-9556-6; Johnsingh AT, 2003, BIOL CONSERV, V111, P385, DOI 10.1016/S0006-3207(02)00307-5; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JONES MC, 1993, STAT COMPUT, V3, P135, DOI 10.1007/BF00147776; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth KU, 2004, TIGERS THEIR PREY PR; Kshettry A, 2014, THESIS; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Mondal K, 2013, ACTA THERIOL, V58, P179, DOI 10.1007/s13364-012-0109-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navya R, 2014, CURR SCI INDIA, V107, P1381; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022285; R Core Team, 2021, R LANGUAGE ENV STAT; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Shehzad W, 2015, ORYX, V49, P248, DOI 10.1017/S0030605313001026; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098803; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Suryawanshi KR, 2014, CONSERV BIOL, V28, P1657, DOI 10.1111/cobi.12320; Takahata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086181; Teichman KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074663; Terborgh J, 2002, PROBLEM PEOPLE PARKS, P307; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Vijayan S, 2002, POPUL ENVIRON, V23, P541, DOI 10.1023/A:1016317819552; Wickham H, 2014, GGPLOT2 IMPLEMENTATI; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007	62	38	38	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177013	10.1371/journal.pone.0177013	http://dx.doi.org/10.1371/journal.pone.0177013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493999	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300049
J	Park, JW; Oh, SA; Yea, JW; Kang, MK				Park, Jae Won; Oh, Se An; Yea, Ji Woon; Kang, Min Kyu			Fabrication of malleable three-dimensional-printed customized bolus using three-dimensional scanner	PLOS ONE			English	Article							RADIOTHERAPY; DISEASE; PHOTON	A three-dimensional (3D)-printed customized bolus (3D bolus) can be used for radiotherapy application to irregular surfaces. However, bolus fabrication based on computed tomography (CT) scans is complicated and also delivers unwanted irradiation. Consequently, we fabricated a bolus using a 3D scanner and evaluated its efficacy. The head of an Alderson Rando phantom was scanned with a 3D scanner. The 3D surface data were exported and reconstructed with Geomagic Design X software. A 3D bolus of 5-mm thickness designed to fit onto the nose was printed with the use of rubber-like printing material, and a radiotherapy plan was developed. We successfully fabricated the customized 3D bolus, and further, a CT simulation indicated an acceptable fit of the 3D bolus to the nose. There was no air gap between the bolus and the phantom surface. The percent depth dose (PDD) curve of the phantom with the 3D bolus showed an enhanced surface dose when compared with that of the phantom without the bolus. The PDD of the 3D bolus was comparable with that of a commercial superflab bolus. The radiotherapy plan considering the 3D bolus showed improved target coverage when compared with that without the bolus. Thus, we successfully fabricated a customized 3D bolus for an irregular surface using a 3D scanner instead of a CT scanner.	[Park, Jae Won; Oh, Se An; Yea, Ji Woon] Yeungnam Univ, Coll Med, Dept Radiat Oncol, 170 Hyeonchung Ro, Daegu, South Korea; [Kang, Min Kyu] Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, 807 Hoguk Ro, Daegu, South Korea	Yeungnam University; Kyungpook National University	Kang, MK (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, 807 Hoguk Ro, Daegu, South Korea.	mkkang@knu.ac.kr	KANG, MIN KYU/ACI-8824-2022	KANG, MIN KYU/0000-0002-7962-7054; Park, Jaewon/0000-0003-1100-5301; Oh, SeAn/0000-0002-8835-2814	Yeungnam University Research Grant	Yeungnam University Research Grant	This work was supported by the 2016 Yeungnam University Research Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the 2016 Yeungnam University Research Grant.	Avelino SR, 2012, ENG MED BIOL SOC EMB; Burleson S, 2015, J APPL CLIN MED PHYS, V16, P166, DOI 10.1120/jacmp.v16i3.5247; Butson MJ, 2000, RADIAT MEAS, V32, P201, DOI 10.1016/S1350-4487(99)00276-0; Jung NH, 2015, RADIAT ONCOL J, V33, P226, DOI 10.3857/roj.2015.33.3.226; Kim MS, 2008, TRENDS CARDIOVAS MED, V18, P210, DOI 10.1016/j.tcm.2008.11.001; Kim SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110746; OHSEAN, 2014, [PROGRESS in MEDICAL PHYSICS, 의학물리], V25, P218, DOI 10.14316/pmp.2014.25.4.218; Park JW, 2016, CANCER RADIOTHER, V20, P205, DOI 10.1016/j.canrad.2015.11.003; Ricotti R, 2016, PHYS MEDICA, V32, P1698, DOI 10.1016/j.ejmp.2016.08.016; Sethi R, 2016, J CONTEMP BRACHYTHER, V8, P210, DOI 10.5114/jcb.2016.60679; Sodian R, 2009, ANN THORAC SURG, V88, P974, DOI 10.1016/j.athoracsur.2009.03.014; Vyas V, 2013, MED DOSIM, V38, P268, DOI 10.1016/j.meddos.2013.02.007; Zou W, 2014, MED PHYS, V41, P443, DOI 10.1118/1.4889225	13	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177562	10.1371/journal.pone.0177562	http://dx.doi.org/10.1371/journal.pone.0177562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494012	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300136
J	Seo, MG; Ouh, IO; Lee, SH; Kim, JW; Rhee, MH; Kwon, OD; Kim, TH; Kwak, D				Seo, Min-Goo; Ouh, In-Ohk; Lee, Seung-Hun; Kim, Jong Wan; Rhee, Man Hee; Kwon, Oh-Deog; Kim, Tae-Hwan; Kwak, Dongmi			Prevalence of Coxiella burnetii in cattle at South Korean national breeding stock farms	PLOS ONE			English	Article							Q-FEVER; DAIRY-CATTLE; INFECTION; TICKS	This is the first study to evaluate the serologic and molecular prevalence of Coxiella burnetii in cattle at national breeding stock farms in South Korea. These government farms have well-organized biosecurity and management systems to prevent livestock diseases. Of the 736 cattle in this study, 77 tested positive for antibodies against C. burnetii antigens (10.5%, 95% CI: 8.3-12.7) and 11 were positive for a C. burnetti infection on PCR analysis (1.5%, 95% CI: 0.6-2.4). Since the 16S rRNA sequences of C. burnetii from all 11 PCR-positive samples were identical, three representative samples (C-CN-3 from the southern region, C-JJ-9 from Jeju Island, and C-CB-37 from the central region) are described in this paper. These three sequences had 99.3-100% identity to those of C. burnetii deposited in GenBank. These sequences clustered with those from USA, Japan, and Greenland, underscoring the sequence similarity among C. burnetii isolates in these countries. Because C. burnetii was detected in cattle at well-managed national breeding stock farms, cattle at non-government operated farms may be more likely to be exposed to C. burnetii in South Korea. Thus, continuous surveillance and control strategies in animals and humans are required to prevent the transmission of C. burnetii to humans.	[Seo, Min-Goo; Lee, Seung-Hun; Rhee, Man Hee; Kwon, Oh-Deog; Kim, Tae-Hwan; Kwak, Dongmi] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea; [Seo, Min-Goo; Ouh, In-Ohk; Lee, Seung-Hun; Kim, Jong Wan] Anim & Plant Quarantine Agcy, Gimcheon, South Korea; [Kwak, Dongmi] Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea	Kyungpook National University; Animal & Plant Quarantine Agency; Kyungpook National University	Kwak, D (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea.; Kwak, D (corresponding author), Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea.	dmkwak@knu.ac.kr	Rhee, Man Hee/O-5705-2016	Rhee, Man Hee/0000-0002-3088-1318; Kwak, Dongmi/0000-0003-0876-3179; Seo, Min-Goo/0000-0003-1752-5105	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2013102]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2013R1A1A2013102). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Guatteo R, 2011, VET MICROBIOL, V149, P1, DOI 10.1016/j.vetmic.2010.10.007; Hirai K, 1998, J VET MED SCI, V60, P781, DOI 10.1292/jvms.60.781; Jung BY, 2014, VET MICROBIOL, V173, P152, DOI 10.1016/j.vetmic.2014.06.029; Keyvanirad N, 2013, IRAN J VET RES, V15, P1; Khalili M, 2011, ASIAN PAC J TROP MED, V4, P58, DOI 10.1016/S1995-7645(11)60033-3; Kim JiYeon, 2014, Korean Journal of Veterinary Research, V54, P147, DOI 10.14405/kjvr.2014.54.3.147; Kim WJ, 2006, J KOREAN MED SCI, V21, P823, DOI 10.3346/jkms.2006.21.5.823; Korean Statistical Information Service, 2014, NUMB FARMS HOUS AN H; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Muskens J, 2011, Vet Rec, V168, P79, DOI 10.1136/vr.c6106; Ouh IO, 2014, KOREAN J VET SERV, V36, P243; Rahimi E, 2010, AFR J MICROBIOL RES, V4, P2324; Seo MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165784; Seo MG, 2016, EMERG INFECT DIS, V22, P2192, DOI 10.3201/eid2212.161236; Seo MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156710; Smith TA, 2015, GENOME BIOL EVOL, V7, P831, DOI 10.1093/gbe/evv016; Thrusfield M, 2005, VET EPIDEMIOLOGY, VThird, P228; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001	22	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177478	10.1371/journal.pone.0177478	http://dx.doi.org/10.1371/journal.pone.0177478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493973	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300117
J	Twining, JP; Bernard, H; Ewers, RM				Twining, Joshua P.; Bernard, Henry; Ewers, Robert M.			Increasing land-use intensity reverses the relative occupancy of two quadrupedal scavengers	PLOS ONE			English	Article							FOREST FRAGMENTATION; VARANUS-SALVATOR; OIL; MESOPREDATORS; CONSERVATION; CARCASSES; ISLAND	Human land use is continuously altering the natural environment, yet the greater ecological implications of this change for many groups that are key to healthy ecosystem functioning remains uncharacterised in the tropics. Terrestrial scavenging vertebrates are one such group, providing integral ecosystem services through the removal of carrion which is a crucial component of both nutrient cycling and disease dynamics. To explore how anthropogenic processes may affect forest scavengers, we investigated the changes in the relative occupancy of two important terrestrial scavengers along a gradient of land use intensity, ranging from protected forest to oil palm plantation in Borneo. We found the Malay civet (Viverra tangalunga) had highest, albeit variable, occupancy in areas of low land use intensity and the Southeast Asian water monitor (Varanus salvator macromaculatus) had highest occupancy in areas of high land use intensity. Land use had no effect on the combined occupancy of the two species. In high land use intensity sites, individual water monitors were larger and had better body condition, but at population level had a highly biased sex ratio with more males than females and increased signs of intraspecific conflict. We did not assess scavenging rate or efficiency as a process, but the high occupancy rates and apparent health of the scavengers in high land use intensity landscapes suggests this ecological process is robust to land use change.	[Twining, Joshua P.; Ewers, Robert M.] Imperial Coll London, Dept Life Sci, London, England; [Bernard, Henry] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Malaysia	Imperial College London; Universiti Malaysia Sabah	Twining, JP (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	joshuaptwining@gmail.com	Twining, Joshua/GXF-8474-2022	Twining, Joshua/0000-0002-0881-9665	Sime Darby Foundation; Sabah Foundation; Benta Wawasan; Sabah Forestry Department; South East Asia Rainforest Research Partnership	Sime Darby Foundation; Sabah Foundation; Benta Wawasan; Sabah Forestry Department; South East Asia Rainforest Research Partnership	Funding came from the Sime Darby Foundation, (http://www.yayasansimedarby.com) who provide financial support to the Sustainability of Altered Forest Ecosystems Project (SAFE). Sime Darby had no input into study design, data collection, analysis or preparation of manuscript. This work was also financially supported by the Sabah Foundation, Benta Wawasan, the Sabah Forestry Department and the South East Asia Rainforest Research Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Sabah Biodiversity Centre for providing research permits, the Sabah Foundation, Benta Wawasan, the Sabah Forestry Department and the South East Asia Rainforest Research Partnership for providing financial support. Ryan Gray, Denny Benasip and the SAFE Project team of Research Assistants provided field assistance, and Marion Pfeifer and Igor Lysenko helped with data analysis. The SAFE Project is funded by the Sime Darby Foundation.	[Anonymous], 2014, R LANG ENV STAT COMP; Ariefiandy A, 2014, BIODIVERS CONSERV, V23, P2473, DOI 10.1007/s10531-014-0733-3; Auliya M., 2003, TAXONOMY LIFE HIST C; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beasley JC, 2011, LANDSCAPE ECOL, V26, P937, DOI 10.1007/s10980-011-9619-x; Bohme W., ZOOLOGICAL SYSTEMATI, V33, P129; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brashares Justin S., 2010, P221; Brown Danny, 2009, Biawak, V3, P26; DeVault T. L., 2003, SCAVENGING VERTEBRAT, P269; DeVault TL, 2002, ACTA THERIOL, V47, P185, DOI 10.1007/BF03192458; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Eagan TS, 2011, CAN J ZOOL, V89, P724, DOI 10.1139/Z11-045; Ewers RM, 2011, PHILOS T R SOC B, V366, P3292, DOI 10.1098/rstb.2011.0049; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; Jennings AP, 2015, MAMMAL RES, V60, P181, DOI 10.1007/s13364-015-0217-1; Jessop Tim, 2010, Biawak, V4, P59; Jessop TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034069; King D., 1999, MONITORS BIOL VARANI; Koch A., 2007, ADV MONITOR RES, V16, P109; Koch Andre, 2010, Russian Journal of Herpetology, V17, P299; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Mateo-Tomas P, 2015, DIVERS DISTRIB, V21, P913, DOI 10.1111/ddi.12330; Moleon M, 2015, BIOSCIENCE, V65, P1003, DOI 10.1093/biosci/biv101; Moleon M, 2014, BIOL REV, V89, P1042, DOI 10.1111/brv.12097; Olson ZH, 2012, OIKOS, V121, P77, DOI 10.1111/j.1600-0706.2011.19771.x; PAYNE J, 1985, FIELD GUIDE MAMMALS; Peterson CA, 2001, J FIELD ORNITHOL, V72, P150, DOI 10.1648/0273-8570-72.1.150; Pfeifer M., REMOTE SENSING ENV, V176, P84; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Putman R. J., 1976, THESIS; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sebastian-Gonzalez E, 2016, ECOLOGY, V97, P95, DOI 10.1890/15-0212.1; Sebastian-Gonzalez E, 2013, IBIS, V155, P881, DOI 10.1111/ibi.12079; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Seymour A. S., J ZOOLOGY, V268, P63; Sha JCM, 2011, NATURAL HIST PROBOSC; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shukor M. N., 1996, FIELDIANA ZOOLOGY, V83; Somaweera R., 2009, LIZARDS SRI LANKA CO, P304; Struebig MJ, 2013, ADV ECOL RES, V48, P183, DOI 10.1016/B978-0-12-417199-2.00003-3; Sweet Samuel S., 2007, Mertensiella, V16, P79; Traeholt Carl, 1994, Malayan Nature Journal, V47, P345; Traeholt Carl, 1993, Malayan Nature Journal, V46, P229; Traeholt Carl, 1997, Malayan Nature Journal, V50, P317; Traeholt Carl, 1997, Malayan Nature Journal, V50, P301; Turner EC, 2011, ENV IMPACT BIOFUELS, P19, DOI DOI 10.5772/20263; Turner EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001572; Uyeda Linda, 2009, Biawak, V3, P9; Uyeda LT, 2015, HERPETOL CONSERV BIO, V10, P753; Wearn O. R., 2015, COMMUNICATION; West G, 2007, ZOO ANIMAL WILDLIFE; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Yue S, 2015, ECOL APPL, V25, P2285, DOI 10.1890/14-1928.1	60	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177143	10.1371/journal.pone.0177143	http://dx.doi.org/10.1371/journal.pone.0177143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494004	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300064
J	Zhang, W; Xu, J; Li, YY; Zou, XF				Zhang, Wei; Xu, Jia; Li, Yuanyuan; Zou, Xiufen			A new two-stage method for revealing missing parts of edges in protein-protein interaction networks	PLOS ONE			English	Article							RANDOM-WALK; PREDICTION; COMPLEXES; DATABASE; RESTART	With the increasing availability of high-throughput data, various computational methods have recently been developed for understanding the cell through protein-protein interaction (PPI) networks at a systems level. However, due to the incompleteness of the original PPI networks those efforts have been significantly hindered. In this paper, we propose a two stage method to predict underlying links between two originally unlinked protein pairs. First, we measure gene expression and gene functional similarly between unlinked protein pairs on Saccharomyces cerevisiae benchmark network and obtain new constructed networks. Then, we select the significant part of the new predicted links by analyzing the difference between essential proteins that have been identified based on the new constructed networks and the original network. Furthermore, we validate the performance of the new method by using the reliable and comprehensive PPI dataset obtained from the STRING database and compare the new proposed method with four other random walk-based methods. Comparing the results indicates that the new proposed strategy performs well in predicting underlying links. This study provides a general paradigm for predicting new interactions between protein pairs and offers new insights into identifying essential proteins.	[Zhang, Wei] East China Jiaotong Univ, Sch Sci, Nanchang 330013, Jiangxi, Peoples R China; [Xu, Jia] East China Jiaotong Univ, Sch Mechatron Engn, Nanchang 330013, Jiangxi, Peoples R China; [Li, Yuanyuan] Wuhan Inst Technol Wuhan, Sch Math & Stat, Wuhan 430072, Peoples R China; [Zou, Xiufen] Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China	East China Jiaotong University; East China Jiaotong University; Wuhan University	Zhang, W (corresponding author), East China Jiaotong Univ, Sch Sci, Nanchang 330013, Jiangxi, Peoples R China.; Zou, XF (corresponding author), Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China.	wzhang_math@whu.edu.cn; xfzou@whu.edu.cn			National Natural Science Foundation of China [11626102, 61672388]; Major Research Plan of the National Natural Science 359 Foundation of China [91530320]; Natural Science Foundation of Jiangxi Province [20161BAB211022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science 359 Foundation of China; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was partly supported by NO. 11626102 and NO. 61672388, National Natural Science Foundation of China (CN), www.nsfc.gov, WZ XFZ; and NO. 91530320, Major Research Plan of the National Natural Science 359 Foundation of China, XFZ; NO.20161BAB211022, Natural Science Foundation of Jiangxi Province (CN), WZ.	Alanis-Lobato G, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00296; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hulovatyy Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090073; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Lei CW, 2013, BIOINFORMATICS, V29, P355, DOI 10.1093/bioinformatics/bts688; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09283; Liu WP, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58007; Lu L, 2009, PHYS REV E, V80; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Przulj N, 2011, BIOESSAYS, V33, P115, DOI 10.1002/bies.201000044; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Tong HH, 2008, KNOWL INF SYST, V14, P327, DOI 10.1007/s10115-007-0094-2; Tong HH, 2006, IEEE DATA MINING, P613; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108716; Wong DLK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S15; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang W, 2015, IEEE ACM T COMPUT BI, V12, P879, DOI 10.1109/TCBB.2014.2386314; Zhang WJS., 2015, SELFORGANIZOLOGY, V2, P91; Zhao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12261	33	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177029	10.1371/journal.pone.0177029	http://dx.doi.org/10.1371/journal.pone.0177029			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493910	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300050
J	de Aguiar, HJAC; Barros, LAC; Alves, DR; Mariano, CDF; Delabie, JHC; Pompolo, SD				Alves Cardoso de Aguiar, Hilton Jeferson; Campos Barros, Luisa Antonia; Alves, Danubia Rodrigues; Ferreira Mariano, Clea dos Santos; Charles Delabie, Jacques Hubert; das Gracas Pompolo, Silvia			Cytogenetic studies on populations of Camponotus rufipes (Fabricius, 1775) and Camponotus renggeri Emery, 1894 (Formicidae: Formicinae)	PLOS ONE			English	Article							ANTS HYMENOPTERA-FORMICIDAE; DINOPONERA-LUCIDA EMERY; CHROMOSOME EVOLUTION; KARYOTYPE EVOLUTION; SPECIES COMPLEX; HETEROCHROMATIN; MYRMICINAE; REGIONS; SEQUENCE; BANDS	Two valid ant species, Camponotus rufipes and Camponotus renggeri, have recently been the subject of a broad discussion with reference to taxa synonymization. Both species are quite common among the Neotropical myrmecofauna and share some unique traits, such as the shape of the scape and the pilosity patterns of the tibiae and scapes. A single morphological trait can help distinguish these species; however, only a combination of different approaches can enlighten our view of the complex phylogenetic relationships prevailing in the different populations of these two taxa. Therefore, focusing on the taxonomic issues concerning these two species, a cytogenetic survey including 10 populations of C. rufipes and two populations of C. renggeri was performed. In order to better understand the extent of the relationship between C. rufipes and C. renggeri, two common Neotropical Camponotus species, C. atriceps and C. cingulatus were taken as outgroups. All four species of Camponotus that were studied had 2n = 40 chromosomes (4sm+34st+2t); however, the abundance of chromosome rearrangements observed, combined with several chromosome markers, suggest that C. rufipes and C. renggeri are two good distinct species although closely related. The already reported chromosome translocation 2n = 39 (1m+4sm+32st+2t) for C. rufipes has been found in different populations as in the unprecedented chromosome inversions found both in C. rufipes and in C. renggeri populations. Within the C. renggeri chromosome inversions, both the heterozygous state 2n = 40 (1m+3sm+34st+2t) and the homozygous state, 2n = 40 (2m+2sm+34st+2t) were identified. However, only heterozygous specimens for chromosome inversions were found among C. rufipes, with karyotype configurations distinct from those found in C. renggeri, with 2n = 40 (1m+4sm+34st+2t). None of the populations studied showed signs of mosaic individuals. With respect to rDNA clusters, the 18S rDNA seemed to be more restricted inside the genome, as C. renggeri showed four 18S rDNA clusters, whereas, C. rufipes, C. atriceps, and C. cingulatus showed only two clusters. The chromosome locations of the 5S rDNA clusters were pointed for the first time in Formicidae, and showed itself to be more widely spread over the genome. By combining different chromosome banding approaches it was possible to demonstrate the crucial importance that chromosome inversions played on the karyotype evolution within these ants. The results also showed that chromosome translocations might be a consequence of the chromatin dynamic condition observed among Camponotus species. The homozygosis condition found in a C. renggeri from a Brazilian savanna population for chromosome inversions and the contrasting heterozygous condition for a different kind of chromosome inversion in C. rufipes from the Brazilian coastal rainforest, opens the window for a chromosome race hypothesis within the group C. renggeri and C. rufipes. The wide distribution, rich ecological interactions, genetic diversity, and morphological variability among C. renggeri and C. rufipes justify questioning of the actual taxonomic status of these species. The answer of this puzzle is clear when observing the number of 18S rDNA clusters of these ants, as C. rufipes has only two clusters whereas C. renggeri has four.	[Alves Cardoso de Aguiar, Hilton Jeferson; Campos Barros, Luisa Antonia; Alves, Danubia Rodrigues; das Gracas Pompolo, Silvia] Univ Fed Vicosa, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil; [Alves Cardoso de Aguiar, Hilton Jeferson; Campos Barros, Luisa Antonia] Univ Fed Amapa, Campus Binac, Oiapoque, Amapa, Brazil; [Ferreira Mariano, Clea dos Santos] CEPEC CEPLAC, Lab Mirmecol, Itabuna, BA, Brazil; [Ferreira Mariano, Clea dos Santos; Charles Delabie, Jacques Hubert] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Charles Delabie, Jacques Hubert] Univ Estadual Santa Cruz, Dept Ciencias Agr & Ambientais, Ilheus, BA, Brazil	Universidade Federal de Vicosa; Fundacao Universidade Federal do Amapa; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz	de Aguiar, HJAC (corresponding author), Univ Fed Vicosa, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil.; de Aguiar, HJAC (corresponding author), Univ Fed Amapa, Campus Binac, Oiapoque, Amapa, Brazil.	hilton.aguiar@hotmail.com	Barros, Luísa A.C./A-4106-2017; Mariano, Cléa/GZM-2747-2022	Aguiar, Hilton/0000-0001-7738-1460; Delabie, Jacques Hubert Charles/0000-0002-2695-1061	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [APQ-00259-13]; Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD)	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was part of the DSc. thesis to author HJACA, and was supported by the Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) process No. APQ-00259-13. The authors wish to thank the Conselho Nacional de Pesquisa (CNPq) for the scholarship granted to HJACA and the research grant to JHCD. We also acknowledge the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD) for the postdoctoral grant provided to LACB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar HJAC, 2016, SOCIOBIOLOGY, V63, P777, DOI 10.13102/sociobiology.v63i2.948; [Anonymous], 2008, INSETOS SOCIAIS BIOL; Barros LAC, 2009, COMP CYTOGENET, V3, P97, DOI 10.3897/compcytogen.v3i2.16; Bertrand Y, 2006, SYST BIODIVERS, V4, P149, DOI 10.1017/S1477200005001908; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bolton B., 2020, ONLINE CATALOG ANTS; Brady Sean G., 2000, P131; Barros LAC, 2016, COMP CYTOGENET, V10, P229, DOI 10.3897/CompCytogen.v10i2.7612; Barros LAC, 2015, CR BIOL, V338, P660, DOI 10.1016/j.crvi.2015.07.006; Barros LAC, 2014, FLA ENTOMOL, V97, P1694, DOI 10.1653/024.097.0444; Barros LAC, 2013, CARYOLOGIA, V66, P59, DOI 10.1080/00087114.2013.780443; Cardoso DC, 2012, COMP CYTOGENET, V6, P107, DOI 10.3897/CompCytogen.v6i2.2397; Castiglia R, 2003, GENETICA, V118, P33, DOI 10.1023/A:1022903112274; Cristiano MP, 2014, COMP CYTOGENET, V8, P223, DOI 10.3897/CompCytogen.v8i3.7510; DOBZHANSKY T, 1955, P NATL ACAD SCI USA, V41, P289, DOI 10.1073/pnas.41.5.289; Dubinin NP, 2010, COMP CYTOGENET, V4, P207, DOI 10.3897/compcytogen.v4i2.42; Mariano CDF, 2008, INSECT CONSERV DIVER, V1, P161, DOI 10.1111/j.1752-4598.2008.00022.x; Groc S, 2009, INSECT CONSERV DIVER, V2, P183, DOI 10.1111/j.1752-4598.2009.00060.x; HASHMI A A, 1973, Studia Entomologica, V16, P1; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Holldobler B., 2009, SUPERORGANISM; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; IMAI HT, 1994, JPN J GENET, V69, P137, DOI 10.1266/jjg.69.137; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1991, JPN J GENET, V66, P635, DOI 10.1266/jjg.66.635; JOHN B, 1966, SCIENCE, V152, P711, DOI 10.1126/science.152.3723.711; Kavalco KF, 2009, GENET MOL BIOL, V32, P477, DOI 10.1590/S1415-47572009005000055; Kell LT, 2009, ICES J MAR SCI, V66, P1776, DOI 10.1093/icesjms/fsp181; King M., 1993, SPECIES EVOLUTION; Kouru KH, 2011, FERTIL STERIL, V95, P806, DOI 10.1016/j.fertnstert.2010.09.022; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lorite P, 1997, HEREDITY, V78, P578, DOI 10.1038/hdy.1997.96; Lorite P, 2010, MYRMECOL NEWS, V13, P89; Mackay WP, 2004, SYSTEMATICS BIOL NEW; Malik HS, 2009, PROG MOL SUBCELL BIO, V48, P33, DOI 10.1007/978-3-642-00182-6_2; Mallet J, 2007, ENCY BIODIVERSITY, V5, P1, DOI [10.1016/B0-12-226865-2/00261-3, DOI 10.1016/B0-12-226865-2/00261-3]; Mariano C. S. F., 2001, Revista Brasileira de Entomologia, V45, P267; Mariano Clea dos Santos Ferreira, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/973897; Mariano Clea S.F., 2006, Myrmecologische Nachrichten, V8, P277; Martins C, 2006, GENETICA, V127, P133, DOI 10.1007/s10709-005-2674-y; MAYR E, 1970, P453; Mayr E, 2001, WHAT EVOLUTION IS CL; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; OKAZAKI S, 1993, MOL CELL BIOL, V13, P1424, DOI 10.1128/MCB.13.3.1424; Pereira JOP, 2006, THESIS; Perrin A, 2010, ANDROLOGIA, V42, P27, DOI 10.1111/j.1439-0272.2009.00951.x; Phillips RB, 2000, CHROMOSOME RES, V8, P27, DOI 10.1023/A:1009271017998; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Ronque MUV, 2016, ZOOL J LINN SOC-LOND, V176, P170, DOI 10.1111/zoj.12303; Rothballer A, 2013, CHROMOSOMA, V122, P415, DOI 10.1007/s00412-013-0417-x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; Seifert B, 2009, MYRMECOL NEWS, V12, P149; Sharma T, 2003, J BIOSCIENCES, V28, P189, DOI 10.1007/BF02706218; Shaw David D., 1998, Journal of Orthoptera Research, V7, P157; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Sumner AT, 1990, CHROMOSOME BANDING; White MJD, 1978, ANIMAL CYTOLOGY EVOL; WILSON E O, 1976, Studia Entomologica, V19, P187; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Zolessi LC, 1983, CARVOLOGIA, V36, P363	63	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177702	10.1371/journal.pone.0177702	http://dx.doi.org/10.1371/journal.pone.0177702			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520797	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500059
J	Buzan, MTA; Wetscherek, A; Heussel, CP; Kreuter, M; Herth, FJ; Warth, A; Kauczor, HU; Pop, CM; Dinkel, J				Buzan, Maria T. A.; Wetscherek, Andreas; Heussel, Claus Peter; Kreuter, Michael; Herth, Felix J.; Warth, Arne; Kauczor, Hans-Ulrich; Pop, Carmen Monica; Dinkel, Julien			Texture analysis using proton density and T2 relaxation in patients with histological usual interstitial pneumonia (UIP) or nonspecific interstitial pneumonia (NSIP)	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; THIN-SECTION CT; NUCLEAR-MAGNETIC-RESONANCE; LUNG-DISEASE; BIOPSY; INFLAMMATION; BLEOMYCIN; TIMES; MRI; ALVEOLITIS	Objectives The purpose of our study was to assess proton density (PD) and T2 relaxation time of usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP) and to evaluate their utility in differentiating the two patterns. Furthermore, we aim to investigate whether these two parameters could help differentiate active-inflammatory and stable-fibrotic lesions in NSIP. Methods 32 patients (mean age: 69 years; M:F, 1: 1) with pathologically proven disease (UIP: NSIP, 1: 1), underwent thoracic thin-section multislice CT scan and 1.5T MRI. A total of 437 regions-of-interest (ROIs) were classified at CT as advanced, moderate or mild alterations. Based on multi-echo single-shot TSE sequence acquired at five echo times, with breath-holding at end-expiration and ECG-triggering, entire lung T2 and PD maps were generated from each subject. The T2 relaxation time and the respective signal intensity were quantified by performing a ROI measurement on the T2 and PD maps in the corresponding CT selected areas of the lung. Results UIP and NSIP regional patterns could not be differentiated by T2 relaxation times or PD values alone. Overall, a strong positive correlation was found between T2 relaxation and PD in NSIP, r = 0.64, p<0.001; however, this correlation was weak in UIP, r = 0.20, p = 0.01. T2 relaxation showed significant statistical difference between active-inflammatory and stable-fibrotic NSIP regions at all levels, p<0.05, while for the analysis of ventral lesions PD proved no statistical difference, p>0.05. Conclusions T2 relaxation times and PD values may provide helpful quantitative information for differentiating NSIP from UIP pattern. These parameters have the potential to differentiate active-inflammatory and stable-fibrotic lesions in NSIP.	[Buzan, Maria T. A.; Pop, Carmen Monica] Iuliu Hatieganu Univ Med & Pharm, Dept Pneumol, Cluj Napoca, Romania; [Buzan, Maria T. A.; Heussel, Claus Peter] Heidelberg Univ Hosp, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany; [Buzan, Maria T. A.; Heussel, Claus Peter; Kauczor, Hans-Ulrich] Univ Hosp Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Buzan, Maria T. A.; Heussel, Claus Peter; Kreuter, Michael; Herth, Felix J.; Warth, Arne; Kauczor, Hans-Ulrich; Dinkel, Julien] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Wetscherek, Andreas] Inst Canc Res, Joint Dept Phys, London, England; [Wetscherek, Andreas] Royal Marsden NHS Fdn Trust, London, England; [Kreuter, Michael; Herth, Felix J.] Heidelberg Univ Hosp, Thoraxklin, Ctr Rare & Interstitial Lung Dis, Pneumol & Resp Crit Care Med, Heidelberg, Germany; [Warth, Arne] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Dinkel, Julien] Ludwig Maximilians Univ Hosp Munich, Inst Clin Radiol, Munich, Germany	Iuliu Hatieganu University of Medicine & Pharmacy; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Munich	Buzan, MTA (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Pneumol, Cluj Napoca, Romania.; Buzan, MTA (corresponding author), Heidelberg Univ Hosp, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany.; Buzan, MTA (corresponding author), Univ Hosp Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.; Buzan, MTA; Dinkel, J (corresponding author), Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany.	Buzan.Maria@umfcluj.ro; julien.dinkel@med.uni-muenchen.de	Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021; Socaciu, Carmen/AAX-2579-2020	Wetscherek (Buzan), Maria Teodora Antuaneta/0000-0003-2924-7587; Wetscherek, Andreas/0000-0003-4799-2193	Dietmar Hopp Stiftung; ERASMUS+ Program	Dietmar Hopp Stiftung; ERASMUS+ Program	This study was supported by grants from the Dietmar Hopp Stiftung and ERASMUS+ Program for PhD students.	Bauman G, 2009, MAGN RESON MED, V62, P656, DOI 10.1002/mrm.22031; Buzan MTA, 2015, EUR RADIOL, V25, P3167, DOI 10.1007/s00330-015-3751-y; Colombi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130653; Cutillo A G, 1986, J Thorac Imaging, V1, P39, DOI 10.1097/00005382-198607000-00007; Cutillo AG, 2002, MAGNET RESON MED, V47, P246, DOI 10.1002/mrm.10082; Daniil ZD, 1999, AM J RESP CRIT CARE, V160, P899, DOI 10.1164/ajrccm.160.3.9903021; Hamlin SA, 2014, RADIOGRAPHICS, V34, P1594, DOI 10.1148/rg.346140030; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hodnett PA, 2013, AM J RESP CRIT CARE, V188, P141, DOI 10.1164/rccm.201208-1544CI; HUBER DJ, 1985, INVEST RADIOL, V20, P460, DOI 10.1097/00004424-198508000-00004; Jacob RE, 2010, J MAGN RESON IMAGING, V31, P1091, DOI 10.1002/jmri.22166; KATZENSTEIN ALA, 1994, AM J SURG PATHOL, V18, P136, DOI 10.1097/00000478-199402000-00003; Kersjes W, 1999, INVEST RADIOL, V34, P13, DOI 10.1097/00004424-199901000-00003; Kreider ME, 2007, ANN THORAC SURG, V83, P1140, DOI 10.1016/j.athoracsur.2006.10.002; Kreuter M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151425; Larsen BT, 2012, ARCH PATHOL LAB MED, V136, P1234, DOI 10.5858/arpa.2012-0225-RA; Lee HY, 2012, AM J ROENTGENOL, V199, P982, DOI 10.2214/AJR.11.8192; Lettieri CJ, 2005, CHEST, V127, P1600, DOI 10.1378/chest.127.5.1600; Lynch DA, 2005, RADIOLOGY, V236, P10, DOI 10.1148/radiol.2361031674; MacDonald SLS, 2001, RADIOLOGY, V221, P600, DOI 10.1148/radiol.2213010158; Martinez Fernando J, 2006, Proc Am Thorac Soc, V3, P315, DOI 10.1513/pats.200602-022TK; MCFADDEN RG, 1987, CHEST, V92, P31, DOI 10.1378/chest.92.1.31; MULLER NL, 1992, AM J ROENTGENOL, V158, P1205; Oltmanns U, 2014, RESPIRATION, V88, P199, DOI 10.1159/000363064; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Piciucchi S, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0245-x; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shin KM, 2008, RADIOLOGY, V249, P328, DOI 10.1148/radiol.2483071378; Silva CIS, 2008, RADIOLOGY, V247, P251, DOI 10.1148/radiol.2471070369; Silva CIS, 2009, J THORAC IMAG, V24, P260, DOI 10.1097/RTI.0b013e3181c1a9eb; SKALINA S, 1984, INVEST RADIOL, V19, P7, DOI 10.1097/00004424-198401000-00003; Sumikawa H, 2006, RADIOLOGY, V241, P258, DOI 10.1148/radiol.2411050928; Sumikawa H, 2012, EUR J RADIOL, V81, P2919, DOI 10.1016/j.ejrad.2011.11.018; Suzuki H, 2008, EUR RADIOL, V18, P522, DOI 10.1007/s00330-007-0808-6; Sverzellati N, 2010, RADIOLOGY, V254, P957, DOI 10.1148/radiol.0990898; Travis WD, 2000, AM J SURG PATHOL, V24, P19, DOI 10.1097/00000478-200001000-00003; Travis WD, 2008, AM J RESP CRIT CARE, V177, P1338, DOI 10.1164/rccm.200611-1685OC; Yi CA, 2008, AM J ROENTGENOL, V190, P878, DOI 10.2214/AJR.07.2833	38	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177689	10.1371/journal.pone.0177689	http://dx.doi.org/10.1371/journal.pone.0177689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520778	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500057
J	Newton, S; Braithwaite, D; Akinyemiju, TF				Newton, Suzy; Braithwaite, Dejana; Akinyemiju, Tomi F.			Socio-economic status over the life course and obesity: Systematic review and meta-analysis	PLOS ONE			English	Review							CARDIOVASCULAR RISK-FACTORS; BODY-MASS-INDEX; SOCIAL-CLASS; EDUCATIONAL-ATTAINMENT; NUTRITION TRANSITION; ABERDEEN CHILDREN; EARLY ADULTHOOD; WOMENS HEALTH; CHILDHOOD; POSITION	Background The purpose of this review was to summarize the published literature on the association of childhood, adulthood and life course socio-economic status (SES) with obesity between January 1990 and June 2015. Methods The major medical electronic databases were searched to identify studies that examined SES over the life-course in relation to obesity. A total of 219 studies were identified through the initial search, and 35 qualified for full review. Of these, 14 publications met our inclusion criteria for the meta-analysis, all from developed or upper-middle income countries. Results There was a consistent association between lower life course SES and obesity among women (summary OR: 1.35, 95% CI: 1.04, 1.76), but not among men (summary OR: 0.92, 95% CI: 0.60, 1.40). Overall, mean BMI was higher among individuals with lower life course SES compared with those with higher life course SES (summary mean BMI difference: 0.65, 95% CI: 0.59, 0.71). Mean waist circumference (WC) was higher among women with lower life course SES compared with those with higher life course SES (summary mean WC: 4.67, 95% CI: 4.15, 5.20), but lower among men (summary mean WC difference: -0.10, 95% CI: -0.11, -0.08). Conclusion The inverse relationship between life course SES and obesity among women was consistent, based mostly on studies in developed countries. Nevertheless, critical information gaps remain in relation to the impact of childhood and life course SES on obesity in developing countries.	[Newton, Suzy; Akinyemiju, Tomi F.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Braithwaite, Dejana] Univ Calif San Francisco, Dept Epidemiol & Biostat, Div Canc Epidemiol, San Francisco, CA 94143 USA; [Akinyemiju, Tomi F.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham	Akinyemiju, TF (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.; Akinyemiju, TF (corresponding author), Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA.	tomiakin@uab.edu	Braithwaite, Dejana/L-9000-2019		FOGARTY INTERNATIONAL CENTER [K01TW010271] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW010271] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Addo J, 2009, PUBLIC HEALTH, V123, P365, DOI 10.1016/j.puhe.2009.02.003; Aitsi-Selmi A, 2013, INT J OBESITY, V37, P439, DOI 10.1038/ijo.2012.64; [Anonymous], 2010, I MED US COMM PREV G; [Anonymous], 2011, GLOBAL STATUS REPORT; [Anonymous], 2003, DIET NUTR PREV CHRON; [Anonymous], 2000, WHO TECHN REP SER; Ball K, 2006, INT J EPIDEMIOL, V35, P131, DOI 10.1093/ije/dyi216; Ball K, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0229-x; Barros AJD, 2006, INT J EPIDEMIOL, V35, P1233, DOI 10.1093/ije/dyl160; Bennett GG, 2007, OBESITY, V15, P172, DOI 10.1038/oby.2007.522; Blane D, 1996, BMJ-BRIT MED J, V313, P1434, DOI 10.1136/bmj.313.7070.1434; Boylan SM, 2014, OBES RES CLIN PRACT, V8, pE163, DOI 10.1016/j.orcp.2013.03.006; Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; Burkert NT, 2015, WOMEN HEALTH, V55, P134, DOI 10.1080/03630242.2014.979967; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chaparro MP, 2014, SOC SCI MED, V120, P199, DOI 10.1016/j.socscimed.2014.09.024; Cohen AK, 2013, OBES REV, V14, P989, DOI 10.1111/obr.12062; Colditz GA, 2014, CA-CANCER J CLIN, V64, P186, DOI 10.3322/caac.21225; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Dundas R, 2006, INT J EPIDEMIOL, V35, P458, DOI 10.1093/ije/dyi239; Ebrahim S, 2004, BMJ-BRIT MED J, V328, P861, DOI 10.1136/bmj.38034.702836.55; Galobardes B, 2008, J EPIDEMIOL COMMUN H, V62, P387, DOI 10.1136/jech.2007.065508; GILBERTS ECAM, 1994, J EPIDEMIOL COMMUN H, V48, P258, DOI 10.1136/jech.48.3.258; Giskes K, 2008, OBESITY, V16, P1377, DOI 10.1038/oby.2008.54; Gonzalez D, 2009, CAD SAUDE PUBLICA, V25, pS427, DOI 10.1590/S0102-311X2009001500008; Hardy R, 2000, INT J OBESITY, V24, P725, DOI 10.1038/sj.ijo.0801238; Hart C, 2008, INT J EPIDEMIOL, V37, P604, DOI 10.1093/ije/dyn052; Heraclides A, 2010, J EPIDEMIOL COMMUN H, V64, P714, DOI 10.1136/jech.2009.087692; Huurre T, 2003, SOC PSYCH PSYCH EPID, V38, P249, DOI 10.1007/s00127-003-0630-7; IOM, 2012, BREAST CANC ENV LIF; Jack D, 2013, PUBLIC HEALTH NUTR, V16, P1197, DOI 10.1017/S1368980012005642; James SA, 2006, AM J PUBLIC HEALTH, V96, P554, DOI 10.2105/AJPH.2004.053447; Jeffery RW, 1996, AM J PUBLIC HEALTH, V86, P1005, DOI 10.2105/AJPH.86.7.1005; Kittleson MM, 2006, ARCH INTERN MED, V166, P2356, DOI 10.1001/archinte.166.21.2356; Kivimaki M, 2006, HEART, V92, P474, DOI 10.1136/hrt.2005.067108; Krieger N, 2001, PUBLIC HEALTH, V115, P175, DOI 10.1016/S0033-3506(01)00440-1; Laaksonen M, 2004, OBES RES, V12, P1851, DOI 10.1038/oby.2004.230; Langenberg C, 2003, J EPIDEMIOL COMMUN H, V57, P816, DOI 10.1136/jech.57.10.816; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P1245, DOI 10.2105/AJPH.2004.041129; Lee H, 2009, POPUL RES POLICY REV, V28, P505, DOI 10.1007/s11113-008-9115-4; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; Malhotra R, 2013, J GERONTOL B-PSYCHOL, V68, P117, DOI 10.1093/geronb/gbs102; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Murray ET, 2011, ANN EPIDEMIOL, V21, P589, DOI 10.1016/j.annepidem.2011.04.005; Nube M, 1998, EUR J CLIN NUTR, V52, P136, DOI 10.1038/sj.ejcn.1600528; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Power C, 2003, INT J OBESITY, V27, P1081, DOI 10.1038/sj.ijo.0802323; Power C, 2005, INT J EPIDEMIOL, V34, P335, DOI 10.1093/ije/dyh394; Power C, 2007, INT J EPIDEMIOL, V36, P532, DOI 10.1093/ije/dyl310; Pudrovska T, 2012, J AGING HEALTH, V24, P323, DOI 10.1177/0898264311422744; Regidor E, 2004, INT J EPIDEMIOL, V33, P723, DOI 10.1093/ije/dyh105; Romaguera D, 2012, AM J CLIN NUTR, V96, P150, DOI 10.3945/ajcn.111.031674; Scharoun-Lee M, 2009, J EPIDEMIOL COMMUN H, V63, P133, DOI 10.1136/jech.2008.075721; Senekal M, 2003, ETHNIC DIS, V13, P109; Senese LC, 2009, EPIDEMIOL REV, V31, P21, DOI 10.1093/epirev/mxp006; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Steyn NP, 2014, ANN NY ACAD SCI, V1311, P88, DOI 10.1111/nyas.12433; Stunkard AJ, 1996, CIBA F SYMP, V201, P174; Tucker-Seeley RD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-313; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organisation, 2015, OB SIT TRENDS	63	137	142	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177151	10.1371/journal.pone.0177151	http://dx.doi.org/10.1371/journal.pone.0177151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28510579	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500014
J	Patel, DP; Krausz, KW; Xie, C; Beyoglu, D; Gonzalez, FJ; Idle, JR				Patel, Daxesh P.; Krausz, Kristopher W.; Xie, Cen; Beyoglu, Diren; Gonzalez, Frank J.; Idle, Jeffrey R.			Metabolic profiling by gas chromatography-mass spectrometry of energy metabolism in high-fat diet-fed obese mice	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; PERFORMANCE LIQUID-CHROMATOGRAPHY; GUT MICROBIOTA; RESISTANT; LIVER; DERIVATIZATION; ADAPTATION; REVEALS; PATHWAY; WEIGHT	A novel, selective and sensitive single-ion monitoring (SIM) gas chromatography-mass spectrometry (GCMS) method was developed and validated for the determination of energy metabolites related to glycolysis, the tricarboxylic acid (TCA) cycle, glutaminolysis, and fatty acid beta-oxidation. This assay used N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) containing 1% tert-butyldimethylchlorosilane (TBDMCS) as derivatizing reagent and was highly reproducible, sensitive, specific and robust. The assay was used to analyze liver tissue and serum from C57BL/6N obese mice fed a high-fat diet (HFD) and C57BL/6N mice fed normal chow for 8 weeks. HFD-fed mice serum displayed statistically significantly reduced concentrations of pyruvate, citrate, succinate, fumarate, and 2-oxoglutarate, with an elevated concentration of pantothenic acid. In liver tissue, HFD-fed mice exhibited depressed levels of glycolysis end-products pyruvate and lactate, glutamate, and the TCA cycle intermediates citrate, succinate, fumarate, malate, and oxaloacetate. Pantothenate levels were 3-fold elevated accompanied by a modest increased gene expression of Scl5a6 that encodes the pantothenate transporter SLC5A6. Since both glucose and fatty acids inhibit coenzyme A synthesis from pantothenate, it was concluded that these data were consistent with downregulated fatty acid beta-oxidation, glutaminolysis, glycolysis, and TCA cycle activity, due to impaired anaplerosis. The novel SIM GCMS assay provided new insights into metabolic effects of HFD in mice.	[Patel, Daxesh P.; Krausz, Kristopher W.; Xie, Cen; Gonzalez, Frank J.; Idle, Jeffrey R.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Beyoglu, Diren; Idle, Jeffrey R.] Univ Bern, Dept Clin Res, Hepatol Res Grp, Bern, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bern	Idle, JR (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Idle, JR (corresponding author), Univ Bern, Dept Clin Res, Hepatol Res Grp, Bern, Switzerland.	idlejr@mail.nih.gov	Patel, Daxesh/AAC-3244-2019; Idle, Jeff/B-1152-2012	Idle, Jeff/0000-0002-6143-1520; Beyoglu, Diren/0000-0001-9882-5841	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC005708, ZIABC005562] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Cancer Institute Intramural Program.	Abbrescia DI, 2012, ARCH BIOCHEM BIOPHYS, V518, P157, DOI 10.1016/j.abb.2011.12.021; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Calderon-Santiago M, 2013, J PHARMACEUT BIOMED, V74, P178, DOI 10.1016/j.jpba.2012.10.029; Ciappio ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084583; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Falegan OS, 2017, METABOLITES, V7, DOI 10.3390/metabo7010006; FDA, 2013, GUID IND BIOAN METH; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Jambocus NGS, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2391592; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kim SH, 2009, ANAL BIOANAL CHEM, V395, P1117, DOI 10.1007/s00216-009-3054-8; Li HK, 2008, J PROTEOME RES, V7, P4775, DOI 10.1021/pr800352k; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Li SY, 2008, OBESITY, V16, P811, DOI 10.1038/oby.2007.116; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Luo GH, 2016, SCI REP-UK, V6, P1, DOI [10.1038/srep35231, 10.1038/s41598-016-0027-y]; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Martinez DL, 2014, BIOCHEM SOC T, V42, P1112, DOI 10.1042/BST20140124; MAWHINNEY TP, 1986, J CHROMATOGR, V361, P117, DOI 10.1016/S0021-9673(01)86899-0; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Ogden Cynthia L, 2010, NCHS Data Brief, P1; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Qian L, 2016, INT J MOL SCI, V17, P1; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Schummer C, 2009, TALANTA, V77, P1473, DOI 10.1016/j.talanta.2008.09.043; Scully T, 2014, NATURE, V508, pS49, DOI 10.1038/508S49a; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Shurubor YI, 2016, ANAL BIOCHEM, V503, P8, DOI 10.1016/j.ab.2016.03.004; Takahashi K, 2015, J NUTR SCI VITAMINOL, V61, P215, DOI 10.3177/jnsv.61.215; Tan B, 2014, ANAL BIOCHEM, V465, P134, DOI 10.1016/j.ab.2014.07.027; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vadlapudi AD, 2012, CURR DRUG TARGETS, V13, P994; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; WOMERSLEY C, 1984, INSECT BIOCHEM, V14, P395, DOI 10.1016/0020-1790(84)90095-7; WOMERSLEY C, 1982, J INVERTEBR PATHOL, V40, P406, DOI 10.1016/0022-2011(82)90179-3; Xu WX, 2012, J PROTEOME RES, V11, P3423, DOI 10.1021/pr300280t; Yang WJ, 2007, EPIDEMIOL REV, V29, P49, DOI 10.1093/epirev/mxm004; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	47	37	37	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177953	10.1371/journal.pone.0177953	http://dx.doi.org/10.1371/journal.pone.0177953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520815	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500083
J	Fields, MA; Bowrey, HE; Gong, J; Moreira, EF; Cai, H; Del Priore, LV				Fields, Mark A.; Bowrey, Hannah E.; Gong, Jie; Moreira, Ernesto F.; Cai, Hui; Del Priore, Lucian V.			Extracellular matrix nitration alters growth factor release and activates bioactive complement in human retinal pigment epithelial cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; BRUCHS MEMBRANE; NATURAL COURSE; DRUSEN; VEGF; RPE; EXPRESSION; PROTEINS	Purpose We have shown previously that non-enzymatic nitration (NEN) of the extracellular matrix (ECM), which serves as a model of Bruch's membrane (BM) aging, has a profound effect on the behavior of the overlying retinal pigment epithelial (RPE) cells, including altered phagocytic ability, reduced cell adhesion, and inhibition of proliferation. We know that transplanted RPE monolayers will encounter a hostile sub-RPE environment, including age-related alterations in BM that may compromise cell function and survival. Here we use our previous NEN model of BM aging to determine the effects of NEN of the ECM on growth factor release and complement activation in RPE cells. Methods Human induced-pluripotent stem cells (iPSCs) were differentiated into RPE cells, and confirmed by immunohistochemistry, confocal microscopy, and polymerase chain reaction. IPSC-derived RPE cells were plated onto RPE-derived ECM under untreated or nitrite-modified conditions. Cells were cultured for 7 days and barrier function measured by transepithelial resistance (TER). Vascular endothelial growth factor (VEGF), pigment epithelium-derived factor (PEDF), and complement component C3a were measured using enzyme-linked immunosorbent assay (ELISA). Results On average nitrite-modified ECM increased VEGF release both apically and basally by 0.15 +/- 0.014 ng/mL (p < 0.0001) and 0.21 +/- 0.022 ng/mL (p < 0.0001), respectively, in iPSC-derived RPE cells. Nitrite-modified ECM increased PEDF release in iPSC-derived RPE cells apically by 0.16 +/- 0.031 ng/mL (p < 0.0001), but not basally (0.27 +/- 0.015 vs. 0.32 +/- 0.029 ng/mL, (p > 0.05)). Nitrite-modified ECM increased production of C3a in iPSC-derived RPE cells by 0.52 +/- 0.123 ng/mL (p < 0.05). Conclusion Nitrite-modified ECM increased VEGF, PEDF release, and C3a production in human iPSC-derived RPE cells. This model demonstrates changes seen in the basement membrane can lead to alterations in the cell biology of the RPE cells that may be related to the development of age-related macular degeneration.	[Fields, Mark A.; Gong, Jie; Cai, Hui; Del Priore, Lucian V.] Yale Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Bowrey, Hannah E.] Rutgers State Univ, Brain Hlth Inst, Piscataway, NJ USA; [Bowrey, Hannah E.] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia; [Moreira, Ernesto F.] Med Univ South Carolina, Dept Ophthalmol, Storm Eye Inst, Charleston, SC USA	Yale University; Rutgers State University New Brunswick; University of Sydney; Medical University of South Carolina	Fields, MA (corresponding author), Yale Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA.	mark.fields@yale.edu		Bowrey, Hannah/0000-0002-3774-4201	Research to Prevent Blindness; Greater New York Center for Retinal Degenerative Disease Foundation Fighting Blindness; BrightFocus Foundation; Lions International Foundation Research Program	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Greater New York Center for Retinal Degenerative Disease Foundation Fighting Blindness; BrightFocus Foundation(BrightFocus Foundation); Lions International Foundation Research Program	Research to Prevent Blindness, www.rpbusa.org. Greater New York Center for Retinal Degenerative Disease Foundation Fighting Blindness, www.blindness.org. BrightFocus Foundation, www.brightfocus.org. The Lions International Foundation Research Program. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Abdelsalam A, 1999, SURV OPHTHALMOL, V44, P1, DOI 10.1016/S0039-6257(99)00072-7; Ablonczy Z, 2014, FASEB J, V28, P2369, DOI 10.1096/fj.13-248021; Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Amano S, 2005, MICROVASC RES, V69, P45, DOI 10.1016/j.mvr.2004.11.001; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; BORLAND C, 1987, INT J EPIDEMIOL, V16, P31, DOI 10.1093/ije/16.1.31; Brandl C, 2015, J CLIN MED, V4, P282, DOI 10.3390/jcm4020282; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Crow JP, 1996, METHOD ENZYMOL, V269, P185; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fett AL, 2012, HISTOL HISTOPATHOL, V27, P357, DOI 10.14670/HH-27.357; Fields MA, 2015, INVEST OPHTH VIS SCI, V56, P4231, DOI 10.1167/iovs.15-16438; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gamm DM, 2013, EXPERT REV OPHTHALMO, V8, P213, DOI 10.1586/EOP.13.14; Gong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143272; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; KARWATOWSKI WSS, 1995, BRIT J OPHTHALMOL, V79, P944, DOI 10.1136/bjo.79.10.944; Kawa MP, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/483960; Kerr CL, 2010, CELL STEM CELL, V6, P497, DOI 10.1016/j.stem.2010.05.014; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klettner A, 2009, GRAEF ARCH CLIN EXP, V247, P1487, DOI 10.1007/s00417-009-1139-x; Kunchithapautham K., 2014, J BIOL CHEM, P7; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; MARSHALL GE, 1992, BRIT J OPHTHALMOL, V76, P607, DOI 10.1136/bjo.76.10.607; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Moreira EF, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.5.10; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Murdaugh LS, 2010, EXP EYE RES, V90, P564, DOI 10.1016/j.exer.2010.01.014; Nguyen HV, 2015, J CLIN MED, V4, P567, DOI 10.3390/jcm4040567; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Nystrom A, 2016, MATRIX BIOL; Ogata N, 2002, INVEST OPHTH VIS SCI, V43, P1168; Ohno-Matsui K, 2003, BIOCHEM BIOPH RES CO, V303, P962, DOI 10.1016/S0006-291X(03)00446-7; Paik DC, 2001, CONNECT TISSUE RES, V42, P111, DOI 10.3109/03008200109014253; Parmeggiani F, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/546786; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; Pons M, 2011, INVEST OPHTH VIS SCI, V52, P3842, DOI 10.1167/iovs.10-6254; QUINN RH, 1992, INVEST OPHTH VIS SCI, V33, P3513; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Solberg Y, 1998, SURV OPHTHALMOL, V42, P535, DOI 10.1016/S0039-6257(98)00002-2; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun K, 2007, MOL VIS, V13, P2310; Sunness JS, 1999, OPHTHALMOLOGY, V106, P910, DOI 10.1016/S0161-6420(99)00509-6; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor H R, 1990, Trans Am Ophthalmol Soc, V88, P163; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Tezel TH, 2004, INVEST OPHTH VIS SCI, V45, P3337, DOI 10.1167/iovs.04-0193; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Tsao YP, 2006, LIFE SCI, V79, P545, DOI 10.1016/j.lfs.2006.01.041; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005304; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Wang Z, 2005, CURR EYE RES, V30, P691, DOI 10.1080/02713680590968259; Wiradjaja F, 2010, BIRTH DEFECTS RES C, V90, P8, DOI 10.1002/bdrc.20172; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270	79	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177763	10.1371/journal.pone.0177763	http://dx.doi.org/10.1371/journal.pone.0177763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505174	gold, Green Published, Green Submitted			2022-12-27	WOS:000401473500042
J	Lin, S; Sterling, NA; Junker, IP; Helm, CT; Smith, GM				Lin, Shen; Sterling, Noelle A.; Junker, Ian P.; Helm, Courtney T.; Smith, George M.			Effects of alpha TAT1 and HDAC5 on axonal regeneration in adult neurons	PLOS ONE			English	Article							TUBULIN ACETYLTRANSFERASE; MICROTUBULE DYNAMICS; NERVOUS-SYSTEM; ACETYLATION; GROWTH; INJURY; INHIBITION; OUTGROWTH; MEC-17; MICE	The role of posttranslational modifications in axonal injury and regeneration has been widely studied but there has been little consensus over the mechanism by which each modification affects adult axonal growth. Acetylation is known to play an important role in a variety of neuronal functions and its homeostasis is controlled by two enzyme families: the Histone Deacetylases (HDACs) and Histone Acetyl Transferases (HATs). Recent studies show that HDAC5 deacetylates microtubules in the axonal cytoplasm as part of an injury-induced regeneration response, but little is known about how acetylation of microtubules plays a role. Alpha-tubulin acetyl transferase (alpha TAT1) is a microtubule specific acetyl transferase that binds to microtubules and directly affects microtubule stability in cells. We hypothesize that increasing tubulin acetylation may play an important role in increasing the rate of axonal growth. In this study, we infected cultured adult DRG neurons with alpha TAT1 and alpha TAT1-D157N, a catalytically inactive mutant, and HDAC5, using lentiviruses. We found that alpha TAT1 significantly increases tubulin acetylation in 293T cells and DRG neurons but alpha TAT1-D157N does not. Furthermore, in neurons infected with alpha TAT1, a significant increase in acetylated tubulin was detected towards the distal portion of the axon but this increase was not detected in neurons infected with alpha TAT1-D157N. However, we found a significant increase in axon lengths of DRG neurons after alpha TAT1 and alpha TAT1-D157N infection, but no effect on axon lengths after infection with HDAC5. Our results suggest that while alpha TAT1 may play a role in axon growth in vitro, the increase is not directly due to acetylation of axonal microtubules. Our results also show that HDAC5 overexpression in the axonal cytoplasm does not play a crucial role in axonal regeneration of cultured DRG neurons. We expressed these genes in DRG neurons in adult rats and performed a sciatic nerve crush. We found that axons did not regenerate any better when infected with any of the constructs compared with control animals. Thus, while alpha TAT1 may be important for axonal growth in vitro, neither alpha TAT1 nor HDAC5 had an effect in vivo on the regeneration of sciatic nerves.	[Lin, Shen; Sterling, Noelle A.; Junker, Ian P.; Helm, Courtney T.; Smith, George M.] Temple Univ, Sch Med, Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil,Dept Neurosci, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Lin, S (corresponding author), Temple Univ, Sch Med, Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil,Dept Neurosci, Philadelphia, PA 19122 USA.	sher.lin@temple.edu			National Institute of Neurological Disorders and Stroke (NINDS) [N5060784]; Shriners Hospital for Pediatric Research grants [84050, 85200, 84294]	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Shriners Hospital for Pediatric Research grants	Support was provided by the National Institute of Neurological Disorders and Stroke (NINDS), contract grant number: N5060784; and by the Shriners Hospital for Pediatric Research grants, contract grant numbers: 84050, 85200 (GMS) and 84294 (SL).	Aguilar A, 2014, MOL BIOL CELL, V25, P1854, DOI 10.1091/mbc.E13-10-0609; AHMAD FJ, 1993, J NEUROSCI, V13, P856; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Baas P.W., 2016, CYTOSKELETON; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; Cho Y, 2014, CURR OPIN NEUROBIOL, V27, P118, DOI 10.1016/j.conb.2014.03.008; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Coombes C, 2016, P NATL ACAD SCI USA, V113, pE7176, DOI 10.1073/pnas.1605397113; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Davenport AM, 2014, J MOL BIOL, V426, P2605, DOI 10.1016/j.jmb.2014.05.009; Gaub P, 2010, CELL DEATH DIFFER, V17, P1392, DOI 10.1038/cdd.2009.216; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Lin S, 2015, J NEUROSCIENCE RES; Morley SJ, 2016, ELIFE, V5, DOI 10.7554/eLife.20813; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Puttagunta R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4527; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Smith GM, 2013, METHODS MOL BIOL, V1078, P153, DOI 10.1007/978-1-62703-640-5_14; Song Y., 2014, TRENDS CELL BIOL; Steczkiewicz K, 2006, CELL CYCLE, V5, P2927, DOI 10.4161/cc.5.24.3572; Tapia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012908; Trakhtenberg EF, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00024; Zhang YJ, 2010, J NEUROSCI RES, V88, P2374, DOI 10.1002/jnr.22394	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177496	10.1371/journal.pone.0177496	http://dx.doi.org/10.1371/journal.pone.0177496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505206	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500024
J	Pittman, JE; Noah, H; Calloway, HE; Davis, SD; Leigh, MW; Drumm, M; Sagei, SD; Accurso, FJ; Knowles, MR; Sontag, MK				Pittman, Jessica E.; Noah, Hannah; Calloway, Hollin E.; Davis, Stephanie D.; Leigh, Margaret W.; Drumm, Mitchell; Sagei, Scott D.; Accurso, Frank J.; Knowles, Michael R.; Sontag, Marci K.			Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; LOWER AIRWAY INFLAMMATION; PULMONARY-FUNCTION; YOUNG-CHILDREN; FUNCTION DECLINE; STENOTROPHOMONAS-MALTOPHILIA; INHALED TOBRAMYCIN; RISK-FACTORS; DISEASE; OUTCOMES	Objective Pseudomonas aeruginosa has been suggested as a major determinant of poor pulmonary outcomes in cystic fibrosis (CF), although other factors play a role. Our objective was to investigate the association of early childhood Pseudomonas infection on differences in lung function in adolescence with CF. Methods Two populations of subjects with CF were studied: from the Gene Modifier Study (GMS), 346 F508del homozygotes with severe vs. mild adolescent lung disease, and from the Colorado Newborn Screen Study (NBS) 172 subjects diagnosed with CF by newborn screening. Associations of Pseudomonas infection and lung function in early childhood with lung function in adolescence were investigated using multivariate linear regression analyses. Results Among GMS subjects, those with severe adolescent lung disease had worse lung function in childhood (FEV1 25 percentage points lower) compared to subjects with mild adolescent lung disease, regardless of early childhood Pseudomonas status. Among NBS subjects, those with lowest adolescent lung function had significantly lower early childhood lung function and faster rate of decline in FEV1 than subjects with highest adolescent lung function; early Pseudomonas infection was not associated with rate of FEV1 decline. The strongest predictor of adolescent lung function was early childhood lung function. Subjects with a higher percentage of cultures positive for Pseudomonas before age 6 or a lower BMI at 2-4 years old also had lower adolescent lung function, though these associations were not as strong as with early childhood lung function. Conclusions In separate analyses of two distinct populations of subjects with CF, we found a strong correlation between lower lung function in early childhood and adolescence, regardless of early childhood Pseudomonas status. Factors in addition to early Pseudomonas infection have a strong impact on lung function in early childhood in CF. Further exploration may identify novel underlying genetic or environmental factors that predispose children with CF to early loss of lung function.	[Pittman, Jessica E.] Washington Univ Sch Med, Div Pediat Allergy, Immunol, & Pulm Med, St Louis, MO USA; [Calloway, Hollin E.; Drumm, Mitchell; Sontag, Marci K.] Stanford Univ Sch Med, Dept Otolaryngol Head Neck Surg, Palo Alto, CA USA; [Calloway, Hollin E.; Drumm, Mitchell; Knowles, Michael R.] Indiana Univ Sch Med Riley Hosp Children, Sect Pediat Pulmonol, Allergy, & Sleep Med, Indianapolis, IN USA; [Drumm, Mitchell; Sagei, Scott D.; Knowles, Michael R.] Univ N Carolina, Chapel Hill, NC USA; [Leigh, Margaret W.; Sagei, Scott D.; Accurso, Frank J.] Univ N Carolina, Chapel Hill, NC USA; [Accurso, Frank J.] Case Western Reserve Univ, Dept Pediat & Genet & Genome Sci, Cleveland, OH USA; [Calloway, Hollin E.; Leigh, Margaret W.; Drumm, Mitchell; Accurso, Frank J.] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA	Washington University (WUSTL); Stanford University; James Whitcomb Riley Hospital Children; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; Children's Hospital Colorado	Pittman, JE (corresponding author), Washington Univ Sch Med, Div Pediat Allergy, Immunol, & Pulm Med, St Louis, MO USA.	pittman_j@kids.wustl.edu		Sontag, Marci/0000-0003-2501-652X	CTSA [UL1 TR001082]; CFF [PITTMA10A0, KNOWLE00A0, SONTAG07A0]; NIH [HL068890]	CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); CFF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CTSA UL1 TR001082 (MKS, SDS, FJA): http://www.ncats.nih.gov/ctsa; CFF PITTMA10A0 (JEP): https: //www.cff.org/Our-Research/For-Researchers/Research-Awards/; CFF KNOWLE00A0 (HEC, MRK): https://www.cff.org/Our-Research/For-Researchers/Research-Awards/; NIH HL068890 (MRK): https://grants.nih.gov/funding/index.htm, CFF SONTAG07A0 (MKS): https://www.cff.org/Our-Research/For-Researchers/Research-Awards/.	ABMAN SH, 1991, J PEDIATR-US, V119, P211, DOI 10.1016/S0022-3476(05)80729-2; Accurso FJ, 2008, J CLIN INVEST, V118, P839, DOI 10.1172/JCI35138; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Braun AT, 2006, J CYST FIBROS, V5, P33, DOI 10.1016/j.jcf.2005.09.008; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Bush A, 2001, Paediatr Respir Rev, V2, P287, DOI 10.1053/prrv.2001.0162; Cogen J, 2015, PEDIATR PULM, V50, P763, DOI 10.1002/ppul.23217; Collaco JM, 2008, JAMA-J AM MED ASSOC, V299, P417, DOI 10.1001/jama.299.4.417; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Cutting GR, 2006, KENDIGS DISORDERS RE; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Davis PB, 1997, J PEDIATR-US, V131, P789, DOI 10.1016/S0022-3476(97)70019-2; DAVIS PB, 2006, KENDIGS DISORDERS RE, P873; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; GAN KH, 1994, NEW ENGL J MED, V330, P865; Gibson RL, 2003, AM J RESP CRIT CARE, V167, P841, DOI 10.1164/rccm.200208-855OC; Goss CH, 2004, THORAX, V59, P955, DOI 10.1136/thx.2003.017707; HAMMOND KB, 1991, NEW ENGL J MED, V325, P769, DOI 10.1056/NEJM199109123251104; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HIBBERT ME, 1990, PEDIATR PULM, V8, P172, DOI 10.1002/ppul.1950080308; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Kozlowska WJ, 2008, AM J RESP CRIT CARE, V178, P42, DOI 10.1164/rccm.200710-1599OC; Kuczmarski RJ OC, 2000, STATISTICS; Levy H, 2008, PEDIATR PULM, V43, P463, DOI 10.1002/ppul.20794; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Linnane BM, 2008, AM J RESP CRIT CARE; Lum S, 2007, THORAX, V62, P341, DOI 10.1136/thx.2006.068262; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; McPhail GL, 2008, J PEDIATR-US, V153, P752, DOI 10.1016/j.jpeds.2008.07.011; Moss RB, 2009, J PEDIATR-US, V154, P162, DOI 10.1016/j.jpeds.2008.09.042; Pittman JE, 2010, PEDIAT PULMONOLOGY; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Rosenfeld M, 1992, Semin Respir Infect, V7, P158; Rosenfeld M, 2003, CURR OPIN PULM MED, V9, P492, DOI 10.1097/00063198-200311000-00008; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sagel SD, 2009, J PEDIATR-US, V154, P183, DOI 10.1016/j.jpeds.2008.08.001; Sawicki GS, 2008, PEDIATR PULM, V43, P1117, DOI 10.1002/ppul.20914; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; Schechter MS, 2003, SEM RESP CRIT CARE M, V24, P639, DOI 10.1055/s-2004-815660; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Waters V, 2012, J CYST FIBROS, V11, P8, DOI 10.1016/j.jcf.2011.07.008; Wolfenden LL, 2009, PAEDIATR RESPIR REV, V10, P32, DOI 10.1016/j.prrv.2008.04.002; Zemel BS, 2000, J PEDIATR-US, V137, P374, DOI 10.1067/mpd.2000.107891	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177215	10.1371/journal.pone.0177215	http://dx.doi.org/10.1371/journal.pone.0177215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505188	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500014
J	Borsatto, T; Sperb-Ludwig, F; Lima, SE; Carvalho, MRS; Fonseca, PAS; Camelo, JS; Ribeiro, EM; de Medeiros, PFV; Lourenco, CM; de Souza, CFM; Boy, R; Felix, TM; Bittar, CM; Pinto, LLC; Neto, EC; Blom, HJ; Schwartz, IVD				Borsatto, Taciane; Sperb-Ludwig, Fernanda; Lima, Samyra E.; Carvalho, Maria R. S.; Fonseca, Pablo A. S.; Camelo, Jose S., Jr.; Ribeiro, Erlane M.; de Medeiros, Paula F. V.; Lourenco, Charles M.; de Souza, Carolina F. M.; Boy, Raquel; Felix, Temis M.; Bittar, Camila M.; Pinto, Louise L. C.; Neto, Eurico C.; Blom, Henk J.; Schwartz, Ida V. D.			Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patients	PLOS ONE			English	Article							MUTATIONS; GENE; DIAGNOSIS; NEWBORNS; SEQUENCE	Introduction The association between the BTD genotype and biochemical phenotype [profound biotinidase deficiency (BD), partial BD or heterozygous activity] is not always consistent. This study aimed to investigate the genotype-biochemical phenotype association in patients with low biotinidase activity. Methods All exons, the 5'UTR and the promoter of the BTD gene were sequenced in 72 Brazilian individuals who exhibited low biotinidase activity. For each patient, the expected biochemical phenotype based on the known genotype was compared with the observed biochemical phenotype. Additional non-genetic factors that could affect the biotinidase activity were also analysed. Results Most individuals were identified by neonatal screening (n = 66/72). When consecutive results for the same patient were compared, age, prematurity and neonatal jaundice appeared to affect the level of biotinidase activity. The biochemical phenotype at the time of the second blood collection changed in 11/22 patients compared to results from the first sample. Three novel variants were found: c. 1337T>C (p. L446P), c. 1466A>G (p. N489S) and c. 962G>A (p. W321*). Some patients with the same genotype presented different biochemical phenotypes. The expected and observed biochemical phenotypes agreed in 68.5% of cases (concordant patients). The non-coding variants c.-183G>A, c.-315A>G and c.-514C>T were present in heterozygosis in 5/17 discordant patients. In addition, c.183G>A and c.-514C>T were also present in 10/37 concordant patients. Conclusions The variants found in the promoter region do not appear to have a strong impact on biotinidase activity. Since there is a disparity between the BTD genotype and biochemical phenotype, and biotinidase activity may be affected by both genetic and non-genetic factors, we suggest that the diagnosis of BD should be based on more than one measurement of plasma biotinidase activity. DNA analysis can be of additional relevance to differentiate between partial BD and heterozygosity.	[Borsatto, Taciane; Sperb-Ludwig, Fernanda; Bittar, Camila M.; Schwartz, Ida V. D.] Univ Fed Rio Grande do Sul, Post Grad Program Genet & Mol Biol, Porto Alegre, RS, Brazil; [Borsatto, Taciane; Sperb-Ludwig, Fernanda; Lima, Samyra E.; Schwartz, Ida V. D.] HCPA, Ctr Expt Res CPE, BRAIN Lab, Porto Alegre, RS, Brazil; [Lima, Samyra E.] Ctr Univ Ritter Reis, Porto Alegre, RS, Brazil; [Carvalho, Maria R. S.; Fonseca, Pablo A. S.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Camelo, Jose S., Jr.; Lourenco, Charles M.] Univ Sao Paulo, Hosp Clin, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Ribeiro, Erlane M.] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil; [de Medeiros, Paula F. V.] Univ Fed Campina Grande, Campina Grande, PB, Brazil; [de Souza, Carolina F. M.; Felix, Temis M.; Bittar, Camila M.; Schwartz, Ida V. D.] HCPA, Med Genet Serv, Porto Alegre, RS, Brazil; [Boy, Raquel] Univ Estado Rio de Janeiro, Dept Pediat, Rio De Janeiro, RJ, Brazil; [Pinto, Louise L. C.] Hosp Infantil Joana Gusmao, Florianopolis, SC, Brazil; [Neto, Eurico C.] CTN Diagnost, Porto Alegre, RS, Brazil; [Blom, Henk J.] Univ Med Ctr Freiburg, Dept Gen Pediat Adolescent Med & Neonatol, Lab Clin Biochem & Metab, Freiburg, Germany	Universidade Federal do Rio Grande do Sul; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal de Campina Grande; Universidade do Estado do Rio de Janeiro; University of Freiburg	Borsatto, T (corresponding author), Univ Fed Rio Grande do Sul, Post Grad Program Genet & Mol Biol, Porto Alegre, RS, Brazil.; Borsatto, T (corresponding author), HCPA, Ctr Expt Res CPE, BRAIN Lab, Porto Alegre, RS, Brazil.	taciborsatto@hotmail.com	Camelo, Jose S/G-3169-2012; Schwartz, Ida/M-1422-2015; Camelo, José/AAL-4716-2020; Ludwig, Fernanda Sperb/W-3200-2019; Carvalho, Maria Raquel/C-7310-2016; Félix, Têmis/B-8073-2010; Carvalho, Maria Raquel Santos/HHN-1690-2022; Fonseca, Pablo/AAZ-2254-2021	Schwartz, Ida/0000-0002-7933-6687; Ludwig, Fernanda Sperb/0000-0002-2460-7064; Carvalho, Maria Raquel/0000-0002-1744-448X; Félix, Têmis/0000-0002-8401-6821; Carvalho, Maria Raquel Santos/0000-0002-1744-448X; Fonseca, Pablo Augusto de Souza/0000-0002-6917-7475; Espindola Lima, Samyra/0000-0002-3881-4507	Fundo de Incentivo a Pesquisa e Eventos/ Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Post Graduate Program in Genetics and Molecular Biology (Universidade Federal do Rio Grande do Sul); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Orphan Europe	Fundo de Incentivo a Pesquisa e Eventos/ Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Post Graduate Program in Genetics and Molecular Biology (Universidade Federal do Rio Grande do Sul); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Orphan Europe	This study received financial support from Fundo de Incentivo a Pesquisa e Eventos/ Hospital de Clinicas de Porto Alegre (FIPE-HCPA) for research materials and publication fee. Post Graduate Program in Genetics and Molecular Biology (Universidade Federal do Rio Grande do Sul) funded the translation. ECN has a commercial affiliation (CTN Diagnosticos) which did not have any role or financial contribution to this research. TB have fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes). FS had fellowship from the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). IVDS, MRSC and PASF have fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). HB receives a research grant of Orphan Europe. The funders did no provide support in the form of salaries for any author, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Jasmi FA, 2015, JIMD REPORTS; Auerbach RK, 2013, BIOINFORMATICS; Borsatto T, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0096-3; COLE H, 1994, J BIOL CHEM, V269, P6566; Cowan TM, 2010, GENET MED, V12, P464, DOI 10.1097/GIM.0b013e3181e4cc0f; Gannavarapu S, 2015, MOL GENET METAB, V116, P146, DOI 10.1016/j.ymgme.2015.08.010; Hymes J, 1996, CLIN CHIM ACTA, V255, P1, DOI 10.1016/0009-8981(96)06396-6; Iqbal F, 2010, MOL GENET METAB, V100, P42, DOI 10.1016/j.ymgme.2009.12.016; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lara MT, 2015, JIMD REPORTS; Li H, 2014, MOL GENET METAB, V112, P242, DOI 10.1016/j.ymgme.2014.04.002; MdS Brasil, 2016, TRIAGEM NEONATAL BIO, P80; Muhl ML, 2001, EUR J HUM GENET, V9, P237, DOI 10.1038/sj.ejhg.5200620; Neto EC, 2004, BRAZ J MED BIOL RES, V37, P295, DOI 10.1590/S0100-879X2004000300001; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pomponio RJ, 1998, MOL GENET METAB, V64, P152, DOI 10.1006/mgme.1998.2706; Procter M, 2016, MOL GENET METAB, V117, P369, DOI 10.1016/j.ymgme.2016.01.002; Safran M, 2010, GENECARDS VERSION 3; Schulpis KH, 2003, EARLY HUM DEV, V72, P15, DOI 10.1016/S0378-3782(02)00097-X; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Senanayake DN, 2015, MOLEC GENET METAB RE, V2, P81, DOI 10.1016/j.ymgmr.2015.01.005; SUORMALA T, 1988, EUR J PEDIATR, V147, P478; Swango KL, 1998, HUM GENET, V102, P571, DOI 10.1007/s004390050742; Thodi G, 2013, GENE, V524, P361, DOI 10.1016/j.gene.2013.04.059; WASTELL HJ, 1988, ARCH DIS CHILD, V63, P1244, DOI 10.1136/adc.63.10.1244; Wiltink RC, 2016, EUR J HUM GENET, V24, P1424, DOI 10.1038/ejhg.2016.65; WOLF B, 1983, CLIN CHIM ACTA, V131, P273, DOI 10.1016/0009-8981(83)90096-7; Wolf B, 2002, MOL GENET METAB, V77, P108, DOI 10.1016/S1096-7192(02)00149-X; Wolf B., 2016, GENETICS MED OFFICIA; Wolf B, 2015, MOL GENET METAB, V114, P382, DOI 10.1016/j.ymgme.2015.01.003; Wolf B, 2012, GENET MED, V14, P565, DOI 10.1038/gim.2011.6; Ye J, 2009, J INHERIT METAB DIS, V32, pS295, DOI 10.1007/s10545-009-1238-1	34	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177503	10.1371/journal.pone.0177503	http://dx.doi.org/10.1371/journal.pone.0177503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498829	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500022
J	Ichikawa, Y; Zemljic-Harpf, AE; Zhang, Z; McKirnan, MD; Manso, AM; Ross, RS; Hammond, HK; Patel, HH; Roth, DM				Ichikawa, Yasuhiro; Zemljic-Harpf, Alice E.; Zhang, Zheng; McKirnan, M. Dan; Manso, Ana Maria; Ross, Robert S.; Hammond, H. Kirk; Patel, Hemal H.; Roth, David M.			Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits	PLOS ONE			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; NITRIC-OXIDE; MULTIDRUG-RESISTANCE; DOXORUBICIN; EXPRESSION; DAUNORUBICIN; MG53; CARDIOTOXICITY; HYPERTROPHY; PREVENTION	Anthracyclines are chemotherapeutic drugs known to induce heart failure in a dose-dependent manner. Mechanisms involved in anthracycline cardiotoxicity are an area of relevant investigation. Caveolins bind, organize and regulate receptors and signaling molecules within cell membranes. Caveolin-3 (Cav-3), integrins and related membrane repair proteins can function as cardioprotective proteins. Expression of these proteins in anthracyclineinduced heart failure has not been evaluated. We tested the hypothesis that daunorubicin alters cardioprotective protein expression in the heart. Rabbits were administered daunorubicin (3 mg/kg, IV) weekly, for three weeks or nine weeks. Nine weeks but not three weeks of daunorubicin resulted in progressive reduced left ventricular function. Cav-3 expression in the heart was unchanged at three weeks of daunorubicin and increased in nine week treated rabbits when compared to control hearts. Electron microscopy showed caveolae in the heart were increased and mitochondrial number and size were decreased after nine weeks of daunorubicin. Activated beta-1 (beta 1) integrin and the membrane repair protein MG53 were increased after nine weeks of daunorubicin vs. controls with no change at the three week time point. The results suggest a potential pathophysiological role for Cav3, integrins and membrane repair in daunorubicin-induced heart failure.	[Ichikawa, Yasuhiro; Zemljic-Harpf, Alice E.; Zhang, Zheng; McKirnan, M. Dan; Manso, Ana Maria; Ross, Robert S.; Hammond, H. Kirk; Patel, Hemal H.; Roth, David M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Ichikawa, Yasuhiro; Zemljic-Harpf, Alice E.; McKirnan, M. Dan; Patel, Hemal H.; Roth, David M.] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA; [Zhang, Zheng; Manso, Ana Maria; Ross, Robert S.; Hammond, H. Kirk] Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Roth, DM (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.; Roth, DM (corresponding author), Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA.	droth@ucsd.edu	Ross, Robert/ABE-1109-2020; Patel, Hemal/C-7325-2019	Ross, Robert/0000-0003-2195-8982; Patel, Hemal/0000-0001-6722-9625	Veteran Affairs Merit Awards from the Department of Veterans Affairs [BX000783, BX003260, BX003774, BX001963]; National Institutes of Health [HL091071, HL107200, HL066941, HL115933, HL127806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, R42HL122038, R01HL115933, R01HL127806] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000783, I01BX003774, I01BX001963] Funding Source: NIH RePORTER	Veteran Affairs Merit Awards from the Department of Veterans Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by Veteran Affairs Merit Awards from the Department of Veterans Affairs (http://www.sandiego.va.gov) BX000783 (DMR), BX003260 (RSR), BX003774 (HKH) and BX001963 (HHP), National Institutes of Health (https://www.nih.gov) HL091071 (HHP), HL107200 (HHP, DMR), HL066941 (HKH, DMR, HHP, RSR), HL115933 (RSR, DMR, HHP), and HL127806 (RSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbagallo F, 2016, CIRC RES, V119, P931, DOI 10.1161/CIRCRESAHA.116.308964; Belanger MM, 2003, ANTI-CANCER DRUG, V14, P281, DOI 10.1097/00001813-200304000-00005; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Blazek AD, 2015, PHYSIOLOGY, V30, P438, DOI 10.1152/physiol.00019.2015; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Fanous I, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0801-5; Feijen EAM, 2015, J CLIN ONCOL, V33, P3774, DOI 10.1200/JCO.2015.61.5187; Feiner EC, 2011, J CARD FAIL, V17, P253, DOI 10.1016/j.cardfail.2010.10.008; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; Hare JM, 2000, CIRC RES, V86, P1085, DOI 10.1161/01.RES.86.10.1085; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Ichikawa Y, 2012, CIRC J, V76, P2456, DOI 10.1253/circj.CJ-12-0215; Israeli-Rosenberg S, 2015, FASEB J, V29, P374, DOI 10.1096/fj.13-243139; Jasmin JF, 2011, AM J PHYSIOL-HEART C, V300, pH1274, DOI 10.1152/ajpheart.01173.2010; Jirkovsky E, 2012, J PHARMACOL EXP THER, V343, P468, DOI 10.1124/jpet.112.198358; Kassan A, 2016, AM J PHYSIOL-CELL PH, V311, pC854, DOI 10.1152/ajpcell.00147.2016; Keefe DL, 2001, SEMIN ONCOL, V28, P2, DOI 10.1053/sonc.2001.26431; Klimtova I, 2002, HUM EXP TOXICOL, V21, P649, DOI 10.1191/0960327102ht311oa; Lemckert FA, 2016, CARDIOVASC RES, V110, P178, DOI 10.1093/cvr/cvw017; Lenneman CG, 2016, CIRC RES, V118, P1008, DOI 10.1161/CIRCRESAHA.115.303633; Li DL, 2016, CIRCULATION; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; Markandeya YS, 2015, J BIOL CHEM, V290, P22085, DOI 10.1074/jbc.M115.674945; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Moslehi JJ, 2016, NEW ENGL J MED, V375, P1457, DOI 10.1056/NEJMra1100265; Moulin M, 2015, CIRC-HEART FAIL, V8, P98, DOI 10.1161/CIRCHEARTFAILURE.114.001180; Oka N, 1997, AM J PHYSIOL-CELL PH, V273, pC1957, DOI 10.1152/ajpcell.1997.273.6.C1957; Oliveira GH, 2015, BLOOD REV; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; PAUL C, 1989, THER DRUG MONIT, V11, P140, DOI 10.1097/00007691-198903000-00004; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Piech A, 2002, AM J PHYSIOL-HEART C, V282, pH219, DOI 10.1152/ajpheart.2002.282.1.H219; Ruiz-Hurtado G, 2007, HYPERTENSION, V50, P1049, DOI 10.1161/HYPERTENSIONAHA.107.093666; Schilling JM, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0542-9; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Sterba M, 2011, J MOL CELL CARDIOL, V50, P849, DOI 10.1016/j.yjmcc.2011.01.018; Sun JH, 2015, CARDIOVASC RES, V106, P227, DOI 10.1093/cvr/cvv044; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Tsutsumi YM, 2010, ANESTHESIOLOGY, V112, P1136, DOI 10.1097/ALN.0b013e3181d3d624; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Yi JS, 2013, J PROTEOME RES, V12, P605, DOI 10.1021/pr300651m; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919; Zhang Y, 2011, CARDIOVASC RES, V91, P108, DOI 10.1093/cvr/cvr029; Zhang Y, 2015, TUMOR BIOL, V36, P2277, DOI 10.1007/s13277-014-2835-7; Zhao JL, 2013, CIRCULATION, V128, pS121, DOI 10.1161/CIRCULATIONAHA.112.000045	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177660	10.1371/journal.pone.0177660	http://dx.doi.org/10.1371/journal.pone.0177660			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498861	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500040
J	Kim, YB; Lee, J; Park, N; Choo, J; Kim, JH; Kim, CH				Kim, Young Bin; Lee, Jurim; Park, Nuri; Choo, Jaegul; Kim, Jong-Hyun; Kim, Chang Hun			When Bitcoin encounters information in an online forum: Using text mining to analyse user opinions and predict value fluctuation	PLOS ONE			English	Article							PATTERNS	Bitcoin is an online currency that is used worldwide to make online payments. It has consequently become an investment vehicle in itself and is traded in a way similar to other open currencies. The ability to predict the price fluctuation of Bitcoin would therefore facilitate future investment and payment decisions. In order to predict the price fluctuation of Bitcoin, we analyse the comments posted in the Bitcoin online forum. Unlike most research on Bitcoin- related online forums, which is limited to simple sentiment analysis and does not pay sufficient attention to note-worthy user comments, our approach involved extracting keywords from Bitcoin-related user comments posted on the online forum with the aim of analytically predicting the price and extent of transaction fluctuation of the currency. The effectiveness of the proposed method is validated based on Bitcoin online forum data ranging over a period of 2.8 years from December 2013 to September 2016.	[Kim, Young Bin; Park, Nuri] Korea Univ, Interdisciplinary Program Visual Informat Proc, Seoul, South Korea; [Lee, Jurim; Choo, Jaegul; Kim, Chang Hun] Korea Univ, Dept Comp Sci, Seoul, South Korea; [Kim, Jong-Hyun] Kangnam Univ, Dept Software Applicat, Yongin, South Korea	Korea University; Korea University; Kangnam University	Kim, CH (corresponding author), Korea Univ, Dept Comp Sci, Seoul, South Korea.	chkim@korea.ac.kr	Choo, Jaegul/ABF-8315-2020	Choo, Jaegul/0000-0003-1071-4835	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, ICT and future Planning [NRF-2016M3C1B6929629, NRF-2016M3C1B6929579, NRF-2017R1A2B2005380]; Institute for Information & communications Technology Promotion(IITP) grant - Korea government(MSIP) [R7518-16-1028]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, ICT and future Planning(National Research Foundation of Korea); Institute for Information & communications Technology Promotion(IITP) grant - Korea government(MSIP)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, ICT and future Planning(NRF-2016M3C1B6929629, NRF-2016M3C1B6929579, NRF-2017R1A2B2005380) and Institute for Information & communications Technology Promotion(IITP) grant funded by the Korea government(MSIP)(R7518-16-1028,High performance computing (HPC) based rendering solution development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Athey, 2016, BITCOIN PRICIN UNPUB; Barber S., 2012, FINANCIAL CRYPTOGRAP, P399, DOI [DOI 10.1007/978-3-642-32946-3, 10.1007/978-3-642-32946-3_29]; Benevenuto F, 2009, IMC'09: PROCEEDINGS OF THE 2009 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P49; Bernstein M.S., 2011, P 5 INT AAAI C WEBL, P50; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bohme R, 2015, J ECON PERSPECT, V29, P213, DOI 10.1257/jep.29.2.213; Bohr J, 2014, ANN CONF PRIV SECUR, P94, DOI 10.1109/PST.2014.6890928; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Bryans D, 2014, INDIANA LAW J, V89, P441; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Choo K. K. R., 2015, HDB DIGITAL CURRENCY, P283, DOI DOI 10.1016/B978-0-12-802117-0.00015-1; Choo KKR, 2014, SECUR J, V27, P1, DOI 10.1057/sj.2012.9; Cohen-Charash Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072031; Coles BA, 2016, COMPUT HUM BEHAV, V60, P233, DOI 10.1016/j.chb.2016.02.070; Dayem AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121610; Feng S, 2012, P 50 ANN M ASS COMP, V2; Fu XH, 2013, KNOWL-BASED SYST, V37, P186, DOI 10.1016/j.knosys.2012.08.003; Granger C.W., 2000, Q REV ECON FINANC, V40, P337, DOI DOI 10.1016/S1062-9769(00)00042-9; Grinberg R., 2012, HASTINGS SCI TECH L, V4, P159; Hau YS, 2011, COMPUT HUM BEHAV, V27, P956, DOI 10.1016/j.chb.2010.11.022; Hayati P, 2009, IND INF 2009 INDIN 2; Juea W, 2011, COMPUTER ENG, V5; Kaminski J, 2014, ARXIV14067577; Kang MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079823; Kim YB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167153; Kim YI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157299; Kristoufek L, 2013, SCI REPORTS, P3; Kristoufek L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123923; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li N, 2010, DECIS SUPPORT SYST, V48, P354, DOI 10.1016/j.dss.2009.09.003; Linton M, 2016, DYNAMIC TOPIC MODELL; Maia M, 2008, P 1 WORKSH SOC NETW, P1, DOI DOI 10.1145/1435497.1435498; Matta M., 2015, POSTERS DEMOS LATE B, P1; Matta M, 2015, UMAP WORKSH; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Moat HS, 2013, SCI REPORTS, P3; Nakamoto S., 2008, BITCOIN PEER TO PEER; Panzarasa P, 2009, J AM SOC INF SCI TEC, V60, P911, DOI 10.1002/asi.21015; Pillai S, 2015, ARXIV150201657; Preis T, 2013, SCI REPORTS, P3; Reid F., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P1318, DOI 10.1109/PASSAT/SocialCom.2011.79; Rout J, 2017, REVISITING SEMISUPER; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Shin Y, 2011, INFOCOM 2011 P IEEE; Shin Y, 2011, NUTS BOLTS FORUM SPA; Sing CC, 2006, EDUC TECHNOL SOC, V9, P250; Stokes R, 2012, INF COMMUN TECHNOL L, V21, P221, DOI 10.1080/13600834.2012.744225; Wang C., 2011, P 17 ACM SIGKDD INT, P448, DOI DOI 10.1145/2020408.2020480; Wang Y, 2012, P 18 ACM SIGKDD INT, P123, DOI [DOI 10.1145/2339530.2339552, 10.1145/2339530.2339552]; Yelowitz A, 2015, APPL ECON LETT, V22, P1030, DOI 10.1080/13504851.2014.995359	53	55	56	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							0177630	10.1371/journal.pone.0177630	http://dx.doi.org/10.1371/journal.pone.0177630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498843	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500036
J	Pio, GM; Xia, Y; Piaseczny, MM; Chu, JE; Allan, AL				Pio, Graciella M.; Xia, Ying; Piaseczny, Matthew M.; Chu, Jenny E.; Allan, Alison L.			Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; MAMMARY EPITHELIAL-CELLS; PLASMA OSTEOPONTIN; ALDEHYDE DEHYDROGENASE; METASTATIC PATTERNS; NICHE; EXPRESSION; INHIBITION; RECEPTOR; SURVIVAL	Breast cancer is a leading cause of cancer death in women, with the majority of these deaths caused by metastasis to distant organs. The most common site of breast cancer metastasis is the bone, which has been shown to provide a rich microenvironment that supports the migration and growth of breast cancer cells. Additionally, growing evidence suggests that breast cancer cells that do successfully metastasize have a stem-like phenotype including high activity of aldehyde dehydrogenase (ALDH) and/or a CD44(+)CD24(-)phenotype. In the current study, we tested the hypothesis that these ALDH (hi) CD44 (+) CD24(-)breast cancer cells interact with factors in the bone secondary organ microenvironment to facilitate metastasis. Specifically, we focused on bone-derived osteopontin and its ability to promote the migration and stem-like phenotype of breast cancer cells. Our results indicate that bone-derived osteopontin promotes the migration, tumorsphere-forming ability and colony-forming ability of whole population and ALDH hi CD44(+)CD24-breast cancer cells in bone marrow-conditioned media (an ex vivo representation of the bone microenvironment) (p <= 0.05). We also demonstrate that CD44 and RGD-dependent cell surface integrins facilitate this functional response to bone-derived osteopontin (p <= 0.05), potentially through activation of WNK-1 and PRAS40-related pathways. Our findings suggest that soluble bone-derived osteopontin enhances the ability of breast cancer cells to migrate to the bone and maintain a stem-like phenotype within the bone microenvironment, and this may contribute to the establishment and growth of bone metastases.	[Pio, Graciella M.; Piaseczny, Matthew M.; Chu, Jenny E.; Allan, Alison L.] Univ Western Univ, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Xia, Ying; Allan, Alison L.] London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada; [Allan, Alison L.] Univ Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada; [Allan, Alison L.] Lawson Hlth Res Inst, Canc Res Labs, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Allan, AL (corresponding author), Univ Western Univ, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada.; Allan, AL (corresponding author), London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada.; Allan, AL (corresponding author), Univ Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada.; Allan, AL (corresponding author), Lawson Hlth Res Inst, Canc Res Labs, London, ON, Canada.	alison.allan@lhsc.on.ca		Chu, Jenny/0000-0002-1841-3175	Canadian Breast Cancer Foundation-Ontario Region; Canada Foundation for Innovation [13199]; Ontario Graduate Scholarship program (Province of Ontario); Canada Graduate Scholarship-Master's program; Canadian Institutes of Health Research (CIHR)-Strategic Training Program; Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit at the London Regional Cancer Program; Ontario Ministry of Research and Innovation	Canadian Breast Cancer Foundation-Ontario Region; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Graduate Scholarship program (Province of Ontario); Canada Graduate Scholarship-Master's program; Canadian Institutes of Health Research (CIHR)-Strategic Training Program(Canadian Institutes of Health Research (CIHR)); Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit at the London Regional Cancer Program; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by grants from the Canadian Breast Cancer Foundation-Ontario Region, the Canada Foundation for Innovation (No. 13199), and donor support from John and Donna Bristol through the London Health Sciences Foundation (to A.L.A.). Studentship and fellowship support were provided by the Ontario Graduate Scholarship program (Province of Ontario, to G.M.P. and J.E.C.), the Canada Graduate Scholarship-Master's program (to M.M.P), the Canadian Institutes of Health Research (CIHR)-Strategic Training Program (to M.M.P., G.M.P and J.E.C.) and the Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit at the London Regional Cancer Program (to M.M.P., G.M.P., J.E.C. and Y.X.). A.L.A. was supported by a CIHR New Investigator Award and an Early Researcher Award from the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; Anborgh PH, 2015, AM J TRANSL RES, V7, P723; Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Benoit Yannick D, 2012, J Signal Transduct, V2012, P248759, DOI 10.1155/2012/248759; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Calvi LM, 2015, BLOOD, V126, P2443, DOI 10.1182/blood-2015-07-533588; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2016, CAN CANC STAT; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chu JE, 2014, NEOPLASIA, V16, P180, DOI 10.1593/neo.132076; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Furger KA, 2003, MOL CANCER RES, V1, P810; Gillespie MT, 1997, INT J CANCER, V73, P812; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Haylock DN, 2005, CELL CYCLE, V4, P1353, DOI 10.4161/cc.4.10.2056; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Kim JH, 2002, JAMA-J AM MED ASSOC, V287, P1671, DOI 10.1001/jama.287.13.1671; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Ling LJ, 2008, CHINESE MED J-PEKING, V121, P1980, DOI 10.1097/00029330-200810020-00006; Lipton A, 2009, J NATL COMPR CANC NE, V7, pS1; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Nanni P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039626; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645; PAGET S, 1989, CANCER METAST REV, V8, P98; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Singhal H, 1997, CLIN CANCER RES, V3, P605; Standal T, 2004, EXP ONCOL, V26, P179; Standal T, 2004, HAEMATOLOGICA, V89, P174; Sterling JA, 2011, BONE, V48, P6, DOI 10.1016/j.bone.2010.07.015; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tuck AB, 2001, J MAMMARY GLAND BIOL, V6, P419, DOI 10.1023/A:1014734930781; Tuck AB, 2001, BREAST CANCER RES TR, V70, P197, DOI 10.1023/A:1013095329825; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Ue T, 1998, INT J CANCER, V79, P127, DOI 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wander SA, 2013, BREAST CANCER RES TR, V138, P369, DOI 10.1007/s10549-012-2389-6; WEISS L, 1992, CLIN EXP METASTAS, V10, P191, DOI 10.1007/BF00132751; XUAN JW, 1994, J CELL BIOCHEM, V54, P247, DOI 10.1002/jcb.240540213; Zhang H, 2014, CELL PHYSIOL BIOCHEM, V33, P991, DOI 10.1159/000358670; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200	64	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177640	10.1371/journal.pone.0177640	http://dx.doi.org/10.1371/journal.pone.0177640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498874	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500038
J	Takeuchi, Y; Saito, A; Ojima, Y; Kagaya, S; Fukami, H; Sato, H; Matsuda, K; Nagasawa, T				Takeuchi, Yoichi; Saito, Ayako; Ojima, Yoshie; Kagaya, Saeko; Fukami, Hirotaka; Sato, Hiroyuki; Matsuda, Ken; Nagasawa, Tasuku			The influence of the Great East Japan earthquake on microscopic polyangiitis: A retrospective observational study	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; SMALL-VESSEL VASCULITIS; SILICA EXPOSURE; ANTINEUTROPHIL; ASSOCIATION; TSUNAMI; GLOMERULONEPHRITIS; ACTIVATION	Background Antineutrophil cytoplasmic antibody-associated vasculitis is triggered by environmental factors, including silica dust exposure. Repeated tsunami waves brought a large volume of silica-containing sludge inland after the Great East Japan earthquake in 2011. We aimed to determine if the serious disaster influenced the clinical features of the microscopic polyangiitis. Methods This is an observational retrospective study conducted in a single institute. A total of 43 patients were included based on the CHCC2012 criteria for microscopic polyangiitis from 2007 to 2015. We used the Poisson regression model to determine the incidence of microscopic polyangiitis within the annual population of the medical district. The participants were selected during a 3-year period from before (N = 13) to after the disaster (N = 20). The differences of parameters and the overall survival between the groups were analyzed. Results The incidence of microscopic polyangiitis increased after the disaster (lambda= 17.4/million/year [ 95% CI: 7.66-39.6] before the disaster and lambda = 33.1/million/year [17.7-61.7] after the disaster, P = 0.044). A high Birmingham Activity Score was associated with a high incidence of microscopic polyangiitis after the disaster. The overall survival of the patients with microscopic polyangiitis declined significantly after the disaster. Conclusions The Great East Japan earthquake influenced the development of the microscopic polyangiitis in our restricted area. The patients who developed after the disaster had severe symptoms and a high mortality rate.	[Takeuchi, Yoichi; Saito, Ayako; Ojima, Yoshie; Kagaya, Saeko; Fukami, Hirotaka; Sato, Hiroyuki; Matsuda, Ken; Nagasawa, Tasuku] Japanese Red Cross Ishinomaki Hosp, Dept Med, Div Nephrol, Ishinomaki, Miyagi, Japan		Takeuchi, Y (corresponding author), Japanese Red Cross Ishinomaki Hosp, Dept Med, Div Nephrol, Ishinomaki, Miyagi, Japan.	muu_tko@yahoo.co.jp		Sato, Hiroyuki/0000-0002-7820-0219; Nagasawa, Tasuku/0000-0002-2012-1171; Fukami, Hirotaka/0000-0002-7375-0748				Arimura Y, 2016, CLIN EXP NEPHROL, V20, P322, DOI 10.1007/s10157-015-1218-8; Bomback AS, 2011, KIDNEY INT, V79, P757, DOI 10.1038/ki.2010.489; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ebisawa K, 2013, RESPIR INVESTIG, V51, P2, DOI 10.1016/j.resinv.2012.10.002; Ellard DR, 2001, INT J PSYCHOPHYSIOL, V41, P93, DOI 10.1016/S0167-8760(00)00180-X; Farquhar HJ, 2017, INTERN MED J, V47, P57, DOI 10.1111/imj.13246; Fujimoto S, 2011, RHEUMATOLOGY, V50, P1916, DOI 10.1093/rheumatology/ker205; Fukuhara N, 2016, ALLERGOL INT, V65, P117, DOI 10.1016/j.alit.2015.09.005; Hogan SL, 2001, J AM SOC NEPHROL, V12, P134, DOI 10.1681/ASN.V121134; Hogan SL, 2007, CLIN J AM SOC NEPHRO, V2, P290, DOI 10.2215/CJN.03501006; Inui T, 2012, SOILS FOUND, V52, P856, DOI 10.1016/j.sandf.2012.11.008; Jagiello P, 2004, HUM GENET, V114, P468, DOI 10.1007/s00439-004-1092-z; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawasaki A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154393; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kuroda H, 2011, W PAC SURVEILL RESPO, V2, P14; Lane SE, 2003, ARTHRITIS RHEUM-US, V48, P814, DOI 10.1002/art.10830; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McCullagh P., 1999, GEN LINEAR MODELS; Nagasawa T, 2016, CLIN EXP NEPHROL, V20, P411, DOI 10.1007/s10157-015-1168-1; Nakahara S, 2013, J EPIDEMIOL, V23, P70, DOI 10.2188/jea.JE20120114; Nakazawa D, 2014, J AM SOC NEPHROL, V25, P990, DOI 10.1681/ASN.2013060606; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; Tervaert JWC, 2012, CLIN REV ALLERG IMMU, V43, P211, DOI 10.1007/s12016-012-8320-4; Tsuchiya N, 2003, J RHEUMATOL, V30, P1534; Ueda Shinsaku, 2014, Ann Vasc Dis, V7, P365, DOI 10.3400/avd.oa.14-00106; van Wijngaarden RAFDL, 2008, CLIN J AM SOC NEPHRO, V3, P237, DOI 10.2215/CJN.03550807; Yamagata K, 2012, CLIN EXP NEPHROL, V16, P580, DOI 10.1007/s10157-012-0598-2; Yamanda S, 2016, INTERNAL MED, V55, P3645, DOI 10.2169/internalmedicine.55.6952; Yamanda S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-000865; Yamanouchi S, 2015, PREHOSP DISASTER MED, V30, P145, DOI 10.1017/S1049023X15000114; Yashiro M, 2000, AM J KIDNEY DIS, V35, P889, DOI 10.1016/S0272-6386(00)70260-5; Yuzawa Y, EVIDENCE BASED CLIN	34	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177482	10.1371/journal.pone.0177482	http://dx.doi.org/10.1371/journal.pone.0177482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498830	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500020
J	Velazquez-Ulloa, NA				Velazquez-Ulloa, Norma Andrea			A Drosophila model for developmental nicotine exposure	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; PRENATAL NICOTINE; CHOLINERGIC SYSTEM; MATERNAL SMOKING; TOBACCO USE; ETHANOL; MELANOGASTER; DOPAMINE; BODY; PREGNANCY	Despite the known health risks of tobacco smoking, many people including pregnant women continue smoking. The effects of developmental nicotine exposure are known, but the underlying mechanisms are not well understood. Drosophila melanogaster is a model organism that can be used for uncovering genetic and molecular mechanisms for drugs of abuse. Here I show that Drosophila can be a model to elucidate the mechanisms for nicotine's effects on a developing organism. Drosophila reared on nicotine food display developmental and behavioral effects similar to those in mammals including decreased survival and weight, increased developmental time, and decreased sensitivity to acute nicotine and ethanol. The Drosophila nicotinic acetylcholine receptor subunit alpha 7 (D alpha 7) mediates some of these effects. A novel role for D alpha 7 on ethanol sedation in Drosophila is also shown. Future research taking advantage of the genetic and molecular tools for Drosophila will allow additional discovery of the mechanisms behind the effects of nicotine during development.	[Velazquez-Ulloa, Norma Andrea] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA		Velazquez-Ulloa, NA (corresponding author), Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA.	nvelazquezulloa@lclark.edu		Velazquez-Ulloa, Norma/0000-0001-5616-2103	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [141799, 160227]	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico), (http://www.conacyt.mx/), scholarships no. 141799 and 160227 to NAVU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abburi C, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0112-15.2016; Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; [Anonymous], 2014, RES 2013 NAT SURV DR; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Bruel-Jungerman E, 2011, BEHAV BRAIN RES, V221, P379, DOI 10.1016/j.bbr.2011.01.021; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Christiansen F, 2011, J NEUROSCI, V31, P9696, DOI 10.1523/JNEUROSCI.6542-10.2011; Colomb J, 2014, F1000RESEARCH; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cornelius MD, 2009, CURR OPIN NEUROL, V22, P121, DOI 10.1097/WCO.0b013e328326f6dc; Cornelius MD, 2000, ALCOHOL RES HEALTH, V24, P242; Dani JA, 2011, TRENDS NEUROSCI, V34, P383, DOI 10.1016/j.tins.2011.05.001; DAR MS, 1994, BRAIN RES, V644, P117; Drenan RM, 2012, PHARMACOL REV, V64, P869, DOI 10.1124/pr.111.004671; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Faville R, 2015, SCI REP-UK, V5, DOI 10.1038/srep08454; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fergusson DM, 1998, ARCH GEN PSYCHIAT, V55, P721, DOI 10.1001/archpsyc.55.8.721; Franke RM, 2008, EUR J NEUROSCI, V27, P2952, DOI 10.1111/j.1460-9568.2008.06253.x; Fuenzalida-Uribe N, 2013, J NEUROCHEM, V125, P281, DOI 10.1111/jnc.12161; Gelbart WM, FBRF0221009 FLYBASE; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Grauso M, 2002, GENETICS, V160, P1519; GUNDELFINGER ED, 1992, BIOCHIM BIOPHYS ACTA, V1137, P299, DOI 10.1016/0167-4889(92)90150-A; Harrod SB, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00116; Hou JM, 2004, J NEUROBIOL, V60, P249, DOI 10.1002/neu.20021; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P67, DOI 10.1007/s10158-006-0039-6; Kaun KR, 2012, HUM GENET, V131, P959, DOI 10.1007/s00439-012-1146-6; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Lansdell SJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-73; Laudenbach V., 2002, FASEB J; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Levin ED, 2006, PHARMACOL BIOCHEM BE, V85, P669, DOI 10.1016/j.pbb.2006.11.006; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Liu Z, 2007, BIOCHEM PHARMACOL, V74, P1112, DOI 10.1016/j.bcp.2007.05.022; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; McClure KD, 2011, DIS MODEL MECH, V4, P335, DOI 10.1242/dmm.006411; Morean ME, 2010, ALCOHOL CLIN EXP RES, V34, P385, DOI 10.1111/j.1530-0277.2009.01103.x; Nakayama M, 2016, J NEUROSCI, V36, P590, DOI 10.1523/JNEUROSCI.2300-15.2016; Nunes-Freitas AL, 2011, TOXICOL SCI, V123, P144, DOI 10.1093/toxsci/kfr147; Oliff Heather S., 1999, Frontiers in Bioscience, V4, pd883, DOI 10.2741/Oliff; Omelchenko N, 2016, BRAIN STRUCT FUNCT, V221, P1939, DOI 10.1007/s00429-015-1014-y; Parker B, 2007, ZEBRAFISH, V4, P59, DOI 10.1089/zeb.2006.9994; Poon K, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00011; Ren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052521; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Salas R, 2007, NEUROPHARMACOLOGY, V53, P863, DOI 10.1016/j.neuropharm.2007.08.017; Samet JM, 2010, NATURE, V463, P1020, DOI 10.1038/4631020a; Sanchez-Diaz I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133956; SCHELLING TC, 1992, SCIENCE, V255, P430, DOI 10.1126/science.1734519; Shopland DR, SMOKING TOBACCO CONT, V10; Slotkin TA, 2005, NEUROPSYCHOPHARMACOL, V30, P129, DOI 10.1038/sj.npp.1300544; Slotkin TA, 2004, BRAIN RES BULL, V64, P227, DOI 10.1016/j.brainresbull.2004.07.005; Smith AM, 2010, J PEDIATR BIOCHEM, V1, P125, DOI 10.3233/JPB-2010-0012; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Svoboda KR, 2002, J NEUROSCI, V22, P10731; Taslim N, 2011, ALCOHOL CLIN EXP RES, V35, P540, DOI 10.1111/j.1530-0277.2010.01371.x; Tizabi Y, 1997, PHARMACOL BIOCHEM BE, V58, P141, DOI 10.1016/S0091-3057(96)00461-3; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; World Health Organization, 2016, TOB FACT SHEET; Wu PP, 2005, J BIOL CHEM, V280, P20987, DOI 10.1074/jbc.M409639200; Xian H, 2003, NICOTINE TOB RES, V5, P245, DOI 10.1080/1462220031000073667; Yu DH, 1996, MOL PHARMACOL, V50, P1010; Zalucki O, 2015, FLY, V9, P7, DOI 10.1080/19336934.2015.1072663; Zhang Y, 2016, ACTA BIOMATER, V40, P243, DOI 10.1016/j.actbio.2016.04.007	76	17	17	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177710	10.1371/journal.pone.0177710	http://dx.doi.org/10.1371/journal.pone.0177710			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498868	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314500043
J	Alberich, R; Castro, JA; Llabres, M; Palmer-Rodriguez, P				Alberich, Ricardo; Castro, Jose A.; Llabres, Merce; Palmer-Rodriguez, Pere			Metabolomics analysis: Finding out metabolic building blocks	PLOS ONE			English	Article							PATHWAY ANALYSIS; NETWORK; EVOLUTION	In this paper we propose a new methodology for the analysis of metabolic networks. We use the notion of strongly connected components of a graph, called in this context metabolic building blocks. Every strongly connected component is contracted to a single node in such a way that the resulting graph is a directed acyclic graph, called a metabolic DAG, with a considerably reduced number of nodes. The property of being a directed acyclic graph brings out a background graph topology that reveals the connectivity of the metabolic network, as well as bridges, isolated nodes and cut nodes. Altogether, it becomes a key information for the discovery of functional metabolic relations. Our methodology has been applied to the glycolysis and the purine metabolic pathways for all organisms in the KEGG database, although it is general enough to work on any database. As expected, using the metabolic DAGs formalism, a considerable reduction on the size of the metabolic networks has been obtained, specially in the case of the purine pathway due to its relative larger size. As a proof of concept, from the information captured by a metabolic DAG and its corresponding metabolic building blocks, we obtain the core of the glycolysis pathway and the core of the purine metabolism pathway and detect some essential metabolic building blocks that reveal the key reactions in both pathways. Finally, the application of our methodology to the glycolysis pathway and the purine metabolism pathway reproduce the tree of life for the whole set of the organisms represented in the KEGG database which supports the utility of this research.	[Alberich, Ricardo; Llabres, Merce; Palmer-Rodriguez, Pere] Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Balearic Island, Spain; [Castro, Jose A.] Univ Balearic Isl, Dept Biol, Palma De Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears	Llabres, M (corresponding author), Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Balearic Island, Spain.	merce.llabres@uib.es	Llabrés, Mercè/R-1954-2019; Rodriguez, Pere A Palmer/G-3098-2015; Llabrés Segura, Maria de la Mercè/K-8725-2014; Castro, Jose A./J-9192-2014	Llabrés, Mercè/0000-0002-5358-6768; Rodriguez, Pere A Palmer/0000-0001-5794-6858; Llabrés Segura, Maria de la Mercè/0000-0002-5358-6768; Castro, Jose A./0000-0001-8262-560X	Spanish Government [DPI2015-67082-P]; Programa Pont La Caixa per a grups de recerca de la UIB	Spanish Government(Spanish GovernmentEuropean Commission); Programa Pont La Caixa per a grups de recerca de la UIB	This work was partially supported by the Spanish Government, through project DPI2015-67082-P, and the Programa Pont La Caixa per a grups de recerca de la UIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research reported in this paper has been partially supported by the Spanish Government, through project DPI2015-67082-P, and the "Programa Pont La Caixa per a grups de recerca de la UIB". We thank F. Rossello A and G. Valiente for several comments on previous versions of this work.	Abaka G, 2013, BIOINFORMATICS, V29, P145, DOI 10.1093/bioinformatics/btt235; Alberich R, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-58; Ay F, 2011, J COMPUT BIOL, V18, P219, DOI 10.1089/cmb.2010.0280; Chartrand G., 2015, GRAPHS DIGRAPHS, V6th; Ebenhoh Oliver, 2004, Genome Inform, V15, P35; Fani R, 2009, PHYS LIFE REV, V6, P23, DOI 10.1016/j.plrev.2008.12.003; Garrity G., 2007, BERGEYS MANUAL SYSTE, V2; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; International Union of Biochemistry and Molecular Biology. Nomenclature committee Webb EC, 1992, ENZ NOM 1992 REC NOM; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Klamt S, 2002, MOL BIOL REP, V29, P233, DOI 10.1023/A:1020390132244; Lazcano A, 1996, CELL, V85, P793, DOI 10.1016/S0092-8674(00)81263-5; Lingam M, 2016, ASTROBIOLOGY, V16, P418, DOI 10.1089/ast.2015.1411; Price ND, 2003, J THEOR BIOL, V225, P185, DOI 10.1016/S0022-5193(03)00237-6; Rison SCG, 2002, CURR OPIN STRUC BIOL, V12, P374, DOI 10.1016/S0959-440X(02)00331-7; Ruggiero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119248; Steinway SN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004338; Sweetlove LJ, 2008, BIOCHEM J, V409, P27, DOI 10.1042/BJ20071115; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Tomar N, 2013, GENE, V521, P1, DOI 10.1016/j.gene.2013.03.017; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Ver Eecke HC, 2009, APPL ENVIRON MICROB, V75, P242, DOI 10.1128/AEM.01462-08; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	25	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177031	10.1371/journal.pone.0177031	http://dx.doi.org/10.1371/journal.pone.0177031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493998	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300052
J	Domingues, RR; Trugilho, PF; Silva, CA; de Melo, ICNA; Melo, LCA; Magriotis, ZM; Sanchez-Monedero, MA				Domingues, Rimena R.; Trugilho, Paulo F.; Silva, Carlos A.; de Melo, Isabel Cristina N. A.; Melo, Leonidas C. A.; Magriotis, Zuy M.; Sanchez-Monedero, Miguel A.			Properties of biochar derived from wood and high-nutrient biomasses with the aim of agronomic and environmental benefits	PLOS ONE			English	Article							PYROLYSIS TEMPERATURE; CHEMICAL-CHARACTERIZATION; SOIL; CARBON; CADMIUM; SHELL; ZINC; BIOAVAILABILITY; CONTAMINANTS; ADSORPTION	Biochar production and use are part of the modern agenda to recycle wastes, and to retain nutrients, pollutants, and heavy metals in the soil and to offset some greenhouse gas emissions. Biochars from wood (eucalyptus sawdust, pine bark), sugarcane bagasse, and substances rich in nutrients (coffee husk, chicken manure) produced at 350, 450 and 750 degrees C were characterized to identify agronomic and environmental benefits, which may enhance soil quality. Biochars derived from wood and sugarcane have greater potential for improving C storage in tropical soils due to a higher aromatic character, high C concentration, low H/C ratio, and FTIR spectra features as compared to nutrient-rich biochars. The high ash content associated with alkaline chemical species such as KHCO3 and CaCO3, verified by XRD analysis, made chicken manure and coffee husk biochars potential liming agents for remediating acidic soils. High Ca and K contents in chicken manure and coffee husk biomass can significantly replace conventional sources of K (mostly imported in Brazil) and Ca, suggesting a high agronomic value for these biochars. High-ash biochars, such as chicken manure and coffee husk, produced at low-temperatures (350 and 450 degrees C) exhibited high CEC values, which can be considered as a potential applicable material to increase nutrient retention in soil. Therefore, the agronomic value of the biochars in this study is predominantly regulated by the nutrient richness of the biomass, but an increase in pyrolysis temperature to 750 degrees C can strongly decrease the adsorptive capacities of chicken manure and coffee husk biochars. A diagram of the agronomic potential and environmental benefits is presented, along with some guidelines to relate biochar properties with potential agronomic and environmental uses. Based on biochar properties, research needs are identified and directions for future trials are delineated.	[Domingues, Rimena R.; Silva, Carlos A.; Melo, Leonidas C. A.] Univ Fed Lavras, UFLA, Dept Soil Sci, Lavras, MG, Brazil; [Trugilho, Paulo F.; de Melo, Isabel Cristina N. A.] Univ Fed Lavras, UFLA, Forest Sci Dept, Lavras, MG, Brazil; [Magriotis, Zuy M.] Univ Fed Lavras, UFLA, Chem Dept, Lavras, MG, Brazil; [Sanchez-Monedero, Miguel A.] Ctr Edafol & Biol Aplicada Segura CEBAS CSIC, Dept Conservac Suelos & Agua & Manejo Residuos Or, Campus Univ Espinardo, Murcia, Spain	Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia	Domingues, RR (corresponding author), Univ Fed Lavras, UFLA, Dept Soil Sci, Lavras, MG, Brazil.	rimena_r@yahoo.com.br	Trugilho, Paulo F/I-5613-2013; Melo, L.C.A./C-1839-2014; Sanchez-Monedero, Miguel A./B-7298-2011; Magriotis, Zuy Maria/AAW-3982-2020	Trugilho, Paulo F/0000-0002-6230-5462; Melo, L.C.A./0000-0002-4034-4209; Sanchez-Monedero, Miguel A./0000-0002-2233-7144; Magriotis, Zuy Maria/0000-0002-1996-3961	Brazilian Ministry of Science, Technology, Innovations and Communications (MCTIC); National Council for Technological and Scientific Development - CNPq [3038592/2011-5, 303899/2015-8]; Coordination for the Improvement of Higher Level Education Personnel [CAPESPROEX AUXPE 590/2014]; CAPES; CNPq	Brazilian Ministry of Science, Technology, Innovations and Communications (MCTIC); National Council for Technological and Scientific Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Education Personnel; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	XDR analyses were performed at XRD1 beam-line of the Brazilian Synchrotron Light Laboratory (LNLS), which is supported by the Brazilian Ministry of Science, Technology, Innovations and Communications (MCTIC). This study was funded by the National Council for Technological and Scientific Development - CNPq,grants 3038592/2011-5 and 303899/2015-8 and Coordination for the Improvement of Higher Level Education Personnel (CAPES-PROEX AUXPE 590/2014). A PhD scholarship for RRD was provided by CAPES and research scholarships for PFT and CAS were provided by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are grateful to Claudineia Olimpia de Assis, PhD, for producing some of the biochar samples. XDR analyses were performed at XRD1 beam-line of the Brazilian Synchrotron Light Laboratory (LNLS), which is supported by the Brazilian Ministry of Science, Technology, Innovations and Communications (MCTIC). This study was funded by the National Council for Technological and Scientific Development - CNPq, grants 3038592/2011-5 and 303899/2015-8 and Coordination for the Improvement of Higher Level Education Personnel (CAPESPROEX AUXPE 590/2014). A PhD scholarship for RRD was provided by CAPES and research scholarships for PFT and CAS were provided by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinata D, 2007, BIORESOURCE TECHNOL, V98, P145, DOI 10.1016/j.biortech.2005.11.006; Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; ASTM, 1990, STANDARD METHOD FOR; Beesley L, 2011, ENVIRON POLLUT, V159, P474, DOI 10.1016/j.envpol.2010.10.016; Beesley L, 2010, ENVIRON POLLUT, V158, P2282, DOI 10.1016/j.envpol.2010.02.003; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XD, 2009, ENVIRON SCI TECHNOL, V43, P3285, DOI 10.1021/es803092k; Cayuela ML, 2015, AGR ECOSYST ENVIRON, V202, P135, DOI 10.1016/j.agee.2014.12.015; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Cheng CH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000642; Chintala R, 2014, CLEAN-SOIL AIR WATER, V42, P626, DOI 10.1002/clen.201300089; CONAB Companhia Nacional de Abastecimento, 2016, AC SAFR BRAS GRAOS; Dominghetti TFD, 2015, REV BRAS PARASITOL V, V24, P387, DOI 10.1590/S1984-29612015079; Deenik JL, 2011, SOIL SCI, V176, P336, DOI 10.1097/SS.0b013e31821fbfea; Domene X, 2015, SCI TOTAL ENVIRON, V512, P552, DOI 10.1016/j.scitotenv.2014.12.035; Enders A, 2012, BIORESOURCE TECHNOL, V114, P644, DOI 10.1016/j.biortech.2012.03.022; Fellet G, 2011, CHEMOSPHERE, V83, P1262, DOI 10.1016/j.chemosphere.2011.03.053; Fernandes AHBM, 2011, B PESQUISA DESENVOLV, V111, P1; Fidel RB, 2017, CHEMOSPHERE, V167, P367, DOI 10.1016/j.chemosphere.2016.09.151; GAI XP, 2014, PLOS ONE, V9, DOI DOI 10.1371/journal.pone.0113888; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Higashikawa FS, 2010, REV BRAS CIENC SOLO, V34, P1743, DOI 10.1590/S0100-06832010000500026; Hossain MK, 2011, J ENVIRON MANAGE, V92, P223, DOI 10.1016/j.jenvman.2010.09.008; Houben D, 2013, CHEMOSPHERE, V92, P1450, DOI 10.1016/j.chemosphere.2013.03.055; Ipea-Instituto de Pesquisa, 2012, RELATORIO PESQUISA; Jindo K, 2014, BIOGEOSCIENCES, V11, P6613, DOI 10.5194/bg-11-6613-2014; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kuzyakov Y, 2014, SOIL BIOL BIOCHEM, V70, P229, DOI 10.1016/j.soilbio.2013.12.021; Lehmann J., 2009, SCI TECHNOL HUM VAL, DOI 10.4324/9781849770552; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065949; Lin Y, 2012, CHEMOSPHERE, V87, P151, DOI 10.1016/j.chemosphere.2011.12.007; Melo LCA, 2013, BIORESOURCES, V8, P4992; Mukherjee A, 2011, GEODERMA, V163, P247, DOI 10.1016/j.geoderma.2011.04.021; Namgay T, 2010, AUST J SOIL RES, V48, P638, DOI 10.1071/SR10049; Novak JM, 2010, GEODERMA, V154, P281, DOI 10.1016/j.geoderma.2009.10.014; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Paz-Ferreiro J, 2014, SOLID EARTH, V5, P65, DOI 10.5194/se-5-65-2014; Pradhan BK, 1999, CARBON, V37, P1323, DOI 10.1016/S0008-6223(98)00328-5; Prakongkep N, 2014, J MET MATER MINER, V24, P7, DOI 10.14456/jmmm.2014.2; Qian LB, 2014, J AGR FOOD CHEM, V62, P373, DOI 10.1021/jf404624h; Rondon MA, 2007, BIOL FERT SOILS, V43, P699, DOI 10.1007/s00374-006-0152-z; Sagrilo E., 2015, GEODERMA REG, V6, P1, DOI DOI 10.1016/j.geodrs.2015.08.006; Santos J. R. A. dos, 2009, Revista Brasileira de Produtos Agroindustriais, V11, P27; Schulz H, 2012, J PLANT NUTR SOIL SC, V175, P410, DOI 10.1002/jpln.201100143; Shenbagavalli S., 2012, INT J ADV RES, V2, P249, DOI DOI 10.2134/JEQ2011.0133; Sigua GC, 2016, CHEMOSPHERE, V142, P168, DOI 10.1016/j.chemosphere.2015.06.016; Singh B, 2010, AUST J SOIL RES, V48, P516, DOI 10.1071/SR10058; Singla A, 2014, AGR ECOSYST ENVIRON, V197, P278, DOI 10.1016/j.agee.2014.08.010; Smider B, 2014, AGR ECOSYST ENVIRON, V191, P99, DOI 10.1016/j.agee.2014.01.024; Song WP, 2012, J ANAL APPL PYROL, V94, P138, DOI 10.1016/j.jaap.2011.11.018; Spokas KA, 2012, J ENVIRON QUAL, V41, P973, DOI 10.2134/jeq2011.0069; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Uchimiya M, 2011, J AGR FOOD CHEM, V59, P2501, DOI 10.1021/jf104206c; Wan Q, 2014, ENVIRON SCI POLLUT R, V21, P2486, DOI 10.1007/s11356-013-2183-y; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Xu G, 2014, ECOL ENG, V62, P54, DOI 10.1016/j.ecoleng.2013.10.027; Xu MZ, 2012, ENERG FUEL, V26, P209, DOI 10.1021/ef2011657; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Yargicoglu EN, 2015, WASTE MANAGE, V36, P256, DOI 10.1016/j.wasman.2014.10.029; Yuan JH, 2011, BIORESOURCE TECHNOL, V102, P3488, DOI 10.1016/j.biortech.2010.11.018; Zhang JN, 2015, SCI REP-UK, V5, DOI 10.1038/srep09406; Zhao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115373; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	65	251	255	26	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176884	10.1371/journal.pone.0176884	http://dx.doi.org/10.1371/journal.pone.0176884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493951	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300037
J	Douglas, SJ; Li, BH; Kliebenstein, DJ; Nambara, E; Riggs, CD				Douglas, Scott J.; Li, Baohua; Kliebenstein, Daniel J.; Nambara, Eiji; Riggs, C. Daniel			A novel Filamentous Flower mutant suppresses brevipedicellus developmental defects and modulates glucosinolate and auxin levels	PLOS ONE			English	Article							ADAXIAL-ABAXIAL POLARITY; MAIZE HOMEOBOX GENE; ARABIDOPSIS-THALIANA; ECTOPIC EXPRESSION; INFLORESCENCE ARCHITECTURE; ORGAN DEVELOPMENT; DEFENSE COMPOUNDS; MERISTEM ACTIVITY; LEAF DEVELOPMENT; CELL FATE	BREVIPEDICELLUS (BP) encodes a class-I KNOTTED1-like homeobox (KNOX) transcription factor that plays a critical role in conditioning a replication competent state in the apical meristem, and it also governs growth and cellular differentiation in internodes and pedicels. To search for factors that modify BP signaling, we conducted a suppressor screen on bp er (erecta) plants and identified a mutant that ameliorates many of the pleiotropic defects of the parent line. Map based cloning and complementation studies revealed that the defect lies in the FILAMENTOUS FLOWER (FIL) gene, a member of the YABBY family of transcriptional regulators that contribute to meristem organization and function, phyllotaxy, leaf and floral organ growth and polarity, and are also known to repress KNOX gene expression. Genetic and cytological analyses of the fil-10 suppressor line indicate that the role of FIL in promoting growth is independent of its previously characterized influences on meristem identity and lateral organ polarity, and likely occurs non-cell-autonomously from superior floral organs. Transcription profiling of inflorescences revealed that FIL downregulates numerous transcription factors which in turn may subordinately regulate inflorescence architecture. In addition, FIL, directly or indirectly, activates over a dozen genes involved in glucosinolate production in part by activating MYB28, a known activator of many aliphatic glucosinolate biosynthesis genes. In the bp er fil-10 suppressor mutant background, enhanced expression of CYP71A13, AMIDASE1 (AMI) and NITRILASE genes suggest that auxin levels can be modulated by shunting glucosinolate metabolites into the IAA biosynthetic pathway, and increased IAA levels in the bp er fil-10 suppressor accompany enhanced internode and pedicel elongation. We propose that FIL acts to oppose KNOX1 gene function through a complex regulatory network that involves changes in secondary metabolites and auxin.	[Douglas, Scott J.; Riggs, C. Daniel] Univ Toronto, Dept Biol Sci, Scarborough, ON, Canada; [Li, Baohua; Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kliebenstein, Daniel J.] Univ Copenhagen, Copenhagen Plant Sci Ctr, DynaMo Ctr Excellence, Copenhagen, Denmark; [Nambara, Eiji; Riggs, C. Daniel] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Nambara, Eiji; Riggs, C. Daniel] Univ Toronto, Ctr Anal Gene Evolut & Funct, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; University of California System; University of California Davis; University of Copenhagen; University of Toronto; University of Toronto	Riggs, CD (corresponding author), Univ Toronto, Dept Biol Sci, Scarborough, ON, Canada.; Riggs, CD (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.; Riggs, CD (corresponding author), Univ Toronto, Ctr Anal Gene Evolut & Funct, Toronto, ON, Canada.	riggs@utsc.utoronto.ca	Nambara, Eiji/E-5533-2012; Riggs, Dan/I-1718-2012	Riggs, Dan/0000-0002-3751-6129	Natural Sciences and Engineering Research Council of Canada [RGPIN 90057-06, RGPIN-2014-03621]; National Science Foundation [IOS 1339125, MCB 1330337]; United States Department of Agriculture [CA-D-PLS-7033-H]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (RGPIN 90057-06 to CDR and RGPIN-2014-03621 to EN), by grants from the National Science Foundation (IOS 1339125 and MCB 1330337 to DJK) and by a grant from the United States Department of Agriculture (Hatch project CA-D-PLS-7033-H to DJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloni R, 2003, PLANTA, V216, P841, DOI 10.1007/s00425-002-0937-8; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Bao F, 2010, PLANT PHYSIOL, V152, P821, DOI 10.1104/pp.109.146183; Bar M, 2015, CURR OPIN PLANT BIOL, V23, P61, DOI 10.1016/j.pbi.2014.10.007; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Bonaccorso O, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-176; Bundy MGR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046262; Byrne ME, 2002, DEVELOPMENT, V129, P1957; Chen QY, 1999, DEVELOPMENT, V126, P2715; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Dinneny JR, 2005, DEVELOPMENT, V132, P4687, DOI 10.1242/dev.02062; Douglas SJ, 2005, DEV BIOL, V284, P451, DOI 10.1016/j.ydbio.2005.06.011; Douglas SJ, 2002, PLANT CELL, V14, P547, DOI 10.1105/tpc.010391; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Franks RG, 2002, DEVELOPMENT, V129, P253; Gallagher TL, 2008, PLANT PHYSIOL, V147, P306, DOI 10.1104/pp.107.114603; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Goldshmidt A, 2008, PLANT CELL, V20, P1217, DOI 10.1105/tpc.107.057877; Gonzalez-Reig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003020; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Grigorova B, 2011, DEVELOPMENT, V138, P2451, DOI 10.1242/dev.058362; Grubb CD, 2004, PLANT J, V40, P893, DOI 10.1111/j.1365-313X.2004.02261.x; Guo XL, 2013, PLANTA, V237, P1135, DOI 10.1007/s00425-012-1834-4; Hamant O, 2010, CR BIOL, V333, P371, DOI 10.1016/j.crvi.2010.01.015; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hasegawa T, 2000, PHYTOCHEMISTRY, V54, P275, DOI 10.1016/S0031-9422(00)00080-7; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Hepworth SR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01052; Ikezaki M, 2010, PLANT J, V61, P70, DOI 10.1111/j.1365-313X.2009.04033.x; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; Jensen LM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00697; Jorgensen ME, 2015, TRENDS PLANT SCI, V20, P508, DOI 10.1016/j.tplants.2015.04.006; Katz E, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1062200; Katz E, 2015, PLANT J, V82, P547, DOI 10.1111/tpj.12824; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Kerwin R, 2015, ELIFE, V4, DOI 10.7554/eLife.05604; Kerwin RE, 2011, PLANT CELL, V23, P471, DOI 10.1105/tpc.110.082065; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kong WW, 2015, PLANT CELL PHYSIOL, V56, P715, DOI 10.1093/pcp/pcu216; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kumaran MK, 1999, SEX PLANT REPROD, V12, P118, DOI 10.1007/s004970050180; Kumaran MK, 2002, PLANT CELL, V14, P2761, DOI 10.1105/tpc.004911; Lee JE, 2014, PLANT J, V80, P122, DOI 10.1111/tpj.12625; Li BH, 2014, PLANT PHYSIOL, V166, P1803, DOI 10.1104/pp.114.248716; Lin WC, 2003, PLANT CELL, V15, P2241, DOI 10.1105/tpc.014969; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; LIU ZC, 1995, DEVELOPMENT, V121, P975; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Long JA, 1998, DEVELOPMENT, V125, P3027; Lugassi N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-131; Machida C, 2015, WIRES DEV BIOL, V4, P655, DOI 10.1002/wdev.196; Maharjan PM, 2014, PLANT J, V80, P797, DOI 10.1111/tpj.12678; Malitsky S, 2008, PLANT PHYSIOL, V148, P2021, DOI 10.1104/pp.108.124784; McHale NA, 2004, PLANT CELL, V16, P1251, DOI 10.1105/tpc.019307; Meister RJ, 2005, PLANT PHYSIOL, V137, P651, DOI 10.1104/pp.104.055368; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Muller A, 1998, PLANTA, V206, P362, DOI 10.1007/s004250050411; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nakajima E, 2001, PLANT GROWTH REGUL, V35, P11, DOI 10.1023/A:1013856400351; Navarro C, 2004, DEVELOPMENT, V131, P3649, DOI 10.1242/dev.01205; NORMANLY J, 1993, P NATL ACAD SCI USA, V90, P10355, DOI 10.1073/pnas.90.21.10355; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfluger J, 2004, DEVELOPMENT, V131, P4697, DOI 10.1242/dev.01306; Pollmann S, 2003, PHYTOCHEMISTRY, V62, P293, DOI 10.1016/S0031-9422(02)00563-0; Prasad K, 2011, CURR BIOL, V21, P1123, DOI 10.1016/j.cub.2011.05.009; Ragni L, 2008, PLANT CELL, V20, P888, DOI 10.1105/tpc.108.058230; Reintanz B, 2001, PLANT CELL, V13, P351, DOI 10.1105/tpc.13.2.351; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sakamoto T, 2001, GENE DEV, V15, P581, DOI 10.1101/gad.867901; Sarojam R, 2010, PLANT CELL, V22, P2113, DOI 10.1105/tpc.110.075853; Sato Y, 1999, EMBO J, V18, P992, DOI 10.1093/emboj/18.4.992; Sawa S, 1999, PLANT CELL, V11, P69, DOI 10.1105/tpc.11.1.69; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; SCHNEEBERGER RG, 1995, GENE DEV, V9, P2292, DOI 10.1101/gad.9.18.2292; Scofield S, 2006, PLANT MOL BIOL, V60, P929, DOI 10.1007/s11103-005-4478-y; Sentoku N, 2000, DEV BIOL, V220, P358, DOI 10.1006/dbio.2000.9624; Shani E, 2009, PLANT CELL, V21, P3078, DOI 10.1105/tpc.109.068148; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; SMITH LG, 1992, DEVELOPMENT, V116, P21; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Stahle MI, 2009, PLANT CELL, V21, P3105, DOI 10.1105/tpc.109.070458; Staldal V, 2008, NEW PHYTOL, V180, P798, DOI 10.1111/j.1469-8137.2008.02625.x; Stokes ME, 2013, PLANT PHYSIOL, V162, P1552, DOI 10.1104/pp.113.215095; Sugawara S, 2009, P NATL ACAD SCI USA, V106, P5430, DOI 10.1073/pnas.0811226106; Tabata R, 2010, PLANT CELL PHYSIOL, V51, P164, DOI 10.1093/pcp/pcp176; Tantikanjana T, 2001, GENE DEV, V15, P1577, DOI 10.1101/gad.887301; Tattersall AD, 2005, PLANT CELL, V17, P1046, DOI 10.1105/tpc.104.029447; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tivendale ND, 2014, TRENDS PLANT SCI, V19, P44, DOI 10.1016/j.tplants.2013.09.012; Venglat SP, 2002, P NATL ACAD SCI USA, V99, P4730, DOI 10.1073/pnas.072626099; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; WilliamsCarrier RE, 1997, DEVELOPMENT, V124, P3737; Wu G, 2008, P NATL ACAD SCI USA, V105, P16392, DOI 10.1073/pnas.0803997105; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622; Yamada K, 2003, J PLANT PHYSIOL, V160, P255, DOI 10.1078/0176-1617-00950; Yamaguchi N, 2007, PLANT CELL PHYSIOL, V48, P1275, DOI 10.1093/pcp/pcm094; Yamaguchi N, 2013, PLANT SCI, V209, P64, DOI 10.1016/j.plantsci.2013.04.009; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Zhao ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005125; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	125	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177045	10.1371/journal.pone.0177045	http://dx.doi.org/10.1371/journal.pone.0177045			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493925	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300053
J	Kang, JH; Park, JS; Yu, JS; Chung, JJ; Kim, JH; Cho, ES; Yoon, DS				Kang, Jung-Hyun; Park, Joon Seong; Yu, Jeong-Sik; Chung, Jae-Joon; Kim, Joo Hee; Cho, Eun-Suk; Yoon, Dong Sup			Prediction of pancreatic fistula after pancreatoduodenectomy by preoperative dynamic CT and fecal elastase-1 levels	PLOS ONE			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; INTERNATIONAL STUDY-GROUP; PLACEBO-CONTROLLED TRIAL; AUTOIMMUNE PANCREATITIS; CLINICAL-EVALUATION; HEAD RESECTION; RISK-FACTORS; DUCT SIZE; COMPLICATIONS; PANCREATICOJEJUNOSTOMY	Objective To validate preoperative dynamic CT and fecal elastase-1 level in predicting the development of pancreatic fistulae after pancreatoduodenectomy. Materials and methods For 146 consecutive patients, CT attenuation values of the nontumorous pancreatic parenchyma were retrospectively measured on precontrast, arterial and equilibrium phase images for calculation of enhancement ratios. CT enhancement ratios and preoperative fecal elastase-1 levels were correlated with the development of pancreatic fistulae using independent t-test, logistic regression models, ROC analysis, Youden method and tree analysis. Results The mean value of enhancement ratio on equilibrium phase was significantly higher (p = 0.001) in the patients without pancreatic fistula (n = 107; 2.26 +/- 3.63) than in the patients with pancreatic fistula (n = 39; 1.04 +/- 0.51); in the logistic regression analyses, it was significant predictor for the development of pancreatic fistulae (odds ratio = 0.243, p = 0.002). The mean preoperative fecal elastase-1 levels were higher (odds ratio = 1.003, p = 0.034) in the pancreatic fistula patients than other patients, but there were no significant differences in the areas under the curve between the prediction values of CT enhancement ratios and fecal elastase-1 combined and those of CT enhancement ratios alone (P = 0.897, p = 0.917) on ROC curve analysis. Tree analysis revealed that the CT enhancement ratio was more powerful predictor of pancreatic fistula than fecal elastase-1 levels. Conclusion The preoperative CT enhancement ratio of pancreas acquired at equilibrium phase regardless of combination with fecal elastase-1 levels might be a useful predictor of the risk of developing a pancreatic fistula following pancreatoduodenectomy.	[Kang, Jung-Hyun; Yu, Jeong-Sik; Chung, Jae-Joon; Kim, Joo Hee; Cho, Eun-Suk] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Park, Joon Seong; Yoon, Dong Sup] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yu, JS (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea.	yjsrad97@yuhs.ac		Yoon, Dong Sup/0000-0001-6444-9606; Park, Joon Seong/0000-0001-8048-9990; Chung, Jae-Joon/0000-0002-7447-1193; Yu, Jeong-Sik/0000-0002-8171-5838; KIM, JOO HEE/0000-0001-5383-3602				Adam U, 2004, AM J SURG, V187, P201, DOI 10.1016/j.amjsurg.2003.11.004; Allen PJ, 2014, NEW ENGL J MED, V370, P2014, DOI 10.1056/NEJMoa1313688; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; CAMERON JL, 1993, ANN SURG, V217, P430, DOI 10.1097/00000658-199305010-00002; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; Dinter DJ, 2009, J GASTROINTEST SURG, V13, P735, DOI 10.1007/s11605-008-0765-7; Dong Z, 2016, REVIEW; Farnell MB, 2005, SURGERY, V138, P618, DOI 10.1016/j.surg.2005.06.044; Fletcher JG, 2003, RADIOLOGY, V229, P81, DOI 10.1148/radiol.2291020582; Friess H, 1996, PANCREAS, V13, P202; Glasbrenner B, 1996, EUR J GASTROEN HEPAT, V8, P1117, DOI 10.1097/00042737-199611000-00016; Hamanaka Y, 1996, SURGERY, V119, P281, DOI 10.1016/S0039-6060(96)80114-0; Hashimoto Y, 2011, J GASTROINTEST SURG, V15, P2193, DOI 10.1007/s11605-011-1687-3; Hashimoto Y, 2010, J AM COLL SURGEONS, V211, P510, DOI 10.1016/j.jamcollsurg.2010.06.018; Hashimoto Y, 2010, SURGERY, V147, P503, DOI 10.1016/j.surg.2009.10.034; Irie H, 1998, AM J ROENTGENOL, V170, P1323, DOI 10.2214/ajr.170.5.9574610; Katschinski M, 1997, PANCREAS, V15, P191, DOI 10.1097/00006676-199708000-00012; Kawamoto S, 2004, AM J ROENTGENOL, V183, P915, DOI 10.2214/ajr.183.4.1830915; Kim T, 2001, AM J ROENTGENOL, V177, P367, DOI 10.2214/ajr.177.2.1770367; Lee SE, 2010, ANN SURG, V251, P932, DOI 10.1097/SLA.0b013e3181d65483; Lillemoe KD, 2004, J GASTROINTEST SURG, V8, P766, DOI 10.1016/j.gassur.2004.06.011; Lin JW, 2004, J GASTROINTEST SURG, V8, P951, DOI 10.1016/j.gassur.2004.09.044; Loser C, 1996, GUT, V39, P580, DOI 10.1136/gut.39.4.580; Lowy AM, 1997, ANN SURG, V226, P632, DOI 10.1097/00000658-199711000-00008; Lu DSK, 1996, RADIOLOGY, V199, P697, DOI 10.1148/radiology.199.3.8637990; Ma LW, 2016, ANN SURG; MARCUS SG, 1995, ANN SURG, V221, P635, DOI 10.1097/00000658-199506000-00003; Murakami H, 2002, ANN SURG, V235, P240, DOI 10.1097/00000658-200202000-00012; Murakami Y, 2008, J SURG ONCOL, V97, P205, DOI 10.1002/jso.20903; Nakamura H, 2009, J GASTROINTEST SURG, V13, P1321, DOI 10.1007/s11605-009-0896-5; Niedergethmann M, 2004, Minerva Chir, V59, P175; Pedrazzoli S, 2009, ANN SURG, V249, P97, DOI 10.1097/SLA.0b013e31819274fe; Poon RTP, 2007, ANN SURG, V246, P425, DOI 10.1097/SLA.0b013e3181492c28; Pratt WB, 2007, ANN SURG, V245, P443, DOI 10.1097/01.sla.0000251708.70219.d2; Richter A, 2003, WORLD J SURG, V27, P324, DOI 10.1007/s00268-002-6659-z; Roder JD, 1999, ANN SURG, V229, P41, DOI 10.1097/00000658-199901000-00005; Sarr MG, 2003, J AM COLL SURGEONS, V196, P556, DOI 10.1016/S1072-7515(03)00104-2; Sato N, 1998, ARCH SURG-CHICAGO, V133, P1094, DOI 10.1001/archsurg.133.10.1094; Stein J, 1996, CLIN CHEM, V42, P222; Suzuki Y, 2002, ARCH SURG-CHICAGO, V137, P1044, DOI 10.1001/archsurg.137.9.1044; SZIEGOLEIT A, 1991, GASTROENTEROLOGY, V100, P768, DOI 10.1016/0016-5085(91)80024-4; Tajima Y, 2004, BRIT J SURG, V91, P595, DOI 10.1002/bjs.4461; Takahashi N, 2009, AM J ROENTGENOL, V193, P479, DOI 10.2214/AJR.08.1883; TREDE M, 1990, ANN SURG, V211, P447, DOI 10.1097/00000658-199004000-00011; YEO CJ, 1995, ANN SURG, V222, P580; Yeo CJ, 2000, ANN SURG, V232, P419, DOI 10.1097/00000658-200009000-00014	46	13	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177052	10.1371/journal.pone.0177052	http://dx.doi.org/10.1371/journal.pone.0177052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493949	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300055
J	Mazanderani, AH; Moyo, F; Sherman, GG				Mazanderani, Ahmad Haeri; Moyo, Faith; Sherman, Gayle G.			Missed diagnostic opportunities within South Africa's early infant diagnosis program, 2010-2015	PLOS ONE			English	Article							HIV-INFECTION; MORTALITY; PREVENTION; BLOOD	Background Samples submitted for HIV PCR testing that fail to yield a positive or negative result represent missed diagnostic opportunities. We describe HIV PCR test rejections and indeterminate results, and the associated delay in diagnosis, within South Africa's early infant diagnosis (EID) program from 2010 to 2015. Methods HIV PCR test data from January 2010 to December 2015 were extracted from the National Health Laboratory Service Corporate Data Warehouse, a central data repository of all registered test-sets within the public health sector in South Africa, by laboratory number, result, date, facility, and testing laboratory. Samples that failed to yield either a positive or negative result were categorized according to the rejection code on the laboratory information system, and descriptive analysis performed using Microsoft Excel. Delay in diagnosis was calculated for patients who had a missed diagnostic opportunity registered between January 2013 and December 2015 by means of a patient linking-algorithm employing demographic details. Results Between 2010 and 2015, 2 178 582 samples were registered for HIV PCR testing of which 6.2% (n = 134 339) failed to yield either a positive or negative result, decreasing proportionally from 7.0% (n = 20 556) in 2010 to 4.4% (n = 21 388) in 2015 (p<0.001). Amongst 76 972 coded missed diagnostic opportunities, 49 585 (64.4%) were a result of pre-analytical error and 27 387 (35.6%) analytical error. Amongst 49 694 patients searched for follow-up results, 16 895 (34.0%) had at least one subsequent HIV PCR test registered after a median of 29 days (IQR: 13-57), of which 8.4% tested positive compared with 3.6% of all samples submitted for the same period. Conclusions Routine laboratory data provides the opportunity for near real-time surveillance and quality improvement within the EID program. Delay in diagnosis and wastage of resources associated with missed diagnostic opportunities must be addressed and infants actively followed-up as South Africa works towards elimination of mother-to-child transmission.	[Mazanderani, Ahmad Haeri; Moyo, Faith; Sherman, Gayle G.] Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Mazanderani, Ahmad Haeri] Univ Pretoria, Dept Med Virol, Pretoria, South Africa; [Moyo, Faith; Sherman, Gayle G.] Wits Hlth Consortium, Paediat HIV Diagnost Syndicate, Johannesburg, South Africa; [Sherman, Gayle G.] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Pretoria; University of Witwatersrand; University of Witwatersrand	Mazanderani, AH (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa.; Mazanderani, AH (corresponding author), Univ Pretoria, Dept Med Virol, Pretoria, South Africa.	ahmadh@nicd.ac.za		Haeri Mazanderani, Ahmad/0000-0001-7644-153X	Discovery Foundation; United Nations Children's Fund; UNICEF	Discovery Foundation; United Nations Children's Fund; UNICEF	This work was supported by Discovery Foundation www.tshikululu.org.za), AHM, and United Nations Children's Fund (www.unicef.org), GGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the National Health Laboratory Service Corporate Data Warehouse manager, Mrs Sue Candy, and the National Health Laboratory Services for provision of laboratory test data and thank UNICEF for partially funding this work.	[Anonymous], 2015, 2013 NAT ANT SENT HI; Barker Pierre, 2015, AIDS, V29 Suppl 2, pS137, DOI 10.1097/QAD.0000000000000718; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Feucht U, 2012, SAMJ S AFR MED J, V102, P149, DOI 10.7196/SAMJ.4951; Innes S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18914; Lilian RR, 2013, PEDIATR INFECT DIS J, V32, P1080, DOI 10.1097/INF.0b013e318290622e; Lippi G, 2006, CLIN CHEM LAB MED, V44, P358, DOI 10.1515/CCLM.2006.073; Lippi G, 2011, CLIN CHEM LAB MED, V49, P1113, DOI 10.1515/CCLM.2011.600; MacLeod W, 2014, ANALYSIS OF BIG DATA; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Maritz J, 2014, J MED VIROL, V86, P82, DOI 10.1002/jmv.23811; Maritz J, 2012, J CLIN VIROL, V53, P106, DOI 10.1016/j.jcv.2011.12.002; Massyn N., 2014, DURBAN HLTH SYSTEMS; Mazanderani AFH, 2014, SAMJ S AFR MED J, V104, P574, DOI [10.7196/SAMJ.8322, 10.7196/samj.8322]; Mazanderani AH, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.451; National Department of Health, 2015, NAT CONS GUILD PREV; National Department of Health, 2004, NAT ANT TREATM GUID; National Department of Health, 2013, S AFR ANT TREATM GUI; National Department of Health, 2010, GUID MAN HIV CHILDR; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Penazzato M, 2014, LANCET INFECT DIS, V14, P650, DOI 10.1016/S1473-3099(13)70262-7; Plebani M, 2010, ANN CLIN BIOCHEM, V47, P101, DOI 10.1258/acb.2009.009222; Roche&REG;, 2013, COBAS AMPLIPREP COBA; Sherman GG, 2014, SAMJ S AFR MED J, V104, P235, DOI [10.7196/SAMJ.7598, 10.7196/samj.7598]; Sherman GG, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010701; Sherman GG, 2016, 8 HIV PED WORKSH 15; Stevens W, 2008, J CLIN MICROBIOL, V46, P3941, DOI 10.1128/JCM.00754-08; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2016, CONGUID UANT DRU; Woldesenbet SA, 2015, JAIDS-J ACQ IMM DEF, V68, pe26, DOI 10.1097/QAI.0000000000000460; World Health Organization, 2014, GLOB GUID CRIT PROC	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177173	10.1371/journal.pone.0177173	http://dx.doi.org/10.1371/journal.pone.0177173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493908	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300066
J	Nissila, E; Douillard, FP; Ritari, J; Paulin, L; Jarvinen, HM; Rasinkangas, P; Haapasalo, K; Meri, S; Jarva, H; de Vos, WM				Nissila, Eija; Douillard, Francois P.; Ritari, Jarmo; Paulin, Lars; Jarvinen, Hanna M.; Rasinkangas, Pia; Haapasalo, Karita; Meri, Seppo; Jarva, Hanna; de Vos, Willem M.			Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system	PLOS ONE			English	Article							STREPTOCOCCUS-PYOGENES INFECTIONS; LACTIC-ACID BACTERIA; FACTOR-H; BIOFILM FORMATION; PROBIOTIC USE; M PROTEIN; AGGREGATION; ADHESION; BINDING; PLATELETS	Lactobacillus rhamnosus strains are ubiquitous in fermented foods, and in the human body where they are commensals naturally present in the normal microbiota composition of gut, vagina and skin. However, in some cases, Lactobacillus spp. have been implicated in bacteremia. The aim of the study was to examine the genomic and immunological properties of 16 clinical blood isolates of L. rhamnosus and to compare them to the well- studied L. rhamnosus probiotic strain GG. Blood cultures from bacteremic patients were collected at the Helsinki University Hospital laboratory in 2005-2011 and L. rhamnosus strains were isolated and characterized by genomic sequencing. The capacity of the L. rhamnosus strains to activate serum complement was studied using immunological assays for complement factor C3a and the terminal pathway complement complex (TCC). Binding of complement regulators factor H and C4bp was also determined using radioligand assays. Furthermore, the isolated strains were evaluated for their ability to aggregate platelets and to form biofilms in vitro. Genomic comparison between the clinical L. rhamnosus strains showed them to be clearly different from L. rhamnosus GG and to cluster in two distinct lineages. All L. rhamnosus strains activated complement in serum and none of them bound complement regulators. Four out of 16 clinical blood isolates induced platelet aggregation and/or formed more biofilms than L. rhamnosus GG, which did not display platelet aggregation activity nor showed strong biofilm formation. These findings suggest that clinical L. rhamnosus isolates show considerable heterogeneity but are clearly different from L. rhamnosus GG at the genomic level. All L. rhamnosus strains are still normally recognized by the human complement system.	[Nissila, Eija; Douillard, Francois P.; Jarvinen, Hanna M.; Haapasalo, Karita; Meri, Seppo; Jarva, Hanna; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Nissila, Eija; Douillard, Francois P.; Jarvinen, Hanna M.; Haapasalo, Karita; Meri, Seppo; Jarva, Hanna; de Vos, Willem M.] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland; [Douillard, Francois P.; Ritari, Jarmo; Rasinkangas, Pia; de Vos, Willem M.] Univ Helsinki, Div Microbiol & Epidemiol, Dept Vet Biosci, Helsinki, Finland; [Ritari, Jarmo] Finnish Red Cross Blood Serv, Helsinki, Finland; [Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Meri, Seppo; Jarva, Hanna] Helsinki Univ Hosp, Lab HUSLAB, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Lab Microbiol, Wageningen, Netherlands	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Wageningen University & Research	Nissila, E; de Vos, WM (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland.; Nissila, E; de Vos, WM (corresponding author), Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland.; de Vos, WM (corresponding author), Univ Helsinki, Div Microbiol & Epidemiol, Dept Vet Biosci, Helsinki, Finland.; de Vos, WM (corresponding author), Wageningen Univ, Lab Microbiol, Wageningen, Netherlands.	eija.nissila@helsinki.fi; willem.devos@wur.nl	Ritari, Jarmo/G-4245-2016; Nissila, Eija/AEQ-3909-2022	Ritari, Jarmo/0000-0002-3458-9314; Nissila, Eija/0000-0002-8089-1266; Haapasalo, Karita/0000-0002-9619-625X	Academy of Finland [28 137389, 141140, 1272870, 1292393]; European Research Council (ERC) [250172]; Sigrid Juselius Foundation; Helsinki University Central Hospital [TYH2017228]	Academy of Finland(Academy of Finland); European Research Council (ERC)(European Research Council (ERC)European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital	This study was supported by the Academy of Finland (28 137389, 141140 and 1272870 to WMdV, 1292393 to SM) and the European Research Council (ERC Advanced Grant 250172 Microbes Inside to WMdV), the Sigrid Juselius Foundation (to SM) and the Helsinki University Central Hospital Grant (TYH2017228 to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the personnel of DNA sequencing and genomics laboratory, Institute Biotechnology, University of Helsinki, Finland. We acknowledge Riitta Lassila and Annukka Jouppila at the Coagulation Disorders Unit, Department of Hematology, and HUSLAB Laboratory Services, University of Helsinki, Helsinki, Finland for providing expertise in platelet aggregation studies. This study was supported by the Academy of Finland (28 137389, 141140 and 1272870 to WMdV, 1292393 to SM) and the European Research Council (ERC Advanced Grant 250172 Microbes Inside to WMdV), the Sigrid Juselius Foundation (to SM) and the Helsinki University Central Hospital Grant (TYH2017228 to SM).	AGUIRRE M, 1993, J APPL BACTERIOL, V75, P95, DOI 10.1111/j.1365-2672.1993.tb02753.x; Aroutcheva A, 2016, PROBIOTICS ANTIMICRO, V8, P31, DOI 10.1007/s12602-016-9209-y; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; Cannon JP, 2005, EUR J CLIN MICROBIOL, V24, P31, DOI 10.1007/s10096-004-1253-y; Ceapa C, 2016, GENOME BIOL EVOL, V8, P1889, DOI 10.1093/gbe/evw123; Cohen SA, 2016, TRANSPL INFECT DIS, V18, P699, DOI 10.1111/tid.12587; Collins J, 2012, MOL MICROBIOL, V85, P862, DOI 10.1111/j.1365-2958.2012.08148.x; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Cox D, 2011, J THROMB HAEMOST, V9, P1097, DOI 10.1111/j.1538-7836.2011.04264.x; Dertli E, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0347-2; Doron S, 2005, GASTROENTEROL CLIN N, V34, P483, DOI 10.1016/j.gtc.2005.05.011; Douillard FP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S8; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EFSA Panel on Biological Hazards, 2012, EFSA Journal, V10, P2724; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Garcia CEV, 2015, APPL ENVIRON MICROB, V81, P2050, DOI 10.1128/AEM.03949-14; Haapasalo K, 2012, J IMMUNOL, V188, P426, DOI 10.4049/jimmunol.1102545; Haapasalo K, 2008, MOL MICROBIOL, V70, P583, DOI 10.1111/j.1365-2958.2008.06347.x; Haghighat L, 2016, INT J STD AIDS, V27, P1223, DOI 10.1177/0956462415590725; HARTY DWS, 1994, INT J FOOD MICROBIOL, V24, P179, DOI 10.1016/0168-1605(94)90117-1; HARTY DWS, 1993, J GEN MICROBIOL, V139, P2945; Hooper LV, 2001, GLYCOBIOLOGY, V11, p1R, DOI 10.1093/glycob/11.2.1R; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Husni RN, 1997, CLIN INFECT DIS, V25, P1048, DOI 10.1086/516109; Ilveskero S, 2001, ARTERIOSCL THROM VAS, V21, P628, DOI 10.1161/01.ATV.21.4.628; Johnsson E, 1996, J IMMUNOL, V157, P3021; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kaplan JB, 2005, VET MICROBIOL, V108, P89, DOI 10.1016/j.vetmic.2005.02.011; Khattab A, 2013, PLACENTA, V34, P162, DOI 10.1016/j.placenta.2012.11.030; Kirjavainen PV, 1999, INFECT IMMUN, V67, P2653, DOI 10.1128/IAI.67.5.2653-2655.1999; Klein G, 1998, J CLIN MICROBIOL, V36, P1781, DOI 10.1128/JCM.36.6.1781-1783.1998; Korpela R, 1997, INT J FOOD MICROBIOL, V37, P83, DOI 10.1016/S0168-1605(97)00049-4; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lu PL, 1999, J FORMOS MED ASSOC, V98, P356; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Meini S, 2015, INFECTION, V43, P777, DOI 10.1007/s15010-015-0798-2; Nadkarni MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090643; Ouwehand AC, 2004, CLIN INFECT DIS, V39, P1858, DOI 10.1086/425741; Pages H., 2016, BIOSTRINGS STRING OB; Rasinkangas P, 2014, APPL ENVIRON MICROB, V80, P7001, DOI 10.1128/AEM.02006-14; Sadowska-Krawczenko I, 2014, BENEF MICROBES, V5, P397, DOI 10.3920/BM2013.0074; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; Salminen MK, 2004, CLIN INFECT DIS, V38, P62, DOI 10.1086/380455; Salminen MK, 2002, CLIN INFECT DIS, V35, P1155, DOI 10.1086/342912; Segers ME, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S7; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Sun ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9322; Suvilehto J, 2008, MICROBES INFECT, V10, P757, DOI 10.1016/j.micinf.2008.04.004; Svensson L, 2014, INFECT IMMUN, V82, P4307, DOI 10.1128/IAI.02020-14; Tena D, 2013, DIAGN MICR INFEC DIS, V76, P510, DOI 10.1016/j.diagmicrobio.2013.03.018; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Wood GC, 2002, PHARMACOTHERAPY, V22, P1180, DOI 10.1592/phco.22.13.1180.33530	58	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176739	10.1371/journal.pone.0176739	http://dx.doi.org/10.1371/journal.pone.0176739			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493885	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300029
J	Shao, Q; Casin, KM; Mackowski, N; Murphy, E; Steenbergen, C; Kohr, MJ				Shao, Qin; Casin, Kevin M.; Mackowski, Nathan; Murphy, Elizabeth; Steenbergen, Charles; Kohr, Mark J.			Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; ESTROGEN-RECEPTOR; INFARCT SIZE; MITOCHONDRIAL PROTEINS; GENDER-DIFFERENCES; CONTROLLED-TRIAL; SEX-DIFFERENCES; RABBIT HEART; NITRIC-OXIDE; NITROSYLATION	Nitric oxide (NO) plays an important role in cardioprotection, and recent work from our group and others has implicated protein S-nitrosylation (SNO) as a critical component of NO-mediated protection in different models, including ischemic pre-and post-conditioning and sexdependent cardioprotection. However, studies have yet to examine whether protein SNO levels are similarly increased with pharmacologic preconditioning in male and female hearts, and whether an increase in protein SNO levels, which is protective in male hearts, is sufficient to increase baseline protection in female hearts. Therefore, we pharmacologically preconditioned male and female hearts with the adenosine A1 receptor agonist N6-cyclohexyl adenosine (CHA). CHA administration prior to ischemia significantly improved functional recovery in both male and female hearts compared to baseline in a Langendorff-perfused heart model of ischemia-reperfusion injury (% of preischemic function +/- SE: male baseline: 37.5 +/- 3.4% vs. male CHA: 55.3 +/- 3.2%; female baseline: 61.4 +/- 5.7% vs. female CHA: 76.0 +/- 6.2%). In a separate set of hearts, we found that CHA increased p-Akt and p-eNOS levels. We also used SNO-resin-assisted capture with LC-MS/MS to identify SNO proteins in male and female hearts, and determined that CHA perfusion induced a modest increase in protein SNO levels in both male (11.4%) and female (12.3%) hearts compared to baseline. These findings support a potential role for protein SNO in a model of pharmacologic preconditioning, and provide evidence to suggest that a modest increase in protein SNO levels is sufficient to protect both male and female hearts from ischemic injury. In addition, a number of the SNO proteins identified with CHA treatment were also observed with other forms of cardioprotective stimuli in prior studies, further supporting a role for protein SNO in cardioprotection.	[Shao, Qin] Shanghai Jiao Tong Univ, Renji Hosp, Dept Cardiol, Sch Med, Shanghai, Peoples R China; [Shao, Qin; Steenbergen, Charles; Kohr, Mark J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Casin, Kevin M.; Mackowski, Nathan; Kohr, Mark J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Whiting Sch Engn, Dept Environm Hlth & Engn, Baltimore, MD 21218 USA; [Murphy, Elizabeth] NHLBI, Syst Biol Ctr, Bldg 10, Bethesda, MD 20892 USA	Shanghai Jiao Tong University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kohr, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.; Kohr, MJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Whiting Sch Engn, Dept Environm Hlth & Engn, Baltimore, MD 21218 USA.	mkohr1@jhu.edu		Casin, Kevin/0000-0003-3734-6075	National Natural Science Foundation of China [81270374, 81570390]; China Scholarship Council (QS); NHLBI/NIH Intramural Program [ZIAHL002065]; National Institutes of Health [T32ES0741, KC, R01HL039752, R00HL114721]; American Heart Association [16GRNT30420019]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL096142, K99HL114721, ZIAHL002065, R00HL114721, ZIAHL006059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council (QS)(China Scholarship Council); NHLBI/NIH Intramural Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Natural Science Foundation of China (81270374, 81570390, QS), the China Scholarship Council (QS), the NHLBI/NIH Intramural Program (ZIAHL002065, EM), the National Institutes of Health (T32ES0741, KC; R01HL039752, CS; R00HL114721, MK), and the American Heart Association (16GRNT30420019, MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio G, 2010, EUR HEART J, V31, P430, DOI 10.1093/eurheartj/ehp457; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Azhar G, 1999, EXP GERONTOL, V34, P699, DOI 10.1016/S0531-5565(99)00031-5; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bibli SI, 2014, J PHARM PHARMACOL, V66, P1140, DOI 10.1111/jphp.12238; Booth EA, 2005, AM J PHYSIOL-HEART C, V289, pH2039, DOI 10.1152/ajpheart.00479.2005; Brown-Steinke K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014007; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Chen C, 2013, LIFE SCI, V93, P265, DOI 10.1016/j.lfs.2013.06.019; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Chouchani ET, 2010, BIOCHEM J, V430, P49, DOI 10.1042/BJ20100633; Cohen MV, 2010, AM J PHYSIOL-HEART C, V299, pH2028, DOI 10.1152/ajpheart.00527.2010; Crabbe DL, 2003, J AM COLL CARDIOL, V41, P300, DOI 10.1016/S0735-1097(02)02710-9; Cross HR, 2002, AM J PHYSIOL-HEART C, V283, pH481, DOI 10.1152/ajpheart.00790.2001; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Fredette N, 2014, FASEB J, V28; Hale SL, 1996, AM HEART J, V132, P258, DOI 10.1016/S0002-8703(96)90419-6; Hatzistergos KE, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001974; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Heusch G, 2016, CIRC RES, V119, P676, DOI 10.1161/CIRCRESAHA.116.308736; HILDEBRANDT P, 1992, AM HEART J, V124, P1139, DOI 10.1016/0002-8703(92)90392-9; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Johnson MS, 2006, AM J PHYSIOL-HEART C, V290, pH2644, DOI 10.1152/ajpheart.01291.2005; Jones DA, 2015, CIRC RES, V116, P437, DOI 10.1161/CIRCRESAHA.116.305082; Kis A, 2003, CARDIOVASC DRUG THER, V17, P415, DOI 10.1023/B:CARD.0000015856.02691.fa; Kloner RA, 2006, EUR HEART J, V27, P2400, DOI 10.1093/eurheartj/ehl094; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Kohr MJ, 2012, CIRC RES, V111, P1308, DOI 10.1161/CIRCRESAHA.112.271320; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Leesar MA, 2001, CIRCULATION, V103, P2935, DOI 10.1161/01.CIR.103.24.2935; Lejay A, 2016, J MOL CELL CARDIOL, V91, P11, DOI 10.1016/j.yjmcc.2015.12.020; Li, 1995, J Thromb Thrombolysis, V2, P221; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Lin J, 2009, CIRCULATION, V120, P245, DOI 10.1161/CIRCULATIONAHA.109.868729; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mahaffey KW, 1999, J AM COLL CARDIOL, V34, P1711, DOI 10.1016/S0735-1097(99)00418-0; Mariani J, 2000, J THORAC CARDIOV SUR, V120, P660, DOI 10.1067/mtc.2000.106528; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Menazza S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002251; Methner C, 2014, EUR J HEART FAIL, V16, P712, DOI 10.1002/ejhf.100; Montagna C, 2014, ANTIOXID REDOX SIGN, V21, P570, DOI 10.1089/ars.2013.5696; MORRIS JL, 1995, BRIT HEART J, V73, P310; Murphy E, 2011, PEDIATR CARDIOL, V32, P354, DOI 10.1007/s00246-010-9877-4; Murray CI, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004721; Nadtochiy SM, 2007, J MOL CELL CARDIOL, V42, P812, DOI 10.1016/j.yjmcc.2007.01.010; Nakamura T, 2015, NEUROBIOL DIS, V84, P99, DOI 10.1016/j.nbd.2015.03.017; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Penna C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0371-z; Penna C, 2011, PFLUG ARCH EUR J PHY, V462, P219, DOI 10.1007/s00424-011-0970-1; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; PRZYKLENK K, 1995, AM HEART J, V129, P1108, DOI 10.1016/0002-8703(95)90390-9; Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061; Ross JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038425; Ruiz-Holst C, 2010, CAN J PHYSIOL PHARM, V88, P121, DOI 10.1139/Y09-115; Shao Q, 2015, AM J PHYSL HEART CIR; Shao Q, 2016, AM J PHYSIOL-HEART C, V310, pH505, DOI 10.1152/ajpheart.00681.2015; Siddiqi N, 2014, EUR HEART J, V35, P1255, DOI 10.1093/eurheartj/ehu096; Sips PY, 2013, AM J PHYSIOL-HEART C, V304, pH1134, DOI 10.1152/ajpheart.00887.2012; Soetkamp D, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0433-x; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2016, CARDIOVASC RES, V110, P96, DOI 10.1093/cvr/cvw037; Sun JH, 2013, FREE RADICAL BIO MED, V54, P105, DOI 10.1016/j.freeradbiomed.2012.09.005; Sun JH, 2012, ANTIOXID REDOX SIGN, V16, P45, DOI 10.1089/ars.2010.3844; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Tong G, 2014, AM J PHYSIOL-HEART C, V306, pH825, DOI 10.1152/ajpheart.00660.2013; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Vander Heide RS, 2013, CIRC RES, V113, P464, DOI 10.1161/CIRCRESAHA.113.300765; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Willems L, 2005, CARDIOVASC RES, V66, P245, DOI 10.1016/j.cardiores.2004.11.008; Willems Laura, 2005, J Mol Cell Cardiol, V38, P245, DOI 10.1016/j.yjmcc.2004.09.014; Zhan EB, 2011, AM J PHYSIOL-HEART C, V301, pH1183, DOI 10.1152/ajpheart.00264.2011	80	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177315	10.1371/journal.pone.0177315	http://dx.doi.org/10.1371/journal.pone.0177315			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493997	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300086
J	Yu, Y; Chen, JM; Yang, XG; Fan, WY; Li, MZ; He, LM				Yu, Ying; Chen, Jing M.; Yang, Xiguang; Fan, Wenyi; Li, Mingze; He, Liming			Influence of site index on the relationship between forest net primary productivity and stand age	PLOS ONE			English	Article							CARBON SEQUESTRATION; BOREAL FORESTS; JACK PINE; GROWTH; BIOMASS; DECLINE; STORAGE; CANADA; PHOTOSYNTHESIS; DISTURBANCE	Previous studies show that forest net primary productivity (NPP) varies pronouncedly with stand age, and these variations play a crucial role in determining forest carbon sinks or sources at regional scales. Some forest carbon cycling models, eg. InTEC (The integrated terrestrial ecosystem C-budget model), calculates annual forest NPP in the long term according to normalized NPP-age relationships and the reference forest NPP at a given age. Therefore, the accurate NPP-age relationship is important for forest NPP estimation. In this study, NPP at various stand ages for twelve major forest stand types in Heilongjiang Province in northeast China is derived from yield tables with consideration of the total biomass increment and foliage and fine-root turnovers. Similar to previous studies, our results also show that forest NPP increases quickly at young ages, reaches the maximum value at middle age (10-40 years old), and then decreases to a relative stable level at old ages. However, we additionally found that forests under better site conditions have faster growth rates in young ages and steeper declines after reaching the maximum. Therefore, when the NPP-age curves for different site indices are normalized against the maximum value of each curve, there are significant differences among them. These differences have implications on the methodology for estimating the spatial distribution of forest carbon sources and sinks.	[Yu, Ying; Fan, Wenyi; Li, Mingze] Northeast Forestry Univ, Sch Forestry, Harbin, Heilongjiang, Peoples R China; [Chen, Jing M.; He, Liming] Univ Toronto, Dept Geog, Toronto, ON, Canada; [Chen, Jing M.; He, Liming] Univ Toronto, Program Planning, Toronto, ON, Canada; [Yang, Xiguang] Northeast Forestry Univ, Key Lab Saline Alkali Vegetat Ecol Restorat SAVER, Minist Educ, Alkali Soil Nat Environm Sci Ctr, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China; University of Toronto; University of Toronto; Northeast Forestry University - China	Fan, WY (corresponding author), Northeast Forestry Univ, Sch Forestry, Harbin, Heilongjiang, Peoples R China.	fanwy5384@163.com	Chen, Jing/AAD-4768-2020; Yang, Xiguang/AAI-2136-2020	Chen, Jing/0000-0002-8682-1293; He, Liming/0000-0003-4010-6814	National Natural Science Foundation of China [31500519, 31500518, 31470640, 31300533]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (No. 31500519, 31500518, 31470640, 31300533), https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#.	[Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; Bradford JB, 2008, GLOBAL CHANGE BIOL, V14, P2882, DOI 10.1111/j.1365-2486.2008.01686.x; BREWER JA, 1985, FOREST SCI, V31, P414; Carmean WH, 1989, NC128 US DEP AGR FOR; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen J, 2000, GLOBAL BIOGEOCHEM CY, V14, P839, DOI 10.1029/1999GB001207; Chen JM, 1999, ECOL MODEL, V124, P99, DOI 10.1016/S0304-3800(99)00156-8; Chen JM, 2003, TELLUS B, V55, P622, DOI 10.1034/j.1600-0889.2003.00036.x; Chen WJ, 2002, CAN J FOREST RES, V32, P833, DOI [10.1139/x01-165, 10.1139/X01-165]; Dean C, 2004, FOREST ECOL MANAG, V194, P109, DOI 10.1016/j.foreco.2004.02.013; DesRochers A, 2001, CAN J FOREST RES, V31, P1012, DOI 10.1139/cjfr-31-6-1012; Dong Li-hu, 2011, Yingyong Shengtai Xuebao, V22, P2653; Euskirchen ES, 2002, ECOL MODEL, V154, P75, DOI 10.1016/S0304-3800(02)00052-2; Fan W, P 2011 INT C MAT REN; Fang J., 2001, CHIN J PLANT ECOL, V25, P414; Gao L, 2012, J GEOPHYS RES-BIOGEO, V117, DOI [10.1029/2011JG001930, 10.1029/2012JG001952]; GOELZ JCG, 1992, CAN J FOREST RES, V22, P776, DOI 10.1139/x92-106; Gough CM, 2007, GLOBAL CHANGE BIOL, V13, P1935, DOI 10.1111/j.1365-2486.2007.01406.x; Gower ST, 1996, TRENDS ECOL EVOL, V11, P378, DOI 10.1016/0169-5347(96)10042-2; Harmon ME, 2001, J FOREST, V99, P24; He LM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003942; Houghton Richard A., 2001, TERRESTRIAL GLOBAL P, P499; Hudiburg T, 2009, ECOL APPL, V19, P163, DOI 10.1890/07-2006.1; Jin S, 2003, FOREST ECOL MANAG, V184, P125, DOI 10.1016/S0378-1127(03)00205-6; Kurz WA, 2009, ECOL MODEL, V220, P480, DOI 10.1016/j.ecolmodel.2008.10.018; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; Liu J, 2002, GLOBAL ECOL BIOGEOGR, V11, P115, DOI 10.1046/j.1466-822X.2002.00278.x; Liu X, 2011, SCAND J FOREST RES, V26, P30, DOI 10.1080/02827581.2010.533692; Luo L, 2010, ESTIMATION INFLUENCI; Mei L., 2006, FIN ROOT TURN CARB A; Mei Li, 2009, Yingyong Shengtai Xuebao, V20, P1791; MURTAUGH PA, 1988, ECOL MODEL, V43, P225, DOI 10.1016/0304-3800(88)90005-1; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Reich PB., 1995, ECOPHYSIOLOGY CONIFE, P225; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; RICKLEFS RE, 1979, AUK, V96, P10; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Schroeder TA, 2011, REMOTE SENS ENVIRON, V115, P1421, DOI 10.1016/j.rse.2011.01.022; Skovsgaard JP, 2008, FORESTRY, V81, P13, DOI 10.1093/forestry/cpm041; Smith FW, 2001, FOREST ECOL MANAG, V144, P175, DOI 10.1016/S0378-1127(00)00369-8; Ter-Mikaelian MT, 2014, MITIG ADAPT STRAT GL, V19, P1063, DOI 10.1007/s11027-013-9460-4; Thomas SC, 2007, J ENVIRON MANAGE, V85, P663, DOI 10.1016/j.jenvman.2006.04.027; Thornley JHM, 2004, TREE PHYSIOL, V24, P765, DOI 10.1093/treephys/24.7.765; Wang P, 2007, J ENVIRON MANAGE, V85, P607, DOI 10.1016/j.jenvman.2006.08.017; Wang SQ, 2011, J ENVIRON MANAGE, V92, P1651, DOI 10.1016/j.jenvman.2011.01.024; Wang Xiao-ke, 1991, HYDRAULIC IND, V2, P32; Xia C, 2004, IEEE INT GEOSC REM S; Yu Ying, 2012, Yingyong Shengtai Xuebao, V23, P341; Zha TS, 2013, AGR FOREST METEOROL, V174, P54, DOI 10.1016/j.agrformet.2013.02.004; Zha T, 2009, GLOBAL CHANGE BIOL, V15, P1475, DOI 10.1111/j.1365-2486.2008.01817.x; Zhao M, 2005, FOREST ECOL MANAG, V207, P295, DOI 10.1016/j.foreco.2004.10.049; Zhou GS, 2002, FOREST ECOL MANAG, V169, P149, DOI 10.1016/S0378-1127(02)00305-5; Zhou L, 2011, ANN FOREST SCI, V68, P953, DOI 10.1007/s13595-011-0101-3; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844; ZWEIFEL JR, 1976, FISH B-NOAA, V74, P609	55	12	14	7	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177084	10.1371/journal.pone.0177084	http://dx.doi.org/10.1371/journal.pone.0177084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493995	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300058
J	Machida, T; Takata, F; Matsumoto, J; Miyamura, T; Hirata, R; Kimura, I; Kataoka, Y; Dohgu, S; Yamauchi, A				Machida, Takashi; Takata, Fuyuko; Matsumoto, Junichi; Miyamura, Tomoyuki; Hirata, Ryosuke; Kimura, Ikuya; Kataoka, Yasufumi; Dohgu, Shinya; Yamauchi, Atsushi			Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PERMEABILITY; RETINOPATHY; APOPTOSIS; RELEASE; CELLS; INFLAMMATION; NEPHROPATHY	Diabetic complications are characterized by the dysfunction of pericytes located around microvascular endothelial cells. The blood-brain barrier (BBB) exhibits hyperpermeability with progression of diabetes. Therefore, brain pericytes at the BBB may be involved in diabetic complications of the central nervous system (CNS). We hypothesized that brain pericytes respond to increased brain thrombin levels in diabetes, leading to BBB dysfunction and diabetic CNS complications. Mice were fed a high-fat diet (HFD) for 2 or 8 weeks to induce obesity. Transport of i.v.-administered sodium fluorescein and I-125-thrombin across the BBB were measured. We evaluated brain endothelial permeability and expression of tight junction proteins in the presence of thrombin-treated brain pericytes using a BBB model of co-cultured rat brain endothelial cells and pericytes. Mice fed a HFD for 8 weeks showed both increased weight gain and impaired glucose tolerance. In parallel, the brain influx rate of sodium fluorescein was significantly greater than that in mice fed a normal diet. HFD feeding inhibited the decline in brain thrombin levels occurring during 6 weeks of feeding. In the HFD fed mice, plasma thrombin levels were significantly increased, by up to 22%. I-125-thrombin was transported across the BBB in normal mice after i.v.injection, with uptake further enhanced by co-injection of unlabeled thrombin. Thrombin-treated brain pericytes increased brain endothelial permeability and caused decreased expression of zona occludens-1 (ZO-1) and occludin and morphological disorganization of ZO-1. Thrombin also increased mRNA expression of interleukin-1 beta and 6 and tumor necrosis factor-alpha in brain pericytes. Thrombin can be transported from circulating blood through the BBB, maintaining constant levels in the brain, where it can stimulate pericytes to induce BBB dysfunction. Thus, the brain pericyte-thrombin interaction may play a key role in causing BBB dysfunction in obesity-associated diabetes and represent a therapeutic target for its CNS complications.	[Machida, Takashi; Takata, Fuyuko; Matsumoto, Junichi; Miyamura, Tomoyuki; Hirata, Ryosuke; Kimura, Ikuya; Kataoka, Yasufumi; Dohgu, Shinya; Yamauchi, Atsushi] Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka, Japan; [Takata, Fuyuko; Kataoka, Yasufumi] PharmaCo Cell Co Ltd, BBB Lab, Nagasaki, Japan	Fukuoka University	Yamauchi, A (corresponding author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka, Japan.	atyama@fukuoka-u.ac.jp	Dohgu, Shinya/AAK-9992-2020		Japan Society for the Promotion of Science, funds [25460236, 26460113, 24790102, 26860177]; Central Research Institute of Fukuoka University [141104, 136005]; Takeda Science Foundation	Japan Society for the Promotion of Science, funds; Central Research Institute of Fukuoka University; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-Aid for Scientific Research [(to YK) (C) 25460236 and (to FT) (C) 26460113], Grants-in-id for Young Scientists [(to T. Machida) (B) 24790102 and (to SD) (B) 26860177] from the Japan Society for the Promotion of Science, funds [(to JM) no. 141104, and (to SD) no. 136005] from the Central Research Institute of Fukuoka University, and funds (to SD) from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BBB Laboratory PharmaCo-Cell Co., Ltd. provided no support in the form of salaries for all authors, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Alabanza LM, 2012, J NEUROIMMUNOL, V245, P48, DOI 10.1016/j.jneuroim.2012.02.004; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Boden G, 2007, J CLIN ENDOCR METAB, V92, P4352, DOI 10.1210/jc.2007-0933; Chang HC, 2014, J AGR FOOD CHEM, V62, P3466, DOI 10.1021/jf403286w; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dominguez RO, 2013, NEUROLOGIA, V28, P57, DOI 10.1016/j.nrl.2011.04.009; Fujita T, 2013, DIABETES-METAB RES, V29, P220, DOI 10.1002/dmrr.2380; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Grammas P, 2004, J ALZHEIMERS DIS, V6, P275; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; Hawkins BT, 2015, J CEREBR BLOOD F MET, V35, P985, DOI 10.1038/jcbfm.2015.9; Humpel C, 2011, EXP GERONTOL, V46, P225, DOI 10.1016/j.exger.2010.11.032; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Jongen C, 2007, DIABETOLOGIA, V50, P1509, DOI 10.1007/s00125-007-0688-y; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; Lee JH, 2015, BRAIN RES, V1613, P73, DOI 10.1016/j.brainres.2015.04.002; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570; Machida T, 2015, NEUROSCI LETT, V599, P109, DOI 10.1016/j.neulet.2015.05.028; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Matsumoto J, 2014, NEUROSCI LETT, V578, P133, DOI 10.1016/j.neulet.2014.06.052; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Price TO, 2012, ENDOCRINOLOGY, V153, P362, DOI 10.1210/en.2011-1638; Roberts RO, 2014, NEUROLOGY, V82, P1132, DOI 10.1212/WNL.0000000000000269; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Shimizu F, 2013, NEUROBIOL AGING, V34, P1902, DOI 10.1016/j.neurobiolaging.2013.01.012; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P70, DOI 10.1136/jnnp.74.1.70; Stranahan AM, 2016, J CEREB BLOOD FLOW M; Takata F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055166; Takata F, 2009, NEUROSCI LETT, V449, P71, DOI 10.1016/j.neulet.2008.10.082; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	50	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177447	10.1371/journal.pone.0177447	http://dx.doi.org/10.1371/journal.pone.0177447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489922	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100077
J	Ren, LL; Li, X; Kang, LH; Brunson, K; Liu, HG; Dong, WM; Li, HM; Min, R; Liu, X; Dong, GH				Ren, Lele; Li, Xin; Kang, Lihong; Brunson, Katherine; Liu, Honggao; Dong, Weimiao; Li, Haiming; Min, Rui; Liu, Xu; Dong, Guanghui			Human paleodiet and animal utilization strategies during the Bronze Age in northwest Yunnan Province, southwest China	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; WESTERN LOESS PLATEAU; BONE-COLLAGEN; FAUNAL REMAINS; TROPHIC LEVEL; HUMAN DIET; NITROGEN; AGRICULTURE; SUBSISTENCE; CARBON	Reconstructing ancient diets and the use of animals and plants augment our understanding of how humans adapted to different environments. Yunnan Province in southwest China is ecologically and environmentally diverse. During the Neolithic and Bronze Age periods, this region was occupied by a variety of local culture groups with diverse subsistence systems and material culture. In this paper, we obtained carbon (delta C-13) and nitrogen (delta N-15) isotopic ratios from human and faunal remains in order to reconstruct human paleodiets and strategies for animal exploitation at the Bronze Age site of Shilinggang (ca. 2500 Cal BP) in northwest Yunnan Province. The delta C-13 results for human samples from Shilinggang demonstrate that people's diets were mainly dominated by C-3-based foodstuffs, probably due to both direct consumption of C-3 food and as a result of C-3 foddering of consumed animals. Auxiliary C-4 food signals can also be detected. High delta N-15 values indicate that meat was an important component of the diet. Analysis of faunal samples indicates that people primarily fed pigs and dogs with human food waste, while sheep/goats and cattle were foddered with other food sources. We compare stable isotope and archaeobotanical data from Shilinggang with data from other Bronze Age sites in Yunnan to explore potential regional variation in subsistence strategies. Our work suggests that people adopted different animal utilization and subsistence strategies in different parts of Yunnan during the Bronze Age period, probably as local adaptations to the highly diversified and isolated environments in the region.	[Ren, Lele; Liu, Honggao; Li, Haiming; Dong, Guanghui] Lanzhou Univ, Coll Earth Environm Sci, MOE Key Lab Western Chinas Environm Syst, Lanzhou, Gansu, Peoples R China; [Li, Xin] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Gansu, Peoples R China; [Kang, Lihong; Min, Rui; Liu, Xu] Yunnan Prov Inst Cultural Rel & Archaeol, Kunming, Peoples R China; [Brunson, Katherine] Brown Univ, Joukowsky Inst Archaeol & Ancient World, Providence, RI 02912 USA; [Liu, Honggao] Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Peoples R China; [Dong, Weimiao] Fudan Univ, Dept Cultural Heritage & Museol, Shanghai, Peoples R China	Lanzhou University; Lanzhou University; Brown University; Yunnan Agricultural University; Fudan University	Dong, GH (corresponding author), Lanzhou Univ, Coll Earth Environm Sci, MOE Key Lab Western Chinas Environm Syst, Lanzhou, Gansu, Peoples R China.	ghdong@lzu.edu.cn	Dong, Guanghui/C-5985-2013	Brunson, Katherine/0000-0001-9793-291X; Dong, Guanghui/0000-0001-8005-759X	National Natural Science Foundation of China [41671077, 41620104007, 41271218]; Fundamental Research Funds for the Central Universities [lzujbky-2015-k09, lzujbky-2016-251]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded by the National Natural Science Foundation of China (Grant Nos. 41671077, 41620104007 and 41271218), Fundamental Research Funds for the Central Universities (lzujbky-2015-k09 and lzujbky-2016-251).	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; AMBROSE SH, 1987, NATURE, V325, P201, DOI 10.1038/325201a0; Ambrose SH, 1997, AM J PHYS ANTHROPOL, V104, P343; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Atahan P, 2011, J ARCHAEOL SCI, V38, P1747, DOI 10.1016/j.jas.2011.03.006; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; Buikstra JE, 1996, HUM BIOL, V68, P155; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; Collard IF, 2002, EVOL ECOL RES, V4, P371; Cucchi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158523; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dong GH, 2016, QUAT INT; Dong GH, 2017, SCI CHINA EARTH SCI, V60, P1110, DOI 10.1007/s11430-016-9037-x; DRASS RR, 1990, PLAINS ANTHROPOL, V35, P175, DOI 10.1080/2052546.1990.11909567; Erickson CL, 2006, BIOCHEM J, V396, P117; Fan Y., 2007, SICHUAN CULTURAL REL, V2, P64; Fang T., 2007, DIETETIC CULTURE RES, V3, P37; Farley NW, 2015, INT J HUMANIT SOC SC, V5, P29; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Guedes JAD, 2015, P NATL ACAD SCI USA, V112, P5625, DOI 10.1073/pnas.1423708112; He XR, 1982, ZOOL RES, VS2, P349; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hou LL, 2013, J ARCHAEOL SCI, V40, P2344, DOI 10.1016/j.jas.2013.01.005; Hu Y., 2008, CHINA SCI D, V38, P693; Hu YW, 2006, J ARCHAEOL SCI, V33, P1319, DOI 10.1016/j.jas.2006.01.007; Jia X, 2016, TRANSITION HUMAN SUB; Jia X, 2013, HOLOCENE, V23, P85, DOI 10.1177/0959683612450203; Jin H.T., 2014, JIANGHAN ARCHAEOLOGY, V3, P109; Jing Y, 2005, J ANTHROPOL ARCHAEOL, V24, P252, DOI 10.1016/j.jaa.2005.03.001; Kang LH, 2015, POPULAR ARCHAEOLOGY, V6, P12; Kohn MJ, 1999, SCIENCE, V283, P335, DOI 10.1126/science.283.5400.335; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Li G., 2002, THESIS; Li HM, 2016, SCI CHINA EARTH SCI, V59, P1562, DOI 10.1007/s11430-016-5292-x; Li SM, 2013, RESEARCH ON THE EVOL, P54; Li XQ, 2009, HOLOCENE, V19, P1213, DOI 10.1177/0959683609345083; Liu L, 2011, J ARCHAEOL SCI, V38, P3524, DOI 10.1016/j.jas.2011.08.015; Ma M, 2015, INT J OSTEOARCHAEOL, V25, P923, DOI 10.1002/oa.2379; Ma MM, 2014, ARCHAEOMETRY, V56, P237, DOI 10.1111/arcm.12071; Ma MM, 2016, QUATERNARY SCI REV, V145, P57, DOI 10.1016/j.quascirev.2016.05.041; Mansur ME, 2009, ARCTIC ANTHROPOL, V82, P342; Mays SA, 2002, ANTIQUITY, V76, P654, DOI 10.1017/S0003598X00091067; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; [胡耀武 Hu Yaowu], 2010, [人类学学报, Acta Anthropologica Sinica], V29, P264; Monson R.K., 1999, C4 PLANT BIOL, P339; Nardoto GB, 2006, AM J PHYS ANTHROPOL, V131, P137, DOI 10.1002/ajpa.20409; National Meteorological Information Center (CMA Meteorological Data Center), 2005, DAT DAT MONTHL SURF; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Pearson JA, 2015, J ARCHAEOL SCI, V57, P69, DOI 10.1016/j.jas.2015.01.007; Pechenkina EA, 2005, J ARCHAEOL SCI, V32, P1176, DOI 10.1016/j.jas.2005.02.015; PRICE TD, 1992, J ARCHAEOL SCI, V19, P513, DOI 10.1016/0305-4403(92)90026-Y; Privat KL, 2002, J ARCHAEOL SCI, V29, P779, DOI 10.1006/jasc.2001.0785; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Roberts P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157408; Schoeninger MJ, 1997, AM J PHYS ANTHROPOL, V103, P69, DOI 10.1002/(SICI)1096-8644(199705)103:1<69::AID-AJPA5>3.0.CO;2-8; Schoeninger MJ, 1999, AM J PRIMATOL, V49, P297, DOI 10.1002/(SICI)1098-2345(199912)49:4<297::AID-AJP2>3.0.CO;2-N; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Shelach G., 1996, ASIAN PERSPECT, V35, P1; Shen J, 2006, HOLOCENE, V16, P265, DOI 10.1191/0959683606hl923rp; Smith AT, 2010, GUIDE ESTIMATES PRB; Somerville AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159982; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; VANDERMERWE NJ, 1978, NATURE, V276, P815, DOI 10.1038/276815a0; Wang C., 2001, B SOIL WATER CONSERV, V21, P20; Wang C, 2016, PLOS ONE; Wang Q., 2014, THESIS; Wang TT, 2015, INT J OSTEOARCHAEOL; Xue Y., 2010, THESIS; Yunnan Provincial Institute of Cultural Relics and Archaeology (YNICRA), 2010, SHIF IN GENGM; Yunnan Provincial Institute of Cultural Relics and Archaeology (YNICRA), 1998, ARCH PAP YUNN PROV; Zanden MJV, 1997, CAN J FISH AQUAT SCI; Zhang J., 2022, VESSEL PLUS, V6, P20, DOI [10.20517/2574-1209.2021.140, DOI 10.20517/2574-1209.2021.140]; Zhang QC, 2011, ARCHAEOLOGY, V1; Zhang XX, 2014, J ARCHAEOL SCI, V50, P414, DOI 10.1016/j.jas.2014.08.001; Zhao DY, 2015, ASIAN ARCHAEOLOGY, V3, P129; Zhao Y., 2011, THESIS; Zhao Z J, 2003, ACTA ARCHAEOL SIN, V2, P28; 胡耀武, 2007, [科学通报, Chinese science bulletin], V52, P85	85	11	13	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177867	10.1371/journal.pone.0177867	http://dx.doi.org/10.1371/journal.pone.0177867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EV8UA	28531221	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400033
J	Abebrese, EL; Ali, SH; Arnold, ZR; Andrews, VM; Armstrong, K; Burns, L; Crowder, HR; Day, RT; Hsu, DG; Jarrell, K; Lee, G; Luo, Y; Mugayo, D; Raza, Z; Friend, K				Abebrese, Emmanuel L.; Ali, Syed H.; Arnold, Zachary R.; Andrews, Victoria M.; Armstrong, Katharine; Burns, Lindsay; Crowder, Hannah R.; Day, R. Thomas, Jr.; Hsu, Daniel G.; Jarrell, Katherine; Lee, Grace; Luo, Yi; Mugayo, Daphine; Raza, Zain; Friend, Kyle			Identification of human short introns	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA INTRONS; NONCODING RNAS; DNA-SEQUENCES; TRANSCRIPTION FACTOR; INTERNAL SEQUENCE; OVALBUMIN GENE; SPLICE SITES; HUMAN GENOME; SEQ	Canonical pre-mRNA splicing requires snRNPs and associated splicing factors to excise conserved intronic sequences, with a minimum intron length required for efficient splicing. Non-canonical splicing-intron excision without the spliceosome-has been documented; most notably, some tRNAs and the XBP1 mRNA contain short introns that are not removed by the spliceosome. There have been some efforts to identify additional short introns, but little is known about how many short introns are processed from mRNAs. Here, we report an approach to identify RNA short introns from RNA-Seq data, discriminating against small genomic deletions. We identify hundreds of short introns conserved among multiple human cell lines. These short introns are often alternatively spliced and are found in a variety of RNAs-both mRNAs and lncRNAs. Short intron splicing efficiency is increased by secondary structure, and we detect both canonical and non-canonical short introns. In many cases, splicing of these short introns from mRNAs is predicted to alter the reading frame and change protein output. Our findings imply that standard gene prediction models which often assume a lower limit for intron size fail to predict short introns effectively. We conclude that short introns are abundant in the human transcriptome, and short intron splicing represents an added layer to mRNA regulation.	[Abebrese, Emmanuel L.; Ali, Syed H.; Arnold, Zachary R.; Andrews, Victoria M.; Armstrong, Katharine; Burns, Lindsay; Crowder, Hannah R.; Day, R. Thomas, Jr.; Hsu, Daniel G.; Jarrell, Katherine; Lee, Grace; Luo, Yi; Mugayo, Daphine; Raza, Zain; Friend, Kyle] Washington & Lee Univ, Dept Chem & Biochem, Lexington, VA 24450 USA	Washington & Lee University	Friend, K (corresponding author), Washington & Lee Univ, Dept Chem & Biochem, Lexington, VA 24450 USA.	friendk@wlu.edu		Crowder, Hannah/0000-0002-0329-1048; Ali, Syed/0000-0003-0524-5376	Washington and Lee University-New Faculty Start-Up Grant; Washington and Lee University	Washington and Lee University-New Faculty Start-Up Grant; Washington and Lee University	This work was supported by Washington and Lee University-New Faculty Start-Up Grant to KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Janice Friend for helpful comments in the preparation of this manuscript and the Dean of the College and Washington and Lee University for financial support (to KF).	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bai YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100864; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CATTERALL JF, 1978, NATURE, V275, P510, DOI 10.1038/275510a0; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; De Bona F, 2008, BIOINFORMATICS, V24, pI174, DOI 10.1093/bioinformatics/btn300; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Goffin L, 2006, MOL BIOL CELL, V17, P5309, DOI 10.1091/mbc.E06-04-0292; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; LOVETT ST, 1993, GENETICS, V135, P631; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Papasaikas P, 2016, TRENDS BIOCHEM SCI, V41, P33, DOI 10.1016/j.tibs.2015.11.003; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PIKIELNY CW, 1983, CELL, V34, P395, DOI 10.1016/0092-8674(83)90373-2; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; RUSKIN B, 1985, NATURE, V317, P732, DOI 10.1038/317732a0; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Sasaki-Haraguchi N, 2012, BIOCHEM BIOPH RES CO, V423, P289, DOI 10.1016/j.bbrc.2012.05.112; SEIF I, 1979, NUCLEIC ACIDS RES, V6, P3387, DOI 10.1093/nar/6.10.3387; Shimada MK, 2015, INT J MOL SCI, V16, P10376, DOI 10.3390/ijms160510376; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Turunen JJ, 2013, WIRES RNA, V4, P61, DOI 10.1002/wrna.1141; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175393	10.1371/journal.pone.0175393	http://dx.doi.org/10.1371/journal.pone.0175393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520720	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700001
J	Evans, SD; Droser, ML; Gehling, JG				Evans, Scott D.; Droser, Mary L.; Gehling, James G.			Highly regulated growth and development of the Ediacara macrofossil Dickinsonia costata	PLOS ONE			English	Article							EVOLUTION; FOSSIL; BIOTA; VENDOBIONTA; PLACOZOANS; MORPHOLOGY; AFFINITY; ANNELIDA; ANIMALS; BIOLOGY	The Ediacara Biota represents the oldest fossil evidence for the appearance of animals but linking these taxa to specific clades has proved challenging. Dickinsonia is an abundant, apparently bilaterally symmetrical Ediacara fossil with uncertain affinities. We identified and measured key morphological features of over 900 specimens of Dickinsonia costata from the Ediacara Member, South Australia to characterize patterns in growth and morphology. Here we show that development in Dickinsonia costata was surprisingly highly regulated to maintain an ovoid shape via terminal addition and the predictable expansion of modules. This result, along with other characters found in Dickinsonia suggests that it does not belong within known animal groups, but that it utilized some of the developmental gene networks of bilaterians, a result predicted by gene sequencing of basal metazoans but previously unidentified in the fossil record. Dickinsonia thus represents an extinct clade located between sponges and the last common ancestor of Protostomes and Deuterostomes, and likely belongs within the Eumetazoa.	[Evans, Scott D.; Droser, Mary L.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Gehling, James G.] South Australia Museum, Adelaide, SA, Australia	University of California System; University of California Riverside; South Australian Museum	Evans, SD (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	sevan004@ucr.edu		Evans, Scott/0000-0001-5654-8495	National Science Foundation [EAR-0074021]; National Aeronautics and Space Administration [NNG04GJ42G]; Australian Council Discovery Grant [DP0453393]; Geological Society of America; Society for Sedimentary Geology; Paleontological Society; Lewis and Clark fund for Exploration and Field Research in Astrobiology; National Science Foundation East Asia and Pacific Summer Institutes fellowship [1414911]; National Geographic Explorers Grant; National Aeronautics and Space Administration Astrobiology Institute [NNA15BB03A]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Australian Council Discovery Grant(Australian Research Council); Geological Society of America; Society for Sedimentary Geology; Paleontological Society; Lewis and Clark fund for Exploration and Field Research in Astrobiology; National Science Foundation East Asia and Pacific Summer Institutes fellowship(National Science Foundation (NSF)); National Geographic Explorers Grant(National Geographic Society); National Aeronautics and Space Administration Astrobiology Institute	This research was supported by a National Science Foundation grant (EAR-0074021) and a National Aeronautics and Space Administration Exobiology grant (NNG04GJ42G) to MLD; an Australian Council Discovery Grant (DP0453393) to JGG; and a Geological Society of America student research grant, a Society for Sedimentary Geology student research grant, a Paleontological Society student research grant, a Lewis and Clark fund for Exploration and Field Research in Astrobiology and a National Science Foundation East Asia and Pacific Summer Institutes fellowship (1414911) to SDE. This work was also supported in part by a National Geographic Explorers Grant to Dr. Mary L. Droser. MLD and SDE acknowledge support from the National Aeronautics and Space Administration Astrobiology Institute (NNA15BB03A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antcliffe JB, 2007, J GEOL SOC LONDON, V164, P49, DOI 10.1144/0016-76492006-080; Brasier MD, 2008, PALAEOGEOGR PALAEOCL, V270, P311, DOI 10.1016/j.palaeo.2008.07.018; Budd GE, 2015, BIOL REV; Cannon JT, 2016, NATURE, V530, P89, DOI 10.1038/nature16520; Cuthill JFH, 2014, P NATL ACAD SCI USA, V111, P13122, DOI 10.1073/pnas.1408542111; Droser ML, 2015, P NATL ACAD SCI USA, V112, P4865, DOI 10.1073/pnas.1403669112; Dzik J, 2003, INTEGR COMP BIOL, V43, P114, DOI 10.1093/icb/43.1.114; Dzik J, 2002, NEUES JAHRB GEOL P-M, P385; Dzik J, 2015, PRECAMBRIAN RES, V269, P139, DOI 10.1016/j.precamres.2015.08.015; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Erwin DH, 2009, PHILOS T R SOC B, V364, P2253, DOI 10.1098/rstb.2009.0038; Evans SD, 2015, PALAEOGEOGR PALAEOCL, V434, P28, DOI 10.1016/j.palaeo.2015.02.006; Fedonkin Mikhail A., 2003, Paleontological Research, V7, P9, DOI 10.2517/prpsj.7.9; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Fusco G, 2004, AM NAT, V163, P167, DOI 10.1086/381042; Fusco G, 2012, EVOLUTION, V66, P314, DOI 10.1111/j.1558-5646.2011.01447.x; Gehling JG, 2013, GEOLOGY, V41, P447, DOI 10.1130/G33881.1; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; Gehling JG, 1999, PALAIOS, V14, P40, DOI 10.2307/3515360; Giere O, 2002, ORG DIVERS EVOL, V2, P289, DOI 10.1078/1439-6092-00044; Glaessner M. F., 1966, Palaeontology, V9, P599; Gold DA, 2015, EVOL DEV, V17, P315, DOI 10.1111/ede.12168; Halanych KM, 2015, J EXP BIOL, V218, P592, DOI 10.1242/jeb.111872; Hannibal RL, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-35; Ivantsov AY, 2007, PALEONTOL J+, V41, P113, DOI 10.1134/S0031030107020013; JENKINS RJF, 1992, ORIGIN EARLY EVOLUTI, P131; Jenner RA, 2004, EVOL DEV, V6, P372, DOI 10.1111/j.1525-142X.2004.04045.x; Joel LV, 2014, J PALEO, V88, P235; KLINGENBERG CP, 1992, J ZOOL, V227, P453, DOI 10.1111/j.1469-7998.1992.tb04406.x; Laflamme M, 2013, GONDWANA RES, V23, P558, DOI 10.1016/j.gr.2012.11.004; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; Maruyama YK, 2004, BIOL BULL-US, V206, P55, DOI 10.2307/1543198; Naimark EB, 2009, PALEONTOL J+, V43, P12, DOI 10.1134/S003103010901002X; PEARSE V B, 1989, Pacific Science, V43, P117; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pisani D, 2015, P NATL ACAD SCI USA, V112, P15402, DOI 10.1073/pnas.1518127112; Retallack GJ, 2007, ALCHERINGA, V31, P215, DOI 10.1080/03115510701484705; Robinson JM, 2013, J EXP ZOOL PART B, V9999B, P1; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; SEILACHER A, 1992, J GEOL SOC LONDON, V149, P607, DOI 10.1144/gsjgs.149.4.0607; Seilacher Adolf, 2003, Paleontological Research, V7, P43, DOI 10.2517/prpsj.7.43; Sperling EA, 2010, EVOL DEV, V12, P201, DOI 10.1111/j.1525-142X.2010.00404.x; SPRIGG REG C., 1949, TRANS ROYAL SOC S AUSTRALIA, V73, P72; Struck TH, 2014, MOL BIOL EVOL, V31, P1833, DOI 10.1093/molbev/msu143; Syed Tareq, 2002, Senckenbergiana Lethaea, V82, P315; Tarhan LG, 2016, GEOLOGY, V44, P951, DOI 10.1130/G38542.1; Tweedt SM, 2015, ADV MAR GENOMICS, V2, P47, DOI 10.1007/978-94-017-9642-2_3; WADE M, 1972, Memoirs of the Queensland Museum, V16, P171; Xiao SH, 2009, TRENDS ECOL EVOL, V24, P31, DOI 10.1016/j.tree.2008.07.015; Zhang XL, 2006, ACTA GEOL SIN-ENGL, V80, P636	51	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176874	10.1371/journal.pone.0176874	http://dx.doi.org/10.1371/journal.pone.0176874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520741	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700031
J	Heber, SD; Hetterich, H; Lorbeer, R; Bayerl, C; Machann, J; Auweter, S; Storz, C; Schlett, CL; Nikolaou, K; Reiser, M; Peters, A; Bamberg, F				Heber, Sophia D.; Hetterich, Holger; Lorbeer, Roberto; Bayerl, Christian; Machann, Juergen; Auweter, Sigrid; Storz, Corinna; Schlett, Christopher L.; Nikolaou, Konstantin; Reiser, Maximilian; Peters, Annette; Bamberg, Fabian			Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease	PLOS ONE			English	Article							BLOOD-GLUCOSE CONCENTRATION; BETA-CELL FUNCTION; ADIPOSE-TISSUE; RISK; STEATOSIS; LIVER; QUANTIFICATION; MRI; ASSOCIATION; COMPARTMENTS	Background/Objective Despite the relevance of pancreatic fat content in the development of metabolic diseases, its association with impaired glucose metabolism, diabetes, and other adipose tissue compartments remains unclear. Thus, we determined differences in pancreatic fat content by magnetic resonance imaging (MRI) between subjects with prediabetes, diabetes, and normal controls in a cohort from the general population. Methods Subjects without history of cardiovascular disease with established diabetes or prediabetes as well as normal controls were included and underwent whole-body MRI on a 3T scanner. Pancreatic fat content was quantified by measuring the proton-density fat fraction (PDFFpanc) using a 3D multi-echo GRE sequence (increment: 1.23 ms, 6 echoes) by placing ROIs in the pancreatic head, body, and tail by independent readers. In addition, hepatic fat content as well as abdominal subcutaneous and visceral adipose tissue (SAT and VAT) were measured by multi-echo GRE and 3D 2-point volume-interpolated DIXON MRI, respectively. Univariate and multivariate analyses were employed to determine associations. Results A total of 385 subjects were included in the analysis (median age: 57 years, 58.2% males), of them 53 were classified as subjects with diabetes, 95 as prediabetes, and 237 as controls (13.8%, 24.7%, and 61.6%; respectively). The median PDFFpanc was 5.2% [IQR 3.3-9.4], and significantly higher in subjects with prediabetes and diabetes as compared to controls (PDFFpanc: 6.2% [IQR: 3.5-12] vs. 8.6% [IQR: 4.3-17.5] vs. 4.9% [3.1-7.4], p<0.001, respectively). After adjusting for age, gender and BMI the association was attenuated (all p>0.12). While in univariate analysis BMI, PDFFhepatic, SAT and VAT were associated with PDFFpanc (all p<0.05), only VAT predicted PDFFpanc independently (beta: 0.02, 95%-confidence interval: 0.01-0.04, p<0.001). Conclusion While pancreatic fat content differs significantly between subjects with prediabetes, diabetes and controls, this association may be confounded by age, gender, and the amount of VAT in this cross-sectional study.	[Heber, Sophia D.; Storz, Corinna; Nikolaou, Konstantin; Bamberg, Fabian] Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Hetterich, Holger; Lorbeer, Roberto; Bayerl, Christian; Auweter, Sigrid; Reiser, Maximilian] Ludwig Maximilian Univ Hosp, Inst Clin Radiol, Munich, Germany; [Machann, Juergen] Univ Hosp Tuebingen, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany; [Machann, Juergen] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis IDM, Tubingen, Germany; [Machann, Juergen] German Ctr Diabet Res DZD, Tubingen, Germany; [Schlett, Christopher L.] Heidelberg Univ, Dept Radiol Diagnost & Intervent Radiol, Heidelberg, Germany; [Reiser, Maximilian; Peters, Annette; Bamberg, Fabian] German Ctr Cardiovasc Dis Res DZHK eV, Munich, Germany; [Peters, Annette] Ludwig Maximilian Univ Hosp, Inst Cardiovasc Prevent, Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bamberg, F (corresponding author), Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany.; Bamberg, F (corresponding author), German Ctr Cardiovasc Dis Res DZHK eV, Munich, Germany.	Fabian.bamberg@uni-tuebingen.de	Storz, Corinna/ABE-2433-2020; Peters, Annette/A-6117-2011	Storz, Corinna/0000-0001-5589-1849; Peters, Annette/0000-0001-6645-0985; Schlett, Christopher/0000-0002-1576-1481	German Research Foundation (DFG, Bonn, Germany); German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany); Centre for Diabetes Research (DZD e.V., Neuherberg, Germany)	German Research Foundation (DFG, Bonn, Germany)(German Research Foundation (DFG)); German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany); Centre for Diabetes Research (DZD e.V., Neuherberg, Germany)	This study was funded by the German Research Foundation (DFG, Bonn, Germany), the German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany) and the Centre for Diabetes Research (DZD e.V., Neuherberg, Germany).	Andersson G, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0120-8; Bamberg F, 2016, DIABETES; Bashir MR, 2015, AM J ROENTGENOL, V204, P297, DOI 10.2214/AJR.14.12457; Begovatz P, 2015, DIABETOLOGIA, V58, P1646, DOI 10.1007/s00125-015-3544-5; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Cole BK, 2010, HYPERTENSION, V55, P715, DOI 10.1161/HYPERTENSIONAHA.109.148049; Dall TM, 2014, DIABETES CARE, V37, P3172, DOI 10.2337/dc14-1036; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Dong Z, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003858; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Han TS, 2016, JRSM CARDIOVASC DIS, V5, DOI 10.1177/2048004016633371; Heni M, 2010, DIABETES-METAB RES, V26, P200, DOI 10.1002/dmrr.1073; Hetterich H, 2015, EUR RADIOL; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hwang YC, 2015, DIABETES CARE, V38, P2100, DOI 10.2337/dc15-0625; Idilman IS, 2015, ABDOM IMAGING, V40, P1512, DOI 10.1007/s00261-015-0385-0; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Kim SY, 2014, RADIOLOGY, V271, P104, DOI 10.1148/radiol.13122883; Kuhn JP, 2015, RADIOLOGY, V276, P129, DOI 10.1148/radiol.15140446; Lesmana CRA, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0404-1; Macauley M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126825; Mathieu P, 2014, REV ENDOCR METAB DIS, V15, P289, DOI 10.1007/s11154-014-9299-3; Mathur A, 2009, J AM COLL SURGEONS, V208, P989, DOI 10.1016/j.jamcollsurg.2008.12.026; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Ou HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062561; Patel NS, 2013, ALIMENT PHARM THER, V37, P630, DOI 10.1111/apt.12237; Patel NS, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/498296; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Reeder SB, 2010, MAGN RESON IMAGING C, V18, P337, DOI 10.1016/j.mric.2010.08.013; Rossi AP, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.5; Rossi AP, 2011, OBESITY, V19, P1747, DOI 10.1038/oby.2011.114; Ruf E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-312; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schneider ALC, 2016, DIABETES CARE, V39, P772, DOI 10.2337/dc15-1335; Schwenzer NF, 2010, INVEST RADIOL, V45, P788, DOI 10.1097/RLI.0b013e3181f10fe1; Sepe PS, 2011, GASTROINTEST ENDOSC, V73, P987, DOI 10.1016/j.gie.2011.01.015; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; van der Zijl NJ, 2011, J CLIN ENDOCR METAB, V96, P459, DOI 10.1210/jc.2010-1722; Wong VWS, 2014, AM J GASTROENTEROL, V109, P589, DOI 10.1038/ajg.2014.1; World Health Organization, 2006, DEF DIAGN DIAB MELL; Wurslin C, 2010, J MAGN RESON IMAGING, V31, P430, DOI 10.1002/jmri.22036; Yamazaki H, 2016, DIABETES CARE	43	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177154	10.1371/journal.pone.0177154	http://dx.doi.org/10.1371/journal.pone.0177154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520813	gold, Green Submitted, Green Published			2022-12-27	WOS:000401487700038
J	Song, SY; Shin, JH; Hyeon, SY; Kim, D; Kang, WK; Choi, SH; Kim, YJ; Kim, EY				Song, Seung Yeon; Shin, Joo Hee; Hyeon, Su Yeong; Kim, Donguk; Kang, Won Ku; Choi, Soo-Han; Kim, Yae-Jean; Kim, Eun Young			Pediatric fluoroquinolone prescription in South Korea before and after a regulatory intervention: A nationwide study, 2007-2015	PLOS ONE			English	Article							ANTIMICROBIAL STEWARDSHIP INTERVENTION; ANTIBIOTIC USE; QUINOLONE RESISTANCE; TRACT-INFECTIONS; CHILDREN; COMMUNITY; POPULATION; EMERGENCE; COUNTRIES; DECREASE	Objective To investigate the impact of national implementation of age restriction on fluoroquinolone prescription in children and adolescents. Methods Data collected from the database of Health Insurance Review and Assessment Service in South Korea, a national health insurance system to analyze fluoroquinolone prescribing practice in children and adolescents younger than 18 years, between 2007 and 2015. The age restriction was implemented in December 2009. The annual prescription rate of FQ per 100,000 person-years was calculated and an autoregressive model was used to predict the prescription pattern if an intervention had not occurred. Results A total of 505,859 children received systemic fluoroquinolone during the study period D 297,054 ciprofloxacin, and 208,805 levofloxacin. After implementation of the drug utilization review program, the annual prescription rate for ciprofloxacin declined by 97.5% ( from 840 to 21 per 100,000 person-years, P < 0.001), and for levofloxacin by 96.4% ( from 598 to 11 per 100,000 person-years, P < 0.001). The decline was more dramatic in the outpatient setting than in the inpatient setting for both drugs. Conclusion The dramatic and sustained decline in prescription number and change in prescription pattern after the regulatory action suggests that the implementation under drug utilization review program was successful in controlling excessive and inappropriate use of fluoroquinolones in children, possibly guiding towards more judicious and selective prescription behavior.	[Song, Seung Yeon; Kang, Won Ku; Kim, Eun Young] Chung Ang Univ, Dept Hlth Social & Clin Pharm, Coll Pharm, Seoul, South Korea; [Shin, Joo Hee] Chungnam Natl Univ, Dept Clin Pharm, Coll Pharm, Daejun, South Korea; [Hyeon, Su Yeong; Kim, Donguk] Sungkyunkwan Univ, Dept Stat, Seoul, South Korea; [Choi, Soo-Han] Hallym Univ, Dept Pediat, Dongtan Sacred Heart Hosp, Gyeonggi Do, South Korea; [Kim, Yae-Jean] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea	Chung Ang University; Chungnam National University; Sungkyunkwan University (SKKU); Hallym University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, EY (corresponding author), Chung Ang Univ, Dept Hlth Social & Clin Pharm, Coll Pharm, Seoul, South Korea.; Kim, YJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	yaejeankim@skku.edu; eykimjcb777@cau.ac.kr		Kim, EunYoung/0000-0003-3525-8805	Korea Food and Drug Administration [1172KFDA294]; National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2015R1A5A1008958]	Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); National Research Foundation of Korea (NRF) grant - Korean government (MSIP)(National Research Foundation of Korea)	This research was supported by a grant from the Korea Food and Drug Administration (1172KFDA294) and National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2015R1A5A1008958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2009, INT J ANTIMICROB AG, V34, P82, DOI 10.1016/j.ijantimicag.2009.02.002; Bradley JS, 2014, PEDIATRICS, V134, pE146, DOI 10.1542/peds.2013-3636; Bradley JS, 2011, PEDIATRICS, V128, pE1034, DOI 10.1542/peds.2011-1496; Burkhardt JE, 1997, CLIN INFECT DIS, V25, P1196, DOI 10.1086/516119; Chalumeau M, 2003, PEDIATRICS, V111, pE714, DOI 10.1542/peds.111.6.e714; Choi Soo-Han, 2013, Korean J Pediatr, V56, P196, DOI 10.3345/kjp.2013.56.5.196; de Lastours V, 2014, J ANTIMICROB CHEMOTH, V69, P3393, DOI 10.1093/jac/dku283; European Medicines Agency, 2008, CIPR BAYER ART 30 RE; Finkelstein JA, 2013, JAMA-J AM MED ASSOC, V309, P2388, DOI 10.1001/jama.2013.6288; Genuini M, 2014, INT J CLIN PHARM TH, V52, P940, DOI 10.5414/CP202103; Gerber JS, 2014, JAMA-J AM MED ASSOC, V312, P2569, DOI 10.1001/jama.2014.14042; Gerber JS, 2013, JAMA-J AM MED ASSOC, V309, P2345, DOI 10.1001/jama.2013.6287; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grady R, 2003, PEDIATR INFECT DIS J, V22, P1128, DOI 10.1097/01.inf.0000101994.25947.12; Hay AD, 2016, BMJ BRIT MED J, V352, pI939, DOI DOI 10.1136/BMJ.I939; Heo JH, 2013, INT J MED INFORM, V82, P987, DOI 10.1016/j.ijmedinf.2013.07.001; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337; Hsueh PR, 2011, J INFECTION, V63, P114, DOI 10.1016/j.jinf.2011.05.015; Kim Logyoung, 2013, [Health Policy and Mangemnet, 보건행정학회지], V23, P152; Kimland E, 2012, CLIN PHARMACOL THER, V91, P796, DOI 10.1038/clpt.2012.26; Korea Ministry of Food and Drug Safety, 2009, PUBL ANN ADD LIST AG; Lau Sheung-Mei, 2004, Journal of Microbiology Immunology and Infection, V37, P185; Lee JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161937; Lee YS, 2014, ARCH PHARM RES, V37, P1295, DOI 10.1007/s12272-014-0333-5; Low DE, 2005, CLIN INFECT DIS, V40, P236, DOI 10.1086/426822; MacDougall C, 2005, CLIN INFECT DIS, V41, P435, DOI 10.1086/432056; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Marra F, 2006, J ANTIMICROB CHEMOTH, V58, P830, DOI 10.1093/jac/dkl275; Murray TS, 2007, PEDIATR ANN, V36, P336, DOI 10.3928/0090-4481-20070601-09; Na KH, 2017, AM J OPHTHALMOL, V176, P157, DOI 10.1016/j.ajo.2017.01.014; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Perz JF, 2002, JAMA-J AM MED ASSOC, V287, P3103, DOI 10.1001/jama.287.23.3103; Pichichero ME, 2007, JAMA-J AM MED ASSOC, V298, P1772, DOI 10.1001/jama.298.15.1772; Porta A, 2010, EUR J CLIN PHARMACOL, V66, P919, DOI 10.1007/s00228-010-0842-1; Powell KR, 2006, PEDIATRICS, V118, P1287, DOI 10.1542/peds.2006-1722; Principi N, 2015, INT J ANTIMICROB AG, V45, P341, DOI 10.1016/j.ijantimicag.2015.01.004; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rubin MA, 2005, CLIN INFECT DIS, V40, P546, DOI 10.1086/427500; Sabharwal V, 2006, PEDIATR INFECT DIS J, V25, P257, DOI 10.1097/01.inf.0000205799.35780.f3; Sarma JB, 2015, J HOSP INFECT, V91, P68, DOI 10.1016/j.jhin.2015.05.006; Shin JY, 2014, PHARMACOEPIDEM DR S, V23, P1320, DOI 10.1002/pds.3696; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Steinke D, 2001, CLIN INFECT DIS, V33, pS193, DOI 10.1086/321848; US Food and Drug Administration, 2016, FDA DRUG SAF COMM FD; US Food and Drug Administration, 2004, CIPR CIPR HYDR 2004; US Food and Drug Administration, 2008, LEV LEV LAB 2008; Weiss K, 2011, CLIN INFECT DIS, V53, P433, DOI 10.1093/cid/cir409; Yang ZT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-245; Yoon YK, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002100; Youngster I, 2017, J PEDIATR-US, V182, P239, DOI 10.1016/j.jpeds.2016.11.027	50	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176420	10.1371/journal.pone.0176420	http://dx.doi.org/10.1371/journal.pone.0176420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520738	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700017
J	Lee, TC; Bonnici, AA; Tamblyn, R; McDonald, EG				Lee, Todd C.; Bonnici, Andre A.; Tamblyn, Robyn; McDonald, Emily G.			Inpatient Z-drug use commonly exceeds safe dosing recommendations	PLOS ONE			English	Article							INSOMNIA; MEDICATIONS; DISCHARGE; ADULTS	Importance In 2016 recommendations for safer prescribing practices were circulated to all doctors in one of Canada's largest provinces, by the college of physicians, following a coroner's inquest into a vehicular death related to Z-drug use. We sought to determine how frequently Z-drug prescriptions in our institution were not adhering to these recommendations. Design Retrospective cohort study. Setting McGill University Health Centre, an 832-bed tertiary care institution in Montreal, Canada. Participants All adult non-obstetrical patients admitted between April 1, 2015 and March 31, 2016. Exposure The receipt of at least one dose of Z-drug as determined by pharmacy records. Main outcomes and measures Adherence to four recommendations related to starting dose, maximal dose, concomitant drug administration, and duration of use were evaluated. Results 1,409 unique patients received a Z-drug during 1,783 admissions representing use in 9.3% of non-obstetrical patients. Standing orders were seen in 42% (745/1783) of admissions. Non-conformity with the coroner's recommendations was common. Overall, 672/1783 (38%) admissions involved a patient receiving more than the recommended daily maximum dose (643/999 older patients, 64%). Of 607 admissions which were longer than 10 days, 257 (39%) involved a prescription which exceeded 10 days. Conclusions and relevance A coroner's recommendation that doctors receive instructions about safe Z-drug prescribing is unprecedented, and was likely required given that use of Z-drugs occurs at doses and durations that often exceed best practice recommendations. Similar interventions may be required in other jurisdictions.	[Lee, Todd C.; Tamblyn, Robyn; McDonald, Emily G.] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada; [Lee, Todd C.; McDonald, Emily G.] McGill Univ, Hlth Ctr, Clin Practice Assessment Unit, Montreal, PQ, Canada; [Lee, Todd C.; Tamblyn, Robyn] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Bonnici, Andre A.] McGill Univ, Hlth Ctr, Pharm Dept, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	McDonald, EG (corresponding author), McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada.; McDonald, EG (corresponding author), McGill Univ, Hlth Ctr, Clin Practice Assessment Unit, Montreal, PQ, Canada.	emily.mcdonald@mcgill.ca	McDonald, Emily/AAS-8905-2020	Lee, Todd/0000-0002-2267-4239				AGS Choosing Wisely Workgroup, 2013, J AM GERIATRICS SOC, V61, P622; Alessi-Severini Silvia, 2014, CMAJ Open, V2, pE208, DOI 10.9778/cmajo.20130076; College des medecins du Quebec, 2016, IM ZOP NOUV POS REC; Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Grad R, 1999, J AM GERIATR SOC, V47, P184, DOI 10.1111/j.1532-5415.1999.tb04576.x; Health Canada, 2014, IMOVANE ZOP NEW DOS; Kapil V, 2014, BRIT J PSYCHIAT, V205, P407, DOI 10.1192/bjp.bp.114.149252; Lee TC, 2016, JAMA INTERNAL MED; McDonald EG, 2015, AM J MED, V128, P193, DOI 10.1016/j.amjmed.2014.10.016; Moloney ME, 2011, AM J PUBLIC HEALTH, V101, P1429, DOI 10.2105/AJPH.2010.300014; Overdyk FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150214; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Regie de l'assurance maladie du Quebec, LIST MED; Scales DC, 2016, J GEN INTERN MED, V31, P196, DOI 10.1007/s11606-015-3501-5; Tamblyn R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-150; US Food and Drug Administration, 2014, FDA DRUG SAF COMM FD	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177645	10.1371/journal.pone.0177645	http://dx.doi.org/10.1371/journal.pone.0177645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520804	Green Published, gold, Green Submitted			2022-12-27	WOS:000401485500051
J	Tapper, S; Tisell, A; Lundberg, P				Tapper, Sofie; Tisell, Anders; Lundberg, Peter			How does motion affect GABA-measurements? Order statistic filtering compared to conventional analysis of MEGA-PRESS MRS	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; BRAIN; NMR; SUPPRESSION; GLUTAMATE; PULSES; 3T	Purpose The aim of this study was to evaluate two post-processing techniques applied to MRS MEGA-PRESS data influenced by motion-induced artifacts. In contrast to the conventional averaging technique, order statistic filtering (OSF) is a known method for artifact reduction. Therefore, this method may be suitable to incorporate in the GABA quantification. Methods Twelve healthy volunteers were scanned three times using a 3 T MR system. One measurement protocol consisted of two MEGA-PRESS measurements, one reference measurement and one measurement including head motions. The resulting datasets were analyzed with the standard averaging technique and with the OSF-technique in two schemes; filtering phase cycles 'RAW PC' and filtering dynamics 'RAW Dyn'. Results The datasets containing artifacts resulted in an underestimation of the concentrations. There was a trend for the OSF-technique to compensate for this reduction when quantifying SNR-intense signals. However, there was no indication that OSF improved the estimated GABA concentrations. Moreover, when only considering the reference measurements, the OSF technique was equally as effective as averaging, which suggests that the techniques are interchangeable. Conclusion OSF performed equally well as the conventional averaging technique for low-SNR signals. For high-SNR signals, OSF performed better and thus could be considered for routine usage.	[Tapper, Sofie; Tisell, Anders; Lundberg, Peter] Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden; [Tapper, Sofie; Tisell, Anders; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth Sci, Radiat Phys, Linkoping, Sweden; [Tisell, Anders; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth Sci, Radiol, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Tapper, S (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden.; Tapper, S (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Radiat Phys, Linkoping, Sweden.	sofie.tapper@liu.se	Lundberg, Peter/AGD-9679-2022	Tapper, Sofie/0000-0002-7809-2481	Knut and Alice Wallenberg Foundation [KAW 2013.0076]; NIH [P41 015909, R01 016089]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Knut and Alice Wallenberg Foundation, Grant number: KAW 2013.0076 (https://www.wallenberg.com/kaw/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Richard Edden is gratefully acknowledged, for very generously providing the MEGA-PRESS pulse sequence and other tools that were developed under NIH GRANTS P41 015909 and R01 016089.	Agarwal N, 2012, AM J NEURORADIOL, V33, P595, DOI 10.3174/ajnr.A2587; Andrews-Shigaki BC, 2011, J MAGN RESON IMAGING, V33, P498, DOI 10.1002/jmri.22467; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bogner W, 2014, NEUROIMAGE, V103, P290, DOI 10.1016/j.neuroimage.2014.09.032; Bydder M, 2008, MAGN RESON IMAGING, V26, P847, DOI 10.1016/j.mri.2008.01.050; Dydak U, 2011, ENVIRON HEALTH PERSP, V119, P219, DOI 10.1289/ehp.1002192; Edden RAE, 2007, MAGN RESON MED, V58, P1276, DOI 10.1002/mrm.21383; Edden RAE, 2012, MAGN RESON MED, V68, P657, DOI 10.1002/mrm.24391; Emir UE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030918; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Harris AD, 2014, MAGN RESON MED, V72, P941, DOI 10.1002/mrm.25009; Henry PG, 2001, MAGNET RESON MED, V45, P517, DOI 10.1002/1522-2594(200103)45:3<517::AID-MRM1068>3.0.CO;2-6; Kaiser LG, 2008, NMR BIOMED, V21, P22, DOI 10.1002/nbm.1150; KLOSE U, 1990, MAGNET RESON MED, V14, P26, DOI 10.1002/mrm.1910140104; Marsman A, 2014, NEUROIMAGE-CLIN, V6, P398, DOI 10.1016/j.nicl.2014.10.005; Mescher M, 1996, J MAGN RESON SER A, V123, P226, DOI 10.1006/jmra.1996.0242; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Morgan PT, 2012, SLEEP, V35, P807, DOI 10.5665/sleep.1880; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Near J, 2015, MAGN RESON MED, V73, P44, DOI 10.1002/mrm.25094; Platt SR, 2007, VET J, V173, P278, DOI 10.1016/j.tvjl.2005.11.007; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Scheenen TWJ, 2008, MAGN RESON MED, V59, P1, DOI 10.1002/mrm.21302; Slotboom J, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104030; Stagg Charlotte J, 2011, Commun Integr Biol, V4, P573, DOI 10.4161/cib.4.5.16213	26	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177795	10.1371/journal.pone.0177795	http://dx.doi.org/10.1371/journal.pone.0177795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520793	Green Published, gold			2022-12-27	WOS:000401485500071
J	Zhou, QQ; Chen, ZD; Lee, JW; Li, XH; Sun, WJ				Zhou, Qiongqiong; Chen, Zhidan; Lee, Jinwook; Li, Xinghui; Sun, Weijiang			Proteomic analysis of tea plants (Camellia sinensis) with purple young shoots during leaf development	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GREEN TEA; ANTHOCYANIN DEGRADATION; TRANSGENIC TOBACCO; CHALCONE ISOMERASE; STRESS RESPONSES; ORYZA-SATIVA; LEAVES; BINDING; EXPRESSION	Tea products made from purple leaves are highly preferred by consumers due to the health benefits. This study developed a proteome reference map related to color changes during leaf growth in tea (Camellia sinensis) plant with purple young shoots using two-dimensional electrophoresis (2-DE). Forty-six differentially expressed proteins were detected in the gel and successfully identified by using MALDI-TOF/TOF-MS. The pronounced changes in the proteomic profile between tender purple leaves (TPL) and mature green leaves (MGL) included: 1) the lower activity of proteins associated with CO2 assimilation, energy metabolism and photo flux efficiency and higher content of anthocyanins in TPL than those in MGL may protect tender leaves against photo-damage; 2) the higher abundance of chalcone synthase (CHS), chalcone isomerase (CHI) and flavonol synthase (FLS) likely contributes to the synthesis of anthocyanins, catechins and flavonols in TPL tissues; 3) higher abundance of stress response proteins, such as glutathione S-transferases (GST) and phospholipid hydroperoxide glutathione peroxidase (PHGPx), could enhance the tolerance of TPL tissues to adverse condition in; and 4) the increased abundance of proteins related to protein synthesis, nucleic acids and cell wall proteins should be beneficial for the proliferation and expansion of leaf cell in TPL tissues. qPCR analysis showed that the expression of differentially abundant proteins was regulated at the transcriptional level. Therefore, the results indicated that higher abundance of CHI and CHS may account for the production of the purple-shoot phenotype in Wuyiqizhong 18 and thereby, enhancing the anthocyanin biosynthesis. The higher abundance of glutamine synthetase (GS) proteins related to the theanine biosynthesis may improve the flavor of tea products from TPL materials. Thus, this work should help to understand the molecular mechanisms underlying the changes in leaf color alteration.	[Zhou, Qiongqiong; Chen, Zhidan; Sun, Weijiang] Fujian Agr & Forestry Univ, Anxi Coll Tea Sci, Fuzhou, Peoples R China; [Zhou, Qiongqiong] Henan Agr Univ, Coll Hort, Zhengzhou, Peoples R China; [Lee, Jinwook] Mokpo Natl Univ, Dept Hort Sci, Muan, South Korea; [Li, Xinghui] Nanjing Agr Univ, Tea Res Inst, Nanjing, Jiangsu, Peoples R China	Fujian Agriculture & Forestry University; Henan Agricultural University; Mokpo National University; Nanjing Agricultural University	Sun, WJ (corresponding author), Fujian Agr & Forestry Univ, Anxi Coll Tea Sci, Fuzhou, Peoples R China.	swj8103@126.com	Lee, Jinwook/G-4515-2011	Lee, Jinwook/0000-0001-6547-2509	National 863 Program [2013AA10260605]; Science and Technology Major Project of Fujian province [2015NZ0002-1]; earmarked fund for Modern Agro-industry Technology Research System [CARS-23]	National 863 Program; Science and Technology Major Project of Fujian province; earmarked fund for Modern Agro-industry Technology Research System	This work was supported by funding from the National 863 Program (2013AA10260605), Science and Technology Major Project of Fujian province (2015NZ0002-1) and the earmarked fund for Modern Agro-industry Technology Research System (CARS-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Barragan A, 2014, BIOL PLANTARUM, V58, P567, DOI 10.1007/s10535-014-0427-4; Borovsky Y, 2004, THEOR APPL GENET, V109, P23, DOI 10.1007/s00122-004-1625-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai G, 2010, J EXP BOT, V61, P623, DOI 10.1093/jxb/erp395; Caruso G, 2008, ANAL BIOANAL CHEM, V391, P381, DOI 10.1007/s00216-008-2008-x; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chen JC, 2004, PLANT MOL BIOL, V55, P521, DOI 10.1007/s11103-004-0590-7; Chen MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep44743; Deng WW, 2008, PHYTOCHEM LETT, V1, P115, DOI 10.1016/j.phytol.2008.06.002; Fujiki H, 2005, CHEM REC, V5, P119, DOI 10.1002/tcr.20039; Geleijnse JM, 1999, ARCH INTERN MED, V159, P2170, DOI 10.1001/archinte.159.18.2170; Hatlestad GJ, 2015, NAT GENET, V47, P92, DOI 10.1038/ng.3163; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004; Hsu CP, 2012, J AGR FOOD CHEM, V60, P3686, DOI 10.1021/jf204619n; Jiang LH, 2013, J AGR FOOD CHEM, V61, P3306, DOI 10.1021/jf304860u; Joshi R, 2015, FOOD CHEM, V176, P357, DOI 10.1016/j.foodchem.2014.12.067; Kaneko S, 2006, J AGR FOOD CHEM, V54, P2688, DOI 10.1021/jf0525232; Katam R, 2016, J PROTEOMICS, V143, P209, DOI 10.1016/j.jprot.2016.05.031; Kerio LC, 2013, FOOD CHEM, V136, P1405, DOI 10.1016/j.foodchem.2012.09.066; Kerio LC, 2012, FOOD CHEM, V131, P31, DOI 10.1016/j.foodchem.2011.08.005; Kilel EC, 2013, FOOD CHEM, V141, P769, DOI 10.1016/j.foodchem.2013.03.051; Kim JS, 2008, PLANT J, V55, P455, DOI 10.1111/j.1365-313X.2008.03518.x; Kim JY, 2007, PLANT J, V50, P439, DOI 10.1111/j.1365-313X.2007.03057.x; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; KOPCZAK SD, 1992, PLANT CELL, V4, P539, DOI 10.1105/tpc.4.5.539; Li Caihong, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.4103/0366-6999.147330; Li F, 2006, PLANT PHYSIOL BIOCH, V44, P455, DOI 10.1016/j.plaphy.2006.08.006; Li WJ, 2000, BBA-GENE STRUCT EXPR, V1493, P225, DOI 10.1016/S0167-4781(00)00152-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maayan I, 2008, PHYSIOL PLANTARUM, V134, P547, DOI 10.1111/j.1399-3054.2008.01150.x; Manetas Y, 2003, FUNCT PLANT BIOL, V30, P265, DOI 10.1071/FP02226; Manetas Y, 2002, PHOTOSYNTHETICA, V40, P349, DOI 10.1023/A:1022614722629; Molina-Rueda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056421; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; Nesumi A, 2012, JARQ-JPN AGR RES Q, V46, P321, DOI 10.6090/jarq.46.321; Nishihara M, 2005, FEBS LETT, V579, P6074, DOI 10.1016/j.febslet.2005.09.073; Nissim-Levi A, 2003, J HORTIC SCI BIOTECH, V78, P61, DOI 10.1080/14620316.2003.11511588; Oren-Shamir M, 2009, PLANT SCI, V177, P310, DOI 10.1016/j.plantsci.2009.06.015; Peng HY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1462-z; Rashid K, 2014, NUTR NEUROSCI, V17, P178, DOI 10.1179/1476830513Y.0000000081; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Vaknin H, 2005, PLANTA, V222, P19, DOI 10.1007/s00425-005-1509-5; Wei K, 2012, FOOD CHEM, V130, P720, DOI 10.1016/j.foodchem.2011.07.092; Yamamoto T, 1997, CHEM APPL GREEN TEA, P160; You X, 2014, TREES-STRUCT FUNCT, V28, P1383, DOI 10.1007/s00468-014-1042-x; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002; Zhai CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073989; Zhang KM, 2011, BIOL PLANTARUM, V55, P361, DOI 10.1007/s10535-011-0055-1; Zheng JL, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1921-9; Zhou QQ, 2016, J SCI FOOD AGR, V96, P1982, DOI 10.1002/jsfa.7308	56	15	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177816	10.1371/journal.pone.0177816	http://dx.doi.org/10.1371/journal.pone.0177816			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520776	gold, Green Published			2022-12-27	WOS:000401485500072
J	Bischoff, AR; Pokhvisneva, I; Leger, E; Gaudreau, H; Steiner, M; Kennedy, JL; O'Donnell, KJ; Diorio, J; Meaney, MJ; Silveira, PP				Bischoff, Adrianne R.; Pokhvisneva, Irina; Leger, Etienne; Gaudreau, Helene; Steiner, Meir; Kennedy, James L.; O'Donnell, Kieran J.; Diorio, Josie; Meaney, Michael J.; Silveira, Patricia P.		MAVAN Res Teaall	Dynamic interaction between fetal adversity and a genetic score reflecting dopamine function on developmental outcomes at 36 months	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; RECEPTOR GENE; RISK-FACTORS; GROWTH; NEURODEVELOPMENT; AGE; ASSOCIATION; DEPRESSION; ATTENTION; CHILDREN	Background Fetal adversity, evidenced by poor fetal growth for instance, is associated with increased risk for several diseases later in life. Classical cut-offs to characterize small (SGA) and large for gestational age (LGA) newborns are used to define long term vulnerability. We aimed at exploring the possible dynamism of different birth weight cut-offs in defining vulnerability in developmental outcomes (through the Bayley Scales of Infant and Toddler Development), using the example of a gene vs. fetal adversity interaction considering gene choices based on functional relevance to the studied outcome. Methods 36-month-old children from an established prospective birth cohort (Maternal Adversity, Vulnerability, and Neurodevelopment) were classified according to birth weight ratio (BWR) (SGA <= 0.85, LGA > 1.15, exploring a wide range of other cut-offs) and genotyped for polymorphisms associated with dopamine signaling (TaqIA-A1 allele, DRD2-141C Ins/Ins, DRD4 7-repeat, DAT1-10-repeat, Met/Met-COMT), composing a score based on the described function, in which hypofunctional variants received lower scores. Results There were 251 children (123 girls and 128 boys). Using the classic cut-offs (0.85 and 1.15), there were no statistically significant interactions between the neonatal groups and the dopamine genetic score. However, when changing the cut-offs, it is possible to see ranges of BWR that could be associated with vulnerability to poorer development according to the variation in the dopamine function. Conclusion The classic birth weight cut-offs to define SGA and LGA newborns should be seen with caution, as depending on the outcome in question, the protocols for long-term follow up could be either too inclusive-therefore most costly, or unable to screen true vulnerabilities-and therefore ineffective to establish early interventions and primary prevention.	[Pokhvisneva, Irina; Gaudreau, Helene; O'Donnell, Kieran J.] Univ Toronto, Div Neonatol, Dept Pediat, Toronto, ON, Canada; [O'Donnell, Kieran J.; Meaney, Michael J.; MAVAN Res Teaall] Hosp Sick Children, Toronto, ON, Canada; [Leger, Etienne; Gaudreau, Helene; O'Donnell, Kieran J.; Meaney, Michael J.] Douglas Mental Hlth Univ Inst, McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada; [Bischoff, Adrianne R.; Gaudreau, Helene; Steiner, Meir; Silveira, Patricia P.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Steiner, Meir] Univ Toronto & Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada; [Gaudreau, Helene; Kennedy, James L.; Silveira, Patricia P.] Canadian Inst Adv Res CI FAR, Child & Brain Dev Program, Toronto, ON, Canada; [Gaudreau, Helene; Kennedy, James L.; Silveira, Patricia P.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McMaster University; Canadian Institute for Advanced Research (CIFAR); McGill University	Silveira, PP (corresponding author), Univ Toronto, Div Neonatol, Dept Pediat, Toronto, ON, Canada.	patricia.pelufosilverira@douglas.mcgill.ca	Kennedy, James Lowery/AAZ-6947-2020; O'Donnell, Kieran/ABC-5593-2020; Silveira, Patricia/K-2364-2019; Meaney, Michael/N-5931-2019	Kennedy, James Lowery/0000-0002-8733-3806; Silveira, Patricia/0000-0001-8626-2519; Bischoff, Adrianne R/0000-0001-9218-1301; Leger, Etienne/0000-0001-5452-9266	Canadian Institutes of Health Research (CIHR); JPB Foundation; Sackler Institute	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); JPB Foundation; Sackler Institute	This work was funded by the Canadian Institutes of Health Research (CIHR), the JPB Foundation and the Sackler Institute. These sponsors had no influence on the study design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Bischoff AR wrote the first draft of the manuscript, and although we had financial support from these granting agencies for the project no honorarium, grant, or other form of payment was given to anyone to produce specifically this manuscript.	Abulseoud OA, 2015, PLOS ONE, V10; Altink ME, 2012, WORLD J BIOL PSYCHIA, V13, P293, DOI 10.3109/15622975.2011.595822; Alves MB, 2015, BEHAV BRAIN RES; [Anonymous], 2006, STAT CAN 2006; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bayley N, 1993, BAYLEY SCALES INFANT; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; Bersani G, 2007, J PERINAT MED, V35, P159, DOI 10.1515/JPM.2007.021; Brookes KJ, 2013, GENOMICS, V101, P273, DOI 10.1016/j.ygeno.2013.03.003; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Buschgens CJM, 2009, EUR CHILD ADOLES PSY, V18, P65, DOI 10.1007/s00787-008-0704-x; Cardinal RN, 2004, ANN NY ACAD SCI, V1021, P33, DOI 10.1196/annals.1308.004; Chiavaroli V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104278; Colman I, 2007, BIOL PSYCHIAT, V62, P1265, DOI 10.1016/j.biopsych.2007.05.012; Costello EJ, 2007, ARCH GEN PSYCHIAT, V64, P338, DOI 10.1001/archpsyc.64.3.338; Daraki V, 2017, EUR CHILD ADOLESC PS; Davids E, 2003, BRAIN RES REV, V42, P1, DOI 10.1016/S0165-0173(02)00274-6; Davis C, 2013, PHYSIOL BEHAV, V118, P63, DOI 10.1016/j.physbeh.2013.05.014; ElBaz Mohamed F, 2016, J CHILD NEUROL; Eriksson JG, 2014, ACTA PHYSIOL, V210, P154, DOI 10.1111/apha.12142; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Esteban FJ, 2010, NEUROIMAGE, V53, P1225, DOI 10.1016/j.neuroimage.2010.07.019; Garcia-Garcia M, 2010, EUR J NEUROSCI, V31, P754, DOI 10.1111/j.1460-9568.2010.07102.x; Gasso P, 2015, J AFFECT DISORDERS, V186, P284, DOI 10.1016/j.jad.2015.07.035; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goel N, 2012, PLOS ONE, V7; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Herva A, 2008, PSYCHIAT RES, V160, P263, DOI 10.1016/j.psychres.2007.07.020; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hultman CM, 1997, BRIT J PSYCHIAT, V170, P128, DOI 10.1192/bjp.170.2.128; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kadesjo B, 1999, J AM ACAD CHILD PSY, V38, P820, DOI 10.1097/00004583-199907000-00011; Kordas K, 2011, J PEDIATR-US, V159, P638, DOI 10.1016/j.jpeds.2011.03.043; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lahti M, 2015, PSYCHOL MED, V45, P985, DOI 10.1017/S0033291714001998; Leitner Y, 2000, J CHILD NEUROL, V15, P781, DOI 10.1177/088307380001501202; Levine TA, 2015, PEDIATRICS, V135, P126, DOI 10.1542/peds.2014-1143; Maitra S, 2014, CELL MOL NEUROBIOL, V34, P549, DOI 10.1007/s10571-014-0038-9; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Molle RD, 2017, NEUROSCI BIOBEHAV R, V73, P326, DOI 10.1016/j.neubiorev.2016.12.028; Molle RD, 2015, BRAIN RES, V1618, P41, DOI 10.1016/j.brainres.2015.05.019; Moore GS, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.044; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; O'Donnell KA, 2014, CAN J PSYCHIAT, V59, P497, DOI 10.1177/070674371405900906; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Qian Y, 2013, GENES BRAIN BEHAV, V12, P604, DOI 10.1111/gbb.12062; R CT, 2014, R LANG ENV STAT COMP; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; Rowe DC, 1997, PERS INDIV DIFFER, V23, P105, DOI 10.1016/S0191-8869(97)00005-6; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; Silveira P. P., 2016, JAMA PEDIAT; Silveira PP, 2007, J PEDIAT, V83, P494, DOI [10.2223/JPED.1728, 10.1590/S0021-75572007000800004]; Stice E, 2012, J NEUROSCI, V32, P10093, DOI 10.1523/JNEUROSCI.1506-12.2012; Szekely A, 2011, GENES BRAIN BEHAV, V10, P129, DOI 10.1111/j.1601-183X.2010.00645.x; Tovo-Rodrigues L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085164; vanderReijdenLakeman IEA, 1997, J CLIN EXP NEUROPSYC, V19, P101, DOI 10.1080/01688639708403840; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Vucetic Z, 2010, NEUROSCIENCE, V168, P359, DOI 10.1016/j.neuroscience.2010.04.010; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; YOUNG AB, 1984, NEUROL CLIN, V2, P417, DOI 10.1016/S0733-8619(18)31082-X; Yue JK, 2016, NEUROGENETICS; Zhang S, 2014, CREATIVITY RES J, V26, P115, DOI 10.1080/10400419.2014.874267	68	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177344	10.1371/journal.pone.0177344	http://dx.doi.org/10.1371/journal.pone.0177344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505190	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500018
J	Ho, YR; Wang, P; Lu, MC; Tseng, ST; Yang, CP; Yan, YH				Ho, Yi-Ran; Wang, Panchalli; Lu, Mei-Chun; Tseng, Shih-Ting; Yang, Chun-Pai; Yan, Yuan-Horng			Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women	PLOS ONE			English	Article							SCREENING-TEST; GLYCATED HEMOGLOBIN; GLYCOSYLATED HEMOGLOBIN; CARDIOVASCULAR-DISEASE; NONDIABETIC ADULTS; MELLITUS; DIAGNOSIS; A1C; PREDICTION; HBA(1C)	Background The objective of this study was to investigate the associations among the mid-pregnancy glycated hemoglobin A1c (HbA1c) level, gestational diabetes (GDM), and risk of adverse pregnancy outcomes in women without overt diabetes and with positive 50-g, 1-h glucose challenge test (GCT) results (140 mg/dL or greater). Methods This prospective study enrolled 1,989 pregnant Taiwanese women. A two-step approach, including a 50-g, 1-h GCT and 100-g, 3-h oral glucose tolerance test (OGTT), was employed for the diagnosis of GDM at weeks 23-32. The mid-pregnancy HbA1c level was measured at the time the OGTT was performed. A receiver operating characteristic (ROC) curve was used to determine the relationship between the mid-pregnancy HbA1c level and GDM. Multiple logistic regression models were implemented to assess the relationships between the mid-pregnancy HbA1c level and adverse pregnancy outcomes. Results An ROC curve demonstrated that the optimal mid-pregnancy HbA1c cut-off point to predict GDM, as diagnosed by the Carpenter-Coustan criteria using a two-step approach, was 5.7%. The area under the ROC curve of the mid-pregnancy HbA1c level for GDM was 0.70. Compared with the levels of 4.5-4.9%, higher mid-pregnancy HbA1c levels (5.0-5.4, 5.5-5.9, 6.0-6.4, 6.5-6.9, and > 7.0%) were significantly associated with increased risks of gestational hypertension or preeclampsia, preterm delivery, admission to the neonatal intensive care unit, low birth weight, and macrosomia (the odds ratio [OR] ranges were 1.20-9.98, 1.31-5.16, 0.88-3.15, 0.89-4.10, and 2.22-27.86, respectively). Conclusions The mid-pregnancy HbA1c level was associated with various adverse pregnancy outcomes in high-risk Taiwanese women. However, it lacked adequate sensitivity and specificity to replace the two-step approach in the diagnosis of GDM. The current study comprised a single-center prospective study; thus, additional, randomized control design studies are required.	[Ho, Yi-Ran; Tseng, Shih-Ting] Kuang Tien Gen Hosp, Dept Endocrinol & Metab, Taichung, Taiwan; [Wang, Panchalli] Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Obstet & Gynecol, Chiayi, Taiwan; [Lu, Mei-Chun; Yang, Chun-Pai; Yan, Yuan-Horng] Kuang Tien Gen Hosp, Dept Med Res, Taichung, Taiwan; [Tseng, Shih-Ting] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Yang, Chun-Pai] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan; [Yang, Chun-Pai; Yan, Yuan-Horng] Hung Kuang Univ, Dept Nutr, Taichung, Taiwan; [Yang, Chun-Pai; Yan, Yuan-Horng] Hung Kuang Univ, Inst Biomed Nutr, Taichung, Taiwan; [Yan, Yuan-Horng] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan	Providence University - Taiwan; Hungkuang University; Hungkuang University; National Taiwan University	Yang, CP; Yan, YH (corresponding author), Kuang Tien Gen Hosp, Dept Med Res, Taichung, Taiwan.; Yang, CP (corresponding author), Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan.; Yang, CP; Yan, YH (corresponding author), Hung Kuang Univ, Dept Nutr, Taichung, Taiwan.; Yang, CP; Yan, YH (corresponding author), Hung Kuang Univ, Inst Biomed Nutr, Taichung, Taiwan.; Yan, YH (corresponding author), Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan.	neuralyung@gmail.com; d97841006@ntu.edu.tw						Agarwal MM, 2005, ACTA OBSTET GYN SCAN, V84, P1159, DOI 10.1111/j.0001-6349.2005.00650.x; Aggarwal V, 2012, DIABETES CARE, V35, P2055, DOI 10.2337/dc11-2531; Anaka O, 2014, OBSTET GYNECOL, V123, p38S, DOI 10.1097/01.AOG.0000447315.90086.64; ARTAL R, 1984, AM J OBSTET GYNECOL, V148, P412, DOI 10.1016/0002-9378(84)90717-8; Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Chamnan P, 2013, DIABETOLOGIA, V56, P1004, DOI 10.1007/s00125-013-2854-8; Claesson R, 2017, PRIM CARE DIABETES, V11, P46, DOI 10.1016/j.pcd.2016.09.002; COUSINS L, 1984, AM J OBSTET GYNECOL, V150, P455, DOI 10.1016/S0002-9378(84)90420-4; Di Angelantonio E, 2014, JAMA-J AM MED ASSOC, V311, P1225, DOI 10.1001/jama.2014.1873; Garner LA, 2014, OBSTET GYNECOL, V123, p52S, DOI 10.1097/01.AOG.0000447343.89639.52; Hughes RCE, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0698-y; Hughes RCE, 2014, DIABETES CARE, V37, P2953, DOI 10.2337/dc14-1312; Kwon SS, 2015, DIABETES RES CLIN PR, V110, P38, DOI 10.1016/j.diabres.2015.07.014; Lowe LP, 2012, DIABETES CARE, V35, P574, DOI 10.2337/dc11-1687; MCFARLAND KF, 1984, OBSTET GYNECOL, V64, P516; Moses RG, 2012, DIABETES RES CLIN PR, V98, P3, DOI 10.1016/j.diabres.2012.05.016; Odsaeter IH, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0168-y; Odsaeter IH, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0039-9; Osmundson SS, 2016, AM J PERINAT, V33, P977, DOI 10.1055/s-0036-1581055; PHELPS RL, 1983, AM J OBSTET GYNECOL, V147, P651, DOI 10.1016/0002-9378(83)90443-X; Rajput R, 2012, DIABETES RES CLIN PR, V98, P104, DOI 10.1016/j.diabres.2012.02.018; Renz PB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135989; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Silbernagel G, 2011, DIABETES CARE, V34, P1355, DOI 10.2337/dc10-2010; Soumya S, 2015, DIABETES TECHNOL THE, V17, P899, DOI 10.1089/dia.2015.0041; Ye M, 2016, DIABETES RES CLIN PR, V114, P43, DOI 10.1016/j.diabres.2016.02.007	27	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177563	10.1371/journal.pone.0177563	http://dx.doi.org/10.1371/journal.pone.0177563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505205	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500029
J	Mckay, J; Tenet, V; Franceschi, S; Chabrier, A; Gheit, T; Gaborieau, V; Chopin, S; Avogbel, PH; Tommasinol, M; Ainouze, M; Hasan, U; Vaccarella, S				Mckay, James; Tenet, Vanessa; Franceschi, Silvia; Chabrier, Amelie; Gheit, Tarik; Gaborieau, Valerie; Chopin, Sandrine; Avogbel, Patrice H.; Tommasinol, Massimo; Ainouze, Michelle; Hasan, Uzma; Vaccarella, Salvatore			Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN-PAPILLOMAVIRUS; SUSCEPTIBILITY LOCI; EXPRESSION; RECEPTOR; CARCINOMA; VARIANT; NKG2D	A small proportion of women who are exposed to infection with human-papillomavirus (HPV) develop cervical cancer (CC). Genetic factors may affect the risk of progression from HPV infection to cervical precancer and cancer. We used samples from the International Agency for Research on Cancer (IARC) multicentric case-control study to evaluate the association of selected genetic variants with CC. Overall, 790 CC cases and 717 controls from Algeria, Morocco, India and Thailand were included. Cervical exfoliated cells were obtained from control women and cervical exfoliated cells or biopsy specimens from cases. HPV-positivity was determined using a general primer GP5+/6+ mediated PCR. Unconditional logistic regression was used to estimate odds ratios (OR) and corresponding 95% confidence intervals (CI) of host genotypes with CC risk, using the homozygous wild type genotype as the referent category and adjusting by age and study centre. The association of polymorphisms with the risk of high-risk HPV-positivity among controls was also evaluated. A statistically significant association was observed between single nucleotide polymorphism (SNP) CHR6 rs2844511 and CC risk: the OR for carriers of the GA or GG genotypes was 0.70 (95% CI: 0.43-1.14) and 0.61 (95% CI: 0.38-0.98), respectively, relative to carriers of AA genotype (p-value for trend 0.03). We also observed associations of borderline significance with the TIPARP rs2665390 polymorphism, which was previously found to be associated with ovarian and breast cancer, and with the EXOC1 rs13117307 polymorphism, which has been linked to cervical cancer in a large study in a Chinese population. We confirmed the association between CC and the rs2844511 polymorphism previously identified in a GWAS study in a Swedish population. The major histocompatibility region of chromosome 6, or perhaps other SNPs in linkage disequilibrium, may be involved in CC onset.	[Mckay, James; Tenet, Vanessa; Franceschi, Silvia; Chabrier, Amelie; Gheit, Tarik; Gaborieau, Valerie; Chopin, Sandrine; Avogbel, Patrice H.; Tommasinol, Massimo; Vaccarella, Salvatore] Int Agcy Res Canc, Lyon, France; [Ainouze, Michelle; Hasan, Uzma] CIRI, Lyon, France; [Ainouze, Michelle; Hasan, Uzma] INSERM, U1111, Lyon, France; [Ainouze, Michelle; Hasan, Uzma] Ecole Normale Super Lyon, Lyon, France; [Ainouze, Michelle; Hasan, Uzma] Univ Lyon 1, Lyon, France; [Ainouze, Michelle; Hasan, Uzma] CNRS, UMR5308, Lyon, France; [Ainouze, Michelle; Hasan, Uzma] Hosp Civils Lyon, Lab Immunol, Ctr Hosp Lyon Sud, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon	Vaccarella, S (corresponding author), Int Agcy Res Canc, Lyon, France.	vaccarella@iarc.fr	AVOGBE, Patrice Hodonou/AHD-7498-2022; franceschi, silvia/M-2452-2014	AVOGBE, Patrice Hodonou/0000-0003-4436-3981; franceschi, silvia/0000-0003-4181-8071; Hasan, Uzma/0000-0002-1770-5539; Vaccarella, Salvatore/0000-0002-2516-2167; Tommasino, Massimo/0000-0002-0890-8596	Institut National du Cancer [INCa CF R251111 PAIRSEIN]; La Ligue contre le Cancer [LNCC Loire R10162CC]	Institut National du Cancer(Institut National du Cancer (INCA) France); La Ligue contre le Cancer(Ligue nationale contre le cancer)	Support was provided to UH by the Institut National du Cancer [www.e-cancer.fr] (Grant number: INCa CF R251111 PAIRSEIN) and to SV by La Ligue contre le Cancer [www.ligue-cancer.net] (Grant number: LNCC Loire R10162CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby P, 2006, INT J CANCER, V119, P1108, DOI 10.1002/ijc.21953; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt;546::AID-IJC9&gt;3.0.CO;2-T; Chen D, 2014, CANCER MED-US, V3, P190, DOI 10.1002/cam4.183; Chen D, 2013, JNCI-J NATL CANCER I, V105, P624, DOI 10.1093/jnci/djt051; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Daud II, 2011, INT J CANCER, V128, P879, DOI 10.1002/ijc.25400; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; DeCarlo CA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/785825; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350; Gheit T, 2009, VACCINE, V27, P636, DOI 10.1016/j.vaccine.2008.11.041; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hammouda D, 2005, INT J CANCER, V113, P483, DOI 10.1002/ijc.20600; Hasan U, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27257; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hasan UA, 2013, J EXP MED, V210, P1369, DOI 10.1084/jem.20122394; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; International Collaboration of Epidemiological Studies of Cervical Cancer, 2006, Int J Cancer, V118, P1481, DOI 10.1002/ijc.21493; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; JACOBS MV, 1995, J CLIN MICROBIOL, V33, P901, DOI 10.1128/JCM.33.4.901-905.1995; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Safaeian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033619; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Shi TY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-19; Shi YY, 2013, NAT GENET, V45, P918, DOI 10.1038/ng.2687; Vaccarella S, 2014, BRIT J CANCER, V111, P965, DOI 10.1038/bjc.2014.362; Vaccarella S, 2016, LANCET ONCOL, V17, P1445, DOI 10.1016/S1470-2045(16)30275-3; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; Yu L, 2010, CANCER IMMUNOL IMMUN, V59, P1021, DOI 10.1007/s00262-010-0825-1	33	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177775	10.1371/journal.pone.0177775	http://dx.doi.org/10.1371/journal.pone.0177775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505207	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500044
J	Smith-Strom, H; Iversen, MM; Igland, J; Ostbye, T; Graue, M; Skeie, S; Wu, B; Rokne, B				Smith-Strom, Hilde; Iversen, Marjolein M.; Igland, Jannicke; Ostbye, Truls; Graue, Marit; Skeie, Svein; Wu, Bei; Rokne, Berit			Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: A retrospective cohort study	PLOS ONE			English	Article							AMPUTATION; DISEASE; CLASSIFICATION; EURODIALE; RISK; ASSOCIATION; INFECTION; ISCHEMIA; EUROPE; RATES	Objectives To investigate whether A) duration of ulcer before start of treatment in specialist health care, and B) severity of ulcer according to University of Texas classification system (UT) at start of treatment (baseline), are independent predictors of healing time. Methods This retrospective cohort study, based on electronic medical record data, included 105 patients from two outpatient clinics in Western Norway with a new diabetic foot ulcer during 2009-2011. The associations of duration of ulcer and ulcer severity with healing time were assessed using cumulative incidence curves and subdistribution hazard ratio estimated using competing risk regression with adjustment for potential confounders. Results Of the 105 participants, 45.7% achieved ulcer healing, 36.2% underwent amputations, 9.5% died before ulcer healing and 8.5% were lost to follow-up. Patients who were referred to specialist health care by a general practitioner >= 52 days after ulcer onset had a 58% (SHR 0.42, CI 0.18-0.98) decreased healing rate compared to patients who were referred earlier, in the adjusted model. High severity (grade 2/3, stage C/D) according to the UT classification system was associated with a decreased healing rate compared to low severity (grade1, stage A/B or grade 2, stage A) with SHR (95% CI) equal to 0.14 (0.05-0.43) after adjustment for referral time and other potential confounders. Conclusion Early detection and referral by both the patient and general practitioner are crucial for optimal foot ulcer healing. Ulcer grade and severity are also important predictors for healing time, and early screening to assess the severity and initiation of prompt treatment is important.	[Smith-Strom, Hilde; Iversen, Marjolein M.; Igland, Jannicke; Graue, Marit; Rokne, Berit] Western Norway Univ Appl Sci, Ctr Evidence Based Practice, Dept Hlth & Social Sci, Bergen, Norway; [Smith-Strom, Hilde; Igland, Jannicke] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Iversen, Marjolein M.] Stavanger Univ Hosp, Dept Med, Sect Endocrinol, Stavanger, Norway; [Ostbye, Truls] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Skeie, Svein] Stavanger Univ Hosp, Dept Res, Stavanger, Norway; [Wu, Bei] Duke Univ, Duke Sch Nursing, Durham, NC USA; [Wu, Bei] NYU, Rory Meyers Coll Nursing, New York, NY USA	Western Norway University of Applied Sciences; University of Bergen; Stavanger University Hospital; Duke University; Stavanger University Hospital; Duke University; New York University	Smith-Strom, H (corresponding author), Western Norway Univ Appl Sci, Ctr Evidence Based Practice, Dept Hlth & Social Sci, Bergen, Norway.; Smith-Strom, H (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	hss@hvl.no	Wu, Bei/X-2404-2019	Wu, Bei/0000-0002-6891-244X; Iversen, Marjolein Memelink/0000-0001-9954-171X	Norwegian Research Council [221065]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported from the Norwegian Research Council, project number 221065. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Brownrigg JRW, 2013, EUR J VASC ENDOVASC, V45, P673, DOI 10.1016/j.ejvs.2013.02.014; Bus S, 2015, DIABETES METABOLISM; Clincal Audit and Registries Management Service, 2016, NAT DIAB FOOT CAR AU; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Game F, 2016, DIABETES-METAB RES, V32, P186, DOI 10.1002/dmrr.2746; Graue M, 2013, SCAND J PRIM HEALTH, V31, P241, DOI 10.3109/02813432.2013.854445; Ince P, 2007, DIABETES CARE, V30, P660, DOI 10.2337/dc06-2043; Lau B., 2009, AM J EPIDEMIOL; Lavery LA, 1997, DIABETIC MED, V14, P46, DOI 10.1002/(SICI)1096-9136(199701)14:1<46::AID-DIA291>3.0.CO;2-T; Margolis DJ, 2002, DIABETES CARE, V25, P1835, DOI 10.2337/diacare.25.10.1835; Ministry of Health and Care Services, 2015, PRIM HLTH CAR SERV T; Monteiro-Soares M, 2012, DIABETES-METAB RES, V28, P574, DOI 10.1002/dmrr.2319; Monteiro-Soares M, 2011, DIABETOLOGIA, V54, P1190, DOI 10.1007/s00125-010-2030-3; National Institute for Health and Care Excellence (NICE), 2019, DIABETIC FOOT PROBLE; Orneholm H, 2015, WOUND REPAIR REGEN, V23, P922, DOI 10.1111/wrr.12328; Oyibo SO, 2001, DIABETES CARE, V24, P84, DOI 10.2337/diacare.24.1.84; Prompers L, 2008, DIABETIC MED, V25, P700, DOI 10.1111/j.1464-5491.2008.02445.x; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Rayman G, 2004, DIABETES CARE, V27, P1892, DOI 10.2337/diacare.27.8.1892; Sanders AP, 2013, DIABETES RES CLIN PR, V102, P105, DOI 10.1016/j.diabres.2013.09.016; van Battum P, 2011, DIABETIC MED, V28, P199, DOI 10.1111/j.1464-5491.2010.03192.x	26	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177176	10.1371/journal.pone.0177176	http://dx.doi.org/10.1371/journal.pone.0177176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498862	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500011
J	Kobayashi, M; Usui-Kawanishi, F; Karasawa, T; Kimura, H; Watanabe, S; Mise, N; Kayama, F; Kasahara, T; Hasebe, N; Takahashi, M				Kobayashi, Motoi; Usui-Kawanishi, Fumitake; Karasawa, Tadayoshi; Kimura, Hiroaki; Watanabe, Sachiko; Mise, Nathan; Kayama, Fujio; Kasahara, Tadashi; Hasebe, Naoyuki; Takahashi, Masafumi			The cardiac glycoside ouabain activates NLRP3 inflammasomes and promotes cardiac inflammation and dysfunction	PLOS ONE			English	Article							MICE DEFICIENT; DIGOXIN; INJURY; INHIBITION; MORTALITY; APOPTOSIS; PROTEIN; ATPASE	Cardiac glycosides such as digoxin are Na+/K+ -ATPase inhibitors that are widely used for the treatment of chronic heart failure and cardiac arrhythmias; however, recent epidemiological studies have suggested a relationship between digoxin treatment and increased mortality. We previously showed that nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasomes, which regulate caspase-1-dependent interleukin (IL)-1 beta release, mediate the sterile cardiovascular inflammation. Because the Na+/K+ -ATPase is involved in inflammatory responses, we investigated the role of NLRP3 inflammasomes in the pathophysiology of cardiac glycoside-induced cardiac inflammation and dysfunction. The cardiac glycoside ouabain induced cardiac dysfunction and injury in wild-type mice primed with a low dose of lipopolysaccharide (LPS), although no cardiac dysfunction was observed in mice treated with either ouabain or LPS alone. Ouabain also induced cardiac inflammatory responses, such as macrophage infiltration and IL-d1 beta release, when mice were primed with LPS. These cardiac manifestations were all significantly attenuated in mice deficient in IL-1 beta. Furthermore, deficiency of NLRP3 inflammasome components, NLRP3 and caspase-1, also attenuated ouabain-induced cardiac dysfunction and inflammation. In vitro experiments revealed that ouabain induced NLRP3 inflammasome activation as well as subsequent IL-1 beta release from macrophages, and this activation was mediated by K+ efflux. Our findings demonstrate that cardiac glycosides promote cardiac inflammation and dysfunction through NLRP3 inflammasomes and provide new insights into the mechanisms underlying the adverse effects of cardiac glycosides.	[Kobayashi, Motoi; Usui-Kawanishi, Fumitake; Karasawa, Tadayoshi; Kimura, Hiroaki; Watanabe, Sachiko; Kasahara, Tadashi; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan; [Mise, Nathan; Kayama, Fujio] Jichi Med Univ, Dept Environm & Prevent Med, Shimotsuke, Tochigi, Japan; [Hasebe, Naoyuki] Asahikawa Med Univ, Dept Med, Div Cardiovasc Resp & Neurol, Asahikawa, Hokkaido, Japan	Jichi Medical University; Jichi Medical University; Asahikawa Medical College	Takahashi, M (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan.	masafumi2@jichi.ac.jp	Watanabe, Sachiko/GRE-6723-2022; 名丹, 三瀬/AAD-1036-2021; sachiko, watanabe/AAM-8862-2021; Kimura, Hiroaki/E-3224-2010	Watanabe, Sachiko/0000-0002-6110-9603; sachiko, watanabe/0000-0002-6110-9603; Kimura, Hiroaki/0000-0002-7441-0382; Takahashi, Masafumi/0000-0003-2716-7532; Karasawa, Tadayoshi/0000-0002-6738-2360	Japan Society for the Promotion of Science (JSPS) [15K09146]; MEXT-supported program for the Strategic Foundation at Private Universities [S1311029]; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) [16gm0610012h0103]; Salt Science Research Foundation [1541]; Grants-in-Aid for Scientific Research [16K19544] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-supported program for the Strategic Foundation at Private Universities; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) through the Grant-in-Aid for Scientific Research (MT:15K09146), MEXT-supported program for the Strategic Foundation at Private Universities (MT:S1311029), Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (MT:16gm0610012h0103), and the Salt Science Research Foundation (MT:No.1541).; We are grateful to Masako Sakurai, Naoko Sugaya, and Namiko Nakada for technical assistance, Dr. Yoichiro Iwakura (Tokyo University of Science), Dr. Hiroko Tsutui (Hyogo College of Medicine), and Dr. Vishava M. Dixit (Genentech) for providing the IL -1 beta<SUP>-/-</SUP>, NLRP3<SUP>-/-</SUP>, and Casp1<SUP>-/-</SUP> mice, respectively. This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) through the Grant-in-Aid for Scientific Research (MT:15K09146), MEXT-supported program for the Strategic Foundation at Private Universities (MT:S1311029), Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (MT:16gm0610012h0103), and the Salt Science Research Foundation (MT:No.1541).	Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kobayashi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26489; Komada T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10901; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu LJ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00382; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Orellana AM, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00010; Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Usui F, 2015, ARTERIOSCL THROM VAS, V35, P127, DOI 10.1161/ATVBAHA.114.303763; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; Washam JB, 2015, LANCET, V385, P2363, DOI 10.1016/S0140-6736(14)61836-5; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Zhang T, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0254-8; Ziff OJ, 2016, TRENDS CARDIOVAS MED, V26, P585, DOI 10.1016/j.tcm.2016.03.011	22	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176676	10.1371/journal.pone.0176676	http://dx.doi.org/10.1371/journal.pone.0176676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493895	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300024
J	Madariaga-Venegas, F; Fernandez-Soto, R; Duarte, LF; Suarez, N; Delgadillo, D; Jara, JA; Fernandez-Ramires, R; Urzua, B; Molina-Berrios, A				Madariaga-Venegas, Francisco; Fernandez-Soto, Roberto; Fernanda Duarte, Luisa; Suarez, Nicole; Delgadillo, Daniela; Jara, Jose A.; Fernandez-Ramires, Ricardo; Urzua, Blanca; Molina-Berrios, Alfredo			Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BIOFILM FORMATION; ANTIFUNGAL SUSCEPTIBILITY; FLUCONAZOLE; EPIDEMIOLOGY; INHIBITORS; EFFICACY	Candida albicans biofilms play a key role in denture stomatitis, one of the most common oral pathologies in elderly people. Because biofilms are highly resistant to antifungals, new pharmacological strategies are needed. Aspirin and nitric oxide-donor molecules have both shown antibiofilm effects on C. albicans, making them promising candidates for treatment. In this study, we evaluated the antifungal/antibiofilm effect of a nitric-oxide releasing aspirin (NO-ASA) on C. albicans isolates from denture stomatitis patients in vitro. Disk diffusion assays showed that while NO-ASA had no antifungal effect, the drug potentiated fluconazole inhibition zone diameters, increasing the effect of fluconazole by 20-30% (p<0.05). The effect of NO-ASA on the morphogenesis of C. albicans was evaluated using light microscopy after inducing hyphae formation. For all clinical strains assayed, 125 mu M NO-ASA significantly decreased the number of filamentous cells present (p<0.01). Adhesion to abiotic surfaces, a critical event for biofilm formation, was evaluated in 96-well polystyrene plates using crystal violet assay; 125 mu M NO-ASA significantly inhibited adhesion. Biofilms were observed with scanning electron microscopy (SEM) and quantified using XTT reduction assay. NO-ASA decreased biofilm formation (IC50 ranging from 300 mu M to 700 mu M), consistent with SEM findings of altered biofilm microarchitecture. PGE(2) and carboxy-PTIO ( an NO scavenger) both blocked the antibiofilm effects of NO-ASA, suggesting that the efficacy of NO-ASA may be associated with both inhibition of PGE(2) synthesis and release of NO. NO-ASA is a promising novel antibiofilm agent for treating fluconazole-resistant strains of C. albicans.	[Madariaga-Venegas, Francisco; Fernandez-Soto, Roberto; Fernanda Duarte, Luisa; Suarez, Nicole; Delgadillo, Daniela; Jara, Jose A.; Urzua, Blanca; Molina-Berrios, Alfredo] Univ Chile, Inst Res Dent Sci, Fac Dent, Santiago, Chile; [Fernandez-Ramires, Ricardo] Univ Chile, Dept Pathol & Oral Med, Fac Dent, Santiago, Chile	Universidad de Chile; Universidad de Chile	Molina-Berrios, A (corresponding author), Univ Chile, Inst Res Dent Sci, Fac Dent, Santiago, Chile.	aemolina@u.uchile.cl	Jara, Jose/GQB-5331-2022; Fernández-Ramires, Ricardo/H-3707-2014; Orellana, Blanca Urzúa/K-1856-2014	Orellana, Blanca Urzúa/0000-0003-2443-2580; Duarte Penaloza, Luisa Fernanda/0000-0003-1828-1800; Fernandez-Ramires, Ricardo/0000-0002-6974-2593; Molina-Berrios, Alfredo/0000-0001-8351-3239	Fondo Nacional de Desarrollo Cientffico y Tecnologico, proyecto FONDECYT [11140227]; Vicerrectoria de Investigacion y Desarrollo (VID); Universidad de Chile; project U-INICIA [2014-82383]; project U-redes [URED-2014-007]	Fondo Nacional de Desarrollo Cientffico y Tecnologico, proyecto FONDECYT; Vicerrectoria de Investigacion y Desarrollo (VID); Universidad de Chile; project U-INICIA; project U-redes	This work was supported by Fondo Nacional de Desarrollo Cientffico y Tecnologico, proyecto FONDECYT (grant number 11140227, AMB) (http://www.conicyt.cl/fondecyt/); Vicerrectoria de Investigacion y Desarrollo (VID), Universidad de Chile, project U-INICIA (grant number 2014-82383, AMB) (http://www.uchile.cl/porta/investgacion/5077/presentaci or); and Vicerrectoria de Investigacion y Desarrollo (VID), Universidad de Chile, project U-redes (grant number URED-2014-007, AMB, RFR, JAJ, BU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdelmegeed E, 2013, J MICROBIOL, V51, P598, DOI 10.1007/s12275-013-3052-6; Al-Bakri AG, 2009, J APPL MICROBIOL, V107, P280, DOI 10.1111/j.1365-2672.2009.04205.x; Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0; Alem MAS, 2004, ANTIMICROB AGENTS CH, V48, P41, DOI 10.1128/AAC.48.1.41-47.2004; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Bonilla Rodriguez Y., 2012, REV ODONTOL MEX, V16, P40; Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8; Dar-Odeh N.S., 2012, INT ARABIC J ANTIMIC, V2, DOI DOI 10.3823/705; de Quadros AU, 2011, FOLIA MICROBIOL, V56, P349, DOI 10.1007/s12223-011-0049-6; Ells R, 2011, MED MICROBIOL IMMUN, V200, P23, DOI 10.1007/s00430-010-0169-7; Figueiral MH, 2015, OPEN DENT J, V9, P46, DOI 10.2174/1874210601509010046; Finkel J.S., 2011, MICROBIOLOGY, V9, P109, DOI DOI 10.1038/NRMICR02475; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Gleiznys Alvydas, 2015, Stomatologija, V17, P54; Heilman BJ, 2013, J INORG BIOCHEM, V123, P18, DOI 10.1016/j.jinorgbio.2013.02.003; Jardeleza C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092117; Konopka K, 2010, ANTON LEEUW INT J G, V97, P413, DOI 10.1007/s10482-010-9417-5; Lee X, 2013, INT J ODONTOSTOMATOL, V7, P279; Macherla C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00193; Mishra NN, 2014, BRAZ J INFECT DIS, V18, P287, DOI 10.1016/j.bjid.2013.09.006; Mitchell KF, 2013, ANTIMICROB AGENTS CH, V57, P1918, DOI 10.1128/AAC.02378-12; National Comittee for Clinical Laboratory Standards, 2009, M44A2 NCCLS; Neidrauer M, 2014, J MED MICROBIOL, V63, P203, DOI 10.1099/jmm.0.067322-0; Nett JE, 2014, EXPERT REV ANTI-INFE, V12, P375, DOI 10.1586/14787210.2014.885838; Oliveira MT, 2010, MICRON, V41, P604, DOI 10.1016/j.micron.2010.03.011; Sardi JDO, 2014, REV IBEROAM MICOL, V31, P22, DOI 10.1016/j.riam.2013.09.014; Pereira CA, 2016, DIAGN MICR INFEC DIS, V85, P66, DOI 10.1016/j.diagmicrobio.2016.01.014; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Privett BJ, 2010, BIOFOULING, V26, P973, DOI 10.1080/08927014.2010.534552; Redding S, 2009, ORAL SURG ORAL MED O, V107, P669, DOI 10.1016/j.tripleo.2009.01.021; Rosato A, 2016, BIOORGAN MED CHEM, V24, P1002, DOI 10.1016/j.bmc.2016.01.026; Sanchez-Vargas LO, 2013, ARCH ORAL BIOL, V58, P1318, DOI 10.1016/j.archoralbio.2013.06.006; Sanita PV, 2013, OR SURG OR MED OR PA, V116, P562, DOI 10.1016/j.oooo.2013.07.002; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Staniszewska M, 2013, BRAZ J MICROBIOL, V44, P813, DOI 10.1590/S1517-83822013005000056; Tobudic S, 2012, MYCOSES, V55, P199, DOI 10.1111/j.1439-0507.2011.02076.x; Turnbull CM, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-12; Wallace JL, 2002, NAT REV DRUG DISCOV, V1, P375, DOI 10.1038/nrd794; Walraven CJ, 2014, MED MYCOL, V52, P131, DOI 10.1093/mmy/myt007; Yarborough A, 2016, J PROSTHODONT, V25, P288, DOI 10.1111/jopr.12454	40	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176755	10.1371/journal.pone.0176755	http://dx.doi.org/10.1371/journal.pone.0176755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493889	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300031
J	Bhattarai, G; Mehlenbacher, SA				Bhattarai, Gehendra; Mehlenbacher, Shawn A.			In silico development and characterization of tri-nucleotide simple sequence repeat markers in hazelnut (Corylus avellana L.)	PLOS ONE			English	Article							FILBERT BLIGHT RESISTANCE; GENETIC-LINKAGE MAP; MICROSATELLITE MARKERS; TRANSCRIPTOME SEQUENCES; GENOTYPING APPLICATIONS; NULL ALLELES; SSR-MARKERS; TRANSFERABILITY; LOCI; GENOME	Plant genomes are now sequenced rapidly and inexpensively. In silico approaches allow efficient development of simple sequence repeat markers, also known as microsatellite markers, from these sequences. A search of the genome sequence of 'Jefferson' hazelnut (Corylus avellana L.) identified 8,708 tri-nucleotide simple sequence repeats with at least five repeat units, and stepwise removal of the less promising sequences led to the development of 150 polymorphic markers. Fragments in the 'Jefferson' sequence containing trinucleotide repeats were used as references and aligned with genomic sequences from seven other cultivars. Following in silico alignment, sequences that showed variation in number of repeat units were selected and primer pairs were designed for 243 of them. Screening on agarose gels identified 173 as polymorphic. Removal of duplicate and previously published sequences reduced the number to 150, for which fluorescent primers and capillary electrophoresis were used for amplicon sizing. These were characterized using 50 diverse hazelnut accessions. Of the 150, 132 generated the expected one or two alleles per accession while 18 amplified more than two amplicons in at least one accession. Diversity parameters of the 132 marker loci averaged 4.73 for number of alleles, 0.51 for expected heterozygosity (H-e), 0.49 for observed heterozygosity (H-o), 0.46 for polymorphism information content (PIC), and 0.04 for frequency of null alleles. The clustering of the 50 accessions in a dendrogram constructed from the 150 markers confirmed the wide genetic diversity and presence of three of the four major geographic groups: Central European, Black Sea, and Spanish-Italian. In the mapping population, 105 loci segregated, of which 101 were assigned to a linkage group (LG), with positions well-dispersed across all 11 LGs. These new markers will be useful for cultivar fingerprinting, diversity studies, genome comparisons, mapping, and alignment of the linkage map with the genome sequence and physical map.	[Bhattarai, Gehendra; Mehlenbacher, Shawn A.] Oregon State Univ, Dept Hort, 4017 ALS Bldg, Corvallis, OR 97331 USA	Oregon State University	Mehlenbacher, SA (corresponding author), Oregon State Univ, Dept Hort, 4017 ALS Bldg, Corvallis, OR 97331 USA.	shawn.mehlenbacher@oregonstate.edu	Bhattarai, Gehendra/ABE-4356-2020; Bhattarai, Gehendra/N-2851-2019	Bhattarai, Gehendra/0000-0002-2381-1629; Bhattarai, Gehendra/0000-0002-2381-1629	Oregon Hazelnut Commission; Oregon Agricultural Experiment Station; U.S. Department of Agriculture, Specific Cooperative Agreement; USDA-NIFA Agriculture and Food Research Initiative Competitive [2014-67013-22421]	Oregon Hazelnut Commission; Oregon Agricultural Experiment Station; U.S. Department of Agriculture, Specific Cooperative Agreement; USDA-NIFA Agriculture and Food Research Initiative Competitive	This work was supported by Oregon Hazelnut Commission to SM; Oregon Agricultural Experiment Station to SM; U.S. Department of Agriculture, Specific Cooperative Agreement to SM and the USDA-NIFA Agriculture and Food Research Initiative Competitive Grant 2014-67013-22421 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Bassil NV, 2005, ACTA HORTIC, P105, DOI 10.17660/ActaHortic.2005.686.13; Bassil NV, 2005, J AM SOC HORTIC SCI, V130, P543, DOI 10.21273/JASHS.130.4.543; Beltramo C, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0450-6; Boccacci P, 2006, GENOME, V49, P598, DOI 10.1139/G06-017; Boccacci P, 2005, MOL ECOL NOTES, V5, P934, DOI 10.1111/j.1471-8286.2005.01121.x; Boccacci P, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0195-7; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Colburn BC, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0616-2; Colburn BC, 2015, J AM SOC HORTIC SCI, V140, P191, DOI 10.21273/JASHS.140.2.191; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gao CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110638; Ghislain M, 2004, THEOR APPL GENET, V108, P881, DOI 10.1007/s00122-003-1494-7; Gimenes MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-9; Gokirmak T, 2009, GENET RESOUR CROP EV, V56, P147, DOI 10.1007/s10722-008-9352-8; Gurcan K, 2010, MOL BREEDING, V26, P551, DOI 10.1007/s11032-010-9464-7; Gurcan K, 2010, TREE GENET GENOMES, V6, P513, DOI 10.1007/s11295-010-0269-y; Gurcan K, 2010, J AM SOC HORTIC SCI, V135, P159, DOI 10.21273/JASHS.135.2.159; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lunde CF, 2000, HORTSCIENCE, V35, P729, DOI 10.21273/HORTSCI.35.4.729; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Mehlenbacher SA, 2006, GENOME, V49, P122, DOI 10.1139/G05-091; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mnejja M, 2010, TREE GENET GENOMES, V6, P689, DOI 10.1007/s11295-010-0284-z; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; MURRAY V, 1993, NUCLEIC ACIDS RES, V21, P2395, DOI 10.1093/nar/21.10.2395; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, THEOR APPL GENET, V118, P327, DOI 10.1007/s00122-008-0902-4; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Richard GF, 2000, EMBO REP, V1, P122, DOI 10.1093/embo-reports/kvd031; Rowley E., 2016, THESIS; Sathuvalli VR, 2011, TREE GENET GENOMES, V7, P337, DOI 10.1007/s11295-010-0335-5; Sathuvalli VR, 2013, TREE GENET GENOMES, V9, P1109, DOI 10.1007/s11295-013-0626-8; Sathuvalli VR, 2012, HORTSCIENCE, V47, P570, DOI 10.21273/HORTSCI.47.5.570; Sathuvalli VR, 2011, J AM SOC HORTIC SCI, V136, P350, DOI 10.21273/JASHS.136.5.350; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vukosavljev M, 2015, MOL ECOL RESOUR, V15, P17, DOI 10.1111/1755-0998.12289; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang ML., 2009, G3GENES GENOMES GENE, V3, P54; Wang Y, 2008, J AM SOC HORTIC SCI, V133, P692, DOI 10.21273/JASHS.133.5.692; Whankaew S, 2013, AFRICAN J BIOTECHNOL, V10, P1768; WRIGHT JM, 1994, REV FISH BIOL FISHER, V4, P384, DOI 10.1007/BF00042912	58	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178061	10.1371/journal.pone.0178061	http://dx.doi.org/10.1371/journal.pone.0178061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531233	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400054
J	Moriki, T; Nakamura, T; Kamijo, Y; Nishimura, Y; Banno, M; Kinoshita, T; Uenishi, H; Tajima, F				Moriki, Takashi; Nakamura, Takeshi; Kamijo, Yoshi-ichiro; Nishimura, Yukihide; Banno, Motohiko; Kinoshita, Tokio; Uenishi, Hiroyasu; Tajima, Fumihiro			Noninvasive positive pressure ventilation enhances the effects of aerobic training on cardiopulmonary function	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; END-EXPIRATORY PRESSURE; MAXIMAL OXYGEN INTAKE; CARDIORESPIRATORY FITNESS; DIASTOLIC VOLUMES; PHYSICAL-ACTIVITY; HEALTHY-MEN; BED REST; EXERCISE; PREDICTION	Purpose The purpose of this study was to determine the effect of aerobic training under noninvasive positive pressure ventilation (NPPV) on maximal oxygen uptake (VO2max). Methods Ten healthy young male volunteers participated in the study. Before the training, stroke volume (SV) and cardiac output (CO) were measured in all subjects under 0, 4, 8, and 12 cmH(2)O NPPV at rest. Then, the subjects exercised on a cycle ergometer at 60% of pretraining VO2max for 30 min daily for 5 consecutive days with/without NPPV. The 5-day exercise protocol was repeated after a three-week washout period without/with NPPV. The primary endpoint was changes in VO2max. The secondary endpoints were changes in SV, CO, maximum heart rate (HRmax), maximum respiratory rate (RRmax), maximum expiratory minute volume (VEmax) and the percent change in plasma volume (PV). Results NPPV at 12 cmH(2)O significantly reduced SV and CO at rest. VO2max significantly increased after 5 days training with and without NPPV, but the magnitude of increase in VO2max after training under 12 cmH(2)O NPPV was significantly higher than after training without NPPV. VEmax significantly increased after training under NPPV, but not after training without NPPV. HRmax and RRmax did not change during training irrespective of NPPV. The percent change in PV was similar between training with and without NPPV. The 5-day training program with NPPV resulted in greater improvement in VO2max than without NPPV. Conclusions Aerobic training under NPPV has add-on effects on VO2max and exercise-related health benefits in healthy young men.	[Moriki, Takashi; Kamijo, Yoshi-ichiro; Nishimura, Yukihide; Banno, Motohiko; Kinoshita, Tokio; Uenishi, Hiroyasu; Tajima, Fumihiro] Wakayama Med Univ, Dept Rehabil Med, Wakayama, Wakayama, Japan; [Nakamura, Takeshi] Yokohama City Univ, Sch Med, Dept Rehabil Med, Yokohama, Kanagawa, Japan	Wakayama Medical University; Yokohama City University	Nakamura, T (corresponding author), Yokohama City Univ, Sch Med, Dept Rehabil Med, Yokohama, Kanagawa, Japan.	take_n@yokohama-cu.ac.jp	Kamijo, Yoshi-ichiro/AAH-2810-2020	Nishimura, Yukihide/0000-0002-5365-1347	MEXT KAKENHI Grant [JP15K01382]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by MEXT KAKENHI Grant Number JP15K01382. The URLs of Ministry of Education, Culture, Sports, Science and Technology (MEXT) is http://www.mext.go.jp/en/index.htm. Author who received funding is TN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KA, 2002, J PHYSIOL-LONDON, V541, P653, DOI 10.1113/jphysiol.2001.013462; ASTRAND PO, 1956, PHYSIOL REV, V36, P307; Baisch F, 2000, EUR J CLIN INVEST, V30, P1055, DOI 10.1046/j.1365-2362.2000.00750.x; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Buchan DS, 2012, J PUBLIC HEALTH RES, V1, P59, DOI 10.4081/jphr.2012.e11; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; CURETON KJ, 1995, MED SCI SPORT EXER, V27, P445; DORINSKY PM, 1983, CHEST, V84, P210, DOI 10.1378/chest.84.2.210; Fernhall Bo, 2008, J Health Hum Serv Adm, V30, P468; FEWELL JE, 1980, CIRC RES, V47, P467, DOI 10.1161/01.RES.47.3.467; FEWELL JE, 1980, CIRC RES, V46, P125, DOI 10.1161/01.RES.46.1.125; Goodman JM, 2005, J APPL PHYSIOL, V98, P454, DOI 10.1152/japplphysiol.00258.2004; Gordon D, 2014, EUR J APPL PHYSIOL, V114, P21, DOI 10.1007/s00421-013-2743-3; Haller JM, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.124; HENKE KG, 1988, J APPL PHYSIOL, V64, P135, DOI 10.1152/jappl.1988.64.1.135; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; Holm Paige, 2004, BMC Physiol, V4, P9, DOI 10.1186/1472-6793-4-9; JARDIN F, 1981, NEW ENGL J MED, V304, P387, DOI 10.1056/NEJM198102123040703; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; JONES NL, 1979, B EUR PHYSIOPATH RES, V15, P321; Kilmer David D, 2005, Phys Med Rehabil Clin N Am, V16, P1053, DOI 10.1016/j.pmr.2005.08.014; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629; Luecke T, 2005, CRIT CARE, V9, P607, DOI 10.1186/cc3877; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Puente-Maestu Luis, 2006, Int J Chron Obstruct Pulmon Dis, V1, P381, DOI 10.2147/copd.2006.1.4.381; Saltin B., 1968, CIRCULATION, V38, P1, DOI 10.1161/01.CIR.38.1.1; Shibasaki M, 2009, AM J PHYSIOL-REG I, V297, pR1706, DOI 10.1152/ajpregu.00242.2009; STORER TW, 1990, MED SCI SPORT EXER, V22, P704, DOI 10.1249/00005768-199010000-00024; STROHL KP, 1981, J APPL PHYSIOL, V51, P1471, DOI 10.1152/jappl.1981.51.6.1471; Sugiura H, 2013, J PHYS THER SCI, V25, P1491, DOI 10.1589/jpts.25.1491; Swain DP, 2002, MED SCI SPORT EXER, V34, P152, DOI 10.1097/00005768-200201000-00023; VANDERSCHANS GP, 1994, CHEST, V105, P782, DOI 10.1378/chest.105.3.782; VIQUERAT CE, 1983, CHEST, V83, P509, DOI 10.1378/chest.83.3.509; Wasserman K, 1997, CHEST, V112, P1091, DOI 10.1378/chest.112.4.1091; Watenpaugh DE, 2000, J APPL PHYSIOL, V89, P218, DOI 10.1152/jappl.2000.89.1.218; Wibmer T, 2014, RESP CARE, V59, P699, DOI 10.4187/respcare.02668	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178003	10.1371/journal.pone.0178003	http://dx.doi.org/10.1371/journal.pone.0178003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531211	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400048
J	Kalm, K; Norris, D				Kalm, Kristjan; Norris, Dennis			Reading positional codes with fMRI: Problems and solutions	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; SERIAL ORDER; FRONTAL-CORTEX; WORKING-MEMORY; MOTOR AREA; SEQUENCES; TIME; REPRESENTATION; INFORMATION	Neural mechanisms which bind items into sequences have been investigated in a large body of research in animal neurophysiology and human neuroimaging. However, a major problem in interpreting this data arises from a fact that several unrelated processes, such as memory load, sensory adaptation, and reward expectation, also change in a consistent manner as the sequence unfolds. In this paper we use computational simulations and data from two fMRI experiments to show that a host of unrelated neural processes can masquerade as sequence representations. We show that dissociating such unrelated processes from a dedicated sequence representation is an especially difficult problem for fMRI data, which is almost exclusively the modality used in human experiments. We suggest that such fMRI results must be treated with caution and in many cases the assumed neural representation might actually reflect unrelated processes.	[Kalm, Kristjan; Norris, Dennis] MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 7EF, England		Kalm, K (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 7EF, England.	kristjan.kalm@mrc-cbu.cam.ac.uk		Norris, Dennis/0000-0001-9257-317X; Kalm, Kristjan/0000-0001-5396-432X	UK Medical Research Council intramural grant [MCA0605PR30]; MRC [MC_UU_00005/11] Funding Source: UKRI; Medical Research Council [MC_UU_00005/11] Funding Source: researchfish	UK Medical Research Council intramural grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded via the UK Medical Research Council intramural grant MCA0605PR30.	Allen TA, 2016, J NEUROSCI, V36, P1547, DOI 10.1523/JNEUROSCI.2874-15.2016; Amiez C, 2007, P NATL ACAD SCI USA, V104, P13786, DOI 10.1073/pnas.0706220104; Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Averbeck BB, 2003, EXP BRAIN RES, V150, P142, DOI 10.1007/s00221-003-1417-5; Averbeck BB, 2007, J NEUROSCI, V27, P2204, DOI 10.1523/JNEUROSCI.4483-06.2007; BARONE P, 1989, EXP BRAIN RES, V78, P447; Berdyyeva TK, 2011, J NEUROPHYSIOL, V105, P2547, DOI 10.1152/jn.00903.2010; Berdyyeva TK, 2010, J NEUROPHYSIOL, V104, P141, DOI 10.1152/jn.00639.2009; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Crowe DA, 2014, J NEUROSCI, V34, P11972, DOI 10.1523/JNEUROSCI.2177-14.2014; De-Wit L, 2016, PSYCHONOMIC B REV; DeVito LM, 2011, J NEUROSCI, V31, P3169, DOI 10.1523/JNEUROSCI.4202-10.2011; DuBrow S, 2016, NEUROBIOLOGY LEARNIN; DuBrow S, 2014, J NEUROSCI, V34, P13998, DOI 10.1523/JNEUROSCI.2535-14.2014; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Ginther MR, 2011, J NEUROSCI, V31, P2706, DOI 10.1523/JNEUROSCI.3413-10.2011; Gouws AD, 2014, J NEUROSCI, V34, P10347, DOI 10.1523/JNEUROSCI.0164-14.2014; Henson R, 1997, Q J EXPT PSYCHOL; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Heusser A, 2016, NATURE NEUROSCIENCE, V19; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Hsieh LT, 2015, NEUROIMAGE, V121, P78, DOI 10.1016/j.neuroimage.2015.07.040; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221; Hyde RA, 2012, NAT NEUROSCI, V15, P1430, DOI 10.1038/nn.3208; Inoue M, 2006, J NEUROPHYSIOL, V95, P1008, DOI 10.1152/jn.00552.2005; Isoda M, 2004, J NEUROPHYSIOL, V92, P653, DOI 10.1152/jn.01201.2003; Kalm K, 2017, NEUROIMAGE; Kalm K, 2014, J NEUROSCI, V34, P6879, DOI 10.1523/JNEUROSCI.4104-13.2014; Kraus BJ, 2013, NEURON, V78, P1090, DOI 10.1016/j.neuron.2013.04.015; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; LEE CL, 1981, J EXP PSYCHOL-HUM L, V7, P149, DOI 10.1037/0278-7393.7.3.149; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; MacDonald CJ, 2013, J NEUROSCI, V33, P14607, DOI 10.1523/JNEUROSCI.1537-13.2013; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Merchant H, 2013, J NEUROSCI, V33, P9082, DOI 10.1523/JNEUROSCI.5513-12.2013; Nakajima T, 2009, J NEUROPHYSIOL, V101, P1883, DOI 10.1152/jn.90636.2008; Naya Y, 2011, SCIENCE, V333, P773, DOI 10.1126/science.1206773; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Nieder A, 2012, P NATL ACAD SCI USA, V109, P11860, DOI 10.1073/pnas.1204580109; Ninokura Y, 2004, J NEUROPHYSIOL, V91, P555, DOI 10.1152/jn.00694.2003; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; Rangel LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4181; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255	57	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176585	10.1371/journal.pone.0176585	http://dx.doi.org/10.1371/journal.pone.0176585			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520725	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700023
J	Aboulela, M; Tanaka, Y; Nishimura, K; Mano, S; Nishimura, M; Ishiguro, S; Kimura, T; Nakagawa, T				Aboulela, Mostafa; Tanaka, Yuji; Nishimura, Kohji; Mano, Shoji; Nishimura, Mikio; Ishiguro, Sumie; Kimura, Tetsuya; Nakagawa, Tsuyoshi			Development of an R4 dual-site (R4DS) gateway cloning system enabling the efficient simultaneous cloning of two desired sets of promoters and open reading frames in a binary vector for plant research	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; TRANSGENE EXPRESSION; STABLE TRANSFORMATION; RESISTANCE GENE; DNA CLONING; ARABIDOPSIS; PROTEIN; MARKER; DIFFERENTIATION; RECOMBINATION	Vast numbers of proteins work cooperatively to exert their functions in various cells. In order to understand the functions and molecular mechanisms of these proteins in plants, analyses of transgenic plants that concomitantly express two protein-coding genes are often required. We developed a novel Gateway cloning technology-compatible binary vector system, the R4 dual-site (R4DS) Gateway cloning system, which enables the easy and efficient cloning of two desired sets of promoters and open reading frames (ORFs) into a binary vector using promoter and ORF entry clones. In this system, C-terminal fusions with 17 kinds of tags including visible reporters and epitope tags are available for each ORF, and selection by four kinds of resistance markers is possible. We verified that the R4DS Gateway cloning system functioned well in Arabidopsis thaliana by observing the expression and localization patterns of fluorescent proteins fused with organelle-targeting signals and driven by stomatal-lineage specific promoters. We also confirmed that the two cloning sites in the R4DS Gateway cloning system were equivalent and independently regulated. The results obtained indicate that the R4DS Gateway cloning system facilitates detailed comparisons of the expression patterns of two promoters as well as co-localization and interaction analyses of two proteins in specific cells in plants.	[Aboulela, Mostafa; Tanaka, Yuji; Nishimura, Kohji; Nakagawa, Tsuyoshi] Shimane Univ, Interdisciplinary Ctr Sci Res, Org Res, Dept Mol & Funct Genom, Matsue, Shimane, Japan; [Aboulela, Mostafa; Nishimura, Kohji; Nakagawa, Tsuyoshi] Tottori Univ, United Grad Sch Agr Sci, Bioresources Sci, Tottori, Japan; [Aboulela, Mostafa] Assiut Univ, Fac Sci, Dept Bot & Microbiol, Assiut, Egypt; [Mano, Shoji] Natl Inst Basic Biol, Dept Evolutionary Biol & Biodivers, Okazaki, Aichi, Japan; [Mano, Shoji] SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan; [Ishiguro, Sumie] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Nagoya, Aichi, Japan; [Kimura, Tetsuya] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie, Japan; [Nishimura, Mikio] Natl Inst Basic Biol, Res Enhancement Strategy Off, Okazaki, Aichi, Japan	Shimane University; Tottori University; Egyptian Knowledge Bank (EKB); Assiut University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; Mie University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Nakagawa, T (corresponding author), Shimane Univ, Interdisciplinary Ctr Sci Res, Org Res, Dept Mol & Funct Genom, Matsue, Shimane, Japan.; Nakagawa, T (corresponding author), Tottori Univ, United Grad Sch Agr Sci, Bioresources Sci, Tottori, Japan.	tnakagaw@life.shimane-u.ac.jp	Ishiguro, Sumie/AAH-2592-2019; ISHIGURO, Sumie/I-6903-2014	Ishiguro, Sumie/0000-0002-6160-7434; Mano, Shoji/0000-0003-1323-3308; Nishimura, Mikio/0000-0001-7960-9721; Tanaka, Yuji/0000-0002-2447-8389; Aboulela, Mostafa/0000-0003-3932-2384	KAKENHI Grant from Japan Society for the Promotion of Science (JSPS) [JP26440157, JP15K07109]; Japan Agency for Medical Research and Development, AMED	KAKENHI Grant from Japan Society for the Promotion of Science (JSPS); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by KAKENHI Grant from Japan Society for the Promotion of Science (JSPS) [Grant-in-Aid for Scientific Research (C) No. JP26440157 to SM and No. JP15K07109 to TN] and Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED, to MN. URL for Kakenhi: http://www.jsps.go.jp/english/e-grants/index.html; URL for AMED: http://www.amed.go.jp/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Benhamed M, 2008, PLANT J, V56, P493, DOI 10.1111/j.1365-313X.2008.03606.x; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Buntru M, 2013, TRANSGENIC RES, V22, P153, DOI 10.1007/s11248-012-9640-0; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cheng ZQ, 2001, MOL BREEDING, V7, P317, DOI 10.1023/A:1011655214556; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Chubet RG, 1996, BIOTECHNIQUES, V20, P136; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Fernandez AI, 2009, PLANT PHYSIOL, V151, P1729, DOI 10.1104/pp.109.147546; Ghareeb H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00246; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Han KH, 1997, TRANSGENIC RES, V6, P415, DOI 10.1023/A:1018439518649; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; He ZM, 2016, J GENET GENOMICS, V43, P199, DOI 10.1016/j.jgg.2016.02.005; Hecker A, 2015, PLANT PHYSIOL, V168, P776, DOI 10.1104/pp.15.00533; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411; Kawakami S., 1997, PLANT BIOTECHNOL, V14, P127; Kim S, 2010, TRANSGENIC RES, V19, P489, DOI 10.1007/s11248-009-9330-8; Kimura T, 2013, BIOSCI BIOTECH BIOCH, V77, P430, DOI 10.1271/bbb.120877; Li MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100948; MLYNAROVA L, 1994, PLANT CELL, V6, P417, DOI 10.1105/tpc.6.3.417; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nakagawa T, 2009, PLANT BIOTECHNOL-NAR, V26, P275, DOI 10.5511/plantbiotechnology.26.275; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; NISHIMURA M, 1986, PLANT PHYSIOL, V81, P313, DOI 10.1104/pp.81.1.313; Petersen K, 2002, PLANT MOL BIOL, V49, P45, DOI 10.1023/A:1014464127973; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Pillitteri LJ, 2008, PLANT CELL PHYSIOL, V49, P934, DOI 10.1093/pcp/pcn067; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Ren F, 2010, J PLANT PHYSIOL, V167, P1412, DOI 10.1016/j.jplph.2010.03.021; Sakamoto W, 1996, PLANT PHYSIOL, V112, P1736; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Sherf BA, 1994, PROMEGA NOTES, V49, P14; Siligato R, 2016, PLANT PHYSIOL, V170, P627, DOI 10.1104/pp.15.01246; Singh T, 2009, PLANT J, V60, P488, DOI 10.1111/j.1365-313X.2009.03970.x; Spiker S, 1996, PLANT PHYSIOL, V110, P15, DOI 10.1104/pp.110.1.15; Sun QX, 2013, PLANT MOL BIOL, V83, P391, DOI 10.1007/s11103-013-0096-2; Tachiki K, 2009, J BIOSCI BIOENG, V108, P11, DOI 10.1016/j.jbiosc.2009.02.010; Tanaka Y, 2011, BIOSCI BIOTECH BIOCH, V75, P804, DOI 10.1271/bbb.110063; Verma D, 2005, PLANT SCI, V169, P704, DOI 10.1016/j.plantsci.2005.05.021; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; Xie MT, 2001, NAT BIOTECHNOL, V19, P677, DOI 10.1038/90296; Yano D, 2003, P NATL ACAD SCI USA, V100, P8589, DOI 10.1073/pnas.1430749100	59	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177889	10.1371/journal.pone.0177889	http://dx.doi.org/10.1371/journal.pone.0177889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520787	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500080
J	Bond, M; Hunt, B; Flynn, B; Huhtinen, P; Ware, R; Richards-Kortum, R				Bond, Meaghan; Hunt, Brady; Flynn, Bailey; Huhtinen, Petri; Ware, Russell; Richards-Kortum, Rebecca			Towards a point-of-care strip test to diagnose sickle cell anemia	PLOS ONE			English	Article							IMAGE-ANALYSIS; DISEASE; IMMUNOASSAY; HEMOGLOBIN; VALIDATION; PLATFORM	A rapid test to identify patients with sickle cell disease could have important benefits in low-resource settings. Sickle cell anemia (SCA) affects about 300,000 newborns each year, the majority of whom are born in sub-Saharan Africa. Low-cost therapies are available to treat SCA, but most countries in sub-Saharan Africa lack robust neonatal screening programs needed to identify patients in need of treatment. To address this need, we developed and evaluated a competitive lateral flow assay that identifies patients with SCA (genotype HbSS) in 15 minutes using undiluted whole blood. A small volume of blood (0.5 mu L-3 mu L) is mixed with antibody-coated blue latex beads in a tube and applied to the strip. Strips are then placed in a well of running buffer and allowed to run for 10 minutes. Laboratory evaluation with samples containing different proportions of hemoglobin A (HbA) and hemoglobin S (HbS) indicated that the test should enable identification of SCA patients but not persons with sickle cell trait (SCT). We evaluated the test using 41 samples from individuals with SCA, SCT, and normal blood. With visual inspection or quantitative analysis, we found a 98% accuracy when differentiating SCA from normal and SCT samples as a group (90% sensitivity and 100% specificity for identifying SCA). This work demonstrates important steps towards making a lateral flow test for hemoglobinopathies more appropriate for point-of-care use; further work is needed before the test is appropriate for clinical use.	[Bond, Meaghan; Hunt, Brady; Flynn, Bailey; Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Huhtinen, Petri] PerkinElmer, Turku, Finland; [Ware, Russell] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA	Rice University; Cincinnati Children's Hospital Medical Center	Richards-Kortum, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	rkortum@rice.edu	Hunt, Brady/AAW-1580-2020; Bond, Meaghan/G-1305-2012	Bond, Meaghan/0000-0002-6360-8107; Hunt, Brady/0000-0002-1143-7668	Doris Duke Charitable Foundation [2013138]; National Science Foundation [0940902]; Perkin Elmer	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Science Foundation(National Science Foundation (NSF)); Perkin Elmer	This work was supported by Grant #2013138 from the Doris Duke Charitable Foundation and the National Science Foundation Graduate Research Fellowship for MB under Grant No. 0940902. In addition, one of the co-authors was employed by Perkin Elmer, which provided access to antibodies under an MTA. Perkin Elmer provided support in the form of salaries for an author [PH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R. J., 2002, MASCULINITY STUDIES, P1; Aygun B, 2012, PEDIATR BLOOD CANCER, V59, P386, DOI 10.1002/pbc.24175; Edoh Dominic, 2006, Afr Health Sci, V6, P51; FEINSTEIN AR, 1975, CLIN PHARMACOL THER, V17, P104; FERNANDO SA, 1992, J IMMUNOL METHODS, V151, P47; Hochmeister MN, 1999, J FORENSIC SCI, V44, P597; Kanter J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0473-6; Luchavez J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-286; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; McGann PT, 2016, AM J HEMATOL, V91, P205, DOI 10.1002/ajh.24232; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Piety NZ, PLOS ONE, V11; Quinn CT, 2016, BRIT J HAEMATOL, V175, P724, DOI 10.1111/bjh.14298; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Weatherall D, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P663; WELLS IC, 1951, J BIOL CHEM, V188, P65; WHITE JC, 1959, BRIT MED BULL, V15, P33, DOI 10.1093/oxfordjournals.bmb.a069711; Williams TN, 2011, TRENDS PARASITOL, V27, P315, DOI 10.1016/j.pt.2011.02.004; WRIGHTSTONE RN, 1968, CLIN CHIM ACTA, V22, P593, DOI 10.1016/0009-8981(68)90108-3; Yang XX, 2013, LAB CHIP, V13, P1464, DOI 10.1039/c3lc41302k; Yang Y-M, 1992, SICKLE CELL DIS PATH, P201	22	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177732	10.1371/journal.pone.0177732	http://dx.doi.org/10.1371/journal.pone.0177732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520780	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500064
J	Ghosh, S; Forney, LA; Wanders, D; Stone, KP; Gettys, TW				Ghosh, Sujoy; Forney, Laura A.; Wanders, Desiree; Stone, Kirsten P.; Gettys, Thomas W.			An integrative analysis of tissue-specific transcriptomic and metabolomic responses to short-term dietary methionine restriction in mice	PLOS ONE			English	Article							OXIDATIVE STRESS; ENRICHMENT ANALYSIS; IN-VIVO; GLUTATHIONE; PATHWAY; LIVER; INFLAMMATION; GENES; ACID; COA	Dietary methionine restriction (MR) produces a coordinated series of transcriptional responses in peripheral tissues that limit fat accretion, remodel lipid metabolism in liver and adipose tissue, and improve overall insulin sensitivity. Hepatic sensing of reduced methionine leads to induction and release of fibroblast growth factor 21 (FGF21), which acts centrally to increase sympathetic tone and activate thermogenesis in adipose tissue. FGF21 also has direct effects in adipose to enhance glucose uptake and oxidation. However, an understanding of how the liver senses and translates reduced dietary methionine into these transcriptional programs remains elusive. A comprehensive systems biology approach integrating transcriptomic and metabolomic readouts in MR-treated mice confirmed that three interconnected mechanisms (fatty acid transport and oxidation, tricarboxylic acid cycle, and oxidative phosphorylation) were activated in MR-treated inguinal adipose tissue. In contrast, the effects of MR in liver involved up-regulation of anti-oxidant responses driven by the nuclear factor, erythroid 2 like 2 transcription factor, NFE2L2. Metabolomic analysis provided evidence for redox imbalance, stemming from large reductions in the master anti-oxidant molecule glutathione coupled with disproportionate increases in ophthalmate and its precursors, glutamate and 2-aminobutyrate. Thus, cysteine and its downstream product, glutathione, emerge as key early hepatic signaling molecules linking dietary MR to its metabolic phenotype.	[Ghosh, Sujoy] Pennington Biomed Res Ctr, Lab Computat Biol, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Ghosh, Sujoy; Forney, Laura A.; Stone, Kirsten P.; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Disorders, Singapore, Singapore; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Ctr Computat Biol, Singapore, Singapore; [Wanders, Desiree] Georgia State Univ, Dept Nutr, Atlanta, GA 30303 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National University of Singapore; National University of Singapore; University System of Georgia; Georgia State University	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Gettys, Thomas W/N-1964-2017; Stone, Kirsten/AAB-3804-2019; Bobart, Laura Forney/AAN-1244-2021	Gettys, Thomas W/0000-0001-7125-7995; Stone, Kirsten/0000-0001-5511-1638; Wanders, Desiree/0000-0003-2638-3954	American Diabetes Association [1-12-BS-58, 7-13-MI-05]; National Institutes of Health [DK-096311, 1F32DK098918-01, 3P30-GM118430, 3P30 DK072476]; National Medical Research Council and Ministry of Health, Singapore; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK096311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118430, P20GM103528] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council and Ministry of Health, Singapore; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Diabetes Association 1-12-BS-58 (TWG), National Institutes of Health DK-096311 (TWG), American Diabetes Association 7-13-MI-05 (TWG), National Institutes of Health 1F32DK098918-01 (DW). SG was supported by funding from the National Medical Research Council and Ministry of Health, Singapore. This work also made use of the Genomics core facilities supported by National Institutes of Health 3P30-GM118430 (TWG) and National Institutes of Health 3P30 DK072476.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRIDGES RJ, 1985, J BIOL CHEM, V260, P7304; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Chen B, 2015, J ENDOCRINOL, V225, pR83, DOI 10.1530/JOE-14-0662; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Dello SAWG, 2013, CLIN NUTR, V32, P325, DOI 10.1016/j.clnu.2012.10.008; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Fujii J, 2011, J CLIN BIOCHEM NUTR, V49, P70, DOI 10.3164/jcbn.10-138SR; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Moffat C, 2014, J LIPID RES, V55, P2458, DOI 10.1194/jlr.M046961; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Perrone CE, 2010, METABOLISM, V59, P1000, DOI 10.1016/j.metabol.2009.10.023; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; SHUG A, 1971, BIOCHEM BIOPH RES CO, V43, P557, DOI 10.1016/0006-291X(71)90650-4; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; STIPANUK MH, 1992, J NUTR, V122, P420, DOI 10.1093/jn/122.3.420; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; Tao SS, 2013, ANTIOXID REDOX SIGN, V19, P1647, DOI 10.1089/ars.2012.5117; van Eunen K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003186; Wanders D, 2017, DIABETES; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; Wanders D, 2015, FASEB J, V29, P2603, DOI 10.1096/fj.14-270348; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	35	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177513	10.1371/journal.pone.0177513	http://dx.doi.org/10.1371/journal.pone.0177513			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520765	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500034
J	Huber, S; Casagrande, F; Hug, MN; Wang, LS; Heine, P; Kummer, L; Pluckthun, A; Hennig, M				Huber, Sylwia; Casagrande, Fabio; Hug, Melanie N.; Wang, Lisha; Heine, Philipp; Kummer, Lutz; Pluckthun, Andreas; Hennig, Michael			SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands	PLOS ONE			English	Article							DRUG DISCOVERY; BIOPHYSICAL METHODS; HIT VALIDATION; A(2A) RECEPTOR; BINDING; IDENTIFICATION; EVOLUTION	The neurotensin receptor 1 represents an important drug target involved in various diseases of the central nervous system. So far, the full exploitation of potential therapeutic activities has been compromised by the lack of compounds with favorable physicochemical and pharmacokinetic properties which efficiently penetrate the blood-brain barrier. Recent progress in the generation of stabilized variants of solubilized neurotensin receptor 1 and its subsequent purification and successful structure determination presents a solid starting point to apply the approach of fragment-based screening to extend the chemical space of known neurotensin receptor 1 ligands. In this report, surface plasmon resonance was used as primary method to screen 6369 compounds. Thereby 44 hits were identified and confirmed in competition as well as dose-response experiments. Furthermore, 4 out of 8 selected hits were validated using nuclear magnetic resonance spectroscopy as orthogonal biophysical method. Computational analysis of the compound structures, taking the known crystal structure of the endogenous peptide agonist into consideration, gave insight into the potential fragment-binding location and interactions and inspires chemistry efforts for further exploration of the fragments.	[Huber, Sylwia; Casagrande, Fabio; Hug, Melanie N.; Wang, Lisha; Hennig, Michael] Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, Basel, Switzerland; [Heine, Philipp; Kummer, Lutz; Pluckthun, Andreas] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Kummer, Lutz] G7 Therapeut AG, Schlieren, Switzerland; [Hennig, Michael] LeadXpro AG, Pk INNOVAARE, Villigen, Switzerland	Roche Holding; University of Zurich	Huber, S; Hennig, M (corresponding author), Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, Basel, Switzerland.	sylwia.huber@roche.com; michael.hennig@leadxpro.com		Heine, Philipp/0000-0003-4504-9003				Aristotelous T, 2013, ACS MED CHEM LETT, V4, P1005, DOI 10.1021/ml400312j; Barroso S, 2000, J BIOL CHEM, V275, P328, DOI 10.1074/jbc.275.1.328; Bayes M, 2005, METHOD FIND EXP CLIN, V27, P193; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Bocquet N, 2015, BBA-BIOMEMBRANES, V1848, P1224, DOI 10.1016/j.bbamem.2015.02.014; Boehm HJ, 2000, J MED CHEM, V43, P2664, DOI 10.1021/jm000017s; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Campos-Olivas R, 2011, CURR TOP MED CHEM, V11, P43, DOI 10.2174/156802611793611887; Carey LI, 2014, 26 NMU; Chen D, 2012, ACS CHEM BIOL, V7, P2064, DOI 10.1021/cb300436c; Chessari G, 2009, DRUG DISCOV TODAY, V14, P668, DOI 10.1016/j.drudis.2009.04.007; Choi SY, 1999, BRIT J PHARMACOL, V126, P1050, DOI 10.1038/sj.bjp.0702378; Christopher JA, 2015, MEDCHEMCOMM, V6, P947, DOI 10.1039/c5md00027k; Christopher JA, 2013, J MED CHEM, V56, P3446, DOI 10.1021/jm400140q; Congreve M, 2011, METHOD ENZYMOL, V493, P115, DOI 10.1016/B978-0-12-381274-2.00005-4; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Demeule M, 2014, J CLIN INVEST, V124, P1199, DOI 10.1172/JCI70647; Dias DM, 2014, PROG BIOPHYS MOL BIO, V116, P101, DOI 10.1016/j.pbiomolbio.2014.08.012; Egloff P, 2014, P NATL ACAD SCI USA, V111, pE655, DOI 10.1073/pnas.1317903111; Feifel D, 1999, J PHARMACOL EXP THER, V288, P710; Fruh V, 2010, CHEM BIOL, V17, P881, DOI 10.1016/j.chembiol.2010.06.011; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; Gully D, 1997, J PHARMACOL EXP THER, V280, P802; Gully D, 1995, FUNDAM CLIN PHARM, V9, P513, DOI 10.1111/j.1472-8206.1995.tb00528.x; Gururaja TL, 2007, CHEM BIOL, V14, P1105, DOI 10.1016/j.chembiol.2007.08.012; Harner MJ, 2013, J BIOMOL NMR, V56, P65, DOI 10.1007/s10858-013-9740-z; Hennig M, 2012, TOP CURR CHEM, V317, P115, DOI 10.1007/128_2011_225; Huber W, 2006, CURR PHARM DESIGN, V12, P3999, DOI 10.2174/138161206778743600; Jolas T, 1997, PROG NEUROBIOL, V52, P455, DOI 10.1016/S0301-0082(97)00025-7; KITABGI P, 1977, P NATL ACAD SCI USA, V74, P1846, DOI 10.1073/pnas.74.5.1846; Kobayashi M, 2010, J BIOMOL SCREEN, V15, P978, DOI 10.1177/1087057110375614; Maurer T, 2013, ENZYMES, V33, P15, DOI 10.1016/B978-0-12-416749-0.00002-6; Meltzer HY, 2004, AM J PSYCHIAT, V161, P975, DOI 10.1176/appi.ajp.161.6.975; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Perspicace S, 2009, J BIOMOL SCREEN, V14, P337, DOI 10.1177/1087057109332595; Petrie KA, 2004, NEUROPSYCHOPHARMACOL, V29, P1878, DOI 10.1038/sj.npp.1300494; Ranganathan A, 2017, ACS CHEM BIOL; Rich RL, 2011, ANAL BIOCHEM, V409, P267, DOI 10.1016/j.ab.2010.10.008; Roberts GCK, 1993, NMR MACROMOLECULES P, Vxviii; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Scott DJ, 2014, BBA-BIOMEMBRANES, V1838, P2817, DOI 10.1016/j.bbamem.2014.07.015; Scott DJ, 2013, J MOL BIOL, V425, P662, DOI 10.1016/j.jmb.2012.11.015; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Shepherd CA, 2014, PROG BIOPHYS MOL BIO, V116, P113, DOI 10.1016/j.pbiomolbio.2014.09.008; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Tyler BM, 1999, NEUROPHARMACOLOGY, V38, P1027, DOI 10.1016/S0028-3908(99)00011-8; Vulpetti A, 2013, CHEMMEDCHEM, V8, P2057, DOI 10.1002/cmdc.201300351; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Zamani L, 2015, S AFR J CHEM-S-AFR T, V68, P133, DOI 10.17159/0379-4350/2015/V68A19	51	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0175842	10.1371/journal.pone.0175842	http://dx.doi.org/10.1371/journal.pone.0175842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510609	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000401485500004
J	Renton, T; Tibbles, A; Topolovec-Vranic, J				Renton, Tian; Tibbles, Alana; Topolovec-Vranic, Jane			Neurofeedback as a form of cognitive rehabilitation therapy following stroke: A systematic review	PLOS ONE			English	Review							RECOVERY; BRAIN; NEUROTHERAPY; PRINCIPLES; HEALTH	Neurofeedback therapy (NFT) has been used within a number of populations however it has not been applied or thoroughly examined as a form of cognitive rehabilitation within a stroke population. Objectives for this systematic review included: i) identifying how NFT is utilized to treat cognitive deficits following stroke, ii) examining the strength and quality of evidence to support the use of NFT as a form of cognitive rehabilitation therapy (CRT) and iii) providing recommendations for future investigations. Searches were conducted using OVID (Medline, Health Star, Embase + Embase Classic) and PubMed databases. Additional searches were completed using the Cochrane Reviews library database, Google Scholar, the University of Toronto online library catalogue, ClinicalTrials.gov website and select journals. Searches were completed Feb/March 2015 and updated in June/July/Aug 2015. Eight studies were eligible for inclusion in this review. Studies were eligible for inclusion if they: i) were specific to a stroke population, ii) delivered CRT via a NFT protocol, iii) included participants who were affected by a cognitive deficit(s) following stroke (i.e. memory loss, loss of executive function, speech impairment etc.). NFT protocols were highly specific and varied within each study. The majority of studies identified improvements in participant cognitive deficits following the initiation of therapy. Reviewers assessed study quality using the Downs and Black Checklist for Measuring Study Quality tool; limited study quality and strength of evidence restricted generalizability of conclusions regarding the use of this therapy to the greater stroke population. Progression in this field requires further inquiry to strengthen methodology quality and study design. Future investigations should aim to standardize NFT protocols in an effort to understand the dose-response relationship between NFT and improvements in functional outcome. Future investigations should also place a large emphasis on long-term participant follow-up.	[Renton, Tian; Tibbles, Alana; Topolovec-Vranic, Jane] Univ Toronto, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON, Canada; [Renton, Tian; Topolovec-Vranic, Jane] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Renton, T (corresponding author), Univ Toronto, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON, Canada.; Renton, T (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON, Canada.	tian.renton@mail.utoronto.ca	Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Renton, Tian/0000-0002-9772-0551				Ammann BC, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0167-2; [Anonymous], 2009, SYSTEMATIC REV; Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P1; Bearden TS, 2003, APPL PSYCHOPHYS BIOF, V28, P241, DOI 10.1023/A:1024689315563; Breteler MHM, 2010, APPL PSYCHOPHYS BIOF, V35, P5, DOI 10.1007/s10484-009-9105-2; Brosseau L, 2006, TOP STROKE REHABIL, V13, P1, DOI 10.1310/3TKX-7XEC-2DTG-XQKH; Cannon KB., 2010, J NEUROTHER, V14, P107, DOI [10.1080/10874201003772155, DOI 10.1080/10874201003772155]; Cho HY, 2015, J PHYS THER SCI, V27, P673, DOI 10.1589/jpts.27.673; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coben R, 2010, APPL PSYCHOPHYS BIOF, V35, P83, DOI 10.1007/s10484-009-9117-y; Corydon Hammond D., 2011, J NEUROTHERAPY, V15, P54, DOI [10.1080/10874208.2010.545760, DOI 10.1080/10874208.2010.545760]; Deeks J J, 2003, Health Technol Assess, V7, piii; Dehghani-Arani F, 2013, APPL PSYCHOPHYS BIOF, V38, P133, DOI 10.1007/s10484-013-9218-5; Doppeimayr M., 2007, BIOFEEDBACK, V35, P126; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Duncan PW, 2000, NEUROPHARMACOLOGY, V39, P835, DOI 10.1016/S0028-3908(00)00003-4; Glasziou P.P., 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1017/CBO9780511543500; Hammond D.C., 2008, J NEUROTHER, V12, P79, DOI [10.1080/10874200802219947, DOI 10.1080/10874200802219947]; Hammond DC, 2007, J NEUROTHER, V10, P25, DOI DOI 10.1300/J184V10N04; Hasbani MJ, 2000, NEUROSCIENTIST, V6, P110, DOI 10.1177/107385840000600208; HIER DB, 1983, NEUROLOGY, V33, P345, DOI 10.1212/WNL.33.3.345; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Kayiran S, 2010, APPL PSYCHOPHYS BIOF, V35, P293, DOI [10.1007/s10484.010.9135.9, 10.1007/s10484-010-9135-9]; Khan KS, 2003, J ROY SOC MED, V96, P118, DOI 10.1258/jrsm.96.3.118; Kiran Swathi, 2012, ISRN Neurol, V2012, P786872, DOI 10.5402/2012/786872; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P21; Liu YW., 2007, CHINA J INFORM SYSTE, V1, P16, DOI DOI 10.1089/SCD.2006.0118; MacLehose R R, 2000, Health Technol Assess, V4, P1; Matthews T. V., 2008, J NEUROTHER, V11, P63, DOI [10.1080/10874200802126290, DOI 10.1080/10874200802126290]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mroczkowska D, 2014, POSTEP PSYCHIATR NEU, V23, P190, DOI 10.1016/j.pin.2014.09.002; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; National Collaborating Centre for Methods and Tools, 2008, QUAL CHECKL HLTH CAR; National Institute of Neurological Disorders and Stroke, 2011, POSTSTR REH FACT SHE; National Stroke Association, POSTSTR COND; Nelson LA, 2007, TOP STROKE REHABIL, V14, P59, DOI 10.1310/tsr1404-59; NeurOptimal, 2017, ADV BRAIN TRAIN SYST; Othmer S., ASS APPL PSYCH BIOF; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Phillips B, 2009, OXFORD CTR EVIDENCE; Putnam JA, 2001, J NEUROTHERAPY, V5, P27; Research ISfN, COD ETH PRINC PROF C; Rickhag M, 2006, J NEUROCHEM, V96, P14, DOI 10.1111/j.1471-4159.2005.03508.x; ROZELLE GR, 1995, BIOFEEDBACK SELF-REG, V20, P211, DOI 10.1007/BF01474514; Simons M, 2011, GUIDELINES WRITING S; Staines WR, CURRENT ISSUES CARDI; Statistics Canada, 2011, 10 LEAD CAUS DEATH; STERMAN MB, 1978, EPILEPSIA, V19, P207, DOI 10.1111/j.1528-1157.1978.tb04483.x; Teasell Robert, 2005, Top Stroke Rehabil, V12, P11; The Heart and Stroke Foundation, 2014, STROK REP 2014 TOG R; Thompson L, 2010, APPL PSYCHOPHYS BIOF, V35, P63, DOI 10.1007/s10484-009-9120-3; Toppi J, 2014, IEEE ENG MED BIO, P6786, DOI 10.1109/EMBC.2014.6945186	54	38	42	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177290	10.1371/journal.pone.0177290	http://dx.doi.org/10.1371/journal.pone.0177290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510578	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500021
J	Gupta, S; Kesarla, R; Chotai, N; Omri, A				Gupta, Shweta; Kesarla, Rajesh; Chotai, Narendra; Omri, Abdelwahab			Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; TRANSCRIPTASE; INHIBITOR	Efavirenz is an anti-viral agent of non-nucleoside reverse transcriptase inhibitor category used as a part of highly active retroviral therapy for the treatment of infections of human immune deficiency virus type-1. A simple, sensitive and rapid reversed D phase high performance liquid chromatographic gradient method was developed and validated for the determination of efavirenz in plasma. The method was developed with high performance liquid chromatography using Waters X-Terra Shield, RP18 50 x 4.6 mm, 3.5 mu m column and a mobile phase consisting of phosphate buffer pH 3.5 and Acetonitrile. The elute was monitored with the UV-Visible detector at 260 nm with a flow rate of 1.5 mL/min. Tenofovir disoproxil fumarate was used as internal standard. The method was validated for linearity, precision, accuracy, specificity, robustness and data obtained were statistically analyzed. Calibration curve was found to be linear over the concentration range of 1-300 mu g/mL. The retention times of efavirenz and tenofovir disoproxil fumarate (internal standard) were 5.941 min and 4.356 min respectively. The regression coefficient value was found to be 0.999. The limit of detection and the limit of quantification obtained were 0.03 and 0.1 mu g/mL respectively. The developed HPLC method can be useful for quantitative pharmacokinetic parameters determination of efavirenz in plasma.	[Gupta, Shweta] Parul Univ, Dept Pharmaceut Technol, Vadodara, Gujarat, India; [Kesarla, Rajesh] ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India; [Chotai, Narendra] AR Coll Pharm, Dept Pharmaceut, Anand, Gujarat, India; [Omri, Abdelwahab] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada	Parul University; ISF College of Pharmacy; Laurentian University	Omri, A (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada.	aomri@laurentian.ca	Omri, Abdelwahab/G-3172-2010; Gupta, Shweta/AGK-3210-2022	Omri, Abdelwahab/0000-0002-4093-5762; Gupta, Shweta/0000-0001-9519-6744	M/s Sun Pharma Ltd.	M/s Sun Pharma Ltd.	This study was materially supported by M/s Sun Pharma Ltd. Sikkim and Paradise Healthcare, Vadodara, India, which provided samples of EFV and TDF, respectively. The infrastructural facilities required for carrying out the experiments were provided by Parul University, India. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this study.	Cundy KC, 1997, ANTIVIR RES, V35, P113, DOI 10.1016/S0166-3542(97)00022-3; Guideline ICH, 2005, GUIDELINE ICH VALIDA, V1, P5; Gunthard HF, 2016, J AM MED ASS, V316; Gupta S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5984014; Hamrapurkar P, 2009, J YOUNG PHARM, V1, P359, DOI 10.4103/0975-1483.59328; Heydari R, 2014, CURR ANAL CHEM, V10, P280, DOI 10.2174/15734110113099990003; Kadam AA, 2012, AM J PHARMTECH RES, V2, P324; Kamble RN, 2015, INT J PHARM PHARM SC, V7, P153; Kappelhoff BS, 2003, J CHROMATOGR B, V792, P353, DOI 10.1016/S1570-0232(03)00325-8; Langmann P, 2001, J CHROMATOGR B, V755, P151, DOI 10.1016/S0378-4347(01)00059-7; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Ramachandran G, 2006, J CHROMATOGR B, V835, P131, DOI 10.1016/j.jchromb.2006.03.014; Ramaswamy A., 2014, ARAB J CHEM; Ravikumar K, 2009, MOL CRYST LIQ CRYST, V515, P190, DOI 10.1080/15421400903291434; Reddy N.P., 2015, INT, V4, P390, DOI [10.3329/icpj.v4i6.23290, DOI 10.3329/ICPJ.V4I6.23290]; Sailaja AL, 2007, CHROMATOGRAPHIA, V65, P359, DOI 10.1365/s10337-006-0170-x; Sarasa-Nacenta M, 2001, J CHROMATOGR B, V763, P53, DOI 10.1016/S0378-4347(01)00357-7; Veldkamp AI, 1999, J CHROMATOGR B, V734, P55, DOI 10.1016/S0378-4347(99)00336-9	18	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0174777	10.1371/journal.pone.0174777	http://dx.doi.org/10.1371/journal.pone.0174777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505168	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500003
J	Collins, D; Jacob, W; Cejalvo, JM; Ceppi, M; James, I; Hasmann, M; Crown, J; Cervantes, A; Weisser, M; Bossenmaier, B				Collins, Denis; Jacob, Wolfgang; Miguel Cejalvo, Juan; Ceppi, Maurizio; James, Ian; Hasmann, Max; Crown, John; Cervantes, Andres; Weisser, Martin; Bossenmaier, Birgit			Direct estrogen receptor (ER)/HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER plus breast cancer	PLOS ONE			English	Article							ENDOCRINE THERAPY; 1ST-LINE TREATMENT; HER2 EXPRESSION; MONOCLONAL-ANTIBODY; RESISTANCE; TRASTUZUMAB; GROWTH; MECHANISMS; AMPLIFICATION; COMBINATION	Bidirectional cross talk between members of the human epidermal growth factor family of receptors (HER) and the estrogen receptor (ER) is believed to underlie resistance mechanisms that develop in response to treatment with anti-HER agents and endocrine therapy. We investigated the interaction between HER2, HER3 and the ER in vitro using human embryonic kidney cells transfected with human HER2, HER3, and ER alpha. We also investigated the additive efficacy of combination regimens consisting of anti-HER3 (lumretuzumab), anti-HER2 (pertuzumab), and endocrine (fulvestrant) therapy in vivo. Our data show that both HER2 and HER3 can directly complex with the ER and can mediate phosphorylation of the ER. Phosphorylation of the ER was only observed in cells that expressed both HER2 and ERa or in heregulin-stimulated cells that expressed both HER3 and ERa. Using a mouse xenograft model of ER+/HER2-low (HER2 immunohistochemistry 1+ or 2+ without gene amplification) human breast cancer we show that the combination of lumretuzumab and pertuzumab is highly efficacious and induces long-lasting tumor regression in vivo and adding endocrine therapy (fulvestrant) to this combination further improved efficacy. In addition, a prolonged clinical response was observed with the combination of lumretuzumab and pertuzumab in a patient with ER+/HER2-low breast cancer who had failed endocrine therapy. These preclinical data confirm that direct cross talk exists between HER2/HER3 and ER which may explain the resistance mechanisms to endocrine therapy and monoclonal antibodies that target HER2 and HER3. Our data also indicate that the triplet of anti-HER2, anti-HER3, and endocrine therapy might be an efficacious combination for treating patients with ER+/HER2-low breast cancer, which is an area of significant unmet medical need.	[Collins, Denis; Crown, John] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland; [Jacob, Wolfgang; Ceppi, Maurizio; Hasmann, Max; Weisser, Martin; Bossenmaier, Birgit] Roche Innovat Ctr Munich, Penzberg, Germany; [Miguel Cejalvo, Juan; Cervantes, Andres] Univ Valencia, Inst Hlth Res NCLIVA, Dept Med Oncol, Valencia, Spain; [James, Ian] A4P Consulting Ltd, Sandwich, Kent, England; [Crown, John] St Vincents Univ Hosp, Dept Med Oncol, Dublin, Ireland	Dublin City University; University of Valencia; University College Dublin; Saint Vincent's University Hospital	Collins, D (corresponding author), Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland.; Weisser, M (corresponding author), Roche Innovat Ctr Munich, Penzberg, Germany.	denis.collins@dcu.ie; martin.weisser@roche.com	Bossenmaier, Birgit/AAN-7075-2020; Collins, Denis/M-3957-2017; Crown, John/AAL-3367-2020; Cervantes, Andres/J-8713-2013	Crown, John/0000-0002-3125-7613; Cervantes, Andres/0000-0003-3806-3691; Collins, Denis/0000-0003-1043-6169	Roche Diagnostics GmbH, Penzberg, Germany	Roche Diagnostics GmbH, Penzberg, Germany	This study and editorial support for the preparation of the manuscript were funded by Roche Diagnostics GmbH, Penzberg, Germany. The study sponsor was involved in the study design, data collection and analysis and the decision to publish the manuscript. A4P Consulting Ltd. provided support in the form of salary for author IJ, funded by Roche Diagnostics, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support for third party writing assistance for this article, furnished by Jamie Ashman, PhD, was provided by Prism Ideas and funded by Roche Diagnostics GmbH, Penzberg, Germany.; The authors would like to thank Frieder Bauss and Thomas Friess from Roche Penzberg for support with the in vivo studies and Sabine Wilson from Roche Penzberg for support with the statistical analysis of western blot biomarker data. Support for third-party writing assistance for this article, furnished by Jamie Ashman, PhD, was provided by Prism Ideas and funded by Roche Diagnostics GmbH, Penzberg, Germany.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Arpino G, 2004, CLIN CANCER RES, V10, P5670, DOI 10.1158/1078-0432.CCR-04-0110; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baselga J, 2010, CLIN BREAST CANCER, V10, P489, DOI 10.3816/CBC.2010.n.065; Calhoun BC, 2015, SEMIN DIAGN PATHOL, V32, P362, DOI 10.1053/j.semdp.2015.02.011; Camp RL, 2003, CANCER RES, V63, P1445; Curley MD, 2015, MOL CANCER THER, V14, P2642, DOI 10.1158/1535-7163.MCT-15-0169; De Laurentiis M, 2005, CLIN CANCER RES, V11, P4741, DOI 10.1158/1078-0432.CCR-04-2569; Dienstmann Rodrigo, 2015, Am Soc Clin Oncol Educ Book, pe149, DOI 10.14694/EdBook_AM.2015.35.e149; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Houston SJ, 1999, BRIT J CANCER, V79, P1220, DOI 10.1038/sj.bjc.6690196; Howlader N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju055; Huober J, 2012, BREAST, V21, P27, DOI 10.1016/j.breast.2011.07.006; Hurvitz SA, 2015, LANCET ONCOL, V16, P816, DOI 10.1016/S1470-2045(15)00051-0; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Lee HJ, 2014, BREAST CANCER RES TR, V145, P615, DOI 10.1007/s10549-014-2983-x; Lousberg L, 2016, THER ADV MED ONCOL, V8, P429, DOI 10.1177/1758834016665077; Massarweh S, 2007, CLIN CANCER RES, V13, P1950, DOI 10.1158/1078-0432.CCR-06-2540; Meneses-Lorente G, 2015, CANCER CHEMOTH PHARM, V75, P837, DOI 10.1007/s00280-015-2697-8; Meulendijks D, 2016, CLIN CANCER RES, V22, P877, DOI 10.1158/1078-0432.CCR-15-1683; Miles D, 2017, EUR J CANCER, V70, P146, DOI 10.1016/j.ejca.2016.09.024; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Mirschberger C, 2013, CANCER RES, V73, P5183, DOI 10.1158/0008-5472.CAN-13-0099; Montemurro F, 2013, ANN ONCOL, V24, P2715, DOI 10.1093/annonc/mdt287; Murphy CG, 2016, ENDOCR-RELAT CANCER, V23, pR337, DOI 10.1530/ERC-16-0121; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Sabnis G, 2009, CANCER RES, V69, P1416, DOI 10.1158/0008-5472.CAN-08-0857; Schettini F, 2016, CANCER TREAT REV, V46, P20, DOI 10.1016/j.ctrv.2016.03.012; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Schneeweiss A, 2016 SAN ANT BREAST; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; THRANE S, 2013, P NATL ACAD SCI USA, V139, P71, DOI DOI 10.1007/S10549-013-2485-2; Tripathy D, 2013, ONCOLOGIST, V18, P501, DOI 10.1634/theoncologist.2012-0414; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Varga Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140652; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; Way Tzong-Der, 2005, Future Oncol, V1, P841, DOI 10.2217/14796694.1.6.841; Winer EP, 2005, J CLIN ONCOL, V23, P1609, DOI 10.1200/JCO.2005.01.005; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396; Yardley DA, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0543-x	49	33	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177331	10.1371/journal.pone.0177331	http://dx.doi.org/10.1371/journal.pone.0177331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493933	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300089
J	Gilbert, PB; Excler, JL; Tomaras, GD; Carpp, LN; Haynes, BF; Liao, HX; Montefiori, DC; Rerks-Ngarm, S; Pitisuttithum, P; Nitayaphan, S; Kaewkungwal, J; Kijak, GH; Tovanabutra, S; Francis, DP; Lee, C; Sinangil, F; Berman, PW; Premsri, N; Kunasol, P; O'Connell, RJ; Michael, NL; Robb, ML; Morrow, R; Corey, L; Kim, JH				Gilbert, Peter B.; Excler, Jean-Louis; Tomaras, Georgia D.; Carpp, Lindsay N.; Haynes, Barton F.; Liao, Hua-Xin; Montefiori, David C.; Rerks-Ngarm, Supachai; Pitisuttithum, Punnee; Nitayaphan, Sorachai; Kaewkungwal, Jaranit; Kijak, Gustavo H.; Tovanabutra, Sodsai; Francis, Donald P.; Lee, Carter; Sinangil, Faruk; Berman, Phillip W.; Premsri, Nakorn; Kunasol, Prayura; O'Connell, Robert J.; Michael, Nelson L.; Robb, Merlin L.; Morrow, Rhoda; Corey, Lawrence; Kim, Jerome H.			Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 GLYCOPROTEIN-D; D SUBUNIT VACCINES; GENITAL HERPES; SYNTHETIC PEPTIDES; EFFICACY TRIAL; NEUTRALIZING ANTIBODY; MONOCLONAL-ANTIBODIES; HIV-1 ACQUISITION	Background In the HIV-1 vaccine trial RV144, ALVAC-HIV prime with an AIDSVAX (R) B/E boost reduced HIV-1 acquisition by 31% at 42 months post first vaccination. The bivalent AIDSVAX (R) B/E vaccine contains two gp120 envelope glycoproteins, one from the subtype B HIV-1 MN isolate and one from the subtype CRF01_AE A244 isolate. Each envelope glycoprotein harbors a highly conserved 27-amino acid HSV-1 glycoprotein D (gD) tag sequence that shares 93% sequence identity with the HSV-2 gD sequence. We assessed whether vaccine-induced anti-gD antibodies protected females against HSV-2 acquisition in RV144. Methods Of the women enrolled in RV144, 777 vaccine and 807 placebo recipients were eligible and randomly selected according to their pre-vaccination HSV-1 and HSV-2 serostatus for analysis. Immunoglobulin G (IgG) and IgA responses to gD were determined by a binding antibody multiplex assay and HSV-2 serostatus was determined by Western blot analysis. Ninety-three percent and 75% of the vaccine recipients had anti-gD IgG and IgA responses two weeks post last vaccination, respectively. There was no evidence of reduction in HSV-2 infection by vaccination compared to placebo recipients over 78 weeks of follow- up. The annual incidence of HSV-2 infection in individuals who were HSV-2 negative at baseline or HSV-1 positive and HSV-2 indeterminate at baseline were 4.38/100 person-years (py) and 3.28/100 py in the vaccine and placebo groups, respectively. Baseline HSV-1 status did not affect subsequent HSV-2 acquisition. Specifically, the estimated odds ratio of HSV-2 infection by Week 78 for female placebo recipients who were baseline HSV-1 positive (n = 422) vs. negative (n = 1120) was 1.14 [95% confidence interval 0.66 to 1.94, p = 0.64)]. No evidence of reduction in the incidence of HSV-2 infection by vaccination was detected. Conclusions AIDSVAX (R) B/E containing gD did not confer protection from HSV-2 acquisition in HSV-2 seronegative women, despite eliciting anti-gD serum antibodies.	[Gilbert, Peter B.; Carpp, Lindsay N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, 1124 Columbia St, Seattle, WA 98104 USA; [Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Excler, Jean-Louis; Kijak, Gustavo H.; Tovanabutra, Sodsai] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Excler, Jean-Louis; Kijak, Gustavo H.; Tovanabutra, Sodsai; Michael, Nelson L.; Robb, Merlin L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Tomaras, Georgia D.; Haynes, Barton F.; Liao, Hua-Xin] Duke Univ, Human Vaccine Inst, Durham, NC USA; [Tomaras, Georgia D.; Haynes, Barton F.; Liao, Hua-Xin] Duke Univ, Sch Med, Ctr HIV AIDS Vaccine Immunol, Durham, NC USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Fac Trop Med, Vaccine Trial Ctr, Bangkok, Thailand; [Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat, Bangkok, Thailand; [Francis, Donald P.; Lee, Carter; Sinangil, Faruk] Global Solut Infect Dis, San Francisco, CA USA; [Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [O'Connell, Robert J.] Armed Forces Res Inst Med Sci, Dept Retrovirol, Bangkok, Thailand; [Morrow, Rhoda] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Morrow, Rhoda; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, HIV Vaccine Trials Network, 1124 Columbia St, Seattle, WA 98104 USA; [Excler, Jean-Louis; Kim, Jerome H.] Int Vaccine Initiat, Seoul, South Korea	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Duke University; Duke University; Duke University; Ministry of Public Health - Thailand; Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University; University of California System; University of California Santa Cruz; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Excler, JL (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.; Excler, JL (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Excler, JL (corresponding author), Int Vaccine Initiat, Seoul, South Korea.	jexcler@hivresearch.org; supachair@biophics.org; oconnellrj@hiv-th.org	Carpp, Lindsay/AAM-1148-2021; Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	U.S. Army Medical Research and Materiel Command [Y1-AI-2642-12]; National Institute of Allergy and Infectious Diseases between the Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-07-2-0067]; U.S. Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institute of Allergy and Infectious Diseases between the Henry M. Jackson Foundation for the Advancement of Military Medicine; U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by an Interagency Agreement (Y1-AI-2642-12)between the U.S. Army Medical Research and Materiel Command and the National Institute of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BALACHANDRAN N, 1982, INFECT IMMUN, V37, P1132, DOI 10.1128/IAI.37.3.1132-1137.1982; Barnabas RV, 2011, JAIDS-J ACQ IMM DEF, V57, P238, DOI 10.1097/QAI.0b013e31821acb5; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BenMohamed L, 2003, J VIROL, V77, P9463, DOI 10.1128/JVI.77.17.9463-9473.2003; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; BERMAN PW, 1985, SCIENCE, V227, P1490, DOI 10.1126/science.2983428; BERMAN PW, 1988, J INFECT DIS, V157, P897, DOI 10.1093/infdis/157.5.897; Biraro S, 2013, TROP MED INT HEALTH, V18, P1257, DOI 10.1111/tmi.12176; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Cairns TM, 2015, J VIROL, V89, P9213, DOI 10.1128/JVI.01213-15; Cairns TM, 2014, J VIROL, V88, P12612, DOI 10.1128/JVI.01930-14; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; Chu CF, 2008, J REPROD IMMUNOL, V78, P58, DOI 10.1016/j.jri.2007.08.004; COHEN GH, 1984, J VIROL, V49, P102, DOI 10.1128/JVI.49.1.102-108.1984; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAMHOF RA, 1993, ARCH VIROL, V130, P187, DOI 10.1007/BF01319007; DEFREITAS EC, 1985, P NATL ACAD SCI USA, V82, P3425, DOI 10.1073/pnas.82.10.3425; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; DIETZSCHOLD B, 1984, J VIROL, V52, P431, DOI 10.1128/JVI.52.2.431-435.1984; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; EISENBERG RJ, 1985, J VIROL, V53, P634, DOI 10.1128/JVI.53.2.634-644.1985; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; GHIASI H, 1994, J VIROL, V68, P2118, DOI 10.1128/JVI.68.4.2118-2126.1994; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; HEBERKATZ E, 1988, J EXP MED, V167, P275, DOI 10.1084/jem.167.2.275; HEBERKATZ E, 1985, J IMMUNOL, V135, P1385; HILBERT A, 1994, SCAND J IMMUNOL, V40, P609, DOI 10.1111/j.1365-3083.1994.tb03512.x; Holtz TH, 2012, INT J STD AIDS, V23, P424, DOI 10.1258/ijsa.2011.011256; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Kim JH, 2015, ANNU REV MED, V66, P423, DOI 10.1146/annurev-med-052912-123749; KOHL S, 1990, J CLIN INVEST, V86, P273, DOI 10.1172/JCI114695; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; LASKY LA, 1984, BIO-TECHNOL, V2, P527, DOI 10.1038/nbt0684-527; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; MARSDEN HS, 1984, J VIROL, V50, P547, DOI 10.1128/JVI.50.2.547-554.1984; Muller WJ, 2009, J GEN VIROL, V90, P1153, DOI 10.1099/vir.0.008771-0; Petro CD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88529; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; STANBERRY LR, 1987, J INFECT DIS, V155, P914, DOI 10.1093/infdis/155.5.914; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; U. S. National Institutes of Health, 2016, HIV VACC TRIAL THAI; Wald A, 2003, J INFECT DIS, V187, P1509, DOI 10.1086/374976; Weiss H, 2004, HERPES S, V11, p24A; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; Yates NL, 2013, MUCOSAL IMMUNOL, V6, P692, DOI 10.1038/mi.2012.107	54	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176428	10.1371/journal.pone.0176428	http://dx.doi.org/10.1371/journal.pone.0176428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493891	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300018
J	Lin, SH; Chung, PH; Wu, YY; Fung, CP; Hsu, CM; Chen, LW				Lin, Shu-Han; Chung, Pei-Hsuan; Wu, Ying-Ying; Fung, Chang-Phone; Hsu, Ching-Mei; Chen, Lee-Wei			Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation	PLOS ONE			English	Article							INTESTINAL BACTERIAL OVERGROWTH; HEPATIC INFLAMMATION; IMMUNE-RESPONSE; ENDOTOXEMIA; INJURY; MOUSE; MODEL; RATS; GUT; DYSFUNCTION	Klebsiella pneumoniae (KP) is the most common pathogen of pyogenic liver abscess in East and Southeast Asia and diabetes mellitus (DM) is a major risk factor. The effect and mechanism of diabetes on KP liver abscess was examined in streptozotocin-induced diabetic mice and Akita mice (C57BL/6J-Ins2(Akita)). KP translocation to liver and plasma alaine transaminase levels were increased and liver clearance of KP was decreased in DM mice. Diabetic mice exhibited overgrowth of Enterococcus as well as E. coli and decreased lactobacilli/bifidas growth in intestine, increased intestinal iNOS protein and nitrite levels in portal vein, and increased IL-1 beta and TNF-alpha expression of Kupffer cells. Fructooligosaccharides (FOS) or dead L. salivarius (dLac) supplementation reversed diabetes-induced enteric dysbiosis, NO levels in portal vein, and KP translocation to liver. L-NAME treatment decreased intestinal iNOS protein expression as well as Kupffer cell activation and increased liver clearance of KP in DM mice. Dead E. coli (2x10(8) CFU/ml) feeding for one week induced iNOS and TLR4 expression of intestine in germ-free (GF) mice. Dead bacteria feeding induced IL-1 beta and TNF-alpha expression of Kupffer cells in GF mice but not in GF TLR4(-/-) mice. In conclusion, balance of intestinal microflora is important for preventing intestinal iNOS expression, Kupffer cell activation, and KP liver translocation in diabetes. Reversal of diabetes-induced enteric dysbiosis with FOS or dead L. salivarius decreases diabetes-induced intestinal iNOS expression and KP liver translocation. Diabetes induces Kupffer cell activation and KP liver translocation through enteric dysbiosis and nitric oxide production.	[Lin, Shu-Han; Fung, Chang-Phone; Chen, Lee-Wei] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan; [Lin, Shu-Han] Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan; [Chung, Pei-Hsuan; Hsu, Ching-Mei] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Wu, Ying-Ying; Chen, Lee-Wei] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital	Chen, LW (corresponding author), Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan.; Chen, LW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan.	lwchen@vghks.gov.tw		Chen, Lee-Wei/0000-0002-3583-1248	National Science Council [NSC101-2314-B-010-005-MY3]; Kaohsiung Veterans General Hospital [VGHKS100-055]	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital	National Science Council (NSC101-2314-B-010-005-MY3) Kaohsiung Veterans General Hospital (VGHKS100-055).	Alican I, 1996, AM J PHYSIOL-GASTR L, V270, pG225, DOI 10.1152/ajpgi.1996.270.2.G225; Ashare A, 2006, AM J RESP CRIT CARE, V173, P644, DOI 10.1164/rccm.200509-1470OC; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Bauer TM, 2002, AM J GASTROENTEROL, V97, P2364; Cesaro C, 2011, DIGEST LIVER DIS, V43, P431, DOI 10.1016/j.dld.2010.10.015; Chung PH, 2016, J NUTR BIOCHEM, V35, P48, DOI 10.1016/j.jnutbio.2016.05.013; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Fung CP, 2011, LAB INVEST, V91, P1029, DOI 10.1038/labinvest.2011.52; GUARNER C, 1993, HEPATOLOGY, V18, P1139; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hunninghake GW, 2010, AM J RESP CRIT CARE, V182, P517, DOI 10.1164/rccm.200911-1757OC; Jun DW, 2010, DIGEST DIS SCI, V55, P1465, DOI 10.1007/s10620-009-0870-9; LICHTMAN SN, 1990, GASTROENTEROLOGY, V98, P414, DOI 10.1016/0016-5085(90)90833-M; Lin YC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-50; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Moro G, 2002, J PEDIATR GASTR NUTR, V34, P291, DOI 10.1097/00005176-200203000-00014; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; PARKS DA, 1983, SURGERY, V94, P415; Sakai N, 2012, HEPATOLOGY, V55, P888, DOI 10.1002/hep.24756; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Sierra S, 2010, ANAEROBE, V16, P195, DOI 10.1016/j.anaerobe.2010.02.001; Szabo G, 2007, SEMIN LIVER DIS, V27, P339, DOI 10.1055/s-2007-991511; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Tang YM, 2009, ALCOHOL CLIN EXP RES, V33, P1220, DOI 10.1111/j.1530-0277.2009.00946.x; Unno N, 1997, GASTROENTEROLOGY, V113, P1246, DOI 10.1053/gast.1997.v113.pm9322519; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Yan AW, 2012, WORLD J HEPATOL, V4, P110, DOI 10.4254/wjh.v4.i4.110	31	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177269	10.1371/journal.pone.0177269	http://dx.doi.org/10.1371/journal.pone.0177269			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493939	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300079
J	Livingstone, M; Wheelhouse, N; Ensor, H; Rocchi, M; Maley, S; Aitchison, K; Wattegedera, S; Wilson, K; Sait, M; Siarkou, V; Vretou, E; Entrican, G; Dagleish, M; Longbottom, D				Livingstone, Morag; Wheelhouse, Nicholas; Ensor, Hannah; Rocchi, Mara; Maley, Stephen; Aitchison, Kevin; Wattegedera, Sean; Wilson, Kim; Sait, Michelle; Siarkou, Victoria; Vretou, Evangelia; Entrican, Gary; Dagleish, Mark; Longbottom, David			Pathogenic outcome following experimental infection of sheep with Chlamydia abortus variant strains LLG and POS	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; CHLAMYDOPHILA-ABORTUS; MONOCLONAL-ANTIBODIES; PLACENTAL TISSUES; GENOME SEQUENCE; PREGNANT SHEEP; PSITTACI; IDENTIFICATION; RESPONSES; REVEALS	This study investigated the pathogenesis of two variant strains (LLG and POS) of Chlamydia abortus, in comparison to a typical wild-type strain (S26/3) which is known to be responsible for late term abortion in small ruminants. Challenge with the three strains at mid-gestation resulted in similar pregnancy outcomes, with abortion occurring in approximately 50-60% of ewes with the mean gestational lengths also being similar. However, differences were observed in the severity of placental pathology, with infection appearing milder for strain LLG, which was reflected in the lower number of organisms shed in vaginal swabs post-partum and less gross pathology and organisms present in placental smears. Results for strain POS were somewhat different than LLG with a more focal restriction of infection observed. Post-abortion antibody responses revealed prominent differences in seropositivity to the major outer membrane protein (MOMP) present in elementary body (EB) preparations under denaturing conditions, most notably with anti-LLG and anti-POS convalescent sera where there was no or reduced detection of MOMP present in EBs derived from the three strains. These results and additional analysis of whole EB and chlamydial outer membrane complex preparations suggest that there are conformational differences in MOMP for the three strains. Overall, the results suggest that gross placental pathology and clinical outcome is not indicative of bacterial colonization and the severity of infection. The results also highlight potential conformational differences in MOMP epitopes that perhaps impact on disease diagnosis and the development of new vaccines.	[Livingstone, Morag; Wheelhouse, Nicholas; Rocchi, Mara; Maley, Stephen; Aitchison, Kevin; Wattegedera, Sean; Wilson, Kim; Sait, Michelle; Entrican, Gary; Dagleish, Mark; Longbottom, David] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Ensor, Hannah] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Siarkou, Victoria] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Lab Microbiol & Infect Dis, Thessaloniki, Greece; [Vretou, Evangelia] Hellenic Pasteur Inst, Dept Microbiol, Formerly Lab Biotechnol, Athens, Greece; [Wheelhouse, Nicholas] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Wilson, Kim] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Sait, Michelle] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Microbiol Diagnost Unit, Melbourne, Vic, Australia	Moredun Research Institute; James Hutton Institute; Aristotle University of Thessaloniki; Edinburgh Napier University; University of Edinburgh; University of Melbourne	Longbottom, D (corresponding author), Moredun Res Inst, Penicuik, Midlothian, Scotland.	david.longbottom@moredun.ac.uk	Longbottom, David/GWZ-8448-2022	Longbottom, David/0000-0003-0086-8443; Sait, Michelle/0000-0001-8782-6128; Ensor, Hannah/0000-0003-3052-7287	Rural and Environment Science and Analytical Services Division of the Scottish Government (RESAS) under the Moredun Research Institute's core Programme of Research; Biotechnology and Biological Sciences Research Council [BB/J015083/1] Funding Source: researchfish; BBSRC [BB/J015083/1] Funding Source: UKRI	Rural and Environment Science and Analytical Services Division of the Scottish Government (RESAS) under the Moredun Research Institute's core Programme of Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Rural and Environment Science and Analytical Services Division of the Scottish Government (RESAS, http://www.gov.scot), under the Moredun Research Institute's core Programme of Research to DL, GE and MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouakane A, 2005, VET REC, V157, P771, DOI 10.1136/vr.157.24.771; Bouakane A, 2003, INFECT IMMUN, V71, P7219, DOI 10.1128/IAI.71.12.7219-7222.2003; Buendia AJ, 1997, FEMS MICROBIOL LETT, V150, P113, DOI 10.1016/S0378-1097(97)00106-7; BUXTON D, 1986, VET REC, V118, P510, DOI 10.1136/vr.118.18.510; Buxton D, 2002, J COMP PATHOL, V127, P133, DOI 10.1053/jcpa.2002.0573; BUXTON D, 1990, J COMP PATHOL, V102, P221, DOI 10.1016/S0021-9975(08)80127-2; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Essig A, 2015, CURR CLIN MICROBIOL, V2, P22, DOI 10.1007/s40588-015-0014-2; Kerr K, 2010, VET MICROBIOL, V144, P392, DOI 10.1016/j.vetmic.2010.01.025; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Livingstone M, 2005, CLIN DIAGN LAB IMMUN, V12, P770, DOI 10.1128/CDLI.12.6.770-777.2005; Livingstone M, 2009, VET MICROBIOL, V135, P134, DOI 10.1016/j.vetmic.2008.09.033; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Longbottom D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057950; Maley SW, 2009, VET MICROBIOL, V135, P122, DOI 10.1016/j.vetmic.2008.09.031; MCCAFFERTY MC, 1995, INFECT IMMUN, V63, P2387, DOI 10.1128/IAI.63.6.2387-2389.1995; MCCLENAGHAN M, 1984, INFECT IMMUN, V45, P384, DOI 10.1128/IAI.45.2.384-389.1984; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Pospischil A, 2002, SWISS MED WKLY, V132, P64; Rodolakis A, 2015, VET MICROBIOL, V181, P107, DOI 10.1016/j.vetmic.2015.07.010; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; Sait M, 2011, J BACTERIOL, V193, P4276, DOI 10.1128/JB.05290-11; Sammin D, 2009, VET MICROBIOL, V135, P90, DOI 10.1016/j.vetmic.2008.09.054; Siarkou V, 2002, VET MICROBIOL, V85, P145, DOI 10.1016/S0378-1135(01)00506-5; Siarkou V., 1992, THESIS; Siarkou VI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126433; Siarkou VI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019813; STAMP J. T., 1950, VET REC, V62, P251; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Vretou E, 1996, VET MICROBIOL, V51, P275, DOI 10.1016/0378-1135(96)00048-X; Vretou E, 2001, INFECT IMMUN, V69, P607, DOI 10.1128/IAI.69.1.607-612.2001; Wilson K, 2009, VET MICROBIOL, V135, P38, DOI 10.1016/j.vetmic.2008.09.043; Wyllie S, 1998, INFECT IMMUN, V66, P5202, DOI 10.1128/IAI.66.11.5202-5207.1998	33	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177653	10.1371/journal.pone.0177653	http://dx.doi.org/10.1371/journal.pone.0177653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494018	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300148
J	Pinheiro, DL; Melkers, J; Newton, S				Pinheiro, Diogo L.; Melkers, Julia; Newton, Sunni			Take me where I want to go: Institutional prestige, advisor sponsorship, and academic career placement preferences	PLOS ONE			English	Article							GENDER; JOB; MOBILITY; SCIENCE; WOMEN; PHD; TRAJECTORIES; PRODUCTIVITY; PERCEPTIONS; INTERESTS	Placement in prestigious research institutions for STEM (science, technology, engineering, and mathematics) PhD recipients is generally considered to be optimal. Yet some doctoral recipients are not interested in intensive research careers and instead seek alternative careers, outside but also within academe (for example teaching positions in Liberal Arts Schools). Recent attention to non-academic pathways has expanded our understanding of alternative PhD careers. However, career preferences and placements are also nuanced along the academic pathway. Existing research on academic careers (mostly research-centric) has found that certain factors have a significant impact on the prestige of both the institutional placement and the salary of PhD recipients. We understand less, however, about the functioning of career preferences and related placements outside of the top academic research institutions. Our work builds on prior studies of academic career placement to explore the impact that prestige of PhD-granting institution, advisor involvement, and cultural capital have on the extent to which STEM PhDs are placed in their preferred academic institution types. What determines whether an individual with a preference for research oriented institutions works at a Research Extensive university? Or whether an individual with a preference for teaching works at a Liberal Arts college? Using survey data from a nationally representative sample of faculty in biology, biochemistry, civil engineering and mathematics at four different Carnegie Classified institution types (Research Extensive, Research Intensive, Master's I & II, and Liberal Arts Colleges), we examine the relative weight of different individual and institutional characteristics on institutional type placement. We find that doctoral institutional prestige plays a significant role in matching individuals with their preferred institutional type, but that advisor involvement only has an impact on those with a preference for research oriented institutions. Gender effects are also observed, particularly in the role of the advisor in affecting preferred career placement.	[Pinheiro, Diogo L.] Savannah State Univ, Dept Sociol, Savannah, GA USA; [Melkers, Julia] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Newton, Sunni] Georgia Inst Technol, Ctr Educ Integrating Sci Math & Comp, Atlanta, GA 30332 USA	University System of Georgia; Savannah State University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Melkers, J (corresponding author), Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA.	jmelkers@gatech.edu	Melkers, Julia/C-4310-2019; Pinheiro, Diogo/J-5927-2019	Pinheiro, Diogo/0000-0002-9938-1864; Melkers, Julia/0000-0001-5045-4068	U. S. National Science Foundation [DRL-0910191]; National Science Foundation (NSF) [DRL-0910191]	U. S. National Science Foundation(National Science Foundation (NSF)); National Science Foundation (NSF)(National Science Foundation (NSF))	This work comes from the U.S. National Science Foundation supported project: NETWISE II: Empirical Research: Breaking through the Reputational Ceiling: Professional Networks as a Determinant of Advancement, Mobility, and Career Outcomes for Women and Minorities in STEM, U. S. National Science Foundation Grant # DRL-0910191 to JM (http://www.nsf.gov/div/index.jsp?div-DRL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Science Foundation (NSF Grant # DRL-0910191). We thank the scientists who took the time to provide data for this study, and the anonymous reviewers who provided constructive and useful feedback.	Austin AE, 2002, J HIGH EDUC, V73, P94, DOI 10.1353/jhe.2002.0001; Baldi S, 1995, SOCIOL QUART, V36, P777, DOI 10.1111/j.1533-8525.1995.tb00464.x; Bedeian AG, 2010, ACAD MANAG LEARN EDU, V9, P11, DOI 10.5465/AMLE.2010.48661188; Bender K., 2009, SCI ENG CAREERS US A, P229, DOI [10.7208/9780226261904-011, DOI 10.7208/9780226261904-011]; Bourdieu Pierre, 2011, CULTURAL THEORY ANTH; Burris V, 2004, AM SOCIOL REV, V69, P239, DOI 10.1177/000312240406900205; Carless SA, 2005, J OCCUP ORGAN PSYCH, V78, P411, DOI 10.1348/096317905X25995; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; Correll SJ, 2001, AM J SOCIOL, V106, P1691, DOI 10.1086/321299; Council of Graduate Schools, PROF DEV SHAP EFF PR; CRANE D, 1965, AM SOCIOL REV, V30, P699, DOI 10.2307/2091138; Fairweather JS, 2005, J HIGH EDUC, V76, P401, DOI 10.1353/jhe.2005.0027; FAIRWEATHER JS, 1995, EDUC EVAL POLICY AN, V17, P179, DOI 10.2307/1164560; Feeney MK, 2010, SCIENTOMETRICS, V85, P767, DOI 10.1007/s11192-010-0256-y; Flattau PE, 1995, RES DOCTORATE PROGRA; Fowler JH, 2007, PS-POLIT SCI POLIT, V40, P729, DOI 10.1017/S104909650707117X; Fox MF, 2001, SOC STUD SCI, V31, P109, DOI 10.1177/030631201031001006; Fuerstman D, 2005, PS-POLIT SCI POLIT, V38, P731; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gabriel AS, 2014, PERS PSYCHOL, V67, P389, DOI 10.1111/peps.12042; Gibbs KD, 2013, CBE-LIFE SCI EDUC, V12, P711, DOI 10.1187/cbe.13-02-0021; Ginther DK, 1999, AM ECON REV, V89, P397, DOI 10.1257/aer.89.2.397; Grunspan DZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148405; HARGENS LL, 1967, SOCIOL EDUC, V40, P24, DOI 10.2307/2112185; HAUSMAN J, 1984, ECONOMETRICA, V52, P1219, DOI 10.2307/1910997; Headworth S, 2015, SOC FORCES; Keith B, 1998, SOC FORCES, V76, P1495, DOI 10.2307/3005843; Kirchmeyer C, 2006, J VOCAT BEHAV, V68, P323, DOI 10.1016/j.jvb.2005.05.002; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Ladner DA, 2012, J PROFESSIONAL ISSUE, V139, P211; Lam A, 2015, HUM RELAT, V68, P811, DOI 10.1177/0018726714545483; Lippa R, 1998, J PERS SOC PSYCHOL, V74, P996, DOI 10.1037/0022-3514.74.4.996; Lippa Richard A., 2005, GENDER NATURE NURTUR, V2nd, DOI 10.4324/9781410612946; Logan JA, 1996, AM J SOCIOL, V102, P114, DOI 10.1086/230910; LONG JS, 1985, SCIENTOMETRICS, V7, P255, DOI 10.1007/BF02017149; LONG JS, 1993, AM SOCIOL REV, V58, P703, DOI 10.2307/2096282; LONG JS, 1995, ANNU REV SOCIOL, V21, P45, DOI 10.1146/annurev.so.21.080195.000401; LONG JS, 1979, AM SOCIOL REV, V44, P816, DOI 10.2307/2094529; Mangematin V, 2000, RES POLICY, V29, P741, DOI 10.1016/S0048-7333(99)00047-5; MASON MA, 2009, ACADEME, V95, P11; McBrier DB, 2003, SOC FORCES, V81, P1201, DOI 10.1353/sof.2003.0065; McCormick A.C., 2001, CARNEGIE CLASSIFICAT; McGinnis R, 1988, ENTRY ACAD EFFECTS S; Miller CC, 2005, J ORGAN BEHAV, V26, P489, DOI 10.1002/job.325; National Institues of Health, 2015, BENZ OFT US OLD PEOP; National Science Foundation, 2008, SCI ENG IND 2008; Noy S, 2012, J HIGH EDUC-UK, V83, P876, DOI 10.1353/jhe.2012.0036; Peng YW, 2015, SOC INDIC RES, V121, P805, DOI 10.1007/s11205-014-0659-x; Pinheiro D, 2014, TECHNOL FORECAST SOC, V81, P56, DOI 10.1016/j.techfore.2012.09.008; Roach M, 2010, RES POLICY, V39, P422, DOI 10.1016/j.respol.2010.01.004; Robst J, 2007, ECON EDUC REV, V26, P397, DOI 10.1016/j.econedurev.2006.08.003; ROSENFELD RA, 1987, J HIGH EDUC, V58, P493, DOI 10.2307/1981784; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Su XH, 2011, J TECHNOL TRANSFER, V36, P275, DOI 10.1007/s10961-009-9133-3; TURNER RH, 1960, AM SOCIOL REV, V25, P855, DOI 10.2307/2089982; van Anders SM, 2004, SEX ROLES, V51, P511, DOI 10.1007/s11199-004-5461-9; West M.S., 2006, AAUP FACULTY GENDER; Wiggins A., 2007, EXPLORING PEER PREST; Williamson IO, 2003, J ORGAN BEHAV, V24, P25, DOI 10.1002/job.178; Wolfinger NH, 2009, SOC FORCES, V87, P1591, DOI 10.1353/sof.0.0182; Xie Y., 2003, WOMEN SCI CAREER PRO; Zhao CM, 2007, J FURTH HIGH EDUC, V31, P263, DOI 10.1080/03098770701424983; Zhao CM, 2005, J HIGH EDUC-UK, V76, P209, DOI 10.1353/jhe.2005.0018	63	13	13	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176977	10.1371/journal.pone.0176977	http://dx.doi.org/10.1371/journal.pone.0176977			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493914	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300047
J	Price, JT; Paladino, FV; Lamont, MM; Witherington, BE; Bates, ST; Soule, T				Price, James T.; Paladino, Frank V.; Lamont, Margaret M.; Witherington, Blair E.; Bates, Scott T.; Soule, Tanya			Characterization of the juvenile green turtle (Chelonia mydas) microbiome throughout an ontogenetic shift from pelagic to neritic habitats	PLOS ONE			English	Article							CARETTA-CARETTA; MARINE TURTLES; LIFE-STAGES; ECOLOGY; FERMENTATION; DIVERSITY; COMMUNITY; FLORIDA; SYSTEM; LAGOON	The gut microbiome of herbivorous animals consists of organisms that efficiently digest the structural carbohydrates of ingested plant material. Green turtles (Chelonia mydas) provide an interesting model of change in these microbial communities because they undergo a pronounced shift from a surface-pelagic distribution and omnivorous diet to a neritic distribution and herbivorous diet. As an alternative to direct sampling of the gut, we investigated the cloacal microbiomes of juvenile green turtles before and after recruitment to neritic waters to observe any changes in their microbial community structure. Cloacal swabs were taken from individual turtles for analysis of the 16S rRNA gene sequences using Illumina sequencing. One fecal sample was also obtained, allowing for a preliminary comparison with the bacterial community of the cloaca. We found significant variation in the juvenile green turtle bacterial communities between pelagic and neritic habitats, suggesting that environmental and dietary factors support different bacterial communities in green turtles from these habitats. This is the first study to characterize the cloacal microbiome of green turtles in the context of their ontogenetic shifts, which could provide valuable insight into the origins of their gut bacteria and how the microbial community supports their shift to herbivory.	[Price, James T.; Paladino, Frank V.; Soule, Tanya] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46202 USA; [Lamont, Margaret M.] US Geol Survey, Gainesville, FL USA; [Witherington, Blair E.] Disneys Anim Sci & Environm, Lake Buena Vista, FL USA; [Bates, Scott T.] Purdue Univ Northwest, Dept Biol Sci, Westville, IN USA; [Price, James T.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA	Purdue University System; Indiana University Purdue University Fort Wayne; United States Department of the Interior; United States Geological Survey; University System of Ohio; Ohio State University	Soule, T (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46202 USA.	soulet@ipfw.edu	Soule, Tanya/AGT-0635-2022; Price, James/Y-7265-2019	Soule, Tanya/0000-0003-2032-6422; Price, James/0000-0002-9439-9731; Paladino, Frank V./0000-0002-6452-0086; Bates, Scott/0000-0002-6184-4296	PADI Foundation; Leatherback Trust; Fort Wayne Children's Zoo Fund; Sea Turtle License Plate; Florida Fish and Wildlife Conservation Commission [14726]; US Geological Survey [17183]; Indiana University-Purdue University Fort Wayne	PADI Foundation; Leatherback Trust; Fort Wayne Children's Zoo Fund; Sea Turtle License Plate; Florida Fish and Wildlife Conservation Commission; US Geological Survey(United States Geological Survey); Indiana University-Purdue University Fort Wayne	This work was supported by the PADI Foundation (http://www.padifoundation.org/) to JTP, Jack W. Schrey Professorship to FVP, The Leatherback Trust (http://www.leatherback.org/) to FVP, The Fort Wayne Children's Zoo Fund (http://kidszoo.org/) to FVP, Sea Turtle License Plate (http://www.helpingseaturtles.org/) to BEW, Florida Fish and Wildlife Conservation Commission (NMFS Permit No. 14726; http://myfwc.com/) to BEW, US Geological Survey (NMFS Permit No. 17183; https://www.usgs.gov/) to MML, and Indiana University-Purdue University Fort Wayne (www.ipfw.edu) to JTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman KFA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01060; Arthur KE, 2014, ECOLOGY, V95, P1285, DOI 10.1890/13-0263.1; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bernardet J.F, 1923, GENUS; BJORNDAL KA, 1985, COPEIA, P736, DOI 10.2307/1444767; BJORNDAL KA, 1979, COMP BIOCHEM PHYS A, V63, P127, DOI 10.1016/0300-9629(79)90638-8; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona L, 2010, J EXP MAR BIOL ECOL, V393, P83, DOI 10.1016/j.jembe.2010.07.004; Colston TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128793; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FLAMMER K, 1988, AVIAN DIS, V32, P79, DOI 10.2307/1590952; Garrity GM, 2015, BERGEYS MANUAL SYSTE; Garrity GM, 2015, BERGEYS MANUAL ARCHA; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Hellein KN, 2011, J WATER HEALTH, V9, P695, DOI 10.2166/wh.2011.154; Hernandez-Gomez O, 2017, MICROB ECOL, V73, P445, DOI 10.1007/s00248-016-0859-9; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Ionescu D, 2016, MANUAL ENV MICROBIOL; Kohl KD, 2017, MOL ECOL, V26, P1175, DOI 10.1111/mec.13921; Lamont MM, 2015, HERPETOL CONSERV BIO, V10, P26; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; MENDONCA MT, 1982, COPEIA, P161; Modica B. P., 2016, THESIS; Rainey FA, 2015, BERGEYS MANUAL SYSTE; Song Y., 2015, BERGEYS MANUAL SYSTE; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Ueki A, 2006, INT J SYST EVOL MICR, V56, P39, DOI 10.1099/ijs.0.63896-0; Vander Zanden HB, 2013, OECOLOGIA, V173, P767, DOI 10.1007/s00442-013-2655-2; Wang DC, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-15; Williams BA, 2001, NUTR RES REV, V14, P207, DOI 10.1079/NRR200127; Williams NC, 2014, ESTUAR COAST, V37, P986, DOI 10.1007/s12237-013-9741-x; WITHERINGTON BE, 1989, COPEIA, P696; Witherington B, 2012, MAR ECOL PROG SER, V463, P1, DOI 10.3354/meps09970; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	38	49	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177642	10.1371/journal.pone.0177642	http://dx.doi.org/10.1371/journal.pone.0177642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493980	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300147
J	Xu, HF; An, JJ; Xu, BJ				Xu, Haifei; An, Juan Ji; Xu, Baoji			Distinct cellular toxicity of two mutant huntingtin mRNA variants due to translation regulation	PLOS ONE			English	Article							ALTERNATIVE CLEAVAGE; UNTRANSLATED REGIONS; TRANSGENIC MICE; DISEASE GENE; BDNF; POLYADENYLATION; PROTEINS; NEURONS; TRANSCRIPTION; EXPRESSION	Huntington's disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion within exon1 of the HTT gene. The gene generates two mRNA variants that carry either a short or long 30 untranslated region (3'UTR) while encoding the same protein. It remains unknown whether the two mRNA variants play distinct roles in HD pathogenesis. We found that the long HTT 3'UTR was capable of guiding mRNA to neuronal dendrites, suggesting that some long-form HTT mRNA is transported to dendrites for local protein synthesis. To assay roles of two HTT mRNA variants in cell bodies, we expressed mRNA harboring HTT exon1 containing 23x or 145x CAGs with the short or long 3'UTR. We found that mutant mRNA containing the short 3'UTR produced more protein aggregates and caused more apoptosis in both cultured neurons and HEK293 cells, compared with mutant mRNA containing the long 3'UTR. Although the two 3'UTRs did not affect mRNA stability, we detected higher levels of protein synthesis from mRNA containing the short 3'UTR than from mRNA containing the long 3'UTR. These results indicate that the long HTT 3'UTR suppresses translation. Thus, short-form mutant HTT mRNA will be more efficient in producing toxic protein than its long-form counterpart.	[Xu, Haifei; An, Juan Ji; Xu, Baoji] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute	Xu, BJ (corresponding author), Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA.	bxu@scripps.edu			National Institutes of Health [R01NS050596, R01NS073930]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050596, R01NS073930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from the National Institutes of Health (R01NS050596 and R01NS073930). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Zhixiang Xu for technical advice on lentivirus preparation. We thank Shaw-wen Wu, Guey-Ying Liao, Xiangyang Xie, and Tingting Xia for critical comments of the manuscript. This work is supported by grants from the National Institutes of Health (R01NS050596 and R01NS073930).	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Group T. H. D. C. R., 1993, CELL, V72, P971, DOI [10.1016/0092-8674(93)90585-E8458085, DOI 10.1016/0092-8674(93)90585-E8458085]; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Irier HA, 2009, J NEUROCHEM, V109, P584, DOI 10.1111/j.1471-4159.2009.05992.x; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; Kremers GJ, 2009, NAT METHODS, V6, P355, DOI [10.1038/NMETH.1319, 10.1038/nmeth.1319]; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Perry RB, 2012, NEURON, V75, P294, DOI 10.1016/j.neuron.2012.05.033; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao T, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00027	35	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177610	10.1371/journal.pone.0177610	http://dx.doi.org/10.1371/journal.pone.0177610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494017	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300145
J	Azoulay, E; Timsit, JF; Lautrette, A; Legriel, S; Max, A; Ruckly, S; Misset, B; Cohen, Y; Wolff, M				Azoulay, Elie; Timsit, Jean-Francois; Lautrette, Alexandre; Legriel, Stephane; Max, Adeline; Ruckly, Stephane; Misset, Benoit; Cohen, Yves; Wolff, Michel			Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; COST-EFFECTIVENESS ANALYSIS; PLACEBO-CONTROLLED TRIAL; INVASIVE CANDIDIASIS; HIGH-RISK; ECHINOCANDIN RESISTANCE; PROSPECTIVE MULTICENTER; ANTIFUNGAL PROPHYLAXIS; NEUTROPENIC PATIENTS; EMPIRIC TREATMENT	Background To demonstrate the feasibility and safety of weekly high-dose liposomal amphotericin B (L-AmB) (as a pre-emptive antifungal treatment) for 2 weeks in patients with septic shock and Candida colonization. Methods Pilot, multicentre, open-label, prospective study conducted in seven French ICUs. Non-immunocompromised patients, receiving mechanical ventilation were eligible if they presented ICU-acquired severe sepsis requiring newly administered antibacterial agents and Candida colonization in at least two sites. Exclusion criteria included the need for antifungal therapy and creatinine > 220 mu mol/L. All patients were to receive a high-dose L-AmB (10 mg/kg/week) for two weeks. A follow-up period of 21 days following the second administration of L-AmB was conducted. Treated patients were compared to 69 matched untreated controls admitted in the same ICUs before the study period. Results Twenty-one patients were included in the study, of which 20 received at least one infusion of high-dose L-AmB. A total of 24 adverse events were identified in 13(61%) patients. Fourteen adverse events were categorized as serious in 8(38%) patients. In four cases the adverse events were considered as potentially related to study drug administration and resulted in L-AmB discontinuation in one patient. Few patients experienced severe renal toxicity since no patient presented with severe hypokalemia. No patients required renal replacement therapy. Compared to matched controls, no significant increase in serum creatinine levels in patients receiving high-dose L-AmB was reported. Conclusions Weekly administration of high-dose L-AmB has a manageable safety profile and is feasible in patients with ICU-acquired sepsis and multiple Candida colonization. Trials of L-AmB versus other antifungal agents used as pre-emptive antifungal therapy are warranted.	[Azoulay, Elie; Max, Adeline] St Louis Univ Hosp, Med ICU, Paris, France; [Timsit, Jean-Francois; Wolff, Michel] Paris Diderot Univ, Med & Infect Dis ICU, Bichat Hosp, Paris, France; [Timsit, Jean-Francois] Grenoble Univ Hosp Albert Michallon, Med ICU, Grenoble, France; [Lautrette, Alexandre] Gabriel Montpied Univ Hosp, Med ICU, Clermont Ferrand, France; [Legriel, Stephane] Versailles Hosp, Medicosurg ICU, Le Chesnay, France; [Ruckly, Stephane] OUTCOMEREATM, Dept Biostat, Bobigny, France; [Misset, Benoit] St Joseph Univ Hosp, Med ICU, Paris, France; [Cohen, Yves] Avicenne Univ Hosp, Med ICU, Bobigny, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Clermont Ferrand; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Azoulay, E (corresponding author), St Louis Univ Hosp, Med ICU, Paris, France.	elie.azoulay@aphp.fr	Legriel, Stephane/J-1307-2017; Misset, Benoit/P-7817-2018	Legriel, Stephane/0000-0003-4782-6734; Misset, Benoit/0000-0001-6466-0065	Gilead Sciences	Gilead Sciences(Gilead Sciences)	An unrestricted research grant was given by Gilead Sciences to FOVEA Group, Rueil-Malmaison, France for supporting the study. The funding source had no role in the design, conduct or data analysis of the present study or in the decision to submit the manuscript for publication.	Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Caillot D, 2007, CANCER, V110, P2740, DOI 10.1002/cncr.23109; Chen H, 2007, CURR MED RES OPIN, V23, P1057, DOI 10.1185/030079907X182130; Cordonnier C, 2008, INT J ANTIMICROB AG, V31, P135, DOI 10.1016/j.ijantimicag.2007.10.001; Cordonnier C, 2009, CLIN INFECT DIS, V48, P1042, DOI 10.1086/597395; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Cornely OA, 2007, CLIN INFECT DIS, V44, P1289, DOI 10.1086/514341; Dannaoui E, 2012, EMERG INFECT DIS, V18, P86, DOI 10.3201/eid1801.110556; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Eggimann P, 2014, INTENS CARE MED, V40, P1429, DOI 10.1007/s00134-014-3355-z; El-Cheikh J, 2007, BONE MARROW TRANSPL, V39, P301, DOI 10.1038/sj.bmt.1705592; Fournier P, 2011, J ANTIMICROB CHEMOTH, V66, P2880, DOI 10.1093/jac/dkr394; Garbino J, 2002, INTENS CARE MED, V28, P1708, DOI 10.1007/s00134-002-1540-y; Garey KW, 2006, MYCOSES, V49, P226, DOI 10.1111/j.1439-0507.2006.01222.x; Giannella M, 2015, TRANSPLANTATION, V99, P848, DOI 10.1097/TP.0000000000000393; Golan Y, 2005, ANN INTERN MED, V143, P857, DOI 10.7326/0003-4819-143-12-200512200-00004; Guery BP, 2009, INTENS CARE MED, V35, P55, DOI 10.1007/s00134-008-1338-7; Hoenigl M, 2012, J ANTIMICROB CHEMOTH, V67, P2029, DOI 10.1093/jac/dks155; Juster-Reicher A, 2003, EUR J CLIN MICROBIOL, V22, P603, DOI 10.1007/s10096-003-0993-4; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; Lanternier F, 2015, J ANTIMICROB CHEMOTH, V70, P3116, DOI 10.1093/jac/dkv236; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leon C, 2006, CRIT CARE MED, V34, P730, DOI 10.1097/01.CCM.0000202208.37364.7D; Leon C, 2009, CRIT CARE MED, V37, P1624, DOI 10.1097/CCM.0b013e31819daa14; Lortholary O, 2014, INTENS CARE MED, V40, P1303, DOI 10.1007/s00134-014-3408-3; Maubon D, 2014, INTENS CARE MED, V40, P1241, DOI 10.1007/s00134-014-3404-7; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Ostrosky-Zeichner L, 2007, EUR J CLIN MICROBIOL, V26, P271, DOI 10.1007/s10096-007-0270-z; Ostrosky-Zeichner L, 2006, CRIT CARE MED, V34, P857, DOI 10.1097/01.CCM.0000201897.78123.44; Ostrosky-Zeichner L, 2014, CLIN INFECT DIS, V58, P1219, DOI 10.1093/cid/ciu074; Pelz R K, 2000, Surg Infect (Larchmt), V1, P273, DOI 10.1089/109629600750067200; Petri MG, 1997, INTENS CARE MED, V23, P317, DOI 10.1007/s001340050334; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2005, J CLIN MICROBIOL, V43, P5848, DOI 10.1128/JCM.43.12.5848-5859.2005; Piarroux R, 2004, CRIT CARE MED, V32, P2443, DOI 10.1097/01.CCM.0000147726.62304.7F; Posteraro B, 2011, CRIT CARE, V15, DOI 10.1186/cc10507; Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955; Rex JH, 2001, CLIN INFECT DIS, V32, P1191, DOI 10.1086/319763; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; Schuster MG, 2008, ANN INTERN MED, V149, P83, DOI 10.7326/0003-4819-149-2-200807150-00004; Shields RK, 2013, ANTIMICROB AGENTS CH, V57, P3528, DOI 10.1128/AAC.00136-13; Tabah A, 2012, INTENS CARE MED, V38, P1930, DOI 10.1007/s00134-012-2695-9; Timsit JF, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-399; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Walsh TJ, 2000, ANTIMICROB AGENTS CH, V44, P2068, DOI 10.1128/AAC.44.8.2068-2076.2000; Walsh TJ, 2001, ANTIMICROB AGENTS CH, V45, P3487, DOI 10.1128/AAC.45.12.3487-3496.2001; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177093	10.1371/journal.pone.0177093	http://dx.doi.org/10.1371/journal.pone.0177093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531175	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400009
J	Bertolino, M; Costa, G; Carella, M; Cattaneo-Vietti, R; Cerrano, C; Pansini, M; Quarta, G; Calcagnile, L; Bavestrello, G				Bertolino, Marco; Costa, Gabriele; Carella, Mirko; Cattaneo-Vietti, Riccardo; Cerrano, Carlo; Pansini, Maurizio; Quarta, Gianluca; Calcagnile, Lucio; Bavestrello, Giorgio			The dynamics of a Mediterranean coralligenous sponge assemblage at decennial and millennial temporal scales	PLOS ONE			English	Article							ROCKY BENTHIC COMMUNITIES; MASS-MORTALITY; MARINE; VARIABILITY; CLIMATE; DEMOSPONGIAE; PORIFERA; SPICULES; CNIDARIA; EOCENE	This paper concerns the changes occurred over both decennial and millennial spans of time in a sponge assemblage present in coralligenous biogenic build-ups growing at 15 m depth in the Ligurian Sea (Western Mediterranean). The comparison of the sponge diversity after a time interval of about 40 years (1973-2014) showed a significant reduction in species richness (about 45%). This decrease affected mainly the massive/erect sponges, and in particular the subclass Keratosa, with a species loss of 67%, while the encrusting and cavity dwelling sponges lost the 36% and 50%, respectively. The boring sponges lost only one species (25%). This changing pattern suggested that the inner habitat of the bioconstructions was less affected by the variations of the environmental conditions or by the human pressures which, on the contrary, strongly affected the species living on the surface of the biogenic build-ups. Five cores extracted from the bioherms, dating back to 3500 YBP, allowed to analyse the siliceous spicules remained trapped in them in order to obtain taxonomic information. Changes at generic level in diversity and abundance were observed at 500/250-years intervals, ranging between 19 and 33 genera. The number of genera showed a sharp decrease since 3500-3000 to 3000-2500 YBP. After this period, the genera regularly increased until 1500-1250 YBP, from when they progressively decreased until 1000-500 YBP. Tentatively, these changes could be related to the different climatic periods that followed one another in the Mediterranean area within the considered time span. The recent depletion in sponge richness recorded in the Ligurian coralligenous can be considered relevant. In fact, the analysis of the spicules indicated that the sponges living in these coralligenous habitats remained enough stable during 3000 years, but could have lost a significant part of their biodiversity in the last decades, coinciding with a series of warming episodes.	[Bertolino, Marco; Costa, Gabriele; Pansini, Maurizio; Bavestrello, Giorgio] Univ Genoa, DiSTAV, Genoa, Italy; [Carella, Mirko] CEAB Carrer Acces Cala St Francesc, Blanes, Spain; [Cattaneo-Vietti, Riccardo; Cerrano, Carlo] Univ Politecn Marche, DiSVA, Via Brecce Bianche, Ancona, Italy; [Quarta, Gianluca; Calcagnile, Lucio] Univ Salento, CEDAD, Via Arnesano, Lecce, Italy	University of Genoa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Marche Polytechnic University; University of Salento	Bavestrello, G (corresponding author), Univ Genoa, DiSTAV, Genoa, Italy.	giorgio.bavestrello@unige.it	Cerrano, Carlo/AAF-3557-2019; Costa, Gabriele/ABF-9784-2020	Cerrano, Carlo/0000-0001-9580-5546; Costa, Gabriele/0000-0003-1766-5247; BERTOLINO, Marco/0000-0003-3233-303X; Bavestrello, Giorgio/0000-0002-5428-2344	SIR grants (Italian Ministry for the Education) [RBSI14CH49]	SIR grants (Italian Ministry for the Education)	This study was financially supported by SIR grants (Italian Ministry for the Education #RBSI14CH49).; This study was financially supported by SIR grants (Italian Ministry for the Education #RBSI14CH49); we are indebted with Prof. Marco Ferrari (University of Genova) for his useful suggestions.	[Anonymous], 1985, W MEDITERRANEAN; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bavestrello G, 2000, MAR ECOL PROG SER, V193, P241, DOI 10.3354/meps193241; Bertolino M, 2014, MAR ECOL-EVOL PERSP, V35, P149, DOI 10.1111/maec.12063; Bertolino M, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.336.5139; Betti F, 2017, MAR ECOL IN PRESS; Bianchi CN, 2014, MEDITERR MAR SCI, V15, P482, DOI 10.12681/mms.678; Boudouresque C. F, 2016, MARINE ANIMAL FOREST; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Calcinai B, 2015, MEDITERR MAR SCI, V16, P413, DOI 10.12681/mms.900; Caleagnile L, 2005, APPL RADIAT ISOTOPES, V62, P623, DOI 10.1016/j.apradiso.2004.08.047; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P235; Cerrano C, 2006, ITAL J ZOOL, V73, P355, DOI 10.1080/11250000600911675; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; D'Elia M, 2004, NUCL INSTRUM METH B, V223, P278, DOI 10.1016/j.nimb.2004.04.056; Dansgaard W, 1984, CLIMATE PROCESSES CL; Di Geronimo I, 2002, GEOBIOS-LYON, V35, P86, DOI 10.1016/S0016-6995(02)00050-5; Drake BL, 2012, J ARCHAEOL SCI, V39, P1862, DOI 10.1016/j.jas.2012.01.029; FANELLI G, 1994, MAR ECOL PROG SER, V110, P1, DOI 10.3354/meps110001; Fraschetti S, 2001, MAR ECOL PROG SER, V212, P1, DOI 10.3354/meps212001; Frisone V, 2014, FACIES, V60, P883, DOI 10.1007/s10347-014-0407-3; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Garrabou J, 2000, EUR J PHYCOL, V35, P1; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; GOT H, 1968, VIE MILIEU B OCEANOG, V19, P9; Hong JS, 1980, THESIS U AIX MARSEIL, P1; Laborel J., 1961, REC TRAV ST MAR ENDO, V23, P37; Laubier L, 1966, ANN I OCEANOGRAPHIQU, V43, P139; Lukowiak M, 2016, CONTRIB ZOOL, V85, P13; Lukowiak M, 2013, PALAIOS, V28, P373, DOI 10.2110/palo.2012.p12-082r; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Mann M.E., 2002, ENCYCLOP GLOB ENV CH, V1, P504; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Pansini M., 1973, BOLLETTINO MUSEI IST, V41, P5; Piazzi L, 2012, MAR POLLUT BULL, V64, P2623, DOI 10.1016/j.marpolbul.2012.07.027; Puce S, 2009, MAR ECOL-EVOL PERSP, V30, P313, DOI 10.1111/j.1439-0485.2009.00283.x; Reale O, 2000, GLOBAL PLANET CHANGE, V25, P163, DOI 10.1016/S0921-8181(00)00002-3; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reimer PJ, 2002, RADIOCARBON, V44, P159, DOI 10.1017/S0033822200064766; Santos GG, 2016, ZOOTAXA, V4158, P105, DOI 10.11646/zootaxa.4158.1.6; SARA M, 1970, Pubblicazioni della Stazione Zoologica di Napoli, V38, P174; Sartoretto S, 1996, AGE SETTLEMENT ACCUM; Sicre MA, 2008, EARTH PLANET SC LETT, V268, P137, DOI 10.1016/j.epsl.2008.01.011; Taricco C, 2009, CLIM PAST, V5, P171, DOI 10.5194/cp-5-171-2009; Teixido A N, 2013, PLOS ONE, V8; Teixido A N, 2011, PLOS ONE, V6; Wiedenmayer F, 1994, CONTRIBUTIONS KNOWLE	50	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177945	10.1371/journal.pone.0177945	http://dx.doi.org/10.1371/journal.pone.0177945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531209	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400043
J	Demczuk, WHB; Martin, I; Hoang, L; Van Caeseele, P; Lefebvre, B; Horsman, G; Haldane, D; Gubbay, J; Ratnam, S; German, G; Bernier, JD; Strudwick, L; McGeer, A; Zhanel, GG; Van Domselaar, G; Graham, M; Mulvey, MR				Demczuk, Walter H. B.; Martin, Irene; Hoang, Linda; Van Caeseele, Paul; Lefebvre, Brigitte; Horsman, Greg; Haldane, David; Gubbay, Jonathan; Ratnam, Sam; German, Gregory; Bernier, Jennifer Daley; Strudwick, Lori; McGeer, Allison; Zhanel, George G.; Van Domselaar, Gary; Graham, Morag; Mulvey, Michael R.			Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing	PLOS ONE			English	Article							CONJUGATE VACCINE; MOLECULAR EPIDEMIOLOGY; UNITED-STATES; RESISTANCE; ENGLAND; REPLACEMENT; ALGORITHM; WALES	Since implementation of the 13-valent polyvalent conjugate vaccine (PCV13) in Canada during 2010, the proportion of PCV13 serotypes causing invasive pneumococcal disease (IPD) has declined from 55% (n = 1492) in 2010 to 31% (n = 764) in 2014. A concurrent increase of non-PCV13 serotypes has occurred and 22F has become the most prevalent serotype in Canada increasing from 7% (n = 183) to 11% (n = 283). Core single nucleotide variant phylogenetic analysis was performed on 137 Streptococcus pneumoniae serotype 22F isolates collected across Canada from 2005-2015. Six phylogenetic lineages (n = 117) were identified among a serotype 22F/ST433 clonal complex (CC), including a recently expanding erythromycin- resistant clone. Erythromycin-resistance was observed in 25 isolates possessing ermB, mef or a 23S rRNA A2061G point mutation; 2 penicillin-resistant isolates had recombinant pbp1a, pbp2a and/or pbp2x; 3 tetracycline-resistant isolates contained tetM; and 1 isolate was multidrug-resistant. Virulence factor analysis indicated a high level of homogeneity among the 22F/ST433 clonal complex strains. A group of 6 phylogenetic outlier strains had differing MLST, antimicrobial resistance and molecular profiles suggestive of capsule switching events. While capsule switch events among S. pneumoniae serotype 22F has been observed, increasing prevalence of S. pneumoniae serotype 22F can be attributed to an evolving homogenous clone expanding nationally through local transmission events.	[Demczuk, Walter H. B.; Martin, Irene; Van Domselaar, Gary; Graham, Morag; Mulvey, Michael R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Hoang, Linda] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Van Caeseele, Paul] Cadham Prov Lab, Winnipeg, MB, Canada; [Lefebvre, Brigitte] Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Horsman, Greg] Saskatchewan Dis Control Lab, Regina, SK, Canada; [Haldane, David] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Gubbay, Jonathan] Publ Hlth Ontario, Toronto, ON, Canada; [Ratnam, Sam] Newfoundland Publ Hlth Lab, St John, NF, Canada; [German, Gregory] Queen Elizabeth Hosp, Charlottetown, PE, Canada; [Bernier, Jennifer Daley] Stanton Territorial Hosp Lab, Yellowknife, NT, Canada; [Strudwick, Lori] Whitehorse Gen Hosp, Whitehorse, YT, Canada; [McGeer, Allison] Mt Sinai Hosp, Toronto Invas Bacterial Dis Network, Toronto, ON, Canada; [Zhanel, George G.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Van Domselaar, Gary; Graham, Morag] Publ Hlth Agcy Canada, Natl Microbiol Lab, Sci Technol Cores & Serv Div, Winnipeg, MB, Canada	Public Health Agency of Canada; Queen Elizabeth II Health Sciences Centre; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Manitoba; Public Health Agency of Canada	Mulvey, MR (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Michael.Mulvey@phac-aspc.gc.ca	McGeer, Allison/AAB-6885-2020; Gubbay, Jonathan/Q-8580-2019; Demczuk, Walter/K-5994-2016	McGeer, Allison/0000-0001-5647-6137; Gubbay, Jonathan/0000-0003-0026-3786; Demczuk, Walter/0000-0003-3723-9843	Public Health Agency of Canada	Public Health Agency of Canada	This work was supported by funding from the Public Health Agency of Canada.; We thank Averil Griffith, Karla Montes and Ravinder Singh Lidder from the Streptococcus and Sexually Transmitted Diseases Unit at NML for their laboratory technical assistance; Franklin Bristow, Aaron Petkau, Philip Mabon, Shane Thiessen, Josh Adam, Thomas Matthews, Adrian Zetner, Cameron Sieffert, and Natalie Knox from the NML Science Technology Cores and Services Division for their infrastructure, technical support and guidance; and the NML Genomics Core Facility for their next generation sequencing and analytical expertise. This work was supported by funding from the Public Health Agency of Canada.	Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Ardanuy C, 2012, PLOS ONE, V27, P73; Ardanuy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043619; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Blumental S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133885; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Caierao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111129; Chang QZ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0797-z; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Clinical and Laboratory Standards Institute, 2016, PERF STANDANT SUSC T; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Del Grosso M, 2006, ANTIMICROB AGENTS CH, V50, P3361, DOI 10.1128/AAC.00277-06; Depardieu F, 2001, ANTIMICROB AGENTS CH, V45, P319, DOI 10.1128/AAC.45.1.319-323.2001; European Centre for Disease Prevention and Control, 2015, ANN EP REP 2014 INV; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Horacio AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153602; Kendall BA, 2016, VACCINE, V34, P474, DOI 10.1016/j.vaccine.2015.12.010; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malhotra-Kumar S, 2005, ANTIMICROB AGENTS CH, V49, P4798, DOI 10.1128/AAC.49.11.4798-4800.2005; Marinier E, 2015, NEPTUNE A TOOL FOR R; Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, DOI [10.1016/j.cmi.2015.08.027, 10.1016/j.cmi.2016.08.001]; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Mosleh MN, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.12714; Nakano S, 2016, VACCINE, V34, P67, DOI 10.1016/j.vaccine.2015.11.015; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Pichon B, 2013, J CLIN MICROBIOL, V51, P820, DOI 10.1128/JCM.01917-12; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Public Health Agency of Canada, NOT DIS ON LIN 2016; Public Health Agency of Canada. National Surveillance of Invasive Streptococcal Disease in Canada, 2014, ANN SUMM 2014; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, P14; Schiffner-Rohe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146338; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Siira L, 2014, MICROB DRUG RESIST, V20, P124, DOI 10.1089/mdr.2013.0156; Slotved HC, 2016, VACCINE, V34, P769, DOI 10.1016/j.vaccine.2015.12.056; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van Hoek AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039150; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	51	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178040	10.1371/journal.pone.0178040	http://dx.doi.org/10.1371/journal.pone.0178040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531208	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400053
J	Xu, L; Guo, QX; Chang, GB; Qiu, LL; Liu, XP; Bi, YL; Zhang, Y; Wang, HZ; Lu, W; Ren, LC; Chen, Y; Zhang, Y; Xu, Q; Chen, GH				Xu, Lu; Guo, Qixin; Chang, Guobin; Qiu, Lingling; Liu, Xiangping; Bi, Yulin; Zhang, Yu; Wang, Hongzhi; Lu, Wei; Ren, Lichen; Chen, Ying; Zhang, Yang; Xu, Qi; Chen, Guohong			Discovery of microRNAs during early spermatogenesis in chicken	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PRIMORDIAL GERM-CELLS; EXPRESSION; PATHWAY; GENES	Spermatogenesis is a complex process that involves many elements. However, until now, little is known at the molecular level about spermatogenesis in poultry. Here we investigated microRNAs and their target genes that may be involved in germ cell development and spermatogonial in chicken. We used next-generation sequencing to analyze miRNA expression profiles in three types of germline cells: primordial germ cells (PGCs), spermatogonial stem cells (SSCs), and spermatogonia (Sp) during early stage of spermatogenesis. After validated the candidate miRNAs and corresponding genes' expression in three types of cells, we found 15 miRNAs that were enriched 21 target genes that may be involved in spermatogenesis. Among the enriched miRNAs, miR-202-5p/3p were up-regulated in the Sp library and down-regulated in the PGCs library. Through RT-qPCR and Dual-Luciferase reporter assay, we confirmed that miR-202-5p bind to LIMK2 and involved in germ cell development. Collectively, we firstly discover the novel miRNAs, like miR-202-5p, and its related genes and pathways, expressed during the early spermatogonial stage in chicken, which will provide new clues for deciphering the molecular mechanism of the miRNAs regulating germline stem cell differentiation and spermatogenesis in chicken.	[Xu, Lu; Guo, Qixin; Chang, Guobin; Qiu, Lingling; Bi, Yulin; Zhang, Yu; Lu, Wei; Ren, Lichen; Chen, Ying; Zhang, Yang; Xu, Qi; Chen, Guohong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Liu, Xiangping; Wang, Hongzhi] Chinese Acad Agr Sci, Poultry Inst, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences	Chang, GB; Chen, GH (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	passioncgb@163.com; ghchen@yzu.edu.cn	XU, Qi/AID-2262-2022; Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	National Natural Science Foundation of China [31372297]; International Agricultural Cooperation and Exchange Programme of China; Six Talent Peaks Project in Jiangsu Province [2015-NY-019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Agricultural Cooperation and Exchange Programme of China; Six Talent Peaks Project in Jiangsu Province	This work was supported by the National Natural Science Foundation of China (31372297), the International Agricultural Cooperation and Exchange Programme of China, and the Six Talent Peaks Project in Jiangsu Province (2015-NY-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breau MA, 2013, P NATL ACAD SCI USA, V110, P16892, DOI 10.1073/pnas.1306282110; Chang GB, 2015, ANIM REPROD SCI, V162, P95, DOI 10.1016/j.anireprosci.2015.09.016; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051724; Dabaja AA, 2015, BASIC CLIN ANDROL, V25, DOI 10.1186/s12610-015-0018-z; Govindaraju A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-82; Hermann BP, 2011, HUM REPROD, V26, P3222, DOI 10.1093/humrep/der343; Hicks JA, 2010, PHYSIOL GENOMICS, V41, P185, DOI 10.1152/physiolgenomics.00156.2009; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hu YC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005019; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Karakaya C, 2015, FERTIL STERIL, V103, P1469, DOI 10.1016/j.fertnstert.2015.02.035; Kruger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008978; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Li BiChun, 2002, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V23, P18; Liu T, 2013, STEM CELLS DEV, V22, P1839, DOI 10.1089/scd.2012.0653; Ma Hao H M, 2012, PLOS ONE, V7; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Saitou M, 2012, COLD SPRING HARB PER, V4; Song H. -W., 2012, SPERMATOGENESIS, V2, P238, DOI [10.4161/spmg.22069, DOI 10.4161/SPMG.22069]; Struijk RB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/903142; [孙敏 SUN Min], 2011, [生物技术, Biotechnology], V21, P16; Wainwright EN, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110155; Xu L, 2016, ANIM REPROD SCI, V166, P99, DOI 10.1016/j.anireprosci.2016.01.008; Zhang ZT, 2015, J BIOL CHEM, V290, P13605, DOI 10.1074/jbc.M114.601401	27	11	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177098	10.1371/journal.pone.0177098	http://dx.doi.org/10.1371/journal.pone.0177098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531200	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400010
J	Aggarwal, R; Chen, Q; Goel, A; Seguy, N; Pendse, R; Ayer, T; Chhatwal, J				Aggarwal, Rakesh; Chen, Qiushi; Goel, Amit; Seguy, Nicole; Pendse, Razia; Ayer, Turgay; Chhatwal, Jagpreet			Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; QUALITY-OF-LIFE; UNITED-STATES; ALL-CAUSE; VIRUS; SOFOSBUVIR; LEDIPASVIR; FIBROSIS; INTERFERON-ALPHA-2B; PEGINTERFERON	Background & aims Availability of directly-acting antivirals (DAAs) has changed the treatment landscape of hepatitis C virus (HCV) infection. The high price of DAAs has restricted their use in several countries. However, in some countries such as India, generic DAAs are available at much cheaper price. This study examined whether generic DAAs could be cost-saving and how long it would take for the treatment to become cost-saving/effective. Methods A previously-validated, mathematical model was adapted to the HCV-infected population in India to compare the outcomes of no treatment versus treatment with DAAs. Model parameters were estimated from published studies. Cost-effectiveness of HCV treatment using available DAAs was calculated, using a payer's perspective. We estimated quality-adjusted life years (QALYs), disability-adjusted life years (DALYs), total costs, and incremental cost-effectiveness ratio of DAAs versus no treatment. One-way and probabilistic sensitivity analyses were conducted. Results Compared with no treatment, the use of generic DAAs in Indian HCV patients would increase the life expectancy by 8.02 years, increase QALYs by 3.89, avert 19.07 DALYs, and reduce the lifetime healthcare costs by $1,309 per-person treated. Treatment became cost-effective within 2 years, and cost-saving within 10 years of its initiation overall and within 5 years in persons with cirrhosis. Treating 10,000 HCV-infected persons could prevent 3400-3850 decompensated cirrhosis, 1800-2500 HCC, and 4000-4550 liver-related deaths. The results were sensitive to the costs of DAAs, pre- and post-treatment diagnostic tests and management of cirrhosis, and quality of life after sustained virologic response. Conclusions Treatment with generic DAAs available in India will improve patient outcomes, provide a good value for money within 2 years, and be ultimately cost-saving. Therefore, in this and similar settings, HCV treatment should be a priority from a public health as well an economic perspective.	[Aggarwal, Rakesh; Goel, Amit] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow, Uttar Pradesh, India; [Chen, Qiushi; Chhatwal, Jagpreet] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Chen, Qiushi; Chhatwal, Jagpreet] Harvard Med Sch, Boston, MA 02115 USA; [Seguy, Nicole] WHO, India Country Off, New Delhi, India; [Pendse, Razia] WHO, Reg Off South East Asia, Communicable Dis Dept, New Delhi, India; [Ayer, Turgay] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; World Health Organization; National Centre for Disease Control (NCDC); World Health Organization; University System of Georgia; Georgia Institute of Technology	Chhatwal, J (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Chhatwal, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	JagChhatwal@mgh.harvard.edu	Chen, Qiushi/AAE-5002-2020; Aggarwal, Rakesh/D-1583-2009; Goel, Amit/H-2822-2019	Aggarwal, Rakesh/0000-0001-9689-494X; Chhatwal, Jagpreet/0000-0001-8741-4430; Goel, Amit/0000-0003-3525-9381	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Blach S, LANCET GAST IN PRESS; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chhatwal J, 2016, CLIN GASTROENTEROL H; Chhatwal J, 2016, PHARMACOECONOMICS, V34, P551, DOI 10.1007/s40273-015-0373-9; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chhatwal J, 2013, VALUE HEALTH, V16, P973, DOI 10.1016/j.jval.2013.07.006; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Gimeno-Ballester V, 2015, EXPERT REV PHARM OUT, P1; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032; Kohli A, 2015, LANCET INFECT DIS, V15, P1049, DOI 10.1016/S1473-3099(15)00157-7; Linas BP, 2015, ANN INTERN MED, V162, P619, DOI 10.7326/M14-1313; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Raghavan P, 2016, EC TIMES        0401; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Shah N, 2013, EXPERT OPIN INV DRUG, V22, P1107, DOI 10.1517/13543784.2013.806482; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Welzel TM, 2016, GUT; Westerhout K, 2015, J MED ECON, P1; WHO, 2016, WHO GUIDELINES SCREE; WHO, 2013, WHO METHODS DATA SOU; Wilson J, 2007, HEALTH TECHNOL ASSES, V11, P1; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2016, VIT HEP STRAT INF MO	36	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176503	10.1371/journal.pone.0176503	http://dx.doi.org/10.1371/journal.pone.0176503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520728	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700019
J	Berdan, EL; Finck, J; Johnston, PR; Waurick, I; Mazzoni, CJ; Mayer, F				Berdan, Emma L.; Finck, Jonas; Johnston, Paul R.; Waurick, Isabelle; Mazzoni, Camila J.; Mayer, Frieder			Transcriptome profiling of ontogeny in the acridid grasshopper Chorthippus biguttulus	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION SIGNALS; DROSOPHILA TAKEOUT GENE; RNA-SEQ DATA; SEXUAL SELECTION; DUSKY-LIKE; ANNOTATION; ORTHOPTERA; CUTICLE; PATHWAY; PROTEIN	Acridid grasshoppers (Orthoptera: Acrididae) are widely used model organisms for developmental, evolutionary, and neurobiological research. Although there has been recent influx of orthopteran transcriptomic resources, many use pooled ontogenetic stages obscuring information about changes in gene expression during development. Here we developed a de novo transcriptome spanning 7 stages in the life cycle of the acridid grasshopper Chorthippus biguttulus. Samples from different stages encompassing embryonic development through adults were used for transcriptomic profiling, revealing patterns of differential gene expression that highlight processes in the different life stages. These patterns were validated with semi-quantitative RT-PCR. Embryonic development showed a strongly differentiated expression pattern compared to all of the other stages and genes upregulated in this stage were involved in signaling, cellular differentiation, and organ development. Our study is one of the first to examine gene expression during post-embryonic development in a hemimetabolous insect and we found that only the fourth and fifth instars had clusters of genes upregulated during these stages. These genes are involved in various processes ranging from synthesis of biogenic amines to chitin binding. These observations indicate that post-embryonic ontogeny is not a continuous process and that some instars are differentiated. Finally, genes upregulated in the imago were generally involved in aging and immunity. Our study highlights the importance of looking at ontogeny as a whole and indicates promising directions for future research in orthopteran development.	[Berdan, Emma L.; Finck, Jonas; Waurick, Isabelle; Mayer, Frieder] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde Berlin, Berlin, Germany; [Finck, Jonas] Humboldt Univ, Dept Biol, Behav Physiol, Berlin, Germany; [Johnston, Paul R.] Free Univ Berlin, Berlin, Germany; [Mazzoni, Camila J.] Berlin Ctr Genom Biodivers Res, Berlin, Germany; [Mazzoni, Camila J.] Leibniz Inst Zoo & Wildtierforsch IZW, Berlin, Germany; [Mayer, Frieder] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Berdan, Emma L.] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Humboldt University of Berlin; Free University of Berlin; Leibniz Institut fur Zoo und Wildtierforschung; University of Gothenburg	Berdan, EL (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde Berlin, Berlin, Germany.; Berdan, EL (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	emma.berdan@gmail.com	Mazzoni, Camila/AAJ-9702-2020	Mazzoni, Camila/0000-0001-6758-5427; Johnston, Paul R./0000-0002-8651-4488; Berdan, Emma/0000-0002-6435-4604	Leibniz Association [SAW-2012-MfN-3]	Leibniz Association	The study is part of the GENART project funded by the Leibniz Association (SAW-2012-MfN-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2013, DEV BIOL, V379, P76, DOI 10.1016/j.ydbio.2013.04.012; BAEHR JC, 1979, J INSECT PHYSIOL, V25, P415, DOI 10.1016/0022-1910(79)90009-X; Bailey NW, 2013, G3-GENES GENOM GENET, V3, P225, DOI 10.1534/g3.112.004341; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLEY D, 1979, J EMBRYOL EXP MORPH, V54, P47; Berdan EL, 2016, MOL ECOL RESOUR, V16, P1478, DOI 10.1111/1755-0998.12530; Berdan EL, 2015, MOL ECOL, V24, P3918, DOI 10.1111/mec.13276; Bolognesi R, 2008, CURR BIOL, V18, P1624, DOI 10.1016/j.cub.2008.09.057; Chen DS, 2009, DEVELOPMENT, V136, P4133, DOI 10.1242/dev.039032; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Danks HV., 1987, INSECT DORMANCY AN E; Danley PD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-109; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Finck J, 2016, J COMP PHYSIOL A, P1; Fraley C., 2012, TECHNICAL REPORT NO; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenfield Michael D., 1997, P197; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Gruntenko NE, 2008, J INSECT PHYSIOL, V54, P902, DOI 10.1016/j.jinsphys.2008.04.004; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Gullan PJ, 2010, THE INSECTS AN OUTLI; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Gupta T, 2003, DEVELOPMENT, V130, P6075, DOI 10.1242/dev.00817; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Helfert B, 1975, ZEITSCHRIFT FUR ANGE; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; Hombria James Castelli-Gair, 2013, JAKSTAT, V2, pe26089, DOI 10.4161/jkst.26089; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; INGRISCH S, 1983, DEUT ENTOMOL Z, V30, P1; Ingrisch S, 1998, DIE HEUSCHRECKEN MIT; Jung I, 2011, FEBS LETT, V585, P1973, DOI 10.1016/j.febslet.2011.05.033; Kiel E, 2002, DIE EMBRYONALENTWICK; Klappert K, 2005, BEHAV ECOL SOCIOBIOL, V58, P36, DOI 10.1007/s00265-004-0902-6; Klappert K, 2003, ANIM BEHAV, V65, P225, DOI 10.1006/anbe.2002.2034; Kunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025613; LAKESHARLAN R, 1993, CELL TISSUE RES, V273, P97, DOI 10.1007/BF00304616; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D, 2015, INSECT BIOCHEM MOLEC, V58, P46, DOI 10.1016/j.ibmb.2015.01.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ly LL, 2013, GENE, V520, P106, DOI 10.1016/j.gene.2013.02.036; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Mayer F, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P451, DOI 10.1007/978-3-642-12425-9_21; Merlin C, 2005, BIOCHEM BIOPH RES CO, V332, P4, DOI 10.1016/j.bbrc.2005.04.084; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Minelli Alessandro, 2013, P91; Nagaraj R, 2012, DEVELOPMENT, V139, P906, DOI 10.1242/dev.074252; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PICHLER F., 1956, OSTERREICH ZOOL ZEITSCHR, V6, P513; Qiu Z, 2016, MOL ECOL RES; Qiu Z., 2016, INT J MOL SCI, V17, DOI [10.3390/ijms17071110, DOI 10.3390/ijms17071110]; Ragge DR, 1998, THE SONGS OF THE GRA; Ronacher B, 2008, J COMP PSYCHOL, V122, P252, DOI 10.1037/0735-7036.122.3.252; RUBTZOV I. A., 1934, BULL ENT RES, V25, P339, DOI 10.1017/S0007485300012736; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schmidt A, 2008, J COMP PHYSIOL A, V194, P221, DOI 10.1007/s00359-007-0295-x; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Tassone EE, 2016, GIGASCIENCE, V5, DOI [10.1186/s13742-016-0109-6, 10.1186/s13742-016-0130-9]; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; Theissinger K, 2016, MAR GENOM, V28, P7, DOI 10.1016/j.margen.2016.02.006; Uvarov B, 1966, GRASSHOPPERS AND LOC; VANWINGERDEN WKRE, 1991, OECOLOGIA, V87, P417, DOI 10.1007/BF00634600; Vedenina Varvara, 2011, Journal of Orthoptera Research, V20, P109; von Helversen Otto, 1994, Progress in Zoology, V39, P253; vonHelversen D, 1997, J COMP PHYSIOL A, V180, P373, DOI 10.1007/s003590050056; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Yoshioka Y, 2008, GENES CELLS, V13, P117, DOI 10.1111/j.1365-2443.2007.01155.x; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479	76	2	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177367	10.1371/journal.pone.0177367	http://dx.doi.org/10.1371/journal.pone.0177367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520760	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700044
J	Iovita, R; Tuvi-Arad, I; Moncel, MH; Despriee, J; Voinchet, P; Bahain, JJ				Iovita, Radu; Tuvi-Arad, Inbal; Moncel, Marie-Helene; Despriee, Jackie; Voinchet, Pierre; Bahain, Jean-Jacques			High handaxe symmetry at the beginning of the European Acheulian: The data from la Noira (France) in context	PLOS ONE			English	Article							ELLIPTIC FOURIER-ANALYSIS; MORPHOMETRIC-ANALYSIS; CENTER REGION; STONE TOOLS; SHAPE; REDUCTION; INDEX; FORM; QUANTIFICATION; SETTLEMENTS	In the last few decades, new discoveries have pushed the beginning of the biface-rich European Acheulian from 500 thousand years (ka) ago back to at least 700 ka, and possibly to 1 million years (Ma) ago. It remains, however, unclear to date if handaxes arrived in Europe as a fully developed technology or if they evolved locally from core-and-flake industries. This issue is also linked with another long-standing debate on the existence and behavioral, cognitive, and social meaning of a possibly chronological trend for increased handaxe symmetry throughout the Lower Paleolithic. The newly discovered sites can provide a link between the much older Acheulian in Africa and the Levant and the well-known assemblages from the later European Acheulian, enabling a rigorous testing of these hypotheses using modern morphometric methods. Here we use the Continuous Symmetry Measure (CSM) method to quantify handaxe symmetry at la Noira, a newly excavated site in central France, which features two archaeological levels, respectively ca. 700 ka and 500 ka old. In order to provide a context for the new data, we use a large aggregate from the well-known 500 ka old site of Boxgrove, England. We show that handaxes from the oldest layer at la Noira, although on average less symmetric than both those from the younger layers at the same site and than those from Boxgrove, are nevertheless much more symmetric than other early Acheulian specimens evaluated using the CSM method. We also correlate trends in symmetry to degree of reduction, demonstrating that raw material availability and discard patterns may affect observed symmetry values. We conclude that it is likely that, by the time the Acheulian arrived in Europe, its makers were, from a cognitive and motor-control point of view, already capable of producing the symmetric variant of this technology.	[Iovita, Radu] Leibniz Forsch Inst Archaol, MONREPOS Archaeol Res Ctr, Neuwied, Germany; [Iovita, Radu] Leibniz Forsch Inst Archaol, Romisch German Zent Museum, Museum Human Behav Evolut, Neuwied, Germany; [Iovita, Radu] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Tuvi-Arad, Inbal] Open Univ Israel, Dept Nat Sci, Raanana, Israel; [Moncel, Marie-Helene; Despriee, Jackie; Voinchet, Pierre; Bahain, Jean-Jacques] Museum Natl Hist Nat, Inst Paleontol Humaine, CNRS, Dept Prehist,UMR 7194, Paris, France	New York University; Open University Israel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Iovita, R (corresponding author), Leibniz Forsch Inst Archaol, MONREPOS Archaeol Res Ctr, Neuwied, Germany.; Iovita, R (corresponding author), Leibniz Forsch Inst Archaol, Romisch German Zent Museum, Museum Human Behav Evolut, Neuwied, Germany.; Iovita, R (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA.	iovita@nyu.edu	Iovita, Radu/B-9580-2015; Bahain, Jean-Jacques/AAB-8910-2019	Iovita, Radu/0000-0001-9531-1159; Bahain, Jean-Jacques/0000-0002-1446-5568	Agence Nationale de la Recherche [2010 BLAN 2006 01]; Association Archea (Region Centre, France); Ministere de la Culture et de la Communication; Museum National d'Histoire Naturelle; Romisch-Germanisches Zentralmuseum, Leibniz-Forschungsinstitut fur Archaologie; Open University of Israel [501291, 503232]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Archea (Region Centre, France); Ministere de la Culture et de la Communication; Museum National d'Histoire Naturelle; Romisch-Germanisches Zentralmuseum, Leibniz-Forschungsinstitut fur Archaologie; Open University of Israel	This work received support from the Agence Nationale de la Recherche, grant no 2010 BLAN 2006 01 - MHM; the Association Archea (Region Centre, France) - MHM; the Ministere de la Culture et de la Communication - MHM; the Museum National d'Histoire Naturelle - MHM; the Romisch-Germanisches Zentralmuseum, Leibniz-Forschungsinstitut fur Archaologie - RI; The Open University of Israel Research Fund grant no's 501291 and 503232 - ITA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2005, COORDIN CHEM REV, V249, P1693, DOI 10.1016/j.ccr.2005.03.031; Andrefsky W, 2006, AM ANTIQUITY, V71, P743, DOI 10.2307/40035887; [Anonymous], 2015, NATURE, DOI [DOI 10.4207/PA.2011.ART53, DOI 10.1038/nature14464]; Aranda V, 2015, INTERNATIONAL CONFER, P270; Archer W, 2016, J HUM EVOL, V97, P58, DOI 10.1016/j.jhevol.2016.05.007; Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Ashton NM, 2003, MULTIPLE APPROACHES, p109 ; Avnir D, 2013, NEXUS NETW J, V15, P171, DOI 10.1007/s00004-013-0144-x; Bailey SE, 2005, AM J PHYS ANTHROPOL, V126, P268, DOI 10.1002/ajpa.20037; Barsky D, 2013, CR PALEVOL, V12, P305, DOI 10.1016/j.crpv.2013.05.007; Barsky D, 2010, QUATERN INT, V223, P71, DOI 10.1016/j.quaint.2009.12.005; Beck C, 2002, J ANTHROPOL ARCHAEOL, V21, P481, DOI 10.1016/S0278-4165(02)00007-7; Bergman CA, 1990, BIG PUZZLE, P265; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Beyries S, 1982, STUDIA PRAEHISTORICA, V2, P235; Boeda E, LES INDUSTRIES A OUT; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Bordes F., 1961, TYPOLOGIE PALEOLITHI; Borel A, 2016, ARCHAEOMETRY; Borel A, 2013, J ANTHR ARCHAEOL; Buchanan B, 2006, J ARCHAEOL SCI, V33, P185, DOI 10.1016/j.jas.2005.07.008; Buchanan B, 2009, J ARCHAEOL SCI; Buchanan B, 2014, ARCHAEOL ANTHROP SCI, V6, P145, DOI 10.1007/s12520-013-0168-x; Cardillo M., 2010, MORPHOMETRICS NONMOR, P325, DOI DOI 10.1007/978-3-540-95853-6_15; Cardini A, 2004, ITAL J ZOOL, V71, P17, DOI 10.1080/11250000409356546; Clark JD, 1994, INTEGR PATHS PAST, V451, P69; Clarkson C, 2002, J ARCHAEOL SCI, V29, P65, DOI 10.1006/jasc.2001.0702; Claud E, 2008, LE STATUT FONCTIONNE; Cole J, 2015, SETTLEMENT SOC COGNI; Corbey R, 2016, EVOL ANTHROPOL, V25, P6, DOI 10.1002/evan.21467; CROMPTON RH, 1993, J HUM EVOL, V25, P175, DOI 10.1006/jhev.1993.1043; Daegling DJ, 2000, J HUM EVOL, V39, P107, DOI 10.1006/jhev.2000.0402; de Azevedo S, 2014, J ARCHAEOL SCI, V41, P297, DOI 10.1016/j.jas.2013.08.013; Despriee J, 2005, DONNEES RECENTES MOD, P431; Despriee J, 2007, QUATERNAIRE, V18, P349; Despriee J, 2011, QUATERNARY SCI REV, V30, P1474, DOI 10.1016/j.quascirev.2011.02.011; Despriee J, 2010, QUATERN INT, V223, P345, DOI 10.1016/j.quaint.2009.07.019; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; Dibble HL, 1999, LITHIC TECHNOL, V24, P38, DOI DOI 10.1080/01977261.1999.11720944; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Dryzun C, 2012, CHEM COMMUN, V48, P5874, DOI 10.1039/c2cc17727g; Dryzun C, 2009, J MATER CHEM, V19, P2062, DOI 10.1039/b817497k; Eren MI, 2009, J ARCHAEOL SCI, V36, P1243, DOI 10.1016/j.jas.2009.01.011; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; Frere J, 1800, ARCHAEOLOGIA, V13, P204; Friess M, 2003, AM J PHYS ANTHROPOL, V122, P11, DOI 10.1002/ajpa.10286; Gallotti R, 2010, AFR ARCHAEOL REV, V27, P291, DOI 10.1007/s10437-010-9083-z; Chacon MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155316; GERO J, 1984, J FIELD ARCHAEOL, V11, P315, DOI 10.1179/009346984791535467; Gowlett J.A.J., 1994, AFR ARCHAEOL REV, V12, P3, DOI DOI 10.1007/BF01953037); Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Hiscock P, 2010, WORLD ARCHAEOL, V42, P545, DOI 10.1080/00438243.2010.517669; Hodgson D, 2015, J ARCHAEOL SCI-REP, V2, P204, DOI 10.1016/j.jasrep.2015.02.002; Hodgson D, 2011, SYMMETRY-BASEL, V3, P37, DOI 10.3390/sym3010037; Hodgson D, 2009, CR PALEVOL, V8, P93, DOI 10.1016/j.crpv.2008.10.009; Iovita R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029029; Iovita R, 2011, J HUM EVOL, V61, P61, DOI 10.1016/j.jhevol.2011.02.007; Iovita R, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P235, DOI 10.1007/978-1-4419-6861-6_10; Iovita R, 2009, J ARCHAEOL SCI, V36, P1447, DOI 10.1016/j.jas.2009.02.008; Jimenez-Arenas JM, 2011, J ARCHAEOL SCI, P1; Johnson J, 1981, YELLOW CREEK ARCHAEO, V2; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Key AJM, 2016, J ARCHAEOL METHOD TH; Kohn M, 1999, ANTIQUITY, V73, P518, DOI 10.1017/S0003598X00065078; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; KUHN SL, 1990, J ARCHAEOL SCI, V17, P583, DOI 10.1016/0305-4403(90)90038-7; Lefevre D, 2010, QUATERN INT, V223, P360, DOI 10.1016/j.quaint.2010.02.020; Lestrel P E, 1982, Prog Clin Biol Res, V101, P393; LESTREL PE, 1976, HUM BIOL, V48, P517; Li H, QUAT INT; Lin SC, 2013, AM ANTIQUITY, V78, P724, DOI 10.7183/0002-7316.78.4.724; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2011, J EVOLUTIONARY PSYCH, V9, P143, DOI [DOI 10.1016/J.JAA.2007.07.003, DOI 10.1556/JEP.9.2011.23.1]; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P2640, DOI 10.1016/j.jas.2008.05.002; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Lycett SJ, 2016, QUATERN INT, V411, P386, DOI 10.1016/j.quaint.2015.08.021; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; Marchal F, 2000, J HUM EVOL, V38, P347, DOI 10.1006/jhev.1999.0360; Martinez K, 2016, J ANTHROPOL ARCHAEOL, V44, P87, DOI 10.1016/j.jaa.2016.09.003; McNabb J, 2015, J ARCHAEOL SCI-REP, V3, P100, DOI 10.1016/j.jasrep.2015.06.004; McPherron S., 2006, AXE AGE ACHEULIAN TO, P267; McPherron S. P., 1999, PREHISTOIRE EUROPEEN, V14, P9; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; McPherron SP, 2003, MULTIPLE APPROACHES, P55; McPherron SP, 1995, LITHICS, P9; Mitchell J, 1997, MICROSCOPY ANAL, P15; Mitchell J, 1995, LITHICS, P64; Moncel M-H, COMPTES REN IN PRESS; Moncel MH, 2016, QUATERN INT, V393, P112, DOI 10.1016/j.quaint.2015.04.051; Moncel MH, 2015, J ANTHROPOL ARCHAEOL, V40, P302, DOI 10.1016/j.jaa.2015.09.005; Moncel MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075529; Nowell A, 2003, MULTIPLE APPROACHES, P193; Nowell A., 2009, PALEOANTHROPOLOGY, V2009, P77; Picin A, 2014, QUATERN INT, V350, P84, DOI 10.1016/j.quaint.2014.05.004; Pinsky M, 2008, J COMPUT CHEM, V29, P190, DOI 10.1002/jcc.20772; Piperno M, 1999, NOTARCHIRICO SITO PL; Pope M, 2015, LITHICS J LITHIC STU, P44; Pope M., 2006, LITHICS J LITHIC STU, V27, P47; Pope M, 2005, HOMINID INDIVIDUAL C, P81; Pope MI, 2002, SIGNIFICANCE BIFACE; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; R Core Team, 2013, R LANG ENV STAT COMP; Roberts MB., 1999, BOXGROVE MIDDLE PLEI; Roberts MB, 1988, REV ARCHEOLOGIQUE PI, V1, P105, DOI DOI 10.3406/pica.1988.1581; ROCHE H, 1987, CR ACAD SCI II, V305, P529; Roche H., 1988, AFR ARCHAEOL REV, V6, P27, DOI [DOI 10.1007/BF01117111, DOI 10.1007/BF01117111)]; Roe D.A., 1968, P PREHIST SOC, VVolume 34, P1, DOI [DOI 10.1016/j.jhevol.2010.02.005, DOI 10.1017/S0079497X00013840]; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Saragusti I, 2005, J ARCHAEOL SCI, V32, P841, DOI 10.1016/j.jas.2005.01.002; Saragusti I, 1998, J ARCHAEOL SCI, P25; Schmittbuhl M, 2003, MATH GEOL, V35, P853, DOI 10.1023/B:MATG.0000007783.72366.0c; Scott GR, 2009, NATURE, V461, P82, DOI 10.1038/nature08214; Shchelinskii VE, 1994, EKSP TRASOLOGICHESKI, P22; Shen GJ, 2012, ANTHROPOLOGIE, V116, P1, DOI 10.1016/j.anthro.2011.12.007; Shipton C, 2015, J ARCHAEOL SCI-REP, V3, P408, DOI 10.1016/j.jasrep.2015.06.029; Shott M.J., 2005, LITHICS DOWN UNDER A, P109; Shott M, 2014, WORLD ARCHAEOL, V46, P1, DOI 10.1080/00438243.2013.879046; Spikins P, 2012, WORLD ARCHAEOL, V44, P378, DOI 10.1080/00438243.2012.725889; Texier P.-J., 2001, PRAEHISTORIA, V2, P51; Texier P.-J., 1995, EVOLUCION HUMANA EUR, V2, P403; Thulman DK, 2012, J ARCHAEOL SCI, V39, P1599, DOI 10.1016/j.jas.2012.01.004; Tuvi-Arad I, 2010, CHEM EDUC RES PRACT, V11, P48, DOI 10.1039/C001046B; Vallverdu A J, 2014, PLOS ONE, V9; Voinchet P, 2010, QUAT GEOCHRONOL, V5, P381, DOI 10.1016/j.quageo.2009.03.005; Wayman JL, 2010, LITHIC TECHNOL, V35, P171, DOI 10.1080/01977261.2010.11721089; White M. J., 1998, P PREHIST SOC, V66, P1; Wilson J, 2008, LITHIC TECHNOLOGY: MEASURES OF PRODUCTION, USE, AND CURATION, P86, DOI 10.1017/CBO9780511499661.005; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; ZABRODSKY H, 1992, J AM CHEM SOC, V114, P7843, DOI 10.1021/ja00046a033; ZABRODSKY H, 1995, IEEE T PATTERN ANAL, V17, P1154, DOI 10.1109/34.476508; Zayit A, 2011, CHIRALITY, V23, P17, DOI 10.1002/chir.20807; Zutovski K, 2016, QUATERN INT, V406, P227, DOI 10.1016/j.quaint.2015.01.033	132	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177063	10.1371/journal.pone.0177063	http://dx.doi.org/10.1371/journal.pone.0177063			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520745	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700035
J	Masuki, S; Nishida, K; Hashimoto, S; Morikawa, M; Takasugi, S; Nagata, M; Taniguchi, S; Rokutan, K; Nose, H				Masuki, Shizue; Nishida, Kensei; Hashimoto, Shigenari; Morikawa, Mayuko; Takasugi, Satoshi; Nagata, Masashi; Taniguchi, Shun'ichiro; Rokutan, Kazuhito; Nose, Hiroshi			Effects of milk product intake on thigh muscle strength and NFKB gene methylation during home-based interval walking training in older women: A randomized, controlled pilot study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RESISTANCE EXERCISE; DNA METHYLATION; KAPPA-B; SKELETAL-MUSCLE; SIGNALING PATHWAYS; METABOLIC SYNDROME; PHYSICAL-FITNESS; BLOOD-PRESSURE; LIFE-STYLE	Background Muscle atrophy with aging is closely associated with chronic systemic inflammation and life-style-related diseases. In the present study, we assessed whether post-exercise milk product intake during 5-month interval walking training (IWT) enhanced the increase in thigh muscle strength and ameliorated susceptibility to inflammation in older women. Methods Subjects [n = 37, 66 +/- 5 (standard deviation) yrs] who had been performing IWT for >6 months participated in this study. They were randomly divided into the following 3 groups: IWT alone (CNT, n = 12), IWT + low-dose post-exercise milk product intake (LD, n = 12; 4 g protein and 3 g carbohydrate) or IWT + a 3-times higher dose of milk product intake than the LD group (HD, n = 13). They were instructed to repeat >= 5 sets of fast and slow walking for 3 min each at >= 70% and 40% peak aerobic capacity for walking, respectively, per day for >= 4 days/week. Results After IWT, thigh muscle strength increased in the HD group (8 +/- 2%) more than in the CNT group (-2 +/- 3%, P = 0.022), despite similar IWT achievements between the groups (P>0.15). Pyrosequencing analysis using whole blood showed that methylation of NFKB1 and NFKB2, master genes of inflammation, was enhanced in the HD group (29 +/- 7% and 44 +/- 11%, respectively) more than in the CNT group (-20 +/- 6% and -10 +/- 6%, respectively; P<0.001). Moreover, the genome-wide DNA methylation analysis showed that several inflammation-related genes were hyper-methylated in the HD group compared with that in the CNT group, suggesting greater pro-inflammatory cytokine gene suppression in the HD group. Conclusion HD milk product intake after exercise produced a greater percent increase in thigh muscle strength and NFKB1 and NFKB2 gene methylation during IWT in physically active older women.	[Masuki, Shizue; Morikawa, Mayuko; Nose, Hiroshi] Shinshu Univ, Dept Sports Med Sci, Grad Sch Med, Matsumoto, Nagano, Japan; [Masuki, Shizue; Morikawa, Mayuko; Taniguchi, Shun'ichiro; Nose, Hiroshi] Shinshu Univ, Inst Biomed Sci, Matsumoto, Nagano, Japan; [Nishida, Kensei; Rokutan, Kazuhito] Tokushima Univ, Inst Biomed Sci, Dept Pathophysiol, Grad Sch, Tokushima, Japan; [Hashimoto, Shigenari] Shinshu Univ Hosp, Adv Prevent Med Ctr, Matsumoto, Nagano, Japan; [Morikawa, Mayuko] Jukunen Taiikudaigaku Res Ctr, Matsumoto, Nagano, Japan; [Takasugi, Satoshi; Nagata, Masashi] Meiji Co Ltd, Food Sci Res Labs, Odawara, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Dept Mol Oncol, Grad Sch Med, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Tokushima University; Shinshu University; Meiji Holdings Co., Ltd.; Shinshu University	Nose, H (corresponding author), Shinshu Univ, Dept Sports Med Sci, Grad Sch Med, Matsumoto, Nagano, Japan.; Nose, H (corresponding author), Shinshu Univ, Inst Biomed Sci, Matsumoto, Nagano, Japan.	nosehir@shinshu-u.ac.jp	Nishida, Kensei/AAF-2829-2020	Nishida, Kensei/0000-0003-2314-785X	Japan Society for the Promotion of Science [25670117, 15H01830, 15H04680]; Meiji Co. Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Meiji Co. Ltd.	This study was funded by grants from the Japan Society for the Promotion of Science (25670117, 15H01830, 15H04680) and by Meiji Co. Ltd. S. Takasugi and MN are full-time employees of Meiji Co. Ltd and were contributed to the study design. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; BENNET WM, 1990, AM J PHYSIOL, V259, pE185, DOI 10.1152/ajpendo.1990.259.2.E185; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Buford TW, 2010, J GERONTOL A-BIOL, V65, P532, DOI 10.1093/gerona/glp196; Cano-Ramos E, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.956013; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; Ching T, 2014, MOL HUM REPROD, V20, P885, DOI 10.1093/molehr/gau046; Crichton GE, 2012, INT DAIRY J, V22, P15, DOI 10.1016/j.idairyj.2011.08.001; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x; Fernandez-Jimenez N, 2014, HUM MOL GENET, V23, P1298, DOI 10.1093/hmg/ddt520; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Heyn H, 2013, CARCINOGENESIS, V34, P102, DOI 10.1093/carcin/bgs321; Holm L, 2008, J APPL PHYSIOL, V105, P274, DOI 10.1152/japplphysiol.00935.2007; Jette AM, 1999, J GERONTOL A-BIOL, V54, pM3, DOI 10.1093/gerona/54.1.M3; Kataoka Y, 2016, J APPL PHYSIOL, V121, P1021, DOI 10.1152/japplphysiol.00033.2016; Kitazawa S, 2002, BIOCHEM BIOPH RES CO, V293, P126, DOI 10.1016/S0006-291X(02)00189-4; Kukuljan S, 2009, J APPL PHYSIOL, V107, P1864, DOI 10.1152/japplphysiol.00392.2009; Laboratory of Physical Fitness Standards, 2007, NEW PHYS FITN STAND, P1; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/276850; McArdle WD, 1999, SPORTS AND EXERCISE, P106; Ministerio da Saude, 2010, DGPRE 001068 P 14012, P1; Ministry of Health, 2011, FY2011 TRENDS FISH, P1; Morikawa M, 2011, BRIT J SPORT MED, V45, P216, DOI 10.1136/bjsm.2009.064816; Morishima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108690; Nemoto K, 2007, MAYO CLIN PROC, V82, P803, DOI 10.4065/82.7.803; Niizeki T, 2007, CIRC J, V71, P1452, DOI 10.1253/circj.71.1452; Nose H, 2009, J PHYSIOL-LONDON, V587, P5569, DOI 10.1113/jphysiol.2009.179499; Okazaki K, 2013, SCAND J MED SCI SPOR, V23, pE286, DOI 10.1111/sms.12076; Okazaki K, 2009, J APPL PHYSIOL, V107, P725, DOI 10.1152/japplphysiol.91265.2008; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Pettersson AML, 2015, DIABETOLOGIA, V58, P2115, DOI 10.1007/s00125-015-3673-x; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Reidy PT, 2016, J NUTR, V146, P155, DOI 10.3945/jn.114.203208; Reitelseder S, 2011, AM J PHYSIOL-ENDOC M, V300, pE231, DOI 10.1152/ajpendo.00513.2010; Ricceri F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106846; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Rodriguez-Miguelez P, 2014, AGE, V36, DOI 10.1007/s11357-014-9734-0; ROSLER K, 1986, J APPL PHYSIOL, V61, P30, DOI 10.1152/jappl.1986.61.1.30; Ruegsegger GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145229; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907; Stancliffe RA, 2011, AM J CLIN NUTR, V94, P422, DOI 10.3945/ajcn.111.013342; Stewart LK, 2007, MED SCI SPORT EXER, V39, P1714, DOI 10.1249/mss.0b013e31811ece1c; Swanson SC, 2000, MED SCI SPORT EXER, V32, P1146, DOI 10.1097/00005768-200006000-00018; Taaffe DR, 2000, J GERONTOL A-BIOL, V55, pM709, DOI 10.1093/gerona/55.12.M709; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka S, 2014, J NUTR SCI VITAMINOL, V60, P305, DOI 10.3177/jnsv.60.305; Tang JE, 2009, J APPL PHYSIOL, V107, P987, DOI 10.1152/japplphysiol.00076.2009; Thompson WR, 2010, ACSMS GUIDELINES FOR, P151; Tipton KD, 2004, MED SCI SPORT EXER, V36, P2073, DOI 10.1249/01.MSS.0000147582.99810.C5; Uenishi K, 2010, ASIA PAC J CLIN NUTR, V19, P432; Unterberg M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156702; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Wong NC, 2013, GENOMICS, V102, P38, DOI 10.1016/j.ygeno.2013.04.014; Wu JH, 2016, J EUR ACAD DERMATOL, V30, P1061, DOI 10.1111/jdv.13111; Yamazaki T, 2009, MED SCI SPORT EXER, V41, P2213, DOI 10.1249/MSS.0b013e3181a9c452; Zhang Y, 2015, INT J SPORTS MED, V36, P769, DOI 10.1055/s-0035-1547221	63	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176757	10.1371/journal.pone.0176757	http://dx.doi.org/10.1371/journal.pone.0176757			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520754	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700028
J	Raghav, A; Ahmad, J; Alam, K				Raghav, Alok; Ahmad, Jamal; Alam, Khursheed			Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus	PLOS ONE			English	Article							ADVANCED GLYCATION ENDPRODUCTS; MODIFIED HUMAN DNA; METABOLIC SYNDROME; END-PRODUCTS; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; URIC-ACID; RECEPTOR; RAGE; NEPHROPATHY	Background Albumin glycation and subsequent formation of advanced glycation end products (AGEs) correlate with diabetes and associated complications. Methods Human Serum Albumin (HSA) was modified with D-glucose for a 40 day period under sterile conditions at 37 degrees C. Modified samples along with native HSA (unmodified) were analyzed for structural modifications by UV and fluorescence, FTIR, Liquid chromatography mass spectrometry (LCMS) and X-ray crystallography. New-Zealand white female rabbits immunized with AGEs, represent auto-antibodies formation as assessed by competitive and direct binding enzyme-linked immunosorbent assay (ELISA). Neo-epitopesagainst In-vitro formed AGEs were characterized in patients with diabetes mellitus type 2 (n = 50), type 1 (n = 50), gestational diabetes (n = 50) and type 2 with chronic kidney disease (CKD) with eGFR level 60-89 mL/min (n = 50) from serum direct binding ELISA. Results Glycated-HSA showed a marked increase in hyperchromicity of 65.82%, 71.98%, 73.62% and 76.63% at. 280 nm along with anincreasein fluorescence intensity of 65.82%, 71.98%, 73.62% and 76.63% in glycated-HSA compared to native. FTIR results showed theshifting of Amide I peak from 1656 cm(-1) to 1659 cm(-1) and Amide II peak from 1554 cm(-1) to 1564 cm(-1) in glycated-HSA, with anew peak appearance of carbonyl group at 1737 cm-1. LCMS chromatogram of glycated-HSA showed thepresence of carboxymethyl lysine (CML) at 279.1 m/z. Immunological analysis showed high antibody titre> 1: 12,800 in theserum of rabbits immunized with glycated-HSA (modified with 400 mg/dL glucose) and inhibition of 84.65% at anantigen concentration of 20 mu g/mL. Maximum serum auto-antibody titre was found in T2DM (0.517 +/- 0.086), T1DM (0.108 +/- 0.092), GDM (0.611 +/- 0.041) and T2DM + CKD (0.096 +/- 0.25) patients immunized with glycated-HSA (modified with 400 mg/dL glucose). Conclusions Non-enzymatic glycosylation of HSA manifests immunological complications in diabetes mellitus due to change in its structure that enhances neo-epitopes generation.	[Raghav, Alok; Ahmad, Jamal] Aligarh Muslim Univ, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India; [Alam, Khursheed] Aligarh Muslim Univ, JN Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Ahmad, J (corresponding author), Aligarh Muslim Univ, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India.	alokalig@gmail.com	Raghav, Alok/AAX-3419-2021	Ahmad, Jamal/0000-0001-9108-5019; Alam, Khursheed/0000-0001-9729-9966				Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Alam K, 2007, CELL IMMUNOL, V247, P12, DOI 10.1016/j.cellimm.2007.06.007; Barnaby OS, 2011, CLIN CHIM ACTA, V412, P277, DOI 10.1016/j.cca.2010.10.018; Barros CMMR, 2007, CLINICS, V62, P327, DOI 10.1590/S1807-59322007000300019; BASSIOUNY AR, 1983, DIABETES, V32, P1182, DOI 10.2337/diabetes.32.12.1182; BENDEDOUCH D, 1983, J PHYS CHEM-US, V87, P1473, DOI 10.1021/j100232a003; Bennett P.H., 2010, JOSLINS DIABETES MEL; BOS OJM, 1989, J BIOL CHEM, V264, P953; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen JF, 2010, MOL CELL BIOCHEM, V335, P137, DOI 10.1007/s11010-009-0250-y; Dixit K, 2005, LIFE SCI, V77, P2626, DOI 10.1016/j.lfs.2005.02.026; DOHERTY P, 1974, J CHEM PHYS, V61, P5426, DOI 10.1063/1.1681898; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Guerin-Dubourg A, 2012, DIABETES METAB, V38, P171, DOI 10.1016/j.diabet.2011.11.002; Habib S, 2005, INT J BIOL MACROMOL, V35, P221, DOI 10.1016/j.ijbiomac.2005.02.005; Habib S, 2009, CELL IMMUNOL, V254, P117, DOI 10.1016/j.cellimm.2008.08.002; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hughes W.L, 1954, PROTEINS; Huijberts MSP, 2008, DIABETES-METAB RES, V24, pS19, DOI 10.1002/dmrr.861; Jaleel A, 2005, DIABETES CARE, V28, P645, DOI 10.2337/diacare.28.3.645; Kalia K, 2004, CLIN CHIM ACTA, V347, P169, DOI 10.1016/j.cccn.2004.04.016; Khan MWA, 2009, AUTOIMMUNITY, V42, P150, DOI 10.1080/08916930802468276; Khan MWA, 2010, INT ARCH ALLERGY IMM, V153, P207, DOI 10.1159/000312639; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; KUME S, 1995, AM J PATHOL, V147, P654; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; MAKINO H, 1995, KIDNEY INT, V48, P517, DOI 10.1038/ki.1995.322; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Monnier VM, 2008, ANN NY ACAD SCI, V1126, P81, DOI 10.1196/annals.1433.052; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; MYINT T, 1995, BBA-MOL BASIS DIS, V1272, P73, DOI 10.1016/0925-4439(95)00067-E; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Neelofar K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172074; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Raghav Alok, INT J BIOL MACROMOLE; Rahmelow K, 1996, ANAL BIOCHEM, V241, P5, DOI 10.1006/abio.1996.0369; Rasheed Z, 2006, AUTOIMMUNITY, V39, P479, DOI 10.1080/08916930600918472; RILEY DP, 1952, NATURE, V169, P138, DOI 10.1038/169138a0; Sakai H, 1996, NEPHROL DIAL TRANSPL, V11, P66; Schalkwijk CG, 1999, DIABETES, V48, P2446, DOI 10.2337/diabetes.48.12.2446; Schleicher, 1981, CLIN CHEM CLIN BIOCH, V19, P81; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Shibayama P, 1999, DIABETES, V48, P1842, DOI 10.2337/diabetes.48.9.1842; Sun N, 2013, INT J MOL MED, V32, P485, DOI 10.3892/ijmm.2013.1402; Turk Z, 2001, CLIN CHIM ACTA, V303, P105, DOI 10.1016/S0009-8981(00)00389-2; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Zohreh S, 2014, PLOS ONE, V9	55	28	28	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176970	10.1371/journal.pone.0176970	http://dx.doi.org/10.1371/journal.pone.0176970			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520799	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700034
J	Feleke, FW; Adole, AA; Bezabih, AM				Feleke, Fentaw Wassie; Adole, Anchamo Anato; Bezabih, Afework Mulugeta			Utilization of growth monitoring and promotion services and associated factors among under two years of age children in Southern Ethiopia	PLOS ONE			English	Article								Growth monitoring and promotion (GMP) is a prevention activity comprised of growth monitoring (GM) linked with promotion that serves as the core activity in an integrated child health and nutrition program. However, different methods of institutional studies have shown that utilization of GM services has remained to be inadequate. There is scarcity of studies conducted about GMP in quantitative method. Therefore, this study was conducted to address the proportion of GMP services and associated factors among children under two years of age in rural communities of Mareka district, Southern Ethiopia. Community based cross-sectional survey was conducted from August to September 2015. Single population proportion formula was used to determine the sample size with multi stage sampling technique. A total of 819 children under two years of age were included. Pretest was done on 10% of the total sample size. Data were analyzed using SPSS version 20.0 software. Bivariate and multivariate logistic regressions used to analyze data. The response rate was 95%. Utilization of GMP services was 16.9%. Institutional delivery AOR (95% CI): 3.01(1.65-5.50), index child age 12-17 months AOR (95% CI): 4.03(2.16-7.51) and 18-23 months AOR (95% CI): 3.08(1.70-5.57), family size 4-5 AOR(95% CI): 0.14(0.06-0.33), family size > 5 AOR(95% CI): 0.34(0.14-0.82), regular GMP attendance AOR (95% CI): 4.37(2.45-7.80), medium wealth index AOR(95% CI): 3.14(1.51-6.52) and high wealth index AOR(95% CI): 3.24 (1.59-6.62) were factors associated with utilization of GMP services. Utilization of GMP services was low. Thus, efforts should be made to improve utilization of GMP services through promotion of institutional delivery, different family planning methods, and regular GMP attendance.	[Feleke, Fentaw Wassie] Mareka Dist Hlth Off, Waka, Ethiopia; [Adole, Anchamo Anato] Hawasssa Univ, Coll Agr, Hawassa, Ethiopia; [Bezabih, Afework Mulugeta] Mekelle Univ, Coll Med & Hlth Sci, Mekele, Ethiopia	Mekelle University	Feleke, FW (corresponding author), Mareka Dist Hlth Off, Waka, Ethiopia.	fentawwassie@gmail.com		Mulugeta, Afework/0000-0003-0707-4363				Akinbode O, 2016, EUROPEAN J PREVENTIV, V4, P73; [Anonymous], 2014, CSA CENTERAL STAT AG; Beyene M, 2015, DIETARY DIVERSITY ME; Bilal S, 2014, PRACTICES CHALLENGES, V32, P441; Charlton KE, 2009, NUTRITION, V25, P1035, DOI 10.1016/j.nut.2009.03.008; Desalegn E., 2014, J GYNECOLOGY OBSTET, V2, P1, DOI [DOI 10.11648/j.jgo.20140201.11, DOI 10.11648/J.JG0.20140201.11]; Faber M, 2003, FOOD NUTR B, V24; Graham WJ, 2001, OPEN J EPIDEMIOL, V17, P97, DOI DOI 10.4236/ojepi.2014.41006; Griffiths M, 2007, GMP HLTH YOUNG CHILD; Gyampoh S, 2014, CHILD FEEDING KNOWLE; Hosmer D, 2013, APPL LOGISTIC REGRAT; Mayhew M, 2014, IMPROVING NUTR AFGHA; Peter R, 2014, S E ASIA J PUBLIC HL, V3; Roberfroid D, 2005, J HEALTH POPUL NUTR, V23, P207; UK Save the children, 2009, ETH NAT NUTR STRAT R; World Bank, 2006, WORLD BANK REPOSITIO; Yonas F, 2016, JOURNAL	17	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177502	10.1371/journal.pone.0177502	http://dx.doi.org/10.1371/journal.pone.0177502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510596	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500033
J	Liu, YL; Liang, J; Xiao, N; Yuan, XG; Zhang, ZH; Hu, M; Hu, YL				Liu, Yulei; Liang, Jun; Xiao, Nan; Yuan, Xiaogang; Zhang, Zhenhao; Hu, Meng; Hu, Yulong			Adaptive double threshold energy detection based on Markov model for cognitive radio	PLOS ONE			English	Article							ACCESS	The rapid development in the area of cognitive radio technology leads the society to higher standards of spectrum sensing performance, particularly in low signal-to-noise ratio (SNR) environment. This article proposes an adaptive double-threshold energy sensing method based on Markov model (ADEMM). When using the double-threshold energy sensing method, the modified Markov model that accounts for the time varying characteristic of the channel occupancy was presented to resolve the 'confused' channel state. Furthermore, in order to overcome the effect of noise uncertainty, the findings of this article introduce an adaptive double-threshold spectrum sensing method that adjusts its thresholds according to the achievable maximal detection probability. Numerical simulations show that the proposed ADEMM achieves better detection performance than the conventional double-threshold energy sensing schemes, especially in very low SNR region.	[Liu, Yulei; Liang, Jun; Xiao, Nan; Zhang, Zhenhao; Hu, Meng; Hu, Yulong] Air Force Engn Univ, Inst Informat & Nav, Xian, Shanxi, Peoples R China; [Yuan, Xiaogang] Lanzhou Jiaotong Univ, Lanzhou Univ, PLA Stn Reserve Training Off, Lanzhou, Gansu, Peoples R China	Air Force Engineering University; Lanzhou Jiaotong University; Lanzhou University	Liu, YL (corresponding author), Air Force Engn Univ, Inst Informat & Nav, Xian, Shanxi, Peoples R China.	huapofeixue@sina.com			National Natural Science Foundation of China [61501496, 61202490]; National Science Foundation of Xi'an Province [2012JM8004]; Aeronautical Science Foundation of China [2013ZC15008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Xi'an Province; Aeronautical Science Foundation of China	This work was supported by the National Natural Science Foundation of China (Grant No. 61501496, 61202490), the National Science Foundation of Xi'an Province (Grant No. 2012JM8004) and the Aeronautical Science Foundation of China (Grant No. 2013ZC15008).	Bagwari A, 2013, CAN J ELECT COMPUT E, V36, P172, DOI 10.1109/CJECE.2014.2303519; Cabric D, 2006, P 1 INT WORKSH TECHN; [陈长兴 Chen Changxing], 2013, [系统工程与电子技术, Systems Engineering & Electronics], V35, P1742; Chen YF, 2011, IEEE INT C EMERG; Chien WB, 2011, IEEE T CIRCUITS-I, V58, P711, DOI 10.1109/TCSI.2010.2078691; Datla D, 2009, IEEE T WIREL COMMUN, V8, P4211, DOI 10.1109/TWC.2009.080989; Fang L, 2013, DEFENCE SCI J, V63, P47; Haykin S, 2009, P IEEE, V97, P849, DOI [10.1109/JPROC.2009.2015711, 10.1109/IITAW.2009.49]; Herath SP, 2011, IEEE T COMMUN, V59, P2443, DOI 10.1109/TCOMM.2011.071111.090349; Horgan D, 2010, P IEEE 4 INT C SIGN; Kay SM, 1998, FUNDAMENTALS STAT SI, VII, P93; Kim J, 2010, IEEE T WIREL COMMUN, V9, P2945, DOI 10.1109/TWC.2010.072210.100223; Ma J, 2009, P IEEE, V97, P805, DOI 10.1109/JPROC.2009.2015707; Maleki S, 2010, P IEEE ICASSP; McHenry MA, 2016, NSF SPECTRUM OCCUPAN; Michelusi N, 2016, IEEE T INFORM THEORY, V62, P7324, DOI 10.1109/TIT.2016.2615182; Pesce M, 2016, IEEE INT CONF COMM, P689, DOI 10.1109/ICCW.2016.7503867; Spaulding AD, 1977, DEFINITION ESTIMATIO, V19, P269; Sun HJ, 2013, IEEE WIREL COMMUN, V20, P74, DOI 10.1109/MWC.2013.6507397; Treeumnuk D, 2013, IET COMMUN, V7, P1969, DOI 10.1049/iet-com.2013.0076; Yucek T, 2009, IEEE COMMUN SURV TUT, V11, P116, DOI 10.1109/SURV.2009.090109; [岳文静 Yue Wenjing], 2011, [中国科学. 信息科学, Scientia Sinica Informationis], V41, P207; Zeng YH, 2009, IEEE T VEH TECHNOL, V58, P1804, DOI 10.1109/TVT.2008.2005267	23	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177625	10.1371/journal.pone.0177625	http://dx.doi.org/10.1371/journal.pone.0177625			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520782	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500047
J	Di Pietro, O; Juarez-Jimenez, J; Munoz-Torrero, D; Laughton, CA; Luque, FJ				Di Pietro, Ornella; Juarez-Jimenez, Jordi; Munoz-Torrero, Diego; Laughton, Charles A.; Luque, F. Javier			Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: Conformational analysis and binding mode of multisite inhibitors	PLOS ONE			English	Article							MEMAPSIN-2 BETA-SECRETASE; PARTICLE MESH EWALD; ACTIVE-SITE; ALZHEIMERS-DISEASE; CRYPTIC POCKET; DESIGN; FLEXIBILITY; DERIVATIVES; DISCOVERY; BIOLOGY	The critical role of BACE-1 in the formation of neurotoxic beta-amyloid peptides in the brain makes it an attractive target for an efficacious treatment of Alzheimer's disease. However, the development of clinically useful BACE-1 inhibitors has proven to be extremely challenging. In this study we examine the binding mode of a novel potent inhibitor (compound 1, with IC50 80 nM) designed by synergistic combination of two fragments-huprine and rhein-that individually are endowed with very low activity against BACE-1. Examination of crystal structures reveals no appropriate binding site large enough to accommodate 1. Therefore we have examined the conformational flexibility of BACE-1 through extended molecular dynamics simulations, paying attention to the highly flexible region shaped by loops 8-14, 154-169 and 307-318. The analysis of the protein dynamics, together with studies of pocket druggability, has allowed us to detect the transient formation of a secondary binding site, which contains Arg307 as a key residue for the interaction with small molecules, at the edge of the catalytic cleft. The formation of this druggable "floppy" pocket would enable the binding of multisite inhibitors targeting both catalytic and secondary sites. Molecular dynamics simulations of BACE-1 bound to huprine-rhein hybrid compounds support the feasibility of this hypothesis. The results provide a basis to explain the high inhibitory potency of the two enantiomeric forms of 1, together with the large dependence on the length of the oligomethylenic linker. Furthermore, the multisite hypothesis has allowed us to rationalize the inhibitory potency of a series of tacrine-chromene hybrid compounds, specifically regarding the apparent lack of sensitivity of the inhibition constant to the chemical modifications introduced in the chromene unit. Overall, these findings pave the way for the exploration of novel functionalities in the design of optimized BACE-1 multisite inhibitors.	[Di Pietro, Ornella; Munoz-Torrero, Diego] Univ Barcelona, Fac Pharm & Food Sci, Lab Pharmaceut Chem, Barcelona, Spain; [Di Pietro, Ornella; Munoz-Torrero, Diego] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Juarez-Jimenez, Jordi; Luque, F. Javier] Univ Barcelona, Fac Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Campus Torribera, Santa Coloma De Gramenet, Spain; [Juarez-Jimenez, Jordi; Luque, F. Javier] Univ Barcelona, Inst Biomed, Campus Torribera, Santa Coloma De Gramenet, Spain; [Laughton, Charles A.] Sch Pharm, Univ Pk, Nottingham, England; [Laughton, Charles A.] Ctr Biomol Sci, Univ Pk, Nottingham, England; [Juarez-Jimenez, Jordi] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh, Midlothian, Scotland	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Nottingham; University of Nottingham; University of Edinburgh	Luque, FJ (corresponding author), Univ Barcelona, Fac Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Campus Torribera, Santa Coloma De Gramenet, Spain.; Luque, FJ (corresponding author), Univ Barcelona, Inst Biomed, Campus Torribera, Santa Coloma De Gramenet, Spain.; Laughton, CA (corresponding author), Sch Pharm, Univ Pk, Nottingham, England.; Laughton, CA (corresponding author), Ctr Biomol Sci, Univ Pk, Nottingham, England.	charles.Iaughton@nottingham.ac.uk; fibuque@ub.edu	Muñoz-Torrero, Diego/K-9787-2014; Jiménez, Jordi Juárez/ABG-7372-2020; Luque, F. Javier/L-9652-2014; Laughton, Charles A/E-5667-2010	Muñoz-Torrero, Diego/0000-0002-8140-8555; Jiménez, Jordi Juárez/0000-0003-1464-1397; Luque, F. Javier/0000-0002-8049-3567; Laughton, Charles A/0000-0003-4090-3960	Ministerio de Economia y Competitividad [SAF2014-57094-R]; Generalitat de Catalunya [2014SGR1189, 2014SGR52]; ICREA Academia; HECBioSim consortium (EPSRC) [EP/L000253/1]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia(ICREA); HECBioSim consortium (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Ministerio de Economia y Competitividad (SAF2014-57094-R), Generalitat de Catalunya (GC; 2014SGR1189, 2014SGR52), and ICREA Academia (FJL). The Consorci de Serveis Universitaris de Catalunya (CSUC; FJL) is acknowledged for providing computational resources. This work used the ARCHER UK National Supercomputing Service (http:/www.archer.ac.uk), via the HECBioSim consortium (EPSRC Grant EP/L000253/1). A fellowship from GC to ODP is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowman GR, 2015, P NATL ACAD SCI USA, V112, P2734, DOI 10.1073/pnas.1417811112; Camps P, 2000, MOL PHARMACOL, V57, P409; Cascella M, 2005, J AM CHEM SOC, V127, P3734, DOI 10.1021/ja044608+; Case DA, 2012, AMBER 12; Cimermancic P, 2016, J MOL BIOL, V428, P709, DOI 10.1016/j.jmb.2016.01.029; Cole SL, 2007, CURR GENOMICS, V8, P509, DOI 10.2174/138920207783769512; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; Edfeldt FNB, 2011, DRUG DISCOV TODAY, V16, P284, DOI 10.1016/j.drudis.2011.02.002; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandez-Bachiller MI, 2012, J MED CHEM, V55, P1303, DOI 10.1021/jm201460y; Friedman R, 2010, PROTEINS, V78, P1575, DOI 10.1002/prot.22674; Galdeano C, 2012, J MED CHEM, V55, P661, DOI 10.1021/jm200840c; Ghosh AK, 2007, J MED CHEM, V50, P2399, DOI 10.1021/jm061338s; Ghosh AK, 2015, CHEMMEDCHEM, V10, P1463, DOI 10.1002/cmdc.201500216; Ghosh AK, 2014, CHEM SOC REV, V43, P6765, DOI 10.1039/c3cs60460h; Gorfe AA, 2005, STRUCTURE, V13, P1487, DOI 10.1016/j.str.2005.06.015; Gutierrez LJ, 2010, J PHYS CHEM A, V114, P10261, DOI 10.1021/jp104983a; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hong L, 2004, BIOCHEMISTRY-US, V43, P4689, DOI 10.1021/bi0498252; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kacker P, 2012, CURR MED CHEM, V19, P6095; Kornacker MG, 2005, BIOCHEMISTRY-US, V44, P11567, DOI 10.1021/bi050932l; Kumalo HM, 2016, J BIOMOL STRUCT DYN, V34, P1008, DOI 10.1080/07391102.2015.1064831; Lama D, 2015, BIOCHEMISTRY-US, V54, P6535, DOI 10.1021/acs.biochem.5b00812; Laurent B, 2015, BIOINFORMATICS, V31, P1478, DOI 10.1093/bioinformatics/btu822; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lee JY, 2009, MOL CELLS, V27, P651, DOI 10.1007/s10059-009-0086-z; Liu S, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-21; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McGaughey GB, 2007, BIOORG MED CHEM LETT, V17, P1117, DOI 10.1016/j.bmcl.2006.11.003; Oleinikovas V, 2016, J AM CHEM SOC, V138, P14257, DOI 10.1021/jacs.6b05425; Park H, 2003, J AM CHEM SOC, V125, P16416; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Ruiz-Carmona S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003571; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schechter I, 2012, BIOCHEM BIOPH RES CO, V425, P497, DOI 10.1016/j.bbrc.2012.08.015; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shkurti Ardita, 2016, SoftwareX, V5, P44, DOI 10.1016/j.softx.2016.04.002; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Tan YS, 2012, ANGEW CHEM INT EDIT, V51, P10078, DOI 10.1002/anie.201205676; Turner RT, 2005, BIOCHEMISTRY-US, V44, P105, DOI 10.1021/bi048106k; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; van der Spoel D., 2005, GROMACS USER MANUAL; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Viayna E, 2014, J MED CHEM, V57, P2549, DOI 10.1021/jm401824w; Walker LC, 2006, AGE AGEING, V35, P332, DOI 10.1093/ageing/afl009; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang WR, 2013, CURR OPIN STRUC BIOL, V23, P797, DOI 10.1016/j.sbi.2013.08.001; Xu YC, 2012, ACTA CRYSTALLOGR D, V68, P13, DOI 10.1107/S0907444911047251; Yuan J, 2013, J MED CHEM, V56, P4156, DOI 10.1021/jm301659n; Zhou LJ, 2011, J BIOL CHEM, V286, P8677, DOI 10.1074/jbc.M110.194860	60	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177683	10.1371/journal.pone.0177683	http://dx.doi.org/10.1371/journal.pone.0177683			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505196	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000401473500033
J	Muller, A; Dahm, M; Bocher, PK; Root-Bernstein, M; Svenning, JC				Muller, Anke; Dahm, Maria; Bocher, Peder Klith; Root-Bernstein, Meredith; Svenning, Jens-Christian			Large herbivores in novel ecosystems - Habitat selection by red deer (Cervus elaphus) in a former brown-coal mining area	PLOS ONE			English	Article							SEED DISPERSAL; SPONTANEOUS SUCCESSION; MOUNTAIN FORESTS; VASCULAR PLANTS; PREDATION RISK; ROE DEER; LANDSCAPE; DIVERSITY; DYNAMICS; IMPACT	After centuries of range contraction, many megafauna species are recolonizing parts of Europe. One example is the red deer (Cervus elaphus), which was able to expand its range and is now found in half the areas it inhabited in the beginning of the 19 th century. Herbivores are important ecosystem engineers, influencing e.g. vegetation. Knowledge on their habitat selection and their influence on ecosystems might be crucial for future landscape management, especially for hybrid and novel ecosystems emerging in post-industrial landscapes. In this study, red deer habitat selection was studied in a former brown-coal mining area in Denmark. Here, natural settings were severely changed during the mining activity and its current landscape is in large parts managed by hunters as suitable deer habitat. We assessed red deer habitat preferences through feces presence and camera traps combined with land cover data from vegetation sampling, remote sensing and official geographic data. Red deer occurrence was negatively associated with human disturbance and positively associated with forage availability, tree cover and mean terrain height. Apparently, red deer are capable of recolonizing former industrial landscapes quite well if key conditions such as forage abundance and cover are appropriate. In the absence of carnivores, human disturbance, such as a hunting regime is a main reason why deer avoid certain areas. The resulting spatial heterogeneity red deer showed in their habitat use of the study area might be a tool to preserve mosaic landscapes of forest and open habitats and thus promote biodiversity in abandoned post-industrial landscapes.	[Muller, Anke; Dahm, Maria; Bocher, Peder Klith; Root-Bernstein, Meredith; Svenning, Jens-Christian] Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus, Mid Jutland, Denmark; [Muller, Anke] Tech Univ Munich, Study Fac Landscape Architecture & Landscape Plan, Freising Weihenstephan, Bavaria, Germany	Aarhus University; Technical University of Munich	Muller, A (corresponding author), Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus, Mid Jutland, Denmark.; Muller, A (corresponding author), Tech Univ Munich, Study Fac Landscape Architecture & Landscape Plan, Freising Weihenstephan, Bavaria, Germany.	anke.mueller@tum.de	Svenning, Jens-Christian/C-8977-2012; Müller, Anke/J-6051-2019	Svenning, Jens-Christian/0000-0002-3415-0862; Müller, Anke/0000-0002-3697-3221; Root-Bernstein, Meredith/0000-0002-2513-1248	Danish National Research Foundation Niels Bohr professorship project Aarhus University Research on the Anthropocene (AURA); Carlsberg Foundation [CF16-0005]	Danish National Research Foundation Niels Bohr professorship project Aarhus University Research on the Anthropocene (AURA); Carlsberg Foundation(Carlsberg Foundation)	We would like to thank the Danish National Research Foundation Niels Bohr professorship project Aarhus University Research on the Anthropocene (AURA)for funding. JCS also acknowledge this work as a contribution to the Carlsberg Foundation "Semper Ardens" project MegaPast2Future (CF16-0005).	Ammer C, 1996, FOREST ECOL MANAG, V88, P43, DOI 10.1016/S0378-1127(96)03808-X; [Anonymous], 2014, R LANG ENV STAT COMP; Baasch A, 2012, J APPL ECOL, V49, P251, DOI 10.1111/j.1365-2664.2011.02086.x; Bang P, 1972, DYRESPOR SPOR SPORTE; Betard F, 2013, GEOHERITAGE, V5, P59, DOI 10.1007/s12371-013-0078-4; Bobrowski M, 2015, FOREST ECOL MANAG, V358, P212, DOI 10.1016/j.foreco.2015.08.031; Bradshaw A, 2000, LANDSCAPE URBAN PLAN, V51, P89, DOI 10.1016/S0169-2046(00)00099-2; Buttenschon R. M., 2007, GRAESNING HOSLAET NA; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Coates P., 2013, PROGR PHYS GEOGRAPHY; Cornelissen P, 2014, BASIC APPL ECOL, V15, P396, DOI 10.1016/j.baae.2014.06.006; CORNWELL SM, 1973, TOWN PLANN REV, V44, P221, DOI 10.3828/tpr.44.3.y2156h11r3571hp8; Danell K., 2006, LARGE HERBIVORE ECOL; Danish Geodata Agency, 2007, DAN NAT HEIGHT MOD; Danish Geodata Agency, 2013, KORT 10; Darimont CT, 2015, SCIENCE, V349, P858, DOI 10.1126/science.aac4249; Debeljak M, 2001, ECOL MODEL, V138, P321, DOI 10.1016/S0304-3800(00)00411-7; Deinet S., 2013, WILDLIFE COMEBACK EU; Ensing EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106997; Flinterup M., 2015, JAEGER, V24, P52; Gill RMA, 2001, FORESTRY, V74, P209, DOI 10.1093/forestry/74.3.209; Gortazar C, 2016, EUR J WILDLIFE RES, V62, P511, DOI 10.1007/s10344-016-1033-x; Harabis F, 2016, ECOL ENG, V90, P438, DOI 10.1016/j.ecoleng.2016.01.070; Haugaard Sunde P, 2014, VIDENSKABELIG RAPPOR, P2244; Haynes G, 2012, GEOMORPHOLOGY, V157, P99, DOI 10.1016/j.geomorph.2011.04.045; Hegland SJ, 2013, FOREST ECOL MANAG, V310, P267, DOI 10.1016/j.foreco.2013.08.031; Heinken T, 2002, FORSTWISS CENTRALBL, V121, P179, DOI 10.1046/j.1439-0337.2002.02029.x; Heinze E, 2011, FOREST ECOL MANAG, V261, P288, DOI 10.1016/j.foreco.2010.10.022; Heneberg P, 2013, J INSECT CONSERV, V17, P473, DOI 10.1007/s10841-012-9529-5; Hobbs RJ, 2016, RESTOR ECOL, V24, P153, DOI 10.1111/rec.12336; Hobbs RJ, 2014, FRONT ECOL ENVIRON, V12, P557, DOI 10.1890/130300; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hughes FMR, 2011, J NAT CONSERV, V19, P245, DOI 10.1016/j.jnc.2011.02.003; Iravani M, 2011, BASIC APPL ECOL, V12, P505, DOI 10.1016/j.baae.2011.07.004; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; Jayakody S, 2011, EUR J WILDLIFE RES, V57, P939, DOI 10.1007/s10344-011-0508-z; Jorritsma ITM, 1999, FOREST ECOL MANAG, V120, P23, DOI 10.1016/S0378-1127(98)00540-4; Kuijper DPJ, 2011, EUR J FOREST RES, V130, P895, DOI 10.1007/s10342-011-0523-3; Kuijper DPJ, 2010, J VEG SCI, V21, P1082, DOI 10.1111/j.1654-1103.2010.01217.x; Lande US, 2014, EUR J WILDLIFE RES, V60, P69, DOI 10.1007/s10344-013-0751-6; LOFT ER, 1988, J WILDLIFE MANAGE, V52, P524, DOI 10.2307/3801604; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; MacCullum B.N., 1992, Geojournal, V27, P23, DOI 10.1007/BF00150633; Malo JE, 1998, ECOGRAPHY, V21, P204, DOI 10.1111/j.1600-0587.1998.tb00673.x; Mansson J, 2011, EUR J WILDLIFE RES, V57, P1017, DOI 10.1007/s10344-011-0512-3; Masse A, 2012, FOREST ECOL MANAG, V285, P67, DOI 10.1016/j.foreco.2012.07.039; Matrai K, 2004, J WILDLIFE MANAGE, V68, P879, DOI 10.2193/0022-541X(2004)068[0879:RUBRDI]2.0.CO;2; Milner JM, 2014, J WILDLIFE MANAGE, V78, P1322, DOI 10.1002/jwmg.798; Mitchell B., 1977, ECOLOGY RED DEER A R; Moore EK, 2015, BIOL CONSERV, V192, P218, DOI 10.1016/j.biocon.2015.09.019; Motta R, 1996, FOREST ECOL MANAG, V88, P93, DOI 10.1016/S0378-1127(96)03814-5; Mysterud A, 2001, J ANIM ECOL, V70, P915, DOI 10.1046/j.0021-8790.2001.00559.x; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; NUGENT G, 1993, NEW ZEAL J ZOOL, V20, P361, DOI 10.1080/03014223.1993.10420359; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Perez-Barberia FJ, 2013, OECOLOGIA, V173, P837, DOI 10.1007/s00442-013-2686-8; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; Reinecke H, 2014, EUR J WILDLIFE RES, V60, P237, DOI 10.1007/s10344-013-0772-1; Rich KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136522; Salek M, 2012, J APPL ECOL, V49, P1417, DOI 10.1111/j.1365-2664.2012.02215.x; Sandom CJ, 2014, P NATL ACAD SCI USA, V111, P4162, DOI 10.1073/pnas.1311014111; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sunde P, 2008, HVOR NEDLAGGES KRON; Svenning JC, 2002, BIOL CONSERV, V104, P133, DOI 10.1016/S0006-3207(01)00162-8; Theuerkauf J, 2008, FOREST ECOL MANAG, V256, P1325, DOI 10.1016/j.foreco.2008.06.030; Timmermann A, 2015, J APPL ECOL, V52, P21, DOI 10.1111/1365-2664.12374; Torres RT, 2014, MAMM BIOL, V79, P52, DOI 10.1016/j.mambio.2013.09.002; Torres RT, 2012, MAMM BIOL, V77, P140, DOI 10.1016/j.mambio.2011.11.002; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Tschope O, 2011, APPL VEG SCI, V14, P200, DOI 10.1111/j.1654-109X.2010.01119.x; Van Uytvanck J., 2014, EUROPEAN WOOD PASTUR, P149, DOI DOI 10.4324/9780203797082; Vojar J, 2016, ECOL ENG, V90, P278, DOI 10.1016/j.ecoleng.2016.01.028; von Oheimb G, 2005, EUR J FOREST RES, V124, P55, DOI 10.1007/s10342-005-0053-y; WELCH D, 1985, J APPL ECOL, V22, P461, DOI 10.2307/2403178; Whitehouse NJ, 2010, QUATERNARY SCI REV, V29, P539, DOI 10.1016/j.quascirev.2009.10.010	75	19	21	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177431	10.1371/journal.pone.0177431	http://dx.doi.org/10.1371/journal.pone.0177431			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505192	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500021
J	Walker, J; Mertens, UK; Schmidt, CO; Chenot, JF				Walker, Jochen; Mertens, Ulf Kai; Schmidt, Carsten Oliver; Chenot, Jean-Francois			Effect on healthcare utilization and costs of spinal manual therapy for acute low back pain in routine care: A propensity score matched cohort study	PLOS ONE			English	Article							CLINICAL-PREDICTION RULE; PHYSICAL-THERAPY; MANIPULATION; GUIDELINES; MANAGEMENT; EXERCISE; UPDATE	Spinal manual therapy (SMT) is a popular treatment option for low back pain (LBP). The aim of our analysis was to evaluate the effects of manual therapy delivered by general practitioners and ambulatory orthopedic surgeons in routine care on follow up consultations, sick leave, health service utilization and costs for acute LBP compared to matched patients not receiving manual therapy. This is a propensity score matched cohort study based on health claims data. We identified a total of 113.652 adult patients with acute LBP and no coded red flags of whom 21.021 (18%) received SMT by physicians. In the final analysis 17.965 patients in each group could be matched. Balance on patients' coded characteristics, comorbidity and prior health service utilization was achieved. The provision of SMT for acute LBP had no relevant impact on follow up visits and days of sick leave for LBP in the index billing period and the following year. SMT was associated with a higher proportion of imaging studies for LBP (30.6% vs. 23%, SMD: 0.164 [95% CI 0.143-0.185]). SMT did not lead to meaningful savings by replacing other health services for LBP. SMT for acute non-specific LBP in routine care was not clinically meaningful effective to reduce sick leave and reconsultation rates compared to no SMT and did not lead to meaningful savings by replacing other health services from the perspective of health insurance. This does not imply that SMT is ineffective but might reflect a problem with selection of suitable patients and the quality and quantity of SMT in routine care. National Manual Medicine societies should state clearly that imaging is not routinely needed prior to SMT in patients with low suspicion of presence of red flags and monitor the quality of provided services.	[Walker, Jochen] Elsevier Hlth Analyt, Berlin, Germany; [Mertens, Ulf Kai] Heidelberg Univ, Inst Psychol, Dept Quantitat Res Methods, Heidelberg, Germany; [Schmidt, Carsten Oliver] Univ Med Greifswald, Inst Community Med, SHIP KEF, Greifswald, Germany; [Chenot, Jean-Francois] Univ Med Greifswald, Inst Community Med, Dept Gen Practice, Greifswald, Germany; [Walker, Jochen] Ingef Inst Angew Gesundheitsforsch, Berlin, Germany	Reed Elsevier; Elsevier; Ruprecht Karls University Heidelberg; Greifswald Medical School; Greifswald Medical School	Chenot, JF (corresponding author), Univ Med Greifswald, Inst Community Med, Dept Gen Practice, Greifswald, Germany.	jchenot@uni-greifswald.de	Schmidt, Carsten Oliver/AAH-2778-2019; Chenot, Jean-Francois/F-8241-2011	Schmidt, Carsten Oliver/0000-0001-5266-9396; Chenot, Jean-Francois/0000-0001-8877-2950	Elsevier Health Analytics	Elsevier Health Analytics	JW was employed by Elsevier Health Analytics at the time of the study. UKM did a student clerkship and received a stipend from Elsevier Health Analytics. Elsevier Health Analytics provided support in the form of salaries for JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham I, 2002, ARCH INTERN MED, V162, P1442, DOI 10.1001/archinte.162.13.1442; Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; [Anonymous], 2011, NATL VERSORGUNGSLEIT; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Chento J-F, 2014, VERSORGUNGS REPORT 2, P155; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Chu E, 2005, WHO GUIDELINES BASIC; Cleland JA, 2009, SPINE, V34, P2720, DOI 10.1097/BRS.0b013e3181b48809; Eisenberg DM, 2007, SPINE, V32, P151, DOI 10.1097/01.brs.0000252697.07214.65; Flynn T, 2002, SPINE, V27, P2835, DOI 10.1097/00007632-200212150-00021; Fritz JM, 2015, JAMA-J AM MED ASSOC, V314, P1459, DOI 10.1001/jama.2015.11648; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Hidalgo B, 2014, J MAN MANIP THER, V22, P59, DOI 10.1179/2042618613Y.0000000041; Ho DE, 2001, J STAT SOFTW, V42, P1; Hoiriis KT, 2004, J MANIP PHYSIOL THER, V27, P388, DOI 10.1016/j.jmpt.2004.05.003; Kendrick D, 2005, BMJ-BRIT MED J, V322, P400; Kent P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-22; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Maigne J. -Y., 2007, Annales de Readaptation et de Medecine Physique, V50, P111, DOI 10.1016/j.annrmp.2006.08.004; Michaleff ZA, 2012, J ELECTROMYOGR KINES, V22, P655, DOI 10.1016/j.jelekin.2012.02.011; National Collaborating Centre for Primary Care, 2009, LOW BACK PAIN EARL M; Oliphant D, 2004, J MANIP PHYSIOL THER, V27, P197, DOI 10.1016/j.jmpt.2003.12.023; Peat G, 2008, PAIN, V139, P483, DOI 10.1016/j.pain.2008.09.002; Pillastrini P, 2012, JOINT BONE SPINE, V79, P176, DOI 10.1016/j.jbspin.2011.03.019; Rubinstein SM, 2013, SPINE, V38, pE158, DOI 10.1097/BRS.0b013e31827dd89d; Stanton TR, 2010, EUR SPINE J, V19, P533, DOI 10.1007/s00586-009-1214-3; Team RC, 2014, R LANG ENV STAT COMP; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; VONKORFF M, 1994, SPINE, V19, pS2041	31	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177255	10.1371/journal.pone.0177255	http://dx.doi.org/10.1371/journal.pone.0177255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505161	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500016
J	Augsburger, M; Elbert, T				Augsburger, Mareike; Elbert, Thomas			When do traumatic experiences alter risk-taking behavior? A machine learning analysis of reports from refugees	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TASK BART; REGRESSION TREES; ABUSE; PROPENSITY; DEPRESSION; EXPOSURE; SCALE; ADOLESCENTS; INSTRUMENT	Exposure to traumatic stressors and subsequent trauma-related mental changes may alter a person's risk-taking behavior. It is unclear whether this relationship depends on the specific types of traumatic experiences. Moreover, the association has never been tested in displaced individuals with substantial levels of traumatic experiences. The present study assessed risk-taking behavior in 56 displaced individuals by means of the balloon analogue risk task (BART). Exposure to traumatic events, symptoms of posttraumatic stress disorder and depression were assessed by means of semi-structured interviews. Using a novel statistical approach (stochastic gradient boosting machines), we analyzed predictors of risk-taking behavior. Exposure to organized violence was associated with less risk-taking, as indicated by fewer adjusted pumps in the BART, as was the reported experience of physical abuse and neglect, emotional abuse, and peer violence in childhood. However, civil traumatic stressors, as well as other events during childhood were associated with lower risk taking. This suggests that the association between global risk-taking behavior and exposure to traumatic stress depends on the particular type of the stressors that have been experienced.	[Augsburger, Mareike; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany; [Augsburger, Mareike; Elbert, Thomas] NGO Vivo Int eV, Allensbach, Germany; [Augsburger, Mareike] Univ Zurich, Dept Psychol, Zurich, Switzerland	University of Konstanz; University of Zurich	Augsburger, M (corresponding author), Univ Konstanz, Dept Psychol, Constance, Germany.; Augsburger, M (corresponding author), NGO Vivo Int eV, Allensbach, Germany.; Augsburger, M (corresponding author), Univ Zurich, Dept Psychol, Zurich, Switzerland.	m.augsburger@psychologie.uzh.ch	Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939; Augsburger, Mareike/0000-0002-6564-0717	European Research Council [ERC-2012-AdG 323977]; Asylum, Migration and Integration Fund of the European Union	European Research Council(European Research Council (ERC)European Commission); Asylum, Migration and Integration Fund of the European Union	This research was supported by the European Research Council (ERC-2012-AdG 323977, MemoTV) and by the Asylum, Migration and Integration Fund of the European Union. The funder provided support in the form of salaries for authors [MA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; APA, 2000, DIAGN STAT MAN MENT; Augsburger M, 2016, PSYCHOL TRAUMA; Ben-Zur H, 2009, PERS SOC PSYCHOL REV, V13, P109, DOI 10.1177/1088868308330104; Berthold SM, 2008, J MULTICULTURAL SOCI, V8, P15; Bornovalova MA, 2008, CHILD ABUSE NEGLECT, V32, P99, DOI 10.1016/j.chiabu.2007.04.009; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Catani C, 2010, VERHALTENSTHERAPIE, V20, P19, DOI 10.1159/000261994; Cavanaugh CE, 2010, AIDS BEHAV, V14, P318, DOI 10.1007/s10461-009-9623-1; Ehlers A., 1996, DTSCH UBERSETZUNG PO; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Fuhrer A, 2016, EUR J EPIDEMIOL, V31, P703, DOI 10.1007/s10654-016-0148-4; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Isele D, 2014, Z KL PSYCH PSYCHOTH, V43, P121, DOI 10.1026/1616-3443/a000257; Kobach A, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01518; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Kuhn M., 2016, CARET CLASSIFICATION; Lamoureux BE, 2012, PSYCHOL TRAUMA-US, V4, P605, DOI 10.1037/a0026079; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Maner JK, 2007, PERS INDIV DIFFER, V42, P665, DOI 10.1016/j.paid.2006.08.016; Moore A. A., 2016, PSYCHOL TRAUMA; Mueller S., PEBL PSYCHOL EXPT BU; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Mueller-Bamouh V, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.27856; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Okello J, 2013, J AFFECT DISORDERS, V151, P715, DOI 10.1016/j.jad.2013.07.030; Peel D, 2000, STAT COMPUT, V10, P339, DOI 10.1023/A:1008981510081; Rheingold A., 2004, TRAUMA HLTH PHYS HLT, P217, DOI DOI 10.1037/10723-009; Richter K, 2015, GESUNDHEITSWESEN, V77, P834, DOI 10.1055/s-0035-1564075; Ridgeway G, PACKAGE GBM SOFTWARE; Rousseau C, 2003, CHILD ABUSE NEGLECT, V27, P1277, DOI 10.1016/j.chiabu.2003.07.001; Schalinski I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127151; Schauer M, 2011, VIVO EVENT CHECKLIST, P77; Sujan AC, 2014, CHILD MALTREATMENT, V19, P145, DOI 10.1177/1077559514543827; Teicher MH, 2011, NARRATIVE EXPOSURE T; The UN Refugee Agency, 2016, GLOB TRENDS FORC DIS; Tull MT, 2016, COMPREHENSIVE GUIDE TO POST-TRAUMATIC STRESS DISORDERS, VOLS 1 AND 2, P803, DOI 10.1007/978-3-319-08359-9_16; Tull MT, 2009, DEPRESS ANXIETY, V26, P1158, DOI 10.1002/da.20637; Tull MT, PSYCHOL VIOLENCE, P803; White TL, 2008, EXP CLIN PSYCHOPHARM, V16, P565, DOI 10.1037/a0014083; Wilson HW, 2015, CHILD PSYCHIAT HUM D, V46, P270, DOI 10.1007/s10578-014-0466-2; Woerner J, 2016, ADDICT BEHAV, V62, P73, DOI 10.1016/j.addbeh.2016.06.006; Xu SH, 2013, SOC BEHAV PERSONAL, V41, P477, DOI 10.2224/sbp.2013.41.3.477	52	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177617	10.1371/journal.pone.0177617	http://dx.doi.org/10.1371/journal.pone.0177617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498865	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500035
J	Froissart, L; Giurfa, M; Sauzet, S; Desouhant, E				Froissart, Lucie; Giurfa, Martin; Sauzet, Sandrine; Desouhant, Emmanuel			Cognitive adaptation in asexual and sexual wasps living in contrasted environments	PLOS ONE			English	Article							VENTURIA-CANESCENS HYMENOPTERA; LONG-TERM-MEMORY; PARASITIC WASP; DIFFERENT HABITATS; NATURAL VARIATION; LARIOPHAGUS-DISTINGUENDUS; DROSOPHILA-MELANOGASTER; PLODIA-INTERPUNCTELLA; NEMERITIS-CANESCENS; GENETIC-VARIABILITY	Differences in learning and memory dynamics between populations are suspected to result from differences in ecological constraints such as resource distribution. The two reproductive modes (strains) of the parasitoid wasp Venturia canescens share the same geographical areas but live in contrasting habitats: arrhenotokous wasps live in the wild (generally orchards), whereas thelytokous ones live mostly in stored-products buildings (e. g. granaries). This species thus represents a relevant biological model for understanding the relationship between the ecological constraints faced by a species and its memory and learning ability. We showed that after having laid eggs in presence of both a synthetic odour and natural olfactory cues of their host, arrhenotokous wasps exhibited a change in their behavioural response towards the synthetic odour that was at least as pronounced as in thelytokous ones even though they were faster in their decision-making process. This is consistent with better learning skills in arrhenotokous wasps. The corresponding memory trace persisted in both strains for at least 51 h. We compare and discuss the learning and memory ablities of both strains as a function of their costs and benefits in their preferential habitats.	[Froissart, Lucie; Sauzet, Sandrine; Desouhant, Emmanuel] Univ Lyon, Univ Claude Bernard, CNRS, Lab Biometrie & Biol Evolut,UMR 5558, Villeurbanne, France; [Froissart, Lucie] Univ Lumiere Lyon 2, Inst Univ Technol Lyon 2, Bron, France; [Giurfa, Martin] Univ Toulouse, CNRS, Res Ctr Anim Cognit, Toulouse, France; [Froissart, Lucie] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Universite Lyon 2; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Lausanne	Froissart, L; Desouhant, E (corresponding author), Univ Lyon, Univ Claude Bernard, CNRS, Lab Biometrie & Biol Evolut,UMR 5558, Villeurbanne, France.; Froissart, L (corresponding author), Univ Lumiere Lyon 2, Inst Univ Technol Lyon 2, Bron, France.	lucie.froissart@unil.ch; emmanuel.desouhant@univ-lyon1.fr	Giurfa, Martin/AAS-4945-2020; Giurfa, Martin/H-5140-2016	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; DESOUHANT, Emmanuel/0000-0003-0317-4463; Froissart, Lucie/0000-0002-8609-1243	Agence Nationale de la Recherche (FR) [JCJC06_138616]; Institut Universitaire de France	Agence Nationale de la Recherche (FR)(French National Research Agency (ANR)); Institut Universitaire de France	This work was supported by the Agence Nationale de la Recherche (FR) (http://www. agence-nationale-recherehe.fr/) grant number JCJC06_138616 to ED. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank F. Debias and X. Fauvergue for their technical assistance, I. Amat, C. Bernstein, E. Leglise and M. Burgy for discussions. M.G. thanks the Institut Universitaire de France for financial support. This support did not benefit directly or indirectly the present study.	Amat I, 2006, OECOLOGIA, V148, P153, DOI 10.1007/s00442-005-0332-9; Amat I, 2003, J INSECT PHYSIOL, V49, P1183, DOI 10.1016/j.jinsphys.2003.09.001; Amat I., 2004, THESIS, V1; Amat I, 2009, BEHAV ECOL SOCIOBIOL, V63, P563, DOI 10.1007/s00265-008-0691-4; Amat I, 2012, ECOL ENTOMOL, V37, P480, DOI 10.1111/j.1365-2311.2012.01388.x; ARTHUR AP, 1971, CAN ENTOMOL, V103, P1137, DOI 10.4039/Ent1031137-8; Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Barke Jorg, 2005, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V16, P27; Beukeboom L. W., 1999, P 8 M EXP APPL ENT N, V10, P23; Bleeker MAK, 2006, ANIM BEHAV, V71, P1343, DOI 10.1016/j.anbehav.2005.09.016; Bowditch TG, 1996, J STORED PROD RES, V32, P123, DOI 10.1016/0022-474X(96)00008-2; Castelo MK, 2003, J INSECT BEHAV, V16, P307, DOI 10.1023/A:1023928204793; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Chuine A, 2015, BIOL J LINN SOC, V114, P279, DOI 10.1111/bij.12421; Collatz J, 2006, LEARN MEMORY, V13, P263, DOI 10.1101/lm.192506; Desouhant E, 2005, ANIM BEHAV, V70, P145, DOI 10.1016/j.anbehav.2004.10.015; Desouhant E, 2010, ANIM COGN, V13, P535, DOI 10.1007/s10071-009-0304-2; Driessen G, 1999, J ANIM ECOL, V68, P445, DOI 10.1046/j.1365-2656.1999.00296.x; Dukas Reuven, 1998, P129; Dunlap AS, 2009, P ROY SOC B-BIOL SCI, V276, P3201, DOI 10.1098/rspb.2009.0602; Eliassen S, 2007, OIKOS, V116, P513, DOI 10.1111/j.2006.0030-1299.15462.x; Eliassen S, 2009, AM NAT, V174, P478, DOI 10.1086/605370; Ferrari MCO, 2010, P ROY SOC B-BIOL SCI, V277, P2205, DOI 10.1098/rspb.2009.2117; Foray V, 2014, FUNCT ECOL, V28, P411, DOI 10.1111/1365-2435.12171; Foray V, 2013, COMP BIOCHEM PHYS A, V164, P77, DOI 10.1016/j.cbpa.2012.10.018; Foray V, 2011, NATURWISSENSCHAFTEN, V98, P683, DOI 10.1007/s00114-011-0818-8; Giurfa M, 2009, LEARN MEMORY, V16, P761, DOI 10.1101/lm.1603009; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Griffith LC, 2009, LEARN MEMORY, V16, P743, DOI 10.1101/lm.956309; HARVEY JA, 1995, EUR J ENTOMOL, V92, P427; Hirvonen H, 1999, ECOL MODEL, V115, P177, DOI 10.1016/S0304-3800(98)00191-4; Hoedjes KM, 2012, GENES BRAIN BEHAV, V11, P879, DOI 10.1111/j.1601-183X.2012.00823.x; Hoedjes KM, 2014, BEHAV PROCESS, V105, P40, DOI 10.1016/j.beproc.2014.02.014; Hoedjes KM, 2011, P ROY SOC B-BIOL SCI, V278, P889, DOI 10.1098/rspb.2010.2199; HOLLIDAY M, 1986, BEHAV GENET, V16, P439, DOI 10.1007/BF01074263; Kaiser L, 2009, ADV PARASIT, V70, P67, DOI 10.1016/S0065-308X(09)70003-X; Koppik M, 2015, ANIM COGN, V18, P593, DOI 10.1007/s10071-014-0828-y; Leach IM, 2012, GENETICA, V140, P53, DOI 10.1007/s10709-012-9657-6; Li D, 2003, HEREDITY, V90, P291, DOI 10.1038/sj.hdy.6800241; Liu YQ, 2009, ENTOMOL EXP APPL, V132, P110, DOI 10.1111/j.1570-7458.2009.00878.x; Lucchetta P, 2007, BEHAV ECOL SOCIOBIOL, V61, P1409, DOI 10.1007/s00265-007-0372-8; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MCNAMARA JM, 1987, J THEOR BIOL, V125, P385, DOI 10.1016/S0022-5193(87)80209-6; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Mery F., 2009, SEB EXP BIOL SER, V63, P24; Mettke-Hofmann C, 2014, WIRES COGN SCI, V5, P345, DOI 10.1002/wcs.1289; Metzger M, 2010, ANIM BEHAV, V79, P1307, DOI 10.1016/j.anbehav.2010.03.003; MUDD A, 1973, ENTOMOL EXP APPL, V16, P291, DOI 10.1007/BF00290701; Muller C, 2006, ANIM BIOL, V56, P221, DOI 10.1163/157075606777304195; Orr MV, 2008, J EXP BIOL, V211, P2807, DOI 10.1242/jeb.020172; PAPAJ DR, 1990, J CHEM ECOL, V16, P3137, DOI 10.1007/BF00979616; Pelosse P, 2007, EVOL ECOL, V21, P669, DOI 10.1007/s10682-006-9145-5; Pelosse P, 2011, BIOL J LINN SOC, V104, P621, DOI 10.1111/j.1095-8312.2011.01741.x; Pelosse P, 2010, ENTOMOL EXP APPL, V135, P68, DOI 10.1111/j.1570-7458.2009.00965.x; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Ratcliffe JM, 2003, ANIM BEHAV, V65, P385, DOI 10.1006/anbe.2003.2059; Reaume CJ, 2011, P ROY SOC B-BIOL SCI, V278, P91, DOI 10.1098/rspb.2010.1337; ROGERS D, 1972, ENTOMOL EXP APPL, V15, P190, DOI 10.1007/BF00435170; SALT G, 1976, ECOL ENTOMOL, V1, P63, DOI 10.1111/j.1365-2311.1976.tb01205.x; Saunders DS, 2002, INSECT CLOCKS; Schneider MV, 2003, HEREDITY, V90, P260, DOI 10.1038/sj.hdy.6800245; Schneider MV, 2002, J EVOLUTION BIOL, V15, P191, DOI 10.1046/j.1420-9101.2002.00394.x; Schurmann D, 2012, ENTOMOL EXP APPL, V143, P199, DOI 10.1111/j.1570-7458.2012.01253.x; Schurmann D, 2009, NATURWISSENSCHAFTEN, V96, P383, DOI 10.1007/s00114-008-0490-9; Searle LV, 1949, GENETIC PSYCHOL MONO, V39, P279; Shettleworth S. J., 2009, COGNITION EVOLUTION; Shettleworth SJ, 2003, BRAIN BEHAV EVOLUT, V62, P108, DOI 10.1159/000072441; Smid HM, 2007, P ROY SOC B-BIOL SCI, V274, P1539, DOI 10.1098/rspb.2007.0305; Steidle JLM, 2003, ENTOMOL EXP APPL, V108, P133, DOI 10.1046/j.1570-7458.2003.00080.x; Stephens DW, 1991, BEHAV ECOL, V2, P77, DOI 10.1093/beheco/2.1.77; Stough S, 2006, CURR OPIN NEUROBIOL, V16, P672, DOI 10.1016/j.conb.2006.10.009; Tentelier C, 2006, BEHAV ECOL, V17, P515, DOI 10.1093/beheco/arj062; Thiel A, 2006, BEHAV ECOL SOCIOBIOL, V59, P614, DOI 10.1007/s00265-005-0088-6; Thiel A, 2013, ANIM COGN, V16, P223, DOI 10.1007/s10071-012-0567-x; Tricoire-Leignel H, 2012, FRONT PHYSL, P3; van den Berg M, 2011, ANIM BEHAV, V81, P325, DOI 10.1016/j.anbehav.2010.11.002; van Nouhuys S, 2008, P ROY SOC B-BIOL SCI, V275, P377, DOI 10.1098/rspb.2007.1446; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vet LEM, 1991, NETH J ZOOL, V41, P202; Wustenberg D, 1998, EUR J NEUROSCI, V10, P2742, DOI 10.1046/j.1460-9568.1998.t01-1-00319.x	83	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177581	10.1371/journal.pone.0177581	http://dx.doi.org/10.1371/journal.pone.0177581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498866	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314500029
J	Colominas-Ciuro, R; Santos, M; Coria, N; Barbosa, A				Colominas-Ciuro, Roger; Santos, Mercedes; Coria, Nestor; Barbosa, Andres			Reproductive effort affects oxidative status and stress in an Antarctic penguin species: An experimental study	PLOS ONE			English	Article							BROOD SIZE; PYGOSCELIS-ANTARCTICA; CHINSTRAP PENGUINS; ADELIE PENGUINS; TRADE-OFF; ENERGY-EXPENDITURE; PARENTAL EFFORT; SEX; DAMAGE; COSTS	The oxidative cost of reproduction has been a matter of debate in recent years presumably because of the lack of proper experimental studies. Based on the hypothesis that different brood sizes produce differential reproductive costs, an experimental manipulation during breeding of Ade A lie penguins was conducted at Hope Bay, Antarctica, to study oxidative status and stress. We predict that a lower reproductive effort should be positively related to low oxidative and physiological stress. We randomly assigned nests with two chicks to a control reproductive effort group (CRE), and by removing one chick from some nests with two chicks, formed a second, low reproductive effort group (LRE). We examined how oxidative status in blood plasma (reactive oxygen metabolites, ROMs, and total antioxidant capacity, OXY) and stress (heterophil/lymphocyte ratio, H/L) responded to a lower production of offspring total biomass. Our nest manipulation showed significant differences in offspring total biomass, which was lower in the LRE group. As predicted, the LRE group had higher antioxidant capacity than individuals in the CRE group. We have also found, although marginally significant, interactions between sex and treatment in the three variables analysed. Females had higher OXY, lower ROMs and lower H/L ratio when rearing one chick, whereas males did so when rearing two except for OXY which was high regardless of treatment. Moreover, there was a significant negative correlation between the H/L ratio and OXY in females. Finally, we have found a negative and significant relationship between the duration of the experiment and OXY and ROMs and positive with H/L ratio which suggests that indeed breeding penguins are paying an effort in physiological terms in relation to the duration of the chick rearing. In conclusion, a reduction of the reproductive effort decreased oxidative stress in this long-lived bird meaning that a link exists between breeding effort and oxidative stress. However, our findings suggest different sex strategies which results in opposite physiological responses presumably depending on different life-history strategies in males and females.	[Colominas-Ciuro, Roger; Barbosa, Andres] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Calle Jose Gutierrez Abascal 2, Madrid, Spain; [Santos, Mercedes; Coria, Nestor] Inst Antartico Argentino, Div Biol, Cerrito 1248, RA-1010 Buenos Aires, DF, Argentina	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Instituto Antartico Argentino	Colominas-Ciuro, R (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Calle Jose Gutierrez Abascal 2, Madrid, Spain.	rcolominas@mncn.csic.es	Barbosa, Andrés/C-3208-2008	Barbosa, Andrés/0000-0001-8434-3649; Colominas-Ciuro, Roger/0000-0001-6312-0702	Spanish Ministry of Economy and Competitiveness [CTM2011-24427, CTM2015-64720]; Spanish Ministry of Economy and Competitiveness FPI (Formacion de Personal Investigador) grant [BES2012-059299]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness FPI (Formacion de Personal Investigador) grant	This study was funded by the Spanish Ministry of Economy and Competitiveness (CTM2011-24427 and CTM2015-64720) to AB. RCC was supported a Spanish Ministry of Economy and Competitiveness FPI (Formacion de Personal Investigador) grant (BES2012-059299; http://www.mineco.gob.es/portal/site/mineco/?lang_choosen=en).	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Amat JA, 1996, J AVIAN BIOL, V27, P177, DOI 10.2307/3677150; Ardia DR, 2005, ECOLOGY, V86, P2040, DOI 10.1890/04-1619; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barbosa A, 2013, ANTARCT SCI, V25, P329, DOI 10.1017/S0954102012000739; Barnes AI, 2003, ANIM BEHAV, V66, P199, DOI 10.1006/anbe.2003.2122; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaulieu M, 2011, FUNCT ECOL, V25, P577, DOI 10.1111/j.1365-2435.2010.01825.x; Beaulieu M, 2010, P ROY SOC B-BIOL SCI, V277, P1087, DOI 10.1098/rspb.2009.1881; Beaulieu M, 2009, BEHAV ECOL, V20, P878, DOI 10.1093/beheco/arp076; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Blount JD, 2016, BIOL REV, V91, P483, DOI 10.1111/brv.12179; Breuner CW, 2013, FUNCT ECOL, V27, P24, DOI 10.1111/1365-2435.12016; CHAPPELL MA, 1993, BEHAV ECOL SOCIOBIOL, V33, P173, DOI 10.1007/BF00216598; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Clarke J, 1998, POLAR BIOL, V20, P248, DOI 10.1007/s003000050301; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; Costantini D., 2014, OXIDATIVE STRESS HOR; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2014, J EXP BIOL, V217, P4237, DOI 10.1242/jeb.114116; Costantini D, 2014, NATURWISSENSCHAFTEN, V101, P541, DOI 10.1007/s00114-014-1190-2; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; DEERENBERG C, 1995, ZOOL-ANAL COMPLEX SY, V99, P39; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; Emaresi G, 2016, J EXP BIOL, V219, P73, DOI 10.1242/jeb.128959; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fletcher Quinn E, 2013, Evolution, V67, P1527, DOI 10.1111/evo.12014; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gonzalez-Medina E, 2015, ANIM BEHAV, V108, P9, DOI 10.1016/j.anbehav.2015.06.025; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harman D., 1957, J GERONTOL, V2; Hayward A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016557; Heiss RS, 2012, PHYSIOL BIOCHEM ZOOL, V85, P499, DOI 10.1086/666840; Horak P, 2000, CAN J ZOOL, V78, P905, DOI 10.1139/cjz-78-6-905; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kuznetsova A, 2014, IMERTEST TEST RANDOM; LISHMAN GS, 1985, J ZOOL, V205, P245, DOI 10.1111/j.1469-7998.1985.tb03532.x; Merino S, 2006, J ANIM ECOL, V75, P1147, DOI 10.1111/j.1365-2656.2006.01135.x; Metcalfe NB, 2013, TRENDS ECOL EVOL, V28, P347, DOI 10.1016/j.tree.2013.01.015; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; MOLE S, 1993, OECOLOGIA, V93, P121, DOI 10.1007/BF00321201; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; MORENO J, 1995, POLAR BIOL, V15, P533; Oldakowski L, 2012, J EXP BIOL, V215, P1799, DOI 10.1242/jeb.068452; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Stearns S.C., 1992, pi; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; Suorsa P, 2004, P ROY SOC B-BIOL SCI, V271, P435, DOI 10.1098/rspb.2003.2620; Team R.C, R LANG ENV STAT COMP; Thierry AM, 2014, BEHAV ECOL SOCIOBIOL, V68, P721, DOI 10.1007/s00265-014-1685-z; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; Tummeleht L, 2006, COMP BIOCHEM PHYS C, V144, P166, DOI 10.1016/j.cbpc.2006.08.004; van der Meer E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127984; Wegmann M, 2015, PHYSIOL BEHAV, V141, P127, DOI 10.1016/j.physbeh.2015.01.017; Widmann M, 2015, MOV ECOL, V3, DOI [10.1186/s40462-015-0052, 10.1186/s40462-015-0052-7]; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; Williams T.D., 1995, PENGUINS; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; WILSON RP, 1991, MAR BIOL, V109, P181, DOI 10.1007/BF01319385; WILSON RP, 1989, POLAR BIOL, V10, P161; Xu YC, 2014, FUNCT ECOL, V28, P402, DOI 10.1111/1365-2435.12168	68	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177124	10.1371/journal.pone.0177124	http://dx.doi.org/10.1371/journal.pone.0177124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493935	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300062
J	de Lannoy, L; Clarke, J; Stotz, PJ; Ross, R				de lannoy, Louise; Clarke, John; Stotz, Paula J.; Ross, Robert			Effects of intensity and amount of exercise on measures of insulin and glucose: Analysis of inter-individual variability	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; TOLERANCE; RESISTANCE; REDUCTION	Aim To determine the separate effects of exercise amount and intensity on the rate of response for glucose and insulin variables, where rate of response was defined as the number of individuals with improvement in glucose and insulin values that was beyond the day-to-day variability of measurement. Methods Participants were 171 sedentary, middle-aged abdominally obese adults who completed a 24-week intervention. Participants were randomly assigned to (1) no-exercise control (n = 51), (2) low-amount, low-intensity exercise (LALI, n = 38), (3) high-amount, low-intensity exercise (HALI, n = 52), or (4) high-amount, high-intensity exercise (HAHI, n = 30). Two-hour glucose, insulin area under the curve (AUC), and fasting insulin were measured during a 2-hour, 75g oral glucose challenge. The day-to-day variability for these measures was calculated to be +/- 2.2 mmol/L, +/- 940.2 pmol/L, and +/- 38.9 pmol/L, respectively. Results At 24 weeks, the number of nonresponders for 2-hr glucose was 98.0%, 86.8%, 94.2%, 86.7% in the control, LALI, HALI, and HAHI groups, respectively. The number of nonresponders for insulin AUC was 88.0%, 75.7%, 75.0%, 80.0% in the control, LALI, HALI, and HAHI groups, respectively. The number of nonresponders for fasting insulin was 88.2%, 84.2%, 84.6%, 93.3% in the control, LALI, HALI, and HAHI groups, respectively. The rate of response was not different between control and any of the exercise groups for any measure (p>0.05). Conclusion The improvement in glucose and insulin measures did not exceed the day-to-day variability of measurement for approximately 80% of the participants independent of exercise amount or intensity.	[de lannoy, Louise; Clarke, John; Stotz, Paula J.; Ross, Robert] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Ross, Robert] Queens Univ, Sch Med, Div Endocrinol & Metab, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Ross, R (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.; Ross, R (corresponding author), Queens Univ, Sch Med, Div Endocrinol & Metab, Kingston, ON, Canada.	rossr@queensu.ca	Gonzalez, Javier T/K-6910-2014	Gonzalez, Javier T/0000-0002-9939-0074; Ross, Robert/0000-0001-6875-785X	Canadian Institutes of Health Research [OHN-63277]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research [grant OHN-63277; http://www.cihr-irsc.gc.ca]. RR received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti ACB, 2007, AM STAT, V52, P119; [Anonymous], 2015, DIABETES CARE, V38, pS20, DOI 10.2337/dc15-S007; [Anonymous], 2008, SERV UDOHAH; [Anonymous], 2014, NAT HLTH NUTR EXAM S; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887; Boule NG, 2005, DIABETES CARE, V28, P108, DOI 10.2337/diacare.28.1.108; Clarke J, 2016, MED SCI SPORTS EXERC; Dallman MF, 1995, ANN NY ACAD SCI, V771, P730, DOI 10.1111/j.1749-6632.1995.tb44724.x; Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gurd BJ, 2016, APPL PHYSIOL NUTR ME, V41, P229, DOI 10.1139/apnm-2015-0449; Hecksteden A, 1985, J APPL PHYSL 1985, V118, P1450, DOI DOI 10.1152/JAPPLPHYSI0L.00714.2014; Hirsch S, 2013, NUTR HOSP, V28, P541, DOI 10.3305/nh.2013.28.2.6161; Hong YL, 1998, J CLIN ENDOCR METAB, V83, P4239, DOI 10.1210/jc.83.12.4239; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; Ranawana V, 2010, NUTR RES, V30, P246, DOI 10.1016/j.nutres.2010.02.004; Rankinen T, 2015, CIRC RES, V116, P909, DOI 10.1161/CIRCRESAHA.116.302888; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Ross R, 2015, MAYO CLIN PROC, V90, P1506, DOI 10.1016/j.mayocp.2015.07.024; Ross R, 2015, ANN INTERN MED, V162, P325, DOI 10.7326/M14-1189; Ross R, 2013, CONTEMP CLIN TRIALS, V34, P155, DOI 10.1016/j.cct.2012.10.010; Utzschneider KM, 2007, DIABETOLOGIA, V50, P2516, DOI 10.1007/s00125-007-0819-5; VALDES CT, 1991, J CLIN ENDOCR METAB, V72, P642, DOI 10.1210/jcem-72-3-642; Vega-Lopez S, 2007, DIABETES CARE, V30, P1412, DOI 10.2337/dc06-1598	26	30	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177095	10.1371/journal.pone.0177095	http://dx.doi.org/10.1371/journal.pone.0177095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493912	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300059
J	Okubo, Y; Masuyama, R; Iwanaga, A; Koike, Y; Kuwatsuka, Y; Ogi, T; Yamamoto, Y; Endo, Y; Tamura, H; Utani, A				Okubo, Yumi; Masuyama, Ritsuko; Iwanaga, Akira; Koike, Yuta; Kuwatsuka, Yutaka; Ogi, Tomoo; Yamamoto, Yosuke; Endo, Yuichiro; Tamura, Hiroshi; Utani, Atsushi			Calcification in dermal fibroblasts from a patient with GGCX syndrome accompanied by upregulation of osteogenic molecules	PLOS ONE			English	Article							MATRIX GLA-PROTEIN; GAMMA-CARBOXYGLUTAMIC ACID; K-DEPENDENT PROTEINS; PSEUDOXANTHOMA ELASTICUM; VITAMIN-K; OSTEOBLAST DIFFERENTIATION; VASCULAR CALCIFICATION; ENDOTHELIAL-CELLS; STEM-CELLS; CUTIS LAXA	Gamma-glutamyl carboxylase (GGCX) gene mutation causes GGCX syndrome (OMIM: 137167), which is characterized by pseudoxanthoma elasticum (PXE)-like symptoms and coagulation impairment. Here, we present a 55-year-old male with a novel homozygous deletion mutation, c. 2,221delT, p. S741LfsX100, in the GGCX gene. Histopathological examination revealed calcium deposits in elastic fibers and vessel walls, and collagen accumulation in the mid-dermis. Studies of dermal fibroblasts from the patient (GGCX dermal fibroblasts) demonstrated that the mutated GGCX protein was larger, but its expression level and intracellular distribution were indistinguishable from those of the wild-type GGCX protein. Immunostaining and an enzyme-linked immunosorbent assay showed an increase in undercarboxylated matrix gamma-carboxyglutamic acid protein (ucMGP), a representative substrate of GGCX and a potent calcification inhibitor, indicating that mutated GGCX was enzymatically inactive. Under osteogenic conditions, calcium deposition was exclusively observed in GGCX dermal fibroblasts. Furthermore, GGCX dermal fibroblast cultures contained 23-and 7.7-fold more alkaline phosphatase (ALP)-positive cells than normal dermal fibroblast cultures (n = 3), without and with osteogenic induction, respectively. Expression and activity of ALP were higher in GGCX dermal fibroblasts than in normal dermal fibroblasts upon osteogenic induction. mRNA levels of other osteogenic markers were also higher in GGCX dermal fibroblasts than in normal dermal fibroblasts, which including bone morphogenetic protein 6, runt-related transcription factor 2, and periostin (POSTN) without osteogenic induction; and osterix, collagen type I alpha 2, and POSTN with osteogenic induction. Together, these data indicate that GGCX dermal fibroblasts trans-differentiate into the osteogenic lineage. This study proposes another mechanism underlying aberrant calcification in patients with GGCX syndrome.	[Okubo, Yumi; Iwanaga, Akira; Koike, Yuta; Kuwatsuka, Yutaka; Utani, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki, Japan; [Okubo, Yumi] Kyushu Univ Hosp, Res & Clin Ctr Yusho & Dioxin ReC2YD, Fukuoka, Japan; [Masuyama, Ritsuko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Bone Biol, Nagasaki, Japan; [Ogi, Tomoo] Nagoya Univ, Res Inst Environm Med, Dept Genet, Aichi, Japan; [Yamamoto, Yosuke] Kyoto Univ, Grad Sch Med, Dept Healthcare Epidemiol Res, Kyoto, Japan; [Yamamoto, Yosuke; Endo, Yuichiro] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Tamura, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Nagasaki University; Kyushu University; Nagasaki University; Nagoya University; Kyoto University; Kyoto University; Kyoto University	Okubo, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki, Japan.; Okubo, Y (corresponding author), Kyushu Univ Hosp, Res & Clin Ctr Yusho & Dioxin ReC2YD, Fukuoka, Japan.	yumiookubo@nagasaki-u.ac.jp	YAMAMOTO, Yosuke/HCH-0666-2022; TAMURA, Hiroshi/H-1855-2011; Koike, Yuta/AFJ-1748-2022; Iwanaga, Akira/GQA-6750-2022	TAMURA, Hiroshi/0000-0002-7740-2732; Ogi, Tomoo/0000-0002-5492-9072; Koike, Yuta/0000-0002-7921-8840				Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Boraldi F, 2013, J INVEST DERMATOL, V133, P946, DOI 10.1038/jid.2012.460; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Buendia P, 2015, FASEB J, V29, P173, DOI 10.1096/fj.14-249706; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Dabisch-Ruthe M, 2014, J DERMATOL SCI, V75, P109, DOI 10.1016/j.jdermsci.2014.04.015; Diekmann U, 2009, J MOL MED, V87, P965, DOI 10.1007/s00109-009-0497-5; Enis DR, 2008, ENDOTHELIUM-J ENDOTH, V15, P59, DOI 10.1080/10623320802092393; Fabbri Elena, 2009, Dermatol Online J, V15, P7; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Gheduzzi Dealba, 2004, Hum Mutat, V24, P438, DOI 10.1002/humu.9284; Glienke J, 2000, EUR J BIOCHEM, V267, P2820, DOI 10.1046/j.1432-1327.2000.01325.x; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Hayashi S, 2013, J DERMATOL SCI, V72, P325, DOI 10.1016/j.jdermsci.2013.07.007; Hee CK, 2009, J ORTHOP RES, V27, P162, DOI 10.1002/jor.20728; Kariminejad A, 2014, J INVEST DERMATOL, V134, P2331, DOI 10.1038/jid.2014.191; Khavandgar Z, 2014, J BONE MINER RES, V29, P327, DOI 10.1002/jbmr.2039; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Li JQ, 2016, J BONE MINER METAB, V34, P367, DOI 10.1007/s00774-015-0734-7; Li QL, 2013, AM J PATHOL, V183, P10, DOI 10.1016/j.ajpath.2013.03.002; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Malhotra R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117098; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Michigami M, 2012, EUR J DERMATOL, V22, P403, DOI 10.1684/ejd.2012.1718; Mine Y, 2014, EUR J DERMATOL, V24, P401, DOI 10.1684/ejd.2014.2335; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nitschke Y, 2012, AM J HUM GENET, V90, P25, DOI 10.1016/j.ajhg.2011.11.020; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Okada M, 2015, HUM MOL GENET, V24, P299, DOI 10.1093/hmg/ddu444; Parker CH, 2014, BIOCHEMISTRY-US, V53, P1511, DOI 10.1021/bi401536m; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; Rashdan NA, 2016, CURR OPIN PHARMACOL, V28, P14, DOI 10.1016/j.coph.2016.02.002; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Tanioka M, 2014, J DERMATOL, V41, P189, DOI 10.1111/1346-8138.12360; Taylor Sarah E B, 2014, Bonekey Rep, V3, P585, DOI 10.1038/bonekey.2014.80; Uitto J, 2014, EXPERT OPIN ORPHAN D, V2, P567, DOI 10.1517/21678707.2014.908702; Utani A, 2010, J DERMATOL, V37, P130, DOI 10.1111/j.1346-8138.2009.00775.x; Vanakker OM, 2007, J INVEST DERMATOL, V127, P581, DOI 10.1038/sj.jid.5700610; Vanakker OM, 2010, LAB INVEST, V90, P895, DOI 10.1038/labinvest.2010.68; Viegas CSB, 2009, AM J PATHOL, V175, P2288, DOI 10.2353/ajpath.2009.090474; Watzka M, 2014, THROMB RES, V134, P856, DOI 10.1016/j.thromres.2014.07.004; Yano H, 2014, BIOCHEM BIOPH RES CO, V452, P531, DOI 10.1016/j.bbrc.2014.08.100; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177375	10.1371/journal.pone.0177375	http://dx.doi.org/10.1371/journal.pone.0177375			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494010	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300095
J	Zgheib, C; Hodges, MM; Hu, JY; Liechty, KW; Xu, JW				Zgheib, Carlos; Hodges, Maggie M.; Hu, Junyi; Liechty, Kenneth W.; Xu, Junwang			Long non-coding RNA Lethe regulates hyperglycemia-induced reactive oxygen species production in macrophages	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASES; NOX FAMILY; PATHOGENESIS; APOPTOSIS	Type 2 diabetes mellitus is a complex, systemic metabolic disease characterized by insulin resistance and resulting hyperglycemia, which is associated with impaired wound healing. The clinical complications associated with hyperglycemia are attributed, in part, to the increased production of reactive oxygen species (ROS). Recent studies revealed that long non-coding RNAs (lncRNAs) play important regulatory roles in many biological processes. Specifically, lncRNA Lethe has been described as exhibiting an anti-inflammatory effect by binding to the p65 subunit of NF kappa B and blocking its binding to DNA and the subsequent activation of downstream genes. We therefore hypothesize that dysregulation of Lethe's expression plays a role in hyperglycemia-induced ROS production. To test our hypothesis, we treated RAW264.7 macrophages with low glucose (5 mM) or high glucose (25 mM) for 24h. High glucose conditions significantly induced ROS production and NOX2 gene expression in RAW cells, while significantly decreasing Lethe gene expression. Overexpression of Lethe in RAW cells eliminated the increased ROS production induced by high glucose conditions, while also attenuating the upregulation of NOX2 expression. Similar results was found also in non-diabetic and diabetic primary macrophage, bone marrow derived macrophage (BMM). Furthermore, overexpression of Lethe in RAW cells treated with high glucose significantly reduced the translocation of p65-NF kappa B to the nucleus, which resulted in decreased NOX2 expression and ROS production. Interestingly, these findings are consistent with the decreased Lethe gene expression and increased NOX2 gene expression observed in a mouse model of diabetic wound healing. These findings provide the first evidence that lncRNA Lethe is involved in the regulation of ROS production in macrophages through modulation of NOX2 gene expression via NF kappa B signaling. Moreover, this is the first report to describe a role of lncRNAs, in particular Lethe, in impaired diabetic wound healing. Further studies are warranted to determine if correction of Lethe expression in diabetic wounds could improve healing.	[Zgheib, Carlos; Hodges, Maggie M.; Hu, Junyi; Liechty, Kenneth W.; Xu, Junwang] Univ Colorado, Dept Surg, Anschutz Med Campus, Aurora, CO 80045 USA; [Zgheib, Carlos; Hodges, Maggie M.; Hu, Junyi; Liechty, Kenneth W.; Xu, Junwang] Childrens Hosp Colorado, Div Pediat Surg, Dept Surg, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Xu, JW (corresponding author), Univ Colorado, Dept Surg, Anschutz Med Campus, Aurora, CO 80045 USA.; Xu, JW (corresponding author), Childrens Hosp Colorado, Div Pediat Surg, Dept Surg, Aurora, CO 80045 USA.	Junwang.Xu@ucdenver.edu	Hodges, Maggie/HCG-9001-2022	Hodges, Maggie/0000-0001-5814-6932	NIH [1R01DK105010-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by NIH 1R01DK105010-01A1.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Arya AK, 2011, DIABETES RES CLIN PR, V94, P377, DOI 10.1016/j.diabres.2011.08.004; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Callahan D, 2016, ANN VASC SURG, V33, P103, DOI 10.1016/j.avsg.2016.01.003; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; GRIESMACHER A, 1995, AM J MED, V98, P469, DOI 10.1016/S0002-9343(99)80347-7; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Jia YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120849; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Luo JD, 2004, CIRCULATION, V110, P2484, DOI 10.1161/01.CIR.0000137969.87365.05; Mauricio D, 1998, DIABETES, V47, P1537, DOI 10.2337/diabetes.47.10.1537; Moseley R, 2004, BRIT J DERMATOL, V150, P401, DOI 10.1111/j.1365-2133.2004.05845.x; Mudge BP, 2002, WOUND REPAIR REGEN, V10, P52, DOI 10.1046/j.1524-475X.2002.10803.x; Ojha N, 2008, FREE RADICAL BIO MED, V44, P682, DOI 10.1016/j.freeradbiomed.2007.10.056; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponugoti B, 2013, J CELL BIOL, V203, P327, DOI 10.1083/jcb.201305074; Porter BO, 1999, EUR J IMMUNOL, V29, P2360, DOI 10.1002/(SICI)1521-4141(199907)29:07<2360::AID-IMMU2360>3.0.CO;2-A; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Rasik AM, 2000, INT J EXP PATHOL, V81, P257, DOI 10.1046/j.1365-2613.2000.00158.x; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rodriguez PG, 2008, DERMATOL SURG, V34, P1159, DOI 10.1111/j.1524-4725.2008.34254.x; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Sun XH, 2016, AM J CARDIOVASC DIS, V6, P17; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wlaschek M, 2005, WOUND REPAIR REGEN, V13, P452, DOI 10.1111/j.1067-1927.2005.00065.x; Xu JW, 2012, DIABETES, V61, P2906, DOI 10.2337/db12-0145; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	39	52	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177453	10.1371/journal.pone.0177453	http://dx.doi.org/10.1371/journal.pone.0177453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494015	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300113
J	Otsubo, Y; Hashimoto, K; Kanbe, T; Sumi, M; Moriuchi, H				Otsubo, Yoshikazu; Hashimoto, Kunio; Kanbe, Taro; Sumi, Muneichiro; Moriuchi, Hiroyuki			Association of cord blood chemokines and other biomarkers with neonatal complications following intrauterine inflammation	PLOS ONE			English	Article							RESPONSE SYNDROME; INTERLEUKIN-6; CYTOKINES; SEPSIS; RISK	Background Intrauterine inflammation has been associated with preterm birth and neonatal complications. Few reports have comprehensively investigated multiple cytokine profiles in cord blood and precisely identified surrogate markers for intrauterine inflammation. Aim To identify the cytokines and surrogate markers associated with intrauterine inflammation and subsequent neonatal complications. Patients and methods We analyzed cord blood samples from 135 patients admitted to the neonatal intensive care unit at Sasebo City General Hospital. We retrospectively determined the associations between the presence of neonatal complications and cord blood cytokines, prenatal factors, and laboratory data at birth. A total of 27 cytokines in the cord blood were measured using a bead-based array sandwich immunoassay. Results Both Th1 and Th2 cytokine levels were low, whereas the levels of growth factors and chemokines were high. In particular, chemokines IL-8, MCP-1, and MIP-1 alpha were significantly higher in very premature neonates when compared with more mature neonates. In addition, some have been shown to be associated with multiple neonatal complications, including patent ductus arteriosus (PDA), respiratory distress syndrome (RDS), and chronic lung disease (CLD). Similarly, the levels of N-terminal pro-brain natriuretic peptide, nucleated RBC, and urinary beta 2-microglobulin were associated with these complications and chemokine levels. Conclusions Our results suggest the association of inflammatory chemokines IL-8, MCP-1, and MIP-1 alpha with intrauterine inflammation, premature birth, and neonatal complications in these perinatal subjects. Furthermore, the association of the aforementioned biomarkers with PDA, RDS, and CLD may help establish early diagnostic measures to predict such neonatal complications following intrauterine inflammation.	[Otsubo, Yoshikazu; Kanbe, Taro; Sumi, Muneichiro] Sasebo City Gen Hosp, Dept Pediat, Sasebo, Nagasaki, Japan; [Otsubo, Yoshikazu; Hashimoto, Kunio; Moriuchi, Hiroyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pediat, Nagasaki, Nagasaki, Japan	Nagasaki University	Otsubo, Y (corresponding author), Sasebo City Gen Hosp, Dept Pediat, Sasebo, Nagasaki, Japan.; Otsubo, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pediat, Nagasaki, Nagasaki, Japan.	y-otsubo@hospital.sasebo.nagasaki.jp	Otsubo, Yoshikazu/I-7747-2019					Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Burns C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00318; Dulay AT, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.040; Glezeva N, 2013, J CARDIOVASC TRANSL, V6, P545, DOI 10.1007/s12265-013-9456-1; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gonzalez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026877; Grisaru-Granovsky S, 2009, J CELL PHYSIOL, V218, P512, DOI 10.1002/jcp.21625; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656; Lieberman E, 2000, PEDIATRICS, V105, P8, DOI 10.1542/peds.105.1.8; Ly Ngoc P, 2006, Clin Mol Allergy, V4, P13; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Nishimaki S, 2009, J OBSTET GYNAECOL RE, V35, P472, DOI 10.1111/j.1447-0756.2008.00988.x; Oddie S, 2002, BRIT MED J, V325, P308, DOI 10.1136/bmj.325.7359.308; Otsubo Y, 2011, J JPN PEDIAT SOC, V115, p1543 ; Romero R, 2012, J PERINAT MED, V40, P19, DOI 10.1515/JPM.2011.100; Shah TA, 2010, PEDIATR RES, V68, P210, DOI 10.1203/00006450-201011001-00409; Takahashi N, 2010, CYTOKINE, V49, P331, DOI 10.1016/j.cyto.2009.11.024; Tutdibi E, 2012, J PERINAT MED, V40, P527, DOI 10.1515/jpm-2011-0204; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X	21	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0175082	10.1371/journal.pone.0175082	http://dx.doi.org/10.1371/journal.pone.0175082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531215	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400001
J	Park, J; Han, E; Lee, SO; Kim, DS				Park, Juhee; Han, Euna; Lee, Soo Ok; Kim, Dong-Sook			Antibiotic use in South Korea from 2007 to 2014: A health insurance database-generated time series analysis	PLOS ONE			English	Article							RESISTANT PATHOGENS; ASIAN COUNTRIES; CONSUMPTION; SURVEILLANCE; NETWORK	Background Inappropriate antibiotic use significantly contributes to antibiotic-resistance, resulting in reduced antibiotic efficacy and increasing physical burden and cost of disease. The goal of this study was to explore antibiotic usage patterns in South Korea using 2007-2014 health insurance claims data. Methods We used the Health Insurance Review & Assessment Service data, which represents nearly the entire population of South Korea, to discern patterns in antibiotic prescribing practices. The daily dose, as defined by the World Health Organization ([defined daily doses]/1000 inhabitants/day, [DID]), was used as a measure of antibiotic use. Subgroup analyses were performed on the basis of patient characteristics (sex, age, and disease) and provider characteristics (type of medical institution). Results Antibiotic use in DID increased from 23.5 in 2007 to 27.7 in 2014. The <= 6 years old age group showed the highest level of usage at 59.21 DID in 2014, and showed an increasing trend each year. DIDs of beta-lactam antibacterials, penicillins (J01C), other beta-lactam antibacterials (J01D), lincosamides and streptogramins (J01F), quinolone antibacterials (J01M), and other antibacterials (J01X) increased over time. Conclusion This study provides valuable statistics regarding antibiotic usage in South Korea; this is important for guiding health policy with regard to antibiotic usage. There is a need for further study exploring antibiotics use and resistance.	[Park, Juhee; Lee, Soo Ok; Kim, Dong-Sook] Hlth Insurance Review & Assessment Serv, Dept Res, Wonju, South Korea; [Han, Euna] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Seoul, South Korea	Yonsei University	Kim, DS (corresponding author), Hlth Insurance Review & Assessment Serv, Dept Res, Wonju, South Korea.	sttone@hira.or.kr		Kim, Dong-Sook/0000-0003-2372-1807; Han, Euna/0000-0003-2656-7059				[Anonymous], 2013, GLOBAL RISK REPORT W; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Health Insurance Review & Assessment, 2014, PRESC AN PROGR REP H; Lee YS, 2014, ARCH PHARM RES, V37, P1295, DOI 10.1007/s12272-014-0333-5; Levy Stuart B., 1992, ANTIBIOTIC PARADOX M; Organisation for Economic Co-operation and Development, 2014, OECD HLTH DAT ORG EC; Sohn HS, 2013, INT J CLIN PHARM TH, V51, P585, DOI 10.5414/CP201827; Song JH, 2010, J KOREAN MED ASSOC, V53, P999, DOI 10.5124/jkma.2010.53.11.999; Song JH, 2004, CLIN INFECT DIS, V38, P1570, DOI 10.1086/420821; Song JH, 2004, J ANTIMICROB CHEMOTH, V53, P457, DOI 10.1093/jac/dkh118; SWEDRES SVARM, 2013, US ANT OCC ANT RES S; World Health Organization, 2014, ANA THER CHEM ATC CL; World Health Organization, 2014, ANT RES GLOB REP SUR	15	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177435	10.1371/journal.pone.0177435	http://dx.doi.org/10.1371/journal.pone.0177435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520761	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700048
J	Pritchard, S; Jackson, MJ; Hikima, A; Lione, L; Benham, CD; Chaudhuri, KR; Rose, S; Jenner, P; Iravani, MM				Pritchard, Sara; Jackson, Michael J.; Hikima, Atsuko; Lione, Lisa; Benham, Christopher D.; Chaudhuri, K. Ray; Rose, Sarah; Jenner, Peter; Iravani, Mahmoud M.			Altered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia	PLOS ONE			English	Article							NONCHOLINERGIC MOTOR TRANSMISSION; LOWER URINARY-TRACT; PARKINSONS-DISEASE; SMOOTH-MUSCLE; RAT MODEL; DYSFUNCTION; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; PATHOPHYSIOLOGY; DEGENERATION; RELAXATION	Bladder hyperreflexia is a common non-motor feature of Parkinson's disease. We now report on the contractility of the isolated primate detrusor strips devoid of nerve input and show that following MPTP, the amplitude and frequency of spontaneous contraction was increased. These responses were unaffected by dopamine D-1 and D-2 receptor agonists A77636 and ropinirole respectively. Contractions by exogenous carbachol, histamine or ATP were similar and no differences in the magnitude of noradrenaline-induced relaxation were seen in detrusor strip obtained from normal and MPTP-treated common marmosets (Callithrix jacchus). However, the neurogenic contractions following electrical field stimulation of the intrinsic nerves (EFS) were markedly greater in strips obtained from MPTP treated animals. EFS evoked non-cholinergic contractions following atropine were also greater but the contribution of the cholinergic innervation as a proportion of the overall contraction was smaller in the detrusor strips of MPTP treated animals, suggesting a preferential enhancement of the non-cholinergic transmission. Although dopaminergic mechanism has been proposed to underlie bladder hyperreflexia in MPTP-treated animals with intact bladder, the present data indicates that the increased neurogenically mediated contractions where no extrinsic innervation exists might be due to long-term adaptive changes locally as a result of the loss of the nigrostriatal output.	[Pritchard, Sara; Lione, Lisa; Benham, Christopher D.; Iravani, Mahmoud M.] Univ Hertfordshire, Dept Pharm Pharmacol & Postgrad Med, Hatfield, Herts, England; [Jackson, Michael J.; Hikima, Atsuko; Rose, Sarah; Jenner, Peter] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, Neurodegenerat Dis Res Grp, London, England; [Chaudhuri, K. Ray] Kings Hlth Partnership, London, England	University of Hertfordshire; University of London; King's College London; King's Health Partners	Iravani, MM (corresponding author), Univ Hertfordshire, Dept Pharm Pharmacol & Postgrad Med, Hatfield, Herts, England.	m.iravani@herts.ac.uk		Ray Chaudhuri, K/0000-0003-2815-0505; Iravani, Mahmoud/0000-0002-4905-9682; ROSE, SARAH/0000-0003-4723-7665				ALBANESE A, 1988, NEUROSCI LETT, V87, P46, DOI 10.1016/0304-3940(88)90143-7; Andersson K E, 1995, Scand J Urol Nephrol Suppl, V175, P43; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Andersson KE, 2003, EUR UROL, V43, P1, DOI 10.1016/S0302-2838(02)00540-7; Bayliss M, 1999, J UROLOGY, V162, P1833, DOI 10.1016/S0022-5347(05)68247-X; Blackett H, 2009, PARKINSONISM RELAT D, V15, P81, DOI 10.1016/j.parkreldis.2007.10.016; Bukhatwa S, 2009, J NEUROCHEM, V109, P52, DOI 10.1111/j.1471-4159.2009.05956.x; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chung BH, 1996, J UROLOGY, V155, P2090, DOI 10.1016/S0022-5347(01)66115-9; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; FITZMAURICE H, 1985, BRIT J UROL, V57, P652, DOI 10.1111/j.1464-410X.1985.tb07025.x; Hallett P.J., NEUROBIOL DIS, V46, P258; Iravani MM, 2006, J NEUROCHEM, V96, P1315, DOI 10.1111/j.1471-4159.2005.03625.x; IRAVANI MM, 1994, BRIT J PHARMACOL, V113, P95, DOI 10.1111/j.1476-5381.1994.tb16179.x; Jackson MJ, 2007, EXP NEUROL, V204, P162, DOI 10.1016/j.expneurol.2006.10.005; KIRBY R, 1986, J NEUROL NEUROSUR PS, V49, P554, DOI 10.1136/jnnp.49.5.554; LUHESHI G, 1990, EUR J PHARMACOL, V185, P203, DOI 10.1016/0014-2999(90)90641-I; LUHESHI GN, 1990, J PHARM PHARMACOL, V42, P223, DOI 10.1111/j.2042-7158.1990.tb05396.x; McMurray G, 1998, BRIT J PHARMACOL, V123, P1579, DOI 10.1038/sj.bjp.0701774; Mitra R, 2015, J PARKINSON DIS, V5, P301, DOI 10.3233/JPD-140509; MOSS HE, 1985, EUR J PHARMACOL, V114, P311, DOI 10.1016/0014-2999(85)90375-9; Ruggieri MR, 2006, NAT CLIN PRACT UROL, V3, P206, DOI 10.1038/ncpuro0456; Sakakibara R, 2008, J NEURAL TRANSM, V115, P443, DOI 10.1007/s00702-007-0855-9; Sakakibara R, 2001, J NEUROL SCI, V187, P55, DOI 10.1016/S0022-510X(01)00521-4; Sakakibara R, 2012, NEUROBIOL DIS, V46, P565, DOI 10.1016/j.nbd.2011.10.002; Santoso AGH, 2011, NEUROUROL URODYNAM, V30, P619, DOI 10.1002/nau.21015; Seki S, 2001, NEUROUROL URODYNAM, V20, P105, DOI 10.1002/1520-6777(2001)20:1<105::AID-NAU12>3.3.CO;2-0; SJOGREN C, 1982, J UROLOGY, V128, P1368, DOI 10.1016/S0022-5347(17)53509-0; Smith L, 1996, MOVEMENT DISORD, V11, P125, DOI 10.1002/mds.870110203; Soler R, 2011, NEUROUROL URODYNAM, V30, P188, DOI 10.1002/nau.20917; Sui G, 2009, CELL CALCIUM, V45, P456, DOI 10.1016/j.ceca.2009.03.001; Winge K, 2005, EUR J NEUROL, V12, P842, DOI 10.1111/j.1468-1331.2005.01087.x; YOSHIMURA N, 1993, NEUROPHARMACOLOGY, V32, P315, DOI 10.1016/0028-3908(93)90151-R; Yoshimura N, 2003, BRIT J PHARMACOL, V139, P1425, DOI 10.1038/sj.bjp.0705388; Yoshimura N, 1998, J PHARMACOL EXP THER, V286, P228; ZAR MA, 1990, J UROLOGY, V143, P835, DOI 10.1016/S0022-5347(17)40112-1	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175797	10.1371/journal.pone.0175797	http://dx.doi.org/10.1371/journal.pone.0175797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520722	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700008
J	Gunaryadi, D; Sugiyo; Hedges, S				Gunaryadi, Donny; Sugiyo; Hedges, Simon			Community-based human-elephant conflict mitigation: The value of an evidence-based approach in promoting the uptake of effective methods	PLOS ONE			English	Article							FARM-BASED MEASURES; CONSERVATION SCIENCE; NATIONAL-PARK; DISTRICT; SUMATRA; DEFENSE; FENCES	Human-elephant conflict (HEC) is a serious threat to elephants and can cause major economic losses. It is widely accepted that reduction of HEC will often require community-based methods for repelling elephants but there are few tests of such methods. We tested community-based crop-guarding methods with and without novel chili-based elephant deterrents and describe changes in farmers' willingness to adopt these methods following our demonstration of their relative effectiveness. In three separate field-trials that took place over almost two years (October 2005 -May 2007) in two villages adjacent to Way Kambas National Park (WKNP) in Indonesia, we found that community-based crop-guarding was effective at keeping Asian elephants (Elephas maximus) out of crop fields in 91.2% (52 out of 57), 87.6% (156 out of 178), and 80.0% (16 out of 20) of attempted raids. Once the method had been shown to be effective at demonstration sites, farmers in 16 villages around WKNP voluntarily adopted it during the July 2008 to March 2009 period and were able to repel elephants in 73.9% (150 out of 203) of attempted raids, with seven villages repelling 100% of attempted raids. These 16 villages had all experienced high levels of HEC in the preceding years; e.g. they accounted for >97% of the 742 HEC incidents recorded for the entire park in 2006. Our work shows, therefore, that a simple evidence-based approach can facilitate significant reductions in HEC at the protected area scale.	[Gunaryadi, Donny; Sugiyo] Wildlife Conservat Soc, Indonesia Program, Bogor, Indonesia; [Hedges, Simon] Wildlife Conservat Soc, Global Conservat Programs, Bronx, NY 10460 USA	Wildlife Conservation Society - Indonesia; Wildlife Conservation Society	Hedges, S (corresponding author), Wildlife Conservat Soc, Global Conservat Programs, Bronx, NY 10460 USA.	shedges@wcs.org			United States Fish & Wildlife Service's Asian Elephant Conservation Fund [98210-5-G175, 98210-4-G940]	United States Fish & Wildlife Service's Asian Elephant Conservation Fund	Funding for this project was provided by the United States Fish & Wildlife Service's Asian Elephant Conservation Fund (https://www.fws.gov/ International/wildlife-without-borders/asiane-elephant-conservation-fund.html) through grants 98210-5-G175 and 98210-4-G940 to SH and DG. We are very grateful to the USFWS. The funder had no role in study design, data collection and manuscript.; Our research was a collaborative project of the Indonesian Ministry of Forestry's Directorate General of Forest Protection and Nature Conservation and the Wildlife Conservation Society (WCS). We are grateful to Mr. Hudiyono (the Head of WKNP), Sukatmoko, Agus Santo, Sukadi, and our village 'self-reliance groups' (Kelompok Swadaya Masyarakat) members, for their dedication and patient dealing with farmers. We thank Martin Tyson, Peter Clyne, and Rosie Woodroffe for useful comments on an earlier version of this paper. Funding for this project was provided by the United States Fish & Wildlife Service's Asian Elephant Conservation Fund through grants 98210-5-G175 and 98210-4-G940 to WCS. We are very grateful to the USFWS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; Creel S, 2013, ECOL LETT, V16, P1413, DOI 10.1111/ele.12145; Davies TE, 2011, CONSERV LETT, V4, P346, DOI 10.1111/j.1755-263X.2011.00182.x; Gopala A, 2011, IUCN 2011 IUCN RED L; Graham MD, 2008, ORYX, V42, P76, DOI 10.1017/S0030605308000677; Hall JA, 2010, CONSERV BIOL, V24, P120, DOI 10.1111/j.1523-1739.2009.01297.x; Hedges S, 2005, BIOL CONSERV, V124, P35, DOI 10.1016/j.biocon.2005.01.004; Hedges S., 2006, DUNG SURVEY STANDARD; Hedges S, 2010, ORYX, V44, P139, DOI 10.1017/S0030605309990093; Nath C.D., 1998, ELEPHANT HUMAN CONFL; Naughton L., 1999, SOCIAL DIMENSIONS HU; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; Nyhus PJ, 2000, ORYX, V34, P262, DOI 10.1017/S0030605300031331; Osborn F. V., 2002, LIVING ELEPHANTS; Osborn FV, 2003, ORYX, V37, P80, DOI 10.1017/S0030605303000152; Osborn FV, 2002, PACHYDERM, V33, P32; Packer C, 2013, Ecol Lett, V16, pe4, DOI 10.1111/ele.12171; Parker G. E., 2007, HUMAN ELEPHANT CONFL; Pfeifer M, 2014, SCIENCE, V345, P389, DOI 10.1126/science.345.6195.389-a; Pullin AS, 2001, CONSERV BIOL, V15, P50, DOI 10.1046/j.1523-1739.2001.99499.x; Sitati NW, 2006, ORYX, V40, P279, DOI 10.1017/S0030605306000834; Sitompul AF., 2004, THESIS; Sitompul Arnold F., 2010, Gajah, V33, P26; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; UNDP/FAO, 1979, INS78061 UNDPFAO; van Aarde RJ, 2006, S AFR J SCI, V102, P385; Woodroffe R, 2014, SCIENCE, V345, P389, DOI 10.1126/science.345.6195.389-b; Woodroffe R, 2014, SCIENCE, V344, P46, DOI 10.1126/science.1246251; World Wildlife Fund (WWF), 2005, HUMAN WILDLIFE CONFL; Young KD, 2011, BIOL CONSERV, V144, P876, DOI 10.1016/j.biocon.2010.11.023; Zimmermann A., 2009, GAJAH, V30, P34	33	30	30	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0173742	10.1371/journal.pone.0173742	http://dx.doi.org/10.1371/journal.pone.0173742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510590	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500002
J	Thombare, K; Ntika, S; Wang, X; Krizhanovskii, C				Thombare, Ketan; Ntika, Stelia; Wang, Xuan; Krizhanovskii, Camilla			Long chain saturated and unsaturated fatty acids exert opposing effects on viability and function of GLP-1-producing cells: Mechanisms of lipotoxicity	PLOS ONE			English	Article							GLP-1 SECRETION; INSULIN-RESISTANCE; GLUCAGON; GLUCOSE; RESPONSES; ACTIVATION; PROTECTION; INTESTINE; METFORMIN; OBESITY	Background and aim Fatty acids acutely stimulate GLP-1 secretion from L-cells in vivo. However, a high fat diet has been shown to reduce the density of L-cells in the mouse intestine and a positive correlation has been indicated between L-cell number and GLP-1 secretion. Thus, the mechanism of fatty acid-stimulated GLP-1 secretion, potential effects of long-term exposure to elevated levels of different fatty acid species, and underlying mechanisms are not fully understood. In the present study, we sought to determine how long-term exposure to saturated (16:0) and unsaturated (18:1) fatty acids, by direct effects on GLP-1-producing cells, alter function and viability, and the underlying mechanisms. Methods GLP-1-secreting GLUTag cells were cultured in the presence/absence of saturated (16:0) and unsaturated (18:1) fatty acids (0.125 mM for 48 h, followed by analyses of viability and apoptosis, as well as involvement of fatty acid oxidation, free fatty acid receptors (FFAR1) and ceramide synthesis. In addition, effects on the expression of proglucagon, prohormone convertase 1/3 (PC1/3), free fatty acid receptors (FFAR1, FFAR3), sodium glucose cotransporter (SGLT) and subsequent secretory response were determined. Results Saturated (16:0) and unsaturated (18:1) fatty acids exerted opposing effects on the induction of apoptosis (1.4-fold increase in DNA fragmentation by palmitate and a 0.5-fold reduction by oleate; p<0.01). Palmitate-induced apoptosis was associated with increased ceramide content and co-incubation with Fumonisin B1 abolished this lipo apoptosis. Oleate, on the other hand, reduced ceramide content, and-unlike palmitate-upregulated FFAR1 and FFAR3, evoking a 2-fold increase in FFAR1-mediated GLP-1 secretion following acute exposure to 0.125 mmol/L palmitate; (p<0.05). Conclusion/Interpretation Saturated (16:0), but not unsaturated (18:1), fatty acids induce ceramide-mediated apoptosis of GLP-1-producing cells. Further, unsaturated fatty acids confer lipoprotection, enhancing viability and function of GLP-1-secreting cells. These data provide potential mechanistic insight contributing to reduced L-cell mass following a high fat diet and differential effects of saturated and unsaturated fatty acids on GLP-1 secretion in vivo.	[Thombare, Ketan; Ntika, Stelia; Wang, Xuan; Krizhanovskii, Camilla] Sodertalje Hosp, Dept Internal Med, Sodertalje, Sweden; [Krizhanovskii, Camilla] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Krizhanovskii, Camilla] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Krizhanovskii, C (corresponding author), Sodertalje Hosp, Dept Internal Med, Sodertalje, Sweden.; Krizhanovskii, C (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.; Krizhanovskii, C (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	camilla.krizhanovskii@sll.se		Thombare, Ketan/0000-0002-0183-3376; Ntika, Stelia/0000-0001-5621-1446	Mats Kleberg Foundation; Folksam Research grants; ToreNilsons Stiftelse [20650*1]; Fredrik & Ingrid Thurings Siftelse [24910*1*13]	Mats Kleberg Foundation; Folksam Research grants; ToreNilsons Stiftelse; Fredrik & Ingrid Thurings Siftelse	Support was provided by: Mats Kleberg Foundation (http://www.matsklebergsstiftelse.se/en/BEVILJADE-BIDRAG/2014/) (Recipient:CK); Folksam Research grants (http://www.folksam.se/om-oss/om-folksam/sponsring-och-samarbeten/forskningsstiftelsen) (Recipient:CK);ToreNilsons Stiftelse (http://www.torenilsonsstiftelse.nu) Grant: 20650*1# (Recipient:CK); Fredrik & Ingrid Thurings Siftelse (http://www.thuringsstiftelse.com) Grant: 24910*1*13 (Recipient:CK).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was graciously funded by the Mats Kleberg Foundation, Folksam Research grants, Tore Nilsons Stiftelse and Fredrik & Ingrid Thurings Siftelse.	Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; Balks HJ, 1997, J CLIN ENDOCR METAB, V82, P786, DOI 10.1210/jc.82.3.786; Beglinger S, 2010, J CLIN ENDOCR METAB, V95, P879, DOI 10.1210/jc.2009-1062; Beysen C, 2002, DIABETOLOGIA, V45, P1533, DOI 10.1007/s00125-002-0964-9; Brubaker PL, 1998, ENDOCRINOLOGY, V139, P4108, DOI 10.1210/en.139.10.4108; Burcelin R, 2001, DIABETES, V50, P1720, DOI 10.2337/diabetes.50.8.1720; Christensen LW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12551; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Guo DY, 2015, BIOCHEM BIOPH RES CO, V466, P740, DOI 10.1016/j.bbrc.2015.09.130; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Halpern KB, 2012, J BIOL CHEM, V287, P20154, DOI 10.1074/jbc.M112.358887; Hayashi H, 2014, METABOLISM, V63, P800, DOI 10.1016/j.metabol.2014.02.012; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Iwai K, 2003, J BIOL CHEM, V278, P9813, DOI 10.1074/jbc.M201867200; Kappe C, 2015, CLIN SCI, V129, P405, DOI 10.1042/CS20140719; Kappe C, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-70; Kappe C, 2013, J GASTROENTEROL, V48, P322, DOI 10.1007/s00535-012-0637-5; Kappe C, 2012, BIOCHEM BIOPH RES CO, V427, P91, DOI 10.1016/j.bbrc.2012.09.010; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; LEE YC, 1992, J BIOL CHEM, V267, P10705; Lindgren O, 2011, J CLIN ENDOCR METAB, V96, P2519, DOI 10.1210/jc.2011-0266; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Muscelli E, 2008, DIABETES, V57, P1340, DOI 10.2337/db07-1315; Petersen N, 2014, DIABETES, V63, P410, DOI 10.2337/db13-0991; Poreba MA, 2012, AM J PHYSIOL-ENDOC M, V303, pE899, DOI 10.1152/ajpendo.00116.2012; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; Richards P, 2016, PEPTIDES, V77, P21, DOI 10.1016/j.peptides.2015.06.006; Sayers SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149549; Thomsen C, 2003, AM J CLIN NUTR, V77, P605, DOI 10.1093/ajcn/77.3.605; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; van Raalte DH, 2016, TRENDS ENDOCRIN MET, V27, P442, DOI 10.1016/j.tem.2016.04.009; Villena J, 2008, FREE RADICAL BIO MED, V44, P1146, DOI 10.1016/j.freeradbiomed.2007.12.017; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009	37	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177605	10.1371/journal.pone.0177605	http://dx.doi.org/10.1371/journal.pone.0177605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520810	Green Submitted, gold, Green Published			2022-12-27	WOS:000401485500043
J	Boye, P; Serres, F; Marescaux, L; Hordeaux, J; Bouchaert, E; Gomes, B; Tierny, D				Boye, Pierre; Serres, Francois; Marescaux, Laurent; Hordeaux, Juliette; Bouchaert, Emmanuel; Gomes, Bruno; Tierny, Dominique			Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma	PLOS ONE			English	Article							VECTORIZED ANTICANCER DRUG; COMBINATION CHEMOTHERAPY PROTOCOL; TARGETING TOPOISOMERASE-II; CANINE LYMPHOMA; CLINICAL-PHARMACOLOGY; HYPOTENSIVE ACTION; CELL LINES; F14512; DOXORUBICIN; CANCER	Comparative oncology has shown that naturally occurring canine cancers are of valuable and translatable interest for the understanding of human cancer biology and the characterization of new therapies. This work was part of a comparative oncology project assessing a new, clinical-stage topoisomerase II inhibitor and comparing it with etoposide in dogs with spontaneous lymphoma with the objective to translate findings from dogs to humans. Etoposide is a topoisomerase II inhibitor widely used in various humans' solid and hematopoietic cancer, but little data is available concerning its potential antitumor efficacy in dogs. Etoposide phosphate is a water-soluble prodrug of etoposide which is expected to be better tolerated in dogs. The objectives of this study were to assess the safety, the tolerability and the efficacy of intravenous etoposide phosphate in dogs with multicentric lymphoma. Seven dose levels were evaluated in a traditional 3+ 3 phase I design. Twenty-seven owned-dogs with high-grade multicentric lymphoma were enrolled and treated with three cycles of etoposide phosphate IV injections every 2 weeks. Adverse effects were graded according to the Veterinary Cooperative Oncology Group criteria. A complete end-staging was realized 45 days after inclusion. The maximal tolerated dose was 300 mg/m(2). At this dose level, the overall response rate was 83.3% (n = 6, 3 PR and 2 CR). Only a moderate reversible gastrointestinal toxicity, no severe myelotoxicity and no hypersensitivity reaction were reported at this dose level. Beyond the characterization of etoposide clinical efficacy in dogs, this study underlined the clinical and therapeutic homologies between dog and human lymphomas.	[Boye, Pierre; Serres, Francois; Hordeaux, Juliette; Bouchaert, Emmanuel; Tierny, Dominique] SIRIC ONCOLille, OCR, Parc Eurasante, Loos, France; [Boye, Pierre; Serres, Francois; Marescaux, Laurent; Tierny, Dominique] SIRIC ONCOLille, Oncovet, Villeneuve Dascq, France; [Gomes, Bruno] Inst Rech Pierre Fabre, Toulouse, France; [Gomes, Bruno] iTeos Therapeut, Gosselies, Belgium	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boye, P (corresponding author), SIRIC ONCOLille, OCR, Parc Eurasante, Loos, France.; Boye, P (corresponding author), SIRIC ONCOLille, Oncovet, Villeneuve Dascq, France.	pierre_boye@hotmail.fr	BOUCHAERT, Emmanuel/AFU-7112-2022	BOUCHAERT, Emmanuel/0000-0003-2558-9862; Tierny, Dominique/0000-0001-5192-6813	OCR; Pierre Fabre Medicament	OCR; Pierre Fabre Medicament	This study was conducted by Oncovet Clinical Research (OCR) as part of a collaborative research project between OCR and Pierre Fabre Medicament. OCR provided support in the form of salaries for authors FS, JH, EB, and DT. OCR did not have any additional role in the study design, preparation of the manuscript. Pierre Fabre Medicament provided support in the form of salaries for BG. Pierre Fabre Medicament did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Annereau JP, 2010, LEUKEMIA RES, V34, P1383, DOI 10.1016/j.leukres.2009.12.021; [Anonymous], VET COMP ONCOL; Barret JM, 2008, CANCER RES, V68, P9845, DOI 10.1158/0008-5472.CAN-08-2748; Bo Lan-Jun, 2006, Ai Zheng, V25, P1553; Brel V, 2011, BIOCHEM PHARMACOL, V82, P1843, DOI 10.1016/j.bcp.2011.08.028; Burton JH, 2013, VET COMP ONCOL, V11, P306, DOI 10.1111/j.1476-5829.2012.00324.x; CARTER RF, 1987, J AM ANIM HOSP ASSOC, V23, P587; Collier Kathleen, 2008, J Oncol Pharm Pract, V14, P51, DOI 10.1177/1078155207085355; Doorduijn JK, 2000, HAEMATOLOGICA, V85, P814; DREWINKO B, 1976, CANCER TREAT REP, V60, P1295; Flory AB, 2008, AM J VET RES, V69, P1316, DOI 10.2460/ajvr.69.10.1316; Gentry AC, 2011, BIOCHEMISTRY-US, V50, P3240, DOI 10.1021/bi200094z; GOUGH WB, 1982, J CARDIOVASC PHARM, V4, P375, DOI 10.1097/00005344-198205000-00006; GREENLEE PG, 1990, CANCER-AM CANCER SOC, V66, P480, DOI 10.1002/1097-0142(19900801)66:3&lt;480::AID-CNCR2820660314&gt;3.0.CO;2-X; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Higginbotham ML, 2013, J AM ANIM HOSP ASSOC, V49, P357, DOI 10.5326/JAAHA-MS-5929; Hoetelmans RWM, 1996, ANN PHARMACOTHER, V30, P367, DOI 10.1177/106002809603000409; HOHENHAUS AE, 1990, J VET INTERN MED, V4, P239, DOI 10.1111/j.1939-1676.1990.tb03115.x; IGWEMEZIE LN, 1995, PHARMACEUT RES, V12, P117, DOI 10.1023/A:1016203107497; Joel S, 1996, CANCER TREAT REV, V22, P179, DOI 10.1016/S0305-7372(96)90002-X; KELLER ET, 1993, J VET INTERN MED, V7, P289, DOI 10.1111/j.1939-1676.1993.tb01021.x; Kruczynski A, 2013, LEUKEMIA, V27, P2139, DOI 10.1038/leu.2013.108; Kruczynski A, 2011, INVEST NEW DRUG, V29, P9, DOI 10.1007/s10637-009-9328-3; Lana S, 2007, J VET INTERN MED, V21, P764; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Leblond P, 2014, INVEST NEW DRUG, V32, P883, DOI 10.1007/s10637-014-0132-3; MASINI E, 1985, AGENTS ACTIONS, V16, P470, DOI 10.1007/BF01983649; McEntee M, 2003, Vet Comp Oncol, V1, P105, DOI 10.1046/j.1476-5829.2003.00015.x; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Mouawad F, 2014, ORAL ONCOL, V50, P113, DOI 10.1016/j.oraloncology.2013.11.003; Mutsaers AJ, 2002, J AM VET MED ASSOC, V220, P1813, DOI 10.2460/javma.2002.220.1813; OGILVIE GK, 1988, AM J VET RES, V49, P1367; Ponce F, 2010, VET PATHOL, V47, P414, DOI 10.1177/0300985810363902; POSTORINO NC, 1989, J AM ANIM HOSP ASSOC, V25, P221; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; ROSE WC, 1990, INVEST NEW DRUG, V8, pS25; Siderov J, 2002, BRIT J CANCER, V86, P12, DOI 10.1038/sj.bjc.6600003; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon D, 2006, J VET INTERN MED, V20, P948, DOI 10.1892/0891-6640(2006)20[948:TODWLU]2.0.CO;2; Simon D, 2008, JAVMA-J AM VET MED A, V232, P879, DOI 10.2460/javma.232.6.879; SINKULE JA, 1984, PHARMACOTHERAPY, V4, P61; SLEVIN ML, 1989, J CLIN ONCOL, V7, P1333, DOI 10.1200/JCO.1989.7.9.1333; Tierny D, 2015, CLIN CANCER RES, V21, P5314, DOI 10.1158/1078-0432.CCR-14-3174; Vail DM, 2010, VET COMP ONCOL, V8, P28, DOI 10.1111/j.1476-5829.2009.00200.x; Valerius KD, 1997, J AM VET MED ASSOC, V210, P512; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Willmann M, 2009, IN VIVO, V23, P911; WOLFF SN, 1987, CANCER CHEMOTH PHARM, V19, P246; Younes A, 2014, LANCET ONCOL, V15, P1019, DOI 10.1016/S1470-2045(14)70311-0; Zemann BI, 1998, J VET INTERN MED, V12, P465, DOI 10.1111/j.1939-1676.1998.tb02151.x	50	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177486	10.1371/journal.pone.0177486	http://dx.doi.org/10.1371/journal.pone.0177486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505195	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500023
J	El Idrissi, NB; Iyer, AM; Ramaglia, V; Rosa, PS; Soares, CT; Baas, F; Das, PK				El Idrissi, Nawal Bahia; Iyer, Anand M.; Ramaglia, Valeria; Rosa, Patricia S.; Soares, Cleverson T.; Baas, Frank; Das, Pranab K.			In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; NECROSIS-FACTOR-ALPHA; WALLERIAN DEGENERATION; REVERSAL REACTIONS; REACTIONAL STATES; PERIPHERAL-NERVE; 2 PARTS; SYSTEM; IMMUNOLOGY; EXPRESSION	Mycobacterium leprae (M. leprae) infection causes nerve damage and the condition worsens often during and long after treatment. Clearance of bacterial antigens including lipoarabinomannan (LAM) during and after treatment in leprosy patients is slow. We previously demonstrated that M. leprae LAM damages peripheral nerves by in situ generation of the membrane attack complex (MAC). Investigating the role of complement activation in skin lesions of leprosy patients might provide insight into the dynamics of in situ immune reactivity and the destructive pathology of M. leprae. In this study, we analyzed in skin lesions of leprosy patients, whether M. leprae antigen LAM deposition correlates with the deposition of complement activation products MAC and C3d on nerves and cells in the surrounding tissue. Skin biopsies of paucibacillary (n = 7), multibacillary leprosy patients (n = 7), and patients with erythema nodosum leprosum (ENL) (n = 6) or reversal reaction (RR) (n = 4) and controls (n = 5) were analyzed. The percentage of C3d, MAC and LAM deposition was significantly higher in the skin biopsies of multibacillary compared to paucibacillary patients (p = < 0.05, p = < 0.001 and p = < 0.001 respectively), with a significant association between LAM and C3d or MAC in the skin biopsies of leprosy patients (r = 0.9578, p< 0.0001 and r = 0.8585, p< 0.0001 respectively). In skin lesions of multibacillary patients, MAC deposition was found on axons and co-localizing with LAM. In skin lesions of paucibacillary patients, we found C3d positive T-cells in and surrounding granulomas, but hardly any MAC deposition. In addition, MAC immunoreactivity was increased in both ENL and RR skin lesions compared to non-reactional leprosy patients (p = < 0.01 and p = < 0.01 respectively). The present findings demonstrate that complement is deposited in skin lesions of leprosy patients, suggesting that inflammation driven by complement activation might contribute to nerve damage in the lesions of these patients. This should be regarded as an important factor in M. leprae nerve damage pathology.	[El Idrissi, Nawal Bahia; Ramaglia, Valeria; Baas, Frank] Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands; [Iyer, Anand M.] Acad Med Ctr, Dept Neuropathol, Amsterdam, Netherlands; [Rosa, Patricia S.; Soares, Cleverson T.] Inst Lauro de Souza Lima, Bauru, Brazil; [Baas, Frank] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Das, Pranab K.] Univ Birmingham, Coll Med Sci, Dept Clin Immunol, Birmingham, W Midlands, England; [Das, Pranab K.] Univ Birmingham, Coll Dent Sci, Dept Clin Immunol, Birmingham, W Midlands, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Birmingham; University of Birmingham	Baas, F (corresponding author), Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands.; Baas, F (corresponding author), Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands.	f.baas@lumc.nl	Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428; Iyer, Anand/0000-0001-6821-1048	Leprosy Foundation of the Netherlands [701.03.08]	Leprosy Foundation of the Netherlands	This work was supported by the Leprosy Foundation of the Netherlands, grant number 701.03.08. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagon MVF, 2010, AM J TROP MED HYG, V83, P637, DOI 10.4269/ajtmh.2010.09-0586; BROWNE SG, 1974, LEPROSY REV, V45, P104; Das PK, 2015, ACTA NEUROPATHOL; Dupnik KM, 2014, J INFECT DIS; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; GELBER RH, 1974, AM J TROP MED HYG, V23, P471, DOI 10.4269/ajtmh.1974.23.471; Gomes GI, 2008, AM J TROP MED HYG, V78, P605, DOI 10.4269/ajtmh.2008.78.605; Hakobyan S, 2016, CLIN EXP IMMUNOL; KHANOLKARYOUNG S, 1995, CLIN EXP IMMUNOL, V99, P196, DOI 10.1111/j.1365-2249.1995.tb05532.x; Knopf PM, 2008, IMMUNOL CELL BIOL, V86, P221, DOI 10.1038/sj.icb.7100147; LEVY E, 1992, CLIN EXP IMMUNOL, V90, P235; Lockwood DNJ, 2002, AM J TROP MED HYG, V66, P409, DOI 10.4269/ajtmh.2002.66.409; MALAVIYA A N, 1972, International Journal of Leprosy and Other Mycobacterial Diseases, V40, P361; MODLIN RL, 1983, CLIN EXP IMMUNOL, V53, P17; Parkash O, 1995, Acta Leprol, V9, P195; PETCHCLAI B, 1973, AM J TROP MED HYG, V22, P761, DOI 10.4269/ajtmh.1973.22.761; Ramaglia V, 2008, AM J PATHOL, V172, P1043, DOI 10.2353/ajpath.2008.070660; Ramaglia V, 2007, J NEUROSCI, V27, P7663, DOI 10.1523/JNEUROSCI.5623-06.2007; Ramaglia V, 2009, MOL IMMUNOL, V47, P302, DOI 10.1016/j.molimm.2009.09.019; Ramaglia V, 2009, MOL IMMUNOL, V46, P1892, DOI 10.1016/j.molimm.2009.01.017; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; ROCHE PW, 1993, INT J LEPROSY, V61, P35; Saitz E W, 1968, Int J Lepr Other Mycobact Dis, V36, P400; SARNO EN, 1991, CLIN EXP IMMUNOL, V84, P103; Suresh R, 2016, J CELL SCI, V129, P1928, DOI 10.1242/jcs.179291; Toapanta FR, 2006, IMMUNOL RES, V36, P197, DOI 10.1385/IR:36:1:197; Verhagen C, 1999, AM J PATHOL, V154, P1793, DOI 10.1016/S0002-9440(10)65435-1; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEMAMBU SNC, 1969, LANCET, V2, P933	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177815	10.1371/journal.pone.0177815	http://dx.doi.org/10.1371/journal.pone.0177815			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505186	gold, Green Published, Green Submitted			2022-12-27	WOS:000401473500045
J	Mollison, D; Seller, R; Bastin, M; Mollison, D; Chandran, S; Wardlaw, J; Connick, P				Mollison, Daisy; Seller, Robin; Bastin, Mark; Mollison, Denis; Chandran, Siddharthan; Wardlaw, Joanna; Connick, Peter			The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis	PLOS ONE			English	Review							BRAIN ATROPHY; NEUROPSYCHOLOGICAL ASSESSMENT; GRAY-MATTER; IMPAIRMENT; ABNORMALITIES; DYSFUNCTION; DEMENTIA; GUIDELINES; PATTERNS; DEFICITS	Background Moderate correlation exists between the imaging quantification of brain white matter lesions and cognitive performance in people with multiple sclerosis (MS). This may reflect the greater importance of other features, including subvisible pathology, or methodological limitations of the primary literature. Objectives To summarise the cognitive clinico-radiological paradox and explore the potential methodological factors that could influence the assessment of this relationship. Methods Systematic review and meta-analysis of primary research relating cognitive function to white matter lesion burden. Results Fifty papers met eligibility criteria for review, and meta-analysis of overall results was possible in thirty-two (2050 participants). Aggregate correlation between cognition and T2 lesion burden was r = -0.30 (95% confidence interval: -0.34, -0.26). Wide methodological variability was seen, particularly related to key factors in the cognitive data capture and image analysis techniques. Conclusions Resolving the persistent clinico-radiological paradox will likely require simultaneous evaluation of multiple components of the complex pathology using optimum measurement techniques for both cognitive and MRI feature quantification. We recommend a consensus initiative to support common standards for image analysis in MS, enabling benchmarking while also supporting ongoing innovation.	[Mollison, Daisy; Seller, Robin; Bastin, Mark; Chandran, Siddharthan; Wardlaw, Joanna; Connick, Peter] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Mollison, Denis] Heriot Watt Univ, Dept Actuarial Math & Stat, Edinburgh, Midlothian, Scotland	University of Edinburgh; Heriot Watt University	Connick, P (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	pconnick@exseed.ed.ac.uk	Wardlaw, Joanna M/Y-3456-2019; Hernandez, María/GYU-3543-2022	Wardlaw, Joanna M/0000-0002-9812-6642; Chandran, Siddharthan/0000-0001-6827-1593	Rowling Scholars Clinical Academic Fellowship; Wellcome Trust [106716/Z/14/Z]	Rowling Scholars Clinical Academic Fellowship; Wellcome Trust(Wellcome Trust)	Daisy Mollison is funded by a Rowling Scholars Clinical Academic Fellowship, http://annerowlingclinic.com/training.html. PC is funded by the Wellcome Trust, https://wellcome.ac.uk/ funding, award number: 106716/Z/14/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Ikhlaaq, 2012, BMJ, V344, pd7762, DOI 10.1136/bmj.d7762; Akbar N, 2010, CAN J NEUROL SCI, V37, P608, DOI 10.1017/S0317167100010775; Amato MP, 2008, NEUROLOGY, V71, P632, DOI 10.1212/01.wnl.0000324621.58447.00; ANZOLA GP, 1990, J NEUROL NEUROSUR PS, V53, P142, DOI 10.1136/jnnp.53.2.142; Archibald CJ, 2004, BRAIN, V127, P1526, DOI 10.1093/brain/awh167; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Bermel RA, 2002, ARCH NEUROL-CHICAGO, V59, P275, DOI 10.1001/archneur.59.2.275; Bomboi G, 2011, J NEUROIMAGING, V21, pe57, DOI 10.1111/j.1552-6569.2010.00488.x; Borenstein M., 2009, INTRO METAANALYSIS; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Christodoulou C, 2003, NEUROLOGY, V60, P1793, DOI 10.1212/01.WNL.0000072264.75989.B8; Comi G, 1999, J NEUROL SCI, V171, P135, DOI 10.1016/S0022-510X(99)00266-X; COMI G, 1995, J NEUROL SCI, V132, P222, DOI 10.1016/0022-510X(95)00168-2; Costa SL, 2016, MULT SCLER; Deloire MSA, 2005, J NEUROL NEUROSUR PS, V76, P519, DOI 10.1136/jnnp.2004.045872; DeLuca GC, 2015, BRAIN PATHOL, V25, P79, DOI 10.1111/bpa.12220; Denney DR, 2004, J INT NEUROPSYCH SOC, V10, P948, DOI 10.1017/S1355617704107030; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Fischer M, 2014, J NEUROL SCI, V343, P91, DOI 10.1016/j.jns.2014.05.042; Francis PL, 2013, AM J NEURORADIOL, V34, P62, DOI 10.3174/ajnr.A3148; FRANKLIN GM, 1988, NEUROLOGY, V38, P1826, DOI 10.1212/WNL.38.12.1826; Hackmack K, 2012, J NEUROL, V259, P2151, DOI 10.1007/s00415-012-6475-9; Harvey Philip D, 2012, Dialogues Clin Neurosci, V14, P91; Heesen C, 2010, BRAIN BEHAV IMMUN, V24, P1148, DOI 10.1016/j.bbi.2010.05.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hohol MJ, 1997, ARCH NEUROL-CHICAGO, V54, P1018, DOI 10.1001/archneur.1997.00550200074013; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; HUBER SJ, 1987, ARCH NEUROL-CHICAGO, V44, P732, DOI 10.1001/archneur.1987.00520190040015; Hulst HE, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-153; Inglese M, 2005, J NEUROL SCI, V233, P15, DOI 10.1016/j.jns.2005.03.001; IZQUIERDO G, 1991, EUR J RADIOL, V13, P220, DOI 10.1016/0720-048X(91)90034-S; Kalkers NF, 2001, NEUROLOGY, V56, P215, DOI 10.1212/WNL.56.2.215; Karlinska I, 2008, NEUROL NEUROCHIR POL, V42, P416; Krause M, 2009, BEHAV BRAIN RES, V205, P280, DOI 10.1016/j.bbr.2009.08.009; Laffon M, 2014, NEUROL THER, V3, P113, DOI 10.1007/s40120-014-0021-x; Langdon DW, 2012, MULT SCLER J, V18, P891, DOI 10.1177/1352458511431076; Lazeron RHC, 2006, MULT SCLER J, V12, P760, DOI 10.1177/1352458506070924; Lazeron RHC, 2005, MULT SCLER J, V11, P524, DOI 10.1191/1352458505ms1201oa; Leavitt VM, 2012, MULT SCLER J, V18, P409, DOI 10.1177/1352458511423651; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin X, 2008, J NEUROL NEUROSUR PS, V79, P437, DOI 10.1136/jnnp.2006.112177; Lund H, 2012, ACTA NEUROL SCAND, V125, P338, DOI 10.1111/j.1600-0404.2011.01574.x; Meijer KA, 2016, MULT SCLER J, V22, P1429, DOI 10.1177/1352458515622694; Mesaros S, 2012, NEUROLOGY, V78, P969, DOI 10.1212/WNL.0b013e31824d5859; Mike A, 2011, AM J NEURORADIOL, V32, P515, DOI 10.3174/ajnr.A2340; Mike A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082422; Millar RB, 2011, STAT PRACT, P1, DOI 10.1002/9780470094846; MOLLER A, 1994, ACTA PSYCHIAT SCAND, V89, P117, DOI 10.1111/j.1600-0447.1994.tb01497.x; Niino M., 2014, CLIN EXP NEUROL, V5, P328, DOI DOI 10.1111/CEN3.12133; Nocentini U, 2001, EUR NEUROL, V45, P11, DOI 10.1159/000052083; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; PATTI F, 1995, FUNCT NEUROL, V10, P83; POZZILLI C, 1991, J NEUROL NEUROSUR PS, V54, P110, DOI 10.1136/jnnp.54.2.110; Rao SM, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/975803; Rocca MA, 2015, LANCET NEUROL, V14, P302, DOI 10.1016/S1474-4422(14)70250-9; RON MA, 1991, PSYCHOL MED, V21, P59, DOI 10.1017/S0033291700014653; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044826; Rovaris M, 2008, NEUROLOGY, V71, P1521, DOI 10.1212/01.wnl.0000319694.14251.95; Rovaris M, 1998, NEUROLOGY, V50, P1601, DOI 10.1212/WNL.50.6.1601; Rovira A, 2015, NAT REV NEUROL, V11, P471, DOI 10.1038/nrneurol.2015.106; Sacco R, 2015, J NEUROL, V262, P1691, DOI 10.1007/s00415-015-7763-y; Sanchez MP, 2008, EUR J NEUROL, V15, P1091, DOI 10.1111/j.1468-1331.2008.02259.x; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Seewann A, 2009, ACTA NEUROL SCAND, V119, P349, DOI 10.1111/j.1600-0404.2008.01137.x; Snyder PJ, 2001, BRAIN COGNITION, V46, P279, DOI 10.1016/S0278-2626(01)80084-1; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Steenwijk MD, 2016, BRAIN, V139, P115, DOI 10.1093/brain/awv337; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sumowsk JF, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00176; Sun X, 1998, Ann Nucl Med, V12, P89; SWIRSKYSACCHETTI T, 1992, J CLIN PSYCHOL, V48, P779, DOI 10.1002/1097-4679(199211)48:6<779::AID-JCLP2270480612>3.0.CO;2-B; Traboulsee A, 2016, AM J NEURORADIOL, V37, P394, DOI 10.3174/ajnr.A4539; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Yildiz M, 2014, CLIN NEUROL NEUROSUR, V127, P54, DOI 10.1016/j.clineuro.2014.09.019; Zivadinov R, 2001, NEURORADIOLOGY, V43, P272, DOI 10.1007/s002340000500	79	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177727	10.1371/journal.pone.0177727	http://dx.doi.org/10.1371/journal.pone.0177727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505177	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500037
J	Alam, S; Chan, C; Qiu, X; Shannon, I; White, CL; Sant, AJ; Nayak, JL				Alam, Shabnam; Chan, Cory; Qiu, Xing; Shannon, Ian; White, Chantelle L.; Sant, Andrea J.; Nayak, Jennifer L.			Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; ANTIBODY-RESPONSES; A VIRUS; PROTECTIVE IMMUNITY; H1N1 VIRUS; MEMORY; EXPANSION; GENERATION; EMERGENCE; EPITOPES	A hallmark of the immune response to influenza is repeated encounters with proteins containing both genetically conserved and variable components. Therefore, the B and T cell repertoire is continually being remodeled, with competition between memory and naive lymphocytes. Our previous work using a mouse model of secondary heterosubtypic influenza infection has shown that this competition results in a focusing of CD4 T cell response specificity towards internal virion proteins with a selective decrease in CD4 T cell reactivity to the novel HA epitopes. Strikingly, this shift in CD4 T cell specificity was associated with a diminished anti-HA antibody response. Here, we sought to determine whether the loss in HA-specific reactivity that occurs as a consequence of immunological memory could be reversed by selectively priming HA-specific CD4 T cells prior to secondary infection. Using a peptide-based priming strategy, we found that selective expansion of the anti-HA CD4 T cell memory repertoire enhanced HA-specific antibody production upon heterosubtypic infection. These results suggest that the potentially deleterious consequences of repeated exposure to conserved influenza internal virion proteins could be reversed by vaccination strategies that selectively arm the HA-specific CD4 T cell compartment. This could be a potentially useful pre-pandemic vaccination strategy to promote accelerated neutralizing antibody production on challenge with a pandemic influenza strain that contains few conserved HA epitopes.	[Alam, Shabnam; Chan, Cory; Shannon, Ian; White, Chantelle L.; Nayak, Jennifer L.] Univ Rochester, Med Ctr, Dept Pediat, Div Infect Dis, Rochester, NY 14642 USA; [Qiu, Xing] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Sant, Andrea J.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Nayak, JL (corresponding author), Univ Rochester, Med Ctr, Dept Pediat, Div Infect Dis, Rochester, NY 14642 USA.	jennifer_nayak@urmc.rochester.edu	Nayak, Jennifer/ADJ-0310-2022		National Institutes of Health, National Institute of Allergy and Infectious Disease [1K08AI106954, HHSN2722014000050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI106954] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Disease under grant number 1K08AI106954 and contract number HHSN2722014000050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2014, J VIROL, V88, P314, DOI 10.1128/JVI.02077-13; Alam S, 2011, J VIROL, V85, P13310, DOI 10.1128/JVI.05728-11; Belz GT, 2007, P NATL ACAD SCI USA, V104, P6341, DOI 10.1073/pnas.0609990104; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; CROFT M, 1994, J IMMUNOL, V152, P2675; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crowe SR, 2006, VACCINE, V24, P457, DOI 10.1016/j.vaccine.2005.07.096; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Herati RS, 2014, J IMMUNOL, V193, P3528, DOI 10.4049/jimmunol.1302503; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; McKinstry KK, 2013, ARCH IMMUNOL THER EX, V61, P341, DOI 10.1007/s00005-013-0236-z; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; Mizgerd JP, 2015, NEW ENGL J MED, V373, P2380, DOI 10.1056/NEJMc1511751; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Nayak JL, 2013, J IMMUNOL, V191, P1001, DOI 10.4049/jimmunol.1203520; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Nayak JL, 2010, VIRAL IMMUNOL, V23, P169, DOI 10.1089/vim.2009.0099; Nayak JL, 2014, J INFECT DIS; Nguyen JL, 2016, JAMA CARDIOL, V1, P274, DOI 10.1001/jamacardio.2016.0433; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Obst R, 2007, P NATL ACAD SCI USA, V104, P15460, DOI 10.1073/pnas.0707331104; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Ravkov EV, 2009, J IMMUNOL, V183, P2382, DOI 10.4049/jimmunol.0900319; Richards KA, 2007, J VIROL, V81, P7608, DOI 10.1128/JVI.02834-06; Richards KA, 2009, J VIROL, V83, P6566, DOI 10.1128/JVI.00302-09; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Strutt TM, 2013, IMMUNOL REV, V255, P149, DOI 10.1111/imr.12088; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Suh WK, 2015, MOL CELLS, V38, P195, DOI 10.14348/molcells.2015.2331; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor J, 2003, Dev Biol (Basel), V115, P97; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; von Essen MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/163453; Wong KK, 2015, EPIDEMIOL INFECT, V143, P640, DOI 10.1017/S0950268814001198; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103; Yarke CA, 2008, J IMMUNOL, V180, P156, DOI 10.4049/jimmunol.180.1.156	52	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176407	10.1371/journal.pone.0176407	http://dx.doi.org/10.1371/journal.pone.0176407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493882	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300016
J	Behets, GJ; Viaene, L; Meijers, B; Blocki, F; Brandenburg, VM; Verhulst, A; D'Haese, PC; Evenepoel, P				Behets, Geert J.; Viaene, Liesbeth; Meijers, Bjorn; Blocki, Frank; Brandenburg, Vincent M.; Verhulst, Anja; D'Haese, Patrick C.; Evenepoel, Pieter			Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SERUM SCLEROSTIN; PARATHYROID-HORMONE; CALCEMIC RESPONSE; DISEASE; DICKKOPF-1; CALCIFICATION; PROGRESSION; EXPRESSION; SKELETAL	Introduction Mounting evidence indicates that a disturbed Wnt-beta-catenin signaling may be involved in the pathogenesis of chronic kidney disease-mineral and bone and mineral disorder (CKD-MBD). Data on the impact of CKD on circulating levels of the Wnt antagonists sclerostin and Dickkopf related protein 1 (DKK1) and the relationship with laboratory parameters of CKD-MBD are incomplete. Methods We analyzed serum sclerostin and DKK1 in 308 patients across the stages of chronic kidney disease (kDOQI stage 1-2 n = 41; CKD stage 3 n = 54; CKD stage 4-5 n = 54; hemodialysis n = 100; peritoneal dialysis n = 59) as well as in 49 healthy controls. We investigated associations with demographics, renal function, parameters of mineral metabolism including 25 (OH) vitamin D, 1,25(OH)(2) vitamin D, biointact fibroblast growth factor 23 (FGF23), and parathyroid hormone (PTH), and bone turnover markers. Results Serum sclerostin, but not DKK1, increases in more advanced stages of CKD and associates with PTH, phosphate, and 1,25(OH)(2) vitamin D concentrations. Bone turnover markers are highest in hemodialysis patients presenting the combination of high PTH with low sclerostin level. Serum DKK1 levels are lower in CKD patients than in controls and are not associated with laboratory parameters of mineral metabolism. Interestingly, a direct association between DKK1 and platelet count was observed. Conclusion In CKD, serum levels of the Wnt inhibitors DKK1 and sclerostin are unrelated, indicating different sites of origin and/or different regulatory mechanisms. Sclerostin, as opposed to DKK1, may qualify as a biomarker of CKD-MBD, particularly in dialysis patients. DKK1 serum levels, remarkably, correlate almost uniquely with blood platelet counts.	[Behets, Geert J.; Verhulst, Anja; D'Haese, Patrick C.] Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, Antwerp, Belgium; [Viaene, Liesbeth; Meijers, Bjorn; Evenepoel, Pieter] KUL Leuven, Dept Immunol & Microbiol, Lab Nephrol, Leuven, Belgium; [Blocki, Frank] DiaSorin Inc, Stillwater, MN USA; [Brandenburg, Vincent M.] Univ Hosp RWTH Aachen, Dept Cardiol, Aachen, Germany	University of Antwerp; RWTH Aachen University; RWTH Aachen University Hospital	Evenepoel, P (corresponding author), KUL Leuven, Dept Immunol & Microbiol, Lab Nephrol, Leuven, Belgium.	Pieter.Evenepoel@uzleuven.be	P, Evenepoel/D-9597-2018; D'Haese, Patrick C/C-9599-2019; Meijers, Bjorn/D-6169-2018	P, Evenepoel/0000-0002-2846-2026; Meijers, Bjorn/0000-0002-2846-2026	Diasorin SAP	Diasorin SAP	FB is an employee of Diasorin Inc. The funder provided support in the form of salaries for author FB and also supplied research materials for the current study. PCD has received previous research grants from Diasorin SAP.	Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P1789, DOI 10.1007/s00198-011-1806-8; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Berdud I, 1996, NEPHROL DIAL TRANSPL, V11, P1292; Brandenburg VM, 2016, PEDIATR NEPHROL, V31, P195, DOI 10.1007/s00467-015-3069-7; Brandenburg VM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-219; Cejka D, 2014, J CLIN ENDOCR METAB, V99, P248, DOI 10.1210/jc.2013-2786; Cejka D, 2012, NEPHROL DIAL TRANSPL, V27, P226, DOI 10.1093/ndt/gfr270; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Claes KJ, 2013, J CLIN ENDOCR METAB, V98, P3221, DOI 10.1210/jc.2013-1521; Costa AG, 2011, J CLIN ENDOCR METAB, V96, P3804, DOI 10.1210/jc.2011-0566; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Delanaye P, 2014, NEPHRON CLIN PRACT, V128, P127, DOI 10.1159/000366449; Drechsler C, 2015, NEPHROL DIAL TRANSPL, V30, P288, DOI 10.1093/ndt/gfu301; Evenepoel P, 2015, KIDNEY INT, V88, P235, DOI 10.1038/ki.2015.156; Fang YF, 2014, J AM SOC NEPHROL, V25, P1760, DOI 10.1681/ASN.2013080818; Garcia-Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111703; Hruska K. A., 2017, BONE; Ishimura E, 2014, J CLIN ENDOCR METAB, V99, P4315, DOI 10.1210/jc.2014-2372; Kanbay M, 2014, J CLIN ENDOCR METAB, V99, pE1854, DOI 10.1210/jc.2014-2042; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Lattanzio S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001000; Malluche HH, 2014, CLIN J AM SOC NEPHRO, V9, P1254, DOI 10.2215/CJN.09470913; MASSRY SG, 1973, ANN INTERN MED, V78, P357, DOI 10.7326/0003-4819-78-3-357; Moyses RMA, 2015, INT UROL NEPHROL, V47, P847, DOI 10.1007/s11255-015-0971-7; Pelletier S, 2015, OSTEOPOROSIS INT, V26, P2165, DOI 10.1007/s00198-015-3127-9; Pelletier S, 2013, CLIN J AM SOC NEPHRO, V8, P819, DOI 10.2215/CJN.07670712; Register TC, 2013, J CLIN ENDOCR METAB, V98, pE60, DOI 10.1210/jc.2012-3038; Ryan ZC, 2013, P NATL ACAD SCI USA, V110, P6199, DOI 10.1073/pnas.1221255110; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Thambiah S, 2012, CALCIFIED TISSUE INT, V90, P473, DOI 10.1007/s00223-012-9595-4; Thompson B, 2012, NAT REV ENDOCRINOL, V8, P529, DOI 10.1038/nrendo.2012.36; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Lierop AH, 2010, EUR J ENDOCRINOL, V163, P833, DOI 10.1530/EJE-10-0699; Vemana HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125764; Voorzanger-Rousselot N, 2009, BRIT J HAEMATOL, V145, P264, DOI 10.1111/j.1365-2141.2009.07587.x; Wang LF, 2015, RENAL FAILURE, V37, P1514, DOI 10.3109/0886022X.2015.1077323; Wesseling-Perry K, 2010, J CLIN ENDOCR METAB, V95, P2772, DOI 10.1210/jc.2009-1909	40	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176411	10.1371/journal.pone.0176411	http://dx.doi.org/10.1371/journal.pone.0176411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493902	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300017
J	Han, S; Wang, Y; Liu, LY; Li, DY; Liu, ZH; Shen, XX; Xu, HY; Zhao, XL; Zhu, Q; Yin, HD				Han, Shunshun; Wang, Yan; Liu, Lingyan; Li, Diyan; Liu, Zihao; Shen, Xiaoxu; Xu, Hengyong; Zhao, Xiaoling; Zhu, Qing; Yin, Huadong			Influence of three lighting regimes during ten weeks growth phase on laying performance, plasma levels-and tissue specific gene expression-of reproductive hormones in Pengxian yellow pullets	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; I MESSENGER-RNA; SEXUAL-MATURITY; PHOTOPERIODIC CONTROL; DOMESTIC PULLETS; BROILER BREEDERS; LAYER STRAINS; 1ST EGG; BIRDS; AGE	The study was conducted to optimize lighting schedule for pre-pubertal (12 to 22 weeks) Chinese native breed Pengxian yellow pullet. A total of 414 healthy pullets (10 weeks), with similar body weight were randomly distributed into three groups (n = 138) and housed in individual cages for up to 12 weeks of age in light controlled rooms and provided normal lighting schedule (10L: 14D). At 12 to 18 weeks of age, pullets were housed in three rooms, having varying lighting schedule viz. G1 (8L: 16D), G2 (10L: 14D), or G3 (12L: 12D). From 19th week onwards lighting schedule was gradually increased every week in incremental manner till all groups started receiving 16L: 8D lighting schedule. The age at first egg, weight of first egg laid, percent peak hen day egg production, concentration of plasma luteinizing and follicle- stimulating hormones and expression of genes regulating synthesis or/and secretion of hypothalamic gonadotropin-releasing hormone-I (GnRH-I), and pituitary LH-beta and FSH-beta were studied during experimental period (12 to 43 weeks of age) of this study. The result indicated that pullets of long day length (G3) group had higher plasma levels of FSH and LH and also better mRNA expression that regulates synthesis or/and secretion of GnRH-I, FSH-beta, and LH-beta before egg laying. The age at first egg (151.3 days) in pullets of G3 group receiving longer lighting hours (12L: 12D) was 8.8 days less (P<0.05) compared to pullets of G1 group, while it was 6.9 days less (P>0.05) compared to G2. However, significantly higher (P<0.05) plasma levels of LH and FSH in pullets of G1 as compared to pullets belonging to G3 group corresponded with the higher (P<0.05) cumulative egg production during the experimental period, while these attributes in G2 group didn't differ from either G1 or G3 groups. Pullets of G1 group had significantly higher levels (P< 0.05) of GnRH-I, FSH-beta, and LH-a mRNA abundances at 43 weeks of age than other two groups and this corresponded with the percent (hen day) peak egg production (75.38%) in pullets in this G1 group that was attained at 32 weeks of age, while the peak production of 71.24% was attained at 30 weeks of age in G3 group. There was no effect of lighting schedule on body weight of pullets, recorded during experimental period, at all occasions; belonging to three groups (G1, G2 and G3) and receiving varying hours of photo-stimulation (P>0.05). It was inferred that the optimum lighting schedule for Chinese native breed Pengxian yellow pullets during 10 weeks of pre-pubertal growth period is short hours of photo-stimulation ( i.e 8L:16D).	[Han, Shunshun; Wang, Yan; Liu, Lingyan; Li, Diyan; Liu, Zihao; Shen, Xiaoxu; Xu, Hengyong; Zhao, Xiaoling; Zhu, Qing; Yin, Huadong] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China; [Liu, Lingyan] Stat Bur Zhongjiang Cty, Deyang, Sichuan, Peoples R China	Sichuan Agricultural University	Yin, HD (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.	yinhuadongsicau@163.com		Li, Diyan/0000-0001-7490-3550	China Agriculture Research System [CARS-41]; thirteen Five Year Plan for breeding program in Sichuan [2016NYZ0050]	China Agriculture Research System; thirteen Five Year Plan for breeding program in Sichuan	This work was supported by China Agriculture Research System (CARS-41), The thirteen Five Year Plan for breeding program in Sichuan (2016NYZ0050).	Baines Elizabeth, 2001, THESIS; BANKS PA, 1989, POULTRY SCI, V68, P739, DOI 10.3382/ps.0680739; Bedecarrats GY, 2009, GEN COMP ENDOCR, V163, P7, DOI 10.1016/j.ygcen.2009.03.010; Cavalchini LG, 1990, CIHEAM OPTIONS MEDIT; Chen H, 2007, POULTRY SCI, V86, P917, DOI 10.1093/ps/86.5.917; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dawson A, 2015, FRONT NEUROENDOCRIN, V37, P52, DOI 10.1016/j.yfrne.2014.08.004; Dunn IC, 1999, J NEUROENDOCRINOL, V11, P371; Dunn IC, 2003, REPRODUCTION, V126, P217, DOI 10.1530/reprod/126.2.217; Kang SW, 2006, GEN COMP ENDOCR, V146, P91, DOI 10.1016/j.ygcen.2005.10.017; Koelkebeck KW, 2001, PHYSL RESPONSES POUL; Leeson S, 2005, POULTRY SCI, V84, P626, DOI 10.1093/ps/84.4.626; Leska A, 2007, REPROD BIOL, V7, P99; Lewis PD, 2005, BRIT POULTRY SCI, V46, P349, DOI 10.1080/00071660500098509; Lewis PD, 2004, BRIT POULTRY SCI, V45, P123, DOI 10.1080/00071660410001668950; Lewis PD, 1996, BRIT POULTRY SCI, V37, P15, DOI 10.1080/00071669608417832; Lewis PD, 2002, J AGR SCI-CAMBRIDGE, V138, P441, DOI 10.1017/S0021859602002162; Lewis PD, 1998, BRIT POULTRY SCI, V39, P662, DOI 10.1080/00071669888548; Lewis PD, 1998, BRIT POULTRY SCI, V39, P147, DOI 10.1080/00071669889538; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Proudman JA, 2006, DOMEST ANIM ENDOCRIN, V31, P141, DOI 10.1016/j.domaniend.2005.10.002; Renema RA., 1999, TECH NEWS, V7, P1; Saldanha CJ, 2001, J BIOL RHYTHM, V16, P39, DOI 10.1177/074873040101600105; Schaper SV, 2012, GEN COMP ENDOCR, V179, P53, DOI 10.1016/j.ygcen.2012.07.021; SHARP PJ, 1993, POULTRY SCI, V72, P897, DOI 10.3382/ps.0720897; Sharp PJ, 2003, CAN J PHYSIOL PHARM, V81, P350, DOI 10.1139/Y03-025; Shi ZD, 2008, WORLD POULTRY SCI J, V64, P343, DOI 10.1017/S0043933908000081; Surbhi, 2015, GEN COMP ENDOCR, V220, P13, DOI 10.1016/j.ygcen.2014.06.001; Thiele H. H., 2010, World Poultry, V26, P18; Thiele HH, 2012, HOUSING MANAGEMENT L; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Tyler NC, 2012, WORLD POULTRY SCI J, V68, P645, DOI 10.1017/S0043933912000785; Wolc A, 2011, BRIT POULTRY SCI, V52, P537, DOI 10.1080/00071668.2011.625493	34	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177358	10.1371/journal.pone.0177358	http://dx.doi.org/10.1371/journal.pone.0177358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493941	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300093
J	Magaard, JL; Seeralan, T; Schulz, H; Brutt, AL				Magaard, Julia Luise; Seeralan, Tharanya; Schulz, Holger; Bruett, Anna Levke			Factors associated with help-seeking behaviour among individuals with major depression: A systematic review	PLOS ONE			English	Review							MENTAL-HEALTH-CARE; SERVICE USE; ANXIETY DISORDERS; UNITED-STATES; RACIAL-DIFFERENCES; NATIONAL-SURVEY; MOOD DISORDERS; TREATMENT GAP; PREVALENCE; COMORBIDITY	Psychological models can help to understand why many people suffering from major depression do not seek help. Using the 'Behavioral Model of Health Services Use', this study systematically reviewed the literature on the characteristics associated with helpseeking behaviour in adults with major depression. Articles were identified by systematically searching the MEDLINE, EMBASE and PsycInfo databases and relevant reference lists. Observational studies investigating the associations between individual or contextual characteristics and professional help-seeking behaviour for emotional problems in adults formally diagnosed with major depression were included. The quality of the included studies was assessed, and factors associated with help-seeking behaviour were qualitatively synthesized. In total, 40 studies based on 26 datasets were included. Several studies investigated predisposing (age (N = 17), gender (N = 16), ethnicity (N = 9), education (N = 11), marital status (N = 12)), enabling (income (N = 12)), need (severity (N = 14), duration (N = 9), number of depressive episodes (N = 6), psychiatric comorbidity (N = 10)) and contextual factors (area (N = 8)). Socio-demographic and need factors appeared to influence helpseeking behaviour. Although existing studies provide insight into the characteristics associated with help seeking for major depression, cohort studies and research on beliefs about, barriers to and perceived need for treatment are lacking. Based on this review, interventions to increase help-seeking behaviour can be designed.	[Magaard, Julia Luise; Seeralan, Tharanya; Schulz, Holger; Bruett, Anna Levke] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Ctr Psychosocial Med, Hamburg, Germany; [Bruett, Anna Levke] Carl von Ossietzky Univ Oldenburg, Dept Hlth Serv Res, Oldenburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Carl von Ossietzky Universitat Oldenburg	Magaard, JL (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Ctr Psychosocial Med, Hamburg, Germany.	j.magaard@uke.de			German Research Foundation (DFG) [BR4859/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was not funded and part of the dissertation of Julia Luise Magaard (JLM). However, JLM, Anna Levke Brutt (ALB) and Tharanya Seeralan (TS) received grants from the German Research Foundation for a pilot study about help-seeking behavior of patients with depression (DFG BR4859/3-1). The German Research Foundation had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper.; This study as not funded and part of the dissertation of Julia Luise Magaard (JLM). However, Anna Levke Brutt (ALB), Tharanya Seeralan (TS) and JLM received grants from the German Research Foundation for a pilot study about help-seeking behavior of patients with depression. The German Research Foundation had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper. The authors declare that they have no competing interests. The authors wish to thank Mr. PD Dr. Levente Kriston for valuable and constructive comments on conduction of systematic reviews. We thank American Journal Experts (AJE) for English language editing.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Allin S, 2009, AM J PUBLIC HEALTH, V99, P1849, DOI 10.2105/AJPH.2008.141499; American Psychiatric Association, 2010, PRACT GUID TREATM PA; Andersen RM, 2008, MED CARE, V46, P647, DOI [10.1097/MLR.0b013e31817a835d, 10.1097/MLR.0b013e31817f4d48]; Aromaa E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-52; Babitsch B., 2012, PSYCHOSOCIAL MED, V9, DOI 10.3205/psm000089; Birnbaum HG, 2010, DEPRESS ANXIETY, V27, P78, DOI 10.1002/da.20580; Bland RC, 1997, CAN J PSYCHIAT, V42, P935, DOI 10.1177/070674379704200904; Boerema AM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0790-0; Bonnewyn A, 2009, J AFFECT DISORDERS, V117, P193, DOI 10.1016/j.jad.2009.01.012; Boyd RC, 2011, J CLIN PSYCHIAT, V72, P1538, DOI 10.4088/JCP.10m06468; Bristow K, 2002, CAN J PSYCHIAT, V47, P660, DOI 10.1177/070674370204700708; Cabello M, 2012, J AFFECT DISORDERS, V141, P22, DOI 10.1016/j.jad.2011.12.009; Cairney J, 2002, SOC PSYCH PSYCH EPID, V37, P236, DOI 10.1007/s00127-002-0539-6; Chartrand H, 2012, J AFFECT DISORDERS, V141, P237, DOI 10.1016/j.jad.2012.03.040; Chen LY, 2013, PSYCHIAT SERV, V64, P863, DOI 10.1176/appi.ps.201200289; Cheung AH, 2007, CAN J PSYCHIAT, V52, P228, DOI 10.1177/070674370705200404; Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129; CORYELL W, 1995, AM J PSYCHIAT, V152, P1124; Crabb R, 2006, J CLIN PSYCHOL, V62, P299, DOI 10.1002/jclp.20231; Demyttenaere K, 2006, J AFFECT DISORDERS, V92, P185, DOI 10.1016/j.jad.2006.01.007; DEW MA, 1991, SOC PSYCH PSYCH EPID, V26, P230, DOI 10.1007/BF00788971; Diala C, 2000, AM J ORTHOPSYCHIAT, V70, P455, DOI 10.1037/h0087736; Doblyte S, 2017, QUAL HEALTH RES, V27, P100, DOI 10.1177/1049732316681282; Elwy AR, 2011, QUAL HEALTH RES, V21, P1495, DOI 10.1177/1049732311413781; FARAVELLI C, 1989, ACTA PSYCHIAT SCAND, V79, P308, DOI 10.1111/j.1600-0447.1989.tb10263.x; FARAVELLI C, 1990, J AFFECT DISORDERS, V20, P135, DOI 10.1016/0165-0327(90)90127-T; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gabilondo A, 2011, PSYCHIAT SERV, V62, P152, DOI 10.1176/ps.62.2.pss6202_0152; Gadalla TM, 2008, WOMEN HEALTH, V47, P1, DOI 10.1300/J013v47n01_01; Gagne S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-135; Gonzalez HM, 2010, ARCH GEN PSYCHIAT, V67, P37, DOI 10.1001/archgenpsychiatry.2009.168; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-81; Hamalainen J, 2008, DEPRESS ANXIETY, V25, P27, DOI 10.1002/da.20256; Hailemariam S, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-23; Hamalainen J, 2004, J AFFECT DISORDERS, V79, P105, DOI 10.1016/S0165-0327(02)00342-7; Hankerson SH, 2011, J NATL MED ASSOC, V103, P576, DOI 10.1016/S0027-9684(15)30383-7; Henshaw EJ, 2009, CLIN PSYCHOL-SCI PR, V16, P420, DOI 10.1111/j.1468-2850.2009.01181.x; Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x; Kadushin C., 2017, WHY PEOPLE GO PSYCHI, DOI [10.4324/9781315135779, DOI 10.4324/9781315135779]; Katz SJ, 1998, J GEN INTERN MED, V13, P77, DOI 10.1046/j.1525-1497.1998.00022.x; Kleinberg A, 2013, EPIDEMIOL PSYCH SCI, V22, P345, DOI 10.1017/S2045796013000504; Kleinberg A, 2013, COMMUNITY MENT HLT J, V49, P427, DOI 10.1007/s10597-012-9499-9; Ko JY, 2012, J WOMENS HEALTH, V21, P830, DOI 10.1089/jwh.2011.3466; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Lin E, 1999, J AFFECT DISORDERS, V53, P153, DOI 10.1016/S0165-0327(98)00116-5; Mackenzie CS, 2012, DEPRESS ANXIETY, V29, P234, DOI 10.1002/da.20911; Manetti A, 2014, AM J GERIAT PSYCHIAT, V22, P1292, DOI 10.1016/j.jagp.2013.05.001; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mojtabai R, 2006, PSYCHIAT SERV, V57, P631, DOI 10.1176/appi.ps.57.5.631; Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2; National Health Service, 2013, CRIT APPR SKILLS PRO; National Health Service, 2013, CRITAICAL APPRAISAL; National Heart Lung and Blood Institute, QUAL ASS TOOL OBS CO; NICE, 2009, DEPR TREATM MAN DEPR; Ohayon MM, 1999, BIOL PSYCHIAT, V45, P300, DOI 10.1016/S0006-3223(98)00011-0; Pescosolido BA, 1999, CURRENT KNOWLEDGE CH, P392; Prins MA, 2008, CLIN PSYCHOL REV, V28, P1038, DOI 10.1016/j.cpr.2008.02.009; Rafful C, 2012, J AFFECT DISORDERS, V138, P165, DOI 10.1016/j.jad.2011.12.040; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; Roy-Byrne PP, 2000, BRIT J PSYCHIAT, V176, P229, DOI 10.1192/bjp.176.3.229; Smith KLW, 2013, HEALTH, V5, P1561, DOI DOI 10.4236/HEALTH.2013.510212; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SUSSMAN LK, 1987, SOC SCI MED, V24, P187, DOI 10.1016/0277-9536(87)90046-3; Tempier R, 2010, CAN J PSYCHIAT, V55, P295, DOI 10.1177/070674371005500505; Tiwari SK, 2008, SOC PSYCH PSYCH EPID, V43, P866, DOI 10.1007/s00127-008-0373-6; Wang JL, 2005, CAN J PSYCHIAT, V50, P652, DOI 10.1177/070674370505001012; Wang JL, 2004, CAN J PSYCHIAT, V49, P37, DOI 10.1177/070674370404900106; Williams DR, 2007, ARCH GEN PSYCHIAT, V64, P305, DOI 10.1001/archpsyc.64.3.305; World Health Organization, 2008, GLOB BURD DIS 2004; Yousaf O, 2015, HEALTH PSYCHOL REV, V9, P264, DOI 10.1080/17437199.2013.840954	73	95	96	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176730	10.1371/journal.pone.0176730	http://dx.doi.org/10.1371/journal.pone.0176730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493904	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300028
J	Wu, ZL; Cao, YH				Wu, Zhenlong; Cao, Yihua			Dynamics of initial drop splashing on a dry smooth surface	PLOS ONE			English	Article							IMPACT; BREAKUP	We simulate the onset and evolution of the earliest splashing of an infinite cylindrical liquid drop on a smooth dry solid surface. A tiny splash is observed to be emitted out of the rim of the lamella in the early stage of the impact. We find that the onset time of the splash is primarily dependent on the characteristic timescale, which is defined by the impact velocity as well as the drop radius, with no strong dependence on either the liquid viscosity or surface tension. Three regimes are found to be responsible for different splashing patterns. The outermost ejected droplets keep extending radially at a uniform speed proportional to the impact speed. Finally, we discuss the underlying mechanism which is responsible for the occurrence of the initial drop splash in the study.	[Wu, Zhenlong] Beihang Univ, Natl Lab Aeronaut & Astronaut, Beijing, Peoples R China; [Wu, Zhenlong; Cao, Yihua] Beihang Univ, Sch Aeronaut Sci & Engn, Beijing, Peoples R China	Beihang University; Beihang University	Wu, ZL (corresponding author), Beihang Univ, Natl Lab Aeronaut & Astronaut, Beijing, Peoples R China.; Wu, ZL (corresponding author), Beihang Univ, Sch Aeronaut Sci & Engn, Beijing, Peoples R China.	jackilongwu@gmail.com						Boelens A, 2016, ARXIV PREPRINT ARXIV; Cao YH, 2014, PROG AEROSP SCI, V71, P85, DOI 10.1016/j.paerosci.2014.07.003; Cheng M, 2015, COMPUT FLUIDS, V115, P11, DOI 10.1016/j.compfluid.2015.03.019; Cober SG, 2012, J APPL METEOROL CLIM, V51, P265, DOI 10.1175/JAMC-D-11-022.1; Coppola G, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3555196; Davidson MR, 2002, CHEM ENG SCI, V57, P3639; Deng X, 2013, LANGMUIR, V29, P7847, DOI 10.1021/la401120j; Driscoll MM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.154502; Fedorchenko AI, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2038367; Feo A, 2012, NASA TM D 2012 21772; Josserand C, 2016, ANNU REV FLUID MECH, V48, P365, DOI 10.1146/annurev-fluid-122414-034401; Josserand C, 2003, PHYS FLUIDS, V15, P1650, DOI 10.1063/1.1572815; Josserand C, 2015, ARXIV 2015 1511 0939, V1511; KELLER JB, 1995, PHYS FLUIDS, V7, P226, DOI 10.1063/1.868723; Kolinski JM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.074503; Latka A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.054501; Mahady K, 2015, J COMPUT PHYS, V294, P243, DOI 10.1016/j.jcp.2015.03.051; Mandre S, 2012, J FLUID MECH, V690, P148, DOI 10.1017/jfm.2011.415; Minemawari H, 2011, NATURE, V475, P364, DOI 10.1038/nature10313; MUNDO C, 1995, INT J MULTIPHAS FLOW, V21, P151, DOI 10.1016/0301-9322(94)00069-V; Quere D, 2005, NATURE, V435, P1168, DOI 10.1038/4351168a; Riboux G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.024507; Schroll RD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.034504; STOW CD, 1981, P ROY SOC LOND A MAT, V373, P419, DOI 10.1098/rspa.1981.0002; Thoroddsen ST, 2012, J FLUID MECH, V706, P560, DOI 10.1017/jfm.2012.281; Vander Wal RL, 2006, EXP FLUIDS, V40, P53, DOI 10.1007/s00348-005-0045-1; Visser CW, 2015, SOFT MATTER, V11, P1708, DOI 10.1039/c4sm02474e; Wang YP, 2004, EXP FLUIDS, V37, P385, DOI 10.1007/S00348-004-0827-x; Xu L, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.184505; Xu L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056316; Xu L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066311; Yarin AL, 2006, ANNU REV FLUID MECH, V38, P159, DOI 10.1146/annurev.fluid.38.050304.092144; 2006, FLUENT 6 3 USERS GUI	33	6	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177390	10.1371/journal.pone.0177390	http://dx.doi.org/10.1371/journal.pone.0177390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493989	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314300101
J	Gouveia, MB; Gherardi, DFM; Lentini, CAD; Dias, DF; Campos, PC				Gouveia, Mainara B.; Gherardi, Douglas F. M.; Lentini, Carlos A. D.; Dias, Daniela F.; Campos, Paula C.			Do the Brazilian sardine commercial landings respond to local ocean circulation?	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; VITORIA EDDY; OCEANOGRAPHY; TRANSPORT; ECOSYSTEM; PATTERNS; ANCHOVY; MODELS; LARVAE; SHELF	It has been reported that sea surface temperature (SST) anomalies, flow intensity and mesoscale ocean processes, all affect sardine production, both in eastern and western boundary current systems. Here we tested the hypothesis whether extreme high and low commercial landings of the Brazilian sardine fisheries in the South Brazil Bight (SBB) are sensitive to different oceanic conditions. An ocean model (ROMS) and an individual based model (Ichthyop) were used to assess the relationship between oceanic conditions during the spawning season and commercial landings of the Brazilian sardine one year later. Model output was compared with remote sensing and analysis data showing good consistency. Simulations indicate that mortality of eggs and larvae by low temperature prior to maximum and minimum landings are significantly higher than mortality caused by offshore advection. However, when periods of maximum and minimum sardine landings are compared with respect to these causes of mortality no significant differences were detected. Results indicate that mortality caused by prevailing oceanic conditions at early life stages alone can not be invoked to explain the observed extreme commercial landings of the Brazilian sardine. Likely influencing factors include starvation and predation interacting with the strategy of spawning "at the right place and at the right time".	[Gouveia, Mainara B.; Gherardi, Douglas F. M.; Dias, Daniela F.; Campos, Paula C.] Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil; [Lentini, Carlos A. D.] Univ Fed Bahia UFBA, Dept Fis Terra & Meio Ambiente, Inst Fis, Salvador, BA, Brazil; [Lentini, Carlos A. D.] Univ Fed Bahia UFBA, GOAT Grp Oceanog Trop, Salvador, BA, Brazil	Instituto Nacional de Pesquisas Espaciais (INPE); Universidade Federal da Bahia; Universidade Federal da Bahia	Gouveia, MB (corresponding author), Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil.	mainara.gouveia@inpe.br	Gouveia, Mainara/AIE-9648-2022; Lentini, Carlos/AAA-4955-2019; Gherardi, Douglas Francisco Marcolino/I-1079-2015	Gouveia, Mainara/0000-0002-6785-1841; Lentini, Carlos/0000-0003-0406-1006; Gherardi, Douglas Francisco Marcolino/0000-0003-3471-7213	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Council for Scientific and Technological Development (CNPq PQ-2) [311835/2014-7]; Sao Paulo Research Foundation (FAPESP) [2015/09767-8]; National Institute for Space Research (INPE); CNPq [311835/2014-7]; FAPESP [2015/09767-8]; Remote Sensing Division (DSR/SERE-II) at INPE-SJC	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq PQ-2)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute for Space Research (INPE); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Remote Sensing Division (DSR/SERE-II) at INPE-SJC	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to MBG, the National Council for Scientific and Technological Development (CNPq PQ-2, grant #311835/2014-7) and Sao Paulo Research Foundation (FAPESP #2015/09767-8) to CADL, and the National Institute for Space Research (INPE) to DFMG, DFD, and PCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Luciano Ponzi Pezzi for his assistance with ROMS and Luiz E. Moraes for helping with fisheries data processing. The third author would like to thank CNPq for the research fellowship (PQ-2, grant #311835/2014-7) and FAPESP for the visiting scientist fellowship (grant #2015/09767-8). He is also grateful to the Remote Sensing Division (DSR/SERE-II) at INPE-SJC for its support during his sabbatical leave. We also thank the US National Oceanographic Data Center for providing the AVHRR product, the Department of Commerce (DOC) from NOAA for OSCAR product. We also thank the National Center for Atmospheric Research Staff (Eds) for CFSR and SODA reanalysis.	BAKUN A, 1990, J CONSEIL, V46, P269; Brochier T, 2011, J MARINE SYST, V87, P109, DOI 10.1016/j.jmarsys.2011.02.025; Campos EJD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026997; Campos EJD, 1999, GEOPHYS RES LETT, V26, P2061, DOI 10.1029/1999GL900297; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Castelao RM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025182; CERGOLE M.C., 1994, B I OCEANOGR-S PAULO, V42, P113; Chaves RR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018647; Checkley DM, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P1; Cox DR, 2002, PHILOS T R SOC A, V360, P1389, DOI 10.1098/rsta.2002.1006; De Almeida RAF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030401; Moraes LED, 2012, ICES J MAR SCI, V69, P939, DOI 10.1093/icesjms/fss061; de Souza RB, 2004, CONT SHELF RES, V24, P241, DOI 10.1016/j.csr.2003.10.001; Dias DF, 2014, PROG OCEANOGR, V123, P38, DOI 10.1016/j.pocean.2014.03.009; Freon P, 2005, B MAR SCI, V76, P385; FreuEn P., 1999, DYNAMICS PELAGIC FIS; Gigliotti ES, 2010, J FISH BIOL, V77, P2248, DOI 10.1111/j.1095-8649.2010.02802.x; Hare JA, 2014, ICES J MAR SCI, V71, P2343, DOI 10.1093/icesjms/fsu018; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Jenkinson A. F., 1995, Q ROY METEOR SOC, V81, P158; Kearney KA, 2012, ECOL MODEL, V237, P43, DOI 10.1016/j.ecolmodel.2012.04.006; Kurtz Frederico W., 2001, Revista Brasileira de Oceanografia, V49, P61; Kurtz FW, THESIS; Lentini CA., 2000, BRAZ J OCEANOGR, V48, P93, DOI 10.1590/S1679-87592000000200001; Lentini CAD, 2001, CONT SHELF RES, V21, P89, DOI 10.1016/S0278-4343(00)00077-7; MACKENZIE BR, 1993, MAR ECOL PROG SER, V94, P207, DOI 10.3354/meps094207; MacKenzie BR, 1995, LIMNOL OCEANOGR, V40, P1278, DOI 10.4319/lo.1995.40.7.1278; Mbaye BC, 2015, FISH OCEANOGR, V24, P69, DOI 10.1111/fog.12094; McCleave J.D., 1984, MECH MIGRATION FISHE; Parada C, 2003, FISH OCEANOGR, V12, P170, DOI 10.1046/j.1365-2419.2003.00235.x; Peck MA, 2012, ADV ECOL RES, V47, P177, DOI 10.1016/B978-0-12-398315-2.00003-X; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Piola AR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021638; Piola AR, 2000, J GEOPHYS RES-OCEANS, V105, P6565, DOI 10.1029/1999JC000300; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rodrigues RR, 2001, CONT SHELF RES, V21, P371, DOI 10.1016/S0278-4343(00)00094-7; Rose KA, 2015, PROG OCEANOGR, V138, P348, DOI 10.1016/j.pocean.2015.01.012; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; SCHMID C, 1995, J PHYS OCEANOGR, V25, P2532, DOI 10.1175/1520-0485(1995)025<2532:TVEAIR>2.0.CO;2; Silva M, 2009, OCEAN MODEL, V30, P256, DOI 10.1016/j.ocemod.2009.07.002; Soares HC, 2011, SCI MAR, V75, P665, DOI 10.3989/scimar.2011.75n4665; Steele JH, 2012, PROG OCEANOGR, V102, P67, DOI 10.1016/j.pocean.2012.03.005; Sunye PS, 1998, FISH OCEANOGR, V7, P89, DOI 10.1046/j.1365-2419.1998.00055.x; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Yoneda NT., 1987, THESIS, V35; Zar JH, 1999, BIOSTATISTICAL ANAL; Zwolinski JP, 2014, ICES J MAR SCI, V71, P2198, DOI 10.1093/icesjms/fst173	47	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176808	10.1371/journal.pone.0176808	http://dx.doi.org/10.1371/journal.pone.0176808			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489925	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100032
J	Li, Z; Yin, PP; Chen, J; Jin, SL; Liu, JQ; Luo, F				Li, Zhen; Yin, Pingping; Chen, Jian; Jin, Shenglan; Liu, Jieqiong; Luo, Fang			CaMKII alpha may modulate fentanyl-induced hyperalgesia via a CeLC-PAG-RVM-spinal cord descending facilitative pain pathway in rats	PLOS ONE			English	Article							ROSTRAL VENTROMEDIAL MEDULLA; OPIOID-INDUCED HYPERALGESIA; PROTEIN-KINASE-II; INDUCED POSTOPERATIVE HYPERALGESIA; PERIAQUEDUCTAL GRAY NEURONS; LONG-LASTING HYPERALGESIA; INDUCED ABNORMAL PAIN; CENTRAL AMYGDALA; SYNAPTIC-TRANSMISSION; NEUROPATHIC PAIN	Each of the lateral capsular division of central nucleus of amygdala(CeLC), periaqueductal gray (PAG), rostral ventromedial medulla(RVM) and spinal cord has been proved to contribute to the development of opioid-induced hyperalgesia(OIH). Especially, Ca2+/calmodulin-dependent protein kinase II alpha (CaMKII alpha) in CeLC and spinal cord seems to play a key role in OIH modulation. However, the pain pathway through which CaMKII alpha modulates OIH is not clear. The pathway from CeLC to spinal cord for this modulation was explored in the present study. Mechanical and thermal hyperalgesia were tested by von Frey test or Hargreaves test, respectively. CaMKII alpha activity (phospho-CaMKII alpha, p- CaMKII alpha) was evaluated by western blot analysis. CaMKII alpha antagonist (KN93) was micro-infused into CeLC, spinal cord or PAG, respectively, to evaluate its effect on behavioral hyperalgesia and p-CaMKII alpha expression in CeLC, PAG, RVM and spinal cord. Then the underlying synaptic mechanism was explored by recording miniature excitatory postsynaptic currents (mEPSCs) on PAG slices using whole-cell voltage-clamp methods. Results showed that inhibition of CeLC, PAG or spinal CaMKII alpha activity respectively by KN93, reversed both mechanical and thermal hyperalgesia. Microinjection of KN93 into CeLC decreased p- CaMKII alpha expression in CeLC, PAG, RVM and spinal cord; while intrathecal KN93 can only block spinal but not CeLC CaMKIIa activity. KN93 injected into PAG just decreased p-CaMKII alpha expression in PAG, RVM and spinal cord, but not in the CeLC. Similarly, whole-cell voltage-clamp recording found the frequency and amplitude of mEPSCs in PAG cells were decreased by KN93 added in PAG slice or micro-infused into CeLC in vivo. These results together with previous findings suggest that CaMKII alpha may modulate OIH via a CeLC-PAG-RVM-spinal cord descending facilitative pain pathway.	[Li, Zhen; Yin, Pingping; Liu, Jieqiong; Luo, Fang] Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Chen, Jian] South Cent Univ Nationalities, Coll Biomed Engn, Key Lab Cognit Sci, State Ethn Affairs Commiss,Lab Membrane Ion Chann, Wuhan, Peoples R China; [Jin, Shenglan] Huazhong Univ Sci & Technol, Tongji Med Coll, Cent Hosp Wuhan, Wuhan, Peoples R China	Huazhong University of Science & Technology; South Central Minzu University; Huazhong University of Science & Technology	Luo, F (corresponding author), Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China.	luofang0909@hotmail.com			National Nature Science Foundation of China [81271234, 81050023]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (grants 81271234 and 81050023) to FL.	Arout CA, 2014, PHYSIOL BEHAV, V130, P28, DOI 10.1016/j.physbeh.2014.02.056; Bee LA, 2007, NEUROSCIENCE, V147, P786, DOI 10.1016/j.neuroscience.2007.05.004; Butler RK, 2011, PHYSIOL BEHAV, V104, P1075, DOI 10.1016/j.physbeh.2011.05.028; Carrasquillo Y, 2007, J NEUROSCI, V27, P1543, DOI 10.1523/JNEUROSCI.3536-06.2007; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; Chen Y, 2010, J NEUROSCI, V30, P38, DOI 10.1523/JNEUROSCI.4346-09.2010; Chen Y, 2009, J PHARMACOL EXP THER, V330, P650, DOI 10.1124/jpet.109.152165; Chen YL, 2009, MOL CELL NEUROSCI, V40, P76, DOI 10.1016/j.mcn.2008.09.003; Cheng JC, 2015, J NEUROSCI, V35, P9689, DOI 10.1523/JNEUROSCI.5039-14.2015; Coulombe MA, 2016, HUM BRAIN MAPP, V37, P1514, DOI 10.1002/hbm.23117; de Novellis V, 2012, EUR J PHARMACOL, V676, P41, DOI 10.1016/j.ejphar.2011.11.034; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; Eidson LN, 2013, J PAIN, V14, P393, DOI 10.1016/j.jpain.2012.12.010; Fabry ME, 2003, METH MOLEC MED, V82, P213; Ferrari LF, 2013, J NEUROSCI, V33, P11002, DOI 10.1523/JNEUROSCI.1785-13.2013; Garzon J, 2011, ANTIOXID REDOX SIGN, V15, P873, DOI 10.1089/ars.2010.3767; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Hamlin AS, 2007, NEUROPHARMACOLOGY, V53, P330, DOI 10.1016/j.neuropharm.2007.05.017; Han JS, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-10; Han JS, 2005, PAIN, V113, P211, DOI 10.1016/j.pain.2004.10.022; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hathway GJ, 2009, J PHYSIOL-LONDON, V587, P2927, DOI 10.1113/jphysiol.2008.168013; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hou WH, 2016, J NEUROSCI, V36, P4549, DOI 10.1523/JNEUROSCI.3309-15.2016; Hu J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-71; Hu XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146393; Jiang M, 2015, PHARMACOL BIOCHEM BE, V134, P35, DOI 10.1016/j.pbb.2015.04.015; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kincaid W, 2006, J NEUROPHYSIOL, V95, P33, DOI 10.1152/jn.00449.2005; Kiritoshi T, 2013, NEUROPHARMACOLOGY, V66, P170, DOI 10.1016/j.neuropharm.2012.03.024; Lee HJ, 2014, KOREAN J ANESTHESIOL, V67, P299, DOI 10.4097/kjae.2014.67.5.299; Lei J, 2014, EXP NEUROL, V257, P88, DOI 10.1016/j.expneurol.2014.04.019; Li Z, 2016, J PHARMACOL EXP THER, V359, P82, DOI 10.1124/jpet.116.233817; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu CE, 2015, J NEUROL SCI, V352, P48, DOI 10.1016/j.jns.2015.03.018; Luo F, 2008, J PHARMACOL EXP THER, V325, P267, DOI 10.1124/jpet.107.132167; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Martin TJ, 2008, EXP CLIN PSYCHOPHARM, V16, P357, DOI 10.1037/a0013597; Mauermann E, 2016, ANESTHESIOLOGY, V124, P453, DOI 10.1097/ALN.0000000000000976; Meng ID, 2007, LIFE SCI, V80, P1915, DOI 10.1016/j.lfs.2007.02.022; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Neubert MJ, 2004, PAIN, V110, P158, DOI 10.1016/j.pain.2004.03.017; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Ni HD, 2016, J NEUROSCI RES, V94, P50, DOI 10.1002/jnr.23672; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Oliveira MA, 2001, BRAIN RES BULL, V54, P55, DOI 10.1016/S0361-9230(00)00420-2; Ossipov MH, 2005, BIOPOLYMERS, V80, P319, DOI 10.1002/bip.20254; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Palazzo E, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-44; Palazzo E, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-82; Penzo MA, 2014, J NEUROSCI, V34, P2432, DOI 10.1523/JNEUROSCI.4166-13.2014; Price TJ, 2005, NEUROSCI LETT, V389, P94, DOI 10.1016/j.neulet.2005.07.029; Rivat C, 2002, ANESTHESIOLOGY, V96, P381, DOI 10.1097/00000542-200202000-00025; Rivat C, 2009, EUR J NEUROSCI, V29, P727, DOI 10.1111/j.1460-9568.2009.06616.x; Rodriguez-Munoz M, 2007, CELL SIGNAL, V19, P2558, DOI 10.1016/j.cellsig.2007.08.003; Roeckel LA, 2016, NEUROSCIENCE; Rosen A, 2004, BRAIN RES, V1001, P87, DOI 10.1016/j.brainres.2003.11.060; Salling MC, 2016, BIOL PSYCHIAT, V79, P430, DOI 10.1016/j.biopsych.2014.10.020; Sanchez-Blazquez P, 2008, NEUROPHARMACOLOGY, V54, P319, DOI 10.1016/j.neuropharm.2007.10.002; Sanchez-Blazquez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011278; Sanna MD, 2015, EUR J PHARMACOL, V764, P271, DOI 10.1016/j.ejphar.2015.07.022; Sanna MD, 2014, NEUROPHARMACOLOGY, V86, P67, DOI 10.1016/j.neuropharm.2014.06.007; Sarhan M, 2005, J COMP NEUROL, V491, P418, DOI 10.1002/cne.20697; Sarhan M, 2013, INT J NEUROPSYCHOPH, V16, P1649, DOI 10.1017/S146114571200168X; Seto SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066404; Shen GF, 2009, BIOCHEM SOC T, V37, P1394, DOI 10.1042/BST0371394; Shoudai K, 2010, J NEUROSCI, V30, P14470, DOI 10.1523/JNEUROSCI.2557-10.2010; Sikand P, 2007, J PHYSIOL-LONDON, V581, P631, DOI 10.1113/jphysiol.2006.118620; Stoicea N, 2015, FRONT PHARMACOL, V6, DOI [10.3382/fphar.2015.00104, 10.3389/fphar.2015.00104]; Toyoda H, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-4; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Vardanyan A, 2009, J PAIN, V10, P243, DOI 10.1016/j.jpain.2008.07.004; Wang LLX, 2003, ADV DRUG DELIVER REV, V55, P949, DOI 10.1016/S0169-409X(03)00098-X; Wang XL, 2007, J PHYSIOL-LONDON, V579, P849, DOI 10.1113/jphysiol.2006.126102; Wang ZJJ, 2010, HEMATOL-AM SOC HEMAT, P403, DOI 10.1182/asheducation-2010.1.403; Wang ZW, 2008, MOL NEUROBIOL, V38, P153, DOI 10.1007/s12035-008-8039-7; Wilkie DJ, 2010, J NATL MED ASSOC, V102, P18, DOI 10.1016/S0027-9684(15)30471-5; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9; Xie JY, 2005, J NEUROSCI, V25, P409, DOI 10.1523/JNEUROSCI.4054-04.2005; Xing JH, 2007, J NEUROPHYSIOL, V97, P503, DOI 10.1152/jn.01023.2006; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Yang K, 2003, BIOCHEM BIOPH RES CO, V302, P233, DOI 10.1016/S0006-291X(03)00156-6; Yu RJ, 2014, NEUROIMAGE-CLIN, V6, P100, DOI 10.1016/j.nicl.2014.08.019; Zhang RX, 2013, NEUROSCIENCE, V252, P359, DOI 10.1016/j.neuroscience.2013.08.030; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	88	7	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177412	10.1371/journal.pone.0177412	http://dx.doi.org/10.1371/journal.pone.0177412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489932	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100074
J	Zhou, Y; Zhou, LS; Wang, Y; Li, XM; Yang, Z				Zhou, Yu; Zhou, Leishan; Wang, Yun; Li, Xiaomeng; Yang, Zhuo			A practical model for the train-set utilization: The case of Beijing-Tianjin passenger dedicated line in China	PLOS ONE			English	Article							RAILWAY ROLLING STOCK; UNITS	As a sustainable transportation mode, high-speed railway (HSR) has become an efficient way to meet the huge travel demand. However, due to the high acquisition and maintenance cost, it is impossible to build enough infrastructure and purchase enough train-sets. Great efforts are required to improve the transport capability of HSR. The utilization efficiency of train-sets (carrying tools of HSR) is one of the most important factors of the transport capacity of HSR. In order to enhance the utilization efficiency of the train-sets, this paper proposed a train-set circulation optimization model to minimize the total connection time. An innovative two-stage approach which contains segments generation and segments combination was designed to solve this model. In order to verify the feasibility of the proposed approach, an experiment was carried out in the Beijing-Tianjin passenger dedicated line, to fulfill a 174 trips train diagram. The model results showed that compared with the traditional Ant Colony Algorithm (ACA), the utilization efficiency of train-sets can be increased from 43.4% (ACA) to 46.9% (Two-Stage), and 1 train-set can be saved up to fulfill the same transportation tasks. The approach proposed in the study is faster and more stable than the traditional ones, by using which, the HSR staff can draw up the train-sets circulation plan more quickly and the utilization efficiency of the HSR system is also improved.	[Zhou, Yu; Zhou, Leishan; Wang, Yun; Li, Xiaomeng] Beijing Jiaotong Univ, Sch Traff & Transportat, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China; [Yang, Zhuo] George Mason Univ, Dept Civil Environm & Infrastruct Engn, Volgenau Sch Engn, Fairfax, VA 22030 USA	Beijing Jiaotong University; George Mason University	Wang, Y (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China.	13114248@bjtu.edu.cn		Li, Xiaomeng/0000-0003-2129-1671	China Railways Corporation [2016X005-D]; Fundamental Research Funds for the Central Universities [2015YJS094]	China Railways Corporation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is financially supported by "China Railways Corporation" (No. 2016X005-D), and "the Fundamental Research Funds for the Central Universities" (2015YJS094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is financially supported by "the Fundamental Research Funds for the Central Universities" (2015YJS094).	Abbink E, 2004, TRANSPORT SCI, V38, P33, DOI 10.1287/trsc.1030.0044; Alfieri A, 2006, TRANSPORT SCI, V40, P378, DOI 10.1287/trsc.1060.0155; [Anonymous], [No title captured]; Barnhart C, 2000, OPER RES, V48, P318, DOI 10.1287/opre.48.2.318.12378; Cacchiani V, 2014, TRANSPORT RES B-METH, V63, P15, DOI 10.1016/j.trb.2014.01.009; Cadarso L, 2014, COMPUT OPER RES, V51, P146, DOI 10.1016/j.cor.2014.05.007; Chen H., 2007, THESIS; Fioole P, 2006, EUR J OPER RES, V172, P1281; [耿敬春 GENG Jingchun], 2006, [铁道学报, Journal of the China Railway Society], V28, P17; Holmberg K, 2003, INFORMS J COMPUT, V15, P42, DOI 10.1287/ijoc.15.1.42.15151; Hong SP, 2009, OMEGA-INT J MANAGE S, V37, P637, DOI 10.1016/j.omega.2008.03.003; Jorgen T., 2016, TRANSPORT RES E-LOG, V91, P15; Lai YC, 2015, COMPUT IND ENG, V85, P284, DOI 10.1016/j.cie.2015.03.016; Maroti G, 2005, TRANSPORT SCI, V39, P518, DOI 10.1287/trsc.1050.0116; Maroti G, 2007, COMPUT OPER RES, V34, P1121, DOI 10.1016/j.cor.2005.05.026; Miao J. R., 2010, J CHINA RAILWAY SOC, V32, P1; Nie L, 2001, J CHINA RAILWAY SOC, V3, P1; Peeters M, 2006, COMPUTERS OPERATIONA, V35, P538; Schrijver A., 1993, CWI Q, P205; Tatsushi N., 2017, COMPUTERS OPERATIONS, V81, P14; Thorlacius P, 2015, J RAIL TRANSPORT PLA, V5, P240, DOI 10.1016/j.jrtpm.2015.11.001; Wagenaar J., 2015, ERIM REPORT SERIES R; Wang Y, 2009, CHINA RAILWAY SCI, V31, P115; Yang J., 2004, RAILWAY TRANSPORT EC, V26, P65; Zhang Chen, 2010, THESIS; Zhao P, 2003, J CHINA RAILWAY SOC, P1; Zhou YP, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-163; 王艳军, 2013, [中国老年学杂志, Chinese Journal of Gerontology], V33, P112; 赵鹏, 1997, 铁道学报, V19, P15	30	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175698	10.1371/journal.pone.0175698	http://dx.doi.org/10.1371/journal.pone.0175698			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489933	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100008
J	Huntsman, BM; Falke, JA; Savereide, JW; Bennett, KE				Huntsman, Brock M.; Falke, Jeffrey A.; Savereide, James W.; Bennett, Katrina E.			The role of density-dependent and -independent processes in spawning habitat selection by salmon in an Arctic riverscape	PLOS ONE			English	Article							CHINOOK SALMON; POPULATION-DYNAMICS; STREAM SALMONIDS; PACIFIC SALMON; CLIMATE-CHANGE; SPECIES RANGE; COMPETITION; LANDSCAPES; ABUNDANCE; IMPACTS	Density-dependent (DD) and density-independent (DI) habitat selection is strongly linked to a species' evolutionary history. Determining the relative importance of each is necessary because declining populations are not always the result of altered DI mechanisms but can often be the result of DD via a reduced carrying capacity. We developed spatially and temporally explicit models throughout the Chena River, Alaska to predict important DI mechanisms that influence Chinook salmon spawning success. We used resource-selection functions to predict suitable spawning habitat based on geomorphic characteristics, a semi-distributed water-and-energy balance hydrologic model to generate stream flow metrics, and modeled stream temperature as a function of climatic variables. Spawner counts were predicted throughout the core and periphery spawning sections of the Chena River from escapement estimates (DD) and DI variables. Additionally, we used isodar analysis to identify whether spawners actively defend spawning habitat or follow an ideal free distribution along the riverscape. Aerial counts were best explained by escapement and reference to the core or periphery, while no models with DI variables were supported in the candidate set. Furthermore, isodar plots indicated habitat selection was best explained by ideal free distributions, although there was strong evidence for active defense of core spawning habitat. Our results are surprising, given salmon commonly defend spawning resources, and are likely due to competition occurring at finer spatial scales than addressed in this study.	[Huntsman, Brock M.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Falke, Jeffrey A.] Univ Alaska Fairbanks, US Geol Survey, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK USA; [Savereide, James W.] Alaska Dept Fish & Game, Div Sport Fish, Fairbanks, AK USA; [Bennett, Katrina E.] Los Alamos Natl Lab, Los Alamos, NM USA; [Huntsman, Brock M.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Alaska Department of Fish & Game; United States Department of Energy (DOE); Los Alamos National Laboratory; New Mexico State University	Huntsman, BM (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA.; Huntsman, BM (corresponding author), New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA.	brockhunts@gmail.com	Bennett, Katrina/AAE-6105-2019	Huntsman, Brock/0000-0003-4090-1949	State of Alaska; ADFG through the Chinook Salmon Research Initiative [G00008902-337930]	State of Alaska; ADFG through the Chinook Salmon Research Initiative	Funding for this research was provided by the State of Alaska and ADFG through the Chinook Salmon Research Initiative, grant awarded to Jeffrey A. Falke (Award #: G00008902-337930).	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; ADFG Chinook Salmon Research Team, 2013, ADFG SPEC PUBL; Anderson JH, 2007, CAN J FISH AQUAT SCI, V64, P1143, DOI 10.1139/F07-087; [Anonymous], 1993, INTRO BOOTSTRAP; Barton K., 2015, MUMIN MULTIMODEL INF; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Benda L, 2007, FOREST SCI, V53, P206; Bennett KE, 2015, J HYDROL, V527, P590, DOI 10.1016/j.jhydrol.2015.04.065; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busch DS, 2013, RIVER RES APPL, V29, P297, DOI 10.1002/rra.1597; Casini M, 2012, P NATL ACAD SCI USA, V109, P8185, DOI 10.1073/pnas.1113286109; Charnov E, 1976, OPTIMAL FORAGING MAR, V9, P129; Clarke SE, 2008, J AM WATER RESOUR AS, V44, P459, DOI 10.1111/j.1752-1688.2008.00175.x; Connor EJ, 2004, N AM J FISH MANAGE, V24, P835, DOI 10.1577/M03-066.1; Cram JM, 2013, ENVIRON BIOL FISH, V96, P109, DOI 10.1007/s10641-012-0026-1; Crozier L, 2006, J ANIM ECOL, V75, P1100, DOI 10.1111/j.1365-2656.2006.01130.x; Crozier LG, 2010, J ANIM ECOL, V79, P342, DOI 10.1111/j.1365-2656.2009.01641.x; Decker S. J., 2010, THESIS; Dupuch A, 2014, OECOLOGIA, V174, P403, DOI 10.1007/s00442-013-2792-7; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Falcy MR, 2015, J ANIM ECOL, V84, P545, DOI 10.1111/1365-2656.12297; Falke JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079232; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gillis DM, 2012, CAN J FISH AQUAT SCI, V69, P1610, DOI 10.1139/F2012-091; Good TP, 2005, UPDATED STATUS FEDER; Grossman GD, 2013, ECOL MONOGR, V76, P217; Guo QF, 2005, OIKOS, V108, P47, DOI 10.1111/j.0030-1299.2005.13149.x; Halliday WD, 2014, J ZOOL, V294, P198, DOI 10.1111/jzo.12168; Halliday WD, 2016, OECOLOGIA, V181, P841, DOI 10.1007/s00442-016-3605-6; Heard William R., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P77; Hedger RD, 2005, J FISH BIOL, V67, P1054, DOI 10.1111/j.0022-1112.2005.00808.x; Hilborn R, 2013, P NATL ACAD SCI USA, V110, P6618, DOI 10.1073/pnas.1303653110; Hughes NF, 1998, ECOLOGY, V79, P281, DOI 10.1890/0012-9658(1998)079[0281:AMOHSB]2.0.CO;2; Huntsman BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091673; Jarema SI, 2009, GLOBAL CHANGE BIOL, V15, P508, DOI 10.1111/j.1365-2486.2008.01732.x; Keefer ML, 2015, J THERM BIOL, V48, P11, DOI 10.1016/j.jtherbio.2014.12.002; Keefer ML, 2014, REV FISH BIOL FISHER, V24, P333, DOI 10.1007/s11160-013-9334-6; Knight TW, 2008, ISR J ECOL EVOL, V54, P345, DOI 10.1560/IJEE.54.3-4.345; Knight TW, 1996, ECOLOGY, V77, P1756, DOI 10.2307/2265781; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Matter AN, 2016, THESIS; Merkle JA, 2015, ECOLOGY, V96, P1793, DOI 10.1890/14-0805.1; Morita K, 2004, J APPL ECOL, V41, P962, DOI 10.1111/j.0021-8901.2004.00927.x; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Morris DW, 2003, WILDLIFE RES, V30, P303, DOI 10.1071/WR02028; Morris DW, 2002, ECOLOGY, V83, P14; MORRIS DW, 1988, EVOL ECOL, V2, P253, DOI 10.1007/BF02214286; MORRIS DW, 1994, EVOL ECOL, V8, P387, DOI 10.1007/BF01238190; Morris DW, 1996, ECOLOGY, V77, P2352, DOI 10.2307/2265737; Moses MM, 2013, EVOL ECOL RES, V15, P809; Nelson GL, 1978, HYDROLOGIC INFORM LA; Neuswanger JR, 2015, CAN J FISH AQUAT SCI, V72, P1125, DOI 10.1139/cjfas-2014-0498; Neville HM, 2006, MOL ECOL, V15, P4589, DOI 10.1111/j.1365-294X.2006.03082.x; Nielson RM, 2013, ECOL EVOL, V3, P2233, DOI 10.1002/ece3.617; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Pulliam RH, 1991, AM NAT             S, V137, P50; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; RODRIGUEZ MA, 1995, EVOL ECOL, V9, P169, DOI 10.1007/BF01237755; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Savereide J.W., 2010, FISHERY DATA SERIES; Shochat E, 2005, OIKOS, V111, P159, DOI 10.1111/j.0030-1299.2005.13907.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Turchin Peter, 1995, P19, DOI 10.1016/B978-012159270-7/50003-8; van Beest FM, 2014, J ANIM ECOL, V83, P147, DOI 10.1111/1365-2656.12115; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; VANDENBERGHE EP, 1989, EVOLUTION, V43, P125, DOI 10.1111/j.1558-5646.1989.tb04212.x; Venables WN, 2002, RANDOM MIXED EFFECTS; Walters AW, 2013, ECOL FRESHW FISH, V22, P508, DOI 10.1111/eff.12046; Ward EJ, 2015, GLOBAL CHANGE BIOL, V21, P2500, DOI 10.1111/gcb.12847; Wenger SJ, 2010, WATER RESOUR RES, V46, P10; Westley PAH, 2015, ECOLOGY, V96, P2823, DOI 10.1890/14-1630.1.sm; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Zuur A. F., 2013, BEGINNERS GUIDE GLM; Zuur AF, 2009, STAT BIOL HLTH, P269	84	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177467	10.1371/journal.pone.0177467	http://dx.doi.org/10.1371/journal.pone.0177467			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531202	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058400018
J	Li, YW; Chiang, KY; Li, YH; Wu, SY; Liu, WT; Lin, CR; Wu, JL				Li, Ya-Wen; Chiang, Keng-Yu; Li, Yen-Hsing; Wu, Sung-Yu; Liu, Wangta; Lin, Chia-Ray; Wu, Jen-Leih			MiR-145 mediates zebrafish hepatic outgrowth through progranulin A signaling	PLOS ONE			English	Article							GRANULIN-EPITHELIN PRECURSOR; FRONTOTEMPORAL LOBAR DEGENERATION; HUMAN HEPATOCELLULAR-CARCINOMA; CANCER CELL-PROLIFERATION; HUMAN OVARIAN-CANCER; HUMAN BREAST-CANCER; GROWTH-FACTOR; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; LIVER SPECIFICATION	MicroRNAs (miRs) are mRNA-regulatory molecules that fine-tune gene expression and modulate both processes of development and tumorigenesis. Our previous studies identified progranulin A (GrnA) as a growth factor which induces zebrafish hepatic outgrowth through MET signaling. We also found that miR-145 is one of potential fine-tuning regulators of GrnA involved in embryonic hepatic outgrowth. The low level of miR-145 seen in hepatocarinogenesis has been shown to promote pathological liver growth. However, little is known about the regulatory mechanism of miR-145 in embryonic liver development. In this study, we demonstrate a significant decrease in miR-145 expression during hepatogenesis. We modulate miR-145 expression in zebrafish embryos by injection with a miR-145 mimic or a miR-145 hairpin inhibitor. Altered embryonic liver outgrowth is observed in response to miR-145 expression modulation. We also confirm a critical role of miR-145 in hepatic outgrowth by using whole-mount in situ hybridization. Loss of miR-145 expression in embryos results in hepatic cell proliferation, and vice versa. Furthermore, we demonstrate that GrnA is a target of miR-145 and GrnA-induced MET signaling is also regulated by miR-145 as determined by luciferase reporter assay and gene expression analysis, respectively. In addition, co-injection of GrnA mRNA with miR-145 mimic or MO-GrnA with miR-145 inhibitor restores the liver defects caused by dysregulation of miR-145 expression. In conclusion, our findings suggest an important role of miR-145 in regulating GrnA-dependent hepatic outgrowth in zebrafish embryonic development.	[Li, Ya-Wen; Wu, Jen-Leih] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Li, Ya-Wen; Chiang, Keng-Yu; Wu, Sung-Yu; Lin, Chia-Ray; Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan; [Chiang, Keng-Yu] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Li, Yen-Hsing] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Liu, Wangta] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Taiwan University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Wu, JL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Wu, JL (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan.	jlwu@gate.sinica.edu.tw			Ministry of Science and Technology (MOST) in Taiwan [104-2313-B-001-005]; Ministry of Science and Technology (MOST)	Ministry of Science and Technology (MOST) in Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	This research is supported by grant 104-2313-B-001-005 from the Ministry of Science and Technology (MOST) in Taiwan.; We thank the Taiwan Zebrafish Core Facility at Academia Sinica (TZCAS) is supported from the Ministry of Science and Technology (MOST) for zebrafish embryos and the Taiwan Mouse Clinic is supported from the National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology (MOST) for technical support. We thank Core Facility of the ICOB, Ms. Shin-Yi Du for technical support. We thank Prof. Jung San Huang in Saint Louis University for manuscript editing.	BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Bogue CW, 2000, DEV DYNAM, V219, P84, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1028>3.0.CO;2-5; Boufraqech M, 2014, ENDOCR-RELAT CANCER, V21, P517, DOI 10.1530/ERC-14-0077; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Coolen M, 2012, DEV CELL, V22, P1052, DOI 10.1016/j.devcel.2012.03.003; Cuevas-Antonio R, 2010, CANCER INVEST, V28, P452, DOI 10.3109/07357900903346455; Donald CD, 2001, ANTICANCER RES, V21, P3739; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; Frampton G, 2012, GUT, V61, P268, DOI 10.1136/gutjnl-2011-300643; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Goedert M, 2006, BRAIN, V129, P2808, DOI 10.1093/brain/awl291; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Huang CX, 2015, FASEB J, V29, P4901, DOI 10.1096/fj.14-267104; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Laudadio I, 2012, GASTROENTEROLOGY, V142, P119, DOI 10.1053/j.gastro.2011.09.001; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Li YH, 2010, J BIOL CHEM, V285, P41001, DOI 10.1074/jbc.M110.138743; Lu RQ, 2001, P NATL ACAD SCI USA, V98, P142, DOI 10.1073/pnas.011525198; Lu Y, 2014, GYNECOL ONCOL, V134, P364, DOI 10.1016/j.ygyno.2014.05.025; Lu Y, 2013, ONCOL REP, V29, P67, DOI 10.3892/or.2012.2084; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Noh JH, 2013, CANCER LETT, V335, P455, DOI 10.1016/j.canlet.2013.03.003; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Smalheiser NR, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-139; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HJ, 2013, BIOCHEM BIOPH RES CO, V441, P693, DOI 10.1016/j.bbrc.2013.10.053; Xiong XK, 2015, BIOCHEM BIOPH RES CO, V465, P262, DOI 10.1016/j.bbrc.2015.08.013; Yan WJ, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/673108; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	51	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177887	10.1371/journal.pone.0177887	http://dx.doi.org/10.1371/journal.pone.0177887			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531199	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400035
J	Nakipova, OV; Averin, AS; Evdokimovskii, EV; Pimenov, OY; Kosarski, L; Ignat'ev, D; Anufriev, A; Kokoz, YM; Reyes, S; Terzic, A; Alekseev, AE				Nakipova, Olga V.; Averin, Alexey S.; Evdokimovskii, Edward V.; Pimenov, Oleg Yu.; Kosarski, Leonid; Ignat'ev, Dmitriy; Anufriev, Andrey; Kokoz, Yuri M.; Reyes, Santiago; Terzic, Andre; Alekseev, Alexey E.			Store- operated Ca2+ entry supports contractile function in hearts of hibernators	PLOS ONE			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; FORCE-FREQUENCY-RELATIONSHIP; RAT VENTRICULAR MYOCYTES; GROUND-SQUIRREL; TRPC CHANNELS; 2-AMINOETHOXYDIPHENYL BORATE; LOW-TEMPERATURE; 2-AMINOETHYLDIPHENYL BORATE; CALCIUM HOMEOSTASIS; ADAPTIVE-MECHANISMS	Hibernators have a distinctive ability to adapt to seasonal changes of body temperature in a range between 37 degrees C and near freezing, exhibiting, among other features, a unique reversibility of cardiac contractility. The adaptation of myocardial contractility in hibernation state relies on alterations of excitation contraction coupling, which becomes less-dependent from extracellular Ca2+ entry and is predominantly controlled by Ca2+ release from sarcoplasmic reticulum, replenished by the Ca2+-ATPase (SERCA). We found that the specific SERCA inhibitor cyclopiazonic acid (CPA), in contrast to its effect in papillary muscles (PM) from rat hearts, did not reduce but rather potentiated contractility of PM from hibernating ground squirrels (GS). In GS ventricles we identified drastically elevated, compared to rats, expression of Orai1, Stim1 and Trpc1/3/4/5/6/7 mRNAs, putative components of store operated Ca2+ channels (SOC). Trpc3 protein levels were found increased in winter compared to summer GS, yet levels of Trpc5, Trpc6 or Trpc7 remained unchanged. Under suppressed voltage-dependent K+, Na+ and Ca2+ currents, the SOC inhibitor 2-aminoethyl diphenylborinate (2-APB) diminished whole-cell membrane currents in isolated cardiomyocytes from hibernating GS, but not from rats. During cooling-reheating cycles (30 degrees C-7 degrees C-30 degrees C) of ground squirrel PM, 2-APB did not affect typical CPA-sensitive elevation of contractile force at low temperatures, but precluded the contractility at 30 degrees C before and after the cooling. Wash-out of 2-APB reversed PM contractility to control values. Thus, we suggest that SOC play a pivotal role in governing the ability of hibernator hearts to maintain their function during the transition in and out of hibernating states.	[Nakipova, Olga V.; Averin, Alexey S.; Kosarski, Leonid; Ignat'ev, Dmitriy] Russian Acad Sci, Inst Cell Biophys, Pushchino, Moscow Region, Russia; [Evdokimovskii, Edward V.; Pimenov, Oleg Yu.; Kokoz, Yuri M.; Alekseev, Alexey E.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia; [Anufriev, Andrey] Russian Acad Sci, Inst Biol, Siberian Div, Yakutsk Branch, Yakutsk, Russia; [Reyes, Santiago; Terzic, Andre; Alekseev, Alexey E.] Mayo Clin, Div Cardiovasc Dis, Dept Mol Pharmacol & Expt Therapeut, Stabile 5, Rochester, MN USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Russian Academy of Sciences; Mayo Clinic	Alekseev, AE (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia.; Alekseev, AE (corresponding author), Mayo Clin, Div Cardiovasc Dis, Dept Mol Pharmacol & Expt Therapeut, Stabile 5, Rochester, MN USA.	alekseev.alexey@mayo.edu	Evdokimovsky, Edward/U-1278-2019	Evdokimovsky, Edward/0000-0001-8248-9054; Pimenov, Oleg Yu/0000-0001-5456-3376	Russian Foundation for Basic Research [13-04-01234]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research 13-04-01234 to OVN, http://www.rfbr.ru/rffi/end/grants.	Alekseev AE, 1996, BIOPHYS J, V70, P786, DOI 10.1016/S0006-3495(96)79618-2; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Braulke LJ, 2010, CRYOBIOLOGY, V60, P198, DOI 10.1016/j.cryobiol.2009.11.001; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; CHARNOCK JS, 1983, BRIT J PHARMACOL, V78, P151, DOI 10.1111/j.1476-5381.1983.tb09375.x; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Collins HE, 2013, AM J PHYSIOL-HEART C, V305, pH446, DOI 10.1152/ajpheart.00104.2013; Correll RN, 2015, J MOL CELL CARDIOL, V87, P38, DOI 10.1016/j.yjmcc.2015.07.032; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Dirksen RT, 2009, J PHYSIOL-LONDON, V587, P3139, DOI 10.1113/jphysiol.2009.172148; Dominguez-Rodriguez A, 2015, J MOL CELL CARDIOL, V87, P74, DOI 10.1016/j.yjmcc.2015.07.002; DRASKOCZY PR, 1967, J PHARMACOL EXP THER, V155, P101; Drew K, 2013, J EXP BIOL, V216, P927, DOI 10.1242/jeb.076174; Eder P, 2007, CARDIOVASC RES, V73, P111, DOI 10.1016/j.cardiores.2006.10.016; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Egorov YV, 2012, AM J PHYSIOL-HEART C, V303, pH1035, DOI 10.1152/ajpheart.00786.2011; Endoh M, 2004, EUR J PHARMACOL, V500, P73, DOI 10.1016/j.ejphar.2004.07.013; Gao LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep20791; Geiser F, 2014, AM J PHYSIOL-REG I, V307, pR1324, DOI 10.1152/ajpregu.00214.2014; HALIKAS G, 1973, COMP BIOCHEM PHYSIOL, V44, P677, DOI 10.1016/0300-9629(73)90522-7; HARRIS MB, 1995, J EXP BIOL, V198, P931; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Heinis FI, 2015, AM J PHYSIOL-REG I, V309, pR368, DOI 10.1152/ajpregu.00365.2014; Ignatev DA, ZHURNAL OBSCHEI BIOL; Jiang Y, 2014, CELL TISSUE RES, V355, P201, DOI 10.1007/s00441-013-1733-4; Johansson BW, 1996, CARDIOVASC RES, V31, P826, DOI 10.1016/S0008-6363(95)00192-1; KHROMOV AS, 1990, CRYO-LETT, V11, P331; Kojima A, 2010, BRIT J PHARMACOL, V161, P1734, DOI 10.1111/j.1476-5381.2010.00986.x; Kokoz YM, 2016, J MOL CELL CARDIOL, V100, P9, DOI 10.1016/j.yjmcc.2016.09.006; KONDO N, 1987, BRIT J PHARMACOL, V91, P315, DOI 10.1111/j.1476-5381.1987.tb10286.x; KONDO N, 1984, SCIENCE, V225, P641, DOI 10.1126/science.6740332; Krishna A, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-54; Li X-C, 2011, PUBLIC GOODS SUPPLY, P6; Liu B, 1997, AM J PHYSIOL-REG I, V272, pR1121, DOI 10.1152/ajpregu.1997.272.4.R1121; LIU B, 1990, CRYOBIOLOGY, V27, P539, DOI 10.1016/0011-2240(90)90041-2; LIU B, 1990, CRYOBIOLOGY, V27, P596, DOI 10.1016/S0011-2240(05)80027-6; LIU B, 1993, AM J PHYSIOL, V264, pR104, DOI 10.1152/ajpregu.1993.264.1.R104; LIU B, 1991, CRYOBIOLOGY, V28, P96, DOI 10.1016/0011-2240(91)90011-C; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; LYMAN CP, 1963, J PHYSIOL-LONDON, V168, P477, DOI 10.1113/jphysiol.1963.sp007204; Makarewich CA, 2014, CIRC RES, V115, P567, DOI 10.1161/CIRCRESAHA.115.303831; Mancarella S, 2011, J BIOL CHEM, V286, P44788, DOI 10.1074/jbc.M111.303081; Marengo FD, 1997, CELL CALCIUM, V21, P263, DOI 10.1016/S0143-4160(97)90114-7; Monasky MM, 2009, J COMP PHYSIOL B, V179, P469, DOI 10.1007/s00360-008-0331-3; Nakipova OV, 2007, CRYOBIOLOGY, V55, P173, DOI 10.1016/j.cryobiol.2007.07.001; Ni ZL, 2010, CAN J PHYSIOL PHARM, V88, P379, DOI 10.1139/Y10-017; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Page MM, 2009, COMP BIOCHEM PHYS A, V152, P115, DOI 10.1016/j.cbpa.2008.09.032; Pang Y, 2002, DIABETES, V51, P3461, DOI 10.2337/diabetes.51.12.3461; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pieske B, 1996, J CLIN INVEST, V98, P764, DOI 10.1172/JCI118849; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Sabourin J, 2016, J BIOL CHEM; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Selye H., 1974, STRESS DISTRESS; Stuyvers BD, 2002, J PHYSIOL-LONDON, V544, P817, DOI 10.1113/jphysiol.2002.024430; Sugizaki MM, 2006, INT J CARDIOL, V112, P191, DOI 10.1016/j.ijcard.2005.08.039; Tang Y J, 1995, Sheng Li Xue Bao, V47, P478; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Vennekens R, 2002, CELL CALCIUM, V31, P253, DOI 10.1016/S0143-4160(02)00055-6; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vizotto VA, 2007, BRAZ J MED BIOL RES, V40, P27, DOI 10.1590/S0100-879X2007000100004; Volkers M, 2012, J CELL SCI, V125, P287, DOI 10.1242/jcs.090464; Wang PP, 2012, EUR J PHARMACOL, V681, P60, DOI 10.1016/j.ejphar.2012.01.045; Wang SQ, 1997, CRYOBIOLOGY, V35, P193, DOI 10.1006/cryo.1997.2040; Wang SQ, 1997, J THERM BIOL, V22, P195, DOI 10.1016/S0306-4565(97)00010-7; Wang SQ, 2002, J EXP BIOL, V205, P2957; Wolkowicz PE, 2011, EUR J PHARMACOL, V668, P208, DOI 10.1016/j.ejphar.2011.06.025; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; ZATZMAN ML, 1984, CRYOBIOLOGY, V21, P593, DOI 10.1016/0011-2240(84)90220-7; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao GL, 2015, P NATL ACAD SCI USA, V112, pE4792, DOI 10.1073/pnas.1423295112	84	13	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177469	10.1371/journal.pone.0177469	http://dx.doi.org/10.1371/journal.pone.0177469			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531217	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400019
J	Olson, LE; Squires, JR; Oakleaf, RJ; Wallace, ZP; Kennedy, PL				Olson, Lucretia E.; Squires, John R.; Oakleaf, Robert J.; Wallace, Zachary P.; Kennedy, Patricia L.			Predicting above-ground density and distribution of small mammal prey species at large spatial scales	PLOS ONE			English	Article							FERRUGINOUS HAWKS; PRESENCE-ABSENCE; TERM DECLINE; GREAT-BASIN; ABUNDANCE; POPULATION; VEGETATION; PRODUCTIVITY; RESPONSES; ECOSYSTEM	Grassland and shrub-steppe ecosystems are increasingly threatened by anthropogenic activities. Loss of native habitats may negatively impact important small mammal prey species. Little information, however, is available on the impact of habitat variability on density of small mammal prey species at broad spatial scales. We examined the relationship between small mammal density and remotely-sensed environmental covariates in shrub-steppe and grassland ecosystems in Wyoming, USA. We sampled four sciurid and leporid species groups using line transect methods, and used hierarchical distance-sampling to model density in response to variation in vegetation, climate, topographic, and anthropogenic variables, while accounting for variation in detection probability. We created spatial predictions of each species' density and distribution. Sciurid and leporid species exhibited mixed responses to vegetation, such that changes to native habitat will likely affect prey species differently. Density of white-tailed prairie dogs (Cynomys leucurus), Wyoming ground squirrels (Urocitellus elegans), and leporids correlated negatively with proportion of shrub or sagebrush cover and positively with herbaceous cover or bare ground, whereas least chipmunks showed a positive correlation with shrub cover and a negative correlation with herbaceous cover. Spatial predictions from our models provide a landscape-scale metric of above-ground prey density, which will facilitate the development of conservation plans for these taxa and their predators at spatial scales relevant to management.	[Olson, Lucretia E.; Squires, John R.] US Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59804 USA; [Oakleaf, Robert J.] Wyoming Game & Fish Dept, Lander, WY USA; [Wallace, Zachary P.; Kennedy, Patricia L.] Oregon State Univ, Dept Fisheries & Wildlife & Eastern Oregon Agr, Union, OR USA; [Wallace, Zachary P.; Kennedy, Patricia L.] Oregon State Univ, Nat Resource Program, Union, OR USA; [Wallace, Zachary P.] Univ Wyoming, Wyoming Nat Divers Database, Laramie, WY 82071 USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; Oregon State University; University of Wyoming	Olson, LE (corresponding author), US Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59804 USA.	lucretiaolson@fs.fed.us			United States Forest Service Rocky Mountain Research Station; Bureau of Land Management; Wyoming Game and Fish Department; Wyoming Wildlife Heritage Foundation; PacifiCorp; Pathfinder Renewable Wind Energy, LLC; Wyoming Governor's Office	United States Forest Service Rocky Mountain Research Station; Bureau of Land Management; Wyoming Game and Fish Department; Wyoming Wildlife Heritage Foundation; PacifiCorp; Pathfinder Renewable Wind Energy, LLC; Wyoming Governor's Office	Funding sources include United States Forest Service Rocky Mountain Research Station, Bureau of Land Management, Wyoming Game and Fish Department, Wyoming Wildlife Heritage Foundation, PacifiCorp, Pathfinder Renewable Wind Energy, LLC, and the Wyoming Governor's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LW, 1983, J APPL ECOL, V20, P403, DOI 10.2307/2403516; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson JE, 2001, ECOL MONOGR, V71, P531, DOI 10.1890/0012-9615(2001)071[0531:LSCIPS]2.0.CO;2; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baker BW, 2013, ECOGRAPHY, V36, P230, DOI 10.1111/j.1600-0587.2012.07614.x; Beetle AA, 1982, AGRICULTRAL EXTENSIO, V779; Bradley Robert D., 2014, Occasional Papers Museum of Texas Tech University, V327, P1; Bruggeman JE, 2015, ECOL APPL, V25, P1932, DOI 10.1890/14-1591.1; Buckland S. T., 2001, INTRODUCTION TO DIST; Burnham K. P., 2002, MODEL SELECTION AND; CHAPMAN J A, 1978, Mammalian Species, P1; CLARK T W, 1970, Great Basin Naturalist, V30, P55; CLARK T W, 1971, Mammalian Species, V7, P1; Clark TW, 1987, MAMMALS IN WYOMING; Collins C. P., 2005, FERRUGINOUS HAWK BUT; Conn PB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141416; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davies KW, 2011, BIOL CONSERV, V144, P2573, DOI 10.1016/j.biocon.2011.07.016; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Finn S.P., 2011, SAGEBRUSH ECOSYSTEM, P69; Fiske IJ, 2011, J STAT SOFTW, V43, P1; FLINDERS JT, 1975, J RANGE MANAGE, V28, P290, DOI 10.2307/3897779; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GRANT WE, 1982, J MAMMAL, V63, P248, DOI 10.2307/1380634; Hanser S. E., 2011, SAGEBRUSH ECOSYSTEM, P337; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Homer CG, 2012, INT J APPL EARTH OBS, V14, P233, DOI 10.1016/j.jag.2011.09.012; HONEYCUTT RL, 1981, SOUTHWEST NAT, V26, P295, DOI 10.2307/3670908; JAKSIC FM, 1992, OECOLOGIA, V89, P90, DOI 10.1007/BF00319020; Jenness J, 2013, DEM SURFACE TOOLS FO; Jenness J, 2013, JENNESS ENTERP; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Keeley WH, 2016, J WILDLIFE MANAGE, V80, P1479, DOI 10.1002/jwmg.21130; Keinath DA, 2010, REPORT PREPARED FOR; Kery M, 2013, J BIOGEOGR, V40, P1463, DOI 10.1111/jbi.12087; Klute DS, 2003, BIOLOGICAL TECHNICAL; Knapp PA, 1996, GLOBAL ENVIRON CHANG, V6, P37, DOI 10.1016/0959-3780(95)00112-3; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Knight D. H., 2014, MOUNTAINS AND PLAINS; Langen TA, 2015, WILDL MANAGE CONSERV, P57; LIM B K, 1987, Mammalian Species, P1, DOI 10.2307/3504001; MACLAREN PA, 1988, GREAT BASIN NAT, V48, P548; Noss RF, 1995, BIOLOGICAL REPORT 28; Nupp TE, 2000, J MAMMAL, V81, P512, DOI 10.1644/1545-1542(2000)081&lt;0512:LLCOSM&gt;2.0.CO;2; Olson LE, 2015, J RAPTOR RES, V49, P400, DOI 10.3356/rapt-49-04-400-412.1; Orrock JL, 2000, ECOL APPL, V10, P1356, DOI 10.1890/1051-0761(2000)010[1356:PPAAOA]2.0.CO;2; PARMENTER RR, 1983, OECOLOGIA, V59, P145, DOI 10.1007/BF00378831; Parmenter RR, 2003, ECOL MONOGR, V73, P1, DOI 10.1890/0012-9615(2003)073[0001:SMDEAF]2.0.CO;2; Pollock JF, 2006, CONSERV BIOL, V20, P882, DOI 10.1111/j.1523-1739.2006.00342.x; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; R. Core Team, 2015, R A LANGUAGE AND ENV; Reeves MC, 2006, RANGELAND ECOL MANAG, V59, P1, DOI 10.2111/1551-5028(2006)59[001:AIEOMP]2.0.CO;2; Rodewald P., 2015, BIRDS N AM; ROGOWITZ GL, 1991, J MAMMAL, V72, P796, DOI 10.2307/1381846; Rowland Mary M., 2010, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P673; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Schmutz JK, 2008, J WILDLIFE MANAGE, V72, P1352, DOI 10.2193/2007-231; Schwarz CJ, 1999, STAT SCI, V14, P427; Sillett TS, 2012, ECOL APPL, V22, P1997, DOI 10.1890/11-1400.1; SMITH GW, 1985, J WILDLIFE MANAGE, V49, P699, DOI 10.2307/3801698; STEENHOF K, 1988, J ANIM ECOL, V57, P37, DOI 10.2307/4761; Steenweg R, 2016, BIOL CONSERV, V201, P192, DOI 10.1016/j.biocon.2016.06.020; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Turner MG, 1989, LANDSCAPE ECOL, V3, P153, DOI 10.1007/BF00131534; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Verts B.J., 2001, Mammalian Species, V653, P1, DOI 10.1644/1545-1410(2001)653<0001:TM>2.0.CO;2; Wallace ZP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152977; Wallace ZP, 2016, J WILDLIFE MANAGE, V80, P78, DOI 10.1002/jwmg.1000; Wang J, 2001, INT J REMOTE SENS, V22, P3827, DOI 10.1080/01431160010007033; Weiss A., 2001, P ESRI US C; Weller C., 2002, FRAGMENTING OUR LAND; West N. E., 1999, SAGEBRUSH STEPPE ECO, P15; White PJ, 1996, J MAMMAL, V77, P370, DOI 10.2307/1382810; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WOFFINDEN ND, 1989, J WILDLIFE MANAGE, V53, P1127, DOI 10.2307/3809619; Zegers D.A., 1984, Mammalian Species, P1, DOI 10.2307/3503955	81	5	5	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177165	10.1371/journal.pone.0177165	http://dx.doi.org/10.1371/journal.pone.0177165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520757	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700039
J	Medland, NA; Chow, EPF; McMahon, JH; Elliott, JH; Hoy, JF; Fairley, CK				Medland, Nicholas A.; Chow, Eric P. F.; McMahon, James H.; Elliott, Julian H.; Hoy, Jennifer F.; Fairley, Christopher K.			Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015	PLOS ONE			English	Article							PREVENTION; CARE	Introduction The HIV care cascade is increasingly used to evaluate HIV treatment programs at the population level. However, the cascade indicators lack the ability to show changes over time, which reduces their utility to guide health policy. Alternatives have been proposed but are complex or result in a delay in results. We propose a new indicator of ART uptake, the time from HIV diagnosis to commencement of ART, and compare it to the existing cascade indicator of proportion of patients on treatment and the WHO proposed cohort cascade indicator of proportion of patients on treatment within one year of diagnosis. Methods and materials Records from patients from the two largest HIV treatment centres in the state of Victoria, Australia (Melbourne Sexual Health Centre and The Alfred Hospital Department of Infectious Diseases) from 2011 to 2015 were extracted. The intervals between date of diagnosis, entry into care and initiation of ART were compared. Results and discussion From 2011 to 2015 the proportion of in-care patients who were on ART rose from 87% to 93% (p<0.0001). From 2011 to 2014, the proportion of patients in care and on ART within one year of diagnosis increased from 43.4% to 78.9% (p = 0.001). The median time from diagnosis to ART fell from 418 days (IQR: 91-1176) to 77 days (IQR: 39-290)(p< 0.001) by calendar year in which ART was commenced. Conclusions From 2011 to 2015 there were substantial and clinically important falls in the median time from diagnosis to commencing ART in those that commenced ART. The size of this dramatic change was not apparent when only reporting the proportion of patients on ART. Time to ART is a useful indicator and can be used to supplement existing cascade indicators in measuring progress toward universal ART coverage.	[Medland, Nicholas A.; Chow, Eric P. F.; Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [McMahon, James H.; Elliott, Julian H.; Hoy, Jennifer F.] Monash Univ, Cent Clin Sch, Alfred Hosp, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Medland, NA (corresponding author), Monash Univ, Cent Clin Sch, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.	nmedland@mshc.org.au	Hoy, Jennifer/AAK-7968-2020; Chow, Eric P.F./W-6684-2019	Chow, Eric P.F./0000-0003-1766-0657; McMahon, James/0000-0003-1460-5572; Medland, Nicholas Andrew/0000-0003-0403-8930; Christopher, Fairley/0000-0001-9081-1664; Hoy, Jennifer/0000-0002-6948-7086	Australian National Health and Medical Research Council [GNT1094518, 1091226, 1111099]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	` This work was supported by the Australian National Health and Medical Research Council to NAM (Postgraduate Scholarship Number GNT1094518), and to EPF Cand JHM (Early Career Fellowships numbers 1091226 and 1111099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2015, GUID US ANT AG HIV 1; Australasian Society of HIV Medicine, 2015, ANT GUID US DHSS GUI; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Grulich AE, 2016, C RETR OPP INF BOSTO; Lesko CR, 2016, AIDS, V30, P2227, DOI 10.1097/QAD.0000000000001183; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mao LM, 2015, MED J AUSTRALIA, V202, P258, DOI 10.5694/mja14.00443; McMahon JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127726; Medland NA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20634; NSW Health, 2014, NSW HIV STRAT 2012 1; Obama B, 2013, EXECUTIVE ORDER HIV; [Pharmaceutical Benefits Advisory Committee Department of Health], 2013, 1 LIN ANT THER ART P; Rodger A, 2016, C RETR OPP INF BOST2; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; TEMPRANO Study Group, 2015, NEW ENGLAND J MED; The Kirby Institute, 2014, VIRAL HEPTATITIS AND; The Kirby Institute, 2015, HIV VIR HEP SEX TRAN; Toren KG, 2016, SEX TRANSM DIS, V43, P34, DOI 10.1097/OLQ.0000000000000376; World Health Organization, 2015, CONS STRAT INF GUID	20	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177634	10.1371/journal.pone.0177634	http://dx.doi.org/10.1371/journal.pone.0177634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520807	gold, Green Submitted, Green Published			2022-12-27	WOS:000401485500049
J	Stover, J; Rosen, JE; Carvalho, MN; Korenromp, EL; Friedman, HS; Cogan, M; Deperthes, B				Stover, John; Rosen, James E.; Carvalho, Maria Nadia; Korenromp, Eline L.; Friedman, Howard S.; Cogan, Matthew; Deperthes, Bidia			The case for investing in the male condom	PLOS ONE			English	Article							FREQUENCY	When used correctly and consistently, the male condom offers triple protection from unintended pregnancy and the transmission of sexually transmitted infections (STIs) and human immunodeficiency virus (HIV). However, with health funding levels stagnant or falling, it is important to understand the cost and health impact associated with prevention technologies. This study is one of the first to attempt to quantify the cost and combined health impact of condom use, as a means to prevent unwanted pregnancy and to prevent transmission of STIs including HIV. This paper describes the analysis to make the case for investment in the male condom, including the cost, impact and cost-effectiveness by three scenarios (low in which 2015 condom use levels are maintained; medium in which condom use trends are used to predict condom use from 2016-2030; and high in which condom use is scaled up, as part of a package of contraceptives, to meet all unmet need for family planning by 2030 and to 90% for HIV and STI prevention by 2016) for 81 countries from 2015-2030. An annual gap between current and desired use of 10.9 billion condoms was identified (4.6 billion for family planning and 6.3 billion for HIV and STIs). Under a high scenario that completely reduces that gap between current and desired use of 10.9 billion condoms, we found that by 2030 countries could avert 240 million DALYs. The additional cost in the 81 countries through 2030 under the medium scenario is $1.9 billion, and $27.5 billion under the high scenario. Through 2030, the cost-effectiveness ratios are $304 per DALY averted for the medium and $115 per DALY averted for the high scenario. Under the three scenarios described above, our analysis demonstrates the cost-effectiveness of the male condom in preventing unintended pregnancy and HIV and STI new infections. Policy makers should increase budgets for condom programming to increase the health return on investment of scarce resources.	[Stover, John; Rosen, James E.; Carvalho, Maria Nadia; Korenromp, Eline L.] Avenir Hlth, Glastonbury, CT 06033 USA; [Friedman, Howard S.; Cogan, Matthew; Deperthes, Bidia] UN Populat Fund UNFPA, New York, NY USA	United Nations Population Fund	Carvalho, MN (corresponding author), Avenir Hlth, Glastonbury, CT 06033 USA.	ncarvalho@avenirhealth.org		Deperthes, Bidia/0000-0001-8029-2266	UNFPA [UNFPA/USA/PSC/15/016]; United Nations Population Fund (UNFPA) [UNFPA/USA/PSC/15/016]	UNFPA; United Nations Population Fund (UNFPA)	This publication was funded through Contract No. UNFPA/USA/PSC/15/016 from UNFPA. The funders reviewed the analysis plan and manuscript.r This analysis was supported by the United Nations Population Fund (UNFPA) under UNFPA/USA/PSC/15/016. We are grateful to the Steering Committee for their contributions to the investment case analysis plan and report. The group included Henk Van Renterghem, Jose A Antonio and Karl-Lorenz Dehne from UNAIDS, Sukanta Sarker from UNFPA, Clancy Broxton from USAID, Nathalie Jeanne Nicole Broutet from WHO, Lee Warner from CDC, Gina Dallabetta from the Gates Foundation, Nina Hasen from Population Services International, Mags Beksinska from Match Research, Hema Srinivasan from the Clinton Health Access Initiative, Mitchell Warren from AVAC, and Paul Feldblum from FHI 360. Disclaimer: The views or opinions expressed in this paper are those of the authors and not of UNFPA.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2011, CONTRACEPTIVE TECHNO; [Anonymous], 2016, DAT FAST TRACK COND; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Gaydosh L, 2013, AIDS BEHAV, V17, P2376, DOI 10.1007/s10461-013-0525-x; Holmes KK, 2004, B WHO, V82; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; PSI, 2009, ANNUAL COST EFFECTIV; RAO KV, 1995, J BIOSOC SCI, V27, P135, DOI 10.1017/S0021932000022653; Slaymaker E., 2012, ESTIMATION COITAL FR; Traore A V, 2002, AIDS, V16, P251; UNAIDS, 2016, M REP DAT FAST TRACK; United Nations Department of Economic and Social Affairs Population Division, 2015, MOD BAS EST PROJ FAM; United Nations Department of Economic and Social Affairs Population Division, 2015, STEASSERA349 UN DEP; United Nations Department of Economic and Social Affairs Population Division, 2015, ESAWP241; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Wall KM, 2013, J HOMOSEXUAL, V60, P1520, DOI 10.1080/00918369.2013.819256; Weissman, 2014, FAMILY PLANNIN UNPUB	19	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177108	10.1371/journal.pone.0177108	http://dx.doi.org/10.1371/journal.pone.0177108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28510591	Green Submitted, Green Published, gold			2022-12-27	WOS:000401485500012
J	Kraft-Todd, GT; Reinero, DA; Kelley, JM; Heberlein, AS; Baer, L; Riess, H				Kraft-Todd, Gordon T.; Reinero, Diego A.; Kelley, John M.; Heberlein, Andrea S.; Baer, Lee; Riess, Helen			Empathic nonverbal behavior increases ratings of both warmth and competence in a medical context	PLOS ONE			English	Article							WHITE COAT CEREMONY; STEREOTYPE CONTENT; UNIVERSAL DIMENSIONS; PATIENT PERCEPTION; FEMALE PHYSICIANS; COMMUNICATION; GENDER; CARE; PROFESSIONALISM; SATISFACTION	In medicine, it is critical that clinicians demonstrate both empathy (perceived as warmth) and competence. Perceptions of these qualities are often intuitive and are based on nonverbal behavior. Emphasizing both warmth and competence may prove problematic, however, because there is evidence that they are inversely related in other settings. We hypothesize that perceptions of physician competence will instead be positively correlated with perceptions of physician warmth and empathy, potentially due to changing conceptions of the physician's role. We test this hypothesis in an analog medical context using a large online sample, manipulating physician nonverbal behaviors suggested to communicate empathy (e.g. eye contact) and competence (the physician's white coat). Participants rated physicians displaying empathic nonverbal behavior as more empathic, warm, and more competent than physicians displaying unempathic nonverbal behavior, adjusting for mood. We found no warmth/competence tradeoff and, additionally, no significant effects of the white coat. Further, compared with male participants, female participants perceived physicians displaying unempathic nonverbal behavior as less empathic. Given the significant consequences of clinician empathy, it is important for clinicians to learn how nonverbal behavior contributes to perceptions of warmth, and use it as another tool to improve their patients' emotional and physical health.	[Kraft-Todd, Gordon T.; Reinero, Diego A.; Kelley, John M.; Heberlein, Andrea S.; Baer, Lee; Riess, Helen] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Empathy & Relat Sci Program, Boston, MA 02115 USA; [Kraft-Todd, Gordon T.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Reinero, Diego A.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Kelley, John M.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA USA; [Kelley, John M.] Endicott Coll, Dept Psychol, Beverly, MA USA; [Heberlein, Andrea S.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University; New York University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston College	Kraft-Todd, GT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Empathy & Relat Sci Program, Boston, MA 02115 USA.; Kraft-Todd, GT (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	gordon.kraft-todd@yale.edu	Reinero, Diego A./V-2144-2019; Kraft-Todd, Gordon/O-5520-2016	Reinero, Diego A./0000-0002-6124-2623; Kraft-Todd, Gordon/0000-0003-1220-9269	Arnold P. Gold Foundation; David Judah Fund, Massachusetts General Hospital	Arnold P. Gold Foundation; David Judah Fund, Massachusetts General Hospital	All authors recognize the funding sources, The Arnold P. Gold Foundation and The David Judah Fund, Massachusetts General Hospital, in completion of their work. The Arnold P. Gold Foundation and The David Judah Fund had no role in study design, collection, analysis, interpretation of data, writing the report, nor in the decision to submit the report for publication.	Aaker J, 2010, J CONSUM RES, V37, P224, DOI 10.1086/651566; Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; AMBADY N, 1993, J PERS SOC PSYCHOL, V64, P431, DOI 10.1037/0022-3514.64.3.431; Arora S, 2010, MED EDUC, V44, P749, DOI 10.1111/j.1365-2923.2010.03709.x; Baron RB, 2013, ACAD MED, V88, P1199, DOI 10.1097/ACM.0b013e31829ed2ed; Beach MC, 2006, J GEN INTERN MED, V21, pS3, DOI 10.1111/j.1525-1497.2006.00302.x; BECKER MH, 1975, MED CARE, V13, P10, DOI 10.1097/00005650-197501000-00002; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Blanch-Hartigan D, 2013, MED CARE, V51, pE16, DOI 10.1097/MLR.0b013e31822945cc; Blanch-Hartigan D, 2010, PATIENT EDUC COUNS, V80, P315, DOI 10.1016/j.pec.2010.06.014; Branch WT, 1998, ANN INTERN MED, V129, P740, DOI 10.7326/0003-4819-129-9-199811010-00012; Brase GL, 2004, J APPL SOC PSYCHOL, V34, P2469, DOI 10.1111/j.1559-1816.2004.tb01987.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; BULLER MK, 1987, J HEALTH SOC BEHAV, V28, P375, DOI 10.2307/2136791; Cadinu MR, 2001, EUR J SOC PSYCHOL, V31, P353, DOI 10.1002/ejsp.46; Carney DR, 2007, J RES PERS, V41, P1054, DOI 10.1016/j.jrp.2007.01.004; Chung H, 2012, PATIENT EDUC COUNS, V89, P387, DOI 10.1016/j.pec.2012.02.017; Cuddy AJC, 2004, J SOC ISSUES, V60, P701, DOI 10.1111/j.0022-4537.2004.00381.x; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; DAVIS MH, 1987, J PERS SOC PSYCHOL, V53, P397, DOI 10.1037/0022-3514.53.2.397; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Davis RL, 2007, CLIN EXP OPHTHALMOL, V35, P51, DOI 10.1111/j.1442-9071.2006.01383.x; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; EAGLY AH, 1989, PERS SOC PSYCHOL B, V15, P543, DOI 10.1177/0146167289154008; Eagly AH, 2000, DEVELOPMENTAL SOCIAL PSYCHOLOGY OF GENDER, P123; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fiske ST, 2010, AM PSYCHOL, V65, P698, DOI 10.1037/0003-066X.65.8.698; Gerteis M., 1993, PATIENTS EYES UNDERS; Giordano LA, 2010, MED CARE RES REV, V67, P27, DOI 10.1177/1077558709341065; Gjerdingen DK, 1989, FAMILY PRACTICE RES; Gledhill JA, 1997, BRIT J PSYCHIAT, V171, P228, DOI 10.1192/bjp.171.3.228; Glick P, 2000, J PERS SOC PSYCHOL, V79, P763, DOI 10.1037/0022-3514.79.5.763; Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491; Gold A, 2006, J CHILD NEUROL, V21, P546, DOI 10.1177/08830738060210060401; Goldberg JL, 2008, ACAD MED, V83, P715, DOI 10.1097/ACM.0b013e31817eba30; Griffith CH, 2003, J GEN INTERN MED, V18, P170, DOI 10.1046/j.1525-1497.2003.10506.x; HAASE RF, 1972, J COUNS PSYCHOL, V19, P417, DOI 10.1037/h0033188; Hall J. A., 2007, FDN HLTH PSYCHOL, P325; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Hall JL, 2001, OPT PHOTONICS NEWS, V12, P44, DOI 10.1364/OPN.12.2.000044; Hall JA, 2015, HEALTH COMMUN, V30, P894, DOI 10.1080/10410236.2014.900892; Hall JA, 2015, HEALTH COMMUN, V30, P423, DOI 10.1080/10410236.2013.865507; Hall JA, 2011, PATIENT EDUC COUNS, V84, P319, DOI 10.1016/j.pec.2011.03.006; Hall JA, 2011, MED CARE, V49, P611, DOI 10.1097/MLR.0b013e318213c03f; Hall JA, 2009, J GEN INTERN MED, V24, P1217, DOI 10.1007/s11606-009-1107-5; HARRIGAN JA, 1985, J NONVERBAL BEHAV, V9, P95, DOI 10.1007/BF00987141; HENNESSY N, 1993, ANAESTHESIA, V48, P219, DOI 10.1111/j.1365-2044.1993.tb06905.x; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hitlin P., RES CROWDSOURCING AG; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; Holoien DS, 2013, J EXP SOC PSYCHOL, V49, P33, DOI 10.1016/j.jesp.2012.09.001; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Huber SJ, 2003, J MED ETHICS, V29, P364, DOI 10.1136/jme.29.6.364; Jones VA, 1999, JAMA-J AM MED ASSOC, V281, P478, DOI 10.1001/jama.281.5.478; Judd CM, 2005, J PERS SOC PSYCHOL, V89, P899, DOI 10.1037/0022-3514.89.6.899; Kavan MG., 2009, J CHILD NEUROL; Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Kervyn N, 2012, J EXP SOC PSYCHOL, V48, P77, DOI 10.1016/j.jesp.2011.08.001; Kim SS, 2004, EVAL HEALTH PROF, V27, P237, DOI 10.1177/0163278704267037; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Knapp M.L., 2014, CENGAGE LEARNING, VEight; Lee TL, 2006, INT J INTERCULT REL, V30, P751, DOI 10.1016/j.ijintrel.2006.06.005; Lill MM, 2005, BMJ-BRIT MED J, V331, P1524, DOI 10.1136/bmj.331.7531.1524; Martin LR, 2005, CLAR SYMP, P3; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Mast MS, 2008, J GEN INTERN MED, V23, P523, DOI 10.1007/s11606-008-0512-5; Mast MS, 2007, PATIENT EDUC COUNS, V67, P315, DOI 10.1016/j.pec.2007.03.005; Mast MS, 2011, PATIENT EDUC COUNS, V83, P174, DOI 10.1016/j.pec.2010.06.030; Mast MS, 2008, MED CARE, V46, P1212, DOI 10.1097/MLR.0b013e31817e1877; Mercer SW, 2004, FAM PRACT, V21, P699, DOI 10.1093/fampra/cmh621; Mercer SW, 2002, BRIT J GEN PRACT, V52, pS9; Montague E, 2013, J PARTICIPATORY MED, V5; Murphy NA, 2014, PERSONALITY SOCIAL P; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Phillips M, PATIENT ED IN PRESS; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Reddy AK, 2010, J PEDIATR OPHTHALMOL, V48, P336; Reddy AK, 2010, J PEDIATR OPHTHALMOL, V48, P40; Reddy AK, 2010, J PEDIATR OPHTHALMOL, V48, P5; Riess H, 2014, ACAD MED, V89, P1108, DOI 10.1097/ACM.0000000000000287; Riess H, 2012, J GEN INTERN MED, V27, P1280, DOI 10.1007/s11606-012-2063-z; Roter D., 2006, DOCTORS TALKING PATI, V2nd ed.; Roter DL, 2006, J GEN INTERN MED, V21, pS28, DOI 10.1111/j.1525-1497.2006.00306.x; Rowland Pamela A, 2005, Curr Surg, V62, P214, DOI 10.1016/j.cursur.2004.08.008; Ruben MA, 2017, HEALTH COMMUN, V32, P970, DOI 10.1080/10410236.2016.1196418; Russell PC, 2002, TEACH LEARN MED, V14, P56; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Smajdor A, 2011, J MED ETHICS, V37, P380, DOI 10.1136/jme.2010.039628; Smith-Hanen SS, 1977, J COUNSELING PSYCHOL; Stewart M, 2000, J FAM PRACTICE, V49, P796; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; Swick HM, 2000, ACAD MED, V75, P612, DOI 10.1097/00001888-200006000-00010; TAYLOR PG, 1987, AM J DIS CHILD, V141, P426, DOI 10.1001/archpedi.1987.04460040084021; TRUAX CB, 1966, J CLIN PSYCHOL, V22, P225, DOI 10.1002/1097-4679(196604)22:2<225::AID-JCLP2270220236>3.0.CO;2-O; Turner Roger Newman, 2007, Complement Ther Clin Pract, V13, P102, DOI 10.1016/j.ctcp.2006.10.001; van Berkhout ET, 2016, J COUNS PSYCHOL, V63, P32, DOI 10.1037/cou0000093; van Vliet LM, 2012, J GEN INTERN MED, V27, P1528, DOI 10.1007/s11606-012-2111-8; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wear D, 1998, ANN INTERN MED, V129, P734, DOI 10.7326/0003-4819-129-9-199811010-00010; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Williams GC., 2000, FAMILIES SYSTEMS HLT, V18, P79, DOI [10.1037/h0091854, DOI 10.1037/H0091854]; WISPE L, 1986, J PERS SOC PSYCHOL, V50, P314, DOI 10.1037/0022-3514.50.2.314; Wojciszke B, 1998, PERS SOC PSYCHOL B, V24, P1251, DOI 10.1177/01461672982412001; Wynia MK, 1999, NEW ENGL J MED, V341, P1612, DOI 10.1056/NEJM199911183412112; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	114	55	56	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177758	10.1371/journal.pone.0177758	http://dx.doi.org/10.1371/journal.pone.0177758			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505180	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500041
J	Wawrzyniak, M; Hoffstaedter, F; Klingbeil, J; Stockert, A; Wrede, K; Hartwigsen, G; Eickhoff, SB; Classen, J; Saur, D				Wawrzyniak, Max; Hoffstaedter, Felix; Klingbeil, Julian; Stockert, Anika; Wrede, Katrin; Hartwigsen, Gesa; Eickhoff, Simon B.; Classen, Joseph; Saur, Dorothee			Fronto-temporal interactions are functionally relevant for semantic control in language processing	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MIDDLE TEMPORAL GYRUS; THETA-BURST STIMULATION; CONTEXTUAL SENTENCE INTEGRATION; RESTING-STATE CONNECTIVITY; INFERIOR FRONTAL GYRUS; HUMAN BRAIN; PREFRONTAL CORTEX; CONTROLLED RETRIEVAL; DISTRIBUTED NETWORK	Semantic cognition, i.e. processing of meaning is based on semantic representations and their controlled retrieval. Semantic control has been shown to be implemented in a network that consists of left inferior frontal (IFG), and anterior and posterior middle temporal gyri (a/pMTG). We aimed to disrupt semantic control processes with continuous theta burst stimulation (cTBS) over left IFG and pMTG and to study whether behavioral effects are moderated by induced alterations in resting-state functional connectivity. To this end, we applied real cTBS over left IFG and left pMTG as well as sham stimulation on 20 healthy participants in a within-subject design. Stimulation was followed by resting-state functional magnetic resonance imaging and a semantic priming paradigm. Resting-state functional connectivity of regions of interest in left IFG, pMTG and aMTG revealed highly interconnected left-lateralized fronto-temporal networks representing the semantic system. We did not find any significant direct modulation of either task performance or resting-state functional connectivity by effective cTBS. However, after sham cTBS, functional connectivity between IFG and pMTG correlated with task performance under high semantic control demands in the semantic priming paradigm. These findings provide evidence for the functional relevance of interactions between IFG and pMTG for semantic control processes. This interaction was functionally less relevant after cTBS over aIFG which might be interpretable in terms of an indirect disruptive effect of cTBS.	[Wawrzyniak, Max; Klingbeil, Julian; Stockert, Anika; Wrede, Katrin; Hartwigsen, Gesa; Saur, Dorothee] Univ Leipzig, Dept Neurol, Language & Aphasia Lab, Leipzig, Germany; [Hoffstaedter, Felix; Eickhoff, Simon B.] Heinrich Heine Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Med Fac, Dusseldorf, Germany; [Hoffstaedter, Felix; Eickhoff, Simon B.] Res Ctr Julich, Inst Neurosci & Med INM 1, Julich, Germany; [Hoffstaedter, Felix; Eickhoff, Simon B.] Heinrich Heine Univ Dusseldorf, Inst Syst Neurosci, Med Fac, Dusseldorf, Germany; [Hartwigsen, Gesa] Max Planck Inst Human Cognit & Brain Sci Leipzig, Dept Neuropsychol, Leipzig, Germany; [Classen, Joseph] Univ Leipzig, Dept Neurol, Human Cort Physiol & Motor Control Lab, Leipzig, Germany	Leipzig University; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Max Planck Society; Leipzig University	Wawrzyniak, M (corresponding author), Univ Leipzig, Dept Neurol, Language & Aphasia Lab, Leipzig, Germany.	max.wawrzyniak@medizin.uni-leipzig.de	Hartwigsen, Gesa/L-2283-2017; Hartwigsen, Gesa/M-1224-2019; Saur, Dorothee/Q-1684-2017; Saur, Dorothee/C-5900-2019; Wawrzyniak, Max/AAN-2723-2021; Eickhoff, Simon B./K-2061-2013	Hartwigsen, Gesa/0000-0002-8084-1330; Hartwigsen, Gesa/0000-0002-8084-1330; Saur, Dorothee/0000-0002-1808-0913; Saur, Dorothee/0000-0002-1808-0913; Wawrzyniak, Max/0000-0002-5089-1214; Stockert, Anika/0000-0001-5804-2498; Hoffstaedter, Felix/0000-0001-7163-3110; Eickhoff, Simon B./0000-0001-6363-2759; Klingbeil, Julian/0000-0002-9306-9212; Classen, Joseph/0000-0001-7182-6967	James S. McDonnell Foundation, Scholar Award Human Cognition [220020292, 20112027]; ("Promotionsforderung") of the Medical Faculty of the University of Leipzig	James S. McDonnell Foundation, Scholar Award Human Cognition; ("Promotionsforderung") of the Medical Faculty of the University of Leipzig	Dorothee Saur was supported by the James S. McDonnell Foundation, Scholar Award Human Cognition (220020292, https://www.jsmf.org/grants/20112027/). Max Wawrzyniak was supported by a scholarship ("Promotionsforderung") of the Medical Faculty of the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almairac F, 2015, BRAIN STRUCT FUNCT, V220, P1983, DOI 10.1007/s00429-014-0773-1; Andoh J, 2015, J NEUROSCI, V35, P14602, DOI 10.1523/JNEUROSCI.2333-15.2015; Antonenko D, 2012, NEUROIMAGE, V62, P1667, DOI 10.1016/j.neuroimage.2012.05.074; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Baumgaertner A, 2002, NEUROIMAGE, V16, P736, DOI 10.1006/nimg.2002.1134; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bruckner S, 2013, NEUROSCIENCE, V233, P64, DOI 10.1016/j.neuroscience.2012.12.033; Chai XQJ, 2016, J NEUROSCI, V36, P755, DOI 10.1523/JNEUROSCI.2234-15.2016; Cocchi L, 2015, J NEUROPHYSIOL, V113, P3375, DOI 10.1152/jn.00850.2014; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Davey J, 2016, NEUROIMAGE, V137, P165, DOI 10.1016/j.neuroimage.2016.05.051; Davey J, 2015, J NEUROSCI, V35, P15230, DOI 10.1523/JNEUROSCI.4705-14.2015; Eldaief MC, 2011, P NATL ACAD SCI USA, V108, P21229, DOI 10.1073/pnas.1113103109; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Gotts SJ, 2013, P NATL ACAD SCI USA, V110, pE3435, DOI 10.1073/pnas.1302581110; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hallam GP, 2016, NEUROPSYCHOLOGIA, V93, P40, DOI 10.1016/j.neuropsychologia.2016.09.012; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Hartwigsen G, 2017, NEUROIMAGE, V147, P812, DOI 10.1016/j.neuroimage.2016.08.026; Hartwigsen G, 2016, CEREB CORTEX, V26, P2590, DOI 10.1093/cercor/bhv092; Hartwigsen G, 2013, P NATL ACAD SCI USA, V110, P16402, DOI 10.1073/pnas.1310190110; Huang J, 2012, BRAIN RES, V1440, P56, DOI 10.1016/j.brainres.2011.11.060; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hubl D, 2008, NEUROSCIENCE, V151, P921, DOI 10.1016/j.neuroscience.2007.10.049; Jefferies E, 2013, CORTEX, V49, P611, DOI 10.1016/j.cortex.2012.10.008; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Muller AM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00228; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Nettekoven C, 2014, J NEUROSCI, V34, P6849, DOI 10.1523/JNEUROSCI.4993-13.2014; Noonan KA, 2013, J COGNITIVE NEUROSCI, V25, P1824, DOI 10.1162/jocn_a_00442; Passow S, 2015, HUM BRAIN MAPP, V36, P2027, DOI 10.1002/hbm.22753; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Paus T, 1998, HUM BRAIN MAPP, V6, P399, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<399::AID-HBM13>3.0.CO;2-H; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Rahnev D, 2013, J NEUROPHYSIOL, V110, P1811, DOI 10.1152/jn.00209.2013; Ralph MAL, 2017, NAT REV NEUROSCI, V18, P42, DOI 10.1038/nrn.2016.150; Rolls ET, 2015, NEUROIMAGE, V122, P1, DOI 10.1016/j.neuroimage.2015.07.075; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Saffran EM, 2000, BRAIN LANG, V71, P204, DOI 10.1006/brln.1999.2251; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Simonyan K, 2015, J NEUROPHYSIOL, V113, P2967, DOI 10.1152/jn.00964.2014; Sommer M, 2002, CLIN NEUROPHYSIOL, V113, P265, DOI 10.1016/S1388-2457(01)00726-X; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stevens WD, 2014, WIRES COGN SCI, V5, P233, DOI 10.1002/wcs.1275; Stokes MG, 2013, J NEUROPHYSIOL, V109, P437, DOI 10.1152/jn.00510.2012; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valchev N, 2015, NEUROIMAGE, V114, P386, DOI 10.1016/j.neuroimage.2015.04.017; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van der Werf YD, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-145; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wang JX, 2014, SCIENCE, V345, P1054, DOI 10.1126/science.1252900; Watanabe T, 2014, HUM BRAIN MAPP, V35, P1896, DOI 10.1002/hbm.22300; Wei T, 2012, J NEUROSCI, V32, P481, DOI 10.1523/JNEUROSCI.1953-11.2012; Whitney C, 2012, J COGNITIVE NEUROSCI, V24, P133, DOI 10.1162/jocn_a_00123; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Willems RM, 2011, PSYCHOL SCI, V22, P849, DOI 10.1177/0956797611412387; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Zhu ZD, 2013, NEUROIMAGE, V76, P325, DOI 10.1016/j.neuroimage.2013.02.060	80	5	8	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177753	10.1371/journal.pone.0177753	http://dx.doi.org/10.1371/journal.pone.0177753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505211	Green Published, gold, Green Submitted			2022-12-27	WOS:000401473500040
J	Vodstrcil, LA; Rupasinghe, TWT; Kong, FYS; Tull, D; Worthington, K; Chen, MY; Huston, WM; Timms, P; McConville, MJ; Fairley, CK; Bradshaw, CS; Tabrizi, SN; Hocking, JS				Vodstrcil, Lenka A.; Rupasinghe, Thusitha W. T.; Kong, Fabian Y. S.; Tull, Dedreia; Worthington, Karen; Chen, Marcus Y.; Huston, Wilhelmina M.; Timms, Peter; McConville, Malcolm J.; Fairley, Christopher K.; Bradshaw, Catriona S.; Tabrizi, Sepehr N.; Hocking, Jane S.			Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS)	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; CHLAMYDIA-TRACHOMATIS; IN-VITRO; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; INFECTION; PLASMA; PHARMACOKINETICS; SUSCEPTIBILITY; DOXYCYCLINE	Background Azithromycin is recommended for the treatment of uncomplicated urogenital chlamydia infection although the standard 1gram dose sometimes fails to eradicate the infection (treatment failure). One hypothesis proposed for treatment failure has been insufficient levels of the antibiotic at the site of infection. We developed an assay using liquid chromatography and tandem mass spectrometry (LC-MS/MS) to measure azithromycin concentration in high-vaginal swabs and monitor how concentration changes over time following routine azithromycin treatment. Methods Azithromycin concentrations were measured in two groups of women either within the first 24h of taking a 1g dose (N = 11) or over 9 days (N = 10). Azithromycin concentrations were normalised to an internal standard (leucine enkephalin), and the bulk lipid species phosphatidylcholine [PC(34: 1)], using an Agilent 6490 triple quadrupole instrument in positive ionisation mode. The abundances of azithromycin, PC(34: 1), and leu-enkephalin were determined by multiple reaction monitoring and absolute levels of azithromycin estimated using standard curves prepared on vaginal specimens. Results Vaginal azithromycin concentrations of women were rapidly obtained after 5h post-treatment (mean concentration = 1031mcg/mg of lipid, range = 173-2693mcg/mg). In women followed for 9 days, peak concentrations were highest after day 2 (mean concentration = 2206mcg/mg, range = 721-5791mcg/mg), and remained high for at least 9 days with a mean concentration of 384mcg/mg (range = 139-1024mcg/mg) on day 9. Conclusion Our study confirmed that a single 1g dose of azithromycin is rapidly absorbed and remains in the vagina at relatively high levels for at least a week, suggesting that poor antibiotic absorption is unlikely to be an explanation for treatment failure.	[Vodstrcil, Lenka A.; Kong, Fabian Y. S.; Worthington, Karen; Bradshaw, Catriona S.; Hocking, Jane S.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia; [Vodstrcil, Lenka A.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Vodstrcil, Lenka A.; Worthington, Karen; Chen, Marcus Y.; Fairley, Christopher K.; Bradshaw, Catriona S.] Monash Univ, Melbourne Sexual Hlth Ctr, Cent Clin Sch, Carlton, Vic, Australia; [Rupasinghe, Thusitha W. T.; Tull, Dedreia; McConville, Malcolm J.] Univ Melbourne, Bio21 Inst, Metabol Australia, Parkville, Vic, Australia; [Huston, Wilhelmina M.] Univ Technol Sydney, Sch Life Sci, Broadway, Sydney, NSW 2007, Australia; [Timms, Peter] Univ Sunshine Coast, Maroochydore, Australia; [Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia; [Tabrizi, Sepehr N.] Univ Melbourne, Royal Womens Hosp Parkville, Melbourne, Vic, Australia	University of Melbourne; Murdoch Children's Research Institute; Monash University; University of Melbourne; University of Technology Sydney; University of the Sunshine Coast; University of Melbourne	Vodstrcil, LA (corresponding author), Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia.; Vodstrcil, LA (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Vodstrcil, LA (corresponding author), Monash Univ, Melbourne Sexual Hlth Ctr, Cent Clin Sch, Carlton, Vic, Australia.	lvodstrcil@mshc.org.au; jhocking@unimelb.edu.au	Hocking, Jane/AAD-5203-2021; Vodstrcil, Lenka/AAF-8722-2020; Vodstrcil, Lenka/AAC-1896-2019; Huston, Wilhelmina/S-7269-2019; Huston, Wilhelmina/B-9984-2008	Hocking, Jane/0000-0001-9329-8501; Vodstrcil, Lenka/0000-0003-3679-9195; Huston, Wilhelmina/0000-0002-0879-1287; Kong, Fabian/0000-0002-9349-3080; Timms, Peter/0000-0002-1682-0025; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678; Tull, Dedreia/0000-0003-2546-6707	National Health and Medical Research Council of Australia [1023239]; NHMRC [1042907]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council of Australia (project grant 1023239) and J.S. Hocking supported by a NHMRC Senior Research Fellowship (1042907).	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Alliance ASH, AUSTR STI MANAGEMENT; Andes D, 2001, CURR OPIN INFECT DIS, V14, P165, DOI 10.1097/00001432-200104000-00010; [Anonymous], SEXUALLY TRANSMITTED; Ballow CH, 1998, CLIN DRUG INVEST, V15, P159, DOI 10.2165/00044011-199815020-00009; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Bhengraj AR, 2010, CHEMOTHERAPY, V56, P371, DOI 10.1159/000314998; Blandizzi C, 1999, J PERIODONTOL, V70, P960, DOI 10.1902/jop.1999.70.9.960; Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS SURV; Chen BM, 2006, J PHARMACEUT BIOMED, V42, P480, DOI 10.1016/j.jpba.2006.05.011; COOPER MA, 1990, J ANTIMICROB CHEMOTH, V26, P533, DOI 10.1093/jac/26.4.533; Craig WA, 2001, CLIN INFECT DIS, V33, pS233, DOI 10.1086/321854; Crokaert F, 1998, CLIN DRUG INVEST, V16, P161, DOI 10.2165/00044011-199816020-00009; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; FOULDS G, 1993, J ANTIMICROB CHEMOTH, V31, P39, DOI 10.1093/jac/31.suppl_E.39; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Handsfield HH, 2011, SEX TRANSM DIS, V38, P1028, DOI 10.1097/OLQ.0b013e318227a366; HARRISON JD, 1991, EUR J CLIN MICROBIOL, V10, P862, DOI 10.1007/BF01975843; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Horner P, 2006, SEX TRANSM INFECT, V82, P340, DOI 10.1136/sti.2005.019158; Horner PJ, 2012, SEX TRANSM INFECT, V88, P154, DOI 10.1136/sextrans-2011-050385; JONES RB, 1990, J INFECT DIS, V162, P1309, DOI 10.1093/infdis/162.6.1309; Kintner J, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00044; Kong FYS, 2014, CLIN INFECT DIS, V59, P193, DOI 10.1093/cid/ciu220; Kong FYS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1030-9; Kutlin A, 1999, ANTIMICROB AGENTS CH, V43, P2268, DOI 10.1128/AAC.43.9.2268; Lanjouw E, 2015, INT J STD AIDS; Lefevre JC, 1998, SEX TRANSM DIS, V25, P350, DOI 10.1097/00007435-199808000-00005; Matzneller P, 2013, ANTIMICROB AGENTS CH, V57, P1736, DOI 10.1128/AAC.02011-12; Misyurina OY, 2004, ANTIMICROB AGENTS CH, V48, P1347, DOI 10.1128/AAC.48.4.1347-1349.2004; MOURAD A, 1980, ANTIMICROB AGENTS CH, V18, P696, DOI 10.1128/AAC.18.5.696; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; Nirogi RVS, 2005, ANAL CHIM ACTA, V553, P1, DOI 10.1016/j.aca.2005.08.007; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Pfizer, 2007, ZITHR PROD INF; Phillips-Campbell R, 2014, ANTIMICROB AGENTS CH, V58, P1782, DOI 10.1128/AAC.02097-13; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; Shen Y, 2010, J PHARMACEUT BIOMED, V52, P99, DOI 10.1016/j.jpba.2009.12.001; Shkarupeta MM, 2007, B EXP BIOL MED+, V143, P713, DOI 10.1007/s10517-007-0221-9; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; Suchland RJ, 2003, ANTIMICROB AGENTS CH, V47, P636, DOI 10.1128/AAC.47.2.636-642.2003; Wang SA, 2005, J INFECT DIS, V191, P917, DOI 10.1086/428290; Wiesenfeld HC, 2001, SEX TRANSM DIS, V28, P321, DOI 10.1097/00007435-200106000-00003; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; WORM AM, 1995, GENITOURIN MED, V71, P244; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Yuzuak N, 2007, CHROMATOGRAPHIA, V66, pS115, DOI 10.1365/s10337-007-0294-7; Zhu H, 2010, ANDROLOGIA, V42, P274, DOI 10.1111/j.1439-0272.2009.01019.x	51	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177615	10.1371/journal.pone.0177615	http://dx.doi.org/10.1371/journal.pone.0177615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498845	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500034
J	Jerez-Roig, J; Ferreira, LMDM; de Araujo, JRT; Lima, KC				Jerez-Roig, Javier; de Brito Macedo Ferreira, Lidiane Maria; Torres de Araujo, Jose Rodolfo; Lima, Kenio Costa			Functional decline in nursing home residents: A prognostic study	PLOS ONE			English	Article							DAILY LIVING ADL; CULTURAL-ADAPTATION; IMPAIRMENT; VALIDATION; DISABILITY; CAPACITY; PEOPLE; RISK	Aim To verify the probability of maintaining functional capacity in basic activities of daily living and identify the prognostic factors of functional decline in institutionalized older adults. Methods A longitudinal study is presented herein, with 5 waves every 6 months, throughout 2 years (2013-2015), conducted with individuals >= 60 years old in 10 nursing homes in the city of Natal-RN (Brazil). Functional capacity was assessed by the items 'eating', 'personal hygiene', 'dressing', 'bathing', 'transferring', 'toileting' and 'walking', through a 5-item Likert scale. Sociodemographic, institution-related and health-related variables were considered to establish the baseline. Time dependent variables included continence decline, cognitive decline, increase in the number of medication, and incidences of falls, hospitalizations and fractures. The actuarial method, the log-rank test and Cox's regression were applied as statistical methods. Results The cumulative probability of functional maintenance was 78.2% (CI 95%: 72.8 - 82.7%), 65.1% (CI 95%: 58.9 - 70.5%), 53.5% (CI 95%: 47.2 - 59.5%) and 44.0% (CI 95%: 37.7 - 50.2%) at 6, 12, 18 and 24 months, respectively. Predicting factors for functional decline were: severe cognitive impairment (HR = 1.96; p = 0.001), continence decline (HR = 1.85; p = 0.002) and incidence of hospitalizations (HR = 1.62; p = 0.020), adjusted by the incidence of depression, age, education level, presence of chronic diseases and low weight. Conclusions The cumulative probability of maintaining functional capacity in institutionalized older adults was only 44% at the 2-year follow-up. Prognostic factors for functional decline included severe cognitive impairment, continence decline and incidence of hospitalizations.	[Jerez-Roig, Javier; de Brito Macedo Ferreira, Lidiane Maria; Lima, Kenio Costa] Fed Univ Rio Grande do Norte UFRN, Odontol Dept, Postgrad Program Collect Hlth, Ave Salgado Filho 1787, Natal, RN, Brazil; [Jerez-Roig, Javier] Can Misses Hosp, Ibiza, Spain; [Torres de Araujo, Jose Rodolfo] Fed Univ Rio Grande do Norte UFRN, Ctr Hlth Sci, Postgrad Program Hlth Sci, Av Gustavo Cordeiro de Farias S-N, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Hospital Can Misses; Universidade Federal do Rio Grande do Norte	Jerez-Roig, J (corresponding author), Fed Univ Rio Grande do Norte UFRN, Odontol Dept, Postgrad Program Collect Hlth, Ave Salgado Filho 1787, Natal, RN, Brazil.; Jerez-Roig, J (corresponding author), Can Misses Hosp, Ibiza, Spain.	javijerez81@hotmail.com	Jerez-Roig, Javier/V-6119-2018	Jerez-Roig, Javier/0000-0002-1968-4452; Lima, Kenio Costa/0000-0002-5668-4398; Torres de Araujo, Jose Rodolfo/0000-0002-4257-6927				Banaszak-Holl J, 2011, J AGING HEALTH, V23, P862, DOI 10.1177/0898264311399759; Burge E, 2013, ARCH GERONTOL GERIAT, V56, P250, DOI 10.1016/j.archger.2012.09.001; Carpenter G Iain, 2006, BMC Geriatr, V6, P7, DOI 10.1186/1471-2318-6-7; Chen LY, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.01.017; Cincura C, 2009, CEREBROVASC DIS, V27, P119, DOI 10.1159/000177918; Coll-Planas L, 2008, Z GERONTOL GERIATR, V41, P283, DOI 10.1007/s00391-008-0563-6; Courtney MD, 2012, J EVAL CLIN PRACT, V18, P128, DOI 10.1111/j.1365-2753.2010.01547.x; de la Iglesia JM, 2001, MED CLIN-BARCELONA, V117, P129; Finlayson M, 2005, J CLIN EPIDEMIOL, V58, P338, DOI 10.1016/j.jclinepi.2004.10.008; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Instituto de Pesquisa Econo A mica Aplicada (IPEA), 2011, COND FUNC INFR I LON, V2014; Javier Jerez-Roig, 2016, J GERIATR PHYS THER; Javier Jerez-Roig, 2017, DISABIL HLTH J, V10, P279; Jerez-Roig J, 2014, NEUROUROL URODYNAM; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Lisboa CR, 2012, REV BRAS ENFERM, V65, P482, DOI 10.1590/S0034-71672012000300013; McConnell ES, 2002, J GERONTOL A-BIOL, V57, pM778, DOI 10.1093/gerona/57.12.M778; Raiche M, 2012, ARCH GERONTOL GERIAT, V55, P399, DOI 10.1016/j.archger.2011.12.007; Reis LA, 2011, REV BRAS ENFERM, V64, P274, DOI 10.1590/S0034-71672011000200009; Rosset I, 2011, REV ESC ENFERM USP, V45, P258; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Goncalves LHT, 2010, CAD SAUDE PUBLICA, V26, P1738, DOI 10.1590/S0102-311X2010000900007; Wang J, 2009, J GERONTOL A-BIOL, V64, P473, DOI 10.1093/gerona/gln040; Wang SY, 2013, ARCH GERONTOL GERIAT, V57, P16, DOI 10.1016/j.archger.2013.03.007; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; World Health Organization, 1984, US EP STUD ELD	26	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177353	10.1371/journal.pone.0177353	http://dx.doi.org/10.1371/journal.pone.0177353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493946	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300092
J	Lassalle, M; Fezeu, LK; Couchoud, C; Hannedouche, T; Massy, ZA; Czernichow, S				Lassalle, Mathilde; Fezeu, Leopold K.; Couchoud, Cecile; Hannedouche, Thierry; Massy, Ziad A.; Czernichow, Sebastien			Obesity and access to kidney transplantation in patients starting dialysis: A prospective cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; RENAL-TRANSPLANTATION; WAITING-LIST; METAANALYSIS; POPULATION; RECIPIENTS; MORTALITY; OUTCOMES; GENDER; TIME	Background Obesity has been linked to poor access to medical care. Although scientific evidence suggest that kidney transplantation improves survival and quality of life in obese patients with end-stage renal disease (ESRD), few data exist on the impact of obesity on access to kidney transplantation in this population. Objectives We aimed to characterize the relationships between body mass index (BMI) at the start of dialysis, changes in BMI after the start of dialysis, and either access to kidney transplantation or overall mortality in dialysis or transplantation among ESRD patients. Methods Between 2002 and 2011, 19524 dialysis patients with ESRD were included in the study via the French nationwide Renal Epidemiology and Information Network. Data on sociodemographic factors, comorbidities and laboratory test results were recorded upon entry into the registry. BMI were obtained at the start of dialysis and then yearly. Cubic spline regression analyses provided a graphic evaluation of the relationships between BMI at the start of dialysis and outcomes. Joint models were used to evaluate the association between the change over time in BMI and outcomes. Results During a median follow-up of 20.3 months, 6634 patients underwent kidney transplantation. A BMI >31 kg/m(2) at the start of the dialysis was associated with a lower likelihood of receiving a kidney transplant, and the likelihood decreased even further with higher BMI values. For patients with BMI >= 30kg/m(2) at the start of the dialysis, a 1 kg/m(2) decrease in BMI during follow-up was associated with a 9% to 11% increase in the likelihood of receiving a transplant. There was an L-shaped relationship between BMI at the start of dialysis and overall mortality. We showed that obese patients with ESRD face barriers to the receipt of a kidney transplant without valid reasons. Conclusion Greater attention to this issue would improve the fairness of the organ allocation process and might improve outcomes for obese patients with ESRD.	[Lassalle, Mathilde; Couchoud, Cecile] Agence Biomed, REIN Registry, F-93212 La Plaine St Denis, France; [Fezeu, Leopold K.] Univ Paris 13, CNAM, INRA U1125,INSERM U1153, Ctr Rech Epidemiol & Stat,EREN,COMUE Sorbonne Par, F-93017 Bobigny, France; [Hannedouche, Thierry] Univ Strasbourg, Dept Nephrol, F-67000 Strasbourg, France; [Hannedouche, Thierry] Hop Univ Strasbourg, F-67000 Strasbourg, France; [Massy, Ziad A.] Ambroise Pare Univ Hosp, AP HP, Div Nephrol, F-92100 Boulogne, France; [Massy, Ziad A.] INSERM, U1018, Res Ctr Epidemiol & Populat Hlth CESP, Team 5, F-94807 Villejuif, France; [Czernichow, Sebastien] INSERM, UMS 011, F-94807 Villejuif, France; [Czernichow, Sebastien] Univ Paris 05, Paris, France; [Czernichow, Sebastien] Hop Europeen Georges Pompidou, AP HP, Dept Nutr, F-75015 Paris, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Czernichow, S (corresponding author), INSERM, UMS 011, F-94807 Villejuif, France.; Czernichow, S (corresponding author), Univ Paris 05, Paris, France.; Czernichow, S (corresponding author), Hop Europeen Georges Pompidou, AP HP, Dept Nutr, F-75015 Paris, France.	sebastien.czernichow@aphp.fr						Bardonnaud N, 2012, TRANSPL P, V44, P2787, DOI 10.1016/j.transproceed.2012.09.031; Bussiere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104901; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Couchoud C, 2013, NEPHROL DIAL TRANSPL, V28, P2215, DOI 10.1093/ndt/gft004; Couchoud C, 2012, TRANSPLANTATION, V94, P513, DOI 10.1097/TP.0b013e31825d156a; Crowther MJ, 2013, STATA J, V13, P165, DOI 10.1177/1536867X1301300112; Dudley CRK, 2009, TRANSPLANTATION, V88, P96, DOI 10.1097/TP.0b013e3181aa901a; Ebpg, 2000, EUROPEAN RENAL AS S7, V15, P1; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; Gill JS, 2013, AM J TRANSPLANT, V13, P2083, DOI 10.1111/ajt.12331; Gill JS, 2014, CLIN J AM SOC NEPHRO, V9, P951, DOI 10.2215/CJN.08310813; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kasiske BL, 2001, AM J TRANSPLANT, V1, P7; Knoll Greg, 2005, CMAJ, V173, pS1, DOI 10.1503/cmaj.1041588; Kramer HJ, 2006, J AM SOC NEPHROL, V17, P1453, DOI 10.1681/ASN.2005111241; Kuo JH, 2012, J SURG RES, V173, P216, DOI 10.1016/j.jss.2011.05.030; Lievense H, 2012, NEPHROL DIAL TRANSPL, V27, P3631, DOI 10.1093/ndt/gfs131; McAdams-DeMarco MA, 2012, AM J TRANSPLANT, V12, P3283, DOI 10.1111/j.1600-6143.2012.04285.x; Molnar MZ, 2011, KIDNEY INT, V80, P219, DOI 10.1038/ki.2011.114; Nicoletto BB, 2014, TRANSPLANTATION, V98, P167, DOI 10.1097/TP.0000000000000028; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Patibandla BK, 2012, CLIN TRANSPLANT, V26, pE307, DOI 10.1111/j.1399-0012.2012.01661.x; Ravanan R, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3451; Rizopoulos D, 2010, J STAT SOFTW, V35, P1; Santos Jr AH, 2015, TRANSPLANTATION; Segev DL, 2008, J AM SOC NEPHROL, V19, P349, DOI 10.1681/ASN.2007050610; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Tsiatis AA, 2004, STAT SINICA, V14, P809; Udayaraj U, 2010, TRANSPLANTATION, V90, P279, DOI 10.1097/TP.0b013e3181e346e3; Vashistha T, 2014, AM J KIDNEY DIS, V63, P612, DOI 10.1053/j.ajkd.2013.07.021; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Ying A, 2015, LANCET, V385, P867, DOI 10.1016/S0140-6736(14)61171-5	34	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176616	10.1371/journal.pone.0176616	http://dx.doi.org/10.1371/journal.pone.0176616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493926	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314300023
J	Spill, YG; Nilges, M				Spill, Yannick G.; Nilges, Michael			SAS profile correlations reveal SAS hierarchical nature and information content	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; PROTEIN ENSEMBLES; SAXS; COMPUTATION; RESOLUTION; RETRIEVAL; MASS	In structural biology, Small-Angle Scattering experiments (SAS) are unique, because although they provide low resolution data, they can be performed in closer-to-native conditions than those arising in X-Ray crystallography. A number of questions on SAS, however, remain unsolved, particularly in the light of modelling ensembles of conformers in solution. In this article, we study the ensemble average and covariance of SAS profiles analytically. Using this ensemble covariance, we demonstrate the hierarchical nature of SAS profiles. Furthermore, we show that the information content is not uniform and reaches its maximum in the intermediate q range. The arguments are generalized using microsecond-scale molecular dynamics trajectories of the lysozyme and on an ensemble of the intrinsically disordered protein p15PAF. We show that for highly flexible systems, the SAS profile is a representation of the ensemble of conformers in solution, and not that of one conformer in particular.	[Spill, Yannick G.; Nilges, Michael] Inst Pasteur, Dept Struct Biol & Chem, Struct Bioinformat Unit, 25 Rue Docteur Roux, F-75015 Paris, France; [Spill, Yannick G.] CNAG CRG, Torre & Planta 10,Parc Cient Barcelona, Barcelona 08028, Spain	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Spill, YG (corresponding author), Inst Pasteur, Dept Struct Biol & Chem, Struct Bioinformat Unit, 25 Rue Docteur Roux, F-75015 Paris, France.; Spill, YG (corresponding author), CNAG CRG, Torre & Planta 10,Parc Cient Barcelona, Barcelona 08028, Spain.	yannick.spill@nsup.org	Nilges, Michael/E-4803-2011; Spill, Yannick/I-5485-2015	Nilges, Michael/0000-0002-1451-8092; Spill, Yannick/0000-0002-7979-0038	European Research Commission [ERC-2011-StG 294809]	European Research Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the European Research Commission (Advanced Grant ERC2011-StG 294809 BayCellS, to MN).; YGS would like to acknowledge Dominique Durand, Patrice Vachette and Frederic Poitevin for fruitful discussion and proofreading of the manuscript, Jochen S. Hub for sharing the lysozyme simulations, and Pau Bernado for discussion on extension to IDPs. This work was funded by the European Research Commission (Advanced Grant ERC-2011-StG 294809 Bay-CellS, to MN).	Anderson TW, 1944, ANN MATH STAT, V15, P345, DOI 10.1214/aoms/1177731206; Antonov LD, 2016, PHYS CHEM CHEM PHYS, V18, P5832, DOI 10.1039/c5cp04886a; Beaucage G, 1996, J APPL CRYSTALLOGR, V29, P134, DOI 10.1107/S0021889895011605; Berlin K, 2013, J AM CHEM SOC, V135, P16595, DOI 10.1021/ja4083717; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chen PC, 2014, BIOPHYS J, V107, P435, DOI 10.1016/j.bpj.2014.06.006; De Biasio A, 2014, BIOPHYS J, V106, P865, DOI 10.1016/j.bpj.2013.12.046; Debye P, 1915, ANN PHYS-BERLIN, V46, P809; Debye P, 1913, ANN PHYS, V348, P49, DOI DOI 10.1002/ANDP.19133480105; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Glatter O., 1982, SMALL ANGLE X RAY SC; Graewert MA, 2013, CURR OPIN STRUC BIOL, V23, P748, DOI 10.1016/j.sbi.2013.06.007; Grishaev A, 2008, J BIOMOL NMR, V40, P95, DOI 10.1007/s10858-007-9211-5; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammouda B, 2010, J APPL CRYSTALLOGR, V43, P716, DOI 10.1107/S0021889810015773; James RW, 1932, PHYS Z, V33, P737; Jensen D. R., 1976, Journal of Statistical Computation and Simulation, V4, P259, DOI 10.1080/00949657608810129; KAM Z, 1977, MACROMOLECULES, V10, P927, DOI 10.1021/ma60059a009; Kirian RA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011921; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kofinger J, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052712; LUZZATI V, 1986, J APPL CRYSTALLOGR, V19, P39, DOI 10.1107/S0021889886090027; Makowski L, 2011, BIOPOLYMERS, V95, P531, DOI 10.1002/bip.21631; Meisburger SP, 2013, BIOPHYS J, V104, P227, DOI [10.1016/j.bpj.2012.11.3817, 10.1016/j.bpj.2012.11.381]; Mendez D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0315; Merzel F, 2002, P NATL ACAD SCI USA, V99, P5378, DOI 10.1073/pnas.082335099; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Moore PB, 2014, BIOPHYS J, V106, P1489, DOI 10.1016/j.bpj.2014.02.016; Park S., 2009, J CHEM PHYS, V130; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Spill YG, 2013, THESIS; Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9; Svergun DI, 2010, BIOL CHEM, V391, P737, DOI 10.1515/BC.2010.093; TAUPIN D, 1982, J APPL CRYSTALLOGR, V15, P289, DOI 10.1107/S0021889882012011; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Tourneret JY, 2005, IEEE SP 13 WORKSH ST, P924; Waller I, 1923, Z PHYS, V17, P398, DOI 10.1007/BF01328696; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107	45	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177309	10.1371/journal.pone.0177309	http://dx.doi.org/10.1371/journal.pone.0177309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493950	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300085
J	Swainson, MG; Batterham, AM; Tsakirides, C; Rutherford, ZH; Hind, K				Swainson, Michelle G.; Batterham, Alan M.; Tsakirides, Costas; Rutherford, Zoe H.; Hind, Karen			Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables	PLOS ONE			English	Article							TO-HEIGHT RATIO; X-RAY ABSORPTIOMETRY; CARDIOMETABOLIC RISK-FACTORS; ALL-CAUSE MORTALITY; IN-VIVO PRECISION; GE LUNAR IDXA; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; GENERALIZED EQUATIONS; SCREENING TOOL	Background The conventional measurement of obesity utilises the body mass index (BMI) criterion. Although there are benefits to this method, there is concern that not all individuals at risk of obesity-associated medical conditions are being identified. Whole-body fat percentage (% FM), and specifically visceral adipose tissue (VAT) mass, are correlated with and potentially implicated in disease trajectories, but are not fully accounted for through BMI evaluation. The aims of this study were (a) to compare five anthropometric predictors of % FM and VAT mass, and (b) to explore new cut-points for the best of these predictors to improve the characterisation of obesity. Methods BMI, waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) and waist/height(0.5) (WHT. 5R) were measured and calculated for 81 adults (40 women, 41 men; mean (SD) age: 38.4 (17.5) years; 94% Caucasian). Total body dual energy X-ray absorptiometry with Corescan (GE Lunar iDXA, Encore version 15.0) was also performed to quantify % FM and VAT mass. Linear regression analysis, stratified by sex, was applied to predict both % FM and VAT mass for each anthropometric variable. Within each sex, we used information theoretic methods (Akaike Information Criterion; AIC) to compare models. For the best anthropometric predictor, we derived tentative cut-points for classifying individuals as obese (> 25% FM for men or > 35% FM for women, or > highest tertile for VAT mass). Results The best predictor of both % FM and VAT mass in men and women was WHtR. Derived cutpoints for predicting whole body obesity were 0.53 in men and 0.54 in women. The cut-point for predicting visceral obesity was 0.59 in both sexes. Conclusions In the absence of more objective measures of central obesity and adiposity, WHtR is a suitable proxy measure in both women and men. The proposed DXA-% FM and VAT mass cutoffs require validation in larger studies, but offer potential for improvement of obesity characterisation and the identification of individuals who would most benefit from therapeutic intervention.	[Swainson, Michelle G.; Tsakirides, Costas; Rutherford, Zoe H.; Hind, Karen] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Batterham, Alan M.] Teesside Univ, Hlth & Social Care Inst, Middlesbrough, Cleveland, England	Leeds Beckett University; University of Teesside	Swainson, MG (corresponding author), Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	m.swainson@leedsbeckett.ac.uk	Rutherford, Zoe/AAQ-3454-2020; Hind, Karen/AAE-6433-2021; Hind, Karen/HII-7471-2022	Rutherford, Zoe/0000-0002-0499-1134; Swainson, Michelle/0000-0002-5223-8710; BATTERHAM, ALAN/0000-0002-7865-7227; Hind, Karen/0000-0002-4546-5536	Medical Research Council [MR/K02325X/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2012, CLIN OBES, V2, P3, DOI 10.1111/j.1758-8111.2012.00037.x; Ashwell M, 1996, BRIT MED J, V312, P377; Ashwell M, 1996, BRIT MED J, V313, P559; Ashwell M, 2005, NUTR FOOD SCI, V35, P360, DOI 10.1108/00346650510625575; Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159; Ashwell M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0207-1; Ashwell Margaret, 2009, Nurs Stand, V23, P49; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Roriz AKC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103499; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Direk K, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-25; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Heo M, 2013, INT J OBESITY, V37, P1154, DOI 10.1038/ijo.2012.201; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hsieh SD, 2005, PREV MED, V40, P216, DOI 10.1016/j.ypmed.2004.05.025; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Kishida K, 2012, ANN MED, V44, P233, DOI 10.3109/07853890.2011.564202; Koster A, 2015, OBESITY, V23, P893, DOI 10.1002/oby.21028; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lam BCC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122985; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Machado LG, 2016, OSTEOPOROSIS INT, V27, P3525, DOI 10.1007/s00198-016-3682-8; Mellis MG, 2014, EUR J CLIN NUTR, V68, P1365, DOI 10.1038/ejcn.2014.213; Miazgowski T, 2014, ENDOCRINE, V47, P500, DOI 10.1007/s12020-014-0180-7; Millar SR, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0069-5; Myint PK, 2014, HEART, V100, P1613, DOI 10.1136/heartjnl-2014-305816; National Institute for Health Care Excellence (NICE), 2014, CG189 NICE; Nevill AM, 2016, SCAND J MED SCI SPOR; Ortega FB, 2016, MAYO CLIN PROC, V91, P443, DOI 10.1016/j.mayocp.2016.01.008; Rothman KJ, 2008, INT J OBES LOND S3, V32; Rothney MP, 2013, OBESITY, V21, P1798, DOI 10.1002/oby.20223; Rothney MP, 2013, OBESITY, V21, pE134, DOI 10.1002/oby.20140; Sarathy H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153588; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2008, WAIST CIRCUMFERENCE	46	130	138	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177175	10.1371/journal.pone.0177175	http://dx.doi.org/10.1371/journal.pone.0177175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493988	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000401314300067
J	Ward, D; Kirkman, K; Tsvuura, Z				Ward, David; Kirkman, Kevin; Tsvuura, Zivanai			An African grassland responds similarly to long-term fertilization to the Park Grass experiment	PLOS ONE			English	Article							RAPID POPULATION DIFFERENTIATION; PLANT-SPECIES DIVERSITY; MODEL SELECTION; ANTHOXANTHUM-ODORATUM; MULTIMODEL INFERENCE; BEHAVIORAL ECOLOGY; MOSAIC ENVIRONMENT; CO-LIMITATION; PRODUCTIVITY; NITROGEN	We compared the results of a long-term (65 years) experiment in a South African grassland with the world's longest-running ecological experiment, the Park Grass study at Rothamsted, U.K. The climate is warm and humid in South Africa and cool and temperate in England. The African grassland has been fertilized with two forms of nitrogen applied at four levels, phosphorus and lime in a crossed design in 96 plots. In 1951, about 84% of plant cover consisted of Themeda triandra, Tristachya leucothrix and Setaria nigrirostris. Currently, the dominant species are Panicum maximum, Setaria sphacelata and Eragrostis curvula, making up 71% of total biomass. As in the Park Grass experiment, we found a significant (additive) interaction effect on ANPP of nitrogen and phosphorus, and a (marginally significant) negative correlation between ANPP and species richness. Unlike the Park Grass experiment, there was no correlation between ANPP and species richness when pH was included as a covariate. There was also a significant negative effect of nitrogen amount and nitrogen form and a positive effect of lime on species richness and species diversity. Soil pH had an important effect on species richness. Liming was insufficient to balance the negative effects on species richness of nitrogen fertilization. There was a significant effect of pH on biomass of three abundant species. There were also significant effects of light on the biomass of four species, with only Panicum maximum having a negative response to light. In all of the abundant species, adding total species richness and ANPP to the model increased the amount of variance explained. The biomass of Eragrostis curvula and P. maximum were negatively correlated with species richness while three other abundant species increased with species richness, suggesting that competition and facilitation were active. Consistent with the results from the Park Grass and other long-term fertilization experiments of grasslands, we found a positive effect of soil pH and a negative effect of nitrogen amount on species richness, a more acutely negative effect on species richness of acidic ammonium sulphate fertilizer than limestone ammonium nitrate, a negative relationship between species richness and biomass, and a positive effect on species richness of lime interacting with nitrogen.	[Ward, David; Kirkman, Kevin; Tsvuura, Zivanai] Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa; [Ward, David] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	University of Kwazulu Natal; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Ward, D (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa.; Ward, D (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	dward21@kent.edu	Kirkman, Kevin P/F-4160-2010; Kirkman, Kevin/GNM-5334-2022; Tsvuura, Zivanai/X-3843-2019	Kirkman, Kevin P/0000-0001-9580-5191; Kirkman, Kevin/0000-0001-9580-5191; Tsvuura, Zivanai/0000-0003-1852-4737	Biotechnology and Biological Sciences Research Council [BBS/E/C/000J0300] Funding Source: researchfish; BBSRC [BBS/E/C/000J0300] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Acocks JPH, 1953, VELD TYPES OF SOUTH, V57; Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Akaike H., 1973, PROCEEDINGS OF THE S; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barnes GR, 1987, J GRASSLAND SOC SO A, V4, P63; Booysen P. de V., 1954, THESIS; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; BOSCH O J H, 1970, Proceedings Grassland Society of Southern Africa, V5, P69; Burnham K. P., 2002, MODEL SELECTION AND; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cashen Rose O., 1947, JOUR AGRIC SCI, V37, P1, DOI 10.1017/S0021859600012971; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2003, OIKOS, V100, P417, DOI 10.1034/j.1600-0706.2003.11697.x; Corp IBM, 2016, IBM SPSS STATISTICS; Craine JM, 2008, NEW PHYTOL, V179, P829, DOI 10.1111/j.1469-8137.2008.02513.x; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; DAVIES MS, 1976, HEREDITY, V36, P59, DOI 10.1038/hdy.1976.6; DODD M, 1995, J ECOL, V83, P277, DOI 10.2307/2261566; DODD ME, 1994, PHILOS T R SOC B, V346, P185, DOI 10.1098/rstb.1994.0140; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Foster BL, 2004, J ECOL, V92, P435, DOI 10.1111/j.0022-0477.2004.00882.x; Foster BL, 2001, ECOL LETT, V4, P530, DOI 10.1046/j.1461-0248.2001.00266.x; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; Freeland JR, 2010, J EVOLUTION BIOL, V23, P776, DOI 10.1111/j.1420-9101.2010.01947.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fynn R, 2011, J VEG SCI, V22, P528, DOI 10.1111/j.1654-1103.2011.01268.x; Fynn RWS, 2005, J VEG SCI, V16, P93, DOI 10.1111/j.1654-1103.2005.tb02342.x; Fynn RWS, 2005, J ECOL, V93, P384, DOI 10.1111/j.0022-0477.2005.00993.x; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; GOUGH L, 1994, OIKOS, V70, P271, DOI 10.2307/3545638; Gough L, 2012, OECOLOGIA, V169, P1053, DOI 10.1007/s00442-012-2264-5; Gould B, 2014, MOL ECOL, V23, P6058, DOI 10.1111/mec.12893; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Haney RL, 2008, RENEW AGR FOOD SYST, V23, P171, DOI 10.1017/S174217050800224X; Haney RL, 2010, COMMUN SOIL SCI PLAN, V41, P1493, DOI 10.1080/00103624.2010.482171; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; INOUYE RS, 1995, ECOLOGY, V76, P1872, DOI 10.2307/1940720; Institute of Soil Classification and Mapping (ISCM),, 1991, KARD SOIL SURV; JENKINSON DS, 1994, J AGR SCI-CAMBRIDGE, V122, P365, DOI 10.1017/S0021859600067290; Kardol P, 2013, OIKOS, V122, P84, DOI 10.1111/j.1600-0706.2012.20546.x; Keddy P, 2000, J ECOL, V88, P413, DOI 10.1046/j.1365-2745.2000.00456.x; Keddy P, 2002, J VEG SCI, V13, P5, DOI 10.1111/j.1654-1103.2002.tb02018.x; Kunin WE, 1998, P NATL ACAD SCI USA, V95, P207, DOI 10.1073/pnas.95.1.207; Lawes JB, 1882, PHILOS T R SOC LONDO, V173, P1181, DOI DOI 10.1098/RSTL.1882.0029; MacDougall AS, 2004, J ECOL, V92, P422, DOI 10.1111/j.0022-0477.2004.00886.x; MANNETJE L.'T., 1963, JOUR BRIT GRASSLAND SOC, V18, P268; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morris C., 2002, Rangelands, V24, P8; Morris C., 2001, B GRASSL SOC S AFR, V11, P7; Morris C. D., 1993, African Journal of Range and Forage Science, V10, P124, DOI 10.1080/10220119.1993.9638338; Mucina L, 2006, THE VEGETATION OF SO; Rajaniemi TK, 2003, OIKOS, V101, P449, DOI 10.1034/j.1600-0706.2003.12128.x; Rajaniemi TK, 2002, J ECOL, V90, P316, DOI 10.1046/j.1365-2745.2001.00662.x; Roux N. P. le, 1986, South African Journal of Plant and Soil, V3, P1; Safford HD, 2001, OIKOS, V95, P282, DOI 10.1034/j.1600-0706.2001.950210.x; SCHLUTER D, 1994, AM NAT, V143, P597, DOI 10.1086/285622; SCOTT J. D., 1956, South African Journal of Science, V52, P240; SEASTEDT TR, 1991, OECOLOGIA, V87, P72, DOI 10.1007/BF00323782; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; SILVERTOWN J, 1994, ECOLOGY, V75, P2430, DOI 10.2307/1940896; SILVERTOWN J, 1987, AM NAT, V130, P807, DOI 10.1086/284748; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Smit G. N., 1993, African Journal of Range and Forage Science, V10, P151, DOI 10.1080/10220119.1993.9638343; SNAYDON RW, 1982, EVOLUTION, V36, P289, DOI [10.2307/2408047, 10.1111/j.1558-5646.1982.tb05044.x]; SNAYDON RW, 1970, EVOLUTION, V24, P257, DOI [10.2307/2406802, 10.1111/j.1558-5646.1970.tb01759.x]; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; Stevens MHH, 2004, J ECOL, V92, P339, DOI 10.1111/j.0022-0477.2004.00866.x; Storkey J, 2015, NATURE, V528, P401, DOI 10.1038/nature16444; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tainton NM, 1976, COMMON VELD AND PAST; TILMAN D, 1994, LONG-TERM EXPERIMENTS IN AGRICULTURAL AND ECOLOGICAL SCIENCES, P287; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1991, ECOLOGY, V72, P1038, DOI 10.2307/1940604; Tilman David, 1993, P13; Tsvuura Z, 2013, AUSTRAL ECOL, V38, P959, DOI 10.1111/aec.12040; Tu YK, 2005, BRIT DENT J, V199, P457, DOI 10.1038/sj.bdj.4812743; Van Oudtshoorn F., 2012, GUIDE TO GRASSES OF; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Ward D, 2016, SOIL BIOLOGY BIOCHEM; WILSON SD, 1991, ECOLOGY, V72, P1050, DOI 10.2307/1940605; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	88	22	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177208	10.1371/journal.pone.0177208	http://dx.doi.org/10.1371/journal.pone.0177208			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493915	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300072
J	Zhu, Y; Hu, QM; Xu, WT; Li, HL; Guo, H; Meng, L; Wei, M; Lu, S; Shao, CW; Wang, N; Yang, GP; Chen, SL				Zhu, Ying; Hu, Qiaomu; Xu, Wenteng; Li, Hailong; Guo, Hua; Meng, Liang; Wei, Min; Lu, Sheng; Shao, Changwei; Wang, Na; Yang, Guanpin; Chen, Songlin			Identification and analysis of the beta-catenin1 gene in half-smooth tongue sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							BETA-CATENIN; EXPRESSION ANALYSIS; MOLECULAR CHARACTERIZATION; SEX; CLONING; DIFFERENTIATION; FIGLA; FISH; SPERMATOGENESIS; METHYLATION	beta-catenin is a key signalling molecule in the canonical Wnt pathway, which plays a role in cell adhesion, embryogenesis and sex determination. However, little is known about its function in teleosts. We cloned and characterized the full-length beta-catenin1 gene from halfsmooth tongue sole (Cynoglossus semilaevis), which was designated CS-beta-catenin1. The CS-beta-catenin1 cDNA consists of 2,346 nucleotides and encodes a protein with 782 amino acids. Although CS-beta-catenin1 was transcribed in the gonads of both sexes, the level was significantly higher in ovaries compared to testes. Furthermore, the mRNA level of CS-beta-catenin1 was significantly upregulated at 160 days and constantly increased until 2 years of age. In situ hybridization revealed that CS-beta-catenin1 mRNA was mainly localized in oocyte cells, especially in stage I, II and III oocytes. When CS-beta-catenin1 expression was inhibited by injection of quercetin in the ovaries, levels of CS-Figla and CS-foxl2 mRNA were significantly down-regulated, and CS-dmrt1 was up-regulated, which suggested that CS-beta-catenin1 is a potential upstream gene of CS-Figla and is involved in the development of the ovaries, i.e., folliculogenesis.	[Zhu, Ying; Lu, Sheng; Yang, Guanpin] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Zhu, Ying; Xu, Wenteng; Li, Hailong; Guo, Hua; Meng, Liang; Wei, Min; Lu, Sheng; Shao, Changwei; Wang, Na; Chen, Songlin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Hu, Qiaomu] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan, Hubei, Peoples R China; [Xu, Wenteng; Li, Hailong; Guo, Hua; Meng, Liang; Wei, Min; Shao, Changwei; Wang, Na; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Chen, SL (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.; Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.	chensl@ysfri.ac.cn	Xu, Wenteng/Q-1552-2018; Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203; Meng, Liang/0000-0003-2642-8446; guo, hua/0000-0002-0329-0088	National Nature Science Foundation of China [31130057, 31530078, 31402293, 31472269]; Taishan Scholar Climbing Project Fund of Shandong of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Climbing Project Fund of Shandong of China	This work was supported by grants from the National Nature Science Foundation of China (31130057,31530078,31402293,31472269), Taishan Scholar Climbing Project Fund of Shandong of China. Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2015C03YQ01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SM, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-89; Bernard P, 2012, ENDOCRINOLOGY, V153, P901, DOI 10.1210/en.2011-1347; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; Chen SL, 2007, MAR BIOTECHNOL, V9, P273, DOI 10.1007/s10126-006-6081-x; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Daugela L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044585; Dong XL, 2011, ACTA OCEANOL SIN, V30, P68, DOI 10.1007/s13131-011-0092-9; Gifford JAH, 2015, REPRODUCTION, V150, pR137, DOI 10.1530/REP-14-0685; Hu QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07167; Hu QM, 2014, AQUACULT INT, V22, P1437, DOI 10.1007/s10499-014-9757-7; Hu QM, 2013, COMP BIOCHEM PHYS B, V165, P181, DOI 10.1016/j.cbpb.2013.03.007; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kirikoshi H, 2001, INT J ONCOL, V19, P767; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Li HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28219; Li HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115917; Li ZJ, 2010, FISH SHELLFISH IMMUN, V29, P89, DOI 10.1016/j.fsi.2010.02.021; Liao XL, 2014, INT J MOL SCI, V15, P12952, DOI 10.3390/ijms150712952; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Liu JX, 2016, COMP BIOCHEM PHYS B, V198, P19, DOI 10.1016/j.cbpb.2016.03.006; Liu JX, 2016, COMP BIOCHEM PHYS B, V193, P1, DOI 10.1016/j.cbpb.2015.12.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miyake Y, 2012, ZOOL SCI, V29, P690, DOI 10.2108/zsj.29.690; Mork L, 2013, EVOL DEV, V15, P96, DOI 10.1111/ede.12020; Munroe DG, 1999, P NATL ACAD SCI USA, V96, P1569, DOI 10.1073/pnas.96.4.1569; Nicol B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131276; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Qiu YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123900; Ren JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep23968; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; de Mitcheson YS, 2008, FISH FISH, V9, P1, DOI 10.1111/j.1467-2979.2007.00266.x; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Shao CW, 2010, MICRON, V41, P47, DOI 10.1016/j.micron.2009.08.002; Shao CW, 2014, GENOME RES, V24, P604, DOI 10.1101/gr.162172.113; Sreenivasan R, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.110874; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wong KY, 2012, CARCINOGENESIS, V33, P1629, DOI 10.1093/carcin/bgs212; Wu GC, 2009, BIOL REPROD, V81, P1073, DOI 10.1095/biolreprod.109.077362; Wu LM, 2016, MOL CELL ENDOCRINOL, V427, P33, DOI 10.1016/j.mce.2016.03.002; Xu WT, 2016, GENE, V592, P215, DOI 10.1016/j.gene.2016.07.062; Xu WT, 2016, GENE, V582, P161, DOI 10.1016/j.gene.2016.02.010; Zhang LY, 2014, MAR GENOM, V18, P45, DOI 10.1016/j.margen.2014.04.004; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435	54	11	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176122	10.1371/journal.pone.0176122	http://dx.doi.org/10.1371/journal.pone.0176122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489928	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100015
J	Barrientos-Gutierrez, T; Zepeda-Tello, R; Rodrigues, ER; Colchero-Aragones, A; Rojas-Martinez, R; Lazcano-Ponce, E; Hernandez-Avila, M; Rivera-Dommarco, J; Meza, R				Barrientos-Gutierrez, Tonatiuh; Zepeda-Tello, Rodrigo; Rodrigues, Eliane R.; Colchero-Aragones, Arantxa; Rojas-Martinez, Rosalba; Lazcano-Ponce, Eduardo; Hernandez-Avila, Mauricio; Rivera-Dommarco, Juan; Meza, Rafael			Expected population weight and diabetes impact of the 1-peso-per-litre tax to sugar sweetened beverages in Mexico	PLOS ONE			English	Article							NUTRITION SURVEY 2012; NATIONAL-HEALTH; ENERGY-INTAKE; EXCISE TAX; OBESITY; OVERWEIGHT; METAANALYSIS; CONSUMPTION; PREVALENCE; ADULTS	Study question What effect on body mass index, obesity and diabetes can we expect from the 1-peso-per-litre tax to sugar sweetened beverages in Mexico? Methods Using recently published estimates of the reductions in beverage purchases due to the tax, we modelled its expected long-term impacts on body mass index (BMI), obesity and diabetes. Microsimulations based on a nationally representative dataset were used to estimate the impact of the tax on BMI and obesity. A Markov population model, built upon an age-period- cohort model of diabetes incidence, was used to estimate the impact on diagnosed diabetes in Mexico. To analyse the potential of tax increases we also modelled a 2-peso-per- litre tax scenario. Study answer and limitations Ten years after the implementation of the tax, we expect an average reduction of 0.15 kg/m(2) per person, which translates into a 2.54% reduction in obesity prevalence. People in the lowest level of socioeconomic status and those between 20 and 35 years of age showed the largest reductions in BMI and overweight and obesity prevalence. Simulations show that by 2030, under the current implementation of 1-peso-per-litre, the tax would prevent 86 to 134 thousand cases of diabetes. Overall, the 2-peso-per-litre scenario is expected to produce twice as much of a reduction. These estimates assume the tax effect on consumption remains stable over time. Sensitivity analyses were conducted to assess the robustness of findings; similar results were obtained with various parameter assumptions and alternative modelling approaches. What this study adds The sugar-sweetened beverages tax in Mexico is expected to produce sizable and sustained reductions in obesity and diabetes. Increasing the tax could produce larger benefits. While encouraging, estimates will need to be updated once data on direct changes in consumption becomes available.	[Barrientos-Gutierrez, Tonatiuh; Zepeda-Tello, Rodrigo; Rojas-Martinez, Rosalba; Lazcano-Ponce, Eduardo] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Rodrigues, Eliane R.] Univ Nacl Autonoma Mexico, Inst Matemat, Mexico City, DF, Mexico; [Colchero-Aragones, Arantxa] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Hernandez-Avila, Mauricio] Natl Inst Publ Hlth, Gen Direct, Cuernavaca, Morelos, Mexico; [Rivera-Dommarco, Juan] Natl Inst Publ Hlth, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Meza, Rafael] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; University of Michigan System; University of Michigan	Barrientos-Gutierrez, T (corresponding author), Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico.	tbarrientos@insp.mx		Barrientos-Gutierrez, Tonatiuh/0000-0002-0826-9106; Zepeda-Tello, Rodrigo/0000-0003-4471-5270; Rojas, Rosalba/0000-0003-4474-7926	Bloomberg Philanthropies; Michigan Centre for Diabetes Translational Research [P30DK092926]; National Institute of Public Health of Mexico; Harvard University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	Bloomberg Philanthropies; Michigan Centre for Diabetes Translational Research; National Institute of Public Health of Mexico; Harvard University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Bloomberg Philanthropies (https://www. bloomberg.org/), the Michigan Centre for Diabetes Translational Research (Grant P30DK092926 http://www.med.umich.edu/intmed/endocrinology/ research/mcdtr.htm) and the National Institute of Public Health of Mexico. In addition, Tonatiuh Barrientos-Gutierrez received support from Harvard University through the Lown Scholar's program (https://www.hsph.harvard.edu/ lownscholars/scholars/). The funders had no role in the study design or the analysis and interpretation of the data. All authors and their institutions reserve intellectual freedom from the funders .	Abdullah A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005629; Abdullah A, 2011, PUBLIC HEALTH NUTR, V14, P119, DOI 10.1017/S1368980010001813; Aburto TC, 2016, J NUTR; Aguilar S, 2012, CONCLUSIONES TOMA PO; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Arredondo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068443; Cervera SB, 2010, GAC MED MEX, V146, P397; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Barquera S, 2013, SALUD PUBLICA MEXICO, V55, pS151, DOI 10.21149/spm.v55s2.5111; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Briggs ADM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-860; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Chriqui JF, 2013, J PUBLIC HEALTH POL, V34, P403, DOI 10.1057/jphp.2013.17; Colchero MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163463; Consejo Nacional de Poblacion, 2016, DAT PROYECC; Ezzati M, 2004, COMP QUANTIFICATION; Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997; Gibbs BB, 2012, J ACAD NUTR DIET, V112, P1347, DOI 10.1016/j.jand.2012.06.012; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Huang TTK, 2015, LANCET, V385, P2422, DOI 10.1016/S0140-6736(14)61743-8; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Institute Metrics Evaluation for Health, 2013, GLOB BURD DIS COMP; Instituto Nacional de Salud Publica, 2012, ENCUESTA NACIONAL DE; Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007; Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004; Ma Y, 2016, LANCET DIABETES ENDO, V4, P105, DOI 10.1016/S2213-8587(15)00477-5; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Manyema M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105287; Sanchez-Romero LM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002158; Meza R, 2015, PREV MED, V81, P445, DOI 10.1016/j.ypmed.2015.10.015; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; OIE, 2015, OIE MAN DIAGN TESTS, P1; Organization W. H, 2009, 2008 2013 ACT PLAN G; Gutierrez JP, 2013, SALUD PUBLICA MEXICO, V55, pS341, DOI 10.21149/spm.v55s2.5133; R Core Team, 2018, R LANG ENV STAT COMP; Rivera-Dommarco JA, 2012, OBESIDAD MEXICO RECO; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; Sanchez-Pimienta TG, 2016, J NUTR, V146, P1888, DOI 10.3945/jn.115.220301; Secretaria de Salud, 2016, BAS DAT DEF; SOETAERT K, 2010, J STAT SOFTWARE, V33, P1; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Te Morenga L, 2013, BR MED J; The NS, 2013, DIABETES CARE, V36, P865, DOI 10.2337/dc12-0536; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Veerman JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151460	55	58	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176336	10.1371/journal.pone.0176336	http://dx.doi.org/10.1371/journal.pone.0176336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520716	gold, Green Submitted, Green Published			2022-12-27	WOS:000401487700015
J	Shen, JT; Li, XL; Li, YP; Wu, B				Shen, Jiantong; Li, Xianglian; Li, Youping; Wu, Bing			Comparative accuracy of CT perfusion in diagnosing acute ischemic stroke: A systematic review of 27 trials	PLOS ONE			English	Review							COMPUTED TOMOGRAPHIC PERFUSION; SOURCE IMAGES; ANGIOGRAPHY; DIFFUSION; BRAIN; EXPOSURE; ROW	Objective To systematically evaluate and compare the diagnostic accuracy of CT perfusion (CTP), non-enhanced computed tomography (NCCT) and computed tomography angiography (CTA) in detecting acute ischemic stroke. Methods We searched seven databases and screened the reference lists of the included studies. The risk of bias in the study quality was assessed using QUADASII. We produced paired forest plots in RevMan to show the variation of the sensitivity and specificity estimates together with their 95% CI. We used a hierarchical summary ROC model to summarize the sensitivity and specificity of CTP in detecting ischemic stroke. Results We identified 27 studies with a total of 2168 patients. The pooled sensitivity of CTP for acute ischemic stroke was 82% (95% CI 75-88%), and the specificity was 96% (95% CI 89-99%). CTP was more sensitive than NCCT and had a similar accuracy with CTA. There were no statistically significant differences in the sensitivity and specificity between patients who underwent CTP within 6 hours of symptom onset and beyond 6 hours after symptom onset. No adverse events were reported in the included studies. Conclusions CTP is more accurate than NCCT and has similar accuracy to CTA in detecting acute ischemic stroke. However, the evidence is not strong. There is potential benefit of using CTP to select stroke patients for treatment, but more high-quality evidence is needed to confirm this result.	[Shen, Jiantong; Li, Youping] Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Minist Hlth China, Chengdu, Peoples R China; [Shen, Jiantong; Li, Xianglian; Li, Youping] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu, Peoples R China; [Wu, Bing] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, YP (corresponding author), Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Minist Hlth China, Chengdu, Peoples R China.; Li, YP (corresponding author), Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu, Peoples R China.	lypgroup1@163.com			Chinese Ministry of Health [ZX0000026]	Chinese Ministry of Health	The study was funded by Chinese Ministry of Health (ZX0000026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels B, 2012, EUR RADIOL, V22, P2559, DOI 10.1007/s00330-012-2529-8; Alves JE, 2014, NEURORADIOL J, V27, P91, DOI 10.15274/NRJ-2014-10010; Biesbroek JM, 2013, CEREBROVASC DIS, V35, P493, DOI 10.1159/000350200; Campbell BCV, 2013, J NEUROL NEUROSUR PS, V84, P613, DOI 10.1136/jnnp-2012-303752; [陈婷 Chen Ting], 2012, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V28, P1290; Cohnen M, 2006, AM J NEURORADIOL, V27, P1741; Dai Feng, 2009, Chinese Journal of Medical Imaging Technology, V25, P1160; Diekmann S, 2010, AM J NEURORADIOL, V31, P1003, DOI 10.3174/ajnr.A1971; Eastwood JD, 2003, AM J NEURORADIOL, V24, P1869; Eckert B, 2011, NEURORADIOLOGY, V53, P79, DOI 10.1007/s00234-010-0702-9; Esteban JM, 2004, NEURORADIOLOGY, V46, P705, DOI 10.1007/s00234-004-1235-x; Fahmi F, 2012, AM J NEURORADIOL, V33, P2074, DOI 10.3174/ajnr.A3110; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Hana T, 2014, J MED INVESTIG, V61, P41, DOI 10.2152/jmi.61.41; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Hoeffner EG, 2004, RADIOLOGY, V231, P632, DOI 10.1148/radiol.2313021488; Huisa BN, 2014, J STROKE CEREBROVASC, V23, P114, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.020; Jain AR, 2013, AM J NEURORADIOL, V34, P1895, DOI 10.3174/ajnr.A3502; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kloska SP, 2004, RADIOLOGY, V233, P79, DOI 10.1148/radiol.2331030028; Koenig M, 1998, RADIOLOGY, V209, P85, DOI 10.1148/radiology.209.1.9769817; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618; Langer RD, 2007, AUSTRALAS RADIOL, V51, P532, DOI 10.1111/j.1440-1673.2007.01901.x; [冷振璞 Leng Zhenpu], 2003, [中华神经科杂志, Chinese Journal of Neurology], V36, P199; Lin K, 2009, CEREBROVASC DIS, V28, P72, DOI 10.1159/000219300; [刘银红 Liu Yinhong], 2005, [中华神经科杂志, Chinese Journal of Neurology], V38, P418; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macaskill P, 2010, COCHRANE HDB SYSTEMA, P1; Mnyusiwalla A, 2009, NEURORADIOLOGY, V51, P635, DOI 10.1007/s00234-009-0543-6; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pepper EM, 2006, J CLIN NEUROSCI, V13, P199, DOI 10.1016/j.jocn.2005.03.030; Rai AT, 2008, J EMERG MED, V35, P287, DOI 10.1016/j.jemermed.2007.08.071; Reichenbach JR, 1999, AM J NEURORADIOL, V20, P1842; Roberts HC, 2001, AM J NEURORADIOL, V22, P1077; Rother J, 2000, ARCH NEUROL-CHICAGO, V57, P1161, DOI 10.1001/archneur.57.8.1161; Sabarudin A, 2014, QUANT IMAGING MED SU, V4, P282, DOI 10.3978/j.issn.2223-4292.2014.07.10; Schramm P, 2004, STROKE, V35, P1652, DOI 10.1161/01.STR.0000131271.54098.22; Sillanpaa N, 2011, CEREBROVASC DIS EXTR, V1, P6, DOI 10.1159/000324324; Sporns P, 2016, CEREBROVASC DIS, V41, P242, DOI 10.1159/000443618; Suzuki Y, 2005, NEUROL MED-CHIR, V45, P333, DOI 10.2176/nmc.45.333; Tan JC, 2007, ANN NEUROL, V61, P533, DOI 10.1002/ana.21130; van der Hoeven EJRJ, 2015, STROKE, V46, P1113, DOI 10.1161/STROKEAHA.115.008718; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wintermark M, 2005, AM J NEURORADIOL, V26, P104; Yamauchi-Kawara C, 2010, BRIT J RADIOL, V83, P1029, DOI 10.1259/bjr/52267127; Youn SW, 2008, AM J ROENTGENOL, V191, pW120, DOI 10.2214/AJR.07.2519; Zebedin D, 2013, EUR J RADIOL, V82, P1059, DOI 10.1016/j.ejrad.2011.11.044; [朱建国 Zhu Jianguo], 2011, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V27, P710	50	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176622	10.1371/journal.pone.0176622	http://dx.doi.org/10.1371/journal.pone.0176622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520753	gold, Green Submitted, Green Published			2022-12-27	WOS:000401487700025
J	Niedermeier, M; Einwanger, J; Hartl, A; Kopp, M				Niedermeier, Martin; Einwanger, Jurgen; Hartl, Arnulf; Kopp, Martin			Affective responses in mountain hiking-A randomized crossover trial focusing on differences between indoor and outdoor activity	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXERCISE; PLEASURE; WALKING; HEALTH; METAANALYSIS; DISPLEASURE; INTENSITIES; INTENTIONS; RATIONALE	Introduction Affective responses during physical activity (PA) are important for engagement in PA programs and for adherence to a physically active lifestyle. Little is known about the affective responses to PA bouts lasting longer than 45 minutes. Therefore, the aims of the present study were to analyse acute effects on affective responses of a three-hour outdoor PA intervention (mountain hiking) compared to a sedentary control situation and to an indoor treadmill condition. Methods Using a randomized crossover design, 42 healthy participants were randomly exposed to three different conditions: outdoor mountain hiking, indoor treadmill walking, and sedentary control situation (approximately three hours each). Measures included the Feeling Scale, Felt Arousal Scale and a Mood Survey Scale. Repeated measures ANOVAs were used to analyse differences between the conditions. Results Compared to the control situation, the participants showed a significant increase in affective valence (d = 1.21, p<.001), activation (d = 0.81, p = .004), elation (d = 1.07, p < .001), and calmness (d = 0.84, p = .004), and a significant decrease in fatigue (d = -1.19, p < .001) and anxiety (d = -.79, p < .001) after mountain hiking. Outdoor mountain hiking showed significantly greater positive effects on affective valence, activation, and fatigue compared to indoor treadmill walking. Discussion The results indicate that a three-hour PA intervention (mountain hiking) elicits higher positive and lower negative affective responses compared to a sedentary control situation and to an indoor PA condition. Outdoor mountain hiking can be recommended by health professionals as a form of PA with the potential to positively influence affective responses.	[Niedermeier, Martin; Kopp, Martin] Univ Innsbruck, Dept Sport Sci, Innsbruck, Austria; [Einwanger, Jurgen] Austrian Alpine Assoc, Innsbruck, Austria; [Hartl, Arnulf] Paracelsus Med Univ, Inst Ecomed, Salzburg, Austria	University of Innsbruck; Paracelsus Private Medical University	Niedermeier, M (corresponding author), Univ Innsbruck, Dept Sport Sci, Innsbruck, Austria.	martin.niedermeier@uibk.ac.at	Niedermeier, Martin/J-4515-2019; Kopp, Martin/K-1369-2017	Niedermeier, Martin/0000-0001-7571-4962; Hartl, Arnulf/0000-0001-9626-6425; Kopp, Martin/0000-0002-3011-387X	Austrian Alpine Association; Generali Insurance Company	Austrian Alpine Association; Generali Insurance Company	This project was supported by a grant of the Austrian Alpine Association (www.alpenverein.at) supported by the Generali Insurance Company (https://www.generali.at).	Abele-Brehm A., 1986, DIAGNOSTICA, V32, P209; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Berto R, 2014, BEHAV SCI, V4, P394, DOI 10.3390/bs4040394; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coon JT, 2011, ENVIRON SCI TECHNOL, V45, P1761, DOI 10.1021/es102947t; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Ekkekakis P, 2004, PREV MED, V38, P149, DOI 10.1016/j.ypmed.2003.09.038; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2000, J BEHAV MED, V23, P245, DOI 10.1023/A:1005558025163; Ekkekakis P, 1999, SPORTS MED, V28, P337, DOI 10.2165/00007256-199928050-00005; Ekkekakis P, 2008, PSYCHOL SPORT EXERC, V9, P246, DOI 10.1016/j.psychsport.2007.04.004; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Ekkekakis P, 2010, OBESITY, V18, P79, DOI 10.1038/oby.2009.204; Ensari I, 2015, DEPRESS ANXIETY, V32, P624, DOI 10.1002/da.22370; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Focht BC, 2009, RES Q EXERCISE SPORT, V80, P611; Fruhauf A, 2016, MENT HEALTH PHYS ACT, V10, P4, DOI 10.1016/j.mhpa.2016.02.002; Gollwitzer P.M., 1996, PSYCHOL ACTION LINKI, V13, P287; Hall EE, 2002, BRIT J HEALTH PSYCH, V7, P47, DOI 10.1348/135910702169358; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Kahneman D., 1999, WELL BEING FDN HEDON, P3, DOI DOI 10.7758/9781610443258; Kopp M, 2012, DIABETES RES CLIN PR, V95, P25, DOI 10.1016/j.diabres.2011.09.017; Kwan BM, 2010, BRIT J HEALTH PSYCH, V15, P115, DOI 10.1348/135910709X433267; Laux L., 1981, STATE TRAIT ANGSTINV; Ledochowski L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119278; Mackay GJ, 2010, PSYCHOL SPORT EXERC, V11, P238, DOI 10.1016/j.psychsport.2010.01.002; McMahan EA, 2015, J POSIT PSYCHOL, V9760, P1, DOI DOI 10.1080/17439760.2014.994224; McNair D., 1971, MANUAL PROFILE MOOD; Noble BJ, 1996, PERCEIVED EXERTION H; Petruzzello SJ, 2001, PSYCHOL SPORT EXERC, V2, P1; Pretty J, 2007, J ENVIRON PLANN MAN, V50, P211, DOI 10.1080/09640560601156466; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Rhodes RE, 2015, ANN BEHAV MED, V49, P715, DOI 10.1007/s12160-015-9704-5; Rogerson M, 2016, PERSPECT PUBLIC HEAL, V136, P171, DOI 10.1177/1757913915589845; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Schober E, 2007, EUR J PEDIATR, V166, P709, DOI 10.1007/s00431-006-0312-z; Schobersberger W, 2010, SLEEP BREATH, V14, P201, DOI 10.1007/s11325-009-0286-y; SHEPHARD RJ, 1991, SPORTS MED, V11, P358, DOI 10.2165/00007256-199111060-00002; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sturm J, 2012, ACTA PSYCHIAT SCAND, V126, P467, DOI 10.1111/j.1600-0447.2012.01860.x; Sudeck G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00900; SVEBAK S, 1985, J PERS SOC PSYCHOL, V48, P107, DOI 10.1037/0022-3514.48.1.107; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tuso Phillip, 2015, Perm J, V19, P84, DOI 10.7812/TPP/14-242; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Van Landuyt LM, 2000, J SPORT EXERCISE PSY, V22, P208, DOI 10.1123/jsep.22.3.208; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; Woo M, 2009, INT J PSYCHOPHYSIOL, V72, P166, DOI 10.1016/j.ijpsycho.2008.12.003	56	48	49	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177719	10.1371/journal.pone.0177719	http://dx.doi.org/10.1371/journal.pone.0177719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520774	Green Published, Green Submitted, gold			2022-12-27	WOS:000401485500062
J	Gareb, B; van Bakelen, NB; Buijs, GJ; Jansma, J; de Visscher, JGAM; Hoppenreijs, TJM; Bergsma, JE; van Minnen, B; Stegenga, B; Bos, RRM				Gareb, B.; van Bakelen, N. B.; Buijs, G. J.; Jansma, J.; de Visscher, J. G. A. M.; Hoppenreijs, Th. J. M.; Bergsma, J. E.; van Minnen, B.; Stegenga, B.; Bos, R. R. M.			Comparison of the long-term clinical performance of a biodegradable and a titanium fixation system in maxillofacial surgery: A multicenter randomized controlled trial	PLOS ONE			English	Article							POLY(L-LACTIDE) BONE PLATES; ORTHOGNATHIC SURGERY; MANDIBULAR FRACTURES; IN-VITRO; REMOVAL; DEVICES; SCREWS; OSTEOSYNTHESIS; COMPLICATIONS; DEGRADATION	Background Biodegradable fixation systems could reduce or eliminate problems associated with titanium removal of implants in a second operation. Aim The aim of this study was to compare the long-term (i.e. >5 years postoperatively) clinical performance of a titanium and a biodegradable system in oral and maxillofacial surgery. Materials and methods The present multicenter Randomized Controlled Trial (RCT) was performed in four hospitals in the Netherlands. Patients treated with a bilateral sagittal split osteotomy (BSSO) and/or a Le Fort-I osteotomy, and those treated for fractures of the mandible, maxilla, or zygoma were included from December 2006 to July 2009. The patients were randomly assigned to either a titanium (KLS Martin) or a biodegradable group (Inion CPS). Results After >5 years postoperatively, plate removal was performed in 22 of the 134 (16.4%) patients treated with titanium and in 23 of the 87 (26.4%) patients treated with the biodegradable system (P = 0.036, hazard ratio (HR) biodegradable (95% CI) = 2.0 (1.05-3.8), HR titanium = 1). Occlusion, VAS pain scores, and MFIQ showed good and (almost) pain free mandibular function in both groups. Conclusion In conclusion, the performance of the Inion CPS biodegradable system was inferior compared to the KLS Martin titanium system regarding plate/screws removal in the abovementioned surgical procedures.	[Gareb, B.; van Bakelen, N. B.; Buijs, G. J.; Jansma, J.; van Minnen, B.; Stegenga, B.; Bos, R. R. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [de Visscher, J. G. A. M.] Med Ctr Leeuwarden, Dept Oral & Maxillofacial Surg, Leeuwarden, Netherlands; [Hoppenreijs, Th. J. M.] Rijnstate Hosp Arnhem, Dept Oral & Maxillofacial Surg, Arnhem, Netherlands; [Bergsma, J. E.] Amphia Hosp Breda, Dept Oral & Maxillofacial Surg, Breda, Netherlands; [Stegenga, B.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral Hlth Care & Clin Epidemiol, UMCG Ctr Dent & Oral Hyg, Groningen, Netherlands	University of Groningen; Medical Center Leeuwarden; Rijnstate Hospital; Amphia Hospital; University of Groningen	Gareb, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands.	b.gareb@umcg.nl	Gareb, Barzi/AAK-5393-2020; Bergsma, je/AAE-9107-2021	Gareb, Barzi/0000-0003-3534-9176; 				Al-Moraissi EA, 2015, J ORAL MAXIL SURG, V73, P1795, DOI 10.1016/j.joms.2015.01.035; Bakathir AA, 2008, ORAL SURG ORAL MED O, V105, pE32, DOI 10.1016/j.tripleo.2008.01.006; BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8; BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D; Bhatt K, 2010, J ORAL MAXIL SURG, V68, P1842, DOI 10.1016/j.joms.2009.09.005; Bhatt V, 2005, J ORAL MAXIL SURG, V63, P756, DOI 10.1016/j.joms.2005.02.005; Bostman OM, 2000, CLIN ORTHOP RELAT R, P216; Buijs GJ, 2006, J DENT RES, V85, P980, DOI 10.1177/154405910608501102; Buijs GJ, 2012, J DENT RES, V91, P299, DOI 10.1177/0022034511434353; Cheung LK, 2004, ORAL SURG ORAL MED O, V98, P386, DOI 10.1016/j.tripleo.2004.02.069; Cordewener FW, 2000, TISSUE ENG, V6, P413, DOI 10.1089/107632700418119; Falter B, 2011, ORAL SURG ORAL MED O, V112, P737, DOI 10.1016/j.tripleo.2011.01.011; Ferretti C, 2008, INT J ORAL MAX SURG, V37, P242, DOI 10.1016/j.ijom.2007.11.015; GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F; Jeon HB, 2016, ARCH PLAST SURG-APS, V43, P40, DOI 10.5999/aps.2016.43.1.40; Kallela L, 2005, ORAL SURG ORAL MED O, V99, P4, DOI 10.1016/j.tripleo.2004.04.017; Kuhlefelt M, 2010, INT J ORAL MAX SURG, V39, P430, DOI 10.1016/j.ijom.2010.01.016; Laine P, 2004, INT J ORAL MAX SURG, V33, P240, DOI 10.1006/ijom.2003.0510; Landes CA, 2006, CLEFT PALATE-CRAN J, V43, P67, DOI 10.1597/04-167R1.1; Lee HB, 2010, J ORAL MAXIL SURG, V68, P2065, DOI 10.1016/j.joms.2009.08.004; Matthew IR, 1999, BRIT J ORAL MAX SURG, V37, P110, DOI 10.1054/bjom.1997.0084; Mazzonetto R, 2004, INT J ORAL MAX SURG, V33, P664, DOI 10.1016/j.ijom.2004.02.001; Nieminen T, 2008, J MATER SCI-MATER M, V19, P1155, DOI 10.1007/s10856-007-3082-x; Raja DR M M, 2013, INT J DENT SCI RES, V1, P60; Rosa JH, 2016, CRANIOMAX TRAUM REC, V9, P134, DOI 10.1055/s-0035-1570074; Stegenga Boudewijn, 1993, Journal of Orofacial Pain, V7, P183; Suuronen R, 1998, J ORAL MAXIL SURG, V56, P604, DOI 10.1016/S0278-2391(98)90461-X; Tuovinen V, 2010, INT J ORAL MAX SURG, V39, P1059, DOI 10.1016/j.ijom.2010.07.012; van Bakelen NB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130330; van Bakelen NB, 2014, J CRANIO MAXILL SURG, V42, P417, DOI 10.1016/j.jcms.2013.05.032; van Bakelen NB, 2013, J DENT RES, V92, P1100, DOI 10.1177/0022034513508953; Yang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067449	32	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177152	10.1371/journal.pone.0177152	http://dx.doi.org/10.1371/journal.pone.0177152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493922	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300065
J	Han, CX; Li, F; Ma, J; Liu, Y; Li, WH; Mao, YQ; Song, YH; Guo, SY; Liu, J				Han, Chenxia; Li, Feng; Ma, Jie; Liu, Yan; Li, Weihong; Mao, Yingqiu; Song, Yuehan; Guo, Siyuan; Liu, Jing			Distinct behavioral and brain changes after different durations of the modified multiple platform method on rats: An animal model of central fatigue	PLOS ONE			English	Article							PARADOXICAL SLEEP-DEPRIVATION; ANXIETY-LIKE BEHAVIOR; LONG-TERM-MEMORY; NMDA RECEPTOR; PLUS-MAZE; HIPPOCAMPUS; MICE; CORTICOSTERONE; DEPRESSION; INTERFERENCE	The modified multiple platform method (MMPM) is a classical sleep deprivation model. It has been widely used in behavioral and brain research, due to its effects on physical and mental functions. However, different MMPM protocols can promote distinct effects in rats. Although the MMPM has been proved to induce central fatigue, the effects of different durations of subjection to the MMPM remain undetermined. This study aims to investigate the changes in behavior, N-Methyl-d-Aspartate receptor 1 (NR1) and 2A (NR2A), as well as the ultrastructural alteration in the hippocampus after different MMPM modelling, to compare the central fatigue effect induced by dynamic MMPM. Rats were randomly divided into four groups: 5-, 14- and 21-day MMPM groups, and a control group. Each MMPM group underwent a 14- hour daily MMPM modelling. After each training session, open field and elevated plus maze tests were performed. Corticosterone levels were detected by ELISA, and the hippocampal NR1 and NR2A were measured by RT-PCR and Western blot analysis. In addition, ultrastructural changes in the hippocampal cornu ammonis 1(CA1) region were determined by transmission electron microscopy (TEM). The findings showed that the 5 and 14 days of MMPM induced a high-stress state, while the 21 days of MMPM induced anxiety and degenerative alteration in the hippocampal morphology. Additionally, hippocampal NR1 and NR2A gene expression decreased in all MMPM groups, whereas the protein expression only decreased in the 21-day group. Overall, different durations of MMPM caused distinct behavioral and brain changes, and the 21 days of MMPM could induce central fatigue.	[Han, Chenxia; Li, Feng; Ma, Jie; Liu, Yan; Li, Weihong; Song, Yuehan; Guo, Siyuan; Liu, Jing] Beijing Univ Chinese Med, Basic Med Sch, Beijing, Peoples R China; [Mao, Yingqiu] Beijing Univ Chinese Med, Sci Res Ctr Chinese Med, Beijing, Peoples R China; [Guo, Siyuan] Xuanwu Hosp, Directors Off, Beijing, Peoples R China; [Liu, Jing] Xinyuanjinfang Tradit Chinese Med Hosp, Tradit Chinese Med Dept, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Capital Medical University	Li, F (corresponding author), Beijing Univ Chinese Med, Basic Med Sch, Beijing, Peoples R China.	lifeng_bucm0610@126.com	HAN, CHENXIA/AAR-1919-2021	HAN, CHENXIA/0000-0003-1727-7236	Beijing University of Chinese Medicine: ''Nautical Traditional Chinese Medicine'' Collaborative Innovation Center [522/0100604299]; Beijing Natural Science Foundation: ''Mechanism research of intervention effect of ''Sini-Suanzaoren'' [7162124]	Beijing University of Chinese Medicine: ''Nautical Traditional Chinese Medicine'' Collaborative Innovation Center; Beijing Natural Science Foundation: ''Mechanism research of intervention effect of ''Sini-Suanzaoren''	This work was supported by Beijing Natural Science Foundation: "Mechanism research of intervention effect of "Sini-Suanzaoren" for PSY-I based on GABA equilibrium mechanism" (No.7162124), and the Collaborative Innovation Project of the Beijing University of Chinese Medicine: "Nautical Traditional Chinese Medicine" Collaborative Innovation Center (No. 522/0100604299).; This work was supported by Beijing Natural Science Foundation: ''Mechanism research of intervention effect of ''Sini-Suanzaoren'' for PSY-I based on GABA equilibrium mechanism'' (No. 7162124), and the Collaborative Innovation Project of the Beijing University of Chinese Medicine: ''Nautical Traditional Chinese Medicine'' Collaborative Innovation Center (No. 522/0100604299).	Alzoubi KH, 2013, HIPPOCAMPUS, V23, P812, DOI 10.1002/hipo.22135; Arai M, 2002, PROG NEURO-PSYCHOPH, V26, P307, DOI 10.1016/S0278-5846(01)00272-X; Armani F, 2012, CNS NEUROSCI THER, V18, P119, DOI 10.1111/j.1755-5949.2010.00224.x; Buccafusco Jerry J, 2009, METHODS BEHAV ANAL N; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chen WZ, 2015, BIOL PHARM BULL, V38, P239, DOI 10.1248/bpb.b14-00599; Cirelli C, 2006, SLEEP MED REV, V10, P307, DOI 10.1016/j.smrv.2006.04.001; Dalsgaard MK, 2007, J NEUROSCI RES, V85, P3334, DOI 10.1002/jnr.21274; Fan Xin-liu, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P512; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Fraser LM, 2010, PSYCHOPHARMACOLOGY, V211, P99, DOI 10.1007/s00213-010-1873-0; Hovens IB, 2013, EXP GERONTOL, V48, P1204, DOI 10.1016/j.exger.2013.07.011; Jia M, 2015, J PSYCHIATR RES, V60, P29, DOI 10.1016/j.jpsychires.2014.09.020; Jinnah H. A, 2005, ASSESSMENT MOVEMENT; Joel D, 2006, PROG NEURO-PSYCHOPH, V30, P374, DOI 10.1016/j.pnpbp.2005.11.006; Krzystanek M, 2015, PHARMACOL REP, V67, P965, DOI 10.1016/j.pharep.2015.01.017; LANCEL M, 1989, PHYSIOL BEHAV, V45, P289, DOI 10.1016/0031-9384(89)90130-3; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; Li SX, 2014, NEUROBIOL DIS, V62, P124, DOI 10.1016/j.nbd.2013.09.004; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019; MILLER NE, 1982, NEUROBIOL AGING, V3, P283, DOI 10.1016/0197-4580(82)90016-1; Mohammed HS, 2011, BEHAV BRAIN RES, V225, P39, DOI 10.1016/j.bbr.2011.06.018; Moreira KM, 2010, SLEEP, V33, P990, DOI 10.1093/sleep/33.7.990; Neckelmann D, 2007, SLEEP, V30, P873, DOI 10.1093/sleep/30.7.873; Newsholme EA, 2006, J NUTR, V136, p274S, DOI 10.1093/jn/136.1.274S; Patti CL, 2010, SLEEP, V33, P1669, DOI 10.1093/sleep/33.12.1669; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PIAZZA PV, 1993, P NATL ACAD SCI USA, V90, P11738, DOI 10.1073/pnas.90.24.11738; Pires GN, 2013, PROG NEURO-PSYCHOPH, V41, P6, DOI 10.1016/j.pnpbp.2012.11.006; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ravassard P, 2016, CEREB CORTEX, V26, P1488, DOI 10.1093/cercor/bhu310; Roullet P, 2001, J NEUROSCI, V21, P2143, DOI 10.1523/JNEUROSCI.21-06-02143.2001; Sagaspe P, 2006, BRAIN COGNITION, V60, P76, DOI 10.1016/j.bandc.2005.10.001; Suchecki D, 1998, J SLEEP RES, V7, P276, DOI 10.1046/j.1365-2869.1998.00122.x; Sun HL, 2013, BEHAV BRAIN RES, V257, P1, DOI 10.1016/j.bbr.2013.08.044; Tang XD, 2007, BEHAV BRAIN RES, V180, P62, DOI 10.1016/j.bbr.2007.02.022; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wang HY, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-3; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Yamamoto T, 2005, FATIGUE SCI, V204, P35; Yamashita M., 2013, JAPAN J COGN NEUROSC, V15, P67, DOI 10.11253/ninchishinkeikagaku.15.67; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; Zagaar M, 2013, SLEEP, V36, P751, DOI 10.5665/sleep.2642	49	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176850	10.1371/journal.pone.0176850	http://dx.doi.org/10.1371/journal.pone.0176850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493899	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300033
J	Le Blond, JS; Baxter, PJ; Bello, D; Raftis, J; Molla, YB; Cuadros, J; Davey, G				Le Blond, Jennifer S.; Baxter, Peter J.; Bello, Dhimiter; Raftis, Jennifer; Molla, Yordanos B.; Cuadros, Javier; Davey, Gail			Haemolytic activity of soil from areas of varying podoconiosis endemicity in Ethiopia	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASE; IN-VITRO; VOLCANIC ASH; ENGINEERED NANOMATERIALS; OXIDE NANOPARTICLES; LUNG INFLAMMATION; SURFACE-CHARGE; LOWER LEGS; ELEPHANTIASIS; QUARTZ	Background Podoconiosis, non-filarial elephantiasis, is a non-infectious disease found in tropical regions such as Ethiopia, localized in highland areas with volcanic soils cultivated by barefoot subsistence farmers. It is thought that soil particles can pass through the soles of the feet and taken up by the lymphatic system, leading to the characteristic chronic oedema of the lower legs that becomes disfiguring and disabling over time. Methods The close association of the disease with volcanic soils led us to investigate the characteristics of soil samples in an endemic area in Ethiopia to identify the potential causal constituents. We used the in vitro haemolysis assay and compared haemolytic activity (HA) with soil samples collected in a non-endemic region of the same area in Ethiopia. We included soil samples that had been previously characterized, in addition we present other data describing the characteristics of the soil and include pure phase mineral standards as comparisons. Results The bulk chemical composition of the soils were statistically significantly different between the podoconiosis-endemic and non-endemic areas, with the exception of CaO and Cr. Likewise, the soil mineralogy was statistically significant for iron oxide, feldspars, mica and chlorite. Smectite and kaolinite clays were widely present and elicited a strong HA, as did quartz, in comparison to other mineral phases tested, although no strong difference was found in HA between soils from the two areas. The relationship was further investigated with principle component analysis (PCA), which showed that a combination of an increase in Y, Zr and Al2O3, and a concurrent increase Fe2O3, TiO2, MnO and Ba in the soils increased HA. Conclusion The mineralogy and chemistry of the soils influenced the HA, although the interplay between the components is complex. Further research should consider the variable biopersistance, hygroscopicity and hardness of the minerals and further characterize the nano-scale particles.	[Le Blond, Jennifer S.] Imperial Coll London, Dept Earth Sci, London, England; [Le Blond, Jennifer S.] Nat Hist Museum, Core Res Labs, London, England; [Baxter, Peter J.] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Bello, Dhimiter] Univ Massachusetts Lowell, Dept Work Environm, Lowell, MA USA; [Raftis, Jennifer] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Molla, Yordanos B.] Addis Ababa Univ, Dept Earth Sci, Addis Ababa, Ethiopia; [Molla, Yordanos B.; Davey, Gail] Univ Sussex, Brighton & Sussex Med Sch, Wellcome Trust Ctr Global Hlth Res, Brighton, E Sussex, England; [Cuadros, Javier] Nat Hist Museum, Dept Earth Sci, London, England	Imperial College London; Natural History Museum London; University of Cambridge; University of Massachusetts System; University of Massachusetts Lowell; University of Edinburgh; Addis Ababa University; University of Brighton; University of Sussex; Natural History Museum London	Le Blond, JS (corresponding author), Imperial Coll London, Dept Earth Sci, London, England.; Le Blond, JS (corresponding author), Nat Hist Museum, Core Res Labs, London, England.	j.le-blond@imperial.ac.uk		Le Blond, Jennifer/0000-0002-1529-9215	Wellcome Trust [WT091956MA]; Junior Research Fellowship held at Imperial College London	Wellcome Trust(Wellcome TrustEuropean Commission); Junior Research Fellowship held at Imperial College London	JSL holds a Junior Research Fellowship held at Imperial College London (www.imperial.ac.uk). GD acquired a Wellcome Trust Enhancement Award (WT091956MA) (https://wellcome.ac.uk/). The above funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Wellcome Trust Enhancement Award (WT091956MA; GD), and a Junior Research Fellowship (JL). The authors acknowledge Chris Rolfe in the Geography Department at the University of Cambridge for access to the Malvern Mastersizer laser diffractometer and Dr Emma Humphreys-Williams in the Imaging and Analysis Centre at the NHM for assistance with the ICP-AES.	ADAMIS Z, 1991, ANN OCCUP HYG, V35, P469, DOI 10.1093/annhyg/35.5.469; Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; BATES CD, 1978, NEW PHYTOL, V81, P459, DOI 10.1111/j.1469-8137.1978.tb02651.x; Baxter PJ, 2014, GEOL SOC MEM, V39, P407, DOI 10.1144/M39.22; Chakhmouradian AR, 2012, RARE EARTH ELEMENTS; Cho WS, 2014, NANOTOXICOLOGY, V8, P202, DOI 10.3109/17435390.2013.773465; Cho WS, 2012, TOXICOL SCI, V126, P469, DOI 10.1093/toxsci/kfs006; Choi J, 2011, TOXICOL SCI, V123, P133, DOI 10.1093/toxsci/kfr149; Clouter A, 2001, TOXICOL SCI, V63, P90, DOI 10.1093/toxsci/63.1.90; Daniel H, 1980, VITRO EFFECTS MINERA, P33; Davey G, 2007, LANCET, V369, P888, DOI 10.1016/S0140-6736(07)60425-5; Deribe K, 2013, PLOS NTD; Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Doshi N, 2010, J R SOC INTERFACE, V7, pS403, DOI 10.1098/rsif.2010.0134.focus; Eberl D. D., 1996, US GEOLOGICAL SURVEY, V96, P171; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; Ferguson JS, 2013, BRIT J DERMATOL, V168, P550, DOI 10.1111/bjd.12134; Ferrell RE., 2010, INTERSTRATIFIED CLAY, P175; Filon FL, 2015, REGUL TOXICOL PHARM, V72, P310, DOI 10.1016/j.yrtph.2015.05.005; Filon FL, 2013, TOXICOL IN VITRO, V27, P121, DOI 10.1016/j.tiv.2012.09.007; Filon FL, 2011, NANOTOXICOLOGY, V5, P493, DOI 10.3109/17435390.2010.551428; FROMMEL D, 1993, TROP GEOGR MED, V45, P165; Fubini B, 1998, ANN OCCUP HYG, V42, P521, DOI 10.1093/annhyg/42.8.521; Fubini B, 1997, ENVIRON HEALTH PERSP, V105, P1013, DOI 10.2307/3433502; Gao N., 2002, ANN OCCUP HYG, V46, P50; Greg S.J., 1982, ADSORPTION SURFACE A; Guthrie GD, 1997, ENVIRON HEALTH PERSP, V105, P1003, DOI 10.2307/3433501; HARLEY JD, 1961, NATURE, V189, P1010, DOI 10.1038/1891010a0; He XX, 2010, TRENDS MOL MED, V16, P574, DOI 10.1016/j.molmed.2010.08.006; HEATHER CJ, 1972, T ROY SOC TROP MED H, V66, P450, DOI 10.1016/0035-9203(72)90276-3; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Hsieh SF, 2013, SMALL, V9, P1853, DOI 10.1002/smll.201201995; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Jonasz M., 1991, PRINCIPLES METHODS A, P143, DOI DOI 10.1017/CBO9780511626142.014; Kaya A, 2005, CAN GEOTECH J, V42, P1280, DOI [10.1139/t05-048, 10.1139/T05-048]; KLOOS H, 1992, TROP DOCT, V22, P109, DOI 10.1177/004947559202200306; Kynicky J, 2012, DIVERSITY RARE EARTH; Labouta H., 2013, NANOMEDICINE, V9, P49; Lademann J., 2009, J BIOMED OPT, V14; Larese FF, 2009, TOXICOLOGY, V255, P33, DOI 10.1016/j.tox.2008.09.025; Le Blond JS, 2015, AM MINERAL, V100, P2518, DOI 10.2138/am-2015-5168CCBY; LIGHT WG, 1977, ENVIRON RES, V13, P135, DOI 10.1016/0013-9351(77)90012-3; Lordan S, 2011, J APPL TOXICOL, V31, P27, DOI 10.1002/jat.1564; Lu SL, 2009, ENVIRON HEALTH PERSP, V117, P241, DOI 10.1289/ehp.11811; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; MACNAB G, 1967, NATURE, V214, P522, DOI 10.1038/214522a0; MATSUZAWA T, 1979, LAB ANIM, V13, P329, DOI 10.1258/002367779780943297; McPherson T, 2006, BRIT J DERMATOL, V154, P933, DOI 10.1111/j.1365-2133.2005.07081.x; Michel C, 2013, PLOS ONE, V9; Molla YB, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-24; Molla YB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002554; Monteiro-Riviere NA, 2012, ADVERSE EFFECTS OF ENGINEERED NANOMATERIALS: EXPOSURE, TOXICOLOGY, AND IMPACT ON HUMAN HEALTH, P185, DOI 10.1016/B978-0-12-386940-1.00011-8; Murad E, 1999, CLAY MINER, V34, P479, DOI 10.1180/000985599546389; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2009, NAT MATER, P8; Nenoff P, 2010, J DTSCH DERMATOL GES, V8, P7, DOI [10.1111/j.1610-0387.2009.07099_supp.x, 10.1111/j.1610-0387.2009.07099.x]; Nolan R. P., 1985, VITRO EFFECTS MINERA, P39; Olphen H. van, 1987, Monograph, Mineralogical Society, P203; OSCARSON DW, 1986, CLAY CLAY MINER, V34, P74, DOI 10.1346/CCMN.1986.0340109; Pal AK, 2015, NANOTOXICOLOGY, V9, P871, DOI 10.3109/17435390.2014.986670; Pal AK, 2014, ACS NANO, V8, P9003, DOI 10.1021/nn502219q; Pan Z, 2009, SMALL, V5, P511, DOI 10.1002/smll.200800798; Pavan C, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0076-y; Pavan C, 2013, CHEM RES TOXICOL, V26, P1188, DOI 10.1021/tx400105f; PRICE EW, 1978, T ROY SOC TROP MED H, V72, P132, DOI 10.1016/0035-9203(78)90048-2; PRICE EW, 1976, T ROY SOC TROP MED H, V70, P288, DOI 10.1016/0035-9203(76)90078-X; Price EW, 1990, PODOCONIOSIS NONFILA; Rushton EK, 2010, J TOXICOL ENV HEAL A, V73, P445, DOI 10.1080/15287390903489422; Schwarze PE, 2007, INHAL TOXICOL, V19, P17, DOI 10.1080/08958370701490445; STALDER K, 1965, NATURE, V207, P875; Towett Erick K., 2015, Geoderma Regional, V5, P157, DOI 10.1016/j.geodrs.2015.06.002; VALLYATHAN V, 1983, ENVIRON RES, V30, P349, DOI 10.1016/0013-9351(83)90220-7; Vallyathan V., 1995, ENVIRON HEALTH PERSP, V02, p111 ; WIESSNER JH, 1989, EXP LUNG RES, V15, P801, DOI 10.3109/01902148909069627; Wilson MR, 2000, OCCUP ENVIRON MED, V57, P727, DOI 10.1136/oem.57.11.727; WOODWORTH CD, 1982, ENVIRON RES, V27, P190, DOI 10.1016/0013-9351(82)90070-6; Woollard KJ, 2009, J BIOL CHEM, V284, P13110, DOI 10.1074/jbc.M809095200; Zeng ZY, 2012, J AM CHEM SOC, V134, P2681, DOI 10.1021/ja209959t; Zook JM, 2011, NANOTOXICOLOGY, V5, P517, DOI 10.3109/17435390.2010.536615	80	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177219	10.1371/journal.pone.0177219	http://dx.doi.org/10.1371/journal.pone.0177219			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493920	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000401314300074
J	Mandizadeh, S; Soofivand, F; Bagheri, S; Salavati-Niasari, M				Mandizadeh, Samira; Soofivand, Faezeh; Bagheri, Samira; Salavati-Niasari, Masoud			SrCrxFe12-xO19 nanoceramics as an effective catalyst for desulfurization of liquid fuels: Green sol-gel synthesis, characterization, magnetic and optical properties	PLOS ONE			English	Article							STRONTIUM HEXAFERRITE; SRFE12O19; FERRITE; PARTICLES; MOSSBAUER; BARIUM	In this work, SrCrxFe12-xO19 (x = 0.0, 0.5, 1.0, 1.5) nanostructures were successfully synthesized by sol-gel auto-combustion method, and different aminoacids were used as green reductants. Various analysis results show that SrCrxFe12-xO19 nanoparticles synthesized successfully. The present study shows that SrCrxFe12-xO19 nanoparticle could be used as adsorbent for the desulfurization of liquid fuels. Increasing of nanoparticles concentration was caused to increase the adsorption rate of sulfur contents of fuel. The adsorption rate of sulfur contents of fuel in various concentrations 4.5, 9.5, and 18.5 g. L-1 of SrCrxFe12-xO19 nanoparticles in solution was estimated about 39, 50, and 62% for 30 min, respectively. The results of catalytic tests reveals that SrCrxFe12-xO19 nanoparticles have the potential to be used as a new kind of semiconductor catalysts for the desulfurization of liquid fuels. Magnetic property of the final sample was measured at room temperature by a vibration sample magnetometer (VSM) and shown that the intrinsic coercivity of product is about 6000 Oe and it exhibits characteristics of single magnetic domains (M-r/M-s = 0.53).	[Mandizadeh, Samira; Soofivand, Faezeh; Salavati-Niasari, Masoud] Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran; [Bagheri, Samira] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, IPS Bldg, Kuala Lumpur, Malaysia	University Kashan; Universiti Malaya	Salavati-Niasari, M (corresponding author), Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran.; Bagheri, S (corresponding author), Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, IPS Bldg, Kuala Lumpur, Malaysia.	samira_bagheri@um.edu.my; salavati@kashanu.ac.ir	Salavati-Niasari, Masoud/AAX-4106-2020	Salavati-Niasari, Masoud/0000-0002-7356-7249	University of Kashan; Iran National Science Foundation (INSF); University of Kashan [159271/8290]	University of Kashan; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); University of Kashan	The authors are grateful to the council of the University of Kashan for providing financial support to undertake this work.; Authors are grateful to the council of Iran National Science Foundation (INSF) and University of Kashan for supporting this work by Grant No (159271/8290).	Abd Aziz A, 2014, CHEM ENG J, V235, P264, DOI 10.1016/j.cej.2013.09.043; Alikhanzadeh-Arani S, 2012, J INORG ORGANOMET P, V22, P1081, DOI 10.1007/s10904-012-9687-7; Ashiq MN, 2009, J ALLOY COMPD, V487, P341, DOI 10.1016/j.jallcom.2009.07.140; ATAIE A, 1995, J MATER SCI, V30, P1429, DOI 10.1007/BF00375243; Ataie A, 2001, J EUR CERAM SOC, V21, P1951, DOI 10.1016/S0955-2219(01)00149-2; Bakker JM, 2005, CHEMPHYSCHEM, V6, P120, DOI 10.1002/cphc.200400345; Bercoff PG, 2009, J MAGN MAGN MATER, V321, P2245, DOI 10.1016/j.jmmm.2009.01.033; CABANAS MV, 1995, J SOLID STATE CHEM, V115, P347, DOI 10.1006/jssc.1995.1143; Chikazumi S., 1964, PHYS MAGNETISM; CHOY JH, 1994, MATER LETT, V19, P257, DOI 10.1016/0167-577X(94)90167-8; DEHAART LGJ, 1985, J ELECTROCHEM SOC, V132, P2933, DOI 10.1149/1.2113696; Fang JY, 2000, J AM CERAM SOC, V83, P1049, DOI 10.1111/j.1151-2916.2000.tb01329.x; Fang QQ, 2005, J MAGN MAGN MATER, V294, P281, DOI 10.1016/j.jmmm.2004.12.024; Fang QQ, 2004, J MAGN MAGN MATER, V278, P122, DOI 10.1016/j.jmmm.2003.12.328; Garcia-Cerda LA, 2004, J ALLOY COMPD, V369, P182, DOI 10.1016/j.jallcom.2003.09.099; Gul IH, 2007, J MAGN MAGN MATER, V311, P494, DOI 10.1016/j.jmmm.2006.08.005; HANEDA K, 1987, IEEE T MAGN, V23, P3134, DOI 10.1109/TMAG.1987.1065394; Jamshidi P, 2013, J CLUST SCI, V24, P1151, DOI 10.1007/s10876-013-0605-0; Jauhar S, 2011, POWDER TECHNOL, V212, P193, DOI 10.1016/j.powtec.2011.05.014; Kim CS, 2000, J APPL PHYS, V87, P6244, DOI 10.1063/1.372668; KULKARNI S, 1989, J MATER SCI, V24, P3739, DOI 10.1007/BF02385764; Lechevallier L, 2004, J MAGN MAGN MATER, V269, P192, DOI 10.1016/S0304-8853(03)00591-2; Linder R, 2005, CHEM PHYS LETT, V409, P260, DOI 10.1016/j.cplett.2005.04.109; Morel A, 2002, J MAGN MAGN MATER, V242, P1405, DOI 10.1016/S0304-8853(01)00962-3; Motahari F, 2014, RSC ADV, V4, P27654, DOI 10.1039/c4ra02697g; Mozaffari M, 2002, PHYSICA B, V321, P45, DOI 10.1016/S0921-4526(02)00819-0; Pieper MW, 2002, J MAGN MAGN MATER, V242, P1408, DOI 10.1016/S0304-8853(01)00963-5; Qiu JX, 2005, APPL SURF SCI, V252, P888, DOI 10.1016/j.apsusc.2005.02.031; Soofivand F, 2013, MATER RES BULL, V48, P2084, DOI 10.1016/j.materresbull.2013.02.025; SURIG C, 1994, IEEE T MAGN, V30, P4092, DOI 10.1109/20.333999; SURIG C, 1993, APPL PHYS LETT, V63, P2836, DOI 10.1063/1.110303; TAUC J, 1968, MATER RES BULL, V3, P37, DOI 10.1016/0025-5408(68)90023-8; Wang YF, 2009, J ALLOY COMPD, V467, P284, DOI 10.1016/j.jallcom.2007.12.037; Xie TP, 2013, APPL SURF SCI, V273, P684, DOI 10.1016/j.apsusc.2013.02.113; Xu XX, 2013, CATAL TODAY, V199, P22, DOI 10.1016/j.cattod.2012.03.013; YAKOVLEV YM, 1969, FIZ TVERD TELA+, V10, P2301; Yang XF, 2009, J ALLOY COMPD, V475, P312, DOI 10.1016/j.jallcom.2008.08.019; Zhong W, 1997, J MAGN MAGN MATER, V168, P196, DOI 10.1016/S0304-8853(96)00664-6; Zuo X, 2002, J APPL PHYS, V91, P7622, DOI 10.1063/1.1450845	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0162891	10.1371/journal.pone.0162891	http://dx.doi.org/10.1371/journal.pone.0162891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493874	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300001
J	Viehman, HA; Zydlewski, GB				Viehman, Haley A.; Zydlewski, Gayle Barbin			Multi-scale temporal patterns in fish presence in a high-velocity tidal channel	PLOS ONE			English	Article							VARIABILITY; BEHAVIOR; DIEL; STATIONARY; MOVEMENTS; MIGRATION; RESPONSES; DYNAMICS; FLOW; BAY	The natural variation of fish presence in high-velocity tidal channels is not well understood. A better understanding of fish use of these areas would aid in predicting fish interactions with marine hydrokinetic (MHK) devices, the effects of which are uncertain but of high concern. To characterize the patterns in fish presence at a tidal energy site in Cobscook Bay, Maine, we examined two years of hydroacoustic data continuously collected at the proposed depth of an MHK turbine with a bottom-mounted, side-looking echosounder. The maximum number of fish counted per hour ranged from hundreds in the early spring to over 1,000 in the fall. Counts varied greatly with tidal and diel cycles in a seasonally changing relationship, likely linked to the seasonally changing fish community of the bay. In the winter and spring, higher hourly counts were generally confined to ebb tides and low slack tides near sunrise and sunset. In summer and fall of each year, the highest fish counts shifted to night and occurred during ebb, low slack, and flood tides. Fish counts were not linked to current speed, and did not decrease as current speed increased, contrary to observations at other tidal power sites. As fish counts may be proportional to the encounter rate of fish with an MHK turbine at the same depth, highly variable counts indicate that the risk to fish is similarly variable. The links between fish presence and environmental cycles at this site will likely be present at other locations with similar environmental forcing, making these observations useful in predicting potential fish interactions at tidal energy sites worldwide.	[Viehman, Haley A.; Zydlewski, Gayle Barbin] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Zydlewski, GB (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.	gayle.zydlewski@maine.edu		Viehman, Haley/0000-0002-0472-3551	United States Department of Energy [DE-EE0003647, DE-EE0006384]; Maine Sea Grant [NA100AR4170081]	United States Department of Energy(United States Department of Energy (DOE)); Maine Sea Grant	This work was supported by awards from the United States Department of Energy (energy.gov), project #DE-EE0003647 and #DE-EE0006384, and by the Maine Sea Grant (seagrant.umaine.edu), project #NA100AR4170081. Maine Agricultural and Experiment Station Publication Number 3528.	Amaral SV, 2015, N AM J FISH MANAGE, V35, P97, DOI 10.1080/02755947.2014.982333; Axenrot T, 2004, ICES J MAR SCI, V61, P1100, DOI 10.1016/j.icesjms.2004.07.006; Benjamins S, 2015, OCEANOGR MAR BIOL, V53, P1; Bigelow HB, 2002, BIGELOW SCHROEDERS F; Blauw AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049319; BLAXTER JHS, 1985, J MAR BIOL ASSOC UK, V65, P1031, DOI 10.1017/S0025315400019494; Broadhurst M, 2014, OCEAN COAST MANAGE, V99, P31, DOI 10.1016/j.ocecoaman.2014.06.008; Brooks DA, 2006, RENEW ENERG, V31, P2284, DOI 10.1016/j.renene.2005.10.013; Castro-Santos T, 2015, ESTUAR COAST, V38, pS203, DOI 10.1007/s12237-013-9680-6; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; COCHRANE NA, 1994, MAR ECOL PROG SER, V107, P55, DOI 10.3354/meps107055; de A Ferreira AS, 2012, MAR BIOL RES, V8, P605; De Robertis A, 2007, ICES J MAR SCI, V64, P1282, DOI 10.1093/icesjms/fsm112; Embling CB, 2012, J APPL ECOL, V49, P481, DOI 10.1111/j.1365-2664.2012.02114.x; FLAGG CN, 1994, DEEP-SEA RES PT II, V41, P411, DOI 10.1016/0967-0645(94)90030-2; Forward RB, 2001, OCEANOGR MAR BIOL, V39, P305; Fraser S, 2017, LIMNOL OCEANOGR-METH, V15, P184, DOI 10.1002/lom3.10155; Gibson RN, 1996, MAR ECOL PROG SER, V130, P1, DOI 10.3354/meps130001; Gibson RN, 2003, HYDROBIOLOGIA, V503, P153, DOI 10.1023/B:HYDR.0000008488.33614.62; GLASS CW, 1986, J FISH BIOL, V29, P71, DOI 10.1111/j.1095-8649.1986.tb05000.x; Hammar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084141; Hartill BW, 2003, MAR FRESHWATER RES, V54, P931, DOI 10.1071/MF02095; HEATH M, 1991, CONT SHELF RES, V11, P1425, DOI 10.1016/0278-4343(91)90020-7; Huse I, 2000, ICES J MAR SCI, V57, P903, DOI 10.1006/jmsc.2000.0577; Korneliussen RJ, 2004, CM2004R2004 ICES, V20; Krumme U, 2008, J EXP MAR BIOL ECOL, V367, P91, DOI 10.1016/j.jembe.2008.08.020; LOVE RH, 1971, FISH BULL NATL OC AT, V69, P703; MACDONALD JS, 1984, FISH B-NOAA, V82, P121; Menard F, 2007, FISH OCEANOGR, V16, P95, DOI 10.1111/j.1365-2419.2006.00415.x; Neilson J.D., 2001, ENCY OCEAN SCI, V2, P411, DOI DOI 10.1016/B978-012374473-9.00020-5; Nilsson LAF, 2003, AQUAT LIVING RESOUR, V16, P317, DOI 10.1016/S0990-7440(03)00039-1; Picco P, 2017, J MARINE SYST, V166, P172, DOI 10.1016/j.jmarsys.2016.07.010; Pittman SJ, 2003, ADV MAR BIOL, V44, P205, DOI 10.1016/S0065-2881(03)44004-2; Porat B., 1997, COURSE DIGITAL SIGNA; Rakowitz G, 2012, FISH RES, V123, P37, DOI 10.1016/j.fishres.2011.11.018; Rao S, 2016, OCEAN DYNAM, V66, P41, DOI 10.1007/s10236-015-0906-y; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; Roesch A, 2014, R PACKAGE VERSION 1; Rouyer T, 2008, P NATL ACAD SCI USA, V105, P5420, DOI 10.1073/pnas.0709034105; Simard Y, 2002, CAN J FISH AQUAT SCI, V59, P197, DOI 10.1139/f01-210; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Staines G, 2015, P 11 EUR WAV TID EN; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; TYLER AV, 1971, J FISH RES BOARD CAN, V28, P935, DOI 10.1139/f71-139; Urmy SS, 2016, DEEP-SEA RES PT I, V113, P22, DOI 10.1016/j.dsr.2016.04.004; Urmy SS, 2012, ICES J MAR SCI, V69, P184, DOI 10.1093/icesjms/fsr205; Viehman H, 2017, DRYAD DIGITAL REPOSI; Viehman HA, 2015, ESTUAR COAST, V38, pS215, DOI 10.1007/s12237-014-9776-7; Viehman HA, 2015, ESTUAR COAST, V38, pS241, DOI 10.1007/s12237-014-9767-8; Vieser J.D., 2014, THESIS; Xu D, 2006, P 9 INT C COAST EST, P176; Zamon JE, 2003, MAR ECOL PROG SER, V261, P243; Zydlewski GB, 2014, 20143604 ME U MAIN	53	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176405	10.1371/journal.pone.0176405	http://dx.doi.org/10.1371/journal.pone.0176405			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493894	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300015
J	Garnier, Y; Ferdinand, S; Etienne-Julan, M; Elana, G; Petras, M; Doumdo, L; Tressieres, B; Lalanne-Mistrih, ML; Hardy-Dessources, MD; Connes, P; Romana, M				Garnier, Yohann; Ferdinand, Severine; Etienne-Julan, Maryse; Elana, Gisele; Petras, Marie; Doumdo, Lydia; Tressieres, Benoit; Lalanne-Mistrih, Marie-Laure; Hardy-Dessources, Marie-Dominique; Connes, Philippe; Romana, Marc			Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ERYTHROCYTE MICROPARTICLES; EXTRACELLULAR VESICLES; PULMONARY-HYPERTENSION; INTERNATIONAL SOCIETY; DISEASE; PLATELET; BLOOD; HEMOSTASIS; CHILDREN	Sickle cell anemia (SCA) and hemoglobin SC (HbSC) disease are the two most common forms of sickle cell disease (SCD), a frequent hemoglobinopathy which exhibits a highly variable clinical course. Although high levels of microparticles (MPs) have been consistently reported in SCA and evidence of their harmful impact on the SCA complication occurrences have been provided, no data on MP pattern in HbSC patients has been reported so far. In this study, we determined and compared the MP patterns of 84 HbSC and 96 SCA children, all at steady-state, using flow cytometry. Most of circulating MPs were derived from platelets (PLTs) and red blood cells (RBCs) in the two SCD syndromes. Moreover, we showed that HbSC patients exhibited lower blood concentration of total MPs compared to SCA patients, resulting mainly from a decrease of MP levels originated from RBCs and to a lesser extent from PLTs. We did not detect any association between blood MP concentrations and the occurrence of painful vaso-occlusive crises, acute chest syndrome and pulmonary hypertension in both patient groups. We also demonstrated for the first time, that whatever the considered genotype, RBC-derived MPs exhibited higher externalized phosphatidylserine level and were larger than PLT-derived MPs.	[Garnier, Yohann; Ferdinand, Severine; Etienne-Julan, Maryse; Lalanne-Mistrih, Marie-Laure; Hardy-Dessources, Marie-Dominique; Connes, Philippe; Romana, Marc] Univ Antilles, Inserm 1134, Lab Excellence GR Ex, Unite Biol Integree Globule Rouge, Paris, France; [Etienne-Julan, Maryse; Petras, Marie; Doumdo, Lydia] CHU Pointe A Pitre, Unite Transversale Drepanocytose, Pointe a Pitre, Guadeloupe, France; [Elana, Gisele] CHU Ft France, Pole Mere Enfant, Fort De France, Martinique, France; [Tressieres, Benoit; Lalanne-Mistrih, Marie-Laure] Inserm DGOS CIC 1424, Ctr Invest Clin Antilles Guyane, Pointe a Pitre, Guadeloupe, France; [Connes, Philippe] Inst Univ France, Paris, France; [Connes, Philippe] Univ Claude Bernard Lyon 1, Lab Excellence GR Ex, Equipe Biol Vasc & Globule Rouge, Lab LIBM EA7424, Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Guadeloupe; CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Universitaire de France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Romana, M (corresponding author), Univ Antilles, Inserm 1134, Lab Excellence GR Ex, Unite Biol Integree Globule Rouge, Paris, France.	marc.romana@inserm.fr	TRESSIERES, Benoit/ABH-1085-2020; , Hardy-dessources/K-9189-2017; Connes, Philippe/J-7835-2019; Romana, Marc/K-6442-2017	, Hardy-dessources/0000-0003-0861-3648; Connes, Philippe/0000-0002-9232-0268; Romana, Marc/0000-0002-8715-9836; GARNIER, Yohann/0000-0002-2720-5829; FERDINAND, Severine/0000-0001-8258-5089; ETIENNE-JULAN, Maryse/0000-0003-1339-6545	CPER/Region Guadeloupe [J-2-1-J210002]; Conseil Regional de la Martinique; Conseil Regional de la Guadeloupe;  [PHRC-API 2012]	CPER/Region Guadeloupe; Conseil Regional de la Martinique; Conseil Regional de la Guadeloupe; 	Part of this study was supported by the "CPER/Region Guadeloupe, grant nr. J-2-1-J210002 (MR), "Conseil Regional de la Martinique" (MR), by the PHRC-API 2012 (MDHD), and by the "Conseil Regional de la Guadeloupe", fellowship to YG.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; ALLAN D, 1982, NATURE, V295, P612, DOI 10.1038/295612a0; Appleton CP, 1997, J AM SOC ECHOCARDIOG, V10, P271, DOI 10.1016/S0894-7317(97)70063-4; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652; Boulanger CM, 2017, NAT REV CARDIOL, V14, P259, DOI 10.1038/nrcardio.2017.7; Camus SM, 2015, BLOOD, V125, P3805, DOI 10.1182/blood-2014-07-589283; Camus SM, 2012, BLOOD, V120, P5050, DOI 10.1182/blood-2012-02-413138; Chaar V, 2005, HAEMATOLOGICA, V90, P188; Cognasse F, 2015, TRANSFUS APHER SCI, V53, P159, DOI 10.1016/j.transci.2015.10.013; Colella MP, 2015, HAEMATOLOGICA, V100, P469, DOI 10.3324/haematol.2014.114587; FABRY ME, 1982, J CLIN INVEST, V70, P1315, DOI 10.1172/JCI110732; Ferrone FA, 2015, AM J HEMATOL, V90, P438, DOI 10.1002/ajh.23958; FRANCIS RB, 1991, BLOOD COAGUL FIBRIN, V2, P341, DOI 10.1097/00001721-199104000-00018; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hebbel RP, 2016, BRIT J HAEMATOL, V174, P16, DOI 10.1111/bjh.14112; Hierso R, 2014, BRIT J HAEMATOL, V166, P601, DOI 10.1111/bjh.12912; Hugel B, 2002, PHYSIOLOGY BETHESDA, V20, P22; Inwald DP, 2000, BRIT J HAEMATOL, V111, P474, DOI 10.1046/j.1365-2141.2000.02353.x; Kasar M, 2014, J THROMB THROMBOLYS, V38, P167, DOI 10.1007/s11239-013-1028-3; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Khalyfa A, 2016, BRIT J HAEMATOL, V174, P786, DOI 10.1111/bjh.14104; Labrouche S, 1996, METABOLISM, V45, P57, DOI 10.1016/S0026-0495(96)90200-0; Lacroix R, 2013, J THROMB HAEMOST, V11, P1190, DOI 10.1111/jth.12207; Lacroix R, 2010, J THROMB HAEMOST, V8, P2571, DOI 10.1111/j.1538-7836.2010.04047.x; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; LAWRENCE C, 1991, BLOOD, V78, P2104, DOI 10.1182/blood.V78.8.2104.bloodjournal7882104; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; LIN MJ, 1989, BLOOD, V74, P1823; Lionnet F, 2012, HAEMATOL-HEMATOL J, V97, P1136, DOI 10.3324/haematol.2011.055202; LIU SC, 1991, SCIENCE, V252, P574, DOI 10.1126/science.2020854; Marsh A, 2015, BRIT J HAEMATOL, V168, P135, DOI 10.1111/bjh.13110; Montoro-Garcia S, 2011, BASIC RES CARDIOL, V106, P911, DOI 10.1007/s00395-011-0198-4; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; Nebor D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087243; Nebor D, 2013, HAEMATOLOGICA, V98, P862, DOI 10.3324/haematol.2012.073619; OWEN JS, 1981, J LIPID RES, V22, P423; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Piccin A, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28414; RANK BH, 1988, BLOOD, V72, P1060; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Solovey A, 1998, J CLIN INVEST, V101, P1899, DOI 10.1172/JCI1932; Tantawy AAG, 2013, PLATELETS, V24, P605, DOI 10.3109/09537104.2012.749397; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; van Beers EJ, 2009, HAEMATOL-HEMATOL J, V94, P1513, DOI 10.3324/haematol.2009.008938; van Tits LJ, 2009, BIOCHEM BIOPH RES CO, V390, P161, DOI 10.1016/j.bbrc.2009.09.102; Westerman M, 2008, BRIT J HAEMATOL, V142, P126, DOI 10.1111/j.1365-2141.2008.07155.x	53	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177397	10.1371/journal.pone.0177397	http://dx.doi.org/10.1371/journal.pone.0177397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489923	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100071
J	Messina, J; Campbell, S; Morris, R; Eyles, E; Sanders, C				Messina, Josie; Campbell, Stephen; Morris, Rebecca; Eyles, Emily; Sanders, Caroline			A narrative systematic review of factors affecting diabetes prevention in primary care settings	PLOS ONE			English	Review							LIFE-STYLE INTERVENTION; PARTICIPATORY DECISION-MAKING; FOLLOW-UP; PHYSICAL-ACTIVITY; GENERAL-PRACTITIONERS; SELF-MANAGEMENT; TYPE-2; PROGRAM; RISK; PROFESSIONALS	Background Type 2 diabetes is impacting millions of people globally; however, many future cases can be prevented through lifestyle changes and interventions. Primary care is an important setting for diabetes prevention, for at-risk populations, because it is a patient's primary point of contact with the health care system and professionals can provide lifestyle counselling and support, as well as monitoring health outcomes. These are all essential elements for diabetes prevention for at-risk adults. Aim To understand the factors related to the delivery and uptake of type 2 diabetes prevention interventions within primary care in higher income countries. Methods For this narrative systematic review, we combined qualitative and quantitative studies of diabetes prevention within a primary care setting for patients at-risk of developing the condition. We used an iterative approach for evidence collection, which included using several data-bases (MEDLINE, Embase, Pysch info, BNI, SSCI, CINAHL, ASSIA), where we combined diabetes terms with primary care terms. Narrative and thematic synthesis were utilised to identify the prominent themes emerging from the data. Results A database of 6646 records was screened by the research team, and 18 papers were included. Three major themes were identified in this review. The first theme of context and setting of diabetes progression includes the risk and progression of diabetes, primary care as a setting, and where the responsibility for change is thought to lie. This review also found mixed views on the value of preventative services within primary care. The second theme focused on the various patient factors associated with diabetes prevention such as a patient's motivation to modify their current lifestyle, perceptions and knowledge (or lack thereof) of the impacts of diabetes, lack of follow-up in healthcare settings, and trust in healthcare professionals. The third theme was centred on professional factors impacting on diabetes prevention which included workload, time constraints, resources, self-efficacy and knowledge as well as professionals' perception of patient motivations towards change. Conclusion This review explored the factors influencing diabetes prevention in primary care, and identified the context of prevention, as well as patient and professional factors related to preventative services being offered in primary care. This systematic review complements previous reviews of real-world settings by exploring the significant factors in prevention, and the findings are relevant to academics, policymakers, patients and practitioners interested in understanding the factors associated with the delivery and uptake of diabetes prevention interventions.	[Messina, Josie; Campbell, Stephen; Morris, Rebecca; Sanders, Caroline] Univ Manchester, Sch Primary Care, Manchester, Lancs, England; [Eyles, Emily] Univ Bristol, Sch Geog Sci, Bristol, Avon, England	University of Manchester; University of Bristol	Messina, J (corresponding author), Univ Manchester, Sch Primary Care, Manchester, Lancs, England.	josie.messina@postgrad.manchester.ac.uk	; Morris, Rebecca/A-1940-2019; Sanders, Caroline/G-8021-2014	Eyles, Emily/0000-0002-2695-7172; Morris, Rebecca/0000-0003-1587-0802; Sanders, Caroline/0000-0002-0539-928X	National Institute for Health Research (NIHR); School for Primary Care Research (SPCR); National Institute for Health Research [SPCR-039] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); School for Primary Care Research (SPCR); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) PhD studentship award https://www.spcr.nihr.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar EJ, 2014, CONTEMP CLIN TRIALS, V39, P132, DOI 10.1016/j.cct.2014.07.008; Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Andersson Susanne, 2008, Prim Care Diabetes, V2, P187, DOI 10.1016/j.pcd.2008.09.001; Ashra NB, 2015, SYSTEMATIC REV METAA; Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Barroso J, 2003, WESTERN J NURS RES, V25, P153, DOI 10.1177/0193945902250034; Barry E, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4717; BATES MJ, 1989, ONLINE REV, V13, P407, DOI 10.1108/eb024320; Booth A, 2008, HEALTH INFO LIBR J, V25, P313, DOI 10.1111/j.1471-1842.2008.00825.x; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bryant T, 2009, HEALTH POLICY, V91, P24, DOI 10.1016/j.healthpol.2008.11.002; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chisholm A, 2012, PATIENT EDUC COUNS, V87, P389, DOI 10.1016/j.pec.2011.12.001; Colagiuri S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-328; Davison C, 1991, LAY EPIDEMIOLOGY PRE, V13; Diabetes UK, 2006, DIAB DIS RED HLTH IN; Diabetes UK, 2012, COST OF DIAB; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Evans PH, 2007, DIABETIC MED, V24, P770, DOI 10.1111/j.1464-5491.2007.02130.x; Everson-Hock ES, 2013, PREV MED, V56, P265, DOI 10.1016/j.ypmed.2013.02.023; Frantsve LME, 2007, PAIN MED, V8, P25, DOI 10.1111/j.1526-4637.2007.00250.x; Gough D, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-28; Grace C, 2009, J DIABETES NURS, V13, P58; Grace C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1931; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Harden A, 2004, J EPIDEMIOL COMMUN H, V58, P794, DOI 10.1136/jech.2003.014829; Heisler M, 2009, CHRONIC ILLN, V5, P165, DOI 10.1177/1742395309339258; Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x; Helmink JHM, 2012, J EVAL CLIN PRACT, V18, P682, DOI 10.1111/j.1365-2753.2011.01654.x; Hornsten A, 2005, DIABETES RES CLIN PR, V68, P65, DOI 10.1016/j.diabres.2004.08.003; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huang MF, 2010, INT J NURS STUD, V47, P542, DOI 10.1016/j.ijnurstu.2009.10.012; Hussain A, 2007, DIABETES RES CLIN PR, V76, P317, DOI 10.1016/j.diabres.2006.09.020; Jallinoja P, 2007, SCAND J PRIM HEALTH, V25, P244, DOI 10.1080/02813430701691778; Johnson M, 2013, DIABETIC MED, V30, P3, DOI 10.1111/dme.12018; Johnson M, 2011, DIABETES RES CLIN PR, V93, P150, DOI 10.1016/j.diabres.2011.06.004; Kanavos P, 2012, DIABETES EXPENDITURE; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Liddy CE, 2013, CAN J DIABETES, V37, P12, DOI 10.1016/j.jcjd.2013.01.006; Lin JJ, 2012, PATIENT EDUC COUNS, V88, P460, DOI 10.1016/j.pec.2012.06.017; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Lu S, 2013, AUST FAM PHYSICIAN, V42, P328; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Messina J, 2013, NICOTINE TOB RES, V15, P875, DOI 10.1093/ntr/nts193; Morrow AS, 2008, PATIENT EDUC COUNS, V72, P418, DOI 10.1016/j.pec.2008.05.017; Moses AC, 2013, AM J PREV MED, V44, pS333, DOI 10.1016/j.amepre.2012.12.011; Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002; Narayan KMV, 2002, BMJ-BRIT MED J, V325, P403, DOI 10.1136/bmj.325.7361.403; NHS Choices, 2012, DIAB SYMPT; Oberski D., 2008, SELF SELECTION BIAS; Oliver S, 2005, EVALUATION, V11, P428, DOI DOI 10.1177/1356389005059383; Pearson M, 2011, EVAL HEALTH PROF, V34, P297, DOI 10.1177/0163278710388029; Rodriguez KM, 2013, CLIN THER, V35, P170, DOI 10.1016/j.clinthera.2013.01.002; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; Savas LA, 2015, PRIM CARE DIABETES, V9, P3, DOI 10.1016/j.pcd.2014.07.003; Schutze H, 2012, AUST J PRIM HEALTH, V18, P129, DOI 10.1071/PY10106; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Troughton J, 2008, PATIENT EDUC COUNS, V72, P88, DOI 10.1016/j.pec.2008.01.026; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vahasarja K, 2015, BRIT J HEALTH PSYCH, V20, P172, DOI 10.1111/bjhp.12088; van Esch SCM, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-31; Vermunt P. W. A., 2013, BMC Family Practice, V14; Vermunt PWA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-79; Weber MB, 2012, ANNU REV NUTR, V32, P417, DOI 10.1146/annurev-nutr-071811-150630; Whitford DL, 2003, DIABETIC MED, V20, P155, DOI 10.1046/j.1464-5491.2003.00892.x; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Whittemore R, 2010, J AM ACAD NURSE PRAC, V22, P684, DOI 10.1111/j.1745-7599.2010.00562.x; Whittemore R, 2009, NURS RES, V58, P2, DOI 10.1097/NNR.0b013e31818fcef3; Williams R, 2004, BRIT J GEN PRACT, V54, P531; Wylie G, 2002, BMJ-BRIT MED J, V324, P1190, DOI 10.1136/bmj.324.7347.1190; Yates T, 2009, POSTGRAD MED J, V85, P475, DOI 10.1136/pgmj.2008.076166	76	28	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177699	10.1371/journal.pone.0177699	http://dx.doi.org/10.1371/journal.pone.0177699			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28531197	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400026
J	Valdersnes, S; Nilsen, BM; Breivik, JF; Borge, A; Maage, A				Valdersnes, Stig; Nilsen, Bente M.; Breivik, Joar F.; Borge, Asbjorn; Maage, Amund			Geographical trends of PFAS in cod livers along the Norwegian coast	PLOS ONE			English	Article							NORTHEAST ARCTIC COD; FRESH-WATER FISH; GADUS-MORHUA L; PERFLUORINATED COMPOUNDS; POLYFLUOROALKYL SUBSTANCES; TISSUE DISTRIBUTION; SPAWNING GROUNDS; FEEDING ECOLOGY; SOMATIC INDEX; BIOACCUMULATION	The level of perfluorinated alkyl substances (PFAS) was determined in North East Arctic cod (Gadus morhua) liver samples from 15 Norwegian fjords and harbors. Five harbors in the eastern part of Norway, six harbors in the western part and four harbours in the northern part. A total of 200 samples were analyzed for 16 PFAS. Determination of PFAS were carried out by LC-MS/MS following sample clean up by solid phase extraction and ultracentrifugation. The predominating PFAS was PFOS, which was found to be higher than the level of quantification (1.5 mu g kg(-1) wet weight) in 72% of the samples. The highest level of PFOS found was 21.8 mu g kg(-1) wet weight in a sample from Kragero in the eastern part of Norway. A significantly higher level of PFOS was found in the eastern fjords and harbors compared to fjords and harbors in the western and northern part of Norway. Within the northern fjords and harbors elevated PFOS levels were found in Narvik, which may indicate a local source there. Variations in PFOS of the cod livers thus reflect differences in levels of pollution between the areas.	[Valdersnes, Stig; Nilsen, Bente M.; Breivik, Joar F.; Maage, Amund] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Borge, Asbjorn] Inst Marine Res, Bergen, Norway	Institute of Marine Research - Norway	Valdersnes, S (corresponding author), Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway.	stig.valdersnes@nifes.no	Maage, Amund/AAH-6421-2021	Maage, Amund/0000-0002-2772-5752	Norwegian Food Safety Authority	Norwegian Food Safety Authority	This work was funded by the Norwegian Food Safety Authority (www.mattilsynet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Norwegian Food Safety Authority for funding this work. We also would like to thank IMR personnel involved in the collection of samples and age determination by reading of otoliths. We thank Arne Duinker at NIFES for assistance in producing the map showing the fjords and harbors.	ADAMS SM, 1985, J FISH BIOL, V26, P111, DOI 10.1111/j.1095-8649.1985.tb04248.x; Alexander J, 2008, EFSA J, V6; Berger U, 2005, J CHROMATOGR A, V1081, P210, DOI 10.1016/j.chroma.2005.05.064; Conder JM, 2008, ENVIRON SCI TECHNOL, V42, P995, DOI 10.1021/es070895g; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; ELIASSEN JE, 1982, J FISH BIOL, V20, P707, DOI 10.1111/j.1095-8649.1982.tb03981.x; Falandysz J, 2007, J ENVIRON SCI HEAL A, V42, P715, DOI 10.1080/10934520701304369; Green NW, 2015, CONTAMINANTS COASTAL, P222; HOP H, 1993, J FISH BIOL, V43, P1; HOP H, 1992, ICES J MAR SCI, V49, P453, DOI 10.1093/icesjms/49.4.453; Hoque MT, 1998, J FISH BIOL, V52, P23, DOI 10.1006/jfbi.1997.0555; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b; Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w; JAKOBSEN T, 1987, FISH RES, V5, P223, DOI 10.1016/0165-7836(87)90042-7; Kelly BC, 2009, ENVIRON SCI TECHNOL, V43, P4037, DOI 10.1021/es9003894; KLEMETSEN A, 1982, J CONSEIL, V40, P101; Labadie P, 2011, ENVIRON POLLUT, V159, P391, DOI 10.1016/j.envpol.2010.10.039; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Martin JW, 2013, ENVIRON TOXICOL CHEM, V32, P2421, DOI 10.1002/etc.2376; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P196, DOI 10.1897/1551-5028(2003)022&lt;0196:BATDOP&gt;2.0.CO;2; Michalsen K, 2008, ICES J MAR SCI, V65, P571, DOI 10.1093/icesjms/fsn019; Morgan MJ, 2004, ICES J MAR SCI, V61, P64, DOI 10.1016/j.icesjms.2003.09.001; Murakami M, 2011, ARCH ENVIRON CON TOX, V61, P631, DOI 10.1007/s00244-011-9660-4; Ng CA, 2014, ENVIRON SCI TECHNOL, V48, P4637, DOI 10.1021/es404008g; Nilsen BM, 2009, FREMMEDSTOFFER VILLF, P77; NMKL, 2009, VAL CHEM AN METH; Nordeide JT, 1998, SARSIA, V83, P373, DOI 10.1080/00364827.1998.10413696; Pan CG, 2014, ECOTOX ENVIRON SAFE, V107, P192, DOI 10.1016/j.ecoenv.2014.05.031; Prevedouros K, 2006, ENVIRON SCI TECHNOL, V40, P32, DOI 10.1021/es0512475; RICKER W E, 1975, P382; ROLLEFSEN G., 1933, FISKERIDIREK SKR SER HAVUNDERS REP NORWEGIAN FISH AND MAR INVEST, V4, P1; Shi YL, 2012, J ENVIRON MONITOR, V14, P636, DOI 10.1039/c1em10772k; Taniyasu S, 2005, J CHROMATOGR A, V1093, P89, DOI 10.1016/j.chroma.2005.07.053; Taylor Matthew D. B KC, 2017, SCI TOTAL ENVIRON, V581, P258; Yaragina NA, 2000, ICES J MAR SCI, V57, P42, DOI 10.1006/jmsc.1999.0493	35	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177947	10.1371/journal.pone.0177947	http://dx.doi.org/10.1371/journal.pone.0177947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531177	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000402058400044
J	Bhagwat, T; Hess, A; Horning, N; Khaing, T; Thein, ZM; Aung, KM; Aung, KH; Phyo, P; Tun, YL; Oo, AH; Neil, A; Thu, WM; Songer, M; Connette, KL; Bernd, A; Huang, Q; Connette, G; Leimgruber, P				Bhagwat, Tejas; Hess, Andrea; Horning, Ned; Khaing, Thiri; Thein, Zaw Min; Aung, Kyaw Moe; Aung, Kyaw Htet; Phyo, Paing; Tun, Ye Lin; Oo, Aung Htat; Neil, Anthony; Thu, Win Myo; Songer, Melissa; Connette, Katherine LaJeunesse; Bernd, Asja; Huang, Qiongyu; Connette, Grant; Leimgruber, Peter			Losing a jewel-Rapid declines in Myanmar's intact forests from 2002-2014	PLOS ONE			English	Article							MAINLAND SOUTHEAST-ASIA; PROTECTED-AREA SYSTEM; PITTA PITTA-GURNEYI; COVER CHANGE; CLOUD SHADOW; HABITAT USE; CONSERVATION; DEFORESTATION; BIODIVERSITY; CLASSIFICATION	New and rapid political and economic changes in Myanmar are increasing the pressures on the country's forests. Yet, little is known about the past and current condition of these forests and how fast they are declining. We mapped forest cover in Myanmar through a consortium of international organizations and environmental non-governmental groups, using freely-available public domain data and open source software tools. We used Landsat satellite imagery to assess the condition and spatial distribution of Myanmar's intact and degraded forests with special focus on changes in intact forest between 2002 and 2014. We found that forests cover 42,365,729 ha or 63% of Myanmar, making it one of the most forested countries in the region. However, severe logging, expanding plantations, and degradation pose increasing threats. Only 38% of the country's forests can be considered intact with canopy cover >80%. Between 2002 and 2014, intact forests declined at a rate of 0.94% annually, totaling more than 2 million ha forest loss. Losses can be extremely high locally and we identified 9 townships as forest conversion hotspots. We also delineated 13 large (> 100,000 ha) and contiguous intact forest landscapes, which are dispersed across Myanmar. The Northern Forest Complex supports four of these landscapes, totaling over 6.1 million ha of intact forest, followed by the Southern Forest Complex with three landscapes, comprising 1.5 million ha. These remaining contiguous forest landscape should have high priority for protection. Our project demonstrates how open source data and software can be used to develop and share critical information on forests when such data are not readily available elsewhere. We provide all data, code, and outputs freely via the internet at (for scripts: https://bitbucket.org/rsbiodiv/; for the data: http://geonode.themimu.info/layers/geonode%3Amyan_ lvl2_ smoothed_ dec2015_ resamp)	[Bhagwat, Tejas; Songer, Melissa; Connette, Katherine LaJeunesse; Huang, Qiongyu; Connette, Grant; Leimgruber, Peter] Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA; [Hess, Andrea] Univ Bayreuth, Dept Geosci, Bayreuth, Germany; [Horning, Ned] Amer Museum Nat Hist, New York, NY 10024 USA; [Khaing, Thiri; Thein, Zaw Min; Aung, Kyaw Htet; Phyo, Paing; Tun, Ye Lin; Oo, Aung Htat; Neil, Anthony; Thu, Win Myo; Bernd, Asja] EcoDev ALARM, Kamayut Township, Yangon, Myanmar; [Khaing, Thiri; Thein, Zaw Min; Aung, Kyaw Moe; Aung, Kyaw Htet; Phyo, Paing; Tun, Ye Lin; Oo, Aung Htat] GMAP, Hlaing Township, Yangon, Myanmar	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Bayreuth; American Museum of Natural History (AMNH)	Leimgruber, P (corresponding author), Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA.	leimgruberp@si.edu	Leimgruber, Peter/O-1304-2015	Leimgruber, Peter/0000-0002-3682-0153; Songer, Melissa/0000-0001-5536-6315; LaJeunesse Connette, Katie/0000-0002-9011-8859; Connette, Grant/0000-0002-9424-6591; Huang, Qiongyu/0000-0002-1450-3587	European Union's Forest Law Enforcement, Governance and Trade (EU FLEGT); Myanmar CSO ALARM (previously ECODEV); Helmsley Charitable Trust; U.S. Agency for International Development (USAID); International Union for Conservation of Nature (IUCN)	European Union's Forest Law Enforcement, Governance and Trade (EU FLEGT); Myanmar CSO ALARM (previously ECODEV); Helmsley Charitable Trust; U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); International Union for Conservation of Nature (IUCN)	We thank our colleagues from local and national conservation organizations and the Ministry of Environmental Conservation and Forestry (MOECAF) for providing expert input in developing our maps and assessing their accuracy. These organizations include Myanmar Environment Rehabilitation-conservation Network (MERN), Friends of Wildlife (FOW), GMAP, Wildlife Conservation Society (WCS), Fauna and Flora International (FFI), and International Union for Conservation of Nature (IUCN). We would like to especially thank U Kyaw Htun, Patrick Oswald, U Myint Aung, U Tin Tun, Made Ferguson, Jake Brunner, and Dan Constable for their continued interest, insights, and help in developing assessment. Funding for this research was provided European Union's Forest Law Enforcement, Governance and Trade (EU FLEGT) project with the Myanmar CSO ALARM (previously ECODEV), the Helmsley Charitable Trust, U.S. Agency for International Development (USAID), and International Union for Conservation of Nature (IUCN).	Ahrends A, 2010, P NATL ACAD SCI USA, V107, P14556, DOI 10.1073/pnas.0914471107; Bodart C, 2011, ISPRS J PHOTOGRAMM, V66, P555, DOI 10.1016/j.isprsjprs.2011.03.003; Brunner J, 1998, LOGGING BURMAS FRONT; Bryant R.L., 1997, POLITICAL ECOLOGY FO; Canty MJ, 2008, REMOTE SENS ENVIRON, V112, P1025, DOI 10.1016/j.rse.2007.07.013; Canty MJ, 2007, P SOC PHOTO-OPT INS, V6748, P74808, DOI 10.1117/12.736409; Cutler DR, 2015, RANDOM FORESTS CLASS, V88, P2783; Defourny P, 2007, INT J REMOTE SENS, V28, P5123; Donald PF, 2009, BIRD CONSERV INT, V19, P353, DOI 10.1017/S0959270909008612; Eames JC, 2005, BIRD CONSERV INT, V15, P3, DOI 10.1017/S095927090500002X; FAO, 2020, GLOBAL FOREST RESOUR; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Fox J, 2014, GLOBAL ENVIRON CHANG, V29, P318, DOI 10.1016/j.gloenvcha.2013.05.011; Fox J, 2013, J PEASANT STUD, V40, P155, DOI 10.1080/03066150.2012.750605; Ghimire B, 2010, REMOTE SENS LETT, V1, P45, DOI 10.1080/01431160903252327; Gin OK, SE ASIA HIST ENCY AN; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Gong P, 2011, GEOMATICS WORLD, V9, P34; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Hansen MC, 2012, REMOTE SENS ENVIRON, V122, P66, DOI 10.1016/j.rse.2011.08.024; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hansen MC, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034001; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hartley CWS., 1988, OIL PALM ELAEIS GUIN, V3rd; Horning N, 2010, RANDOM FORESTS ALGOR, V2010, P1; Kim DH, 2014, REMOTE SENS ENVIRON, V155, P178, DOI 10.1016/j.rse.2014.08.017; Koy K, 2005, ANIM CONSERV, V8, P289, DOI 10.1017/S1367943005002209; Kyaw WW, 2011, ENRGY PROCED, V9, DOI 10.1016/j.egypro.2011.09.038; Leimgruber P, 2011, ECOLOGY CONSERVATION, P59; Leimgruber P, 2005, ENVIRON CONSERV, V32, P356, DOI 10.1017/S0376892905002493; Li P, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8010044; Li P, 2014, REMOTE SENS-BASEL, V6, P1654, DOI 10.3390/rs6021654; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; MoECAF, 2011, NAT BIOD STRAT ACT P; Mon MS, 2012, FOREST ECOL MANAG, V267, P190, DOI 10.1016/j.foreco.2011.11.036; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Olander LP, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/025011; Paul A, 2005, CURR SCI INDIA, V89, P623; Perz SG, 2013, LAND USE POLICY, V34, P27, DOI 10.1016/j.landusepol.2013.01.009; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; RAHMAN H, 1994, INT J REMOTE SENS, V15, P123, DOI 10.1080/01431169408954055; Rao M, 2002, CONSERV BIOL, V16, P360, DOI 10.1046/j.1523-1739.2002.00219.x; Rao M, 2013, AMBIO, V42, P789, DOI 10.1007/s13280-013-0423-5; Rodriguez-Galiano VF, 2012, REMOTE SENS ENVIRON, V121, P93, DOI 10.1016/j.rse.2011.12.003; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Saxon E.C., 2014, 1 FAUN FLOR INT; Schmidt-Vogt D, 2009, HUM ECOL, V37, P269, DOI 10.1007/s10745-009-9239-0; Selmier WT, 2013, BUS HORIZONS, V56, P757, DOI 10.1016/j.bushor.2013.08.003; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Smith JH, 2002, PHOTOGRAMM ENG REM S, V68, P65; Songer M, 2011, ECOLOGY CONSERVATION, P305; Songer M, 2009, BIODIVERS CONSERV, V18, P1001, DOI 10.1007/s10531-008-9490-5; Sovacool BK, 2013, ENERGY SUSTAIN DEV, V17, P305, DOI 10.1016/j.esd.2013.03.010; Stibig HJ, 2014, BIOGEOSCIENCES, V11, P247, DOI 10.5194/bg-11-247-2014; Stibig H-J, 2007, JRC SCI TECH REPORTS; Tantipisanuh N, 2016, BIOL CONSERV, V195, P203, DOI 10.1016/j.biocon.2015.12.043; Telmer KM, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P131, DOI 10.1007/978-0-387-93958-2_6; Webb EL, 2014, GLOBAL ENVIRON CHANG, V24, P321, DOI 10.1016/j.gloenvcha.2013.10.007; Win NN, 2013, OSRORAS102EC IPC AS; Wohlfart C, 2014, TROP CONSERV SCI, V7, P597, DOI 10.1177/194008291400700402; Yu L, 2012, INT J REMOTE SENS, V33, P3966, DOI 10.1080/01431161.2011.636081; Zhu Z, 2015, REMOTE SENS ENVIRON, V159, P269, DOI 10.1016/j.rse.2014.12.014; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	67	64	66	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176364	10.1371/journal.pone.0176364	http://dx.doi.org/10.1371/journal.pone.0176364			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520726	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700016
J	Schuppe, ER; Pradhan, DS; Thonkulpitak, K; Drilling, C; Black, M; Grober, MS				Schuppe, Eric R.; Pradhan, Devaleena S.; Thonkulpitak, Kevin; Drilling, Cathleen; Black, Michael; Grober, Matthew S.			Sex differences in neuromuscular androgen receptor expression and sociosexual behavior in a sex changing fish	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SPINAL-CORD; BLUEGILL SUNFISH; LIMB MUSCLES; BRAIN; MOTOR; COURTSHIP; NUCLEUS; 11-KETOTESTOSTERONE; IMMUNOREACTIVITY	Androgen signaling, via receptor binding, is critical for regulating the physiological and morphological foundations of male-typical reproductive behavior in vertebrates. Muscles essential for male courtship behavior and copulation are highly sensitive to androgens. Differences in the distribution and density of the androgen receptor (AR) are important for maintaining dimorphic musculature and thus may provide for anatomical identification of sexually selected traits. In Lythrypnus dalli, a bi-directional hermaphroditic teleost fish, both sexes produce agonistic approach displays, but reproductive behavior is sexually dimorphic. The male-specific courtship behavior is characterized by rapid jerky movements (involving dorsal fin erection) towards a female or around their nest. Activation of the supracarinalis muscle is involved in dorsal fin contributions to both agonistic and sociosexual behavior in other fishes, suggesting that differences in goby sexual behavior may be reflected in sexual dimorphism in AR signaling in this muscle. We examined sex differences in the local distribution of AR in supracarinalis muscle and spinal cord. Our results demonstrate that males do express more AR in the supracarinalis muscle relative to females, but there was no sex difference in the number of spinal motoneurons expressing AR. Interestingly, AR expression in the supracarinalis muscle was also related to rates of sociosexual behavior in males, providing evidence that sexual selection may influence muscle androgenic sensitivity to enhance display vigor. Sex differences in the distribution and number of cells expressing AR in the supracarinalis muscle may underlie the expression of dimorphic behaviors in L. dalli.	[Schuppe, Eric R.; Pradhan, Devaleena S.; Thonkulpitak, Kevin; Drilling, Cathleen; Black, Michael; Grober, Matthew S.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Black, Michael] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Schuppe, Eric R.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Pradhan, Devaleena S.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Wake Forest University; University of California System; University of California Los Angeles	Schuppe, ER (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.; Schuppe, ER (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	ericschuppe@gmail.com	Pradhan, Devaleena/AAF-7296-2019	Pradhan, Devaleena/0000-0002-7755-2538	NSF [IBN-9723817]; Georgia Research Alliance; GSU-RPE	NSF(National Science Foundation (NSF)); Georgia Research Alliance; GSU-RPE	This study was supported in part by NSF IBN-9723817 to MSG. Additional support was provided by the Georgia Research Alliance and GSU-RPE program.	Aizawa K, 2010, STEROIDS, V75, P219, DOI 10.1016/j.steroids.2009.12.002; [Anonymous], 2015, SIMULTANEOUS COURTSH; Black MP, 2005, P ROY SOC B-BIOL SCI, V272, P2435, DOI 10.1098/rspb.2005.3210; BRANTLEY RK, 1993, BRAIN BEHAV EVOLUT, V42, P336, DOI 10.1159/000114170; BREEDLOVE SM, 1981, BRAIN RES, V225, P297; Chaikovskii VS, 1984, PROBLEMY ENDOKRINOLO, V31, P78; Chakraborty SB, 2011, AQUACULT INT, V19, P1119, DOI 10.1007/s10499-011-9428-x; Copp C., 1884, P CANADIAN I; Fargo KN, 2009, FRONT NEUROENDOCRIN, V30, P130, DOI 10.1016/j.yfrne.2009.04.005; Feng NY, 2010, ENDOCRINOLOGY, V151, P1042, DOI 10.1210/en.2009-0901; Fischer LM, 1991, SEMINARS NEUROSCIENC; Flammang BE, 2008, J EXP BIOL, V211, P587, DOI 10.1242/jeb.012096; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; FREEMAN LM, 1995, J NEUROBIOL, V27, P51, DOI 10.1002/neu.480270106; Fuxjager MJ, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0156-y; Fuxjager MJ, 2015, FUNCT ECOL, V29, P1197, DOI 10.1111/1365-2435.12438; Fuxjager MJ, 2013, ENDOCRINOLOGY, V154, P3168, DOI 10.1210/en.2013-1302; Fuxjager MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051482; Fuxjager MJ, 2012, ENDOCRINOLOGY, V153, P3780, DOI 10.1210/en.2012-1313; Gustavson S, 1994, SOC NEUROSCI; Herrel A, 1996, NETH J ZOOL, V46, P253; Holmes MM, 2005, J NEUROENDOCRINOL, V17, P560, DOI 10.1111/j.1365-2826.2005.01339.x; Huyghe K, 2010, J EXP ZOOL PART A, V313A, P9, DOI 10.1002/jez.569; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P25, DOI 10.1007/s004180050003; Liu XC, 2009, GEN COMP ENDOCR, V160, P93, DOI 10.1016/j.ygcen.2008.10.026; Lorenzi V, 2008, GEN COMP ENDOCR, V155, P438, DOI 10.1016/j.ygcen.2007.07.010; Lorenzi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051158; Mangiamele LA, 2016, P NATL ACAD SCI USA; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; Neal JK, 2007, HORM BEHAV, V52, P228, DOI 10.1016/j.yhbeh.2007.04.009; Perez J, 1996, J NEUROBIOL, V30, P556, DOI 10.1002/(SICI)1097-4695(199608)30:4<556::AID-NEU10>3.3.CO;2-3; Pouso P, 2010, HORM BEHAV, V58, P729, DOI 10.1016/j.yhbeh.2010.07.005; Pradhan DS, 2014, HORM BEHAV, V65, P47, DOI 10.1016/j.yhbeh.2013.11.006; Pradhan DS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0239; Reavis Robert H., 1999, Acta Ethologica, V2, P51, DOI 10.1007/PL00012232; Robson MA, 2000, FUNCT ECOL, V14, P338, DOI 10.1046/j.1365-2435.2000.00427.x; Rodgers CMC, 2013, HORM BEHAV, V63, P454, DOI 10.1016/j.yhbeh.2012.12.008; Rodgers EW, 2007, J FISH BIOL, V70, P1660, DOI 10.1111/j.1095-8649.2007.01427.x; Rodgers EW, 2006, HORM BEHAV, V49, P610, DOI 10.1016/j.yhbeh.2006.01.008; Rodgers EW, 2005, BIOL BULL-US, V208, P120, DOI 10.2307/3593120; SASSOON DA, 1987, J NEUROSCI, V7, P3198; Schlinger BA, 2013, FRONT NEUROENDOCRIN, V34, P143, DOI 10.1016/j.yfrne.2013.04.001; Schultz JD, 2001, J COMP PHYSIOL A, V187, P677; Schuppe ER, 2016, EVOL DEV, V18, P285, DOI 10.1111/ede.12207; Sengelaub DR, 2008, HORM BEHAV, V53, P596, DOI 10.1016/j.yhbeh.2007.11.008; St Mary C., 1994, BEHAV ECOLOGY, V5, P304, DOI DOI 10.1093/BEHEC0/5.3.304; Stewart TA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2159; Watson NV, 2001, J NEUROSCI, V21, P1062, DOI 10.1523/JNEUROSCI.21-03-01062.2001; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P1499, DOI 10.1249/01.MSS.0000139795.83030.D1; Zuloaga DG, 2008, HORM BEHAV, V53, P613, DOI 10.1016/j.yhbeh.2008.01.013	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177711	10.1371/journal.pone.0177711	http://dx.doi.org/10.1371/journal.pone.0177711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520775	gold, Green Published, Green Submitted			2022-12-27	WOS:000401485500061
J	Buchner, A; Illg, A; Majdani, O; Lenarz, T				Buechner, Andreas; Illg, Angelika; Majdani, Omid; Lenarz, Thomas			Investigation of the effect of cochlear implant electrode length on speech comprehension in quiet and noise compared with the results with users of electro-acoustic-stimulation, a retrospective analysis	PLOS ONE			English	Article							INSERTION DEPTH; HEARING PRESERVATION; SPIRAL GANGLION; PERCEPTION; RECOGNITION; PITCH; PLACE; PERFORMANCE; POSITION; OUTCOMES	Objectives This investigation evaluated the effect of cochlear implant (CI) electrode length on speech comprehension in quiet and noise and compare the results with those of EAS users. Methodes 91 adults with some degree of residual hearing were implanted with a FLEX20, FLEX24, or FLEX28 electrode. Some subjects were postoperative electric-acoustic-stimulation (EAS) users; the other subjects were in the groups of electric stimulation-only (ES-only). Speech perception was tested in quiet and noise at 3 and 6 months of ES or EAS use. Speech comprehension results were analyzed and correlated to electrode length. Results While the FLEX20 ES and FLEX24 ES groups were still in their learning phase between the 3 to 6 months interval, the FLEX28 ES group was already reaching a performance plateau at the three months appointment yielding remarkably high test scores. EAS subjects using FLEX20 or FLEX24 electrodes outscored ES-only subjects with the same short electrodes on all 3 tests at each interval, reaching significance with FLEX20 ES and FLEX24 ES subjects on all 3 tests at the 3-months interval and on 2 tests at the 6-months interval. Amongst ES-only subjects at the 3-months interval, FLEX28 ES subjects significantly outscored FLEX20 ES subjects on all 3 tests and the FLEX24 ES subjects on 2 tests. At the-6 months interval, FLEX28 ES subjects still exceeded the other ES-only subjects although the difference did not reach significance. Conclusions Among ES-only users, the FLEX28 ES users had the best speech comprehension scores, at the 3-months appointment and tendentially at the 6 months appointment. EAS users showed significantly better speech comprehension results compared to ES-only users with the same short electrodes.	[Buechner, Andreas; Illg, Angelika; Majdani, Omid; Lenarz, Thomas] Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany	Hannover Medical School	Illg, A (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany.	illg@hoerzentrum-hannover.de	Majdani, Omid/J-1372-2019	Majdani, Omid/0000-0002-8582-7204				Armstrong M, 1997, AM J OTOL, V18, pS140; Berenstein CK, 2008, EAR HEARING, V29, P250, DOI 10.1097/AUD.0b013e3181645336; Brockmeier SJ, 2010, ADV OTO-RHINO-LARYNG, V67, P70, DOI [10.1179/146701010X12671177440343, 10.1159/000262598]; Buchman CA, 2014, OTOL NEUROTOL, V35, P1773, DOI 10.1097/MAO.0000000000000541; Buchner A, 2009, AUDIOL NEURO-OTOL, V14, P8, DOI 10.1159/000206490; Causon A, 2015, OTOL NEUROTOL, V36, P1137, DOI 10.1097/MAO.0000000000000753; Ching TYC, 2004, EAR HEARING, V25, P9, DOI 10.1097/01.AUD.0000111261.84611.C8; Dorman MF, 2010, INT J AUDIOL, V49, P912, DOI 10.3109/14992027.2010.509113; Finley CC, 2008, OTOL NEUROTOL, V29, P920, DOI 10.1097/MAO.0b013e318184f492; Franke-Trieger A, 2014, OTOL NEUROTOL, V35, P58, DOI 10.1097/MAO.0000000000000211; Friesen L M, 2000, J Am Acad Audiol, V11, P418; Fu QJ, 1999, EAR HEARING, V20, P332, DOI 10.1097/00003446-199908000-00006; Gani M, 2007, JARO-J ASSOC RES OTO, V8, P69, DOI 10.1007/s10162-006-0065-4; Gantz BJ, 2003, LARYNGOSCOPE, V113, P1726, DOI 10.1097/00005537-200310000-00012; Gfeller Kate E, 2006, Audiol Neurootol, V11 Suppl 1, P12, DOI 10.1159/000095608; Hamzavi J, 2006, ACTA OTO-LARYNGOL, V126, P1182, DOI 10.1080/00016480600672683; Helbig S, 2008, ORL-J OTO-RHIN-LARYN, V70, P359, DOI 10.1159/000163031; Helbig S, 2011, OTOL NEUROTOL, V32, P973, DOI 10.1097/MAO.0b013e31822558c4; Hochmair Ingeborg, 2006, Trends Amplif, V10, P201, DOI 10.1177/1084713806296720; HochmairDesoyer I, 1997, AM J OTOL, V18, pS83; Illg A, 2014, OTOL NEUROTOL, V35, pE240, DOI 10.1097/MAO.0000000000000529; James Chris J, 2006, Audiol Neurootol, V11 Suppl 1, P57, DOI 10.1159/000095615; Kos MI, 2007, EUR ARCH OTO-RHINO-L, V264, P1369, DOI 10.1007/s00405-007-0354-5; Landsberger DM, 2016, EAR HEARING, V37, pE149, DOI 10.1097/AUD.0000000000000250; Landsberger DM, 2015, EAR HEARING, V36, pE207, DOI 10.1097/AUD.0000000000000163; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Lehnhardt E., 2001, PRAXIS AUDIOMETRIE, P173; Lenarz T, 2002, EAR HEARING, V23, p90S, DOI 10.1097/00003446-200202001-00011; Lenarz Thomas, 2006, Audiol Neurootol, V11 Suppl 1, P34, DOI 10.1159/000095612; Lorens A, 2008, LARYNGOSCOPE, V118, P288, DOI 10.1097/MLG.0b013e3181598887; Pelliccia P, 2014, ACTA OTORHINOLARYNGO, V34, P42; Rader T, 2016, HEARING RES, V339, P94, DOI 10.1016/j.heares.2016.06.013; Reiss LAJ, 2014, JARO-J ASSOC RES OTO, V15, P235, DOI 10.1007/s10162-013-0434-8; Schatzer R, 2014, HEARING RES, V309, P26, DOI 10.1016/j.heares.2013.11.003; Skarzynski H, 2014, Cochlear Implants Int, V15 Suppl 1, pS24, DOI 10.1179/1467010014Z.000000000187; Skinner MW, 2002, JARO-J ASSOC RES OTO, V3, P332, DOI 10.1007/s101620020013; Smith Z.M., 2013, IEEE ENG MED BIOL SO; Srinivasan AG, 2013, HEARING RES, V299, P29, DOI 10.1016/j.heares.2013.02.004; Stakhovskaya O, 2007, JARO-J ASSOC RES OTO, V8, P220, DOI 10.1007/s10162-007-0076-9; Tamir S, 2012, AUDIOL NEURO-OTOL, V17, P331, DOI 10.1159/000339894; Tillery KH, 2012, J ACOUST SOC AM, V131, P416, DOI 10.1121/1.3664101; Trieger A, 2011, OTOL NEUROTOL, V32, P152, DOI 10.1097/MAO.0b013e3181fcf04d; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; Tyler RS, 2002, EAR HEARING, V23, P98, DOI 10.1097/00003446-200204000-00003; van der Marel KS, 2015, AUDIOL NEURO-OTOL, V20, P202, DOI 10.1159/000377616; van der Marel KS, 2014, EAR HEARING, V35, pE9, DOI 10.1097/01.aud.0000436256.06395.63; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Yukawa K, 2004, AUDIOL NEURO-OTOL, V9, P163, DOI 10.1159/000077267	49	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0174900	10.1371/journal.pone.0174900	http://dx.doi.org/10.1371/journal.pone.0174900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505158	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500004
J	Rengstl, B; Kim, S; Doring, C; Weiser, C; Bein, J; Bankov, K; Herling, M; Newrzela, S; Hansmann, ML; Hartmann, S				Rengstl, Benjamin; Kim, Sooji; Doering, Claudia; Weiser, Christian; Bein, Julia; Bankov, Katrin; Herling, Marco; Newrzela, Sebastian; Hansmann, Martin-Leo; Hartmann, Sylvia			Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other	PLOS ONE			English	Article							CANCER STEM-CELLS; SIDE-POPULATION; PROTEIN BRCA2; B-CELLS; DISEASE; CYTOKINESIS; LYMPHOCYTES; IDENTIFICATION; TARGET; KM-H2	The hallmark of classical Hodgkin lymphoma (cHL) is the presence of giant, mostly multinucleated Hodgkin-Reed-Sternberg (HRS) cells. Whereas it has recently been shown that giant HRS cells evolve from small Hodgkin cells by incomplete cytokinesis and re-fusion of tethered sister cells, it remains unsolved why this phenomenon particularly takes place in this lymphoma and what the differences between these cell types of variable sizes are. The aim of the present study was to characterize microdissected small and giant HRS cells by gene expression profiling and to assess differences of clonal growth behavior as well as susceptibility toward cytotoxic intervention between these different cell types to provide more insight into their distinct cellular potential. Applying stringent filter criteria, only two differentially expressed genes between small and giant HRS cells, SHFM1 and LDHB, were identified. With looser filter criteria, 13 genes were identified to be differentially overexpressed in small compared to giant HRS cells. These were mainly related to energy metabolism and protein synthesis, further suggesting that small Hodgkin cells resemble the proliferative compartment of cHL. SHFM1, which is known to be involved in the generation of giant cells, was downregulated in giant RS cells at the RNA level. However, reduced mRNA levels of SHFM1, LDHB and HSPA8 did not translate into decreased protein levels in giant HRS cells. In cell culture experiments it was observed that the fraction of small and big HRS cells was adjusted to the basic level several days after enrichment of these populations via cell sorting, indicating that small and big HRS cells can reconstitute the full spectrum of cells usually observed in the culture. However, assessment of clonal growth of HRS cells indicated a significantly reduced potential of big HRS cells to form single cell colonies. Taken together, our findings pinpoint to strong similarities but also some differences between small and big HRS cells.	[Rengstl, Benjamin; Kim, Sooji; Doering, Claudia; Weiser, Christian; Bein, Julia; Bankov, Katrin; Newrzela, Sebastian; Hansmann, Martin-Leo; Hartmann, Sylvia] Goethe Univ, Dr Senckenberg Inst Pathol, Frankfurt, Germany; [Herling, Marco] Univ Cologne, Dept Internal Med 1, Lab Lymphocyte Signaling & Oncoproteome, Cologne, Germany; [Herling, Marco] Univ Cologne, CECAD, CIO Koln Bonn, Cologne, Germany; [Herling, Marco] Univ Cologne, CMMC, Cologne, Germany	Goethe University Frankfurt; University of Cologne; University of Cologne; University of Cologne	Hartmann, S (corresponding author), Goethe Univ, Dr Senckenberg Inst Pathol, Frankfurt, Germany.	s.hartmann@em.uni-frankfurt.de	Hartmann, Sylvia/AAJ-4376-2021		Deutsche Forschungsgemeinschaft [HA6145/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by the Deutsche Forschungsgemeinschaft (HA6145/2-1).	Chang KC, 2009, AM J CLIN PATHOL, V132, P50, DOI 10.1309/AJCPBDFR5L5UOAUZ; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; de Carvalho AX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124629; DREXLER HG, 1989, INT J CANCER, V43, P1083, DOI 10.1002/ijc.2910430622; Hartmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078812; Hartmann S, 2013, INT J CANCER, V133, P2609, DOI 10.1002/ijc.28273; HSU PL, 1991, INT J HEMATOL, V54, P315; HSU SM, 1988, BLOOD, V71, P1382; Jansen MPHM, 1999, J PATHOL, V189, P527; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Knecht H, 1996, ONCOGENE, V13, P947; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kuppers R, 2001, BLOOD, V97, P818, DOI 10.1182/blood.V97.3.818; Lajoie V, 2015, BLOOD, V125, P2101, DOI 10.1182/blood-2014-08-594176; Lekomtsev S, 2010, J CELL SCI, V123, P1395, DOI 10.1242/jcs.068015; Ma Y, 2008, BLOOD, V111, P2339, DOI 10.1182/blood-2007-09-112128; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Marston NJ, 1999, MOL CELL BIOL, V19, P4633; Nakashima M, 2010, CANCER SCI, V101, P2490, DOI 10.1111/j.1349-7006.2010.01693.x; NEWCOM SR, 1988, INT J CELL CLONING, V6, P417, DOI 10.1002/stem.5530060606; Reed D., 1902, JOHNS HOPKINS HOS RE, V10, P133; Rengstl B, 2013, P NATL ACAD SCI USA, V110, P20729, DOI 10.1073/pnas.1312509110; Renne C, 2005, BLOOD, V105, P4051, DOI 10.1182/blood-2004-10-4008; Shafer JA, 2010, LEUKEMIA LYMPHOMA, V51, P870, DOI 10.3109/10428191003713968; SINKOVICS JG, 1991, CRIT REV IMMUNOL, V11, P33; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; STEIN H, 1982, INT J CANCER, V30, P445, DOI 10.1002/ijc.2910300411; Sternberg C. U., 1898, Z HEILK, V19, P21; Teruya-Feldstein J, 2000, LEUKEMIA LYMPHOMA, V38, P363, DOI 10.3109/10428190009087027; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499	30	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177378	10.1371/journal.pone.0177378	http://dx.doi.org/10.1371/journal.pone.0177378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505189	Green Published, Green Submitted, gold			2022-12-27	WOS:000401473500019
J	Wei, LQ; Zhangi, XM; Lyu, C; Hu, SY; Li, Z				Wei, Liuqing; Zhangi, Xuemin; Lyu, Chuang; Hu, Siyuan; Li, Zhen			Brain activation of semantic category-based grouping in multiple identity tracking task	PLOS ONE			English	Article							OBJECT TRACKING; ATTENTIVE TRACKING; WORKING-MEMORY; EYE-MOVEMENTS; DEFICIT; KNOWLEDGE; ORGANIZATION; LANGUAGE; CORTEX; COMMON	Using Multiple Identity Tracking task and the functional magnetic resonance imaging (fMRI) technology, the present study aimed to isolate and visualize the functional anatomy of neural systems involved in the semantic category-based grouping process. Three experiment conditions were selected and compared: the category-based targets grouping (TG) condition, the targets-distractors grouping (TDG) condition and the homogenous condition. In the TG condition, observers could utilize the categorical distinction between targets and distractors, to construct a uniform presentation of targets, that is, to form a group of the targets to facilitate tracking. In the TDG condition, half the targets and half the distractors belonged to the same category. Observers had to inhibit the grouping of targets and distractors in one category to complete tracking. In the homogenous condition, where targets and distractors consisted of the same objects, no grouping could be formed. The "TG-Homogenous" contrast (p< 0.01) revealed the activation of the left fusiform and the pars triangularis of inferior frontal gyrus (IFG). The "TG-TDG" contrast only revealed the activation of the left anterior cingulate gyrus (ACC). The fusiform and IFG pars triangularis might participate in the representation of semantic knowledge, IFG pars triangularis might relate intensely with the classification of semantic categories. The ACC might be responsible for the initiation and maintenance of grouping representation.	[Wei, Liuqing; Zhangi, Xuemin; Lyu, Chuang; Hu, Siyuan] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing, Peoples R China; [Zhangi, Xuemin; Hu, Siyuan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Zhangi, Xuemin; Hu, Siyuan] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Zhangi, Xuemin; Hu, Siyuan] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing, Peoples R China; [Li, Zhen] EMetric LLC, San Antonio, TX USA	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Zhangi, XM (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing, Peoples R China.; Zhangi, XM (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Zhangi, XM (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Zhangi, XM (corresponding author), Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing, Peoples R China.	xmzhang@bnu.edu.cn			National Natural Science Foundation of China [31271083, 61632014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the General Program of National Natural Science Foundation of China (31271083) (to XZ) and the Key Program of National Natural Science Foundation of China (61632014) (to XZ). The funders provided support in the form of experimental expenses for authors [XZ, LW and CL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. eMetric, LLC provides support in the form of salaries for author [ZL], but did not play any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blundo C, 2006, COGN NEUROPSYCHOL, V23, P1248, DOI 10.1080/02643290600896449; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Chouinard PA, 2010, NEUROPSYCHOLOGIA, V48, P409, DOI 10.1016/j.neuropsychologia.2009.09.032; Clarke A, 2015, TRENDS COGN SCI, V19, P677, DOI 10.1016/j.tics.2015.08.008; Cohen MA, 2011, ATTEN PERCEPT PSYCHO, V73, P1422, DOI 10.3758/s13414-011-0089-7; Drew T, 2013, COGNITION, V126, P213, DOI 10.1016/j.cognition.2012.10.003; ELLIS AW, 1989, BRAIN, V112, P1469, DOI 10.1093/brain/112.6.1469; Fehd HM, 2008, COGNITION, V108, P201, DOI 10.1016/j.cognition.2007.11.008; Fehd HM, 2010, J VISION, V10, DOI 10.1167/10.4.19; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; George M S, 1994, Hum Brain Mapp, V1, P194, DOI 10.1002/hbm.460010305; HART J, 1985, NATURE, V316, P439, DOI 10.1038/316439a0; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; Howe PDL, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00307; Huff M, 2010, VIS COGN, V18, P1368, DOI 10.1080/13506285.2010.495878; Keane BP, 2011, J EXP PSYCHOL HUMAN, V37, P685, DOI 10.1037/a0020674; Laiacona M, 2001, COGNITIVE NEUROPSYCH, V18, P39, DOI 10.1080/02643290042000035; Liu TW, 2012, VISION RES, V66, P31, DOI 10.1016/j.visres.2012.06.009; Lukavsky J, 2013, J VISION, V13, DOI 10.1167/13.7.9; Lyu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145489; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Makovski T, 2009, J EXP PSYCHOL HUMAN, V35, P1687, DOI 10.1037/a0016453; Makovski T, 2009, VIS COGN, V17, P180, DOI 10.1080/13506280802211334; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Miceli G, 2000, COGN NEUROPSYCHOL, V17, P489, DOI 10.1080/02643290050110629; Ogawa H., 2002, JAPANESE J PSYCHONOM, V21, P49; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Ren DG, 2009, J VISION, V9, DOI 10.1167/9.5.18; SACCHETT C, 1992, COGNITIVE NEUROPSYCH, V9, P73, DOI 10.1080/02643299208252053; Samson D, 2003, COGN NEUROPSYCHOL, V20, P373, DOI 10.1080/02643290244000329; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Suganuma M, 2006, PERCEPTION, V35, P483, DOI 10.1068/p5487; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Wang CD, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00657; Wei LQ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00589; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; Zelinsky GJ, 2008, VIS COGN, V16, P553, DOI 10.1080/13506280802000752	49	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177709	10.1371/journal.pone.0177709	http://dx.doi.org/10.1371/journal.pone.0177709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505166	Green Submitted, Green Published, gold			2022-12-27	WOS:000401473500034
J	Gok, A; Ngendahimana, DK; Fagerholm, CL; French, RH; Sun, JY; Bruckman, LS				Gok, Abdulkerim; Ngendahimana, David K.; Fagerholm, Cara L.; French, Roger H.; Sun, Jiayang; Bruckman, Laura S.			Predictive models of poly(ethylene-terephthalate) film degradation under multi-factor accelerated weathering exposures	PLOS ONE			English	Article							PHOTOCHEMICAL DEGRADATION; ELECTRICAL-PROPERTIES; PHASE-CHANGE; KINETICS; PHOTODEGRADATION; HYDROLYSIS; MECHANISMS; SCATTERING; ANALYTICS; PARTICLES	Accelerated weathering exposures were performed on poly(ethylene-terephthalate) (PET) films. Longitudinal multi-level predictive models as a function of PET grades and exposure types were developed for the change in yellowness index (YI) and haze (%). Exposures with similar change in YI were modeled using a linear fixed-effects modeling approach. Due to the complex nature of haze formation, measurement uncertainty, and the differences in the samples' responses, the change in haze (%) depended on individual samples' responses and a linear mixed-effects modeling approach was used. When compared to fixed-effects models, the addition of random effects in the haze formation models significantly increased the variance explained. For both modeling approaches, diagnostic plots confirmed independence and homogeneity with normally distributed residual errors. Predictive R 2 values for true prediction error and predictive power of the models demonstrated that the models were not subject to over-fitting. These models enable prediction under pre-defined exposure conditions for a given exposure time (or photo-dosage in case of UV light exposure). PET degradation under cyclic exposures combining UV light and condensing humidity is caused by photolytic and hydrolytic mechanisms causing yellowing and haze formation. Quantitative knowledge of these degradation pathways enable cross-correlation of these lab-based exposures with real-world conditions for service life prediction.	[Gok, Abdulkerim] Gebze Tech Univ, Dept Mat Sci & Engn, Gebze, Kocaeli, Turkey; [Gok, Abdulkerim; Fagerholm, Cara L.; French, Roger H.; Bruckman, Laura S.] Case Western Reserve Univ, Dept Mat Sci & Engn, Solar Durabil & Lifetime Extens SDLE Res Ctr, Cleveland, OH 44106 USA; [Ngendahimana, David K.; Sun, Jiayang] Case Western Reserve Univ, Dept Epidemiol & Biostat, Ctr Stat Res Comp & Collaborat SR2c, Cleveland, OH 44106 USA	Gebze Technical University; Case Western Reserve University; Case Western Reserve University	Gok, A (corresponding author), Gebze Tech Univ, Dept Mat Sci & Engn, Gebze, Kocaeli, Turkey.; Gok, A; Bruckman, LS (corresponding author), Case Western Reserve Univ, Dept Mat Sci & Engn, Solar Durabil & Lifetime Extens SDLE Res Ctr, Cleveland, OH 44106 USA.	agok@gtu.edu.tr; laura.bruckman@case.edu	Gok, Abdulkerim/Y-8830-2019; French, Roger H/E-1986-2011; Bruckman, Laura/X-4067-2019	Gok, Abdulkerim/0000-0003-3433-7106; French, Roger H/0000-0002-6162-0532; Bruckman, Laura/0000-0003-1271-1072; Sun, Jiayang/0000-0002-0870-7014	3M Company Corporate Research Analytical Laboratory [1401945]; Ohio Third Frontier, Wright Project Program Award Tech [12-004]	3M Company Corporate Research Analytical Laboratory(3M); Ohio Third Frontier, Wright Project Program Award Tech	This research was supported by 3M Company Corporate Research Analytical Laboratory (Agreement Control Number: 1401945), and performed at the Solar Durability and Lifetime Extension (SDLE) Research Center (funded through Ohio Third Frontier, Wright Project Program Award Tech 12-004) at Case Western Reserve University. The funders had no role in study design, data collection and analysis, interpretation of data, writing of the paper, or decision to submit for publication.; This research was performed at Solar Durability and Lifetime Extension (SDLE) Research Center (funded through Ohio Third Frontier, Wright Project Program Award Tech 12-004) at Case Western Reserve University. The authors would like to thank Tekra Corp. for providing samples.	ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; ALLEN DM, 1971, TECHNOMETRICS, V13, P469, DOI 10.2307/1267161; [Anonymous], 2013, J MAT, DOI DOI 10.1155/2013/102691; [Anonymous], 2010, G172022010E1 ASTM; [Anonymous], WK57612 ASTM; [Anonymous], 2016, G15416 ASTM; [Anonymous], WK55620 ASTM; [Anonymous], 2011, G166002011 ASTM; [Anonymous], 2015, E31315E1 ASTM; [Anonymous], 2013, D100313 ASTM; [Anonymous], 2012, G17303 ASTM; Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Avrami M., 1940, J CHEM PHYS, V8, P212, DOI [DOI 10.1063/1.1750631, 10.1063/1.1750631]; Bates D.M., 2010, LME4 MIXED EFFECTS M; Bruckman LS, 2013, PROC SPIE, V8825, DOI 10.1117/12.2024717; Bruckman LS, 2013, IEEE ACCESS, V1, P384, DOI 10.1109/ACCESS.2013.2267611; BUXBAUM LH, 1968, ANGEW CHEM INT EDIT, V7, P182, DOI 10.1002/anie.196801821; DAY M, 1971, J POLYM SCI POL LETT, V9, P665, DOI 10.1002/pol.1971.110090906; DAY M, 1972, J APPL POLYM SCI, V16, P191, DOI 10.1002/app.1972.070160117; DAY M, 1972, J APPL POLYM SCI, V16, P203, DOI 10.1002/app.1972.070160118; DAY M, 1972, J APPL POLYM SCI, V16, P175, DOI 10.1002/app.1972.070160116; Diez DM, 2015, CETINKAYA RUNDEL M O; Faraway J.J., 2002, PRACTICAL REGRESSION; Felder TC, 2014, P SOC PHOTO-OPT INS, V9179; French RH, 2015, CURR OPIN SOLID ST M, V19, P212, DOI 10.1016/j.cossms.2014.12.008; Gok Abdulkerim, 2015, 2015 IEEE 42nd Photovoltaic Specialist Conference (PVSC). Proceedings, P1, DOI 10.1109/PVSC.2015.7355601; Gok Abdulkerim, 2016, DEGRADATION PATHWAY; HASTIE T, 2009, SPRINGER SERIES STAT; Hossain MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131279; IEC, 2016, 61215 IEC; ILISKOVIC N, 1986, POLYM DEGRAD STABIL, V15, P173, DOI 10.1016/0141-3910(86)90071-6; ILISKOVIC N, 1985, POLYM DEGRAD STABIL, V13, P139, DOI 10.1016/0141-3910(85)90063-1; James G., 2014, INTRO STAT LEARNING; Kaci M, 2001, J APPL POLYM SCI, V82, P3284, DOI 10.1002/app.2187; Koehl M, 2009, POLYM FILMS PHOTOVOL; Koehl M, 2012, SOL ENERG MAT SOL C, V99, P282, DOI 10.1016/j.solmat.2011.12.011; Koehl M, 2011, SOL ENERG MAT SOL C, V95, P1638, DOI 10.1016/j.solmat.2011.01.020; Kontges M, 2014, PERFORMANCE RELIABIL; LAUNAY A, 1994, POLYM DEGRAD STABIL, V46, P319, DOI 10.1016/0141-3910(94)90148-1; McMahon W., 1959, J CHEM ENG DATA, V4, P57, DOI DOI 10.1021/JE60001A009; McNeil LE, 2001, J APPL PHYS, V89, P1898, DOI 10.1063/1.1336564; Murray MP, 2012, MRS ONLINE P LIB, V1391; Murray MP, 2012, J PHOTON ENERGY, V2, DOI 10.1117/1.JPE.2.022004; Nettleton D, 2006, PLANT CELL, V18, P2112, DOI 10.1105/tpc.106.041616; Novoa FD, 2014, SOL ENERG MAT SOL C, V120, P87, DOI 10.1016/j.solmat.2013.08.020; Oreski G, 2005, SOL ENERGY, V79, P612, DOI 10.1016/j.solener.2005.02.008; Oreski G, 2011, QUALIFICATION POLYM, V8112; Peshek TJ, 2016, J VAC SCI TECHNOL B, V34, DOI 10.1116/1.4960628; Pickett J. E., 2015, SERVICE LIFE PREDICT, P41, DOI [DOI 10.1007/978-3-319-06034-7_3, 10.1007/978-3-319-06034-7_3]; Pickett JE, 2013, POLYM DEGRAD STABIL, V98, P1311, DOI 10.1016/j.polymdegradstab.2013.04.001; Pickett JE, 2000, ENVIR SC P, V21, P163; PICKETT JE, 1993, POLYM DEGRAD STABIL, V42, P231, DOI 10.1016/0141-3910(93)90219-9; RAVINDRANATH K, 1986, CHEM ENG SCI, V41, P2197, DOI 10.1016/0009-2509(86)85070-9; Ross RG, 2014, IEEE J PHOTOVOLT, V4, P291, DOI 10.1109/JPHOTOV.2013.2281102; Thiele ES, 1998, J AM CERAM SOC, V81, P469, DOI 10.1111/j.1151-2916.1998.tb02364.x; Trentin A, 2013, IEEE ENER CONV, P1, DOI 10.1109/ECCE.2013.6646673; Turnbull L, 2012, J APPL POLYM SCI, V124, P4517, DOI 10.1002/app.35476; Wheeler NR, 2015, P SOC PHOTO-OPT INS, V9563; Wheeler NR, 2014, 40 IEEE PVSC; Whitfield K, 2012, 2012 38TH IEEE PHOTOVOLTAIC SPECIALISTS CONFERENCE (PVSC), P1864, DOI 10.1109/PVSC.2012.6317957; Xia Z, 2009, PHOT SPEC C PVSC 200, P000523	62	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177614	10.1371/journal.pone.0177614	http://dx.doi.org/10.1371/journal.pone.0177614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498875	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314500033
J	Li, YM; Li, JW; Liu, H; Liu, YL; Cui, BB				Li, Yongmin; Li, Jingwen; Liu, He; Liu, Yanlong; Cui, Binbin			Expression of MYSM1 is associated with tumor progression in colorectal cancer	PLOS ONE			English	Article							STEM-CELL MAINTENANCE; DIFFERENTIATION; CARCINOMA; COMPLEX; CHAINS	Colorectal cancer, the third most common cancer in both men and women, has gradually increased in recent years. MYSM1has been investigated as a regulator of hematopoiesis and lymphocyte development in human. It has been reported that some tumor-related genes were modulated by MYSM1. However, its exact role in cancer development remains unclear. Herein, we aimed to examine the expression level of MYSM1 in tumor tissues and its correlation with clinicopathology and survivals of patients with colorectal cancer (CRC). MYSM1expressions in tumor specimens resected from 123 CRC patients were detected by immunochemistry and Western blot analysis. The results showed that MYSM1 was significantly highly expressed in carcinoma tissues compared with adjacent normal mucosa tissues (P<0.05). Correlation analyses by Pearson's chi-square test demonstrated that MYSM1 in tumors was positively correlated with tumor status (pathological assessment of the primary tumor (pT, P<0.001), regional lymph nodes (pN, P = 0.013), distant metastasis (pM, P<0.001)) and clinic stage (P<0.001); Whereas, MYSM1 was not associated with tumor size of CRC patients and was positively associated with tumor differentiation grade (P = 0.015). Patients with positiveMYSM1expression showed poor survival compared with the MYSM1 negative group (P<0.001). Simultaneously, multivariate Cox regression analysis indicated thatMYSM1 expression in tumor cells was an independent factor for reduced overall survival in CRC patients (P<0.001). Additionally, MYSM1 in CRC SW480 cells was silenced by small interference RNA (siRNA) technology. Scratch assay and Transwell assay showed that MYSM1 silencing decreased migration and invasion abilities of SW480 cells. These data suggested that expression of MYSM1 was associated with the progression of CRC and might be a potential biomarker for clinical prognosis.	[Li, Yongmin; Li, Jingwen; Liu, He; Liu, Yanlong; Cui, Binbin] Harbin Med Univ, Affiliated Tumor Hosp, Dept Colorectal Surg, Harbin, Peoples R China	Harbin Medical University	Liu, YL; Cui, BB (corresponding author), Harbin Med Univ, Affiliated Tumor Hosp, Dept Colorectal Surg, Harbin, Peoples R China.	lyanlong77@163.com; cuibbin328@163.com	Liu, Yanlong/AAL-3503-2021		National Natural Science Foundation of China [81272704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 81272704). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the National Natural Science Foundation of China (Grant No. 81272704). Deliberated by the Harbin Medical University ethics committee, the present project declared by Binbin Cui involving the use of clinical specimens meets the medical ethics review requirements from Harbin Medical University, agreed to declare.	Belle JI, 2016, CELL DEATH DIFFER, V23, P759, DOI 10.1038/cdd.2015.140; Belle JI, 2015, BLOOD, V125, P2344, DOI 10.1182/blood-2014-05-574111; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Gu YC, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1841; Hong J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060767; Hu J, 2015, LUNG CANCER, V88, P239, DOI 10.1016/j.lungcan.2015.02.019; Jiang XX, 2011, IMMUNITY, V35, P883, DOI 10.1016/j.immuni.2011.11.010; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu YL, 2010, J GASTROEN HEPATOL, V25, P1800, DOI 10.1111/j.1440-1746.2010.06352.x; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Nijnik A, 2012, BLOOD, V119, P1370, DOI 10.1182/blood-2011-05-352666; O'Sullivan Brian, 2003, Semin Surg Oncol, V21, P30, DOI 10.1002/ssu.10019; Qian SH, 2016, ONCOL REP, V35, P3705, DOI 10.3892/or.2016.4705; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Wang T, 2013, BLOOD, V122, P2812, DOI 10.1182/blood-2013-03-489641; Wang ZJ, 2015, HUM PATHOL, V46, P1006, DOI 10.1016/j.humpath.2015.04.001; Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60; Zhou L, 2016, TUMOR BIOL, V37, P15583, DOI 10.1007/s13277-015-4138-z; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	20	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177235	10.1371/journal.pone.0177235	http://dx.doi.org/10.1371/journal.pone.0177235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498834	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314500013
J	Liu, C; Wang, SF; Xu, WL; Liu, XX				Liu, Chen; Wang, Shufen; Xu, Wenling; Liu, Xianxian			Genome-wide transcriptome profiling of radish (Raphanus sativus L.) in response to vernalization	PLOS ONE			English	Article							FLOWERING-TIME CONTROL; CHROMATIN MODIFICATION; HISTONE METHYLATION; COLD-ACCLIMATION; CBF GENES; LOCUS-C; RNA-SEQ; ARABIDOPSIS; COMPLEX; FLC	Vernalization is a key process for premature bolting. Although many studies on vernalization have been reported, the molecular mechanism of vernalization is still largely unknown in radish. In this study, we sequenced the transcriptomes of radish seedlings at three different time points during vernalization. More than 36 million clean reads were generated for each sample and the portions mapped to the reference genome were all above 67.0%. Our results show that the differentially expressed genes (DEGs) between room temperature and the early stage of vernalization (4,845) are the most in all treatments pairs. A series of vernalization related genes, including two FLOWERING LOCUS C (FLC) genes, were screened according to the annotations. A total of 775 genes were also filtered as the vernalization related candidates based on their expression profiles. Cold stress responsive genes were also analyzed to further confirm the sequencing result. Several key genes in vernalization or cold stress response were validated by quantitative RT-PCR (RT-qPCR). This study identified a number of genes that may be involved in vernalization, which are useful for other functional genomics research in radish.	[Liu, Chen; Wang, Shufen; Xu, Wenling; Liu, Xianxian] Shandong Acad Agr Sci, Natl Vegetable Improvement Ctr, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol,Shando, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Wang, SF (corresponding author), Shandong Acad Agr Sci, Natl Vegetable Improvement Ctr, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol,Shando, Jinan, Shandong, Peoples R China.	mwangshufen@sina.com			Modern Agricultural Industrial Technology System Funding of Shandong Province, China [SDAIT-05-01]; Youth Foundation of Shandong Academy of Agricultural Sciences [2016YQN22]; National Science and Technology Pillar Program [2012BAD02B01-6, 2013BAD01B04-18]; National Key Research and Development Program of China [2016YFD0100204-27]; "948" Project, China [2015Z60]	Modern Agricultural Industrial Technology System Funding of Shandong Province, China; Youth Foundation of Shandong Academy of Agricultural Sciences; National Science and Technology Pillar Program; National Key Research and Development Program of China; "948" Project, China	This study was supported by the Modern Agricultural Industrial Technology System Funding of Shandong Province, China (project no. SDAIT-05-01, http://cyjstx.sdny.gov.cn/, SW), the Youth Foundation of Shandong Academy of Agricultural Sciences (project no. 2016YQN22, http://www.saas.ac.cn/saas/, CL), the National Science and Technology Pillar Program during the 12th Five Year Plan of China (project no. 2012BAD02B01-6, http://www.most.gov.cn/, SW and 2013BAD01B04-18, http://www.most.gov.cn/, XL), the National Key Research and Development Program of China (project no. 2016YFD0100204-27, http://www.most.gov.cn/, XL), the "948" Project, China (project no. 2015Z60, http.://www.most.gov.cn/, WX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bergonzi S, 2013, SCIENCE, V340, P1094, DOI 10.1126/science.1234116; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; Chanter D., 1990, TEACHING STAT, V12, P90; Choi K, 2011, PLANT CELL, V23, P289, DOI 10.1105/tpc.110.075911; Dhankhar B. S., 2006, Haryana Journal of Horticultural Sciences, V35, P324; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Guo Jun, 2014, Acta Agriculturae Zhejiangensis, V26, P656; Han T, 2013, CHINA VEGETABLES, P93; Han TaiLi, 2009, Acta Horticulturae Sinica, V36, P151; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kalia P, 2004, INDIAN HORTICULTURE, V49, P33; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Dong-Hwan, 2014, Arabidopsis Book, V12, pe0171, DOI 10.1199/tab.0171; Kim DH, 2013, PLANT CELL, V25, P454, DOI 10.1105/tpc.112.104760; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kitashiba H, 2014, DNA RES, V21, P481, DOI 10.1093/dnares/dsu014; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kurepin LV, 2013, INT J MOL SCI, V14, P12729, DOI 10.3390/ijms140612729; Lee YP, 2008, THEOR APPL GENET, V117, P905, DOI 10.1007/s00122-008-0830-3; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Liu X., 2016, SCI PROGRAM, V2016, P14, DOI DOI 10.1016/J.CELREP.2016.01.038; Lu ZhaoLiang, 2008, Agricultural Sciences in China, V7, P823, DOI 10.1016/S1671-2927(08)60119-4; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mei SY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010042; Mitsui Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10835; NIEUWHOF M, 1991, EUPHYTICA, V55, P171, DOI 10.1007/BF00025230; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Park Hyun Ji, 2015, Journal of Plant Biotechnology, V42, P215, DOI 10.5010/JPB.2015.42.3.215; Park S, 2007, INT J PLANT BREEDING, V1, P119; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pin PA, 2012, CURR BIOL, V22, P1095, DOI 10.1016/j.cub.2012.04.007; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Su Hua, 2007, Acta Horticulturae Sinica, V34, P671; Sun MX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141446; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vagujfalvi A, 2005, MOL GENET GENOMICS, V274, P506, DOI 10.1007/s00438-005-0047-y; [王利琳 Wang Lilin], 2004, [浙江大学学报. 理学版, Journal of Zhejiang University], V31, P202; Wang M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1629-7; Wang S, 2012, SHANDONG AGR SCI, V44, P133; Wang S, 2016, SHANDONG AGR SCI, V48, P32; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Xu F, 2012, INT J MOL SCI, V13, P3773, DOI 10.3390/ijms13033773; Yi G, 2015, HORTIC ENVIRON BIOTE, V55, P548; Zhang BingKui, 2012, Acta Horticulturae Sinica, V39, P399; Zhang H, 2014, J CHANGJIANG VEGETAB, P13; Zhang H., 2011, OPTICAL ENG, V50, P1; Zou XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045751	58	10	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177594	10.1371/journal.pone.0177594	http://dx.doi.org/10.1371/journal.pone.0177594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498850	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314500031
J	Allotey, P; Allotey-Reidpath, C; Reidpath, DD				Allotey, Pascale; Allotey-Reidpath, Caitlin; Reidpath, Daniel D.			Gender bias in clinical case reports: A cross-sectional study of the "big five" medical journals	PLOS ONE			English	Article								Background Gender bias in medical journals can affect the science and the benefit to patients. It has never been investigated in clinical case reports. The oversight is important because of the role clinical case reports play in hypothesis generation and medical education. We investigated contemporary gender bias in case reports for the highest ranked journals in general and internal medicine. Methods PubMed case reports data from 2011 to 2016 were extracted for the Annals of Internal Medicine, British Medical Journal, the Journal of the American Medical Association, The Lancet, and New England Journal of Medicine. The gender of the patients were identified and a text analysis of the Medical Subject Headings conducted. Results A total of 2,742 case reports were downloaded and 2,582 (95.6%) reports contributed to the final analysis. A pooled analysis showed a statistically significant gender bias against female case reports (0.45; 95% CI: 0.43 - 0.47). The Annals of Internal Medicine was the only journal with a point estimate (non significant) in the direction of a bias against male patients. The text analysis identified no substantive difference in the focus of the case reports and no obvious explanation for the bias. Conclusion Gender bias, previously identified in clinical research and in clinical authorship, extends into the patients presented in clinical case reports. Whether it is driven by authors or editors is not clear, but it likely contributes to and supports an overall male bias of clinical medicine.	[Allotey, Pascale; Reidpath, Daniel D.] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Malaysia; [Allotey-Reidpath, Caitlin; Reidpath, Daniel D.] Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland	Monash University; Monash University Sunway; University of Edinburgh	Reidpath, DD (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Malaysia.; Reidpath, DD (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland.	daniel.reidpath@monash.edu		Allotey, Pascale/0000-0002-6942-5774; Reidpath, Daniel/0000-0002-8796-0420				[Anonymous], 2021, LANG ENV STAT COMP; Dijkstra AF, 2008, MED EDUC, V42, P1021, DOI 10.1111/j.1365-2923.2008.03150.x; Filardo G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i847; Florek AG, 2016, J MED CASE REPORTS, P10; Grimes DA, 2002, LANCET, V359, P145, DOI 10.1016/S0140-6736(02)07373-7; Hamberg K, 2008, WOMENS HEALTH, V4, P237, DOI 10.2217/17455057.4.3.237; Heidari Shirin, 2016, Res Integr Peer Rev, V1, P2, DOI 10.1186/s41073-016-0007-6; Kovalchik S., 2016, RISMED DOWNLOAD CONT; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Nissen Trygve, 2014, BMC Res Notes, V7, P264, DOI 10.1186/1756-0500-7-264; Ovseiko PV, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0126-z; Pierson DJ, 2009, RESP CARE, V54, P1372; Rabesandratana T., 2014, SCI AAAS; Reidpath DD, 2000, STAT MED, V19, P1295, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1295::AID-SIM493>3.0.CO;2-Z; Reidpath DD, 2016, R SCRIPT EXTRACTING; ROLAND CG, 1968, J AMER MED ASSOC, V205, P281, DOI 10.1001/jama.205.5.281; Schiebinger L, 2003, J CLIN INVEST, V112, P973, DOI 10.1172/JCI200329993; Schiebinger L, 2016, J AM COLL CARDIOL, V67, P136, DOI 10.1016/j.jacc.2015.11.029; Sniderman AD, 1996, CAN J CARDIOL, V12, P1031; Thomson Reuters, 2015, INC J CIT REP; Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0	21	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177386	10.1371/journal.pone.0177386	http://dx.doi.org/10.1371/journal.pone.0177386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493948	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314300100
J	De Pascale, G; Pennisi, MA; Vallecoccia, MS; Bello, G; Maviglia, R; Montini, L; Di Gravio, V; Cutuli, SL; Conti, G; Antonelli, M				De Pascale, Gennaro; Pennisi, Mariano Alberto; Vallecoccia, Maria Sole; Bello, Giuseppe; Maviglia, Riccardo; Montini, Luca; Di Gravio, Valentina; Cutuli, Salvatore Lucio; Conti, Giorgio; Antonelli, Massimo			CO2 driven endotracheal tube cuff control in critically ill patients: A randomized controlled study	PLOS ONE			English	Article							SUBGLOTTIC SECRETION DRAINAGE; VENTILATOR-ASSOCIATED PNEUMONIA; PRESSURE CONTROL; POLYURETHANE; INTUBATION; PREVENTION; SCORE	Background To determine the safety and clinical efficacy of an innovative integrated airway system (AnapnoGuard(TM) 100 system) that continuously monitors and controls the cuff pressure (P-cuff), while facilitating the aspiration of subglottic secretions (SS). Methods This was a prospective, single centre, open-label, randomized, controlled feasibility and safety trial. The primary endpoint of the study was the rate of device related adverse events (AE) and serious AE (SAE) as a result of using AnapnoGuard (AG) 100 during mechanical ventilation. Secondary endpoints were: (1) mechanical complications rate (2) ICU staff satisfaction; (3) VAP occurrence; (4) length of mechanical ventilation; (5) length of Intensive Care Unit stay and mortality; (6) volume of evacuated subglottic secretions. Sixty patients were randomized to be intubated with the AG endotracheal-tube (ETT) and connected to the AG 100 system allowing P-cuff adjustment and SS aspiration; or with an ETT combined with SS drainage and P-cuff controlled manually. Results No difference in adverse events rate was identified between the groups. The use of AG system was associated with a significantly higher incidence of P-cuff determinations in the safety range (97.3% vs. 71%; p<0.01) and a trend to a greater volume of aspirated SS secretions: (192.0[64-413] ml vs. 150[50-200], p = 0.19 (total)); (57.8[20-88.7] ml vs. 50[18.7-62] ml, p = 0.11 (daily)). No inter-group difference was detected using AG system vs. controls in terms of post-extubation throat pain level (0 [0-2] vs. 0 [0-3]; p = 0.7), hoarseness (42.9% vs. 75%; p = 0.55) and tracheal mucosa oedema (16.7% vs. 10%; p = 0.65). Patients enrolled in the AG group had a trend to reduced VAP risk of ventilator-associated pneumonia(VAP) (14.8% vs. 40%; p = 0.06), which were more frequently monomicrobial (25% vs. 70%; p = 0.03). No statistically significant difference was observed in duration of mechanical ventilation, ICU stay, and mortality. Conclusions The use AG 100 system and AG tube in critically ill intubated patients is safe and effective in P-cuff control and SS drainage. Its protective role against VAP needs to be confirmed in a larger randomized trial.	[De Pascale, Gennaro; Pennisi, Mariano Alberto; Vallecoccia, Maria Sole; Bello, Giuseppe; Maviglia, Riccardo; Montini, Luca; Di Gravio, Valentina; Cutuli, Salvatore Lucio; Conti, Giorgio; Antonelli, Massimo] Sacro Cuore Catholic Univ, A Gemelli Hosp, Dept Anesthesiol & Intens Care, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Pascale, G (corresponding author), Sacro Cuore Catholic Univ, A Gemelli Hosp, Dept Anesthesiol & Intens Care, Rome, Italy.	gennaro.depascalemd@gmail.com	Montini, Luca/GVT-8378-2022; Conti, Giorgio/AAB-9546-2022; maviglia, riccardo/AAK-9195-2020; Bello, Giuseppe/AAC-2548-2019; , SLC/H-8204-2016	Conti, Giorgio/0000-0002-8566-9365; MONTINI, Luca/0000-0003-4602-5134; PENNISI, Mariano Alberto/0000-0001-8761-5144; maviglia, riccardo/0000-0001-8009-6943	Hospitech Respiration LTD (Petach-Tikva, Israel)	Hospitech Respiration LTD (Petach-Tikva, Israel)	The study was sponsored by Hospitech Respiration LTD (Petach-Tikva, Israel). The funders contributed to the study design and data analysis but they did not have any role in data collection, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Berra L, 2004, CRIT CARE MED, V32, P2071, DOI 10.1097/01.CCM.0000142575.86468.9B; Caroff DA, 2016, CRIT CARE MED, V44, P830, DOI 10.1097/CCM.0000000000001414; Chenelle CT, 2015, AM J RESP CRIT CARE, V192, P639; CRAVEN DE, 1988, INFECT CONT HOSP EP, V9, P57, DOI 10.2307/30144142; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Deslee G, 2000, AM J RESP CRIT CARE, V162, P1169, DOI 10.1164/ajrccm.162.3.9910047; Dezfulian C, 2005, AM J MED, V118, P11, DOI 10.1016/j.amjmed.2004.07.051; Duguet A, 2007, INTENS CARE MED, V33, P128, DOI 10.1007/s00134-006-0417-x; Dullenkopf A, 2003, INTENS CARE MED, V29, P1849, DOI 10.1007/s00134-003-1933-6; Efrati S, 2005, ANESTH ANALG, V101, P1081, DOI 10.1213/01.ane.0000167641.64815.1a; Efrati S, 2014, J CLIN MONITORING CO; Efrati S, 2010, INTENS CARE MED, V36, P984, DOI 10.1007/s00134-010-1835-3; ESTES RJ, 1995, INTENS CARE MED, V21, P365, DOI 10.1007/BF01705418; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; File TM, 2010, CLIN INFECT DIS, V51, pS42, DOI 10.1086/653048; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LOESER EA, 1978, ANESTH ANALG, V57, P577, DOI 10.1213/00000539-197857050-00013; Lorente L, 2007, AM J RESP CRIT CARE, V176, P1079, DOI 10.1164/rccm.200705-761OC; Lorente L, 2014, CRIT CARE, V18, DOI 10.1186/cc13837; Muscedere J, 2011, CRIT CARE MED, V39, P1985, DOI 10.1097/CCM.0b013e318218a4d9; Nseir S, 2007, CRIT CARE, V11, DOI 10.1186/cc6142; Nseir S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0087-3; Nseir S, 2011, AM J RESP CRIT CARE, V184, P1041, DOI 10.1164/rccm.201104-0630OC; Nseir S, 2009, EUR J ANAESTH, V26, P229, DOI 10.1097/EJA.0b013e3283222b6e; Philippart F, 2015, AM J RESP CRIT CARE, V191, P637, DOI 10.1164/rccm.201408-1398OC; Pirrone M, 2016, CURR OPIN INFECT DIS, V29, P160, DOI 10.1097/QCO.0000000000000255; Rello J, 1996, AM J RESP CRIT CARE, V154, P111, DOI 10.1164/ajrccm.154.1.8680665; SEEGOBIN RD, 1984, BRIT MED J, V288, P965, DOI 10.1136/bmj.288.6422.965; Smulders K, 2002, CHEST, V121, P858, DOI 10.1378/chest.121.3.858; Stauffer JL, 1994, PRINCIPLES PRACTICE, P711; Valencia M, 2007, CRIT CARE MED, V35, P1543, DOI 10.1097/01.CCM.0000266686.95843.7D; Vallecoccia MS, 2015, MINERVA ANESTESIOL, V81, P352; Zanella A, 2011, INTENS CARE MED, V37, P343, DOI 10.1007/s00134-010-2106-z	34	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0175476	10.1371/journal.pone.0175476	http://dx.doi.org/10.1371/journal.pone.0175476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493877	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300006
J	Khan, MN; Islam, MM; Shariff, AA; Alam, MM; Rahman, MM				Khan, Md Nuruzzaman; Islam, M. Mofizul; Shariff, Asma Ahmad; Alam, Md Mahmudul; Rahman, Md Mostafizur			Socio-demographic predictors and average annual rates of caesarean section in Bangladesh between 2004 and 2014	PLOS ONE			English	Article							MATERNAL OBESITY; DECISION-MAKING; PREGNANCY; DELIVERY; RISK; BIRTH; OUTCOMES; WEIGHT; COMPLICATIONS; DETERMINANTS	Background Globally the rates of caesarean section (CS) have steadily increased in recent decades. This rise is not fully accounted for by increases in clinical factors which indicate the need for CS. We investigated the socio-demographic predictors of CS and the average annual rates of CS in Bangladesh between 2004 and 2014. Methods Data were derived from four waves of nationally representative Bangladesh Demographic and Health Survey (BDHS) conducted between 2004 and 2014. Rate of change analysis was used to calculate the average annual rate of increase in CS from 2004 to 2014, by socio-demographic categories. Multi-level logistic regression was used to identify the socio-demographic predictors of CS in a cross-sectional analysis of the 2014 BDHS data. Result CS rates increased from 3.5% in 2004 to 23% in 2014. The average annual rate of increase in CS was higher among women of advanced maternal age (>= 35 years), urban areas, and relatively high socio-economic status; with higher education, and who regularly accessed antenatal services. The multi-level logistic regression model indicated that lower (<= 19) and advanced maternal age (>= 35), urban location, relatively high socio-economic status, higher education, birth of few children (<= 2), antenatal healthcare visits, overweight or obese were the key factors associated with increased utilization of CS. Underweight was a protective factor for CS. Conclusion The use of CS has increased considerably in Bangladesh over the survey years. This rising trend and the risk of having CS vary significantly across regions and socio-economic status. Very high use of CS among women of relatively high socio-economic status and substantial urban-rural difference call for public awareness and practice guideline enforcement aimed at optimizing the use of CS.	[Khan, Md Nuruzzaman] Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh; [Islam, M. Mofizul] La Trobe Univ, Dept Publ Hlth, Melbourne, Vic, Australia; [Shariff, Asma Ahmad] Univ Malaya, Ctr Fdn Studies Sci, Kuala Lumpur, Malaysia; [Alam, Md Mahmudul] Univ Rajshahi, Dept Stat, Rajshahi, Bangladesh; [Rahman, Md Mostafizur] Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh	La Trobe University; Universiti Malaya; University of Rajshahi; University of Rajshahi	Rahman, MM (corresponding author), Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh.	mos_pshd@yahoo.com	Khan, Nuruzzaman/K-8677-2019	Khan, Md Nuruzzaman/0000-0002-4550-4363	Department of Population Science and Human Resource Development, University of Rajshahi, Bangladesh	Department of Population Science and Human Resource Development, University of Rajshahi, Bangladesh	Data used in this study has been collected from MEASURE DHS Archive. The authors thank MEASURE DHS for granting permission to use the data. The authors also acknowledge the support of Department of Population Science and Human Resource Development, University of Rajshahi, Bangladesh, where this study was conducted.	Ahmed I, 2016, PAK J MED SCI, V32, P314, DOI 10.12669/pjms.322.9138; Al-Kubaisy W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-235; Althabe F, 2006, LANCET, V368, P1472, DOI 10.1016/S0140-6736(06)69616-5; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2004, BDHS BANGL DEM HLTH; [Anonymous], 2007, BDHS BANGL DEM HLTH; [Anonymous], 2011, BDHS BANGL DEM HLTH; [Anonymous], 2013, BDHS BANGL DEM HLTH; Anwar I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120309; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Arsenault C, 2013, B WORLD HEALTH ORGAN, V91, P207, DOI 10.2471/BLT.12.108969; Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; BETRAN AP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148343; Brown K, 2010, WOMENS HEALTH, V6, P197, DOI 10.2217/WHE.10.9; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, V91, P914, DOI 10.2471/BLT.13.117598; Chongsuvivatwong V, 2010, J OBSTET GYNAECOL RE, V36, P45, DOI 10.1111/j.1447-0756.2009.01100.x; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Collin Simon M, 2007, Int J Equity Health, V6, P9, DOI 10.1186/1475-9276-6-9; Darmasseelane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087896; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; Diamond-Smith N, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-6; Djelantik AAAMJ, 2012, BJOG-INT J OBSTET GY, V119, P283, DOI 10.1111/j.1471-0528.2011.03205.x; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Edwards LE, 1996, OBSTET GYNECOL, V87, P389, DOI 10.1016/0029-7844(95)00446-7; Epstein RM, 2013, MED CARE RES REV, V70, p94S, DOI 10.1177/1077558712459216; Fabri R, 2015, INT J GYNECOL OBSTET, V76, p87 ; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Gaillard R, 2014, HYPERTENSION, V63, P683, DOI 10.1161/HYPERTENSIONAHA.113.02671; Hasan F SM, 2015, MAL J NUTR, V21, P345; Kamal S. M. M., 2009, Asian Population Studies, V5, P153, DOI 10.1080/17441730902992075; Kamal SMM, 2013, J HEALTH POPUL NUTR, V31, P96; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Khan MN, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0181-0; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; McCourt C, 2007, BIRTH-ISS PERINAT C, V34, P65, DOI 10.1111/j.1523-536X.2006.00147.x; McDonald Sarah D, 2010, BMJ, V341, pc3428, DOI 10.1136/bmj.c3428; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Nazir S., 2015, DETERMINANTS CESAREA; Neuman M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005982; Rahman M, 2014, IRAN J PUBLIC HEALTH, V43, P16; Rahman M, 2012, TROP J PHARM RES, V11, P823, DOI 10.4314/tjpr.v11i5.17; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; The DHS Program, WEALTH IND; Tromp M, 2010, J EPIDEMIOLOGY COMMU; UNICEF, TECHN NOT CALC AV AN; WHO, 2010, WOR HEALT REP, P1; WHO UNFPA UNICEF, 2009, MON EM OBST CAR HDB; Wilmink FA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.052; Witt WP, 2015, MATERN CHILD HLTH J, V19, P84, DOI 10.1007/s10995-014-1498-8; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104; Yoshioka-Maeda K, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0830-2	55	50	51	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177579	10.1371/journal.pone.0177579	http://dx.doi.org/10.1371/journal.pone.0177579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493956	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314300140
J	Narula, U; Ruiz, A; McQuaide, M; DeMarse, TB; Wheeler, BC; Brewer, GJ				Narula, Udit; Ruiz, Andres; McQuaide, McKinley; DeMarse, Thomas B.; Wheeler, Bruce C.; Brewer, Gregory J.			Narrow microtunnel technology for the isolation and precise identification of axonal communication among distinct hippocampal subregion networks	PLOS ONE			English	Article							IN-VITRO; NERVE-FIBERS; NEURONS; CULTURE; PLATFORM; DEVICE	Communication between different sub regions of the hippocampus is fundamental to learning and memory. However accurate knowledge about information transfer between sub regions from access to the activity in individual axons is lacking. MEMS devices with micro-tunnels connecting two sub networks have begun to approach this problem but the commonly used 10 mu m wide tunnels frequently measure signals from multiple axons. To reduce this complexity, we compared polydimethylsiloxane (PDMS) microtunnel devices each with a separate tunnel width of 2.5, 5 or 10 mu m bridging two wells aligned over a multi electrode array (MEA). Primary rat neurons were grown in the chambers with neurons from the dentate gyrus on one side and hippocampal CA3 on the other. After 2-3 weeks of culture, spontaneous activity in the axons inside the tunnels was recorded. We report electrophysiological, exploratory data analysis for feature clustering and visual evidence to support the expectation that 2.5 mu m wide tunnels have fewer axons per tunnel and therefore more clearly delineated signals than 10 or 5 mu m wide tunnels. Several measures indicated that fewer axons per electrode enabled more accurate detection of spikes. A clustering analysis comparing the variations of spike height and width for different tunnel widths revealed tighter clusters representing unique spikes with less height and width variation when measured in narrow tunnels. Wider tunnels tended toward more diffuse clusters from a continuum of spike heights and widths. Standard deviations for multiple cluster measures, such as Average Dissimilarity, Silhouette Value (S) and Separation Factor (average dissimilarity/S value), support a conclusion that 2.5 mu m wide tunnels containing fewer axons enable more precise determination of individual action potential peaks, their propagation direction, timing, and information transfer between sub networks.	[Narula, Udit; Ruiz, Andres; McQuaide, McKinley; Brewer, Gregory J.] Univ Calif Irvine, Biomed Engn, Irvine, CA USA; [DeMarse, Thomas B.; Wheeler, Bruce C.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA; [DeMarse, Thomas B.] Univ Florida, Dept Pediat Neurol, Gainesville, FL USA; [Wheeler, Bruce C.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Brewer, Gregory J.] Univ Calif Irvine, MIND Inst, Irvine, CA USA	University of California System; University of California Irvine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Diego; University of California System; University of California Irvine	Brewer, GJ (corresponding author), Univ Calif Irvine, Biomed Engn, Irvine, CA USA.; Brewer, GJ (corresponding author), Univ Calif Irvine, MIND Inst, Irvine, CA USA.	gjbrewer@uci.edu	Wheeler, Bruce C/G-1965-2011		NIH [R01 NS052233]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052233] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by NIH R01 NS052233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from NIH, R01 NS052233. We thank Brendon Cheng for initiating this project and designing the masks for the device molds. We thank Sheng-Po Fang (University of Florida) for manufacture of the SU-8 mold to create the PDMS devices.	Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Berdondini L, 2006, SENSOR ACTUAT B-CHEM, V114, P530, DOI 10.1016/j.snb.2005.04.042; Bhattacharya A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00045; Binczak S, 2001, PHYSICA D, V148, P159, DOI 10.1016/S0167-2789(00)00173-1; Bologna LL, 2010, NEURAL NETWORKS, V23, P685, DOI 10.1016/j.neunet.2010.05.002; Brewer GJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00165; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Claverol-Tinture E, 2007, IEEE T BIO-MED ENG, V54, P331, DOI 10.1109/TBME.2006.880903; Claverol-Tinture E, 2005, J NEURAL ENG, V2, pL1, DOI 10.1088/1741-2560/2/2/L01; Dworak BJ, 2009, LAB CHIP, V9, P404, DOI 10.1039/b806689b; Feinerman O, 2007, J NEUROPHYSIOL, V97, P2937, DOI 10.1152/jn.00958.2006; Ghosh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18428; Kanagasabapathi TT, 2013, J NEUROSCI METH, V214, P1, DOI 10.1016/j.jneumeth.2012.12.019; Katz B, 1940, J PHYSIOL-LONDON, V97, P471, DOI 10.1113/jphysiol.1940.sp003823; Pan LB, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00032; Pan LB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046031; Qiu C, 2015, J NEUROSCI, V35, P15800, DOI 10.1523/JNEUROSCI.1045-15.2015; Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Volman V, 2005, PHYS BIOL, V2, P98, DOI 10.1088/1478-3975/2/2/003; Wang L, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026010	24	12	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176868	10.1371/journal.pone.0176868	http://dx.doi.org/10.1371/journal.pone.0176868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493886	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314300034
J	Souris, M; Marcombe, S; Laforet, J; Brey, PT; Corbel, V; Overgaard, HJ				Souris, Marc; Marcombe, Sebastien; Laforet, Julie; Brey, Paul T.; Corbel, Vincent; Overgaard, Hans J.			Modeling spatial variation in risk of presence and insecticide resistance for malaria vectors in Laos	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; FOREST MALARIA; TRANSMISSION; DENSITIES; IMPACT; DIRUS	Climatic, sociological and environmental conditions are known to affect the spatial distribution of malaria vectors and disease transmission. Intensive use of insecticides in the agricultural and public health sectors exerts a strong selective pressure on resistance genes in malaria vectors. Spatio-temporal models of favorable conditions for Anopheles species' presence were developed to estimate the probability of presence of malaria vectors and insecticide resistance in Lao PDR. These models were based on environmental and meteorological conditions, and demographic factors. GIS software was used to build and manage a spatial database with data collected from various geographic information providers. GIS was also used to build and run the models. Results showed that potential insecticide use and therefore the probability of resistance to insecticide is greater in the southwestern part of the country, specifically in Champasack province and where malaria incidence is already known to be high. These findings can help national authorities to implement targeted and effective vector control strategies for malaria prevention and elimination among populations most at risk. Results can also be used to focus the insecticide resistance surveillance in Anopheles mosquito populations in more restricted area, reducing the area of surveys, and making the implementation of surveillance system for Anopheles mosquito insecticide resistance possible.	[Souris, Marc] EPV Aix Marseille Univ, IRD 190, IHU Mediterranee Infect, UMR Emergence Pathol Virales,Inserm 1207,EHESP, Marseille, France; [Souris, Marc] Asian Inst Technol, Remote Sensing & GIS FoS, Klongluang, Pathumthani, Thailand; [Marcombe, Sebastien; Brey, Paul T.] Inst Pasteur Laos, Viangchan, Laos; [Laforet, Julie] Univ Toulouse Le Mirail, Dept Geog & Amenagement UFR Sci Espaces Soc Univ, Toulouse, France; [Corbel, Vincent; Overgaard, Hans J.] UM1 CNRS 5290 IRD 224, MIVEGEC, UMR Malad Infect & Vecteurs Ecol Genet Evolut & C, Montpellier, France; [Overgaard, Hans J.] Kasetsart Univ, Dept Entomol, Fac Agr, Bangkok, Thailand; [Overgaard, Hans J.] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Asian Institute of Technology; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Kasetsart University; Norwegian University of Life Sciences	Souris, M (corresponding author), EPV Aix Marseille Univ, IRD 190, IHU Mediterranee Infect, UMR Emergence Pathol Virales,Inserm 1207,EHESP, Marseille, France.; Souris, M (corresponding author), Asian Inst Technol, Remote Sensing & GIS FoS, Klongluang, Pathumthani, Thailand.	marc.souris@ird.fr	Overgaard, Hans/AAE-9972-2020	corbel, vincent/0000-0003-0995-3257	French Ministry of Foreign Affaires 5% PC Initiative; MALVEC program	French Ministry of Foreign Affaires 5% PC Initiative; MALVEC program	This project was funded by the French Ministry of Foreign Affaires 5% PC Initiative, as part of the MALVEC program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 2015, WHO MAL REP; [Anonymous], SE ASIAN J TROP MED; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Charoenpanyanet A, 2010, THESIS; Damos P, 2012, PSYCHE; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Food and Agriculture Organization (FAO), 2005, P AS REG WORKSH IMPL; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HAYES RO, 1985, B WORLD HEALTH ORGAN, V63, P361; Heong KL, 2002, AGR ECOSYST ENVIRON, V92, P137, DOI 10.1016/S0167-8809(01)00304-8; Hightower AW, 1998, AM J TROP MED HYG, V58, P266, DOI 10.4269/ajtmh.1998.58.266; Jorgensen P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-59; Keating Joseph, 2004, Int J Health Geogr, V3, P9, DOI 10.1186/1476-072X-3-9; Kerns T., 2008, ANAL HOSPITALISED MO; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Messerli Peter, 2008, GEOGRAPHY POVERTY IN; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558; Morgan K, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P327, DOI 10.5772/55709; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Obsomer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050475; Overgaard H., 2006, MALARIA MOSQUITO RES; Overgaard HJ, 2003, LANDSCAPE ECOL, V18, P605, DOI 10.1023/A:1026074910038; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Reid R, 1968, STUD I MED RES MALAY, V31, P1; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P183, DOI 10.4269/ajtmh.1982.31.183; Santos-Vega M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005155; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sithiprasasna Ratana, 2005, Int J Health Geogr, V4, P17, DOI 10.1186/1476-072X-4-17; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; SOURIS Marc, 2017, LAOS SAVGIS DAT; Srivastava A, 2001, CURR SCI INDIA, V80, P1129; Suwonkerd W, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P273, DOI 10.5772/56347; Tangena JAA, 2016, TRENDS PARASITOL, V32, P402, DOI 10.1016/j.pt.2016.01.009; Thomson MC, 1999, AM J TROP MED HYG, V61, P2, DOI 10.4269/ajtmh.1999.61.2; THOMSON R. C. MUIRHEAD, 1940, JOUR MALARIA INST INDIA, V3-4, P265; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; United Nations, 2013, MILL DEV GOALS PROGR; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450	47	9	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177274	10.1371/journal.pone.0177274	http://dx.doi.org/10.1371/journal.pone.0177274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494013	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314300081
J	Crawley, SE; Gordon, JR; Kowles, KA; Potter, MF; Haynes, KF				Crawley, Sydney E.; Gordon, Jennifer R.; Kowles, Katelyn A.; Potter, Michael F.; Haynes, Kenneth F.			Impact of sublethal exposure to a pyrethroid-neonicotinoid insecticide on mating, fecundity and development in the bed bug Cimex lectularius L. (Hemiptera: Cimicidae)	PLOS ONE			English	Article							FEEDING-BEHAVIOR; MOTH LEPIDOPTERA; SITOBION-AVENAE; PESTICIDES; RESISTANCE; REPRODUCTION; ARTHROPODS; NOCTUIDAE; GROWTH; APHID	Sublethal exposure to an insecticide may alter insect feeding, mating, oviposition, fecundity, development, and many other life history parameters. Such effects may have population-level consequences that are not apparent in traditional dose-mortality evaluations. Earlier, we found that a routinely used combination insecticide that includes a pyrethroid and a neonicotinoid (Temprid (R) SC) had deleterious effects on multiple bed bug (Cimex lectularius, L.) behaviors. Here, we demonstrate that sublethal exposure impacts physiology and reproduction as well. We report that sublethal exposure to Temprid SC has variable aberrant effects on bed bugs depending on the strain, including: a reduction in male mating success and delayed oviposition by females. However, after sublethal exposure, egg hatch rate consistently declined in every strain tested, anywhere from 34%-73%. Conversely, impact on fifth instar eclosion time was not significant. While the strains that we tested varied in their respective magnitude of sublethal effects, taken together, these effects could reduce bed bug population growth. These changes in bed bug behavior and fecundity could lead to improved efficacy of Temprid SC in the field, but recovery of impacted bugs must be considered in future studies. Sublethal effects should not be overlooked when evaluating insecticide efficacy, as it is likely that other products may also have indirect effects on population dynamics that could either aid or inhibit successful management of pest populations.	[Crawley, Sydney E.; Gordon, Jennifer R.; Kowles, Katelyn A.; Potter, Michael F.; Haynes, Kenneth F.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	University of Kentucky	Haynes, KF (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	khaynes@uky.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch [KY008066]	National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch	This work was supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch Project KY008066 (https.//nifausdagov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Scott Bessin for technical assistance. This is publication No. 17-08-023 of the Kentucky Agricultural Experiment Station and is published with the approval of the Director. This work is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch Project KY008066.	Ahmad S, 2013, INT J TROP INSECT SC, V33, P264, DOI 10.1017/S1742758413000246; Alinejad M, 2014, EXP APPL ACAROL, V64, P361, DOI 10.1007/s10493-014-9830-y; Analytical Software, 2013, STAT 10 0 WIND; Biddinger DJ, 1999, J ECON ENTOMOL, V92, P314, DOI 10.1093/jee/92.2.314; CLARK DC, 1992, ARCH INSECT BIOCHEM, V19, P105, DOI 10.1002/arch.940190204; Crawley SC, 2016, PEST MANAG SCI; Cresswell JE., 2006, ECOTOXICOLOGY, V20, P149; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Gordon JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10807; Gordon JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03836; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; He YX, 2013, INT J BIOL SCI, V9, P246, DOI 10.7150/ijbs.5762; Jones SC, 2015, J MED ENTOMOL, V52, P413, DOI 10.1093/jme/tjv008; Jones Susan C., 2013, Insects, V4, P230, DOI 10.3390/insects4020230; LINN CE, 1984, ARCH INSECT BIOCHEM, V1, P331, DOI 10.1002/arch.940010405; Lu YH, 2016, B ENTOMOL RES, V106, P551, DOI 10.1017/S0007485316000286; Maltby L, 1999, ECOL APPL, V9, P431, DOI 10.1890/1051-0761(1999)009[0431:SSTIOO]2.0.CO;2; MELLANBY KENNETH, 1939, PARASITOLOGY, V31, P193, DOI 10.1017/S0031182000012750; Miao J, 2014, PEST MANAG SCI, V70, P55, DOI 10.1002/ps.3523; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Pan HS, 2014, J PEST SCI, V87, P731, DOI 10.1007/s10340-014-0610-6; Potter MF., 2015, PESTWORLD        NOV, VNovember/December, P4; Potter MF, 2010, PEST CONTROL TECHNOL, V38, P70; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero A, 2016, J MED ENTOMOL, V53, P727, DOI 10.1093/jme/tjv253; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; Shi XB, 2011, PEST MANAG SCI, V67, P1528, DOI 10.1002/ps.2207; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Thompson HM, 2010, PEST MANAG SCI, V66, P1157, DOI 10.1002/ps.1994; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456	36	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177410	10.1371/journal.pone.0177410	http://dx.doi.org/10.1371/journal.pone.0177410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489937	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100072
